data_2lc1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lc1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.438 -1.052 0 N-CA-C 109.334 -0.617 . . . . 73.140000000000001 109.334 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.418 ' HB3' ' OE1' ' A' ' 22' ' ' GLN . 11.4 m -102.56 115.48 30.66 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.751 -0.833 . . . . 74.519999999999996 108.751 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.4 110.27 25.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.175 -0.676 . . . . 72.299999999999997 109.175 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.57 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 11.7 m -106.14 126.09 51.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.227 -0.897 . . . . 72.519999999999996 108.605 -177.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' THR . 46.2 mt -93.05 115.04 27.73 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.858 -1.164 . . . . 61.119999999999997 107.858 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -92.16 114.36 26.89 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.232 -1.025 . . . . 74.420000000000002 108.232 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -113.26 130.68 56.17 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.852 -0.613 . . . . 74.230000000000004 110.27 -171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.73 99.96 12.76 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.11 -1.07 . . . . 63.329999999999998 108.11 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.68 -13.47 31.7 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.114 -1.403 . . . . 75.510000000000005 108.019 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.74 -37.86 1.82 Allowed Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 108.392 -1.883 . . . . 74.140000000000001 108.392 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -100.52 -53.19 3.16 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.3 0.571 . . . . 54.109999999999999 110.075 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.33 89.19 0.89 Allowed Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 109.152 -1.579 . . . . 61.140000000000001 109.152 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.282 -0.636 . . . . 73.420000000000002 109.282 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.7 p -130.57 138.76 50.32 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.861 0.362 . . . . 75.420000000000002 110.853 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -132.79 124.65 28.44 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.638 -1.245 . . . . 74.209999999999994 107.638 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.418 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 25.9 tt0 -92.55 139.96 30.05 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.735 -0.786 . . . . 72.340000000000003 108.963 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.14 133.9 52.57 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.416 0.447 . . . . 73.430000000000007 111.548 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.08 156.03 21.25 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.706 -1.59 . . . . 74.319999999999993 106.706 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.18 116.59 17.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.521 0.677 . . . . 73.109999999999999 109.178 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.43 23.07 Favored Glycine 0 C--N 1.289 -2.062 0 N-CA-C 106.792 -2.523 . . . . 73.439999999999998 106.792 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 45.9 p -105.45 131.28 53.07 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 119.431 1.615 . . . . 72.109999999999999 112.004 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -103.2 110.29 22.19 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.458 -1.312 . . . . 71.319999999999993 107.458 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -95.64 121.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.411 -0.359 . . . . 75.099999999999994 110.262 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.6 mt -105.98 130.17 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 123.947 0.899 . . . . 73.340000000000003 109.808 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.03 -174.37 40.15 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 110.97 -0.852 . . . . 50.439999999999998 110.97 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 42' ' ' ASP . 25.0 mtp180 -107.21 104.94 14.69 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.608 -0.837 . . . . 74.019999999999996 109.448 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.67 169.28 37.14 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.198 -1.161 . . . . 64.439999999999998 110.198 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.62 -14.24 56.97 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.502 -1.295 . . . . 75.219999999999999 107.502 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.91 -4.56 59.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.138 -1.846 . . . . 71.430000000000007 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 47' ' ' ARG . . . -109.35 147.56 32.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.978 -1.01 . . . . 73.409999999999997 109.375 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -93.68 -32.84 13.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.385 0.612 . . . . 74.129999999999995 110.988 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -118.82 124.96 48.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.919 -1.511 . . . . 74.439999999999998 106.919 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -105.76 130.73 53.7 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.781 0.324 . . . . 74.049999999999997 111.747 -174.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.8 mt -85.8 145.91 42.44 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 74.219999999999999 112.238 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.18 -33.57 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.261 2.641 . . . . 74.340000000000003 114.598 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.46 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 5.3 t70 -93.25 179.95 5.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.577 -0.898 . . . . 75.430000000000007 108.577 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.4 t -118.68 171.04 8.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.116 0.484 . . . . 63.43 110.262 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.46 61.15 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 108.937 -1.665 . . . . 74.25 108.937 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.42 129.55 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 CA-C-N 113.281 -1.46 . . . . 71.219999999999999 107.834 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -77.11 171.9 14.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.849 -0.426 . . . . 73.030000000000001 109.849 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 16.9 ptt180 -58.2 -46.56 85.61 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-O 121.593 0.711 . . . . 75.430000000000007 109.792 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.432 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 37.3 mtp180 -119.12 95.9 5.0 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 104.42 -2.437 . . . . 75.519999999999996 104.42 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -98.22 -32.05 11.77 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.198 -0.91 . . . . 74.219999999999999 108.91 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -163.87 145.39 9.0 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.816 -0.809 . . . . 74.040000000000006 108.816 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -137.84 143.61 41.05 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.02 0.438 . . . . 72.450000000000003 110.447 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 65.8 mt -125.42 116.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.71 -0.677 . . . . 73.439999999999998 109.783 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 58.0 ttp180 -91.39 113.63 25.94 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.805 -1.183 . . . . 71.549999999999997 107.805 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 -102.22 125.32 48.89 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 116.002 -0.545 . . . . 71.510000000000005 110.126 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -133.38 168.89 17.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.195 -1.409 . . . . 72.230000000000004 107.195 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.64 58.53 2.09 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 114.968 0.747 . . . . 63.439999999999998 114.968 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -170.73 -68.12 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.905 0.882 . . . . 73.519999999999996 108.974 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.85 156.83 42.91 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 CA-C-O 121.259 0.552 . . . . 74.109999999999999 111.52 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.2 114.62 28.93 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.088 -0.96 . . . . 51.450000000000003 109.442 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.4 tt -80.91 113.77 19.34 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.755 -1.111 . . . . 75.400000000000006 109.241 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.39 120.82 40.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.291 -1.003 . . . . 75.150000000000006 108.291 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.02 121.16 30.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.307 -0.257 . . . . 63.539999999999999 110.307 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -87.98 124.44 33.72 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.687 -0.857 . . . . 71.099999999999994 108.687 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.99 76.28 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 176.34 153.05 0.18 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.636 -1.987 . . . . 71.409999999999997 105.636 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.9 m -110.19 -53.44 2.68 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.237 0.829 . . . . 74.340000000000003 113.237 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 t -71.74 -38.57 70.42 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.567 0.58 . . . . 75.219999999999999 112.567 -172.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -116.89 23.74 11.71 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.318 -1.364 . . . . 75.430000000000007 107.318 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 163.43 19.65 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 113.41 -1.723 . . . . 71.040000000000006 113.864 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 m -84.74 143.86 28.88 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 123.894 0.877 . . . . 73.219999999999999 111.899 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 p -112.0 141.1 46.07 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.517 -0.765 . . . . 75.349999999999994 110.285 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.3 m -114.11 120.86 65.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.822 -1.547 . . . . 74.319999999999993 106.822 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.417 HD21 ' CG ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 61.83 24.34 14.47 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.236 1.014 . . . . 70.349999999999994 109.83 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 79.59 5.34 2.05 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.534 1.533 . . . . 75.150000000000006 112.513 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.65 30.82 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.953 -0.388 . . . . 72.109999999999999 109.953 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.26 127.84 14.75 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.382 2.055 . . . . 74.209999999999994 111.737 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.89 166.75 14.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.734 -0.839 . . . . 65.129999999999995 108.734 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -106.07 -31.91 8.51 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.973 -1.121 . . . . 73.140000000000001 107.973 174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.08 35.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.99 -1.459 . . . . 74.310000000000002 110.338 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -153.67 153.03 31.51 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.535 -0.913 . . . . 75.140000000000001 108.535 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -114.58 126.25 54.7 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.209 -1.034 . . . . 74.219999999999999 108.209 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.1 mt -56.88 147.55 23.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.032 1.123 . . . . 75.340000000000003 114.032 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 147.96 39.52 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.005 -1.109 . . . . 74.439999999999998 108.005 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 28.9 t70 -65.39 124.89 23.46 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 71.030000000000001 110.862 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.87 64.43 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 115.22 -0.9 . . . . 70.049999999999997 112.992 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' CG ' HD21 ' A' ' 73' ' ' ASN . 2.6 t70 -83.23 156.88 22.92 Favored 'General case' 0 C--O 1.249 1.071 0 C-N-CA 119.505 -0.878 . . . . 64.25 108.717 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.08 113.23 43.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.361 -0.607 . . . . 74.409999999999997 109.361 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.2 mt -110.06 117.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.097 -0.705 . . . . 73.549999999999997 109.097 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -120.52 123.64 43.41 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.448 -0.501 . . . . 62.329999999999998 111.263 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 163.43 23.03 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.24 -0.891 . . . . 73.549999999999997 108.959 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -42.12 103.89 0.04 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 115.598 0.999 . . . . 64.219999999999999 115.598 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 m170 69.25 12.09 8.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.602 1.561 . . . . 74.030000000000001 113.503 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.7 m -149.21 115.37 5.76 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.334 0.588 . . . . 71.109999999999999 111.075 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.95 143.32 43.13 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.178 0.513 . . . . 75.129999999999995 111.243 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.28 142.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.215 -0.902 . . . . 73.450000000000003 111.387 -171.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.7 mm -111.41 132.81 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.0 -1.111 . . . . 74.340000000000003 108.0 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.55 126.86 43.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 120.846 0.355 . . . . 74.140000000000001 111.453 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.15 125.97 52.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.755 -0.832 . . . . 75.030000000000001 108.755 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 84.3 mtp -114.35 116.5 29.04 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.852 -0.796 . . . . 75.439999999999998 108.852 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.57 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 48.2 m-70 . . . . . 0 C--N 1.28 -2.438 0 N-CA-C 107.463 -1.31 . . . . 75.140000000000001 107.463 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.505 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 84.8 m . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 108.07 -1.085 . . . . 75.209999999999994 108.07 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -123.63 125.03 44.09 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.986 -0.746 . . . . 65.329999999999998 108.986 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.5 124.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.268 -1.012 . . . . 74.439999999999998 108.268 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.421 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.7 m -117.2 124.71 49.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.939 -0.763 . . . . 72.109999999999999 108.939 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 mt -90.88 124.9 35.54 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.231 -1.025 . . . . 75.420000000000002 108.231 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -107.82 120.12 41.36 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.821 -0.807 . . . . 74.099999999999994 108.821 -177.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -114.27 125.83 54.34 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.307 -0.998 . . . . 74.450000000000003 108.307 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.92 100.12 10.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 118.959 -1.096 . . . . 73.540000000000006 108.083 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.92 38.59 2.23 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 113.418 -1.719 . . . . 62.439999999999998 107.961 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.03 -54.81 0.64 Allowed Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.392 -1.083 . . . . 63.020000000000003 110.392 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 t -111.83 -56.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.711 -1.218 . . . . 74.219999999999999 107.711 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.79 109.83 0.47 Allowed Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.516 -0.849 . . . . 74.129999999999995 112.712 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -95.9 141.37 29.41 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.502 -0.925 . . . . 73.409999999999997 108.502 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.2 p -128.74 135.01 48.63 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.56 -0.456 . . . . 75.209999999999994 111.502 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -121.03 110.96 16.88 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.579 -0.897 . . . . 73.319999999999993 108.579 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -78.79 129.3 34.46 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.847 -0.797 . . . . 75.540000000000006 108.847 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.35 125.56 29.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.704 -0.851 . . . . 70.340000000000003 108.704 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -100.78 170.49 8.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.375 -0.602 . . . . 71.319999999999993 109.375 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.32 134.84 57.45 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.348 1.03 . . . . 62.420000000000002 111.594 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.52 -175.62 15.87 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 109.165 -1.574 . . . . 72.239999999999995 109.165 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 57.4 p -96.1 137.48 35.11 Favored 'General case' 0 N--CA 1.415 -2.176 0 C-N-CA 119.47 -0.892 . . . . 73.140000000000001 110.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -114.46 111.74 21.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.457 -0.942 . . . . 62.310000000000002 108.457 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.77 124.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.089 -1.078 . . . . 74.349999999999994 108.089 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -109.01 129.76 63.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 123.435 0.459 . . . . 64.329999999999998 109.791 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.26 -163.39 29.5 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.161 -1.576 . . . . 75.109999999999999 109.161 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.53 ' C ' ' HA ' ' A' ' 47' ' ' ARG . 52.1 mtm180 -126.34 105.86 9.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 119.105 1.453 . . . . 71.150000000000006 112.364 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.27 -178.52 42.52 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 107.129 -2.388 . . . . 64.109999999999999 107.129 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -74.96 -11.43 60.11 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.085 0.945 . . . . 75.040000000000006 110.333 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.55 -23.03 29.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.918 -1.037 . . . . 75.049999999999997 109.304 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.31 130.99 35.57 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.819 0.819 . . . . 51.420000000000002 113.037 -171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.24 -26.02 22.56 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.832 -1.076 . . . . 71.349999999999994 108.85 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -131.85 115.68 16.24 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.204 -1.036 . . . . 72.230000000000004 108.204 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -95.93 112.12 23.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.983 -0.553 . . . . 61.420000000000002 111.06 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 44.8 mt -71.63 128.99 89.09 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 110.266 -0.272 . . . . 65.109999999999999 110.266 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -73.61 40.19 0.53 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.203 2.602 . . . . 75.230000000000004 113.839 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.0 152.67 29.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.929 -0.767 . . . . 72.450000000000003 108.929 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.4 m -97.16 118.32 33.32 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.59 -0.522 . . . . 73.510000000000005 109.59 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.07 -13.43 21.77 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.521 -0.847 . . . . 70.340000000000003 112.448 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.36 122.28 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.429 0.633 . . . . 74.129999999999995 109.361 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -65.19 164.14 13.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.008 -0.997 . . . . 73.420000000000002 112.176 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.53 ' HA ' ' C ' ' A' ' 32' ' ' ARG . 48.1 mtp180 -54.41 -49.29 70.26 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.829 0.852 . . . . 75.340000000000003 109.926 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -120.6 101.97 8.11 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 106.087 -1.819 . . . . 61.439999999999998 106.087 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -104.05 -32.49 9.18 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.473 0.654 . . . . 75.420000000000002 109.402 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -162.68 149.93 13.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.74 -0.837 . . . . 72.349999999999994 108.74 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.29 138.22 50.37 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.202 0.525 . . . . 71.230000000000004 110.269 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.4 mt -119.15 116.22 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.12 -0.696 . . . . 75.129999999999995 109.12 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 5.5 tmm_? -93.7 107.23 19.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.616 -1.624 . . . . 73.540000000000006 106.616 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.404 ' HZ2' ' O ' ' A' ' 7' ' ' THR . 50.8 t-105 -110.82 146.6 36.14 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.945 -1.025 . . . . 75.099999999999994 109.559 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -149.78 165.23 33.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 103.929 -2.619 . . . . 64.109999999999999 103.929 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.67 37.01 0.86 Allowed Glycine 0 C--N 1.305 -1.148 0 CA-C-N 119.133 0.879 . . . . 71.340000000000003 114.679 -175.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -137.4 -71.15 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 124.034 0.934 . . . . 75.209999999999994 109.903 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -130.81 159.32 42.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.53 -0.304 . . . . 75.340000000000003 110.692 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.54 116.68 31.26 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.763 -0.653 . . . . 75.329999999999998 110.289 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.8 116.7 32.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.098 -0.704 . . . . 72.209999999999994 109.098 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.3 tt -104.81 142.6 34.44 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.332 -0.394 . . . . 74.150000000000006 110.537 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.14 127.62 26.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.817 -0.629 . . . . 64.540000000000006 109.676 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -83.0 140.42 32.74 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.644 -0.707 . . . . 73.140000000000001 109.226 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.26 77.44 1.73 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.035 -1.098 . . . . 75.030000000000001 108.035 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -178.1 121.21 0.1 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.438 -0.578 . . . . 75.230000000000004 109.438 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -88.75 -20.1 25.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.137 0.494 . . . . 72.120000000000005 110.447 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -89.33 -52.44 5.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.42 0.629 . . . . 75.530000000000001 111.382 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -111.21 28.75 8.43 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.7 -0.682 . . . . 75.239999999999995 110.194 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.06 129.98 5.5 Favored Glycine 0 N--CA 1.47 0.939 0 O-C-N 124.574 1.171 . . . . 62.509999999999998 114.933 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 m -74.94 152.09 38.83 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 124.733 1.213 . . . . 70.329999999999998 113.044 -172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.6 p -119.3 144.66 46.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.121 -0.945 . . . . 73.420000000000002 110.107 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.36 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.039 -1.097 . . . . 74.510000000000005 108.039 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 61.14 25.93 15.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.81 0.814 . . . . 64.129999999999995 109.666 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 85.54 -4.57 0.85 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.82 2.048 . . . . 74.420000000000002 113.855 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -89.61 124.39 64.24 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.864 -0.421 . . . . 63.210000000000001 109.864 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.15 125.5 12.55 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.76 2.307 . . . . 71.430000000000007 111.81 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -139.02 166.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.384 -0.371 . . . . 75.25 110.64 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -105.74 -14.48 15.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.71 -0.848 . . . . 74.340000000000003 108.71 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -161.78 155.63 21.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.118 -1.067 . . . . 73.329999999999998 108.118 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -161.34 143.41 11.96 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.349 0.405 . . . . 74.099999999999994 109.909 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.23 111.79 23.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.119 -1.067 . . . . 72.019999999999996 108.119 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.46 135.95 54.13 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.902 0.705 . . . . 65.530000000000001 112.902 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.0 164.66 19.67 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.079 -1.082 . . . . 64.140000000000001 108.079 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.49 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 28.8 t70 -71.95 124.36 24.74 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.456 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.91 13.21 56.87 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.743 -0.662 . . . . 74.519999999999996 113.091 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.67 137.45 42.18 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 117.628 0.714 . . . . 61.119999999999997 111.714 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.1 112.16 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.276 -1.379 . . . . 74.099999999999994 107.276 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.5 mt -111.6 106.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 C-N-CA 119.322 -0.951 . . . . 75.239999999999995 109.44 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -104.26 131.89 51.09 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.635 -0.711 . . . . 73.510000000000005 109.678 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.18 164.5 20.14 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.412 -0.959 . . . . 75.310000000000002 108.412 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.26 125.82 25.9 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.995 -1.098 . . . . 75.329999999999998 110.532 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m170 83.1 -23.6 0.2 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.217 1.562 . . . . 73.219999999999999 115.217 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -153.21 -171.75 4.02 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.643 1.111 . . . . 74.219999999999999 111.999 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.66 147.58 30.14 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.988 -0.745 . . . . 74.409999999999997 108.988 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.6 tp -130.41 135.58 60.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.005 -1.109 . . . . 74.310000000000002 108.005 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 53.4 mt -101.0 132.09 47.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.698 -0.852 . . . . 74.420000000000002 108.698 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.5 t -100.26 116.35 43.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.446 0.641 . . . . 74.439999999999998 111.158 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.49 ' HD3' ' OD1' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -115.63 125.87 53.45 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.415 -1.328 . . . . 70.219999999999999 107.415 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.5 mtm -112.52 111.74 22.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.229 -0.988 . . . . 50.329999999999998 110.547 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.505 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 21.1 m-70 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 108.012 -1.107 . . . . 72.409999999999997 108.012 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.439 -1.01 0 CA-C-O 121.305 0.574 . . . . 73.209999999999994 109.621 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m -107.65 117.28 33.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 115.746 -0.661 . . . . 71.140000000000001 109.644 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -91.29 114.86 29.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 106.726 -1.583 . . . . 73.439999999999998 106.726 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -110.61 124.07 51.18 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.037 -0.727 . . . . 72.120000000000005 109.037 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.44 128.92 42.68 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.44 -0.578 . . . . 74.25 109.44 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -105.39 119.59 39.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.559 -0.904 . . . . 75.519999999999996 108.559 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -102.39 120.15 40.01 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 123.755 0.822 . . . . 71.340000000000003 108.934 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -100.17 100.99 11.91 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.659 -1.216 . . . . 73.400000000000006 110.153 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -103.53 5.03 36.49 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 112.99 -1.914 . . . . 65.140000000000001 108.502 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.16 -19.81 31.71 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.475 -1.45 . . . . 74.120000000000005 109.475 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -103.5 -53.5 2.78 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.226 -1.028 . . . . 73.420000000000002 108.226 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.34 83.03 1.69 Allowed Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.396 -0.82 . . . . 63.420000000000002 111.698 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.402 ' NE ' ' HA ' ' A' ' 19' ' ' ARG . 4.5 mmp_? -100.37 163.81 12.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.724 -0.28 . . . . 75.299999999999997 110.273 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 p -135.61 152.24 51.05 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.741 0.305 . . . . 64.230000000000004 110.983 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -142.24 132.51 24.87 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.357 -0.979 . . . . 72.439999999999998 108.357 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.08 125.03 33.15 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.363 -0.606 . . . . 74.040000000000006 109.363 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.28 127.64 33.25 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.165 -0.679 . . . . 72.540000000000006 109.165 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.78 168.6 10.56 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.568 -0.742 . . . . 75.439999999999998 109.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.94 131.5 40.73 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.674 0.749 . . . . 75.510000000000005 111.423 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.66 -173.79 15.05 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 108.382 -1.887 . . . . 73.150000000000006 108.382 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.3 p -106.81 142.77 35.91 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 118.549 1.174 . . . . 65.230000000000004 111.856 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 7.5 p30 -117.8 140.77 49.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.339 -0.615 . . . . 74.310000000000002 109.339 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.86 124.14 53.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.613 -0.884 . . . . 74.430000000000007 108.613 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.6 mt -106.91 120.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 124.477 1.111 . . . . 74.540000000000006 110.147 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.63 -176.43 35.54 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.547 -1.421 . . . . 51.240000000000002 109.547 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 61.6 mtt180 -103.99 107.12 17.86 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 118.35 1.075 . . . . 74.329999999999998 111.418 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.38 -172.42 38.85 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 110.444 -1.062 . . . . 72.230000000000004 110.444 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -29.26 15.11 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 122.959 0.504 . . . . 73.439999999999998 110.823 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -82.14 -19.73 39.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 137.69 54.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.048 -0.978 . . . . 75.420000000000002 109.566 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 28' ' ' ASN . 49.8 mt-30 -97.89 -24.51 15.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.483 0.659 . . . . 70.019999999999996 110.318 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -131.14 124.26 30.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.373 -1.343 . . . . 71.420000000000002 107.373 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 134.25 55.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.406 -0.361 . . . . 74.519999999999996 110.93 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.7 147.56 86.85 Favored Pre-proline 0 CA--C 1.502 -0.898 0 CA-C-N 115.604 -0.725 . . . . 74.430000000000007 111.807 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.13 26.37 0.61 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 123.584 2.856 . . . . 74.120000000000005 113.267 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -137.72 176.4 8.74 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.697 -0.853 . . . . 73.510000000000005 108.697 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -105.28 170.66 7.75 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.374 -0.602 . . . . 74.530000000000001 109.374 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 2.69 79.75 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.925 -0.47 . . . . 71.319999999999993 111.925 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.4 t -95.13 133.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.989 -0.745 . . . . 74.5 108.989 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -72.39 176.34 5.41 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.122 0.569 . . . . 74.519999999999996 109.653 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.0 ptm180 -66.09 -34.92 79.16 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.379 0.609 . . . . 74.319999999999993 110.359 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.51 109.65 12.94 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.791 -1.188 . . . . 72.409999999999997 107.791 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -103.99 -34.16 8.56 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.854 -0.612 . . . . 75.219999999999999 109.501 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 tt -165.88 160.03 16.48 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.301 -1.0 . . . . 73.430000000000007 108.301 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.8 138.52 32.3 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 109.781 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.19 115.19 49.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 109.202 -0.666 . . . . 72.120000000000005 109.202 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -97.2 107.79 20.38 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 108.817 -0.809 . . . . 74.340000000000003 108.817 174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -97.48 107.24 19.7 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.1 171.35 8.07 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.006 -1.85 . . . . 74.540000000000006 106.006 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.14 49.58 4.14 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 119.817 -1.182 . . . . 62.009999999999998 114.003 -174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -171.66 -64.04 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.871 0.868 . . . . 74.25 109.178 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.32 149.67 17.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 CA-C-O 121.323 0.582 . . . . 73.400000000000006 112.15 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.75 103.18 14.81 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.275 -0.875 . . . . 65.310000000000002 109.347 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.24 113.49 21.15 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.362 -0.836 . . . . 75.310000000000002 109.162 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.8 tm? -100.52 120.32 39.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.145 -1.057 . . . . 73.5 108.145 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.89 126.68 43.7 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.875 -0.417 . . . . 74.450000000000003 109.875 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 11.3 t70 -97.25 139.17 33.62 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 122.848 0.459 . . . . 75.310000000000002 110.722 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.11 75.91 1.26 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.431 -0.952 . . . . 65.299999999999997 108.431 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.55 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 33.3 t-20 -166.46 154.04 9.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.57 -1.27 . . . . 73.450000000000003 107.57 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.4 t -108.92 -48.71 3.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.989 0.423 . . . . 70.040000000000006 110.341 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -89.33 -35.91 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.648 0.611 . . . . 71.319999999999993 112.648 -175.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.55 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.2 m120 -105.39 27.06 8.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.537 -0.542 . . . . 63.140000000000001 109.537 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.79 128.46 20.78 Favored Glycine 0 C--O 1.251 1.158 0 O-C-N 124.894 1.371 . . . . 51.109999999999999 112.264 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -62.01 133.04 54.83 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 124.124 0.969 . . . . 74.140000000000001 112.54 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.0 p -103.42 140.08 37.94 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.513 -0.767 . . . . 74.400000000000006 109.459 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.26 119.58 56.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.937 -1.134 . . . . 75.349999999999994 107.937 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.26 30.97 20.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.404 0.682 . . . . 72.140000000000001 110.54 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 t30 82.09 -1.53 1.49 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.738 2.015 . . . . 65.319999999999993 112.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.98 124.19 44.52 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 121.487 -0.758 . . . . 75.150000000000006 109.431 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.14 124.3 4.83 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.765 1.643 . . . . 72.150000000000006 110.441 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.2 m -148.68 151.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 74.340000000000003 107.432 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 77.1 mt-30 -96.69 -0.46 48.31 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.957 -0.697 . . . . 72.540000000000006 111.327 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.54 130.12 15.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.794 -0.639 . . . . 71.310000000000002 110.119 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.402 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 69.2 t-105 -159.89 152.97 21.82 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.588 -1.264 . . . . 73.230000000000004 107.588 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.89 124.4 50.59 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.967 -1.093 . . . . 75.340000000000003 108.115 173.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 97' ' ' VAL . 69.0 mt -65.1 139.4 58.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.949 0.722 . . . . 71.430000000000007 112.949 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -135.65 168.5 19.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.059 -0.719 . . . . 73.340000000000003 109.059 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.48 121.09 19.03 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.917 -0.401 . . . . 74.400000000000006 109.917 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.2 9.84 40.85 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.905 -0.664 . . . . 53.5 112.698 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -78.38 126.26 30.52 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 120.008 -0.677 . . . . 71.439999999999998 110.005 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.67 112.31 26.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.22 -1.4 . . . . 75.230000000000004 107.22 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.4 mt -120.01 139.28 47.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 120.291 -0.564 . . . . 75.219999999999999 110.861 -172.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.623 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.0 mpt_? -120.37 131.24 54.75 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.138 -1.06 . . . . 74.450000000000003 108.138 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -131.73 164.52 25.79 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.336 -0.987 . . . . 74.150000000000006 108.336 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -33.55 97.07 0.01 OUTLIER Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.002 1.161 . . . . 75.5 116.002 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.0 m170 72.07 13.95 5.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.698 1.599 . . . . 72.450000000000003 114.801 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t -153.62 -178.3 6.93 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.31 0.576 . . . . 75.099999999999994 110.178 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.74 153.08 45.75 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.762 -0.586 . . . . 73.519999999999996 109.448 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -141.45 141.37 30.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.762 -0.829 . . . . 74.019999999999996 108.762 -175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.73 125.69 72.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.469 -0.937 . . . . 65.409999999999997 108.469 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 82' ' ' LEU . 79.4 t -93.26 128.67 44.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 111.938 0.348 . . . . 62.439999999999998 111.938 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -119.16 151.26 38.63 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.767 -0.827 . . . . 75.209999999999994 108.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 89.2 mtp -128.34 120.01 26.19 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.314 -0.403 . . . . 73.329999999999998 110.262 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 . . . . . 0 C--N 1.294 -1.842 0 N-CA-C 108.333 -0.988 . . . . 72.140000000000001 108.333 -179.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m . . . . . 0 N--CA 1.415 -2.216 0 N-CA-C 108.56 -0.904 . . . . 73.400000000000006 108.56 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 99' ' ' MET . 54.0 p -158.43 143.98 16.69 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.337 -1.727 . . . . 75.310000000000002 106.337 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.82 126.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 120.159 -0.617 . . . . 75.349999999999994 111.226 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 25.3 m -120.77 132.07 54.84 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.984 -1.117 . . . . 72.319999999999993 107.984 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.12 135.76 33.72 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.68 -0.489 . . . . 74.239999999999995 109.68 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -116.57 124.86 50.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.726 -0.67 . . . . 71.200000000000003 111.19 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.6 133.66 48.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.137 -1.061 . . . . 74.450000000000003 108.137 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.96 101.71 7.72 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.04 -1.064 . . . . 64.329999999999998 112.592 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.04 -47.53 68.13 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.661 -1.607 . . . . 73.420000000000002 106.661 171.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.29 45.69 0.01 OUTLIER Glycine 0 N--CA 1.427 -1.9 0 N-CA-C 105.979 -2.848 . . . . 54.200000000000003 105.979 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -162.5 -52.79 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.193 -1.039 . . . . 73.019999999999996 108.193 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.12 92.37 2.14 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.691 -0.766 . . . . 70.409999999999997 111.93 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -99.13 150.24 22.23 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.31 -0.996 . . . . 74.099999999999994 108.31 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 35.8 p -142.94 132.25 23.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.663 0.602 . . . . 75.400000000000006 109.859 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -134.54 135.26 42.19 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.505 -1.665 . . . . 74.150000000000006 106.505 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 33.5 tt0 -101.71 144.31 30.57 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.093 -0.643 . . . . 74.0 111.156 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.88 139.23 38.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.715 -0.675 . . . . 74.040000000000006 110.359 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -95.29 157.86 15.71 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.347 -1.353 . . . . 75.340000000000003 107.347 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.5 146.03 55.2 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.182 0.515 . . . . 73.340000000000003 111.576 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.43 -171.44 15.81 Favored Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 107.723 -2.151 . . . . 75.150000000000006 107.723 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 67.1 p -96.63 127.46 42.63 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.638 -1.225 . . . . 71.549999999999997 111.084 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.476 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -103.57 113.58 27.19 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.389 -1.708 . . . . 73.420000000000002 106.389 -178.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -89.83 132.3 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.964 -0.562 . . . . 72.510000000000005 109.694 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -116.07 132.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.684 -0.689 . . . . 74.349999999999994 109.859 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 158.4 -162.23 32.23 Favored Glycine 0 CA--C 1.495 -1.162 0 N-CA-C 108.611 -1.796 . . . . 34.240000000000002 108.611 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -122.17 103.69 8.96 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.008 -1.479 . . . . 71.430000000000007 107.008 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.535 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 174.84 176.16 42.92 Favored Glycine 0 N--CA 1.414 -2.828 0 N-CA-C 110.935 -0.866 . . . . 70.439999999999998 110.935 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -52.1 -40.36 61.15 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.751 1.22 . . . . 75.340000000000003 113.373 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.68 -37.07 73.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.491 . . . . 74.230000000000004 111.453 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.78 15.9 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.357 -0.838 . . . . 72.219999999999999 112.795 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -75.35 -36.15 61.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.434 -0.95 . . . . 64.340000000000003 108.434 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -105.45 108.87 20.62 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.536 -0.913 . . . . 65.230000000000004 108.536 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.6 mmt85 -87.66 121.35 29.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.152 -0.931 . . . . 73.230000000000004 109.455 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.19 130.53 68.94 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.362 -0.607 . . . . 75.420000000000002 109.362 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.02 -1.91 9.48 Favored 'Trans proline' 0 C--N 1.325 -0.696 0 C-N-CA 122.013 1.808 . . . . 62.020000000000003 111.049 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -88.67 -176.65 5.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.937 -1.029 . . . . 73.129999999999995 111.234 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.0 t -123.21 170.89 9.79 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.694 -0.484 . . . . 74.319999999999993 109.694 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.03 71.79 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.57 -1.412 . . . . 75.319999999999993 109.57 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.85 144.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.295 -0.952 . . . . 74.109999999999999 111.0 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.5 p -91.84 -167.68 1.84 Allowed 'General case' 0 C--O 1.254 1.292 0 C-N-CA 124.137 0.975 . . . . 74.430000000000007 109.499 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.535 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 5.6 ptt180 -80.84 -34.29 33.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 118.247 -1.381 . . . . 74.400000000000006 109.287 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -124.04 100.7 6.86 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.412 -1.699 . . . . 75.420000000000002 106.412 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -100.81 -34.37 9.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.124 -0.944 . . . . 72.140000000000001 109.717 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 tt -162.14 148.37 13.34 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.003 -0.74 . . . . 74.150000000000006 109.003 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.31 139.61 50.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.281 0.562 . . . . 75.549999999999997 109.824 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.6 mt -113.85 113.81 44.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.981 -0.748 . . . . 74.129999999999995 108.981 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 86.6 mtt180 -91.71 107.03 18.92 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.915 -1.143 . . . . 74.239999999999995 107.915 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -103.13 126.93 50.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.721 -0.672 . . . . 73.329999999999998 111.289 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -128.27 162.87 26.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.409 -2.071 . . . . 74.530000000000001 105.409 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.11 51.27 1.65 Allowed Glycine 0 CA--C 1.534 1.262 0 N-CA-C 116.345 1.298 . . . . 44.409999999999997 116.345 -172.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -62.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.525 -0.917 . . . . 75.420000000000002 108.525 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.76 138.85 38.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-O 121.42 0.628 . . . . 71.200000000000003 112.162 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . . . -103.99 114.04 28.0 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.376 -0.829 . . . . 72.329999999999998 110.233 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 5.7 tt -91.25 110.34 21.62 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.623 -0.88 . . . . 70.439999999999998 108.623 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -94.21 121.9 36.2 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.233 -1.395 . . . . 75.109999999999999 107.233 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.29 120.56 24.58 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.154 0.502 . . . . 73.219999999999999 110.384 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.31 138.1 33.09 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.461 -0.791 . . . . 72.450000000000003 108.941 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.06 76.8 1.4 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 109.356 -0.609 . . . . 73.219999999999999 109.356 -174.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 160.79 151.76 0.01 OUTLIER 'General case' 0 C--O 1.198 -1.653 0 C-N-CA 125.914 1.686 . . . . 74.030000000000001 109.606 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -104.35 -12.31 16.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 121.562 -0.711 . . . . 72.209999999999994 109.716 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -72.73 -64.36 0.98 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.645 -0.707 . . . . 75.049999999999997 111.674 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -107.12 28.93 7.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.958 -1.127 . . . . 73.319999999999993 107.958 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.79 120.89 2.73 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.452 -1.249 . . . . 74.140000000000001 113.245 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 m -70.29 142.8 52.23 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 124.903 1.281 . . . . 75.329999999999998 112.373 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 76' ' ' PRO . 12.9 p -105.38 141.25 37.22 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.613 -0.721 . . . . 65.109999999999999 111.262 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.86 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 106.67 -1.604 . . . . 75.010000000000005 106.67 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.49 23.92 11.27 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.456 -0.572 . . . . 75.030000000000001 109.456 -170.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 74.42 15.03 3.53 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.756 1.622 . . . . 72.299999999999997 111.712 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.57 123.71 37.2 Favored Pre-proline 0 C--N 1.315 -0.897 0 O-C-N 121.267 -0.896 . . . . 71.519999999999996 109.012 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.408 ' N ' HG22 ' A' ' 71' ' ' THR . 57.4 Cg_endo -77.31 125.16 7.58 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 121.981 1.787 . . . . 71.019999999999996 111.859 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.28 170.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.867 -0.606 . . . . 74.099999999999994 110.011 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -91.13 -47.02 7.78 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.163 -1.051 . . . . 71.209999999999994 108.163 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.5 pt-20 -141.26 151.8 43.99 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.169 -0.923 . . . . 74.530000000000001 109.875 177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -157.11 152.03 25.87 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.268 -1.012 . . . . 73.209999999999994 108.268 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 79.3 mt-30 -101.36 119.36 38.64 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.903 -0.719 . . . . 71.109999999999999 109.348 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 78.2 mt -56.29 143.2 34.87 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 124.087 0.867 . . . . 72.140000000000001 111.656 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.97 39.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.602 -1.259 . . . . 73.319999999999993 107.602 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.79 127.85 34.05 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.729 -0.471 . . . . 75.209999999999994 109.729 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.22 -5.35 52.51 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.897 -0.592 . . . . 64.340000000000003 111.88 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.64 127.65 33.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 75.310000000000002 109.986 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.11 112.41 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.75 -1.204 . . . . 74.340000000000003 107.75 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.3 mt -103.39 125.02 57.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 108.196 -1.039 . . . . 75.099999999999994 108.196 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -129.55 124.92 35.06 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.061 0.458 . . . . 74.040000000000006 111.521 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -100.81 163.39 12.34 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 105.005 -2.22 . . . . 74.439999999999998 105.005 170.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.94 85.74 0.88 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 118.414 -1.851 . . . . 75.439999999999998 111.339 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 161.68 -54.07 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 126.632 1.973 . . . . 73.409999999999997 108.155 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -133.37 155.37 49.59 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.793 0.806 . . . . 74.400000000000006 111.734 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -121.27 144.02 48.85 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 114.359 -1.291 . . . . 75.219999999999999 109.038 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 tp -134.82 146.74 30.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.373 -1.343 . . . . 74.219999999999999 107.373 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.74 137.6 45.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.499 0.591 . . . . 74.530000000000001 109.456 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 82' ' ' LEU . 99.1 t -89.14 127.64 41.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.87 0.367 . . . . 73.150000000000006 111.421 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.09 145.18 47.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.684 -0.689 . . . . 74.129999999999995 109.208 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' SER . 90.0 mtp -122.02 124.35 43.78 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.523 -0.547 . . . . 74.439999999999998 109.523 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.444 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 10.0 m170 . . . . . 0 C--N 1.302 -1.485 0 CA-C-O 118.852 -0.594 . . . . 75.450000000000003 110.024 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.421 -1.924 0 N-CA-C 110.055 -0.35 . . . . 73.129999999999995 110.055 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -116.13 115.29 25.78 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.875 -1.158 . . . . 70.120000000000005 107.875 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -95.44 117.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.965 -0.754 . . . . 72.430000000000007 108.965 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.432 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.8 m -123.68 135.58 53.97 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.888 -1.051 . . . . 70.340000000000003 110.643 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 mt -85.93 126.98 34.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.139 -1.06 . . . . 70.400000000000006 108.139 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -111.47 128.36 55.98 Favored 'General case' 0 C--N 1.286 -2.181 0 O-C-N 123.752 0.658 . . . . 75.209999999999994 111.099 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.5 tp -136.55 128.26 28.96 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.456 -0.942 . . . . 75.430000000000007 108.456 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.6 100.08 12.95 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.685 -1.228 . . . . 51.539999999999999 107.685 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -125.17 84.31 2.26 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 107.294 -1.372 . . . . 71.299999999999997 107.294 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.62 -73.14 1.23 Allowed Glycine 0 C--N 1.289 -2.029 0 CA-C-N 114.731 -1.122 . . . . 72.439999999999998 110.328 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -121.84 -35.58 3.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.554 -0.906 . . . . 64.120000000000005 108.554 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.38 115.97 1.21 Allowed Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 120.507 -0.854 . . . . 55.219999999999999 111.443 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -100.56 142.01 32.63 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.204 -1.406 . . . . 74.530000000000001 107.204 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.7 p -141.44 132.42 26.08 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.434 0.459 . . . . 62.119999999999997 111.415 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -121.52 111.99 17.94 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.82 -0.627 . . . . 75.540000000000006 109.469 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.15 132.02 34.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.556 -0.535 . . . . 73.420000000000002 109.556 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.42 138.19 43.16 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.898 -1.047 . . . . 63.439999999999998 109.997 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -103.5 168.5 9.11 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.411 -0.589 . . . . 75.329999999999998 109.411 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -61.41 118.79 7.42 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 124.212 0.945 . . . . 72.430000000000007 112.745 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.19 -173.36 18.5 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.356 -1.498 . . . . 74.5 109.356 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 62.0 p -95.79 119.2 33.86 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 117.94 0.87 . . . . 72.109999999999999 110.904 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.445 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -96.28 110.24 22.59 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.091 -1.448 . . . . 75.439999999999998 107.091 -176.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.96 128.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.362 -0.607 . . . . 73.420000000000002 109.362 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.28 132.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.266 -0.642 . . . . 74.209999999999994 109.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 155.08 -171.06 33.3 Favored Glycine 0 CA--C 1.481 -2.067 0 N-CA-C 109.756 -1.338 . . . . 71.439999999999998 109.756 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 73.3 mtp180 -120.44 105.27 10.71 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.631 -0.828 . . . . 73.140000000000001 108.856 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 155.6 13.71 Favored Glycine 0 N--CA 1.416 -2.648 0 N-CA-C 107.327 -2.309 . . . . 72.450000000000003 107.327 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.89 -17.69 65.02 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 118.017 0.909 . . . . 74.239999999999995 112.25 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.61 ' OD2' ' HD3' ' A' ' 48' ' ' ARG . 19.9 t70 -89.51 -2.01 58.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.74 0.781 . . . . 74.349999999999994 109.629 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.44 152.81 19.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.802 -0.636 . . . . 74.209999999999994 109.486 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.14 -46.95 6.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.984 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -107.87 118.56 37.05 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.597 -0.89 . . . . 74.120000000000005 108.597 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 22.5 mmt85 -95.91 123.79 39.65 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.639 -0.71 . . . . 73.230000000000004 109.138 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 mt -78.48 141.68 61.32 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.929 -0.397 . . . . 75.099999999999994 109.929 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.92 5.06 6.57 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.234 1.956 . . . . 73.450000000000003 114.333 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -111.7 172.72 6.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.572 -1.27 . . . . 74.439999999999998 107.572 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -112.65 156.5 22.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.052 -0.722 . . . . 74.310000000000002 109.052 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -22.46 17.28 Favored Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 109.955 -1.258 . . . . 73.400000000000006 109.955 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.24 136.12 25.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.747 -0.726 . . . . 73.400000000000006 109.052 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -69.58 177.61 2.88 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 122.845 0.458 . . . . 74.129999999999995 110.96 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 3.8 ptp180 -63.64 -40.59 97.25 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.368 -0.533 . . . . 74.409999999999997 111.125 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.61 ' HD3' ' OD2' ' A' ' 35' ' ' ASP . 45.1 mtm180 -131.9 113.7 13.76 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 106.01 -1.848 . . . . 74.439999999999998 106.01 171.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -104.32 -38.43 6.85 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-O 121.526 0.679 . . . . 72.099999999999994 110.35 -174.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 5.1 tt -160.3 153.51 21.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.577 -0.897 . . . . 75.340000000000003 108.577 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -138.24 124.52 20.46 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.31 0.576 . . . . 73.030000000000001 109.968 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' SER . 61.7 mt -99.19 119.22 46.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.91 -0.774 . . . . 73.010000000000005 108.91 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -91.44 107.06 18.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.131 -1.433 . . . . 75.219999999999999 107.131 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -102.46 116.8 33.36 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.882 0.849 . . . . 75.200000000000003 110.5 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 57' ' ' GLN . 23.0 t70 -119.21 161.55 20.17 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.83 -1.545 . . . . 75.120000000000005 106.83 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.81 37.93 1.48 Allowed Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.429 0.559 . . . . 74.519999999999996 112.825 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 55' ' ' ASP . 24.9 mt-30 -136.89 -70.04 0.46 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.622 1.169 . . . . 73.430000000000007 108.392 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.08 159.38 32.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.949 -0.389 . . . . 72.439999999999998 109.949 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.02 106.52 18.87 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.601 0.715 . . . . 73.329999999999998 109.39 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.8 tp -90.79 111.98 23.59 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.198 -0.91 . . . . 74.400000000000006 111.185 -176.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -86.95 122.34 30.67 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.54 -1.281 . . . . 73.209999999999994 107.54 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.94 123.08 31.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 72.450000000000003 110.014 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.61 145.97 27.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.507 -0.553 . . . . 62.039999999999999 109.507 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.67 77.09 1.7 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.247 -1.39 . . . . 75.310000000000002 107.247 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -174.18 159.48 3.2 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.58 -0.526 . . . . 74.530000000000001 109.58 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -108.27 -54.55 2.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 120.851 0.357 . . . . 70.109999999999999 111.29 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 t -90.15 -24.44 21.06 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.794 -0.566 . . . . 74.109999999999999 111.963 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -105.51 26.98 8.81 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.6 -0.518 . . . . 71.230000000000004 109.6 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.92 126.66 18.3 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.294 0.996 . . . . 74.420000000000002 113.022 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -72.49 147.47 46.01 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.315 0.646 . . . . 74.400000000000006 111.557 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -113.37 146.91 38.7 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.762 -0.654 . . . . 70.430000000000007 110.285 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.38 116.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.955 -1.128 . . . . 74.030000000000001 107.955 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.33 24.47 14.57 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.997 0.919 . . . . 73.439999999999998 109.704 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m120 83.69 5.85 0.74 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 126.723 2.009 . . . . 64.510000000000005 113.398 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.64 127.17 34.81 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.63 -0.507 . . . . 75.099999999999994 109.63 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.02 125.29 9.22 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.513 2.142 . . . . 74.239999999999995 112.489 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -142.31 161.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.21 -0.663 . . . . 63.520000000000003 109.21 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -89.35 -28.19 19.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.207 0.527 . . . . 74.340000000000003 110.253 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.55 158.83 40.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.438 -0.949 . . . . 75.409999999999997 108.438 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -157.68 152.2 24.99 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.69 -0.856 . . . . 75.329999999999998 108.69 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -100.04 107.7 19.69 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.277 -1.379 . . . . 71.340000000000003 107.277 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.87 143.51 37.11 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.946 0.779 . . . . 70.430000000000007 113.043 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.99 163.5 29.07 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 115.124 -0.944 . . . . 75.420000000000002 108.513 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.19 112.2 6.37 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.444 -0.576 . . . . 64.109999999999999 109.444 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 3.9 27.03 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 121.004 -0.617 . . . . 64.400000000000006 113.148 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.89 139.36 35.95 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 117.832 0.816 . . . . 71.310000000000002 110.931 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.9 t -98.95 113.12 32.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.919 -0.771 . . . . 73.510000000000005 108.919 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.79 110.75 26.11 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.08 -1.452 . . . . 74.430000000000007 107.08 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.418 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 18.5 ttt180 -113.73 121.35 43.81 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.659 0.742 . . . . 75.230000000000004 111.901 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.81 163.28 22.49 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.14 -1.391 . . . . 73.030000000000001 107.722 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.34 120.05 9.12 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 123.563 0.54 . . . . 74.5 113.133 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.2 m170 86.24 -17.02 0.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.041 1.736 . . . . 75.329999999999998 114.96 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.8 m -150.67 127.88 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 118.977 0.808 . . . . 73.299999999999997 112.652 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' OE1' ' HD2' ' A' ' 89' ' ' ARG . 10.1 pt-20 -110.8 131.92 54.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.498 -0.927 . . . . 74.349999999999994 108.498 171.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 144.72 34.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.807 -0.633 . . . . 72.140000000000001 110.184 -174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.38 127.81 58.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.539 -0.911 . . . . 72.209999999999994 108.539 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.3 t -87.54 128.16 40.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.638 -0.255 . . . . 73.25 110.459 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -116.47 149.38 39.59 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.471 -0.566 . . . . 74.030000000000001 109.471 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.8 mtp -126.92 106.22 9.16 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.087 -1.079 . . . . 73.409999999999997 108.087 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 . . . . . 0 C--N 1.272 -2.774 0 CA-C-N 114.281 -1.327 . . . . 62.0 108.058 -176.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.436 -1.134 0 CA-C-O 120.757 0.313 . . . . 74.450000000000003 111.433 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.4 p -122.69 132.99 54.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.674 -1.232 . . . . 72.230000000000004 107.674 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.59 129.55 71.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 122.383 1.087 . . . . 73.239999999999995 111.118 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 m -132.43 128.71 38.1 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.759 -1.11 . . . . 74.219999999999999 108.309 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.38 148.83 21.81 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.405 -0.961 . . . . 75.530000000000001 108.405 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -126.81 125.42 41.66 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.195 -0.602 . . . . 75.120000000000005 110.202 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.568 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.3 tp -83.15 124.73 30.79 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.812 -0.81 . . . . 73.540000000000006 108.812 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -90.12 98.44 11.77 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 106.321 -1.733 . . . . 74.239999999999995 106.321 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -150.63 77.55 1.29 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.904 -1.043 . . . . 72.430000000000007 109.386 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.93 -65.61 4.02 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 115.375 -0.83 . . . . 61.229999999999997 113.025 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 p -100.56 -47.36 4.9 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.456 0.646 . . . . 71.209999999999994 111.193 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 106.82 91.27 2.21 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.367 -1.093 . . . . 72.140000000000001 110.367 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.52 158.21 15.65 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 110.478 -0.193 . . . . 65.019999999999996 110.478 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -121.88 148.93 44.1 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.108 0.781 . . . . 74.239999999999995 113.108 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -136.97 117.24 13.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.667 -1.234 . . . . 73.049999999999997 107.667 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -83.41 139.07 33.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.322 -0.621 . . . . 73.310000000000002 109.322 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.5 mt -85.48 139.7 31.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.815 -0.439 . . . . 73.329999999999998 109.815 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -101.55 165.16 11.39 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.935 0.398 . . . . 71.310000000000002 110.344 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -69.75 113.26 6.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.096 -0.956 . . . . 75.439999999999998 109.914 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.28 -174.57 19.94 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.08 -1.608 . . . . 60.310000000000002 109.08 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 p -106.78 145.85 31.58 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.385 -0.926 . . . . 64.129999999999995 110.857 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.75 135.43 54.56 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.464 -0.569 . . . . 72.200000000000003 109.464 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.68 119.54 46.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.257 -1.016 . . . . 74.430000000000007 108.257 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 58.1 mt -101.8 127.73 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.301 0.572 . . . . 71.219999999999999 110.158 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.44 -178.09 37.49 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.335 -1.506 . . . . 75.109999999999999 109.335 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 29.1 mtm105 -110.99 106.52 15.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.356 1.078 . . . . 75.400000000000006 111.42 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.4 41.8 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 107.168 -2.373 . . . . 75.319999999999993 107.168 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -85.56 -16.01 40.79 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.175 0.988 . . . . 72.329999999999998 108.457 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.5 -12.57 60.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.113 -1.403 . . . . 70.5 109.273 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 47' ' ' ARG . . . -98.37 158.02 15.84 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.776 -1.102 . . . . 72.019999999999996 108.553 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -106.65 -39.06 5.94 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.347 0.594 . . . . 71.120000000000005 110.397 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 89.7 t80 -115.72 114.88 25.42 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.904 -1.147 . . . . 74.420000000000002 107.904 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 61.7 mtm180 -96.91 124.14 40.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.094 -0.503 . . . . 74.230000000000004 110.499 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 66.6 mt -71.4 134.17 84.79 Favored Pre-proline 0 CA--C 1.501 -0.926 0 N-CA-C 107.573 -1.269 . . . . 75.299999999999997 107.573 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.28 35.01 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.967 1.778 . . . . 74.329999999999998 112.111 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.8 -175.55 3.44 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.043 0.449 . . . . 63.340000000000003 110.417 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.5 m -111.17 148.59 32.43 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.123 0.969 . . . . 74.329999999999998 110.005 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.82 -0.85 61.07 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 111.679 -0.568 . . . . 60.200000000000003 111.679 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.14 127.69 45.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.867 -0.79 . . . . 74.340000000000003 108.867 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.1 m -78.96 177.3 8.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.166 -0.47 . . . . 41.340000000000003 110.185 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.41 -50.63 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.904 0.32 . . . . 74.209999999999994 110.97 177.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.62 114.6 26.66 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 107.025 -1.472 . . . . 75.340000000000003 107.025 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -105.31 -42.97 5.11 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.605 0.717 . . . . 72.219999999999999 109.097 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 tt -163.17 159.8 23.4 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.56 -0.904 . . . . 75.109999999999999 108.56 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -138.85 151.1 46.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.518 -0.549 . . . . 72.439999999999998 109.518 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.48 121.44 62.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.542 -0.91 . . . . 63.240000000000002 108.542 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 63.4 mtt180 -105.6 107.94 19.2 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.206 -0.664 . . . . 73.349999999999994 109.206 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.72 133.98 52.07 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.996 -0.547 . . . . 75.439999999999998 110.616 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.79 -179.93 6.34 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.436 -2.431 . . . . 65.549999999999997 104.436 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.36 42.62 2.92 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 119.445 1.02 . . . . 50.439999999999998 113.867 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -141.62 -76.78 0.28 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 110.203 -0.295 . . . . 74.239999999999995 110.203 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.12 158.1 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.711 0.291 . . . . 72.439999999999998 110.557 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.51 112.38 24.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.403 0.62 . . . . 71.510000000000005 110.289 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 6.1 tt -88.96 124.87 34.66 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.272 -0.876 . . . . 70.040000000000006 108.797 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.74 123.55 49.71 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.347 -1.353 . . . . 75.430000000000007 107.347 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.74 124.68 28.59 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.187 0.518 . . . . 52.509999999999998 110.999 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 14.9 t70 -89.3 112.47 23.55 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.357 -0.979 . . . . 73.430000000000007 108.357 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 mt -101.53 76.45 1.67 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.422 -2.066 . . . . 73.140000000000001 105.422 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -173.81 139.64 0.7 Allowed 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.899 -0.72 . . . . 71.129999999999995 109.708 -165.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -108.56 -53.38 2.65 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.283 0.563 . . . . 63.229999999999997 110.003 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -66.02 -48.64 70.45 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.277 -0.874 . . . . 60.450000000000003 113.05 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -106.4 29.77 6.57 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 119.173 -0.441 . . . . 73.329999999999998 109.94 -170.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.23 121.94 2.83 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.18 0.832 . . . . 65.049999999999997 115.18 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.7 m -69.08 149.17 49.01 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.734 1.614 . . . . 75.219999999999999 112.336 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 38.5 p -112.4 145.78 39.51 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.345 0.593 . . . . 61.219999999999999 111.814 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.405 HG12 HG13 ' A' ' 88' ' ' ILE . 33.9 m -116.07 117.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 107.431 -1.322 . . . . 74.140000000000001 107.431 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 58.88 33.26 22.94 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.675 -0.693 . . . . 71.239999999999995 110.295 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 82.46 -3.36 1.4 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.86 1.664 . . . . 73.209999999999994 112.428 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.15 129.31 25.39 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.684 -0.635 . . . . 64.109999999999999 110.089 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.12 125.58 7.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.501 2.134 . . . . 73.519999999999996 113.529 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.68 174.47 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 107.295 -1.372 . . . . 74.439999999999998 107.295 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.2 mt-30 -117.4 -17.73 10.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 112.979 0.733 . . . . 73.329999999999998 112.979 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.61 131.52 27.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 109.908 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -147.57 152.33 37.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.842 -0.799 . . . . 74.340000000000003 108.842 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -106.41 113.8 27.53 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.181 -1.044 . . . . 74.140000000000001 108.181 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.436 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.2 mt -57.85 149.56 22.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.107 -0.952 . . . . 71.329999999999998 112.486 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.09 166.79 23.8 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.321 -0.854 . . . . 64.319999999999993 109.15 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.8 t70 -71.67 115.72 11.19 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.994 0.426 . . . . 72.150000000000006 110.201 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.46 14.34 28.1 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.813 -0.63 . . . . 74.409999999999997 112.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -88.76 135.66 33.4 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 120.438 -0.505 . . . . 73.439999999999998 110.74 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.21 113.46 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.008 -0.738 . . . . 64.329999999999998 109.008 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.405 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -105.76 113.53 42.84 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.805 -1.183 . . . . 74.049999999999997 107.805 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.462 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 61.5 mtt180 -99.81 106.28 18.14 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 116.272 -0.422 . . . . 74.340000000000003 109.954 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -115.5 164.69 13.93 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.013 -0.994 . . . . 71.209999999999994 109.001 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -27.39 88.78 0.01 OUTLIER Glycine 0 N--CA 1.484 1.856 0 C-N-CA 125.303 1.43 . . . . 71.439999999999998 116.331 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 58.08 21.35 7.81 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.76 1.624 . . . . 72.540000000000006 111.491 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.0 m -137.01 114.25 10.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.12 -1.067 . . . . 63.439999999999998 108.12 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.22 125.4 54.1 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 120.099 -0.64 . . . . 70.519999999999996 109.799 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 13' ' ' LEU . 1.7 pp -122.48 149.43 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-O 120.953 0.406 . . . . 72.5 111.36 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -110.39 122.45 64.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.767 -1.568 . . . . 74.329999999999998 106.767 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 82' ' ' LEU . 55.1 t -80.41 126.56 39.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 120.85 0.357 . . . . 75.040000000000006 111.057 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.0 mmm-85 -116.9 142.3 47.11 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.35 0.595 . . . . 64.540000000000006 109.678 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.429 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 79.6 mtp -123.06 121.25 35.57 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.925 -1.034 . . . . 74.540000000000006 109.144 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 107.168 -1.419 . . . . 73.439999999999998 107.168 -177.641 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.433 -1.312 0 N-CA-C 106.831 -1.544 . . . . 73.400000000000006 106.831 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -121.48 114.77 21.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.494 -0.483 . . . . 74.129999999999995 109.95 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 23' ' ' LEU . 3.7 p -95.76 126.41 48.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.713 -1.217 . . . . 71.019999999999996 107.713 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 m -131.06 136.54 48.54 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.28 -0.873 . . . . 72.450000000000003 109.264 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.47 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.0 pp -101.8 131.41 48.13 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 109.966 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.92 114.26 28.24 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.28 -1.378 . . . . 73.540000000000006 107.28 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.16 119.31 38.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.43 0.692 . . . . 74.239999999999995 110.521 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -93.36 100.0 12.41 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.949 -1.13 . . . . 63.530000000000001 107.949 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.91 -13.59 15.76 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.167 -1.378 . . . . 73.439999999999998 109.179 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.22 -12.93 6.02 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.87 -1.292 . . . . 70.540000000000006 109.87 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -120.12 -35.81 3.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 120.816 0.341 . . . . 74.319999999999993 110.593 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 91.82 1.38 Allowed Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.139 -1.184 . . . . 41.130000000000003 110.139 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -113.51 159.43 19.56 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 110.476 -0.194 . . . . 75.120000000000005 110.476 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.8 p -130.22 136.33 49.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.882 0.373 . . . . 74.349999999999994 110.024 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -135.62 121.55 19.91 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.042 -0.526 . . . . 74.109999999999999 109.638 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.915 -0.584 . . . . 72.340000000000003 109.762 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB2' HG11 ' A' ' 9' ' ' VAL . 88.3 mt -76.86 133.91 39.17 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.503 -0.771 . . . . 61.210000000000001 110.265 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -102.99 158.45 16.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 108.767 -0.827 . . . . 75.349999999999994 108.767 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.9 mp0 -48.5 127.27 12.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.492 1.517 . . . . 73.219999999999999 111.445 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.1 -174.8 15.81 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.255 -1.538 . . . . 64.420000000000002 109.255 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 81.8 p -95.73 123.35 39.26 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 118.319 -1.353 . . . . 73.129999999999995 110.882 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.51 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -92.57 109.74 21.15 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.065 -1.828 . . . . 74.430000000000007 106.065 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.21 129.42 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.596 -0.729 . . . . 74.209999999999994 110.842 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -107.57 133.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.54 -0.911 . . . . 72.530000000000001 108.54 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 154.79 177.5 28.17 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.193 -1.563 . . . . 74.129999999999995 109.193 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 49.7 mtp85 -112.52 105.0 13.12 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.884 1.342 . . . . 75.530000000000001 109.858 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.89 179.32 46.31 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 110.039 -1.225 . . . . 74.230000000000004 110.039 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -72.41 -25.44 61.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.073 0.939 . . . . 74.040000000000006 108.937 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.98 8.48 12.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.665 -1.152 . . . . 71.129999999999995 111.526 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.91 155.19 44.59 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.079 0.466 . . . . 63.100000000000001 112.013 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -99.63 -54.73 2.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.017 -0.992 . . . . 71.420000000000002 109.987 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -101.48 108.92 20.64 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 74.129999999999995 109.217 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 33.5 ptt180 -96.08 118.13 32.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.105 -0.498 . . . . 75.040000000000006 111.802 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.65 140.19 97.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.278 -0.874 . . . . 73.430000000000007 110.509 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -92.71 17.92 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.601 2.201 . . . . 75.329999999999998 112.283 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.64 -173.49 2.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -112.0 146.91 37.04 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.193 0.597 . . . . 74.329999999999998 109.564 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 -27.36 16.82 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.818 -0.706 . . . . 73.519999999999996 111.384 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.34 133.02 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 123.435 0.694 . . . . 65.340000000000003 111.586 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -80.27 -171.47 3.02 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.392 1.077 . . . . 71.200000000000003 109.552 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 33.4 ptt180 -78.02 -34.78 50.49 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.35 -0.94 . . . . 71.310000000000002 109.587 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -129.07 115.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 103.582 -2.748 . . . . 71.129999999999995 103.582 172.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 5.3 t60 -103.76 -42.41 5.63 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.55 0.691 . . . . 73.120000000000005 109.143 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 4.9 tt -166.45 151.14 7.78 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.429 -0.952 . . . . 72.409999999999997 108.429 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.63 134.94 45.5 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.122 -0.695 . . . . 72.129999999999995 109.122 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -102.55 112.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.028 -1.471 . . . . 75.200000000000003 107.028 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 40.2 ttt85 -91.65 107.38 19.17 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 121.548 0.689 . . . . 75.040000000000006 109.779 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -96.49 112.54 24.24 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.948 -1.024 . . . . 74.310000000000002 109.056 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -119.27 167.38 11.92 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.172 -1.788 . . . . 71.219999999999999 106.172 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.98 42.36 2.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.592 -0.813 . . . . 54.210000000000001 112.566 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -136.68 -66.86 0.52 Allowed 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 124.041 0.936 . . . . 71.019999999999996 108.56 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.11 159.77 4.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.719 1.208 . . . . 73.439999999999998 108.31 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.36 107.59 19.24 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.652 0.739 . . . . 75.549999999999997 109.101 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 tt -88.49 115.41 25.98 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.79 -1.095 . . . . 72.200000000000003 109.789 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.8 tm? -97.21 124.94 41.44 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.318 -1.364 . . . . 72.430000000000007 107.318 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.429 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -140.57 125.6 18.43 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 120.678 0.275 . . . . 74.140000000000001 111.409 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.703 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 1.2 m-20 -73.52 139.61 45.79 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 115.798 -0.637 . . . . 71.200000000000003 109.948 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.9 tp -130.68 77.15 1.77 Allowed 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.534 -1.284 . . . . 72.519999999999996 107.534 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -179.82 174.64 0.91 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.419 -1.326 . . . . 73.25 107.419 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 p -109.03 -55.03 2.46 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.642 0.608 . . . . 72.239999999999995 112.642 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -89.52 -29.95 18.58 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.466 0.913 . . . . 74.109999999999999 113.466 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.562 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 90.2 m-20 -84.57 27.38 0.72 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.427 0.691 . . . . 72.140000000000001 112.219 -172.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.51 122.73 6.68 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.967 1.417 . . . . 74.150000000000006 113.951 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.703 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 52.7 m -71.84 148.68 45.95 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 125.035 1.334 . . . . 71.319999999999993 112.622 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 p -112.92 141.03 47.22 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.435 -0.802 . . . . 63.32 109.505 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.03 118.25 53.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.755 -1.202 . . . . 74.120000000000005 107.755 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 57.81 38.22 27.23 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.556 -0.747 . . . . 71.540000000000006 109.88 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.39 -10.61 1.17 Allowed 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.605 1.962 . . . . 71.400000000000006 112.001 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -92.37 121.81 65.75 Favored Pre-proline 0 C--N 1.323 -0.57 0 O-C-N 122.124 -0.36 . . . . 72.120000000000005 110.7 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.47 125.19 13.0 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.837 2.358 . . . . 75.030000000000001 112.552 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.99 -177.9 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.974 -0.751 . . . . 75.209999999999994 108.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -128.83 6.25 5.53 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.589 -0.522 . . . . 72.540000000000006 109.589 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.45 153.16 3.44 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.907 -1.146 . . . . 73.329999999999998 107.907 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.456 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 76.3 t-105 -166.91 152.29 7.73 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.711 -0.848 . . . . 73.140000000000001 108.711 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -104.66 111.52 24.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.643 -1.243 . . . . 71.409999999999997 107.643 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB3' HG13 ' A' ' 97' ' ' VAL . 56.0 mt -58.13 141.3 50.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.898 1.073 . . . . 64.530000000000001 113.898 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.97 162.46 32.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.529 -1.286 . . . . 64.239999999999995 107.529 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.0 126.36 27.79 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.575 -0.284 . . . . 75.150000000000006 110.396 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.63 1.94 57.56 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.907 -0.663 . . . . 65.120000000000005 113.414 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -73.07 129.58 38.39 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.362 0.581 . . . . 61.229999999999997 111.135 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.43 116.28 35.32 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 N-CA-C 107.284 -1.376 . . . . 75.530000000000001 107.284 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.9 mt -122.43 134.28 66.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 C-N-CA 119.971 -0.692 . . . . 52.240000000000002 110.6 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -124.19 123.35 40.08 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 73.219999999999999 110.004 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -101.81 162.57 12.81 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 105.81 -1.922 . . . . 70.409999999999997 105.81 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -46.33 102.86 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 O-C-N 123.749 0.655 . . . . 64.239999999999995 113.786 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 m170 79.52 15.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.712 1.375 . . . . 73.140000000000001 114.712 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -151.02 141.11 22.14 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.475 -0.766 . . . . 71.450000000000003 111.94 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -118.75 139.29 51.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.037 0.446 . . . . 72.5 111.235 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 9.5 tp -139.8 142.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-N 115.301 -0.863 . . . . 75.239999999999995 109.527 -172.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -109.88 134.51 51.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.029 -1.1 . . . . 74.040000000000006 108.029 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 82' ' ' LEU . 85.0 t -96.92 121.73 47.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.141 0.496 . . . . 75.430000000000007 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -117.47 132.29 56.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.865 -0.791 . . . . 73.099999999999994 108.865 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.0 mtp -116.36 116.87 28.52 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.064 -0.717 . . . . 75.219999999999999 109.064 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--N 1.278 -2.537 0 N-CA-C 107.506 -1.294 . . . . 63.420000000000002 107.506 -177.732 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m . . . . . 0 N--CA 1.409 -2.491 0 N-CA-C 107.82 -1.178 . . . . 71.209999999999994 107.82 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -113.04 114.3 26.67 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.201 -1.407 . . . . 75.209999999999994 107.201 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 108.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.813 -1.18 . . . . 74.299999999999997 107.813 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 m -111.41 123.23 49.79 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.095 -1.076 . . . . 75.450000000000003 108.095 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.4 pp -88.53 130.02 35.33 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.602 -0.888 . . . . 70.329999999999998 108.602 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.93 108.85 19.76 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.622 -1.621 . . . . 65.219999999999999 106.622 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.48 117.8 29.39 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.524 -0.546 . . . . 73.540000000000006 109.524 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -126.77 103.53 7.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.951 -1.1 . . . . 72.099999999999994 112.925 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -48.87 9.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.9 -2.259 . . . . 74.430000000000007 104.9 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 171.29 44.27 0.04 OUTLIER Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 103.591 -3.804 . . . . 53.439999999999998 103.591 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -132.49 -45.94 0.9 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.644 -1.278 . . . . 72.099999999999994 110.86 -166.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.72 51.04 8.38 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.49 -1.044 . . . . 75.340000000000003 110.49 -172.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -84.47 143.1 29.6 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.747 0.419 . . . . 74.209999999999994 110.355 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.9 p -146.68 132.36 18.88 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.645 -0.707 . . . . 71.299999999999997 109.199 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -144.8 127.69 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.456 -0.338 . . . . 72.25 110.099 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.07 127.46 36.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.41 -0.959 . . . . 62.520000000000003 108.41 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.0 mt -58.31 143.46 44.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.567 0.951 . . . . 71.239999999999995 113.567 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 2.3 mmp_? -100.01 151.61 21.16 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.559 -1.201 . . . . 72.430000000000007 108.022 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.85 130.14 40.88 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.683 0.754 . . . . 73.530000000000001 111.367 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.65 -176.54 16.61 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 106.763 -2.535 . . . . 62.32 106.763 -172.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 51.7 p -89.71 133.27 34.75 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 118.388 -1.325 . . . . 74.439999999999998 111.303 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.485 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -101.72 109.83 21.68 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.194 -2.15 . . . . 74.200000000000003 105.194 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.4 mt -86.2 123.96 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.976 -0.556 . . . . 75.25 111.149 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -107.91 129.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.768 -0.827 . . . . 75.329999999999998 108.768 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.48 -179.03 37.15 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.888 -0.885 . . . . 74.439999999999998 110.888 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 40.1 mtp85 -107.43 106.38 16.75 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.732 -0.84 . . . . 73.510000000000005 108.732 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.71 -178.13 48.63 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 109.562 -1.415 . . . . 74.120000000000005 109.562 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -93.43 -21.05 19.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.004 0.431 . . . . 64.230000000000004 110.786 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -92.76 -3.59 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 75.209999999999994 110.056 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.11 165.96 20.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.049 -0.978 . . . . 73.310000000000002 108.911 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -109.35 -52.16 2.8 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.65 0.738 . . . . 74.239999999999995 110.028 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -108.82 116.73 32.53 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.366 -0.975 . . . . 74.310000000000002 108.366 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mpt_? -94.92 127.86 41.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.159 -0.473 . . . . 70.120000000000005 110.973 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 68.7 mt -79.98 136.07 54.59 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.101 -0.5 . . . . 73.040000000000006 111.138 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 33.9 Cg_exo -61.98 -29.15 81.5 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.407 2.738 . . . . 71.450000000000003 114.4 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 21.5 t70 -95.03 169.0 10.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.709 -0.849 . . . . 63.119999999999997 108.709 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -107.23 -177.34 3.33 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 121.036 -0.266 . . . . 74.540000000000006 110.321 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.22 78.39 Favored Glycine 0 C--O 1.238 0.395 0 N-CA-C 108.807 -1.717 . . . . 74.120000000000005 108.807 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.47 130.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 113.294 -1.453 . . . . 73.230000000000004 108.095 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.1 m -79.11 -177.48 5.65 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.244 -0.651 . . . . 74.299999999999997 109.244 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 15.4 ptt180 -64.49 -41.56 96.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.572 0.701 . . . . 74.109999999999999 109.415 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -121.02 104.36 9.74 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.245 -1.761 . . . . 73.209999999999994 106.245 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -100.0 -31.44 11.45 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.948 -1.024 . . . . 75.319999999999993 108.877 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 tt -164.28 145.89 8.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.108 -0.701 . . . . 74.230000000000004 109.108 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.95 132.92 47.66 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.292 0.567 . . . . 71.540000000000006 110.05 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.3 mt -108.53 112.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.642 -1.244 . . . . 74.019999999999996 107.642 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 16.3 ttt-85 -91.35 107.71 19.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -99.51 115.32 29.07 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-O 121.672 0.749 . . . . 74.519999999999996 110.324 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.83 164.6 14.42 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.051 -1.463 . . . . 73.319999999999993 107.051 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.56 52.91 3.91 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.415 -1.074 . . . . 70.409999999999997 110.415 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.36 -71.73 0.3 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 125.7 1.6 . . . . 64.409999999999997 107.793 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 m -149.76 160.0 5.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.908 1.283 . . . . 71.140000000000001 107.896 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . . . -93.24 106.15 18.15 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.585 -0.895 . . . . 73.299999999999997 108.585 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -82.48 118.31 23.14 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.277 -0.874 . . . . 73.420000000000002 110.096 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -99.54 120.13 39.15 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.545 -0.909 . . . . 74.150000000000006 108.545 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.0 123.48 34.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.815 -0.439 . . . . 72.540000000000006 109.815 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.64 138.82 32.77 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.868 -0.605 . . . . 74.310000000000002 110.994 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.92 77.52 1.62 Allowed 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.979 0.511 . . . . 73.340000000000003 109.913 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.441 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 32.9 t-20 -175.31 138.67 0.43 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.842 0.746 . . . . 74.040000000000006 110.473 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 p -96.54 -38.46 9.97 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.361 -0.381 . . . . 75.319999999999993 111.854 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 t -89.32 -44.4 10.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.346 0.499 . . . . 73.420000000000002 112.346 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.441 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.4 m120 -105.98 27.37 8.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.129 -0.693 . . . . 75.129999999999995 109.129 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.96 138.36 26.32 Favored Glycine 0 C--O 1.248 1.004 0 CA-C-N 114.527 -1.215 . . . . 33.219999999999999 113.923 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 30.0 m -72.25 137.73 47.0 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 124.406 1.082 . . . . 70.409999999999997 113.299 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 p -105.91 140.75 38.45 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.373 -0.83 . . . . 72.530000000000001 109.674 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 88' ' ' ILE . 35.2 m -119.55 116.04 49.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.602 -1.259 . . . . 75.299999999999997 107.602 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 57.84 30.86 19.69 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.445 0.64 . . . . 75.030000000000001 110.167 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 88.72 -10.88 0.45 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.659 1.984 . . . . 74.540000000000006 113.677 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.7 117.81 66.3 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 121.413 -0.804 . . . . 71.439999999999998 110.913 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.86 124.91 11.5 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 121.76 1.64 . . . . 74.519999999999996 110.319 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.95 175.98 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 110.168 -0.308 . . . . 75.099999999999994 110.168 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.05 -31.84 9.49 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.659 0.599 . . . . 61.109999999999999 109.42 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -142.73 147.86 36.31 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.048 -0.524 . . . . 73.450000000000003 110.199 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -162.23 152.17 16.47 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -107.92 109.41 20.91 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.979 -0.688 . . . . 73.519999999999996 109.154 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 79.0 mt -57.1 122.02 11.41 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.479 -1.237 . . . . 75.230000000000004 111.923 -175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.9 166.59 11.08 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.924 -1.139 . . . . 72.439999999999998 107.924 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 126.4 29.13 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.462 -0.335 . . . . 73.239999999999995 110.628 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.16 57.73 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.929 -0.578 . . . . 75.230000000000004 113.071 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.06 139.88 46.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.984 0.392 . . . . 55.310000000000002 111.411 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.69 117.19 48.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.753 -0.658 . . . . 72.439999999999998 109.673 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.469 HG13 HG11 ' A' ' 72' ' ' VAL . 1.9 mp -111.98 124.55 68.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 123.368 0.667 . . . . 72.319999999999993 109.28 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 70' ' ' THR . 38.5 ttm180 -120.37 115.73 24.11 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.405 -0.591 . . . . 72.430000000000007 109.405 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -126.81 139.29 53.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.409 -1.33 . . . . 72.109999999999999 107.409 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.86 88.02 0.0 OUTLIER Glycine 0 N--CA 1.496 2.636 0 O-C-N 125.032 1.457 . . . . 71.430000000000007 116.297 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.5 t60 75.37 -19.66 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.327 1.451 . . . . 74.120000000000005 113.034 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.6 m -96.55 132.46 42.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 122.869 0.468 . . . . 72.299999999999997 111.171 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -125.78 117.63 23.83 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.013 0.911 . . . . 75.099999999999994 110.387 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -127.64 141.57 46.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 114.53 -1.214 . . . . 75.549999999999997 111.914 -170.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.86 133.34 51.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.095 -1.076 . . . . 74.200000000000003 108.095 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.38 124.54 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 120.869 0.366 . . . . 73.120000000000005 110.84 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -119.25 130.58 55.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.741 -0.663 . . . . 74.439999999999998 111.126 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.1 mtt -106.17 111.93 24.75 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.975 -0.75 . . . . 75.450000000000003 108.975 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 . . . . . 0 C--N 1.277 -2.586 0 N-CA-C 108.306 -0.998 . . . . 75.129999999999995 108.306 179.104 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.426 -1.633 0 N-CA-C 109.305 -0.628 . . . . 75.510000000000005 109.305 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -101.56 115.57 30.81 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.804 -0.813 . . . . 64.329999999999998 108.804 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.24 122.02 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 106.251 -1.759 . . . . 72.219999999999999 106.251 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.6 m -135.66 131.22 35.46 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.615 -0.513 . . . . 74.219999999999999 109.615 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.468 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -93.94 126.86 39.39 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.377 -0.601 . . . . 74.310000000000002 109.377 175.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.8 108.72 21.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.759 -1.2 . . . . 75.420000000000002 107.759 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.02 114.36 28.23 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.824 -0.626 . . . . 74.340000000000003 109.778 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.7 99.62 11.69 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.551 -1.648 . . . . 74.019999999999996 106.551 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -146.89 79.75 1.52 Allowed 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.596 -1.184 . . . . 64.129999999999995 108.953 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.23 -62.39 0.29 Allowed Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.19 -0.914 . . . . 74.450000000000003 111.656 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -128.23 -38.92 1.75 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.425 0.528 . . . . 63.549999999999997 112.425 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.59 86.16 0.79 Allowed Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.784 -0.926 . . . . 73.140000000000001 110.784 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -100.38 167.37 10.44 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.462 0.305 . . . . 73.409999999999997 110.72 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.9 p -141.65 140.55 33.29 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.845 -0.616 . . . . 73.409999999999997 110.388 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.4 121.83 31.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.082 -1.081 . . . . 74.430000000000007 108.082 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -86.67 125.88 34.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.414 -1.328 . . . . 74.109999999999999 107.414 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.47 121.72 18.3 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.783 -0.644 . . . . 72.150000000000006 110.671 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -82.78 150.59 26.54 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.867 -0.79 . . . . 73.340000000000003 108.867 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -57.76 124.98 21.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.242 0.964 . . . . 74.200000000000003 110.309 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.17 -164.04 16.35 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.761 -2.136 . . . . 74.420000000000002 107.761 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.5 p -100.65 134.64 43.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.011 1.406 . . . . 75.230000000000004 111.31 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -111.78 110.07 20.24 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.205 -1.776 . . . . 72.420000000000002 106.205 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 45.7 mt -102.27 136.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 110.214 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -115.08 135.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.257 1.458 0 N-CA-C 109.49 -0.559 . . . . 71.010000000000005 109.49 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.88 -175.97 29.63 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 110.287 -1.125 . . . . 64.120000000000005 110.287 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 87.5 mtt180 -105.76 105.19 15.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.546 -0.861 . . . . 74.310000000000002 110.233 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.26 162.21 26.67 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 108.886 -1.686 . . . . 71.109999999999999 108.886 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.14 -18.32 62.52 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.218 0.532 . . . . 72.109999999999999 109.578 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.78 -29.03 65.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.624 -1.171 . . . . 72.129999999999995 109.596 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.434 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . . . -88.16 154.18 20.65 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.323 -0.853 . . . . 72.400000000000006 110.675 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -93.04 -46.57 7.4 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.598 -0.89 . . . . 74.239999999999995 108.598 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -111.74 117.7 33.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.916 -1.038 . . . . 75.239999999999995 109.313 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.5 mpt_? -96.55 136.7 36.7 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.705 -0.48 . . . . 70.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.33 146.76 51.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.655 -0.248 . . . . 75.519999999999996 110.365 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.92 12.54 2.42 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.051 2.501 . . . . 70.329999999999998 112.322 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.33 152.61 32.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 111.227 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.5 m -95.18 151.88 18.84 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.48 26.37 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 110.348 -1.101 . . . . 64.340000000000003 110.348 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -98.75 138.6 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 108.71 -0.848 . . . . 62.420000000000002 108.71 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.1 m -81.42 175.42 10.57 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.416 0.15 . . . . 72.25 111.347 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 2.3 ptm180 -60.86 -36.53 79.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.256 0.622 . . . . 74.439999999999998 111.42 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -131.94 97.55 4.2 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.366 -2.087 . . . . 74.319999999999993 105.366 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -95.85 -37.44 10.72 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.565 0.698 . . . . 73.329999999999998 109.746 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -158.99 143.24 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.696 -0.684 . . . . 74.439999999999998 109.182 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -134.57 126.68 29.77 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.596 -0.729 . . . . 75.209999999999994 111.073 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -103.46 112.91 38.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.465 -0.939 . . . . 72.420000000000002 108.465 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.73 107.67 19.37 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 106.012 -1.847 . . . . 72.430000000000007 106.012 177.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -105.55 108.37 19.85 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.482 -0.781 . . . . 72.439999999999998 109.552 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.82 161.73 13.7 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 105.935 -1.876 . . . . 72.430000000000007 105.935 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.03 60.4 3.06 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.498 -0.858 . . . . 64.019999999999996 111.828 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -177.72 -50.36 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.729 1.212 . . . . 75.120000000000005 109.865 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.51 145.12 35.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 112.64 0.607 . . . . 74.25 112.64 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.92 102.14 11.52 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 115.235 -0.893 . . . . 72.010000000000005 109.432 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 tp -94.29 109.72 21.52 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.9 -1.046 . . . . 74.409999999999997 111.085 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.98 116.75 29.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.621 -1.251 . . . . 74.010000000000005 107.621 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.6 121.13 32.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.942 0.401 . . . . 73.409999999999997 110.834 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.0 134.44 35.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.309 -0.859 . . . . 73.200000000000003 109.141 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.15 77.61 1.75 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.835 -1.172 . . . . 63.240000000000002 107.835 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -170.54 162.72 8.18 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.183 -1.043 . . . . 71.109999999999999 108.183 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 m -108.65 -53.27 2.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 120.475 -0.49 . . . . 75.030000000000001 112.103 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -88.43 -26.69 21.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.371 0.605 . . . . 74.319999999999993 111.895 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -104.85 28.25 7.32 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 122.887 0.475 . . . . 70.530000000000001 110.147 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.76 115.82 1.52 Allowed Glycine 0 C--O 1.246 0.87 0 O-C-N 125.004 1.44 . . . . 71.420000000000002 112.367 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 m -59.19 134.16 56.75 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.321 1.048 . . . . 61.329999999999998 112.676 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 139.67 38.01 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 108.161 -1.051 . . . . 55.329999999999998 108.161 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.51 120.59 62.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.508 -0.923 . . . . 65.400000000000006 108.508 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 59.22 29.13 18.63 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.584 1.183 . . . . 63.0 109.08 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.271 95.8 m-20 67.11 25.26 9.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 112.8 -2.0 . . . . 73.340000000000003 113.92 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.07 125.38 27.68 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.623 -0.881 . . . . 64.219999999999999 108.623 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.8 130.73 14.94 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.339 2.026 . . . . 72.219999999999999 112.675 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.77 176.89 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.044 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -106.44 -38.09 6.3 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.872 -0.788 . . . . 75.310000000000002 108.872 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.02 148.73 42.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.888 -1.051 . . . . 72.329999999999998 110.597 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -153.16 151.97 30.73 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.674 -0.861 . . . . 73.219999999999999 108.674 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -102.2 116.35 32.48 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.578 -1.267 . . . . 74.519999999999996 107.578 173.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.04 138.03 54.94 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 123.729 0.643 . . . . 74.329999999999998 112.152 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.25 169.06 14.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.688 -1.227 . . . . 74.299999999999997 107.688 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.54 124.8 28.84 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.476 -0.329 . . . . 74.109999999999999 110.648 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.97 6.06 56.17 Favored Glycine 0 N--CA 1.436 -1.348 0 CA-C-N 116.016 -0.538 . . . . 70.25 112.295 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.46 134.8 46.83 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.964 0.411 . . . . 71.519999999999996 111.383 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.42 113.21 35.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 N-CA-C 107.79 -1.189 . . . . 75.329999999999998 107.79 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.3 122.4 68.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 C-N-CA 119.863 -0.735 . . . . 73.329999999999998 111.238 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -105.73 109.98 22.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.658 -0.701 . . . . 71.219999999999999 109.13 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -110.7 164.83 12.36 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.672 -0.862 . . . . 74.219999999999999 108.672 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -47.23 106.29 0.15 Allowed Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.689 0.618 . . . . 61.210000000000001 113.444 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 75.81 12.63 2.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.696 1.599 . . . . 72.230000000000004 114.786 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.0 t -154.85 150.4 27.44 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.58 -0.848 . . . . 74.439999999999998 111.531 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.91 128.67 47.92 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.236 0.541 . . . . 75.230000000000004 109.818 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.468 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.4 tp -124.91 148.89 29.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 116.211 -0.45 . . . . 73.420000000000002 110.626 -170.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.91 122.82 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.684 -1.228 . . . . 73.140000000000001 107.684 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 81.8 t -90.58 122.78 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.93 0.395 . . . . 73.439999999999998 110.184 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -119.54 140.98 49.65 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.77 -0.65 . . . . 75.420000000000002 110.516 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 58.2 mtt -121.82 114.53 21.19 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.24 -1.022 . . . . 74.519999999999996 108.24 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 . . . . . 0 C--N 1.278 -2.541 0 N-CA-C 107.024 -1.473 . . . . 75.319999999999993 107.024 -178.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.423 -1.804 0 CA-C-O 120.877 0.37 . . . . 74.420000000000002 111.404 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 m -115.85 114.64 24.99 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.829 -1.174 . . . . 74.150000000000006 107.829 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 25.5 t -91.35 115.9 31.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.402 -0.962 . . . . 73.140000000000001 108.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.465 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.9 m -118.6 127.74 53.89 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 115.742 -0.663 . . . . 73.349999999999994 110.231 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 20' ' ' THR . 69.1 mt -90.57 121.71 32.75 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.91 -1.041 . . . . 60.140000000000001 108.387 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.68 114.52 28.79 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 123.889 0.743 . . . . 75.209999999999994 109.339 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 tp -118.18 109.02 15.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 123.918 0.887 . . . . 75.150000000000006 109.713 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -97.44 101.6 13.17 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.105 -0.702 . . . . 71.329999999999998 109.105 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -97.18 5.26 50.45 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.835 -0.802 . . . . 71.219999999999999 108.835 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.99 -40.43 0.62 Allowed Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 114.671 -1.15 . . . . 74.540000000000006 110.269 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 m -112.01 -50.95 2.88 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 112.889 0.7 . . . . 75.150000000000006 112.889 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.76 82.25 0.55 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.669 -0.776 . . . . 64.109999999999999 111.983 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.11 150.19 22.84 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 110.133 -0.321 . . . . 74.209999999999994 110.133 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.8 p -133.61 145.87 50.42 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 116.138 -0.483 . . . . 62.149999999999999 111.114 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -137.97 129.58 28.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.572 -0.899 . . . . 71.319999999999993 108.572 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 53.1 tt0 -92.39 134.93 34.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.214 -0.662 . . . . 70.319999999999993 109.214 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -60.19 139.92 57.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.433 0.635 . . . . 72.25 111.971 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -95.88 169.65 9.85 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.255 -0.884 . . . . 75.019999999999996 109.757 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.2 pm0 -75.09 122.67 23.93 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 123.536 0.735 . . . . 73.239999999999995 110.758 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.52 -164.93 12.02 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.461 -1.056 . . . . 75.310000000000002 110.461 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.7 t -107.65 142.85 36.97 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 117.116 0.458 . . . . 73.530000000000001 111.433 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.411 ' ND2' ' HB ' ' A' ' 52' ' ' ILE . 7.2 p30 -117.89 117.75 30.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.532 0.682 . . . . 74.349999999999994 109.57 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -91.69 112.3 25.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.99 -1.005 . . . . 72.409999999999997 108.559 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.9 mt -90.3 128.1 42.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 123.914 0.759 . . . . 75.200000000000003 110.009 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.44 175.15 34.11 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.62 -0.992 . . . . 74.0 110.62 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -109.22 106.69 16.65 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.809 -0.811 . . . . 74.420000000000002 108.809 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.01 173.2 42.35 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 109.424 -1.47 . . . . 74.420000000000002 109.424 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -81.72 -16.53 50.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.144 0.497 . . . . 71.530000000000001 110.461 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.46 6.3 49.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.051 0.929 . . . . 75.439999999999998 109.739 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.79 161.46 13.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.107 -0.951 . . . . 65.329999999999998 110.07 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -109.42 -50.27 3.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.542 0.687 . . . . 75.400000000000006 109.595 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 54.2 t80 -106.51 123.85 48.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.2 -1.407 . . . . 75.549999999999997 107.2 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 51.0 mtt180 -111.3 133.34 53.7 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 120.867 -0.333 . . . . 75.299999999999997 110.599 -174.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.63 149.28 71.1 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.534 . . . . 74.310000000000002 110.484 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 -0.09 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.534 2.156 . . . . 72.349999999999994 114.123 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.19 -173.5 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.245 -0.982 . . . . 74.219999999999999 112.085 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 m -96.31 174.35 6.92 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.33 1.052 . . . . 72.239999999999995 108.549 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.89 -21.05 39.41 Favored Glycine 0 CA--C 1.498 -0.996 0 N-CA-C 109.572 -1.411 . . . . 73.109999999999999 109.572 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.12 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.417 -1.392 . . . . 71.310000000000002 108.864 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -88.63 -173.51 4.17 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.451 -0.574 . . . . 74.200000000000003 109.451 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -72.39 -42.73 64.86 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.216 -1.031 . . . . 71.019999999999996 108.216 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.426 HH21 HD21 ' A' ' 64' ' ' LEU . 11.0 mtp180 -120.78 101.84 7.99 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.786 -1.931 . . . . 75.120000000000005 105.786 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -98.97 -43.93 6.52 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.855 -0.424 . . . . 74.120000000000005 109.855 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -159.49 151.17 20.31 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.442 -0.577 . . . . 73.430000000000007 109.442 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -126.78 127.37 44.93 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.351 0.596 . . . . 75.530000000000001 110.744 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.411 ' HB ' ' ND2' ' A' ' 28' ' ' ASN . 70.8 mt -100.43 117.1 45.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.408 -1.33 . . . . 72.099999999999994 107.408 174.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -105.91 110.05 22.21 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.401 -0.592 . . . . 75.239999999999995 109.401 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -104.89 132.43 51.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.489 -0.778 . . . . 74.310000000000002 110.374 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.73 166.88 23.63 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.123 -2.177 . . . . 74.329999999999998 105.123 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.02 65.24 1.91 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 118.377 0.535 . . . . 54.539999999999999 113.13 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -159.16 -78.03 0.07 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.42 -0.956 . . . . 75.019999999999996 108.42 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 m -142.27 159.97 19.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.818 -0.808 . . . . 74.219999999999999 108.818 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 82' ' ' LEU . . . -91.26 114.01 26.42 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.461 -0.57 . . . . 62.299999999999997 109.461 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.0 tp -83.71 108.35 16.71 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.912 -1.04 . . . . 73.120000000000005 109.867 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -93.92 110.83 22.48 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.324 -1.362 . . . . 75.140000000000001 107.324 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.33 119.0 29.82 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.629 -0.508 . . . . 72.349999999999994 109.629 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -95.18 141.18 29.09 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.907 -0.588 . . . . 72.329999999999998 111.445 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.426 HD21 HH21 ' A' ' 48' ' ' ARG . 3.6 mm? -102.15 102.07 12.47 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 122.863 0.465 . . . . 74.530000000000001 110.871 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 67.62 85.14 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.458 1.103 . . . . 74.549999999999997 111.628 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.0 m -65.16 -14.73 61.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.223 1.194 . . . . 74.319999999999993 114.223 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -55.17 -38.27 68.09 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.96 0.886 . . . . 74.430000000000007 110.429 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -121.87 0.52 9.76 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.144 -1.058 . . . . 71.439999999999998 108.144 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 -137.27 1.41 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.026 -1.443 . . . . 74.239999999999995 115.78 -170.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -114.18 152.8 30.65 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-O 122.068 0.937 . . . . 74.420000000000002 113.106 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -121.8 141.21 51.45 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.795 -1.093 . . . . 73.109999999999999 110.448 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.44 HG11 HG13 ' A' ' 88' ' ' ILE . 29.6 m -110.79 124.77 67.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.488 -2.041 . . . . 74.219999999999999 105.488 174.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 62.21 24.13 14.34 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.477 0.711 . . . . 62.240000000000002 109.211 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 71.25 20.77 4.94 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.216 1.407 . . . . 74.239999999999995 110.668 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.63 130.49 24.77 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.981 -0.748 . . . . 65.150000000000006 108.981 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.33 137.39 30.9 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 122.709 2.273 . . . . 73.099999999999994 112.761 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.4 m -143.56 161.22 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.435 -0.58 . . . . 73.150000000000006 109.435 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -85.65 -45.46 11.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.923 -0.769 . . . . 73.140000000000001 108.923 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.33 151.72 38.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.971 -1.013 . . . . 71.299999999999997 108.736 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.427 ' CD2' HG21 ' A' ' 72' ' ' VAL . 64.6 t-105 -151.94 148.87 28.28 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.141 -1.059 . . . . 64.109999999999999 108.141 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.45 108.04 19.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.731 -1.211 . . . . 74.510000000000005 107.731 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.419 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 81.8 mt -57.06 148.26 22.17 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.434 -0.803 . . . . 74.310000000000002 111.702 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.53 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -147.34 164.04 34.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.796 -1.187 . . . . 63.420000000000002 107.796 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.35 119.81 9.81 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.702 0.626 . . . . 75.340000000000003 111.867 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.34 16.27 35.32 Favored Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 115.525 -0.761 . . . . 64.420000000000002 113.034 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.07 146.75 23.48 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 119.212 -0.995 . . . . 70.310000000000002 108.615 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.04 112.91 42.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.11 -0.7 . . . . 62.200000000000003 109.11 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.44 HG13 HG11 ' A' ' 72' ' ' VAL . 1.8 mp -105.83 119.69 55.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.414 -0.958 . . . . 73.109999999999999 108.414 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -121.9 116.96 25.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 119.493 -0.883 . . . . 74.129999999999995 111.343 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.54 164.97 13.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.536 -1.211 . . . . 74.329999999999998 108.547 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -39.2 107.91 0.08 OUTLIER Glycine 0 N--CA 1.479 1.55 0 O-C-N 123.964 0.79 . . . . 62.32 114.443 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 69.5 -4.03 1.47 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.304 1.442 . . . . 72.319999999999993 114.864 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 m -129.42 112.96 14.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.354 0.597 . . . . 73.329999999999998 111.345 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.73 132.68 49.77 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.775 -1.194 . . . . 75.340000000000003 107.775 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.417 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.1 tp -134.69 140.41 45.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.861 -0.422 . . . . 73.549999999999997 109.861 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.17 128.6 56.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.785 -1.191 . . . . 73.219999999999999 107.785 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.95 116.51 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.177 0.513 . . . . 74.209999999999994 110.774 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -110.77 129.31 55.88 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.608 -0.724 . . . . 75.25 109.336 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.53 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 86.4 mtp -111.62 108.54 18.05 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.777 -1.194 . . . . 71.239999999999995 107.777 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 C--N 1.27 -2.883 0 CA-C-N 114.756 -1.111 . . . . 74.420000000000002 108.463 -176.297 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.418 -2.048 0 N-CA-C 108.302 -0.999 . . . . 74.140000000000001 108.302 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -118.99 115.49 24.45 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.851 -1.166 . . . . 65.340000000000003 107.851 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 23' ' ' LEU . 6.2 p -93.63 127.76 45.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.022 0 CA-C-O 121.503 0.668 . . . . 74.200000000000003 109.211 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.4 m -125.64 131.73 52.59 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.409 -0.814 . . . . 73.230000000000004 109.142 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.65 133.07 36.35 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.346 -0.613 . . . . 75.420000000000002 109.346 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -105.2 109.21 21.11 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.068 -1.827 . . . . 55.200000000000003 106.068 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.21 122.21 44.27 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.078 -0.51 . . . . 65.340000000000003 110.502 -175.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.59 99.33 12.38 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.358 -2.089 . . . . 74.329999999999998 105.358 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -121.31 -6.77 9.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.16 -0.927 . . . . 74.400000000000006 110.778 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.17 -15.8 12.01 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 109.913 -1.275 . . . . 62.100000000000001 109.913 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 m -111.61 -44.24 3.53 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.969 -0.752 . . . . 64.510000000000005 108.969 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.59 67.67 1.19 Allowed Glycine 0 CA--C 1.48 -2.141 0 N-CA-C 107.848 -2.101 . . . . 71.409999999999997 107.848 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -91.92 154.08 19.07 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.015 -0.592 . . . . 72.319999999999993 110.479 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 45.6 p -130.17 131.95 45.84 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.025 -1.102 . . . . 75.239999999999995 108.025 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -134.84 125.64 27.22 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.586 -0.524 . . . . 73.530000000000001 109.586 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.81 121.84 26.95 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.946 -0.761 . . . . 75.439999999999998 108.946 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB2' HG11 ' A' ' 9' ' ' VAL . 80.0 mt -66.12 139.25 58.14 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.161 -0.927 . . . . 73.319999999999993 111.923 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.58 153.46 21.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.482 -1.673 . . . . 72.129999999999995 106.482 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.24 133.88 48.49 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 73.140000000000001 111.598 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.4 -166.6 13.26 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 107.522 -2.231 . . . . 72.510000000000005 107.522 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 61.1 p -106.45 128.96 54.47 Favored 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.432 -1.307 . . . . 70.219999999999999 111.19 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -96.99 111.87 23.89 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.55 -1.278 . . . . 74.219999999999999 107.55 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mm -85.8 123.81 39.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.98 -0.555 . . . . 75.340000000000003 110.342 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.4 mt -109.52 138.19 38.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.849 -0.614 . . . . 72.409999999999997 109.606 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 152.4 -162.51 29.92 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.952 -0.859 . . . . 61.229999999999997 110.952 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.4 mtt180 -121.52 105.88 10.87 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 117.663 0.732 . . . . 72.430000000000007 109.373 176.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.49 47.74 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 120.061 -1.066 . . . . 75.140000000000001 111.318 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -75.73 -23.73 56.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.764 0.792 . . . . 71.540000000000006 109.088 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.38 -18.87 44.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.759 -1.109 . . . . 71.129999999999995 110.498 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.18 136.25 36.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.895 -0.593 . . . . 74.239999999999995 111.833 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.73 -24.05 16.14 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.575 -0.898 . . . . 75.129999999999995 108.575 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -133.29 120.0 20.5 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.617 -1.174 . . . . 73.409999999999997 108.594 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 79.6 mtt180 -97.82 130.57 44.74 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.14 0.495 . . . . 73.340000000000003 111.321 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -77.6 144.83 70.22 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.473 -0.785 . . . . 72.030000000000001 111.057 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 9.22 2.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.963 2.442 . . . . 74.209999999999994 113.448 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -123.42 163.64 20.45 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.503 -1.295 . . . . 72.230000000000004 107.503 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 m -110.23 172.11 7.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.82 -0.807 . . . . 75.340000000000003 108.82 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.19 5.27 62.33 Favored Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 109.472 -1.451 . . . . 73.319999999999993 109.472 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.36 145.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.036 -1.082 . . . . 72.099999999999994 108.306 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -79.07 173.43 12.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.197 0.199 . . . . 51.219999999999999 110.627 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.5 ptp180 -65.15 -31.06 72.05 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.653 0.739 . . . . 74.409999999999997 110.566 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -134.08 109.59 9.05 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.728 -2.323 . . . . 72.310000000000002 104.728 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -104.56 -35.82 7.72 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 123.807 0.692 . . . . 72.430000000000007 110.247 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -162.86 149.57 12.8 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.689 -0.486 . . . . 74.129999999999995 109.689 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.25 122.53 37.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.451 0.643 . . . . 71.420000000000002 109.964 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.9 mt -96.29 104.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.783 -1.562 . . . . 72.340000000000003 106.783 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 63.8 ttt180 -91.84 107.29 19.11 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.777 0.799 . . . . 74.319999999999993 109.802 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -94.86 106.95 18.96 Favored 'General case' 0 N--CA 1.391 -3.395 0 N-CA-C 107.384 -1.339 . . . . 75.030000000000001 107.384 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -106.3 -175.36 2.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.671 -1.603 . . . . 63.240000000000002 106.671 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.02 57.26 4.32 Favored Glycine 0 C--N 1.285 -2.261 0 C-N-CA 119.493 -1.337 . . . . 42.509999999999998 115.445 -171.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -179.3 -65.59 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.602 0.761 . . . . 71.239999999999995 109.666 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.46 156.56 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.269 -0.423 . . . . 61.509999999999998 109.998 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.35 109.8 22.49 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.161 -1.051 . . . . 51.310000000000002 108.161 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.39 122.52 31.99 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.979 -1.01 . . . . 75.450000000000003 110.505 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -103.27 125.51 49.95 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.678 -1.23 . . . . 75.420000000000002 107.678 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.07 124.65 26.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.995 -0.372 . . . . 73.450000000000003 109.995 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.53 137.87 32.17 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.495 -0.775 . . . . 74.519999999999996 109.183 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.9 tp -133.89 75.97 1.63 Allowed 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.688 0.756 . . . . 74.129999999999995 109.121 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.558 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 38.5 t-20 -173.07 142.52 1.06 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.897 -1.52 . . . . 71.519999999999996 106.897 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -95.69 -47.68 6.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.89 -0.724 . . . . 61.43 110.834 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.452 HG21 ' ND2' ' A' ' 68' ' ' ASN . 12.2 t -88.92 -12.43 41.69 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.327 0.584 . . . . 60.439999999999998 112.302 -174.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.558 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 36.5 m-80 -121.43 27.55 8.23 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.778 -0.576 . . . . 64.25 111.07 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.38 113.95 0.79 Allowed Glycine 0 N--CA 1.481 1.676 0 O-C-N 124.403 1.064 . . . . 72.439999999999998 113.777 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 m -63.82 146.71 53.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.013 1.325 . . . . 73.409999999999997 112.57 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -109.73 140.74 43.25 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 115.183 -0.917 . . . . 63.299999999999997 112.467 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 27.5 m -118.88 122.03 68.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 105.832 -1.914 . . . . 75.310000000000002 105.832 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 62.69 25.38 15.08 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.042 -0.725 . . . . 75.340000000000003 109.042 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.7 t30 79.58 4.86 2.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.215 1.406 . . . . 75.319999999999993 111.745 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.0 34.15 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 121.545 -0.722 . . . . 71.420000000000002 109.933 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.74 130.98 15.29 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.277 1.985 . . . . 73.540000000000006 111.596 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.4 159.07 40.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.255 -0.43 . . . . 74.219999999999999 110.645 -175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -82.11 -38.74 24.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.993 -0.743 . . . . 73.239999999999995 108.993 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.1 155.54 36.98 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.577 -0.897 . . . . 75.109999999999999 108.577 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.437 ' CD2' HG22 ' A' ' 72' ' ' VAL . 54.0 t-105 -159.98 149.1 17.6 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.309 -0.997 . . . . 73.239999999999995 108.309 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -100.8 115.17 29.69 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.045 -1.062 . . . . 72.150000000000006 108.642 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 88' ' ' ILE . 62.3 mt -61.91 147.9 45.27 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.568 -1.196 . . . . 72.530000000000001 111.415 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.86 168.01 19.84 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.891 -1.522 . . . . 74.25 106.891 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 121.3 16.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.551 -0.537 . . . . 72.349999999999994 109.551 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.1 44.18 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 115.6 -0.727 . . . . 71.120000000000005 112.398 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.1 152.86 25.14 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 107.405 -1.331 . . . . 75.109999999999999 107.405 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 39.1 t -114.16 112.87 42.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.081 -0.34 . . . . 71.299999999999997 110.081 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 72' ' ' VAL . 1.6 mp -107.44 114.14 45.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.558 -1.275 . . . . 72.409999999999997 107.558 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.5 ' HG3' ' HB3' ' A' ' 94' ' ' GLU . 15.5 ttt180 -123.43 127.6 48.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 120.275 -0.57 . . . . 65.099999999999994 110.361 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.37 163.34 33.04 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.696 -1.594 . . . . 71.519999999999996 106.696 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -45.46 119.38 3.5 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.59 0.556 . . . . 62.350000000000001 114.003 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 29.0 t60 78.75 -33.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.134 1.374 . . . . 74.299999999999997 113.181 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.1 m -114.2 116.77 29.58 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.416 0.627 . . . . 72.230000000000004 111.56 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.5 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 11.5 pt-20 -116.9 121.71 42.24 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.828 -0.805 . . . . 75.219999999999999 108.828 173.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -126.49 136.83 59.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.881 -1.054 . . . . 73.25 111.94 -170.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -105.55 127.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.098 -1.075 . . . . 70.140000000000001 108.098 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 55.5 t -86.99 125.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 116.412 -0.358 . . . . 75.329999999999998 110.969 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -115.68 149.52 38.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.718 -0.475 . . . . 74.540000000000006 109.718 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.3 mtt -130.26 116.92 19.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.456 0.646 . . . . 73.409999999999997 110.323 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.08 -1.081 . . . . 71.319999999999993 108.08 -178.846 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.432 -1.368 0 CA-C-O 121.116 0.484 . . . . 70.439999999999998 110.682 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -111.15 116.87 31.82 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.542 -1.281 . . . . 74.319999999999993 107.542 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.0 t -99.81 132.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.555 -0.535 . . . . 75.120000000000005 109.555 -175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.1 m -135.66 127.64 29.59 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.912 -0.773 . . . . 73.129999999999995 108.912 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.3 pp -95.84 139.96 31.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.821 -0.437 . . . . 75.510000000000005 109.821 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -112.05 106.32 14.93 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.115 -0.698 . . . . 65.230000000000004 109.115 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.07 126.42 50.24 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.404 -0.962 . . . . 74.209999999999994 108.404 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -94.25 100.87 12.85 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 117.752 -1.579 . . . . 74.319999999999993 110.479 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.61 -0.11 57.55 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.495 -1.23 . . . . 74.430000000000007 109.016 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 42.69 0.96 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.566 -1.814 . . . . 64.409999999999997 108.566 -173.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.4 t -177.59 -24.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.865 -0.668 . . . . 74.5 111.289 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.1 71.29 1.05 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.463 -0.875 . . . . 55.219999999999999 110.951 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -88.72 153.47 21.07 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 122.824 0.45 . . . . 75.150000000000006 110.228 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.8 p -129.75 132.63 46.63 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.461 0.648 . . . . 74.519999999999996 111.989 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -125.62 127.23 46.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.394 -0.965 . . . . 74.340000000000003 108.394 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.563 -0.532 . . . . 72.540000000000006 109.563 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.2 mt -81.03 122.19 26.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.881 -0.785 . . . . 74.019999999999996 108.881 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -91.67 156.18 17.78 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.0 -0.68 . . . . 75.310000000000002 109.314 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.17 132.71 51.19 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.621 1.201 . . . . 73.230000000000004 111.302 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.41 -162.5 12.47 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 107.279 -2.329 . . . . 71.25 107.279 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.5 p -106.21 131.57 53.29 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 118.618 -1.233 . . . . 74.430000000000007 111.164 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.67 111.52 23.85 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.493 -1.299 . . . . 75.420000000000002 107.493 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.9 mm -85.69 121.9 37.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.098 -0.704 . . . . 75.129999999999995 109.098 -176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.0 mt -112.57 132.83 60.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.605 -0.725 . . . . 75.25 109.704 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 145.53 -161.24 28.2 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 109.807 -1.317 . . . . 72.120000000000005 109.807 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 84.1 mtt180 -121.55 106.53 11.47 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.908 -0.775 . . . . 74.420000000000002 108.908 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.83 179.0 43.79 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.541 -1.024 . . . . 75.400000000000006 110.541 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -64.41 -46.45 83.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.865 0.691 . . . . 73.25 112.865 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.22 1.95 55.96 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.163 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 124.12 23.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.551 -0.907 . . . . 72.239999999999995 108.551 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -89.38 -38.04 14.41 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.672 0.749 . . . . 75.319999999999993 109.588 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -117.61 112.17 20.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.191 -0.913 . . . . 75.0 109.051 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -89.41 133.54 34.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.488 -0.778 . . . . 71.25 111.174 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 HD11 ' CD1' ' A' ' 90' ' ' LEU . 85.5 mt -89.67 140.22 28.05 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 115.458 -0.792 . . . . 61.200000000000003 111.628 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.95 -23.0 30.45 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.11 2.54 . . . . 74.549999999999997 112.018 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -72.01 164.67 25.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.788 -0.642 . . . . 71.140000000000001 109.518 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -129.71 149.38 51.48 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 108.446 -0.946 . . . . 74.430000000000007 108.446 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.28 48.2 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 107.553 -2.219 . . . . 75.140000000000001 107.553 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -88.28 143.14 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 112.695 -1.753 . . . . 74.349999999999994 108.743 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 m -78.01 169.48 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 110.055 -0.35 . . . . 73.439999999999998 110.055 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 19.2 ptt180 -65.39 -37.27 86.49 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.865 0.84 . . . . 75.329999999999998 109.115 172.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -123.69 100.41 6.77 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 105.098 -2.186 . . . . 74.519999999999996 105.098 169.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -95.07 -32.44 13.11 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.904 -0.776 . . . . 61.420000000000002 108.904 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 tt -167.57 143.17 3.99 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.59 -0.732 . . . . 74.129999999999995 109.222 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -124.47 126.12 45.38 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.941 -0.572 . . . . 74.129999999999995 110.337 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 69.1 mt -103.14 112.9 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.519 -0.919 . . . . 74.319999999999993 108.519 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -90.79 110.13 21.33 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.563 -0.903 . . . . 73.540000000000006 108.563 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -99.86 110.54 22.89 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 114.986 -1.006 . . . . 71.099999999999994 108.755 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -116.41 174.42 6.07 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.357 -2.09 . . . . 73.209999999999994 105.357 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.98 32.39 2.73 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 120.272 -0.966 . . . . 74.140000000000001 112.908 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -134.83 -65.59 0.62 Allowed 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.414 0.685 . . . . 75.040000000000006 109.315 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.04 159.51 26.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 115.886 -0.597 . . . . 53.240000000000002 109.7 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 109.97 21.76 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.662 -0.866 . . . . 71.329999999999998 108.662 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 14.2 mt -89.65 119.54 30.15 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.131 -1.395 . . . . 54.240000000000002 112.935 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -100.94 108.41 20.15 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 113.311 -1.768 . . . . 73.140000000000001 108.08 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.0 115.76 25.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.884 -0.413 . . . . 71.439999999999998 109.884 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.45 134.85 34.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.812 -0.631 . . . . 75.430000000000007 110.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -126.35 75.97 1.58 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.508 -0.923 . . . . 73.019999999999996 108.508 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -170.3 122.63 0.66 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 121.107 0.479 . . . . 75.010000000000005 110.124 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.3 m -93.38 -14.22 27.11 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.891 -0.506 . . . . 71.349999999999994 111.269 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -89.14 -56.45 3.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.859 0.838 . . . . 73.049999999999997 110.706 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -119.71 29.55 7.52 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.157 -0.929 . . . . 75.329999999999998 109.423 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.4 130.98 5.96 Favored Glycine 0 C--O 1.251 1.184 0 CA-C-N 114.238 -1.346 . . . . 73.239999999999995 113.486 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -66.93 143.43 56.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 125.66 1.584 . . . . 52.530000000000001 113.168 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 p -107.95 141.72 39.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.591 -1.186 . . . . 75.400000000000006 110.275 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 80' ' ' TRP . 31.4 m -120.76 120.64 63.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.844 -1.539 . . . . 73.510000000000005 106.844 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 61.64 25.96 15.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.463 0.649 . . . . 73.230000000000004 109.621 -175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.8 t30 78.15 3.15 2.8 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.46 1.904 . . . . 75.319999999999993 111.358 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.73 124.02 51.85 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.371 -0.603 . . . . 74.430000000000007 109.371 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.14 125.94 11.92 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.248 1.966 . . . . 65.239999999999995 111.155 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.91 166.58 25.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 116.476 -0.329 . . . . 71.310000000000002 110.164 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.452 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 25.1 pt20 -100.67 -26.8 13.68 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.254 -0.646 . . . . 62.219999999999999 109.254 174.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 78' ' ' GLN . 10.6 pt-20 -158.52 148.96 20.05 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.785 -0.643 . . . . 72.140000000000001 109.814 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.446 ' CD2' HG21 ' A' ' 72' ' ' VAL . 53.7 t-105 -163.84 152.93 14.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.302 -0.999 . . . . 75.420000000000002 108.302 -172.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -105.67 121.31 43.73 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.321 -0.952 . . . . 73.549999999999997 109.07 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.62 151.09 47.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.205 -0.907 . . . . 73.349999999999994 113.106 -174.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.49 165.75 25.52 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.14 -1.43 . . . . 64.299999999999997 107.14 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.12 121.25 16.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.933 0.396 . . . . 64.430000000000007 109.969 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.34 8.2 53.29 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.708 -0.678 . . . . 74.420000000000002 111.693 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.12 134.02 36.13 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 107.566 -1.272 . . . . 74.5 107.566 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -98.93 112.81 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.341 -0.614 . . . . 65.209999999999994 109.341 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.09 129.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 106.958 -1.497 . . . . 73.540000000000006 106.958 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -138.24 149.29 45.61 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.814 -0.754 . . . . 74.310000000000002 110.969 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 40' ' ' LEU . 2.0 pt? -138.32 165.55 26.46 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.852 -2.277 . . . . 75.530000000000001 104.852 172.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -34.84 102.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.833 0 N-CA-C 115.98 1.152 . . . . 63.119999999999997 115.98 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 60.85 17.96 8.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.4 1.08 . . . . 64.109999999999999 113.908 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -131.6 114.01 14.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.819 -0.808 . . . . 72.409999999999997 108.819 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.06 139.8 49.92 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.586 0.708 . . . . 75.439999999999998 112.013 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.51 137.11 50.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.71 -1.132 . . . . 74.329999999999998 110.392 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.78 126.04 65.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.827 -0.805 . . . . 63.299999999999997 108.827 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.0 t -85.07 126.36 40.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.674 -0.239 . . . . 72.099999999999994 110.693 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -115.31 145.05 42.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.572 -0.529 . . . . 74.120000000000005 109.572 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.0 mtt -130.37 127.49 39.49 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.693 -0.685 . . . . 74.129999999999995 109.598 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 107.173 -1.417 . . . . 75.409999999999997 107.173 178.311 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.204 0.526 . . . . 74.430000000000007 111.329 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -116.52 134.74 54.5 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.722 -1.214 . . . . 71.150000000000006 107.722 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 23' ' ' LEU . 3.4 p -101.37 114.81 41.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.435 -0.95 . . . . 72.340000000000003 108.435 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.5 m -124.43 136.05 53.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 114.663 -1.153 . . . . 75.150000000000006 110.667 -169.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 20' ' ' THR . 57.7 mt -89.23 126.37 35.47 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.476 -1.238 . . . . 75.329999999999998 109.402 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.61 114.51 28.65 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.709 -1.219 . . . . 75.540000000000006 107.709 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 62.8 tp -118.07 110.99 18.31 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.671 -0.863 . . . . 65.209999999999994 108.671 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.06 100.26 12.41 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 117.764 -1.575 . . . . 65.319999999999993 109.629 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.6 30.43 3.61 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 106.382 -1.71 . . . . 72.530000000000001 106.382 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.5 47.08 17.18 Favored Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.177 -1.969 . . . . 74.019999999999996 108.177 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -162.81 -29.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.154 0.582 . . . . 72.129999999999995 111.785 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.91 3.46 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.692 -0.963 . . . . 72.239999999999995 110.692 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -87.95 148.21 24.68 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 110.062 -0.347 . . . . 73.450000000000003 110.062 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 22.9 p -135.45 132.24 37.18 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.076 0.465 . . . . 62.200000000000003 111.789 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -128.25 126.21 40.45 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.218 -1.401 . . . . 74.219999999999999 107.218 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -94.87 141.08 29.06 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.432 -0.507 . . . . 73.099999999999994 110.305 -175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HB2' HG12 ' A' ' 9' ' ' VAL . 95.6 mt -80.48 140.82 35.72 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.605 -0.517 . . . . 75.400000000000006 109.605 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -96.61 169.06 10.15 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.387 -0.525 . . . . 65.340000000000003 110.274 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.62 112.99 11.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.265 0.978 . . . . 73.319999999999993 110.43 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.38 -159.65 23.19 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.124 -1.991 . . . . 62.299999999999997 108.124 -174.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.6 p -101.27 131.44 47.29 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.139 -1.024 . . . . 73.530000000000001 110.646 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 24.6 m-80 -106.67 112.33 25.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 74.099999999999994 107.774 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -96.95 126.1 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.401 -0.222 . . . . 74.129999999999995 110.401 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.06 142.97 31.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 C-N-CA 123.545 0.738 . . . . 64.040000000000006 109.837 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 153.49 -154.0 25.21 Favored Glycine 0 CA--C 1.475 -2.453 0 N-CA-C 110.683 -0.967 . . . . 63.109999999999999 110.683 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 16.7 mmm180 -131.73 104.83 7.12 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.256 0.55 . . . . 75.099999999999994 109.789 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 169.97 37.63 Favored Glycine 0 N--CA 1.41 -3.06 0 N-CA-C 108.99 -1.644 . . . . 71.450000000000003 108.99 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.16 -14.22 60.53 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.693 0.759 . . . . 74.319999999999993 109.701 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.19 -10.01 40.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.355 -0.838 . . . . 73.299999999999997 110.704 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -90.59 149.2 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.363 -0.606 . . . . 74.230000000000004 109.363 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 86.8 mt-30 -87.25 -49.28 7.37 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.742 -0.836 . . . . 75.510000000000005 108.742 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -105.44 111.42 24.13 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.397 -0.82 . . . . 73.349999999999994 109.069 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -91.16 122.55 33.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.477 -0.783 . . . . 63.240000000000002 110.725 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.63 158.4 74.36 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.147 -0.933 . . . . 74.219999999999999 112.033 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.78 26.68 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.533 2.822 . . . . 73.450000000000003 112.161 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.72 153.38 47.19 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.181 -1.415 . . . . 73.510000000000005 107.181 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -121.39 161.32 22.34 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 120.235 -0.586 . . . . 73.329999999999998 109.625 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.56 -15.47 24.51 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 108.502 -1.839 . . . . 63.350000000000001 108.502 -172.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.9 t -76.93 149.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 125.449 1.5 . . . . 72.319999999999993 108.894 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.0 m -75.67 163.39 27.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 119.597 -0.24 . . . . 75.230000000000004 110.901 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 44.6 ptt85 -60.28 -41.39 93.21 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 120.94 0.4 . . . . 75.439999999999998 110.681 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -121.53 107.07 11.99 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 106.323 -1.732 . . . . 74.219999999999999 106.323 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -103.21 -34.04 8.97 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.654 -1.157 . . . . 75.129999999999995 108.945 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 tt -166.39 148.51 6.72 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 115.669 -0.696 . . . . 72.510000000000005 109.134 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.32 144.45 42.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.856 -0.794 . . . . 71.349999999999994 108.856 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.4 mt -117.2 119.13 60.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 109.555 -0.535 . . . . 74.329999999999998 109.555 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -91.17 107.72 19.39 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.599 -1.259 . . . . 75.329999999999998 107.599 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -105.44 118.71 37.26 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.714 -0.675 . . . . 71.230000000000004 109.366 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.45 -178.84 4.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.564 -2.384 . . . . 73.420000000000002 104.564 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.3 53.42 4.78 Favored Glycine 0 C--N 1.297 -1.601 0 C-N-CA 119.856 -1.164 . . . . 42.43 112.721 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -147.74 -77.45 0.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.487 0.715 . . . . 73.349999999999994 109.333 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.61 159.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.043 -0.725 . . . . 65.109999999999999 109.043 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.93 107.84 19.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.111 -1.07 . . . . 74.329999999999998 108.111 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.88 113.27 20.38 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.377 -0.828 . . . . 70.109999999999999 108.828 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -90.29 119.59 30.72 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 124.805 1.242 . . . . 74.319999999999993 108.347 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.14 119.72 28.28 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.535 -0.543 . . . . 44.030000000000001 109.535 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 131.58 42.35 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.844 -0.617 . . . . 74.219999999999999 111.148 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.68 76.72 1.11 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.057 -0.719 . . . . 74.310000000000002 109.057 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -176.43 139.9 0.35 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.527 -0.916 . . . . 54.509999999999998 108.527 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -108.25 -50.23 3.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.928 -0.397 . . . . 64.209999999999994 109.928 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -59.1 -49.03 79.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.65 0.738 . . . . 72.510000000000005 111.549 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -121.38 28.14 7.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.695 0.76 . . . . 74.299999999999997 109.28 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.95 144.65 9.7 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 113.83 -1.532 . . . . 74.400000000000006 115.182 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.8 m -75.65 143.13 42.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.492 1.117 . . . . 72.109999999999999 112.063 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.9 p -110.91 148.83 31.61 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.813 -0.631 . . . . 74.409999999999997 111.043 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 88' ' ' ILE . 34.1 m -114.87 118.38 58.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.663 -1.236 . . . . 70.219999999999999 107.663 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.4 29.84 19.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.569 0.7 . . . . 72.329999999999998 110.415 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 77.62 13.26 1.86 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.198 1.799 . . . . 70.200000000000003 111.242 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.97 128.14 25.9 Favored Pre-proline 0 C--N 1.32 -0.706 0 O-C-N 121.859 -0.526 . . . . 73.299999999999997 109.598 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.19 125.74 11.69 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.689 2.259 . . . . 62.5 112.467 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.69 -177.2 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.125 -1.065 . . . . 72.349999999999994 108.125 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -125.39 -27.28 3.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.356 0.41 . . . . 72.209999999999994 110.784 175.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.76 134.47 28.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 74.299999999999997 109.727 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -149.13 152.15 35.61 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.917 -0.771 . . . . 74.140000000000001 108.917 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -101.7 107.52 18.77 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.468 -1.678 . . . . 71.219999999999999 106.468 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 82.9 mt -58.9 137.49 57.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.154 0.502 . . . . 75.150000000000006 112.054 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.01 163.47 24.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.859 -1.163 . . . . 74.349999999999994 107.859 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.91 117.93 8.31 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.426 -0.352 . . . . 74.420000000000002 110.204 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.48 -0.98 30.83 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.825 -0.702 . . . . 51.32 113.814 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -80.07 141.65 35.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.523 0.662 . . . . 73.329999999999998 111.305 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.22 113.77 39.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 N-CA-C 108.682 -0.859 . . . . 73.230000000000004 108.682 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.432 HG13 HG13 ' A' ' 72' ' ' VAL . 1.8 mp -107.34 114.16 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.661 -0.866 . . . . 75.540000000000006 108.661 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 94' ' ' GLU . 37.3 ttt180 -106.57 109.42 21.33 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.031 -1.067 . . . . 74.430000000000007 112.04 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -112.79 164.43 13.4 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.684 -1.599 . . . . 74.239999999999995 106.684 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -24.58 99.14 0.01 OUTLIER Glycine 0 N--CA 1.485 1.908 0 O-C-N 124.661 1.225 . . . . 73.219999999999999 116.092 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 t60 77.65 -28.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.79 1.636 . . . . 72.430000000000007 113.581 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 m -114.73 119.6 37.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 113.495 0.924 . . . . 73.430000000000007 113.495 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 6.8 pt-20 -94.16 115.11 27.35 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.661 -0.866 . . . . 74.200000000000003 108.661 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.483 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.0 tp -103.34 140.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.941 -1.027 . . . . 74.25 109.239 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.3 mt -101.68 121.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.063 -1.088 . . . . 74.420000000000002 108.063 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.5 t -87.6 118.3 33.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.463 -0.335 . . . . 75.349999999999994 110.167 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -119.58 150.55 40.11 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 109.524 -0.547 . . . . 74.409999999999997 109.524 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mtt -117.25 120.41 38.15 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.347 -0.982 . . . . 71.430000000000007 108.347 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 . . . . . 0 C--N 1.273 -2.726 0 N-CA-C 107.633 -1.247 . . . . 70.030000000000001 107.633 -177.17 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.432 -1.369 0 N-CA-C 109.317 -0.623 . . . . 75.540000000000006 109.317 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -144.53 131.85 20.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.371 -0.603 . . . . 63.020000000000003 109.371 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.16 113.23 35.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.579 -1.267 . . . . 71.129999999999995 107.579 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 129.55 55.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.26 -0.882 . . . . 73.209999999999994 109.719 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' THR . 83.5 mt -87.56 123.54 32.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.202 -1.036 . . . . 74.129999999999995 108.202 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.72 120.72 41.79 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 116.145 -0.479 . . . . 73.530000000000001 109.746 -175.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.67 146.89 51.42 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 107.289 -1.374 . . . . 73.420000000000002 107.289 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -95.23 118.36 31.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.817 -1.153 . . . . 74.329999999999998 110.986 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.15 -6.18 22.46 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.08 -1.418 . . . . 73.310000000000002 109.273 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.81 31.85 2.02 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.829 -1.708 . . . . 70.030000000000001 108.829 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.5 t 171.37 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.781 -1.933 . . . . 72.310000000000002 105.781 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.5 100.58 1.25 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.167 -1.016 . . . . 71.310000000000002 113.011 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 mtm-85 -86.21 158.68 19.68 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.81 -1.181 . . . . 73.209999999999994 107.81 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.7 p -139.61 138.43 36.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 116.053 -0.521 . . . . 73.239999999999995 110.191 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.0 118.4 30.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.121 -1.437 . . . . 72.25 107.121 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -92.82 132.22 37.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.469 -0.937 . . . . 63.439999999999998 108.469 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.06 122.05 25.06 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.04 -0.356 . . . . 73.319999999999993 110.04 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -85.84 166.89 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.928 -1.138 . . . . 73.219999999999999 107.928 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -67.61 123.29 20.06 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.263 -0.643 . . . . 73.239999999999995 109.263 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.37 -163.94 14.69 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 110.041 -1.224 . . . . 40.420000000000002 110.041 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.9 p -99.46 141.13 32.65 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 117.947 0.873 . . . . 71.129999999999995 111.565 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -122.71 115.59 22.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.891 -1.522 . . . . 61.240000000000002 106.891 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -97.15 133.61 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.544 -0.298 . . . . 72.519999999999996 111.396 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.9 mt -107.73 133.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.574 -0.899 . . . . 72.030000000000001 108.574 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.4 -161.21 31.98 Favored Glycine 0 CA--C 1.49 -1.478 0 N-CA-C 110.756 -0.938 . . . . 72.109999999999999 110.756 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.6 mtm180 -123.37 105.8 10.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.158 -1.053 . . . . 75.310000000000002 108.158 174.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.05 -176.29 48.01 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 109.21 -1.556 . . . . 74.540000000000006 109.21 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -88.18 -16.12 34.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.409 0.623 . . . . 72.239999999999995 109.438 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.921 0.867 . . . . 72.230000000000004 109.781 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.75 145.41 28.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.739 -0.664 . . . . 75.140000000000001 110.72 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -105.11 -12.36 16.16 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.895 0.855 . . . . 75.219999999999999 109.764 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -139.77 121.81 15.7 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.91 -1.885 . . . . 63.240000000000002 105.91 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.7 ttt180 -100.37 131.54 46.24 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.333 -0.394 . . . . 75.430000000000007 111.426 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.2 mt -92.01 138.51 24.62 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.826 -0.625 . . . . 74.510000000000005 109.489 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -92.9 12.46 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 122.96 2.44 . . . . 74.439999999999998 111.691 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -93.31 -173.31 3.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.875 -0.602 . . . . 71.099999999999994 109.891 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -113.5 152.35 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.553 0.216 . . . . 73.129999999999995 111.139 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.74 86.92 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.237 0.354 . . . . 71.230000000000004 112.877 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.51 114.51 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.438 -0.578 . . . . 74.540000000000006 109.438 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -64.22 176.69 0.97 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 124.186 0.994 . . . . 73.420000000000002 110.894 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 23.7 ptt85 -63.8 -34.75 78.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.63 0.729 . . . . 74.140000000000001 109.818 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -120.67 109.16 14.88 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.659 -1.238 . . . . 73.439999999999998 107.659 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.426 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 18.9 t60 -103.33 -31.76 9.89 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.479 -0.934 . . . . 74.5 108.479 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 tt -167.3 152.94 7.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.536 -0.913 . . . . 75.239999999999995 108.536 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -135.34 140.41 45.06 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.293 0.568 . . . . 75.200000000000003 109.923 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.0 mt -115.89 114.21 45.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.9 -0.778 . . . . 72.439999999999998 108.9 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.47 110.23 21.64 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.949 -0.759 . . . . 74.409999999999997 108.949 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -99.93 108.66 20.95 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.769 -0.65 . . . . 74.209999999999994 111.295 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -107.81 162.57 13.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.595 -1.632 . . . . 73.319999999999993 106.595 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.67 66.72 1.06 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.847 0.699 . . . . 72.230000000000004 114.847 -175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -169.22 -72.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.953 0.901 . . . . 73.319999999999993 108.978 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.57 159.15 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.51 -0.922 . . . . 73.109999999999999 108.51 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.83 120.81 40.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.416 0.627 . . . . 74.420000000000002 110.145 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.2 tp -80.93 125.46 30.15 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.868 -1.06 . . . . 73.349999999999994 109.882 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -111.62 120.55 42.45 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.315 -0.624 . . . . 73.129999999999995 109.315 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.98 124.53 40.95 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.407 -0.59 . . . . 75.519999999999996 109.407 176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.71 133.8 38.0 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.396 -0.366 . . . . 74.129999999999995 111.157 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.61 76.41 1.34 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.803 -0.443 . . . . 72.129999999999995 109.803 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -173.0 133.61 0.54 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.292 0.496 . . . . 70.0 109.748 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -98.75 -35.75 10.05 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.116 0.484 . . . . 64.099999999999994 111.271 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -87.93 -32.48 18.89 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.23 0.538 . . . . 71.230000000000004 112.151 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -122.56 28.66 7.25 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.07 -0.394 . . . . 74.129999999999995 110.334 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.05 133.17 6.54 Favored Glycine 0 C--O 1.246 0.902 0 O-C-N 124.949 1.405 . . . . 75.129999999999995 113.985 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -74.11 136.68 42.96 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.906 0.882 . . . . 75.049999999999997 112.366 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 28.2 p -111.13 143.68 41.48 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.896 -0.593 . . . . 70.409999999999997 110.49 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 80' ' ' TRP . 35.0 m -111.9 121.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.687 -1.597 . . . . 74.430000000000007 106.687 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.13 23.41 13.61 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.504 0.721 . . . . 64.400000000000006 110.023 -169.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 75.66 9.31 3.58 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.054 1.342 . . . . 72.129999999999995 110.866 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.43 124.04 50.29 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.246 -0.65 . . . . 70.349999999999994 109.246 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.72 126.76 15.9 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.116 2.544 . . . . 73.400000000000006 113.038 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 159.87 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.386 -0.825 . . . . 75.019999999999996 109.013 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.34 -19.7 14.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.1 -0.704 . . . . 74.430000000000007 109.1 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.74 149.43 34.38 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.387 -0.824 . . . . 75.120000000000005 110.289 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.464 ' CD2' HG22 ' A' ' 72' ' ' VAL . 77.3 t-105 -159.76 152.83 21.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.194 -0.669 . . . . 74.439999999999998 109.194 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.16 114.95 29.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.58 -1.267 . . . . 75.230000000000004 107.58 174.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.8 mt -56.92 132.83 53.81 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 112.953 0.723 . . . . 74.409999999999997 112.953 -174.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.49 155.37 39.06 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.382 -1.34 . . . . 61.049999999999997 107.382 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.52 128.3 35.68 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 123.24 0.337 . . . . 73.450000000000003 111.169 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.04 55.41 Favored Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 115.757 -0.656 . . . . 71.25 112.487 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.13 136.76 34.33 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 108.705 -0.85 . . . . 74.219999999999999 108.705 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.65 111.61 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.456 -1.313 . . . . 74.129999999999995 107.456 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.67 118.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 CA-C-O 121.292 0.568 . . . . 72.439999999999998 109.554 -174.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.409 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 24.2 mtp180 -111.97 106.71 15.47 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.95 0.881 . . . . 74.420000000000002 110.439 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.426 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 0.5 OUTLIER -108.3 164.47 12.28 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.372 -1.286 . . . . 70.219999999999999 108.267 178.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -28.25 90.97 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 O-C-N 124.752 1.282 . . . . 71.439999999999998 115.837 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 60.68 11.78 3.32 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 125.86 1.664 . . . . 74.530000000000001 112.418 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 m -131.37 113.5 13.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.788 -0.819 . . . . 73.319999999999993 108.788 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -105.94 136.9 44.77 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.841 -0.744 . . . . 60.520000000000003 110.81 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.422 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 10.7 tp -129.72 146.31 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 108.741 -0.837 . . . . 75.140000000000001 108.741 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -111.97 133.24 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.622 -0.881 . . . . 74.5 108.622 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.0 t -90.9 114.54 28.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.901 -0.407 . . . . 65.310000000000002 109.901 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -114.49 122.44 46.58 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.002 -0.545 . . . . 75.120000000000005 110.315 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.7 mtt -101.93 125.9 48.71 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.37 -0.832 . . . . 74.049999999999997 110.573 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.293 -1.864 0 CA-C-N 114.519 -1.219 . . . . 73.409999999999997 108.877 178.502 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 m . . . . . 0 N--CA 1.431 -1.402 0 N-CA-C 108.811 -0.811 . . . . 74.340000000000003 108.811 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 17.4 m -123.41 146.75 47.74 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.338 -0.986 . . . . 74.129999999999995 108.338 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 23' ' ' LEU . 3.1 p -135.85 115.81 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 107.349 -1.352 . . . . 72.150000000000006 107.349 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -114.79 131.96 56.63 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.175 -1.375 . . . . 71.219999999999999 110.361 -170.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 pp -98.7 133.52 42.91 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.799 -0.815 . . . . 74.439999999999998 108.799 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -99.9 120.64 40.1 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.782 -0.644 . . . . 65.230000000000004 110.692 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.5 tp -129.85 111.32 12.47 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.261 -0.882 . . . . 70.409999999999997 110.082 -174.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -89.0 100.58 13.33 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.04 -1.464 . . . . 53.409999999999997 108.848 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.61 9.62 40.97 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.699 -1.591 . . . . 61.43 108.568 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.4 -13.77 10.17 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.293 -0.867 . . . . 71.120000000000005 111.113 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 m -137.23 13.32 3.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.852 -0.174 . . . . 70.349999999999994 111.374 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.31 83.6 0.04 OUTLIER Glycine 0 C--N 1.345 1.079 0 N-CA-C 114.279 0.471 . . . . 73.510000000000005 114.279 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -98.77 144.38 28.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.281 0.562 . . . . 75.129999999999995 111.237 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.4 p -122.5 134.45 54.57 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.897 -1.149 . . . . 74.519999999999996 107.897 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -137.25 131.75 32.8 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.577 0.214 . . . . 74.319999999999993 111.577 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.39 136.07 38.38 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.846 -0.427 . . . . 74.409999999999997 109.846 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' A' ' 9' ' ' VAL . 43.8 mt -68.31 139.62 55.92 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.803 -0.635 . . . . 73.040000000000006 110.038 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -105.31 152.98 22.24 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.404 -0.591 . . . . 74.140000000000001 109.404 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.33 136.96 58.22 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 124.344 1.027 . . . . 74.420000000000002 111.518 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.49 -164.11 12.45 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.722 -2.151 . . . . 74.340000000000003 107.722 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.6 p -104.43 130.03 52.36 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.233 -1.387 . . . . 72.120000000000005 112.236 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -99.95 108.97 21.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 105.409 -2.071 . . . . 74.099999999999994 105.409 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.9 mt -98.57 130.34 47.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.886 -0.597 . . . . 72.040000000000006 110.948 -173.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.0 mt -101.99 123.4 55.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.143 -1.058 . . . . 72.540000000000006 108.143 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.4 -176.4 39.57 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.702 -1.359 . . . . 75.319999999999993 109.702 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -115.03 106.16 13.81 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 117.63 0.715 . . . . 73.319999999999993 109.309 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.56 177.49 44.65 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.509 -1.036 . . . . 73.019999999999996 110.509 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -81.19 -16.95 51.36 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.5 0.667 . . . . 73.430000000000007 109.622 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.61 -23.85 31.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.653 0.739 . . . . 74.430000000000007 110.086 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 47' ' ' ARG . . . -82.99 162.42 21.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.127 -0.942 . . . . 72.019999999999996 110.95 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -104.36 -58.46 1.88 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.811 -0.811 . . . . 62.200000000000003 108.811 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.35 129.95 46.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.575 -0.738 . . . . 75.540000000000006 109.16 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 24.8 mtm180 -108.37 131.13 55.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.103 -0.499 . . . . 75.120000000000005 110.364 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.64 142.36 57.27 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.382 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -89.1 27.79 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.032 2.488 . . . . 71.230000000000004 110.917 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -135.09 -177.7 4.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.959 -1.126 . . . . 74.400000000000006 107.959 -174.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -116.46 178.68 4.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.731 -0.84 . . . . 75.439999999999998 108.731 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.76 79.52 Favored Glycine 0 C--N 1.317 -0.476 0 N-CA-C 110.213 -1.155 . . . . 63.140000000000001 110.213 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.9 136.47 53.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 114.347 -0.927 . . . . 74.340000000000003 109.584 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -89.7 -164.43 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.821 -0.807 . . . . 72.219999999999999 108.821 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 35.8 ptt180 -78.27 -30.42 48.49 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 118.767 -1.173 . . . . 73.200000000000003 108.557 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -121.87 108.03 12.98 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.038 -1.467 . . . . 72.140000000000001 107.038 170.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -104.21 -34.78 8.24 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.047 -1.094 . . . . 73.109999999999999 108.047 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tt -165.42 142.92 5.83 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.976 -1.12 . . . . 73.5 107.976 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -131.14 129.88 42.37 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.508 0.67 . . . . 72.200000000000003 110.936 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.44 110.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 115.376 -0.829 . . . . 71.400000000000006 108.951 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 25.2 ttt180 -90.57 110.19 21.33 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.994 -0.743 . . . . 73.109999999999999 108.994 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -94.68 107.64 19.64 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.146 -1.057 . . . . 75.030000000000001 108.146 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.36 152.49 31.39 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 105.145 -2.169 . . . . 71.340000000000003 105.145 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.24 57.54 2.81 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 118.423 0.556 . . . . 71.120000000000005 112.365 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -159.22 -60.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.432 -1.322 . . . . 74.129999999999995 107.432 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.7 m -143.88 156.91 16.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 115.54 -0.755 . . . . 71.299999999999997 109.924 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.25 102.64 14.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.787 -1.19 . . . . 75.019999999999996 107.787 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.23 116.9 23.84 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.226 -0.897 . . . . 72.510000000000005 109.858 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -99.4 119.35 37.83 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.901 -1.148 . . . . 74.519999999999996 107.901 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.16 27.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.183 0.516 . . . . 73.310000000000002 110.307 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 5.9 t70 -85.99 138.87 31.67 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.887 0.875 . . . . 72.310000000000002 109.316 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.04 76.67 1.69 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -166.24 150.07 7.58 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.802 -0.561 . . . . 74.530000000000001 109.899 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 m -108.22 -30.28 8.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.207 0.527 . . . . 70.109999999999999 111.409 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.9 m -88.94 -60.29 2.0 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.145 0.974 . . . . 65.409999999999997 111.867 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -104.4 28.6 6.77 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 125.048 1.339 . . . . 73.340000000000003 109.519 -168.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.86 139.25 5.0 Favored Glycine 0 C--O 1.256 1.531 0 CA-C-N 114.017 -1.447 . . . . 71.530000000000001 113.71 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -83.61 155.74 23.07 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.13 0.972 . . . . 63.329999999999998 112.381 -172.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.4 p -118.98 153.71 34.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.952 -0.567 . . . . 74.209999999999994 110.261 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 HG13 ' A' ' 88' ' ' ILE . 35.6 m -116.6 116.28 51.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.816 -1.179 . . . . 62.409999999999997 107.816 175.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 62.36 27.1 16.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.018 0.913 . . . . 71.209999999999994 109.359 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.87 15.97 3.03 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.307 1.843 . . . . 74.049999999999997 111.26 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.23 123.74 38.7 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 108.693 -0.855 . . . . 73.200000000000003 108.693 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.62 124.4 9.28 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.173 1.915 . . . . 74.230000000000004 112.998 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -156.25 169.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 104.963 -2.236 . . . . 73.400000000000006 104.963 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.1 mt-30 -113.24 -6.23 13.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.394 -0.923 . . . . 74.230000000000004 112.536 175.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.43 140.59 21.25 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.163 -0.615 . . . . 73.420000000000002 111.909 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -163.29 152.56 14.82 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.205 -1.035 . . . . 74.540000000000006 108.205 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.59 116.7 33.13 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.777 -0.823 . . . . 71.409999999999997 108.777 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.6 mt -61.77 130.38 45.51 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.678 0.622 . . . . 74.140000000000001 112.678 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -126.78 167.84 15.23 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.88 -0.785 . . . . 72.219999999999999 108.88 173.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 26.2 t70 -60.55 124.45 20.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.465 -0.334 . . . . 71.519999999999996 110.634 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.9 -7.36 52.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.721 -0.752 . . . . 70.420000000000002 113.622 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -73.97 135.04 43.16 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 117.179 0.49 . . . . 74.099999999999994 111.488 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.92 113.07 39.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.718 -0.845 . . . . 74.239999999999995 108.718 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.499 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 1.8 mp -98.27 113.22 32.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 106.55 -1.648 . . . . 75.109999999999999 106.55 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -115.5 116.21 27.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.25 0.548 . . . . 74.299999999999997 111.193 -169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -123.79 164.71 18.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.892 1.277 . . . . 71.439999999999998 108.365 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.39 113.8 0.9 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.642 0.617 . . . . 74.319999999999993 114.642 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.8 m80 64.82 7.13 3.69 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.85 1.26 . . . . 73.150000000000006 114.068 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.4 m -140.83 125.87 18.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.779 -0.369 . . . . 55.219999999999999 110.939 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.92 121.78 40.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.163 -0.68 . . . . 75.510000000000005 109.163 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.499 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 6.9 tp -109.74 125.7 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 N-CA-C 108.725 -0.843 . . . . 74.430000000000007 108.725 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.51 129.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.158 -0.682 . . . . 74.329999999999998 109.158 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.4 t -94.52 123.88 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.568 0.699 . . . . 71.239999999999995 111.961 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -112.92 119.24 37.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.043 -0.98 . . . . 73.209999999999994 108.677 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 85.6 mtp -107.1 120.99 43.59 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.298 -0.561 . . . . 74.150000000000006 110.591 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 28.4 m-70 . . . . . 0 C--N 1.283 -2.32 0 N-CA-C 107.137 -1.431 . . . . 75.439999999999998 107.137 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.436 -1.174 0 N-CA-C 109.102 -0.703 . . . . 74.099999999999994 109.102 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.0 m -134.4 138.2 44.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.332 -0.618 . . . . 74.530000000000001 109.332 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.64 109.56 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.233 -1.395 . . . . 72.230000000000004 107.233 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.419 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 57.0 m -108.63 122.38 46.98 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.293 -1.003 . . . . 71.450000000000003 108.293 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 47.1 mt -87.7 128.7 35.3 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.672 -1.233 . . . . 73.140000000000001 107.672 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -100.97 117.64 35.41 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 107.055 -1.461 . . . . 74.519999999999996 107.055 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.3 tp -91.94 125.85 36.8 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.672 -0.695 . . . . 65.400000000000006 109.385 -175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.58 100.13 11.72 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 107.466 -1.309 . . . . 75.219999999999999 107.466 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -126.95 -14.01 5.64 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.768 -1.106 . . . . 54.439999999999998 109.701 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.41 -29.98 6.18 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.382 -1.087 . . . . 61.140000000000001 110.382 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -90.11 -35.03 15.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.123 -1.066 . . . . 64.439999999999998 108.123 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.39 57.93 2.39 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 109.85 -1.3 . . . . 74.439999999999998 109.85 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.9 mmp_? -87.51 162.88 16.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.562 -0.319 . . . . 75.219999999999999 110.304 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 p -128.59 143.4 50.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.872 0.368 . . . . 74.439999999999998 110.764 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -127.27 113.1 15.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.829 -0.804 . . . . 74.420000000000002 108.829 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.71 132.68 35.3 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.849 -0.797 . . . . 74.510000000000005 108.849 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.89 132.13 53.02 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.051 0.845 . . . . 72.450000000000003 111.454 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.32 145.54 32.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.094 -1.076 . . . . 73.209999999999994 108.094 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.99 113.56 10.16 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.087 0.946 . . . . 73.420000000000002 109.901 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.83 -161.01 24.75 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 107.041 -2.424 . . . . 75.209999999999994 107.041 -173.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.2 p -107.56 137.69 45.13 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 118.449 1.125 . . . . 74.430000000000007 112.311 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -120.76 120.89 36.92 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.254 -0.647 . . . . 65.329999999999998 109.254 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.62 121.22 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.535 -0.913 . . . . 72.219999999999999 108.535 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 76.2 mt -97.96 130.01 47.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.005 -0.739 . . . . 71.219999999999999 109.005 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.97 -173.11 36.6 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 110.182 -1.167 . . . . 75.010000000000005 110.182 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 40' ' ' LEU . 25.9 mtm105 -124.08 107.22 11.04 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 117.678 0.739 . . . . 64.439999999999998 110.179 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.47 176.71 44.87 Favored Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.529 -1.028 . . . . 62.210000000000001 110.529 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -55.64 -32.22 62.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.954 0.902 . . . . 75.099999999999994 112.244 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -95.26 1.55 54.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.212 -0.449 . . . . 63.520000000000003 111.894 -173.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.03 149.76 24.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.039 0.447 . . . . 74.239999999999995 112.069 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -107.24 -57.77 2.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.867 0.867 . . . . 72.340000000000003 108.716 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 19.8 t80 -101.67 117.06 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.992 -1.855 . . . . 75.530000000000001 105.992 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 36.6 mtm180 -107.89 126.58 52.84 Favored 'General case' 0 C--N 1.279 -2.476 0 C-N-CA 120.445 -0.502 . . . . 71.430000000000007 111.573 -174.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.546 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 63.3 mt -75.45 148.75 83.49 Favored Pre-proline 0 C--O 1.21 -0.998 0 CA-C-N 115.756 -0.657 . . . . 74.209999999999994 109.434 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.57 11.65 2.84 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.476 2.118 . . . . 75.129999999999995 113.925 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -116.39 -177.37 3.16 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.427 -0.582 . . . . 74.430000000000007 109.427 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 m -128.69 149.65 50.59 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 123.234 0.614 . . . . 73.540000000000006 109.629 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -16.67 24.02 Favored Glycine 0 CA--C 1.495 -1.182 0 N-CA-C 108.548 -1.821 . . . . 62.009999999999998 108.548 -175.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 t -80.69 128.37 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.372 -1.414 . . . . 74.219999999999999 107.401 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -68.39 166.19 17.21 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 123.502 0.501 . . . . 71.230000000000004 112.104 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.3 ptt-85 -62.26 -37.63 86.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.58 0.705 . . . . 74.040000000000006 109.437 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 51' ' ' GLU . 21.7 mtp180 -126.22 95.8 4.5 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.725 -2.695 . . . . 74.510000000000005 103.725 169.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -92.12 -37.47 12.73 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.772 0.796 . . . . 72.219999999999999 109.148 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -161.75 150.02 15.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.094 -1.076 . . . . 61.340000000000003 108.094 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 48' ' ' ARG . 8.4 pt-20 -139.77 125.98 20.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.662 0.744 . . . . 72.219999999999999 111.313 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.99 121.89 52.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.045 -0.98 . . . . 64.519999999999996 108.36 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -106.25 107.18 18.05 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.716 -1.216 . . . . 74.219999999999999 107.716 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -108.65 121.19 44.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.954 0.883 . . . . 74.010000000000005 112.959 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -133.41 158.13 43.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.542 -1.651 . . . . 63.119999999999997 106.542 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.41 68.41 0.53 Allowed Glycine 0 C--N 1.314 -0.684 0 N-CA-C 114.772 0.669 . . . . 70.129999999999995 114.772 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -165.79 -70.72 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.727 -1.212 . . . . 74.0 107.727 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.57 150.99 29.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.802 0.334 . . . . 73.239999999999995 110.614 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.98 112.69 24.53 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.294 0.568 . . . . 75.129999999999995 109.494 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 tt -84.23 117.7 23.69 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.954 -1.021 . . . . 74.040000000000006 108.873 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.77 109.94 21.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.222 -1.399 . . . . 73.439999999999998 107.222 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 111.09 21.09 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.264 0.554 . . . . 72.040000000000006 110.023 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 136.79 35.85 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.591 -0.892 . . . . 75.340000000000003 108.591 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.51 106.31 16.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.534 -0.913 . . . . 75.120000000000005 108.534 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.533 ' OD1' ' HB ' ' A' ' 67' ' ' THR . 28.7 t-20 69.78 89.47 0.1 Allowed 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.11 -0.95 . . . . 74.129999999999995 111.39 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.73 -18.14 64.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.956 . . . . 73.340000000000003 111.868 -175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.533 ' HB ' ' OD1' ' A' ' 65' ' ' ASN . 18.5 m -46.44 -53.58 10.84 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 73.120000000000005 110.979 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -122.34 27.13 8.08 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.654 -1.61 . . . . 73.230000000000004 106.654 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.88 -144.91 17.91 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.337 -1.302 . . . . 64.219999999999999 115.854 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -107.4 156.47 18.9 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.124 -1.038 . . . . 74.510000000000005 112.842 -169.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 p -119.21 140.81 49.59 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.175 -0.921 . . . . 75.340000000000003 109.8 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 88' ' ' ILE . 35.9 m -114.91 115.74 50.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.712 -1.218 . . . . 74.200000000000003 107.712 177.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.99 28.63 18.41 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.844 0.831 . . . . 75.400000000000006 109.115 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 81.18 0.06 1.71 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.194 2.198 . . . . 74.310000000000002 111.603 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.41 121.34 58.76 Favored Pre-proline 0 C--N 1.316 -0.884 0 O-C-N 121.556 -0.715 . . . . 74.140000000000001 109.724 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.11 125.45 9.26 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.094 1.862 . . . . 75.150000000000006 110.941 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.78 161.65 18.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.0 -1.111 . . . . 73.299999999999997 108.0 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -88.5 -18.45 28.18 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.177 0.513 . . . . 64.420000000000002 111.518 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.73 152.39 17.7 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.2 -0.667 . . . . 74.439999999999998 109.2 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -154.52 151.76 29.28 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.589 -0.893 . . . . 75.420000000000002 108.589 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -101.93 108.26 19.66 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.53 -1.285 . . . . 63.43 107.53 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.31 146.81 38.19 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.879 0.737 . . . . 73.439999999999998 112.068 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.4 170.62 18.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.754 -1.202 . . . . 73.239999999999995 107.754 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.27 128.27 35.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.706 0.288 . . . . 72.109999999999999 111.127 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.76 2.74 57.29 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 120.967 -0.635 . . . . 64.329999999999998 112.933 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -85.17 134.03 34.18 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 120.192 -0.603 . . . . 75.120000000000005 110.573 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.27 114.86 41.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.723 -0.672 . . . . 72.400000000000006 109.466 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.64 109.6 26.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 N-CA-C 107.475 -1.305 . . . . 74.109999999999999 107.475 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.2 ttp85 -110.41 120.02 41.1 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.681 0.753 . . . . 74.299999999999997 110.207 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.94 165.0 15.23 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 114.63 -1.168 . . . . 75.310000000000002 108.559 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.98 100.97 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.405 0.922 . . . . 34.229999999999997 115.405 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.9 m170 71.54 17.99 5.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.279 1.432 . . . . 71.299999999999997 113.603 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.5 m -154.28 135.7 14.18 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.947 -0.47 . . . . 72.109999999999999 111.778 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.839 -0.538 . . . . 74.209999999999994 110.025 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.549 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.2 tp -126.9 137.34 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.812 -0.81 . . . . 74.310000000000002 108.812 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -107.45 127.37 63.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.46 -0.57 . . . . 74.519999999999996 109.46 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.3 t -85.15 119.98 34.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.142 0.496 . . . . 74.209999999999994 111.262 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -113.86 126.16 54.87 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.0 mtt -115.22 131.42 56.93 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.776 0.798 . . . . 74.230000000000004 111.416 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.419 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 78.6 m-70 . . . . . 0 C--N 1.279 -2.5 0 CA-C-N 114.385 -1.28 . . . . 73.319999999999993 108.123 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.93 -0.767 . . . . 71.010000000000005 108.93 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -104.85 115.02 29.59 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.711 -0.848 . . . . 74.099999999999994 108.711 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.63 113.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.753 -1.203 . . . . 62.439999999999998 107.753 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -117.63 117.28 28.96 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.967 -0.753 . . . . 75.400000000000006 108.967 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.48 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -87.7 137.25 32.5 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 108.476 -0.935 . . . . 74.319999999999993 108.476 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -108.52 125.84 52.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.901 -0.778 . . . . 72.530000000000001 108.901 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -133.16 114.77 14.24 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.47 0.653 . . . . 75.319999999999993 110.968 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.9 102.17 13.5 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.106 -0.702 . . . . 64.430000000000007 109.106 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.64 10.77 37.59 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.57 1.176 . . . . 74.409999999999997 108.935 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.6 39.43 1.1 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.927 -1.269 . . . . 61.520000000000003 109.927 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -170.71 -61.87 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.983 -0.747 . . . . 61.329999999999998 108.983 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.09 92.58 1.56 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.012 -0.835 . . . . 70.319999999999993 111.012 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.444 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.5 mmp_? -123.65 165.63 16.89 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 122.21 -0.583 . . . . 74.099999999999994 110.858 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.2 p -136.45 149.16 48.09 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.946 -0.761 . . . . 63.210000000000001 108.946 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.426 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 88.3 t80 -140.34 119.69 13.02 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.879 -0.785 . . . . 64.349999999999994 108.879 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -85.13 134.11 34.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.052 -1.092 . . . . 74.430000000000007 108.052 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.83 131.12 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.654 0.596 . . . . 70.209999999999994 110.968 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -90.05 150.14 22.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.385 -1.339 . . . . 71.299999999999997 107.385 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.72 118.32 14.41 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.926 0.87 . . . . 62.520000000000003 111.333 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 -168.6 23.82 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 107.232 -2.347 . . . . 73.540000000000006 107.232 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.9 p -106.67 129.71 54.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 118.822 1.311 . . . . 71.409999999999997 110.687 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -110.54 129.27 55.83 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.209 -0.451 . . . . 65.109999999999999 109.849 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.4 mt -99.09 125.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.388 -0.597 . . . . 72.439999999999998 109.388 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.4 135.55 46.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.99 -0.744 . . . . 74.120000000000005 108.99 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 147.17 -168.06 28.34 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 110.566 -1.014 . . . . 73.140000000000001 110.566 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 mtm105 -116.31 106.6 13.84 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.536 -0.866 . . . . 75.319999999999993 110.868 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.21 177.84 46.27 Favored Glycine 0 N--CA 1.403 -3.563 0 N-CA-C 109.772 -1.331 . . . . 71.099999999999994 109.772 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -76.57 -20.13 57.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.653 0.74 . . . . 75.150000000000006 110.222 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.61 -29.11 19.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.165 -0.925 . . . . 72.099999999999994 109.511 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.09 142.31 57.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.855 -1.066 . . . . 51.009999999999998 110.62 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -94.98 -47.98 6.18 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.178 -1.045 . . . . 74.340000000000003 108.178 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -109.37 113.74 26.81 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.879 -1.055 . . . . 74.230000000000004 109.134 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mpt_? -90.01 113.5 25.2 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.747 -0.66 . . . . 63.009999999999998 111.677 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 mt -80.49 125.91 79.78 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.307 -0.406 . . . . 73.319999999999993 110.658 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 7.9 Cg_exo -69.83 6.92 1.15 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.243 2.629 . . . . 72.099999999999994 116.016 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.89 175.85 7.05 Favored 'General case' 0 C--O 1.252 1.184 0 O-C-N 121.187 -0.946 . . . . 75.5 110.141 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.476 ' HA ' HH21 ' A' ' 32' ' ' ARG . 25.0 m -113.15 138.71 49.55 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.229 -0.656 . . . . 74.349999999999994 109.229 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.58 -13.57 32.75 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 109.693 -1.363 . . . . 70.219999999999999 109.693 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.5 123.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 CA-C-N 114.081 -1.06 . . . . 64.150000000000006 108.639 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 m -75.56 171.91 13.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.964 -0.562 . . . . 65.019999999999996 111.878 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.9 ptm180 -61.01 -31.28 70.9 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.929 0.871 . . . . 72.319999999999993 110.464 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -134.58 99.86 4.47 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 103.446 -2.798 . . . . 72.439999999999998 103.446 171.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -96.18 -36.82 10.81 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.551 0.691 . . . . 74.450000000000003 109.42 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.4 tt -162.62 148.06 12.33 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 71.209999999999994 108.137 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.47 142.49 49.26 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 109.456 -0.572 . . . . 72.209999999999994 109.456 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.63 114.31 45.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.46 -0.941 . . . . 75.340000000000003 108.46 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 50.2 ttt180 -91.71 107.55 19.29 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.034 -1.098 . . . . 75.030000000000001 108.034 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -106.98 117.75 34.87 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.927 -0.579 . . . . 65.310000000000002 110.417 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.4 160.63 19.62 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.125 -1.806 . . . . 75.549999999999997 106.125 174.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.82 59.35 1.72 Allowed Glycine 0 C--N 1.305 -1.171 0 C-N-CA 121.406 -0.426 . . . . 74.409999999999997 113.48 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -171.19 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.216 1.007 . . . . 71.239999999999995 109.545 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -134.35 150.68 31.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.963 0.411 . . . . 73.519999999999996 111.288 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.32 104.95 14.68 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.165 -0.925 . . . . 75.510000000000005 108.614 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.1 tp -89.18 109.73 20.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.776 -1.102 . . . . 71.239999999999995 110.236 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.7 tm? -92.45 124.2 36.32 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.018 -1.104 . . . . 75.430000000000007 108.018 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.49 127.34 40.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.795 0.331 . . . . 65.329999999999998 110.403 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.73 129.26 43.0 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.853 0.861 . . . . 71.420000000000002 111.289 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.82 76.91 1.47 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.787 0.435 . . . . 72.439999999999998 110.184 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 179.95 114.79 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 108.587 -0.894 . . . . 72.129999999999995 108.587 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.3 m -83.78 -24.07 31.22 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.85 -0.531 . . . . 75.439999999999998 111.264 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -80.49 -58.82 2.94 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.354 0.597 . . . . 74.25 109.893 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -103.82 28.57 6.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.477 0.711 . . . . 74.25 110.363 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.37 131.24 5.9 Favored Glycine 0 C--O 1.242 0.644 0 O-C-N 124.703 1.252 . . . . 71.150000000000006 114.793 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 m -76.68 137.64 39.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 124.196 0.999 . . . . 72.150000000000006 112.095 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 25.3 p -107.13 149.55 27.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.206 -0.452 . . . . 74.549999999999997 110.339 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 80' ' ' TRP . 30.4 m -114.0 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.865 -1.161 . . . . 74.209999999999994 107.865 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 62.16 26.82 16.13 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.201 -0.909 . . . . 72.200000000000003 109.9 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.54 26.04 0.9 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.324 1.85 . . . . 75.25 111.309 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.34 130.7 24.58 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.698 -0.683 . . . . 71.239999999999995 109.638 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.83 125.8 10.22 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.83 2.353 . . . . 53.420000000000002 113.372 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 m -142.63 166.43 15.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.004 -0.739 . . . . 74.340000000000003 109.004 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -106.41 -30.43 9.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.346 -0.388 . . . . 63.210000000000001 110.856 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 7.0 pt-20 -134.95 146.69 49.36 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.805 -0.813 . . . . 74.150000000000006 108.805 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.412 ' CD2' HG23 ' A' ' 72' ' ' VAL . 74.0 t-105 -157.06 148.96 22.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 75.040000000000006 109.727 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -99.99 105.2 16.86 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.028 -1.101 . . . . 71.430000000000007 108.028 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.9 mt -56.66 131.02 47.79 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 116.044 -0.525 . . . . 73.010000000000005 111.932 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.22 163.23 18.86 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.611 -0.885 . . . . 75.319999999999993 108.611 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.27 123.58 20.34 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.047 0.451 . . . . 75.510000000000005 109.786 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -8.69 44.62 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-N 115.93 -0.577 . . . . 64.129999999999995 112.48 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.98 133.27 47.09 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 117.11 0.455 . . . . 71.319999999999993 111.321 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 t -103.5 113.55 40.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.89 -0.781 . . . . 75.420000000000002 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.49 118.63 43.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 N-CA-C 107.049 -1.463 . . . . 75.230000000000004 107.049 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 60.6 mtp180 -118.66 129.87 55.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.492 0.663 . . . . 72.430000000000007 111.863 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.7 164.87 19.0 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 106.231 -1.766 . . . . 74.25 106.231 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.21 108.41 0.16 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 123.719 0.637 . . . . 74.5 113.107 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 77.81 -35.79 0.21 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.959 1.703 . . . . 62.520000000000003 113.152 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.6 m -100.0 130.33 46.15 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.9 -0.5 . . . . 74.349999999999994 111.059 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.78 147.63 49.98 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.002 0.43 . . . . 63.329999999999998 111.033 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.48 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.7 137.71 42.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.705 -0.68 . . . . 73.109999999999999 110.927 -175.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.91 125.86 64.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.604 -0.888 . . . . 74.340000000000003 108.604 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.7 t -87.67 121.68 38.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 110.82 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -121.24 143.04 49.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.697 -0.483 . . . . 72.430000000000007 109.697 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.05 140.04 50.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.048 -0.524 . . . . 65.340000000000003 109.928 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 . . . . . 0 C--N 1.287 -2.112 0 N-CA-C 107.772 -1.196 . . . . 73.340000000000003 107.772 177.136 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.6 m . . . . . 0 N--CA 1.411 -2.395 0 N-CA-C 106.273 -1.751 . . . . 73.049999999999997 106.273 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' A' ' 22' ' ' GLN . 18.7 m -107.17 114.29 28.25 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.108 -1.071 . . . . 74.219999999999999 108.108 176.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 23' ' ' LEU . 4.3 p -98.43 124.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.522 0.677 . . . . 72.420000000000002 109.708 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -128.7 130.17 46.78 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.521 -0.763 . . . . 73.409999999999997 109.817 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.41 136.39 33.01 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.449 -0.574 . . . . 75.310000000000002 109.449 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -122.74 134.03 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.572 0.749 . . . . 64.010000000000005 110.76 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -148.28 146.63 28.69 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.567 -1.642 . . . . 73.239999999999995 106.567 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -105.67 118.55 36.88 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 119.043 -1.063 . . . . 73.549999999999997 111.326 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -113.89 6.65 16.71 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.286 -1.325 . . . . 63.119999999999997 108.808 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.14 33.41 0.79 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.724 -0.751 . . . . 73.409999999999997 112.611 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p 176.85 -39.41 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.975 0.91 . . . . 72.420000000000002 110.339 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.98 93.72 2.21 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.867 -1.293 . . . . 73.329999999999998 109.867 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -88.47 149.01 23.89 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.103 -1.073 . . . . 74.310000000000002 108.103 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 24.1 p -146.35 132.33 19.2 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.821 0.701 . . . . 73.140000000000001 111.088 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -129.51 124.68 34.55 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.169 -1.419 . . . . 75.129999999999995 107.169 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.426 ' NE2' ' HB3' ' A' ' 8' ' ' SER . 35.6 tt0 -93.11 131.52 38.08 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 120.993 0.425 . . . . 74.030000000000001 110.686 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.1 mt -77.08 140.08 40.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.229 -0.896 . . . . 73.530000000000001 108.854 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 2.8 mpt_? -109.25 169.96 8.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.664 -1.236 . . . . 74.409999999999997 107.664 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.16 130.97 46.9 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.637 0.732 . . . . 75.420000000000002 111.666 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.79 -170.54 14.92 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.519 -1.833 . . . . 70.319999999999993 108.519 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -99.61 129.57 45.77 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 118.727 -1.189 . . . . 74.319999999999993 110.441 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -108.27 109.7 21.11 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.584 -1.265 . . . . 75.030000000000001 107.584 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.34 131.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.382 -0.827 . . . . 73.439999999999998 109.502 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.69 128.21 64.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 109.209 -0.663 . . . . 75.010000000000005 109.209 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 162.99 -171.44 38.77 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 110.795 -0.922 . . . . 72.219999999999999 110.795 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HG3' ' CG1' ' A' ' 45' ' ' VAL . 65.8 mtt180 -110.26 107.62 17.45 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 117.607 0.704 . . . . 74.319999999999993 109.91 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.68 177.14 45.41 Favored Glycine 0 N--CA 1.408 -3.172 0 N-CA-C 109.769 -1.332 . . . . 64.25 109.769 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -86.01 -22.99 27.0 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.866 -1.161 . . . . 72.230000000000004 107.866 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.65 -27.29 55.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.864 -1.062 . . . . 71.519999999999996 108.854 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 139.59 38.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.655 -1.157 . . . . 75.140000000000001 110.451 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -82.09 -45.52 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.497 0.665 . . . . 75.340000000000003 109.921 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -116.43 129.03 56.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.592 -0.892 . . . . 74.549999999999997 108.592 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -102.19 140.05 36.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.983 -0.553 . . . . 73.230000000000004 110.584 -178.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.23 147.77 39.16 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.343 -0.39 . . . . 72.329999999999998 111.038 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -86.0 8.28 4.59 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.948 2.432 . . . . 63.229999999999997 111.042 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -116.51 160.22 20.93 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.131 0.972 . . . . 73.239999999999995 108.835 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -111.51 -177.86 3.3 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.764 -0.374 . . . . 73.230000000000004 110.316 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.0 -11.8 71.31 Favored Glycine 0 CA--C 1.51 -0.229 0 N-CA-C 109.622 -1.391 . . . . 73.400000000000006 109.622 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 32' ' ' ARG . 8.3 p -86.35 149.66 4.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 125.284 1.434 . . . . 71.200000000000003 110.094 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -97.4 -174.29 2.89 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 107.971 -1.122 . . . . 72.519999999999996 107.971 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -74.1 -37.6 64.11 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.884 -1.154 . . . . 71.439999999999998 107.884 175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -115.47 94.05 4.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.504 -1.295 . . . . 75.340000000000003 107.504 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -105.24 -37.53 6.85 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.785 -1.098 . . . . 74.340000000000003 109.503 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -161.45 152.45 18.31 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.36 -0.978 . . . . 70.219999999999999 108.36 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -136.28 138.86 42.19 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.196 0.522 . . . . 75.120000000000005 109.86 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -110.61 114.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.965 -0.754 . . . . 75.239999999999995 108.965 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 63.7 ttt180 -90.42 109.54 20.66 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.101 -1.074 . . . . 74.019999999999996 108.101 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -107.71 114.94 29.25 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.422 -0.808 . . . . 73.129999999999995 110.958 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.98 167.75 13.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.678 -1.601 . . . . 75.219999999999999 106.678 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.7 72.79 1.49 Allowed Glycine 0 C--N 1.302 -1.328 0 C-N-CA 121.096 -0.573 . . . . 64.400000000000006 114.485 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -168.48 -71.42 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.844 0.858 . . . . 75.219999999999999 108.735 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.8 157.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.439 -0.948 . . . . 74.120000000000005 108.439 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . . . -97.83 119.12 35.86 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.446 -0.576 . . . . 72.0 109.446 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.2 tt -86.96 110.57 20.12 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.087 -1.079 . . . . 71.349999999999994 108.087 -177.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -90.47 114.62 26.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.334 -1.358 . . . . 73.099999999999994 107.334 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.99 115.72 24.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.935 0.398 . . . . 63.409999999999997 110.685 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.24 136.33 37.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.704 -0.68 . . . . 74.420000000000002 109.473 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -132.97 76.67 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.17 -1.048 . . . . 74.329999999999998 108.17 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -174.58 146.25 0.99 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.883 -0.784 . . . . 72.010000000000005 108.883 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -102.3 -32.93 9.8 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.494 0.553 . . . . 71.349999999999994 112.494 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -90.16 -37.69 14.01 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.853 0.686 . . . . 74.329999999999998 112.853 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -107.12 28.37 8.11 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.694 0.798 . . . . 72.230000000000004 110.102 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.65 124.42 4.86 Favored Glycine 0 N--CA 1.474 1.209 0 O-C-N 124.471 1.107 . . . . 74.219999999999999 113.616 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -67.95 146.24 53.77 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.581 1.152 . . . . 70.340000000000003 113.354 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.0 p -117.06 141.11 48.67 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.144 -0.935 . . . . 73.230000000000004 110.332 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 88' ' ' ILE . 27.3 m -109.96 116.68 52.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.073 -1.084 . . . . 74.420000000000002 108.073 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 59.96 29.85 19.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.908 0.861 . . . . 73.540000000000006 109.253 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.7 t30 78.22 8.47 2.31 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.504 1.922 . . . . 75.150000000000006 111.357 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.79 122.24 49.82 Favored Pre-proline 0 C--N 1.318 -0.785 0 O-C-N 121.678 -0.639 . . . . 75.030000000000001 109.807 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.32 127.01 14.3 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 122.562 2.174 . . . . 71.219999999999999 111.903 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.69 168.26 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 122.488 0.315 . . . . 73.200000000000003 110.275 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.52 -34.58 10.93 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.375 -0.602 . . . . 74.430000000000007 109.375 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -148.23 153.84 39.27 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.843 -0.617 . . . . 75.219999999999999 109.717 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -157.32 151.34 24.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.274 -1.009 . . . . 75.120000000000005 108.274 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.281 0.8 OUTLIER -101.06 108.69 20.46 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-O 121.71 0.766 . . . . 74.5 111.192 174.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 86.1 mt -56.97 143.58 37.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.842 -1.072 . . . . 74.510000000000005 112.638 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.74 169.55 16.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.696 -1.224 . . . . 63.240000000000002 107.696 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -72.09 112.14 7.91 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.809 -0.441 . . . . 73.140000000000001 109.809 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.61 13.61 18.18 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.932 -0.652 . . . . 64.439999999999998 113.404 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -87.25 140.72 29.26 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 117.769 0.784 . . . . 73.230000000000004 110.863 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.81 113.36 36.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 N-CA-C 108.768 -0.827 . . . . 75.0 108.768 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.452 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.1 107.6 22.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 109.125 -0.694 . . . . 75.420000000000002 109.125 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.463 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 39.9 ttm180 -100.06 111.94 24.24 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.49 0.662 . . . . 73.230000000000004 110.95 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -115.82 164.33 14.54 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.177 -1.374 . . . . 72.400000000000006 107.445 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -36.68 99.55 0.01 OUTLIER Glycine 0 CA--C 1.535 1.343 0 N-CA-C 115.909 1.123 . . . . 71.400000000000006 115.909 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.9 m80 83.09 -1.32 1.21 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.346 1.858 . . . . 75.040000000000006 115.275 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -150.4 138.05 19.84 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.889 -1.124 . . . . 74.140000000000001 111.713 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.54 119.66 39.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.455 0.645 . . . . 73.109999999999999 109.566 176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.442 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.6 tp -103.6 139.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.295 -0.866 . . . . 71.129999999999995 109.124 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.88 129.31 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.054 -1.091 . . . . 72.25 108.054 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 82' ' ' LEU . 69.9 t -95.88 120.46 45.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.482 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -117.01 150.91 37.83 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.313 -0.625 . . . . 70.349999999999994 109.313 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.0 mtt -126.44 122.17 34.52 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.711 0.767 . . . . 75.430000000000007 110.521 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 . . . . . 0 C--N 1.285 -2.214 0 N-CA-C 107.661 -1.237 . . . . 73.450000000000003 107.661 -178.0 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 N--CA 1.413 -2.316 0 N-CA-C 108.711 -0.848 . . . . 70.209999999999994 108.711 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.0 p -121.71 118.87 30.18 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.454 -1.313 . . . . 75.299999999999997 107.454 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.64 123.19 48.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 122.201 1.001 . . . . 72.329999999999998 111.329 -173.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.564 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 19.7 m -118.21 129.5 55.53 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-N 114.179 -1.373 . . . . 74.420000000000002 108.277 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -92.61 130.0 38.38 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 108.373 -0.973 . . . . 73.230000000000004 108.373 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -101.11 114.98 29.42 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.397 -1.334 . . . . 74.019999999999996 107.397 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -111.36 124.9 53.19 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.163 -1.051 . . . . 72.340000000000003 108.163 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.57 101.44 11.31 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 117.081 -1.848 . . . . 72.030000000000001 111.959 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -83.24 -15.32 50.79 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.735 -1.575 . . . . 65.239999999999995 108.594 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.44 42.05 0.51 Allowed Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 107.362 -2.295 . . . . 73.030000000000001 107.362 -171.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -164.4 -25.85 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.725 -0.738 . . . . 73.129999999999995 111.794 -171.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 70.21 1.29 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 120.388 -0.91 . . . . 74.010000000000005 110.924 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -92.64 161.4 14.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.695 -0.483 . . . . 73.400000000000006 109.695 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.6 p -138.6 135.25 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.093 0.473 . . . . 71.430000000000007 110.507 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -130.76 117.2 19.05 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.141 -1.059 . . . . 74.129999999999995 108.141 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 32.5 tt0 -88.44 128.35 35.53 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.093 -0.643 . . . . 73.209999999999994 110.072 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.88 136.83 57.3 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.124 -0.944 . . . . 74.400000000000006 112.064 -174.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -93.23 163.39 13.64 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.387 -1.279 . . . . 72.430000000000007 109.266 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.82 126.95 29.29 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.821 0.7 . . . . 74.219999999999999 111.156 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.42 -161.75 15.27 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.938 -0.865 . . . . 72.310000000000002 110.938 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 67.8 p -93.99 126.0 38.94 Favored 'General case' 0 N--CA 1.418 -2.043 0 C-N-CA 119.381 -0.927 . . . . 71.209999999999994 111.81 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.6 129.94 45.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.954 -1.869 . . . . 63.329999999999998 105.954 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.5 mm -106.72 137.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 112.187 0.44 . . . . 73.239999999999995 112.187 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.01 136.39 50.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.76 -1.2 . . . . 65.140000000000001 107.76 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.692 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.74 -152.15 24.14 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.068 -1.213 . . . . 65.209999999999994 110.068 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.667 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 76.5 mtt180 -131.91 106.46 8.08 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.216 1.008 . . . . 72.099999999999994 108.617 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.92 -168.1 40.19 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 119.739 -1.22 . . . . 74.140000000000001 111.974 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.6 -43.69 96.19 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.511 0.725 . . . . 74.340000000000003 109.914 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.25 -37.02 82.82 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 114.714 -1.13 . . . . 53.520000000000003 110.578 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.54 105.49 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 114.288 1.218 . . . . 74.239999999999995 114.288 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 44.5 mt-30 -77.14 -47.77 19.5 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.814 -1.539 . . . . 75.519999999999996 107.076 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -95.24 115.45 27.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.788 -1.56 . . . . 74.319999999999993 106.788 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 99.2 mtt180 -109.45 137.38 47.4 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 120.78 0.324 . . . . 75.549999999999997 111.602 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 72.7 mt -90.65 134.5 30.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.773 -0.648 . . . . 73.409999999999997 111.964 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 18.3 Cg_exo -71.29 -19.74 28.83 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.35 2.7 . . . . 74.319999999999993 113.593 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.11 178.5 6.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 122.221 -0.299 . . . . 75.040000000000006 111.713 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 85.2 m -109.55 168.15 9.61 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 108.328 -0.989 . . . . 75.010000000000005 108.328 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.5 9.45 53.03 Favored Glycine 0 CA--C 1.499 -0.955 0 N-CA-C 108.408 -1.877 . . . . 63.32 108.408 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 49' ' ' HIS . 7.4 p -118.3 120.74 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 CA-C-N 113.326 -1.437 . . . . 73.310000000000002 109.744 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 m -82.15 -170.0 2.67 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.279 -0.638 . . . . 74.319999999999993 109.279 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 40.6 ptt180 -65.2 -28.12 69.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.928 -0.709 . . . . 74.040000000000006 111.436 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -131.96 118.94 20.43 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.352 -0.981 . . . . 75.519999999999996 108.352 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.469 ' HB2' HG23 ' A' ' 45' ' ' VAL . 30.6 t60 -103.85 -31.03 9.99 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 124.43 1.092 . . . . 75.530000000000001 108.795 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 tt -167.31 147.46 5.37 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.904 -0.776 . . . . 74.150000000000006 108.904 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.12 136.88 49.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.857 0.723 . . . . 74.0 110.112 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 27' ' ' SER . 64.9 mt -115.51 110.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.036 -1.098 . . . . 73.329999999999998 108.036 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 41.8 ttm105 -91.32 106.97 18.88 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.689 0.757 . . . . 75.329999999999998 109.03 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -97.17 107.06 19.5 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.644 -1.162 . . . . 74.109999999999999 110.33 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -107.25 -179.73 4.01 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.642 -1.984 . . . . 61.240000000000002 105.642 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.01 3.7 69.63 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 119.931 -1.128 . . . . 65.219999999999999 112.266 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -97.07 -75.2 0.55 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 122.893 0.477 . . . . 75.519999999999996 110.554 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.07 160.67 23.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.656 0.782 . . . . 73.439999999999998 109.639 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.07 104.88 17.41 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.391 -0.966 . . . . 64.420000000000002 108.391 177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 tt -80.51 110.87 16.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.623 -1.171 . . . . 75.420000000000002 109.159 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.9 121.74 34.57 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.177 -1.046 . . . . 74.310000000000002 108.177 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.99 112.27 14.47 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.391 -0.596 . . . . 74.549999999999997 109.391 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.76 135.98 36.64 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.446 -0.946 . . . . 74.129999999999995 108.446 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.9 tp -133.83 76.6 1.67 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.508 0.67 . . . . 73.430000000000007 109.827 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -163.06 164.21 25.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.479 -1.304 . . . . 63.439999999999998 107.479 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.6 p -106.27 -54.19 2.51 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.768 0.318 . . . . 65.219999999999999 111.545 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -89.21 -35.79 16.01 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.685 0.994 . . . . 74.219999999999999 113.685 -171.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.536 ' OD1' ' HA3' ' A' ' 91' ' ' GLY . 64.2 t30 -114.26 27.5 9.44 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.044 -0.725 . . . . 75.540000000000006 109.044 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.15 136.59 25.35 Favored Glycine 0 C--O 1.245 0.814 0 CA-C-N 114.039 -1.437 . . . . 74.120000000000005 113.713 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 136.27 38.65 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 124.259 1.024 . . . . 73.510000000000005 110.899 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 142.06 35.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.297 -1.001 . . . . 73.530000000000001 108.297 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.436 HG12 HG13 ' A' ' 88' ' ' ILE . 29.7 m -117.2 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.682 -0.488 . . . . 73.319999999999993 109.682 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.15 35.76 25.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 74.019999999999996 110.521 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 65.12 23.18 12.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.279 1.432 . . . . 74.439999999999998 110.11 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.29 122.03 29.03 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.901 -0.778 . . . . 73.040000000000006 108.901 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.44 124.1 3.12 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 121.039 1.159 . . . . 71.430000000000007 111.797 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -144.18 179.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.803 -1.184 . . . . 73.549999999999997 107.803 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -104.16 -37.2 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 74.239999999999995 109.799 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -134.04 151.58 51.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.09 -0.707 . . . . 74.329999999999998 109.09 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -160.8 152.46 19.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.902 -1.148 . . . . 74.430000000000007 107.902 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.253 4.9 pp0? -109.98 113.06 25.47 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.809 -0.756 . . . . 75.319999999999993 110.162 173.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.7 mt -60.89 126.25 26.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.549 -1.205 . . . . 64.230000000000004 112.408 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.12 160.4 22.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.508 -0.923 . . . . 75.439999999999998 108.508 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 33.6 t70 -61.82 119.53 8.95 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 111.193 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.33 36.7 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.633 -0.712 . . . . 73.099999999999994 112.771 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.27 138.43 43.6 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 120.27 -0.572 . . . . 71.129999999999995 111.711 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -98.74 113.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.831 -0.803 . . . . 71.340000000000003 108.831 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.436 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -103.87 116.37 47.52 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 N-CA-C 107.277 -1.379 . . . . 74.019999999999996 107.277 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -114.51 121.71 44.34 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.709 -0.848 . . . . 73.430000000000007 108.709 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.69 162.87 18.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.441 -0.948 . . . . 72.219999999999999 108.441 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.536 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -76.97 87.13 0.97 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 119.038 -1.553 . . . . 70.310000000000002 110.694 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 t60 168.42 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.933 1.693 . . . . 64.420000000000002 108.366 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.7 p -168.15 -170.93 1.4 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.625 -0.716 . . . . 64.150000000000006 110.266 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.38 151.15 50.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.256 0.551 . . . . 71.349999999999994 109.979 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.44 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.95 142.24 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.056 -0.974 . . . . 74.319999999999993 110.833 -177.124 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.2 129.48 65.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.533 -0.914 . . . . 73.310000000000002 108.533 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.85 124.08 39.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.863 0.364 . . . . 71.510000000000005 110.231 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 12.9 mmm180 -123.66 135.07 53.7 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.576 -0.738 . . . . 74.140000000000001 110.324 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.1 mtt -113.66 124.88 53.37 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.534 0.683 . . . . 75.040000000000006 111.148 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.564 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 35.8 m-70 . . . . . 0 C--N 1.291 -1.943 0 N-CA-C 107.359 -1.349 . . . . 73.040000000000006 107.359 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.427 -1.617 0 CA-C-O 120.942 0.401 . . . . 75.019999999999996 109.934 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -125.12 139.34 53.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.51 -1.293 . . . . 65.030000000000001 107.51 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 p -117.13 122.01 69.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-O 121.787 0.803 . . . . 74.340000000000003 112.051 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.502 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 13.2 m -113.21 131.58 55.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.954 -1.128 . . . . 75.25 107.954 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 21' ' ' TYR . 4.4 pp -102.95 135.47 44.57 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.336 -0.616 . . . . 75.510000000000005 109.336 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 24.1 mt-30 -102.09 119.07 38.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.391 -0.368 . . . . 75.129999999999995 110.082 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 tp -107.79 135.09 49.79 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.644 -0.707 . . . . 74.040000000000006 109.417 -175.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.47 99.21 12.11 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 118.673 -1.211 . . . . 75.120000000000005 108.63 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -108.8 38.93 2.13 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.049 -1.834 . . . . 73.239999999999995 106.049 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.07 -54.02 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.512 -1.222 . . . . 55.439999999999998 110.881 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -87.82 -26.81 22.64 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.715 0.769 . . . . 74.420000000000002 109.916 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.83 96.73 0.93 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.048 -1.221 . . . . 74.519999999999996 110.048 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -102.08 165.79 10.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.149 -0.686 . . . . 70.140000000000001 109.149 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 12' ' ' GLN . 38.1 p -128.43 136.95 51.56 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 120.733 0.302 . . . . 73.310000000000002 110.474 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.453 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 82.3 t80 -128.36 123.53 34.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.344 -1.354 . . . . 73.409999999999997 107.344 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.0 tt0 -96.12 133.22 40.66 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.964 -0.754 . . . . 73.400000000000006 108.964 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.46 143.58 46.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.824 -0.626 . . . . 73.439999999999998 109.787 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -108.4 152.11 25.12 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.512 -1.292 . . . . 75.319999999999993 107.512 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.68 126.76 28.49 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.538 0.685 . . . . 75.519999999999996 111.423 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.24 -169.37 19.11 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 107.254 -2.339 . . . . 55.329999999999998 107.254 -174.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -106.49 128.75 54.33 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 118.899 1.349 . . . . 72.219999999999999 110.239 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -110.34 146.35 35.92 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.104 -0.953 . . . . 64.200000000000003 108.56 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.4 mt -123.73 135.47 63.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 109.814 -0.439 . . . . 74.530000000000001 109.814 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 64.9 mt -107.5 134.71 48.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.28 -1.007 . . . . 72.439999999999998 108.28 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.701 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 156.75 -152.02 23.4 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 108.667 -1.773 . . . . 41.329999999999998 108.667 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.666 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 67.2 mtp180 -135.49 106.88 6.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.566 1.183 . . . . 74.030000000000001 109.23 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.81 171.85 41.67 Favored Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.497 -1.841 . . . . 62.119999999999997 108.497 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -77.02 -17.05 59.08 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.197 0.999 . . . . 74.120000000000005 110.696 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -94.05 -4.4 49.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.416 -0.811 . . . . 74.409999999999997 110.198 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.27 133.86 34.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 74.540000000000006 109.816 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -81.67 -57.85 3.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.748 -0.66 . . . . 70.019999999999996 109.706 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 84.2 t80 -101.31 110.23 22.2 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.825 -1.176 . . . . 75.150000000000006 107.825 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.701 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 90.8 mtt180 -96.52 123.1 40.08 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.548 -0.751 . . . . 74.510000000000005 111.27 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.8 mt -75.98 138.36 69.14 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.716 -0.674 . . . . 74.439999999999998 112.006 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.04 38.16 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.39 2.726 . . . . 75.310000000000002 112.668 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -134.92 173.22 11.95 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.95 -1.13 . . . . 74.310000000000002 107.95 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -122.34 155.87 35.1 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.988 -0.745 . . . . 73.340000000000003 108.988 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.06 -23.86 26.37 Favored Glycine 0 C--N 1.312 -0.775 0 N-CA-C 109.155 -1.578 . . . . 74.200000000000003 109.155 -174.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.48 141.16 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.87 -1.165 . . . . 71.540000000000006 109.637 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -76.3 -177.23 3.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.35 -0.841 . . . . 71.549999999999997 111.146 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.3 ptm180 -65.46 -39.87 92.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 74.129999999999995 109.861 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -126.2 119.85 28.54 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.176 -1.416 . . . . 75.219999999999999 107.176 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -105.33 -35.94 7.36 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.757 1.223 . . . . 52.420000000000002 109.641 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 9.1 tt -166.05 151.15 8.44 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 108.293 -1.003 . . . . 64.239999999999995 108.293 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -136.26 141.77 43.92 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.043 0.449 . . . . 64.109999999999999 110.323 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 70.0 mt -120.69 118.72 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 115.666 -0.697 . . . . 74.400000000000006 109.469 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.7 ttt180 -91.57 111.06 22.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.505 -1.295 . . . . 75.219999999999999 107.505 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -106.22 126.52 52.32 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.411 0.624 . . . . 73.109999999999999 109.793 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -139.0 172.42 12.87 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.422 -2.066 . . . . 71.340000000000003 105.422 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.7 69.32 2.39 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 120.761 -0.733 . . . . 73.329999999999998 112.311 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -162.88 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.46 -0.941 . . . . 75.319999999999993 108.46 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.17 159.5 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.779 -0.823 . . . . 73.329999999999998 108.779 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 82' ' ' LEU . . . -94.59 115.1 27.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.118 -0.697 . . . . 71.049999999999997 109.118 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 56.6 tp -85.64 110.44 19.28 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.351 -0.84 . . . . 63.310000000000002 111.212 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.6 128.25 36.01 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.237 -1.023 . . . . 74.219999999999999 108.237 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -136.12 122.65 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.103 -0.703 . . . . 70.109999999999999 109.103 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.27 129.68 37.24 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.625 0.578 . . . . 72.109999999999999 110.069 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.49 75.26 1.57 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.44 -0.345 . . . . 73.310000000000002 110.477 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t30 169.53 107.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.784 0.833 . . . . 72.140000000000001 109.679 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.9 t -78.53 -22.24 47.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.342 -0.39 . . . . 64.140000000000001 110.735 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -65.02 -45.82 83.9 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.109 0.481 . . . . 74.420000000000002 111.907 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -118.95 28.33 8.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.139 -0.689 . . . . 74.230000000000004 109.139 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.14 129.63 4.53 Favored Glycine 0 C--O 1.258 1.649 0 O-C-N 124.838 1.336 . . . . 70.439999999999998 115.045 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -80.0 145.79 32.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.926 -1.137 . . . . 70.439999999999998 112.466 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -121.29 142.53 49.86 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.308 -0.86 . . . . 64.430000000000007 110.542 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.516 HG22 ' CD2' ' A' ' 80' ' ' TRP . 35.6 m -117.53 119.46 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.684 -1.599 . . . . 73.319999999999993 106.684 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 62.24 24.58 14.64 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.035 0.934 . . . . 72.340000000000003 108.652 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 77.91 6.39 2.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.551 1.54 . . . . 75.420000000000002 112.854 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.63 118.26 66.15 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 74.019999999999996 108.795 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.76 125.28 11.47 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 121.552 1.501 . . . . 71.409999999999997 110.646 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.29 169.15 19.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.873 -0.788 . . . . 71.209999999999994 108.873 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -107.03 -20.16 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.353 . . . . 71.0 110.77 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.61 146.41 25.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.19 -0.67 . . . . 75.439999999999998 109.19 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.516 ' CD2' HG22 ' A' ' 72' ' ' VAL . 66.7 t-105 -160.89 152.29 19.19 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.749 -0.834 . . . . 71.319999999999993 108.749 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -104.57 103.11 12.72 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.03 -0.73 . . . . 74.120000000000005 109.03 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 58.5 mt -59.52 145.04 45.6 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.967 -1.015 . . . . 71.099999999999994 111.414 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.01 169.51 17.67 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.123 -1.066 . . . . 73.299999999999997 108.123 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.83 119.12 12.0 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 123.346 0.404 . . . . 73.25 110.13 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.09 53.04 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.703 -0.68 . . . . 54.43 113.522 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -82.06 146.32 29.72 Favored 'General case' 0 C--O 1.255 1.384 0 N-CA-C 107.728 -1.212 . . . . 50.310000000000002 107.728 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.09 112.79 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.193 -0.669 . . . . 64.409999999999997 109.193 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.479 HG13 HG13 ' A' ' 72' ' ' VAL . 1.8 mp -105.71 127.58 60.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.283 -1.377 . . . . 74.340000000000003 107.283 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 90' ' ' LEU . 2.4 tmm_? -134.56 134.35 41.26 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.088 -1.079 . . . . 74.540000000000006 108.088 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.419 ' N ' ' HD2' ' A' ' 89' ' ' ARG . 2.0 pt? -127.31 162.47 26.18 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.476 -1.305 . . . . 74.400000000000006 107.476 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.4 86.98 0.51 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 119.158 -1.496 . . . . 75.109999999999999 111.148 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.0 t60 169.46 -48.79 0.01 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.145 1.778 . . . . 71.25 108.781 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.0 t -164.16 -175.37 3.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.938 -0.574 . . . . 71.140000000000001 110.111 -174.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -123.62 145.15 49.15 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.46 -0.941 . . . . 72.129999999999995 108.46 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -136.64 137.1 47.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.687 0.756 . . . . 75.400000000000006 111.843 -176.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.9 mt -107.62 131.65 57.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.488 -0.93 . . . . 73.040000000000006 108.488 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.6 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.622 0.249 . . . . 73.030000000000001 110.665 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -127.28 140.95 51.86 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.402 -0.363 . . . . 74.310000000000002 110.597 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.8 mtt -113.45 134.28 54.75 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.945 -0.57 . . . . 74.129999999999995 109.999 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.502 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 19.9 m-70 . . . . . 0 C--N 1.289 -2.038 0 N-CA-C 106.962 -1.496 . . . . 72.239999999999995 106.962 -177.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 109.743 -0.465 . . . . 75.329999999999998 109.743 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB2' ' CD2' ' A' ' 100' ' ' HIS . 15.2 m -85.07 115.11 22.69 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.616 -1.253 . . . . 72.329999999999998 107.616 174.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.44 106.85 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.846 -1.909 . . . . 71.420000000000002 105.846 174.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.6 m -113.97 119.36 36.95 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.496 -0.775 . . . . 73.510000000000005 109.216 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 3.2 pp -91.72 130.7 37.46 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.523 -0.762 . . . . 75.340000000000003 110.805 178.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.69 119.63 39.84 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.275 -1.33 . . . . 73.299999999999997 107.579 -175.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -107.5 116.91 32.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.508 -0.553 . . . . 75.310000000000002 109.508 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.98 99.52 12.21 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.642 -1.614 . . . . 62.219999999999999 106.642 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -115.06 -19.06 11.04 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.309 -1.314 . . . . 65.430000000000007 109.868 -177.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.2 4.85 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 110.757 -0.937 . . . . 63.009999999999998 110.757 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 t -122.29 -33.88 3.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.321 -0.622 . . . . 60.009999999999998 109.321 175.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.03 79.13 1.38 Allowed Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.463 -1.855 . . . . 70.209999999999994 108.463 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -89.51 145.46 25.27 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.883 -0.414 . . . . 75.109999999999999 109.883 -176.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.3 p -134.16 135.29 43.0 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.102 0.477 . . . . 72.239999999999995 111.211 -176.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -139.03 120.42 14.91 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.75 -0.659 . . . . 74.439999999999998 110.69 178.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -83.46 127.23 33.53 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.523 -0.917 . . . . 73.420000000000002 108.523 176.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.78 149.33 50.7 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.05 -0.523 . . . . 74.109999999999999 111.019 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -102.64 162.38 12.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.199 -1.408 . . . . 72.25 107.199 173.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.88 145.66 51.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.215 -0.661 . . . . 74.109999999999999 109.215 177.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.51 -168.2 15.25 Favored Glycine 0 N--CA 1.412 -2.936 0 N-CA-C 106.887 -2.485 . . . . 71.340000000000003 106.887 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 30.0 p -103.03 130.95 50.32 Favored 'General case' 0 C--N 1.27 -2.853 0 C-N-CA 118.499 -1.28 . . . . 72.310000000000002 111.519 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.508 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -102.35 110.42 22.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.843 -1.91 . . . . 75.040000000000006 105.843 -179.009 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.2 mt -97.86 132.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 120.929 0.395 . . . . 75.420000000000002 111.538 -173.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.44 133.69 55.05 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 C-N-CA 123.846 0.858 . . . . 75.109999999999999 109.601 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.465 ' HA2' ' CG2' ' A' ' 45' ' ' VAL . . . 151.54 -173.75 30.82 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.686 -0.966 . . . . 73.340000000000003 110.686 177.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 97.5 mtt180 -118.19 104.23 10.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.119 -1.437 . . . . 74.109999999999999 107.119 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 -176.93 48.05 Favored Glycine 0 N--CA 1.42 -2.427 0 N-CA-C 111.401 -0.68 . . . . 72.120000000000005 111.401 -175.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 35' ' ' ASP . 10.4 pt20 -58.74 -49.6 77.02 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 124.016 0.926 . . . . 71.040000000000006 113.135 -176.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 13.5 m-20 -81.8 -19.87 40.29 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.203 0.525 . . . . 63.020000000000003 111.016 -172.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.62 145.5 45.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.572 -0.74 . . . . 75.239999999999995 112.12 -174.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -106.81 -55.84 2.27 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.014 -0.994 . . . . 74.540000000000006 108.667 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -95.0 125.37 39.62 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.809 -1.087 . . . . 74.010000000000005 109.872 -177.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -97.7 144.59 27.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.344 -0.984 . . . . 72.439999999999998 108.344 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 58.2 mt -94.56 131.16 31.47 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 109.489 -0.56 . . . . 73.409999999999997 109.489 173.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 21.2 Cg_exo -67.54 -26.48 40.12 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.112 2.542 . . . . 74.340000000000003 112.605 -178.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 168.38 11.4 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.349 -0.387 . . . . 60.399999999999999 110.633 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -84.68 -177.05 6.49 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.021 -0.733 . . . . 74.239999999999995 109.021 178.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.91 66.9 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.138 -0.785 . . . . 71.530000000000001 111.138 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 11.1 p -90.15 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.284 -0.958 . . . . 73.219999999999999 109.356 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -102.38 -174.07 2.48 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.861 -0.422 . . . . 75.209999999999994 109.861 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 36.1 ptt180 -64.43 -41.6 96.5 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.891 0.853 . . . . 73.530000000000001 110.269 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -129.26 107.75 9.79 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 104.012 -2.588 . . . . 74.329999999999998 104.012 172.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -101.35 -37.36 8.51 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.935 0.772 . . . . 72.420000000000002 109.145 -176.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -165.09 147.97 8.22 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.996 -0.547 . . . . 64.409999999999997 109.896 -177.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -133.27 132.45 41.42 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.491 -0.559 . . . . 71.129999999999995 109.491 176.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.5 mt -106.76 113.62 43.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 108.843 -0.799 . . . . 74.140000000000001 108.843 176.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 29.9 ttt180 -91.25 111.43 22.91 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.482 0.658 . . . . 72.510000000000005 109.541 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -104.4 127.45 52.08 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.47 -0.786 . . . . 75.420000000000002 110.567 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -132.14 172.73 12.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.531 -2.026 . . . . 74.219999999999999 105.531 176.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.67 53.09 3.97 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.684 -0.769 . . . . 74.439999999999998 111.681 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -140.79 -80.48 0.26 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 124.728 1.211 . . . . 71.510000000000005 107.784 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.34 160.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 C-N-CA 125.326 1.45 . . . . 65.5 107.1 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 82' ' ' LEU . . . -91.24 115.49 28.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.47 0.652 . . . . 72.219999999999999 109.604 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 tp -85.17 114.12 22.05 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.07 -0.968 . . . . 73.510000000000005 110.5 -177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -92.11 113.49 25.77 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.641 -1.244 . . . . 74.430000000000007 107.641 -179.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.75 121.14 39.39 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.826 -0.435 . . . . 75.420000000000002 109.826 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -91.48 133.0 35.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.627 -0.715 . . . . 74.5 111.43 -177.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.55 76.12 1.39 Allowed 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.645 -0.872 . . . . 64.019999999999996 108.645 173.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -173.7 112.14 0.19 Allowed 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 109.048 -0.723 . . . . 75.230000000000004 109.048 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -84.31 -17.67 38.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.322 0.49 . . . . 62.340000000000003 112.322 -178.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -89.19 -55.93 3.47 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.424 0.63 . . . . 75.219999999999999 111.084 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -110.5 29.57 7.59 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.659 0.784 . . . . 75.409999999999997 109.905 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.48 141.49 2.5 Favored Glycine 0 C--O 1.258 1.632 0 O-C-N 125.018 1.449 . . . . 73.450000000000003 115.745 -175.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.2 m -65.29 135.36 55.25 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.466 -1.367 . . . . 75.329999999999998 112.463 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 75' ' ' ALA . 1.3 m -113.37 139.84 48.54 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.594 -1.632 . . . . 74.209999999999994 106.594 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.451 HG11 HG13 ' A' ' 88' ' ' ILE . 29.2 m -120.26 121.24 65.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.228 -0.656 . . . . 71.430000000000007 109.228 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 58.35 29.88 18.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.829 0.824 . . . . 74.540000000000006 110.319 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t30 76.9 23.78 0.96 Allowed 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 126.07 1.748 . . . . 74.439999999999998 111.05 179.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 71' ' ' THR . . . -125.82 118.04 24.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 121.752 -0.593 . . . . 73.219999999999999 110.144 177.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.86 133.4 31.29 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.566 2.177 . . . . 74.120000000000005 112.177 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.23 169.14 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 75.329999999999998 110.199 -177.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -102.81 -21.47 14.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.387 -0.968 . . . . 61.149999999999999 108.387 174.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -157.78 155.63 30.14 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.254 -1.017 . . . . 74.010000000000005 108.254 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -161.0 151.99 18.63 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 72.120000000000005 108.741 -178.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.97 103.46 14.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.764 -0.828 . . . . 72.439999999999998 108.764 176.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.428 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 89.8 mt -57.6 139.99 52.16 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.93 0.715 . . . . 61.32 112.93 -176.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.9 166.6 23.25 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.814 -1.18 . . . . 63.020000000000003 107.814 173.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.15 118.78 9.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.872 0.368 . . . . 72.120000000000005 110.854 -179.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.15 35.71 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.004 -0.617 . . . . 45.539999999999999 113.134 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -87.1 136.51 32.9 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.909 -0.716 . . . . 74.230000000000004 109.874 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 t -100.33 113.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.074 -0.713 . . . . 74.200000000000003 109.074 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.451 HG13 HG11 ' A' ' 72' ' ' VAL . 1.8 mp -102.71 111.95 34.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.972 -0.751 . . . . 74.329999999999998 108.972 -178.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -107.63 119.96 40.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.627 -0.715 . . . . 72.0 110.104 -178.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -125.27 164.3 20.65 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.405 -0.816 . . . . 74.530000000000001 108.942 -176.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.75 112.06 0.62 Allowed Glycine 0 CA--C 1.529 0.938 0 O-C-N 123.574 0.546 . . . . 52.229999999999997 113.315 178.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 71.7 6.67 5.74 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.399 1.479 . . . . 74.099999999999994 114.834 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.7 t -149.2 163.35 37.88 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.794 -0.762 . . . . 61.420000000000002 111.241 -177.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.88 126.36 13.22 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.518 -0.919 . . . . 74.430000000000007 108.518 176.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.517 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 7.9 tp -124.42 138.04 55.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.62 -0.718 . . . . 74.129999999999995 109.071 -173.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.8 125.15 65.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.859 -0.793 . . . . 75.040000000000006 108.859 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -89.87 121.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.706 0.288 . . . . 63.009999999999998 111.423 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -120.36 151.22 39.56 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.199 -0.667 . . . . 74.200000000000003 109.199 176.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.1 mtt -125.42 145.61 49.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.274 0.559 . . . . 71.140000000000001 111.597 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.441 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 12.3 m-70 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 107.932 -1.136 . . . . 75.450000000000003 107.932 178.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 120.685 0.279 . . . . 75.239999999999995 110.457 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 m -93.05 115.29 27.97 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 106.966 -1.494 . . . . 72.239999999999995 106.966 174.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -105.51 120.79 56.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.895 0.855 . . . . 75.049999999999997 110.447 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 11.6 m -119.6 137.68 53.7 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.864 -1.062 . . . . 61.439999999999998 109.624 -172.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -97.55 136.68 37.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.333 -0.618 . . . . 72.409999999999997 109.333 178.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 115.87 28.72 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.584 -1.635 . . . . 71.319999999999993 106.584 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.79 134.71 49.53 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.986 -0.552 . . . . 73.5 111.826 -175.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.42 99.9 5.03 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.08 -1.822 . . . . 54.130000000000003 106.08 171.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -114.78 8.17 16.01 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 113.82 -1.537 . . . . 70.140000000000001 110.206 -176.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.82 -48.03 0.99 Allowed Glycine 0 CA--C 1.491 -1.457 0 N-CA-C 109.358 -1.497 . . . . 70.109999999999999 109.358 -176.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -127.35 -39.57 1.87 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.967 -0.753 . . . . 70.230000000000004 108.967 175.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.97 116.8 1.61 Allowed Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 120.41 -0.9 . . . . 70.129999999999995 111.869 177.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.5 mtm105 -118.61 156.73 28.68 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.28 -0.267 . . . . 74.129999999999995 110.28 175.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.5 p -126.36 152.88 45.68 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.067 -0.515 . . . . 74.430000000000007 110.587 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -148.02 131.58 16.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.698 -1.593 . . . . 74.310000000000002 106.698 176.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 21.0 tt0 -91.94 131.37 37.3 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.917 -0.713 . . . . 74.239999999999995 109.785 -178.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HB2' HG12 ' A' ' 9' ' ' VAL . 96.8 mt -68.51 147.15 52.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.744 . . . . 71.209999999999994 108.99 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -118.25 150.57 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.801 -0.814 . . . . 74.439999999999998 108.801 -177.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.32 116.97 2.7 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.97 1.418 . . . . 73.450000000000003 112.75 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.0 -172.67 20.08 Favored Glycine 0 N--CA 1.418 -2.524 0 N-CA-C 107.585 -2.206 . . . . 74.129999999999995 107.585 -174.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 33.6 p -106.72 134.25 50.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 118.487 1.144 . . . . 74.549999999999997 111.175 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -106.02 122.13 45.53 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.06 -0.718 . . . . 74.409999999999997 109.06 178.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.1 mm -88.86 121.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.358 -0.837 . . . . 74.540000000000006 108.997 -177.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 75.5 mt -103.12 126.12 57.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 74.129999999999995 108.725 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.41 -159.56 32.49 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 110.282 -1.127 . . . . 44.439999999999998 110.282 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.7 mtp180 -129.45 105.36 8.05 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.575 -0.898 . . . . 73.540000000000006 108.575 175.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.52 -164.54 34.31 Favored Glycine 0 N--CA 1.415 -2.717 0 N-CA-C 110.527 -1.029 . . . . 75.099999999999994 110.527 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -79.14 -38.47 35.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.21 -0.663 . . . . 73.299999999999997 109.21 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.48 -37.03 84.21 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.954 . . . . 74.310000000000002 109.552 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.96 118.56 7.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 114.137 -1.392 . . . . 72.150000000000006 111.894 -176.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -90.25 -37.47 14.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.402 -1.333 . . . . 73.310000000000002 107.402 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 34.7 t80 -107.1 114.19 28.1 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.184 -2.154 . . . . 73.239999999999995 105.184 176.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 92.9 mtt180 -106.9 131.55 53.85 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.939 -0.573 . . . . 75.439999999999998 110.899 -171.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.94 144.42 41.71 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.554 -0.748 . . . . 71.319999999999993 111.5 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -89.46 5.62 4.71 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.761 2.307 . . . . 74.409999999999997 114.3 -178.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.66 -176.12 3.17 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.884 -0.726 . . . . 71.400000000000006 109.317 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -106.3 175.97 5.32 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.7 0.286 . . . . 72.409999999999997 110.758 -174.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.84 80.88 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 110.763 -0.935 . . . . 73.340000000000003 110.763 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.446 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 22.5 t -103.69 130.19 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 114.903 -0.648 . . . . 73.230000000000004 109.915 -175.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 178.59 7.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.032 -0.729 . . . . 61.140000000000001 109.032 177.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 16.9 ptm180 -67.81 -31.16 70.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.702 0.763 . . . . 74.319999999999993 109.791 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -133.71 100.53 4.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.166 -2.161 . . . . 75.099999999999994 105.166 172.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -94.71 -38.5 10.78 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.091 -0.707 . . . . 73.040000000000006 109.091 -178.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.93 156.42 19.89 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.892 -1.151 . . . . 74.450000000000003 107.892 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -137.04 147.47 46.2 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 109.027 -0.731 . . . . 71.109999999999999 109.027 176.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.3 mt -116.14 111.29 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 107.948 -1.13 . . . . 73.310000000000002 107.948 174.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.6 ttt180 -91.23 115.48 28.06 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.843 -1.169 . . . . 73.239999999999995 107.843 175.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -108.67 106.8 17.01 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 108.573 -0.899 . . . . 73.019999999999996 108.573 176.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.38 172.42 6.97 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 105.471 -2.048 . . . . 71.420000000000002 105.471 177.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 63.15 4.44 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 120.25 -0.976 . . . . 75.299999999999997 112.004 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -162.92 -68.55 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 61.399999999999999 108.795 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.8 m -137.99 157.08 32.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 109.877 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.31 106.08 18.09 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.479 -0.934 . . . . 74.340000000000003 108.479 178.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.7 tt -90.01 115.15 27.08 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.113 -0.949 . . . . 75.519999999999996 108.987 -174.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.2 117.6 31.77 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.705 -1.591 . . . . 75.340000000000003 106.705 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.63 33.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.86 -0.422 . . . . 75.5 109.86 178.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -95.7 128.17 42.35 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.117 -0.698 . . . . 74.329999999999998 109.117 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.47 77.37 1.05 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 105.681 -1.97 . . . . 74.040000000000006 105.681 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.401 HD22 ' C ' ' A' ' 68' ' ' ASN . 8.4 t30 -178.48 132.26 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.496 -0.482 . . . . 64.439999999999998 110.45 -164.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 p -109.21 -53.52 2.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.188 0.811 . . . . 75.120000000000005 113.188 178.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -71.68 -34.79 69.98 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.458 0.91 . . . . 63.149999999999999 113.458 -173.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' C ' HD22 ' A' ' 65' ' ' ASN . 5.0 m-20 -107.47 29.27 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.319 -0.623 . . . . 74.340000000000003 109.319 -176.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.27 129.38 4.67 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 124.263 0.977 . . . . 72.299999999999997 115.366 -171.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.6 m -74.23 139.0 44.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.503 -0.849 . . . . 72.340000000000003 111.152 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -103.35 141.26 36.24 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.379 0.609 . . . . 74.319999999999993 111.462 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 88' ' ' ILE . 27.0 m -116.98 117.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.376 -1.342 . . . . 74.299999999999997 107.376 174.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.55 34.63 24.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.696 -0.684 . . . . 72.530000000000001 110.134 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 86.27 -10.2 0.69 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.784 1.634 . . . . 64.409999999999997 112.995 178.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.32 124.95 47.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 121.745 -0.597 . . . . 73.329999999999998 111.158 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.52 125.42 10.1 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 122.47 2.113 . . . . 73.400000000000006 111.502 178.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.19 172.87 15.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 110.24 -0.281 . . . . 72.0 110.24 -177.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -102.59 -35.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.205 -0.665 . . . . 64.319999999999993 109.205 175.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.41 149.72 30.41 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.915 -0.584 . . . . 73.319999999999993 110.008 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -159.05 152.56 22.8 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.254 -1.017 . . . . 73.25 108.254 -173.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.41 111.75 24.59 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.659 -0.817 . . . . 75.140000000000001 109.825 174.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -58.34 134.67 56.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.21 -1.359 . . . . 74.329999999999998 112.43 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.32 164.29 16.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.617 -0.883 . . . . 75.340000000000003 108.617 172.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 26.2 t70 -66.97 114.48 5.8 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.13 0.49 . . . . 74.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.05 0.55 33.72 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.399 -0.819 . . . . 73.329999999999998 112.567 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -72.01 142.46 49.33 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.218 0.509 . . . . 72.409999999999997 111.494 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.64 113.78 42.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.262 -0.881 . . . . 74.25 108.941 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.418 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 2.9 mp -110.79 116.61 52.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.421 -0.955 . . . . 71.540000000000006 108.421 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -117.35 130.78 56.73 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.691 0.758 . . . . 75.400000000000006 110.785 -177.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -131.28 163.98 26.6 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.576 -1.268 . . . . 62.149999999999999 107.576 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.35 98.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.959 0.787 . . . . 64.409999999999997 114.865 -177.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 75.02 19.64 2.31 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 125.762 1.625 . . . . 74.349999999999994 114.071 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -148.37 138.32 22.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.613 -0.514 . . . . 70.510000000000005 109.613 176.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -133.62 120.58 20.88 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.607 0.718 . . . . 73.030000000000001 109.862 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.418 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 9.7 tp -116.04 140.83 36.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.961 -1.018 . . . . 70.200000000000003 110.178 -172.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.15 138.13 39.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.5 -0.926 . . . . 74.409999999999997 108.5 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.55 124.44 54.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 120.886 0.374 . . . . 75.120000000000005 110.993 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -121.19 139.6 53.15 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.683 -0.858 . . . . 71.209999999999994 108.683 177.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.4 mtt -123.27 138.33 54.65 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 120.855 0.36 . . . . 73.519999999999996 110.622 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 108.488 -0.93 . . . . 73.409999999999997 108.488 -178.401 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 109.172 -0.677 . . . . 74.430000000000007 109.172 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -119.66 114.85 22.83 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.249 -1.019 . . . . 70.430000000000007 108.249 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.79 126.29 48.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.683 -0.858 . . . . 73.040000000000006 108.683 -175.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 46.0 m -131.84 122.85 26.4 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.805 -0.813 . . . . 75.040000000000006 108.805 -175.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 pp -88.9 136.39 33.03 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-O 121.207 0.527 . . . . 74.310000000000002 109.999 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.78 109.8 21.03 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.815 -1.084 . . . . 75.519999999999996 109.031 -172.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -99.49 105.66 17.6 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.298 -1.001 . . . . 63.130000000000003 108.298 175.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -92.29 100.49 13.07 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.149 -1.021 . . . . 73.450000000000003 108.721 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.97 -28.84 12.88 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.276 -0.875 . . . . 71.540000000000006 109.203 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.07 -51.11 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.852 -1.067 . . . . 73.219999999999999 111.397 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.7 m -114.38 -2.3 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.366 -0.491 . . . . 74.349999999999994 111.857 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.91 103.07 1.13 Allowed Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 121.298 -0.477 . . . . 64.140000000000001 113.357 178.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.73 158.29 16.06 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.664 -0.865 . . . . 75.329999999999998 108.664 173.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -139.31 141.02 37.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 123.49 0.493 . . . . 75.120000000000005 110.182 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -136.06 114.32 11.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.523 -0.547 . . . . 73.310000000000002 109.523 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 35.7 tt0 -76.28 134.89 39.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 109.003 -0.74 . . . . 74.409999999999997 109.003 177.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.09 136.87 52.92 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.902 -0.59 . . . . 71.129999999999995 110.074 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.408 ' HG2' ' OD1' ' A' ' 28' ' ' ASN . 9.4 ptp180 -75.37 158.4 32.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.287 -1.375 . . . . 74.129999999999995 107.287 175.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -73.54 132.87 43.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.287 -1.375 . . . . 72.310000000000002 107.287 171.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.43 -150.19 17.25 Favored Glycine 0 C--N 1.282 -2.45 0 N-CA-C 107.706 -2.157 . . . . 54.009999999999998 107.706 -173.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 p -104.56 139.69 39.07 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.578 -1.249 . . . . 74.25 112.539 -178.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 27.6 m-80 -107.16 110.05 22.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.172 -1.788 . . . . 73.340000000000003 106.172 176.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -100.47 122.38 52.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.657 -0.247 . . . . 73.510000000000005 111.047 -173.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 78.0 mt -109.51 129.0 65.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.712 -0.848 . . . . 75.109999999999999 108.712 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.35 179.27 37.7 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 109.701 -1.36 . . . . 63.130000000000003 109.701 178.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 70.8 mtp180 -112.1 105.37 13.73 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.766 -1.198 . . . . 74.400000000000006 107.766 179.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.48 164.76 31.05 Favored Glycine 0 N--CA 1.409 -3.112 0 N-CA-C 109.258 -1.537 . . . . 55.140000000000001 109.258 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.96 -25.72 67.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.836 0.318 . . . . 74.439999999999998 111.275 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.28 -29.04 59.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 54.229999999999997 110.405 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 47' ' ' ARG . . . -75.62 153.36 37.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 73.209999999999994 112.386 -175.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -97.52 -43.61 7.17 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.35 -0.841 . . . . 73.340000000000003 109.633 -178.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 80.1 t80 -117.57 128.07 54.59 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.872 -1.159 . . . . 72.409999999999997 107.872 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.83 137.42 47.65 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 112.386 0.513 . . . . 72.510000000000005 112.386 -178.541 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.34 142.72 54.86 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 74.340000000000003 110.751 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -86.72 35.76 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.858 2.372 . . . . 71.200000000000003 112.304 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.27 -177.52 5.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.843 -0.799 . . . . 64.040000000000006 108.843 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.9 m -113.94 158.63 20.86 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.124 -0.695 . . . . 73.049999999999997 109.124 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.86 -2.18 44.97 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.06 -1.216 . . . . 53.409999999999997 110.06 -178.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.67 136.03 24.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 113.936 -1.132 . . . . 75.030000000000001 109.516 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 5.2 m -76.13 175.8 8.61 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.495 -0.928 . . . . 72.430000000000007 108.495 177.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.7 ptp180 -68.42 -29.46 68.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.831 0.824 . . . . 75.409999999999997 109.055 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 46' ' ' SER . 75.2 mtm180 -128.39 103.38 7.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 104.015 -2.587 . . . . 74.530000000000001 104.015 168.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -91.85 -33.36 14.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.356 -0.609 . . . . 75.519999999999996 109.356 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 tt -162.8 147.3 11.65 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.15 -0.685 . . . . 73.209999999999994 109.15 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -129.23 143.86 51.01 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.425 0.631 . . . . 75.319999999999993 109.995 175.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -113.36 106.14 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 107.454 -1.313 . . . . 72.200000000000003 107.454 172.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -92.06 107.91 19.56 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.869 -1.16 . . . . 74.200000000000003 107.869 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.33 126.33 52.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 74.109999999999999 111.575 -174.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -136.68 155.19 50.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 105.551 -2.018 . . . . 63.549999999999997 105.551 176.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 55.43 1.74 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 118.302 0.501 . . . . 63.219999999999999 113.468 -177.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -149.21 -63.39 0.23 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.634 1.174 . . . . 73.439999999999998 108.048 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.93 159.61 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 123.536 0.734 . . . . 74.450000000000003 109.306 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.7 101.89 11.37 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.761 -1.199 . . . . 75.299999999999997 107.761 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.3 tp -90.13 101.81 14.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.019 -0.991 . . . . 75.439999999999998 111.225 -172.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.37 131.24 34.43 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.602 -1.259 . . . . 72.420000000000002 107.602 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 78' ' ' GLN . . . -138.77 116.88 11.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.39 . . . . 73.010000000000005 110.538 178.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -86.2 135.79 33.44 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.812 -0.631 . . . . 74.549999999999997 109.801 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.16 76.9 1.42 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.568 -1.271 . . . . 73.430000000000007 107.568 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 175.31 147.1 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.928 -0.767 . . . . 70.310000000000002 108.928 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 p -109.58 -48.01 3.29 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.962 0.727 . . . . 74.150000000000006 112.962 175.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -67.31 -33.94 76.33 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.642 0.734 . . . . 72.549999999999997 112.307 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' ND2' ' HA3' ' A' ' 91' ' ' GLY . 65.3 t30 -121.4 27.4 8.32 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.568 -1.271 . . . . 73.400000000000006 107.568 -173.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.41 143.01 4.87 Favored Glycine 0 C--O 1.25 1.147 0 CA-C-N 114.493 -1.231 . . . . 52.240000000000002 115.404 -175.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.2 m -84.53 151.23 24.71 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.003 0.906 . . . . 72.420000000000002 112.432 -176.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.4 p -121.38 143.8 49.01 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.164 -0.925 . . . . 71.040000000000006 110.967 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 80' ' ' TRP . 32.6 m -109.84 121.64 63.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 106.061 -1.829 . . . . 74.439999999999998 106.061 174.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 61.57 24.62 14.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.615 0.722 . . . . 72.219999999999999 109.302 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.5 10.26 2.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 126.326 1.85 . . . . 75.409999999999997 110.984 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.24 125.93 34.93 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.577 -0.702 . . . . 52.350000000000001 109.156 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 125.51 10.45 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.639 2.226 . . . . 72.349999999999994 114.124 -176.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -151.93 177.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 106.335 -1.728 . . . . 74.450000000000003 106.335 178.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 21.5 mt-30 -119.36 -37.08 3.23 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 109.729 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.91 133.56 55.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.627 -0.715 . . . . 75.420000000000002 109.352 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.435 ' CD2' HG21 ' A' ' 72' ' ' VAL . 76.8 t-105 -158.49 141.39 14.66 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 121.779 0.8 . . . . 74.530000000000001 111.115 -176.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -88.58 104.26 16.68 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 113.735 -1.575 . . . . 75.319999999999993 107.088 173.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.97 150.84 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.749 -0.66 . . . . 63.009999999999998 111.98 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.28 165.49 26.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.71 -0.848 . . . . 73.299999999999997 108.71 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.39 111.47 7.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.307 0.575 . . . . 73.019999999999996 110.207 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.1 19.56 16.46 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.604 -0.725 . . . . 64.540000000000006 111.901 -178.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.99 129.46 34.87 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.274 -1.38 . . . . 71.120000000000005 107.274 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.42 113.03 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.49 -0.93 . . . . 72.450000000000003 108.49 -178.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.437 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 42.3 mm -96.23 106.53 18.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.04 -1.837 . . . . 72.409999999999997 106.04 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 24.8 ttt85 -103.19 106.28 16.76 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.556 -1.276 . . . . 74.209999999999994 107.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -106.95 163.93 12.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.706 -1.133 . . . . 71.299999999999997 109.433 -174.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.469 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -41.3 101.05 0.02 OUTLIER Glycine 0 C--N 1.309 -0.929 0 N-CA-C 115.924 1.129 . . . . 63.009999999999998 115.924 -175.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 36.2 m80 74.29 15.77 3.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.739 1.616 . . . . 74.140000000000001 113.463 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.2 t -151.66 176.63 11.18 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.921 -0.399 . . . . 70.219999999999999 109.921 178.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.61 144.57 24.5 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.27 -1.011 . . . . 75.340000000000003 108.27 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.437 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 9.8 tp -140.4 140.56 34.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.826 -0.805 . . . . 71.5 108.826 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.5 mt -104.66 117.39 50.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.96 -0.755 . . . . 74.299999999999997 108.96 -178.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.24 122.23 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 110.369 -0.234 . . . . 71.420000000000002 110.369 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -115.83 151.57 35.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.361 -0.607 . . . . 72.120000000000005 109.361 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 mtt -122.1 117.03 25.31 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.634 -0.712 . . . . 73.140000000000001 109.445 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 . . . . . 0 C--N 1.275 -2.66 0 N-CA-C 108.063 -1.088 . . . . 75.329999999999998 108.063 -178.579 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 109.525 -0.546 . . . . 74.319999999999993 109.525 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -108.67 115.53 30.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.078 -0.51 . . . . 75.340000000000003 109.744 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.25 110.5 26.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.766 -1.198 . . . . 72.430000000000007 107.766 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -112.53 120.8 42.86 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.687 -0.857 . . . . 74.140000000000001 108.687 -174.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -91.53 137.34 32.44 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.647 -0.501 . . . . 74.099999999999994 109.647 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -104.02 127.3 51.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.389 -1.337 . . . . 72.540000000000006 107.389 174.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.6 135.22 52.94 Favored 'General case' 0 C--N 1.269 -2.892 0 O-C-N 123.399 0.437 . . . . 71.310000000000002 111.385 -173.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 100.33 11.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.732 -1.581 . . . . 73.030000000000001 106.732 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -104.36 1.69 30.49 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 113.606 -1.633 . . . . 73.209999999999994 110.059 -176.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.5 -41.54 1.86 Allowed Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 108.584 -1.807 . . . . 74.230000000000004 108.584 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -112.59 -63.92 1.37 Allowed 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.28 -1.378 . . . . 64.530000000000001 107.28 173.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.49 109.04 0.39 Allowed Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 111.242 -0.743 . . . . 53.100000000000001 111.242 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -101.11 157.08 17.03 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.104 -0.702 . . . . 73.200000000000003 109.104 177.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.0 p -137.75 132.6 32.99 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.628 -1.249 . . . . 71.0 107.628 174.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -138.49 129.31 26.62 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.797 -0.816 . . . . 71.430000000000007 108.797 -173.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -87.46 120.94 29.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.679 -0.86 . . . . 72.329999999999998 108.679 177.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.52 137.87 23.43 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 124.355 1.034 . . . . 74.239999999999995 111.475 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -85.12 144.7 28.05 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 108.9 -0.778 . . . . 73.420000000000002 108.9 -177.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.7 113.53 8.82 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.077 0.941 . . . . 73.010000000000005 109.947 178.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.58 -167.37 23.15 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 106.573 -2.611 . . . . 74.319999999999993 106.573 -171.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 58.1 p -106.46 127.76 53.54 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 118.981 1.39 . . . . 63.539999999999999 111.179 177.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -102.0 112.58 25.28 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.425 -0.807 . . . . 64.120000000000005 108.97 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.34 120.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.255 -0.884 . . . . 73.230000000000004 109.443 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.4 mt -99.99 130.62 48.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.238 -0.892 . . . . 74.040000000000006 109.194 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 157.32 -161.34 31.17 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.713 -1.355 . . . . 73.030000000000001 109.713 178.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 60.6 mtp180 -129.76 105.23 7.89 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.056 -1.461 . . . . 74.430000000000007 107.056 173.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.34 -176.19 47.69 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.944 -0.646 . . . . 65.310000000000002 111.615 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -63.23 -30.03 71.25 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 124.739 1.216 . . . . 75.319999999999993 113.177 -176.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.39 -6.61 37.11 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.822 0.344 . . . . 75.329999999999998 111.686 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 115.12 18.23 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.892 0.377 . . . . 74.340000000000003 111.992 -174.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 12.9 mm-40 -89.31 -29.44 19.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.478 -0.783 . . . . 74.219999999999999 109.434 177.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 85.4 t80 -115.18 108.95 17.29 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.259 -1.756 . . . . 75.230000000000004 106.259 173.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 59.5 mtt180 -99.13 120.63 39.82 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.035 -0.984 . . . . 74.329999999999998 110.375 -172.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.9 mt -73.05 138.32 79.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.886 -0.597 . . . . 73.5 110.557 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -84.35 1.67 8.56 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.41 2.074 . . . . 71.409999999999997 113.868 -177.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -102.85 163.63 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.308 -0.627 . . . . 54.229999999999997 109.308 -178.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.6 m -100.45 147.93 25.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 120.909 0.385 . . . . 71.129999999999995 110.455 -177.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.69 7.99 30.94 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 110.626 -0.99 . . . . 74.450000000000003 110.626 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.2 t -99.31 133.61 41.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 75.120000000000005 108.391 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.6 m -69.94 175.87 4.11 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.753 0.311 . . . . 52.109999999999999 111.388 178.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.2 ptp180 -65.27 -28.85 69.63 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.606 0.717 . . . . 70.420000000000002 111.299 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -135.59 119.16 16.99 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.579 -2.378 . . . . 74.25 104.579 169.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.577 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 3.7 t60 -104.62 -45.16 4.69 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.96 -0.756 . . . . 75.019999999999996 108.96 -177.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -163.29 154.25 16.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.279 -1.378 . . . . 75.109999999999999 107.279 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -136.84 143.89 43.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.698 -0.482 . . . . 73.420000000000002 109.698 176.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -112.42 115.26 49.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 108.562 -0.903 . . . . 74.430000000000007 108.562 177.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.421 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 47.3 ttt180 -93.0 107.25 19.07 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-O 121.305 0.574 . . . . 74.420000000000002 109.539 176.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -97.31 107.16 19.61 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.522 -1.288 . . . . 75.549999999999997 107.522 175.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.62 -173.18 2.4 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 105.18 -2.156 . . . . 71.150000000000006 105.18 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.58 4.75 85.12 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 118.797 -1.668 . . . . 72.430000000000007 111.969 -177.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -117.94 -61.31 1.7 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.578 -0.311 . . . . 70.319999999999993 111.817 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 157.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.949 0.404 . . . . 74.099999999999994 111.414 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.68 104.66 15.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.172 -1.047 . . . . 72.549999999999997 108.172 176.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.9 tt -91.25 118.34 30.4 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.737 -1.12 . . . . 75.409999999999997 110.077 -174.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.04 122.32 43.87 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.217 -1.401 . . . . 72.450000000000003 107.217 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.6 118.95 12.85 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.489 -0.485 . . . . 74.400000000000006 112.008 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.463 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 0.8 OUTLIER -66.05 139.75 58.21 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.399 -0.963 . . . . 74.200000000000003 108.399 172.577 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -126.82 75.4 1.56 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 105.858 -1.904 . . . . 64.219999999999999 105.858 178.736 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 11.2 t-20 158.11 163.63 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 106.46 -1.681 . . . . 75.129999999999995 106.46 -178.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.9 m -108.04 -44.82 4.09 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 118.014 0.37 . . . . 60.25 111.711 176.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 m -73.99 -30.21 62.37 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.454 0.645 . . . . 74.340000000000003 111.649 -175.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.577 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.7 m120 -86.65 28.29 0.89 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.045 -0.409 . . . . 54.0 110.51 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.0 123.62 4.83 Favored Glycine 0 C--O 1.24 0.528 0 N-CA-C 116.116 1.206 . . . . 73.140000000000001 116.116 -174.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.463 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 88.0 m -91.77 151.04 20.79 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 124.733 1.213 . . . . 74.409999999999997 110.019 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 p -118.76 140.68 49.54 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 116.226 -0.443 . . . . 65.340000000000003 110.508 176.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.27 117.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.84 -1.17 . . . . 74.319999999999993 107.84 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 59.85 30.01 19.56 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.71 0.804 . . . . 75.120000000000005 110.325 -177.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 t30 79.79 1.41 2.14 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.948 1.699 . . . . 72.319999999999993 110.949 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.76 25.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 O-C-N 121.884 -0.51 . . . . 70.109999999999999 110.139 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.39 125.91 5.92 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.705 2.27 . . . . 74.519999999999996 112.469 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.01 -177.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.884 -1.154 . . . . 74.150000000000006 107.884 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.11 -10.15 7.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.046 0.45 . . . . 73.430000000000007 110.112 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -153.41 135.24 14.57 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 109.6 -0.519 . . . . 73.420000000000002 109.6 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -151.73 151.93 32.06 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.748 -0.66 . . . . 74.310000000000002 109.916 -174.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -102.78 114.65 29.09 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 74.340000000000003 108.182 174.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.5 143.74 49.18 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.87 0.692 . . . . 72.200000000000003 112.87 -176.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.3 166.57 23.47 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.255 -1.017 . . . . 74.530000000000001 108.255 171.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.78 115.7 10.23 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.133 -0.321 . . . . 73.329999999999998 110.133 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 0.87 26.8 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.076 -0.583 . . . . 64.519999999999996 113.05 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -74.15 129.87 38.68 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.296 -0.562 . . . . 74.140000000000001 111.073 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.67 112.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 108.009 -1.108 . . . . 65.400000000000006 108.009 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.83 129.87 70.24 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 N-CA-C 109.736 -0.468 . . . . 73.349999999999994 109.736 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -123.75 131.9 53.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 110.093 -0.336 . . . . 73.310000000000002 110.093 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.13 140.17 37.84 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.369 -1.345 . . . . 61.009999999999998 107.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.48 88.3 0.0 OUTLIER Glycine 0 N--CA 1.489 2.178 0 O-C-N 125.4 1.688 . . . . 73.209999999999994 116.482 -174.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.7 m80 80.68 -33.51 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.596 1.558 . . . . 75.040000000000006 114.367 177.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -101.1 162.27 13.01 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.268 -0.573 . . . . 64.409999999999997 110.918 -173.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.06 143.18 31.77 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.28 0.562 . . . . 73.239999999999995 110.116 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.459 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -140.16 138.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 114.9 -1.046 . . . . 74.439999999999998 110.118 -173.563 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.17 128.36 67.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.936 -0.764 . . . . 75.219999999999999 108.936 177.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 63.9 t -89.18 129.26 40.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 112.521 0.563 . . . . 75.230000000000004 112.521 -177.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.32 137.12 51.97 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.313 -0.995 . . . . 73.239999999999995 108.313 172.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.3 mtp -126.27 112.42 15.7 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.464 -0.569 . . . . 63.229999999999997 109.464 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 . . . . . 0 C--N 1.275 -2.654 0 N-CA-C 108.255 -1.017 . . . . 73.340000000000003 108.255 -178.631 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.423 -1.82 0 N-CA-C 109.487 -0.56 . . . . 74.129999999999995 109.487 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.5 m -105.16 114.59 28.88 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.433 -0.951 . . . . 72.439999999999998 108.433 176.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -99.61 114.14 36.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.525 -1.287 . . . . 74.549999999999997 107.525 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.5 m -124.18 123.77 41.0 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.891 -0.781 . . . . 74.299999999999997 108.891 -176.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.485 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -102.99 128.23 49.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.71 -0.677 . . . . 75.430000000000007 109.311 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.57 132.7 51.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.387 -0.824 . . . . 72.109999999999999 110.424 -175.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.7 tp -121.5 111.55 17.4 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.378 -0.828 . . . . 73.329999999999998 109.321 -177.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -127.23 100.79 6.22 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.916 0.865 . . . . 73.219999999999999 109.735 177.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.05 19.53 15.67 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.555 -1.276 . . . . 71.299999999999997 107.555 174.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.75 16.82 12.0 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.666 -1.373 . . . . 63.329999999999998 109.666 -171.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 p -117.36 -68.32 0.93 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.317 0.58 . . . . 74.430000000000007 110.542 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.66 53.31 1.56 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.919 -0.872 . . . . 70.420000000000002 110.919 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.08 156.76 17.0 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.852 0.358 . . . . 72.510000000000005 111.121 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.2 p -132.34 143.98 50.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.777 -0.823 . . . . 73.219999999999999 108.777 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -135.48 134.16 39.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.392 -1.336 . . . . 74.200000000000003 107.392 175.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -110.06 135.07 51.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.846 -0.798 . . . . 73.140000000000001 108.846 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.85 128.23 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.76 . . . . 73.340000000000003 111.65 -176.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -104.5 153.2 21.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.456 -2.424 . . . . 73.430000000000007 104.456 172.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.02 143.95 55.84 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.12 0.962 . . . . 72.340000000000003 113.336 -173.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.12 177.37 16.5 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 107.648 -2.181 . . . . 75.219999999999999 107.648 -174.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 29.8 t -100.09 125.17 46.15 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.479 -0.888 . . . . 72.329999999999998 108.854 176.033 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -108.07 120.57 42.7 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.942 -1.026 . . . . 75.230000000000004 110.319 -177.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.4 mt -86.05 127.81 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.889 -1.051 . . . . 74.400000000000006 110.539 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.412 HG21 HD23 ' A' ' 40' ' ' LEU . 55.4 mt -103.27 119.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 125.321 1.448 . . . . 72.349999999999994 108.329 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 167.46 -151.75 19.64 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.416 -0.674 . . . . 51.450000000000003 111.416 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 82.9 mtm180 -131.8 105.03 7.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 117.769 0.784 . . . . 74.150000000000006 109.519 176.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.84 -163.8 33.6 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.314 -0.946 . . . . 72.549999999999997 111.215 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -86.96 -34.16 19.4 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.931 -0.766 . . . . 75.049999999999997 108.931 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -33.48 74.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.385 -0.825 . . . . 65.230000000000004 109.585 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.03 129.19 39.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.833 -1.076 . . . . 71.019999999999996 110.779 -178.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -90.72 -26.67 19.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.544 -1.28 . . . . 74.239999999999995 107.544 178.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.63 116.17 25.46 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.218 -1.356 . . . . 71.530000000000001 107.411 178.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -101.58 117.34 34.7 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.974 -0.557 . . . . 73.129999999999995 111.218 -175.806 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD23 HG21 ' A' ' 30' ' ' ILE . 4.0 mm? -78.1 125.24 85.49 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.666 -0.697 . . . . 74.540000000000006 110.732 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -74.6 2.6 6.22 Favored 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 122.416 2.077 . . . . 75.299999999999997 113.658 178.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -104.85 -173.38 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.093 -1.077 . . . . 75.329999999999998 108.093 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -124.78 167.12 15.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.68 -0.859 . . . . 75.450000000000003 108.68 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.01 -3.48 62.27 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 108.818 -1.713 . . . . 64.120000000000005 108.818 -174.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.75 131.41 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.168 -1.516 . . . . 75.010000000000005 107.458 179.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -93.41 -177.57 4.47 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.503 -0.317 . . . . 72.25 111.81 -175.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.8 ptm180 -63.79 -36.03 82.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.516 0.674 . . . . 71.430000000000007 111.913 -177.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -133.17 99.4 4.54 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 105.481 -2.044 . . . . 72.400000000000006 105.481 175.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -104.37 -46.42 4.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.978 -1.01 . . . . 65.040000000000006 109.546 -176.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 tt -153.49 159.75 42.36 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.069 -1.086 . . . . 72.420000000000002 108.069 -176.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.0 149.68 40.34 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.177 -0.675 . . . . 74.299999999999997 109.177 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' SER . 68.3 mt -118.74 115.43 48.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.828 -0.804 . . . . 71.430000000000007 108.828 175.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -91.55 107.42 19.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.344 -1.354 . . . . 73.129999999999995 107.344 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -115.43 132.36 56.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.789 -0.641 . . . . 73.120000000000005 111.305 -177.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -143.0 169.39 17.65 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.627 -1.99 . . . . 53.439999999999998 105.627 173.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 65.67 1.77 Allowed Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.8 -0.714 . . . . 75.519999999999996 112.07 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -155.89 -73.47 0.11 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.249 1.02 . . . . 75.319999999999993 108.443 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.95 159.22 16.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.66 0.784 . . . . 73.439999999999998 109.332 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 82' ' ' LEU . . . -103.85 104.69 14.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.193 -0.669 . . . . 71.510000000000005 109.193 178.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.28 114.07 26.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.204 -0.907 . . . . 71.230000000000004 109.788 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.75 122.51 36.29 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.896 -1.52 . . . . 74.439999999999998 106.896 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.78 124.47 18.33 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.71 -0.396 . . . . 73.120000000000005 110.568 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 70' ' ' THR . 12.9 m-20 -72.45 143.98 48.27 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.466 -0.939 . . . . 74.230000000000004 108.466 174.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -121.98 75.72 1.24 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.874 -1.158 . . . . 75.310000000000002 107.874 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 165.87 153.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 104.939 -2.245 . . . . 73.319999999999993 104.939 -178.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -97.2 -33.66 11.4 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.798 -0.761 . . . . 74.010000000000005 112.387 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 t -89.1 -28.95 19.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.758 -0.377 . . . . 75.209999999999994 111.351 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -88.63 27.38 1.3 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 122.568 0.347 . . . . 75.209999999999994 111.882 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.82 129.38 47.08 Favored Glycine 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 73.150000000000006 112.001 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.564 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 15.6 m -86.79 157.75 19.52 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 124.821 1.248 . . . . 74.349999999999994 113.053 -173.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 p -102.69 140.7 36.62 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.134 0.492 . . . . 74.519999999999996 110.732 178.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.05 120.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.672 -1.232 . . . . 73.310000000000002 107.672 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 59.29 32.02 21.61 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.694 0.798 . . . . 74.530000000000001 109.924 -176.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.7 t30 75.4 9.27 3.74 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.0 1.32 . . . . 74.409999999999997 110.953 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.9 41.99 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.488 -0.56 . . . . 72.120000000000005 109.488 177.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.33 125.35 11.23 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.4 2.067 . . . . 62.119999999999997 111.913 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.28 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.635 -0.876 . . . . 65.349999999999994 108.635 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -126.61 -0.64 6.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.422 -0.584 . . . . 74.109999999999999 109.422 171.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -165.29 147.16 7.65 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.479 -0.934 . . . . 73.519999999999996 108.479 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -166.95 151.84 7.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.508 -0.923 . . . . 75.319999999999993 108.508 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -105.03 118.62 36.99 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.557 -0.857 . . . . 71.230000000000004 109.57 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 78.0 mt -61.62 150.23 36.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.644 -1.162 . . . . 73.299999999999997 113.717 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.52 174.77 10.66 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.844 -1.071 . . . . 73.209999999999994 108.154 172.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.06 112.3 12.36 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.655 -0.498 . . . . 73.310000000000002 109.655 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.0 14.85 11.41 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.665 -0.778 . . . . 71.209999999999994 113.153 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -79.98 121.46 25.51 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 119.523 -0.871 . . . . 72.319999999999993 110.692 175.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 112.61 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 106.743 -1.577 . . . . 75.109999999999999 106.743 175.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.8 mt -120.45 140.1 45.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 109.388 -0.597 . . . . 63.229999999999997 109.388 -174.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -132.2 123.64 27.42 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.519 -0.872 . . . . 73.239999999999995 111.507 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -108.11 163.66 12.97 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.762 -1.57 . . . . 75.450000000000003 106.762 176.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.92 104.51 0.05 OUTLIER Glycine 0 CA--C 1.533 1.171 0 O-C-N 123.996 0.81 . . . . 72.019999999999996 114.403 -178.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.0 m80 80.32 -5.11 1.81 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.262 1.579 . . . . 73.140000000000001 115.262 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.4 m -138.17 136.51 36.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.995 0.816 . . . . 72.209999999999994 111.795 -177.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -107.56 138.44 43.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.226 -0.657 . . . . 75.310000000000002 109.226 175.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 5.4 tp -126.9 131.71 70.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.624 -0.88 . . . . 73.319999999999993 108.624 -175.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.5 119.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.654 -0.869 . . . . 72.310000000000002 108.654 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 95.6 t -90.62 125.01 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.209 0.528 . . . . 72.219999999999999 111.35 -178.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.76 149.42 42.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.401 -0.818 . . . . 74.310000000000002 109.728 178.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' SER . 59.4 mtt -129.6 110.47 11.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.624 0.726 . . . . 53.439999999999998 109.459 176.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--N 1.278 -2.535 0 CA-C-N 114.852 -1.067 . . . . 72.019999999999996 109.857 -176.53 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.458 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 52.3 m . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 109.514 -0.55 . . . . 72.329999999999998 109.514 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -113.0 128.53 56.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.104 -0.498 . . . . 51.450000000000003 109.756 176.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -103.35 124.72 57.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 75.430000000000007 109.031 177.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.4 m -126.16 134.82 51.18 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.303 -0.862 . . . . 71.420000000000002 109.559 -173.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.7 mt -93.89 135.12 35.55 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.277 -1.009 . . . . 75.530000000000001 108.277 178.213 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -114.83 126.62 55.04 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 109.762 -0.458 . . . . 73.239999999999995 109.762 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -123.61 114.85 20.56 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.381 -0.97 . . . . 72.439999999999998 108.381 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -118.39 101.93 8.54 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.9 0.857 . . . . 73.140000000000001 111.608 -179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.25 26.76 10.05 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.025 -1.843 . . . . 65.019999999999996 106.025 174.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.39 43.07 4.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.91 -2.076 . . . . 63.140000000000001 107.91 -173.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -147.73 -61.91 0.27 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.845 -0.677 . . . . 73.430000000000007 111.12 -172.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.88 39.8 5.73 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.002 -0.839 . . . . 74.209999999999994 111.002 -178.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.24 151.06 36.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 110.08 -0.341 . . . . 72.439999999999998 110.08 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.5 p -134.92 144.76 47.65 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.908 -0.587 . . . . 75.510000000000005 111.049 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -129.65 116.1 18.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.341 -0.615 . . . . 71.299999999999997 109.341 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -80.44 131.93 35.66 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.688 -0.486 . . . . 75.120000000000005 109.688 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 9' ' ' VAL . 93.7 mt -85.05 122.34 29.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.817 -1.179 . . . . 72.409999999999997 107.817 174.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -93.89 178.88 5.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.966 -0.694 . . . . 72.299999999999997 109.236 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 132.46 45.99 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.441 0.639 . . . . 72.239999999999995 111.153 -176.038 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.37 -159.67 16.94 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.237 -1.545 . . . . 74.400000000000006 109.237 -176.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 p -106.6 144.61 33.01 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.371 -0.531 . . . . 74.510000000000005 109.625 177.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -121.89 112.05 17.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.134 -1.061 . . . . 53.539999999999999 108.134 -176.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.5 mm -86.2 130.56 36.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 109.399 -0.593 . . . . 71.340000000000003 109.399 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.435 HG12 ' HB3' ' A' ' 38' ' ' PHE . 61.0 mt -115.69 135.79 54.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 123.238 0.615 . . . . 75.310000000000002 110.319 -178.049 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 148.23 -163.69 28.94 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 111.646 -0.582 . . . . 62.240000000000002 111.646 177.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.3 mtt180 -115.71 107.1 14.65 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.978 0.418 . . . . 74.439999999999998 110.114 176.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.62 -178.88 48.4 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.425 -1.47 . . . . 63.439999999999998 109.425 179.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.52 -13.69 53.99 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.502 0.668 . . . . 75.319999999999993 109.699 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -83.57 -24.38 31.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.2 -0.909 . . . . 52.240000000000002 109.449 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.67 139.25 31.53 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.55 -0.75 . . . . 64.150000000000006 111.955 -173.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -92.58 -44.92 8.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.474 -0.785 . . . . 74.230000000000004 108.942 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.435 ' HB3' HG12 ' A' ' 30' ' ' ILE . 68.6 t80 -101.42 108.58 20.22 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.219 -1.03 . . . . 71.239999999999995 108.219 177.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.8 mtm-85 -96.19 127.39 42.16 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.865 -1.061 . . . . 74.209999999999994 108.464 -177.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 9.3 mp -80.14 149.75 70.17 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 112.006 0.373 . . . . 64.099999999999994 112.006 -178.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.3 Cg_exo -71.69 -12.28 28.79 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.755 2.303 . . . . 53.350000000000001 112.342 177.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.56 165.05 11.7 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.6 0.593 . . . . 73.510000000000005 112.6 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -102.1 162.56 12.82 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.917 -1.142 . . . . 73.140000000000001 107.917 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.99 -0.48 41.39 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 109.458 -1.457 . . . . 50.119999999999997 109.458 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.441 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 t -102.93 131.29 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.921 -1.139 . . . . 74.420000000000002 108.614 -176.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 m -75.88 172.23 13.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.297 -0.41 . . . . 74.25 111.565 -178.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 1.4 ptm180 -64.65 -42.2 95.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.384 0.611 . . . . 73.239999999999995 110.819 177.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -123.64 93.69 4.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 104.791 -2.3 . . . . 72.510000000000005 104.791 171.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.525 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 22.6 t60 -96.26 -30.61 13.36 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 115.182 -0.917 . . . . 75.319999999999993 109.524 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 tt -163.5 146.99 10.35 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 109.321 -0.622 . . . . 74.310000000000002 109.321 -178.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.04 123.38 30.36 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.382 0.611 . . . . 71.230000000000004 111.257 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -104.26 119.18 52.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.826 -0.625 . . . . 74.549999999999997 109.696 177.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -100.71 114.52 28.34 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.516 -0.92 . . . . 74.420000000000002 108.516 177.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -113.76 134.46 54.75 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.697 0.76 . . . . 73.140000000000001 112.164 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -148.18 164.71 33.1 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 103.758 -2.682 . . . . 74.099999999999994 103.758 174.144 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.14 58.23 1.08 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 118.893 0.77 . . . . 74.319999999999993 113.005 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -135.58 -78.41 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.203 -1.406 . . . . 75.209999999999994 107.203 178.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -149.41 159.37 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 105.705 -1.961 . . . . 75.109999999999999 105.705 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.58 113.12 24.74 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.171 -0.677 . . . . 72.150000000000006 109.171 178.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.5 tp -83.72 106.74 15.66 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.052 -0.976 . . . . 73.310000000000002 110.335 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.6 tm? -94.99 111.44 23.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.519 1.128 . . . . 72.409999999999997 108.246 -177.163 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.06 121.43 38.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.168 -0.308 . . . . 75.319999999999993 110.168 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.93 136.6 34.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.129 -0.693 . . . . 65.439999999999998 109.129 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -125.72 76.05 1.54 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.356 -1.72 . . . . 72.109999999999999 106.356 -177.979 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 30.4 t-20 174.55 141.91 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.055 -1.091 . . . . 75.25 108.055 -178.063 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -108.35 -53.12 2.67 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.91 0.386 . . . . 72.049999999999997 111.095 177.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.0 m -66.46 -37.32 84.87 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.83 0.852 . . . . 61.43 112.089 -175.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.56 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 25.9 m-80 -115.9 27.2 9.44 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.681 -1.229 . . . . 74.239999999999995 107.681 -178.254 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.26 152.06 3.31 Favored Glycine 0 C--O 1.243 0.709 0 CA-C-N 114.279 -1.328 . . . . 73.120000000000005 115.624 -174.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 m -87.95 147.3 25.11 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.675 0.79 . . . . 53.310000000000002 112.17 -176.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -118.03 146.67 43.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.183 0.993 . . . . 72.0 110.637 178.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.96 127.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.019 -1.475 . . . . 72.430000000000007 107.019 176.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.04 26.95 12.58 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.052 0.941 . . . . 65.109999999999999 111.933 -178.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 73.91 22.48 2.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.798 1.239 . . . . 72.209999999999994 110.272 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.97 134.2 24.93 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.338 -0.846 . . . . 72.099999999999994 108.904 176.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.42 137.41 14.82 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.043 1.828 . . . . 63.539999999999999 111.856 179.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.1 170.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.091 -1.077 . . . . 72.340000000000003 108.091 179.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.71 -31.6 10.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.647 -0.501 . . . . 74.129999999999995 109.647 172.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.07 145.38 25.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 120.901 0.382 . . . . 74.349999999999994 110.091 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.424 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 63.4 t-105 -150.99 152.5 33.62 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.392 -0.966 . . . . 74.450000000000003 108.392 -173.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.95 124.22 49.12 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 107.549 -1.278 . . . . 71.430000000000007 107.549 174.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.3 mt -56.22 151.02 13.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.804 1.039 . . . . 73.099999999999994 113.804 -173.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.44 43.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.217 -1.401 . . . . 44.149999999999999 107.217 178.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.61 115.67 9.13 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.843 -179.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.42 10.06 45.6 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.852 -0.689 . . . . 62.25 112.741 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.38 144.45 32.69 Favored 'General case' 0 C--O 1.252 1.201 0 C-N-CA 119.27 -0.972 . . . . 72.099999999999994 108.937 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.9 t -102.06 112.54 35.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.196 -1.039 . . . . 71.230000000000004 108.196 -178.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.7 mt -110.81 127.89 67.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 C-N-CA 120.093 -0.643 . . . . 71.109999999999999 109.744 -177.13 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -121.32 119.46 32.25 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 109.568 -0.53 . . . . 75.349999999999994 109.568 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 1.5 pt? -114.32 137.92 51.18 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.349 -1.723 . . . . 64.349999999999994 106.349 177.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 5.31 86.17 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 O-C-N 124.785 1.303 . . . . 60.420000000000002 115.638 -166.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 55.12 16.79 1.7 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.974 1.842 . . . . 73.439999999999998 115.974 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -123.8 128.01 48.91 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.117 -0.697 . . . . 65.109999999999999 109.117 177.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.57 139.25 46.0 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.149 0.796 . . . . 73.400000000000006 113.149 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 tp -127.39 142.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.407 -1.331 . . . . 74.439999999999998 107.407 -177.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.9 133.46 51.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.662 -0.866 . . . . 72.430000000000007 108.662 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 81.4 t -100.72 126.18 54.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 120.836 0.351 . . . . 73.120000000000005 111.668 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -119.79 138.2 53.5 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.009 -0.542 . . . . 75.150000000000006 109.807 174.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.1 mtp -124.11 113.73 18.75 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.345 -0.613 . . . . 74.540000000000006 109.345 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.458 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 56.6 m-70 . . . . . 0 C--N 1.28 -2.42 0 N-CA-C 108.295 -1.002 . . . . 72.230000000000004 108.295 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 N--CA 1.428 -1.554 0 N-CA-C 108.539 -0.911 . . . . 74.209999999999994 108.539 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -124.46 115.19 20.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.51 -1.293 . . . . 72.329999999999998 107.51 176.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.31 131.07 36.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.279 -1.008 . . . . 74.299999999999997 108.279 -177.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.521 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 37.9 m -137.61 132.81 33.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.502 -0.772 . . . . 75.239999999999995 108.922 -174.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -93.23 136.75 33.2 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 120.216 -0.594 . . . . 74.010000000000005 109.649 177.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -109.04 129.52 55.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.732 -0.667 . . . . 74.340000000000003 111.476 -175.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -119.8 136.15 54.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.13 -1.396 . . . . 73.310000000000002 108.158 -177.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.79 98.91 11.7 Favored 'General case' 0 CA--C 1.467 -2.222 0 CA-C-O 122.574 1.178 . . . . 63.149999999999999 107.976 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 15.8 t70 -133.8 92.97 3.04 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 113.18 -1.827 . . . . 65.040000000000006 108.093 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.63 -61.54 4.12 Favored Glycine 0 C--N 1.292 -1.877 0 CA-C-N 114.565 -1.198 . . . . 54.140000000000001 110.634 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 p -135.73 -37.72 0.74 Allowed 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.609 -0.796 . . . . 75.239999999999995 109.792 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.9 120.07 1.06 Allowed Glycine 0 N--CA 1.41 -3.05 0 N-CA-C 110.444 -1.063 . . . . 71.140000000000001 110.444 -178.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 29.4 mmt180 -105.73 154.25 20.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.303 -1.369 . . . . 75.340000000000003 107.303 175.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.521 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 62.8 p -138.04 133.8 33.99 Favored 'General case' 0 C--N 1.283 -2.291 0 O-C-N 123.312 0.382 . . . . 74.109999999999999 110.685 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -117.85 114.48 23.31 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.752 -1.203 . . . . 75.430000000000007 107.752 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.18 135.72 38.53 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.13 -1.063 . . . . 74.340000000000003 108.13 179.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.3 mt -73.45 129.45 38.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.028 0.442 . . . . 74.140000000000001 110.034 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -79.58 151.83 30.42 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.2 -1.407 . . . . 73.409999999999997 107.2 176.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.25 113.35 12.51 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.274 1.035 . . . . 70.450000000000003 111.697 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.13 -166.48 26.0 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 106.367 -2.693 . . . . 72.420000000000002 106.367 -172.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 97.3 p -97.42 119.49 36.05 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 119.622 1.711 . . . . 73.230000000000004 111.078 177.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -88.03 108.46 19.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 106.998 -1.482 . . . . 74.010000000000005 106.998 -178.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.21 116.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.278 -0.874 . . . . 74.540000000000006 109.225 -175.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -99.34 128.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 123.484 0.714 . . . . 72.430000000000007 110.143 -177.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.68 26.65 Favored Glycine 0 CA--C 1.487 -1.661 0 CA-C-N 115.274 -0.875 . . . . 60.530000000000001 111.057 176.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -128.69 105.91 8.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.501 0.667 . . . . 70.209999999999994 111.349 176.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.07 166.52 33.56 Favored Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 108.92 -1.672 . . . . 65.420000000000002 108.92 176.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -74.88 -16.9 60.65 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.82 0.81 . . . . 73.239999999999995 109.283 176.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.98 -10.72 59.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.291 -0.868 . . . . 73.239999999999995 109.734 178.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.16 169.51 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 74.430000000000007 110.404 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -109.56 -47.39 3.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.447 0.641 . . . . 72.019999999999996 109.965 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -108.21 127.22 53.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.215 -0.902 . . . . 64.420000000000002 108.8 -177.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -95.23 127.28 41.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.048 -0.723 . . . . 74.129999999999995 109.048 -174.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.409 HD11 HG22 ' A' ' 45' ' ' VAL . 38.1 mt -83.47 150.01 59.13 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.675 -0.41 . . . . 75.310000000000002 110.318 175.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -95.03 34.39 0.17 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 123.37 2.713 . . . . 75.040000000000006 112.325 179.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -138.6 179.75 6.29 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.13 -0.628 . . . . 71.329999999999998 110.004 -178.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 m -112.67 162.41 15.75 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.696 -0.853 . . . . 64.299999999999997 108.696 -176.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.08 -20.77 48.86 Favored Glycine 0 CA--C 1.5 -0.862 0 C-N-CA 121.021 -0.609 . . . . 74.310000000000002 111.938 176.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.409 HG22 HD11 ' A' ' 40' ' ' LEU . 9.9 p -79.29 142.55 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.228 -0.486 . . . . 75.409999999999997 111.097 -178.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 m -80.13 -170.5 2.52 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.8 0.84 . . . . 74.200000000000003 109.317 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -77.8 -47.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.141 -1.024 . . . . 75.010000000000005 109.403 175.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -109.43 109.32 20.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 107.528 -1.286 . . . . 75.420000000000002 107.528 171.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -104.36 -45.28 4.71 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.664 -1.235 . . . . 75.25 107.664 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 5.8 tt -159.25 151.96 21.71 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 114.845 -1.07 . . . . 73.450000000000003 108.215 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -136.96 140.77 42.45 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.757 -0.831 . . . . 75.430000000000007 108.757 175.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.8 mt -106.83 115.86 49.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 107.782 -1.192 . . . . 75.450000000000003 107.782 176.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 48.1 mtt180 -90.32 107.07 18.91 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.79 -1.559 . . . . 64.299999999999997 106.79 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -112.06 115.59 29.14 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.845 -1.07 . . . . 74.310000000000002 109.967 -176.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.01 160.46 22.74 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.107 -1.812 . . . . 72.409999999999997 106.107 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.14 54.07 2.25 Favored Glycine 0 C--N 1.311 -0.822 0 CA-C-N 118.078 0.399 . . . . 73.349999999999994 113.295 -178.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -156.27 -63.23 0.11 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.466 -0.939 . . . . 64.409999999999997 108.466 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.6 159.41 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 122.868 0.467 . . . . 64.439999999999998 110.833 -178.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.03 110.92 22.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.071 -0.513 . . . . 74.019999999999996 110.139 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 4.9 tt -100.74 118.04 36.04 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.746 -0.835 . . . . 65.299999999999997 108.746 -177.335 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -94.75 123.58 38.29 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.686 -1.227 . . . . 72.219999999999999 107.686 179.083 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.89 124.74 36.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 75.329999999999998 111.306 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.29 138.44 31.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.644 0.778 . . . . 54.240000000000002 109.892 179.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.0 76.53 1.66 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.732 -0.47 . . . . 75.209999999999994 109.732 177.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.52 142.45 0.57 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.748 -0.464 . . . . 71.329999999999998 109.748 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 p -96.32 -46.96 6.2 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.409 -0.516 . . . . 64.109999999999999 110.832 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 t -80.14 -36.85 34.61 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.937 -176.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -103.89 28.49 6.63 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 122.23 -0.294 . . . . 71.409999999999997 110.873 -176.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.07 125.67 5.76 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 124.561 1.163 . . . . 61.030000000000001 113.943 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.3 m -75.68 147.61 39.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 124.282 1.033 . . . . 72.450000000000003 112.505 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -112.4 140.89 46.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.454 -0.794 . . . . 71.239999999999995 110.747 176.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.68 119.53 58.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.79 -1.189 . . . . 74.439999999999998 107.79 177.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 55.26 36.26 26.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.388 0.613 . . . . 72.239999999999995 110.189 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 80.09 -2.92 1.99 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.029 1.731 . . . . 75.540000000000006 111.783 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.74 123.03 49.15 Favored Pre-proline 0 C--N 1.32 -0.692 0 O-C-N 121.524 -0.735 . . . . 75.230000000000004 110.77 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.55 125.47 10.12 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.653 2.235 . . . . 75.239999999999995 110.885 177.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -142.57 173.93 6.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.73 -0.47 . . . . 72.510000000000005 109.73 -177.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.1 -30.99 8.12 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.739 -0.664 . . . . 63.329999999999998 109.567 172.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 13.2 pt-20 -145.53 146.55 31.47 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.041 0.448 . . . . 74.209999999999994 110.88 173.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -154.9 152.17 29.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.739 -1.208 . . . . 72.420000000000002 107.739 -173.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -105.97 116.33 31.75 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.864 -1.134 . . . . 74.340000000000003 110.059 174.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 97' ' ' VAL . 74.2 mt -56.65 148.01 21.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.328 -1.305 . . . . 75.510000000000005 113.735 -174.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.78 37.6 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.425 -1.324 . . . . 60.310000000000002 107.425 170.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 21.3 t70 -71.26 120.93 17.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.105 0.479 . . . . 62.039999999999999 110.48 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.63 11.07 33.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.251 -0.886 . . . . 71.120000000000005 112.158 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -74.15 134.98 42.84 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 117.277 0.538 . . . . 64.450000000000003 111.362 177.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.8 t -97.31 112.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.151 -1.055 . . . . 75.510000000000005 108.151 179.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.14 125.59 74.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 119.801 -0.76 . . . . 74.25 110.54 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.429 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 59.3 mtt-85 -111.58 115.29 28.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 111.112 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.47 165.5 13.15 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.974 -1.012 . . . . 70.030000000000001 109.109 177.517 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.06 100.41 0.01 OUTLIER Glycine 0 N--CA 1.475 1.236 0 O-C-N 123.972 0.795 . . . . 54.130000000000003 114.765 -176.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.3 m170 65.53 10.79 6.93 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.584 1.554 . . . . 73.049999999999997 113.184 178.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 m -138.58 118.02 12.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.065 0.46 . . . . 71.409999999999997 111.447 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.15 142.1 33.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.744 -0.382 . . . . 75.109999999999999 110.01 172.662 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.9 tp -139.09 148.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.779 -0.452 . . . . 75.530000000000001 109.779 -172.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.15 131.19 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.128 -1.064 . . . . 70.409999999999997 108.128 176.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.407 HG21 HD22 ' A' ' 82' ' ' LEU . 85.9 t -87.33 128.55 39.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 120.801 0.334 . . . . 72.109999999999999 110.239 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -125.01 151.32 45.71 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.129 -0.693 . . . . 75.150000000000006 109.129 -179.759 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -129.76 130.35 45.28 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.943 -0.571 . . . . 74.25 110.357 176.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 . . . . . 0 C--N 1.286 -2.153 0 N-CA-C 106.168 -1.79 . . . . 74.349999999999994 106.168 175.18 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.41 -2.436 0 N-CA-C 108.739 -0.838 . . . . 75.120000000000005 108.739 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 m -103.82 119.93 39.93 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.843 -1.54 . . . . 74.239999999999995 106.843 176.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -107.51 124.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.615 0.722 . . . . 75.420000000000002 111.256 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 22.4 m -124.83 134.97 52.54 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.603 -1.258 . . . . 74.540000000000006 107.603 -175.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.453 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -100.55 143.78 30.31 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.566 -0.454 . . . . 74.140000000000001 110.812 -178.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 46.9 mt-30 -110.73 127.37 55.3 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 107.979 -1.119 . . . . 74.099999999999994 107.979 174.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.49 145.97 49.85 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.644 0.735 . . . . 75.230000000000004 110.724 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.41 101.56 13.49 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.063 -0.971 . . . . 60.130000000000003 110.251 -178.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.1 -32.5 10.55 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.603 -1.18 . . . . 74.150000000000006 109.605 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.73 -34.38 3.62 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 107.725 -2.15 . . . . 71.010000000000005 107.725 -171.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -87.91 -41.53 13.12 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.898 -1.149 . . . . 74.25 107.898 176.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 94.13 2.34 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 109.618 -1.393 . . . . 73.099999999999994 109.618 -177.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -120.09 154.91 34.0 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.924 0.712 . . . . 74.129999999999995 112.924 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.437 HG21 ' HG2' ' A' ' 12' ' ' GLN . 34.5 p -133.55 153.09 51.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.383 -1.28 . . . . 74.430000000000007 108.161 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.429 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 59.9 t80 -153.48 131.51 11.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.898 -1.149 . . . . 74.420000000000002 107.898 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.5 tt0 -93.75 141.25 28.71 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.356 -0.938 . . . . 74.439999999999998 110.649 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HB2' HG11 ' A' ' 9' ' ' VAL . 91.4 mt -78.16 126.14 30.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.026 -0.534 . . . . 75.340000000000003 110.486 -178.431 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -82.79 152.87 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.317 -1.364 . . . . 72.019999999999996 107.317 178.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.42 120.66 21.96 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.988 0.899 . . . . 74.329999999999998 109.737 176.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.18 -167.89 24.25 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 105.548 -3.021 . . . . 71.219999999999999 105.548 -171.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -106.83 143.39 35.0 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 118.738 1.269 . . . . 74.150000000000006 110.694 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -125.56 145.26 50.2 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.701 -0.851 . . . . 73.150000000000006 108.701 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -121.83 131.9 72.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.61 -0.515 . . . . 75.150000000000006 109.61 -177.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.1 mt -107.84 131.65 57.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 124.399 1.08 . . . . 73.420000000000002 109.779 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.73 -157.95 27.45 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 110.06 -1.216 . . . . 73.340000000000003 110.06 177.263 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 43.6 mtm180 -130.49 106.68 8.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.52 0.66 . . . . 72.400000000000006 109.997 174.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.82 -164.66 29.96 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 110.019 -1.232 . . . . 71.219999999999999 110.019 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -80.68 -39.3 27.45 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.135 0.493 . . . . 73.219999999999999 110.431 -178.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.0 -21.07 44.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 74.310000000000002 110.288 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.47 23.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.781 -0.645 . . . . 55.399999999999999 110.996 -178.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -99.15 -44.88 6.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.916 0.865 . . . . 74.25 108.803 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -100.27 122.55 43.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 106.743 -1.577 . . . . 75.109999999999999 106.743 178.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 17.8 mtp180 -98.14 134.82 40.67 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 112.754 0.65 . . . . 64.230000000000004 112.754 -174.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 38.9 mt -97.62 114.21 64.59 Favored Pre-proline 0 N--CA 1.42 -1.95 0 N-CA-C 107.477 -1.305 . . . . 75.109999999999999 107.477 169.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.505 ' HD2' ' NE2' ' A' ' 92' ' ' HIS . 16.2 Cg_exo -70.06 20.21 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.725 2.95 . . . . 74.340000000000003 113.907 -176.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -97.75 178.27 5.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.557 -0.534 . . . . 65.540000000000006 109.557 -176.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 m -115.59 133.05 56.41 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 109.399 -0.593 . . . . 71.310000000000002 109.399 -177.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.1 -2.85 35.27 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.433 -1.067 . . . . 42.0 110.433 -178.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.98 138.89 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 107.961 -1.126 . . . . 74.030000000000001 107.961 -179.435 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -83.76 166.4 18.05 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.668 -0.242 . . . . 70.430000000000007 111.145 -177.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 35.2 ptt180 -62.99 -36.66 84.3 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.8 0.81 . . . . 74.420000000000002 109.899 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -129.26 100.67 5.68 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 102.545 -3.132 . . . . 74.120000000000005 102.545 171.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -99.26 -37.29 9.33 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.781 -0.645 . . . . 72.129999999999995 109.328 -174.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -161.29 147.15 14.21 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.032 -1.469 . . . . 74.150000000000006 107.032 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -144.33 142.72 30.58 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 121.328 0.585 . . . . 73.349999999999994 110.971 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -119.58 128.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.262 -0.881 . . . . 74.400000000000006 109.523 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -107.38 111.76 24.25 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.157 -1.423 . . . . 75.230000000000004 107.157 177.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.293 0.568 . . . . 74.349999999999994 111.054 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -149.07 -174.03 4.53 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.74 -1.578 . . . . 75.200000000000003 106.74 173.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.11 2.59 60.56 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 119.961 -1.114 . . . . 71.140000000000001 114.704 -173.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG2' HG12 ' A' ' 58' ' ' VAL . 61.6 tt0 -93.51 -75.24 0.5 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.167 0.484 . . . . 75.099999999999994 111.123 177.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 57' ' ' GLN . 16.0 m -135.75 159.35 39.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 122.529 0.332 . . . . 74.129999999999995 110.6 -176.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.33 102.24 13.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.915 -1.143 . . . . 74.019999999999996 107.915 175.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 tp -93.67 113.41 25.48 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.357 -0.838 . . . . 73.439999999999998 111.093 -174.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.64 129.41 49.22 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.127 -1.064 . . . . 65.310000000000002 108.127 -179.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.27 125.71 28.28 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.863 0.363 . . . . 71.129999999999995 110.893 177.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.74 128.78 35.31 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.615 -1.254 . . . . 72.120000000000005 107.615 175.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.6 OUTLIER -124.37 78.27 1.64 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.932 -0.766 . . . . 72.219999999999999 108.932 -174.331 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 8.0 p30 175.52 161.92 0.28 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.029 -0.36 . . . . 73.510000000000005 110.029 177.054 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.9 m -108.97 -12.02 14.91 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.238 0.542 . . . . 75.25 111.369 176.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -79.17 -55.47 5.08 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.411 0.893 . . . . 75.420000000000002 113.411 -172.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -121.92 30.1 6.79 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.759 1.224 . . . . 75.129999999999995 110.1 -169.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.77 115.67 0.87 Allowed Glycine 0 C--O 1.251 1.192 0 O-C-N 124.861 1.351 . . . . 73.430000000000007 113.322 -172.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 m -61.07 139.04 58.17 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 125.751 1.621 . . . . 74.319999999999993 113.302 -172.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 p -102.65 142.18 34.25 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.955 -1.021 . . . . 64.329999999999998 110.927 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.62 118.55 56.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.448 -1.316 . . . . 73.340000000000003 107.448 175.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 60.88 32.95 20.07 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.332 1.053 . . . . 74.129999999999995 110.997 -177.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.7 t30 78.02 16.5 1.36 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.904 1.682 . . . . 73.140000000000001 112.031 174.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.57 134.77 26.65 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.19 -0.67 . . . . 75.340000000000003 109.19 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.14 140.83 25.53 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.414 2.076 . . . . 74.400000000000006 112.834 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.26 174.48 3.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.865 -0.791 . . . . 75.319999999999993 108.865 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -96.26 -47.29 6.09 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.405 -0.961 . . . . 75.400000000000006 108.405 173.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -142.26 150.74 41.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.849 -0.614 . . . . 75.219999999999999 110.68 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -152.2 151.23 30.74 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.303 -0.629 . . . . 74.400000000000006 109.303 -173.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -98.25 113.94 26.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.62 -0.882 . . . . 73.109999999999999 108.62 173.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.51 131.84 52.02 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.758 -0.655 . . . . 72.099999999999994 112.251 -176.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.41 154.29 42.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.775 -1.194 . . . . 74.219999999999999 107.775 172.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.63 123.21 17.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.188 -0.46 . . . . 71.049999999999997 110.264 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.88 6.14 56.22 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 120.602 -0.809 . . . . 53.149999999999999 113.02 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -81.48 137.46 35.61 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.111 -0.636 . . . . 63.0 111.065 176.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.05 113.02 34.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.609 0 CA-C-N 115.581 -0.736 . . . . 73.010000000000005 109.264 -178.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.448 ' HB ' HG21 ' A' ' 95' ' ' ILE . 73.2 mt -112.15 141.35 27.92 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.127 0 N-CA-C 108.201 -1.037 . . . . 74.140000000000001 108.201 -177.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -140.27 126.07 19.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.728 -0.789 . . . . 75.349999999999994 112.85 -177.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.22 144.45 48.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.959 -1.497 . . . . 73.409999999999997 106.959 175.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.22 88.25 0.02 OUTLIER Glycine 0 C--O 1.239 0.458 0 N-CA-C 115.862 1.105 . . . . 54.329999999999998 115.862 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.505 ' NE2' ' HD2' ' A' ' 41' ' ' PRO . 84.2 t60 162.35 -47.88 0.0 OUTLIER 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.139 2.175 . . . . 75.329999999999998 107.04 176.114 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.8 m -149.27 134.78 18.53 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.845 -1.07 . . . . 74.010000000000005 111.541 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.53 141.92 27.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.22 -1.77 . . . . 60.109999999999999 106.22 169.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -132.91 136.15 56.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-O 121.035 0.445 . . . . 73.010000000000005 111.317 -172.113 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.4 mt -114.94 129.53 70.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.772 -0.825 . . . . 63.210000000000001 108.772 177.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.11 127.96 38.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.908 -0.587 . . . . 74.439999999999998 111.648 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -119.59 134.29 55.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.806 -0.634 . . . . 73.129999999999995 109.882 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.2 mtt -119.02 133.96 55.49 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 116.006 -0.543 . . . . 75.010000000000005 110.451 177.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 . . . . . 0 C--N 1.289 -2.06 0 N-CA-C 107.952 -1.129 . . . . 74.25 107.952 177.903 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.417 -2.106 0 N-CA-C 106.386 -1.709 . . . . 74.510000000000005 106.386 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.4 m -121.84 139.63 53.39 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.699 -0.801 . . . . 75.530000000000001 110.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -124.04 120.52 59.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.065 -1.458 . . . . 71.319999999999993 107.065 176.4 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 m -118.43 128.43 54.61 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.661 -0.7 . . . . 74.450000000000003 109.275 -173.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.98 133.34 34.35 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.086 -0.709 . . . . 72.439999999999998 109.086 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.09 113.79 26.26 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.404 -1.332 . . . . 72.420000000000002 107.404 -176.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.0 tp -112.63 110.56 20.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.828 -0.623 . . . . 72.230000000000004 109.861 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -110.59 107.89 17.65 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.55 0.69 . . . . 64.140000000000001 110.415 176.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.47 24.51 11.53 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.79 -1.559 . . . . 74.349999999999994 106.79 177.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 44.36 2.86 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 108.345 -1.902 . . . . 63.509999999999998 108.345 -174.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -159.35 -70.76 0.08 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.424 0.631 . . . . 54.030000000000001 110.54 -175.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.65 73.29 0.91 Allowed Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.988 -1.245 . . . . 74.120000000000005 109.988 -177.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -103.67 155.65 18.4 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.87 -0.419 . . . . 74.299999999999997 109.87 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.5 p -141.46 136.0 30.84 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.239 0.542 . . . . 75.209999999999994 111.942 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' A' ' 11' ' ' LEU . 92.5 t80 -133.58 139.88 46.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.375 -1.343 . . . . 73.319999999999993 107.375 176.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.46 135.43 46.87 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.48 -0.488 . . . . 72.439999999999998 110.003 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -63.78 145.88 54.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.582 -0.736 . . . . 71.349999999999994 112.834 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -97.91 161.25 13.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.909 -1.145 . . . . 72.530000000000001 107.909 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.01 117.93 17.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.504 0.669 . . . . 73.239999999999995 110.645 -178.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.64 -169.72 16.66 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 109.022 -1.631 . . . . 73.109999999999999 109.022 -175.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 t -107.43 146.57 31.53 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 121.794 0.807 . . . . 64.299999999999997 112.047 -179.336 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -122.01 129.92 52.86 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.072 -0.967 . . . . 74.120000000000005 109.01 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.32 125.85 54.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.048 -1.093 . . . . 75.420000000000002 108.048 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.92 131.05 56.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.334 -0.617 . . . . 75.010000000000005 109.334 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.72 -159.56 28.2 Favored Glycine 0 CA--C 1.488 -1.626 0 N-CA-C 110.255 -1.138 . . . . 61.439999999999998 110.255 177.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.67 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 71.6 mtt-85 -128.96 105.72 8.4 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 117.568 0.684 . . . . 72.209999999999994 109.613 176.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.11 -179.01 48.65 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.194 -1.162 . . . . 75.219999999999999 110.194 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -68.15 -22.36 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.476 0.711 . . . . 61.25 112.886 -176.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -97.74 -7.77 30.02 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 120.773 0.321 . . . . 73.200000000000003 110.509 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.43 130.71 38.41 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.263 0.554 . . . . 75.549999999999997 111.591 -173.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -92.3 -49.17 6.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.124 -1.065 . . . . 75.430000000000007 108.124 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -112.46 125.95 54.78 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.972 -1.013 . . . . 73.549999999999997 108.665 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 10.1 mmt180 -99.01 134.52 41.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.714 -0.847 . . . . 63.340000000000003 108.714 -177.005 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.88 141.5 47.6 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.197 -0.668 . . . . 72.340000000000003 109.197 174.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.07 -36.43 65.61 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.747 2.964 . . . . 71.030000000000001 114.181 -178.037 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.26 170.92 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.119 0.785 . . . . 74.239999999999995 113.119 -175.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p -103.16 165.23 11.15 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.017 -0.992 . . . . 64.349999999999994 108.5 173.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.0 -23.25 34.21 Favored Glycine 0 CA--C 1.501 -0.8 0 N-CA-C 109.781 -1.328 . . . . 74.310000000000002 109.781 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.1 136.36 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.271 -0.965 . . . . 75.129999999999995 108.751 175.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.7 m -67.04 161.38 24.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.413 0.523 . . . . 75.230000000000004 112.413 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.67 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 27.8 ptt180 -54.85 -40.54 69.74 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.515 175.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.92 106.82 9.16 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 102.879 -3.008 . . . . 75.319999999999993 102.879 170.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -98.36 -39.4 8.82 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 109.091 -0.707 . . . . 52.229999999999997 109.091 -177.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 tt -162.36 150.32 14.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.756 -0.831 . . . . 75.540000000000006 108.756 -176.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.95 135.25 48.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.243 0.544 . . . . 75.319999999999993 110.011 178.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.54 120.96 62.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.093 -1.447 . . . . 74.219999999999999 107.093 174.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -111.65 111.74 22.95 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.069 0.461 . . . . 73.409999999999997 109.979 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -104.35 115.84 31.09 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.455 -0.793 . . . . 74.540000000000006 110.758 -178.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.81 171.6 7.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.217 -1.771 . . . . 74.420000000000002 106.217 177.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.79 53.35 4.31 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.973 -0.632 . . . . 64.200000000000003 112.98 -177.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -150.43 -78.41 0.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.508 1.123 . . . . 75.019999999999996 108.657 177.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.8 159.84 27.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 70.5 108.546 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.48 120.69 33.21 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.45 0.643 . . . . 54.32 110.556 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.05 133.41 34.36 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.943 -1.026 . . . . 74.540000000000006 108.508 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.1 125.29 45.87 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.265 -1.013 . . . . 70.340000000000003 108.265 -178.041 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.22 135.8 46.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.607 0.241 . . . . 74.109999999999999 110.436 177.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.72 119.08 38.15 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.932 0.893 . . . . 65.010000000000005 110.011 -177.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.87 77.91 1.62 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.036 -1.838 . . . . 74.430000000000007 106.036 179.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.446 HD22 ' C ' ' A' ' 68' ' ' ASN . 8.1 t30 -173.56 131.31 0.45 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.055 -0.52 . . . . 71.239999999999995 110.16 -165.121 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -108.15 -43.33 4.41 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 113.073 0.768 . . . . 73.409999999999997 113.073 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -88.62 -26.18 22.04 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.631 0.974 . . . . 74.530000000000001 113.631 -170.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.446 ' C ' HD22 ' A' ' 65' ' ' ASN . 5.8 m-20 -115.59 30.12 7.56 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.199 -0.667 . . . . 74.340000000000003 109.199 -177.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.93 127.22 4.13 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 124.528 1.143 . . . . 74.030000000000001 114.503 -171.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.0 m -66.69 136.71 55.94 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.103 0.961 . . . . 74.540000000000006 112.756 -176.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 17.8 p -107.58 140.46 40.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.581 -0.736 . . . . 64.549999999999997 110.688 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 80' ' ' TRP . 27.9 m -117.4 117.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.627 -1.249 . . . . 74.349999999999994 107.627 177.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 86' ' ' ASP . 5.5 m-80 57.76 31.07 19.94 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.594 -0.73 . . . . 74.010000000000005 110.775 -172.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.9 t30 80.44 3.03 1.86 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 126.327 1.851 . . . . 73.340000000000003 111.777 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.26 118.9 65.19 Favored Pre-proline 0 C--N 1.319 -0.722 0 O-C-N 121.458 -0.776 . . . . 64.219999999999999 109.877 177.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.04 129.24 21.38 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.417 2.078 . . . . 73.209999999999994 111.772 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 m -140.97 167.68 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 110.021 -0.363 . . . . 65.019999999999996 110.021 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -109.14 -18.35 13.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.569 0.7 . . . . 73.120000000000005 109.289 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -151.61 155.15 37.82 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.194 -1.039 . . . . 72.450000000000003 108.194 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . 0.433 ' CD2' HG22 ' A' ' 72' ' ' VAL . 73.5 t-105 -159.87 151.92 20.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.015 -0.735 . . . . 74.140000000000001 109.015 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.74 111.56 24.12 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.507 -1.294 . . . . 64.040000000000006 107.507 174.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.477 ' HB3' HG11 ' A' ' 97' ' ' VAL . 64.9 mt -56.93 131.87 50.96 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.383 1.052 . . . . 72.319999999999993 112.636 -174.103 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.93 165.66 20.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.596 -0.89 . . . . 72.329999999999998 108.596 175.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.45 116.56 11.92 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.099 -0.704 . . . . 75.319999999999993 109.099 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.43 9.44 23.51 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.871 -0.68 . . . . 75.310000000000002 112.906 179.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.556 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 49.2 m-20 -81.44 117.5 21.93 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.652 -0.819 . . . . 75.150000000000006 111.884 177.328 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.76 112.34 25.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.161 -1.792 . . . . 74.019999999999996 106.161 175.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.9 mt -112.03 124.39 68.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.092 0 CA-C-O 120.894 0.378 . . . . 71.409999999999997 110.458 -172.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.556 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.3 mpt_? -109.55 120.37 42.29 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.226 -0.657 . . . . 75.049999999999997 109.226 177.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.55 164.16 20.38 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.172 -0.677 . . . . 74.219999999999999 109.172 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.3 108.58 0.6 Allowed Glycine 0 C--N 1.316 -0.575 0 O-C-N 123.506 0.504 . . . . 63.340000000000003 112.959 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 72.75 16.07 4.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.562 1.545 . . . . 75.010000000000005 114.093 177.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.8 t -154.05 167.0 31.26 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.901 -0.499 . . . . 74.430000000000007 110.581 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.24 132.31 14.34 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.749 -0.834 . . . . 71.120000000000005 108.749 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tp -141.21 146.25 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.981 -0.377 . . . . 75.219999999999999 109.981 -173.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.52 135.27 53.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.043 -1.095 . . . . 74.349999999999994 108.043 175.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 82' ' ' LEU . 78.0 t -98.42 130.97 46.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 112.18 0.437 . . . . 71.019999999999996 112.18 -178.262 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -119.32 150.37 40.25 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.899 -0.778 . . . . 74.140000000000001 108.899 174.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.1 mtp -129.38 147.38 51.2 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.258 0.551 . . . . 72.209999999999994 111.314 -178.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 35.6 m-70 . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 106.693 -1.595 . . . . 74.25 106.693 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' HIS . 86.3 m . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 107.682 -1.229 . . . . 65.25 107.682 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.1 m -101.53 124.34 47.04 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.279 -0.569 . . . . 74.409999999999997 109.638 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.79 115.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.009 -0.737 . . . . 74.530000000000001 109.009 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.478 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 31.2 m -112.26 123.66 50.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.289 -1.004 . . . . 72.030000000000001 108.289 -178.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 54.9 mt -94.43 128.85 41.25 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.777 -0.823 . . . . 70.150000000000006 108.777 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.64 110.48 21.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.894 -1.15 . . . . 74.299999999999997 107.894 -178.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 56.3 tp -104.41 131.17 52.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.831 0.852 . . . . 73.230000000000004 110.669 -175.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.436 ' HB3' ' OE2' ' A' ' 94' ' ' GLU . 32.9 t70 -98.32 101.23 12.63 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.996 0.903 . . . . 72.239999999999995 109.728 175.246 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -102.43 -0.62 32.17 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.449 -1.25 . . . . 71.239999999999995 107.759 176.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.43 -21.57 19.15 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.56 -1.2 . . . . 64.349999999999994 110.527 -176.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -109.77 -45.56 3.63 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.306 0.574 . . . . 62.32 109.918 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.56 102.42 2.36 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.379 -1.089 . . . . 71.299999999999997 110.379 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.434 ' HA ' ' HE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -114.98 151.8 33.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 109.847 -0.427 . . . . 71.239999999999995 109.847 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.3 p -135.04 142.37 46.34 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.165 -0.47 . . . . 71.450000000000003 110.86 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -140.83 133.94 29.4 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.471 -1.307 . . . . 73.129999999999995 107.471 177.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -102.51 136.97 41.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.898 -0.779 . . . . 72.530000000000001 108.898 179.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.8 mt -74.77 133.48 41.96 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.195 -0.457 . . . . 73.219999999999999 110.745 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -101.04 164.42 11.81 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.486 -1.301 . . . . 72.0 107.486 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.31 125.15 24.69 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.193 0.52 . . . . 71.140000000000001 111.172 -179.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.63 -164.73 12.16 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 109.112 -1.595 . . . . 73.209999999999994 109.112 -176.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.5 p -92.18 135.46 33.97 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 118.214 1.007 . . . . 73.310000000000002 111.588 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -114.32 120.18 39.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.564 -1.643 . . . . 75.439999999999998 106.564 -178.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.19 133.0 59.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 120.495 0.188 . . . . 72.319999999999993 111.063 -175.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.13 137.79 42.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 109.181 -0.674 . . . . 65.109999999999999 109.181 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.54 -151.7 22.52 Favored Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 108.274 -1.93 . . . . 72.200000000000003 108.274 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.9 mtm180 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.361 -1.348 . . . . 75.319999999999993 107.361 172.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.14 -177.21 47.78 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.604 -1.398 . . . . 73.340000000000003 109.604 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -78.49 -18.72 54.41 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.101 0.45 . . . . 72.049999999999997 111.557 178.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.79 -6.47 55.91 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.046 0.451 . . . . 70.120000000000005 110.678 173.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.81 140.55 29.4 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.41 -0.959 . . . . 74.540000000000006 108.41 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -102.04 -52.43 3.16 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.043 -1.095 . . . . 74.25 108.043 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -98.92 108.47 21.16 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.73 -1.581 . . . . 64.549999999999997 106.73 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 19.8 ptt85 -97.21 129.46 44.55 Favored 'General case' 0 N--CA 1.41 -2.44 0 C-N-CA 119.907 -0.717 . . . . 62.43 110.69 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.96 137.54 72.95 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.677 -0.692 . . . . 74.329999999999998 109.535 178.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.57 -5.21 16.27 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.588 2.192 . . . . 71.0 111.632 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -86.27 -173.78 4.72 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.014 -0.539 . . . . 72.109999999999999 111.264 -176.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.477 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.8 t -132.17 164.91 25.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.615 -0.883 . . . . 74.319999999999993 108.615 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.88 -29.41 12.53 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.253 -1.539 . . . . 71.400000000000006 109.253 -175.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.34 143.33 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 CA-C-N 114.086 -1.057 . . . . 74.430000000000007 109.899 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -87.64 -176.75 5.67 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.055 0.542 . . . . 63.130000000000003 110.307 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 20.5 ptt180 -67.18 -39.3 86.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.253 0.549 . . . . 75.109999999999999 110.588 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -127.2 114.28 17.46 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.102 -1.814 . . . . 75.430000000000007 106.102 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.505 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 67.7 t60 -104.13 -37.36 7.35 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 121.369 0.604 . . . . 74.5 109.74 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 tt -161.02 145.71 13.85 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 116.084 -0.507 . . . . 71.129999999999995 109.845 -176.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.39 139.68 49.51 Favored 'General case' 0 C--N 1.3 -1.543 0 CA-C-N 115.798 -0.637 . . . . 73.120000000000005 110.222 179.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 83.9 mt -121.75 116.74 50.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.455 -0.793 . . . . 73.439999999999998 109.268 178.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 -91.44 107.77 19.43 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.803 -1.184 . . . . 65.239999999999995 107.803 176.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -97.55 113.02 24.65 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.19 0.995 . . . . 74.040000000000006 112.766 -175.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.33 150.44 45.48 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.137 -1.801 . . . . 75.530000000000001 106.137 173.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.51 75.96 0.52 Allowed Glycine 0 C--N 1.307 -1.065 0 O-C-N 123.513 0.508 . . . . 64.430000000000007 113.834 -174.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -166.41 -68.29 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.148 -1.427 . . . . 72.310000000000002 107.148 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.9 m -149.06 150.86 13.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 106.449 -1.686 . . . . 73.25 106.449 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.9 126.39 36.04 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.26 -0.576 . . . . 74.409999999999997 109.849 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.9 tt -83.11 107.52 15.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.118 -1.067 . . . . 70.200000000000003 108.118 -178.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.75 120.96 34.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.148 -1.056 . . . . 74.310000000000002 108.148 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.0 119.57 23.38 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.246 0.546 . . . . 74.420000000000002 110.219 176.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.44 134.73 37.33 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.819 -0.808 . . . . 75.129999999999995 108.819 177.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.42 77.24 1.63 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.439 -1.319 . . . . 74.510000000000005 107.439 -177.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.52 163.76 8.4 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.39 -0.524 . . . . 73.25 109.946 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 p -108.13 -54.86 2.45 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.527 179.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.441 HG22 ' OD1' ' A' ' 68' ' ' ASN . 5.9 t -90.0 -24.05 21.33 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.411 0.624 . . . . 73.409999999999997 112.518 -175.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.441 ' OD1' HG22 ' A' ' 67' ' ' THR . 3.1 m-20 -105.54 22.77 14.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.727 -0.608 . . . . 74.239999999999995 110.066 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.0 118.83 2.9 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 124.442 1.089 . . . . 75.140000000000001 114.384 -175.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 m -65.54 138.46 58.07 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.824 1.25 . . . . 72.439999999999998 113.298 -176.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.43 140.86 38.68 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 108.132 -1.062 . . . . 71.329999999999998 108.132 -179.576 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.08 121.13 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.165 -0.959 . . . . 74.219999999999999 110.208 178.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 58.98 25.86 14.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.232 1.013 . . . . 74.230000000000004 110.586 -177.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 77.7 20.79 1.03 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.997 1.719 . . . . 63.409999999999997 112.63 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.81 125.9 26.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.661 -0.866 . . . . 65.230000000000004 108.661 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.19 128.14 11.88 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.692 2.261 . . . . 75.230000000000004 113.839 -175.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -146.51 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.332 -0.988 . . . . 74.209999999999994 108.332 -178.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -116.89 -32.34 5.13 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.744 -0.382 . . . . 73.430000000000007 110.209 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -129.36 149.81 50.99 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.238 -0.653 . . . . 75.209999999999994 109.238 177.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -158.71 152.72 23.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.083 -0.71 . . . . 73.140000000000001 109.083 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -105.54 109.66 21.71 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.485 -0.931 . . . . 73.349999999999994 108.485 176.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 60.4 mt -64.56 137.55 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.648 0.592 . . . . 75.409999999999997 112.346 -177.26 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.2 163.76 28.89 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.787 -1.56 . . . . 65.409999999999997 106.787 171.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.41 121.89 13.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.633 0.254 . . . . 74.109999999999999 110.786 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.73 -11.21 30.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.701 -0.761 . . . . 75.340000000000003 113.37 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -67.04 138.39 57.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 113.065 0.765 . . . . 74.540000000000006 113.065 -179.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.18 113.4 39.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.083 -0.962 . . . . 71.400000000000006 108.468 175.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.0 mp -109.09 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.548 -1.279 . . . . 72.540000000000006 107.548 179.222 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -100.33 106.76 18.42 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.356 -0.609 . . . . 72.219999999999999 109.356 -176.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -82.38 160.52 22.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.219 -1.4 . . . . 73.049999999999997 107.219 176.488 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 92' ' ' HIS . . . -70.64 86.42 0.35 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.978 -1.582 . . . . 71.310000000000002 111.192 179.113 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 61.1 t-80 163.61 -63.29 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.56 1.944 . . . . 74.030000000000001 108.765 177.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.8 m -143.47 174.98 10.28 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.066 -1.087 . . . . 75.510000000000005 108.066 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.436 ' OE2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -114.78 149.41 37.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.306 0.854 . . . . 75.219999999999999 113.306 177.159 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 6.9 tp -119.56 127.39 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.711 -1.218 . . . . 72.530000000000001 107.711 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -103.55 132.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.101 -0.703 . . . . 75.420000000000002 109.101 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.17 117.86 37.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.16 -0.473 . . . . 64.530000000000001 111.332 -178.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -116.69 130.9 57.01 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.257 -1.016 . . . . 74.319999999999993 108.257 175.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.5 mtt -114.43 128.59 56.42 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.496 0.665 . . . . 73.019999999999996 111.807 -178.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.478 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 44.6 m-70 . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 107.38 -1.341 . . . . 74.409999999999997 107.38 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.731 0 N-CA-C 110.091 -1.203 . . . . 54.020000000000003 110.091 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -106.27 176.54 5.13 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.071 0.435 . . . . 75.239999999999995 110.453 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.64 -59.41 2.53 Favored Glycine 0 C--N 1.306 -1.093 0 N-CA-C 109.748 -1.341 . . . . 73.530000000000001 109.748 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -134.07 144.39 48.6 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.105 -1.072 . . . . 72.329999999999998 108.105 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.77 159.9 21.61 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.65 -0.5 . . . . 64.430000000000007 109.65 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.87 -144.44 16.87 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.758 -0.937 . . . . 73.140000000000001 110.758 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.8 m -60.74 116.09 4.15 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.334 -0.617 . . . . 73.140000000000001 109.334 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.418 ' HB3' ' OE1' ' A' ' 22' ' ' GLN . 11.4 m -102.56 115.48 30.66 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.751 -0.833 . . . . 74.519999999999996 108.751 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.4 110.27 25.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.175 -0.676 . . . . 72.299999999999997 109.175 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.57 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 11.7 m -106.14 126.09 51.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.227 -0.897 . . . . 72.519999999999996 108.605 -177.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 20' ' ' THR . 46.2 mt -93.05 115.04 27.73 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.858 -1.164 . . . . 61.119999999999997 107.858 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -92.16 114.36 26.89 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.232 -1.025 . . . . 74.420000000000002 108.232 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -113.26 130.68 56.17 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.852 -0.613 . . . . 74.230000000000004 110.27 -171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.73 99.96 12.76 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.11 -1.07 . . . . 63.329999999999998 108.11 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.68 -13.47 31.7 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.114 -1.403 . . . . 75.510000000000005 108.019 175.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.74 -37.86 1.82 Allowed Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 108.392 -1.883 . . . . 74.140000000000001 108.392 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -100.52 -53.19 3.16 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.3 0.571 . . . . 54.109999999999999 110.075 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.33 89.19 0.89 Allowed Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 109.152 -1.579 . . . . 61.140000000000001 109.152 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.282 -0.636 . . . . 73.420000000000002 109.282 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.7 p -130.57 138.76 50.32 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.861 0.362 . . . . 75.420000000000002 110.853 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -132.79 124.65 28.44 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.638 -1.245 . . . . 74.209999999999994 107.638 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.418 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 25.9 tt0 -92.55 139.96 30.05 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.735 -0.786 . . . . 72.340000000000003 108.963 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.14 133.9 52.57 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.416 0.447 . . . . 73.430000000000007 111.548 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.08 156.03 21.25 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.706 -1.59 . . . . 74.319999999999993 106.706 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.18 116.59 17.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.521 0.677 . . . . 73.109999999999999 109.178 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.43 23.07 Favored Glycine 0 C--N 1.289 -2.062 0 N-CA-C 106.792 -2.523 . . . . 73.439999999999998 106.792 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 45.9 p -105.45 131.28 53.07 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 119.431 1.615 . . . . 72.109999999999999 112.004 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -103.2 110.29 22.19 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.458 -1.312 . . . . 71.319999999999993 107.458 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -95.64 121.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.411 -0.359 . . . . 75.099999999999994 110.262 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.6 mt -105.98 130.17 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 123.947 0.899 . . . . 73.340000000000003 109.808 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.03 -174.37 40.15 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 110.97 -0.852 . . . . 50.439999999999998 110.97 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 42' ' ' ASP . 25.0 mtp180 -107.21 104.94 14.69 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.608 -0.837 . . . . 74.019999999999996 109.448 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.67 169.28 37.14 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.198 -1.161 . . . . 64.439999999999998 110.198 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.62 -14.24 56.97 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.502 -1.295 . . . . 75.219999999999999 107.502 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.91 -4.56 59.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.138 -1.846 . . . . 71.430000000000007 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 47' ' ' ARG . . . -109.35 147.56 32.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.978 -1.01 . . . . 73.409999999999997 109.375 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -93.68 -32.84 13.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.385 0.612 . . . . 74.129999999999995 110.988 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -118.82 124.96 48.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.919 -1.511 . . . . 74.439999999999998 106.919 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.525 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -105.76 130.73 53.7 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.781 0.324 . . . . 74.049999999999997 111.747 -174.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 52.8 mt -85.8 145.91 42.44 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 74.219999999999999 112.238 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -72.18 -33.57 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.261 2.641 . . . . 74.340000000000003 114.598 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.46 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 5.3 t70 -93.25 179.95 5.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.577 -0.898 . . . . 75.430000000000007 108.577 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.4 t -118.68 171.04 8.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.116 0.484 . . . . 63.43 110.262 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.46 61.15 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 108.937 -1.665 . . . . 74.25 108.937 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.42 129.55 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 CA-C-N 113.281 -1.46 . . . . 71.219999999999999 107.834 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -77.11 171.9 14.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.849 -0.426 . . . . 73.030000000000001 109.849 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 16.9 ptt180 -58.2 -46.56 85.61 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-O 121.593 0.711 . . . . 75.430000000000007 109.792 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.432 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 37.3 mtp180 -119.12 95.9 5.0 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 104.42 -2.437 . . . . 75.519999999999996 104.42 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -98.22 -32.05 11.77 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.198 -0.91 . . . . 74.219999999999999 108.91 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.7 tt -163.87 145.39 9.0 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.816 -0.809 . . . . 74.040000000000006 108.816 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -137.84 143.61 41.05 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.02 0.438 . . . . 72.450000000000003 110.447 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 65.8 mt -125.42 116.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.71 -0.677 . . . . 73.439999999999998 109.783 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 58.0 ttp180 -91.39 113.63 25.94 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.805 -1.183 . . . . 71.549999999999997 107.805 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 -102.22 125.32 48.89 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 116.002 -0.545 . . . . 71.510000000000005 110.126 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -133.38 168.89 17.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.195 -1.409 . . . . 72.230000000000004 107.195 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.64 58.53 2.09 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 114.968 0.747 . . . . 63.439999999999998 114.968 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -170.73 -68.12 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.905 0.882 . . . . 73.519999999999996 108.974 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.85 156.83 42.91 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 CA-C-O 121.259 0.552 . . . . 74.109999999999999 111.52 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.2 114.62 28.93 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.088 -0.96 . . . . 51.450000000000003 109.442 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.4 tt -80.91 113.77 19.34 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.755 -1.111 . . . . 75.400000000000006 109.241 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -101.39 120.82 40.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.291 -1.003 . . . . 75.150000000000006 108.291 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.02 121.16 30.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.307 -0.257 . . . . 63.539999999999999 110.307 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -87.98 124.44 33.72 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.687 -0.857 . . . . 71.099999999999994 108.687 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.99 76.28 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 176.34 153.05 0.18 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.636 -1.987 . . . . 71.409999999999997 105.636 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.9 m -110.19 -53.44 2.68 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.237 0.829 . . . . 74.340000000000003 113.237 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 t -71.74 -38.57 70.42 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.567 0.58 . . . . 75.219999999999999 112.567 -172.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -116.89 23.74 11.71 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.318 -1.364 . . . . 75.430000000000007 107.318 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 163.43 19.65 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 113.41 -1.723 . . . . 71.040000000000006 113.864 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 m -84.74 143.86 28.88 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 123.894 0.877 . . . . 73.219999999999999 111.899 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 p -112.0 141.1 46.07 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.517 -0.765 . . . . 75.349999999999994 110.285 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.3 m -114.11 120.86 65.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.822 -1.547 . . . . 74.319999999999993 106.822 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.417 HD21 ' CG ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 61.83 24.34 14.47 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.236 1.014 . . . . 70.349999999999994 109.83 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 79.59 5.34 2.05 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.534 1.533 . . . . 75.150000000000006 112.513 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.65 30.82 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.953 -0.388 . . . . 72.109999999999999 109.953 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.26 127.84 14.75 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.382 2.055 . . . . 74.209999999999994 111.737 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.9 m -142.89 166.75 14.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.734 -0.839 . . . . 65.129999999999995 108.734 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -106.07 -31.91 8.51 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.973 -1.121 . . . . 73.140000000000001 107.973 174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.08 35.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.99 -1.459 . . . . 74.310000000000002 110.338 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 72.7 t-105 -153.67 153.03 31.51 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.535 -0.913 . . . . 75.140000000000001 108.535 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -114.58 126.25 54.7 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.209 -1.034 . . . . 74.219999999999999 108.209 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.1 mt -56.88 147.55 23.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.032 1.123 . . . . 75.340000000000003 114.032 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 147.96 39.52 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.005 -1.109 . . . . 74.439999999999998 108.005 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.455 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 28.9 t70 -65.39 124.89 23.46 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 71.030000000000001 110.862 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.87 64.43 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 115.22 -0.9 . . . . 70.049999999999997 112.992 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' CG ' HD21 ' A' ' 73' ' ' ASN . 2.6 t70 -83.23 156.88 22.92 Favored 'General case' 0 C--O 1.249 1.071 0 C-N-CA 119.505 -0.878 . . . . 64.25 108.717 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.08 113.23 43.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.361 -0.607 . . . . 74.409999999999997 109.361 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 59.2 mt -110.06 117.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.097 -0.705 . . . . 73.549999999999997 109.097 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -120.52 123.64 43.41 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.448 -0.501 . . . . 62.329999999999998 111.263 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 163.43 23.03 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.24 -0.891 . . . . 73.549999999999997 108.959 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -42.12 103.89 0.04 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 115.598 0.999 . . . . 64.219999999999999 115.598 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 m170 69.25 12.09 8.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.602 1.561 . . . . 74.030000000000001 113.503 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.7 m -149.21 115.37 5.76 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.334 0.588 . . . . 71.109999999999999 111.075 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.95 143.32 43.13 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.178 0.513 . . . . 75.129999999999995 111.243 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.28 142.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.215 -0.902 . . . . 73.450000000000003 111.387 -171.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.7 mm -111.41 132.81 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.0 -1.111 . . . . 74.340000000000003 108.0 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.55 126.86 43.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 120.846 0.355 . . . . 74.140000000000001 111.453 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -117.15 125.97 52.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.755 -0.832 . . . . 75.030000000000001 108.755 176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 84.3 mtp -114.35 116.5 29.04 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.852 -0.796 . . . . 75.439999999999998 108.852 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.57 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 48.2 m-70 . . . . . 0 C--N 1.28 -2.438 0 N-CA-C 107.463 -1.31 . . . . 75.140000000000001 107.463 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.49 0 N-CA-C 110.002 -1.239 . . . . 74.099999999999994 110.002 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -79.88 131.52 35.88 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.689 -0.856 . . . . 70.209999999999994 108.689 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.41 65.71 3.95 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 110.659 -0.976 . . . . 74.209999999999994 110.659 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -150.38 158.36 44.07 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.24 -0.652 . . . . 71.430000000000007 109.24 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.32 160.04 17.81 Favored 'General case' 0 C--O 1.247 0.974 0 CA-C-O 121.249 0.547 . . . . 73.430000000000007 110.709 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.34 -69.71 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.482 -1.447 . . . . 54.329999999999998 109.482 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.505 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 84.8 m -137.14 128.0 27.34 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.07 -1.085 . . . . 75.209999999999994 108.07 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -123.63 125.03 44.09 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.986 -0.746 . . . . 65.329999999999998 108.986 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.5 124.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.268 -1.012 . . . . 74.439999999999998 108.268 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.421 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.7 m -117.2 124.71 49.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.939 -0.763 . . . . 72.109999999999999 108.939 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.52 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 mt -90.88 124.9 35.54 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.231 -1.025 . . . . 75.420000000000002 108.231 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.42 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -107.82 120.12 41.36 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.821 -0.807 . . . . 74.099999999999994 108.821 -177.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -114.27 125.83 54.34 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.307 -0.998 . . . . 74.450000000000003 108.307 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.92 100.12 10.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 118.959 -1.096 . . . . 73.540000000000006 108.083 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.92 38.59 2.23 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 113.418 -1.719 . . . . 62.439999999999998 107.961 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.03 -54.81 0.64 Allowed Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.392 -1.083 . . . . 63.020000000000003 110.392 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 t -111.83 -56.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.711 -1.218 . . . . 74.219999999999999 107.711 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.79 109.83 0.47 Allowed Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.516 -0.849 . . . . 74.129999999999995 112.712 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -95.9 141.37 29.41 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.502 -0.925 . . . . 73.409999999999997 108.502 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.2 p -128.74 135.01 48.63 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.56 -0.456 . . . . 75.209999999999994 111.502 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -121.03 110.96 16.88 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.579 -0.897 . . . . 73.319999999999993 108.579 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -78.79 129.3 34.46 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.847 -0.797 . . . . 75.540000000000006 108.847 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.35 125.56 29.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.704 -0.851 . . . . 70.340000000000003 108.704 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -100.78 170.49 8.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.375 -0.602 . . . . 71.319999999999993 109.375 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.32 134.84 57.45 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.348 1.03 . . . . 62.420000000000002 111.594 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.52 -175.62 15.87 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 109.165 -1.574 . . . . 72.239999999999995 109.165 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 57.4 p -96.1 137.48 35.11 Favored 'General case' 0 N--CA 1.415 -2.176 0 C-N-CA 119.47 -0.892 . . . . 73.140000000000001 110.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -114.46 111.74 21.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.457 -0.942 . . . . 62.310000000000002 108.457 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.77 124.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.089 -1.078 . . . . 74.349999999999994 108.089 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -109.01 129.76 63.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 123.435 0.459 . . . . 64.329999999999998 109.791 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.26 -163.39 29.5 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.161 -1.576 . . . . 75.109999999999999 109.161 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.53 ' C ' ' HA ' ' A' ' 47' ' ' ARG . 52.1 mtm180 -126.34 105.86 9.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 119.105 1.453 . . . . 71.150000000000006 112.364 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -172.27 -178.52 42.52 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 107.129 -2.388 . . . . 64.109999999999999 107.129 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -74.96 -11.43 60.11 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.085 0.945 . . . . 75.040000000000006 110.333 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.55 -23.03 29.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.918 -1.037 . . . . 75.049999999999997 109.304 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.31 130.99 35.57 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.819 0.819 . . . . 51.420000000000002 113.037 -171.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.24 -26.02 22.56 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.832 -1.076 . . . . 71.349999999999994 108.85 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -131.85 115.68 16.24 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.204 -1.036 . . . . 72.230000000000004 108.204 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -95.93 112.12 23.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.983 -0.553 . . . . 61.420000000000002 111.06 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 44.8 mt -71.63 128.99 89.09 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 110.266 -0.272 . . . . 65.109999999999999 110.266 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -73.61 40.19 0.53 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.203 2.602 . . . . 75.230000000000004 113.839 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.0 152.67 29.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.929 -0.767 . . . . 72.450000000000003 108.929 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.4 m -97.16 118.32 33.32 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.59 -0.522 . . . . 73.510000000000005 109.59 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.07 -13.43 21.77 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.521 -0.847 . . . . 70.340000000000003 112.448 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.36 122.28 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.429 0.633 . . . . 74.129999999999995 109.361 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -65.19 164.14 13.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.008 -0.997 . . . . 73.420000000000002 112.176 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.53 ' HA ' ' C ' ' A' ' 32' ' ' ARG . 48.1 mtp180 -54.41 -49.29 70.26 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.829 0.852 . . . . 75.340000000000003 109.926 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -120.6 101.97 8.11 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 106.087 -1.819 . . . . 61.439999999999998 106.087 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -104.05 -32.49 9.18 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.473 0.654 . . . . 75.420000000000002 109.402 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -162.68 149.93 13.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.74 -0.837 . . . . 72.349999999999994 108.74 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.29 138.22 50.37 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.202 0.525 . . . . 71.230000000000004 110.269 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.4 mt -119.15 116.22 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.12 -0.696 . . . . 75.129999999999995 109.12 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 5.5 tmm_? -93.7 107.23 19.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.616 -1.624 . . . . 73.540000000000006 106.616 177.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.404 ' HZ2' ' O ' ' A' ' 7' ' ' THR . 50.8 t-105 -110.82 146.6 36.14 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.945 -1.025 . . . . 75.099999999999994 109.559 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -149.78 165.23 33.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 103.929 -2.619 . . . . 64.109999999999999 103.929 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.67 37.01 0.86 Allowed Glycine 0 C--N 1.305 -1.148 0 CA-C-N 119.133 0.879 . . . . 71.340000000000003 114.679 -175.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -137.4 -71.15 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 124.034 0.934 . . . . 75.209999999999994 109.903 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -130.81 159.32 42.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.53 -0.304 . . . . 75.340000000000003 110.692 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.54 116.68 31.26 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.763 -0.653 . . . . 75.329999999999998 110.289 -178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.8 116.7 32.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.098 -0.704 . . . . 72.209999999999994 109.098 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.3 tt -104.81 142.6 34.44 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.332 -0.394 . . . . 74.150000000000006 110.537 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.14 127.62 26.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.817 -0.629 . . . . 64.540000000000006 109.676 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -83.0 140.42 32.74 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.644 -0.707 . . . . 73.140000000000001 109.226 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.26 77.44 1.73 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.035 -1.098 . . . . 75.030000000000001 108.035 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -178.1 121.21 0.1 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.438 -0.578 . . . . 75.230000000000004 109.438 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -88.75 -20.1 25.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.137 0.494 . . . . 72.120000000000005 110.447 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -89.33 -52.44 5.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.42 0.629 . . . . 75.530000000000001 111.382 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -111.21 28.75 8.43 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.7 -0.682 . . . . 75.239999999999995 110.194 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.06 129.98 5.5 Favored Glycine 0 N--CA 1.47 0.939 0 O-C-N 124.574 1.171 . . . . 62.509999999999998 114.933 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 m -74.94 152.09 38.83 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 124.733 1.213 . . . . 70.329999999999998 113.044 -172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.6 p -119.3 144.66 46.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.121 -0.945 . . . . 73.420000000000002 110.107 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.1 m -116.36 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.039 -1.097 . . . . 74.510000000000005 108.039 177.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 61.14 25.93 15.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.81 0.814 . . . . 64.129999999999995 109.666 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 85.54 -4.57 0.85 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.82 2.048 . . . . 74.420000000000002 113.855 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -89.61 124.39 64.24 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.864 -0.421 . . . . 63.210000000000001 109.864 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -69.15 125.5 12.55 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.76 2.307 . . . . 71.430000000000007 111.81 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -139.02 166.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.384 -0.371 . . . . 75.25 110.64 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -105.74 -14.48 15.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.71 -0.848 . . . . 74.340000000000003 108.71 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -161.78 155.63 21.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.118 -1.067 . . . . 73.329999999999998 108.118 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -161.34 143.41 11.96 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.349 0.405 . . . . 74.099999999999994 109.909 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.23 111.79 23.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.119 -1.067 . . . . 72.019999999999996 108.119 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 69.5 mt -56.46 135.95 54.13 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.902 0.705 . . . . 65.530000000000001 112.902 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.0 164.66 19.67 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.079 -1.082 . . . . 64.140000000000001 108.079 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.49 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 28.8 t70 -71.95 124.36 24.74 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.456 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.91 13.21 56.87 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.743 -0.662 . . . . 74.519999999999996 113.091 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.67 137.45 42.18 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 117.628 0.714 . . . . 61.119999999999997 111.714 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.1 112.16 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.276 -1.379 . . . . 74.099999999999994 107.276 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.5 mt -111.6 106.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 C-N-CA 119.322 -0.951 . . . . 75.239999999999995 109.44 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -104.26 131.89 51.09 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.635 -0.711 . . . . 73.510000000000005 109.678 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -125.18 164.5 20.14 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.412 -0.959 . . . . 75.310000000000002 108.412 -176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.26 125.82 25.9 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.995 -1.098 . . . . 75.329999999999998 110.532 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m170 83.1 -23.6 0.2 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.217 1.562 . . . . 73.219999999999999 115.217 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -153.21 -171.75 4.02 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.643 1.111 . . . . 74.219999999999999 111.999 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.66 147.58 30.14 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.988 -0.745 . . . . 74.409999999999997 108.988 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.6 tp -130.41 135.58 60.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.005 -1.109 . . . . 74.310000000000002 108.005 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 53.4 mt -101.0 132.09 47.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.698 -0.852 . . . . 74.420000000000002 108.698 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.5 t -100.26 116.35 43.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.446 0.641 . . . . 74.439999999999998 111.158 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.49 ' HD3' ' OD1' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -115.63 125.87 53.45 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.415 -1.328 . . . . 70.219999999999999 107.415 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.5 mtm -112.52 111.74 22.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.229 -0.988 . . . . 50.329999999999998 110.547 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.505 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 21.1 m-70 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 108.012 -1.107 . . . . 72.409999999999997 108.012 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 N-CA-C 110.361 -1.096 . . . . 64.239999999999995 110.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -144.5 15.33 1.62 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.225 0.536 . . . . 75.439999999999998 111.3 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.13 172.58 14.18 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.647 -0.981 . . . . 65.319999999999993 110.647 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -80.37 73.1 7.26 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.19 0.995 . . . . 75.540000000000006 110.219 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.61 124.5 10.61 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.323 -1.308 . . . . 73.209999999999994 107.916 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.01 94.12 0.1 Allowed Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 110.409 -1.076 . . . . 52.329999999999998 110.409 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.0 m -55.05 116.66 2.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 124.246 0.615 . . . . 73.209999999999994 109.621 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m -107.65 117.28 33.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 115.746 -0.661 . . . . 71.140000000000001 109.644 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -91.29 114.86 29.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 106.726 -1.583 . . . . 73.439999999999998 106.726 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -110.61 124.07 51.18 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.037 -0.727 . . . . 72.120000000000005 109.037 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.44 128.92 42.68 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.44 -0.578 . . . . 74.25 109.44 177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -105.39 119.59 39.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.559 -0.904 . . . . 75.519999999999996 108.559 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -102.39 120.15 40.01 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 123.755 0.822 . . . . 71.340000000000003 108.934 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -100.17 100.99 11.91 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.659 -1.216 . . . . 73.400000000000006 110.153 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -103.53 5.03 36.49 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 112.99 -1.914 . . . . 65.140000000000001 108.502 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.16 -19.81 31.71 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.475 -1.45 . . . . 74.120000000000005 109.475 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -103.5 -53.5 2.78 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.226 -1.028 . . . . 73.420000000000002 108.226 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.34 83.03 1.69 Allowed Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.396 -0.82 . . . . 63.420000000000002 111.698 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.402 ' NE ' ' HA ' ' A' ' 19' ' ' ARG . 4.5 mmp_? -100.37 163.81 12.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.724 -0.28 . . . . 75.299999999999997 110.273 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 p -135.61 152.24 51.05 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.741 0.305 . . . . 64.230000000000004 110.983 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -142.24 132.51 24.87 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.357 -0.979 . . . . 72.439999999999998 108.357 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.08 125.03 33.15 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.363 -0.606 . . . . 74.040000000000006 109.363 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 78.1 mt -71.28 127.64 33.25 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.165 -0.679 . . . . 72.540000000000006 109.165 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.78 168.6 10.56 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.568 -0.742 . . . . 75.439999999999998 109.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.94 131.5 40.73 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.674 0.749 . . . . 75.510000000000005 111.423 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.66 -173.79 15.05 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 108.382 -1.887 . . . . 73.150000000000006 108.382 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.3 p -106.81 142.77 35.91 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 118.549 1.174 . . . . 65.230000000000004 111.856 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 7.5 p30 -117.8 140.77 49.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.339 -0.615 . . . . 74.310000000000002 109.339 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.86 124.14 53.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.613 -0.884 . . . . 74.430000000000007 108.613 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.6 mt -106.91 120.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 124.477 1.111 . . . . 74.540000000000006 110.147 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.63 -176.43 35.54 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.547 -1.421 . . . . 51.240000000000002 109.547 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.589 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 61.6 mtt180 -103.99 107.12 17.86 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 118.35 1.075 . . . . 74.329999999999998 111.418 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.38 -172.42 38.85 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 110.444 -1.062 . . . . 72.230000000000004 110.444 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.35 -29.26 15.11 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 122.959 0.504 . . . . 73.439999999999998 110.823 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -82.14 -19.73 39.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 137.69 54.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.048 -0.978 . . . . 75.420000000000002 109.566 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.478 ' NE2' ' HA ' ' A' ' 28' ' ' ASN . 49.8 mt-30 -97.89 -24.51 15.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.483 0.659 . . . . 70.019999999999996 110.318 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -131.14 124.26 30.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.373 -1.343 . . . . 71.420000000000002 107.373 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 134.25 55.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.406 -0.361 . . . . 74.519999999999996 110.93 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.7 147.56 86.85 Favored Pre-proline 0 CA--C 1.502 -0.898 0 CA-C-N 115.604 -0.725 . . . . 74.430000000000007 111.807 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.13 26.37 0.61 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 123.584 2.856 . . . . 74.120000000000005 113.267 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -137.72 176.4 8.74 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.697 -0.853 . . . . 73.510000000000005 108.697 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -105.28 170.66 7.75 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.374 -0.602 . . . . 74.530000000000001 109.374 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 2.69 79.75 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.925 -0.47 . . . . 71.319999999999993 111.925 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.4 t -95.13 133.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.989 -0.745 . . . . 74.5 108.989 -178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -72.39 176.34 5.41 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.122 0.569 . . . . 74.519999999999996 109.653 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.0 ptm180 -66.09 -34.92 79.16 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.379 0.609 . . . . 74.319999999999993 110.359 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.51 109.65 12.94 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.791 -1.188 . . . . 72.409999999999997 107.791 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -103.99 -34.16 8.56 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.854 -0.612 . . . . 75.219999999999999 109.501 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.0 tt -165.88 160.03 16.48 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.301 -1.0 . . . . 73.430000000000007 108.301 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.8 138.52 32.3 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 109.781 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 64.0 mt -113.19 115.19 49.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 109.202 -0.666 . . . . 72.120000000000005 109.202 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 62.0 ttt180 -97.2 107.79 20.38 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 108.817 -0.809 . . . . 74.340000000000003 108.817 174.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -97.48 107.24 19.7 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.1 171.35 8.07 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.006 -1.85 . . . . 74.540000000000006 106.006 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.14 49.58 4.14 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 119.817 -1.182 . . . . 62.009999999999998 114.003 -174.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -171.66 -64.04 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.871 0.868 . . . . 74.25 109.178 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.32 149.67 17.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 CA-C-O 121.323 0.582 . . . . 73.400000000000006 112.15 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.75 103.18 14.81 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.275 -0.875 . . . . 65.310000000000002 109.347 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.24 113.49 21.15 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.362 -0.836 . . . . 75.310000000000002 109.162 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.402 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.8 tm? -100.52 120.32 39.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.145 -1.057 . . . . 73.5 108.145 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.89 126.68 43.7 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.875 -0.417 . . . . 74.450000000000003 109.875 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 11.3 t70 -97.25 139.17 33.62 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 122.848 0.459 . . . . 75.310000000000002 110.722 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.11 75.91 1.26 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.431 -0.952 . . . . 65.299999999999997 108.431 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.55 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 33.3 t-20 -166.46 154.04 9.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.57 -1.27 . . . . 73.450000000000003 107.57 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.4 t -108.92 -48.71 3.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.989 0.423 . . . . 70.040000000000006 110.341 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -89.33 -35.91 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.648 0.611 . . . . 71.319999999999993 112.648 -175.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.55 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.2 m120 -105.39 27.06 8.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.537 -0.542 . . . . 63.140000000000001 109.537 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.79 128.46 20.78 Favored Glycine 0 C--O 1.251 1.158 0 O-C-N 124.894 1.371 . . . . 51.109999999999999 112.264 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -62.01 133.04 54.83 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 124.124 0.969 . . . . 74.140000000000001 112.54 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.623 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.0 p -103.42 140.08 37.94 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.513 -0.767 . . . . 74.400000000000006 109.459 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.26 119.58 56.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.937 -1.134 . . . . 75.349999999999994 107.937 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.26 30.97 20.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.404 0.682 . . . . 72.140000000000001 110.54 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 t30 82.09 -1.53 1.49 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.738 2.015 . . . . 65.319999999999993 112.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.98 124.19 44.52 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 121.487 -0.758 . . . . 75.150000000000006 109.431 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.14 124.3 4.83 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.765 1.643 . . . . 72.150000000000006 110.441 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.2 m -148.68 151.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 74.340000000000003 107.432 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 77.1 mt-30 -96.69 -0.46 48.31 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.957 -0.697 . . . . 72.540000000000006 111.327 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.54 130.12 15.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.794 -0.639 . . . . 71.310000000000002 110.119 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.402 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 69.2 t-105 -159.89 152.97 21.82 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.588 -1.264 . . . . 73.230000000000004 107.588 -178.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.89 124.4 50.59 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.967 -1.093 . . . . 75.340000000000003 108.115 173.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 97' ' ' VAL . 69.0 mt -65.1 139.4 58.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.949 0.722 . . . . 71.430000000000007 112.949 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -135.65 168.5 19.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.059 -0.719 . . . . 73.340000000000003 109.059 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.48 121.09 19.03 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.917 -0.401 . . . . 74.400000000000006 109.917 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.2 9.84 40.85 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.905 -0.664 . . . . 53.5 112.698 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -78.38 126.26 30.52 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 120.008 -0.677 . . . . 71.439999999999998 110.005 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.67 112.31 26.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.22 -1.4 . . . . 75.230000000000004 107.22 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.4 mt -120.01 139.28 47.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 120.291 -0.564 . . . . 75.219999999999999 110.861 -172.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.623 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.0 mpt_? -120.37 131.24 54.75 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.138 -1.06 . . . . 74.450000000000003 108.138 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -131.73 164.52 25.79 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.336 -0.987 . . . . 74.150000000000006 108.336 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -33.55 97.07 0.01 OUTLIER Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.002 1.161 . . . . 75.5 116.002 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.0 m170 72.07 13.95 5.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.698 1.599 . . . . 72.450000000000003 114.801 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t -153.62 -178.3 6.93 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.31 0.576 . . . . 75.099999999999994 110.178 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.74 153.08 45.75 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.762 -0.586 . . . . 73.519999999999996 109.448 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -141.45 141.37 30.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.762 -0.829 . . . . 74.019999999999996 108.762 -175.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.73 125.69 72.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.469 -0.937 . . . . 65.409999999999997 108.469 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 82' ' ' LEU . 79.4 t -93.26 128.67 44.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 111.938 0.348 . . . . 62.439999999999998 111.938 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -119.16 151.26 38.63 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.767 -0.827 . . . . 75.209999999999994 108.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 89.2 mtp -128.34 120.01 26.19 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.314 -0.403 . . . . 73.329999999999998 110.262 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 . . . . . 0 C--N 1.294 -1.842 0 N-CA-C 108.333 -0.988 . . . . 72.140000000000001 108.333 -179.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.704 0 N-CA-C 110.622 -0.991 . . . . 62.329999999999998 110.622 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -92.89 -4.91 52.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.106 0.479 . . . . 70.409999999999997 111.762 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.22 98.79 1.77 Allowed Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 109.192 -1.563 . . . . 70.340000000000003 109.192 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 m -81.43 -35.52 30.54 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 121.126 -0.23 . . . . 73.510000000000005 111.359 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.26 112.64 19.72 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.512 -0.922 . . . . 72.230000000000004 108.512 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.68 -52.7 0.49 Allowed Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 108.873 -1.691 . . . . 71.230000000000004 108.873 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 m -146.15 115.88 7.25 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 108.56 -0.904 . . . . 73.400000000000006 108.56 171.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 99' ' ' MET . 54.0 p -158.43 143.98 16.69 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.337 -1.727 . . . . 75.310000000000002 106.337 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.82 126.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 120.159 -0.617 . . . . 75.349999999999994 111.226 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 25.3 m -120.77 132.07 54.84 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.984 -1.117 . . . . 72.319999999999993 107.984 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.12 135.76 33.72 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.68 -0.489 . . . . 74.239999999999995 109.68 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -116.57 124.86 50.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.726 -0.67 . . . . 71.200000000000003 111.19 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.6 133.66 48.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.137 -1.061 . . . . 74.450000000000003 108.137 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.96 101.71 7.72 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.04 -1.064 . . . . 64.329999999999998 112.592 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.04 -47.53 68.13 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.661 -1.607 . . . . 73.420000000000002 106.661 171.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.29 45.69 0.01 OUTLIER Glycine 0 N--CA 1.427 -1.9 0 N-CA-C 105.979 -2.848 . . . . 54.200000000000003 105.979 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -162.5 -52.79 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.193 -1.039 . . . . 73.019999999999996 108.193 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.12 92.37 2.14 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.691 -0.766 . . . . 70.409999999999997 111.93 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -99.13 150.24 22.23 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.31 -0.996 . . . . 74.099999999999994 108.31 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 35.8 p -142.94 132.25 23.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.663 0.602 . . . . 75.400000000000006 109.859 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -134.54 135.26 42.19 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.505 -1.665 . . . . 74.150000000000006 106.505 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 33.5 tt0 -101.71 144.31 30.57 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.093 -0.643 . . . . 74.0 111.156 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 76.1 mt -78.88 139.23 38.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.715 -0.675 . . . . 74.040000000000006 110.359 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -95.29 157.86 15.71 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.347 -1.353 . . . . 75.340000000000003 107.347 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.5 146.03 55.2 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.182 0.515 . . . . 73.340000000000003 111.576 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.43 -171.44 15.81 Favored Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 107.723 -2.151 . . . . 75.150000000000006 107.723 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.421 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 67.1 p -96.63 127.46 42.63 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.638 -1.225 . . . . 71.549999999999997 111.084 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.476 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -103.57 113.58 27.19 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.389 -1.708 . . . . 73.420000000000002 106.389 -178.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -89.83 132.3 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.964 -0.562 . . . . 72.510000000000005 109.694 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -116.07 132.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.684 -0.689 . . . . 74.349999999999994 109.859 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 158.4 -162.23 32.23 Favored Glycine 0 CA--C 1.495 -1.162 0 N-CA-C 108.611 -1.796 . . . . 34.240000000000002 108.611 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -122.17 103.69 8.96 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.008 -1.479 . . . . 71.430000000000007 107.008 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.535 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 174.84 176.16 42.92 Favored Glycine 0 N--CA 1.414 -2.828 0 N-CA-C 110.935 -0.866 . . . . 70.439999999999998 110.935 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -52.1 -40.36 61.15 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.751 1.22 . . . . 75.340000000000003 113.373 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.68 -37.07 73.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.491 . . . . 74.230000000000004 111.453 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.78 15.9 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.357 -0.838 . . . . 72.219999999999999 112.795 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -75.35 -36.15 61.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.434 -0.95 . . . . 64.340000000000003 108.434 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -105.45 108.87 20.62 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.536 -0.913 . . . . 65.230000000000004 108.536 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.6 mmt85 -87.66 121.35 29.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.152 -0.931 . . . . 73.230000000000004 109.455 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 44.2 mt -79.19 130.53 68.94 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.362 -0.607 . . . . 75.420000000000002 109.362 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.02 -1.91 9.48 Favored 'Trans proline' 0 C--N 1.325 -0.696 0 C-N-CA 122.013 1.808 . . . . 62.020000000000003 111.049 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -88.67 -176.65 5.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.937 -1.029 . . . . 73.129999999999995 111.234 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.0 t -123.21 170.89 9.79 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.694 -0.484 . . . . 74.319999999999993 109.694 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.03 71.79 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.57 -1.412 . . . . 75.319999999999993 109.57 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.85 144.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.295 -0.952 . . . . 74.109999999999999 111.0 -173.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.5 p -91.84 -167.68 1.84 Allowed 'General case' 0 C--O 1.254 1.292 0 C-N-CA 124.137 0.975 . . . . 74.430000000000007 109.499 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.535 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 5.6 ptt180 -80.84 -34.29 33.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 118.247 -1.381 . . . . 74.400000000000006 109.287 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -124.04 100.7 6.86 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.412 -1.699 . . . . 75.420000000000002 106.412 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -100.81 -34.37 9.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.124 -0.944 . . . . 72.140000000000001 109.717 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 tt -162.14 148.37 13.34 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.003 -0.74 . . . . 74.150000000000006 109.003 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.31 139.61 50.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.281 0.562 . . . . 75.549999999999997 109.824 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.6 mt -113.85 113.81 44.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.981 -0.748 . . . . 74.129999999999995 108.981 175.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 86.6 mtt180 -91.71 107.03 18.92 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.915 -1.143 . . . . 74.239999999999995 107.915 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -103.13 126.93 50.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.721 -0.672 . . . . 73.329999999999998 111.289 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -128.27 162.87 26.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.409 -2.071 . . . . 74.530000000000001 105.409 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.11 51.27 1.65 Allowed Glycine 0 CA--C 1.534 1.262 0 N-CA-C 116.345 1.298 . . . . 44.409999999999997 116.345 -172.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -62.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.525 -0.917 . . . . 75.420000000000002 108.525 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.76 138.85 38.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-O 121.42 0.628 . . . . 71.200000000000003 112.162 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . . . -103.99 114.04 28.0 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.376 -0.829 . . . . 72.329999999999998 110.233 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 5.7 tt -91.25 110.34 21.62 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.623 -0.88 . . . . 70.439999999999998 108.623 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -94.21 121.9 36.2 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.233 -1.395 . . . . 75.109999999999999 107.233 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.29 120.56 24.58 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.154 0.502 . . . . 73.219999999999999 110.384 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.31 138.1 33.09 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.461 -0.791 . . . . 72.450000000000003 108.941 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.06 76.8 1.4 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 109.356 -0.609 . . . . 73.219999999999999 109.356 -174.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 160.79 151.76 0.01 OUTLIER 'General case' 0 C--O 1.198 -1.653 0 C-N-CA 125.914 1.686 . . . . 74.030000000000001 109.606 173.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -104.35 -12.31 16.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 121.562 -0.711 . . . . 72.209999999999994 109.716 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -72.73 -64.36 0.98 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.645 -0.707 . . . . 75.049999999999997 111.674 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -107.12 28.93 7.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.958 -1.127 . . . . 73.319999999999993 107.958 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.79 120.89 2.73 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.452 -1.249 . . . . 74.140000000000001 113.245 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 m -70.29 142.8 52.23 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 124.903 1.281 . . . . 75.329999999999998 112.373 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 76' ' ' PRO . 12.9 p -105.38 141.25 37.22 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.613 -0.721 . . . . 65.109999999999999 111.262 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.86 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 106.67 -1.604 . . . . 75.010000000000005 106.67 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.49 23.92 11.27 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.456 -0.572 . . . . 75.030000000000001 109.456 -170.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 74.42 15.03 3.53 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.756 1.622 . . . . 72.299999999999997 111.712 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.57 123.71 37.2 Favored Pre-proline 0 C--N 1.315 -0.897 0 O-C-N 121.267 -0.896 . . . . 71.519999999999996 109.012 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.408 ' N ' HG22 ' A' ' 71' ' ' THR . 57.4 Cg_endo -77.31 125.16 7.58 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 121.981 1.787 . . . . 71.019999999999996 111.859 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.28 170.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.867 -0.606 . . . . 74.099999999999994 110.011 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -91.13 -47.02 7.78 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.163 -1.051 . . . . 71.209999999999994 108.163 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.5 pt-20 -141.26 151.8 43.99 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.169 -0.923 . . . . 74.530000000000001 109.875 177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -157.11 152.03 25.87 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.268 -1.012 . . . . 73.209999999999994 108.268 -175.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 79.3 mt-30 -101.36 119.36 38.64 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.903 -0.719 . . . . 71.109999999999999 109.348 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 78.2 mt -56.29 143.2 34.87 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 124.087 0.867 . . . . 72.140000000000001 111.656 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.97 39.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.602 -1.259 . . . . 73.319999999999993 107.602 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.79 127.85 34.05 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.729 -0.471 . . . . 75.209999999999994 109.729 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.22 -5.35 52.51 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.897 -0.592 . . . . 64.340000000000003 111.88 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.64 127.65 33.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 75.310000000000002 109.986 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.11 112.41 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.75 -1.204 . . . . 74.340000000000003 107.75 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.3 mt -103.39 125.02 57.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 108.196 -1.039 . . . . 75.099999999999994 108.196 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -129.55 124.92 35.06 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.061 0.458 . . . . 74.040000000000006 111.521 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -100.81 163.39 12.34 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 105.005 -2.22 . . . . 74.439999999999998 105.005 170.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.94 85.74 0.88 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 118.414 -1.851 . . . . 75.439999999999998 111.339 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 161.68 -54.07 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 126.632 1.973 . . . . 73.409999999999997 108.155 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -133.37 155.37 49.59 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.793 0.806 . . . . 74.400000000000006 111.734 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -121.27 144.02 48.85 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 114.359 -1.291 . . . . 75.219999999999999 109.038 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.3 tp -134.82 146.74 30.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.373 -1.343 . . . . 74.219999999999999 107.373 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.74 137.6 45.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.499 0.591 . . . . 74.530000000000001 109.456 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.401 HG12 ' HB3' ' A' ' 82' ' ' LEU . 99.1 t -89.14 127.64 41.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.87 0.367 . . . . 73.150000000000006 111.421 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.09 145.18 47.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.684 -0.689 . . . . 74.129999999999995 109.208 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.469 ' HA ' ' O ' ' A' ' 8' ' ' SER . 90.0 mtp -122.02 124.35 43.78 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.523 -0.547 . . . . 74.439999999999998 109.523 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.444 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 10.0 m170 . . . . . 0 C--N 1.302 -1.485 0 CA-C-O 118.852 -0.594 . . . . 75.450000000000003 110.024 -175.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.505 0 N-CA-C 110.453 -1.059 . . . . 43.140000000000001 110.453 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -145.2 93.06 2.33 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.511 0.672 . . . . 74.549999999999997 109.612 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.21 -122.44 0.9 Allowed Glycine 0 N--CA 1.425 -2.08 0 C-N-CA 119.999 -1.096 . . . . 74.409999999999997 111.992 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.4 m -79.78 75.52 6.46 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 122.895 0.478 . . . . 73.430000000000007 111.583 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.47 100.86 0.09 Allowed 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.976 0.91 . . . . 75.209999999999994 109.88 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.85 45.94 1.37 Allowed Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.136 -1.586 . . . . 64.400000000000006 109.136 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m -139.17 116.84 11.44 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 114.804 -0.698 . . . . 73.129999999999995 110.055 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.9 m -116.13 115.29 25.78 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.875 -1.158 . . . . 70.120000000000005 107.875 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -95.44 117.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.965 -0.754 . . . . 72.430000000000007 108.965 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.432 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.8 m -123.68 135.58 53.97 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.888 -1.051 . . . . 70.340000000000003 110.643 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.453 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 mt -85.93 126.98 34.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.139 -1.06 . . . . 70.400000000000006 108.139 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -111.47 128.36 55.98 Favored 'General case' 0 C--N 1.286 -2.181 0 O-C-N 123.752 0.658 . . . . 75.209999999999994 111.099 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.5 tp -136.55 128.26 28.96 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.456 -0.942 . . . . 75.430000000000007 108.456 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.6 100.08 12.95 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.685 -1.228 . . . . 51.539999999999999 107.685 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -125.17 84.31 2.26 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 107.294 -1.372 . . . . 71.299999999999997 107.294 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.62 -73.14 1.23 Allowed Glycine 0 C--N 1.289 -2.029 0 CA-C-N 114.731 -1.122 . . . . 72.439999999999998 110.328 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -121.84 -35.58 3.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.554 -0.906 . . . . 64.120000000000005 108.554 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.38 115.97 1.21 Allowed Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 120.507 -0.854 . . . . 55.219999999999999 111.443 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -100.56 142.01 32.63 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.204 -1.406 . . . . 74.530000000000001 107.204 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.7 p -141.44 132.42 26.08 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.434 0.459 . . . . 62.119999999999997 111.415 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -121.52 111.99 17.94 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.82 -0.627 . . . . 75.540000000000006 109.469 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.15 132.02 34.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.556 -0.535 . . . . 73.420000000000002 109.556 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.42 138.19 43.16 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.898 -1.047 . . . . 63.439999999999998 109.997 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -103.5 168.5 9.11 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.411 -0.589 . . . . 75.329999999999998 109.411 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -61.41 118.79 7.42 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 124.212 0.945 . . . . 72.430000000000007 112.745 -175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.19 -173.36 18.5 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.356 -1.498 . . . . 74.5 109.356 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 62.0 p -95.79 119.2 33.86 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 117.94 0.87 . . . . 72.109999999999999 110.904 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.445 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -96.28 110.24 22.59 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.091 -1.448 . . . . 75.439999999999998 107.091 -176.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.96 128.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.362 -0.607 . . . . 73.420000000000002 109.362 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.28 132.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.266 -0.642 . . . . 74.209999999999994 109.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 155.08 -171.06 33.3 Favored Glycine 0 CA--C 1.481 -2.067 0 N-CA-C 109.756 -1.338 . . . . 71.439999999999998 109.756 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 73.3 mtp180 -120.44 105.27 10.71 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.631 -0.828 . . . . 73.140000000000001 108.856 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 155.6 13.71 Favored Glycine 0 N--CA 1.416 -2.648 0 N-CA-C 107.327 -2.309 . . . . 72.450000000000003 107.327 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.89 -17.69 65.02 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 118.017 0.909 . . . . 74.239999999999995 112.25 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.61 ' OD2' ' HD3' ' A' ' 48' ' ' ARG . 19.9 t70 -89.51 -2.01 58.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.74 0.781 . . . . 74.349999999999994 109.629 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.44 152.81 19.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.802 -0.636 . . . . 74.209999999999994 109.486 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.14 -46.95 6.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.984 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -107.87 118.56 37.05 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.597 -0.89 . . . . 74.120000000000005 108.597 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 22.5 mmt85 -95.91 123.79 39.65 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.639 -0.71 . . . . 73.230000000000004 109.138 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.6 mt -78.48 141.68 61.32 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.929 -0.397 . . . . 75.099999999999994 109.929 176.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.92 5.06 6.57 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.234 1.956 . . . . 73.450000000000003 114.333 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -111.7 172.72 6.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.572 -1.27 . . . . 74.439999999999998 107.572 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -112.65 156.5 22.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.052 -0.722 . . . . 74.310000000000002 109.052 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -22.46 17.28 Favored Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 109.955 -1.258 . . . . 73.400000000000006 109.955 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.1 p -77.24 136.12 25.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.747 -0.726 . . . . 73.400000000000006 109.052 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -69.58 177.61 2.88 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 122.845 0.458 . . . . 74.129999999999995 110.96 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 3.8 ptp180 -63.64 -40.59 97.25 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.368 -0.533 . . . . 74.409999999999997 111.125 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.61 ' HD3' ' OD2' ' A' ' 35' ' ' ASP . 45.1 mtm180 -131.9 113.7 13.76 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 106.01 -1.848 . . . . 74.439999999999998 106.01 171.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -104.32 -38.43 6.85 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-O 121.526 0.679 . . . . 72.099999999999994 110.35 -174.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 5.1 tt -160.3 153.51 21.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.577 -0.897 . . . . 75.340000000000003 108.577 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -138.24 124.52 20.46 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.31 0.576 . . . . 73.030000000000001 109.968 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' SER . 61.7 mt -99.19 119.22 46.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.91 -0.774 . . . . 73.010000000000005 108.91 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -91.44 107.06 18.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.131 -1.433 . . . . 75.219999999999999 107.131 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -102.46 116.8 33.36 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.882 0.849 . . . . 75.200000000000003 110.5 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' C ' ' H ' ' A' ' 57' ' ' GLN . 23.0 t70 -119.21 161.55 20.17 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.83 -1.545 . . . . 75.120000000000005 106.83 179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.81 37.93 1.48 Allowed Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.429 0.559 . . . . 74.519999999999996 112.825 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 55' ' ' ASP . 24.9 mt-30 -136.89 -70.04 0.46 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.622 1.169 . . . . 73.430000000000007 108.392 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.08 159.38 32.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.949 -0.389 . . . . 72.439999999999998 109.949 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.02 106.52 18.87 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.601 0.715 . . . . 73.329999999999998 109.39 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.8 tp -90.79 111.98 23.59 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.198 -0.91 . . . . 74.400000000000006 111.185 -176.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -86.95 122.34 30.67 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.54 -1.281 . . . . 73.209999999999994 107.54 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.44 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.94 123.08 31.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 72.450000000000003 110.014 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.61 145.97 27.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.507 -0.553 . . . . 62.039999999999999 109.507 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.67 77.09 1.7 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.247 -1.39 . . . . 75.310000000000002 107.247 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -174.18 159.48 3.2 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.58 -0.526 . . . . 74.530000000000001 109.58 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -108.27 -54.55 2.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 120.851 0.357 . . . . 70.109999999999999 111.29 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 t -90.15 -24.44 21.06 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.794 -0.566 . . . . 74.109999999999999 111.963 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -105.51 26.98 8.81 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.6 -0.518 . . . . 71.230000000000004 109.6 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.92 126.66 18.3 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.294 0.996 . . . . 74.420000000000002 113.022 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -72.49 147.47 46.01 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.315 0.646 . . . . 74.400000000000006 111.557 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -113.37 146.91 38.7 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.762 -0.654 . . . . 70.430000000000007 110.285 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.38 116.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.955 -1.128 . . . . 74.030000000000001 107.955 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.33 24.47 14.57 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.997 0.919 . . . . 73.439999999999998 109.704 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m120 83.69 5.85 0.74 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 126.723 2.009 . . . . 64.510000000000005 113.398 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.64 127.17 34.81 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.63 -0.507 . . . . 75.099999999999994 109.63 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.02 125.29 9.22 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.513 2.142 . . . . 74.239999999999995 112.489 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -142.31 161.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.21 -0.663 . . . . 63.520000000000003 109.21 -178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -89.35 -28.19 19.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.207 0.527 . . . . 74.340000000000003 110.253 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.55 158.83 40.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.438 -0.949 . . . . 75.409999999999997 108.438 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -157.68 152.2 24.99 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.69 -0.856 . . . . 75.329999999999998 108.69 -176.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -100.04 107.7 19.69 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.277 -1.379 . . . . 71.340000000000003 107.277 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.1 mt -56.87 143.51 37.11 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.946 0.779 . . . . 70.430000000000007 113.043 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.99 163.5 29.07 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 115.124 -0.944 . . . . 75.420000000000002 108.513 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.19 112.2 6.37 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.444 -0.576 . . . . 64.109999999999999 109.444 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 3.9 27.03 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 121.004 -0.617 . . . . 64.400000000000006 113.148 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.89 139.36 35.95 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 117.832 0.816 . . . . 71.310000000000002 110.931 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.9 t -98.95 113.12 32.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.919 -0.771 . . . . 73.510000000000005 108.919 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.79 110.75 26.11 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.08 -1.452 . . . . 74.430000000000007 107.08 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.418 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 18.5 ttt180 -113.73 121.35 43.81 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.659 0.742 . . . . 75.230000000000004 111.901 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.81 163.28 22.49 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.14 -1.391 . . . . 73.030000000000001 107.722 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.34 120.05 9.12 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 123.563 0.54 . . . . 74.5 113.133 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.2 m170 86.24 -17.02 0.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.041 1.736 . . . . 75.329999999999998 114.96 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.8 m -150.67 127.88 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 118.977 0.808 . . . . 73.299999999999997 112.652 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' OE1' ' HD2' ' A' ' 89' ' ' ARG . 10.1 pt-20 -110.8 131.92 54.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.498 -0.927 . . . . 74.349999999999994 108.498 171.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 144.72 34.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.807 -0.633 . . . . 72.140000000000001 110.184 -174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.38 127.81 58.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.539 -0.911 . . . . 72.209999999999994 108.539 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 74.3 t -87.54 128.16 40.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.638 -0.255 . . . . 73.25 110.459 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -116.47 149.38 39.59 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.471 -0.566 . . . . 74.030000000000001 109.471 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.8 mtp -126.92 106.22 9.16 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.087 -1.079 . . . . 73.409999999999997 108.087 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 . . . . . 0 C--N 1.272 -2.774 0 CA-C-N 114.281 -1.327 . . . . 62.0 108.058 -176.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.462 0 N-CA-C 110.756 -0.938 . . . . 73.200000000000003 110.756 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -164.12 152.64 13.16 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 108.593 -0.891 . . . . 72.409999999999997 108.593 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -168.76 142.32 7.33 Favored Glycine 0 N--CA 1.424 -2.155 0 N-CA-C 110.572 -1.011 . . . . 60.340000000000003 110.572 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m -85.63 -25.57 26.55 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.319 -0.622 . . . . 72.230000000000004 109.319 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.34 146.51 36.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.134 -1.061 . . . . 73.129999999999995 108.134 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.01 -78.35 0.24 Allowed Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.251 -0.739 . . . . 45.420000000000002 111.251 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m -147.69 116.33 6.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.554 -0.38 . . . . 74.450000000000003 111.433 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.4 p -122.69 132.99 54.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.674 -1.232 . . . . 72.230000000000004 107.674 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.59 129.55 71.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 122.383 1.087 . . . . 73.239999999999995 111.118 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 m -132.43 128.71 38.1 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.759 -1.11 . . . . 74.219999999999999 108.309 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.38 148.83 21.81 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.405 -0.961 . . . . 75.530000000000001 108.405 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -126.81 125.42 41.66 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.195 -0.602 . . . . 75.120000000000005 110.202 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.568 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.3 tp -83.15 124.73 30.79 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.812 -0.81 . . . . 73.540000000000006 108.812 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -90.12 98.44 11.77 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 106.321 -1.733 . . . . 74.239999999999995 106.321 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -150.63 77.55 1.29 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.904 -1.043 . . . . 72.430000000000007 109.386 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.93 -65.61 4.02 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 115.375 -0.83 . . . . 61.229999999999997 113.025 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 p -100.56 -47.36 4.9 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.456 0.646 . . . . 71.209999999999994 111.193 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.568 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 106.82 91.27 2.21 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.367 -1.093 . . . . 72.140000000000001 110.367 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.52 158.21 15.65 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 110.478 -0.193 . . . . 65.019999999999996 110.478 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -121.88 148.93 44.1 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.108 0.781 . . . . 74.239999999999995 113.108 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -136.97 117.24 13.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.667 -1.234 . . . . 73.049999999999997 107.667 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -83.41 139.07 33.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.322 -0.621 . . . . 73.310000000000002 109.322 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 94.5 mt -85.48 139.7 31.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.815 -0.439 . . . . 73.329999999999998 109.815 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -101.55 165.16 11.39 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.935 0.398 . . . . 71.310000000000002 110.344 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -69.75 113.26 6.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.096 -0.956 . . . . 75.439999999999998 109.914 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.28 -174.57 19.94 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.08 -1.608 . . . . 60.310000000000002 109.08 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 p -106.78 145.85 31.58 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.385 -0.926 . . . . 64.129999999999995 110.857 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.75 135.43 54.56 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.464 -0.569 . . . . 72.200000000000003 109.464 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.68 119.54 46.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.257 -1.016 . . . . 74.430000000000007 108.257 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 58.1 mt -101.8 127.73 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.301 0.572 . . . . 71.219999999999999 110.158 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.44 -178.09 37.49 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.335 -1.506 . . . . 75.109999999999999 109.335 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 29.1 mtm105 -110.99 106.52 15.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.356 1.078 . . . . 75.400000000000006 111.42 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.4 41.8 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 107.168 -2.373 . . . . 75.319999999999993 107.168 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -85.56 -16.01 40.79 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.175 0.988 . . . . 72.329999999999998 108.457 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.5 -12.57 60.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.113 -1.403 . . . . 70.5 109.273 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 47' ' ' ARG . . . -98.37 158.02 15.84 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.776 -1.102 . . . . 72.019999999999996 108.553 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -106.65 -39.06 5.94 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.347 0.594 . . . . 71.120000000000005 110.397 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 89.7 t80 -115.72 114.88 25.42 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.904 -1.147 . . . . 74.420000000000002 107.904 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 61.7 mtm180 -96.91 124.14 40.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.094 -0.503 . . . . 74.230000000000004 110.499 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 66.6 mt -71.4 134.17 84.79 Favored Pre-proline 0 CA--C 1.501 -0.926 0 N-CA-C 107.573 -1.269 . . . . 75.299999999999997 107.573 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.28 35.01 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.967 1.778 . . . . 74.329999999999998 112.111 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.8 -175.55 3.44 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.043 0.449 . . . . 63.340000000000003 110.417 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.5 m -111.17 148.59 32.43 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.123 0.969 . . . . 74.329999999999998 110.005 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.82 -0.85 61.07 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 111.679 -0.568 . . . . 60.200000000000003 111.679 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.14 127.69 45.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.867 -0.79 . . . . 74.340000000000003 108.867 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.1 m -78.96 177.3 8.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.166 -0.47 . . . . 41.340000000000003 110.185 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.41 -50.63 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.904 0.32 . . . . 74.209999999999994 110.97 177.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.62 114.6 26.66 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 107.025 -1.472 . . . . 75.340000000000003 107.025 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -105.31 -42.97 5.11 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.605 0.717 . . . . 72.219999999999999 109.097 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 tt -163.17 159.8 23.4 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.56 -0.904 . . . . 75.109999999999999 108.56 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -138.85 151.1 46.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.518 -0.549 . . . . 72.439999999999998 109.518 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -123.48 121.44 62.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.542 -0.91 . . . . 63.240000000000002 108.542 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 63.4 mtt180 -105.6 107.94 19.2 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.206 -0.664 . . . . 73.349999999999994 109.206 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.72 133.98 52.07 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.996 -0.547 . . . . 75.439999999999998 110.616 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.79 -179.93 6.34 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.436 -2.431 . . . . 65.549999999999997 104.436 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.36 42.62 2.92 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 119.445 1.02 . . . . 50.439999999999998 113.867 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -141.62 -76.78 0.28 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 110.203 -0.295 . . . . 74.239999999999995 110.203 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.12 158.1 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.711 0.291 . . . . 72.439999999999998 110.557 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.51 112.38 24.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.403 0.62 . . . . 71.510000000000005 110.289 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.458 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 6.1 tt -88.96 124.87 34.66 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.272 -0.876 . . . . 70.040000000000006 108.797 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.74 123.55 49.71 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.347 -1.353 . . . . 75.430000000000007 107.347 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.74 124.68 28.59 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.187 0.518 . . . . 52.509999999999998 110.999 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 14.9 t70 -89.3 112.47 23.55 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.357 -0.979 . . . . 73.430000000000007 108.357 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 mt -101.53 76.45 1.67 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.422 -2.066 . . . . 73.140000000000001 105.422 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -173.81 139.64 0.7 Allowed 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.899 -0.72 . . . . 71.129999999999995 109.708 -165.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -108.56 -53.38 2.65 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.283 0.563 . . . . 63.229999999999997 110.003 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -66.02 -48.64 70.45 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.277 -0.874 . . . . 60.450000000000003 113.05 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -106.4 29.77 6.57 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 119.173 -0.441 . . . . 73.329999999999998 109.94 -170.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.23 121.94 2.83 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.18 0.832 . . . . 65.049999999999997 115.18 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.7 m -69.08 149.17 49.01 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.734 1.614 . . . . 75.219999999999999 112.336 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 38.5 p -112.4 145.78 39.51 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.345 0.593 . . . . 61.219999999999999 111.814 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.405 HG12 HG13 ' A' ' 88' ' ' ILE . 33.9 m -116.07 117.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 107.431 -1.322 . . . . 74.140000000000001 107.431 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 58.88 33.26 22.94 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.675 -0.693 . . . . 71.239999999999995 110.295 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 82.46 -3.36 1.4 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.86 1.664 . . . . 73.209999999999994 112.428 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.15 129.31 25.39 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.684 -0.635 . . . . 64.109999999999999 110.089 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.12 125.58 7.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.501 2.134 . . . . 73.519999999999996 113.529 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.68 174.47 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 107.295 -1.372 . . . . 74.439999999999998 107.295 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.423 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.2 mt-30 -117.4 -17.73 10.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 112.979 0.733 . . . . 73.329999999999998 112.979 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.61 131.52 27.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 109.908 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -147.57 152.33 37.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.842 -0.799 . . . . 74.340000000000003 108.842 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -106.41 113.8 27.53 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.181 -1.044 . . . . 74.140000000000001 108.181 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.436 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.2 mt -57.85 149.56 22.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.107 -0.952 . . . . 71.329999999999998 112.486 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.09 166.79 23.8 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.321 -0.854 . . . . 64.319999999999993 109.15 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.8 t70 -71.67 115.72 11.19 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.994 0.426 . . . . 72.150000000000006 110.201 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.46 14.34 28.1 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.813 -0.63 . . . . 74.409999999999997 112.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -88.76 135.66 33.4 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 120.438 -0.505 . . . . 73.439999999999998 110.74 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.21 113.46 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.008 -0.738 . . . . 64.329999999999998 109.008 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.405 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -105.76 113.53 42.84 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.805 -1.183 . . . . 74.049999999999997 107.805 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.462 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 61.5 mtt180 -99.81 106.28 18.14 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 116.272 -0.422 . . . . 74.340000000000003 109.954 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -115.5 164.69 13.93 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.013 -0.994 . . . . 71.209999999999994 109.001 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -27.39 88.78 0.01 OUTLIER Glycine 0 N--CA 1.484 1.856 0 C-N-CA 125.303 1.43 . . . . 71.439999999999998 116.331 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 58.08 21.35 7.81 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.76 1.624 . . . . 72.540000000000006 111.491 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.0 m -137.01 114.25 10.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.12 -1.067 . . . . 63.439999999999998 108.12 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.22 125.4 54.1 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 120.099 -0.64 . . . . 70.519999999999996 109.799 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.434 HG23 ' HA ' ' A' ' 13' ' ' LEU . 1.7 pp -122.48 149.43 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-O 120.953 0.406 . . . . 72.5 111.36 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -110.39 122.45 64.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.767 -1.568 . . . . 74.329999999999998 106.767 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 82' ' ' LEU . 55.1 t -80.41 126.56 39.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 120.85 0.357 . . . . 75.040000000000006 111.057 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.0 mmm-85 -116.9 142.3 47.11 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.35 0.595 . . . . 64.540000000000006 109.678 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.429 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 79.6 mtp -123.06 121.25 35.57 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.925 -1.034 . . . . 74.540000000000006 109.144 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 107.168 -1.419 . . . . 73.439999999999998 107.168 -177.641 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.624 0 N-CA-C 110.468 -1.053 . . . . 70.030000000000001 110.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -118.34 59.76 0.8 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 122.901 1.334 . . . . 75.040000000000006 108.639 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.32 -82.69 1.63 Allowed Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 108.126 -1.989 . . . . 32.039999999999999 108.126 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 m -84.89 88.49 7.42 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.388 0.613 . . . . 71.209999999999994 109.925 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.28 81.7 1.66 Allowed 'General case' 0 N--CA 1.414 -2.272 0 CA-C-O 122.107 0.956 . . . . 74.409999999999997 108.978 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.17 -53.14 0.27 Allowed Glycine 0 C--N 1.288 -2.138 0 N-CA-C 108.028 -2.029 . . . . 73.120000000000005 108.028 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 m -70.83 115.3 9.82 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.831 -1.544 . . . . 73.400000000000006 106.831 172.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -121.48 114.77 21.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.494 -0.483 . . . . 74.129999999999995 109.95 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.411 HG11 ' HB2' ' A' ' 23' ' ' LEU . 3.7 p -95.76 126.41 48.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.713 -1.217 . . . . 71.019999999999996 107.713 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 m -131.06 136.54 48.54 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.28 -0.873 . . . . 72.450000000000003 109.264 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.47 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.0 pp -101.8 131.41 48.13 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 109.966 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.92 114.26 28.24 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.28 -1.378 . . . . 73.540000000000006 107.28 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.16 119.31 38.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.43 0.692 . . . . 74.239999999999995 110.521 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -93.36 100.0 12.41 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.949 -1.13 . . . . 63.530000000000001 107.949 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.91 -13.59 15.76 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.167 -1.378 . . . . 73.439999999999998 109.179 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.22 -12.93 6.02 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.87 -1.292 . . . . 70.540000000000006 109.87 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -120.12 -35.81 3.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 120.816 0.341 . . . . 74.319999999999993 110.593 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 91.82 1.38 Allowed Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.139 -1.184 . . . . 41.130000000000003 110.139 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -113.51 159.43 19.56 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 110.476 -0.194 . . . . 75.120000000000005 110.476 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.8 p -130.22 136.33 49.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.882 0.373 . . . . 74.349999999999994 110.024 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -135.62 121.55 19.91 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.042 -0.526 . . . . 74.109999999999999 109.638 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.915 -0.584 . . . . 72.340000000000003 109.762 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB2' HG11 ' A' ' 9' ' ' VAL . 88.3 mt -76.86 133.91 39.17 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.503 -0.771 . . . . 61.210000000000001 110.265 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -102.99 158.45 16.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 108.767 -0.827 . . . . 75.349999999999994 108.767 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.9 mp0 -48.5 127.27 12.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.492 1.517 . . . . 73.219999999999999 111.445 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.1 -174.8 15.81 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.255 -1.538 . . . . 64.420000000000002 109.255 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 81.8 p -95.73 123.35 39.26 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 118.319 -1.353 . . . . 73.129999999999995 110.882 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.51 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -92.57 109.74 21.15 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.065 -1.828 . . . . 74.430000000000007 106.065 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.21 129.42 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.596 -0.729 . . . . 74.209999999999994 110.842 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -107.57 133.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.54 -0.911 . . . . 72.530000000000001 108.54 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 154.79 177.5 28.17 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.193 -1.563 . . . . 74.129999999999995 109.193 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 49.7 mtp85 -112.52 105.0 13.12 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.884 1.342 . . . . 75.530000000000001 109.858 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.89 179.32 46.31 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 110.039 -1.225 . . . . 74.230000000000004 110.039 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -72.41 -25.44 61.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.073 0.939 . . . . 74.040000000000006 108.937 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.98 8.48 12.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.665 -1.152 . . . . 71.129999999999995 111.526 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.91 155.19 44.59 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.079 0.466 . . . . 63.100000000000001 112.013 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -99.63 -54.73 2.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.017 -0.992 . . . . 71.420000000000002 109.987 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -101.48 108.92 20.64 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 74.129999999999995 109.217 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 33.5 ptt180 -96.08 118.13 32.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.105 -0.498 . . . . 75.040000000000006 111.802 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.65 140.19 97.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.278 -0.874 . . . . 73.430000000000007 110.509 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -92.71 17.92 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.601 2.201 . . . . 75.329999999999998 112.283 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.64 -173.49 2.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -112.0 146.91 37.04 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.193 0.597 . . . . 74.329999999999998 109.564 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 -27.36 16.82 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.818 -0.706 . . . . 73.519999999999996 111.384 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.34 133.02 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 123.435 0.694 . . . . 65.340000000000003 111.586 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -80.27 -171.47 3.02 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.392 1.077 . . . . 71.200000000000003 109.552 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 33.4 ptt180 -78.02 -34.78 50.49 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.35 -0.94 . . . . 71.310000000000002 109.587 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -129.07 115.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 103.582 -2.748 . . . . 71.129999999999995 103.582 172.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.562 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 5.3 t60 -103.76 -42.41 5.63 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.55 0.691 . . . . 73.120000000000005 109.143 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 4.9 tt -166.45 151.14 7.78 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.429 -0.952 . . . . 72.409999999999997 108.429 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.63 134.94 45.5 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.122 -0.695 . . . . 72.129999999999995 109.122 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -102.55 112.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.028 -1.471 . . . . 75.200000000000003 107.028 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 40.2 ttt85 -91.65 107.38 19.17 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 121.548 0.689 . . . . 75.040000000000006 109.779 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -96.49 112.54 24.24 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.948 -1.024 . . . . 74.310000000000002 109.056 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -119.27 167.38 11.92 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.172 -1.788 . . . . 71.219999999999999 106.172 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.98 42.36 2.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.592 -0.813 . . . . 54.210000000000001 112.566 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -136.68 -66.86 0.52 Allowed 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 124.041 0.936 . . . . 71.019999999999996 108.56 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.11 159.77 4.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.719 1.208 . . . . 73.439999999999998 108.31 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.36 107.59 19.24 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.652 0.739 . . . . 75.549999999999997 109.101 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 tt -88.49 115.41 25.98 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.79 -1.095 . . . . 72.200000000000003 109.789 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.8 tm? -97.21 124.94 41.44 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.318 -1.364 . . . . 72.430000000000007 107.318 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.429 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -140.57 125.6 18.43 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 120.678 0.275 . . . . 74.140000000000001 111.409 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.703 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 1.2 m-20 -73.52 139.61 45.79 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 115.798 -0.637 . . . . 71.200000000000003 109.948 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.9 tp -130.68 77.15 1.77 Allowed 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.534 -1.284 . . . . 72.519999999999996 107.534 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -179.82 174.64 0.91 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.419 -1.326 . . . . 73.25 107.419 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 p -109.03 -55.03 2.46 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.642 0.608 . . . . 72.239999999999995 112.642 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -89.52 -29.95 18.58 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.466 0.913 . . . . 74.109999999999999 113.466 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.562 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 90.2 m-20 -84.57 27.38 0.72 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.427 0.691 . . . . 72.140000000000001 112.219 -172.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.51 122.73 6.68 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.967 1.417 . . . . 74.150000000000006 113.951 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.703 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 52.7 m -71.84 148.68 45.95 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 125.035 1.334 . . . . 71.319999999999993 112.622 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 p -112.92 141.03 47.22 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.435 -0.802 . . . . 63.32 109.505 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.03 118.25 53.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.755 -1.202 . . . . 74.120000000000005 107.755 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 57.81 38.22 27.23 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.556 -0.747 . . . . 71.540000000000006 109.88 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.39 -10.61 1.17 Allowed 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.605 1.962 . . . . 71.400000000000006 112.001 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -92.37 121.81 65.75 Favored Pre-proline 0 C--N 1.323 -0.57 0 O-C-N 122.124 -0.36 . . . . 72.120000000000005 110.7 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.47 125.19 13.0 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.837 2.358 . . . . 75.030000000000001 112.552 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.99 -177.9 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.974 -0.751 . . . . 75.209999999999994 108.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -128.83 6.25 5.53 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.589 -0.522 . . . . 72.540000000000006 109.589 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.45 153.16 3.44 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.907 -1.146 . . . . 73.329999999999998 107.907 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.456 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 76.3 t-105 -166.91 152.29 7.73 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.711 -0.848 . . . . 73.140000000000001 108.711 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -104.66 111.52 24.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.643 -1.243 . . . . 71.409999999999997 107.643 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB3' HG13 ' A' ' 97' ' ' VAL . 56.0 mt -58.13 141.3 50.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.898 1.073 . . . . 64.530000000000001 113.898 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.97 162.46 32.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.529 -1.286 . . . . 64.239999999999995 107.529 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.0 126.36 27.79 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.575 -0.284 . . . . 75.150000000000006 110.396 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.63 1.94 57.56 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.907 -0.663 . . . . 65.120000000000005 113.414 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -73.07 129.58 38.39 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.362 0.581 . . . . 61.229999999999997 111.135 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.43 116.28 35.32 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 N-CA-C 107.284 -1.376 . . . . 75.530000000000001 107.284 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.9 mt -122.43 134.28 66.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 C-N-CA 119.971 -0.692 . . . . 52.240000000000002 110.6 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -124.19 123.35 40.08 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 73.219999999999999 110.004 175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -101.81 162.57 12.81 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 105.81 -1.922 . . . . 70.409999999999997 105.81 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -46.33 102.86 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 O-C-N 123.749 0.655 . . . . 64.239999999999995 113.786 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 m170 79.52 15.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.712 1.375 . . . . 73.140000000000001 114.712 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -151.02 141.11 22.14 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.475 -0.766 . . . . 71.450000000000003 111.94 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -118.75 139.29 51.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.037 0.446 . . . . 72.5 111.235 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 9.5 tp -139.8 142.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-N 115.301 -0.863 . . . . 75.239999999999995 109.527 -172.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -109.88 134.51 51.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.029 -1.1 . . . . 74.040000000000006 108.029 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 82' ' ' LEU . 85.0 t -96.92 121.73 47.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.141 0.496 . . . . 75.430000000000007 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -117.47 132.29 56.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.865 -0.791 . . . . 73.099999999999994 108.865 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.0 mtp -116.36 116.87 28.52 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.064 -0.717 . . . . 75.219999999999999 109.064 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--N 1.278 -2.537 0 N-CA-C 107.506 -1.294 . . . . 63.420000000000002 107.506 -177.732 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.751 0 N-CA-C 111.328 -0.709 . . . . 53.420000000000002 111.328 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -59.92 123.83 18.28 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.969 0.908 . . . . 72.319999999999993 112.263 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.26 76.23 0.51 Allowed Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.408 -1.077 . . . . 45.5 110.408 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -62.79 121.07 12.54 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.185 -0.672 . . . . 64.310000000000002 109.185 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.86 -175.75 2.88 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 123.867 0.729 . . . . 74.510000000000005 110.109 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.14 -58.26 5.01 Favored Glycine 0 CA--C 1.496 -1.137 0 N-CA-C 109.888 -1.285 . . . . 70.349999999999994 109.888 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m -144.64 114.76 7.45 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 107.82 -1.178 . . . . 71.209999999999994 107.82 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -113.04 114.3 26.67 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.201 -1.407 . . . . 75.209999999999994 107.201 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 108.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.813 -1.18 . . . . 74.299999999999997 107.813 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 m -111.41 123.23 49.79 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.095 -1.076 . . . . 75.450000000000003 108.095 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.4 pp -88.53 130.02 35.33 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.602 -0.888 . . . . 70.329999999999998 108.602 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.93 108.85 19.76 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.622 -1.621 . . . . 65.219999999999999 106.622 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.48 117.8 29.39 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.524 -0.546 . . . . 73.540000000000006 109.524 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -126.77 103.53 7.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.951 -1.1 . . . . 72.099999999999994 112.925 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -48.87 9.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.9 -2.259 . . . . 74.430000000000007 104.9 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 171.29 44.27 0.04 OUTLIER Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 103.591 -3.804 . . . . 53.439999999999998 103.591 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -132.49 -45.94 0.9 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.644 -1.278 . . . . 72.099999999999994 110.86 -166.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.72 51.04 8.38 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.49 -1.044 . . . . 75.340000000000003 110.49 -172.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -84.47 143.1 29.6 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.747 0.419 . . . . 74.209999999999994 110.355 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.551 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.9 p -146.68 132.36 18.88 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.645 -0.707 . . . . 71.299999999999997 109.199 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -144.8 127.69 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.456 -0.338 . . . . 72.25 110.099 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.07 127.46 36.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.41 -0.959 . . . . 62.520000000000003 108.41 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.0 mt -58.31 143.46 44.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.567 0.951 . . . . 71.239999999999995 113.567 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 2.3 mmp_? -100.01 151.61 21.16 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.559 -1.201 . . . . 72.430000000000007 108.022 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.85 130.14 40.88 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.683 0.754 . . . . 73.530000000000001 111.367 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.65 -176.54 16.61 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 106.763 -2.535 . . . . 62.32 106.763 -172.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 51.7 p -89.71 133.27 34.75 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 118.388 -1.325 . . . . 74.439999999999998 111.303 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.485 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -101.72 109.83 21.68 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.194 -2.15 . . . . 74.200000000000003 105.194 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.4 mt -86.2 123.96 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.976 -0.556 . . . . 75.25 111.149 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -107.91 129.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.768 -0.827 . . . . 75.329999999999998 108.768 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.48 -179.03 37.15 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.888 -0.885 . . . . 74.439999999999998 110.888 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 40.1 mtp85 -107.43 106.38 16.75 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.732 -0.84 . . . . 73.510000000000005 108.732 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.71 -178.13 48.63 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 109.562 -1.415 . . . . 74.120000000000005 109.562 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -93.43 -21.05 19.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.004 0.431 . . . . 64.230000000000004 110.786 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -92.76 -3.59 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 75.209999999999994 110.056 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.11 165.96 20.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.049 -0.978 . . . . 73.310000000000002 108.911 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -109.35 -52.16 2.8 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.65 0.738 . . . . 74.239999999999995 110.028 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -108.82 116.73 32.53 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.366 -0.975 . . . . 74.310000000000002 108.366 -178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.534 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mpt_? -94.92 127.86 41.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.159 -0.473 . . . . 70.120000000000005 110.973 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 68.7 mt -79.98 136.07 54.59 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.101 -0.5 . . . . 73.040000000000006 111.138 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 33.9 Cg_exo -61.98 -29.15 81.5 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.407 2.738 . . . . 71.450000000000003 114.4 -178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 21.5 t70 -95.03 169.0 10.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.709 -0.849 . . . . 63.119999999999997 108.709 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -107.23 -177.34 3.33 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 121.036 -0.266 . . . . 74.540000000000006 110.321 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.22 78.39 Favored Glycine 0 C--O 1.238 0.395 0 N-CA-C 108.807 -1.717 . . . . 74.120000000000005 108.807 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.47 130.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 113.294 -1.453 . . . . 73.230000000000004 108.095 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.1 m -79.11 -177.48 5.65 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.244 -0.651 . . . . 74.299999999999997 109.244 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.559 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 15.4 ptt180 -64.49 -41.56 96.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.572 0.701 . . . . 74.109999999999999 109.415 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -121.02 104.36 9.74 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.245 -1.761 . . . . 73.209999999999994 106.245 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.2 t60 -100.0 -31.44 11.45 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.948 -1.024 . . . . 75.319999999999993 108.877 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.1 tt -164.28 145.89 8.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.108 -0.701 . . . . 74.230000000000004 109.108 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.95 132.92 47.66 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.292 0.567 . . . . 71.540000000000006 110.05 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.3 mt -108.53 112.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.642 -1.244 . . . . 74.019999999999996 107.642 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 16.3 ttt-85 -91.35 107.71 19.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -99.51 115.32 29.07 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-O 121.672 0.749 . . . . 74.519999999999996 110.324 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.83 164.6 14.42 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.051 -1.463 . . . . 73.319999999999993 107.051 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.56 52.91 3.91 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.415 -1.074 . . . . 70.409999999999997 110.415 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.36 -71.73 0.3 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 125.7 1.6 . . . . 64.409999999999997 107.793 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 m -149.76 160.0 5.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.908 1.283 . . . . 71.140000000000001 107.896 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . . . -93.24 106.15 18.15 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.585 -0.895 . . . . 73.299999999999997 108.585 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -82.48 118.31 23.14 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.277 -0.874 . . . . 73.420000000000002 110.096 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -99.54 120.13 39.15 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.545 -0.909 . . . . 74.150000000000006 108.545 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.0 123.48 34.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.815 -0.439 . . . . 72.540000000000006 109.815 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.64 138.82 32.77 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.868 -0.605 . . . . 74.310000000000002 110.994 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.92 77.52 1.62 Allowed 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.979 0.511 . . . . 73.340000000000003 109.913 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.441 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 32.9 t-20 -175.31 138.67 0.43 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.842 0.746 . . . . 74.040000000000006 110.473 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 p -96.54 -38.46 9.97 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.361 -0.381 . . . . 75.319999999999993 111.854 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 t -89.32 -44.4 10.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.346 0.499 . . . . 73.420000000000002 112.346 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.441 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.4 m120 -105.98 27.37 8.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.129 -0.693 . . . . 75.129999999999995 109.129 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.96 138.36 26.32 Favored Glycine 0 C--O 1.248 1.004 0 CA-C-N 114.527 -1.215 . . . . 33.219999999999999 113.923 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 30.0 m -72.25 137.73 47.0 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 124.406 1.082 . . . . 70.409999999999997 113.299 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 p -105.91 140.75 38.45 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.373 -0.83 . . . . 72.530000000000001 109.674 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.469 HG11 HG13 ' A' ' 88' ' ' ILE . 35.2 m -119.55 116.04 49.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.602 -1.259 . . . . 75.299999999999997 107.602 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 57.84 30.86 19.69 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.445 0.64 . . . . 75.030000000000001 110.167 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 88.72 -10.88 0.45 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.659 1.984 . . . . 74.540000000000006 113.677 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.7 117.81 66.3 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 121.413 -0.804 . . . . 71.439999999999998 110.913 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.86 124.91 11.5 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 121.76 1.64 . . . . 74.519999999999996 110.319 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.95 175.98 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 110.168 -0.308 . . . . 75.099999999999994 110.168 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.05 -31.84 9.49 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.659 0.599 . . . . 61.109999999999999 109.42 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -142.73 147.86 36.31 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.048 -0.524 . . . . 73.450000000000003 110.199 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -162.23 152.17 16.47 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -107.92 109.41 20.91 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.979 -0.688 . . . . 73.519999999999996 109.154 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 79.0 mt -57.1 122.02 11.41 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.479 -1.237 . . . . 75.230000000000004 111.923 -175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.9 166.59 11.08 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.924 -1.139 . . . . 72.439999999999998 107.924 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 126.4 29.13 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.462 -0.335 . . . . 73.239999999999995 110.628 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.16 57.73 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.929 -0.578 . . . . 75.230000000000004 113.071 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.06 139.88 46.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.984 0.392 . . . . 55.310000000000002 111.411 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.69 117.19 48.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.753 -0.658 . . . . 72.439999999999998 109.673 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.469 HG13 HG11 ' A' ' 72' ' ' VAL . 1.9 mp -111.98 124.55 68.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 123.368 0.667 . . . . 72.319999999999993 109.28 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 70' ' ' THR . 38.5 ttm180 -120.37 115.73 24.11 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.405 -0.591 . . . . 72.430000000000007 109.405 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -126.81 139.29 53.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.409 -1.33 . . . . 72.109999999999999 107.409 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.86 88.02 0.0 OUTLIER Glycine 0 N--CA 1.496 2.636 0 O-C-N 125.032 1.457 . . . . 71.430000000000007 116.297 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.5 t60 75.37 -19.66 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.327 1.451 . . . . 74.120000000000005 113.034 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.6 m -96.55 132.46 42.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 122.869 0.468 . . . . 72.299999999999997 111.171 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -125.78 117.63 23.83 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.013 0.911 . . . . 75.099999999999994 110.387 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.428 HG13 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -127.64 141.57 46.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 114.53 -1.214 . . . . 75.549999999999997 111.914 -170.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.86 133.34 51.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.095 -1.076 . . . . 74.200000000000003 108.095 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.38 124.54 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 120.869 0.366 . . . . 73.120000000000005 110.84 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -119.25 130.58 55.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.741 -0.663 . . . . 74.439999999999998 111.126 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.1 mtt -106.17 111.93 24.75 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.975 -0.75 . . . . 75.450000000000003 108.975 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 . . . . . 0 C--N 1.277 -2.586 0 N-CA-C 108.306 -0.998 . . . . 75.129999999999995 108.306 179.104 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.881 0 N-CA-C 110.412 -1.075 . . . . 43.049999999999997 110.412 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 65.68 -72.24 0.08 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.421 1.488 . . . . 74.530000000000001 112.174 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.02 164.38 18.4 Favored Glycine 0 N--CA 1.416 -2.691 0 N-CA-C 111.599 -0.601 . . . . 71.140000000000001 111.599 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -84.64 141.84 30.35 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.731 -0.84 . . . . 73.219999999999999 108.731 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.21 138.82 55.9 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.139 -1.06 . . . . 72.129999999999995 108.139 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.02 -53.55 45.48 Favored Glycine 0 CA--C 1.508 -0.399 0 C-N-CA 120.494 -0.86 . . . . 71.319999999999993 111.084 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m -73.87 116.0 13.98 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.305 -0.628 . . . . 75.510000000000005 109.305 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -101.56 115.57 30.81 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.804 -0.813 . . . . 64.329999999999998 108.804 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.24 122.02 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 106.251 -1.759 . . . . 72.219999999999999 106.251 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.6 m -135.66 131.22 35.46 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.615 -0.513 . . . . 74.219999999999999 109.615 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.468 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -93.94 126.86 39.39 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.377 -0.601 . . . . 74.310000000000002 109.377 175.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.8 108.72 21.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.759 -1.2 . . . . 75.420000000000002 107.759 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.02 114.36 28.23 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.824 -0.626 . . . . 74.340000000000003 109.778 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.7 99.62 11.69 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.551 -1.648 . . . . 74.019999999999996 106.551 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -146.89 79.75 1.52 Allowed 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.596 -1.184 . . . . 64.129999999999995 108.953 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.23 -62.39 0.29 Allowed Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.19 -0.914 . . . . 74.450000000000003 111.656 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -128.23 -38.92 1.75 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.425 0.528 . . . . 63.549999999999997 112.425 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.59 86.16 0.79 Allowed Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.784 -0.926 . . . . 73.140000000000001 110.784 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -100.38 167.37 10.44 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.462 0.305 . . . . 73.409999999999997 110.72 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.9 p -141.65 140.55 33.29 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.845 -0.616 . . . . 73.409999999999997 110.388 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.4 121.83 31.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.082 -1.081 . . . . 74.430000000000007 108.082 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -86.67 125.88 34.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.414 -1.328 . . . . 74.109999999999999 107.414 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.47 121.72 18.3 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.783 -0.644 . . . . 72.150000000000006 110.671 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -82.78 150.59 26.54 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.867 -0.79 . . . . 73.340000000000003 108.867 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -57.76 124.98 21.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.242 0.964 . . . . 74.200000000000003 110.309 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.17 -164.04 16.35 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.761 -2.136 . . . . 74.420000000000002 107.761 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 80.5 p -100.65 134.64 43.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.011 1.406 . . . . 75.230000000000004 111.31 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -111.78 110.07 20.24 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.205 -1.776 . . . . 72.420000000000002 106.205 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 45.7 mt -102.27 136.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.676 -0.693 . . . . 72.040000000000006 110.214 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -115.08 135.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.257 1.458 0 N-CA-C 109.49 -0.559 . . . . 71.010000000000005 109.49 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.88 -175.97 29.63 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 110.287 -1.125 . . . . 64.120000000000005 110.287 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 87.5 mtt180 -105.76 105.19 15.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.546 -0.861 . . . . 74.310000000000002 110.233 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.26 162.21 26.67 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 108.886 -1.686 . . . . 71.109999999999999 108.886 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.14 -18.32 62.52 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.218 0.532 . . . . 72.109999999999999 109.578 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.78 -29.03 65.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.624 -1.171 . . . . 72.129999999999995 109.596 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.434 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . . . -88.16 154.18 20.65 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.323 -0.853 . . . . 72.400000000000006 110.675 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -93.04 -46.57 7.4 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.598 -0.89 . . . . 74.239999999999995 108.598 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -111.74 117.7 33.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.916 -1.038 . . . . 75.239999999999995 109.313 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.496 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.5 mpt_? -96.55 136.7 36.7 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.705 -0.48 . . . . 70.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -83.33 146.76 51.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.655 -0.248 . . . . 75.519999999999996 110.365 178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.92 12.54 2.42 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.051 2.501 . . . . 70.329999999999998 112.322 177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.33 152.61 32.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 111.227 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.5 m -95.18 151.88 18.84 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.48 26.37 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 110.348 -1.101 . . . . 64.340000000000003 110.348 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -98.75 138.6 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 108.71 -0.848 . . . . 62.420000000000002 108.71 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.1 m -81.42 175.42 10.57 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.416 0.15 . . . . 72.25 111.347 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 2.3 ptm180 -60.86 -36.53 79.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.256 0.622 . . . . 74.439999999999998 111.42 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -131.94 97.55 4.2 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.366 -2.087 . . . . 74.319999999999993 105.366 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -95.85 -37.44 10.72 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.565 0.698 . . . . 73.329999999999998 109.746 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -158.99 143.24 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.696 -0.684 . . . . 74.439999999999998 109.182 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -134.57 126.68 29.77 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.596 -0.729 . . . . 75.209999999999994 111.073 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -103.46 112.91 38.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.465 -0.939 . . . . 72.420000000000002 108.465 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.73 107.67 19.37 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 106.012 -1.847 . . . . 72.430000000000007 106.012 177.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -105.55 108.37 19.85 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.482 -0.781 . . . . 72.439999999999998 109.552 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.82 161.73 13.7 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 105.935 -1.876 . . . . 72.430000000000007 105.935 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.03 60.4 3.06 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.498 -0.858 . . . . 64.019999999999996 111.828 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -177.72 -50.36 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.729 1.212 . . . . 75.120000000000005 109.865 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.51 145.12 35.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 112.64 0.607 . . . . 74.25 112.64 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.92 102.14 11.52 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 115.235 -0.893 . . . . 72.010000000000005 109.432 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 tp -94.29 109.72 21.52 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.9 -1.046 . . . . 74.409999999999997 111.085 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -94.98 116.75 29.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.621 -1.251 . . . . 74.010000000000005 107.621 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.6 121.13 32.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.942 0.401 . . . . 73.409999999999997 110.834 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.0 134.44 35.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.309 -0.859 . . . . 73.200000000000003 109.141 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.15 77.61 1.75 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.835 -1.172 . . . . 63.240000000000002 107.835 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -170.54 162.72 8.18 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.183 -1.043 . . . . 71.109999999999999 108.183 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 m -108.65 -53.27 2.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 120.475 -0.49 . . . . 75.030000000000001 112.103 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -88.43 -26.69 21.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.371 0.605 . . . . 74.319999999999993 111.895 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -104.85 28.25 7.32 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 122.887 0.475 . . . . 70.530000000000001 110.147 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.76 115.82 1.52 Allowed Glycine 0 C--O 1.246 0.87 0 O-C-N 125.004 1.44 . . . . 71.420000000000002 112.367 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 m -59.19 134.16 56.75 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.321 1.048 . . . . 61.329999999999998 112.676 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 139.67 38.01 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 108.161 -1.051 . . . . 55.329999999999998 108.161 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.51 120.59 62.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.508 -0.923 . . . . 65.400000000000006 108.508 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 59.22 29.13 18.63 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.584 1.183 . . . . 63.0 109.08 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.271 95.8 m-20 67.11 25.26 9.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 112.8 -2.0 . . . . 73.340000000000003 113.92 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.07 125.38 27.68 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.623 -0.881 . . . . 64.219999999999999 108.623 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.8 130.73 14.94 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.339 2.026 . . . . 72.219999999999999 112.675 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.77 176.89 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.044 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -106.44 -38.09 6.3 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.872 -0.788 . . . . 75.310000000000002 108.872 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.02 148.73 42.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.888 -1.051 . . . . 72.329999999999998 110.597 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -153.16 151.97 30.73 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.674 -0.861 . . . . 73.219999999999999 108.674 -176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -102.2 116.35 32.48 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.578 -1.267 . . . . 74.519999999999996 107.578 173.823 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.04 138.03 54.94 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 123.729 0.643 . . . . 74.329999999999998 112.152 -177.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.25 169.06 14.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.688 -1.227 . . . . 74.299999999999997 107.688 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.54 124.8 28.84 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.476 -0.329 . . . . 74.109999999999999 110.648 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.97 6.06 56.17 Favored Glycine 0 N--CA 1.436 -1.348 0 CA-C-N 116.016 -0.538 . . . . 70.25 112.295 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.46 134.8 46.83 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.964 0.411 . . . . 71.519999999999996 111.383 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.42 113.21 35.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 N-CA-C 107.79 -1.189 . . . . 75.329999999999998 107.79 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.3 122.4 68.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 C-N-CA 119.863 -0.735 . . . . 73.329999999999998 111.238 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -105.73 109.98 22.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.658 -0.701 . . . . 71.219999999999999 109.13 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -110.7 164.83 12.36 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.672 -0.862 . . . . 74.219999999999999 108.672 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -47.23 106.29 0.15 Allowed Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.689 0.618 . . . . 61.210000000000001 113.444 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 75.81 12.63 2.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.696 1.599 . . . . 72.230000000000004 114.786 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.0 t -154.85 150.4 27.44 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.58 -0.848 . . . . 74.439999999999998 111.531 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.91 128.67 47.92 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.236 0.541 . . . . 75.230000000000004 109.818 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.468 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.4 tp -124.91 148.89 29.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 116.211 -0.45 . . . . 73.420000000000002 110.626 -170.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.91 122.82 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.684 -1.228 . . . . 73.140000000000001 107.684 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 81.8 t -90.58 122.78 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.93 0.395 . . . . 73.439999999999998 110.184 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -119.54 140.98 49.65 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.77 -0.65 . . . . 75.420000000000002 110.516 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 58.2 mtt -121.82 114.53 21.19 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.24 -1.022 . . . . 74.519999999999996 108.24 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 . . . . . 0 C--N 1.278 -2.541 0 N-CA-C 107.024 -1.473 . . . . 75.319999999999993 107.024 -178.653 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.729 0 N-CA-C 110.854 -0.898 . . . . 43.049999999999997 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -137.76 172.36 13.06 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 122.282 0.233 . . . . 74.319999999999993 110.409 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.4 ' HA3' ' HB ' ' A' ' 7' ' ' THR . . . -121.36 -179.99 16.17 Favored Glycine 0 N--CA 1.434 -1.482 0 O-C-N 123.871 0.732 . . . . 73.430000000000007 111.302 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 m -50.94 -46.89 61.14 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.242 1.417 . . . . 70.120000000000005 114.434 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.09 10.62 30.83 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.677 0.621 . . . . 74.109999999999999 112.677 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.27 12.34 54.67 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 109.287 -1.525 . . . . 73.319999999999993 109.287 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HB ' ' HA3' ' A' ' 3' ' ' GLY . 12.9 m -54.71 116.58 2.78 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 125.906 1.682 . . . . 74.420000000000002 111.404 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 m -115.85 114.64 24.99 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.829 -1.174 . . . . 74.150000000000006 107.829 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 25.5 t -91.35 115.9 31.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.402 -0.962 . . . . 73.140000000000001 108.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.465 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.9 m -118.6 127.74 53.89 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 115.742 -0.663 . . . . 73.349999999999994 110.231 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.579 ' O ' ' HA ' ' A' ' 20' ' ' THR . 69.1 mt -90.57 121.71 32.75 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.91 -1.041 . . . . 60.140000000000001 108.387 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.68 114.52 28.79 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 123.889 0.743 . . . . 75.209999999999994 109.339 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 tp -118.18 109.02 15.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 123.918 0.887 . . . . 75.150000000000006 109.713 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -97.44 101.6 13.17 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.105 -0.702 . . . . 71.329999999999998 109.105 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -97.18 5.26 50.45 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.835 -0.802 . . . . 71.219999999999999 108.835 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.99 -40.43 0.62 Allowed Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 114.671 -1.15 . . . . 74.540000000000006 110.269 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 m -112.01 -50.95 2.88 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 112.889 0.7 . . . . 75.150000000000006 112.889 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.76 82.25 0.55 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.669 -0.776 . . . . 64.109999999999999 111.983 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.11 150.19 22.84 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 110.133 -0.321 . . . . 74.209999999999994 110.133 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.8 p -133.61 145.87 50.42 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 116.138 -0.483 . . . . 62.149999999999999 111.114 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -137.97 129.58 28.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.572 -0.899 . . . . 71.319999999999993 108.572 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 53.1 tt0 -92.39 134.93 34.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.214 -0.662 . . . . 70.319999999999993 109.214 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -60.19 139.92 57.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.433 0.635 . . . . 72.25 111.971 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -95.88 169.65 9.85 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.255 -0.884 . . . . 75.019999999999996 109.757 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.2 pm0 -75.09 122.67 23.93 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 123.536 0.735 . . . . 73.239999999999995 110.758 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.52 -164.93 12.02 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.461 -1.056 . . . . 75.310000000000002 110.461 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.7 t -107.65 142.85 36.97 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 117.116 0.458 . . . . 73.530000000000001 111.433 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.411 ' ND2' ' HB ' ' A' ' 52' ' ' ILE . 7.2 p30 -117.89 117.75 30.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.532 0.682 . . . . 74.349999999999994 109.57 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -91.69 112.3 25.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.99 -1.005 . . . . 72.409999999999997 108.559 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.9 mt -90.3 128.1 42.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 123.914 0.759 . . . . 75.200000000000003 110.009 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.44 175.15 34.11 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.62 -0.992 . . . . 74.0 110.62 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -109.22 106.69 16.65 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.809 -0.811 . . . . 74.420000000000002 108.809 176.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.01 173.2 42.35 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 109.424 -1.47 . . . . 74.420000000000002 109.424 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -81.72 -16.53 50.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.144 0.497 . . . . 71.530000000000001 110.461 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.46 6.3 49.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.051 0.929 . . . . 75.439999999999998 109.739 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.79 161.46 13.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.107 -0.951 . . . . 65.329999999999998 110.07 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -109.42 -50.27 3.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.542 0.687 . . . . 75.400000000000006 109.595 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 54.2 t80 -106.51 123.85 48.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.2 -1.407 . . . . 75.549999999999997 107.2 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.441 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 51.0 mtt180 -111.3 133.34 53.7 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 120.867 -0.333 . . . . 75.299999999999997 110.599 -174.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.63 149.28 71.1 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.534 . . . . 74.310000000000002 110.484 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 -0.09 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.534 2.156 . . . . 72.349999999999994 114.123 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.19 -173.5 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.245 -0.982 . . . . 74.219999999999999 112.085 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 m -96.31 174.35 6.92 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.33 1.052 . . . . 72.239999999999995 108.549 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.89 -21.05 39.41 Favored Glycine 0 CA--C 1.498 -0.996 0 N-CA-C 109.572 -1.411 . . . . 73.109999999999999 109.572 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.12 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.417 -1.392 . . . . 71.310000000000002 108.864 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -88.63 -173.51 4.17 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.451 -0.574 . . . . 74.200000000000003 109.451 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -72.39 -42.73 64.86 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.216 -1.031 . . . . 71.019999999999996 108.216 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.426 HH21 HD21 ' A' ' 64' ' ' LEU . 11.0 mtp180 -120.78 101.84 7.99 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.786 -1.931 . . . . 75.120000000000005 105.786 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -98.97 -43.93 6.52 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.855 -0.424 . . . . 74.120000000000005 109.855 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -159.49 151.17 20.31 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.442 -0.577 . . . . 73.430000000000007 109.442 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -126.78 127.37 44.93 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.351 0.596 . . . . 75.530000000000001 110.744 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.411 ' HB ' ' ND2' ' A' ' 28' ' ' ASN . 70.8 mt -100.43 117.1 45.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.408 -1.33 . . . . 72.099999999999994 107.408 174.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -105.91 110.05 22.21 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.401 -0.592 . . . . 75.239999999999995 109.401 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -104.89 132.43 51.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.489 -0.778 . . . . 74.310000000000002 110.374 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.73 166.88 23.63 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.123 -2.177 . . . . 74.329999999999998 105.123 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.02 65.24 1.91 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 118.377 0.535 . . . . 54.539999999999999 113.13 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -159.16 -78.03 0.07 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.42 -0.956 . . . . 75.019999999999996 108.42 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 m -142.27 159.97 19.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.818 -0.808 . . . . 74.219999999999999 108.818 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' A' ' 82' ' ' LEU . . . -91.26 114.01 26.42 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.461 -0.57 . . . . 62.299999999999997 109.461 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 69.0 tp -83.71 108.35 16.71 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.912 -1.04 . . . . 73.120000000000005 109.867 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -93.92 110.83 22.48 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.324 -1.362 . . . . 75.140000000000001 107.324 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.33 119.0 29.82 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.629 -0.508 . . . . 72.349999999999994 109.629 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -95.18 141.18 29.09 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.907 -0.588 . . . . 72.329999999999998 111.445 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.426 HD21 HH21 ' A' ' 48' ' ' ARG . 3.6 mm? -102.15 102.07 12.47 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 122.863 0.465 . . . . 74.530000000000001 110.871 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 67.62 85.14 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.458 1.103 . . . . 74.549999999999997 111.628 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.0 m -65.16 -14.73 61.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.223 1.194 . . . . 74.319999999999993 114.223 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -55.17 -38.27 68.09 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.96 0.886 . . . . 74.430000000000007 110.429 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -121.87 0.52 9.76 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.144 -1.058 . . . . 71.439999999999998 108.144 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 -137.27 1.41 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.026 -1.443 . . . . 74.239999999999995 115.78 -170.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -114.18 152.8 30.65 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-O 122.068 0.937 . . . . 74.420000000000002 113.106 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -121.8 141.21 51.45 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.795 -1.093 . . . . 73.109999999999999 110.448 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.44 HG11 HG13 ' A' ' 88' ' ' ILE . 29.6 m -110.79 124.77 67.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.488 -2.041 . . . . 74.219999999999999 105.488 174.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 62.21 24.13 14.34 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.477 0.711 . . . . 62.240000000000002 109.211 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 71.25 20.77 4.94 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.216 1.407 . . . . 74.239999999999995 110.668 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.63 130.49 24.77 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.981 -0.748 . . . . 65.150000000000006 108.981 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.33 137.39 30.9 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 122.709 2.273 . . . . 73.099999999999994 112.761 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.4 m -143.56 161.22 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.435 -0.58 . . . . 73.150000000000006 109.435 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -85.65 -45.46 11.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.923 -0.769 . . . . 73.140000000000001 108.923 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.33 151.72 38.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.971 -1.013 . . . . 71.299999999999997 108.736 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.427 ' CD2' HG21 ' A' ' 72' ' ' VAL . 64.6 t-105 -151.94 148.87 28.28 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.141 -1.059 . . . . 64.109999999999999 108.141 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.45 108.04 19.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.731 -1.211 . . . . 74.510000000000005 107.731 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.419 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 81.8 mt -57.06 148.26 22.17 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.434 -0.803 . . . . 74.310000000000002 111.702 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.53 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -147.34 164.04 34.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.796 -1.187 . . . . 63.420000000000002 107.796 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.35 119.81 9.81 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.702 0.626 . . . . 75.340000000000003 111.867 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.34 16.27 35.32 Favored Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 115.525 -0.761 . . . . 64.420000000000002 113.034 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.07 146.75 23.48 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 119.212 -0.995 . . . . 70.310000000000002 108.615 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.04 112.91 42.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.11 -0.7 . . . . 62.200000000000003 109.11 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.44 HG13 HG11 ' A' ' 72' ' ' VAL . 1.8 mp -105.83 119.69 55.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.414 -0.958 . . . . 73.109999999999999 108.414 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -121.9 116.96 25.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 119.493 -0.883 . . . . 74.129999999999995 111.343 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.54 164.97 13.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.536 -1.211 . . . . 74.329999999999998 108.547 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -39.2 107.91 0.08 OUTLIER Glycine 0 N--CA 1.479 1.55 0 O-C-N 123.964 0.79 . . . . 62.32 114.443 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 69.5 -4.03 1.47 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.304 1.442 . . . . 72.319999999999993 114.864 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 m -129.42 112.96 14.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.354 0.597 . . . . 73.329999999999998 111.345 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.73 132.68 49.77 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.775 -1.194 . . . . 75.340000000000003 107.775 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.417 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.1 tp -134.69 140.41 45.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.861 -0.422 . . . . 73.549999999999997 109.861 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.17 128.6 56.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.785 -1.191 . . . . 73.219999999999999 107.785 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.95 116.51 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.177 0.513 . . . . 74.209999999999994 110.774 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -110.77 129.31 55.88 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.608 -0.724 . . . . 75.25 109.336 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.53 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 86.4 mtp -111.62 108.54 18.05 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.777 -1.194 . . . . 71.239999999999995 107.777 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 C--N 1.27 -2.883 0 CA-C-N 114.756 -1.111 . . . . 74.420000000000002 108.463 -176.297 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.188 0 N-CA-C 109.853 -1.299 . . . . 62.229999999999997 109.853 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.477 ' HB3' ' HA3' ' A' ' 56' ' ' GLY . 16.5 p80 -130.77 144.54 51.52 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 115.11 1.522 . . . . 74.340000000000003 115.11 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.55 161.24 34.4 Favored Glycine 0 N--CA 1.412 -2.947 0 N-CA-C 104.509 -3.437 . . . . 73.430000000000007 104.509 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 m -86.39 71.5 10.45 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 119.44 1.62 . . . . 63.509999999999998 111.216 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.32 100.96 1.08 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.332 -1.304 . . . . 73.25 107.884 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.29 -45.75 1.09 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 108.248 -1.941 . . . . 71.409999999999997 108.248 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m -145.46 115.03 7.22 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.302 -0.999 . . . . 74.140000000000001 108.302 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -118.99 115.49 24.45 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.851 -1.166 . . . . 65.340000000000003 107.851 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.489 HG11 ' HB2' ' A' ' 23' ' ' LEU . 6.2 p -93.63 127.76 45.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.022 0 CA-C-O 121.503 0.668 . . . . 74.200000000000003 109.211 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.4 m -125.64 131.73 52.59 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.409 -0.814 . . . . 73.230000000000004 109.142 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.574 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.65 133.07 36.35 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.346 -0.613 . . . . 75.420000000000002 109.346 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -105.2 109.21 21.11 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.068 -1.827 . . . . 55.200000000000003 106.068 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.21 122.21 44.27 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.078 -0.51 . . . . 65.340000000000003 110.502 -175.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.59 99.33 12.38 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.358 -2.089 . . . . 74.329999999999998 105.358 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -121.31 -6.77 9.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.16 -0.927 . . . . 74.400000000000006 110.778 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.17 -15.8 12.01 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 109.913 -1.275 . . . . 62.100000000000001 109.913 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 m -111.61 -44.24 3.53 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.969 -0.752 . . . . 64.510000000000005 108.969 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.59 67.67 1.19 Allowed Glycine 0 CA--C 1.48 -2.141 0 N-CA-C 107.848 -2.101 . . . . 71.409999999999997 107.848 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -91.92 154.08 19.07 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.015 -0.592 . . . . 72.319999999999993 110.479 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 45.6 p -130.17 131.95 45.84 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.025 -1.102 . . . . 75.239999999999995 108.025 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -134.84 125.64 27.22 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.586 -0.524 . . . . 73.530000000000001 109.586 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.81 121.84 26.95 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.946 -0.761 . . . . 75.439999999999998 108.946 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB2' HG11 ' A' ' 9' ' ' VAL . 80.0 mt -66.12 139.25 58.14 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.161 -0.927 . . . . 73.319999999999993 111.923 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.58 153.46 21.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.482 -1.673 . . . . 72.129999999999995 106.482 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.24 133.88 48.49 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 73.140000000000001 111.598 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.4 -166.6 13.26 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 107.522 -2.231 . . . . 72.510000000000005 107.522 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 61.1 p -106.45 128.96 54.47 Favored 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.432 -1.307 . . . . 70.219999999999999 111.19 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -96.99 111.87 23.89 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.55 -1.278 . . . . 74.219999999999999 107.55 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mm -85.8 123.81 39.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.98 -0.555 . . . . 75.340000000000003 110.342 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.4 mt -109.52 138.19 38.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.849 -0.614 . . . . 72.409999999999997 109.606 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 152.4 -162.51 29.92 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.952 -0.859 . . . . 61.229999999999997 110.952 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.4 mtt180 -121.52 105.88 10.87 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 117.663 0.732 . . . . 72.430000000000007 109.373 176.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.49 47.74 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 120.061 -1.066 . . . . 75.140000000000001 111.318 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -75.73 -23.73 56.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.764 0.792 . . . . 71.540000000000006 109.088 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.38 -18.87 44.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.759 -1.109 . . . . 71.129999999999995 110.498 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.18 136.25 36.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.895 -0.593 . . . . 74.239999999999995 111.833 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.73 -24.05 16.14 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.575 -0.898 . . . . 75.129999999999995 108.575 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -133.29 120.0 20.5 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.617 -1.174 . . . . 73.409999999999997 108.594 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 79.6 mtt180 -97.82 130.57 44.74 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.14 0.495 . . . . 73.340000000000003 111.321 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 82.2 mt -77.6 144.83 70.22 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.473 -0.785 . . . . 72.030000000000001 111.057 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 9.22 2.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.963 2.442 . . . . 74.209999999999994 113.448 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -123.42 163.64 20.45 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.503 -1.295 . . . . 72.230000000000004 107.503 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.7 m -110.23 172.11 7.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.82 -0.807 . . . . 75.340000000000003 108.82 -176.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 94.19 5.27 62.33 Favored Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 109.472 -1.451 . . . . 73.319999999999993 109.472 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.36 145.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.036 -1.082 . . . . 72.099999999999994 108.306 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -79.07 173.43 12.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.197 0.199 . . . . 51.219999999999999 110.627 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.626 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.5 ptp180 -65.15 -31.06 72.05 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.653 0.739 . . . . 74.409999999999997 110.566 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 25.3 mtm-85 -134.08 109.59 9.05 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.728 -2.323 . . . . 72.310000000000002 104.728 174.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -104.56 -35.82 7.72 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 123.807 0.692 . . . . 72.430000000000007 110.247 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -162.86 149.57 12.8 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.689 -0.486 . . . . 74.129999999999995 109.689 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.25 122.53 37.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.451 0.643 . . . . 71.420000000000002 109.964 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.9 mt -96.29 104.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.783 -1.562 . . . . 72.340000000000003 106.783 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 63.8 ttt180 -91.84 107.29 19.11 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.777 0.799 . . . . 74.319999999999993 109.802 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -94.86 106.95 18.96 Favored 'General case' 0 N--CA 1.391 -3.395 0 N-CA-C 107.384 -1.339 . . . . 75.030000000000001 107.384 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -106.3 -175.36 2.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.671 -1.603 . . . . 63.240000000000002 106.671 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.477 ' HA3' ' HB3' ' A' ' 2' ' ' HIS . . . -88.02 57.26 4.32 Favored Glycine 0 C--N 1.285 -2.261 0 C-N-CA 119.493 -1.337 . . . . 42.509999999999998 115.445 -171.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -179.3 -65.59 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.602 0.761 . . . . 71.239999999999995 109.666 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.46 156.56 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.269 -0.423 . . . . 61.509999999999998 109.998 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.35 109.8 22.49 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.161 -1.051 . . . . 51.310000000000002 108.161 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.39 122.52 31.99 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.979 -1.01 . . . . 75.450000000000003 110.505 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -103.27 125.51 49.95 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.678 -1.23 . . . . 75.420000000000002 107.678 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.07 124.65 26.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.995 -0.372 . . . . 73.450000000000003 109.995 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.53 137.87 32.17 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.495 -0.775 . . . . 74.519999999999996 109.183 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 27.9 tp -133.89 75.97 1.63 Allowed 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.688 0.756 . . . . 74.129999999999995 109.121 -178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.558 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 38.5 t-20 -173.07 142.52 1.06 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.897 -1.52 . . . . 71.519999999999996 106.897 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -95.69 -47.68 6.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.89 -0.724 . . . . 61.43 110.834 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.452 HG21 ' ND2' ' A' ' 68' ' ' ASN . 12.2 t -88.92 -12.43 41.69 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.327 0.584 . . . . 60.439999999999998 112.302 -174.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.558 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 36.5 m-80 -121.43 27.55 8.23 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.778 -0.576 . . . . 64.25 111.07 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.38 113.95 0.79 Allowed Glycine 0 N--CA 1.481 1.676 0 O-C-N 124.403 1.064 . . . . 72.439999999999998 113.777 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.7 m -63.82 146.71 53.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.013 1.325 . . . . 73.409999999999997 112.57 -175.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -109.73 140.74 43.25 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 115.183 -0.917 . . . . 63.299999999999997 112.467 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 27.5 m -118.88 122.03 68.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 105.832 -1.914 . . . . 75.310000000000002 105.832 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 62.69 25.38 15.08 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.042 -0.725 . . . . 75.340000000000003 109.042 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.7 t30 79.58 4.86 2.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.215 1.406 . . . . 75.319999999999993 111.745 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.0 34.15 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 121.545 -0.722 . . . . 71.420000000000002 109.933 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.74 130.98 15.29 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.277 1.985 . . . . 73.540000000000006 111.596 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.9 m -135.4 159.07 40.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.255 -0.43 . . . . 74.219999999999999 110.645 -175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -82.11 -38.74 24.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.993 -0.743 . . . . 73.239999999999995 108.993 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.1 155.54 36.98 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.577 -0.897 . . . . 75.109999999999999 108.577 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.437 ' CD2' HG22 ' A' ' 72' ' ' VAL . 54.0 t-105 -159.98 149.1 17.6 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.309 -0.997 . . . . 73.239999999999995 108.309 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -100.8 115.17 29.69 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.045 -1.062 . . . . 72.150000000000006 108.642 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 88' ' ' ILE . 62.3 mt -61.91 147.9 45.27 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.568 -1.196 . . . . 72.530000000000001 111.415 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.86 168.01 19.84 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.891 -1.522 . . . . 74.25 106.891 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 121.3 16.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.551 -0.537 . . . . 72.349999999999994 109.551 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.1 44.18 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 115.6 -0.727 . . . . 71.120000000000005 112.398 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.1 152.86 25.14 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 107.405 -1.331 . . . . 75.109999999999999 107.405 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 39.1 t -114.16 112.87 42.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.081 -0.34 . . . . 71.299999999999997 110.081 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 72' ' ' VAL . 1.6 mp -107.44 114.14 45.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.558 -1.275 . . . . 72.409999999999997 107.558 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.5 ' HG3' ' HB3' ' A' ' 94' ' ' GLU . 15.5 ttt180 -123.43 127.6 48.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 120.275 -0.57 . . . . 65.099999999999994 110.361 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.37 163.34 33.04 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.696 -1.594 . . . . 71.519999999999996 106.696 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -45.46 119.38 3.5 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.59 0.556 . . . . 62.350000000000001 114.003 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 29.0 t60 78.75 -33.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.134 1.374 . . . . 74.299999999999997 113.181 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.1 m -114.2 116.77 29.58 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.416 0.627 . . . . 72.230000000000004 111.56 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.5 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 11.5 pt-20 -116.9 121.71 42.24 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.828 -0.805 . . . . 75.219999999999999 108.828 173.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -126.49 136.83 59.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.881 -1.054 . . . . 73.25 111.94 -170.402 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -105.55 127.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.098 -1.075 . . . . 70.140000000000001 108.098 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 55.5 t -86.99 125.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 116.412 -0.358 . . . . 75.329999999999998 110.969 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -115.68 149.52 38.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.718 -0.475 . . . . 74.540000000000006 109.718 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.3 mtt -130.26 116.92 19.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.456 0.646 . . . . 73.409999999999997 110.323 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.08 -1.081 . . . . 71.319999999999993 108.08 -178.846 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.621 0 N-CA-C 111.003 -0.839 . . . . 53.32 111.003 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -91.18 101.26 13.99 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.361 -0.494 . . . . 75.040000000000006 111.046 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.02 173.71 47.69 Favored Glycine 0 N--CA 1.432 -1.576 0 CA-C-N 115.408 -0.814 . . . . 74.219999999999999 111.838 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -72.37 118.8 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.222 -0.659 . . . . 74.349999999999994 109.222 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.92 15.72 2.86 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.041 0.924 . . . . 73.450000000000003 109.229 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.94 -165.24 30.29 Favored Glycine 0 N--CA 1.413 -2.888 0 N-CA-C 108.314 -1.914 . . . . 64.439999999999998 108.314 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 m -78.88 132.39 36.78 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.116 0.484 . . . . 70.439999999999998 110.682 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -111.15 116.87 31.82 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.542 -1.281 . . . . 74.319999999999993 107.542 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.0 t -99.81 132.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.555 -0.535 . . . . 75.120000000000005 109.555 -175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.1 m -135.66 127.64 29.59 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.912 -0.773 . . . . 73.129999999999995 108.912 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.3 pp -95.84 139.96 31.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.821 -0.437 . . . . 75.510000000000005 109.821 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -112.05 106.32 14.93 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.115 -0.698 . . . . 65.230000000000004 109.115 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.07 126.42 50.24 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.404 -0.962 . . . . 74.209999999999994 108.404 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -94.25 100.87 12.85 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 117.752 -1.579 . . . . 74.319999999999993 110.479 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.61 -0.11 57.55 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.495 -1.23 . . . . 74.430000000000007 109.016 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 42.69 0.96 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.566 -1.814 . . . . 64.409999999999997 108.566 -173.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.4 t -177.59 -24.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.865 -0.668 . . . . 74.5 111.289 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.1 71.29 1.05 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.463 -0.875 . . . . 55.219999999999999 110.951 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -88.72 153.47 21.07 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 122.824 0.45 . . . . 75.150000000000006 110.228 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.8 p -129.75 132.63 46.63 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.461 0.648 . . . . 74.519999999999996 111.989 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -125.62 127.23 46.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.394 -0.965 . . . . 74.340000000000003 108.394 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.563 -0.532 . . . . 72.540000000000006 109.563 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.2 mt -81.03 122.19 26.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.881 -0.785 . . . . 74.019999999999996 108.881 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -91.67 156.18 17.78 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.0 -0.68 . . . . 75.310000000000002 109.314 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.17 132.71 51.19 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.621 1.201 . . . . 73.230000000000004 111.302 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.41 -162.5 12.47 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 107.279 -2.329 . . . . 71.25 107.279 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.5 p -106.21 131.57 53.29 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 118.618 -1.233 . . . . 74.430000000000007 111.164 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.67 111.52 23.85 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.493 -1.299 . . . . 75.420000000000002 107.493 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.9 mm -85.69 121.9 37.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.098 -0.704 . . . . 75.129999999999995 109.098 -176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.0 mt -112.57 132.83 60.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.605 -0.725 . . . . 75.25 109.704 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 145.53 -161.24 28.2 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 109.807 -1.317 . . . . 72.120000000000005 109.807 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 84.1 mtt180 -121.55 106.53 11.47 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.908 -0.775 . . . . 74.420000000000002 108.908 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.83 179.0 43.79 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.541 -1.024 . . . . 75.400000000000006 110.541 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -64.41 -46.45 83.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.865 0.691 . . . . 73.25 112.865 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.22 1.95 55.96 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.163 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 124.12 23.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.551 -0.907 . . . . 72.239999999999995 108.551 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -89.38 -38.04 14.41 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.672 0.749 . . . . 75.319999999999993 109.588 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -117.61 112.17 20.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.191 -0.913 . . . . 75.0 109.051 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.561 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -89.41 133.54 34.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.488 -0.778 . . . . 71.25 111.174 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 HD11 ' CD1' ' A' ' 90' ' ' LEU . 85.5 mt -89.67 140.22 28.05 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 115.458 -0.792 . . . . 61.200000000000003 111.628 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.95 -23.0 30.45 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.11 2.54 . . . . 74.549999999999997 112.018 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -72.01 164.67 25.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.788 -0.642 . . . . 71.140000000000001 109.518 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -129.71 149.38 51.48 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 108.446 -0.946 . . . . 74.430000000000007 108.446 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.28 48.2 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 107.553 -2.219 . . . . 75.140000000000001 107.553 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -88.28 143.14 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 112.695 -1.753 . . . . 74.349999999999994 108.743 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 m -78.01 169.48 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 110.055 -0.35 . . . . 73.439999999999998 110.055 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 19.2 ptt180 -65.39 -37.27 86.49 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.865 0.84 . . . . 75.329999999999998 109.115 172.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -123.69 100.41 6.77 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 105.098 -2.186 . . . . 74.519999999999996 105.098 169.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -95.07 -32.44 13.11 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.904 -0.776 . . . . 61.420000000000002 108.904 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.3 tt -167.57 143.17 3.99 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.59 -0.732 . . . . 74.129999999999995 109.222 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -124.47 126.12 45.38 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.941 -0.572 . . . . 74.129999999999995 110.337 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 69.1 mt -103.14 112.9 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.519 -0.919 . . . . 74.319999999999993 108.519 175.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -90.79 110.13 21.33 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.563 -0.903 . . . . 73.540000000000006 108.563 176.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -99.86 110.54 22.89 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 114.986 -1.006 . . . . 71.099999999999994 108.755 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -116.41 174.42 6.07 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.357 -2.09 . . . . 73.209999999999994 105.357 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.98 32.39 2.73 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 120.272 -0.966 . . . . 74.140000000000001 112.908 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -134.83 -65.59 0.62 Allowed 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.414 0.685 . . . . 75.040000000000006 109.315 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.04 159.51 26.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 115.886 -0.597 . . . . 53.240000000000002 109.7 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 109.97 21.76 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.662 -0.866 . . . . 71.329999999999998 108.662 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 14.2 mt -89.65 119.54 30.15 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.131 -1.395 . . . . 54.240000000000002 112.935 -176.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -100.94 108.41 20.15 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 113.311 -1.768 . . . . 73.140000000000001 108.08 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.0 115.76 25.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.884 -0.413 . . . . 71.439999999999998 109.884 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.45 134.85 34.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.812 -0.631 . . . . 75.430000000000007 110.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 21.7 mt -126.35 75.97 1.58 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.508 -0.923 . . . . 73.019999999999996 108.508 177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -170.3 122.63 0.66 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 121.107 0.479 . . . . 75.010000000000005 110.124 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.3 m -93.38 -14.22 27.11 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.891 -0.506 . . . . 71.349999999999994 111.269 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -89.14 -56.45 3.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.859 0.838 . . . . 73.049999999999997 110.706 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -119.71 29.55 7.52 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.157 -0.929 . . . . 75.329999999999998 109.423 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.4 130.98 5.96 Favored Glycine 0 C--O 1.251 1.184 0 CA-C-N 114.238 -1.346 . . . . 73.239999999999995 113.486 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -66.93 143.43 56.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 125.66 1.584 . . . . 52.530000000000001 113.168 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 p -107.95 141.72 39.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.591 -1.186 . . . . 75.400000000000006 110.275 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.446 HG21 ' CD2' ' A' ' 80' ' ' TRP . 31.4 m -120.76 120.64 63.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.844 -1.539 . . . . 73.510000000000005 106.844 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 61.64 25.96 15.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.463 0.649 . . . . 73.230000000000004 109.621 -175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.8 t30 78.15 3.15 2.8 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.46 1.904 . . . . 75.319999999999993 111.358 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.73 124.02 51.85 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.371 -0.603 . . . . 74.430000000000007 109.371 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.14 125.94 11.92 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.248 1.966 . . . . 65.239999999999995 111.155 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.91 166.58 25.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 116.476 -0.329 . . . . 71.310000000000002 110.164 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.452 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 25.1 pt20 -100.67 -26.8 13.68 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.254 -0.646 . . . . 62.219999999999999 109.254 174.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 78' ' ' GLN . 10.6 pt-20 -158.52 148.96 20.05 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.785 -0.643 . . . . 72.140000000000001 109.814 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.446 ' CD2' HG21 ' A' ' 72' ' ' VAL . 53.7 t-105 -163.84 152.93 14.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.302 -0.999 . . . . 75.420000000000002 108.302 -172.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -105.67 121.31 43.73 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.321 -0.952 . . . . 73.549999999999997 109.07 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.62 151.09 47.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.205 -0.907 . . . . 73.349999999999994 113.106 -174.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.49 165.75 25.52 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.14 -1.43 . . . . 64.299999999999997 107.14 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.12 121.25 16.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.933 0.396 . . . . 64.430000000000007 109.969 178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.34 8.2 53.29 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.708 -0.678 . . . . 74.420000000000002 111.693 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.12 134.02 36.13 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 107.566 -1.272 . . . . 74.5 107.566 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -98.93 112.81 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.341 -0.614 . . . . 65.209999999999994 109.341 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.09 129.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 106.958 -1.497 . . . . 73.540000000000006 106.958 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -138.24 149.29 45.61 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.814 -0.754 . . . . 74.310000000000002 110.969 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.45 ' CD1' HD11 ' A' ' 40' ' ' LEU . 2.0 pt? -138.32 165.55 26.46 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.852 -2.277 . . . . 75.530000000000001 104.852 172.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -34.84 102.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.833 0 N-CA-C 115.98 1.152 . . . . 63.119999999999997 115.98 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 60.85 17.96 8.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.4 1.08 . . . . 64.109999999999999 113.908 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -131.6 114.01 14.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.819 -0.808 . . . . 72.409999999999997 108.819 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.06 139.8 49.92 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.586 0.708 . . . . 75.439999999999998 112.013 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.51 137.11 50.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.71 -1.132 . . . . 74.329999999999998 110.392 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.78 126.04 65.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.827 -0.805 . . . . 63.299999999999997 108.827 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.0 t -85.07 126.36 40.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.674 -0.239 . . . . 72.099999999999994 110.693 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -115.31 145.05 42.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.572 -0.529 . . . . 74.120000000000005 109.572 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 56.0 mtt -130.37 127.49 39.49 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.693 -0.685 . . . . 74.129999999999995 109.598 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 107.173 -1.417 . . . . 75.409999999999997 107.173 178.311 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.67 0 N-CA-C 111.731 -0.548 . . . . 74.040000000000006 111.731 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -105.05 -28.75 10.85 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.922 0.391 . . . . 74.439999999999998 110.349 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.62 -157.99 51.11 Favored Glycine 0 C--O 1.249 1.075 0 N-CA-C 110.861 -0.896 . . . . 61.100000000000001 110.861 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -88.3 84.22 6.87 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.04 -1.096 . . . . 73.099999999999994 108.04 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.55 36.61 0.65 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.118 -0.946 . . . . 74.450000000000003 108.669 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.45 -15.48 63.97 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.117 -0.947 . . . . 75.540000000000006 112.323 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m -57.42 115.9 3.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.204 0.526 . . . . 74.430000000000007 111.329 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -116.52 134.74 54.5 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.722 -1.214 . . . . 71.150000000000006 107.722 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 HG12 ' HB2' ' A' ' 23' ' ' LEU . 3.4 p -101.37 114.81 41.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.435 -0.95 . . . . 72.340000000000003 108.435 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.5 m -124.43 136.05 53.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 114.663 -1.153 . . . . 75.150000000000006 110.667 -169.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 20' ' ' THR . 57.7 mt -89.23 126.37 35.47 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.476 -1.238 . . . . 75.329999999999998 109.402 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.61 114.51 28.65 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.709 -1.219 . . . . 75.540000000000006 107.709 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 62.8 tp -118.07 110.99 18.31 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.671 -0.863 . . . . 65.209999999999994 108.671 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.06 100.26 12.41 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 117.764 -1.575 . . . . 65.319999999999993 109.629 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.6 30.43 3.61 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 106.382 -1.71 . . . . 72.530000000000001 106.382 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.5 47.08 17.18 Favored Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.177 -1.969 . . . . 74.019999999999996 108.177 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -162.81 -29.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.154 0.582 . . . . 72.129999999999995 111.785 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.91 3.46 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.692 -0.963 . . . . 72.239999999999995 110.692 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -87.95 148.21 24.68 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 110.062 -0.347 . . . . 73.450000000000003 110.062 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 22.9 p -135.45 132.24 37.18 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.076 0.465 . . . . 62.200000000000003 111.789 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -128.25 126.21 40.45 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.218 -1.401 . . . . 74.219999999999999 107.218 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -94.87 141.08 29.06 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.432 -0.507 . . . . 73.099999999999994 110.305 -175.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HB2' HG12 ' A' ' 9' ' ' VAL . 95.6 mt -80.48 140.82 35.72 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.605 -0.517 . . . . 75.400000000000006 109.605 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -96.61 169.06 10.15 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.387 -0.525 . . . . 65.340000000000003 110.274 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.62 112.99 11.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.265 0.978 . . . . 73.319999999999993 110.43 -178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.38 -159.65 23.19 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.124 -1.991 . . . . 62.299999999999997 108.124 -174.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.6 p -101.27 131.44 47.29 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.139 -1.024 . . . . 73.530000000000001 110.646 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 24.6 m-80 -106.67 112.33 25.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 74.099999999999994 107.774 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -96.95 126.1 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.401 -0.222 . . . . 74.129999999999995 110.401 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.06 142.97 31.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 C-N-CA 123.545 0.738 . . . . 64.040000000000006 109.837 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 153.49 -154.0 25.21 Favored Glycine 0 CA--C 1.475 -2.453 0 N-CA-C 110.683 -0.967 . . . . 63.109999999999999 110.683 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.547 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 16.7 mmm180 -131.73 104.83 7.12 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.256 0.55 . . . . 75.099999999999994 109.789 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 169.97 37.63 Favored Glycine 0 N--CA 1.41 -3.06 0 N-CA-C 108.99 -1.644 . . . . 71.450000000000003 108.99 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.16 -14.22 60.53 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.693 0.759 . . . . 74.319999999999993 109.701 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.19 -10.01 40.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.355 -0.838 . . . . 73.299999999999997 110.704 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -90.59 149.2 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.363 -0.606 . . . . 74.230000000000004 109.363 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 86.8 mt-30 -87.25 -49.28 7.37 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.742 -0.836 . . . . 75.510000000000005 108.742 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -105.44 111.42 24.13 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.397 -0.82 . . . . 73.349999999999994 109.069 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -91.16 122.55 33.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.477 -0.783 . . . . 63.240000000000002 110.725 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 79.9 mt -65.63 158.4 74.36 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.147 -0.933 . . . . 74.219999999999999 112.033 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.78 26.68 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.533 2.822 . . . . 73.450000000000003 112.161 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.72 153.38 47.19 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.181 -1.415 . . . . 73.510000000000005 107.181 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -121.39 161.32 22.34 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 120.235 -0.586 . . . . 73.329999999999998 109.625 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.56 -15.47 24.51 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 108.502 -1.839 . . . . 63.350000000000001 108.502 -172.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 51.9 t -76.93 149.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 125.449 1.5 . . . . 72.319999999999993 108.894 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.0 m -75.67 163.39 27.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 119.597 -0.24 . . . . 75.230000000000004 110.901 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 44.6 ptt85 -60.28 -41.39 93.21 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 120.94 0.4 . . . . 75.439999999999998 110.681 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -121.53 107.07 11.99 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 106.323 -1.732 . . . . 74.219999999999999 106.323 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -103.21 -34.04 8.97 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.654 -1.157 . . . . 75.129999999999995 108.945 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 tt -166.39 148.51 6.72 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 115.669 -0.696 . . . . 72.510000000000005 109.134 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.32 144.45 42.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.856 -0.794 . . . . 71.349999999999994 108.856 175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.4 mt -117.2 119.13 60.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 109.555 -0.535 . . . . 74.329999999999998 109.555 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -91.17 107.72 19.39 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.599 -1.259 . . . . 75.329999999999998 107.599 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -105.44 118.71 37.26 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.714 -0.675 . . . . 71.230000000000004 109.366 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.45 -178.84 4.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.564 -2.384 . . . . 73.420000000000002 104.564 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.3 53.42 4.78 Favored Glycine 0 C--N 1.297 -1.601 0 C-N-CA 119.856 -1.164 . . . . 42.43 112.721 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -147.74 -77.45 0.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.487 0.715 . . . . 73.349999999999994 109.333 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.61 159.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.043 -0.725 . . . . 65.109999999999999 109.043 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.93 107.84 19.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.111 -1.07 . . . . 74.329999999999998 108.111 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.88 113.27 20.38 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.377 -0.828 . . . . 70.109999999999999 108.828 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -90.29 119.59 30.72 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 124.805 1.242 . . . . 74.319999999999993 108.347 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.14 119.72 28.28 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.535 -0.543 . . . . 44.030000000000001 109.535 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 131.58 42.35 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.844 -0.617 . . . . 74.219999999999999 111.148 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.68 76.72 1.11 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.057 -0.719 . . . . 74.310000000000002 109.057 178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -176.43 139.9 0.35 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.527 -0.916 . . . . 54.509999999999998 108.527 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -108.25 -50.23 3.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.928 -0.397 . . . . 64.209999999999994 109.928 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -59.1 -49.03 79.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.65 0.738 . . . . 72.510000000000005 111.549 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -121.38 28.14 7.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.695 0.76 . . . . 74.299999999999997 109.28 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.95 144.65 9.7 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 113.83 -1.532 . . . . 74.400000000000006 115.182 -177.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.8 m -75.65 143.13 42.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.492 1.117 . . . . 72.109999999999999 112.063 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.9 p -110.91 148.83 31.61 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.813 -0.631 . . . . 74.409999999999997 111.043 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 88' ' ' ILE . 34.1 m -114.87 118.38 58.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.663 -1.236 . . . . 70.219999999999999 107.663 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.4 29.84 19.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.569 0.7 . . . . 72.329999999999998 110.415 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 77.62 13.26 1.86 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.198 1.799 . . . . 70.200000000000003 111.242 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.97 128.14 25.9 Favored Pre-proline 0 C--N 1.32 -0.706 0 O-C-N 121.859 -0.526 . . . . 73.299999999999997 109.598 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.19 125.74 11.69 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.689 2.259 . . . . 62.5 112.467 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.69 -177.2 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.125 -1.065 . . . . 72.349999999999994 108.125 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -125.39 -27.28 3.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.356 0.41 . . . . 72.209999999999994 110.784 175.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.76 134.47 28.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 74.299999999999997 109.727 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -149.13 152.15 35.61 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.917 -0.771 . . . . 74.140000000000001 108.917 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -101.7 107.52 18.77 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.468 -1.678 . . . . 71.219999999999999 106.468 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 82.9 mt -58.9 137.49 57.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.154 0.502 . . . . 75.150000000000006 112.054 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.01 163.47 24.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.859 -1.163 . . . . 74.349999999999994 107.859 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.91 117.93 8.31 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.426 -0.352 . . . . 74.420000000000002 110.204 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.48 -0.98 30.83 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.825 -0.702 . . . . 51.32 113.814 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -80.07 141.65 35.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.523 0.662 . . . . 73.329999999999998 111.305 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.22 113.77 39.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 N-CA-C 108.682 -0.859 . . . . 73.230000000000004 108.682 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.432 HG13 HG13 ' A' ' 72' ' ' VAL . 1.8 mp -107.34 114.16 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.661 -0.866 . . . . 75.540000000000006 108.661 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 94' ' ' GLU . 37.3 ttt180 -106.57 109.42 21.33 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.031 -1.067 . . . . 74.430000000000007 112.04 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -112.79 164.43 13.4 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.684 -1.599 . . . . 74.239999999999995 106.684 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -24.58 99.14 0.01 OUTLIER Glycine 0 N--CA 1.485 1.908 0 O-C-N 124.661 1.225 . . . . 73.219999999999999 116.092 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 t60 77.65 -28.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.79 1.636 . . . . 72.430000000000007 113.581 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 m -114.73 119.6 37.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 113.495 0.924 . . . . 73.430000000000007 113.495 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 6.8 pt-20 -94.16 115.11 27.35 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.661 -0.866 . . . . 74.200000000000003 108.661 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.483 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.0 tp -103.34 140.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.941 -1.027 . . . . 74.25 109.239 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.3 mt -101.68 121.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.063 -1.088 . . . . 74.420000000000002 108.063 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.5 t -87.6 118.3 33.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.463 -0.335 . . . . 75.349999999999994 110.167 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -119.58 150.55 40.11 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 109.524 -0.547 . . . . 74.409999999999997 109.524 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mtt -117.25 120.41 38.15 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.347 -0.982 . . . . 71.430000000000007 108.347 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 . . . . . 0 C--N 1.273 -2.726 0 N-CA-C 107.633 -1.247 . . . . 70.030000000000001 107.633 -177.17 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.154 0 N-CA-C 110.321 -1.112 . . . . 64.430000000000007 110.321 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -134.38 168.19 19.37 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 117.514 0.657 . . . . 73.099999999999994 110.199 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -118.9 163.09 13.27 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.62 -0.992 . . . . 72.409999999999997 110.62 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -76.52 102.78 6.2 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.592 -0.892 . . . . 72.140000000000001 108.592 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.29 79.18 1.87 Allowed 'General case' 0 N--CA 1.415 -2.178 0 CA-C-O 121.826 0.822 . . . . 63.340000000000003 110.713 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.84 -30.22 21.37 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.374 -1.491 . . . . 74.140000000000001 109.374 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -65.7 116.75 7.24 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 123.433 0.693 . . . . 75.540000000000006 109.317 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -144.53 131.85 20.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.371 -0.603 . . . . 63.020000000000003 109.371 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.16 113.23 35.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.579 -1.267 . . . . 71.129999999999995 107.579 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 129.55 55.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.26 -0.882 . . . . 73.209999999999994 109.719 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 20' ' ' THR . 83.5 mt -87.56 123.54 32.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.202 -1.036 . . . . 74.129999999999995 108.202 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.72 120.72 41.79 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 116.145 -0.479 . . . . 73.530000000000001 109.746 -175.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.67 146.89 51.42 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 107.289 -1.374 . . . . 73.420000000000002 107.289 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -95.23 118.36 31.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.817 -1.153 . . . . 74.329999999999998 110.986 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -103.15 -6.18 22.46 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.08 -1.418 . . . . 73.310000000000002 109.273 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.81 31.85 2.02 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.829 -1.708 . . . . 70.030000000000001 108.829 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.5 t 171.37 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.781 -1.933 . . . . 72.310000000000002 105.781 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.5 100.58 1.25 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.167 -1.016 . . . . 71.310000000000002 113.011 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.7 mtm-85 -86.21 158.68 19.68 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.81 -1.181 . . . . 73.209999999999994 107.81 176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.7 p -139.61 138.43 36.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 116.053 -0.521 . . . . 73.239999999999995 110.191 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.0 118.4 30.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.121 -1.437 . . . . 72.25 107.121 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -92.82 132.22 37.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.469 -0.937 . . . . 63.439999999999998 108.469 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.06 122.05 25.06 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.04 -0.356 . . . . 73.319999999999993 110.04 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -85.84 166.89 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.928 -1.138 . . . . 73.219999999999999 107.928 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -67.61 123.29 20.06 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.263 -0.643 . . . . 73.239999999999995 109.263 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.37 -163.94 14.69 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 110.041 -1.224 . . . . 40.420000000000002 110.041 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.9 p -99.46 141.13 32.65 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 117.947 0.873 . . . . 71.129999999999995 111.565 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -122.71 115.59 22.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.891 -1.522 . . . . 61.240000000000002 106.891 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -97.15 133.61 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.544 -0.298 . . . . 72.519999999999996 111.396 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.9 mt -107.73 133.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.574 -0.899 . . . . 72.030000000000001 108.574 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.4 -161.21 31.98 Favored Glycine 0 CA--C 1.49 -1.478 0 N-CA-C 110.756 -0.938 . . . . 72.109999999999999 110.756 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.6 mtm180 -123.37 105.8 10.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.158 -1.053 . . . . 75.310000000000002 108.158 174.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.05 -176.29 48.01 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 109.21 -1.556 . . . . 74.540000000000006 109.21 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -88.18 -16.12 34.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.409 0.623 . . . . 72.239999999999995 109.438 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.921 0.867 . . . . 72.230000000000004 109.781 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.75 145.41 28.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.739 -0.664 . . . . 75.140000000000001 110.72 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -105.11 -12.36 16.16 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.895 0.855 . . . . 75.219999999999999 109.764 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -139.77 121.81 15.7 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.91 -1.885 . . . . 63.240000000000002 105.91 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.7 ttt180 -100.37 131.54 46.24 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.333 -0.394 . . . . 75.430000000000007 111.426 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.2 mt -92.01 138.51 24.62 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.826 -0.625 . . . . 74.510000000000005 109.489 174.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -92.9 12.46 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 122.96 2.44 . . . . 74.439999999999998 111.691 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -93.31 -173.31 3.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.875 -0.602 . . . . 71.099999999999994 109.891 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -113.5 152.35 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.553 0.216 . . . . 73.129999999999995 111.139 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.74 86.92 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.237 0.354 . . . . 71.230000000000004 112.877 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.8 t -88.51 114.51 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.438 -0.578 . . . . 74.540000000000006 109.438 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -64.22 176.69 0.97 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 124.186 0.994 . . . . 73.420000000000002 110.894 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 23.7 ptt85 -63.8 -34.75 78.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.63 0.729 . . . . 74.140000000000001 109.818 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -120.67 109.16 14.88 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.659 -1.238 . . . . 73.439999999999998 107.659 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.426 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 18.9 t60 -103.33 -31.76 9.89 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.479 -0.934 . . . . 74.5 108.479 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 tt -167.3 152.94 7.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.536 -0.913 . . . . 75.239999999999995 108.536 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -135.34 140.41 45.06 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.293 0.568 . . . . 75.200000000000003 109.923 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.0 mt -115.89 114.21 45.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.9 -0.778 . . . . 72.439999999999998 108.9 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.47 110.23 21.64 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.949 -0.759 . . . . 74.409999999999997 108.949 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -99.93 108.66 20.95 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.769 -0.65 . . . . 74.209999999999994 111.295 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -107.81 162.57 13.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.595 -1.632 . . . . 73.319999999999993 106.595 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.67 66.72 1.06 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.847 0.699 . . . . 72.230000000000004 114.847 -175.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -169.22 -72.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.953 0.901 . . . . 73.319999999999993 108.978 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.57 159.15 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.51 -0.922 . . . . 73.109999999999999 108.51 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.83 120.81 40.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.416 0.627 . . . . 74.420000000000002 110.145 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.2 tp -80.93 125.46 30.15 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.868 -1.06 . . . . 73.349999999999994 109.882 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -111.62 120.55 42.45 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.315 -0.624 . . . . 73.129999999999995 109.315 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.98 124.53 40.95 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.407 -0.59 . . . . 75.519999999999996 109.407 176.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.71 133.8 38.0 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.396 -0.366 . . . . 74.129999999999995 111.157 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.61 76.41 1.34 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.803 -0.443 . . . . 72.129999999999995 109.803 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -173.0 133.61 0.54 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.292 0.496 . . . . 70.0 109.748 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -98.75 -35.75 10.05 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.116 0.484 . . . . 64.099999999999994 111.271 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -87.93 -32.48 18.89 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.23 0.538 . . . . 71.230000000000004 112.151 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -122.56 28.66 7.25 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.07 -0.394 . . . . 74.129999999999995 110.334 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.05 133.17 6.54 Favored Glycine 0 C--O 1.246 0.902 0 O-C-N 124.949 1.405 . . . . 75.129999999999995 113.985 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.1 m -74.11 136.68 42.96 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.906 0.882 . . . . 75.049999999999997 112.366 -174.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 28.2 p -111.13 143.68 41.48 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.896 -0.593 . . . . 70.409999999999997 110.49 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 80' ' ' TRP . 35.0 m -111.9 121.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.687 -1.597 . . . . 74.430000000000007 106.687 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.13 23.41 13.61 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.504 0.721 . . . . 64.400000000000006 110.023 -169.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 75.66 9.31 3.58 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.054 1.342 . . . . 72.129999999999995 110.866 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.43 124.04 50.29 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.246 -0.65 . . . . 70.349999999999994 109.246 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.72 126.76 15.9 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.116 2.544 . . . . 73.400000000000006 113.038 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 159.87 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.386 -0.825 . . . . 75.019999999999996 109.013 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.34 -19.7 14.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.1 -0.704 . . . . 74.430000000000007 109.1 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.74 149.43 34.38 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.387 -0.824 . . . . 75.120000000000005 110.289 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.464 ' CD2' HG22 ' A' ' 72' ' ' VAL . 77.3 t-105 -159.76 152.83 21.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.194 -0.669 . . . . 74.439999999999998 109.194 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.16 114.95 29.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.58 -1.267 . . . . 75.230000000000004 107.58 174.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.8 mt -56.92 132.83 53.81 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 112.953 0.723 . . . . 74.409999999999997 112.953 -174.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.49 155.37 39.06 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.382 -1.34 . . . . 61.049999999999997 107.382 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.52 128.3 35.68 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 123.24 0.337 . . . . 73.450000000000003 111.169 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.04 55.41 Favored Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 115.757 -0.656 . . . . 71.25 112.487 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.13 136.76 34.33 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 108.705 -0.85 . . . . 74.219999999999999 108.705 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.65 111.61 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.456 -1.313 . . . . 74.129999999999995 107.456 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 53.9 mt -107.67 118.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 CA-C-O 121.292 0.568 . . . . 72.439999999999998 109.554 -174.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.409 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 24.2 mtp180 -111.97 106.71 15.47 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.95 0.881 . . . . 74.420000000000002 110.439 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.426 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 0.5 OUTLIER -108.3 164.47 12.28 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.372 -1.286 . . . . 70.219999999999999 108.267 178.372 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -28.25 90.97 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 O-C-N 124.752 1.282 . . . . 71.439999999999998 115.837 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 60.68 11.78 3.32 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 125.86 1.664 . . . . 74.530000000000001 112.418 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 m -131.37 113.5 13.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.788 -0.819 . . . . 73.319999999999993 108.788 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -105.94 136.9 44.77 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.841 -0.744 . . . . 60.520000000000003 110.81 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.422 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 10.7 tp -129.72 146.31 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 108.741 -0.837 . . . . 75.140000000000001 108.741 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -111.97 133.24 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.622 -0.881 . . . . 74.5 108.622 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.0 t -90.9 114.54 28.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.901 -0.407 . . . . 65.310000000000002 109.901 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -114.49 122.44 46.58 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.002 -0.545 . . . . 75.120000000000005 110.315 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.7 mtt -101.93 125.9 48.71 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.37 -0.832 . . . . 74.049999999999997 110.573 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.293 -1.864 0 CA-C-N 114.519 -1.219 . . . . 73.409999999999997 108.877 178.502 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.796 0 N-CA-C 111.528 -0.629 . . . . 73.510000000000005 111.528 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -126.03 142.23 51.61 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.237 -0.653 . . . . 64.510000000000005 109.237 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.38 -16.42 80.62 Favored Glycine 0 C--N 1.313 -0.713 0 N-CA-C 111.206 -0.757 . . . . 63.25 111.206 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -57.97 -41.34 82.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.352 0.661 . . . . 62.420000000000002 110.024 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.24 104.42 16.38 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.141 -1.059 . . . . 64.439999999999998 108.141 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.04 -31.63 1.44 Allowed Glycine 0 C--N 1.3 -1.436 0 N-CA-C 109.716 -1.354 . . . . 70.430000000000007 109.716 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 m -146.04 116.63 7.6 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.811 -0.811 . . . . 74.340000000000003 108.811 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 17.4 m -123.41 146.75 47.74 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.338 -0.986 . . . . 74.129999999999995 108.338 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 23' ' ' LEU . 3.1 p -135.85 115.81 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 107.349 -1.352 . . . . 72.150000000000006 107.349 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -114.79 131.96 56.63 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.175 -1.375 . . . . 71.219999999999999 110.361 -170.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 pp -98.7 133.52 42.91 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.799 -0.815 . . . . 74.439999999999998 108.799 174.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -99.9 120.64 40.1 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.782 -0.644 . . . . 65.230000000000004 110.692 178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.5 tp -129.85 111.32 12.47 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.261 -0.882 . . . . 70.409999999999997 110.082 -174.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -89.0 100.58 13.33 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.04 -1.464 . . . . 53.409999999999997 108.848 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.61 9.62 40.97 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.699 -1.591 . . . . 61.43 108.568 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.4 -13.77 10.17 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.293 -0.867 . . . . 71.120000000000005 111.113 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 m -137.23 13.32 3.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.852 -0.174 . . . . 70.349999999999994 111.374 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.31 83.6 0.04 OUTLIER Glycine 0 C--N 1.345 1.079 0 N-CA-C 114.279 0.471 . . . . 73.510000000000005 114.279 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -98.77 144.38 28.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.281 0.562 . . . . 75.129999999999995 111.237 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 77.4 p -122.5 134.45 54.57 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.897 -1.149 . . . . 74.519999999999996 107.897 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -137.25 131.75 32.8 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.577 0.214 . . . . 74.319999999999993 111.577 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.39 136.07 38.38 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.846 -0.427 . . . . 74.409999999999997 109.846 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB2' HG12 ' A' ' 9' ' ' VAL . 43.8 mt -68.31 139.62 55.92 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.803 -0.635 . . . . 73.040000000000006 110.038 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -105.31 152.98 22.24 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.404 -0.591 . . . . 74.140000000000001 109.404 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.33 136.96 58.22 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 124.344 1.027 . . . . 74.420000000000002 111.518 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.49 -164.11 12.45 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.722 -2.151 . . . . 74.340000000000003 107.722 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.6 p -104.43 130.03 52.36 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.233 -1.387 . . . . 72.120000000000005 112.236 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -99.95 108.97 21.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 105.409 -2.071 . . . . 74.099999999999994 105.409 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.9 mt -98.57 130.34 47.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.886 -0.597 . . . . 72.040000000000006 110.948 -173.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.0 mt -101.99 123.4 55.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.143 -1.058 . . . . 72.540000000000006 108.143 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.4 -176.4 39.57 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.702 -1.359 . . . . 75.319999999999993 109.702 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -115.03 106.16 13.81 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 117.63 0.715 . . . . 73.319999999999993 109.309 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.56 177.49 44.65 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.509 -1.036 . . . . 73.019999999999996 110.509 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -81.19 -16.95 51.36 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.5 0.667 . . . . 73.430000000000007 109.622 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.61 -23.85 31.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.653 0.739 . . . . 74.430000000000007 110.086 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 47' ' ' ARG . . . -82.99 162.42 21.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.127 -0.942 . . . . 72.019999999999996 110.95 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -104.36 -58.46 1.88 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.811 -0.811 . . . . 62.200000000000003 108.811 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.35 129.95 46.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.575 -0.738 . . . . 75.540000000000006 109.16 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 24.8 mtm180 -108.37 131.13 55.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.103 -0.499 . . . . 75.120000000000005 110.364 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.64 142.36 57.27 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.382 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -89.1 27.79 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.032 2.488 . . . . 71.230000000000004 110.917 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -135.09 -177.7 4.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.959 -1.126 . . . . 74.400000000000006 107.959 -174.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -116.46 178.68 4.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.731 -0.84 . . . . 75.439999999999998 108.731 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.76 79.52 Favored Glycine 0 C--N 1.317 -0.476 0 N-CA-C 110.213 -1.155 . . . . 63.140000000000001 110.213 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.8 p -116.9 136.47 53.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 114.347 -0.927 . . . . 74.340000000000003 109.584 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -89.7 -164.43 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.821 -0.807 . . . . 72.219999999999999 108.821 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 36' ' ' ALA . 35.8 ptt180 -78.27 -30.42 48.49 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 118.767 -1.173 . . . . 73.200000000000003 108.557 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -121.87 108.03 12.98 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.038 -1.467 . . . . 72.140000000000001 107.038 170.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -104.21 -34.78 8.24 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.047 -1.094 . . . . 73.109999999999999 108.047 177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tt -165.42 142.92 5.83 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.976 -1.12 . . . . 73.5 107.976 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -131.14 129.88 42.37 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.508 0.67 . . . . 72.200000000000003 110.936 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.44 110.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 115.376 -0.829 . . . . 71.400000000000006 108.951 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 25.2 ttt180 -90.57 110.19 21.33 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.994 -0.743 . . . . 73.109999999999999 108.994 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -94.68 107.64 19.64 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.146 -1.057 . . . . 75.030000000000001 108.146 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.36 152.49 31.39 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 105.145 -2.169 . . . . 71.340000000000003 105.145 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.24 57.54 2.81 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 118.423 0.556 . . . . 71.120000000000005 112.365 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -159.22 -60.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.432 -1.322 . . . . 74.129999999999995 107.432 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.7 m -143.88 156.91 16.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 115.54 -0.755 . . . . 71.299999999999997 109.924 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.25 102.64 14.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.787 -1.19 . . . . 75.019999999999996 107.787 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.23 116.9 23.84 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.226 -0.897 . . . . 72.510000000000005 109.858 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -99.4 119.35 37.83 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.901 -1.148 . . . . 74.519999999999996 107.901 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.16 27.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.183 0.516 . . . . 73.310000000000002 110.307 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.413 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 5.9 t70 -85.99 138.87 31.67 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.887 0.875 . . . . 72.310000000000002 109.316 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.04 76.67 1.69 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -166.24 150.07 7.58 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.802 -0.561 . . . . 74.530000000000001 109.899 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 m -108.22 -30.28 8.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.207 0.527 . . . . 70.109999999999999 111.409 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.9 m -88.94 -60.29 2.0 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.145 0.974 . . . . 65.409999999999997 111.867 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -104.4 28.6 6.77 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 125.048 1.339 . . . . 73.340000000000003 109.519 -168.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.86 139.25 5.0 Favored Glycine 0 C--O 1.256 1.531 0 CA-C-N 114.017 -1.447 . . . . 71.530000000000001 113.71 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -83.61 155.74 23.07 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.13 0.972 . . . . 63.329999999999998 112.381 -172.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.4 p -118.98 153.71 34.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.952 -0.567 . . . . 74.209999999999994 110.261 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.405 HG11 HG13 ' A' ' 88' ' ' ILE . 35.6 m -116.6 116.28 51.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.816 -1.179 . . . . 62.409999999999997 107.816 175.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 62.36 27.1 16.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.018 0.913 . . . . 71.209999999999994 109.359 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.87 15.97 3.03 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.307 1.843 . . . . 74.049999999999997 111.26 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.23 123.74 38.7 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 108.693 -0.855 . . . . 73.200000000000003 108.693 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.62 124.4 9.28 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.173 1.915 . . . . 74.230000000000004 112.998 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.8 m -156.25 169.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 104.963 -2.236 . . . . 73.400000000000006 104.963 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.1 mt-30 -113.24 -6.23 13.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.394 -0.923 . . . . 74.230000000000004 112.536 175.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -151.43 140.59 21.25 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.163 -0.615 . . . . 73.420000000000002 111.909 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -163.29 152.56 14.82 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.205 -1.035 . . . . 74.540000000000006 108.205 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.59 116.7 33.13 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.777 -0.823 . . . . 71.409999999999997 108.777 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.6 mt -61.77 130.38 45.51 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.678 0.622 . . . . 74.140000000000001 112.678 -175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.526 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -126.78 167.84 15.23 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.88 -0.785 . . . . 72.219999999999999 108.88 173.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 26.2 t70 -60.55 124.45 20.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.465 -0.334 . . . . 71.519999999999996 110.634 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.9 -7.36 52.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.721 -0.752 . . . . 70.420000000000002 113.622 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -73.97 135.04 43.16 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 117.179 0.49 . . . . 74.099999999999994 111.488 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.92 113.07 39.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.718 -0.845 . . . . 74.239999999999995 108.718 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.499 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 1.8 mp -98.27 113.22 32.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 106.55 -1.648 . . . . 75.109999999999999 106.55 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -115.5 116.21 27.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.25 0.548 . . . . 74.299999999999997 111.193 -169.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -123.79 164.71 18.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.892 1.277 . . . . 71.439999999999998 108.365 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.39 113.8 0.9 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.642 0.617 . . . . 74.319999999999993 114.642 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.8 m80 64.82 7.13 3.69 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.85 1.26 . . . . 73.150000000000006 114.068 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.4 m -140.83 125.87 18.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.779 -0.369 . . . . 55.219999999999999 110.939 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.92 121.78 40.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.163 -0.68 . . . . 75.510000000000005 109.163 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.499 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 6.9 tp -109.74 125.7 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 N-CA-C 108.725 -0.843 . . . . 74.430000000000007 108.725 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.51 129.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.158 -0.682 . . . . 74.329999999999998 109.158 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.4 t -94.52 123.88 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.568 0.699 . . . . 71.239999999999995 111.961 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -112.92 119.24 37.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.043 -0.98 . . . . 73.209999999999994 108.677 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 85.6 mtp -107.1 120.99 43.59 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.298 -0.561 . . . . 74.150000000000006 110.591 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 28.4 m-70 . . . . . 0 C--N 1.283 -2.32 0 N-CA-C 107.137 -1.431 . . . . 75.439999999999998 107.137 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.545 0 N-CA-C 110.996 -0.842 . . . . 73.040000000000006 110.996 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -124.8 179.9 4.8 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 122.614 -0.345 . . . . 74.010000000000005 110.172 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.29 -59.88 4.8 Favored Glycine 0 C--N 1.316 -0.573 0 N-CA-C 110.533 -1.027 . . . . 75.209999999999994 110.533 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -151.57 133.41 14.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.769 -1.197 . . . . 75.0 107.769 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.47 104.2 9.91 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.845 0.355 . . . . 73.409999999999997 111.544 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.42 -27.87 50.2 Favored Glycine 0 C--N 1.316 -0.583 0 N-CA-C 110.419 -1.072 . . . . 71.430000000000007 110.419 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m -66.47 116.69 7.72 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.102 -0.703 . . . . 74.099999999999994 109.102 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.0 m -134.4 138.2 44.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.332 -0.618 . . . . 74.530000000000001 109.332 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.64 109.56 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.233 -1.395 . . . . 72.230000000000004 107.233 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.419 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 57.0 m -108.63 122.38 46.98 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.293 -1.003 . . . . 71.450000000000003 108.293 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 47.1 mt -87.7 128.7 35.3 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.672 -1.233 . . . . 73.140000000000001 107.672 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -100.97 117.64 35.41 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 107.055 -1.461 . . . . 74.519999999999996 107.055 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.3 tp -91.94 125.85 36.8 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.672 -0.695 . . . . 65.400000000000006 109.385 -175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.58 100.13 11.72 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 107.466 -1.309 . . . . 75.219999999999999 107.466 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -126.95 -14.01 5.64 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.768 -1.106 . . . . 54.439999999999998 109.701 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.41 -29.98 6.18 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.382 -1.087 . . . . 61.140000000000001 110.382 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -90.11 -35.03 15.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.123 -1.066 . . . . 64.439999999999998 108.123 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.39 57.93 2.39 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 109.85 -1.3 . . . . 74.439999999999998 109.85 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.9 mmp_? -87.51 162.88 16.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.562 -0.319 . . . . 75.219999999999999 110.304 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.9 p -128.59 143.4 50.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.872 0.368 . . . . 74.439999999999998 110.764 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -127.27 113.1 15.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.829 -0.804 . . . . 74.420000000000002 108.829 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.71 132.68 35.3 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.849 -0.797 . . . . 74.510000000000005 108.849 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 65.5 mt -59.89 132.13 53.02 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.051 0.845 . . . . 72.450000000000003 111.454 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.32 145.54 32.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.094 -1.076 . . . . 73.209999999999994 108.094 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.99 113.56 10.16 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.087 0.946 . . . . 73.420000000000002 109.901 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.83 -161.01 24.75 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 107.041 -2.424 . . . . 75.209999999999994 107.041 -173.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.2 p -107.56 137.69 45.13 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 118.449 1.125 . . . . 74.430000000000007 112.311 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -120.76 120.89 36.92 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.254 -0.647 . . . . 65.329999999999998 109.254 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.62 121.22 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.535 -0.913 . . . . 72.219999999999999 108.535 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 76.2 mt -97.96 130.01 47.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.005 -0.739 . . . . 71.219999999999999 109.005 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.97 -173.11 36.6 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 110.182 -1.167 . . . . 75.010000000000005 110.182 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.546 ' HD3' ' O ' ' A' ' 40' ' ' LEU . 25.9 mtm105 -124.08 107.22 11.04 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 117.678 0.739 . . . . 64.439999999999998 110.179 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.47 176.71 44.87 Favored Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.529 -1.028 . . . . 62.210000000000001 110.529 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -55.64 -32.22 62.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.954 0.902 . . . . 75.099999999999994 112.244 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -95.26 1.55 54.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.212 -0.449 . . . . 63.520000000000003 111.894 -173.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.03 149.76 24.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.039 0.447 . . . . 74.239999999999995 112.069 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -107.24 -57.77 2.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.867 0.867 . . . . 72.340000000000003 108.716 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 19.8 t80 -101.67 117.06 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.992 -1.855 . . . . 75.530000000000001 105.992 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 36.6 mtm180 -107.89 126.58 52.84 Favored 'General case' 0 C--N 1.279 -2.476 0 C-N-CA 120.445 -0.502 . . . . 71.430000000000007 111.573 -174.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.546 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 63.3 mt -75.45 148.75 83.49 Favored Pre-proline 0 C--O 1.21 -0.998 0 CA-C-N 115.756 -0.657 . . . . 74.209999999999994 109.434 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.57 11.65 2.84 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.476 2.118 . . . . 75.129999999999995 113.925 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -116.39 -177.37 3.16 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.427 -0.582 . . . . 74.430000000000007 109.427 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 m -128.69 149.65 50.59 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 123.234 0.614 . . . . 73.540000000000006 109.629 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -16.67 24.02 Favored Glycine 0 CA--C 1.495 -1.182 0 N-CA-C 108.548 -1.821 . . . . 62.009999999999998 108.548 -175.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.5 t -80.69 128.37 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.372 -1.414 . . . . 74.219999999999999 107.401 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -68.39 166.19 17.21 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 123.502 0.501 . . . . 71.230000000000004 112.104 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.3 ptt-85 -62.26 -37.63 86.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.58 0.705 . . . . 74.040000000000006 109.437 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 51' ' ' GLU . 21.7 mtp180 -126.22 95.8 4.5 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.725 -2.695 . . . . 74.510000000000005 103.725 169.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -92.12 -37.47 12.73 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.772 0.796 . . . . 72.219999999999999 109.148 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -161.75 150.02 15.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.094 -1.076 . . . . 61.340000000000003 108.094 -178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 48' ' ' ARG . 8.4 pt-20 -139.77 125.98 20.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.662 0.744 . . . . 72.219999999999999 111.313 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.99 121.89 52.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.045 -0.98 . . . . 64.519999999999996 108.36 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -106.25 107.18 18.05 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.716 -1.216 . . . . 74.219999999999999 107.716 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -108.65 121.19 44.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.954 0.883 . . . . 74.010000000000005 112.959 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -133.41 158.13 43.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.542 -1.651 . . . . 63.119999999999997 106.542 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.41 68.41 0.53 Allowed Glycine 0 C--N 1.314 -0.684 0 N-CA-C 114.772 0.669 . . . . 70.129999999999995 114.772 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -165.79 -70.72 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.727 -1.212 . . . . 74.0 107.727 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.57 150.99 29.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.802 0.334 . . . . 73.239999999999995 110.614 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.98 112.69 24.53 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.294 0.568 . . . . 75.129999999999995 109.494 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 tt -84.23 117.7 23.69 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.954 -1.021 . . . . 74.040000000000006 108.873 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -100.77 109.94 21.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.222 -1.399 . . . . 73.439999999999998 107.222 179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 111.09 21.09 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.264 0.554 . . . . 72.040000000000006 110.023 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 136.79 35.85 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.591 -0.892 . . . . 75.340000000000003 108.591 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.51 106.31 16.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.534 -0.913 . . . . 75.120000000000005 108.534 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.533 ' OD1' ' HB ' ' A' ' 67' ' ' THR . 28.7 t-20 69.78 89.47 0.1 Allowed 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.11 -0.95 . . . . 74.129999999999995 111.39 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.73 -18.14 64.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.956 . . . . 73.340000000000003 111.868 -175.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.533 ' HB ' ' OD1' ' A' ' 65' ' ' ASN . 18.5 m -46.44 -53.58 10.84 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 73.120000000000005 110.979 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -122.34 27.13 8.08 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.654 -1.61 . . . . 73.230000000000004 106.654 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.88 -144.91 17.91 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.337 -1.302 . . . . 64.219999999999999 115.854 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -107.4 156.47 18.9 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.124 -1.038 . . . . 74.510000000000005 112.842 -169.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 p -119.21 140.81 49.59 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.175 -0.921 . . . . 75.340000000000003 109.8 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 88' ' ' ILE . 35.9 m -114.91 115.74 50.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.712 -1.218 . . . . 74.200000000000003 107.712 177.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.99 28.63 18.41 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.844 0.831 . . . . 75.400000000000006 109.115 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 81.18 0.06 1.71 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.194 2.198 . . . . 74.310000000000002 111.603 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.41 121.34 58.76 Favored Pre-proline 0 C--N 1.316 -0.884 0 O-C-N 121.556 -0.715 . . . . 74.140000000000001 109.724 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -75.11 125.45 9.26 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.094 1.862 . . . . 75.150000000000006 110.941 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.78 161.65 18.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.0 -1.111 . . . . 73.299999999999997 108.0 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -88.5 -18.45 28.18 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.177 0.513 . . . . 64.420000000000002 111.518 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.73 152.39 17.7 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.2 -0.667 . . . . 74.439999999999998 109.2 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -154.52 151.76 29.28 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.589 -0.893 . . . . 75.420000000000002 108.589 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -101.93 108.26 19.66 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.53 -1.285 . . . . 63.43 107.53 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 86.5 mt -59.31 146.81 38.19 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.879 0.737 . . . . 73.439999999999998 112.068 -176.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.4 170.62 18.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.754 -1.202 . . . . 73.239999999999995 107.754 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.27 128.27 35.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.706 0.288 . . . . 72.109999999999999 111.127 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.76 2.74 57.29 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 120.967 -0.635 . . . . 64.329999999999998 112.933 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -85.17 134.03 34.18 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 120.192 -0.603 . . . . 75.120000000000005 110.573 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.27 114.86 41.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.723 -0.672 . . . . 72.400000000000006 109.466 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.64 109.6 26.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 N-CA-C 107.475 -1.305 . . . . 74.109999999999999 107.475 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.2 ttp85 -110.41 120.02 41.1 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.681 0.753 . . . . 74.299999999999997 110.207 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.94 165.0 15.23 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 114.63 -1.168 . . . . 75.310000000000002 108.559 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.98 100.97 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.405 0.922 . . . . 34.229999999999997 115.405 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.9 m170 71.54 17.99 5.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.279 1.432 . . . . 71.299999999999997 113.603 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.5 m -154.28 135.7 14.18 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.947 -0.47 . . . . 72.109999999999999 111.778 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.839 -0.538 . . . . 74.209999999999994 110.025 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.549 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.2 tp -126.9 137.34 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.812 -0.81 . . . . 74.310000000000002 108.812 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -107.45 127.37 63.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.46 -0.57 . . . . 74.519999999999996 109.46 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.3 t -85.15 119.98 34.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.142 0.496 . . . . 74.209999999999994 111.262 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -113.86 126.16 54.87 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.0 mtt -115.22 131.42 56.93 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.776 0.798 . . . . 74.230000000000004 111.416 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.419 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 78.6 m-70 . . . . . 0 C--N 1.279 -2.5 0 CA-C-N 114.385 -1.28 . . . . 73.319999999999993 108.123 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.966 0 N-CA-C 110.669 -0.972 . . . . 53.100000000000001 110.669 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -77.75 -59.86 2.61 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.608 -0.886 . . . . 63.520000000000003 108.608 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.2 137.32 2.17 Favored Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 115.381 -0.827 . . . . 63.119999999999997 111.435 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 m -87.81 -16.99 32.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.309 0.576 . . . . 71.0 109.587 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.49 92.81 2.96 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.312 -0.858 . . . . 72.510000000000005 108.816 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.44 80.59 0.26 Allowed Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 110.349 -1.1 . . . . 62.219999999999999 110.349 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 m -57.08 115.43 2.64 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.93 -0.767 . . . . 71.010000000000005 108.93 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -104.85 115.02 29.59 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.711 -0.848 . . . . 74.099999999999994 108.711 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.63 113.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.753 -1.203 . . . . 62.439999999999998 107.753 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -117.63 117.28 28.96 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.967 -0.753 . . . . 75.400000000000006 108.967 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.48 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -87.7 137.25 32.5 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 108.476 -0.935 . . . . 74.319999999999993 108.476 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -108.52 125.84 52.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.901 -0.778 . . . . 72.530000000000001 108.901 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -133.16 114.77 14.24 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.47 0.653 . . . . 75.319999999999993 110.968 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.9 102.17 13.5 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.106 -0.702 . . . . 64.430000000000007 109.106 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.64 10.77 37.59 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.57 1.176 . . . . 74.409999999999997 108.935 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.6 39.43 1.1 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.927 -1.269 . . . . 61.520000000000003 109.927 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -170.71 -61.87 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.983 -0.747 . . . . 61.329999999999998 108.983 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.09 92.58 1.56 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.012 -0.835 . . . . 70.319999999999993 111.012 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.444 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.5 mmp_? -123.65 165.63 16.89 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 122.21 -0.583 . . . . 74.099999999999994 110.858 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.2 p -136.45 149.16 48.09 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.946 -0.761 . . . . 63.210000000000001 108.946 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.426 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 88.3 t80 -140.34 119.69 13.02 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.879 -0.785 . . . . 64.349999999999994 108.879 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -85.13 134.11 34.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.052 -1.092 . . . . 74.430000000000007 108.052 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.83 131.12 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.654 0.596 . . . . 70.209999999999994 110.968 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -90.05 150.14 22.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.385 -1.339 . . . . 71.299999999999997 107.385 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.72 118.32 14.41 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.926 0.87 . . . . 62.520000000000003 111.333 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 -168.6 23.82 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 107.232 -2.347 . . . . 73.540000000000006 107.232 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.9 p -106.67 129.71 54.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 118.822 1.311 . . . . 71.409999999999997 110.687 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -110.54 129.27 55.83 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.209 -0.451 . . . . 65.109999999999999 109.849 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.4 mt -99.09 125.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.388 -0.597 . . . . 72.439999999999998 109.388 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.4 135.55 46.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.99 -0.744 . . . . 74.120000000000005 108.99 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 147.17 -168.06 28.34 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 110.566 -1.014 . . . . 73.140000000000001 110.566 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 mtm105 -116.31 106.6 13.84 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.536 -0.866 . . . . 75.319999999999993 110.868 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.21 177.84 46.27 Favored Glycine 0 N--CA 1.403 -3.563 0 N-CA-C 109.772 -1.331 . . . . 71.099999999999994 109.772 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -76.57 -20.13 57.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.653 0.74 . . . . 75.150000000000006 110.222 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.61 -29.11 19.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.165 -0.925 . . . . 72.099999999999994 109.511 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.09 142.31 57.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.855 -1.066 . . . . 51.009999999999998 110.62 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -94.98 -47.98 6.18 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.178 -1.045 . . . . 74.340000000000003 108.178 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -109.37 113.74 26.81 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.879 -1.055 . . . . 74.230000000000004 109.134 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.678 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mpt_? -90.01 113.5 25.2 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.747 -0.66 . . . . 63.009999999999998 111.677 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 mt -80.49 125.91 79.78 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.307 -0.406 . . . . 73.319999999999993 110.658 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 7.9 Cg_exo -69.83 6.92 1.15 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.243 2.629 . . . . 72.099999999999994 116.016 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.89 175.85 7.05 Favored 'General case' 0 C--O 1.252 1.184 0 O-C-N 121.187 -0.946 . . . . 75.5 110.141 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.476 ' HA ' HH21 ' A' ' 32' ' ' ARG . 25.0 m -113.15 138.71 49.55 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.229 -0.656 . . . . 74.349999999999994 109.229 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.58 -13.57 32.75 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 109.693 -1.363 . . . . 70.219999999999999 109.693 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 45.0 t -75.5 123.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 CA-C-N 114.081 -1.06 . . . . 64.150000000000006 108.639 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 m -75.56 171.91 13.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.964 -0.562 . . . . 65.019999999999996 111.878 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.9 ptm180 -61.01 -31.28 70.9 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.929 0.871 . . . . 72.319999999999993 110.464 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -134.58 99.86 4.47 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 103.446 -2.798 . . . . 72.439999999999998 103.446 171.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -96.18 -36.82 10.81 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.551 0.691 . . . . 74.450000000000003 109.42 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.4 tt -162.62 148.06 12.33 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 71.209999999999994 108.137 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.47 142.49 49.26 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 109.456 -0.572 . . . . 72.209999999999994 109.456 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.63 114.31 45.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.46 -0.941 . . . . 75.340000000000003 108.46 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.435 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 50.2 ttt180 -91.71 107.55 19.29 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.034 -1.098 . . . . 75.030000000000001 108.034 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -106.98 117.75 34.87 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.927 -0.579 . . . . 65.310000000000002 110.417 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.4 160.63 19.62 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.125 -1.806 . . . . 75.549999999999997 106.125 174.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.82 59.35 1.72 Allowed Glycine 0 C--N 1.305 -1.171 0 C-N-CA 121.406 -0.426 . . . . 74.409999999999997 113.48 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -171.19 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.216 1.007 . . . . 71.239999999999995 109.545 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -134.35 150.68 31.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.963 0.411 . . . . 73.519999999999996 111.288 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.32 104.95 14.68 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.165 -0.925 . . . . 75.510000000000005 108.614 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.1 tp -89.18 109.73 20.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.776 -1.102 . . . . 71.239999999999995 110.236 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.7 tm? -92.45 124.2 36.32 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.018 -1.104 . . . . 75.430000000000007 108.018 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.49 127.34 40.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.795 0.331 . . . . 65.329999999999998 110.403 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.73 129.26 43.0 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.853 0.861 . . . . 71.420000000000002 111.289 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.82 76.91 1.47 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.787 0.435 . . . . 72.439999999999998 110.184 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 179.95 114.79 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 108.587 -0.894 . . . . 72.129999999999995 108.587 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.3 m -83.78 -24.07 31.22 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.85 -0.531 . . . . 75.439999999999998 111.264 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -80.49 -58.82 2.94 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.354 0.597 . . . . 74.25 109.893 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -103.82 28.57 6.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.477 0.711 . . . . 74.25 110.363 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.37 131.24 5.9 Favored Glycine 0 C--O 1.242 0.644 0 O-C-N 124.703 1.252 . . . . 71.150000000000006 114.793 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 m -76.68 137.64 39.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 124.196 0.999 . . . . 72.150000000000006 112.095 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 25.3 p -107.13 149.55 27.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.206 -0.452 . . . . 74.549999999999997 110.339 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.412 HG23 ' CD2' ' A' ' 80' ' ' TRP . 30.4 m -114.0 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.865 -1.161 . . . . 74.209999999999994 107.865 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 62.16 26.82 16.13 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.201 -0.909 . . . . 72.200000000000003 109.9 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.54 26.04 0.9 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.324 1.85 . . . . 75.25 111.309 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.34 130.7 24.58 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.698 -0.683 . . . . 71.239999999999995 109.638 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.83 125.8 10.22 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.83 2.353 . . . . 53.420000000000002 113.372 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 28.0 m -142.63 166.43 15.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.004 -0.739 . . . . 74.340000000000003 109.004 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -106.41 -30.43 9.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.346 -0.388 . . . . 63.210000000000001 110.856 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 7.0 pt-20 -134.95 146.69 49.36 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.805 -0.813 . . . . 74.150000000000006 108.805 175.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.412 ' CD2' HG23 ' A' ' 72' ' ' VAL . 74.0 t-105 -157.06 148.96 22.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 75.040000000000006 109.727 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -99.99 105.2 16.86 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.028 -1.101 . . . . 71.430000000000007 108.028 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.9 mt -56.66 131.02 47.79 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 116.044 -0.525 . . . . 73.010000000000005 111.932 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.22 163.23 18.86 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.611 -0.885 . . . . 75.319999999999993 108.611 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.27 123.58 20.34 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.047 0.451 . . . . 75.510000000000005 109.786 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -8.69 44.62 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-N 115.93 -0.577 . . . . 64.129999999999995 112.48 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.98 133.27 47.09 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 117.11 0.455 . . . . 71.319999999999993 111.321 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 t -103.5 113.55 40.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.89 -0.781 . . . . 75.420000000000002 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.49 118.63 43.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 N-CA-C 107.049 -1.463 . . . . 75.230000000000004 107.049 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 60.6 mtp180 -118.66 129.87 55.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.492 0.663 . . . . 72.430000000000007 111.863 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.7 164.87 19.0 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 106.231 -1.766 . . . . 74.25 106.231 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.21 108.41 0.16 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 123.719 0.637 . . . . 74.5 113.107 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 77.81 -35.79 0.21 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.959 1.703 . . . . 62.520000000000003 113.152 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.6 m -100.0 130.33 46.15 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.9 -0.5 . . . . 74.349999999999994 111.059 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.78 147.63 49.98 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.002 0.43 . . . . 63.329999999999998 111.033 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.48 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.7 137.71 42.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.705 -0.68 . . . . 73.109999999999999 110.927 -175.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.91 125.86 64.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.604 -0.888 . . . . 74.340000000000003 108.604 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.7 t -87.67 121.68 38.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 110.82 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -121.24 143.04 49.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.697 -0.483 . . . . 72.430000000000007 109.697 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.05 140.04 50.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.048 -0.524 . . . . 65.340000000000003 109.928 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 . . . . . 0 C--N 1.287 -2.112 0 N-CA-C 107.772 -1.196 . . . . 73.340000000000003 107.772 177.136 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.187 0 N-CA-C 109.888 -1.285 . . . . 50.509999999999998 109.888 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -111.77 157.18 20.84 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 108.052 -1.092 . . . . 72.540000000000006 108.052 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.61 179.21 46.0 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 110.456 -1.058 . . . . 71.319999999999993 110.456 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m -85.73 152.04 23.38 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.163 -0.68 . . . . 73.140000000000001 109.163 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.67 -16.48 55.66 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.231 -1.025 . . . . 64.129999999999995 108.231 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.5 -37.54 3.77 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 109.592 -1.403 . . . . 44.310000000000002 109.592 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.6 m -146.78 134.83 21.5 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 106.273 -1.751 . . . . 73.049999999999997 106.273 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.426 ' HB3' ' NE2' ' A' ' 22' ' ' GLN . 18.7 m -107.17 114.29 28.25 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.108 -1.071 . . . . 74.219999999999999 108.108 176.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 23' ' ' LEU . 4.3 p -98.43 124.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.522 0.677 . . . . 72.420000000000002 109.708 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -128.7 130.17 46.78 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.521 -0.763 . . . . 73.409999999999997 109.817 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.41 136.39 33.01 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.449 -0.574 . . . . 75.310000000000002 109.449 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -122.74 134.03 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.572 0.749 . . . . 64.010000000000005 110.76 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -148.28 146.63 28.69 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.567 -1.642 . . . . 73.239999999999995 106.567 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -105.67 118.55 36.88 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 119.043 -1.063 . . . . 73.549999999999997 111.326 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -113.89 6.65 16.71 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.286 -1.325 . . . . 63.119999999999997 108.808 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.14 33.41 0.79 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.724 -0.751 . . . . 73.409999999999997 112.611 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p 176.85 -39.41 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.975 0.91 . . . . 72.420000000000002 110.339 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.98 93.72 2.21 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.867 -1.293 . . . . 73.329999999999998 109.867 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -88.47 149.01 23.89 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.103 -1.073 . . . . 74.310000000000002 108.103 -178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 24.1 p -146.35 132.33 19.2 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.821 0.701 . . . . 73.140000000000001 111.088 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -129.51 124.68 34.55 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.169 -1.419 . . . . 75.129999999999995 107.169 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.426 ' NE2' ' HB3' ' A' ' 8' ' ' SER . 35.6 tt0 -93.11 131.52 38.08 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 120.993 0.425 . . . . 74.030000000000001 110.686 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.1 mt -77.08 140.08 40.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.229 -0.896 . . . . 73.530000000000001 108.854 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.403 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 2.8 mpt_? -109.25 169.96 8.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.664 -1.236 . . . . 74.409999999999997 107.664 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.16 130.97 46.9 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.637 0.732 . . . . 75.420000000000002 111.666 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.79 -170.54 14.92 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.519 -1.833 . . . . 70.319999999999993 108.519 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -99.61 129.57 45.77 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 118.727 -1.189 . . . . 74.319999999999993 110.441 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -108.27 109.7 21.11 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.584 -1.265 . . . . 75.030000000000001 107.584 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.34 131.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.382 -0.827 . . . . 73.439999999999998 109.502 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.69 128.21 64.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 109.209 -0.663 . . . . 75.010000000000005 109.209 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.64 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 162.99 -171.44 38.77 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 110.795 -0.922 . . . . 72.219999999999999 110.795 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HG3' ' CG1' ' A' ' 45' ' ' VAL . 65.8 mtt180 -110.26 107.62 17.45 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 117.607 0.704 . . . . 74.319999999999993 109.91 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.68 177.14 45.41 Favored Glycine 0 N--CA 1.408 -3.172 0 N-CA-C 109.769 -1.332 . . . . 64.25 109.769 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -86.01 -22.99 27.0 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.866 -1.161 . . . . 72.230000000000004 107.866 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.65 -27.29 55.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.864 -1.062 . . . . 71.519999999999996 108.854 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 139.59 38.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.655 -1.157 . . . . 75.140000000000001 110.451 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -82.09 -45.52 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.497 0.665 . . . . 75.340000000000003 109.921 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -116.43 129.03 56.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.592 -0.892 . . . . 74.549999999999997 108.592 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -102.19 140.05 36.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.983 -0.553 . . . . 73.230000000000004 110.584 -178.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.23 147.77 39.16 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.343 -0.39 . . . . 72.329999999999998 111.038 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -86.0 8.28 4.59 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.948 2.432 . . . . 63.229999999999997 111.042 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -116.51 160.22 20.93 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.131 0.972 . . . . 73.239999999999995 108.835 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -111.51 -177.86 3.3 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.764 -0.374 . . . . 73.230000000000004 110.316 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.0 -11.8 71.31 Favored Glycine 0 CA--C 1.51 -0.229 0 N-CA-C 109.622 -1.391 . . . . 73.400000000000006 109.622 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' CG1' ' HG3' ' A' ' 32' ' ' ARG . 8.3 p -86.35 149.66 4.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 125.284 1.434 . . . . 71.200000000000003 110.094 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -97.4 -174.29 2.89 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 107.971 -1.122 . . . . 72.519999999999996 107.971 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -74.1 -37.6 64.11 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.884 -1.154 . . . . 71.439999999999998 107.884 175.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -115.47 94.05 4.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.504 -1.295 . . . . 75.340000000000003 107.504 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -105.24 -37.53 6.85 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.785 -1.098 . . . . 74.340000000000003 109.503 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -161.45 152.45 18.31 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.36 -0.978 . . . . 70.219999999999999 108.36 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -136.28 138.86 42.19 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.196 0.522 . . . . 75.120000000000005 109.86 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -110.61 114.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.965 -0.754 . . . . 75.239999999999995 108.965 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 63.7 ttt180 -90.42 109.54 20.66 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.101 -1.074 . . . . 74.019999999999996 108.101 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -107.71 114.94 29.25 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.422 -0.808 . . . . 73.129999999999995 110.958 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.98 167.75 13.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.678 -1.601 . . . . 75.219999999999999 106.678 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.7 72.79 1.49 Allowed Glycine 0 C--N 1.302 -1.328 0 C-N-CA 121.096 -0.573 . . . . 64.400000000000006 114.485 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -168.48 -71.42 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.844 0.858 . . . . 75.219999999999999 108.735 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.8 157.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.439 -0.948 . . . . 74.120000000000005 108.439 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HB2' ' HB2' ' A' ' 82' ' ' LEU . . . -97.83 119.12 35.86 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.446 -0.576 . . . . 72.0 109.446 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.2 tt -86.96 110.57 20.12 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.087 -1.079 . . . . 71.349999999999994 108.087 -177.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -90.47 114.62 26.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.334 -1.358 . . . . 73.099999999999994 107.334 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.99 115.72 24.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.935 0.398 . . . . 63.409999999999997 110.685 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.24 136.33 37.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.704 -0.68 . . . . 74.420000000000002 109.473 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -132.97 76.67 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.17 -1.048 . . . . 74.329999999999998 108.17 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -174.58 146.25 0.99 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.883 -0.784 . . . . 72.010000000000005 108.883 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -102.3 -32.93 9.8 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.494 0.553 . . . . 71.349999999999994 112.494 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -90.16 -37.69 14.01 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.853 0.686 . . . . 74.329999999999998 112.853 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -107.12 28.37 8.11 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.694 0.798 . . . . 72.230000000000004 110.102 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.65 124.42 4.86 Favored Glycine 0 N--CA 1.474 1.209 0 O-C-N 124.471 1.107 . . . . 74.219999999999999 113.616 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -67.95 146.24 53.77 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.581 1.152 . . . . 70.340000000000003 113.354 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.0 p -117.06 141.11 48.67 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.144 -0.935 . . . . 73.230000000000004 110.332 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.452 HG12 HG13 ' A' ' 88' ' ' ILE . 27.3 m -109.96 116.68 52.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.073 -1.084 . . . . 74.420000000000002 108.073 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 59.96 29.85 19.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.908 0.861 . . . . 73.540000000000006 109.253 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.7 t30 78.22 8.47 2.31 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.504 1.922 . . . . 75.150000000000006 111.357 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.79 122.24 49.82 Favored Pre-proline 0 C--N 1.318 -0.785 0 O-C-N 121.678 -0.639 . . . . 75.030000000000001 109.807 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.32 127.01 14.3 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 122.562 2.174 . . . . 71.219999999999999 111.903 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.69 168.26 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 122.488 0.315 . . . . 73.200000000000003 110.275 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.52 -34.58 10.93 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.375 -0.602 . . . . 74.430000000000007 109.375 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -148.23 153.84 39.27 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.843 -0.617 . . . . 75.219999999999999 109.717 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -157.32 151.34 24.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.274 -1.009 . . . . 75.120000000000005 108.274 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.281 0.8 OUTLIER -101.06 108.69 20.46 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-O 121.71 0.766 . . . . 74.5 111.192 174.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 86.1 mt -56.97 143.58 37.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.842 -1.072 . . . . 74.510000000000005 112.638 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.74 169.55 16.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.696 -1.224 . . . . 63.240000000000002 107.696 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -72.09 112.14 7.91 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.809 -0.441 . . . . 73.140000000000001 109.809 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.61 13.61 18.18 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.932 -0.652 . . . . 64.439999999999998 113.404 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -87.25 140.72 29.26 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 117.769 0.784 . . . . 73.230000000000004 110.863 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.81 113.36 36.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 N-CA-C 108.768 -0.827 . . . . 75.0 108.768 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.452 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.1 107.6 22.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 109.125 -0.694 . . . . 75.420000000000002 109.125 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.463 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 39.9 ttm180 -100.06 111.94 24.24 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.49 0.662 . . . . 73.230000000000004 110.95 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -115.82 164.33 14.54 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.177 -1.374 . . . . 72.400000000000006 107.445 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -36.68 99.55 0.01 OUTLIER Glycine 0 CA--C 1.535 1.343 0 N-CA-C 115.909 1.123 . . . . 71.400000000000006 115.909 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.9 m80 83.09 -1.32 1.21 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.346 1.858 . . . . 75.040000000000006 115.275 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -150.4 138.05 19.84 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.889 -1.124 . . . . 74.140000000000001 111.713 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.54 119.66 39.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.455 0.645 . . . . 73.109999999999999 109.566 176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.442 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.6 tp -103.6 139.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.295 -0.866 . . . . 71.129999999999995 109.124 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.88 129.31 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.054 -1.091 . . . . 72.25 108.054 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.411 HG12 ' HB3' ' A' ' 82' ' ' LEU . 69.9 t -95.88 120.46 45.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.482 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -117.01 150.91 37.83 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.313 -0.625 . . . . 70.349999999999994 109.313 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.0 mtt -126.44 122.17 34.52 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.711 0.767 . . . . 75.430000000000007 110.521 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 . . . . . 0 C--N 1.285 -2.214 0 N-CA-C 107.661 -1.237 . . . . 73.450000000000003 107.661 -178.0 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.913 0 N-CA-C 111.307 -0.717 . . . . 52.219999999999999 111.307 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -122.56 100.39 6.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.459 0.647 . . . . 74.409999999999997 109.904 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.22 29.49 2.92 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.145 -0.934 . . . . 55.140000000000001 111.304 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -120.4 157.64 28.87 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.767 -0.827 . . . . 73.25 108.767 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.21 155.95 39.92 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.272 -0.422 . . . . 75.219999999999999 110.321 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.36 63.59 2.94 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.169 -0.772 . . . . 64.329999999999998 111.169 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.3 m -141.7 115.79 9.34 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.711 -0.848 . . . . 70.209999999999994 108.711 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.0 p -121.71 118.87 30.18 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.454 -1.313 . . . . 75.299999999999997 107.454 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 p -96.64 123.19 48.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 122.201 1.001 . . . . 72.329999999999998 111.329 -173.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.564 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 19.7 m -118.21 129.5 55.53 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-N 114.179 -1.373 . . . . 74.420000000000002 108.277 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.44 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -92.61 130.0 38.38 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 108.373 -0.973 . . . . 73.230000000000004 108.373 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -101.11 114.98 29.42 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.397 -1.334 . . . . 74.019999999999996 107.397 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -111.36 124.9 53.19 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.163 -1.051 . . . . 72.340000000000003 108.163 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.57 101.44 11.31 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 117.081 -1.848 . . . . 72.030000000000001 111.959 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -83.24 -15.32 50.79 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.735 -1.575 . . . . 65.239999999999995 108.594 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.44 42.05 0.51 Allowed Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 107.362 -2.295 . . . . 73.030000000000001 107.362 -171.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -164.4 -25.85 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.725 -0.738 . . . . 73.129999999999995 111.794 -171.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 70.21 1.29 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 120.388 -0.91 . . . . 74.010000000000005 110.924 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -92.64 161.4 14.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.695 -0.483 . . . . 73.400000000000006 109.695 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.6 p -138.6 135.25 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.093 0.473 . . . . 71.430000000000007 110.507 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -130.76 117.2 19.05 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.141 -1.059 . . . . 74.129999999999995 108.141 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 32.5 tt0 -88.44 128.35 35.53 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.093 -0.643 . . . . 73.209999999999994 110.072 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.2 mt -64.88 136.83 57.3 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.124 -0.944 . . . . 74.400000000000006 112.064 -174.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -93.23 163.39 13.64 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.387 -1.279 . . . . 72.430000000000007 109.266 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.82 126.95 29.29 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.821 0.7 . . . . 74.219999999999999 111.156 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.42 -161.75 15.27 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.938 -0.865 . . . . 72.310000000000002 110.938 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 67.8 p -93.99 126.0 38.94 Favored 'General case' 0 N--CA 1.418 -2.043 0 C-N-CA 119.381 -0.927 . . . . 71.209999999999994 111.81 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.478 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.6 129.94 45.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.954 -1.869 . . . . 63.329999999999998 105.954 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.5 mm -106.72 137.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 112.187 0.44 . . . . 73.239999999999995 112.187 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.01 136.39 50.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.76 -1.2 . . . . 65.140000000000001 107.76 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.692 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.74 -152.15 24.14 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.068 -1.213 . . . . 65.209999999999994 110.068 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.667 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 76.5 mtt180 -131.91 106.46 8.08 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.216 1.008 . . . . 72.099999999999994 108.617 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.92 -168.1 40.19 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 119.739 -1.22 . . . . 74.140000000000001 111.974 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.6 -43.69 96.19 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.511 0.725 . . . . 74.340000000000003 109.914 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.25 -37.02 82.82 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 114.714 -1.13 . . . . 53.520000000000003 110.578 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.54 105.49 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 114.288 1.218 . . . . 74.239999999999995 114.288 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.478 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 44.5 mt-30 -77.14 -47.77 19.5 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.814 -1.539 . . . . 75.519999999999996 107.076 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -95.24 115.45 27.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.788 -1.56 . . . . 74.319999999999993 106.788 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 99.2 mtt180 -109.45 137.38 47.4 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 120.78 0.324 . . . . 75.549999999999997 111.602 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 72.7 mt -90.65 134.5 30.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.773 -0.648 . . . . 73.409999999999997 111.964 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 18.3 Cg_exo -71.29 -19.74 28.83 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.35 2.7 . . . . 74.319999999999993 113.593 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.11 178.5 6.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 122.221 -0.299 . . . . 75.040000000000006 111.713 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 85.2 m -109.55 168.15 9.61 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 108.328 -0.989 . . . . 75.010000000000005 108.328 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.5 9.45 53.03 Favored Glycine 0 CA--C 1.499 -0.955 0 N-CA-C 108.408 -1.877 . . . . 63.32 108.408 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 49' ' ' HIS . 7.4 p -118.3 120.74 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 CA-C-N 113.326 -1.437 . . . . 73.310000000000002 109.744 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 m -82.15 -170.0 2.67 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.279 -0.638 . . . . 74.319999999999993 109.279 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.667 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 40.6 ptt180 -65.2 -28.12 69.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.928 -0.709 . . . . 74.040000000000006 111.436 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 23.5 mtm180 -131.96 118.94 20.43 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.352 -0.981 . . . . 75.519999999999996 108.352 172.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.469 ' HB2' HG23 ' A' ' 45' ' ' VAL . 30.6 t60 -103.85 -31.03 9.99 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 124.43 1.092 . . . . 75.530000000000001 108.795 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.3 tt -167.31 147.46 5.37 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.904 -0.776 . . . . 74.150000000000006 108.904 -179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.12 136.88 49.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.857 0.723 . . . . 74.0 110.112 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 27' ' ' SER . 64.9 mt -115.51 110.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.036 -1.098 . . . . 73.329999999999998 108.036 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 41.8 ttm105 -91.32 106.97 18.88 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.689 0.757 . . . . 75.329999999999998 109.03 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -97.17 107.06 19.5 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.644 -1.162 . . . . 74.109999999999999 110.33 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -107.25 -179.73 4.01 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.642 -1.984 . . . . 61.240000000000002 105.642 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.01 3.7 69.63 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 119.931 -1.128 . . . . 65.219999999999999 112.266 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -97.07 -75.2 0.55 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 122.893 0.477 . . . . 75.519999999999996 110.554 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.07 160.67 23.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.656 0.782 . . . . 73.439999999999998 109.639 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.07 104.88 17.41 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.391 -0.966 . . . . 64.420000000000002 108.391 177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.2 tt -80.51 110.87 16.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.623 -1.171 . . . . 75.420000000000002 109.159 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.9 121.74 34.57 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.177 -1.046 . . . . 74.310000000000002 108.177 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.99 112.27 14.47 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.391 -0.596 . . . . 74.549999999999997 109.391 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.76 135.98 36.64 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.446 -0.946 . . . . 74.129999999999995 108.446 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.9 tp -133.83 76.6 1.67 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.508 0.67 . . . . 73.430000000000007 109.827 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -163.06 164.21 25.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.479 -1.304 . . . . 63.439999999999998 107.479 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.6 p -106.27 -54.19 2.51 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.768 0.318 . . . . 65.219999999999999 111.545 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -89.21 -35.79 16.01 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.685 0.994 . . . . 74.219999999999999 113.685 -171.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.536 ' OD1' ' HA3' ' A' ' 91' ' ' GLY . 64.2 t30 -114.26 27.5 9.44 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.044 -0.725 . . . . 75.540000000000006 109.044 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.15 136.59 25.35 Favored Glycine 0 C--O 1.245 0.814 0 CA-C-N 114.039 -1.437 . . . . 74.120000000000005 113.713 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 136.27 38.65 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 124.259 1.024 . . . . 73.510000000000005 110.899 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 142.06 35.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.297 -1.001 . . . . 73.530000000000001 108.297 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.436 HG12 HG13 ' A' ' 88' ' ' ILE . 29.7 m -117.2 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.682 -0.488 . . . . 73.319999999999993 109.682 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.15 35.76 25.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 74.019999999999996 110.521 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 65.12 23.18 12.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.279 1.432 . . . . 74.439999999999998 110.11 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.29 122.03 29.03 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.901 -0.778 . . . . 73.040000000000006 108.901 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.44 124.1 3.12 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 121.039 1.159 . . . . 71.430000000000007 111.797 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -144.18 179.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.803 -1.184 . . . . 73.549999999999997 107.803 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -104.16 -37.2 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 74.239999999999995 109.799 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -134.04 151.58 51.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.09 -0.707 . . . . 74.329999999999998 109.09 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -160.8 152.46 19.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.902 -1.148 . . . . 74.430000000000007 107.902 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.253 4.9 pp0? -109.98 113.06 25.47 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.809 -0.756 . . . . 75.319999999999993 110.162 173.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.7 mt -60.89 126.25 26.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.549 -1.205 . . . . 64.230000000000004 112.408 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.12 160.4 22.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.508 -0.923 . . . . 75.439999999999998 108.508 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 33.6 t70 -61.82 119.53 8.95 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 111.193 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.33 36.7 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.633 -0.712 . . . . 73.099999999999994 112.771 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.27 138.43 43.6 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 120.27 -0.572 . . . . 71.129999999999995 111.711 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -98.74 113.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.831 -0.803 . . . . 71.340000000000003 108.831 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.436 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -103.87 116.37 47.52 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 N-CA-C 107.277 -1.379 . . . . 74.019999999999996 107.277 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -114.51 121.71 44.34 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.709 -0.848 . . . . 73.430000000000007 108.709 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.69 162.87 18.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.441 -0.948 . . . . 72.219999999999999 108.441 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.536 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -76.97 87.13 0.97 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 119.038 -1.553 . . . . 70.310000000000002 110.694 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 t60 168.42 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.933 1.693 . . . . 64.420000000000002 108.366 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.7 p -168.15 -170.93 1.4 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.625 -0.716 . . . . 64.150000000000006 110.266 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.38 151.15 50.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.256 0.551 . . . . 71.349999999999994 109.979 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.44 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.95 142.24 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.056 -0.974 . . . . 74.319999999999993 110.833 -177.124 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.2 129.48 65.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.533 -0.914 . . . . 73.310000000000002 108.533 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.85 124.08 39.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.863 0.364 . . . . 71.510000000000005 110.231 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.427 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 12.9 mmm180 -123.66 135.07 53.7 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.576 -0.738 . . . . 74.140000000000001 110.324 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.1 mtt -113.66 124.88 53.37 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.534 0.683 . . . . 75.040000000000006 111.148 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.564 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 35.8 m-70 . . . . . 0 C--N 1.291 -1.943 0 N-CA-C 107.359 -1.349 . . . . 73.040000000000006 107.359 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.568 0 N-CA-C 109.785 -1.326 . . . . 53.140000000000001 109.785 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -81.92 149.91 27.99 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 117.375 0.587 . . . . 71.420000000000002 110.407 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.54 30.07 11.23 Favored Glycine 0 C--N 1.294 -1.772 0 N-CA-C 109.43 -1.468 . . . . 73.420000000000002 109.43 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m -60.67 133.22 55.88 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 124.258 1.023 . . . . 73.409999999999997 111.468 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.08 146.5 25.41 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.961 -1.126 . . . . 73.329999999999998 107.961 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -144.63 161.36 28.02 Favored Glycine 0 N--CA 1.426 -1.984 0 N-CA-C 109.542 -1.423 . . . . 75.519999999999996 109.542 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m -129.7 116.27 18.56 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 117.391 0.595 . . . . 75.019999999999996 109.934 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -125.12 139.34 53.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.51 -1.293 . . . . 65.030000000000001 107.51 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 p -117.13 122.01 69.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-O 121.787 0.803 . . . . 74.340000000000003 112.051 -174.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.502 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 13.2 m -113.21 131.58 55.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.954 -1.128 . . . . 75.25 107.954 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 21' ' ' TYR . 4.4 pp -102.95 135.47 44.57 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.336 -0.616 . . . . 75.510000000000005 109.336 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 24.1 mt-30 -102.09 119.07 38.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.391 -0.368 . . . . 75.129999999999995 110.082 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 tp -107.79 135.09 49.79 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.644 -0.707 . . . . 74.040000000000006 109.417 -175.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.47 99.21 12.11 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 118.673 -1.211 . . . . 75.120000000000005 108.63 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -108.8 38.93 2.13 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.049 -1.834 . . . . 73.239999999999995 106.049 176.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.07 -54.02 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.512 -1.222 . . . . 55.439999999999998 110.881 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -87.82 -26.81 22.64 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.715 0.769 . . . . 74.420000000000002 109.916 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.83 96.73 0.93 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.048 -1.221 . . . . 74.519999999999996 110.048 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.7 mtm180 -102.08 165.79 10.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.149 -0.686 . . . . 70.140000000000001 109.149 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.443 HG23 ' HG2' ' A' ' 12' ' ' GLN . 38.1 p -128.43 136.95 51.56 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 120.733 0.302 . . . . 73.310000000000002 110.474 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.453 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 82.3 t80 -128.36 123.53 34.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.344 -1.354 . . . . 73.409999999999997 107.344 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.0 tt0 -96.12 133.22 40.66 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.964 -0.754 . . . . 73.400000000000006 108.964 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 92.3 mt -73.46 143.58 46.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.824 -0.626 . . . . 73.439999999999998 109.787 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -108.4 152.11 25.12 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.512 -1.292 . . . . 75.319999999999993 107.512 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.68 126.76 28.49 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.538 0.685 . . . . 75.519999999999996 111.423 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.24 -169.37 19.11 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 107.254 -2.339 . . . . 55.329999999999998 107.254 -174.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -106.49 128.75 54.33 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 118.899 1.349 . . . . 72.219999999999999 110.239 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -110.34 146.35 35.92 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.104 -0.953 . . . . 64.200000000000003 108.56 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.4 mt -123.73 135.47 63.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 109.814 -0.439 . . . . 74.530000000000001 109.814 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 64.9 mt -107.5 134.71 48.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.28 -1.007 . . . . 72.439999999999998 108.28 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.701 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 156.75 -152.02 23.4 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 108.667 -1.773 . . . . 41.329999999999998 108.667 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.666 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 67.2 mtp180 -135.49 106.88 6.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.566 1.183 . . . . 74.030000000000001 109.23 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.81 171.85 41.67 Favored Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.497 -1.841 . . . . 62.119999999999997 108.497 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -77.02 -17.05 59.08 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.197 0.999 . . . . 74.120000000000005 110.696 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -94.05 -4.4 49.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.416 -0.811 . . . . 74.409999999999997 110.198 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.27 133.86 34.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 74.540000000000006 109.816 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.3 mm-40 -81.67 -57.85 3.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.748 -0.66 . . . . 70.019999999999996 109.706 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 84.2 t80 -101.31 110.23 22.2 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.825 -1.176 . . . . 75.150000000000006 107.825 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.701 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 90.8 mtt180 -96.52 123.1 40.08 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.548 -0.751 . . . . 74.510000000000005 111.27 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 55.8 mt -75.98 138.36 69.14 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.716 -0.674 . . . . 74.439999999999998 112.006 -177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.04 38.16 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.39 2.726 . . . . 75.310000000000002 112.668 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -134.92 173.22 11.95 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.95 -1.13 . . . . 74.310000000000002 107.95 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -122.34 155.87 35.1 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.988 -0.745 . . . . 73.340000000000003 108.988 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.06 -23.86 26.37 Favored Glycine 0 C--N 1.312 -0.775 0 N-CA-C 109.155 -1.578 . . . . 74.200000000000003 109.155 -174.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.48 141.16 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.87 -1.165 . . . . 71.540000000000006 109.637 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -76.3 -177.23 3.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.35 -0.841 . . . . 71.549999999999997 111.146 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.3 ptm180 -65.46 -39.87 92.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 74.129999999999995 109.861 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -126.2 119.85 28.54 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.176 -1.416 . . . . 75.219999999999999 107.176 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -105.33 -35.94 7.36 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.757 1.223 . . . . 52.420000000000002 109.641 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 9.1 tt -166.05 151.15 8.44 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 108.293 -1.003 . . . . 64.239999999999995 108.293 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -136.26 141.77 43.92 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.043 0.449 . . . . 64.109999999999999 110.323 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 70.0 mt -120.69 118.72 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 115.666 -0.697 . . . . 74.400000000000006 109.469 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.7 ttt180 -91.57 111.06 22.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.505 -1.295 . . . . 75.219999999999999 107.505 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -106.22 126.52 52.32 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.411 0.624 . . . . 73.109999999999999 109.793 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -139.0 172.42 12.87 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.422 -2.066 . . . . 71.340000000000003 105.422 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.7 69.32 2.39 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 120.761 -0.733 . . . . 73.329999999999998 112.311 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -162.88 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.46 -0.941 . . . . 75.319999999999993 108.46 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.17 159.5 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.779 -0.823 . . . . 73.329999999999998 108.779 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 82' ' ' LEU . . . -94.59 115.1 27.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.118 -0.697 . . . . 71.049999999999997 109.118 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 56.6 tp -85.64 110.44 19.28 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.351 -0.84 . . . . 63.310000000000002 111.212 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -89.6 128.25 36.01 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.237 -1.023 . . . . 74.219999999999999 108.237 -178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -136.12 122.65 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.103 -0.703 . . . . 70.109999999999999 109.103 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.27 129.68 37.24 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.625 0.578 . . . . 72.109999999999999 110.069 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.49 75.26 1.57 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.44 -0.345 . . . . 73.310000000000002 110.477 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t30 169.53 107.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.784 0.833 . . . . 72.140000000000001 109.679 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.9 t -78.53 -22.24 47.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.342 -0.39 . . . . 64.140000000000001 110.735 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -65.02 -45.82 83.9 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.109 0.481 . . . . 74.420000000000002 111.907 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -118.95 28.33 8.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.139 -0.689 . . . . 74.230000000000004 109.139 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.14 129.63 4.53 Favored Glycine 0 C--O 1.258 1.649 0 O-C-N 124.838 1.336 . . . . 70.439999999999998 115.045 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -80.0 145.79 32.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.926 -1.137 . . . . 70.439999999999998 112.466 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -121.29 142.53 49.86 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.308 -0.86 . . . . 64.430000000000007 110.542 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.516 HG22 ' CD2' ' A' ' 80' ' ' TRP . 35.6 m -117.53 119.46 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.684 -1.599 . . . . 73.319999999999993 106.684 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 62.24 24.58 14.64 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.035 0.934 . . . . 72.340000000000003 108.652 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 77.91 6.39 2.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.551 1.54 . . . . 75.420000000000002 112.854 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.63 118.26 66.15 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 74.019999999999996 108.795 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.76 125.28 11.47 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 121.552 1.501 . . . . 71.409999999999997 110.646 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.29 169.15 19.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.873 -0.788 . . . . 71.209999999999994 108.873 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -107.03 -20.16 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.353 . . . . 71.0 110.77 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.61 146.41 25.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.19 -0.67 . . . . 75.439999999999998 109.19 176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.516 ' CD2' HG22 ' A' ' 72' ' ' VAL . 66.7 t-105 -160.89 152.29 19.19 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.749 -0.834 . . . . 71.319999999999993 108.749 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -104.57 103.11 12.72 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.03 -0.73 . . . . 74.120000000000005 109.03 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 58.5 mt -59.52 145.04 45.6 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.967 -1.015 . . . . 71.099999999999994 111.414 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.01 169.51 17.67 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.123 -1.066 . . . . 73.299999999999997 108.123 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.83 119.12 12.0 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 123.346 0.404 . . . . 73.25 110.13 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.09 53.04 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.703 -0.68 . . . . 54.43 113.522 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -82.06 146.32 29.72 Favored 'General case' 0 C--O 1.255 1.384 0 N-CA-C 107.728 -1.212 . . . . 50.310000000000002 107.728 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.09 112.79 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.193 -0.669 . . . . 64.409999999999997 109.193 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.479 HG13 HG13 ' A' ' 72' ' ' VAL . 1.8 mp -105.71 127.58 60.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.283 -1.377 . . . . 74.340000000000003 107.283 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 90' ' ' LEU . 2.4 tmm_? -134.56 134.35 41.26 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.088 -1.079 . . . . 74.540000000000006 108.088 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.419 ' N ' ' HD2' ' A' ' 89' ' ' ARG . 2.0 pt? -127.31 162.47 26.18 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.476 -1.305 . . . . 74.400000000000006 107.476 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.4 86.98 0.51 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 119.158 -1.496 . . . . 75.109999999999999 111.148 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.0 t60 169.46 -48.79 0.01 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.145 1.778 . . . . 71.25 108.781 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.0 t -164.16 -175.37 3.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.938 -0.574 . . . . 71.140000000000001 110.111 -174.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -123.62 145.15 49.15 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.46 -0.941 . . . . 72.129999999999995 108.46 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -136.64 137.1 47.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.687 0.756 . . . . 75.400000000000006 111.843 -176.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.9 mt -107.62 131.65 57.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.488 -0.93 . . . . 73.040000000000006 108.488 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.6 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.622 0.249 . . . . 73.030000000000001 110.665 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -127.28 140.95 51.86 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.402 -0.363 . . . . 74.310000000000002 110.597 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.8 mtt -113.45 134.28 54.75 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.945 -0.57 . . . . 74.129999999999995 109.999 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.502 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 19.9 m-70 . . . . . 0 C--N 1.289 -2.038 0 N-CA-C 106.962 -1.496 . . . . 72.239999999999995 106.962 -177.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.146 0 N-CA-C 110.479 -1.049 . . . . 64.420000000000002 110.479 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.3 m170 64.99 84.49 0.15 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.393 1.077 . . . . 64.109999999999999 110.754 -176.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.07 -99.51 1.55 Allowed Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 115.412 -0.813 . . . . 73.209999999999994 111.711 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.663 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 31.8 m -74.27 -41.11 61.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 113.075 0.769 . . . . 55.409999999999997 113.075 -176.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.38 34.14 20.69 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.148 -1.056 . . . . 51.039999999999999 108.148 -174.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.63 -94.75 0.75 Allowed Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.165 -1.574 . . . . 71.120000000000005 109.165 -174.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.0 m -119.98 124.96 47.22 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 117.131 0.466 . . . . 75.329999999999998 109.743 176.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.663 ' OG ' ' HA ' ' A' ' 4' ' ' SER . 15.2 m -85.07 115.11 22.69 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.616 -1.253 . . . . 72.329999999999998 107.616 174.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.44 106.85 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.846 -1.909 . . . . 71.420000000000002 105.846 174.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.6 m -113.97 119.36 36.95 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.496 -0.775 . . . . 73.510000000000005 109.216 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 3.2 pp -91.72 130.7 37.46 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.523 -0.762 . . . . 75.340000000000003 110.805 178.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.69 119.63 39.84 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.275 -1.33 . . . . 73.299999999999997 107.579 -175.185 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -107.5 116.91 32.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.508 -0.553 . . . . 75.310000000000002 109.508 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.98 99.52 12.21 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.642 -1.614 . . . . 62.219999999999999 106.642 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -115.06 -19.06 11.04 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.309 -1.314 . . . . 65.430000000000007 109.868 -177.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.2 4.85 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 110.757 -0.937 . . . . 63.009999999999998 110.757 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 t -122.29 -33.88 3.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.321 -0.622 . . . . 60.009999999999998 109.321 175.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.03 79.13 1.38 Allowed Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.463 -1.855 . . . . 70.209999999999994 108.463 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -89.51 145.46 25.27 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.883 -0.414 . . . . 75.109999999999999 109.883 -176.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.3 p -134.16 135.29 43.0 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.102 0.477 . . . . 72.239999999999995 111.211 -176.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -139.03 120.42 14.91 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.75 -0.659 . . . . 74.439999999999998 110.69 178.078 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -83.46 127.23 33.53 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.523 -0.917 . . . . 73.420000000000002 108.523 176.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.78 149.33 50.7 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.05 -0.523 . . . . 74.109999999999999 111.019 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -102.64 162.38 12.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.199 -1.408 . . . . 72.25 107.199 173.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.88 145.66 51.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.215 -0.661 . . . . 74.109999999999999 109.215 177.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.51 -168.2 15.25 Favored Glycine 0 N--CA 1.412 -2.936 0 N-CA-C 106.887 -2.485 . . . . 71.340000000000003 106.887 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 30.0 p -103.03 130.95 50.32 Favored 'General case' 0 C--N 1.27 -2.853 0 C-N-CA 118.499 -1.28 . . . . 72.310000000000002 111.519 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.508 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -102.35 110.42 22.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.843 -1.91 . . . . 75.040000000000006 105.843 -179.009 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.2 mt -97.86 132.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 120.929 0.395 . . . . 75.420000000000002 111.538 -173.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.44 133.69 55.05 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 C-N-CA 123.846 0.858 . . . . 75.109999999999999 109.601 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.465 ' HA2' ' CG2' ' A' ' 45' ' ' VAL . . . 151.54 -173.75 30.82 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.686 -0.966 . . . . 73.340000000000003 110.686 177.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 97.5 mtt180 -118.19 104.23 10.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.119 -1.437 . . . . 74.109999999999999 107.119 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 -176.93 48.05 Favored Glycine 0 N--CA 1.42 -2.427 0 N-CA-C 111.401 -0.68 . . . . 72.120000000000005 111.401 -175.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.466 ' HG3' ' N ' ' A' ' 35' ' ' ASP . 10.4 pt20 -58.74 -49.6 77.02 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 124.016 0.926 . . . . 71.040000000000006 113.135 -176.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 13.5 m-20 -81.8 -19.87 40.29 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.203 0.525 . . . . 63.020000000000003 111.016 -172.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.62 145.5 45.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.572 -0.74 . . . . 75.239999999999995 112.12 -174.785 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -106.81 -55.84 2.27 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.014 -0.994 . . . . 74.540000000000006 108.667 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -95.0 125.37 39.62 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.809 -1.087 . . . . 74.010000000000005 109.872 -177.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -97.7 144.59 27.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.344 -0.984 . . . . 72.439999999999998 108.344 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 58.2 mt -94.56 131.16 31.47 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 109.489 -0.56 . . . . 73.409999999999997 109.489 173.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 21.2 Cg_exo -67.54 -26.48 40.12 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.112 2.542 . . . . 74.340000000000003 112.605 -178.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 168.38 11.4 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.349 -0.387 . . . . 60.399999999999999 110.633 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -84.68 -177.05 6.49 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.021 -0.733 . . . . 74.239999999999995 109.021 178.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.91 66.9 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.138 -0.785 . . . . 71.530000000000001 111.138 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.465 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 11.1 p -90.15 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.284 -0.958 . . . . 73.219999999999999 109.356 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -102.38 -174.07 2.48 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.861 -0.422 . . . . 75.209999999999994 109.861 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 36.1 ptt180 -64.43 -41.6 96.5 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.891 0.853 . . . . 73.530000000000001 110.269 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -129.26 107.75 9.79 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 104.012 -2.588 . . . . 74.329999999999998 104.012 172.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -101.35 -37.36 8.51 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.935 0.772 . . . . 72.420000000000002 109.145 -176.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -165.09 147.97 8.22 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.996 -0.547 . . . . 64.409999999999997 109.896 -177.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -133.27 132.45 41.42 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.491 -0.559 . . . . 71.129999999999995 109.491 176.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.5 mt -106.76 113.62 43.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 108.843 -0.799 . . . . 74.140000000000001 108.843 176.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 29.9 ttt180 -91.25 111.43 22.91 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.482 0.658 . . . . 72.510000000000005 109.541 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -104.4 127.45 52.08 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.47 -0.786 . . . . 75.420000000000002 110.567 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -132.14 172.73 12.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.531 -2.026 . . . . 74.219999999999999 105.531 176.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.67 53.09 3.97 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.684 -0.769 . . . . 74.439999999999998 111.681 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -140.79 -80.48 0.26 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 124.728 1.211 . . . . 71.510000000000005 107.784 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.34 160.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 C-N-CA 125.326 1.45 . . . . 65.5 107.1 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.428 ' HB1' ' HB2' ' A' ' 82' ' ' LEU . . . -91.24 115.49 28.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.47 0.652 . . . . 72.219999999999999 109.604 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 tp -85.17 114.12 22.05 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.07 -0.968 . . . . 73.510000000000005 110.5 -177.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -92.11 113.49 25.77 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.641 -1.244 . . . . 74.430000000000007 107.641 -179.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.75 121.14 39.39 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.826 -0.435 . . . . 75.420000000000002 109.826 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -91.48 133.0 35.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.627 -0.715 . . . . 74.5 111.43 -177.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -123.55 76.12 1.39 Allowed 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.645 -0.872 . . . . 64.019999999999996 108.645 173.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -173.7 112.14 0.19 Allowed 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 109.048 -0.723 . . . . 75.230000000000004 109.048 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -84.31 -17.67 38.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.322 0.49 . . . . 62.340000000000003 112.322 -178.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -89.19 -55.93 3.47 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.424 0.63 . . . . 75.219999999999999 111.084 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -110.5 29.57 7.59 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.659 0.784 . . . . 75.409999999999997 109.905 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.48 141.49 2.5 Favored Glycine 0 C--O 1.258 1.632 0 O-C-N 125.018 1.449 . . . . 73.450000000000003 115.745 -175.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.2 m -65.29 135.36 55.25 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.466 -1.367 . . . . 75.329999999999998 112.463 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 75' ' ' ALA . 1.3 m -113.37 139.84 48.54 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.594 -1.632 . . . . 74.209999999999994 106.594 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.451 HG11 HG13 ' A' ' 88' ' ' ILE . 29.2 m -120.26 121.24 65.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.228 -0.656 . . . . 71.430000000000007 109.228 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 58.35 29.88 18.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.829 0.824 . . . . 74.540000000000006 110.319 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t30 76.9 23.78 0.96 Allowed 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 126.07 1.748 . . . . 74.439999999999998 111.05 179.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.401 ' N ' HG21 ' A' ' 71' ' ' THR . . . -125.82 118.04 24.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 121.752 -0.593 . . . . 73.219999999999999 110.144 177.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.86 133.4 31.29 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.566 2.177 . . . . 74.120000000000005 112.177 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.23 169.14 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 75.329999999999998 110.199 -177.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -102.81 -21.47 14.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.387 -0.968 . . . . 61.149999999999999 108.387 174.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -157.78 155.63 30.14 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.254 -1.017 . . . . 74.010000000000005 108.254 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -161.0 151.99 18.63 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 72.120000000000005 108.741 -178.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.97 103.46 14.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.764 -0.828 . . . . 72.439999999999998 108.764 176.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.428 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 89.8 mt -57.6 139.99 52.16 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.93 0.715 . . . . 61.32 112.93 -176.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.9 166.6 23.25 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.814 -1.18 . . . . 63.020000000000003 107.814 173.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.15 118.78 9.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.872 0.368 . . . . 72.120000000000005 110.854 -179.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.15 35.71 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.004 -0.617 . . . . 45.539999999999999 113.134 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -87.1 136.51 32.9 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.909 -0.716 . . . . 74.230000000000004 109.874 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 t -100.33 113.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.074 -0.713 . . . . 74.200000000000003 109.074 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.451 HG13 HG11 ' A' ' 72' ' ' VAL . 1.8 mp -102.71 111.95 34.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.972 -0.751 . . . . 74.329999999999998 108.972 -178.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -107.63 119.96 40.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.627 -0.715 . . . . 72.0 110.104 -178.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -125.27 164.3 20.65 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.405 -0.816 . . . . 74.530000000000001 108.942 -176.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.75 112.06 0.62 Allowed Glycine 0 CA--C 1.529 0.938 0 O-C-N 123.574 0.546 . . . . 52.229999999999997 113.315 178.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 71.7 6.67 5.74 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.399 1.479 . . . . 74.099999999999994 114.834 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.7 t -149.2 163.35 37.88 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.794 -0.762 . . . . 61.420000000000002 111.241 -177.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.88 126.36 13.22 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.518 -0.919 . . . . 74.430000000000007 108.518 176.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.517 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 7.9 tp -124.42 138.04 55.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.62 -0.718 . . . . 74.129999999999995 109.071 -173.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.8 125.15 65.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.859 -0.793 . . . . 75.040000000000006 108.859 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -89.87 121.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.706 0.288 . . . . 63.009999999999998 111.423 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -120.36 151.22 39.56 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.199 -0.667 . . . . 74.200000000000003 109.199 176.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.1 mtt -125.42 145.61 49.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.274 0.559 . . . . 71.140000000000001 111.597 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.441 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 12.3 m-70 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 107.932 -1.136 . . . . 75.450000000000003 107.932 178.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.761 0 N-CA-C 111.24 -0.744 . . . . 43.240000000000002 111.24 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -60.31 114.6 3.0 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.85 0.833 . . . . 72.420000000000002 111.765 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.15 -20.7 37.4 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.75 -0.738 . . . . 72.150000000000006 111.445 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.1 m -84.24 69.72 10.48 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.426 1.108 . . . . 72.450000000000003 109.592 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.12 165.74 33.83 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 105.878 -1.897 . . . . 54.109999999999999 105.878 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 141.28 -162.2 26.86 Favored Glycine 0 C--N 1.284 -2.326 0 N-CA-C 109.002 -1.639 . . . . 54.530000000000001 109.002 -177.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m -142.54 119.31 11.16 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 117.059 0.43 . . . . 75.239999999999995 110.457 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 m -93.05 115.29 27.97 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 106.966 -1.494 . . . . 72.239999999999995 106.966 174.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -105.51 120.79 56.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.895 0.855 . . . . 75.049999999999997 110.447 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 11.6 m -119.6 137.68 53.7 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.864 -1.062 . . . . 61.439999999999998 109.624 -172.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -97.55 136.68 37.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.333 -0.618 . . . . 72.409999999999997 109.333 178.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 115.87 28.72 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.584 -1.635 . . . . 71.319999999999993 106.584 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.79 134.71 49.53 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.986 -0.552 . . . . 73.5 111.826 -175.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.42 99.9 5.03 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.08 -1.822 . . . . 54.130000000000003 106.08 171.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -114.78 8.17 16.01 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 113.82 -1.537 . . . . 70.140000000000001 110.206 -176.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.82 -48.03 0.99 Allowed Glycine 0 CA--C 1.491 -1.457 0 N-CA-C 109.358 -1.497 . . . . 70.109999999999999 109.358 -176.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -127.35 -39.57 1.87 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.967 -0.753 . . . . 70.230000000000004 108.967 175.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.97 116.8 1.61 Allowed Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 120.41 -0.9 . . . . 70.129999999999995 111.869 177.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.5 mtm105 -118.61 156.73 28.68 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.28 -0.267 . . . . 74.129999999999995 110.28 175.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.5 p -126.36 152.88 45.68 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.067 -0.515 . . . . 74.430000000000007 110.587 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -148.02 131.58 16.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.698 -1.593 . . . . 74.310000000000002 106.698 176.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 21.0 tt0 -91.94 131.37 37.3 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.917 -0.713 . . . . 74.239999999999995 109.785 -178.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.468 ' HB2' HG12 ' A' ' 9' ' ' VAL . 96.8 mt -68.51 147.15 52.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.744 . . . . 71.209999999999994 108.99 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -118.25 150.57 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.801 -0.814 . . . . 74.439999999999998 108.801 -177.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.32 116.97 2.7 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.97 1.418 . . . . 73.450000000000003 112.75 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.0 -172.67 20.08 Favored Glycine 0 N--CA 1.418 -2.524 0 N-CA-C 107.585 -2.206 . . . . 74.129999999999995 107.585 -174.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 33.6 p -106.72 134.25 50.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 118.487 1.144 . . . . 74.549999999999997 111.175 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -106.02 122.13 45.53 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.06 -0.718 . . . . 74.409999999999997 109.06 178.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.1 mm -88.86 121.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.358 -0.837 . . . . 74.540000000000006 108.997 -177.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 75.5 mt -103.12 126.12 57.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 74.129999999999995 108.725 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.41 -159.56 32.49 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 110.282 -1.127 . . . . 44.439999999999998 110.282 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.7 mtp180 -129.45 105.36 8.05 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.575 -0.898 . . . . 73.540000000000006 108.575 175.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.52 -164.54 34.31 Favored Glycine 0 N--CA 1.415 -2.717 0 N-CA-C 110.527 -1.029 . . . . 75.099999999999994 110.527 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -79.14 -38.47 35.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.21 -0.663 . . . . 73.299999999999997 109.21 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.48 -37.03 84.21 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.954 . . . . 74.310000000000002 109.552 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.96 118.56 7.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 114.137 -1.392 . . . . 72.150000000000006 111.894 -176.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -90.25 -37.47 14.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.402 -1.333 . . . . 73.310000000000002 107.402 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 34.7 t80 -107.1 114.19 28.1 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.184 -2.154 . . . . 73.239999999999995 105.184 176.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.587 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 92.9 mtt180 -106.9 131.55 53.85 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.939 -0.573 . . . . 75.439999999999998 110.899 -171.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.94 144.42 41.71 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.554 -0.748 . . . . 71.319999999999993 111.5 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -89.46 5.62 4.71 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.761 2.307 . . . . 74.409999999999997 114.3 -178.468 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.66 -176.12 3.17 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.884 -0.726 . . . . 71.400000000000006 109.317 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -106.3 175.97 5.32 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.7 0.286 . . . . 72.409999999999997 110.758 -174.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.84 80.88 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 110.763 -0.935 . . . . 73.340000000000003 110.763 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.446 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 22.5 t -103.69 130.19 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 114.903 -0.648 . . . . 73.230000000000004 109.915 -175.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 178.59 7.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.032 -0.729 . . . . 61.140000000000001 109.032 177.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 16.9 ptm180 -67.81 -31.16 70.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.702 0.763 . . . . 74.319999999999993 109.791 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -133.71 100.53 4.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.166 -2.161 . . . . 75.099999999999994 105.166 172.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -94.71 -38.5 10.78 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.091 -0.707 . . . . 73.040000000000006 109.091 -178.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.93 156.42 19.89 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.892 -1.151 . . . . 74.450000000000003 107.892 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -137.04 147.47 46.2 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 109.027 -0.731 . . . . 71.109999999999999 109.027 176.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.3 mt -116.14 111.29 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 107.948 -1.13 . . . . 73.310000000000002 107.948 174.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.442 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.6 ttt180 -91.23 115.48 28.06 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.843 -1.169 . . . . 73.239999999999995 107.843 175.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -108.67 106.8 17.01 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 108.573 -0.899 . . . . 73.019999999999996 108.573 176.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.38 172.42 6.97 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 105.471 -2.048 . . . . 71.420000000000002 105.471 177.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 63.15 4.44 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 120.25 -0.976 . . . . 75.299999999999997 112.004 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -162.92 -68.55 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 61.399999999999999 108.795 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.8 m -137.99 157.08 32.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 109.877 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.31 106.08 18.09 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.479 -0.934 . . . . 74.340000000000003 108.479 178.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.7 tt -90.01 115.15 27.08 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.113 -0.949 . . . . 75.519999999999996 108.987 -174.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.2 117.6 31.77 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.705 -1.591 . . . . 75.340000000000003 106.705 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.63 33.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.86 -0.422 . . . . 75.5 109.86 178.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -95.7 128.17 42.35 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.117 -0.698 . . . . 74.329999999999998 109.117 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.47 77.37 1.05 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 105.681 -1.97 . . . . 74.040000000000006 105.681 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.401 HD22 ' C ' ' A' ' 68' ' ' ASN . 8.4 t30 -178.48 132.26 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.496 -0.482 . . . . 64.439999999999998 110.45 -164.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 p -109.21 -53.52 2.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.188 0.811 . . . . 75.120000000000005 113.188 178.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -71.68 -34.79 69.98 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.458 0.91 . . . . 63.149999999999999 113.458 -173.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' C ' HD22 ' A' ' 65' ' ' ASN . 5.0 m-20 -107.47 29.27 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.319 -0.623 . . . . 74.340000000000003 109.319 -176.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.27 129.38 4.67 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 124.263 0.977 . . . . 72.299999999999997 115.366 -171.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.6 m -74.23 139.0 44.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.503 -0.849 . . . . 72.340000000000003 111.152 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -103.35 141.26 36.24 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.379 0.609 . . . . 74.319999999999993 111.462 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 88' ' ' ILE . 27.0 m -116.98 117.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.376 -1.342 . . . . 74.299999999999997 107.376 174.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.55 34.63 24.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.696 -0.684 . . . . 72.530000000000001 110.134 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 86.27 -10.2 0.69 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.784 1.634 . . . . 64.409999999999997 112.995 178.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.32 124.95 47.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 121.745 -0.597 . . . . 73.329999999999998 111.158 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.52 125.42 10.1 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 122.47 2.113 . . . . 73.400000000000006 111.502 178.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.19 172.87 15.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 110.24 -0.281 . . . . 72.0 110.24 -177.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -102.59 -35.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.205 -0.665 . . . . 64.319999999999993 109.205 175.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.41 149.72 30.41 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.915 -0.584 . . . . 73.319999999999993 110.008 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -159.05 152.56 22.8 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.254 -1.017 . . . . 73.25 108.254 -173.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.41 111.75 24.59 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.659 -0.817 . . . . 75.140000000000001 109.825 174.308 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -58.34 134.67 56.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.21 -1.359 . . . . 74.329999999999998 112.43 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.32 164.29 16.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.617 -0.883 . . . . 75.340000000000003 108.617 172.567 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 26.2 t70 -66.97 114.48 5.8 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.13 0.49 . . . . 74.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.05 0.55 33.72 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.399 -0.819 . . . . 73.329999999999998 112.567 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -72.01 142.46 49.33 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.218 0.509 . . . . 72.409999999999997 111.494 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.64 113.78 42.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.262 -0.881 . . . . 74.25 108.941 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.418 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 2.9 mp -110.79 116.61 52.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.421 -0.955 . . . . 71.540000000000006 108.421 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -117.35 130.78 56.73 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.691 0.758 . . . . 75.400000000000006 110.785 -177.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -131.28 163.98 26.6 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.576 -1.268 . . . . 62.149999999999999 107.576 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.35 98.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.959 0.787 . . . . 64.409999999999997 114.865 -177.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 75.02 19.64 2.31 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 125.762 1.625 . . . . 74.349999999999994 114.071 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -148.37 138.32 22.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.613 -0.514 . . . . 70.510000000000005 109.613 176.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -133.62 120.58 20.88 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.607 0.718 . . . . 73.030000000000001 109.862 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.418 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 9.7 tp -116.04 140.83 36.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.961 -1.018 . . . . 70.200000000000003 110.178 -172.252 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.15 138.13 39.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.5 -0.926 . . . . 74.409999999999997 108.5 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.55 124.44 54.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 120.886 0.374 . . . . 75.120000000000005 110.993 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.4 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -121.19 139.6 53.15 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.683 -0.858 . . . . 71.209999999999994 108.683 177.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.4 mtt -123.27 138.33 54.65 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 120.855 0.36 . . . . 73.519999999999996 110.622 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 108.488 -0.93 . . . . 73.409999999999997 108.488 -178.401 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.633 0 N-CA-C 111.509 -0.637 . . . . 62.149999999999999 111.509 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -82.02 95.42 7.42 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.071 0.463 . . . . 73.209999999999994 110.985 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.25 -175.32 41.75 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.959 -1.656 . . . . 71.230000000000004 108.959 178.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -86.92 150.46 24.07 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.429 -0.582 . . . . 65.019999999999996 109.429 178.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.32 -30.81 67.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.26 0.552 . . . . 72.120000000000005 109.794 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.98 -49.09 0.92 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.757 -0.735 . . . . 71.030000000000001 111.919 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 m -146.31 124.99 12.52 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.172 -0.677 . . . . 74.430000000000007 109.172 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -119.66 114.85 22.83 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.249 -1.019 . . . . 70.430000000000007 108.249 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.79 126.29 48.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.683 -0.858 . . . . 73.040000000000006 108.683 -175.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 46.0 m -131.84 122.85 26.4 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.805 -0.813 . . . . 75.040000000000006 108.805 -175.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 pp -88.9 136.39 33.03 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-O 121.207 0.527 . . . . 74.310000000000002 109.999 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.78 109.8 21.03 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.815 -1.084 . . . . 75.519999999999996 109.031 -172.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -99.49 105.66 17.6 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.298 -1.001 . . . . 63.130000000000003 108.298 175.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -92.29 100.49 13.07 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.149 -1.021 . . . . 73.450000000000003 108.721 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.97 -28.84 12.88 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.276 -0.875 . . . . 71.540000000000006 109.203 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.07 -51.11 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.852 -1.067 . . . . 73.219999999999999 111.397 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.7 m -114.38 -2.3 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.366 -0.491 . . . . 74.349999999999994 111.857 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.91 103.07 1.13 Allowed Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 121.298 -0.477 . . . . 64.140000000000001 113.357 178.164 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.73 158.29 16.06 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.664 -0.865 . . . . 75.329999999999998 108.664 173.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -139.31 141.02 37.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 123.49 0.493 . . . . 75.120000000000005 110.182 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -136.06 114.32 11.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.523 -0.547 . . . . 73.310000000000002 109.523 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 35.7 tt0 -76.28 134.89 39.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 109.003 -0.74 . . . . 74.409999999999997 109.003 177.55 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.09 136.87 52.92 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.902 -0.59 . . . . 71.129999999999995 110.074 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.408 ' HG2' ' OD1' ' A' ' 28' ' ' ASN . 9.4 ptp180 -75.37 158.4 32.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.287 -1.375 . . . . 74.129999999999995 107.287 175.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -73.54 132.87 43.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.287 -1.375 . . . . 72.310000000000002 107.287 171.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.43 -150.19 17.25 Favored Glycine 0 C--N 1.282 -2.45 0 N-CA-C 107.706 -2.157 . . . . 54.009999999999998 107.706 -173.006 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 p -104.56 139.69 39.07 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.578 -1.249 . . . . 74.25 112.539 -178.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 27.6 m-80 -107.16 110.05 22.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.172 -1.788 . . . . 73.340000000000003 106.172 176.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -100.47 122.38 52.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.657 -0.247 . . . . 73.510000000000005 111.047 -173.864 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 78.0 mt -109.51 129.0 65.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.712 -0.848 . . . . 75.109999999999999 108.712 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.35 179.27 37.7 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 109.701 -1.36 . . . . 63.130000000000003 109.701 178.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 70.8 mtp180 -112.1 105.37 13.73 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.766 -1.198 . . . . 74.400000000000006 107.766 179.047 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.48 164.76 31.05 Favored Glycine 0 N--CA 1.409 -3.112 0 N-CA-C 109.258 -1.537 . . . . 55.140000000000001 109.258 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.96 -25.72 67.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.836 0.318 . . . . 74.439999999999998 111.275 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.28 -29.04 59.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 54.229999999999997 110.405 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 47' ' ' ARG . . . -75.62 153.36 37.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 73.209999999999994 112.386 -175.537 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -97.52 -43.61 7.17 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.35 -0.841 . . . . 73.340000000000003 109.633 -178.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.417 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 80.1 t80 -117.57 128.07 54.59 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.872 -1.159 . . . . 72.409999999999997 107.872 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.83 137.42 47.65 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 112.386 0.513 . . . . 72.510000000000005 112.386 -178.541 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.34 142.72 54.86 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 74.340000000000003 110.751 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -86.72 35.76 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.858 2.372 . . . . 71.200000000000003 112.304 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.27 -177.52 5.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.843 -0.799 . . . . 64.040000000000006 108.843 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.9 m -113.94 158.63 20.86 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.124 -0.695 . . . . 73.049999999999997 109.124 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.86 -2.18 44.97 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.06 -1.216 . . . . 53.409999999999997 110.06 -178.175 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.67 136.03 24.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 113.936 -1.132 . . . . 75.030000000000001 109.516 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 5.2 m -76.13 175.8 8.61 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.495 -0.928 . . . . 72.430000000000007 108.495 177.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.7 ptp180 -68.42 -29.46 68.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.831 0.824 . . . . 75.409999999999997 109.055 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 46' ' ' SER . 75.2 mtm180 -128.39 103.38 7.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 104.015 -2.587 . . . . 74.530000000000001 104.015 168.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -91.85 -33.36 14.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.356 -0.609 . . . . 75.519999999999996 109.356 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 tt -162.8 147.3 11.65 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.15 -0.685 . . . . 73.209999999999994 109.15 -178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -129.23 143.86 51.01 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.425 0.631 . . . . 75.319999999999993 109.995 175.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -113.36 106.14 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 107.454 -1.313 . . . . 72.200000000000003 107.454 172.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -92.06 107.91 19.56 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.869 -1.16 . . . . 74.200000000000003 107.869 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.33 126.33 52.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 74.109999999999999 111.575 -174.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -136.68 155.19 50.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 105.551 -2.018 . . . . 63.549999999999997 105.551 176.482 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 55.43 1.74 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 118.302 0.501 . . . . 63.219999999999999 113.468 -177.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -149.21 -63.39 0.23 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.634 1.174 . . . . 73.439999999999998 108.048 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.93 159.61 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 123.536 0.734 . . . . 74.450000000000003 109.306 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.7 101.89 11.37 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.761 -1.199 . . . . 75.299999999999997 107.761 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.3 tp -90.13 101.81 14.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.019 -0.991 . . . . 75.439999999999998 111.225 -172.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -85.37 131.24 34.43 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.602 -1.259 . . . . 72.420000000000002 107.602 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 78' ' ' GLN . . . -138.77 116.88 11.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.39 . . . . 73.010000000000005 110.538 178.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -86.2 135.79 33.44 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.812 -0.631 . . . . 74.549999999999997 109.801 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.16 76.9 1.42 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.568 -1.271 . . . . 73.430000000000007 107.568 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 175.31 147.1 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.928 -0.767 . . . . 70.310000000000002 108.928 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 p -109.58 -48.01 3.29 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.962 0.727 . . . . 74.150000000000006 112.962 175.241 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -67.31 -33.94 76.33 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.642 0.734 . . . . 72.549999999999997 112.307 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' ND2' ' HA3' ' A' ' 91' ' ' GLY . 65.3 t30 -121.4 27.4 8.32 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.568 -1.271 . . . . 73.400000000000006 107.568 -173.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.41 143.01 4.87 Favored Glycine 0 C--O 1.25 1.147 0 CA-C-N 114.493 -1.231 . . . . 52.240000000000002 115.404 -175.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.2 m -84.53 151.23 24.71 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.003 0.906 . . . . 72.420000000000002 112.432 -176.014 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.4 p -121.38 143.8 49.01 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.164 -0.925 . . . . 71.040000000000006 110.967 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.435 HG21 ' CD2' ' A' ' 80' ' ' TRP . 32.6 m -109.84 121.64 63.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 106.061 -1.829 . . . . 74.439999999999998 106.061 174.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 61.57 24.62 14.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.615 0.722 . . . . 72.219999999999999 109.302 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.5 10.26 2.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 126.326 1.85 . . . . 75.409999999999997 110.984 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.24 125.93 34.93 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.577 -0.702 . . . . 52.350000000000001 109.156 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 125.51 10.45 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.639 2.226 . . . . 72.349999999999994 114.124 -176.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -151.93 177.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 106.335 -1.728 . . . . 74.450000000000003 106.335 178.467 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.487 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 21.5 mt-30 -119.36 -37.08 3.23 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 109.729 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.91 133.56 55.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.627 -0.715 . . . . 75.420000000000002 109.352 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.435 ' CD2' HG21 ' A' ' 72' ' ' VAL . 76.8 t-105 -158.49 141.39 14.66 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 121.779 0.8 . . . . 74.530000000000001 111.115 -176.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -88.58 104.26 16.68 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 113.735 -1.575 . . . . 75.319999999999993 107.088 173.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.97 150.84 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.749 -0.66 . . . . 63.009999999999998 111.98 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.28 165.49 26.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.71 -0.848 . . . . 73.299999999999997 108.71 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.39 111.47 7.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.307 0.575 . . . . 73.019999999999996 110.207 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.1 19.56 16.46 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.604 -0.725 . . . . 64.540000000000006 111.901 -178.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.99 129.46 34.87 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.274 -1.38 . . . . 71.120000000000005 107.274 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.42 113.03 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.49 -0.93 . . . . 72.450000000000003 108.49 -178.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.437 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 42.3 mm -96.23 106.53 18.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.04 -1.837 . . . . 72.409999999999997 106.04 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.494 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 24.8 ttt85 -103.19 106.28 16.76 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.556 -1.276 . . . . 74.209999999999994 107.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -106.95 163.93 12.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.706 -1.133 . . . . 71.299999999999997 109.433 -174.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -41.3 101.05 0.02 OUTLIER Glycine 0 C--N 1.309 -0.929 0 N-CA-C 115.924 1.129 . . . . 63.009999999999998 115.924 -175.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 36.2 m80 74.29 15.77 3.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.739 1.616 . . . . 74.140000000000001 113.463 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.2 t -151.66 176.63 11.18 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.921 -0.399 . . . . 70.219999999999999 109.921 178.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.61 144.57 24.5 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.27 -1.011 . . . . 75.340000000000003 108.27 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.437 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 9.8 tp -140.4 140.56 34.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.826 -0.805 . . . . 71.5 108.826 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.5 mt -104.66 117.39 50.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.96 -0.755 . . . . 74.299999999999997 108.96 -178.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.24 122.23 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 110.369 -0.234 . . . . 71.420000000000002 110.369 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -115.83 151.57 35.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.361 -0.607 . . . . 72.120000000000005 109.361 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 mtt -122.1 117.03 25.31 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.634 -0.712 . . . . 73.140000000000001 109.445 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 . . . . . 0 C--N 1.275 -2.66 0 N-CA-C 108.063 -1.088 . . . . 75.329999999999998 108.063 -178.579 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.574 0 N-CA-C 110.813 -0.915 . . . . 60.140000000000001 110.813 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -83.17 102.92 12.19 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.344 0.592 . . . . 73.340000000000003 109.815 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.14 43.61 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.217 -1.553 . . . . 71.420000000000002 109.217 -179.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -99.46 10.73 40.85 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.228 -0.486 . . . . 55.329999999999998 109.979 -176.046 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.05 85.33 0.14 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.011 1.324 . . . . 64.200000000000003 111.178 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.88 -163.32 20.42 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 109.265 -1.534 . . . . 62.130000000000003 109.265 175.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m -57.83 116.22 3.33 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 117.38 0.59 . . . . 74.319999999999993 109.525 178.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -108.67 115.53 30.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.078 -0.51 . . . . 75.340000000000003 109.744 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.25 110.5 26.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.766 -1.198 . . . . 72.430000000000007 107.766 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -112.53 120.8 42.86 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.687 -0.857 . . . . 74.140000000000001 108.687 -174.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -91.53 137.34 32.44 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.647 -0.501 . . . . 74.099999999999994 109.647 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -104.02 127.3 51.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.389 -1.337 . . . . 72.540000000000006 107.389 174.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.6 135.22 52.94 Favored 'General case' 0 C--N 1.269 -2.892 0 O-C-N 123.399 0.437 . . . . 71.310000000000002 111.385 -173.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 100.33 11.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.732 -1.581 . . . . 73.030000000000001 106.732 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -104.36 1.69 30.49 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 113.606 -1.633 . . . . 73.209999999999994 110.059 -176.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.5 -41.54 1.86 Allowed Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 108.584 -1.807 . . . . 74.230000000000004 108.584 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -112.59 -63.92 1.37 Allowed 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.28 -1.378 . . . . 64.530000000000001 107.28 173.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.49 109.04 0.39 Allowed Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 111.242 -0.743 . . . . 53.100000000000001 111.242 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -101.11 157.08 17.03 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.104 -0.702 . . . . 73.200000000000003 109.104 177.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.0 p -137.75 132.6 32.99 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.628 -1.249 . . . . 71.0 107.628 174.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -138.49 129.31 26.62 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.797 -0.816 . . . . 71.430000000000007 108.797 -173.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -87.46 120.94 29.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.679 -0.86 . . . . 72.329999999999998 108.679 177.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.52 137.87 23.43 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 124.355 1.034 . . . . 74.239999999999995 111.475 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -85.12 144.7 28.05 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 108.9 -0.778 . . . . 73.420000000000002 108.9 -177.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.7 113.53 8.82 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.077 0.941 . . . . 73.010000000000005 109.947 178.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.58 -167.37 23.15 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 106.573 -2.611 . . . . 74.319999999999993 106.573 -171.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 58.1 p -106.46 127.76 53.54 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 118.981 1.39 . . . . 63.539999999999999 111.179 177.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -102.0 112.58 25.28 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.425 -0.807 . . . . 64.120000000000005 108.97 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.34 120.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.255 -0.884 . . . . 73.230000000000004 109.443 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.4 mt -99.99 130.62 48.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.238 -0.892 . . . . 74.040000000000006 109.194 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 157.32 -161.34 31.17 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.713 -1.355 . . . . 73.030000000000001 109.713 178.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 60.6 mtp180 -129.76 105.23 7.89 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.056 -1.461 . . . . 74.430000000000007 107.056 173.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.34 -176.19 47.69 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.944 -0.646 . . . . 65.310000000000002 111.615 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -63.23 -30.03 71.25 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 124.739 1.216 . . . . 75.319999999999993 113.177 -176.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.39 -6.61 37.11 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.822 0.344 . . . . 75.329999999999998 111.686 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 115.12 18.23 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.892 0.377 . . . . 74.340000000000003 111.992 -174.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.436 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 12.9 mm-40 -89.31 -29.44 19.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.478 -0.783 . . . . 74.219999999999999 109.434 177.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 85.4 t80 -115.18 108.95 17.29 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.259 -1.756 . . . . 75.230000000000004 106.259 173.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 59.5 mtt180 -99.13 120.63 39.82 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.035 -0.984 . . . . 74.329999999999998 110.375 -172.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.9 mt -73.05 138.32 79.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.886 -0.597 . . . . 73.5 110.557 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -84.35 1.67 8.56 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.41 2.074 . . . . 71.409999999999997 113.868 -177.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -102.85 163.63 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.308 -0.627 . . . . 54.229999999999997 109.308 -178.326 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.6 m -100.45 147.93 25.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 120.909 0.385 . . . . 71.129999999999995 110.455 -177.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.69 7.99 30.94 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 110.626 -0.99 . . . . 74.450000000000003 110.626 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 38.2 t -99.31 133.61 41.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 75.120000000000005 108.391 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.6 m -69.94 175.87 4.11 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.753 0.311 . . . . 52.109999999999999 111.388 178.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.2 ptp180 -65.27 -28.85 69.63 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.606 0.717 . . . . 70.420000000000002 111.299 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -135.59 119.16 16.99 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.579 -2.378 . . . . 74.25 104.579 169.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.577 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 3.7 t60 -104.62 -45.16 4.69 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.96 -0.756 . . . . 75.019999999999996 108.96 -177.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -163.29 154.25 16.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.279 -1.378 . . . . 75.109999999999999 107.279 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -136.84 143.89 43.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.698 -0.482 . . . . 73.420000000000002 109.698 176.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -112.42 115.26 49.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 108.562 -0.903 . . . . 74.430000000000007 108.562 177.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.421 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 47.3 ttt180 -93.0 107.25 19.07 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-O 121.305 0.574 . . . . 74.420000000000002 109.539 176.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -97.31 107.16 19.61 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.522 -1.288 . . . . 75.549999999999997 107.522 175.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.62 -173.18 2.4 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 105.18 -2.156 . . . . 71.150000000000006 105.18 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.58 4.75 85.12 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 118.797 -1.668 . . . . 72.430000000000007 111.969 -177.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -117.94 -61.31 1.7 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.578 -0.311 . . . . 70.319999999999993 111.817 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 157.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.949 0.404 . . . . 74.099999999999994 111.414 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.68 104.66 15.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.172 -1.047 . . . . 72.549999999999997 108.172 176.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.9 tt -91.25 118.34 30.4 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.737 -1.12 . . . . 75.409999999999997 110.077 -174.592 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.04 122.32 43.87 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.217 -1.401 . . . . 72.450000000000003 107.217 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.6 118.95 12.85 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.489 -0.485 . . . . 74.400000000000006 112.008 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.463 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 0.8 OUTLIER -66.05 139.75 58.21 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.399 -0.963 . . . . 74.200000000000003 108.399 172.577 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -126.82 75.4 1.56 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 105.858 -1.904 . . . . 64.219999999999999 105.858 178.736 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 11.2 t-20 158.11 163.63 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 106.46 -1.681 . . . . 75.129999999999995 106.46 -178.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.9 m -108.04 -44.82 4.09 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 118.014 0.37 . . . . 60.25 111.711 176.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 m -73.99 -30.21 62.37 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.454 0.645 . . . . 74.340000000000003 111.649 -175.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.577 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.7 m120 -86.65 28.29 0.89 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.045 -0.409 . . . . 54.0 110.51 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.0 123.62 4.83 Favored Glycine 0 C--O 1.24 0.528 0 N-CA-C 116.116 1.206 . . . . 73.140000000000001 116.116 -174.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.463 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 88.0 m -91.77 151.04 20.79 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 124.733 1.213 . . . . 74.409999999999997 110.019 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 p -118.76 140.68 49.54 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 116.226 -0.443 . . . . 65.340000000000003 110.508 176.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.27 117.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.84 -1.17 . . . . 74.319999999999993 107.84 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 59.85 30.01 19.56 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.71 0.804 . . . . 75.120000000000005 110.325 -177.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 t30 79.79 1.41 2.14 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.948 1.699 . . . . 72.319999999999993 110.949 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.76 25.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 O-C-N 121.884 -0.51 . . . . 70.109999999999999 110.139 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.39 125.91 5.92 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.705 2.27 . . . . 74.519999999999996 112.469 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.01 -177.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.884 -1.154 . . . . 74.150000000000006 107.884 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.11 -10.15 7.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.046 0.45 . . . . 73.430000000000007 110.112 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -153.41 135.24 14.57 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 109.6 -0.519 . . . . 73.420000000000002 109.6 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -151.73 151.93 32.06 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.748 -0.66 . . . . 74.310000000000002 109.916 -174.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -102.78 114.65 29.09 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 74.340000000000003 108.182 174.393 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.5 143.74 49.18 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.87 0.692 . . . . 72.200000000000003 112.87 -176.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.3 166.57 23.47 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.255 -1.017 . . . . 74.530000000000001 108.255 171.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.78 115.7 10.23 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.133 -0.321 . . . . 73.329999999999998 110.133 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 0.87 26.8 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.076 -0.583 . . . . 64.519999999999996 113.05 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -74.15 129.87 38.68 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.296 -0.562 . . . . 74.140000000000001 111.073 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.67 112.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 108.009 -1.108 . . . . 65.400000000000006 108.009 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.83 129.87 70.24 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 N-CA-C 109.736 -0.468 . . . . 73.349999999999994 109.736 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -123.75 131.9 53.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 110.093 -0.336 . . . . 73.310000000000002 110.093 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.13 140.17 37.84 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.369 -1.345 . . . . 61.009999999999998 107.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.48 88.3 0.0 OUTLIER Glycine 0 N--CA 1.489 2.178 0 O-C-N 125.4 1.688 . . . . 73.209999999999994 116.482 -174.069 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.7 m80 80.68 -33.51 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.596 1.558 . . . . 75.040000000000006 114.367 177.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -101.1 162.27 13.01 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.268 -0.573 . . . . 64.409999999999997 110.918 -173.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.06 143.18 31.77 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.28 0.562 . . . . 73.239999999999995 110.116 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.459 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -140.16 138.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 114.9 -1.046 . . . . 74.439999999999998 110.118 -173.563 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.17 128.36 67.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.936 -0.764 . . . . 75.219999999999999 108.936 177.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 63.9 t -89.18 129.26 40.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 112.521 0.563 . . . . 75.230000000000004 112.521 -177.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.32 137.12 51.97 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.313 -0.995 . . . . 73.239999999999995 108.313 172.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.3 mtp -126.27 112.42 15.7 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.464 -0.569 . . . . 63.229999999999997 109.464 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 . . . . . 0 C--N 1.275 -2.654 0 N-CA-C 108.255 -1.017 . . . . 73.340000000000003 108.255 -178.631 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.22 0 N-CA-C 110.47 -1.052 . . . . 64.319999999999993 110.47 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -84.85 98.76 10.49 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 121.374 0.607 . . . . 73.5 111.149 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.04 128.23 1.65 Allowed Glycine 0 N--CA 1.416 -2.654 0 N-CA-C 109.154 -1.579 . . . . 62.140000000000001 109.154 178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.0 m -77.97 -28.1 49.3 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.621 0.724 . . . . 70.439999999999998 109.604 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.41 119.76 29.19 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.815 -1.18 . . . . 71.230000000000004 107.815 177.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.49 69.61 3.25 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 110.641 -0.984 . . . . 62.43 110.641 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 83.5 m -141.75 117.63 10.51 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 109.487 -0.56 . . . . 74.129999999999995 109.487 -177.152 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.5 m -105.16 114.59 28.88 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.433 -0.951 . . . . 72.439999999999998 108.433 176.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -99.61 114.14 36.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.525 -1.287 . . . . 74.549999999999997 107.525 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.5 m -124.18 123.77 41.0 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.891 -0.781 . . . . 74.299999999999997 108.891 -176.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.485 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -102.99 128.23 49.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.71 -0.677 . . . . 75.430000000000007 109.311 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.57 132.7 51.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.387 -0.824 . . . . 72.109999999999999 110.424 -175.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.7 tp -121.5 111.55 17.4 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.378 -0.828 . . . . 73.329999999999998 109.321 -177.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -127.23 100.79 6.22 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.916 0.865 . . . . 73.219999999999999 109.735 177.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.05 19.53 15.67 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.555 -1.276 . . . . 71.299999999999997 107.555 174.795 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.75 16.82 12.0 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.666 -1.373 . . . . 63.329999999999998 109.666 -171.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 p -117.36 -68.32 0.93 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.317 0.58 . . . . 74.430000000000007 110.542 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.66 53.31 1.56 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.919 -0.872 . . . . 70.420000000000002 110.919 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.08 156.76 17.0 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.852 0.358 . . . . 72.510000000000005 111.121 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.2 p -132.34 143.98 50.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.777 -0.823 . . . . 73.219999999999999 108.777 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -135.48 134.16 39.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.392 -1.336 . . . . 74.200000000000003 107.392 175.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -110.06 135.07 51.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.846 -0.798 . . . . 73.140000000000001 108.846 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.85 128.23 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.76 . . . . 73.340000000000003 111.65 -176.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -104.5 153.2 21.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.456 -2.424 . . . . 73.430000000000007 104.456 172.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.02 143.95 55.84 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.12 0.962 . . . . 72.340000000000003 113.336 -173.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.12 177.37 16.5 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 107.648 -2.181 . . . . 75.219999999999999 107.648 -174.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 29.8 t -100.09 125.17 46.15 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.479 -0.888 . . . . 72.329999999999998 108.854 176.033 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -108.07 120.57 42.7 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.942 -1.026 . . . . 75.230000000000004 110.319 -177.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.4 mt -86.05 127.81 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.889 -1.051 . . . . 74.400000000000006 110.539 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.412 HG21 HD23 ' A' ' 40' ' ' LEU . 55.4 mt -103.27 119.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 125.321 1.448 . . . . 72.349999999999994 108.329 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.593 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 167.46 -151.75 19.64 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.416 -0.674 . . . . 51.450000000000003 111.416 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 82.9 mtm180 -131.8 105.03 7.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 117.769 0.784 . . . . 74.150000000000006 109.519 176.376 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.84 -163.8 33.6 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.314 -0.946 . . . . 72.549999999999997 111.215 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -86.96 -34.16 19.4 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.931 -0.766 . . . . 75.049999999999997 108.931 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -33.48 74.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.385 -0.825 . . . . 65.230000000000004 109.585 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.03 129.19 39.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.833 -1.076 . . . . 71.019999999999996 110.779 -178.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -90.72 -26.67 19.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.544 -1.28 . . . . 74.239999999999995 107.544 178.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.63 116.17 25.46 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.218 -1.356 . . . . 71.530000000000001 107.411 178.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.593 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -101.58 117.34 34.7 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.974 -0.557 . . . . 73.129999999999995 111.218 -175.806 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD23 HG21 ' A' ' 30' ' ' ILE . 4.0 mm? -78.1 125.24 85.49 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.666 -0.697 . . . . 74.540000000000006 110.732 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -74.6 2.6 6.22 Favored 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 122.416 2.077 . . . . 75.299999999999997 113.658 178.159 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -104.85 -173.38 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.093 -1.077 . . . . 75.329999999999998 108.093 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -124.78 167.12 15.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.68 -0.859 . . . . 75.450000000000003 108.68 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.01 -3.48 62.27 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 108.818 -1.713 . . . . 64.120000000000005 108.818 -174.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.75 131.41 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.168 -1.516 . . . . 75.010000000000005 107.458 179.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -93.41 -177.57 4.47 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.503 -0.317 . . . . 72.25 111.81 -175.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.8 ptm180 -63.79 -36.03 82.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.516 0.674 . . . . 71.430000000000007 111.913 -177.196 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -133.17 99.4 4.54 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 105.481 -2.044 . . . . 72.400000000000006 105.481 175.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -104.37 -46.42 4.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.978 -1.01 . . . . 65.040000000000006 109.546 -176.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 tt -153.49 159.75 42.36 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.069 -1.086 . . . . 72.420000000000002 108.069 -176.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.0 149.68 40.34 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.177 -0.675 . . . . 74.299999999999997 109.177 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 27' ' ' SER . 68.3 mt -118.74 115.43 48.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.828 -0.804 . . . . 71.430000000000007 108.828 175.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -91.55 107.42 19.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.344 -1.354 . . . . 73.129999999999995 107.344 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -115.43 132.36 56.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.789 -0.641 . . . . 73.120000000000005 111.305 -177.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -143.0 169.39 17.65 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.627 -1.99 . . . . 53.439999999999998 105.627 173.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 65.67 1.77 Allowed Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.8 -0.714 . . . . 75.519999999999996 112.07 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -155.89 -73.47 0.11 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.249 1.02 . . . . 75.319999999999993 108.443 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.95 159.22 16.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.66 0.784 . . . . 73.439999999999998 109.332 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' A' ' 82' ' ' LEU . . . -103.85 104.69 14.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.193 -0.669 . . . . 71.510000000000005 109.193 178.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.28 114.07 26.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.204 -0.907 . . . . 71.230000000000004 109.788 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.75 122.51 36.29 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.896 -1.52 . . . . 74.439999999999998 106.896 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.78 124.47 18.33 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.71 -0.396 . . . . 73.120000000000005 110.568 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.564 ' OD2' ' HB ' ' A' ' 70' ' ' THR . 12.9 m-20 -72.45 143.98 48.27 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.466 -0.939 . . . . 74.230000000000004 108.466 174.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -121.98 75.72 1.24 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.874 -1.158 . . . . 75.310000000000002 107.874 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 165.87 153.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 104.939 -2.245 . . . . 73.319999999999993 104.939 -178.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -97.2 -33.66 11.4 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.798 -0.761 . . . . 74.010000000000005 112.387 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 t -89.1 -28.95 19.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.758 -0.377 . . . . 75.209999999999994 111.351 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -88.63 27.38 1.3 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 122.568 0.347 . . . . 75.209999999999994 111.882 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.82 129.38 47.08 Favored Glycine 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 73.150000000000006 112.001 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.564 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 15.6 m -86.79 157.75 19.52 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 124.821 1.248 . . . . 74.349999999999994 113.053 -173.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 p -102.69 140.7 36.62 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.134 0.492 . . . . 74.519999999999996 110.732 178.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.05 120.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.672 -1.232 . . . . 73.310000000000002 107.672 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 59.29 32.02 21.61 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.694 0.798 . . . . 74.530000000000001 109.924 -176.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.7 t30 75.4 9.27 3.74 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.0 1.32 . . . . 74.409999999999997 110.953 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.9 41.99 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.488 -0.56 . . . . 72.120000000000005 109.488 177.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.33 125.35 11.23 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.4 2.067 . . . . 62.119999999999997 111.913 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.28 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.635 -0.876 . . . . 65.349999999999994 108.635 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -126.61 -0.64 6.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.422 -0.584 . . . . 74.109999999999999 109.422 171.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -165.29 147.16 7.65 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.479 -0.934 . . . . 73.519999999999996 108.479 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -166.95 151.84 7.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.508 -0.923 . . . . 75.319999999999993 108.508 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -105.03 118.62 36.99 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.557 -0.857 . . . . 71.230000000000004 109.57 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 78.0 mt -61.62 150.23 36.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.644 -1.162 . . . . 73.299999999999997 113.717 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.52 174.77 10.66 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.844 -1.071 . . . . 73.209999999999994 108.154 172.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.06 112.3 12.36 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.655 -0.498 . . . . 73.310000000000002 109.655 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.0 14.85 11.41 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.665 -0.778 . . . . 71.209999999999994 113.153 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -79.98 121.46 25.51 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 119.523 -0.871 . . . . 72.319999999999993 110.692 175.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 112.61 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 106.743 -1.577 . . . . 75.109999999999999 106.743 175.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.8 mt -120.45 140.1 45.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 109.388 -0.597 . . . . 63.229999999999997 109.388 -174.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -132.2 123.64 27.42 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.519 -0.872 . . . . 73.239999999999995 111.507 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -108.11 163.66 12.97 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.762 -1.57 . . . . 75.450000000000003 106.762 176.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.92 104.51 0.05 OUTLIER Glycine 0 CA--C 1.533 1.171 0 O-C-N 123.996 0.81 . . . . 72.019999999999996 114.403 -178.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.0 m80 80.32 -5.11 1.81 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.262 1.579 . . . . 73.140000000000001 115.262 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.4 m -138.17 136.51 36.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.995 0.816 . . . . 72.209999999999994 111.795 -177.668 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -107.56 138.44 43.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.226 -0.657 . . . . 75.310000000000002 109.226 175.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.485 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 5.4 tp -126.9 131.71 70.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.624 -0.88 . . . . 73.319999999999993 108.624 -175.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.5 119.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.654 -0.869 . . . . 72.310000000000002 108.654 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 95.6 t -90.62 125.01 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.209 0.528 . . . . 72.219999999999999 111.35 -178.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.76 149.42 42.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.401 -0.818 . . . . 74.310000000000002 109.728 178.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.426 ' HA ' ' O ' ' A' ' 8' ' ' SER . 59.4 mtt -129.6 110.47 11.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.624 0.726 . . . . 53.439999999999998 109.459 176.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--N 1.278 -2.535 0 CA-C-N 114.852 -1.067 . . . . 72.019999999999996 109.857 -176.53 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.807 -0.917 . . . . 75.530000000000001 110.807 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -100.51 147.21 26.16 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 110.001 -0.37 . . . . 71.120000000000005 110.001 -179.448 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.55 -102.46 1.2 Allowed Glycine 0 C--N 1.302 -1.344 0 N-CA-C 109.156 -1.578 . . . . 72.219999999999999 109.156 176.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -105.7 -0.12 25.79 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.412 -0.588 . . . . 72.010000000000005 109.412 176.57 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.3 17.82 7.41 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.827 1.251 . . . . 73.310000000000002 111.96 179.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.07 -59.82 4.5 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 110.346 -1.102 . . . . 70.150000000000006 110.346 -175.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.458 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 52.3 m -138.7 121.05 15.97 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 123.876 0.871 . . . . 72.329999999999998 109.514 177.021 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -113.0 128.53 56.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.104 -0.498 . . . . 51.450000000000003 109.756 176.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.423 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -103.35 124.72 57.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 75.430000000000007 109.031 177.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.4 m -126.16 134.82 51.18 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.303 -0.862 . . . . 71.420000000000002 109.559 -173.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.7 mt -93.89 135.12 35.55 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.277 -1.009 . . . . 75.530000000000001 108.277 178.213 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -114.83 126.62 55.04 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 109.762 -0.458 . . . . 73.239999999999995 109.762 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -123.61 114.85 20.56 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.381 -0.97 . . . . 72.439999999999998 108.381 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -118.39 101.93 8.54 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.9 0.857 . . . . 73.140000000000001 111.608 -179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.25 26.76 10.05 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.025 -1.843 . . . . 65.019999999999996 106.025 174.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.39 43.07 4.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.91 -2.076 . . . . 63.140000000000001 107.91 -173.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -147.73 -61.91 0.27 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.845 -0.677 . . . . 73.430000000000007 111.12 -172.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.88 39.8 5.73 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.002 -0.839 . . . . 74.209999999999994 111.002 -178.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.24 151.06 36.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 110.08 -0.341 . . . . 72.439999999999998 110.08 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.5 p -134.92 144.76 47.65 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.908 -0.587 . . . . 75.510000000000005 111.049 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -129.65 116.1 18.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.341 -0.615 . . . . 71.299999999999997 109.341 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -80.44 131.93 35.66 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.688 -0.486 . . . . 75.120000000000005 109.688 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HB2' HG13 ' A' ' 9' ' ' VAL . 93.7 mt -85.05 122.34 29.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.817 -1.179 . . . . 72.409999999999997 107.817 174.745 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -93.89 178.88 5.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.966 -0.694 . . . . 72.299999999999997 109.236 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 132.46 45.99 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.441 0.639 . . . . 72.239999999999995 111.153 -176.038 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.37 -159.67 16.94 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.237 -1.545 . . . . 74.400000000000006 109.237 -176.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 p -106.6 144.61 33.01 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.371 -0.531 . . . . 74.510000000000005 109.625 177.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -121.89 112.05 17.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.134 -1.061 . . . . 53.539999999999999 108.134 -176.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.5 mm -86.2 130.56 36.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 109.399 -0.593 . . . . 71.340000000000003 109.399 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.435 HG12 ' HB3' ' A' ' 38' ' ' PHE . 61.0 mt -115.69 135.79 54.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 123.238 0.615 . . . . 75.310000000000002 110.319 -178.049 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 148.23 -163.69 28.94 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 111.646 -0.582 . . . . 62.240000000000002 111.646 177.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.3 mtt180 -115.71 107.1 14.65 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.978 0.418 . . . . 74.439999999999998 110.114 176.205 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.62 -178.88 48.4 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.425 -1.47 . . . . 63.439999999999998 109.425 179.05 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.52 -13.69 53.99 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.502 0.668 . . . . 75.319999999999993 109.699 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -83.57 -24.38 31.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.2 -0.909 . . . . 52.240000000000002 109.449 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.67 139.25 31.53 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.55 -0.75 . . . . 64.150000000000006 111.955 -173.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -92.58 -44.92 8.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.474 -0.785 . . . . 74.230000000000004 108.942 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.435 ' HB3' HG12 ' A' ' 30' ' ' ILE . 68.6 t80 -101.42 108.58 20.22 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.219 -1.03 . . . . 71.239999999999995 108.219 177.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.8 mtm-85 -96.19 127.39 42.16 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.865 -1.061 . . . . 74.209999999999994 108.464 -177.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 9.3 mp -80.14 149.75 70.17 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 112.006 0.373 . . . . 64.099999999999994 112.006 -178.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.3 Cg_exo -71.69 -12.28 28.79 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.755 2.303 . . . . 53.350000000000001 112.342 177.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.56 165.05 11.7 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.6 0.593 . . . . 73.510000000000005 112.6 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -102.1 162.56 12.82 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.917 -1.142 . . . . 73.140000000000001 107.917 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.99 -0.48 41.39 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 109.458 -1.457 . . . . 50.119999999999997 109.458 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.441 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 t -102.93 131.29 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.921 -1.139 . . . . 74.420000000000002 108.614 -176.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 m -75.88 172.23 13.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.297 -0.41 . . . . 74.25 111.565 -178.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 1.4 ptm180 -64.65 -42.2 95.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.384 0.611 . . . . 73.239999999999995 110.819 177.403 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -123.64 93.69 4.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 104.791 -2.3 . . . . 72.510000000000005 104.791 171.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.525 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 22.6 t60 -96.26 -30.61 13.36 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 115.182 -0.917 . . . . 75.319999999999993 109.524 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 tt -163.5 146.99 10.35 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 109.321 -0.622 . . . . 74.310000000000002 109.321 -178.194 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.04 123.38 30.36 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.382 0.611 . . . . 71.230000000000004 111.257 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -104.26 119.18 52.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.826 -0.625 . . . . 74.549999999999997 109.696 177.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -100.71 114.52 28.34 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.516 -0.92 . . . . 74.420000000000002 108.516 177.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -113.76 134.46 54.75 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.697 0.76 . . . . 73.140000000000001 112.164 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -148.18 164.71 33.1 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 103.758 -2.682 . . . . 74.099999999999994 103.758 174.144 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.14 58.23 1.08 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 118.893 0.77 . . . . 74.319999999999993 113.005 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -135.58 -78.41 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.203 -1.406 . . . . 75.209999999999994 107.203 178.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -149.41 159.37 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 105.705 -1.961 . . . . 75.109999999999999 105.705 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.58 113.12 24.74 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.171 -0.677 . . . . 72.150000000000006 109.171 178.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.5 tp -83.72 106.74 15.66 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.052 -0.976 . . . . 73.310000000000002 110.335 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.6 tm? -94.99 111.44 23.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.519 1.128 . . . . 72.409999999999997 108.246 -177.163 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.06 121.43 38.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.168 -0.308 . . . . 75.319999999999993 110.168 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.93 136.6 34.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.129 -0.693 . . . . 65.439999999999998 109.129 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.5 OUTLIER -125.72 76.05 1.54 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.356 -1.72 . . . . 72.109999999999999 106.356 -177.979 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 30.4 t-20 174.55 141.91 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.055 -1.091 . . . . 75.25 108.055 -178.063 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -108.35 -53.12 2.67 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.91 0.386 . . . . 72.049999999999997 111.095 177.615 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.0 m -66.46 -37.32 84.87 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.83 0.852 . . . . 61.43 112.089 -175.785 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.56 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 25.9 m-80 -115.9 27.2 9.44 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.681 -1.229 . . . . 74.239999999999995 107.681 -178.254 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.26 152.06 3.31 Favored Glycine 0 C--O 1.243 0.709 0 CA-C-N 114.279 -1.328 . . . . 73.120000000000005 115.624 -174.477 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 m -87.95 147.3 25.11 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.675 0.79 . . . . 53.310000000000002 112.17 -176.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -118.03 146.67 43.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.183 0.993 . . . . 72.0 110.637 178.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.96 127.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.019 -1.475 . . . . 72.430000000000007 107.019 176.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.04 26.95 12.58 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.052 0.941 . . . . 65.109999999999999 111.933 -178.484 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 73.91 22.48 2.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.798 1.239 . . . . 72.209999999999994 110.272 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.97 134.2 24.93 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.338 -0.846 . . . . 72.099999999999994 108.904 176.111 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.42 137.41 14.82 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.043 1.828 . . . . 63.539999999999999 111.856 179.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.1 170.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.091 -1.077 . . . . 72.340000000000003 108.091 179.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.71 -31.6 10.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.647 -0.501 . . . . 74.129999999999995 109.647 172.793 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.07 145.38 25.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 120.901 0.382 . . . . 74.349999999999994 110.091 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.424 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 63.4 t-105 -150.99 152.5 33.62 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.392 -0.966 . . . . 74.450000000000003 108.392 -173.816 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.95 124.22 49.12 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 107.549 -1.278 . . . . 71.430000000000007 107.549 174.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.3 mt -56.22 151.02 13.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.804 1.039 . . . . 73.099999999999994 113.804 -173.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.44 43.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.217 -1.401 . . . . 44.149999999999999 107.217 178.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.61 115.67 9.13 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.12 0.486 . . . . 74.239999999999995 110.843 -179.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.42 10.06 45.6 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.852 -0.689 . . . . 62.25 112.741 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.38 144.45 32.69 Favored 'General case' 0 C--O 1.252 1.201 0 C-N-CA 119.27 -0.972 . . . . 72.099999999999994 108.937 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.9 t -102.06 112.54 35.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.196 -1.039 . . . . 71.230000000000004 108.196 -178.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.7 mt -110.81 127.89 67.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 C-N-CA 120.093 -0.643 . . . . 71.109999999999999 109.744 -177.13 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -121.32 119.46 32.25 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 109.568 -0.53 . . . . 75.349999999999994 109.568 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.525 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 1.5 pt? -114.32 137.92 51.18 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.349 -1.723 . . . . 64.349999999999994 106.349 177.677 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 5.31 86.17 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 O-C-N 124.785 1.303 . . . . 60.420000000000002 115.638 -166.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 55.12 16.79 1.7 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.974 1.842 . . . . 73.439999999999998 115.974 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -123.8 128.01 48.91 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.117 -0.697 . . . . 65.109999999999999 109.117 177.705 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.57 139.25 46.0 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.149 0.796 . . . . 73.400000000000006 113.149 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 tp -127.39 142.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.407 -1.331 . . . . 74.439999999999998 107.407 -177.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.9 133.46 51.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.662 -0.866 . . . . 72.430000000000007 108.662 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 81.4 t -100.72 126.18 54.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 120.836 0.351 . . . . 73.120000000000005 111.668 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -119.79 138.2 53.5 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.009 -0.542 . . . . 75.150000000000006 109.807 174.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.1 mtp -124.11 113.73 18.75 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.345 -0.613 . . . . 74.540000000000006 109.345 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.458 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 56.6 m-70 . . . . . 0 C--N 1.28 -2.42 0 N-CA-C 108.295 -1.002 . . . . 72.230000000000004 108.295 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.227 0 N-CA-C 110.226 -1.15 . . . . 72.239999999999995 110.226 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -153.73 176.78 11.72 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.319 -0.993 . . . . 71.150000000000006 108.319 179.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.64 62.18 3.55 Favored Glycine 0 C--N 1.317 -0.502 0 N-CA-C 111.203 -0.759 . . . . 72.109999999999999 111.203 178.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.6 m -56.61 133.3 53.56 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.582 1.153 . . . . 64.349999999999994 111.789 -177.509 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.16 80.23 1.67 Allowed 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.105 -0.952 . . . . 72.120000000000005 108.888 177.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.06 -35.95 5.9 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 108.717 -1.753 . . . . 72.540000000000006 108.717 175.435 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.6 m -146.8 115.84 6.92 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.539 -0.911 . . . . 74.209999999999994 108.539 174.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -124.46 115.19 20.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.51 -1.293 . . . . 72.329999999999998 107.51 176.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.31 131.07 36.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.279 -1.008 . . . . 74.299999999999997 108.279 -177.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.521 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 37.9 m -137.61 132.81 33.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.502 -0.772 . . . . 75.239999999999995 108.922 -174.637 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.4 pp -93.23 136.75 33.2 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 120.216 -0.594 . . . . 74.010000000000005 109.649 177.739 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -109.04 129.52 55.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.732 -0.667 . . . . 74.340000000000003 111.476 -175.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -119.8 136.15 54.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.13 -1.396 . . . . 73.310000000000002 108.158 -177.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.79 98.91 11.7 Favored 'General case' 0 CA--C 1.467 -2.222 0 CA-C-O 122.574 1.178 . . . . 63.149999999999999 107.976 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.428 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 15.8 t70 -133.8 92.97 3.04 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 113.18 -1.827 . . . . 65.040000000000006 108.093 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.63 -61.54 4.12 Favored Glycine 0 C--N 1.292 -1.877 0 CA-C-N 114.565 -1.198 . . . . 54.140000000000001 110.634 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 p -135.73 -37.72 0.74 Allowed 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.609 -0.796 . . . . 75.239999999999995 109.792 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.9 120.07 1.06 Allowed Glycine 0 N--CA 1.41 -3.05 0 N-CA-C 110.444 -1.063 . . . . 71.140000000000001 110.444 -178.158 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.428 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 29.4 mmt180 -105.73 154.25 20.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.303 -1.369 . . . . 75.340000000000003 107.303 175.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.521 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 62.8 p -138.04 133.8 33.99 Favored 'General case' 0 C--N 1.283 -2.291 0 O-C-N 123.312 0.382 . . . . 74.109999999999999 110.685 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -117.85 114.48 23.31 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.752 -1.203 . . . . 75.430000000000007 107.752 174.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.18 135.72 38.53 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.13 -1.063 . . . . 74.340000000000003 108.13 179.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.3 mt -73.45 129.45 38.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.028 0.442 . . . . 74.140000000000001 110.034 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -79.58 151.83 30.42 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.2 -1.407 . . . . 73.409999999999997 107.2 176.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -75.25 113.35 12.51 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.274 1.035 . . . . 70.450000000000003 111.697 -178.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.13 -166.48 26.0 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 106.367 -2.693 . . . . 72.420000000000002 106.367 -172.301 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 97.3 p -97.42 119.49 36.05 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 119.622 1.711 . . . . 73.230000000000004 111.078 177.571 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -88.03 108.46 19.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 106.998 -1.482 . . . . 74.010000000000005 106.998 -178.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.3 mt -91.21 116.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.278 -0.874 . . . . 74.540000000000006 109.225 -175.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -99.34 128.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 123.484 0.714 . . . . 72.430000000000007 110.143 -177.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.68 26.65 Favored Glycine 0 CA--C 1.487 -1.661 0 CA-C-N 115.274 -0.875 . . . . 60.530000000000001 111.057 176.692 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -128.69 105.91 8.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.501 0.667 . . . . 70.209999999999994 111.349 176.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.07 166.52 33.56 Favored Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 108.92 -1.672 . . . . 65.420000000000002 108.92 176.424 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -74.88 -16.9 60.65 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.82 0.81 . . . . 73.239999999999995 109.283 176.497 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.98 -10.72 59.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.291 -0.868 . . . . 73.239999999999995 109.734 178.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.16 169.51 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 74.430000000000007 110.404 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -109.56 -47.39 3.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.447 0.641 . . . . 72.019999999999996 109.965 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -108.21 127.22 53.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.215 -0.902 . . . . 64.420000000000002 108.8 -177.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -95.23 127.28 41.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.048 -0.723 . . . . 74.129999999999995 109.048 -174.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.409 HD11 HG22 ' A' ' 45' ' ' VAL . 38.1 mt -83.47 150.01 59.13 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.675 -0.41 . . . . 75.310000000000002 110.318 175.137 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -95.03 34.39 0.17 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 123.37 2.713 . . . . 75.040000000000006 112.325 179.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -138.6 179.75 6.29 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.13 -0.628 . . . . 71.329999999999998 110.004 -178.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 m -112.67 162.41 15.75 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.696 -0.853 . . . . 64.299999999999997 108.696 -176.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.08 -20.77 48.86 Favored Glycine 0 CA--C 1.5 -0.862 0 C-N-CA 121.021 -0.609 . . . . 74.310000000000002 111.938 176.936 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.409 HG22 HD11 ' A' ' 40' ' ' LEU . 9.9 p -79.29 142.55 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.228 -0.486 . . . . 75.409999999999997 111.097 -178.099 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 m -80.13 -170.5 2.52 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.8 0.84 . . . . 74.200000000000003 109.317 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -77.8 -47.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.141 -1.024 . . . . 75.010000000000005 109.403 175.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -109.43 109.32 20.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 107.528 -1.286 . . . . 75.420000000000002 107.528 171.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -104.36 -45.28 4.71 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.664 -1.235 . . . . 75.25 107.664 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 5.8 tt -159.25 151.96 21.71 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 114.845 -1.07 . . . . 73.450000000000003 108.215 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -136.96 140.77 42.45 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.757 -0.831 . . . . 75.430000000000007 108.757 175.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.8 mt -106.83 115.86 49.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 107.782 -1.192 . . . . 75.450000000000003 107.782 176.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 48.1 mtt180 -90.32 107.07 18.91 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.79 -1.559 . . . . 64.299999999999997 106.79 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -112.06 115.59 29.14 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.845 -1.07 . . . . 74.310000000000002 109.967 -176.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.01 160.46 22.74 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.107 -1.812 . . . . 72.409999999999997 106.107 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.14 54.07 2.25 Favored Glycine 0 C--N 1.311 -0.822 0 CA-C-N 118.078 0.399 . . . . 73.349999999999994 113.295 -178.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -156.27 -63.23 0.11 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.466 -0.939 . . . . 64.409999999999997 108.466 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.6 159.41 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 122.868 0.467 . . . . 64.439999999999998 110.833 -178.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.03 110.92 22.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.071 -0.513 . . . . 74.019999999999996 110.139 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 4.9 tt -100.74 118.04 36.04 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.746 -0.835 . . . . 65.299999999999997 108.746 -177.335 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -94.75 123.58 38.29 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.686 -1.227 . . . . 72.219999999999999 107.686 179.083 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.485 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.89 124.74 36.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 75.329999999999998 111.306 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.29 138.44 31.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.644 0.778 . . . . 54.240000000000002 109.892 179.085 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.0 76.53 1.66 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.732 -0.47 . . . . 75.209999999999994 109.732 177.187 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.52 142.45 0.57 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.748 -0.464 . . . . 71.329999999999998 109.748 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 p -96.32 -46.96 6.2 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.409 -0.516 . . . . 64.109999999999999 110.832 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 t -80.14 -36.85 34.61 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.937 -176.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -103.89 28.49 6.63 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 122.23 -0.294 . . . . 71.409999999999997 110.873 -176.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.07 125.67 5.76 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 124.561 1.163 . . . . 61.030000000000001 113.943 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.3 m -75.68 147.61 39.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 124.282 1.033 . . . . 72.450000000000003 112.505 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 p -112.4 140.89 46.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.454 -0.794 . . . . 71.239999999999995 110.747 176.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.68 119.53 58.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.79 -1.189 . . . . 74.439999999999998 107.79 177.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 55.26 36.26 26.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.388 0.613 . . . . 72.239999999999995 110.189 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 80.09 -2.92 1.99 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.029 1.731 . . . . 75.540000000000006 111.783 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.74 123.03 49.15 Favored Pre-proline 0 C--N 1.32 -0.692 0 O-C-N 121.524 -0.735 . . . . 75.230000000000004 110.77 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.55 125.47 10.12 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.653 2.235 . . . . 75.239999999999995 110.885 177.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -142.57 173.93 6.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.73 -0.47 . . . . 72.510000000000005 109.73 -177.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.1 -30.99 8.12 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.739 -0.664 . . . . 63.329999999999998 109.567 172.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 13.2 pt-20 -145.53 146.55 31.47 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.041 0.448 . . . . 74.209999999999994 110.88 173.773 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 34.0 t-105 -154.9 152.17 29.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.739 -1.208 . . . . 72.420000000000002 107.739 -173.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -105.97 116.33 31.75 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.864 -1.134 . . . . 74.340000000000003 110.059 174.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 97' ' ' VAL . 74.2 mt -56.65 148.01 21.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.328 -1.305 . . . . 75.510000000000005 113.735 -174.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.78 37.6 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.425 -1.324 . . . . 60.310000000000002 107.425 170.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 21.3 t70 -71.26 120.93 17.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.105 0.479 . . . . 62.039999999999999 110.48 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.63 11.07 33.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.251 -0.886 . . . . 71.120000000000005 112.158 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -74.15 134.98 42.84 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 117.277 0.538 . . . . 64.450000000000003 111.362 177.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.8 t -97.31 112.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.151 -1.055 . . . . 75.510000000000005 108.151 179.612 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.14 125.59 74.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 119.801 -0.76 . . . . 74.25 110.54 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.429 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 59.3 mtt-85 -111.58 115.29 28.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 111.112 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.47 165.5 13.15 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.974 -1.012 . . . . 70.030000000000001 109.109 177.517 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.06 100.41 0.01 OUTLIER Glycine 0 N--CA 1.475 1.236 0 O-C-N 123.972 0.795 . . . . 54.130000000000003 114.765 -176.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.3 m170 65.53 10.79 6.93 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.584 1.554 . . . . 73.049999999999997 113.184 178.504 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 m -138.58 118.02 12.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.065 0.46 . . . . 71.409999999999997 111.447 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HB3' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.15 142.1 33.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.744 -0.382 . . . . 75.109999999999999 110.01 172.662 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.9 tp -139.09 148.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.779 -0.452 . . . . 75.530000000000001 109.779 -172.834 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.15 131.19 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.128 -1.064 . . . . 70.409999999999997 108.128 176.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.407 HG21 HD22 ' A' ' 82' ' ' LEU . 85.9 t -87.33 128.55 39.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 120.801 0.334 . . . . 72.109999999999999 110.239 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.409 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -125.01 151.32 45.71 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.129 -0.693 . . . . 75.150000000000006 109.129 -179.759 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -129.76 130.35 45.28 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.943 -0.571 . . . . 74.25 110.357 176.805 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 . . . . . 0 C--N 1.286 -2.153 0 N-CA-C 106.168 -1.79 . . . . 74.349999999999994 106.168 175.18 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.721 0 N-CA-C 111.65 -0.58 . . . . 71.099999999999994 111.65 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -80.9 86.45 6.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.032 -0.729 . . . . 71.450000000000003 109.032 177.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.38 -141.89 15.86 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.064 -1.215 . . . . 73.519999999999996 110.064 -176.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 6' ' ' GLY . 20.7 t 55.38 -126.82 2.18 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.059 0.944 . . . . 72.109999999999999 109.807 178.784 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.28 -40.67 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.891 1.677 . . . . 75.439999999999998 112.875 178.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 4' ' ' SER . . . 145.15 -57.07 0.53 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 106.928 -2.469 . . . . 54.420000000000002 106.928 -178.845 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.0 m -107.33 115.98 31.12 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 108.739 -0.838 . . . . 75.120000000000005 108.739 175.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 m -103.82 119.93 39.93 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.843 -1.54 . . . . 74.239999999999995 106.843 176.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -107.51 124.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.615 0.722 . . . . 75.420000000000002 111.256 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 22.4 m -124.83 134.97 52.54 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.603 -1.258 . . . . 74.540000000000006 107.603 -175.635 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.453 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -100.55 143.78 30.31 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.566 -0.454 . . . . 74.140000000000001 110.812 -178.502 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.479 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 46.9 mt-30 -110.73 127.37 55.3 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 107.979 -1.119 . . . . 74.099999999999994 107.979 174.506 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.49 145.97 49.85 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.644 0.735 . . . . 75.230000000000004 110.724 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.41 101.56 13.49 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.063 -0.971 . . . . 60.130000000000003 110.251 -178.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.1 -32.5 10.55 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.603 -1.18 . . . . 74.150000000000006 109.605 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.73 -34.38 3.62 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 107.725 -2.15 . . . . 71.010000000000005 107.725 -171.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -87.91 -41.53 13.12 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.898 -1.149 . . . . 74.25 107.898 176.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 94.13 2.34 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 109.618 -1.393 . . . . 73.099999999999994 109.618 -177.23 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -120.09 154.91 34.0 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.924 0.712 . . . . 74.129999999999995 112.924 -178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.437 HG21 ' HG2' ' A' ' 12' ' ' GLN . 34.5 p -133.55 153.09 51.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.383 -1.28 . . . . 74.430000000000007 108.161 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.429 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 59.9 t80 -153.48 131.51 11.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.898 -1.149 . . . . 74.420000000000002 107.898 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.5 tt0 -93.75 141.25 28.71 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.356 -0.938 . . . . 74.439999999999998 110.649 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HB2' HG11 ' A' ' 9' ' ' VAL . 91.4 mt -78.16 126.14 30.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.026 -0.534 . . . . 75.340000000000003 110.486 -178.431 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -82.79 152.87 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.317 -1.364 . . . . 72.019999999999996 107.317 178.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.42 120.66 21.96 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.988 0.899 . . . . 74.329999999999998 109.737 176.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.18 -167.89 24.25 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 105.548 -3.021 . . . . 71.219999999999999 105.548 -171.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -106.83 143.39 35.0 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 118.738 1.269 . . . . 74.150000000000006 110.694 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -125.56 145.26 50.2 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.701 -0.851 . . . . 73.150000000000006 108.701 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -121.83 131.9 72.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.61 -0.515 . . . . 75.150000000000006 109.61 -177.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.1 mt -107.84 131.65 57.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 124.399 1.08 . . . . 73.420000000000002 109.779 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.73 -157.95 27.45 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 110.06 -1.216 . . . . 73.340000000000003 110.06 177.263 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 43.6 mtm180 -130.49 106.68 8.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.52 0.66 . . . . 72.400000000000006 109.997 174.741 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.82 -164.66 29.96 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 110.019 -1.232 . . . . 71.219999999999999 110.019 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -80.68 -39.3 27.45 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.135 0.493 . . . . 73.219999999999999 110.431 -178.082 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.0 -21.07 44.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 74.310000000000002 110.288 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.47 23.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.781 -0.645 . . . . 55.399999999999999 110.996 -178.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -99.15 -44.88 6.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.916 0.865 . . . . 74.25 108.803 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -100.27 122.55 43.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 106.743 -1.577 . . . . 75.109999999999999 106.743 178.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 17.8 mtp180 -98.14 134.82 40.67 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 112.754 0.65 . . . . 64.230000000000004 112.754 -174.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 38.9 mt -97.62 114.21 64.59 Favored Pre-proline 0 N--CA 1.42 -1.95 0 N-CA-C 107.477 -1.305 . . . . 75.109999999999999 107.477 169.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.505 ' HD2' ' NE2' ' A' ' 92' ' ' HIS . 16.2 Cg_exo -70.06 20.21 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.725 2.95 . . . . 74.340000000000003 113.907 -176.457 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -97.75 178.27 5.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.557 -0.534 . . . . 65.540000000000006 109.557 -176.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 m -115.59 133.05 56.41 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 109.399 -0.593 . . . . 71.310000000000002 109.399 -177.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.1 -2.85 35.27 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.433 -1.067 . . . . 42.0 110.433 -178.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.98 138.89 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 107.961 -1.126 . . . . 74.030000000000001 107.961 -179.435 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -83.76 166.4 18.05 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.668 -0.242 . . . . 70.430000000000007 111.145 -177.5 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 35.2 ptt180 -62.99 -36.66 84.3 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.8 0.81 . . . . 74.420000000000002 109.899 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -129.26 100.67 5.68 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 102.545 -3.132 . . . . 74.120000000000005 102.545 171.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -99.26 -37.29 9.33 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.781 -0.645 . . . . 72.129999999999995 109.328 -174.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -161.29 147.15 14.21 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.032 -1.469 . . . . 74.150000000000006 107.032 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -144.33 142.72 30.58 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 121.328 0.585 . . . . 73.349999999999994 110.971 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -119.58 128.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.262 -0.881 . . . . 74.400000000000006 109.523 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -107.38 111.76 24.25 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.157 -1.423 . . . . 75.230000000000004 107.157 177.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.293 0.568 . . . . 74.349999999999994 111.054 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -149.07 -174.03 4.53 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.74 -1.578 . . . . 75.200000000000003 106.74 173.414 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.11 2.59 60.56 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 119.961 -1.114 . . . . 71.140000000000001 114.704 -173.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG2' HG12 ' A' ' 58' ' ' VAL . 61.6 tt0 -93.51 -75.24 0.5 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.167 0.484 . . . . 75.099999999999994 111.123 177.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG12 ' HG2' ' A' ' 57' ' ' GLN . 16.0 m -135.75 159.35 39.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 122.529 0.332 . . . . 74.129999999999995 110.6 -176.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.33 102.24 13.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.915 -1.143 . . . . 74.019999999999996 107.915 175.459 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 tp -93.67 113.41 25.48 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.357 -0.838 . . . . 73.439999999999998 111.093 -174.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.64 129.41 49.22 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.127 -1.064 . . . . 65.310000000000002 108.127 -179.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.27 125.71 28.28 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.863 0.363 . . . . 71.129999999999995 110.893 177.079 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.74 128.78 35.31 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.615 -1.254 . . . . 72.120000000000005 107.615 175.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.6 OUTLIER -124.37 78.27 1.64 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.932 -0.766 . . . . 72.219999999999999 108.932 -174.331 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 8.0 p30 175.52 161.92 0.28 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.029 -0.36 . . . . 73.510000000000005 110.029 177.054 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.9 m -108.97 -12.02 14.91 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.238 0.542 . . . . 75.25 111.369 176.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -79.17 -55.47 5.08 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.411 0.893 . . . . 75.420000000000002 113.411 -172.894 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -121.92 30.1 6.79 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.759 1.224 . . . . 75.129999999999995 110.1 -169.195 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.77 115.67 0.87 Allowed Glycine 0 C--O 1.251 1.192 0 O-C-N 124.861 1.351 . . . . 73.430000000000007 113.322 -172.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 m -61.07 139.04 58.17 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 125.751 1.621 . . . . 74.319999999999993 113.302 -172.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 p -102.65 142.18 34.25 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.955 -1.021 . . . . 64.329999999999998 110.927 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.62 118.55 56.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.448 -1.316 . . . . 73.340000000000003 107.448 175.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 60.88 32.95 20.07 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.332 1.053 . . . . 74.129999999999995 110.997 -177.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.7 t30 78.02 16.5 1.36 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.904 1.682 . . . . 73.140000000000001 112.031 174.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.57 134.77 26.65 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.19 -0.67 . . . . 75.340000000000003 109.19 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.14 140.83 25.53 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.414 2.076 . . . . 74.400000000000006 112.834 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.26 174.48 3.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.865 -0.791 . . . . 75.319999999999993 108.865 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -96.26 -47.29 6.09 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.405 -0.961 . . . . 75.400000000000006 108.405 173.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -142.26 150.74 41.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.849 -0.614 . . . . 75.219999999999999 110.68 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -152.2 151.23 30.74 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.303 -0.629 . . . . 74.400000000000006 109.303 -173.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -98.25 113.94 26.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.62 -0.882 . . . . 73.109999999999999 108.62 173.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -60.51 131.84 52.02 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.758 -0.655 . . . . 72.099999999999994 112.251 -176.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.41 154.29 42.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.775 -1.194 . . . . 74.219999999999999 107.775 172.201 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.63 123.21 17.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.188 -0.46 . . . . 71.049999999999997 110.264 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.88 6.14 56.22 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 120.602 -0.809 . . . . 53.149999999999999 113.02 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -81.48 137.46 35.61 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.111 -0.636 . . . . 63.0 111.065 176.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.05 113.02 34.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.609 0 CA-C-N 115.581 -0.736 . . . . 73.010000000000005 109.264 -178.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.448 ' HB ' HG21 ' A' ' 95' ' ' ILE . 73.2 mt -112.15 141.35 27.92 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.127 0 N-CA-C 108.201 -1.037 . . . . 74.140000000000001 108.201 -177.436 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -140.27 126.07 19.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.728 -0.789 . . . . 75.349999999999994 112.85 -177.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.22 144.45 48.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.959 -1.497 . . . . 73.409999999999997 106.959 175.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.22 88.25 0.02 OUTLIER Glycine 0 C--O 1.239 0.458 0 N-CA-C 115.862 1.105 . . . . 54.329999999999998 115.862 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.505 ' NE2' ' HD2' ' A' ' 41' ' ' PRO . 84.2 t60 162.35 -47.88 0.0 OUTLIER 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.139 2.175 . . . . 75.329999999999998 107.04 176.114 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.8 m -149.27 134.78 18.53 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.845 -1.07 . . . . 74.010000000000005 111.541 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.53 141.92 27.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.22 -1.77 . . . . 60.109999999999999 106.22 169.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -132.91 136.15 56.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-O 121.035 0.445 . . . . 73.010000000000005 111.317 -172.113 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.4 mt -114.94 129.53 70.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.772 -0.825 . . . . 63.210000000000001 108.772 177.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.11 127.96 38.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.908 -0.587 . . . . 74.439999999999998 111.648 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -119.59 134.29 55.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.806 -0.634 . . . . 73.129999999999995 109.882 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.2 mtt -119.02 133.96 55.49 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 116.006 -0.543 . . . . 75.010000000000005 110.451 177.953 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 . . . . . 0 C--N 1.289 -2.06 0 N-CA-C 107.952 -1.129 . . . . 74.25 107.952 177.903 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.121 0 N-CA-C 110.062 -1.215 . . . . 54.240000000000002 110.062 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -102.61 146.38 28.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.952 -1.129 . . . . 74.150000000000006 107.952 175.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 108.77 123.85 4.88 Favored Glycine 0 C--N 1.288 -2.103 0 N-CA-C 109.852 -1.299 . . . . 62.130000000000003 109.852 -178.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m -109.78 -2.32 17.4 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.561 -0.162 . . . . 54.130000000000003 110.561 -177.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.82 27.6 16.94 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.921 0.867 . . . . 62.530000000000001 109.143 -175.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.09 101.83 2.4 Favored Glycine 0 N--CA 1.417 -2.597 0 CA-C-N 114.472 -1.24 . . . . 72.409999999999997 112.632 -173.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 m -103.99 129.12 51.56 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.386 -1.709 . . . . 74.510000000000005 106.386 174.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.4 m -121.84 139.63 53.39 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.699 -0.801 . . . . 75.530000000000001 110.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -124.04 120.52 59.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.065 -1.458 . . . . 71.319999999999993 107.065 176.4 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 m -118.43 128.43 54.61 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.661 -0.7 . . . . 74.450000000000003 109.275 -173.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.98 133.34 34.35 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.086 -0.709 . . . . 72.439999999999998 109.086 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.09 113.79 26.26 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.404 -1.332 . . . . 72.420000000000002 107.404 -176.469 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.0 tp -112.63 110.56 20.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.828 -0.623 . . . . 72.230000000000004 109.861 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -110.59 107.89 17.65 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.55 0.69 . . . . 64.140000000000001 110.415 176.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.47 24.51 11.53 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.79 -1.559 . . . . 74.349999999999994 106.79 177.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 44.36 2.86 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 108.345 -1.902 . . . . 63.509999999999998 108.345 -174.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -159.35 -70.76 0.08 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.424 0.631 . . . . 54.030000000000001 110.54 -175.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.65 73.29 0.91 Allowed Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.988 -1.245 . . . . 74.120000000000005 109.988 -177.396 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -103.67 155.65 18.4 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.87 -0.419 . . . . 74.299999999999997 109.87 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.5 p -141.46 136.0 30.84 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.239 0.542 . . . . 75.209999999999994 111.942 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.404 ' HB3' HD13 ' A' ' 11' ' ' LEU . 92.5 t80 -133.58 139.88 46.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.375 -1.343 . . . . 73.319999999999993 107.375 176.803 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.46 135.43 46.87 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.48 -0.488 . . . . 72.439999999999998 110.003 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -63.78 145.88 54.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.582 -0.736 . . . . 71.349999999999994 112.834 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -97.91 161.25 13.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.909 -1.145 . . . . 72.530000000000001 107.909 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.01 117.93 17.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.504 0.669 . . . . 73.239999999999995 110.645 -178.57 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.64 -169.72 16.66 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 109.022 -1.631 . . . . 73.109999999999999 109.022 -175.606 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 t -107.43 146.57 31.53 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 121.794 0.807 . . . . 64.299999999999997 112.047 -179.336 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -122.01 129.92 52.86 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.072 -0.967 . . . . 74.120000000000005 109.01 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.32 125.85 54.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.048 -1.093 . . . . 75.420000000000002 108.048 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.92 131.05 56.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.334 -0.617 . . . . 75.010000000000005 109.334 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.72 -159.56 28.2 Favored Glycine 0 CA--C 1.488 -1.626 0 N-CA-C 110.255 -1.138 . . . . 61.439999999999998 110.255 177.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.67 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 71.6 mtt-85 -128.96 105.72 8.4 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 117.568 0.684 . . . . 72.209999999999994 109.613 176.749 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.11 -179.01 48.65 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.194 -1.162 . . . . 75.219999999999999 110.194 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -68.15 -22.36 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.476 0.711 . . . . 61.25 112.886 -176.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -97.74 -7.77 30.02 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 120.773 0.321 . . . . 73.200000000000003 110.509 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.43 130.71 38.41 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.263 0.554 . . . . 75.549999999999997 111.591 -173.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -92.3 -49.17 6.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.124 -1.065 . . . . 75.430000000000007 108.124 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -112.46 125.95 54.78 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.972 -1.013 . . . . 73.549999999999997 108.665 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 10.1 mmt180 -99.01 134.52 41.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.714 -0.847 . . . . 63.340000000000003 108.714 -177.005 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.88 141.5 47.6 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.197 -0.668 . . . . 72.340000000000003 109.197 174.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.07 -36.43 65.61 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.747 2.964 . . . . 71.030000000000001 114.181 -178.037 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.26 170.92 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.119 0.785 . . . . 74.239999999999995 113.119 -175.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p -103.16 165.23 11.15 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.017 -0.992 . . . . 64.349999999999994 108.5 173.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.0 -23.25 34.21 Favored Glycine 0 CA--C 1.501 -0.8 0 N-CA-C 109.781 -1.328 . . . . 74.310000000000002 109.781 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.1 136.36 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.271 -0.965 . . . . 75.129999999999995 108.751 175.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.7 m -67.04 161.38 24.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.413 0.523 . . . . 75.230000000000004 112.413 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.67 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 27.8 ptt180 -54.85 -40.54 69.74 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.515 175.564 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.92 106.82 9.16 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 102.879 -3.008 . . . . 75.319999999999993 102.879 170.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -98.36 -39.4 8.82 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 109.091 -0.707 . . . . 52.229999999999997 109.091 -177.23 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 tt -162.36 150.32 14.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.756 -0.831 . . . . 75.540000000000006 108.756 -176.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.95 135.25 48.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.243 0.544 . . . . 75.319999999999993 110.011 178.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.54 120.96 62.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.093 -1.447 . . . . 74.219999999999999 107.093 174.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -111.65 111.74 22.95 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.069 0.461 . . . . 73.409999999999997 109.979 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -104.35 115.84 31.09 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.455 -0.793 . . . . 74.540000000000006 110.758 -178.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.81 171.6 7.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.217 -1.771 . . . . 74.420000000000002 106.217 177.757 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.79 53.35 4.31 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.973 -0.632 . . . . 64.200000000000003 112.98 -177.49 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -150.43 -78.41 0.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.508 1.123 . . . . 75.019999999999996 108.657 177.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.8 159.84 27.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 70.5 108.546 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.48 120.69 33.21 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.45 0.643 . . . . 54.32 110.556 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.05 133.41 34.36 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.943 -1.026 . . . . 74.540000000000006 108.508 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.1 125.29 45.87 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.265 -1.013 . . . . 70.340000000000003 108.265 -178.041 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.22 135.8 46.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.607 0.241 . . . . 74.109999999999999 110.436 177.12 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.72 119.08 38.15 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.932 0.893 . . . . 65.010000000000005 110.011 -177.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.87 77.91 1.62 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.036 -1.838 . . . . 74.430000000000007 106.036 179.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.446 HD22 ' C ' ' A' ' 68' ' ' ASN . 8.1 t30 -173.56 131.31 0.45 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.055 -0.52 . . . . 71.239999999999995 110.16 -165.121 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -108.15 -43.33 4.41 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 113.073 0.768 . . . . 73.409999999999997 113.073 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -88.62 -26.18 22.04 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.631 0.974 . . . . 74.530000000000001 113.631 -170.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.446 ' C ' HD22 ' A' ' 65' ' ' ASN . 5.8 m-20 -115.59 30.12 7.56 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.199 -0.667 . . . . 74.340000000000003 109.199 -177.205 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.93 127.22 4.13 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 124.528 1.143 . . . . 74.030000000000001 114.503 -171.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.0 m -66.69 136.71 55.94 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.103 0.961 . . . . 74.540000000000006 112.756 -176.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 17.8 p -107.58 140.46 40.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.581 -0.736 . . . . 64.549999999999997 110.688 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 80' ' ' TRP . 27.9 m -117.4 117.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.627 -1.249 . . . . 74.349999999999994 107.627 177.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' A' ' 86' ' ' ASP . 5.5 m-80 57.76 31.07 19.94 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.594 -0.73 . . . . 74.010000000000005 110.775 -172.569 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.9 t30 80.44 3.03 1.86 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 126.327 1.851 . . . . 73.340000000000003 111.777 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.26 118.9 65.19 Favored Pre-proline 0 C--N 1.319 -0.722 0 O-C-N 121.458 -0.776 . . . . 64.219999999999999 109.877 177.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.04 129.24 21.38 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.417 2.078 . . . . 73.209999999999994 111.772 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 m -140.97 167.68 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 110.021 -0.363 . . . . 65.019999999999996 110.021 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -109.14 -18.35 13.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.569 0.7 . . . . 73.120000000000005 109.289 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -151.61 155.15 37.82 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.194 -1.039 . . . . 72.450000000000003 108.194 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . 0.433 ' CD2' HG22 ' A' ' 72' ' ' VAL . 73.5 t-105 -159.87 151.92 20.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.015 -0.735 . . . . 74.140000000000001 109.015 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.74 111.56 24.12 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.507 -1.294 . . . . 64.040000000000006 107.507 174.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' HB3' HG11 ' A' ' 97' ' ' VAL . 64.9 mt -56.93 131.87 50.96 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.383 1.052 . . . . 72.319999999999993 112.636 -174.103 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.93 165.66 20.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.596 -0.89 . . . . 72.329999999999998 108.596 175.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.45 116.56 11.92 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.099 -0.704 . . . . 75.319999999999993 109.099 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.43 9.44 23.51 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.871 -0.68 . . . . 75.310000000000002 112.906 179.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.556 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 49.2 m-20 -81.44 117.5 21.93 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.652 -0.819 . . . . 75.150000000000006 111.884 177.328 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.76 112.34 25.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.161 -1.792 . . . . 74.019999999999996 106.161 175.454 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.9 mt -112.03 124.39 68.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.092 0 CA-C-O 120.894 0.378 . . . . 71.409999999999997 110.458 -172.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.556 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.3 mpt_? -109.55 120.37 42.29 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.226 -0.657 . . . . 75.049999999999997 109.226 177.653 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.55 164.16 20.38 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.172 -0.677 . . . . 74.219999999999999 109.172 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.3 108.58 0.6 Allowed Glycine 0 C--N 1.316 -0.575 0 O-C-N 123.506 0.504 . . . . 63.340000000000003 112.959 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 72.75 16.07 4.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.562 1.545 . . . . 75.010000000000005 114.093 177.8 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.8 t -154.05 167.0 31.26 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.901 -0.499 . . . . 74.430000000000007 110.581 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.24 132.31 14.34 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.749 -0.834 . . . . 71.120000000000005 108.749 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.0 tp -141.21 146.25 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.981 -0.377 . . . . 75.219999999999999 109.981 -173.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.52 135.27 53.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.043 -1.095 . . . . 74.349999999999994 108.043 175.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 82' ' ' LEU . 78.0 t -98.42 130.97 46.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 112.18 0.437 . . . . 71.019999999999996 112.18 -178.262 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -119.32 150.37 40.25 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.899 -0.778 . . . . 74.140000000000001 108.899 174.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.1 mtp -129.38 147.38 51.2 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.258 0.551 . . . . 72.209999999999994 111.314 -178.775 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.447 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 35.6 m-70 . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 106.693 -1.595 . . . . 74.25 106.693 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.968 0 N-CA-C 110.449 -1.06 . . . . 61.530000000000001 110.449 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -118.49 147.99 43.06 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.885 -0.783 . . . . 71.450000000000003 108.885 176.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.36 53.71 4.24 Favored Glycine 0 C--N 1.314 -0.667 0 O-C-N 123.399 0.437 . . . . 75.409999999999997 113.014 -177.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 m -88.61 137.64 32.14 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.413 -0.958 . . . . 73.439999999999998 108.413 178.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.15 95.13 9.05 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.915 0.388 . . . . 73.209999999999994 110.317 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.55 -76.98 1.27 Allowed Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 109.166 -1.573 . . . . 74.439999999999998 109.166 176.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 100' ' ' HIS . 86.3 m -123.21 116.92 24.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.682 -1.229 . . . . 65.25 107.682 175.561 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.1 m -101.53 124.34 47.04 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.279 -0.569 . . . . 74.409999999999997 109.638 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.79 115.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.009 -0.737 . . . . 74.530000000000001 109.009 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.478 ' HG1' ' CD2' ' A' ' 100' ' ' HIS . 31.2 m -112.26 123.66 50.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.289 -1.004 . . . . 72.030000000000001 108.289 -178.816 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 54.9 mt -94.43 128.85 41.25 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.777 -0.823 . . . . 70.150000000000006 108.777 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.64 110.48 21.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.894 -1.15 . . . . 74.299999999999997 107.894 -178.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 56.3 tp -104.41 131.17 52.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.831 0.852 . . . . 73.230000000000004 110.669 -175.618 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.436 ' HB3' ' OE2' ' A' ' 94' ' ' GLU . 32.9 t70 -98.32 101.23 12.63 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.996 0.903 . . . . 72.239999999999995 109.728 175.246 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -102.43 -0.62 32.17 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.449 -1.25 . . . . 71.239999999999995 107.759 176.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.43 -21.57 19.15 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.56 -1.2 . . . . 64.349999999999994 110.527 -176.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -109.77 -45.56 3.63 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.306 0.574 . . . . 62.32 109.918 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.56 102.42 2.36 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.379 -1.089 . . . . 71.299999999999997 110.379 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.434 ' HA ' ' HE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -114.98 151.8 33.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 109.847 -0.427 . . . . 71.239999999999995 109.847 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.3 p -135.04 142.37 46.34 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.165 -0.47 . . . . 71.450000000000003 110.86 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -140.83 133.94 29.4 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.471 -1.307 . . . . 73.129999999999995 107.471 177.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -102.51 136.97 41.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.898 -0.779 . . . . 72.530000000000001 108.898 179.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.8 mt -74.77 133.48 41.96 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.195 -0.457 . . . . 73.219999999999999 110.745 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -101.04 164.42 11.81 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.486 -1.301 . . . . 72.0 107.486 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.31 125.15 24.69 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.193 0.52 . . . . 71.140000000000001 111.172 -179.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.63 -164.73 12.16 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 109.112 -1.595 . . . . 73.209999999999994 109.112 -176.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 63.5 p -92.18 135.46 33.97 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 118.214 1.007 . . . . 73.310000000000002 111.588 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -114.32 120.18 39.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.564 -1.643 . . . . 75.439999999999998 106.564 -178.799 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.19 133.0 59.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 120.495 0.188 . . . . 72.319999999999993 111.063 -175.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.13 137.79 42.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 109.181 -0.674 . . . . 65.109999999999999 109.181 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.698 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.54 -151.7 22.52 Favored Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 108.274 -1.93 . . . . 72.200000000000003 108.274 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.9 mtm180 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.361 -1.348 . . . . 75.319999999999993 107.361 172.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.14 -177.21 47.78 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.604 -1.398 . . . . 73.340000000000003 109.604 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -78.49 -18.72 54.41 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.101 0.45 . . . . 72.049999999999997 111.557 178.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.79 -6.47 55.91 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.046 0.451 . . . . 70.120000000000005 110.678 173.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.81 140.55 29.4 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.41 -0.959 . . . . 74.540000000000006 108.41 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -102.04 -52.43 3.16 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.043 -1.095 . . . . 74.25 108.043 179.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -98.92 108.47 21.16 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.73 -1.581 . . . . 64.549999999999997 106.73 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 19.8 ptt85 -97.21 129.46 44.55 Favored 'General case' 0 N--CA 1.41 -2.44 0 C-N-CA 119.907 -0.717 . . . . 62.43 110.69 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.96 137.54 72.95 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.677 -0.692 . . . . 74.329999999999998 109.535 178.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.57 -5.21 16.27 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.588 2.192 . . . . 71.0 111.632 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -86.27 -173.78 4.72 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.014 -0.539 . . . . 72.109999999999999 111.264 -176.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.477 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.8 t -132.17 164.91 25.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.615 -0.883 . . . . 74.319999999999993 108.615 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.88 -29.41 12.53 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.253 -1.539 . . . . 71.400000000000006 109.253 -175.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.34 143.33 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 CA-C-N 114.086 -1.057 . . . . 74.430000000000007 109.899 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -87.64 -176.75 5.67 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.055 0.542 . . . . 63.130000000000003 110.307 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 20.5 ptt180 -67.18 -39.3 86.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.253 0.549 . . . . 75.109999999999999 110.588 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -127.2 114.28 17.46 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.102 -1.814 . . . . 75.430000000000007 106.102 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.505 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 67.7 t60 -104.13 -37.36 7.35 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 121.369 0.604 . . . . 74.5 109.74 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.9 tt -161.02 145.71 13.85 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 116.084 -0.507 . . . . 71.129999999999995 109.845 -176.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.39 139.68 49.51 Favored 'General case' 0 C--N 1.3 -1.543 0 CA-C-N 115.798 -0.637 . . . . 73.120000000000005 110.222 179.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 83.9 mt -121.75 116.74 50.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.455 -0.793 . . . . 73.439999999999998 109.268 178.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.6 mtp-105 -91.44 107.77 19.43 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.803 -1.184 . . . . 65.239999999999995 107.803 176.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -97.55 113.02 24.65 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.19 0.995 . . . . 74.040000000000006 112.766 -175.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.33 150.44 45.48 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.137 -1.801 . . . . 75.530000000000001 106.137 173.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.51 75.96 0.52 Allowed Glycine 0 C--N 1.307 -1.065 0 O-C-N 123.513 0.508 . . . . 64.430000000000007 113.834 -174.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -166.41 -68.29 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.148 -1.427 . . . . 72.310000000000002 107.148 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.9 m -149.06 150.86 13.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 106.449 -1.686 . . . . 73.25 106.449 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.9 126.39 36.04 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.26 -0.576 . . . . 74.409999999999997 109.849 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.9 tt -83.11 107.52 15.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.118 -1.067 . . . . 70.200000000000003 108.118 -178.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.75 120.96 34.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.148 -1.056 . . . . 74.310000000000002 108.148 -179.101 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.0 119.57 23.38 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.246 0.546 . . . . 74.420000000000002 110.219 176.637 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.44 134.73 37.33 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.819 -0.808 . . . . 75.129999999999995 108.819 177.358 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.42 77.24 1.63 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.439 -1.319 . . . . 74.510000000000005 107.439 -177.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.52 163.76 8.4 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.39 -0.524 . . . . 73.25 109.946 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 p -108.13 -54.86 2.45 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.527 179.461 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.441 HG22 ' OD1' ' A' ' 68' ' ' ASN . 5.9 t -90.0 -24.05 21.33 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.411 0.624 . . . . 73.409999999999997 112.518 -175.554 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.441 ' OD1' HG22 ' A' ' 67' ' ' THR . 3.1 m-20 -105.54 22.77 14.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.727 -0.608 . . . . 74.239999999999995 110.066 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.0 118.83 2.9 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 124.442 1.089 . . . . 75.140000000000001 114.384 -175.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 m -65.54 138.46 58.07 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.824 1.25 . . . . 72.439999999999998 113.298 -176.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.43 140.86 38.68 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 108.132 -1.062 . . . . 71.329999999999998 108.132 -179.576 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.08 121.13 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.165 -0.959 . . . . 74.219999999999999 110.208 178.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 58.98 25.86 14.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.232 1.013 . . . . 74.230000000000004 110.586 -177.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 77.7 20.79 1.03 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.997 1.719 . . . . 63.409999999999997 112.63 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.81 125.9 26.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.661 -0.866 . . . . 65.230000000000004 108.661 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.19 128.14 11.88 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.692 2.261 . . . . 75.230000000000004 113.839 -175.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -146.51 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.332 -0.988 . . . . 74.209999999999994 108.332 -178.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -116.89 -32.34 5.13 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.744 -0.382 . . . . 73.430000000000007 110.209 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -129.36 149.81 50.99 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.238 -0.653 . . . . 75.209999999999994 109.238 177.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -158.71 152.72 23.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.083 -0.71 . . . . 73.140000000000001 109.083 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -105.54 109.66 21.71 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.485 -0.931 . . . . 73.349999999999994 108.485 176.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 60.4 mt -64.56 137.55 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.648 0.592 . . . . 75.409999999999997 112.346 -177.26 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.2 163.76 28.89 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.787 -1.56 . . . . 65.409999999999997 106.787 171.74 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.41 121.89 13.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.633 0.254 . . . . 74.109999999999999 110.786 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.73 -11.21 30.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.701 -0.761 . . . . 75.340000000000003 113.37 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -67.04 138.39 57.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 113.065 0.765 . . . . 74.540000000000006 113.065 -179.12 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.18 113.4 39.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.083 -0.962 . . . . 71.400000000000006 108.468 175.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 88' ' ' ILE . 3.0 mp -109.09 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.548 -1.279 . . . . 72.540000000000006 107.548 179.222 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -100.33 106.76 18.42 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.356 -0.609 . . . . 72.219999999999999 109.356 -176.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -82.38 160.52 22.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.219 -1.4 . . . . 73.049999999999997 107.219 176.488 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 92' ' ' HIS . . . -70.64 86.42 0.35 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.978 -1.582 . . . . 71.310000000000002 111.192 179.113 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.443 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 61.1 t-80 163.61 -63.29 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.56 1.944 . . . . 74.030000000000001 108.765 177.515 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.8 m -143.47 174.98 10.28 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.066 -1.087 . . . . 75.510000000000005 108.066 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.436 ' OE2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -114.78 149.41 37.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.306 0.854 . . . . 75.219999999999999 113.306 177.159 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 6.9 tp -119.56 127.39 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.711 -1.218 . . . . 72.530000000000001 107.711 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -103.55 132.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.101 -0.703 . . . . 75.420000000000002 109.101 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.17 117.86 37.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.16 -0.473 . . . . 64.530000000000001 111.332 -178.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -116.69 130.9 57.01 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.257 -1.016 . . . . 74.319999999999993 108.257 175.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.5 mtt -114.43 128.59 56.42 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.496 0.665 . . . . 73.019999999999996 111.807 -178.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.478 ' CD2' ' HG1' ' A' ' 10' ' ' THR . 44.6 m-70 . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 107.38 -1.341 . . . . 74.409999999999997 107.38 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.438 -1.052 0 N-CA-C 109.334 -0.617 . . . . 73.14 109.334 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.429 ' HB3' ' OE1' ' A' ' 22' ' ' GLN . 11.4 m -102.56 115.48 30.66 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.751 -0.833 . . . . 74.52 108.751 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.4 110.27 25.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.175 -0.676 . . . . 65.11 109.175 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 m -106.14 126.09 51.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.227 -0.897 . . . . 72.52 108.605 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 20' ' ' THR . 46.2 mt -93.05 115.04 27.73 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.858 -1.164 . . . . 61.12 107.858 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -92.16 114.36 26.89 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.232 -1.025 . . . . 74.42 108.232 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -113.26 130.68 56.17 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.852 -0.613 . . . . 73.02 110.27 -171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.73 99.96 12.76 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.11 -1.07 . . . . 63.33 108.11 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 7.3 p-10 -91.68 -13.47 31.7 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.114 -1.403 . . . . 74.42 108.019 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.74 -37.86 1.82 Allowed Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 108.392 -1.883 . . . . 74.14 108.392 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -100.52 -53.19 3.16 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.3 0.571 . . . . 54.11 110.075 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.33 89.19 0.89 Allowed Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 109.152 -1.579 . . . . 61.14 109.152 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 3.8 mmp_? -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.282 -0.636 . . . . 71.51 109.282 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.7 p -130.57 138.76 50.32 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.861 0.362 . . . . 75.42 110.853 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -132.79 124.65 28.44 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.638 -1.245 . . . . 74.21 107.638 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.429 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 25.9 tt0 -92.55 139.96 30.05 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.735 -0.786 . . . . 72.34 108.963 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.14 133.9 52.57 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.416 0.447 . . . . 73.33 111.548 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.08 156.03 21.25 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.706 -1.59 . . . . 74.11 106.706 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -76.18 116.59 17.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.521 0.677 . . . . 72.01 109.178 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.43 23.07 Favored Glycine 0 C--N 1.289 -2.062 0 N-CA-C 106.792 -2.523 . . . . 70.24 106.792 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 45.9 p -105.45 131.28 53.07 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 119.431 1.615 . . . . 72.11 112.004 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -103.2 110.29 22.19 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.458 -1.312 . . . . 54.55 107.458 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -95.64 121.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.411 -0.359 . . . . 53.41 110.262 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.6 mt -105.98 130.17 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 123.947 0.899 . . . . 54.14 109.808 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.03 -174.37 40.15 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 110.97 -0.852 . . . . 50.44 110.97 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 42' ' ' ASP . 25.0 mtp180 -107.21 104.94 14.69 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.608 -0.837 . . . . 73.43 109.448 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.67 169.28 37.14 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.198 -1.161 . . . . 64.44 110.198 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.62 -14.24 56.97 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.502 -1.295 . . . . 53.53 107.502 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.91 -4.56 59.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.138 -1.846 . . . . 71.43 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -109.35 147.56 32.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.978 -1.01 . . . . 61.2 109.375 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -93.68 -32.84 13.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.385 0.612 . . . . 73.42 110.988 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -118.82 124.96 48.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.919 -1.511 . . . . 74.44 106.919 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -105.76 130.73 53.7 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.781 0.324 . . . . 74.05 111.747 -174.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 52.8 mt -85.8 145.91 42.44 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 65.01 112.238 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.8 Cg_exo -72.18 -33.57 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.261 2.641 . . . . 65.44 114.598 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 5.3 t70 -93.25 179.95 5.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.577 -0.898 . . . . 42.1 108.577 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.4 t -118.68 171.04 8.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.116 0.484 . . . . 51.35 110.262 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.46 61.15 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 108.937 -1.665 . . . . 74.25 108.937 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.42 129.55 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 CA-C-N 113.281 -1.46 . . . . 71.22 107.834 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -77.11 171.9 14.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.849 -0.426 . . . . 73.03 109.849 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 16.9 ptt180 -58.2 -46.56 85.61 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-O 121.593 0.711 . . . . 75.43 109.792 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.421 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 37.3 mtp180 -119.12 95.9 5.0 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 104.42 -2.437 . . . . 75.52 104.42 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -98.22 -32.05 11.77 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.198 -0.91 . . . . 74.22 108.91 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD11 HD21 ' A' ' 61' ' ' LEU . 6.7 tt -163.87 145.39 9.0 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.816 -0.809 . . . . 72.04 108.816 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -137.84 143.61 41.05 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.02 0.438 . . . . 72.45 110.447 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 65.8 mt -125.42 116.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.71 -0.677 . . . . 73.44 109.783 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 58.0 ttp180 -91.39 113.63 25.94 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.805 -1.183 . . . . 70.41 107.805 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 -102.22 125.32 48.89 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 116.002 -0.545 . . . . 71.51 110.126 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -133.38 168.89 17.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.195 -1.409 . . . . 72.23 107.195 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.64 58.53 2.09 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 114.968 0.747 . . . . 43.25 114.968 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -170.73 -68.12 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.905 0.882 . . . . 60.14 108.974 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.85 156.83 42.91 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 CA-C-O 121.259 0.552 . . . . 74.11 111.52 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -102.2 114.62 28.93 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.088 -0.96 . . . . 51.45 109.442 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.4 tt -80.91 113.77 19.34 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.755 -1.111 . . . . 75.4 109.241 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.492 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -101.39 120.82 40.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.291 -1.003 . . . . 64.31 108.291 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.02 121.16 30.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.307 -0.257 . . . . 51.33 110.307 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -87.98 124.44 33.72 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.687 -0.857 . . . . 63.21 108.687 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.99 76.28 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 176.34 153.05 0.18 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.636 -1.987 . . . . 71.41 105.636 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.9 m -110.19 -53.44 2.68 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.237 0.829 . . . . 73.13 113.237 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 t -71.74 -38.57 70.42 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.567 0.58 . . . . 75.22 112.567 -172.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -116.89 23.74 11.71 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.318 -1.364 . . . . 75.43 107.318 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 163.43 19.65 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 113.41 -1.723 . . . . 52.04 113.864 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 m -84.74 143.86 28.88 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 123.894 0.877 . . . . 73.22 111.899 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 p -112.0 141.1 46.07 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.517 -0.765 . . . . 63.21 110.285 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 80' ' ' TRP . 33.3 m -114.11 120.86 65.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.822 -1.547 . . . . 54.43 106.822 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.83 24.34 14.47 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.236 1.014 . . . . 70.35 109.83 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 79.59 5.34 2.05 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.534 1.533 . . . . 44.44 112.513 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.65 30.82 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.953 -0.388 . . . . 62.32 109.953 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.26 127.84 14.75 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.382 2.055 . . . . 54.23 111.737 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 80' ' ' TRP . 26.9 m -142.89 166.75 14.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.734 -0.839 . . . . 64.42 108.734 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -106.07 -31.91 8.51 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.973 -1.121 . . . . 65.42 107.973 174.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.08 35.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.99 -1.459 . . . . 63.32 110.338 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.486 ' HB2' HG21 ' A' ' 77' ' ' VAL . 72.7 t-105 -153.67 153.03 31.51 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.535 -0.913 . . . . 75.14 108.535 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -114.58 126.25 54.7 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.209 -1.034 . . . . 74.22 108.209 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 42.1 mt -56.88 147.55 23.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.032 1.123 . . . . 75.34 114.032 -171.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 147.96 39.52 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.005 -1.109 . . . . 74.44 108.005 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 28.9 t70 -65.39 124.89 23.46 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 71.03 110.862 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.87 64.43 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 115.22 -0.9 . . . . 70.05 112.992 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.23 156.88 22.92 Favored 'General case' 0 C--O 1.249 1.071 0 C-N-CA 119.505 -0.878 . . . . 64.25 108.717 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.08 113.23 43.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.361 -0.607 . . . . 74.41 109.361 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.414 HD11 HD22 ' A' ' 82' ' ' LEU . 59.2 mt -110.06 117.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.097 -0.705 . . . . 71.3 109.097 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -120.52 123.64 43.41 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.448 -0.501 . . . . 55.32 111.263 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 163.43 23.03 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.24 -0.891 . . . . 72.13 108.959 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -42.12 103.89 0.04 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 115.598 0.999 . . . . 64.22 115.598 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 m170 69.25 12.09 8.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.602 1.561 . . . . 73.22 113.503 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.7 m -149.21 115.37 5.76 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.334 0.588 . . . . 64.4 111.075 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.95 143.32 43.13 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.178 0.513 . . . . 65.25 111.243 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.28 142.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.215 -0.902 . . . . 73.45 111.387 -171.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.7 mm -111.41 132.81 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.0 -1.111 . . . . 74.34 108.0 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.55 126.86 43.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 120.846 0.355 . . . . 62.05 111.453 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.442 ' HA ' ' HE ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -117.15 125.97 52.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.755 -0.832 . . . . 63.32 108.755 176.168 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.505 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 84.3 mtp -114.35 116.5 29.04 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.852 -0.796 . . . . 75.44 108.852 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 . . . . . 0 C--N 1.28 -2.438 0 N-CA-C 107.463 -1.31 . . . . 75.14 107.463 -179.025 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.494 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 84.8 m . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 108.07 -1.085 . . . . 75.21 108.07 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -123.63 125.03 44.09 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.986 -0.746 . . . . 52.51 108.986 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.5 124.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.268 -1.012 . . . . 74.44 108.268 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.428 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.7 m -117.2 124.71 49.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.939 -0.763 . . . . 72.11 108.939 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 mt -90.88 124.9 35.54 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.231 -1.025 . . . . 75.42 108.231 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -107.82 120.12 41.36 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.821 -0.807 . . . . 74.1 108.821 -177.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -114.27 125.83 54.34 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.307 -0.998 . . . . 74.45 108.307 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.92 100.12 10.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 118.959 -1.096 . . . . 63.22 108.083 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.92 38.59 2.23 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 113.418 -1.719 . . . . 62.44 107.961 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.03 -54.81 0.64 Allowed Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.392 -1.083 . . . . 63.02 110.392 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 t -111.83 -56.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.711 -1.218 . . . . 74.22 107.711 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.79 109.83 0.47 Allowed Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.516 -0.849 . . . . 74.13 112.712 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -95.9 141.37 29.41 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.502 -0.925 . . . . 73.41 108.502 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.2 p -128.74 135.01 48.63 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.56 -0.456 . . . . 73.12 111.502 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -121.03 110.96 16.88 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.579 -0.897 . . . . 73.32 108.579 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -78.79 129.3 34.46 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.847 -0.797 . . . . 73.54 108.847 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.35 125.56 29.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.704 -0.851 . . . . 70.34 108.704 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -100.78 170.49 8.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.375 -0.602 . . . . 71.32 109.375 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.32 134.84 57.45 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.348 1.03 . . . . 62.42 111.594 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.52 -175.62 15.87 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 109.165 -1.574 . . . . 72.24 109.165 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 57.4 p -96.1 137.48 35.11 Favored 'General case' 0 N--CA 1.415 -2.176 0 C-N-CA 119.47 -0.892 . . . . 73.14 110.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -114.46 111.74 21.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.457 -0.942 . . . . 62.31 108.457 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.77 124.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.089 -1.078 . . . . 50.04 108.089 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -109.01 129.76 63.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 123.435 0.459 . . . . 64.33 109.791 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.26 -163.39 29.5 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.161 -1.576 . . . . 71.51 109.161 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.542 ' C ' ' HA ' ' A' ' 47' ' ' ARG . 52.1 mtm180 -126.34 105.86 9.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 119.105 1.453 . . . . 63.23 112.364 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' HA3' ' HG2' ' A' ' 47' ' ' ARG . . . -172.27 -178.52 42.52 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 107.129 -2.388 . . . . 64.11 107.129 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -74.96 -11.43 60.11 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.085 0.945 . . . . 72.33 110.333 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.55 -23.03 29.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.918 -1.037 . . . . 72.34 109.304 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.31 130.99 35.57 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.819 0.819 . . . . 51.42 113.037 -171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.24 -26.02 22.56 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.832 -1.076 . . . . 62.34 108.85 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -131.85 115.68 16.24 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.204 -1.036 . . . . 72.23 108.204 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.657 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -95.93 112.12 23.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.983 -0.553 . . . . 60.01 111.06 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 44.8 mt -71.63 128.99 89.09 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 110.266 -0.272 . . . . 62.05 110.266 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -73.61 40.19 0.53 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.203 2.602 . . . . 75.23 113.839 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.0 152.67 29.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.929 -0.767 . . . . 72.45 108.929 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.4 m -97.16 118.32 33.32 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.59 -0.522 . . . . 73.51 109.59 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.07 -13.43 21.77 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.521 -0.847 . . . . 70.34 112.448 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.36 122.28 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.429 0.633 . . . . 74.13 109.361 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -65.19 164.14 13.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.008 -0.997 . . . . 73.42 112.176 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HA ' ' C ' ' A' ' 32' ' ' ARG . 48.1 mtp180 -54.41 -49.29 70.26 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.829 0.852 . . . . 73.21 109.926 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -120.6 101.97 8.11 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 106.087 -1.819 . . . . 61.13 106.087 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -104.05 -32.49 9.18 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.473 0.654 . . . . 53.23 109.402 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -162.68 149.93 13.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.74 -0.837 . . . . 71.12 108.74 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.29 138.22 50.37 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.202 0.525 . . . . 61.42 110.269 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' SER . 79.4 mt -119.15 116.22 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.12 -0.696 . . . . 62.04 109.12 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -93.7 107.23 19.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.616 -1.624 . . . . 71.33 106.616 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.403 ' HZ2' ' O ' ' A' ' 7' ' ' THR . 50.8 t-105 -110.82 146.6 36.14 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.945 -1.025 . . . . 74.05 109.559 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -149.78 165.23 33.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 103.929 -2.619 . . . . 51.14 103.929 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.67 37.01 0.86 Allowed Glycine 0 C--N 1.305 -1.148 0 CA-C-N 119.133 0.879 . . . . 71.34 114.679 -175.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -137.4 -71.15 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 124.034 0.934 . . . . 75.21 109.903 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -130.81 159.32 42.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.53 -0.304 . . . . 64.4 110.692 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.54 116.68 31.26 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.763 -0.653 . . . . 75.33 110.289 -178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.8 116.7 32.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.098 -0.704 . . . . 72.1 109.098 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HD21 ' A' ' 82' ' ' LEU . 7.3 tt -104.81 142.6 34.44 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.332 -0.394 . . . . 72.51 110.537 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.14 127.62 26.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.817 -0.629 . . . . 64.54 109.676 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -83.0 140.42 32.74 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.644 -0.707 . . . . 73.14 109.226 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.26 77.44 1.73 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.035 -1.098 . . . . 71.24 108.035 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -178.1 121.21 0.1 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.438 -0.578 . . . . 71.11 109.438 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -88.75 -20.1 25.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.137 0.494 . . . . 72.12 110.447 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -89.33 -52.44 5.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.42 0.629 . . . . 75.33 111.382 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -111.21 28.75 8.43 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.7 -0.682 . . . . 75.24 110.194 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.06 129.98 5.5 Favored Glycine 0 N--CA 1.47 0.939 0 O-C-N 124.574 1.171 . . . . 53.42 114.933 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 90' ' ' LEU . 9.0 m -74.94 152.09 38.83 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 124.733 1.213 . . . . 70.33 113.044 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.6 p -119.3 144.66 46.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.121 -0.945 . . . . 73.42 110.107 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 80' ' ' TRP . 28.1 m -116.36 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.039 -1.097 . . . . 43.23 108.039 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 61.14 25.93 15.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.81 0.814 . . . . 45.03 109.666 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 85.54 -4.57 0.85 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.82 2.048 . . . . 74.42 113.855 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -89.61 124.39 64.24 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.864 -0.421 . . . . 63.21 109.864 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 16.2 Cg_exo -69.15 125.5 12.55 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.76 2.307 . . . . 62.34 111.81 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -139.02 166.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.384 -0.371 . . . . 75.25 110.64 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -105.74 -14.48 15.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.71 -0.848 . . . . 72.35 108.71 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -161.78 155.63 21.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.118 -1.067 . . . . 70.32 108.118 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.403 ' CD2' HG21 ' A' ' 72' ' ' VAL . 75.8 t-105 -161.34 143.41 11.96 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.349 0.405 . . . . 74.1 109.909 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.23 111.79 23.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.119 -1.067 . . . . 72.02 108.119 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 69.5 mt -56.46 135.95 54.13 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.902 0.705 . . . . 54.22 112.902 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.0 164.66 19.67 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.079 -1.082 . . . . 61.53 108.079 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.513 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 28.8 t70 -71.95 124.36 24.74 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.152 -0.476 . . . . 72.51 110.456 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.91 13.21 56.87 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.743 -0.662 . . . . 74.52 113.091 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.67 137.45 42.18 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 117.628 0.714 . . . . 54.14 111.714 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.1 112.16 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.276 -1.379 . . . . 63.51 107.276 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.5 mt -111.6 106.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 C-N-CA 119.322 -0.951 . . . . 72.42 109.44 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -104.26 131.89 51.09 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.635 -0.711 . . . . 73.51 109.678 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.3 pt? -125.18 164.5 20.14 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.412 -0.959 . . . . 74.24 108.412 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.26 125.82 25.9 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.995 -1.098 . . . . 75.33 110.532 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m170 83.1 -23.6 0.2 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.217 1.562 . . . . 62.24 115.217 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -153.21 -171.75 4.02 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.643 1.111 . . . . 74.22 111.999 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.66 147.58 30.14 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.988 -0.745 . . . . 74.41 108.988 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.6 tp -130.41 135.58 60.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.005 -1.109 . . . . 74.31 108.005 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 53.4 mt -101.0 132.09 47.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.698 -0.852 . . . . 72.12 108.698 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 82' ' ' LEU . 72.5 t -100.26 116.35 43.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.446 0.641 . . . . 72.42 111.158 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.513 ' HD3' ' OD1' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -115.63 125.87 53.45 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.415 -1.328 . . . . 70.22 107.415 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.5 mtm -112.52 111.74 22.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.229 -0.988 . . . . 43.23 110.547 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.494 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 21.1 m-70 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 108.012 -1.107 . . . . 71.12 108.012 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.439 -1.01 0 CA-C-O 121.305 0.574 . . . . 73.21 109.621 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m -107.65 117.28 33.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 115.746 -0.661 . . . . 71.14 109.644 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 23' ' ' LEU . 40.7 t -91.29 114.86 29.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 106.726 -1.583 . . . . 73.44 106.726 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -110.61 124.07 51.18 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.037 -0.727 . . . . 72.12 109.037 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 95' ' ' ILE . 4.5 pp -95.44 128.92 42.68 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.44 -0.578 . . . . 74.25 109.44 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -105.39 119.59 39.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.559 -0.904 . . . . 75.52 108.559 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -102.39 120.15 40.01 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 123.755 0.822 . . . . 71.25 108.934 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -100.17 100.99 11.91 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.659 -1.216 . . . . 73.4 110.153 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -103.53 5.03 36.49 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 112.99 -1.914 . . . . 65.14 108.502 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.16 -19.81 31.71 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.475 -1.45 . . . . 74.12 109.475 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -103.5 -53.5 2.78 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.226 -1.028 . . . . 63.34 108.226 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.34 83.03 1.69 Allowed Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.396 -0.82 . . . . 63.42 111.698 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 19' ' ' ARG . 4.5 mmp_? -100.37 163.81 12.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.724 -0.28 . . . . 72.12 110.273 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 14.9 p -135.61 152.24 51.05 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.741 0.305 . . . . 64.23 110.983 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.437 ' HB3' HD11 ' A' ' 11' ' ' LEU . 90.1 t80 -142.24 132.51 24.87 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.357 -0.979 . . . . 72.44 108.357 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.08 125.03 33.15 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.363 -0.606 . . . . 74.04 109.363 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.427 HD13 HG21 ' A' ' 52' ' ' ILE . 78.1 mt -71.28 127.64 33.25 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.165 -0.679 . . . . 72.54 109.165 174.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.78 168.6 10.56 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.568 -0.742 . . . . 64.51 109.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.94 131.5 40.73 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.674 0.749 . . . . 43.24 111.423 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.66 -173.79 15.05 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 108.382 -1.887 . . . . 64.1 108.382 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.3 p -106.81 142.77 35.91 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 118.549 1.174 . . . . 64.23 111.856 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -117.8 140.77 49.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.339 -0.615 . . . . 74.31 109.339 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.86 124.14 53.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.613 -0.884 . . . . 74.43 108.613 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 38' ' ' PHE . 52.6 mt -106.91 120.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 124.477 1.111 . . . . 71.01 110.147 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.63 -176.43 35.54 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.547 -1.421 . . . . 51.24 109.547 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 61.6 mtt180 -103.99 107.12 17.86 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 118.35 1.075 . . . . 71.53 111.418 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.38 -172.42 38.85 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 110.444 -1.062 . . . . 71.53 110.444 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -94.35 -29.26 15.11 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 122.959 0.504 . . . . 73.44 110.823 179.14 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -82.14 -19.73 39.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.873 -0.788 . . . . 72.24 108.873 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 137.69 54.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.048 -0.978 . . . . 60.31 109.566 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -97.89 -24.51 15.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.483 0.659 . . . . 70.02 110.318 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' HB3' HG12 ' A' ' 30' ' ' ILE . 40.2 t80 -131.14 124.26 30.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.373 -1.343 . . . . 71.42 107.373 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 134.25 55.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.406 -0.361 . . . . 74.52 110.93 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.423 HD13 HG11 ' A' ' 45' ' ' VAL . 6.8 mp -73.7 147.56 86.85 Favored Pre-proline 0 CA--C 1.502 -0.898 0 CA-C-N 115.604 -0.725 . . . . 74.43 111.807 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.13 26.37 0.61 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 123.584 2.856 . . . . 74.12 113.267 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -137.72 176.4 8.74 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.697 -0.853 . . . . 73.51 108.697 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -105.28 170.66 7.75 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.374 -0.602 . . . . 74.53 109.374 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 2.69 79.75 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.925 -0.47 . . . . 71.32 111.925 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 40' ' ' LEU . 33.4 t -95.13 133.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.989 -0.745 . . . . 74.5 108.989 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -72.39 176.34 5.41 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.122 0.569 . . . . 74.52 109.653 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.0 ptm180 -66.09 -34.92 79.16 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.379 0.609 . . . . 74.32 110.359 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.51 109.65 12.94 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.791 -1.188 . . . . 63.12 107.791 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 59.9 t60 -103.99 -34.16 8.56 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.854 -0.612 . . . . 75.22 109.501 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.409 HD11 HD21 ' A' ' 61' ' ' LEU . 9.0 tt -165.88 160.03 16.48 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.301 -1.0 . . . . 73.43 108.301 -176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.8 138.52 32.3 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.089 0.471 . . . . 63.32 109.781 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 23' ' ' LEU . 64.0 mt -113.19 115.19 49.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 109.202 -0.666 . . . . 72.12 109.202 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 62.0 ttt180 -97.2 107.79 20.38 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 108.817 -0.809 . . . . 50.13 108.817 174.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -97.48 107.24 19.7 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.657 -0.868 . . . . 74.33 108.657 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.1 171.35 8.07 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.006 -1.85 . . . . 74.54 106.006 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.14 49.58 4.14 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 119.817 -1.182 . . . . 54.24 114.003 -174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -171.66 -64.04 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.871 0.868 . . . . 74.25 109.178 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.32 149.67 17.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 CA-C-O 121.323 0.582 . . . . 73.4 112.15 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -99.75 103.18 14.81 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.275 -0.875 . . . . 65.31 109.347 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.24 113.49 21.15 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.362 -0.836 . . . . 71.02 109.162 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -100.52 120.32 39.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.145 -1.057 . . . . 73.5 108.145 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.89 126.68 43.7 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.875 -0.417 . . . . 74.45 109.875 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 11.3 t70 -97.25 139.17 33.62 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 122.848 0.459 . . . . 64.12 110.722 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.11 75.91 1.26 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.431 -0.952 . . . . 65.3 108.431 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.562 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 33.3 t-20 -166.46 154.04 9.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.57 -1.27 . . . . 73.45 107.57 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.4 t -108.92 -48.71 3.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.989 0.423 . . . . 70.04 110.341 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -89.33 -35.91 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.648 0.611 . . . . 71.32 112.648 -175.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.562 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.2 m120 -105.39 27.06 8.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.537 -0.542 . . . . 51.35 109.537 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.79 128.46 20.78 Favored Glycine 0 C--O 1.251 1.158 0 O-C-N 124.894 1.371 . . . . 51.11 112.264 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -62.01 133.04 54.83 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 124.124 0.969 . . . . 74.14 112.54 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.635 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.0 p -103.42 140.08 37.94 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.513 -0.767 . . . . 74.4 109.459 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 77' ' ' VAL . 27.5 m -124.26 119.58 56.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.937 -1.134 . . . . 75.35 107.937 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.26 30.97 20.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.404 0.682 . . . . 72.14 110.54 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 t30 82.09 -1.53 1.49 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.738 2.015 . . . . 64.3 112.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.98 124.19 44.52 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 121.487 -0.758 . . . . 75.15 109.431 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.14 124.3 4.83 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.765 1.643 . . . . 72.15 110.441 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 72' ' ' VAL . 28.2 m -148.68 151.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 73.24 107.432 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 77.1 mt-30 -96.69 -0.46 48.31 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.957 -0.697 . . . . 72.54 111.327 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.54 130.12 15.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.794 -0.639 . . . . 71.31 110.119 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -159.89 152.97 21.82 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.588 -1.264 . . . . 71.01 107.588 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.89 124.4 50.59 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.967 -1.093 . . . . 73.44 108.115 173.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.569 ' HB3' HG11 ' A' ' 97' ' ' VAL . 69.0 mt -65.1 139.4 58.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.949 0.722 . . . . 71.43 112.949 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -135.65 168.5 19.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.059 -0.719 . . . . 73.34 109.059 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.48 121.09 19.03 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.917 -0.401 . . . . 73.53 109.917 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.2 9.84 40.85 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.905 -0.664 . . . . 53.5 112.698 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -78.38 126.26 30.52 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 120.008 -0.677 . . . . 70.43 110.005 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.67 112.31 26.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.22 -1.4 . . . . 75.23 107.22 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 95' ' ' ILE . 57.4 mt -120.01 139.28 47.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 120.291 -0.564 . . . . 75.22 110.861 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.635 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.0 mpt_? -120.37 131.24 54.75 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.138 -1.06 . . . . 74.45 108.138 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 2.2 pt? -131.73 164.52 25.79 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.336 -0.987 . . . . 74.15 108.336 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -33.55 97.07 0.01 OUTLIER Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.002 1.161 . . . . 65.42 116.002 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.0 m170 72.07 13.95 5.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.698 1.599 . . . . 72.45 114.801 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t -153.62 -178.3 6.93 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.31 0.576 . . . . 71.32 110.178 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.74 153.08 45.75 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.762 -0.586 . . . . 72.44 109.448 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.519 HD11 HD13 ' A' ' 11' ' ' LEU . 8.9 tp -141.45 141.37 30.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.762 -0.829 . . . . 72.44 108.762 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.73 125.69 72.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.469 -0.937 . . . . 65.41 108.469 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.569 HG11 ' HB3' ' A' ' 82' ' ' LEU . 79.4 t -93.26 128.67 44.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 111.938 0.348 . . . . 62.44 111.938 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -119.16 151.26 38.63 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.767 -0.827 . . . . 72.13 108.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 89.2 mtp -128.34 120.01 26.19 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.314 -0.403 . . . . 73.33 110.262 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 . . . . . 0 C--N 1.294 -1.842 0 N-CA-C 108.333 -0.988 . . . . 72.14 108.333 -179.732 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.577 HG22 ' HH2' ' A' ' 54' ' ' TRP . 31.9 m . . . . . 0 N--CA 1.415 -2.216 0 N-CA-C 108.56 -0.904 . . . . 65.43 108.56 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 99' ' ' MET . 54.0 p -158.43 143.98 16.69 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.337 -1.727 . . . . 33.51 106.337 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.82 126.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 120.159 -0.617 . . . . 63.4 111.226 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 25.3 m -120.77 132.07 54.84 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.984 -1.117 . . . . 72.1 107.984 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.12 135.76 33.72 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.68 -0.489 . . . . 74.24 109.68 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -116.57 124.86 50.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.726 -0.67 . . . . 70.34 111.19 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.6 133.66 48.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.137 -1.061 . . . . 74.45 108.137 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.96 101.71 7.72 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.04 -1.064 . . . . 64.33 112.592 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.04 -47.53 68.13 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.661 -1.607 . . . . 71.4 106.661 171.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.29 45.69 0.01 OUTLIER Glycine 0 N--CA 1.427 -1.9 0 N-CA-C 105.979 -2.848 . . . . 43.0 105.979 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -162.5 -52.79 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.193 -1.039 . . . . 73.02 108.193 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.12 92.37 2.14 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.691 -0.766 . . . . 44.14 111.93 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -99.13 150.24 22.23 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.31 -0.996 . . . . 74.1 108.31 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 35.8 p -142.94 132.25 23.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.663 0.602 . . . . 75.4 109.859 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -134.54 135.26 42.19 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.505 -1.665 . . . . 74.15 106.505 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 33.5 tt0 -101.71 144.31 30.57 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.093 -0.643 . . . . 54.21 111.156 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 52' ' ' ILE . 76.1 mt -78.88 139.23 38.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.715 -0.675 . . . . 33.21 110.359 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -95.29 157.86 15.71 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.347 -1.353 . . . . 74.51 107.347 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.5 146.03 55.2 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.182 0.515 . . . . 73.34 111.576 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.43 -171.44 15.81 Favored Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 107.723 -2.151 . . . . 75.15 107.723 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 67.1 p -96.63 127.46 42.63 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.638 -1.225 . . . . 52.32 111.084 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -103.57 113.58 27.19 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.389 -1.708 . . . . 73.42 106.389 -178.138 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -89.83 132.3 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.964 -0.562 . . . . 72.51 109.694 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -116.07 132.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.684 -0.689 . . . . 74.35 109.859 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 158.4 -162.23 32.23 Favored Glycine 0 CA--C 1.495 -1.162 0 N-CA-C 108.611 -1.796 . . . . 34.24 108.611 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 56.1 mtp180 -122.17 103.69 8.96 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.008 -1.479 . . . . 71.31 107.008 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.594 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 174.84 176.16 42.92 Favored Glycine 0 N--CA 1.414 -2.828 0 N-CA-C 110.935 -0.866 . . . . 61.42 110.935 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -52.1 -40.36 61.15 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.751 1.22 . . . . 74.04 113.373 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.68 -37.07 73.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.491 . . . . 71.02 111.453 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.78 15.9 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.357 -0.838 . . . . 72.22 112.795 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -75.35 -36.15 61.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.434 -0.95 . . . . 62.23 108.434 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -105.45 108.87 20.62 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.536 -0.913 . . . . 65.23 108.536 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.6 mmt85 -87.66 121.35 29.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.152 -0.931 . . . . 72.25 109.455 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD12 HG21 ' A' ' 45' ' ' VAL . 44.2 mt -79.19 130.53 68.94 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.362 -0.607 . . . . 72.14 109.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.02 -1.91 9.48 Favored 'Trans proline' 0 C--N 1.325 -0.696 0 C-N-CA 122.013 1.808 . . . . 53.24 111.049 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -88.67 -176.65 5.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.937 -1.029 . . . . 73.13 111.234 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.0 t -123.21 170.89 9.79 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.694 -0.484 . . . . 74.2 109.694 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.03 71.79 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.57 -1.412 . . . . 75.32 109.57 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 40' ' ' LEU . 7.1 p -113.85 144.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.295 -0.952 . . . . 72.33 111.0 -173.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.5 p -91.84 -167.68 1.84 Allowed 'General case' 0 C--O 1.254 1.292 0 C-N-CA 124.137 0.975 . . . . 64.04 109.499 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 5.6 ptt180 -80.84 -34.29 33.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 118.247 -1.381 . . . . 73.15 109.287 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -124.04 100.7 6.86 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.412 -1.699 . . . . 72.24 106.412 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -100.81 -34.37 9.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.124 -0.944 . . . . 64.42 109.717 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 tt -162.14 148.37 13.34 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.003 -0.74 . . . . 63.23 109.003 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.31 139.61 50.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.281 0.562 . . . . 75.55 109.824 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 23' ' ' LEU . 69.6 mt -113.85 113.81 44.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.981 -0.748 . . . . 74.13 108.981 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 86.6 mtt180 -91.71 107.03 18.92 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.915 -1.143 . . . . 64.32 107.915 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.577 ' HH2' HG22 ' A' ' 7' ' ' THR . 47.7 t-105 -103.13 126.93 50.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.721 -0.672 . . . . 73.33 111.289 -175.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -128.27 162.87 26.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.409 -2.071 . . . . 53.04 105.409 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.11 51.27 1.65 Allowed Glycine 0 CA--C 1.534 1.262 0 N-CA-C 116.345 1.298 . . . . 44.41 116.345 -172.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -62.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.525 -0.917 . . . . 75.42 108.525 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.76 138.85 38.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-O 121.42 0.628 . . . . 71.14 112.162 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -103.99 114.04 28.0 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.376 -0.829 . . . . 72.22 110.233 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 5.7 tt -91.25 110.34 21.62 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.623 -0.88 . . . . 70.44 108.623 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -94.21 121.9 36.2 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.233 -1.395 . . . . 75.11 107.233 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.29 120.56 24.58 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.154 0.502 . . . . 62.13 110.384 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.31 138.1 33.09 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.461 -0.791 . . . . 72.45 108.941 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.8 OUTLIER -123.06 76.8 1.4 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 109.356 -0.609 . . . . 73.22 109.356 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER 160.79 151.76 0.01 OUTLIER 'General case' 0 C--O 1.198 -1.653 0 C-N-CA 125.914 1.686 . . . . 73.44 109.606 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -104.35 -12.31 16.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 121.562 -0.711 . . . . 72.21 109.716 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -72.73 -64.36 0.98 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.645 -0.707 . . . . 44.21 111.674 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -107.12 28.93 7.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.958 -1.127 . . . . 73.32 107.958 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.79 120.89 2.73 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.452 -1.249 . . . . 74.14 113.245 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 m -70.29 142.8 52.23 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 124.903 1.281 . . . . 75.33 112.373 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 76' ' ' PRO . 12.9 p -105.38 141.25 37.22 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.613 -0.721 . . . . 65.11 111.262 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.86 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 106.67 -1.604 . . . . 51.04 106.67 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.49 23.92 11.27 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.456 -0.572 . . . . 75.03 109.456 -170.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 74.42 15.03 3.53 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.756 1.622 . . . . 72.3 111.712 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.57 123.71 37.2 Favored Pre-proline 0 C--N 1.315 -0.897 0 O-C-N 121.267 -0.896 . . . . 71.52 109.012 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.411 ' N ' HG22 ' A' ' 71' ' ' THR . 57.4 Cg_endo -77.31 125.16 7.58 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 121.981 1.787 . . . . 71.02 111.859 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.4 m -135.28 170.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.867 -0.606 . . . . 61.24 110.011 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -91.13 -47.02 7.78 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.163 -1.051 . . . . 70.45 108.163 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.5 pt-20 -141.26 151.8 43.99 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.169 -0.923 . . . . 74.53 109.875 177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.493 ' HB2' HG21 ' A' ' 77' ' ' VAL . 23.3 t-105 -157.11 152.03 25.87 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.268 -1.012 . . . . 73.21 108.268 -175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 79.3 mt-30 -101.36 119.36 38.64 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.903 -0.719 . . . . 63.53 109.348 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' HG11 ' A' ' 97' ' ' VAL . 78.2 mt -56.29 143.2 34.87 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 124.087 0.867 . . . . 54.41 111.656 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.97 39.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.602 -1.259 . . . . 73.32 107.602 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.79 127.85 34.05 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.729 -0.471 . . . . 75.21 109.729 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.22 -5.35 52.51 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.897 -0.592 . . . . 63.02 111.88 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.64 127.65 33.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 75.31 109.986 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.11 112.41 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.75 -1.204 . . . . 74.34 107.75 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.405 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 40.3 mt -103.39 125.02 57.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 108.196 -1.039 . . . . 75.1 108.196 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -129.55 124.92 35.06 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.061 0.458 . . . . 71.14 111.521 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -100.81 163.39 12.34 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 105.005 -2.22 . . . . 73.23 105.005 170.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.94 85.74 0.88 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 118.414 -1.851 . . . . 75.44 111.339 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 161.68 -54.07 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 126.632 1.973 . . . . 72.13 108.155 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -133.37 155.37 49.59 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.793 0.806 . . . . 74.31 111.734 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -121.27 144.02 48.85 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 114.359 -1.291 . . . . 74.23 109.038 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 8.3 tp -134.82 146.74 30.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.373 -1.343 . . . . 74.22 107.373 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.74 137.6 45.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.499 0.591 . . . . 74.33 109.456 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 82' ' ' LEU . 99.1 t -89.14 127.64 41.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.87 0.367 . . . . 61.32 111.421 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.09 145.18 47.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.684 -0.689 . . . . 73.12 109.208 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' SER . 90.0 mtp -122.02 124.35 43.78 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.523 -0.547 . . . . 73.53 109.523 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.4 m80 . . . . . 0 C--N 1.302 -1.485 0 CA-C-O 118.852 -0.594 . . . . 75.45 110.024 -175.393 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.421 -1.924 0 N-CA-C 110.055 -0.35 . . . . 73.13 110.055 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.9 m -116.13 115.29 25.78 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.875 -1.158 . . . . 70.12 107.875 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.3 p -95.44 117.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.965 -0.754 . . . . 54.54 108.965 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.443 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.8 m -123.68 135.58 53.97 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.888 -1.051 . . . . 63.41 110.643 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 mt -85.93 126.98 34.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.139 -1.06 . . . . 70.4 108.139 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -111.47 128.36 55.98 Favored 'General case' 0 C--N 1.286 -2.181 0 O-C-N 123.752 0.658 . . . . 75.21 111.099 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.5 tp -136.55 128.26 28.96 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.456 -0.942 . . . . 75.43 108.456 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.6 100.08 12.95 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.685 -1.228 . . . . 41.2 107.685 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -125.17 84.31 2.26 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 107.294 -1.372 . . . . 63.11 107.294 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.62 -73.14 1.23 Allowed Glycine 0 C--N 1.289 -2.029 0 CA-C-N 114.731 -1.122 . . . . 55.2 110.328 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -121.84 -35.58 3.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.554 -0.906 . . . . 61.14 108.554 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.38 115.97 1.21 Allowed Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 120.507 -0.854 . . . . 44.22 111.443 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -100.56 142.01 32.63 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.204 -1.406 . . . . 63.24 107.204 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.7 p -141.44 132.42 26.08 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.434 0.459 . . . . 61.41 111.415 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -121.52 111.99 17.94 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.82 -0.627 . . . . 75.54 109.469 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.15 132.02 34.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.556 -0.535 . . . . 70.44 109.556 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HB2' HG13 ' A' ' 9' ' ' VAL . 96.3 mt -74.42 138.19 43.16 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.898 -1.047 . . . . 63.44 109.997 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -103.5 168.5 9.11 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.411 -0.589 . . . . 75.33 109.411 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.5 pm0 -61.41 118.79 7.42 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 124.212 0.945 . . . . 55.32 112.745 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.19 -173.36 18.5 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.356 -1.498 . . . . 74.5 109.356 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 62.0 p -95.79 119.2 33.86 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 117.94 0.87 . . . . 72.11 110.904 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -96.28 110.24 22.59 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.091 -1.448 . . . . 75.44 107.091 -176.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.96 128.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.362 -0.607 . . . . 73.42 109.362 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.28 132.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.266 -0.642 . . . . 73.24 109.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 155.08 -171.06 33.3 Favored Glycine 0 CA--C 1.481 -2.067 0 N-CA-C 109.756 -1.338 . . . . 71.44 109.756 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 73.3 mtp180 -120.44 105.27 10.71 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.631 -0.828 . . . . 73.14 108.856 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 155.6 13.71 Favored Glycine 0 N--CA 1.416 -2.648 0 N-CA-C 107.327 -2.309 . . . . 72.45 107.327 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.89 -17.69 65.02 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 118.017 0.909 . . . . 74.24 112.25 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.626 ' OD2' ' HD3' ' A' ' 48' ' ' ARG . 19.9 t70 -89.51 -2.01 58.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.74 0.781 . . . . 74.35 109.629 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.44 152.81 19.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.802 -0.636 . . . . 74.21 109.486 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.14 -46.95 6.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.12 0.486 . . . . 62.1 110.984 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -107.87 118.56 37.05 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.597 -0.89 . . . . 74.12 108.597 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 22.5 mmt85 -95.91 123.79 39.65 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.639 -0.71 . . . . 73.23 109.138 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 HG21 ' A' ' 45' ' ' VAL . 57.6 mt -78.48 141.68 61.32 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.929 -0.397 . . . . 73.45 109.929 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.92 5.06 6.57 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.234 1.956 . . . . 71.23 114.333 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -111.7 172.72 6.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.572 -1.27 . . . . 74.44 107.572 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -112.65 156.5 22.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.052 -0.722 . . . . 71.22 109.052 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -22.46 17.28 Favored Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 109.955 -1.258 . . . . 73.23 109.955 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 40' ' ' LEU . 7.1 p -77.24 136.12 25.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.747 -0.726 . . . . 64.0 109.052 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -69.58 177.61 2.88 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 122.845 0.458 . . . . 74.13 110.96 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 3.8 ptp180 -63.64 -40.59 97.25 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.368 -0.533 . . . . 70.23 111.125 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.626 ' HD3' ' OD2' ' A' ' 35' ' ' ASP . 45.1 mtm180 -131.9 113.7 13.76 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 106.01 -1.848 . . . . 74.44 106.01 171.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -104.32 -38.43 6.85 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-O 121.526 0.679 . . . . 63.4 110.35 -174.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.485 HD11 HD21 ' A' ' 61' ' ' LEU . 5.1 tt -160.3 153.51 21.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.577 -0.897 . . . . 64.34 108.577 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -138.24 124.52 20.46 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.31 0.576 . . . . 64.53 109.968 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' SER . 61.7 mt -99.19 119.22 46.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.91 -0.774 . . . . 64.4 108.91 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.469 ' HD2' HD23 ' A' ' 60' ' ' LEU . 51.9 mtt-85 -91.44 107.06 18.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.131 -1.433 . . . . 71.35 107.131 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -102.46 116.8 33.36 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.882 0.849 . . . . 75.2 110.5 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -119.21 161.55 20.17 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.83 -1.545 . . . . 75.12 106.83 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.81 37.93 1.48 Allowed Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.429 0.559 . . . . 74.52 112.825 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -136.89 -70.04 0.46 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.622 1.169 . . . . 73.43 108.392 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.08 159.38 32.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.949 -0.389 . . . . 72.44 109.949 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.02 106.52 18.87 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.601 0.715 . . . . 73.33 109.39 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.469 HD23 ' HD2' ' A' ' 53' ' ' ARG . 60.8 tp -90.79 111.98 23.59 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.198 -0.91 . . . . 74.24 111.185 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 50' ' ' LEU . 2.9 tm? -86.95 122.34 30.67 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.54 -1.281 . . . . 63.54 107.54 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.94 123.08 31.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 72.45 110.014 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.61 145.97 27.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.507 -0.553 . . . . 62.04 109.507 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.67 77.09 1.7 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.247 -1.39 . . . . 73.45 107.247 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -174.18 159.48 3.2 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.58 -0.526 . . . . 74.53 109.58 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -108.27 -54.55 2.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 120.851 0.357 . . . . 62.55 111.29 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 t -90.15 -24.44 21.06 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.794 -0.566 . . . . 74.11 111.963 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -105.51 26.98 8.81 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.6 -0.518 . . . . 71.23 109.6 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.92 126.66 18.3 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.294 0.996 . . . . 74.42 113.022 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -72.49 147.47 46.01 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.315 0.646 . . . . 74.4 111.557 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -113.37 146.91 38.7 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.762 -0.654 . . . . 70.22 110.285 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.38 116.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.955 -1.128 . . . . 50.4 107.955 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.33 24.47 14.57 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.997 0.919 . . . . 63.3 109.704 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m120 83.69 5.85 0.74 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 126.723 2.009 . . . . 64.51 113.398 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.64 127.17 34.81 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.63 -0.507 . . . . 75.1 109.63 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.02 125.29 9.22 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.513 2.142 . . . . 74.24 112.489 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 80' ' ' TRP . 35.7 m -142.31 161.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.21 -0.663 . . . . 63.52 109.21 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -89.35 -28.19 19.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.207 0.527 . . . . 74.34 110.253 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.55 158.83 40.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.438 -0.949 . . . . 62.52 108.438 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.408 ' HB2' HG21 ' A' ' 77' ' ' VAL . 70.8 t-105 -157.68 152.2 24.99 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.69 -0.856 . . . . 73.02 108.69 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -100.04 107.7 19.69 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.277 -1.379 . . . . 65.23 107.277 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 97' ' ' VAL . 89.1 mt -56.87 143.51 37.11 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.946 0.779 . . . . 61.12 113.043 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.99 163.5 29.07 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 115.124 -0.944 . . . . 74.35 108.513 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.7 t70 -70.19 112.2 6.37 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.444 -0.576 . . . . 54.23 109.444 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 3.9 27.03 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 121.004 -0.617 . . . . 64.4 113.148 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.89 139.36 35.95 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 117.832 0.816 . . . . 53.01 110.931 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.9 t -98.95 113.12 32.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.919 -0.771 . . . . 73.22 108.919 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.79 110.75 26.11 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.08 -1.452 . . . . 74.43 107.08 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 18.5 ttt180 -113.73 121.35 43.81 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.659 0.742 . . . . 73.34 111.901 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.81 163.28 22.49 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.14 -1.391 . . . . 73.03 107.722 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.34 120.05 9.12 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 123.563 0.54 . . . . 74.5 113.133 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.2 m170 86.24 -17.02 0.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.041 1.736 . . . . 75.33 114.96 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.8 m -150.67 127.88 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 118.977 0.808 . . . . 73.3 112.652 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' OE1' ' HD2' ' A' ' 89' ' ' ARG . 10.1 pt-20 -110.8 131.92 54.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.498 -0.927 . . . . 74.35 108.498 171.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 144.72 34.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.807 -0.633 . . . . 72.14 110.184 -174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.38 127.81 58.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.539 -0.911 . . . . 72.21 108.539 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.453 HG21 HD22 ' A' ' 82' ' ' LEU . 74.3 t -87.54 128.16 40.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.638 -0.255 . . . . 61.04 110.459 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -116.47 149.38 39.59 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.471 -0.566 . . . . 74.03 109.471 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.43 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 88.8 mtp -126.92 106.22 9.16 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.087 -1.079 . . . . 73.41 108.087 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 44.0 m-70 . . . . . 0 C--N 1.272 -2.774 0 CA-C-N 114.281 -1.327 . . . . 62.0 108.058 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.436 -1.134 0 CA-C-O 120.757 0.313 . . . . 74.45 111.433 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.4 p -122.69 132.99 54.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.674 -1.232 . . . . 63.43 107.674 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.59 129.55 71.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 122.383 1.087 . . . . 53.33 111.118 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 m -132.43 128.71 38.1 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.759 -1.11 . . . . 74.22 108.309 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 95' ' ' ILE . 4.4 pp -92.38 148.83 21.81 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.405 -0.961 . . . . 75.53 108.405 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -126.81 125.42 41.66 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.195 -0.602 . . . . 71.22 110.202 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.3 tp -83.15 124.73 30.79 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.812 -0.81 . . . . 62.04 108.812 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -90.12 98.44 11.77 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 106.321 -1.733 . . . . 72.14 106.321 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -150.63 77.55 1.29 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.904 -1.043 . . . . 72.43 109.386 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.93 -65.61 4.02 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 115.375 -0.83 . . . . 55.34 113.025 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 p -100.56 -47.36 4.9 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.456 0.646 . . . . 70.31 111.193 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 106.82 91.27 2.21 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.367 -1.093 . . . . 72.14 110.367 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.52 158.21 15.65 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 110.478 -0.193 . . . . 61.33 110.478 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -121.88 148.93 44.1 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.108 0.781 . . . . 45.23 113.108 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -136.97 117.24 13.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.667 -1.234 . . . . 73.05 107.667 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -83.41 139.07 33.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.322 -0.621 . . . . 73.31 109.322 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 52' ' ' ILE . 94.5 mt -85.48 139.7 31.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.815 -0.439 . . . . 73.33 109.815 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -101.55 165.16 11.39 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.935 0.398 . . . . 70.24 110.344 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -69.75 113.26 6.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.096 -0.956 . . . . 75.44 109.914 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.28 -174.57 19.94 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.08 -1.608 . . . . 60.31 109.08 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 p -106.78 145.85 31.58 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.385 -0.926 . . . . 55.54 110.857 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -122.75 135.43 54.56 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.464 -0.569 . . . . 71.43 109.464 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.68 119.54 46.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.257 -1.016 . . . . 74.2 108.257 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 58.1 mt -101.8 127.73 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.301 0.572 . . . . 62.13 110.158 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.44 -178.09 37.49 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.335 -1.506 . . . . 75.11 109.335 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 29.1 mtm105 -110.99 106.52 15.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.356 1.078 . . . . 71.53 111.42 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.4 41.8 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 107.168 -2.373 . . . . 75.32 107.168 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -85.56 -16.01 40.79 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.175 0.988 . . . . 72.33 108.457 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.5 -12.57 60.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.113 -1.403 . . . . 70.5 109.273 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -98.37 158.02 15.84 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.776 -1.102 . . . . 72.02 108.553 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -106.65 -39.06 5.94 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.347 0.594 . . . . 71.12 110.397 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 89.7 t80 -115.72 114.88 25.42 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.904 -1.147 . . . . 74.42 107.904 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 61.7 mtm180 -96.91 124.14 40.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.094 -0.503 . . . . 74.23 110.499 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 66.6 mt -71.4 134.17 84.79 Favored Pre-proline 0 CA--C 1.501 -0.926 0 N-CA-C 107.573 -1.269 . . . . 75.3 107.573 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.28 35.01 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.967 1.778 . . . . 74.33 112.111 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.8 -175.55 3.44 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.043 0.449 . . . . 41.34 110.417 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.5 m -111.17 148.59 32.43 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.123 0.969 . . . . 74.33 110.005 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.82 -0.85 61.07 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 111.679 -0.568 . . . . 31.43 111.679 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.14 127.69 45.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.867 -0.79 . . . . 71.43 108.867 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.1 m -78.96 177.3 8.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.166 -0.47 . . . . 41.34 110.185 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.41 -50.63 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.904 0.32 . . . . 74.21 110.97 177.151 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.62 114.6 26.66 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 107.025 -1.472 . . . . 75.34 107.025 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -105.31 -42.97 5.11 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.605 0.717 . . . . 72.22 109.097 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 tt -163.17 159.8 23.4 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.56 -0.904 . . . . 74.32 108.56 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -138.85 151.1 46.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.518 -0.549 . . . . 65.43 109.518 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 23' ' ' LEU . 70.8 mt -123.48 121.44 62.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.542 -0.91 . . . . 63.24 108.542 176.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 63.4 mtt180 -105.6 107.94 19.2 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.206 -0.664 . . . . 73.15 109.206 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.72 133.98 52.07 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.996 -0.547 . . . . 75.44 110.616 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.79 -179.93 6.34 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.436 -2.431 . . . . 65.55 104.436 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.36 42.62 2.92 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 119.445 1.02 . . . . 25.5 113.867 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -141.62 -76.78 0.28 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 110.203 -0.295 . . . . 71.14 110.203 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.12 158.1 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.711 0.291 . . . . 63.25 110.557 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.51 112.38 24.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.403 0.62 . . . . 71.51 110.289 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 6.1 tt -88.96 124.87 34.66 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.272 -0.876 . . . . 61.13 108.797 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.74 123.55 49.71 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.347 -1.353 . . . . 74.25 107.347 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.74 124.68 28.59 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.187 0.518 . . . . 52.51 110.999 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 14.9 t70 -89.3 112.47 23.55 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.357 -0.979 . . . . 73.15 108.357 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 mt -101.53 76.45 1.67 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.422 -2.066 . . . . 73.14 105.422 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 68' ' ' ASN . 19.9 t30 -173.81 139.64 0.7 Allowed 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.899 -0.72 . . . . 71.13 109.708 -165.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -108.56 -53.38 2.65 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.283 0.563 . . . . 63.23 110.003 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -66.02 -48.64 70.45 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.277 -0.874 . . . . 34.13 113.05 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.477 ' HB2' HD21 ' A' ' 65' ' ' ASN . 20.0 m-80 -106.4 29.77 6.57 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 119.173 -0.441 . . . . 60.41 109.94 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.23 121.94 2.83 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.18 0.832 . . . . 65.05 115.18 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.7 m -69.08 149.17 49.01 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.734 1.614 . . . . 75.22 112.336 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 38.5 p -112.4 145.78 39.51 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.345 0.593 . . . . 54.22 111.814 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 88' ' ' ILE . 33.9 m -116.07 117.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 107.431 -1.322 . . . . 74.14 107.431 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 58.88 33.26 22.94 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.675 -0.693 . . . . 71.24 110.295 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 82.46 -3.36 1.4 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.86 1.664 . . . . 73.21 112.428 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.15 129.31 25.39 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.684 -0.635 . . . . 54.12 110.089 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.12 125.58 7.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.501 2.134 . . . . 73.52 113.529 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.68 174.47 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 107.295 -1.372 . . . . 73.33 107.295 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.456 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.2 mt-30 -117.4 -17.73 10.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 112.979 0.733 . . . . 71.34 112.979 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.61 131.52 27.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.421 . . . . 74.02 109.908 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -147.57 152.33 37.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.842 -0.799 . . . . 74.34 108.842 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -106.41 113.8 27.53 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.181 -1.044 . . . . 74.14 108.181 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.2 mt -57.85 149.56 22.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.107 -0.952 . . . . 71.33 112.486 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.09 166.79 23.8 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.321 -0.854 . . . . 54.44 109.15 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.8 t70 -71.67 115.72 11.19 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.994 0.426 . . . . 72.15 110.201 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.46 14.34 28.1 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.813 -0.63 . . . . 71.11 112.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -88.76 135.66 33.4 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 120.438 -0.505 . . . . 73.44 110.74 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.21 113.46 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.008 -0.738 . . . . 61.41 109.008 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -105.76 113.53 42.84 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.805 -1.183 . . . . 74.05 107.805 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 61.5 mtt180 -99.81 106.28 18.14 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 116.272 -0.422 . . . . 73.22 109.954 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -115.5 164.69 13.93 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.013 -0.994 . . . . 54.42 109.001 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -27.39 88.78 0.01 OUTLIER Glycine 0 N--CA 1.484 1.856 0 C-N-CA 125.303 1.43 . . . . 64.4 116.331 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 58.08 21.35 7.81 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.76 1.624 . . . . 72.54 111.491 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.0 m -137.01 114.25 10.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.12 -1.067 . . . . 63.44 108.12 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.22 125.4 54.1 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 120.099 -0.64 . . . . 70.52 109.799 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 13' ' ' LEU . 1.7 pp -122.48 149.43 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-O 120.953 0.406 . . . . 53.1 111.36 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -110.39 122.45 64.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.767 -1.568 . . . . 44.52 106.767 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' ' 82' ' ' LEU . 55.1 t -80.41 126.56 39.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 120.85 0.357 . . . . 75.04 111.057 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.0 mmm-85 -116.9 142.3 47.11 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.35 0.595 . . . . 64.54 109.678 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 79.6 mtp -123.06 121.25 35.57 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.925 -1.034 . . . . 74.24 109.144 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 107.168 -1.419 . . . . 73.44 107.168 -177.641 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.433 -1.312 0 N-CA-C 106.831 -1.544 . . . . 73.4 106.831 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -121.48 114.77 21.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.494 -0.483 . . . . 74.13 109.95 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.7 p -95.76 126.41 48.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.713 -1.217 . . . . 55.02 107.713 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 m -131.06 136.54 48.54 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.28 -0.873 . . . . 72.45 109.264 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 95' ' ' ILE . 4.0 pp -101.8 131.41 48.13 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 116.151 -0.477 . . . . 73.04 109.966 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.92 114.26 28.24 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.28 -1.378 . . . . 62.34 107.28 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.16 119.31 38.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.43 0.692 . . . . 73.24 110.521 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -93.36 100.0 12.41 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.949 -1.13 . . . . 63.53 107.949 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.91 -13.59 15.76 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.167 -1.378 . . . . 73.44 109.179 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.22 -12.93 6.02 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.87 -1.292 . . . . 34.32 109.87 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -120.12 -35.81 3.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 120.816 0.341 . . . . 74.32 110.593 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 91.82 1.38 Allowed Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.139 -1.184 . . . . 33.24 110.139 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -113.51 159.43 19.56 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 110.476 -0.194 . . . . 74.43 110.476 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.8 p -130.22 136.33 49.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.882 0.373 . . . . 74.35 110.024 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -135.62 121.55 19.91 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.042 -0.526 . . . . 74.11 109.638 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.915 -0.584 . . . . 52.1 109.762 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.3 mt -76.86 133.91 39.17 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.503 -0.771 . . . . 61.21 110.265 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -102.99 158.45 16.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 108.767 -0.827 . . . . 72.11 108.767 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 1.9 mp0 -48.5 127.27 12.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.492 1.517 . . . . 73.22 111.445 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.1 -174.8 15.81 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.255 -1.538 . . . . 64.42 109.255 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 81.8 p -95.73 123.35 39.26 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 118.319 -1.353 . . . . 73.13 110.882 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.517 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -92.57 109.74 21.15 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.065 -1.828 . . . . 74.43 106.065 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.21 129.42 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.596 -0.729 . . . . 60.4 110.842 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -107.57 133.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.54 -0.911 . . . . 72.53 108.54 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 154.79 177.5 28.17 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.193 -1.563 . . . . 74.13 109.193 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 49.7 mtp85 -112.52 105.0 13.12 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.884 1.342 . . . . 75.53 109.858 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.89 179.32 46.31 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 110.039 -1.225 . . . . 74.23 110.039 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -72.41 -25.44 61.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.073 0.939 . . . . 73.32 108.937 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.98 8.48 12.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.665 -1.152 . . . . 71.13 111.526 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.91 155.19 44.59 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.079 0.466 . . . . 63.1 112.013 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -99.63 -54.73 2.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.017 -0.992 . . . . 71.42 109.987 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -101.48 108.92 20.64 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 71.43 109.217 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 33.5 ptt180 -96.08 118.13 32.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.105 -0.498 . . . . 75.04 111.802 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.65 140.19 97.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.278 -0.874 . . . . 71.34 110.509 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -92.71 17.92 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.601 2.201 . . . . 75.33 112.283 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.64 -173.49 2.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.491 -0.929 . . . . 71.32 108.491 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -112.0 146.91 37.04 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.193 0.597 . . . . 60.32 109.564 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 -27.36 16.82 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.818 -0.706 . . . . 73.52 111.384 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.34 133.02 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 123.435 0.694 . . . . 65.34 111.586 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -80.27 -171.47 3.02 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.392 1.077 . . . . 71.14 109.552 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 33.4 ptt180 -78.02 -34.78 50.49 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.35 -0.94 . . . . 63.44 109.587 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HB3' HD23 ' A' ' 64' ' ' LEU . 63.4 mtp180 -129.07 115.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 103.582 -2.748 . . . . 64.03 103.582 172.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 5.3 t60 -103.76 -42.41 5.63 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.55 0.691 . . . . 73.12 109.143 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 4.9 tt -166.45 151.14 7.78 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.429 -0.952 . . . . 72.41 108.429 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.63 134.94 45.5 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.122 -0.695 . . . . 72.13 109.122 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -102.55 112.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.028 -1.471 . . . . 75.2 107.028 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 40.2 ttt85 -91.65 107.38 19.17 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 121.548 0.689 . . . . 73.41 109.779 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -96.49 112.54 24.24 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.948 -1.024 . . . . 74.12 109.056 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -119.27 167.38 11.92 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.172 -1.788 . . . . 55.22 106.172 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.98 42.36 2.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.592 -0.813 . . . . 52.1 112.566 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -136.68 -66.86 0.52 Allowed 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 124.041 0.936 . . . . 71.02 108.56 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.11 159.77 4.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.719 1.208 . . . . 73.44 108.31 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.36 107.59 19.24 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.652 0.739 . . . . 75.55 109.101 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 tt -88.49 115.41 25.98 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.79 -1.095 . . . . 72.2 109.789 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.8 tm? -97.21 124.94 41.44 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.318 -1.364 . . . . 72.43 107.318 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -140.57 125.6 18.43 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 120.678 0.275 . . . . 62.23 111.409 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.667 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 1.2 m-20 -73.52 139.61 45.79 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 115.798 -0.637 . . . . 64.13 109.948 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.418 HD23 ' HB3' ' A' ' 48' ' ' ARG . 32.9 tp -130.68 77.15 1.77 Allowed 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.534 -1.284 . . . . 53.55 107.534 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -179.82 174.64 0.91 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.419 -1.326 . . . . 73.25 107.419 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 p -109.03 -55.03 2.46 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.642 0.608 . . . . 72.24 112.642 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -89.52 -29.95 18.58 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.466 0.913 . . . . 74.11 113.466 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.574 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 90.2 m-20 -84.57 27.38 0.72 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.427 0.691 . . . . 54.43 112.219 -172.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.51 122.73 6.68 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.967 1.417 . . . . 64.33 113.951 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.667 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 52.7 m -71.84 148.68 45.95 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 125.035 1.334 . . . . 71.32 112.622 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 p -112.92 141.03 47.22 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.435 -0.802 . . . . 54.24 109.505 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.03 118.25 53.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.755 -1.202 . . . . 64.32 107.755 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 57.81 38.22 27.23 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.556 -0.747 . . . . 70.23 109.88 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.39 -10.61 1.17 Allowed 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.605 1.962 . . . . 65.01 112.001 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -92.37 121.81 65.75 Favored Pre-proline 0 C--N 1.323 -0.57 0 O-C-N 122.124 -0.36 . . . . 52.24 110.7 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.47 125.19 13.0 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.837 2.358 . . . . 75.03 112.552 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.99 -177.9 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.974 -0.751 . . . . 75.21 108.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -128.83 6.25 5.53 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.589 -0.522 . . . . 72.23 109.589 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.45 153.16 3.44 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.907 -1.146 . . . . 73.33 107.907 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.448 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 76.3 t-105 -166.91 152.29 7.73 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.711 -0.848 . . . . 73.14 108.711 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -104.66 111.52 24.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.643 -1.243 . . . . 44.03 107.643 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' HG11 ' A' ' 97' ' ' VAL . 56.0 mt -58.13 141.3 50.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.898 1.073 . . . . 64.53 113.898 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.97 162.46 32.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.529 -1.286 . . . . 53.4 107.529 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.0 126.36 27.79 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.575 -0.284 . . . . 75.15 110.396 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.63 1.94 57.56 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.907 -0.663 . . . . 62.02 113.414 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -73.07 129.58 38.39 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.362 0.581 . . . . 53.2 111.135 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.43 116.28 35.32 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 N-CA-C 107.284 -1.376 . . . . 75.53 107.284 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.9 mt -122.43 134.28 66.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 C-N-CA 119.971 -0.692 . . . . 50.02 110.6 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.408 ' HG2' ' CB ' ' A' ' 94' ' ' GLU . 27.7 mtp-105 -124.19 123.35 40.08 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 73.1 110.004 175.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.5 pt? -101.81 162.57 12.81 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 105.81 -1.922 . . . . 65.54 105.81 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -46.33 102.86 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 O-C-N 123.749 0.655 . . . . 64.24 113.786 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 m170 79.52 15.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.712 1.375 . . . . 73.14 114.712 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -151.02 141.11 22.14 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.475 -0.766 . . . . 71.45 111.94 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 89' ' ' ARG . 9.2 pt-20 -118.75 139.29 51.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.037 0.446 . . . . 52.13 111.235 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.493 HD11 HD13 ' A' ' 11' ' ' LEU . 9.5 tp -139.8 142.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-N 115.301 -0.863 . . . . 75.24 109.527 -172.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -109.88 134.51 51.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.029 -1.1 . . . . 53.54 108.029 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' A' ' 82' ' ' LEU . 85.0 t -96.92 121.73 47.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.141 0.496 . . . . 75.43 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -117.47 132.29 56.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.865 -0.791 . . . . 72.12 108.865 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.0 mtp -116.36 116.87 28.52 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.064 -0.717 . . . . 64.11 109.064 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--N 1.278 -2.537 0 N-CA-C 107.506 -1.294 . . . . 63.42 107.506 -177.732 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m . . . . . 0 N--CA 1.409 -2.491 0 N-CA-C 107.82 -1.178 . . . . 50.04 107.82 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -113.04 114.3 26.67 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.201 -1.407 . . . . 54.24 107.201 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 108.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.813 -1.18 . . . . 60.4 107.813 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 m -111.41 123.23 49.79 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.095 -1.076 . . . . 73.0 108.095 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.4 pp -88.53 130.02 35.33 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.602 -0.888 . . . . 62.2 108.602 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.93 108.85 19.76 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.622 -1.621 . . . . 54.12 106.622 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.48 117.8 29.39 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.524 -0.546 . . . . 73.21 109.524 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -126.77 103.53 7.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.951 -1.1 . . . . 72.1 112.925 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -48.87 9.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.9 -2.259 . . . . 74.43 104.9 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 171.29 44.27 0.04 OUTLIER Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 103.591 -3.804 . . . . 34.34 103.591 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -132.49 -45.94 0.9 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.644 -1.278 . . . . 72.1 110.86 -166.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.72 51.04 8.38 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.49 -1.044 . . . . 75.34 110.49 -172.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -84.47 143.1 29.6 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.747 0.419 . . . . 74.21 110.355 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.9 p -146.68 132.36 18.88 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.645 -0.707 . . . . 71.3 109.199 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -144.8 127.69 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.456 -0.338 . . . . 72.25 110.099 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.07 127.46 36.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.41 -0.959 . . . . 62.04 108.41 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.0 mt -58.31 143.46 44.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.567 0.951 . . . . 63.45 113.567 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 2.3 mmp_? -100.01 151.61 21.16 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.559 -1.201 . . . . 72.43 108.022 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -70.85 130.14 40.88 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.683 0.754 . . . . 72.42 111.367 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.65 -176.54 16.61 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 106.763 -2.535 . . . . 62.32 106.763 -172.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 51.7 p -89.71 133.27 34.75 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 118.388 -1.325 . . . . 74.44 111.303 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -101.72 109.83 21.68 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.194 -2.15 . . . . 74.2 105.194 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.4 mt -86.2 123.96 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.976 -0.556 . . . . 75.25 111.149 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.467 HG23 ' HD2' ' A' ' 38' ' ' PHE . 67.7 mt -107.91 129.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.768 -0.827 . . . . 72.42 108.768 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.48 -179.03 37.15 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.888 -0.885 . . . . 74.44 110.888 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 40.1 mtp85 -107.43 106.38 16.75 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.732 -0.84 . . . . 73.51 108.732 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.71 -178.13 48.63 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 109.562 -1.415 . . . . 53.4 109.562 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -93.43 -21.05 19.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.004 0.431 . . . . 61.13 110.786 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -92.76 -3.59 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 73.04 110.056 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.11 165.96 20.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.049 -0.978 . . . . 42.23 108.911 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -109.35 -52.16 2.8 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.65 0.738 . . . . 64.24 110.028 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.467 ' HD2' HG23 ' A' ' 30' ' ' ILE . 92.0 t80 -108.82 116.73 32.53 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.366 -0.975 . . . . 74.31 108.366 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mpt_? -94.92 127.86 41.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.159 -0.473 . . . . 62.4 110.973 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.98 136.07 54.59 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.101 -0.5 . . . . 71.42 111.138 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.98 -29.15 81.5 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.407 2.738 . . . . 71.25 114.4 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 21.5 t70 -95.03 169.0 10.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.709 -0.849 . . . . 63.12 108.709 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -107.23 -177.34 3.33 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 121.036 -0.266 . . . . 74.15 110.321 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.22 78.39 Favored Glycine 0 C--O 1.238 0.395 0 N-CA-C 108.807 -1.717 . . . . 74.12 108.807 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.47 130.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 113.294 -1.453 . . . . 55.14 108.095 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.1 m -79.11 -177.48 5.65 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.244 -0.651 . . . . 74.3 109.244 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 15.4 ptt180 -64.49 -41.56 96.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.572 0.701 . . . . 74.11 109.415 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -121.02 104.36 9.74 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.245 -1.761 . . . . 72.22 106.245 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 15.2 t60 -100.0 -31.44 11.45 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.948 -1.024 . . . . 75.03 108.877 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.486 HD11 HD21 ' A' ' 61' ' ' LEU . 8.1 tt -164.28 145.89 8.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.108 -0.701 . . . . 74.23 109.108 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.95 132.92 47.66 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.292 0.567 . . . . 71.54 110.05 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.3 mt -108.53 112.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.642 -1.244 . . . . 74.02 107.642 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 16.3 ttt-85 -91.35 107.71 19.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.471 -1.307 . . . . 74.31 107.471 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -99.51 115.32 29.07 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-O 121.672 0.749 . . . . 74.52 110.324 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.83 164.6 14.42 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.051 -1.463 . . . . 62.42 107.051 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.56 52.91 3.91 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.415 -1.074 . . . . 70.41 110.415 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.36 -71.73 0.3 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 125.7 1.6 . . . . 64.41 107.793 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 m -149.76 160.0 5.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.908 1.283 . . . . 70.32 107.896 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -93.24 106.15 18.15 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.585 -0.895 . . . . 71.34 108.585 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -82.48 118.31 23.14 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.277 -0.874 . . . . 64.42 110.096 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.486 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -99.54 120.13 39.15 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.545 -0.909 . . . . 74.01 108.545 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.0 123.48 34.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.815 -0.439 . . . . 51.44 109.815 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.64 138.82 32.77 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.868 -0.605 . . . . 73.43 110.994 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.92 77.52 1.62 Allowed 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.979 0.511 . . . . 64.34 109.913 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 32.9 t-20 -175.31 138.67 0.43 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.842 0.746 . . . . 74.04 110.473 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 p -96.54 -38.46 9.97 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.361 -0.381 . . . . 75.32 111.854 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 t -89.32 -44.4 10.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.346 0.499 . . . . 63.44 112.346 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.438 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.4 m120 -105.98 27.37 8.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.129 -0.693 . . . . 74.21 109.129 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.96 138.36 26.32 Favored Glycine 0 C--O 1.248 1.004 0 CA-C-N 114.527 -1.215 . . . . 32.23 113.923 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 30.0 m -72.25 137.73 47.0 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 124.406 1.082 . . . . 64.23 113.299 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 p -105.91 140.75 38.45 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.373 -0.83 . . . . 72.53 109.674 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 88' ' ' ILE . 35.2 m -119.55 116.04 49.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.602 -1.259 . . . . 54.51 107.602 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 57.84 30.86 19.69 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.445 0.64 . . . . 72.21 110.167 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 88.72 -10.88 0.45 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.659 1.984 . . . . 74.54 113.677 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.7 117.81 66.3 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 121.413 -0.804 . . . . 71.44 110.913 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.86 124.91 11.5 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 121.76 1.64 . . . . 70.4 110.319 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.95 175.98 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 110.168 -0.308 . . . . 75.1 110.168 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.05 -31.84 9.49 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.659 0.599 . . . . 61.11 109.42 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -142.73 147.86 36.31 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.048 -0.524 . . . . 73.45 110.199 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -162.23 152.17 16.47 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.596 -1.261 . . . . 75.44 107.596 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -107.92 109.41 20.91 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.979 -0.688 . . . . 73.52 109.154 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 79.0 mt -57.1 122.02 11.41 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.479 -1.237 . . . . 54.05 111.923 -175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.9 166.59 11.08 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.924 -1.139 . . . . 72.11 107.924 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 126.4 29.13 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.462 -0.335 . . . . 71.41 110.628 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.16 57.73 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.929 -0.578 . . . . 44.11 113.071 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.06 139.88 46.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.984 0.392 . . . . 55.31 111.411 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.69 117.19 48.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.753 -0.658 . . . . 62.11 109.673 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -111.98 124.55 68.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 123.368 0.667 . . . . 63.44 109.28 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 70' ' ' THR . 38.5 ttm180 -120.37 115.73 24.11 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.405 -0.591 . . . . 72.43 109.405 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 90' ' ' LEU . 2.1 pt? -126.81 139.29 53.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.409 -1.33 . . . . 70.13 107.409 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.86 88.02 0.0 OUTLIER Glycine 0 N--CA 1.496 2.636 0 O-C-N 125.032 1.457 . . . . 44.34 116.297 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.5 t60 75.37 -19.66 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.327 1.451 . . . . 74.12 113.034 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.6 m -96.55 132.46 42.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 122.869 0.468 . . . . 72.3 111.171 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -125.78 117.63 23.83 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.013 0.911 . . . . 64.12 110.387 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -127.64 141.57 46.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 114.53 -1.214 . . . . 62.32 111.914 -170.559 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.86 133.34 51.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.095 -1.076 . . . . 74.2 108.095 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.38 124.54 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 120.869 0.366 . . . . 71.53 110.84 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -119.25 130.58 55.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.741 -0.663 . . . . 74.33 111.126 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.1 mtt -106.17 111.93 24.75 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.975 -0.75 . . . . 44.31 108.975 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 . . . . . 0 C--N 1.277 -2.586 0 N-CA-C 108.306 -0.998 . . . . 75.13 108.306 179.104 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.426 -1.633 0 N-CA-C 109.305 -0.628 . . . . 75.51 109.305 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -101.56 115.57 30.81 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.804 -0.813 . . . . 64.33 108.804 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.24 122.02 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 106.251 -1.759 . . . . 72.22 106.251 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.6 m -135.66 131.22 35.46 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.615 -0.513 . . . . 74.0 109.615 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -93.94 126.86 39.39 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.377 -0.601 . . . . 70.42 109.377 175.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.8 108.72 21.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.759 -1.2 . . . . 74.45 107.759 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.02 114.36 28.23 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.824 -0.626 . . . . 72.41 109.778 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.7 99.62 11.69 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.551 -1.648 . . . . 74.02 106.551 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -146.89 79.75 1.52 Allowed 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.596 -1.184 . . . . 64.13 108.953 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.23 -62.39 0.29 Allowed Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.19 -0.914 . . . . 70.12 111.656 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -128.23 -38.92 1.75 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.425 0.528 . . . . 63.55 112.425 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.59 86.16 0.79 Allowed Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.784 -0.926 . . . . 73.14 110.784 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -100.38 167.37 10.44 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.462 0.305 . . . . 73.41 110.72 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.9 p -141.65 140.55 33.29 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.845 -0.616 . . . . 72.11 110.388 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.4 121.83 31.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.082 -1.081 . . . . 74.43 108.082 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -86.67 125.88 34.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.414 -1.328 . . . . 74.11 107.414 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.47 121.72 18.3 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.783 -0.644 . . . . 72.15 110.671 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -82.78 150.59 26.54 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.867 -0.79 . . . . 73.34 108.867 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -57.76 124.98 21.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.242 0.964 . . . . 61.34 110.309 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.17 -164.04 16.35 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.761 -2.136 . . . . 74.42 107.761 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 80.5 p -100.65 134.64 43.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.011 1.406 . . . . 75.23 111.31 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -111.78 110.07 20.24 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.205 -1.776 . . . . 72.42 106.205 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 45.7 mt -102.27 136.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.676 -0.693 . . . . 71.43 110.214 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -115.08 135.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.257 1.458 0 N-CA-C 109.49 -0.559 . . . . 71.01 109.49 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.88 -175.97 29.63 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 110.287 -1.125 . . . . 64.12 110.287 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 87.5 mtt180 -105.76 105.19 15.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.546 -0.861 . . . . 61.04 110.233 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.26 162.21 26.67 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 108.886 -1.686 . . . . 71.11 108.886 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.14 -18.32 62.52 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.218 0.532 . . . . 72.11 109.578 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.78 -29.03 65.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.624 -1.171 . . . . 72.13 109.596 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . . . -88.16 154.18 20.65 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.323 -0.853 . . . . 72.4 110.675 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -93.04 -46.57 7.4 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.598 -0.89 . . . . 63.04 108.598 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -111.74 117.7 33.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.916 -1.038 . . . . 73.22 109.313 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.5 mpt_? -96.55 136.7 36.7 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.705 -0.48 . . . . 70.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 82.2 mt -83.33 146.76 51.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.655 -0.248 . . . . 75.52 110.365 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 4.1 Cg_exo -79.92 12.54 2.42 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.051 2.501 . . . . 64.35 112.322 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.33 152.61 32.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.227 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.5 m -95.18 151.88 18.84 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.619 -1.252 . . . . 74.22 107.619 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.48 26.37 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 110.348 -1.101 . . . . 64.34 110.348 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -98.75 138.6 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.1 m -81.42 175.42 10.57 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.416 0.15 . . . . 61.11 111.347 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 2.3 ptm180 -60.86 -36.53 79.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.256 0.622 . . . . 74.03 111.42 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -131.94 97.55 4.2 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.366 -2.087 . . . . 74.32 105.366 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -95.85 -37.44 10.72 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.565 0.698 . . . . 64.1 109.746 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 61' ' ' LEU . 6.8 tt -158.99 143.24 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.696 -0.684 . . . . 74.44 109.182 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -134.57 126.68 29.77 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.596 -0.729 . . . . 74.11 111.073 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -103.46 112.91 38.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.465 -0.939 . . . . 72.42 108.465 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 0.0 OUTLIER -91.73 107.67 19.37 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 106.012 -1.847 . . . . 72.43 106.012 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -105.55 108.37 19.85 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.482 -0.781 . . . . 72.44 109.552 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.82 161.73 13.7 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 105.935 -1.876 . . . . 72.43 105.935 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.03 60.4 3.06 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.498 -0.858 . . . . 64.02 111.828 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -177.72 -50.36 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.729 1.212 . . . . 72.01 109.865 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.51 145.12 35.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 112.64 0.607 . . . . 74.25 112.64 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.92 102.14 11.52 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 115.235 -0.893 . . . . 72.01 109.432 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 tp -94.29 109.72 21.52 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.9 -1.046 . . . . 74.41 111.085 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 50' ' ' LEU . 3.0 tm? -94.98 116.75 29.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.621 -1.251 . . . . 61.2 107.621 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.6 121.13 32.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.942 0.401 . . . . 61.43 110.834 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.0 134.44 35.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.309 -0.859 . . . . 73.2 109.141 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.15 77.61 1.75 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.835 -1.172 . . . . 63.24 107.835 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -170.54 162.72 8.18 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.183 -1.043 . . . . 64.3 108.183 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 m -108.65 -53.27 2.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 120.475 -0.49 . . . . 75.03 112.103 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -88.43 -26.69 21.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.371 0.605 . . . . 74.32 111.895 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -104.85 28.25 7.32 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 122.887 0.475 . . . . 45.23 110.147 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.76 115.82 1.52 Allowed Glycine 0 C--O 1.246 0.87 0 O-C-N 125.004 1.44 . . . . 71.42 112.367 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 m -59.19 134.16 56.75 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.321 1.048 . . . . 61.13 112.676 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 139.67 38.01 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 108.161 -1.051 . . . . 44.15 108.161 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.51 120.59 62.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.508 -0.923 . . . . 65.4 108.508 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 59.22 29.13 18.63 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.584 1.183 . . . . 52.52 109.08 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.271 95.8 m-20 67.11 25.26 9.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 112.8 -2.0 . . . . 71.02 113.92 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.07 125.38 27.68 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.623 -0.881 . . . . 64.22 108.623 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.8 130.73 14.94 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.339 2.026 . . . . 70.11 112.675 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG21 ' HB2' ' A' ' 80' ' ' TRP . 34.7 m -141.77 176.89 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -106.44 -38.09 6.3 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.872 -0.788 . . . . 75.31 108.872 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.02 148.73 42.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.888 -1.051 . . . . 63.2 110.597 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.443 ' HB2' HG21 ' A' ' 77' ' ' VAL . 68.9 t-105 -153.16 151.97 30.73 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.674 -0.861 . . . . 73.22 108.674 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.2 116.35 32.48 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.578 -1.267 . . . . 74.52 107.578 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.403 HD22 HG21 ' A' ' 97' ' ' VAL . 77.9 mt -57.04 138.03 54.94 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 123.729 0.643 . . . . 74.33 112.152 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.25 169.06 14.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.688 -1.227 . . . . 74.3 107.688 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 24.9 t70 -79.54 124.8 28.84 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.476 -0.329 . . . . 73.44 110.648 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.97 6.06 56.17 Favored Glycine 0 N--CA 1.436 -1.348 0 CA-C-N 116.016 -0.538 . . . . 70.25 112.295 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.46 134.8 46.83 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.964 0.411 . . . . 71.52 111.383 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.42 113.21 35.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 N-CA-C 107.79 -1.189 . . . . 75.33 107.79 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.3 122.4 68.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 C-N-CA 119.863 -0.735 . . . . 73.33 111.238 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -105.73 109.98 22.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.658 -0.701 . . . . 63.55 109.13 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.9 pt? -110.7 164.83 12.36 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.672 -0.862 . . . . 61.13 108.672 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -47.23 106.29 0.15 Allowed Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.689 0.618 . . . . 61.21 113.444 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 75.81 12.63 2.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.696 1.599 . . . . 50.21 114.786 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.0 t -154.85 150.4 27.44 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.58 -0.848 . . . . 74.44 111.531 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.91 128.67 47.92 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.236 0.541 . . . . 75.23 109.818 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.4 tp -124.91 148.89 29.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 116.211 -0.45 . . . . 73.42 110.626 -170.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.91 122.82 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.684 -1.228 . . . . 73.14 107.684 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 82' ' ' LEU . 81.8 t -90.58 122.78 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.93 0.395 . . . . 64.53 110.184 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -119.54 140.98 49.65 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.77 -0.65 . . . . 61.22 110.516 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.416 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 58.2 mtt -121.82 114.53 21.19 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.24 -1.022 . . . . 74.24 108.24 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 . . . . . 0 C--N 1.278 -2.541 0 N-CA-C 107.024 -1.473 . . . . 74.44 107.024 -178.653 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.423 -1.804 0 CA-C-O 120.877 0.37 . . . . 74.42 111.404 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 m -115.85 114.64 24.99 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.829 -1.174 . . . . 74.15 107.829 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 25.5 t -91.35 115.9 31.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.402 -0.962 . . . . 73.14 108.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.479 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.9 m -118.6 127.74 53.89 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 115.742 -0.663 . . . . 73.35 110.231 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 20' ' ' THR . 69.1 mt -90.57 121.71 32.75 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.91 -1.041 . . . . 54.24 108.387 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.68 114.52 28.79 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 123.889 0.743 . . . . 75.21 109.339 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 tp -118.18 109.02 15.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 123.918 0.887 . . . . 64.23 109.713 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -97.44 101.6 13.17 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.105 -0.702 . . . . 71.33 109.105 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -97.18 5.26 50.45 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.835 -0.802 . . . . 71.22 108.835 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.99 -40.43 0.62 Allowed Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 114.671 -1.15 . . . . 74.54 110.269 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 m -112.01 -50.95 2.88 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 112.889 0.7 . . . . 60.04 112.889 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.76 82.25 0.55 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.669 -0.776 . . . . 64.11 111.983 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.11 150.19 22.84 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 110.133 -0.321 . . . . 64.21 110.133 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.8 p -133.61 145.87 50.42 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 116.138 -0.483 . . . . 61.33 111.114 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -137.97 129.58 28.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.572 -0.899 . . . . 65.44 108.572 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 53.1 tt0 -92.39 134.93 34.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.214 -0.662 . . . . 53.25 109.214 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -60.19 139.92 57.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.433 0.635 . . . . 72.25 111.971 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -95.88 169.65 9.85 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.255 -0.884 . . . . 71.42 109.757 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 1.2 pm0 -75.09 122.67 23.93 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 123.536 0.735 . . . . 73.24 110.758 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.52 -164.93 12.02 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.461 -1.056 . . . . 75.31 110.461 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.7 t -107.65 142.85 36.97 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 117.116 0.458 . . . . 54.12 111.433 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -117.89 117.75 30.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.532 0.682 . . . . 74.35 109.57 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -91.69 112.3 25.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.99 -1.005 . . . . 50.12 108.559 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.9 mt -90.3 128.1 42.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 123.914 0.759 . . . . 72.25 110.009 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.44 175.15 34.11 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.62 -0.992 . . . . 74.0 110.62 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 48.9 mtm180 -109.22 106.69 16.65 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.809 -0.811 . . . . 74.42 108.809 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.01 173.2 42.35 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 109.424 -1.47 . . . . 44.43 109.424 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -81.72 -16.53 50.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.144 0.497 . . . . 64.44 110.461 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.46 6.3 49.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.051 0.929 . . . . 64.12 109.739 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.79 161.46 13.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.107 -0.951 . . . . 65.33 110.07 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -109.42 -50.27 3.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.542 0.687 . . . . 75.4 109.595 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 54.2 t80 -106.51 123.85 48.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.2 -1.407 . . . . 75.55 107.2 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 51.0 mtt180 -111.3 133.34 53.7 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 120.867 -0.333 . . . . 75.3 110.599 -174.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.63 149.28 71.1 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.534 . . . . 74.31 110.484 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 -0.09 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.534 2.156 . . . . 72.35 114.123 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.19 -173.5 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.245 -0.982 . . . . 63.31 112.085 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 44' ' ' GLY . 7.1 m -96.31 174.35 6.92 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.33 1.052 . . . . 72.24 108.549 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 43' ' ' THR . . . 103.89 -21.05 39.41 Favored Glycine 0 CA--C 1.498 -0.996 0 N-CA-C 109.572 -1.411 . . . . 73.11 109.572 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.12 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.417 -1.392 . . . . 65.42 108.864 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -88.63 -173.51 4.17 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.451 -0.574 . . . . 53.32 109.451 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 21.1 ptt180 -72.39 -42.73 64.86 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.216 -1.031 . . . . 65.35 108.216 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.457 HH21 HD21 ' A' ' 64' ' ' LEU . 11.0 mtp180 -120.78 101.84 7.99 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.786 -1.931 . . . . 75.12 105.786 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -98.97 -43.93 6.52 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.855 -0.424 . . . . 74.12 109.855 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -159.49 151.17 20.31 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.442 -0.577 . . . . 73.43 109.442 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -126.78 127.37 44.93 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.351 0.596 . . . . 75.53 110.744 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -100.43 117.1 45.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.408 -1.33 . . . . 71.23 107.408 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 12.7 ttm180 -105.91 110.05 22.21 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.401 -0.592 . . . . 73.14 109.401 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -104.89 132.43 51.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.489 -0.778 . . . . 74.31 110.374 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.73 166.88 23.63 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.123 -2.177 . . . . 73.12 105.123 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.02 65.24 1.91 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 118.377 0.535 . . . . 33.5 113.13 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -159.16 -78.03 0.07 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.42 -0.956 . . . . 75.02 108.42 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 m -142.27 159.97 19.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.818 -0.808 . . . . 74.22 108.818 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.26 114.01 26.42 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.461 -0.57 . . . . 62.3 109.461 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 69.0 tp -83.71 108.35 16.71 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.912 -1.04 . . . . 63.43 109.867 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.5 tm? -93.92 110.83 22.48 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.324 -1.362 . . . . 62.14 107.324 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.33 119.0 29.82 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.629 -0.508 . . . . 64.32 109.629 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -95.18 141.18 29.09 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.907 -0.588 . . . . 43.0 111.445 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.457 HD21 HH21 ' A' ' 48' ' ' ARG . 3.6 mm? -102.15 102.07 12.47 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 122.863 0.465 . . . . 74.53 110.871 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 67.62 85.14 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.458 1.103 . . . . 61.52 111.628 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.0 m -65.16 -14.73 61.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.223 1.194 . . . . 74.32 114.223 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -55.17 -38.27 68.09 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.96 0.886 . . . . 74.43 110.429 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -121.87 0.52 9.76 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.144 -1.058 . . . . 71.44 108.144 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 -137.27 1.41 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.026 -1.443 . . . . 74.24 115.78 -170.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -114.18 152.8 30.65 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-O 122.068 0.937 . . . . 74.42 113.106 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -121.8 141.21 51.45 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.795 -1.093 . . . . 63.11 110.448 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 88' ' ' ILE . 29.6 m -110.79 124.77 67.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.488 -2.041 . . . . 64.21 105.488 174.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 62.21 24.13 14.34 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.477 0.711 . . . . 62.24 109.211 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 71.25 20.77 4.94 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.216 1.407 . . . . 74.24 110.668 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.63 130.49 24.77 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.981 -0.748 . . . . 65.15 108.981 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.33 137.39 30.9 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 122.709 2.273 . . . . 63.42 112.761 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 80' ' ' TRP . 22.4 m -143.56 161.22 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.435 -0.58 . . . . 51.33 109.435 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -85.65 -45.46 11.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.923 -0.769 . . . . 73.14 108.923 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 12.3 pt-20 -145.33 151.72 38.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.971 -1.013 . . . . 71.3 108.736 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.459 ' HB2' HG21 ' A' ' 77' ' ' VAL . 64.6 t-105 -151.94 148.87 28.28 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.141 -1.059 . . . . 64.11 108.141 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.45 108.04 19.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.731 -1.211 . . . . 72.31 107.731 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 81.8 mt -57.06 148.26 22.17 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.434 -0.803 . . . . 51.03 111.702 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -147.34 164.04 34.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.796 -1.187 . . . . 55.34 107.796 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.35 119.81 9.81 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.702 0.626 . . . . 75.34 111.867 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.34 16.27 35.32 Favored Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 115.525 -0.761 . . . . 64.42 113.034 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.07 146.75 23.48 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 119.212 -0.995 . . . . 61.44 108.615 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.04 112.91 42.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.11 -0.7 . . . . 62.2 109.11 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.83 119.69 55.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.414 -0.958 . . . . 70.22 108.414 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -121.9 116.96 25.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 119.493 -0.883 . . . . 74.13 111.343 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -116.54 164.97 13.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.536 -1.211 . . . . 74.33 108.547 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -39.2 107.91 0.08 OUTLIER Glycine 0 N--CA 1.479 1.55 0 O-C-N 123.964 0.79 . . . . 62.32 114.443 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 69.5 -4.03 1.47 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.304 1.442 . . . . 72.32 114.864 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 m -129.42 112.96 14.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.354 0.597 . . . . 73.33 111.345 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.73 132.68 49.77 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.775 -1.194 . . . . 75.34 107.775 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.1 tp -134.69 140.41 45.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.861 -0.422 . . . . 70.11 109.861 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.17 128.6 56.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.785 -1.191 . . . . 73.22 107.785 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.95 116.51 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.177 0.513 . . . . 62.03 110.774 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -110.77 129.31 55.88 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.608 -0.724 . . . . 75.25 109.336 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 86.4 mtp -111.62 108.54 18.05 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.777 -1.194 . . . . 63.23 107.777 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 C--N 1.27 -2.883 0 CA-C-N 114.756 -1.111 . . . . 74.42 108.463 -176.297 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.418 -2.048 0 N-CA-C 108.302 -0.999 . . . . 74.14 108.302 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -118.99 115.49 24.45 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.851 -1.166 . . . . 63.14 107.851 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 23' ' ' LEU . 6.2 p -93.63 127.76 45.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.022 0 CA-C-O 121.503 0.668 . . . . 74.2 109.211 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.4 m -125.64 131.73 52.59 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.409 -0.814 . . . . 55.24 109.142 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.65 133.07 36.35 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.346 -0.613 . . . . 73.24 109.346 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -105.2 109.21 21.11 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.068 -1.827 . . . . 55.2 106.068 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.21 122.21 44.27 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.078 -0.51 . . . . 63.44 110.502 -175.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.59 99.33 12.38 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.358 -2.089 . . . . 64.42 105.358 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -121.31 -6.77 9.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.16 -0.927 . . . . 74.4 110.778 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.17 -15.8 12.01 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 109.913 -1.275 . . . . 62.1 109.913 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 m -111.61 -44.24 3.53 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.969 -0.752 . . . . 62.33 108.969 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.59 67.67 1.19 Allowed Glycine 0 CA--C 1.48 -2.141 0 N-CA-C 107.848 -2.101 . . . . 61.53 107.848 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -91.92 154.08 19.07 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.015 -0.592 . . . . 61.3 110.479 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 45.6 p -130.17 131.95 45.84 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.025 -1.102 . . . . 54.24 108.025 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -134.84 125.64 27.22 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.586 -0.524 . . . . 73.53 109.586 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.81 121.84 26.95 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.946 -0.761 . . . . 75.44 108.946 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.546 ' HB2' HG13 ' A' ' 9' ' ' VAL . 80.0 mt -66.12 139.25 58.14 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.161 -0.927 . . . . 65.24 111.923 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.58 153.46 21.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.482 -1.673 . . . . 72.13 106.482 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.24 133.88 48.49 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 73.14 111.598 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.4 -166.6 13.26 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 107.522 -2.231 . . . . 72.51 107.522 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 61.1 p -106.45 128.96 54.47 Favored 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.432 -1.307 . . . . 70.22 111.19 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -96.99 111.87 23.89 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.55 -1.278 . . . . 74.22 107.55 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mm -85.8 123.81 39.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.98 -0.555 . . . . 73.32 110.342 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.4 mt -109.52 138.19 38.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.849 -0.614 . . . . 54.31 109.606 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 152.4 -162.51 29.92 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.952 -0.859 . . . . 61.02 110.952 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.638 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.4 mtt180 -121.52 105.88 10.87 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 117.663 0.732 . . . . 62.45 109.373 176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.49 47.74 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 120.061 -1.066 . . . . 75.14 111.318 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -75.73 -23.73 56.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.764 0.792 . . . . 64.23 109.088 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.38 -18.87 44.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.759 -1.109 . . . . 71.13 110.498 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.18 136.25 36.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.895 -0.593 . . . . 74.24 111.833 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.73 -24.05 16.14 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.575 -0.898 . . . . 24.24 108.575 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -133.29 120.0 20.5 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.617 -1.174 . . . . 71.11 108.594 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 79.6 mtt180 -97.82 130.57 44.74 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.14 0.495 . . . . 72.54 111.321 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD12 HG11 ' A' ' 45' ' ' VAL . 82.2 mt -77.6 144.83 70.22 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.473 -0.785 . . . . 61.32 111.057 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 9.22 2.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.963 2.442 . . . . 63.04 113.448 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -123.42 163.64 20.45 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.503 -1.295 . . . . 72.23 107.503 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 44' ' ' GLY . 11.7 m -110.23 172.11 7.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.82 -0.807 . . . . 75.34 108.82 -176.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' H ' HG22 ' A' ' 43' ' ' THR . . . 94.19 5.27 62.33 Favored Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 109.472 -1.451 . . . . 52.41 109.472 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 40' ' ' LEU . 43.9 t -100.36 145.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.036 -1.082 . . . . 53.13 108.306 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -79.07 173.43 12.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.197 0.199 . . . . 41.14 110.627 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.5 ptp180 -65.15 -31.06 72.05 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.653 0.739 . . . . 72.14 110.566 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 64' ' ' LEU . 25.3 mtm-85 -134.08 109.59 9.05 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.728 -2.323 . . . . 72.31 104.728 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -104.56 -35.82 7.72 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 123.807 0.692 . . . . 71.11 110.247 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -162.86 149.57 12.8 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.689 -0.486 . . . . 62.13 109.689 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.25 122.53 37.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.451 0.643 . . . . 63.53 109.964 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.9 mt -96.29 104.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.783 -1.562 . . . . 63.31 106.783 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 63.8 ttt180 -91.84 107.29 19.11 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.777 0.799 . . . . 62.11 109.802 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -94.86 106.95 18.96 Favored 'General case' 0 N--CA 1.391 -3.395 0 N-CA-C 107.384 -1.339 . . . . 75.03 107.384 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -106.3 -175.36 2.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.671 -1.603 . . . . 63.22 106.671 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.02 57.26 4.32 Favored Glycine 0 C--N 1.285 -2.261 0 C-N-CA 119.493 -1.337 . . . . 42.51 115.445 -171.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -179.3 -65.59 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.602 0.761 . . . . 70.52 109.666 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.46 156.56 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.269 -0.423 . . . . 61.51 109.998 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.35 109.8 22.49 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.161 -1.051 . . . . 51.31 108.161 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.39 122.52 31.99 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.979 -1.01 . . . . 75.45 110.505 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -103.27 125.51 49.95 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.678 -1.23 . . . . 73.53 107.678 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.07 124.65 26.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.995 -0.372 . . . . 73.45 109.995 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.53 137.87 32.17 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.495 -0.775 . . . . 74.52 109.183 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 48' ' ' ARG . 27.9 tp -133.89 75.97 1.63 Allowed 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.688 0.756 . . . . 31.41 109.121 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 38.5 t-20 -173.07 142.52 1.06 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.897 -1.52 . . . . 71.52 106.897 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -95.69 -47.68 6.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.89 -0.724 . . . . 61.43 110.834 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -88.92 -12.43 41.69 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.327 0.584 . . . . 60.44 112.302 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.56 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 18.5 m120 -121.43 27.55 8.23 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.778 -0.576 . . . . 52.25 111.07 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.38 113.95 0.79 Allowed Glycine 0 N--CA 1.481 1.676 0 O-C-N 124.403 1.064 . . . . 72.44 113.777 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 90' ' ' LEU . 24.7 m -63.82 146.71 53.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.013 1.325 . . . . 65.43 112.57 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -109.73 140.74 43.25 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 115.183 -0.917 . . . . 63.3 112.467 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 27.5 m -118.88 122.03 68.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 105.832 -1.914 . . . . 75.31 105.832 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.4 m120 62.69 25.38 15.08 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.042 -0.725 . . . . 74.43 109.042 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.7 t30 79.58 4.86 2.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.215 1.406 . . . . 75.32 111.745 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.0 34.15 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 121.545 -0.722 . . . . 71.42 109.933 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.74 130.98 15.29 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.277 1.985 . . . . 73.54 111.596 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.9 m -135.4 159.07 40.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.255 -0.43 . . . . 54.11 110.645 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -82.11 -38.74 24.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.993 -0.743 . . . . 73.23 108.993 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.1 155.54 36.98 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.577 -0.897 . . . . 75.11 108.577 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.535 ' HB2' HG21 ' A' ' 77' ' ' VAL . 54.0 t-105 -159.98 149.1 17.6 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.309 -0.997 . . . . 73.24 108.309 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -100.8 115.17 29.69 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.045 -1.062 . . . . 72.15 108.642 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.552 HD22 HD11 ' A' ' 88' ' ' ILE . 62.3 mt -61.91 147.9 45.27 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.568 -1.196 . . . . 72.53 111.415 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.86 168.01 19.84 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.891 -1.522 . . . . 52.1 106.891 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 121.3 16.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.551 -0.537 . . . . 72.35 109.551 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.1 44.18 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 115.6 -0.727 . . . . 71.12 112.398 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.1 152.86 25.14 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 107.405 -1.331 . . . . 53.25 107.405 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 39.1 t -114.16 112.87 42.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.081 -0.34 . . . . 71.3 110.081 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.552 HD11 HD22 ' A' ' 82' ' ' LEU . 1.6 mp -107.44 114.14 45.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.558 -1.275 . . . . 72.41 107.558 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' HG3' ' HB3' ' A' ' 94' ' ' GLU . 15.5 ttt180 -123.43 127.6 48.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 120.275 -0.57 . . . . 65.1 110.361 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.0 OUTLIER -140.37 163.34 33.04 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.696 -1.594 . . . . 71.12 106.696 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -45.46 119.38 3.5 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.59 0.556 . . . . 62.35 114.003 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 29.0 t60 78.75 -33.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.134 1.374 . . . . 74.3 113.181 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.1 m -114.2 116.77 29.58 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.416 0.627 . . . . 64.13 111.56 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.572 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 11.5 pt-20 -116.9 121.71 42.24 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.828 -0.805 . . . . 75.22 108.828 173.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -126.49 136.83 59.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.881 -1.054 . . . . 71.2 111.94 -170.402 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -105.55 127.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.098 -1.075 . . . . 70.14 108.098 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 82' ' ' LEU . 55.5 t -86.99 125.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 116.412 -0.358 . . . . 75.33 110.969 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -115.68 149.52 38.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.718 -0.475 . . . . 73.2 109.718 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.3 mtt -130.26 116.92 19.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.456 0.646 . . . . 73.41 110.323 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.08 -1.081 . . . . 71.32 108.08 -178.846 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.432 -1.368 0 CA-C-O 121.116 0.484 . . . . 70.44 110.682 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -111.15 116.87 31.82 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.542 -1.281 . . . . 74.32 107.542 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.418 HG22 ' HG2' ' A' ' 99' ' ' MET . 25.0 t -99.81 132.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.555 -0.535 . . . . 53.41 109.555 -175.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.1 m -135.66 127.64 29.59 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.912 -0.773 . . . . 51.41 108.912 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 95' ' ' ILE . 4.3 pp -95.84 139.96 31.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.821 -0.437 . . . . 75.51 109.821 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -112.05 106.32 14.93 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.115 -0.698 . . . . 65.23 109.115 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.07 126.42 50.24 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.404 -0.962 . . . . 70.21 108.404 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -94.25 100.87 12.85 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 117.752 -1.579 . . . . 74.32 110.479 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.61 -0.11 57.55 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.495 -1.23 . . . . 74.43 109.016 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 42.69 0.96 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.566 -1.814 . . . . 64.41 108.566 -173.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.4 t -177.59 -24.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.865 -0.668 . . . . 74.5 111.289 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.1 71.29 1.05 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.463 -0.875 . . . . 44.12 110.951 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -88.72 153.47 21.07 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 122.824 0.45 . . . . 72.33 110.228 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.8 p -129.75 132.63 46.63 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.461 0.648 . . . . 74.52 111.989 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -125.62 127.23 46.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.394 -0.965 . . . . 74.34 108.394 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.563 -0.532 . . . . 72.22 109.563 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.2 mt -81.03 122.19 26.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.881 -0.785 . . . . 74.02 108.881 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -91.67 156.18 17.78 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.0 -0.68 . . . . 75.31 109.314 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.17 132.71 51.19 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.621 1.201 . . . . 73.23 111.302 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.41 -162.5 12.47 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 107.279 -2.329 . . . . 71.25 107.279 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.5 p -106.21 131.57 53.29 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 118.618 -1.233 . . . . 74.43 111.164 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.67 111.52 23.85 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.493 -1.299 . . . . 73.31 107.493 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.9 mm -85.69 121.9 37.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.098 -0.704 . . . . 75.13 109.098 -176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 38' ' ' PHE . 71.0 mt -112.57 132.83 60.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.605 -0.725 . . . . 75.25 109.704 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 145.53 -161.24 28.2 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 109.807 -1.317 . . . . 40.02 109.807 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.733 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 84.1 mtt180 -121.55 106.53 11.47 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.908 -0.775 . . . . 55.41 108.908 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.83 179.0 43.79 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.541 -1.024 . . . . 75.4 110.541 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -64.41 -46.45 83.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.865 0.691 . . . . 63.03 112.865 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.22 1.95 55.96 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.877 0.37 . . . . 74.54 111.163 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 124.12 23.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.551 -0.907 . . . . 43.51 108.551 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -89.38 -38.04 14.41 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.672 0.749 . . . . 75.32 109.588 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HD2' HG23 ' A' ' 30' ' ' ILE . 86.1 t80 -117.61 112.17 20.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.191 -0.913 . . . . 75.0 109.051 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -89.41 133.54 34.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.488 -0.778 . . . . 62.11 111.174 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 90' ' ' LEU . 85.5 mt -89.67 140.22 28.05 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 115.458 -0.792 . . . . 61.1 111.628 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.95 -23.0 30.45 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.11 2.54 . . . . 74.55 112.018 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -72.01 164.67 25.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.788 -0.642 . . . . 64.14 109.518 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -129.71 149.38 51.48 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 108.446 -0.946 . . . . 74.43 108.446 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.28 48.2 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 107.553 -2.219 . . . . 41.11 107.553 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -88.28 143.14 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 112.695 -1.753 . . . . 74.35 108.743 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 m -78.01 169.48 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 19.2 ptt180 -65.39 -37.27 86.49 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.865 0.84 . . . . 75.33 109.115 172.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB3' HD12 ' A' ' 64' ' ' LEU . 98.9 mtt180 -123.69 100.41 6.77 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 105.098 -2.186 . . . . 74.52 105.098 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -95.07 -32.44 13.11 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.904 -0.776 . . . . 54.54 108.904 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD11 HD21 ' A' ' 61' ' ' LEU . 8.3 tt -167.57 143.17 3.99 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.59 -0.732 . . . . 74.13 109.222 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -124.47 126.12 45.38 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.941 -0.572 . . . . 74.13 110.337 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.14 112.9 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.519 -0.919 . . . . 64.42 108.519 175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 73.5 ttt180 -90.79 110.13 21.33 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.563 -0.903 . . . . 61.31 108.563 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -99.86 110.54 22.89 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 114.986 -1.006 . . . . 71.1 108.755 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -116.41 174.42 6.07 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.357 -2.09 . . . . 64.15 105.357 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.98 32.39 2.73 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 120.272 -0.966 . . . . 74.14 112.908 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -134.83 -65.59 0.62 Allowed 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.414 0.685 . . . . 73.24 109.315 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.04 159.51 26.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 115.886 -0.597 . . . . 53.24 109.7 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 109.97 21.76 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.662 -0.866 . . . . 71.33 108.662 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.65 119.54 30.15 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.131 -1.395 . . . . 54.24 112.935 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -100.94 108.41 20.15 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 113.311 -1.768 . . . . 73.14 108.08 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.0 115.76 25.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.884 -0.413 . . . . 71.44 109.884 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.45 134.85 34.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.812 -0.631 . . . . 75.43 110.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 48' ' ' ARG . 21.7 mt -126.35 75.97 1.58 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.508 -0.923 . . . . 62.32 108.508 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -170.3 122.63 0.66 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 121.107 0.479 . . . . 70.44 110.124 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.3 m -93.38 -14.22 27.11 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.891 -0.506 . . . . 71.35 111.269 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -89.14 -56.45 3.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.859 0.838 . . . . 71.11 110.706 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -119.71 29.55 7.52 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.157 -0.929 . . . . 75.33 109.423 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.4 130.98 5.96 Favored Glycine 0 C--O 1.251 1.184 0 CA-C-N 114.238 -1.346 . . . . 73.24 113.486 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -66.93 143.43 56.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 125.66 1.584 . . . . 52.53 113.168 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 p -107.95 141.72 39.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.591 -1.186 . . . . 75.4 110.275 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 80' ' ' TRP . 31.4 m -120.76 120.64 63.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.844 -1.539 . . . . 70.2 106.844 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 61.64 25.96 15.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.463 0.649 . . . . 60.34 109.621 -175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.8 t30 78.15 3.15 2.8 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.46 1.904 . . . . 75.32 111.358 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.73 124.02 51.85 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.371 -0.603 . . . . 74.43 109.371 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.14 125.94 11.92 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.248 1.966 . . . . 61.54 111.155 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.91 166.58 25.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 116.476 -0.329 . . . . 62.13 110.164 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.476 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 25.1 pt20 -100.67 -26.8 13.68 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.254 -0.646 . . . . 62.22 109.254 174.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.476 ' HG2' ' HG3' ' A' ' 78' ' ' GLN . 10.6 pt-20 -158.52 148.96 20.05 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.785 -0.643 . . . . 72.14 109.814 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.472 ' CD2' HG21 ' A' ' 72' ' ' VAL . 53.7 t-105 -163.84 152.93 14.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.302 -0.999 . . . . 72.55 108.302 -172.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -105.67 121.31 43.73 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.321 -0.952 . . . . 73.55 109.07 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.62 151.09 47.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.205 -0.907 . . . . 70.25 113.106 -174.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.49 165.75 25.52 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.14 -1.43 . . . . 64.3 107.14 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 19.4 t70 -69.12 121.25 16.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.933 0.396 . . . . 60.33 109.969 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.34 8.2 53.29 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.708 -0.678 . . . . 74.11 111.693 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.12 134.02 36.13 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 107.566 -1.272 . . . . 72.41 107.566 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -98.93 112.81 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.341 -0.614 . . . . 65.21 109.341 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.441 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.09 129.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 106.958 -1.497 . . . . 73.54 106.958 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -138.24 149.29 45.61 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.814 -0.754 . . . . 74.31 110.969 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.472 ' CD1' HD13 ' A' ' 40' ' ' LEU . 2.0 pt? -138.32 165.55 26.46 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.852 -2.277 . . . . 75.53 104.852 172.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -34.84 102.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.833 0 N-CA-C 115.98 1.152 . . . . 31.42 115.98 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 60.85 17.96 8.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.4 1.08 . . . . 64.11 113.908 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -131.6 114.01 14.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.819 -0.808 . . . . 72.41 108.819 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.06 139.8 49.92 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.586 0.708 . . . . 75.44 112.013 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -135.51 137.11 50.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.71 -1.132 . . . . 74.33 110.392 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.78 126.04 65.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.827 -0.805 . . . . 62.14 108.827 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.0 t -85.07 126.36 40.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.674 -0.239 . . . . 70.34 110.693 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -115.31 145.05 42.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.572 -0.529 . . . . 74.12 109.572 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.418 ' HG2' HG22 ' A' ' 9' ' ' VAL . 56.0 mtt -130.37 127.49 39.49 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.693 -0.685 . . . . 74.13 109.598 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 107.173 -1.417 . . . . 74.24 107.173 178.311 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.204 0.526 . . . . 61.5 111.329 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -116.52 134.74 54.5 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.722 -1.214 . . . . 63.32 107.722 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.4 p -101.37 114.81 41.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.435 -0.95 . . . . 72.34 108.435 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.5 m -124.43 136.05 53.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 114.663 -1.153 . . . . 71.21 110.667 -169.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 20' ' ' THR . 57.7 mt -89.23 126.37 35.47 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.476 -1.238 . . . . 61.11 109.402 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -106.61 114.51 28.65 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.709 -1.219 . . . . 74.41 107.709 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 62.8 tp -118.07 110.99 18.31 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.671 -0.863 . . . . 63.43 108.671 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.06 100.26 12.41 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 117.764 -1.575 . . . . 65.32 109.629 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.6 30.43 3.61 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 106.382 -1.71 . . . . 72.53 106.382 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.5 47.08 17.18 Favored Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.177 -1.969 . . . . 63.13 108.177 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -162.81 -29.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.154 0.582 . . . . 72.13 111.785 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.91 3.46 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.692 -0.963 . . . . 62.01 110.692 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -87.95 148.21 24.68 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 110.062 -0.347 . . . . 73.24 110.062 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 22.9 p -135.45 132.24 37.18 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.076 0.465 . . . . 54.3 111.789 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -128.25 126.21 40.45 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.218 -1.401 . . . . 74.22 107.218 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -94.87 141.08 29.06 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.432 -0.507 . . . . 73.1 110.305 -175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.445 ' HB2' HG13 ' A' ' 9' ' ' VAL . 95.6 mt -80.48 140.82 35.72 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.605 -0.517 . . . . 71.02 109.605 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -96.61 169.06 10.15 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.387 -0.525 . . . . 65.34 110.274 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -74.62 112.99 11.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.265 0.978 . . . . 73.32 110.43 -178.143 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.38 -159.65 23.19 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.124 -1.991 . . . . 62.3 108.124 -174.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.6 p -101.27 131.44 47.29 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.139 -1.024 . . . . 51.41 110.646 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.446 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 24.6 m-80 -106.67 112.33 25.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 74.1 107.774 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -96.95 126.1 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.401 -0.222 . . . . 74.13 110.401 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.06 142.97 31.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 C-N-CA 123.545 0.738 . . . . 64.04 109.837 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 153.49 -154.0 25.21 Favored Glycine 0 CA--C 1.475 -2.453 0 N-CA-C 110.683 -0.967 . . . . 45.14 110.683 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 16.7 mmm180 -131.73 104.83 7.12 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.256 0.55 . . . . 72.24 109.789 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 169.97 37.63 Favored Glycine 0 N--CA 1.41 -3.06 0 N-CA-C 108.99 -1.644 . . . . 71.45 108.99 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.16 -14.22 60.53 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.693 0.759 . . . . 74.01 109.701 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.19 -10.01 40.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.355 -0.838 . . . . 73.3 110.704 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -90.59 149.2 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.363 -0.606 . . . . 73.44 109.363 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 86.8 mt-30 -87.25 -49.28 7.37 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.742 -0.836 . . . . 75.51 108.742 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -105.44 111.42 24.13 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.397 -0.82 . . . . 73.35 109.069 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -91.16 122.55 33.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.477 -0.783 . . . . 63.24 110.725 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD12 HG11 ' A' ' 45' ' ' VAL . 79.9 mt -65.63 158.4 74.36 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.147 -0.933 . . . . 74.22 112.033 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.78 26.68 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.533 2.822 . . . . 73.45 112.161 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.72 153.38 47.19 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.181 -1.415 . . . . 73.51 107.181 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -121.39 161.32 22.34 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 120.235 -0.586 . . . . 73.33 109.625 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.56 -15.47 24.51 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 108.502 -1.839 . . . . 63.35 108.502 -172.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 40' ' ' LEU . 51.9 t -76.93 149.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 125.449 1.5 . . . . 72.32 108.894 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.0 m -75.67 163.39 27.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 119.597 -0.24 . . . . 75.23 110.901 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 44.6 ptt85 -60.28 -41.39 93.21 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 120.94 0.4 . . . . 73.13 110.681 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -121.53 107.07 11.99 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 106.323 -1.732 . . . . 74.22 106.323 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -103.21 -34.04 8.97 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.654 -1.157 . . . . 75.13 108.945 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.51 HD11 HD21 ' A' ' 61' ' ' LEU . 7.9 tt -166.39 148.51 6.72 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 115.669 -0.696 . . . . 72.51 109.134 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HG2' HD21 ' A' ' 64' ' ' LEU . 12.6 pt-20 -137.32 144.45 42.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.856 -0.794 . . . . 71.35 108.856 175.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.4 mt -117.2 119.13 60.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 109.555 -0.535 . . . . 74.33 109.555 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -91.17 107.72 19.39 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.599 -1.259 . . . . 75.11 107.599 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -105.44 118.71 37.26 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.714 -0.675 . . . . 71.23 109.366 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.45 -178.84 4.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.564 -2.384 . . . . 64.4 104.564 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.3 53.42 4.78 Favored Glycine 0 C--N 1.297 -1.601 0 C-N-CA 119.856 -1.164 . . . . 31.4 112.721 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -147.74 -77.45 0.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.487 0.715 . . . . 73.35 109.333 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.61 159.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.043 -0.725 . . . . 42.25 109.043 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.93 107.84 19.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.111 -1.07 . . . . 54.32 108.111 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.88 113.27 20.38 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.377 -0.828 . . . . 70.11 108.828 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -90.29 119.59 30.72 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 124.805 1.242 . . . . 62.32 108.347 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.14 119.72 28.28 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.535 -0.543 . . . . 43.15 109.535 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 131.58 42.35 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.844 -0.617 . . . . 74.22 111.148 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.5 mm? -118.68 76.72 1.11 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.057 -0.719 . . . . 63.43 109.057 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 38.1 t-20 -176.43 139.9 0.35 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.527 -0.916 . . . . 54.32 108.527 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -108.25 -50.23 3.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.928 -0.397 . . . . 53.21 109.928 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -59.1 -49.03 79.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.65 0.738 . . . . 72.51 111.549 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -121.38 28.14 7.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.695 0.76 . . . . 54.14 109.28 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 65' ' ' ASN . . . -49.95 144.65 9.7 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 113.83 -1.532 . . . . 74.03 115.182 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.8 m -75.65 143.13 42.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.492 1.117 . . . . 42.11 112.063 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.9 p -110.91 148.83 31.61 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.813 -0.631 . . . . 74.41 111.043 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG12 HG13 ' A' ' 88' ' ' ILE . 34.1 m -114.87 118.38 58.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.663 -1.236 . . . . 65.14 107.663 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.4 29.84 19.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.569 0.7 . . . . 72.33 110.415 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 77.62 13.26 1.86 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.198 1.799 . . . . 70.2 111.242 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.97 128.14 25.9 Favored Pre-proline 0 C--N 1.32 -0.706 0 O-C-N 121.859 -0.526 . . . . 73.3 109.598 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.19 125.74 11.69 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.689 2.259 . . . . 62.41 112.467 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.69 -177.2 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.125 -1.065 . . . . 72.35 108.125 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -125.39 -27.28 3.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.356 0.41 . . . . 64.44 110.784 175.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.76 134.47 28.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 45.33 109.727 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -149.13 152.15 35.61 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.917 -0.771 . . . . 73.54 108.917 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -101.7 107.52 18.77 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.468 -1.678 . . . . 71.22 106.468 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 82.9 mt -58.9 137.49 57.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.154 0.502 . . . . 61.23 112.054 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.01 163.47 24.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.859 -1.163 . . . . 42.02 107.859 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.91 117.93 8.31 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.426 -0.352 . . . . 64.42 110.204 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.48 -0.98 30.83 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.825 -0.702 . . . . 51.32 113.814 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -80.07 141.65 35.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.523 0.662 . . . . 73.33 111.305 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.22 113.77 39.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 N-CA-C 108.682 -0.859 . . . . 73.03 108.682 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.465 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -107.34 114.16 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.661 -0.866 . . . . 75.54 108.661 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 94' ' ' GLU . 37.3 ttt180 -106.57 109.42 21.33 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.031 -1.067 . . . . 72.14 112.04 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 90' ' ' LEU . 2.0 pt? -112.79 164.43 13.4 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.684 -1.599 . . . . 71.44 106.684 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -24.58 99.14 0.01 OUTLIER Glycine 0 N--CA 1.485 1.908 0 O-C-N 124.661 1.225 . . . . 73.22 116.092 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 t60 77.65 -28.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.79 1.636 . . . . 72.43 113.581 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 m -114.73 119.6 37.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 113.495 0.924 . . . . 73.43 113.495 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 6.8 pt-20 -94.16 115.11 27.35 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.661 -0.866 . . . . 64.03 108.661 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.0 tp -103.34 140.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.941 -1.027 . . . . 61.11 109.239 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 69.3 mt -101.68 121.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.063 -1.088 . . . . 64.32 108.063 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 82' ' ' LEU . 72.5 t -87.6 118.3 33.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.463 -0.335 . . . . 44.23 110.167 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -119.58 150.55 40.11 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 109.524 -0.547 . . . . 73.44 109.524 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mtt -117.25 120.41 38.15 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.347 -0.982 . . . . 64.34 108.347 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 . . . . . 0 C--N 1.273 -2.726 0 N-CA-C 107.633 -1.247 . . . . 70.03 107.633 -177.17 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.432 -1.369 0 N-CA-C 109.317 -0.623 . . . . 74.11 109.317 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -144.53 131.85 20.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.371 -0.603 . . . . 63.02 109.371 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.16 113.23 35.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.579 -1.267 . . . . 65.14 107.579 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 129.55 55.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.26 -0.882 . . . . 73.21 109.719 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' THR . 83.5 mt -87.56 123.54 32.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.202 -1.036 . . . . 74.13 108.202 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.72 120.72 41.79 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 116.145 -0.479 . . . . 61.12 109.746 -175.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.67 146.89 51.42 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 107.289 -1.374 . . . . 73.42 107.289 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -95.23 118.36 31.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.817 -1.153 . . . . 74.33 110.986 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' ' 19' ' ' ARG . 12.5 t70 -103.15 -6.18 22.46 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.08 -1.418 . . . . 73.31 109.273 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.81 31.85 2.02 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.829 -1.708 . . . . 70.03 108.829 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.5 t 171.37 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.781 -1.933 . . . . 71.24 105.781 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.5 100.58 1.25 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.167 -1.016 . . . . 71.31 113.011 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 15' ' ' ASP . 26.7 mtm-85 -86.21 158.68 19.68 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.81 -1.181 . . . . 73.21 107.81 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.7 p -139.61 138.43 36.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 116.053 -0.521 . . . . 72.13 110.191 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.0 118.4 30.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.121 -1.437 . . . . 72.25 107.121 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -92.82 132.22 37.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.469 -0.937 . . . . 52.01 108.469 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.06 122.05 25.06 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.04 -0.356 . . . . 43.31 110.04 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -85.84 166.89 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.928 -1.138 . . . . 73.22 107.928 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -67.61 123.29 20.06 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.263 -0.643 . . . . 73.24 109.263 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.37 -163.94 14.69 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 110.041 -1.224 . . . . 40.42 110.041 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.9 p -99.46 141.13 32.65 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 117.947 0.873 . . . . 71.13 111.565 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -122.71 115.59 22.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.891 -1.522 . . . . 61.24 106.891 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -97.15 133.61 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.544 -0.298 . . . . 72.52 111.396 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.429 HG12 ' HB3' ' A' ' 38' ' ' PHE . 67.9 mt -107.73 133.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.574 -0.899 . . . . 72.03 108.574 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.4 -161.21 31.98 Favored Glycine 0 CA--C 1.49 -1.478 0 N-CA-C 110.756 -0.938 . . . . 53.5 110.756 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.6 mtm180 -123.37 105.8 10.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.158 -1.053 . . . . 75.31 108.158 174.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.05 -176.29 48.01 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 109.21 -1.556 . . . . 74.54 109.21 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -88.18 -16.12 34.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.409 0.623 . . . . 62.41 109.438 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.921 0.867 . . . . 72.23 109.781 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.75 145.41 28.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.739 -0.664 . . . . 75.14 110.72 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -105.11 -12.36 16.16 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.895 0.855 . . . . 75.01 109.764 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.429 ' HB3' HG12 ' A' ' 30' ' ' ILE . 44.3 t80 -139.77 121.81 15.7 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.91 -1.885 . . . . 63.24 105.91 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.7 ttt180 -100.37 131.54 46.24 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.333 -0.394 . . . . 72.42 111.426 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 90' ' ' LEU . 61.2 mt -92.01 138.51 24.62 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.826 -0.625 . . . . 74.51 109.489 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -92.9 12.46 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 122.96 2.44 . . . . 74.44 111.691 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -93.31 -173.31 3.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.875 -0.602 . . . . 62.05 109.891 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -113.5 152.35 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.553 0.216 . . . . 72.43 111.139 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.74 86.92 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.237 0.354 . . . . 71.23 112.877 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 49' ' ' HIS . 48.8 t -88.51 114.51 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.438 -0.578 . . . . 72.32 109.438 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -64.22 176.69 0.97 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 124.186 0.994 . . . . 71.12 110.894 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 23.7 ptt85 -63.8 -34.75 78.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.63 0.729 . . . . 74.14 109.818 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -120.67 109.16 14.88 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.659 -1.238 . . . . 73.44 107.659 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 18.9 t60 -103.33 -31.76 9.89 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.479 -0.934 . . . . 62.15 108.479 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.449 HD11 HD21 ' A' ' 61' ' ' LEU . 8.4 tt -167.3 152.94 7.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.536 -0.913 . . . . 75.24 108.536 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -135.34 140.41 45.06 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.293 0.568 . . . . 75.2 109.923 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.0 mt -115.89 114.21 45.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.9 -0.778 . . . . 72.44 108.9 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 19.1 ttt180 -92.47 110.23 21.64 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.949 -0.759 . . . . 74.41 108.949 176.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -99.93 108.66 20.95 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.769 -0.65 . . . . 74.21 111.295 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -107.81 162.57 13.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.595 -1.632 . . . . 73.32 106.595 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.67 66.72 1.06 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.847 0.699 . . . . 72.23 114.847 -175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -169.22 -72.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.953 0.901 . . . . 73.32 108.978 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.57 159.15 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.51 -0.922 . . . . 70.4 108.51 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -99.83 120.81 40.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.416 0.627 . . . . 73.41 110.145 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 67.2 tp -80.93 125.46 30.15 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.868 -1.06 . . . . 72.44 109.882 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.449 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -111.62 120.55 42.45 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.315 -0.624 . . . . 52.4 109.315 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.98 124.53 40.95 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.407 -0.59 . . . . 75.52 109.407 176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.71 133.8 38.0 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.396 -0.366 . . . . 44.22 111.157 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.61 76.41 1.34 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.803 -0.443 . . . . 72.13 109.803 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -173.0 133.61 0.54 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.292 0.496 . . . . 64.0 109.748 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -98.75 -35.75 10.05 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.116 0.484 . . . . 60.02 111.271 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -87.93 -32.48 18.89 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.23 0.538 . . . . 52.03 112.151 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -122.56 28.66 7.25 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.07 -0.394 . . . . 74.13 110.334 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.05 133.17 6.54 Favored Glycine 0 C--O 1.246 0.902 0 O-C-N 124.949 1.405 . . . . 75.13 113.985 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 90' ' ' LEU . 22.1 m -74.11 136.68 42.96 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.906 0.882 . . . . 75.05 112.366 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 28.2 p -111.13 143.68 41.48 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.896 -0.593 . . . . 70.41 110.49 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 80' ' ' TRP . 35.0 m -111.9 121.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.687 -1.597 . . . . 74.43 106.687 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.13 23.41 13.61 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.504 0.721 . . . . 61.02 110.023 -169.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 75.66 9.31 3.58 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.054 1.342 . . . . 72.04 110.866 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.43 124.04 50.29 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.246 -0.65 . . . . 70.35 109.246 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.72 126.76 15.9 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.116 2.544 . . . . 35.33 113.038 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 159.87 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.386 -0.825 . . . . 53.32 109.013 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.34 -19.7 14.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.1 -0.704 . . . . 74.43 109.1 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.74 149.43 34.38 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.387 -0.824 . . . . 70.2 110.289 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.484 ' CD2' HG21 ' A' ' 72' ' ' VAL . 77.3 t-105 -159.76 152.83 21.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.194 -0.669 . . . . 65.3 109.194 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.16 114.95 29.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.58 -1.267 . . . . 72.24 107.58 174.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD22 HD11 ' A' ' 88' ' ' ILE . 32.8 mt -56.92 132.83 53.81 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 112.953 0.723 . . . . 74.41 112.953 -174.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.49 155.37 39.06 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.382 -1.34 . . . . 61.05 107.382 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.52 128.3 35.68 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 123.24 0.337 . . . . 62.15 111.169 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.04 55.41 Favored Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 115.757 -0.656 . . . . 62.43 112.487 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.13 136.76 34.33 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 108.705 -0.85 . . . . 74.22 108.705 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.65 111.61 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.456 -1.313 . . . . 74.13 107.456 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 82' ' ' LEU . 53.9 mt -107.67 118.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 CA-C-O 121.292 0.568 . . . . 72.44 109.554 -174.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 24.2 mtp180 -111.97 106.71 15.47 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.95 0.881 . . . . 72.04 110.439 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.613 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 0.5 OUTLIER -108.3 164.47 12.28 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.372 -1.286 . . . . 63.41 108.267 178.372 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -28.25 90.97 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 O-C-N 124.752 1.282 . . . . 61.11 115.837 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 60.68 11.78 3.32 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 125.86 1.664 . . . . 74.42 112.418 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 m -131.37 113.5 13.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.788 -0.819 . . . . 73.32 108.788 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -105.94 136.9 44.77 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.841 -0.744 . . . . 60.52 110.81 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 10.7 tp -129.72 146.31 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 108.741 -0.837 . . . . 71.14 108.741 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -111.97 133.24 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.622 -0.881 . . . . 74.5 108.622 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.0 t -90.9 114.54 28.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.901 -0.407 . . . . 65.31 109.901 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -114.49 122.44 46.58 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.002 -0.545 . . . . 64.13 110.315 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.7 mtt -101.93 125.9 48.71 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.37 -0.832 . . . . 74.05 110.573 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.293 -1.864 0 CA-C-N 114.519 -1.219 . . . . 72.32 108.877 178.502 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 m . . . . . 0 N--CA 1.431 -1.402 0 N-CA-C 108.811 -0.811 . . . . 74.34 108.811 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 17.4 m -123.41 146.75 47.74 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.338 -0.986 . . . . 74.13 108.338 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.1 p -135.85 115.81 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 107.349 -1.352 . . . . 52.32 107.349 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -114.79 131.96 56.63 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.175 -1.375 . . . . 60.55 110.361 -170.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 95' ' ' ILE . 4.2 pp -98.7 133.52 42.91 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.799 -0.815 . . . . 51.2 108.799 174.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' O ' HD12 ' A' ' 95' ' ' ILE . 43.3 mt-30 -99.9 120.64 40.1 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.782 -0.644 . . . . 65.23 110.692 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.5 tp -129.85 111.32 12.47 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.261 -0.882 . . . . 70.41 110.082 -174.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -89.0 100.58 13.33 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.04 -1.464 . . . . 53.41 108.848 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.61 9.62 40.97 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.699 -1.591 . . . . 61.43 108.568 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.4 -13.77 10.17 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.293 -0.867 . . . . 71.12 111.113 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 m -137.23 13.32 3.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.852 -0.174 . . . . 70.35 111.374 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.31 83.6 0.04 OUTLIER Glycine 0 C--N 1.345 1.079 0 N-CA-C 114.279 0.471 . . . . 73.51 114.279 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -98.77 144.38 28.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.281 0.562 . . . . 74.32 111.237 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.421 HG22 ' HG2' ' A' ' 12' ' ' GLN . 77.4 p -122.5 134.45 54.57 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.897 -1.149 . . . . 74.52 107.897 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -137.25 131.75 32.8 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.577 0.214 . . . . 74.32 111.577 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.39 136.07 38.38 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.846 -0.427 . . . . 61.23 109.846 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.576 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.8 mt -68.31 139.62 55.92 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.803 -0.635 . . . . 72.24 110.038 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -105.31 152.98 22.24 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.404 -0.591 . . . . 74.14 109.404 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.33 136.96 58.22 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 124.344 1.027 . . . . 73.31 111.518 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.49 -164.11 12.45 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.722 -2.151 . . . . 73.11 107.722 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.6 p -104.43 130.03 52.36 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.233 -1.387 . . . . 72.12 112.236 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -99.95 108.97 21.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 105.409 -2.071 . . . . 55.25 105.409 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.496 HG21 ' HG2' ' A' ' 48' ' ' ARG . 57.9 mt -98.57 130.34 47.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.886 -0.597 . . . . 72.04 110.948 -173.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.0 mt -101.99 123.4 55.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.143 -1.058 . . . . 71.31 108.143 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.4 -176.4 39.57 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.702 -1.359 . . . . 50.45 109.702 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -115.03 106.16 13.81 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 117.63 0.715 . . . . 73.32 109.309 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.56 177.49 44.65 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.509 -1.036 . . . . 62.5 110.509 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -81.19 -16.95 51.36 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.5 0.667 . . . . 72.0 109.622 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.61 -23.85 31.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.653 0.739 . . . . 74.43 110.086 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -82.99 162.42 21.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.127 -0.942 . . . . 72.02 110.95 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -104.36 -58.46 1.88 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.811 -0.811 . . . . 62.2 108.811 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.35 129.95 46.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.575 -0.738 . . . . 61.12 109.16 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 24.8 mtm180 -108.37 131.13 55.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.103 -0.499 . . . . 73.03 110.364 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.64 142.36 57.27 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 116.185 -0.461 . . . . 72.53 110.382 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -89.1 27.79 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.032 2.488 . . . . 71.23 110.917 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -135.09 -177.7 4.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.959 -1.126 . . . . 74.4 107.959 -174.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -116.46 178.68 4.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.731 -0.84 . . . . 71.13 108.731 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.76 79.52 Favored Glycine 0 C--N 1.317 -0.476 0 N-CA-C 110.213 -1.155 . . . . 63.14 110.213 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 49' ' ' HIS . 4.8 p -116.9 136.47 53.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 114.347 -0.927 . . . . 70.14 109.584 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -89.7 -164.43 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.821 -0.807 . . . . 62.22 108.821 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 35.8 ptt180 -78.27 -30.42 48.49 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 118.767 -1.173 . . . . 54.43 108.557 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HG2' HG21 ' A' ' 29' ' ' ILE . 78.5 mtt180 -121.87 108.03 12.98 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.038 -1.467 . . . . 65.22 107.038 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.567 ' HB2' HG23 ' A' ' 45' ' ' VAL . 25.3 t60 -104.21 -34.78 8.24 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.047 -1.094 . . . . 70.12 108.047 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tt -165.42 142.92 5.83 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.976 -1.12 . . . . 71.53 107.976 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -131.14 129.88 42.37 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.508 0.67 . . . . 72.2 110.936 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.44 110.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 115.376 -0.829 . . . . 71.12 108.951 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 25.2 ttt180 -90.57 110.19 21.33 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.994 -0.743 . . . . 64.54 108.994 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -94.68 107.64 19.64 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.146 -1.057 . . . . 75.03 108.146 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.36 152.49 31.39 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 105.145 -2.169 . . . . 71.34 105.145 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.24 57.54 2.81 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 118.423 0.556 . . . . 52.34 112.365 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -159.22 -60.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.432 -1.322 . . . . 74.13 107.432 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.7 m -143.88 156.91 16.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 115.54 -0.755 . . . . 64.43 109.924 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -95.25 102.64 14.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.787 -1.19 . . . . 71.34 107.787 175.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.23 116.9 23.84 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.226 -0.897 . . . . 72.51 109.858 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -99.4 119.35 37.83 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.901 -1.148 . . . . 74.52 107.901 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.16 27.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.183 0.516 . . . . 71.35 110.307 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 5.9 t70 -85.99 138.87 31.67 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.887 0.875 . . . . 72.31 109.316 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.04 76.67 1.69 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.508 -1.293 . . . . 75.31 107.508 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -166.24 150.07 7.58 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.802 -0.561 . . . . 50.31 109.899 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 m -108.22 -30.28 8.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.207 0.527 . . . . 60.35 111.409 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.9 m -88.94 -60.29 2.0 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.145 0.974 . . . . 65.41 111.867 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -104.4 28.6 6.77 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 125.048 1.339 . . . . 72.22 109.519 -168.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.86 139.25 5.0 Favored Glycine 0 C--O 1.256 1.531 0 CA-C-N 114.017 -1.447 . . . . 54.0 113.71 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 90' ' ' LEU . 7.0 m -83.61 155.74 23.07 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.13 0.972 . . . . 63.33 112.381 -172.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.4 p -118.98 153.71 34.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.952 -0.567 . . . . 65.13 110.261 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.431 HG12 HG13 ' A' ' 88' ' ' ILE . 35.6 m -116.6 116.28 51.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.816 -1.179 . . . . 54.11 107.816 175.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 62.36 27.1 16.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.018 0.913 . . . . 71.21 109.359 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.87 15.97 3.03 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.307 1.843 . . . . 74.05 111.26 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.23 123.74 38.7 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 108.693 -0.855 . . . . 73.11 108.693 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.62 124.4 9.28 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.173 1.915 . . . . 73.11 112.998 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 72' ' ' VAL . 35.8 m -156.25 169.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 104.963 -2.236 . . . . 73.4 104.963 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.1 mt-30 -113.24 -6.23 13.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.394 -0.923 . . . . 74.23 112.536 175.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 7.0 pt-20 -151.43 140.59 21.25 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.163 -0.615 . . . . 73.42 111.909 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -163.29 152.56 14.82 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.205 -1.035 . . . . 74.54 108.205 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.59 116.7 33.13 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.777 -0.823 . . . . 71.41 108.777 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.6 mt -61.77 130.38 45.51 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.678 0.622 . . . . 74.14 112.678 -175.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -126.78 167.84 15.23 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.88 -0.785 . . . . 72.22 108.88 173.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 26.2 t70 -60.55 124.45 20.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.465 -0.334 . . . . 64.04 110.634 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.9 -7.36 52.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.721 -0.752 . . . . 70.42 113.622 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -73.97 135.04 43.16 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 117.179 0.49 . . . . 74.1 111.488 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.92 113.07 39.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.718 -0.845 . . . . 74.24 108.718 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.506 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 1.8 mp -98.27 113.22 32.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 106.55 -1.648 . . . . 73.41 106.55 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -115.5 116.21 27.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.25 0.548 . . . . 73.2 111.193 -169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.1 pt? -123.79 164.71 18.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.892 1.277 . . . . 71.33 108.365 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.39 113.8 0.9 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.642 0.617 . . . . 54.43 114.642 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.8 m80 64.82 7.13 3.69 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.85 1.26 . . . . 73.15 114.068 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.4 m -140.83 125.87 18.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.779 -0.369 . . . . 55.22 110.939 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.92 121.78 40.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.163 -0.68 . . . . 74.14 109.163 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.576 HD11 HD13 ' A' ' 11' ' ' LEU . 6.9 tp -109.74 125.7 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 N-CA-C 108.725 -0.843 . . . . 61.42 108.725 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.51 129.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.158 -0.682 . . . . 74.02 109.158 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.4 t -94.52 123.88 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.568 0.699 . . . . 71.24 111.961 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -112.92 119.24 37.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.043 -0.98 . . . . 73.21 108.677 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 85.6 mtp -107.1 120.99 43.59 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.298 -0.561 . . . . 71.31 110.591 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 28.4 m-70 . . . . . 0 C--N 1.283 -2.32 0 N-CA-C 107.137 -1.431 . . . . 73.54 107.137 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.436 -1.174 0 N-CA-C 109.102 -0.703 . . . . 61.23 109.102 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.0 m -134.4 138.2 44.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.332 -0.618 . . . . 73.42 109.332 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.64 109.56 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.233 -1.395 . . . . 72.23 107.233 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.406 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 57.0 m -108.63 122.38 46.98 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.293 -1.003 . . . . 64.22 108.293 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.563 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 47.1 mt -87.7 128.7 35.3 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.672 -1.233 . . . . 73.11 107.672 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -100.97 117.64 35.41 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 107.055 -1.461 . . . . 74.52 107.055 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 95' ' ' ILE . 50.3 tp -91.94 125.85 36.8 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.672 -0.695 . . . . 55.54 109.385 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.58 100.13 11.72 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 107.466 -1.309 . . . . 75.2 107.466 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -126.95 -14.01 5.64 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.768 -1.106 . . . . 54.44 109.701 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.41 -29.98 6.18 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.382 -1.087 . . . . 61.14 110.382 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -90.11 -35.03 15.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.123 -1.066 . . . . 61.21 108.123 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.39 57.93 2.39 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 109.85 -1.3 . . . . 51.13 109.85 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 19' ' ' ARG . 3.9 mmp_? -87.51 162.88 16.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.562 -0.319 . . . . 64.45 110.304 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 33.9 p -128.59 143.4 50.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.872 0.368 . . . . 74.44 110.764 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -127.27 113.1 15.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.829 -0.804 . . . . 74.42 108.829 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.71 132.68 35.3 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.849 -0.797 . . . . 74.51 108.849 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD22 HD21 ' A' ' 28' ' ' ASN . 65.5 mt -59.89 132.13 53.02 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.051 0.845 . . . . 62.42 111.454 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.32 145.54 32.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.094 -1.076 . . . . 73.21 108.094 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.99 113.56 10.16 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.087 0.946 . . . . 73.42 109.901 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.83 -161.01 24.75 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 107.041 -2.424 . . . . 75.21 107.041 -173.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.2 p -107.56 137.69 45.13 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 118.449 1.125 . . . . 74.43 112.311 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.424 HD21 HD22 ' A' ' 23' ' ' LEU . 7.1 p30 -120.76 120.89 36.92 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.254 -0.647 . . . . 65.33 109.254 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.62 121.22 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.535 -0.913 . . . . 72.22 108.535 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 76.2 mt -97.96 130.01 47.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.005 -0.739 . . . . 64.21 109.005 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.97 -173.11 36.6 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 110.182 -1.167 . . . . 72.24 110.182 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 40' ' ' LEU . 25.9 mtm105 -124.08 107.22 11.04 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 117.678 0.739 . . . . 64.44 110.179 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.47 176.71 44.87 Favored Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.529 -1.028 . . . . 53.12 110.529 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -55.64 -32.22 62.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.954 0.902 . . . . 75.1 112.244 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -95.26 1.55 54.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.212 -0.449 . . . . 63.52 111.894 -173.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.03 149.76 24.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.039 0.447 . . . . 74.24 112.069 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -107.24 -57.77 2.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.867 0.867 . . . . 72.34 108.716 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 19.8 t80 -101.67 117.06 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.992 -1.855 . . . . 75.53 105.992 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 36.6 mtm180 -107.89 126.58 52.84 Favored 'General case' 0 C--N 1.279 -2.476 0 C-N-CA 120.445 -0.502 . . . . 45.02 111.573 -174.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.54 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 63.3 mt -75.45 148.75 83.49 Favored Pre-proline 0 C--O 1.21 -0.998 0 CA-C-N 115.756 -0.657 . . . . 74.21 109.434 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.57 11.65 2.84 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.476 2.118 . . . . 54.34 113.925 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -116.39 -177.37 3.16 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.427 -0.582 . . . . 70.14 109.427 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 m -128.69 149.65 50.59 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 123.234 0.614 . . . . 73.54 109.629 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -16.67 24.02 Favored Glycine 0 CA--C 1.495 -1.182 0 N-CA-C 108.548 -1.821 . . . . 60.11 108.548 -175.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' HA2' ' A' ' 31' ' ' GLY . 31.5 t -80.69 128.37 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.372 -1.414 . . . . 71.23 107.401 177.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -68.39 166.19 17.21 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 123.502 0.501 . . . . 63.32 112.104 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.486 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.3 ptt-85 -62.26 -37.63 86.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.58 0.705 . . . . 72.12 109.437 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.432 HH21 ' CD ' ' A' ' 51' ' ' GLU . 21.7 mtp180 -126.22 95.8 4.5 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.725 -2.695 . . . . 74.23 103.725 169.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -92.12 -37.47 12.73 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.772 0.796 . . . . 71.33 109.148 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 HD21 ' A' ' 61' ' ' LEU . 5.7 tt -161.75 150.02 15.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.094 -1.076 . . . . 54.02 108.094 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' CD ' HH21 ' A' ' 48' ' ' ARG . 8.4 pt-20 -139.77 125.98 20.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.662 0.744 . . . . 72.22 111.313 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.99 121.89 52.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.045 -0.98 . . . . 64.52 108.36 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -106.25 107.18 18.05 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.716 -1.216 . . . . 74.22 107.716 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -108.65 121.19 44.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.954 0.883 . . . . 74.01 112.959 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -133.41 158.13 43.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.542 -1.651 . . . . 50.21 106.542 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.41 68.41 0.53 Allowed Glycine 0 C--N 1.314 -0.684 0 N-CA-C 114.772 0.669 . . . . 70.13 114.772 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -165.79 -70.72 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.727 -1.212 . . . . 64.51 107.727 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.57 150.99 29.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.802 0.334 . . . . 72.32 110.614 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -97.98 112.69 24.53 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.294 0.568 . . . . 75.13 109.494 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 tt -84.23 117.7 23.69 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.954 -1.021 . . . . 71.0 108.873 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.479 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -100.77 109.94 21.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.222 -1.399 . . . . 73.11 107.222 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 111.09 21.09 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.264 0.554 . . . . 71.44 110.023 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 136.79 35.85 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.591 -0.892 . . . . 71.41 108.591 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.51 106.31 16.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.534 -0.913 . . . . 75.12 108.534 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.564 ' OD1' ' HB ' ' A' ' 67' ' ' THR . 28.7 t-20 69.78 89.47 0.1 Allowed 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.11 -0.95 . . . . 74.13 111.39 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.73 -18.14 64.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.956 . . . . 73.34 111.868 -175.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.564 ' HB ' ' OD1' ' A' ' 65' ' ' ASN . 18.5 m -46.44 -53.58 10.84 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 71.43 110.979 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -122.34 27.13 8.08 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.654 -1.61 . . . . 72.4 106.654 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.88 -144.91 17.91 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.337 -1.302 . . . . 62.41 115.854 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -107.4 156.47 18.9 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.124 -1.038 . . . . 74.51 112.842 -169.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 p -119.21 140.81 49.59 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.175 -0.921 . . . . 73.3 109.8 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.475 HG12 HG13 ' A' ' 88' ' ' ILE . 35.9 m -114.91 115.74 50.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.712 -1.218 . . . . 70.23 107.712 177.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.99 28.63 18.41 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.844 0.831 . . . . 72.12 109.115 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 81.18 0.06 1.71 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.194 2.198 . . . . 54.33 111.603 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -97.41 121.34 58.76 Favored Pre-proline 0 C--N 1.316 -0.884 0 O-C-N 121.556 -0.715 . . . . 74.14 109.724 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 5.7 Cg_exo -75.11 125.45 9.26 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.094 1.862 . . . . 75.15 110.941 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.78 161.65 18.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.0 -1.111 . . . . 72.44 108.0 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -88.5 -18.45 28.18 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.177 0.513 . . . . 62.15 111.518 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.73 152.39 17.7 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.2 -0.667 . . . . 74.44 109.2 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -154.52 151.76 29.28 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.589 -0.893 . . . . 75.42 108.589 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -101.93 108.26 19.66 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.53 -1.285 . . . . 52.44 107.53 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 97' ' ' VAL . 86.5 mt -59.31 146.81 38.19 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.879 0.737 . . . . 73.44 112.068 -176.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.4 170.62 18.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.754 -1.202 . . . . 54.15 107.754 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.27 128.27 35.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.706 0.288 . . . . 72.11 111.127 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.76 2.74 57.29 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 120.967 -0.635 . . . . 64.33 112.933 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -85.17 134.03 34.18 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 120.192 -0.603 . . . . 63.44 110.573 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.27 114.86 41.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.723 -0.672 . . . . 71.42 109.466 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.64 109.6 26.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 N-CA-C 107.475 -1.305 . . . . 73.33 107.475 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.2 ttp85 -110.41 120.02 41.1 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.681 0.753 . . . . 72.31 110.207 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.2 pt? -119.94 165.0 15.23 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 114.63 -1.168 . . . . 75.31 108.559 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.98 100.97 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.405 0.922 . . . . 34.23 115.405 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.9 m170 71.54 17.99 5.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.279 1.432 . . . . 71.3 113.603 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.5 m -154.28 135.7 14.18 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.947 -0.47 . . . . 72.11 111.778 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.839 -0.538 . . . . 65.42 110.025 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.2 tp -126.9 137.34 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.812 -0.81 . . . . 73.2 108.812 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -107.45 127.37 63.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.46 -0.57 . . . . 74.52 109.46 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 82' ' ' LEU . 53.3 t -85.15 119.98 34.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.142 0.496 . . . . 72.51 111.262 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -113.86 126.16 54.87 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.298 -1.001 . . . . 73.54 108.298 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.0 mtt -115.22 131.42 56.93 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.776 0.798 . . . . 43.41 111.416 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 . . . . . 0 C--N 1.279 -2.5 0 CA-C-N 114.385 -1.28 . . . . 71.04 108.123 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.93 -0.767 . . . . 71.01 108.93 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -104.85 115.02 29.59 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.711 -0.848 . . . . 74.1 108.711 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.63 113.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.753 -1.203 . . . . 62.44 107.753 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -117.63 117.28 28.96 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.967 -0.753 . . . . 75.4 108.967 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -87.7 137.25 32.5 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 108.476 -0.935 . . . . 65.21 108.476 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -108.52 125.84 52.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.901 -0.778 . . . . 60.15 108.901 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -133.16 114.77 14.24 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.47 0.653 . . . . 75.32 110.968 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.9 102.17 13.5 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.106 -0.702 . . . . 64.43 109.106 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.64 10.77 37.59 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.57 1.176 . . . . 74.41 108.935 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.6 39.43 1.1 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.927 -1.269 . . . . 61.52 109.927 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -170.71 -61.87 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.983 -0.747 . . . . 44.4 108.983 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.09 92.58 1.56 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.012 -0.835 . . . . 70.32 111.012 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.5 mmp_? -123.65 165.63 16.89 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 122.21 -0.583 . . . . 61.11 110.858 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.2 p -136.45 149.16 48.09 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.946 -0.761 . . . . 31.32 108.946 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 88.3 t80 -140.34 119.69 13.02 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.879 -0.785 . . . . 64.35 108.879 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -85.13 134.11 34.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.052 -1.092 . . . . 74.43 108.052 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.83 131.12 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.654 0.596 . . . . 64.45 110.968 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -90.05 150.14 22.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.385 -1.339 . . . . 71.3 107.385 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.72 118.32 14.41 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.926 0.87 . . . . 51.43 111.333 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 -168.6 23.82 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 107.232 -2.347 . . . . 73.54 107.232 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.9 p -106.67 129.71 54.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 118.822 1.311 . . . . 71.41 110.687 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -110.54 129.27 55.83 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.209 -0.451 . . . . 65.11 109.849 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.4 mt -99.09 125.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.388 -0.597 . . . . 72.44 109.388 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.4 135.55 46.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.99 -0.744 . . . . 74.12 108.99 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 147.17 -168.06 28.34 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 110.566 -1.014 . . . . 64.1 110.566 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 mtm105 -116.31 106.6 13.84 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.536 -0.866 . . . . 74.14 110.868 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.21 177.84 46.27 Favored Glycine 0 N--CA 1.403 -3.563 0 N-CA-C 109.772 -1.331 . . . . 71.1 109.772 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -76.57 -20.13 57.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.653 0.74 . . . . 75.15 110.222 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.61 -29.11 19.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.165 -0.925 . . . . 61.3 109.511 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.09 142.31 57.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.855 -1.066 . . . . 51.01 110.62 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -94.98 -47.98 6.18 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.178 -1.045 . . . . 74.34 108.178 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -109.37 113.74 26.81 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.879 -1.055 . . . . 73.11 109.134 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mpt_? -90.01 113.5 25.2 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.747 -0.66 . . . . 54.44 111.677 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 mt -80.49 125.91 79.78 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.307 -0.406 . . . . 65.12 110.658 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 7.9 Cg_exo -69.83 6.92 1.15 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.243 2.629 . . . . 70.54 116.016 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.89 175.85 7.05 Favored 'General case' 0 C--O 1.252 1.184 0 O-C-N 121.187 -0.946 . . . . 72.45 110.141 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.5 ' HA ' HH21 ' A' ' 32' ' ' ARG . 25.0 m -113.15 138.71 49.55 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.229 -0.656 . . . . 74.35 109.229 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.58 -13.57 32.75 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 109.693 -1.363 . . . . 70.22 109.693 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.443 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 45.0 t -75.5 123.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 CA-C-N 114.081 -1.06 . . . . 62.53 108.639 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 m -75.56 171.91 13.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.964 -0.562 . . . . 65.02 111.878 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.9 ptm180 -61.01 -31.28 70.9 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.929 0.871 . . . . 72.32 110.464 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -134.58 99.86 4.47 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 103.446 -2.798 . . . . 64.01 103.446 171.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -96.18 -36.82 10.81 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.551 0.691 . . . . 72.21 109.42 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 61' ' ' LEU . 7.4 tt -162.62 148.06 12.33 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 71.21 108.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.47 142.49 49.26 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 109.456 -0.572 . . . . 72.21 109.456 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.63 114.31 45.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.46 -0.941 . . . . 75.34 108.46 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 50.2 ttt180 -91.71 107.55 19.29 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.034 -1.098 . . . . 64.1 108.034 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -106.98 117.75 34.87 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.927 -0.579 . . . . 65.31 110.417 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.4 160.63 19.62 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.125 -1.806 . . . . 75.55 106.125 174.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.82 59.35 1.72 Allowed Glycine 0 C--N 1.305 -1.171 0 C-N-CA 121.406 -0.426 . . . . 74.41 113.48 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -171.19 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.216 1.007 . . . . 71.15 109.545 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -134.35 150.68 31.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.963 0.411 . . . . 71.23 111.288 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -107.32 104.95 14.68 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.165 -0.925 . . . . 75.51 108.614 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.1 tp -89.18 109.73 20.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.776 -1.102 . . . . 61.21 110.236 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -92.45 124.2 36.32 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.018 -1.104 . . . . 75.43 108.018 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.49 127.34 40.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.795 0.331 . . . . 51.12 110.403 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.73 129.26 43.0 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.853 0.861 . . . . 71.42 111.289 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.82 76.91 1.47 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.787 0.435 . . . . 72.42 110.184 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 179.95 114.79 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 108.587 -0.894 . . . . 72.13 108.587 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.3 m -83.78 -24.07 31.22 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.85 -0.531 . . . . 70.4 111.264 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -80.49 -58.82 2.94 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.354 0.597 . . . . 74.25 109.893 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -103.82 28.57 6.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.477 0.711 . . . . 72.21 110.363 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.37 131.24 5.9 Favored Glycine 0 C--O 1.242 0.644 0 O-C-N 124.703 1.252 . . . . 63.43 114.793 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 m -76.68 137.64 39.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 124.196 0.999 . . . . 44.22 112.095 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 25.3 p -107.13 149.55 27.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.206 -0.452 . . . . 74.55 110.339 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 80' ' ' TRP . 30.4 m -114.0 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.865 -1.161 . . . . 74.21 107.865 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 62.16 26.82 16.13 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.201 -0.909 . . . . 72.2 109.9 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.54 26.04 0.9 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.324 1.85 . . . . 61.53 111.309 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.34 130.7 24.58 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.698 -0.683 . . . . 71.24 109.638 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.83 125.8 10.22 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.83 2.353 . . . . 53.42 113.372 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 80' ' ' TRP . 28.0 m -142.63 166.43 15.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.004 -0.739 . . . . 74.33 109.004 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -106.41 -30.43 9.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.346 -0.388 . . . . 40.43 110.856 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.95 146.69 49.36 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.805 -0.813 . . . . 64.41 108.805 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.432 ' HB2' HG21 ' A' ' 77' ' ' VAL . 74.0 t-105 -157.06 148.96 22.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 75.04 109.727 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -99.99 105.2 16.86 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.028 -1.101 . . . . 71.1 108.028 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 87.9 mt -56.66 131.02 47.79 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 116.044 -0.525 . . . . 73.01 111.932 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.22 163.23 18.86 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.611 -0.885 . . . . 65.04 108.611 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.27 123.58 20.34 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.047 0.451 . . . . 75.51 109.786 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -8.69 44.62 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-N 115.93 -0.577 . . . . 64.13 112.48 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.98 133.27 47.09 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 117.11 0.455 . . . . 71.32 111.321 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 t -103.5 113.55 40.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.89 -0.781 . . . . 74.24 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.49 118.63 43.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 N-CA-C 107.049 -1.463 . . . . 75.23 107.049 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 60.6 mtp180 -118.66 129.87 55.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.492 0.663 . . . . 62.54 111.863 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.7 164.87 19.0 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 106.231 -1.766 . . . . 74.25 106.231 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.21 108.41 0.16 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 123.719 0.637 . . . . 71.45 113.107 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 77.81 -35.79 0.21 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.959 1.703 . . . . 61.42 113.152 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.6 m -100.0 130.33 46.15 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.9 -0.5 . . . . 55.31 111.059 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.78 147.63 49.98 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.002 0.43 . . . . 63.33 111.033 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.7 137.71 42.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.705 -0.68 . . . . 73.11 110.927 -175.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.91 125.86 64.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.604 -0.888 . . . . 70.33 108.604 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.7 t -87.67 121.68 38.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.865 0.364 . . . . 75.33 110.82 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -121.24 143.04 49.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.697 -0.483 . . . . 72.14 109.697 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.05 140.04 50.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.048 -0.524 . . . . 65.22 109.928 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 . . . . . 0 C--N 1.287 -2.112 0 N-CA-C 107.772 -1.196 . . . . 63.4 107.772 177.136 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.6 m . . . . . 0 N--CA 1.411 -2.395 0 N-CA-C 106.273 -1.751 . . . . 64.12 106.273 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -107.17 114.29 28.25 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.108 -1.071 . . . . 74.22 108.108 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 23' ' ' LEU . 4.3 p -98.43 124.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.522 0.677 . . . . 72.42 109.708 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -128.7 130.17 46.78 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.521 -0.763 . . . . 73.41 109.817 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.41 136.39 33.01 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.449 -0.574 . . . . 73.31 109.449 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -122.74 134.03 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.572 0.749 . . . . 63.42 110.76 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.44 ' HB3' HD12 ' A' ' 95' ' ' ILE . 2.5 pp -148.28 146.63 28.69 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.567 -1.642 . . . . 73.24 106.567 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -105.67 118.55 36.88 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 119.043 -1.063 . . . . 72.44 111.326 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -113.89 6.65 16.71 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.286 -1.325 . . . . 63.12 108.808 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.14 33.41 0.79 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.724 -0.751 . . . . 71.44 112.611 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p 176.85 -39.41 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.975 0.91 . . . . 72.42 110.339 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.98 93.72 2.21 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.867 -1.293 . . . . 73.33 109.867 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 29.7 mmt180 -88.47 149.01 23.89 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.103 -1.073 . . . . 74.31 108.103 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 24.1 p -146.35 132.33 19.2 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.821 0.701 . . . . 73.14 111.088 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.415 ' HB3' HD11 ' A' ' 11' ' ' LEU . 55.4 t80 -129.51 124.68 34.55 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.169 -1.419 . . . . 72.53 107.169 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -93.11 131.52 38.08 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 120.993 0.425 . . . . 74.03 110.686 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.1 mt -77.08 140.08 40.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.229 -0.896 . . . . 52.42 108.854 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 2.8 mpt_? -109.25 169.96 8.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.664 -1.236 . . . . 73.33 107.664 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.16 130.97 46.9 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.637 0.732 . . . . 75.42 111.666 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.79 -170.54 14.92 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.519 -1.833 . . . . 70.32 108.519 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -99.61 129.57 45.77 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 118.727 -1.189 . . . . 74.32 110.441 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -108.27 109.7 21.11 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.584 -1.265 . . . . 75.03 107.584 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.34 131.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.382 -0.827 . . . . 72.13 109.502 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.69 128.21 64.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 109.209 -0.663 . . . . 75.01 109.209 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 162.99 -171.44 38.77 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 110.795 -0.922 . . . . 63.52 110.795 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -110.26 107.62 17.45 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 117.607 0.704 . . . . 74.32 109.91 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.68 177.14 45.41 Favored Glycine 0 N--CA 1.408 -3.172 0 N-CA-C 109.769 -1.332 . . . . 64.25 109.769 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -86.01 -22.99 27.0 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.866 -1.161 . . . . 62.44 107.866 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.65 -27.29 55.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.864 -1.062 . . . . 71.52 108.854 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 139.59 38.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.655 -1.157 . . . . 75.14 110.451 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -82.09 -45.52 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.497 0.665 . . . . 74.14 109.921 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -116.43 129.03 56.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.592 -0.892 . . . . 74.55 108.592 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -102.19 140.05 36.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.983 -0.553 . . . . 71.54 110.584 -178.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.23 147.77 39.16 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.343 -0.39 . . . . 65.52 111.038 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -86.0 8.28 4.59 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.948 2.432 . . . . 63.23 111.042 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -116.51 160.22 20.93 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.131 0.972 . . . . 62.42 108.835 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -111.51 -177.86 3.3 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.764 -0.374 . . . . 73.23 110.316 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.0 -11.8 71.31 Favored Glycine 0 CA--C 1.51 -0.229 0 N-CA-C 109.622 -1.391 . . . . 73.4 109.622 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' CG ' ' A' ' 49' ' ' HIS . 8.3 p -86.35 149.66 4.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 125.284 1.434 . . . . 71.2 110.094 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -97.4 -174.29 2.89 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 107.971 -1.122 . . . . 72.52 107.971 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -74.1 -37.6 64.11 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.884 -1.154 . . . . 71.44 107.884 175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -115.47 94.05 4.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.504 -1.295 . . . . 75.34 107.504 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.408 ' CG ' HG23 ' A' ' 45' ' ' VAL . 24.0 t60 -105.24 -37.53 6.85 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.785 -1.098 . . . . 74.34 109.503 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -161.45 152.45 18.31 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.36 -0.978 . . . . 70.22 108.36 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -136.28 138.86 42.19 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.196 0.522 . . . . 71.3 109.86 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -110.61 114.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.965 -0.754 . . . . 74.14 108.965 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 63.7 ttt180 -90.42 109.54 20.66 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.101 -1.074 . . . . 74.02 108.101 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -107.71 114.94 29.25 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.422 -0.808 . . . . 72.14 110.958 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.98 167.75 13.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.678 -1.601 . . . . 73.45 106.678 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.7 72.79 1.49 Allowed Glycine 0 C--N 1.302 -1.328 0 C-N-CA 121.096 -0.573 . . . . 54.43 114.485 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -168.48 -71.42 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.844 0.858 . . . . 75.22 108.735 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.8 157.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.439 -0.948 . . . . 73.53 108.439 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -97.83 119.12 35.86 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.446 -0.576 . . . . 63.32 109.446 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.2 tt -86.96 110.57 20.12 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.087 -1.079 . . . . 71.35 108.087 -177.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -90.47 114.62 26.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.334 -1.358 . . . . 54.15 107.334 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.99 115.72 24.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.935 0.398 . . . . 53.42 110.685 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.24 136.33 37.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.704 -0.68 . . . . 74.42 109.473 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -132.97 76.67 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.17 -1.048 . . . . 74.33 108.17 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -174.58 146.25 0.99 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.883 -0.784 . . . . 72.01 108.883 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -102.3 -32.93 9.8 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.494 0.553 . . . . 64.11 112.494 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -90.16 -37.69 14.01 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.853 0.686 . . . . 74.33 112.853 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -107.12 28.37 8.11 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.694 0.798 . . . . 72.23 110.102 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.65 124.42 4.86 Favored Glycine 0 N--CA 1.474 1.209 0 O-C-N 124.471 1.107 . . . . 74.22 113.616 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -67.95 146.24 53.77 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.581 1.152 . . . . 64.3 113.354 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.0 p -117.06 141.11 48.67 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.144 -0.935 . . . . 73.23 110.332 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 88' ' ' ILE . 27.3 m -109.96 116.68 52.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.073 -1.084 . . . . 74.42 108.073 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 59.96 29.85 19.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.908 0.861 . . . . 71.35 109.253 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.7 t30 78.22 8.47 2.31 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.504 1.922 . . . . 75.15 111.357 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.79 122.24 49.82 Favored Pre-proline 0 C--N 1.318 -0.785 0 O-C-N 121.678 -0.639 . . . . 65.42 109.807 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.32 127.01 14.3 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 122.562 2.174 . . . . 71.22 111.903 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.69 168.26 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 122.488 0.315 . . . . 55.13 110.275 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.52 -34.58 10.93 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.375 -0.602 . . . . 74.43 109.375 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -148.23 153.84 39.27 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.843 -0.617 . . . . 75.22 109.717 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -157.32 151.34 24.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.274 -1.009 . . . . 75.12 108.274 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.281 0.8 OUTLIER -101.06 108.69 20.46 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-O 121.71 0.766 . . . . 74.5 111.192 174.144 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.1 mt -56.97 143.58 37.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.842 -1.072 . . . . 74.51 112.638 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.74 169.55 16.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.696 -1.224 . . . . 63.24 107.696 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -72.09 112.14 7.91 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.809 -0.441 . . . . 34.43 109.809 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.61 13.61 18.18 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.932 -0.652 . . . . 61.44 113.404 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -87.25 140.72 29.26 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 117.769 0.784 . . . . 73.23 110.863 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.81 113.36 36.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 N-CA-C 108.768 -0.827 . . . . 72.02 108.768 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.473 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.1 107.6 22.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 109.125 -0.694 . . . . 75.42 109.125 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.463 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 39.9 ttm180 -100.06 111.94 24.24 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.49 0.662 . . . . 65.15 110.95 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.6 pt? -115.82 164.33 14.54 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.177 -1.374 . . . . 72.4 107.445 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -36.68 99.55 0.01 OUTLIER Glycine 0 CA--C 1.535 1.343 0 N-CA-C 115.909 1.123 . . . . 71.4 115.909 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.9 m80 83.09 -1.32 1.21 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.346 1.858 . . . . 73.33 115.275 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -150.4 138.05 19.84 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.889 -1.124 . . . . 74.14 111.713 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 10.5 pt-20 -110.54 119.66 39.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.455 0.645 . . . . 73.11 109.566 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.6 tp -103.6 139.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.295 -0.866 . . . . 71.13 109.124 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.88 129.31 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.054 -1.091 . . . . 72.25 108.054 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 82' ' ' LEU . 69.9 t -95.88 120.46 45.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.482 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -117.01 150.91 37.83 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.313 -0.625 . . . . 70.35 109.313 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.0 mtt -126.44 122.17 34.52 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.711 0.767 . . . . 71.2 110.521 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 . . . . . 0 C--N 1.285 -2.214 0 N-CA-C 107.661 -1.237 . . . . 71.21 107.661 -178.0 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 N--CA 1.413 -2.316 0 N-CA-C 108.711 -0.848 . . . . 70.21 108.711 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.0 p -121.71 118.87 30.18 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.454 -1.313 . . . . 75.3 107.454 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG13 HD12 ' A' ' 23' ' ' LEU . 3.3 p -96.64 123.19 48.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 122.201 1.001 . . . . 72.33 111.329 -173.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.7 m -118.21 129.5 55.53 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-N 114.179 -1.373 . . . . 60.32 108.277 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -92.61 130.0 38.38 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 108.373 -0.973 . . . . 51.4 108.373 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -101.11 114.98 29.42 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.397 -1.334 . . . . 72.52 107.397 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -111.36 124.9 53.19 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.163 -1.051 . . . . 72.34 108.163 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.57 101.44 11.31 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 117.081 -1.848 . . . . 72.03 111.959 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -83.24 -15.32 50.79 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.735 -1.575 . . . . 64.4 108.594 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.44 42.05 0.51 Allowed Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 107.362 -2.295 . . . . 73.03 107.362 -171.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -164.4 -25.85 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.725 -0.738 . . . . 64.12 111.794 -171.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 70.21 1.29 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 120.388 -0.91 . . . . 74.01 110.924 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -92.64 161.4 14.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.695 -0.483 . . . . 44.14 109.695 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.6 p -138.6 135.25 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.093 0.473 . . . . 61.02 110.507 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -130.76 117.2 19.05 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.141 -1.059 . . . . 64.13 108.141 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 32.5 tt0 -88.44 128.35 35.53 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.093 -0.643 . . . . 73.21 110.072 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 HG13 ' A' ' 9' ' ' VAL . 91.2 mt -64.88 136.83 57.3 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.124 -0.944 . . . . 62.23 112.064 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -93.23 163.39 13.64 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.387 -1.279 . . . . 72.43 109.266 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.82 126.95 29.29 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.821 0.7 . . . . 71.51 111.156 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.42 -161.75 15.27 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.938 -0.865 . . . . 44.24 110.938 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 67.8 p -93.99 126.0 38.94 Favored 'General case' 0 N--CA 1.418 -2.043 0 C-N-CA 119.381 -0.927 . . . . 71.21 111.81 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.6 129.94 45.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.954 -1.869 . . . . 63.33 105.954 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.5 mm -106.72 137.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 112.187 0.44 . . . . 73.24 112.187 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.01 136.39 50.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.76 -1.2 . . . . 52.25 107.76 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.74 -152.15 24.14 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.068 -1.213 . . . . 65.21 110.068 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 76.5 mtt180 -131.91 106.46 8.08 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.216 1.008 . . . . 63.13 108.617 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 36' ' ' ALA . . . 175.92 -168.1 40.19 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 119.739 -1.22 . . . . 71.24 111.974 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.6 -43.69 96.19 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.511 0.725 . . . . 72.04 109.914 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.25 -37.02 82.82 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 114.714 -1.13 . . . . 53.52 110.578 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB3' ' H ' ' A' ' 33' ' ' GLY . . . -72.54 105.49 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 114.288 1.218 . . . . 74.23 114.288 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 44.5 mt-30 -77.14 -47.77 19.5 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.814 -1.539 . . . . 74.05 107.076 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -95.24 115.45 27.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.788 -1.56 . . . . 74.32 106.788 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 99.2 mtt180 -109.45 137.38 47.4 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 120.78 0.324 . . . . 74.11 111.602 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 72.7 mt -90.65 134.5 30.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.773 -0.648 . . . . 73.41 111.964 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 18.3 Cg_exo -71.29 -19.74 28.83 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.35 2.7 . . . . 71.24 113.593 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.11 178.5 6.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 122.221 -0.299 . . . . 75.04 111.713 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 85.2 m -109.55 168.15 9.61 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 108.328 -0.989 . . . . 75.01 108.328 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.5 9.45 53.03 Favored Glycine 0 CA--C 1.499 -0.955 0 N-CA-C 108.408 -1.877 . . . . 63.22 108.408 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 49' ' ' HIS . 7.4 p -118.3 120.74 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 CA-C-N 113.326 -1.437 . . . . 73.31 109.744 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 m -82.15 -170.0 2.67 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.279 -0.638 . . . . 74.32 109.279 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 40.6 ptt180 -65.2 -28.12 69.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.928 -0.709 . . . . 73.32 111.436 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 48' ' ' ARG . 23.5 mtm180 -131.96 118.94 20.43 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.352 -0.981 . . . . 75.52 108.352 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.604 ' HB2' HG23 ' A' ' 45' ' ' VAL . 30.6 t60 -103.85 -31.03 9.99 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 124.43 1.092 . . . . 72.13 108.795 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 61' ' ' LEU . 9.3 tt -167.31 147.46 5.37 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.904 -0.776 . . . . 73.11 108.904 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.12 136.88 49.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.857 0.723 . . . . 74.0 110.112 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' SER . 64.9 mt -115.51 110.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.036 -1.098 . . . . 44.13 108.036 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 41.8 ttm105 -91.32 106.97 18.88 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.689 0.757 . . . . 75.14 109.03 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -97.17 107.06 19.5 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.644 -1.162 . . . . 74.11 110.33 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -107.25 -179.73 4.01 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.642 -1.984 . . . . 55.24 105.642 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.01 3.7 69.63 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 119.931 -1.128 . . . . 44.41 112.266 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -97.07 -75.2 0.55 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 122.893 0.477 . . . . 75.52 110.554 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.07 160.67 23.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.656 0.782 . . . . 73.44 109.639 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.07 104.88 17.41 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.391 -0.966 . . . . 41.52 108.391 177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.2 tt -80.51 110.87 16.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.623 -1.171 . . . . 63.13 109.159 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -92.9 121.74 34.57 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.177 -1.046 . . . . 74.24 108.177 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.99 112.27 14.47 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.391 -0.596 . . . . 74.55 109.391 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.76 135.98 36.64 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.446 -0.946 . . . . 74.13 108.446 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.9 tp -133.83 76.6 1.67 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.508 0.67 . . . . 60.41 109.827 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -163.06 164.21 25.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.479 -1.304 . . . . 63.31 107.479 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.6 p -106.27 -54.19 2.51 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.768 0.318 . . . . 61.51 111.545 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -89.21 -35.79 16.01 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.685 0.994 . . . . 73.4 113.685 -171.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.533 ' OD1' ' HA3' ' A' ' 91' ' ' GLY . 64.2 t30 -114.26 27.5 9.44 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.044 -0.725 . . . . 61.33 109.044 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.15 136.59 25.35 Favored Glycine 0 C--O 1.245 0.814 0 CA-C-N 114.039 -1.437 . . . . 74.12 113.713 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 136.27 38.65 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 124.259 1.024 . . . . 53.14 110.899 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 142.06 35.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.297 -1.001 . . . . 73.53 108.297 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 88' ' ' ILE . 29.7 m -117.2 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.682 -0.488 . . . . 41.4 109.682 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.15 35.76 25.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 70.21 110.521 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 65.12 23.18 12.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.279 1.432 . . . . 74.44 110.11 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.29 122.03 29.03 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.901 -0.778 . . . . 73.04 108.901 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.44 124.1 3.12 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 121.039 1.159 . . . . 71.43 111.797 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -144.18 179.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.803 -1.184 . . . . 72.11 107.803 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -104.16 -37.2 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 71.42 109.799 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -134.04 151.58 51.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.09 -0.707 . . . . 62.13 109.09 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -160.8 152.46 19.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.902 -1.148 . . . . 74.43 107.902 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.253 4.9 pp0? -109.98 113.06 25.47 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.809 -0.756 . . . . 73.2 110.162 173.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.7 mt -60.89 126.25 26.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.549 -1.205 . . . . 62.01 112.408 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.12 160.4 22.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.508 -0.923 . . . . 72.31 108.508 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 33.6 t70 -61.82 119.53 8.95 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.201 0.524 . . . . 75.23 111.193 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.33 36.7 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.633 -0.712 . . . . 73.1 112.771 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.27 138.43 43.6 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 120.27 -0.572 . . . . 71.13 111.711 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -98.74 113.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.831 -0.803 . . . . 62.23 108.831 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.469 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -103.87 116.37 47.52 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 N-CA-C 107.277 -1.379 . . . . 74.02 107.277 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -114.51 121.71 44.34 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.709 -0.848 . . . . 64.13 108.709 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.69 162.87 18.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.441 -0.948 . . . . 72.22 108.441 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.533 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -76.97 87.13 0.97 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 119.038 -1.553 . . . . 70.31 110.694 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 t60 168.42 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.933 1.693 . . . . 64.42 108.366 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.7 p -168.15 -170.93 1.4 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.625 -0.716 . . . . 54.31 110.266 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.38 151.15 50.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.256 0.551 . . . . 62.01 109.979 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.447 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.95 142.24 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.056 -0.974 . . . . 72.4 110.833 -177.124 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.2 129.48 65.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.533 -0.914 . . . . 73.31 108.533 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.85 124.08 39.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.863 0.364 . . . . 71.51 110.231 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.449 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 12.9 mmm180 -123.66 135.07 53.7 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.576 -0.738 . . . . 64.33 110.324 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.1 mtt -113.66 124.88 53.37 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.534 0.683 . . . . 54.01 111.148 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.6 m80 . . . . . 0 C--N 1.291 -1.943 0 N-CA-C 107.359 -1.349 . . . . 62.35 107.359 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.427 -1.617 0 CA-C-O 120.942 0.401 . . . . 63.01 109.934 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -125.12 139.34 53.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.51 -1.293 . . . . 65.03 107.51 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -117.13 122.01 69.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-O 121.787 0.803 . . . . 61.45 112.051 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 13.2 m -113.21 131.58 55.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.954 -1.128 . . . . 75.25 107.954 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 95' ' ' ILE . 4.4 pp -102.95 135.47 44.57 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.336 -0.616 . . . . 75.51 109.336 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 76.6 mt-30 -102.09 119.07 38.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.391 -0.368 . . . . 75.13 110.082 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 tp -107.79 135.09 49.79 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.644 -0.707 . . . . 54.41 109.417 -175.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.47 99.21 12.11 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 118.673 -1.211 . . . . 75.12 108.63 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 36.7 t70 -108.8 38.93 2.13 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.049 -1.834 . . . . 70.32 106.049 176.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.07 -54.02 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.512 -1.222 . . . . 55.44 110.881 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -87.82 -26.81 22.64 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.715 0.769 . . . . 74.42 109.916 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.83 96.73 0.93 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.048 -1.221 . . . . 74.52 110.048 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.429 ' HG3' ' HB3' ' A' ' 15' ' ' ASP . 14.7 mtm180 -102.08 165.79 10.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.149 -0.686 . . . . 63.1 109.149 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 12' ' ' GLN . 38.1 p -128.43 136.95 51.56 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 120.733 0.302 . . . . 73.31 110.474 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.467 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 82.3 t80 -128.36 123.53 34.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.344 -1.354 . . . . 63.14 107.344 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.0 tt0 -96.12 133.22 40.66 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.964 -0.754 . . . . 73.4 108.964 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HB2' HG13 ' A' ' 9' ' ' VAL . 92.3 mt -73.46 143.58 46.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.824 -0.626 . . . . 73.44 109.787 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -108.4 152.11 25.12 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.512 -1.292 . . . . 75.32 107.512 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.68 126.76 28.49 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.538 0.685 . . . . 72.32 111.423 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.24 -169.37 19.11 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 107.254 -2.339 . . . . 53.35 107.254 -174.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -106.49 128.75 54.33 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 118.899 1.349 . . . . 65.15 110.239 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HG3' ' A' ' 37' ' ' GLN . 6.1 p30 -110.34 146.35 35.92 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.104 -0.953 . . . . 64.2 108.56 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.41 HG21 ' HG2' ' A' ' 48' ' ' ARG . 60.4 mt -123.73 135.47 63.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 109.814 -0.439 . . . . 73.31 109.814 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 64.9 mt -107.5 134.71 48.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.28 -1.007 . . . . 72.23 108.28 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 156.75 -152.02 23.4 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 108.667 -1.773 . . . . 41.33 108.667 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.702 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 67.2 mtp180 -135.49 106.88 6.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.566 1.183 . . . . 73.42 109.23 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.81 171.85 41.67 Favored Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.497 -1.841 . . . . 62.12 108.497 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -77.02 -17.05 59.08 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.197 0.999 . . . . 74.12 110.696 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -94.05 -4.4 49.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.416 -0.811 . . . . 63.24 110.198 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.27 133.86 34.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 54.24 109.816 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 28' ' ' ASN . 73.3 mm-40 -81.67 -57.85 3.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.748 -0.66 . . . . 63.42 109.706 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 84.2 t80 -101.31 110.23 22.2 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.825 -1.176 . . . . 70.21 107.825 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 90.8 mtt180 -96.52 123.1 40.08 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.548 -0.751 . . . . 74.33 111.27 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 45' ' ' VAL . 55.8 mt -75.98 138.36 69.14 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.716 -0.674 . . . . 74.44 112.006 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.04 38.16 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.39 2.726 . . . . 74.25 112.668 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -134.92 173.22 11.95 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.95 -1.13 . . . . 74.31 107.95 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -122.34 155.87 35.1 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.988 -0.745 . . . . 62.55 108.988 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.06 -23.86 26.37 Favored Glycine 0 C--N 1.312 -0.775 0 N-CA-C 109.155 -1.578 . . . . 74.2 109.155 -174.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG21 HD12 ' A' ' 40' ' ' LEU . 7.3 p -81.48 141.16 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.87 -1.165 . . . . 70.44 109.637 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -76.3 -177.23 3.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.35 -0.841 . . . . 71.55 111.146 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.702 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.3 ptm180 -65.46 -39.87 92.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 74.13 109.861 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.41 ' HG2' HG21 ' A' ' 29' ' ' ILE . 50.6 mtm-85 -126.2 119.85 28.54 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.176 -1.416 . . . . 73.51 107.176 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.404 ' HB2' HG23 ' A' ' 45' ' ' VAL . 49.6 t60 -105.33 -35.94 7.36 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.757 1.223 . . . . 51.53 109.641 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.491 HD11 HD21 ' A' ' 61' ' ' LEU . 9.1 tt -166.05 151.15 8.44 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 108.293 -1.003 . . . . 62.24 108.293 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -136.26 141.77 43.92 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.043 0.449 . . . . 61.22 110.323 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 70.0 mt -120.69 118.72 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 115.666 -0.697 . . . . 71.2 109.469 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.7 ttt180 -91.57 111.06 22.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.505 -1.295 . . . . 75.22 107.505 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -106.22 126.52 52.32 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.411 0.624 . . . . 73.11 109.793 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -139.0 172.42 12.87 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.422 -2.066 . . . . 71.34 105.422 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.7 69.32 2.39 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 120.761 -0.733 . . . . 53.44 112.311 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -162.88 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.46 -0.941 . . . . 74.03 108.46 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.17 159.5 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.779 -0.823 . . . . 64.3 108.779 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -94.59 115.1 27.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.118 -0.697 . . . . 52.14 109.118 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -85.64 110.44 19.28 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.351 -0.84 . . . . 61.21 111.212 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 50' ' ' LEU . 2.4 tm? -89.6 128.25 36.01 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.237 -1.023 . . . . 71.32 108.237 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -136.12 122.65 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.103 -0.703 . . . . 64.11 109.103 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.27 129.68 37.24 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.625 0.578 . . . . 64.34 110.069 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.49 75.26 1.57 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.477 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t30 169.53 107.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.784 0.833 . . . . 72.14 109.679 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.9 t -78.53 -22.24 47.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.342 -0.39 . . . . 64.14 110.735 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -65.02 -45.82 83.9 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.109 0.481 . . . . 74.42 111.907 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -118.95 28.33 8.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.139 -0.689 . . . . 73.12 109.139 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.14 129.63 4.53 Favored Glycine 0 C--O 1.258 1.649 0 O-C-N 124.838 1.336 . . . . 70.44 115.045 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -80.0 145.79 32.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.926 -1.137 . . . . 70.44 112.466 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -121.29 142.53 49.86 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.308 -0.86 . . . . 43.11 110.542 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 80' ' ' TRP . 35.6 m -117.53 119.46 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.684 -1.599 . . . . 73.11 106.684 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 62.24 24.58 14.64 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.035 0.934 . . . . 63.21 108.652 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 77.91 6.39 2.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.551 1.54 . . . . 62.0 112.854 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.63 118.26 66.15 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 74.02 108.795 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.76 125.28 11.47 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 121.552 1.501 . . . . 71.41 110.646 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.8 m -137.29 169.15 19.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.873 -0.788 . . . . 51.12 108.873 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -107.03 -20.16 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.353 . . . . 71.0 110.77 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.8 pt-20 -152.61 146.41 25.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.19 -0.67 . . . . 73.0 109.19 176.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CD2' HG21 ' A' ' 72' ' ' VAL . 66.7 t-105 -160.89 152.29 19.19 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.749 -0.834 . . . . 71.32 108.749 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -104.57 103.11 12.72 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.03 -0.73 . . . . 74.12 109.03 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.447 HD22 HD11 ' A' ' 88' ' ' ILE . 58.5 mt -59.52 145.04 45.6 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.967 -1.015 . . . . 63.22 111.414 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.01 169.51 17.67 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.123 -1.066 . . . . 73.3 108.123 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.83 119.12 12.0 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 123.346 0.404 . . . . 73.25 110.13 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.09 53.04 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.703 -0.68 . . . . 54.43 113.522 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -82.06 146.32 29.72 Favored 'General case' 0 C--O 1.255 1.384 0 N-CA-C 107.728 -1.212 . . . . 45.23 107.728 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.09 112.79 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.193 -0.669 . . . . 64.41 109.193 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.512 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.71 127.58 60.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.283 -1.377 . . . . 74.34 107.283 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 90' ' ' LEU . 2.4 tmm_? -134.56 134.35 41.26 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.088 -1.079 . . . . 70.13 108.088 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 90' ' ' LEU . 2.0 pt? -127.31 162.47 26.18 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.476 -1.305 . . . . 74.4 107.476 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.4 86.98 0.51 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 119.158 -1.496 . . . . 53.1 111.148 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.0 t60 169.46 -48.79 0.01 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.145 1.778 . . . . 71.25 108.781 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.0 t -164.16 -175.37 3.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.938 -0.574 . . . . 71.14 110.111 -174.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -123.62 145.15 49.15 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.46 -0.941 . . . . 72.13 108.46 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -136.64 137.1 47.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.687 0.756 . . . . 75.4 111.843 -176.36 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.9 mt -107.62 131.65 57.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.488 -0.93 . . . . 73.04 108.488 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.6 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.622 0.249 . . . . 63.32 110.665 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -127.28 140.95 51.86 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.402 -0.363 . . . . 72.21 110.597 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.8 mtt -113.45 134.28 54.75 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.945 -0.57 . . . . 64.5 109.999 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--N 1.289 -2.038 0 N-CA-C 106.962 -1.496 . . . . 72.24 106.962 -177.012 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 109.743 -0.465 . . . . 75.33 109.743 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.448 ' HB2' ' CD2' ' A' ' 100' ' ' HIS . 15.2 m -85.07 115.11 22.69 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.616 -1.253 . . . . 72.33 107.616 174.206 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.44 106.85 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.846 -1.909 . . . . 71.42 105.846 174.119 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.6 m -113.97 119.36 36.95 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.496 -0.775 . . . . 53.5 109.216 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 3.2 pp -91.72 130.7 37.46 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.523 -0.762 . . . . 75.13 110.805 178.731 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.69 119.63 39.84 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.275 -1.33 . . . . 73.3 107.579 -175.185 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -107.5 116.91 32.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.508 -0.553 . . . . 61.21 109.508 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.98 99.52 12.21 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.642 -1.614 . . . . 60.1 106.642 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -115.06 -19.06 11.04 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.309 -1.314 . . . . 62.44 109.868 -177.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.2 4.85 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 110.757 -0.937 . . . . 63.01 110.757 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 t -122.29 -33.88 3.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.321 -0.622 . . . . 43.34 109.321 175.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.03 79.13 1.38 Allowed Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.463 -1.855 . . . . 70.21 108.463 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -89.51 145.46 25.27 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.883 -0.414 . . . . 55.5 109.883 -176.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 30.3 p -134.16 135.29 43.0 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.102 0.477 . . . . 64.12 111.211 -176.608 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 11' ' ' LEU . 46.4 t80 -139.03 120.42 14.91 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.75 -0.659 . . . . 74.44 110.69 178.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -83.46 127.23 33.53 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.523 -0.917 . . . . 73.11 108.523 176.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.78 149.33 50.7 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.05 -0.523 . . . . 74.11 111.019 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -102.64 162.38 12.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.199 -1.408 . . . . 70.35 107.199 173.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.88 145.66 51.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.215 -0.661 . . . . 72.24 109.215 177.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.51 -168.2 15.25 Favored Glycine 0 N--CA 1.412 -2.936 0 N-CA-C 106.887 -2.485 . . . . 64.44 106.887 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 30.0 p -103.03 130.95 50.32 Favored 'General case' 0 C--N 1.27 -2.853 0 C-N-CA 118.499 -1.28 . . . . 72.31 111.519 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.523 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -102.35 110.42 22.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.843 -1.91 . . . . 75.04 105.843 -179.009 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.2 mt -97.86 132.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 120.929 0.395 . . . . 33.25 111.538 -173.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.44 133.69 55.05 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 C-N-CA 123.846 0.858 . . . . 75.11 109.601 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA2' ' CG2' ' A' ' 45' ' ' VAL . . . 151.54 -173.75 30.82 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.686 -0.966 . . . . 43.43 110.686 177.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.687 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 97.5 mtt180 -118.19 104.23 10.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.119 -1.437 . . . . 74.11 107.119 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 -176.93 48.05 Favored Glycine 0 N--CA 1.42 -2.427 0 N-CA-C 111.401 -0.68 . . . . 72.12 111.401 -175.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 35' ' ' ASP . 10.4 pt20 -58.74 -49.6 77.02 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 124.016 0.926 . . . . 71.04 113.135 -176.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 13.5 m-20 -81.8 -19.87 40.29 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.203 0.525 . . . . 61.3 111.016 -172.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.62 145.5 45.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.572 -0.74 . . . . 75.24 112.12 -174.785 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -106.81 -55.84 2.27 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.014 -0.994 . . . . 74.54 108.667 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -95.0 125.37 39.62 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.809 -1.087 . . . . 74.01 109.872 -177.397 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -97.7 144.59 27.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.344 -0.984 . . . . 72.44 108.344 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 58.2 mt -94.56 131.16 31.47 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 109.489 -0.56 . . . . 65.44 109.489 173.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 21.2 Cg_exo -67.54 -26.48 40.12 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.112 2.542 . . . . 53.4 112.605 -178.256 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 168.38 11.4 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.349 -0.387 . . . . 51.32 110.633 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -84.68 -177.05 6.49 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.021 -0.733 . . . . 74.24 109.021 178.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.91 66.9 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.138 -0.785 . . . . 71.53 111.138 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.481 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 11.1 p -90.15 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.284 -0.958 . . . . 73.22 109.356 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -102.38 -174.07 2.48 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.861 -0.422 . . . . 75.21 109.861 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 36.1 ptt180 -64.43 -41.6 96.5 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.891 0.853 . . . . 72.44 110.269 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -129.26 107.75 9.79 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 104.012 -2.588 . . . . 73.21 104.012 172.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -101.35 -37.36 8.51 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.935 0.772 . . . . 72.42 109.145 -176.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.489 HD11 HD21 ' A' ' 61' ' ' LEU . 7.5 tt -165.09 147.97 8.22 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.996 -0.547 . . . . 53.05 109.896 -177.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HG2' HD21 ' A' ' 64' ' ' LEU . 11.8 pt-20 -133.27 132.45 41.42 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.491 -0.559 . . . . 71.13 109.491 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.5 mt -106.76 113.62 43.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 108.843 -0.799 . . . . 74.14 108.843 176.603 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 29.9 ttt180 -91.25 111.43 22.91 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.482 0.658 . . . . 71.35 109.541 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -104.4 127.45 52.08 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.47 -0.786 . . . . 75.42 110.567 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -132.14 172.73 12.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.531 -2.026 . . . . 74.22 105.531 176.384 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.67 53.09 3.97 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.684 -0.769 . . . . 74.44 111.681 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -140.79 -80.48 0.26 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 124.728 1.211 . . . . 71.51 107.784 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.34 160.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 C-N-CA 125.326 1.45 . . . . 65.22 107.1 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.24 115.49 28.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.47 0.652 . . . . 63.34 109.604 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 tp -85.17 114.12 22.05 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.07 -0.968 . . . . 73.51 110.5 -177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.489 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -92.11 113.49 25.77 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.641 -1.244 . . . . 74.43 107.641 -179.027 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.75 121.14 39.39 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.826 -0.435 . . . . 64.4 109.826 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -91.48 133.0 35.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.627 -0.715 . . . . 74.5 111.43 -177.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.457 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.2 mm? -123.55 76.12 1.39 Allowed 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.645 -0.872 . . . . 51.33 108.645 173.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -173.7 112.14 0.19 Allowed 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 109.048 -0.723 . . . . 75.23 109.048 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -84.31 -17.67 38.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.322 0.49 . . . . 62.34 112.322 -178.34 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -89.19 -55.93 3.47 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.424 0.63 . . . . 61.42 111.084 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -110.5 29.57 7.59 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.659 0.784 . . . . 75.41 109.905 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.48 141.49 2.5 Favored Glycine 0 C--O 1.258 1.632 0 O-C-N 125.018 1.449 . . . . 73.45 115.745 -175.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.2 m -65.29 135.36 55.25 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.466 -1.367 . . . . 72.31 112.463 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 75' ' ' ALA . 1.3 m -113.37 139.84 48.54 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.594 -1.632 . . . . 74.2 106.594 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 88' ' ' ILE . 29.2 m -120.26 121.24 65.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.228 -0.656 . . . . 71.43 109.228 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 58.35 29.88 18.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.829 0.824 . . . . 72.15 110.319 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t30 76.9 23.78 0.96 Allowed 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 126.07 1.748 . . . . 74.44 111.05 179.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 71' ' ' THR . . . -125.82 118.04 24.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 121.752 -0.593 . . . . 73.22 110.144 177.62 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.86 133.4 31.29 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.566 2.177 . . . . 74.12 112.177 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.23 169.14 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 50.13 110.199 -177.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -102.81 -21.47 14.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.387 -0.968 . . . . 60.23 108.387 174.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -157.78 155.63 30.14 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.254 -1.017 . . . . 74.01 108.254 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.407 ' CD2' HG21 ' A' ' 72' ' ' VAL . 71.2 t-105 -161.0 151.99 18.63 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 72.12 108.741 -178.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -101.97 103.46 14.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.764 -0.828 . . . . 71.04 108.764 176.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 89.8 mt -57.6 139.99 52.16 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.93 0.715 . . . . 61.32 112.93 -176.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.9 166.6 23.25 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.814 -1.18 . . . . 63.02 107.814 173.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.15 118.78 9.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.872 0.368 . . . . 72.12 110.854 -179.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.15 35.71 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.004 -0.617 . . . . 43.25 113.134 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -87.1 136.51 32.9 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.909 -0.716 . . . . 74.23 109.874 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 t -100.33 113.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.074 -0.713 . . . . 73.24 109.074 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.48 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -102.71 111.95 34.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.972 -0.751 . . . . 73.33 108.972 -178.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -107.63 119.96 40.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.627 -0.715 . . . . 71.31 110.104 -178.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.6 pt? -125.27 164.3 20.65 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.405 -0.816 . . . . 74.53 108.942 -176.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.75 112.06 0.62 Allowed Glycine 0 CA--C 1.529 0.938 0 O-C-N 123.574 0.546 . . . . 52.23 113.315 178.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 71.7 6.67 5.74 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.399 1.479 . . . . 74.1 114.834 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.7 t -149.2 163.35 37.88 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.794 -0.762 . . . . 44.11 111.241 -177.144 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.88 126.36 13.22 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.518 -0.919 . . . . 74.43 108.518 176.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 7.9 tp -124.42 138.04 55.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.62 -0.718 . . . . 70.23 109.071 -173.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.8 125.15 65.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.859 -0.793 . . . . 71.15 108.859 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -89.87 121.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.706 0.288 . . . . 62.12 111.423 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -120.36 151.22 39.56 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.199 -0.667 . . . . 74.2 109.199 176.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.1 mtt -125.42 145.61 49.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.274 0.559 . . . . 70.13 111.597 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 12.3 m-70 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 107.932 -1.136 . . . . 75.45 107.932 178.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 120.685 0.279 . . . . 50.34 110.457 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 m -93.05 115.29 27.97 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 106.966 -1.494 . . . . 72.24 106.966 174.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -105.51 120.79 56.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.895 0.855 . . . . 72.41 110.447 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 11.6 m -119.6 137.68 53.7 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.864 -1.062 . . . . 61.44 109.624 -172.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 95' ' ' ILE . 4.5 pp -97.55 136.68 37.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.333 -0.618 . . . . 71.5 109.333 178.699 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 115.87 28.72 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.584 -1.635 . . . . 71.32 106.584 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.79 134.71 49.53 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.986 -0.552 . . . . 73.5 111.826 -175.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.42 99.9 5.03 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.08 -1.822 . . . . 44.42 106.08 171.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 19' ' ' ARG . 23.9 t70 -114.78 8.17 16.01 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 113.82 -1.537 . . . . 64.22 110.206 -176.566 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.82 -48.03 0.99 Allowed Glycine 0 CA--C 1.491 -1.457 0 N-CA-C 109.358 -1.497 . . . . 70.11 109.358 -176.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -127.35 -39.57 1.87 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.967 -0.753 . . . . 52.44 108.967 175.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.97 116.8 1.61 Allowed Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 120.41 -0.9 . . . . 70.13 111.869 177.316 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 15' ' ' ASP . 44.5 mtm105 -118.61 156.73 28.68 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.28 -0.267 . . . . 74.13 110.28 175.134 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.5 p -126.36 152.88 45.68 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.067 -0.515 . . . . 74.43 110.587 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 57.3 t80 -148.02 131.58 16.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.698 -1.593 . . . . 74.31 106.698 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 21.0 tt0 -91.94 131.37 37.3 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.917 -0.713 . . . . 74.12 109.785 -178.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HB2' HG13 ' A' ' 9' ' ' VAL . 96.8 mt -68.51 147.15 52.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.744 . . . . 62.13 108.99 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -118.25 150.57 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.801 -0.814 . . . . 74.44 108.801 -177.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.32 116.97 2.7 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.97 1.418 . . . . 73.45 112.75 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.0 -172.67 20.08 Favored Glycine 0 N--CA 1.418 -2.524 0 N-CA-C 107.585 -2.206 . . . . 74.13 107.585 -174.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 33.6 p -106.72 134.25 50.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 118.487 1.144 . . . . 74.55 111.175 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.02 122.13 45.53 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.06 -0.718 . . . . 74.41 109.06 178.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.1 mm -88.86 121.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.358 -0.837 . . . . 64.44 108.997 -177.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 75.5 mt -103.12 126.12 57.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 74.13 108.725 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.41 -159.56 32.49 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 110.282 -1.127 . . . . 22.14 110.282 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.7 mtp180 -129.45 105.36 8.05 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.575 -0.898 . . . . 73.54 108.575 175.232 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.52 -164.54 34.31 Favored Glycine 0 N--CA 1.415 -2.717 0 N-CA-C 110.527 -1.029 . . . . 75.1 110.527 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -79.14 -38.47 35.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.21 -0.663 . . . . 73.11 109.21 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.48 -37.03 84.21 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.954 . . . . 74.31 109.552 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.96 118.56 7.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 114.137 -1.392 . . . . 51.42 111.894 -176.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -90.25 -37.47 14.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.402 -1.333 . . . . 64.13 107.402 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 34.7 t80 -107.1 114.19 28.1 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.184 -2.154 . . . . 73.24 105.184 176.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 92.9 mtt180 -106.9 131.55 53.85 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.939 -0.573 . . . . 63.11 110.899 -171.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.94 144.42 41.71 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.554 -0.748 . . . . 71.14 111.5 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -89.46 5.62 4.71 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.761 2.307 . . . . 74.41 114.3 -178.468 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.66 -176.12 3.17 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.884 -0.726 . . . . 64.44 109.317 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -106.3 175.97 5.32 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.7 0.286 . . . . 72.41 110.758 -174.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.84 80.88 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 110.763 -0.935 . . . . 72.32 110.763 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.461 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 22.5 t -103.69 130.19 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 114.903 -0.648 . . . . 61.41 109.915 -175.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 178.59 7.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.032 -0.729 . . . . 61.14 109.032 177.182 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 16.9 ptm180 -67.81 -31.16 70.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.702 0.763 . . . . 73.43 109.791 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -133.71 100.53 4.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.166 -2.161 . . . . 74.24 105.166 172.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -94.71 -38.5 10.78 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.091 -0.707 . . . . 73.04 109.091 -178.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.93 156.42 19.89 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.892 -1.151 . . . . 70.12 107.892 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -137.04 147.47 46.2 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 109.027 -0.731 . . . . 70.45 109.027 176.12 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.3 mt -116.14 111.29 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 107.948 -1.13 . . . . 73.31 107.948 174.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.6 ttt180 -91.23 115.48 28.06 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.843 -1.169 . . . . 72.22 107.843 175.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -108.67 106.8 17.01 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 108.573 -0.899 . . . . 73.01 108.573 176.334 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.38 172.42 6.97 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 105.471 -2.048 . . . . 71.42 105.471 177.16 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 63.15 4.44 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 120.25 -0.976 . . . . 63.35 112.004 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -162.92 -68.55 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 32.41 108.795 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.8 m -137.99 157.08 32.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 CA-C-N 116.178 -0.465 . . . . 71.33 109.877 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.31 106.08 18.09 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.479 -0.934 . . . . 74.04 108.479 178.121 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.7 tt -90.01 115.15 27.08 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.113 -0.949 . . . . 75.52 108.987 -174.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.2 117.6 31.77 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.705 -1.591 . . . . 70.43 106.705 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.63 33.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.86 -0.422 . . . . 73.02 109.86 178.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -95.7 128.17 42.35 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.117 -0.698 . . . . 74.33 109.117 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.47 77.37 1.05 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 105.681 -1.97 . . . . 74.04 105.681 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.454 HD21 ' C ' ' A' ' 68' ' ' ASN . 8.4 t30 -178.48 132.26 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.496 -0.482 . . . . 64.44 110.45 -164.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 p -109.21 -53.52 2.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.188 0.811 . . . . 75.12 113.188 178.157 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -71.68 -34.79 69.98 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.458 0.91 . . . . 42.53 113.458 -173.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.454 ' C ' HD21 ' A' ' 65' ' ' ASN . 5.0 m-20 -107.47 29.27 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.319 -0.623 . . . . 73.12 109.319 -176.398 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.27 129.38 4.67 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 124.263 0.977 . . . . 72.3 115.366 -171.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.6 m -74.23 139.0 44.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.503 -0.849 . . . . 71.52 111.152 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -103.35 141.26 36.24 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.379 0.609 . . . . 72.03 111.462 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.442 HG12 HG13 ' A' ' 88' ' ' ILE . 27.0 m -116.98 117.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.376 -1.342 . . . . 74.3 107.376 174.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.55 34.63 24.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.696 -0.684 . . . . 72.53 110.134 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 86.27 -10.2 0.69 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.784 1.634 . . . . 64.41 112.995 178.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.32 124.95 47.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 121.745 -0.597 . . . . 73.33 111.158 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.52 125.42 10.1 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 122.47 2.113 . . . . 73.4 111.502 178.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.19 172.87 15.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 110.24 -0.281 . . . . 70.25 110.24 -177.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -102.59 -35.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.205 -0.665 . . . . 64.32 109.205 175.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.41 149.72 30.41 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.915 -0.584 . . . . 60.3 110.008 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -159.05 152.56 22.8 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.254 -1.017 . . . . 72.43 108.254 -173.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.41 111.75 24.59 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.659 -0.817 . . . . 75.14 109.825 174.308 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -58.34 134.67 56.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.21 -1.359 . . . . 74.33 112.43 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.32 164.29 16.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.617 -0.883 . . . . 75.34 108.617 172.567 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.417 ' CG ' HH21 ' A' ' 98' ' ' ARG . 26.2 t70 -66.97 114.48 5.8 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.13 0.49 . . . . 74.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.05 0.55 33.72 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.399 -0.819 . . . . 73.33 112.567 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -72.01 142.46 49.33 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.218 0.509 . . . . 72.41 111.494 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.64 113.78 42.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.262 -0.881 . . . . 74.25 108.941 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.442 HG13 HG12 ' A' ' 72' ' ' VAL . 2.9 mp -110.79 116.61 52.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.421 -0.955 . . . . 71.51 108.421 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -117.35 130.78 56.73 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.691 0.758 . . . . 75.4 110.785 -177.168 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -131.28 163.98 26.6 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.576 -1.268 . . . . 54.51 107.576 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.35 98.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.959 0.787 . . . . 64.41 114.865 -177.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 75.02 19.64 2.31 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 125.762 1.625 . . . . 74.35 114.071 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -148.37 138.32 22.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.613 -0.514 . . . . 70.51 109.613 176.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -133.62 120.58 20.88 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.607 0.718 . . . . 73.03 109.862 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 11' ' ' LEU . 9.7 tp -116.04 140.83 36.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.961 -1.018 . . . . 62.25 110.178 -172.252 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.15 138.13 39.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.5 -0.926 . . . . 74.41 108.5 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.55 124.44 54.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 120.886 0.374 . . . . 75.12 110.993 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.417 HH21 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -121.19 139.6 53.15 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.683 -0.858 . . . . 71.21 108.683 177.878 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.4 mtt -123.27 138.33 54.65 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 120.855 0.36 . . . . 73.52 110.622 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 108.488 -0.93 . . . . 73.41 108.488 -178.401 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 109.172 -0.677 . . . . 74.43 109.172 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -119.66 114.85 22.83 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.249 -1.019 . . . . 52.23 108.249 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.79 126.29 48.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.683 -0.858 . . . . 62.14 108.683 -175.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 46.0 m -131.84 122.85 26.4 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.805 -0.813 . . . . 53.24 108.805 -175.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 pp -88.9 136.39 33.03 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-O 121.207 0.527 . . . . 55.24 109.999 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.78 109.8 21.03 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.815 -1.084 . . . . 75.52 109.031 -172.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -99.49 105.66 17.6 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.298 -1.001 . . . . 51.51 108.298 175.236 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -92.29 100.49 13.07 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.149 -1.021 . . . . 73.45 108.721 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.97 -28.84 12.88 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.276 -0.875 . . . . 71.54 109.203 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.07 -51.11 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.852 -1.067 . . . . 61.01 111.397 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.7 m -114.38 -2.3 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.366 -0.491 . . . . 74.35 111.857 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.91 103.07 1.13 Allowed Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 121.298 -0.477 . . . . 52.21 113.357 178.164 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.73 158.29 16.06 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.664 -0.865 . . . . 73.42 108.664 173.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -139.31 141.02 37.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 123.49 0.493 . . . . 75.12 110.182 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -136.06 114.32 11.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.523 -0.547 . . . . 73.31 109.523 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 28.8 tt0 -76.28 134.89 39.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 109.003 -0.74 . . . . 74.41 109.003 177.55 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.09 136.87 52.92 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.902 -0.59 . . . . 70.23 110.074 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HG2' ' OD1' ' A' ' 28' ' ' ASN . 9.4 ptp180 -75.37 158.4 32.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.287 -1.375 . . . . 74.13 107.287 175.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -73.54 132.87 43.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.287 -1.375 . . . . 72.31 107.287 171.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.43 -150.19 17.25 Favored Glycine 0 C--N 1.282 -2.45 0 N-CA-C 107.706 -2.157 . . . . 54.01 107.706 -173.006 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 p -104.56 139.69 39.07 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.578 -1.249 . . . . 74.25 112.539 -178.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 27.6 m-80 -107.16 110.05 22.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.172 -1.788 . . . . 60.34 106.172 176.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -100.47 122.38 52.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.657 -0.247 . . . . 70.35 111.047 -173.864 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 78.0 mt -109.51 129.0 65.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.712 -0.848 . . . . 75.11 108.712 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.35 179.27 37.7 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 109.701 -1.36 . . . . 63.13 109.701 178.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 70.8 mtp180 -112.1 105.37 13.73 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.766 -1.198 . . . . 73.32 107.766 179.047 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.48 164.76 31.05 Favored Glycine 0 N--CA 1.409 -3.112 0 N-CA-C 109.258 -1.537 . . . . 55.14 109.258 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.96 -25.72 67.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.836 0.318 . . . . 74.44 111.275 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.28 -29.04 59.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 45.41 110.405 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -75.62 153.36 37.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 73.21 112.386 -175.537 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -97.52 -43.61 7.17 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.35 -0.841 . . . . 73.34 109.633 -178.662 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 80.1 t80 -117.57 128.07 54.59 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.872 -1.159 . . . . 72.41 107.872 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.83 137.42 47.65 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 112.386 0.513 . . . . 72.51 112.386 -178.541 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.34 142.72 54.86 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 74.34 110.751 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -86.72 35.76 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.858 2.372 . . . . 71.2 112.304 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.27 -177.52 5.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.843 -0.799 . . . . 64.04 108.843 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.9 m -113.94 158.63 20.86 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.124 -0.695 . . . . 73.05 109.124 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.86 -2.18 44.97 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.06 -1.216 . . . . 53.41 110.06 -178.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.67 136.03 24.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 113.936 -1.132 . . . . 73.22 109.516 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 5.2 m -76.13 175.8 8.61 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.495 -0.928 . . . . 72.43 108.495 177.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.7 ptp180 -68.42 -29.46 68.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.831 0.824 . . . . 75.41 109.055 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' SER . 75.2 mtm180 -128.39 103.38 7.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 104.015 -2.587 . . . . 74.53 104.015 168.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -91.85 -33.36 14.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.356 -0.609 . . . . 75.23 109.356 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.437 HD11 HD21 ' A' ' 61' ' ' LEU . 7.2 tt -162.8 147.3 11.65 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.15 -0.685 . . . . 62.23 109.15 -178.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -129.23 143.86 51.01 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.425 0.631 . . . . 75.32 109.995 175.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -113.36 106.14 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 107.454 -1.313 . . . . 51.1 107.454 172.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -92.06 107.91 19.56 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.869 -1.16 . . . . 51.33 107.869 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.33 126.33 52.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 74.11 111.575 -174.296 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -136.68 155.19 50.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 105.551 -2.018 . . . . 63.55 105.551 176.482 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 55.43 1.74 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 118.302 0.501 . . . . 63.22 113.468 -177.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -149.21 -63.39 0.23 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.634 1.174 . . . . 72.54 108.048 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.93 159.61 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 123.536 0.734 . . . . 74.45 109.306 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.7 101.89 11.37 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.761 -1.199 . . . . 75.3 107.761 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.3 tp -90.13 101.81 14.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.019 -0.991 . . . . 75.44 111.225 -172.365 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -85.37 131.24 34.43 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.602 -1.259 . . . . 42.55 107.602 178.029 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 78' ' ' GLN . . . -138.77 116.88 11.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.39 . . . . 72.35 110.538 178.149 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -86.2 135.79 33.44 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.812 -0.631 . . . . 74.55 109.801 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.16 76.9 1.42 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.568 -1.271 . . . . 61.04 107.568 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 175.31 147.1 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.928 -0.767 . . . . 70.31 108.928 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 p -109.58 -48.01 3.29 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.962 0.727 . . . . 74.15 112.962 175.241 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -67.31 -33.94 76.33 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.642 0.734 . . . . 60.35 112.307 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' ND2' ' HA3' ' A' ' 91' ' ' GLY . 65.3 t30 -121.4 27.4 8.32 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.568 -1.271 . . . . 64.41 107.568 -173.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.41 143.01 4.87 Favored Glycine 0 C--O 1.25 1.147 0 CA-C-N 114.493 -1.231 . . . . 52.24 115.404 -175.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.2 m -84.53 151.23 24.71 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.003 0.906 . . . . 52.05 112.432 -176.014 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.4 p -121.38 143.8 49.01 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.164 -0.925 . . . . 64.21 110.967 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 80' ' ' TRP . 32.6 m -109.84 121.64 63.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 106.061 -1.829 . . . . 65.15 106.061 174.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 61.57 24.62 14.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.615 0.722 . . . . 72.22 109.302 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.5 10.26 2.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 126.326 1.85 . . . . 75.34 110.984 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.24 125.93 34.93 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.577 -0.702 . . . . 51.34 109.156 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 125.51 10.45 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.639 2.226 . . . . 72.35 114.124 -176.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -151.93 177.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 106.335 -1.728 . . . . 64.5 106.335 178.467 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 72.0 mt-30 -119.36 -37.08 3.23 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.195 0.521 . . . . 73.13 109.729 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.91 133.56 55.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.627 -0.715 . . . . 61.32 109.352 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.466 ' CD2' HG21 ' A' ' 72' ' ' VAL . 76.8 t-105 -158.49 141.39 14.66 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 121.779 0.8 . . . . 74.53 111.115 -176.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -88.58 104.26 16.68 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 113.735 -1.575 . . . . 61.14 107.088 173.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.97 150.84 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.749 -0.66 . . . . 63.01 111.98 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.28 165.49 26.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.71 -0.848 . . . . 73.3 108.71 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.39 111.47 7.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.307 0.575 . . . . 73.02 110.207 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.1 19.56 16.46 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.604 -0.725 . . . . 64.54 111.901 -178.09 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.99 129.46 34.87 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.274 -1.38 . . . . 71.12 107.274 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.42 113.03 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.49 -0.93 . . . . 72.45 108.49 -178.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.453 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 42.3 mm -96.23 106.53 18.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.04 -1.837 . . . . 72.3 106.04 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 24.8 ttt85 -103.19 106.28 16.76 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.556 -1.276 . . . . 71.23 107.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -106.95 163.93 12.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.706 -1.133 . . . . 71.3 109.433 -174.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.481 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -41.3 101.05 0.02 OUTLIER Glycine 0 C--N 1.309 -0.929 0 N-CA-C 115.924 1.129 . . . . 63.01 115.924 -175.252 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 36.2 m80 74.29 15.77 3.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.739 1.616 . . . . 70.1 113.463 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.2 t -151.66 176.63 11.18 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.921 -0.399 . . . . 70.22 109.921 178.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.61 144.57 24.5 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.27 -1.011 . . . . 75.34 108.27 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 9.8 tp -140.4 140.56 34.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.826 -0.805 . . . . 71.5 108.826 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.5 mt -104.66 117.39 50.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.96 -0.755 . . . . 73.24 108.96 -178.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.24 122.23 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 110.369 -0.234 . . . . 64.24 110.369 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -115.83 151.57 35.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.361 -0.607 . . . . 72.12 109.361 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 mtt -122.1 117.03 25.31 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.634 -0.712 . . . . 63.23 109.445 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 . . . . . 0 C--N 1.275 -2.66 0 N-CA-C 108.063 -1.088 . . . . 74.2 108.063 -178.579 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 109.525 -0.546 . . . . 73.31 109.525 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -108.67 115.53 30.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.078 -0.51 . . . . 75.34 109.744 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.25 110.5 26.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.766 -1.198 . . . . 72.41 107.766 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -112.53 120.8 42.86 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.687 -0.857 . . . . 72.53 108.687 -174.578 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -91.53 137.34 32.44 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.647 -0.501 . . . . 63.12 109.647 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 26.6 mt-30 -104.02 127.3 51.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.389 -1.337 . . . . 64.5 107.389 174.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.6 135.22 52.94 Favored 'General case' 0 C--N 1.269 -2.892 0 O-C-N 123.399 0.437 . . . . 61.1 111.385 -173.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 100.33 11.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.732 -1.581 . . . . 73.03 106.732 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.4 ' CB ' ' HG2' ' A' ' 19' ' ' ARG . 16.8 t70 -104.36 1.69 30.49 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 113.606 -1.633 . . . . 73.21 110.059 -176.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.5 -41.54 1.86 Allowed Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 108.584 -1.807 . . . . 64.24 108.584 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -112.59 -63.92 1.37 Allowed 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.28 -1.378 . . . . 51.42 107.28 173.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.49 109.04 0.39 Allowed Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 111.242 -0.743 . . . . 53.1 111.242 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.4 ' HG2' ' CB ' ' A' ' 15' ' ' ASP . 35.6 mmt180 -101.11 157.08 17.03 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.104 -0.702 . . . . 73.2 109.104 177.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.0 p -137.75 132.6 32.99 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.628 -1.249 . . . . 71.0 107.628 174.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -138.49 129.31 26.62 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.797 -0.816 . . . . 70.34 108.797 -173.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -87.46 120.94 29.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.679 -0.86 . . . . 72.33 108.679 177.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.52 137.87 23.43 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 124.355 1.034 . . . . 70.42 111.475 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -85.12 144.7 28.05 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 108.9 -0.778 . . . . 73.42 108.9 -177.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.7 113.53 8.82 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.077 0.941 . . . . 71.4 109.947 178.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.58 -167.37 23.15 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 106.573 -2.611 . . . . 74.32 106.573 -171.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 58.1 p -106.46 127.76 53.54 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 118.981 1.39 . . . . 52.5 111.179 177.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -102.0 112.58 25.28 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.425 -0.807 . . . . 64.12 108.97 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.34 120.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.255 -0.884 . . . . 73.23 109.443 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.4 mt -99.99 130.62 48.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.238 -0.892 . . . . 64.05 109.194 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 157.32 -161.34 31.17 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.713 -1.355 . . . . 73.03 109.713 178.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.725 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 60.6 mtp180 -129.76 105.23 7.89 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.056 -1.461 . . . . 74.43 107.056 173.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.34 -176.19 47.69 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.944 -0.646 . . . . 64.22 111.615 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -63.23 -30.03 71.25 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 124.739 1.216 . . . . 75.32 113.177 -176.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.39 -6.61 37.11 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.822 0.344 . . . . 75.33 111.686 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 115.12 18.23 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.892 0.377 . . . . 74.34 111.992 -174.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.459 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 12.9 mm-40 -89.31 -29.44 19.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.478 -0.783 . . . . 72.23 109.434 177.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 85.4 t80 -115.18 108.95 17.29 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.259 -1.756 . . . . 75.23 106.259 173.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 59.5 mtt180 -99.13 120.63 39.82 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.035 -0.984 . . . . 74.33 110.375 -172.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.9 mt -73.05 138.32 79.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.886 -0.597 . . . . 70.34 110.557 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -84.35 1.67 8.56 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.41 2.074 . . . . 71.41 113.868 -177.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -102.85 163.63 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.308 -0.627 . . . . 54.23 109.308 -178.326 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.6 m -100.45 147.93 25.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 120.909 0.385 . . . . 55.21 110.455 -177.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.69 7.99 30.94 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 110.626 -0.99 . . . . 74.45 110.626 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG13 ' HD1' ' A' ' 49' ' ' HIS . 38.2 t -99.31 133.61 41.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 70.24 108.391 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.6 m -69.94 175.87 4.11 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.753 0.311 . . . . 52.11 111.388 178.425 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.2 ptp180 -65.27 -28.85 69.63 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.606 0.717 . . . . 65.51 111.299 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -135.59 119.16 16.99 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.579 -2.378 . . . . 74.25 104.579 169.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 3.7 t60 -104.62 -45.16 4.69 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.96 -0.756 . . . . 75.02 108.96 -177.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -163.29 154.25 16.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.279 -1.378 . . . . 75.11 107.279 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -136.84 143.89 43.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.698 -0.482 . . . . 73.42 109.698 176.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -112.42 115.26 49.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 108.562 -0.903 . . . . 74.21 108.562 177.311 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 47.3 ttt180 -93.0 107.25 19.07 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-O 121.305 0.574 . . . . 71.31 109.539 176.607 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -97.31 107.16 19.61 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.522 -1.288 . . . . 75.55 107.522 175.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.62 -173.18 2.4 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 105.18 -2.156 . . . . 71.15 105.18 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.58 4.75 85.12 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 118.797 -1.668 . . . . 72.43 111.969 -177.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -117.94 -61.31 1.7 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.578 -0.311 . . . . 70.32 111.817 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 157.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.949 0.404 . . . . 74.1 111.414 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 82' ' ' LEU . . . -102.68 104.66 15.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.172 -1.047 . . . . 64.43 108.172 176.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.9 tt -91.25 118.34 30.4 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.737 -1.12 . . . . 60.44 110.077 -174.592 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.04 122.32 43.87 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.217 -1.401 . . . . 72.45 107.217 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.6 118.95 12.85 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.489 -0.485 . . . . 74.33 112.008 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.446 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 0.8 OUTLIER -66.05 139.75 58.21 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.399 -0.963 . . . . 74.2 108.399 172.577 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -126.82 75.4 1.56 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 105.858 -1.904 . . . . 63.54 105.858 178.736 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 11.2 t-20 158.11 163.63 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 106.46 -1.681 . . . . 75.13 106.46 -178.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.9 m -108.04 -44.82 4.09 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 118.014 0.37 . . . . 60.25 111.711 176.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 m -73.99 -30.21 62.37 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.454 0.645 . . . . 74.34 111.649 -175.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.586 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.7 m120 -86.65 28.29 0.89 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.045 -0.409 . . . . 51.43 110.51 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.0 123.62 4.83 Favored Glycine 0 C--O 1.24 0.528 0 N-CA-C 116.116 1.206 . . . . 42.42 116.116 -174.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.446 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 88.0 m -91.77 151.04 20.79 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 124.733 1.213 . . . . 72.41 110.019 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 p -118.76 140.68 49.54 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 116.226 -0.443 . . . . 65.34 110.508 176.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.27 117.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.84 -1.17 . . . . 53.04 107.84 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 59.85 30.01 19.56 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.71 0.804 . . . . 72.03 110.325 -177.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 t30 79.79 1.41 2.14 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.948 1.699 . . . . 72.32 110.949 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.76 25.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 O-C-N 121.884 -0.51 . . . . 34.14 110.139 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.39 125.91 5.92 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.705 2.27 . . . . 74.52 112.469 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.01 -177.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.884 -1.154 . . . . 74.15 107.884 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.11 -10.15 7.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.046 0.45 . . . . 64.51 110.112 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -153.41 135.24 14.57 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 109.6 -0.519 . . . . 73.42 109.6 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -151.73 151.93 32.06 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.748 -0.66 . . . . 74.31 109.916 -174.524 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -102.78 114.65 29.09 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 72.32 108.182 174.393 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD12 ' HB1' ' A' ' 59' ' ' ALA . 64.3 mt -59.5 143.74 49.18 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.87 0.692 . . . . 65.2 112.87 -176.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.3 166.57 23.47 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.255 -1.017 . . . . 74.53 108.255 171.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.78 115.7 10.23 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.133 -0.321 . . . . 73.33 110.133 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 0.87 26.8 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.076 -0.583 . . . . 63.33 113.05 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -74.15 129.87 38.68 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.296 -0.562 . . . . 74.11 111.073 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.67 112.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 108.009 -1.108 . . . . 64.44 108.009 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.83 129.87 70.24 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 N-CA-C 109.736 -0.468 . . . . 73.01 109.736 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -123.75 131.9 53.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 110.093 -0.336 . . . . 71.43 110.093 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.13 140.17 37.84 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.369 -1.345 . . . . 61.01 107.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.48 88.3 0.0 OUTLIER Glycine 0 N--CA 1.489 2.178 0 O-C-N 125.4 1.688 . . . . 73.21 116.482 -174.069 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.7 m80 80.68 -33.51 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.596 1.558 . . . . 73.42 114.367 177.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -101.1 162.27 13.01 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.268 -0.573 . . . . 64.41 110.918 -173.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.06 143.18 31.77 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.28 0.562 . . . . 63.2 110.116 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -140.16 138.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 114.9 -1.046 . . . . 74.44 110.118 -173.563 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.17 128.36 67.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.936 -0.764 . . . . 74.21 108.936 177.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 82' ' ' LEU . 63.9 t -89.18 129.26 40.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 112.521 0.563 . . . . 75.23 112.521 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.32 137.12 51.97 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.313 -0.995 . . . . 63.32 108.313 172.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.3 mtp -126.27 112.42 15.7 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.464 -0.569 . . . . 54.44 109.464 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 . . . . . 0 C--N 1.275 -2.654 0 N-CA-C 108.255 -1.017 . . . . 73.34 108.255 -178.631 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.423 -1.82 0 N-CA-C 109.487 -0.56 . . . . 74.13 109.487 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.5 m -105.16 114.59 28.88 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.433 -0.951 . . . . 72.44 108.433 176.31 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -99.61 114.14 36.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.525 -1.287 . . . . 74.55 107.525 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.5 m -124.18 123.77 41.0 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.891 -0.781 . . . . 70.32 108.891 -176.199 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -102.99 128.23 49.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.71 -0.677 . . . . 64.51 109.311 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.57 132.7 51.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.387 -0.824 . . . . 65.34 110.424 -175.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.7 tp -121.5 111.55 17.4 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.378 -0.828 . . . . 65.41 109.321 -177.321 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -127.23 100.79 6.22 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.916 0.865 . . . . 54.33 109.735 177.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.05 19.53 15.67 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.555 -1.276 . . . . 71.3 107.555 174.795 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.75 16.82 12.0 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.666 -1.373 . . . . 61.11 109.666 -171.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 p -117.36 -68.32 0.93 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.317 0.58 . . . . 71.43 110.542 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.66 53.31 1.56 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.919 -0.872 . . . . 64.11 110.919 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.08 156.76 17.0 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.852 0.358 . . . . 51.31 111.121 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.2 p -132.34 143.98 50.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.777 -0.823 . . . . 73.22 108.777 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -135.48 134.16 39.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.392 -1.336 . . . . 74.2 107.392 175.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -110.06 135.07 51.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.846 -0.798 . . . . 53.45 108.846 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.85 128.23 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.76 . . . . 73.34 111.65 -176.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -104.5 153.2 21.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.456 -2.424 . . . . 72.42 104.456 172.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.02 143.95 55.84 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.12 0.962 . . . . 72.34 113.336 -173.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.12 177.37 16.5 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 107.648 -2.181 . . . . 75.22 107.648 -174.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 29.8 t -100.09 125.17 46.15 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.479 -0.888 . . . . 72.33 108.854 176.033 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -108.07 120.57 42.7 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.942 -1.026 . . . . 74.42 110.319 -177.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.4 mt -86.05 127.81 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.889 -1.051 . . . . 74.01 110.539 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.602 HG23 HD21 ' A' ' 40' ' ' LEU . 55.4 mt -103.27 119.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 125.321 1.448 . . . . 65.21 108.329 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 167.46 -151.75 19.64 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.416 -0.674 . . . . 51.13 111.416 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 82.9 mtm180 -131.8 105.03 7.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 117.769 0.784 . . . . 74.1 109.519 176.376 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.84 -163.8 33.6 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.314 -0.946 . . . . 55.11 111.215 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -86.96 -34.16 19.4 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.931 -0.766 . . . . 75.05 108.931 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -33.48 74.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.385 -0.825 . . . . 65.23 109.585 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.03 129.19 39.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.833 -1.076 . . . . 71.02 110.779 -178.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -90.72 -26.67 19.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.544 -1.28 . . . . 74.04 107.544 178.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.63 116.17 25.46 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.218 -1.356 . . . . 71.53 107.411 178.004 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -101.58 117.34 34.7 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.974 -0.557 . . . . 65.2 111.218 -175.806 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.602 HD21 HG23 ' A' ' 30' ' ' ILE . 4.0 mm? -78.1 125.24 85.49 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.666 -0.697 . . . . 74.54 110.732 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -74.6 2.6 6.22 Favored 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 122.416 2.077 . . . . 63.44 113.658 178.159 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -104.85 -173.38 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.093 -1.077 . . . . 75.33 108.093 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -124.78 167.12 15.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.68 -0.859 . . . . 75.45 108.68 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.01 -3.48 62.27 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 108.818 -1.713 . . . . 64.12 108.818 -174.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.75 131.41 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.168 -1.516 . . . . 75.01 107.458 179.1 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -93.41 -177.57 4.47 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.503 -0.317 . . . . 72.25 111.81 -175.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.8 ptm180 -63.79 -36.03 82.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.516 0.674 . . . . 71.43 111.913 -177.196 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -133.17 99.4 4.54 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 105.481 -2.044 . . . . 62.23 105.481 175.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -104.37 -46.42 4.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.978 -1.01 . . . . 61.2 109.546 -176.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 tt -153.49 159.75 42.36 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.069 -1.086 . . . . 64.15 108.069 -176.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.0 149.68 40.34 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.177 -0.675 . . . . 63.23 109.177 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' SER . 68.3 mt -118.74 115.43 48.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.828 -0.804 . . . . 71.43 108.828 175.152 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -91.55 107.42 19.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.344 -1.354 . . . . 73.13 107.344 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -115.43 132.36 56.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.789 -0.641 . . . . 71.33 111.305 -177.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -143.0 169.39 17.65 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.627 -1.99 . . . . 53.44 105.627 173.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 65.67 1.77 Allowed Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.8 -0.714 . . . . 75.52 112.07 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -155.89 -73.47 0.11 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.249 1.02 . . . . 63.21 108.443 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.95 159.22 16.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.66 0.784 . . . . 63.02 109.332 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -103.85 104.69 14.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.193 -0.669 . . . . 70.04 109.193 178.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.28 114.07 26.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.204 -0.907 . . . . 71.23 109.788 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.75 122.51 36.29 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.896 -1.52 . . . . 74.44 106.896 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.78 124.47 18.33 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.71 -0.396 . . . . 72.22 110.568 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.512 ' OD2' ' HB ' ' A' ' 70' ' ' THR . 12.9 m-20 -72.45 143.98 48.27 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.466 -0.939 . . . . 61.3 108.466 174.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -121.98 75.72 1.24 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.874 -1.158 . . . . 72.23 107.874 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 165.87 153.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 104.939 -2.245 . . . . 73.32 104.939 -178.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -97.2 -33.66 11.4 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.798 -0.761 . . . . 74.01 112.387 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 t -89.1 -28.95 19.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.758 -0.377 . . . . 65.34 111.351 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -88.63 27.38 1.3 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 122.568 0.347 . . . . 71.22 111.882 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.82 129.38 47.08 Favored Glycine 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 43.43 112.001 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 15.6 m -86.79 157.75 19.52 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 124.821 1.248 . . . . 74.35 113.053 -173.201 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 p -102.69 140.7 36.62 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.134 0.492 . . . . 74.52 110.732 178.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.05 120.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.672 -1.232 . . . . 73.31 107.672 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 59.29 32.02 21.61 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.694 0.798 . . . . 74.53 109.924 -176.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.7 t30 75.4 9.27 3.74 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.0 1.32 . . . . 71.11 110.953 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.9 41.99 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.488 -0.56 . . . . 60.43 109.488 177.536 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.33 125.35 11.23 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.4 2.067 . . . . 62.12 111.913 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.28 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.635 -0.876 . . . . 53.33 108.635 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -126.61 -0.64 6.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.422 -0.584 . . . . 74.11 109.422 171.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -165.29 147.16 7.65 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.479 -0.934 . . . . 44.43 108.479 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -166.95 151.84 7.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.508 -0.923 . . . . 75.32 108.508 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -105.03 118.62 36.99 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.557 -0.857 . . . . 71.23 109.57 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 78.0 mt -61.62 150.23 36.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.644 -1.162 . . . . 73.3 113.717 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.52 174.77 10.66 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.844 -1.071 . . . . 73.21 108.154 172.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.06 112.3 12.36 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.655 -0.498 . . . . 73.31 109.655 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.0 14.85 11.41 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.665 -0.778 . . . . 71.21 113.153 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -79.98 121.46 25.51 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 119.523 -0.871 . . . . 72.32 110.692 175.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 112.61 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 106.743 -1.577 . . . . 62.3 106.743 175.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 95' ' ' ILE . 57.8 mt -120.45 140.1 45.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 109.388 -0.597 . . . . 63.23 109.388 -174.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -132.2 123.64 27.42 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.519 -0.872 . . . . 73.24 111.507 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.5 pt? -108.11 163.66 12.97 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.762 -1.57 . . . . 65.44 106.762 176.452 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.92 104.51 0.05 OUTLIER Glycine 0 CA--C 1.533 1.171 0 O-C-N 123.996 0.81 . . . . 72.02 114.403 -178.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.0 m80 80.32 -5.11 1.81 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.262 1.579 . . . . 73.14 115.262 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.4 m -138.17 136.51 36.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.995 0.816 . . . . 72.21 111.795 -177.668 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -107.56 138.44 43.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.226 -0.657 . . . . 64.1 109.226 175.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 5.4 tp -126.9 131.71 70.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.624 -0.88 . . . . 73.32 108.624 -175.652 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.5 119.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.654 -0.869 . . . . 72.31 108.654 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG11 ' HB3' ' A' ' 82' ' ' LEU . 95.6 t -90.62 125.01 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.209 0.528 . . . . 65.25 111.35 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.76 149.42 42.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.401 -0.818 . . . . 74.21 109.728 178.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' SER . 59.4 mtt -129.6 110.47 11.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.624 0.726 . . . . 53.44 109.459 176.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--N 1.278 -2.535 0 CA-C-N 114.852 -1.067 . . . . 72.02 109.857 -176.53 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.465 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 52.3 m . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 109.514 -0.55 . . . . 72.25 109.514 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -113.0 128.53 56.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.104 -0.498 . . . . 51.45 109.756 176.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -103.35 124.72 57.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 75.43 109.031 177.428 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.4 m -126.16 134.82 51.18 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.303 -0.862 . . . . 71.42 109.559 -173.35 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.7 mt -93.89 135.12 35.55 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.277 -1.009 . . . . 73.21 108.277 178.213 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -114.83 126.62 55.04 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 109.762 -0.458 . . . . 65.44 109.762 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -123.61 114.85 20.56 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.381 -0.97 . . . . 72.12 108.381 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -118.39 101.93 8.54 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.9 0.857 . . . . 63.53 111.608 -179.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.25 26.76 10.05 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.025 -1.843 . . . . 64.45 106.025 174.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.39 43.07 4.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.91 -2.076 . . . . 63.14 107.91 -173.47 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -147.73 -61.91 0.27 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.845 -0.677 . . . . 73.43 111.12 -172.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.88 39.8 5.73 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.002 -0.839 . . . . 74.21 111.002 -178.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.24 151.06 36.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 110.08 -0.341 . . . . 72.44 110.08 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.5 p -134.92 144.76 47.65 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.908 -0.587 . . . . 75.51 111.049 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -129.65 116.1 18.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.341 -0.615 . . . . 55.2 109.341 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -80.44 131.93 35.66 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.688 -0.486 . . . . 75.12 109.688 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.513 HD13 HG21 ' A' ' 52' ' ' ILE . 93.7 mt -85.05 122.34 29.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.817 -1.179 . . . . 72.41 107.817 174.745 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -93.89 178.88 5.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.966 -0.694 . . . . 71.31 109.236 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 132.46 45.99 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.441 0.639 . . . . 72.24 111.153 -176.038 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.37 -159.67 16.94 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.237 -1.545 . . . . 74.4 109.237 -176.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 p -106.6 144.61 33.01 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.371 -0.531 . . . . 60.03 109.625 177.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -121.89 112.05 17.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.134 -1.061 . . . . 43.32 108.134 -176.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.5 mm -86.2 130.56 36.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 109.399 -0.593 . . . . 71.34 109.399 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 38' ' ' PHE . 61.0 mt -115.69 135.79 54.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 123.238 0.615 . . . . 75.31 110.319 -178.049 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 148.23 -163.69 28.94 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 111.646 -0.582 . . . . 62.24 111.646 177.646 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.3 mtt180 -115.71 107.1 14.65 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.978 0.418 . . . . 74.44 110.114 176.205 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.62 -178.88 48.4 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.425 -1.47 . . . . 44.42 109.425 179.05 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.52 -13.69 53.99 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.502 0.668 . . . . 74.43 109.699 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -83.57 -24.38 31.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.2 -0.909 . . . . 52.24 109.449 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.67 139.25 31.53 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.55 -0.75 . . . . 54.21 111.955 -173.209 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -92.58 -44.92 8.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.474 -0.785 . . . . 74.23 108.942 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HB3' HG12 ' A' ' 30' ' ' ILE . 68.6 t80 -101.42 108.58 20.22 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.219 -1.03 . . . . 62.43 108.219 177.037 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.8 mtm-85 -96.19 127.39 42.16 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.865 -1.061 . . . . 74.21 108.464 -177.737 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 9.3 mp -80.14 149.75 70.17 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 112.006 0.373 . . . . 62.52 112.006 -178.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.3 Cg_exo -71.69 -12.28 28.79 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.755 2.303 . . . . 43.25 112.342 177.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.56 165.05 11.7 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.6 0.593 . . . . 73.51 112.6 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -102.1 162.56 12.82 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.917 -1.142 . . . . 73.14 107.917 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.99 -0.48 41.39 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 109.458 -1.457 . . . . 50.12 109.458 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.471 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 t -102.93 131.29 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.921 -1.139 . . . . 43.11 108.614 -176.449 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 m -75.88 172.23 13.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.297 -0.41 . . . . 74.25 111.565 -178.039 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 1.4 ptm180 -64.65 -42.2 95.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.384 0.611 . . . . 64.24 110.819 177.403 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -123.64 93.69 4.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 104.791 -2.3 . . . . 72.21 104.791 171.059 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.587 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 22.6 t60 -96.26 -30.61 13.36 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 115.182 -0.917 . . . . 74.42 109.524 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 tt -163.5 146.99 10.35 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 109.321 -0.622 . . . . 64.25 109.321 -178.194 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.04 123.38 30.36 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.382 0.611 . . . . 71.23 111.257 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 23' ' ' LEU . 69.1 mt -104.26 119.18 52.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.826 -0.625 . . . . 74.55 109.696 177.442 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -100.71 114.52 28.34 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.516 -0.92 . . . . 72.34 108.516 177.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -113.76 134.46 54.75 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.697 0.76 . . . . 73.14 112.164 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -148.18 164.71 33.1 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 103.758 -2.682 . . . . 63.31 103.758 174.144 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.14 58.23 1.08 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 118.893 0.77 . . . . 64.21 113.005 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -135.58 -78.41 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.203 -1.406 . . . . 75.21 107.203 178.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -149.41 159.37 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 105.705 -1.961 . . . . 73.25 105.705 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -95.58 113.12 24.74 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.171 -0.677 . . . . 54.25 109.171 178.092 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.5 tp -83.72 106.74 15.66 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.052 -0.976 . . . . 62.13 110.335 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.6 tm? -94.99 111.44 23.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.519 1.128 . . . . 72.02 108.246 -177.163 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.06 121.43 38.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.168 -0.308 . . . . 75.32 110.168 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.93 136.6 34.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.129 -0.693 . . . . 65.44 109.129 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.72 76.05 1.54 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.356 -1.72 . . . . 72.11 106.356 -177.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.573 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 30.4 t-20 174.55 141.91 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.055 -1.091 . . . . 75.25 108.055 -178.063 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -108.35 -53.12 2.67 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.91 0.386 . . . . 72.05 111.095 177.615 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.0 m -66.46 -37.32 84.87 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.83 0.852 . . . . 54.43 112.089 -175.785 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.573 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 25.9 m-80 -115.9 27.2 9.44 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.681 -1.229 . . . . 72.13 107.681 -178.254 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.26 152.06 3.31 Favored Glycine 0 C--O 1.243 0.709 0 CA-C-N 114.279 -1.328 . . . . 73.12 115.624 -174.477 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 m -87.95 147.3 25.11 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.675 0.79 . . . . 43.43 112.17 -176.53 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -118.03 146.67 43.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.183 0.993 . . . . 60.4 110.637 178.401 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.96 127.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.019 -1.475 . . . . 52.51 107.019 176.038 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.04 26.95 12.58 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.052 0.941 . . . . 63.24 111.933 -178.484 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 73.91 22.48 2.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.798 1.239 . . . . 72.21 110.272 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -122.97 134.2 24.93 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.338 -0.846 . . . . 53.12 108.904 176.111 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 6.1 Cg_exo -78.42 137.41 14.82 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.043 1.828 . . . . 63.54 111.856 179.629 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.1 170.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.091 -1.077 . . . . 72.34 108.091 179.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.71 -31.6 10.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.647 -0.501 . . . . 70.34 109.647 172.793 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.07 145.38 25.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 120.901 0.382 . . . . 65.21 110.091 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.41 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 63.4 t-105 -150.99 152.5 33.62 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.392 -0.966 . . . . 74.45 108.392 -173.816 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.95 124.22 49.12 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 107.549 -1.278 . . . . 61.21 107.549 174.688 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 42.3 mt -56.22 151.02 13.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.804 1.039 . . . . 73.1 113.804 -173.171 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.44 43.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.217 -1.401 . . . . 44.15 107.217 178.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.61 115.67 9.13 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.12 0.486 . . . . 73.01 110.843 -179.173 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.42 10.06 45.6 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.852 -0.689 . . . . 62.25 112.741 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.38 144.45 32.69 Favored 'General case' 0 C--O 1.252 1.201 0 C-N-CA 119.27 -0.972 . . . . 72.1 108.937 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.9 t -102.06 112.54 35.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.196 -1.039 . . . . 61.13 108.196 -178.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.7 mt -110.81 127.89 67.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 C-N-CA 120.093 -0.643 . . . . 71.11 109.744 -177.13 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -121.32 119.46 32.25 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 109.568 -0.53 . . . . 75.35 109.568 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.587 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 1.5 pt? -114.32 137.92 51.18 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.349 -1.723 . . . . 64.35 106.349 177.677 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 5.31 86.17 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 O-C-N 124.785 1.303 . . . . 60.42 115.638 -166.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 55.12 16.79 1.7 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.974 1.842 . . . . 73.44 115.974 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -123.8 128.01 48.91 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.117 -0.697 . . . . 60.43 109.117 177.705 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.57 139.25 46.0 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.149 0.796 . . . . 73.4 113.149 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 tp -127.39 142.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.407 -1.331 . . . . 74.3 107.407 -177.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.9 133.46 51.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.662 -0.866 . . . . 72.43 108.662 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 82' ' ' LEU . 81.4 t -100.72 126.18 54.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 120.836 0.351 . . . . 62.02 111.668 -178.392 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -119.79 138.2 53.5 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.009 -0.542 . . . . 75.15 109.807 174.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.1 mtp -124.11 113.73 18.75 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.345 -0.613 . . . . 73.33 109.345 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.465 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 56.6 m-70 . . . . . 0 C--N 1.28 -2.42 0 N-CA-C 108.295 -1.002 . . . . 62.14 108.295 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 N--CA 1.428 -1.554 0 N-CA-C 108.539 -0.911 . . . . 63.42 108.539 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -124.46 115.19 20.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.51 -1.293 . . . . 72.33 107.51 176.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.31 131.07 36.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.279 -1.008 . . . . 74.3 108.279 -177.346 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.534 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 37.9 m -137.61 132.81 33.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.502 -0.772 . . . . 74.43 108.922 -174.637 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.431 HD13 HD11 ' A' ' 95' ' ' ILE . 4.4 pp -93.23 136.75 33.2 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 120.216 -0.594 . . . . 60.45 109.649 177.739 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -109.04 129.52 55.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.732 -0.667 . . . . 74.34 111.476 -175.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -119.8 136.15 54.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.13 -1.396 . . . . 73.31 108.158 -177.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.79 98.91 11.7 Favored 'General case' 0 CA--C 1.467 -2.222 0 CA-C-O 122.574 1.178 . . . . 63.15 107.976 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 15.8 t70 -133.8 92.97 3.04 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 113.18 -1.827 . . . . 64.2 108.093 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.63 -61.54 4.12 Favored Glycine 0 C--N 1.292 -1.877 0 CA-C-N 114.565 -1.198 . . . . 54.14 110.634 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 p -135.73 -37.72 0.74 Allowed 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.609 -0.796 . . . . 71.4 109.792 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.9 120.07 1.06 Allowed Glycine 0 N--CA 1.41 -3.05 0 N-CA-C 110.444 -1.063 . . . . 62.32 110.444 -178.158 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 29.4 mmt180 -105.73 154.25 20.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.303 -1.369 . . . . 75.34 107.303 175.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 62.8 p -138.04 133.8 33.99 Favored 'General case' 0 C--N 1.283 -2.291 0 O-C-N 123.312 0.382 . . . . 70.24 110.685 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 55.9 t80 -117.85 114.48 23.31 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.752 -1.203 . . . . 74.01 107.752 174.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.18 135.72 38.53 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.13 -1.063 . . . . 64.55 108.13 179.126 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.3 mt -73.45 129.45 38.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.028 0.442 . . . . 72.34 110.034 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -79.58 151.83 30.42 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.2 -1.407 . . . . 73.32 107.2 176.691 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 4.6 pt-20 -75.25 113.35 12.51 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.274 1.035 . . . . 70.45 111.697 -178.775 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.13 -166.48 26.0 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 106.367 -2.693 . . . . 72.42 106.367 -172.301 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 97.3 p -97.42 119.49 36.05 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 119.622 1.711 . . . . 70.33 111.078 177.571 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 27.2 m-80 -88.03 108.46 19.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 106.998 -1.482 . . . . 74.01 106.998 -178.804 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.409 HG21 ' HG2' ' A' ' 48' ' ' ARG . 57.3 mt -91.21 116.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.278 -0.874 . . . . 74.54 109.225 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -99.34 128.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 123.484 0.714 . . . . 64.01 110.143 -177.642 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.68 26.65 Favored Glycine 0 CA--C 1.487 -1.661 0 CA-C-N 115.274 -0.875 . . . . 54.04 111.057 176.692 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -128.69 105.91 8.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.501 0.667 . . . . 64.34 111.349 176.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.07 166.52 33.56 Favored Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 108.92 -1.672 . . . . 65.42 108.92 176.424 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -74.88 -16.9 60.65 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.82 0.81 . . . . 73.24 109.283 176.497 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.98 -10.72 59.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.291 -0.868 . . . . 73.24 109.734 178.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.16 169.51 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 74.43 110.404 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -109.56 -47.39 3.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.447 0.641 . . . . 71.31 109.965 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -108.21 127.22 53.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.215 -0.902 . . . . 64.42 108.8 -177.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -95.23 127.28 41.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.048 -0.723 . . . . 74.13 109.048 -174.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 45' ' ' VAL . 38.1 mt -83.47 150.01 59.13 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.675 -0.41 . . . . 73.34 110.318 175.137 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -95.03 34.39 0.17 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 123.37 2.713 . . . . 75.04 112.325 179.015 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -138.6 179.75 6.29 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.13 -0.628 . . . . 63.42 110.004 -178.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 m -112.67 162.41 15.75 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.696 -0.853 . . . . 64.3 108.696 -176.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.08 -20.77 48.86 Favored Glycine 0 CA--C 1.5 -0.862 0 C-N-CA 121.021 -0.609 . . . . 51.33 111.938 176.936 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 40' ' ' LEU . 9.9 p -79.29 142.55 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.228 -0.486 . . . . 75.33 111.097 -178.099 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 m -80.13 -170.5 2.52 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.8 0.84 . . . . 55.51 109.317 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -77.8 -47.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.141 -1.024 . . . . 73.15 109.403 175.809 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.409 ' HG2' HG21 ' A' ' 29' ' ' ILE . 54.5 mtt180 -109.43 109.32 20.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 107.528 -1.286 . . . . 75.42 107.528 171.319 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -104.36 -45.28 4.71 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.664 -1.235 . . . . 75.25 107.664 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 5.8 tt -159.25 151.96 21.71 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 114.845 -1.07 . . . . 72.54 108.215 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HG2' HD21 ' A' ' 64' ' ' LEU . 14.5 pt-20 -136.96 140.77 42.45 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.757 -0.831 . . . . 75.43 108.757 175.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.8 mt -106.83 115.86 49.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 107.782 -1.192 . . . . 75.0 107.782 176.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 48.1 mtt180 -90.32 107.07 18.91 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.79 -1.559 . . . . 64.3 106.79 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -112.06 115.59 29.14 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.845 -1.07 . . . . 74.31 109.967 -176.279 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.01 160.46 22.74 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.107 -1.812 . . . . 64.2 106.107 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.14 54.07 2.25 Favored Glycine 0 C--N 1.311 -0.822 0 CA-C-N 118.078 0.399 . . . . 73.35 113.295 -178.358 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -156.27 -63.23 0.11 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.466 -0.939 . . . . 64.41 108.466 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.6 159.41 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 122.868 0.467 . . . . 64.44 110.833 -178.092 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.03 110.92 22.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.071 -0.513 . . . . 74.02 110.139 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 4.9 tt -100.74 118.04 36.04 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.746 -0.835 . . . . 54.2 108.746 -177.335 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -94.75 123.58 38.29 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.686 -1.227 . . . . 54.31 107.686 179.083 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.89 124.74 36.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 64.42 111.306 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.29 138.44 31.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.644 0.778 . . . . 44.54 109.892 179.085 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.7 mm? -127.0 76.53 1.66 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.732 -0.47 . . . . 74.32 109.732 177.187 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.52 142.45 0.57 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.748 -0.464 . . . . 71.33 109.748 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 p -96.32 -46.96 6.2 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.409 -0.516 . . . . 64.11 110.832 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 t -80.14 -36.85 34.61 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.937 -176.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -103.89 28.49 6.63 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 122.23 -0.294 . . . . 71.41 110.873 -176.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.07 125.67 5.76 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 124.561 1.163 . . . . 61.03 113.943 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.3 m -75.68 147.61 39.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 124.282 1.033 . . . . 55.4 112.505 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.2 p -112.4 140.89 46.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.454 -0.794 . . . . 64.41 110.747 176.733 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.68 119.53 58.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.79 -1.189 . . . . 73.34 107.79 177.439 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 55.26 36.26 26.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.388 0.613 . . . . 72.24 110.189 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 80.09 -2.92 1.99 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.029 1.731 . . . . 75.54 111.783 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.74 123.03 49.15 Favored Pre-proline 0 C--N 1.32 -0.692 0 O-C-N 121.524 -0.735 . . . . 75.23 110.77 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.55 125.47 10.12 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.653 2.235 . . . . 75.24 110.885 177.186 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 80' ' ' TRP . 35.7 m -142.57 173.93 6.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.73 -0.47 . . . . 72.21 109.73 -177.432 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.1 -30.99 8.12 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.739 -0.664 . . . . 62.02 109.567 172.758 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 13.2 pt-20 -145.53 146.55 31.47 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.041 0.448 . . . . 74.21 110.88 173.773 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.401 ' HB2' HG21 ' A' ' 77' ' ' VAL . 34.0 t-105 -154.9 152.17 29.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.739 -1.208 . . . . 72.42 107.739 -173.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -105.97 116.33 31.75 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.864 -1.134 . . . . 74.34 110.059 174.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 97' ' ' VAL . 74.2 mt -56.65 148.01 21.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.328 -1.305 . . . . 75.51 113.735 -174.668 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.78 37.6 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.425 -1.324 . . . . 60.31 107.425 170.625 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 21.3 t70 -71.26 120.93 17.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.105 0.479 . . . . 62.04 110.48 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.63 11.07 33.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.251 -0.886 . . . . 71.12 112.158 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -74.15 134.98 42.84 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 117.277 0.538 . . . . 64.45 111.362 177.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.8 t -97.31 112.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.151 -1.055 . . . . 75.51 108.151 179.612 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.14 125.59 74.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 119.801 -0.76 . . . . 74.25 110.54 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.473 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 59.3 mtt-85 -111.58 115.29 28.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.177 -0.465 . . . . 72.04 111.112 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.47 165.5 13.15 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.974 -1.012 . . . . 61.31 109.109 177.517 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.06 100.41 0.01 OUTLIER Glycine 0 N--CA 1.475 1.236 0 O-C-N 123.972 0.795 . . . . 42.43 114.765 -176.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.3 m170 65.53 10.79 6.93 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.584 1.554 . . . . 73.05 113.184 178.504 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 m -138.58 118.02 12.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.065 0.46 . . . . 71.41 111.447 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.15 142.1 33.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.744 -0.382 . . . . 75.11 110.01 172.662 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.431 HD11 HD13 ' A' ' 11' ' ' LEU . 7.9 tp -139.09 148.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.779 -0.452 . . . . 75.53 109.779 -172.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.15 131.19 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.128 -1.064 . . . . 64.2 108.128 176.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 82' ' ' LEU . 85.9 t -87.33 128.55 39.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 120.801 0.334 . . . . 70.43 110.239 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.411 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -125.01 151.32 45.71 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.129 -0.693 . . . . 75.15 109.129 -179.759 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -129.76 130.35 45.28 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.943 -0.571 . . . . 63.01 110.357 176.805 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 . . . . . 0 C--N 1.286 -2.153 0 N-CA-C 106.168 -1.79 . . . . 74.35 106.168 175.18 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.41 -2.436 0 N-CA-C 108.739 -0.838 . . . . 75.12 108.739 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 m -103.82 119.93 39.93 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.843 -1.54 . . . . 70.23 106.843 176.391 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -107.51 124.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.615 0.722 . . . . 75.42 111.256 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 22.4 m -124.83 134.97 52.54 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.603 -1.258 . . . . 71.43 107.603 -175.635 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.471 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -100.55 143.78 30.31 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.566 -0.454 . . . . 65.44 110.812 -178.502 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HG2' HG22 ' A' ' 20' ' ' THR . 46.9 mt-30 -110.73 127.37 55.3 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 107.979 -1.119 . . . . 70.22 107.979 174.506 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.49 145.97 49.85 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.644 0.735 . . . . 73.25 110.724 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.41 101.56 13.49 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.063 -0.971 . . . . 60.13 110.251 -178.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.1 -32.5 10.55 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.603 -1.18 . . . . 74.15 109.605 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.73 -34.38 3.62 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 107.725 -2.15 . . . . 71.01 107.725 -171.251 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -87.91 -41.53 13.12 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.898 -1.149 . . . . 74.25 107.898 176.539 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 94.13 2.34 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 109.618 -1.393 . . . . 73.1 109.618 -177.23 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' ARG . 22.2 mmt180 -120.09 154.91 34.0 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.924 0.712 . . . . 74.13 112.924 -178.168 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.545 HG22 ' HG2' ' A' ' 12' ' ' GLN . 34.5 p -133.55 153.09 51.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.383 -1.28 . . . . 71.33 108.161 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.443 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 59.9 t80 -153.48 131.51 11.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.898 -1.149 . . . . 74.42 107.898 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.5 tt0 -93.75 141.25 28.71 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.356 -0.938 . . . . 74.44 110.649 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.4 mt -78.16 126.14 30.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.026 -0.534 . . . . 75.34 110.486 -178.431 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -82.79 152.87 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.317 -1.364 . . . . 65.12 107.317 178.233 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.42 120.66 21.96 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.988 0.899 . . . . 74.33 109.737 176.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.18 -167.89 24.25 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 105.548 -3.021 . . . . 40.01 105.548 -171.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -106.83 143.39 35.0 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 118.738 1.269 . . . . 72.42 110.694 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.56 145.26 50.2 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.701 -0.851 . . . . 73.15 108.701 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -121.83 131.9 72.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.61 -0.515 . . . . 64.32 109.61 -177.4 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 38' ' ' PHE . 80.1 mt -107.84 131.65 57.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 124.399 1.08 . . . . 60.31 109.779 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.73 -157.95 27.45 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 110.06 -1.216 . . . . 73.34 110.06 177.263 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 43.6 mtm180 -130.49 106.68 8.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.52 0.66 . . . . 72.31 109.997 174.741 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.82 -164.66 29.96 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 110.019 -1.232 . . . . 71.22 110.019 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -80.68 -39.3 27.45 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.135 0.493 . . . . 65.54 110.431 -178.082 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.0 -21.07 44.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 72.23 110.288 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.47 23.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.781 -0.645 . . . . 54.34 110.996 -178.569 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -99.15 -44.88 6.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.916 0.865 . . . . 65.24 108.803 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.424 ' HB3' HG12 ' A' ' 30' ' ' ILE . 60.3 t80 -100.27 122.55 43.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 106.743 -1.577 . . . . 75.11 106.743 178.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 17.8 mtp180 -98.14 134.82 40.67 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 112.754 0.65 . . . . 64.23 112.754 -174.289 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 38.9 mt -97.62 114.21 64.59 Favored Pre-proline 0 N--CA 1.42 -1.95 0 N-CA-C 107.477 -1.305 . . . . 71.45 107.477 169.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.521 ' HD2' ' NE2' ' A' ' 92' ' ' HIS . 16.2 Cg_exo -70.06 20.21 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.725 2.95 . . . . 74.3 113.907 -176.457 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -97.75 178.27 5.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.557 -0.534 . . . . 65.54 109.557 -176.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 m -115.59 133.05 56.41 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 109.399 -0.593 . . . . 71.31 109.399 -177.083 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.1 -2.85 35.27 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.433 -1.067 . . . . 42.0 110.433 -178.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.98 138.89 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 107.961 -1.126 . . . . 73.22 107.961 -179.435 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -83.76 166.4 18.05 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.668 -0.242 . . . . 64.4 111.145 -177.5 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 35.2 ptt180 -62.99 -36.66 84.3 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.8 0.81 . . . . 74.35 109.899 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -129.26 100.67 5.68 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 102.545 -3.132 . . . . 73.1 102.545 171.074 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -99.26 -37.29 9.33 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.781 -0.645 . . . . 72.13 109.328 -174.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -161.29 147.15 14.21 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.032 -1.469 . . . . 74.01 107.032 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -144.33 142.72 30.58 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 121.328 0.585 . . . . 73.35 110.971 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -119.58 128.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.262 -0.881 . . . . 41.41 109.523 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 36.1 ttt180 -107.38 111.76 24.25 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.157 -1.423 . . . . 63.25 107.157 177.332 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.293 0.568 . . . . 74.35 111.054 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -149.07 -174.03 4.53 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.74 -1.578 . . . . 74.01 106.74 173.414 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.11 2.59 60.56 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 119.961 -1.114 . . . . 35.15 114.704 -173.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HG2' HG13 ' A' ' 58' ' ' VAL . 61.6 tt0 -93.51 -75.24 0.5 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.167 0.484 . . . . 75.1 111.123 177.894 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.453 HG13 ' HG2' ' A' ' 57' ' ' GLN . 16.0 m -135.75 159.35 39.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 122.529 0.332 . . . . 64.44 110.6 -176.297 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -96.33 102.24 13.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.915 -1.143 . . . . 74.02 107.915 175.459 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 52.6 tp -93.67 113.41 25.48 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.357 -0.838 . . . . 73.44 111.093 -174.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.64 129.41 49.22 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.127 -1.064 . . . . 55.12 108.127 -179.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.27 125.71 28.28 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.863 0.363 . . . . 71.13 110.893 177.079 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.74 128.78 35.31 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.615 -1.254 . . . . 72.12 107.615 175.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.6 OUTLIER -124.37 78.27 1.64 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.932 -0.766 . . . . 65.43 108.932 -174.331 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 8.0 p30 175.52 161.92 0.28 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.029 -0.36 . . . . 73.51 110.029 177.054 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.9 m -108.97 -12.02 14.91 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.238 0.542 . . . . 75.25 111.369 176.22 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -79.17 -55.47 5.08 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.411 0.893 . . . . 75.42 113.411 -172.894 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -121.92 30.1 6.79 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.759 1.224 . . . . 75.13 110.1 -169.195 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.77 115.67 0.87 Allowed Glycine 0 C--O 1.251 1.192 0 O-C-N 124.861 1.351 . . . . 73.43 113.322 -172.179 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 m -61.07 139.04 58.17 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 125.751 1.621 . . . . 64.0 113.302 -172.413 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 p -102.65 142.18 34.25 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.955 -1.021 . . . . 64.33 110.927 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.62 118.55 56.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.448 -1.316 . . . . 62.1 107.448 175.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 60.88 32.95 20.07 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.332 1.053 . . . . 71.05 110.997 -177.191 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.7 t30 78.02 16.5 1.36 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.904 1.682 . . . . 63.55 112.031 174.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.57 134.77 26.65 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.19 -0.67 . . . . 63.33 109.19 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.14 140.83 25.53 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.414 2.076 . . . . 74.4 112.834 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.26 174.48 3.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.865 -0.791 . . . . 74.11 108.865 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -96.26 -47.29 6.09 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.405 -0.961 . . . . 74.34 108.405 173.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -142.26 150.74 41.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.849 -0.614 . . . . 73.33 110.68 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -152.2 151.23 30.74 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.303 -0.629 . . . . 54.54 109.303 -173.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -98.25 113.94 26.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.62 -0.882 . . . . 71.44 108.62 173.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 65.9 mt -60.51 131.84 52.02 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.758 -0.655 . . . . 72.1 112.251 -176.845 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.41 154.29 42.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.775 -1.194 . . . . 74.22 107.775 172.201 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.63 123.21 17.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.188 -0.46 . . . . 71.05 110.264 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.88 6.14 56.22 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 120.602 -0.809 . . . . 53.15 113.02 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -81.48 137.46 35.61 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.111 -0.636 . . . . 63.0 111.065 176.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.05 113.02 34.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.609 0 CA-C-N 115.581 -0.736 . . . . 70.23 109.264 -178.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.504 ' HB ' HG23 ' A' ' 95' ' ' ILE . 73.2 mt -112.15 141.35 27.92 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.127 0 N-CA-C 108.201 -1.037 . . . . 63.13 108.201 -177.436 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -140.27 126.07 19.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.728 -0.789 . . . . 75.35 112.85 -177.593 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.22 144.45 48.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.959 -1.497 . . . . 71.23 106.959 175.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.22 88.25 0.02 OUTLIER Glycine 0 C--O 1.239 0.458 0 N-CA-C 115.862 1.105 . . . . 24.2 115.862 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.521 ' NE2' ' HD2' ' A' ' 41' ' ' PRO . 84.2 t60 162.35 -47.88 0.0 OUTLIER 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.139 2.175 . . . . 74.32 107.04 176.114 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.8 m -149.27 134.78 18.53 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.845 -1.07 . . . . 74.01 111.541 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.53 141.92 27.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.22 -1.77 . . . . 52.1 106.22 169.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -132.91 136.15 56.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-O 121.035 0.445 . . . . 65.25 111.317 -172.113 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.4 mt -114.94 129.53 70.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.772 -0.825 . . . . 60.11 108.772 177.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.11 127.96 38.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.908 -0.587 . . . . 74.44 111.648 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -119.59 134.29 55.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.806 -0.634 . . . . 73.13 109.882 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.2 mtt -119.02 133.96 55.49 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 116.006 -0.543 . . . . 75.01 110.451 177.953 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 . . . . . 0 C--N 1.289 -2.06 0 N-CA-C 107.952 -1.129 . . . . 74.25 107.952 177.903 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.417 -2.106 0 N-CA-C 106.386 -1.709 . . . . 73.1 106.386 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.4 m -121.84 139.63 53.39 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.699 -0.801 . . . . 72.11 110.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -124.04 120.52 59.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.065 -1.458 . . . . 60.43 107.065 176.4 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 m -118.43 128.43 54.61 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.661 -0.7 . . . . 74.45 109.275 -173.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.98 133.34 34.35 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.086 -0.709 . . . . 72.2 109.086 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.09 113.79 26.26 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.404 -1.332 . . . . 72.42 107.404 -176.469 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.0 tp -112.63 110.56 20.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.828 -0.623 . . . . 70.25 109.861 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -110.59 107.89 17.65 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.55 0.69 . . . . 63.45 110.415 176.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.47 24.51 11.53 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.79 -1.559 . . . . 74.35 106.79 177.472 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 44.36 2.86 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 108.345 -1.902 . . . . 41.51 108.345 -174.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -159.35 -70.76 0.08 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.424 0.631 . . . . 54.03 110.54 -175.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.65 73.29 0.91 Allowed Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.988 -1.245 . . . . 53.33 109.988 -177.396 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -103.67 155.65 18.4 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.87 -0.419 . . . . 71.45 109.87 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.5 p -141.46 136.0 30.84 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.239 0.542 . . . . 74.04 111.942 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 11' ' ' LEU . 92.5 t80 -133.58 139.88 46.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.375 -1.343 . . . . 73.12 107.375 176.803 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.46 135.43 46.87 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.48 -0.488 . . . . 54.01 110.003 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -63.78 145.88 54.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.582 -0.736 . . . . 71.35 112.834 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -97.91 161.25 13.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.909 -1.145 . . . . 72.3 107.909 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -75.01 117.93 17.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.504 0.669 . . . . 72.4 110.645 -178.57 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.64 -169.72 16.66 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 109.022 -1.631 . . . . 73.11 109.022 -175.606 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 t -107.43 146.57 31.53 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 121.794 0.807 . . . . 44.14 112.047 -179.336 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -122.01 129.92 52.86 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.072 -0.967 . . . . 74.12 109.01 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.32 125.85 54.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.048 -1.093 . . . . 42.04 108.048 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.92 131.05 56.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.334 -0.617 . . . . 75.01 109.334 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.72 -159.56 28.2 Favored Glycine 0 CA--C 1.488 -1.626 0 N-CA-C 110.255 -1.138 . . . . 53.42 110.255 177.617 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 71.6 mtt-85 -128.96 105.72 8.4 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 117.568 0.684 . . . . 53.14 109.613 176.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.11 -179.01 48.65 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.194 -1.162 . . . . 75.22 110.194 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -68.15 -22.36 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.476 0.711 . . . . 54.44 112.886 -176.683 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -97.74 -7.77 30.02 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 120.773 0.321 . . . . 73.2 110.509 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.43 130.71 38.41 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.263 0.554 . . . . 75.55 111.591 -173.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -92.3 -49.17 6.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.124 -1.065 . . . . 65.15 108.124 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -112.46 125.95 54.78 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.972 -1.013 . . . . 73.55 108.665 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 10.1 mmt180 -99.01 134.52 41.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.714 -0.847 . . . . 63.34 108.714 -177.005 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.88 141.5 47.6 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.197 -0.668 . . . . 72.34 109.197 174.384 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.07 -36.43 65.61 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.747 2.964 . . . . 71.03 114.181 -178.037 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.26 170.92 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.119 0.785 . . . . 74.24 113.119 -175.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p -103.16 165.23 11.15 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.017 -0.992 . . . . 64.35 108.5 173.292 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.0 -23.25 34.21 Favored Glycine 0 CA--C 1.501 -0.8 0 N-CA-C 109.781 -1.328 . . . . 74.31 109.781 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.1 136.36 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.271 -0.965 . . . . 43.14 108.751 175.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.7 m -67.04 161.38 24.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.413 0.523 . . . . 75.23 112.413 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 27.8 ptt180 -54.85 -40.54 69.74 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.967 0.889 . . . . 74.52 110.515 175.564 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.92 106.82 9.16 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 102.879 -3.008 . . . . 70.12 102.879 170.829 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -98.36 -39.4 8.82 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 109.091 -0.707 . . . . 51.14 109.091 -177.23 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 tt -162.36 150.32 14.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.756 -0.831 . . . . 74.24 108.756 -176.887 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.95 135.25 48.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.243 0.544 . . . . 74.41 110.011 178.656 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.54 120.96 62.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.093 -1.447 . . . . 74.22 107.093 174.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -111.65 111.74 22.95 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.069 0.461 . . . . 73.34 109.979 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -104.35 115.84 31.09 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.455 -0.793 . . . . 74.54 110.758 -178.505 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.81 171.6 7.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.217 -1.771 . . . . 74.42 106.217 177.757 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.79 53.35 4.31 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.973 -0.632 . . . . 64.2 112.98 -177.49 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -150.43 -78.41 0.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.508 1.123 . . . . 75.02 108.657 177.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.8 159.84 27.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 63.21 108.546 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.48 120.69 33.21 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.45 0.643 . . . . 45.42 110.556 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.05 133.41 34.36 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.943 -1.026 . . . . 70.25 108.508 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.1 125.29 45.87 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.265 -1.013 . . . . 70.34 108.265 -178.041 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.22 135.8 46.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.607 0.241 . . . . 74.11 110.436 177.12 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.72 119.08 38.15 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.932 0.893 . . . . 65.01 110.011 -177.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.87 77.91 1.62 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.036 -1.838 . . . . 74.43 106.036 179.106 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.509 HD21 ' C ' ' A' ' 68' ' ' ASN . 8.1 t30 -173.56 131.31 0.45 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.055 -0.52 . . . . 63.41 110.16 -165.121 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -108.15 -43.33 4.41 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 113.073 0.768 . . . . 70.02 113.073 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -88.62 -26.18 22.04 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.631 0.974 . . . . 61.31 113.631 -170.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.509 ' C ' HD21 ' A' ' 65' ' ' ASN . 5.8 m-20 -115.59 30.12 7.56 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.199 -0.667 . . . . 74.34 109.199 -177.205 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.93 127.22 4.13 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 124.528 1.143 . . . . 40.15 114.503 -171.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.0 m -66.69 136.71 55.94 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.103 0.961 . . . . 74.54 112.756 -176.148 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 17.8 p -107.58 140.46 40.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.581 -0.736 . . . . 64.55 110.688 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 80' ' ' TRP . 27.9 m -117.4 117.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.627 -1.249 . . . . 74.35 107.627 177.006 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 86' ' ' ASP . 1.7 m120 57.76 31.07 19.94 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.594 -0.73 . . . . 74.01 110.775 -172.569 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.9 t30 80.44 3.03 1.86 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 126.327 1.851 . . . . 70.42 111.777 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.26 118.9 65.19 Favored Pre-proline 0 C--N 1.319 -0.722 0 O-C-N 121.458 -0.776 . . . . 64.22 109.877 177.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.04 129.24 21.38 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.417 2.078 . . . . 73.21 111.772 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 m -140.97 167.68 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 110.021 -0.363 . . . . 65.02 110.021 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -109.14 -18.35 13.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.569 0.7 . . . . 62.42 109.289 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -151.61 155.15 37.82 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.194 -1.039 . . . . 65.23 108.194 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' TRP . . . . . 0.456 ' CD2' HG21 ' A' ' 72' ' ' VAL . 73.5 t-105 -159.87 151.92 20.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.015 -0.735 . . . . 74.14 109.015 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.74 111.56 24.12 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.507 -1.294 . . . . 64.04 107.507 174.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.507 ' HB3' HG11 ' A' ' 97' ' ' VAL . 64.9 mt -56.93 131.87 50.96 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.383 1.052 . . . . 61.13 112.636 -174.103 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.93 165.66 20.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.596 -0.89 . . . . 60.41 108.596 175.461 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.45 116.56 11.92 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.099 -0.704 . . . . 75.32 109.099 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.43 9.44 23.51 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.871 -0.68 . . . . 44.21 112.906 179.015 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.409 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 49.2 m-20 -81.44 117.5 21.93 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.652 -0.819 . . . . 71.21 111.884 177.328 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.76 112.34 25.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.161 -1.792 . . . . 64.42 106.161 175.454 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.9 mt -112.03 124.39 68.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.092 0 CA-C-O 120.894 0.378 . . . . 51.32 110.458 -172.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.3 mpt_? -109.55 120.37 42.29 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.226 -0.657 . . . . 72.42 109.226 177.653 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.55 164.16 20.38 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.172 -0.677 . . . . 74.22 109.172 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.3 108.58 0.6 Allowed Glycine 0 C--N 1.316 -0.575 0 O-C-N 123.506 0.504 . . . . 63.34 112.959 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 72.75 16.07 4.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.562 1.545 . . . . 75.01 114.093 177.8 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.8 t -154.05 167.0 31.26 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.901 -0.499 . . . . 54.31 110.581 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.24 132.31 14.34 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.749 -0.834 . . . . 65.5 108.749 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.426 HD11 HD13 ' A' ' 11' ' ' LEU . 11.0 tp -141.21 146.25 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.981 -0.377 . . . . 74.31 109.981 -173.605 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.52 135.27 53.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.043 -1.095 . . . . 74.22 108.043 175.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 82' ' ' LEU . 78.0 t -98.42 130.97 46.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 112.18 0.437 . . . . 71.02 112.18 -178.262 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -119.32 150.37 40.25 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.899 -0.778 . . . . 74.14 108.899 174.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.1 mtp -129.38 147.38 51.2 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.258 0.551 . . . . 65.23 111.314 -178.775 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 35.6 m-70 . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 106.693 -1.595 . . . . 64.34 106.693 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' HIS . 86.3 m . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 107.682 -1.229 . . . . 65.25 107.682 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 21.1 m -101.53 124.34 47.04 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.279 -0.569 . . . . 74.41 109.638 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.79 115.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.009 -0.737 . . . . 74.53 109.009 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -112.26 123.66 50.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.289 -1.004 . . . . 72.03 108.289 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 95' ' ' ILE . 54.9 mt -94.43 128.85 41.25 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.777 -0.823 . . . . 63.54 108.777 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.64 110.48 21.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.894 -1.15 . . . . 71.5 107.894 -178.871 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 56.3 tp -104.41 131.17 52.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.831 0.852 . . . . 73.23 110.669 -175.618 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' OE2' ' A' ' 94' ' ' GLU . 32.9 t70 -98.32 101.23 12.63 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.996 0.903 . . . . 52.44 109.728 175.246 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -102.43 -0.62 32.17 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.449 -1.25 . . . . 71.24 107.759 176.106 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.43 -21.57 19.15 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.56 -1.2 . . . . 64.35 110.527 -176.409 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -109.77 -45.56 3.63 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.306 0.574 . . . . 62.32 109.918 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.56 102.42 2.36 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.379 -1.089 . . . . 71.3 110.379 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.443 ' NE ' ' HA ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -114.98 151.8 33.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 109.847 -0.427 . . . . 54.02 109.847 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.3 p -135.04 142.37 46.34 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.86 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -140.83 133.94 29.4 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.471 -1.307 . . . . 72.5 107.471 177.482 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -102.51 136.97 41.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.898 -0.779 . . . . 53.42 108.898 179.345 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 11' ' ' LEU . 83.8 mt -74.77 133.48 41.96 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.195 -0.457 . . . . 70.13 110.745 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -101.04 164.42 11.81 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.486 -1.301 . . . . 72.0 107.486 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.31 125.15 24.69 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.193 0.52 . . . . 71.14 111.172 -179.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.63 -164.73 12.16 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 109.112 -1.595 . . . . 73.21 109.112 -176.084 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 63.5 p -92.18 135.46 33.97 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 118.214 1.007 . . . . 73.31 111.588 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 27.1 m-80 -114.32 120.18 39.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.564 -1.643 . . . . 65.42 106.564 -178.799 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.19 133.0 59.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 120.495 0.188 . . . . 72.32 111.063 -175.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.13 137.79 42.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 109.181 -0.674 . . . . 65.11 109.181 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.54 -151.7 22.52 Favored Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 108.274 -1.93 . . . . 62.24 108.274 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.9 mtm180 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.361 -1.348 . . . . 71.41 107.361 172.091 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.14 -177.21 47.78 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.604 -1.398 . . . . 73.34 109.604 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -78.49 -18.72 54.41 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.101 0.45 . . . . 60.1 111.557 178.672 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.79 -6.47 55.91 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.046 0.451 . . . . 70.12 110.678 173.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.81 140.55 29.4 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.41 -0.959 . . . . 64.32 108.41 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 70.3 mt-30 -102.04 -52.43 3.16 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.043 -1.095 . . . . 74.25 108.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -98.92 108.47 21.16 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.73 -1.581 . . . . 62.51 106.73 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.716 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 19.8 ptt85 -97.21 129.46 44.55 Favored 'General case' 0 N--CA 1.41 -2.44 0 C-N-CA 119.907 -0.717 . . . . 62.43 110.69 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.96 137.54 72.95 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.677 -0.692 . . . . 74.12 109.535 178.184 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.57 -5.21 16.27 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.588 2.192 . . . . 63.02 111.632 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -86.27 -173.78 4.72 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.014 -0.539 . . . . 62.34 111.264 -176.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.526 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.8 t -132.17 164.91 25.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.615 -0.883 . . . . 74.32 108.615 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.88 -29.41 12.53 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.253 -1.539 . . . . 71.4 109.253 -175.249 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.34 143.33 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 CA-C-N 114.086 -1.057 . . . . 62.2 109.899 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -87.64 -176.75 5.67 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.055 0.542 . . . . 62.14 110.307 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 20.5 ptt180 -67.18 -39.3 86.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.253 0.549 . . . . 64.03 110.588 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -127.2 114.28 17.46 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.102 -1.814 . . . . 75.43 106.102 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.52 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 67.7 t60 -104.13 -37.36 7.35 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 121.369 0.604 . . . . 74.5 109.74 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 61' ' ' LEU . 7.9 tt -161.02 145.71 13.85 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 116.084 -0.507 . . . . 64.33 109.845 -176.543 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.39 139.68 49.51 Favored 'General case' 0 C--N 1.3 -1.543 0 CA-C-N 115.798 -0.637 . . . . 73.12 110.222 179.795 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 83.9 mt -121.75 116.74 50.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.455 -0.793 . . . . 73.44 109.268 178.214 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 38.6 mtp-105 -91.44 107.77 19.43 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.803 -1.184 . . . . 63.02 107.803 176.898 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -97.55 113.02 24.65 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.19 0.995 . . . . 74.01 112.766 -175.059 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.33 150.44 45.48 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.137 -1.801 . . . . 75.53 106.137 173.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.51 75.96 0.52 Allowed Glycine 0 C--N 1.307 -1.065 0 O-C-N 123.513 0.508 . . . . 64.43 113.834 -174.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -166.41 -68.29 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.148 -1.427 . . . . 72.31 107.148 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.9 m -149.06 150.86 13.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 106.449 -1.686 . . . . 73.25 106.449 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.9 126.39 36.04 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.26 -0.576 . . . . 74.41 109.849 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.9 tt -83.11 107.52 15.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.118 -1.067 . . . . 70.2 108.118 -178.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -93.75 120.96 34.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.148 -1.056 . . . . 74.31 108.148 -179.101 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.0 119.57 23.38 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.246 0.546 . . . . 74.33 110.219 176.637 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.44 134.73 37.33 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.819 -0.808 . . . . 75.13 108.819 177.358 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.42 77.24 1.63 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.439 -1.319 . . . . 74.32 107.439 -177.53 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.52 163.76 8.4 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.39 -0.524 . . . . 73.25 109.946 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 p -108.13 -54.86 2.45 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.527 179.461 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.445 HG23 ' OD1' ' A' ' 68' ' ' ASN . 5.9 t -90.0 -24.05 21.33 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.411 0.624 . . . . 52.45 112.518 -175.554 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' ' 67' ' ' THR . 3.1 m-20 -105.54 22.77 14.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.727 -0.608 . . . . 62.31 110.066 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.0 118.83 2.9 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 124.442 1.089 . . . . 73.02 114.384 -175.975 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 m -65.54 138.46 58.07 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.824 1.25 . . . . 65.54 113.298 -176.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.43 140.86 38.68 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 108.132 -1.062 . . . . 71.33 108.132 -179.576 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.08 121.13 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.165 -0.959 . . . . 74.22 110.208 178.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 58.98 25.86 14.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.232 1.013 . . . . 72.14 110.586 -177.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 77.7 20.79 1.03 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.997 1.719 . . . . 63.41 112.63 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.81 125.9 26.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.661 -0.866 . . . . 64.01 108.661 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.19 128.14 11.88 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.692 2.261 . . . . 72.03 113.839 -175.401 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -146.51 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.332 -0.988 . . . . 70.04 108.332 -178.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -116.89 -32.34 5.13 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.744 -0.382 . . . . 73.43 110.209 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -129.36 149.81 50.99 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.238 -0.653 . . . . 75.21 109.238 177.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -158.71 152.72 23.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.083 -0.71 . . . . 72.1 109.083 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -105.54 109.66 21.71 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.485 -0.931 . . . . 61.01 108.485 176.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 60.4 mt -64.56 137.55 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.648 0.592 . . . . 74.35 112.346 -177.26 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.2 163.76 28.89 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.787 -1.56 . . . . 65.41 106.787 171.74 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.41 121.89 13.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.633 0.254 . . . . 74.11 110.786 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.73 -11.21 30.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.701 -0.761 . . . . 72.33 113.37 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -67.04 138.39 57.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 113.065 0.765 . . . . 74.12 113.065 -179.12 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.18 113.4 39.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.083 -0.962 . . . . 71.4 108.468 175.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 95' ' ' ILE . 3.0 mp -109.09 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.548 -1.279 . . . . 72.54 107.548 179.222 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -100.33 106.76 18.42 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.356 -0.609 . . . . 72.22 109.356 -176.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -82.38 160.52 22.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.219 -1.4 . . . . 72.34 107.219 176.488 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' HIS . . . -70.64 86.42 0.35 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.978 -1.582 . . . . 71.31 111.192 179.113 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 61.1 t-80 163.61 -63.29 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.56 1.944 . . . . 74.03 108.765 177.515 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.8 m -143.47 174.98 10.28 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.066 -1.087 . . . . 71.54 108.066 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' OE2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -114.78 149.41 37.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.306 0.854 . . . . 73.21 113.306 177.159 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 11' ' ' LEU . 6.9 tp -119.56 127.39 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.711 -1.218 . . . . 63.52 107.711 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -103.55 132.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.101 -0.703 . . . . 50.43 109.101 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.17 117.86 37.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.16 -0.473 . . . . 51.42 111.332 -178.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -116.69 130.9 57.01 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.257 -1.016 . . . . 74.32 108.257 175.326 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.5 mtt -114.43 128.59 56.42 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.496 0.665 . . . . 64.41 111.807 -178.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' THR . 44.6 m-70 . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 107.38 -1.341 . . . . 74.41 107.38 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.731 0 N-CA-C 110.091 -1.203 . . . . 54.02 110.091 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -106.27 176.54 5.13 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.071 0.435 . . . . 75.24 110.453 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.64 -59.41 2.53 Favored Glycine 0 C--N 1.306 -1.093 0 N-CA-C 109.748 -1.341 . . . . 73.53 109.748 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -134.07 144.39 48.6 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.105 -1.072 . . . . 72.33 108.105 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.77 159.9 21.61 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.65 -0.5 . . . . 63.52 109.65 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.87 -144.44 16.87 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.758 -0.937 . . . . 73.14 110.758 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.8 m -60.74 116.09 4.15 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.334 -0.617 . . . . 73.14 109.334 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.429 ' HB3' ' OE1' ' A' ' 22' ' ' GLN . 11.4 m -102.56 115.48 30.66 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.751 -0.833 . . . . 74.52 108.751 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.4 110.27 25.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.175 -0.676 . . . . 65.11 109.175 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 m -106.14 126.09 51.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.227 -0.897 . . . . 72.52 108.605 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 20' ' ' THR . 46.2 mt -93.05 115.04 27.73 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.858 -1.164 . . . . 61.12 107.858 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -92.16 114.36 26.89 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.232 -1.025 . . . . 74.42 108.232 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -113.26 130.68 56.17 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.852 -0.613 . . . . 73.02 110.27 -171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.73 99.96 12.76 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.11 -1.07 . . . . 63.33 108.11 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 7.3 p-10 -91.68 -13.47 31.7 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.114 -1.403 . . . . 74.42 108.019 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.74 -37.86 1.82 Allowed Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 108.392 -1.883 . . . . 74.14 108.392 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -100.52 -53.19 3.16 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.3 0.571 . . . . 54.11 110.075 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.33 89.19 0.89 Allowed Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 109.152 -1.579 . . . . 61.14 109.152 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 3.8 mmp_? -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.282 -0.636 . . . . 71.51 109.282 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.7 p -130.57 138.76 50.32 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.861 0.362 . . . . 75.42 110.853 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -132.79 124.65 28.44 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.638 -1.245 . . . . 74.21 107.638 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.429 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 25.9 tt0 -92.55 139.96 30.05 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.735 -0.786 . . . . 72.34 108.963 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.14 133.9 52.57 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.416 0.447 . . . . 73.33 111.548 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.08 156.03 21.25 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.706 -1.59 . . . . 74.11 106.706 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -76.18 116.59 17.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.521 0.677 . . . . 72.01 109.178 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.43 23.07 Favored Glycine 0 C--N 1.289 -2.062 0 N-CA-C 106.792 -2.523 . . . . 70.24 106.792 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 45.9 p -105.45 131.28 53.07 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 119.431 1.615 . . . . 72.11 112.004 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -103.2 110.29 22.19 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.458 -1.312 . . . . 54.55 107.458 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -95.64 121.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.411 -0.359 . . . . 53.41 110.262 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.6 mt -105.98 130.17 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 123.947 0.899 . . . . 54.14 109.808 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.03 -174.37 40.15 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 110.97 -0.852 . . . . 50.44 110.97 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 42' ' ' ASP . 25.0 mtp180 -107.21 104.94 14.69 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.608 -0.837 . . . . 73.43 109.448 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.67 169.28 37.14 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.198 -1.161 . . . . 64.44 110.198 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.62 -14.24 56.97 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.502 -1.295 . . . . 53.53 107.502 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.91 -4.56 59.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.138 -1.846 . . . . 71.43 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -109.35 147.56 32.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.978 -1.01 . . . . 61.2 109.375 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -93.68 -32.84 13.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.385 0.612 . . . . 73.42 110.988 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -118.82 124.96 48.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.919 -1.511 . . . . 74.44 106.919 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -105.76 130.73 53.7 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.781 0.324 . . . . 74.05 111.747 -174.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 52.8 mt -85.8 145.91 42.44 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 65.01 112.238 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.8 Cg_exo -72.18 -33.57 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.261 2.641 . . . . 65.44 114.598 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 5.3 t70 -93.25 179.95 5.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.577 -0.898 . . . . 42.1 108.577 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.4 t -118.68 171.04 8.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.116 0.484 . . . . 51.35 110.262 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.46 61.15 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 108.937 -1.665 . . . . 74.25 108.937 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.42 129.55 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 CA-C-N 113.281 -1.46 . . . . 71.22 107.834 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -77.11 171.9 14.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.849 -0.426 . . . . 73.03 109.849 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 16.9 ptt180 -58.2 -46.56 85.61 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-O 121.593 0.711 . . . . 75.43 109.792 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.421 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 37.3 mtp180 -119.12 95.9 5.0 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 104.42 -2.437 . . . . 75.52 104.42 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -98.22 -32.05 11.77 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.198 -0.91 . . . . 74.22 108.91 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD11 HD21 ' A' ' 61' ' ' LEU . 6.7 tt -163.87 145.39 9.0 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.816 -0.809 . . . . 72.04 108.816 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -137.84 143.61 41.05 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.02 0.438 . . . . 72.45 110.447 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 65.8 mt -125.42 116.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.71 -0.677 . . . . 73.44 109.783 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 58.0 ttp180 -91.39 113.63 25.94 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.805 -1.183 . . . . 70.41 107.805 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 -102.22 125.32 48.89 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 116.002 -0.545 . . . . 71.51 110.126 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -133.38 168.89 17.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.195 -1.409 . . . . 72.23 107.195 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.64 58.53 2.09 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 114.968 0.747 . . . . 43.25 114.968 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -170.73 -68.12 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.905 0.882 . . . . 60.14 108.974 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.85 156.83 42.91 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 CA-C-O 121.259 0.552 . . . . 74.11 111.52 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -102.2 114.62 28.93 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.088 -0.96 . . . . 51.45 109.442 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.4 tt -80.91 113.77 19.34 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.755 -1.111 . . . . 75.4 109.241 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.492 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -101.39 120.82 40.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.291 -1.003 . . . . 64.31 108.291 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.02 121.16 30.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.307 -0.257 . . . . 51.33 110.307 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -87.98 124.44 33.72 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.687 -0.857 . . . . 63.21 108.687 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.99 76.28 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 176.34 153.05 0.18 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.636 -1.987 . . . . 71.41 105.636 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.9 m -110.19 -53.44 2.68 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.237 0.829 . . . . 73.13 113.237 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 t -71.74 -38.57 70.42 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.567 0.58 . . . . 75.22 112.567 -172.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -116.89 23.74 11.71 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.318 -1.364 . . . . 75.43 107.318 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 163.43 19.65 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 113.41 -1.723 . . . . 52.04 113.864 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 m -84.74 143.86 28.88 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 123.894 0.877 . . . . 73.22 111.899 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 p -112.0 141.1 46.07 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.517 -0.765 . . . . 63.21 110.285 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 80' ' ' TRP . 33.3 m -114.11 120.86 65.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.822 -1.547 . . . . 54.43 106.822 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.83 24.34 14.47 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.236 1.014 . . . . 70.35 109.83 -175.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 79.59 5.34 2.05 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.534 1.533 . . . . 44.44 112.513 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.65 30.82 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.953 -0.388 . . . . 62.32 109.953 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.26 127.84 14.75 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.382 2.055 . . . . 54.23 111.737 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 80' ' ' TRP . 26.9 m -142.89 166.75 14.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.734 -0.839 . . . . 64.42 108.734 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -106.07 -31.91 8.51 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.973 -1.121 . . . . 65.42 107.973 174.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.08 35.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.99 -1.459 . . . . 63.32 110.338 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.486 ' HB2' HG21 ' A' ' 77' ' ' VAL . 72.7 t-105 -153.67 153.03 31.51 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.535 -0.913 . . . . 75.14 108.535 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -114.58 126.25 54.7 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.209 -1.034 . . . . 74.22 108.209 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 42.1 mt -56.88 147.55 23.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.032 1.123 . . . . 75.34 114.032 -171.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 147.96 39.52 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.005 -1.109 . . . . 74.44 108.005 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 28.9 t70 -65.39 124.89 23.46 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 71.03 110.862 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.87 64.43 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 115.22 -0.9 . . . . 70.05 112.992 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.23 156.88 22.92 Favored 'General case' 0 C--O 1.249 1.071 0 C-N-CA 119.505 -0.878 . . . . 64.25 108.717 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.08 113.23 43.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.361 -0.607 . . . . 74.41 109.361 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.414 HD11 HD22 ' A' ' 82' ' ' LEU . 59.2 mt -110.06 117.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.097 -0.705 . . . . 71.3 109.097 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -120.52 123.64 43.41 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.448 -0.501 . . . . 55.32 111.263 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 163.43 23.03 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.24 -0.891 . . . . 72.13 108.959 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -42.12 103.89 0.04 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 115.598 0.999 . . . . 64.22 115.598 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 m170 69.25 12.09 8.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.602 1.561 . . . . 73.22 113.503 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.7 m -149.21 115.37 5.76 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.334 0.588 . . . . 64.4 111.075 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.95 143.32 43.13 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.178 0.513 . . . . 65.25 111.243 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.28 142.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.215 -0.902 . . . . 73.45 111.387 -171.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.7 mm -111.41 132.81 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.0 -1.111 . . . . 74.34 108.0 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.55 126.86 43.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 120.846 0.355 . . . . 62.05 111.453 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.442 ' HA ' ' HE ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -117.15 125.97 52.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.755 -0.832 . . . . 63.32 108.755 176.168 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.505 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 84.3 mtp -114.35 116.5 29.04 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.852 -0.796 . . . . 75.44 108.852 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 . . . . . 0 C--N 1.28 -2.438 0 N-CA-C 107.463 -1.31 . . . . 75.14 107.463 -179.025 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.49 0 N-CA-C 110.002 -1.239 . . . . 43.05 110.002 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -79.88 131.52 35.88 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.689 -0.856 . . . . 70.21 108.689 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.41 65.71 3.95 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 110.659 -0.976 . . . . 74.21 110.659 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -150.38 158.36 44.07 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.24 -0.652 . . . . 65.1 109.24 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.32 160.04 17.81 Favored 'General case' 0 C--O 1.247 0.974 0 CA-C-O 121.249 0.547 . . . . 63.12 110.709 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.34 -69.71 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.482 -1.447 . . . . 54.33 109.482 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.494 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 84.8 m -137.14 128.0 27.34 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.07 -1.085 . . . . 75.21 108.07 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -123.63 125.03 44.09 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.986 -0.746 . . . . 52.51 108.986 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.5 124.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.268 -1.012 . . . . 74.44 108.268 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.428 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.7 m -117.2 124.71 49.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.939 -0.763 . . . . 72.11 108.939 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 mt -90.88 124.9 35.54 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.231 -1.025 . . . . 75.42 108.231 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -107.82 120.12 41.36 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.821 -0.807 . . . . 74.1 108.821 -177.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -114.27 125.83 54.34 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.307 -0.998 . . . . 74.45 108.307 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.92 100.12 10.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 118.959 -1.096 . . . . 63.22 108.083 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.92 38.59 2.23 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 113.418 -1.719 . . . . 62.44 107.961 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.03 -54.81 0.64 Allowed Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.392 -1.083 . . . . 63.02 110.392 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 t -111.83 -56.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.711 -1.218 . . . . 74.22 107.711 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.79 109.83 0.47 Allowed Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.516 -0.849 . . . . 74.13 112.712 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -95.9 141.37 29.41 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.502 -0.925 . . . . 73.41 108.502 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.2 p -128.74 135.01 48.63 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.56 -0.456 . . . . 73.12 111.502 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -121.03 110.96 16.88 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.579 -0.897 . . . . 73.32 108.579 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -78.79 129.3 34.46 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.847 -0.797 . . . . 73.54 108.847 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.35 125.56 29.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.704 -0.851 . . . . 70.34 108.704 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -100.78 170.49 8.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.375 -0.602 . . . . 71.32 109.375 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.32 134.84 57.45 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.348 1.03 . . . . 62.42 111.594 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.52 -175.62 15.87 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 109.165 -1.574 . . . . 72.24 109.165 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 57.4 p -96.1 137.48 35.11 Favored 'General case' 0 N--CA 1.415 -2.176 0 C-N-CA 119.47 -0.892 . . . . 73.14 110.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -114.46 111.74 21.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.457 -0.942 . . . . 62.31 108.457 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.77 124.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.089 -1.078 . . . . 50.04 108.089 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -109.01 129.76 63.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 123.435 0.459 . . . . 64.33 109.791 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.26 -163.39 29.5 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.161 -1.576 . . . . 71.51 109.161 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.542 ' C ' ' HA ' ' A' ' 47' ' ' ARG . 52.1 mtm180 -126.34 105.86 9.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 119.105 1.453 . . . . 63.23 112.364 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' HA3' ' HG2' ' A' ' 47' ' ' ARG . . . -172.27 -178.52 42.52 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 107.129 -2.388 . . . . 64.11 107.129 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -74.96 -11.43 60.11 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.085 0.945 . . . . 72.33 110.333 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.55 -23.03 29.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.918 -1.037 . . . . 72.34 109.304 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.31 130.99 35.57 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.819 0.819 . . . . 51.42 113.037 -171.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.24 -26.02 22.56 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.832 -1.076 . . . . 62.34 108.85 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -131.85 115.68 16.24 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.204 -1.036 . . . . 72.23 108.204 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.657 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -95.93 112.12 23.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.983 -0.553 . . . . 60.01 111.06 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 44.8 mt -71.63 128.99 89.09 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 110.266 -0.272 . . . . 62.05 110.266 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -73.61 40.19 0.53 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.203 2.602 . . . . 75.23 113.839 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.0 152.67 29.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.929 -0.767 . . . . 72.45 108.929 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.4 m -97.16 118.32 33.32 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.59 -0.522 . . . . 73.51 109.59 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.07 -13.43 21.77 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.521 -0.847 . . . . 70.34 112.448 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.36 122.28 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.429 0.633 . . . . 74.13 109.361 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -65.19 164.14 13.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.008 -0.997 . . . . 73.42 112.176 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HA ' ' C ' ' A' ' 32' ' ' ARG . 48.1 mtp180 -54.41 -49.29 70.26 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.829 0.852 . . . . 73.21 109.926 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -120.6 101.97 8.11 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 106.087 -1.819 . . . . 61.13 106.087 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -104.05 -32.49 9.18 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.473 0.654 . . . . 53.23 109.402 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -162.68 149.93 13.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.74 -0.837 . . . . 71.12 108.74 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.29 138.22 50.37 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.202 0.525 . . . . 61.42 110.269 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' SER . 79.4 mt -119.15 116.22 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.12 -0.696 . . . . 62.04 109.12 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -93.7 107.23 19.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.616 -1.624 . . . . 71.33 106.616 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.403 ' HZ2' ' O ' ' A' ' 7' ' ' THR . 50.8 t-105 -110.82 146.6 36.14 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.945 -1.025 . . . . 74.05 109.559 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -149.78 165.23 33.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 103.929 -2.619 . . . . 51.14 103.929 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.67 37.01 0.86 Allowed Glycine 0 C--N 1.305 -1.148 0 CA-C-N 119.133 0.879 . . . . 71.34 114.679 -175.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -137.4 -71.15 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 124.034 0.934 . . . . 75.21 109.903 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -130.81 159.32 42.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.53 -0.304 . . . . 64.4 110.692 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.54 116.68 31.26 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.763 -0.653 . . . . 75.33 110.289 -178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.8 116.7 32.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.098 -0.704 . . . . 72.1 109.098 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HD21 ' A' ' 82' ' ' LEU . 7.3 tt -104.81 142.6 34.44 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.332 -0.394 . . . . 72.51 110.537 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.14 127.62 26.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.817 -0.629 . . . . 64.54 109.676 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -83.0 140.42 32.74 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.644 -0.707 . . . . 73.14 109.226 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.26 77.44 1.73 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.035 -1.098 . . . . 71.24 108.035 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -178.1 121.21 0.1 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.438 -0.578 . . . . 71.11 109.438 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -88.75 -20.1 25.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.137 0.494 . . . . 72.12 110.447 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -89.33 -52.44 5.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.42 0.629 . . . . 75.33 111.382 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -111.21 28.75 8.43 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.7 -0.682 . . . . 75.24 110.194 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.06 129.98 5.5 Favored Glycine 0 N--CA 1.47 0.939 0 O-C-N 124.574 1.171 . . . . 53.42 114.933 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 90' ' ' LEU . 9.0 m -74.94 152.09 38.83 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 124.733 1.213 . . . . 70.33 113.044 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.6 p -119.3 144.66 46.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.121 -0.945 . . . . 73.42 110.107 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 80' ' ' TRP . 28.1 m -116.36 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.039 -1.097 . . . . 43.23 108.039 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 61.14 25.93 15.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.81 0.814 . . . . 45.03 109.666 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 85.54 -4.57 0.85 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.82 2.048 . . . . 74.42 113.855 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -89.61 124.39 64.24 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.864 -0.421 . . . . 63.21 109.864 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 16.2 Cg_exo -69.15 125.5 12.55 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.76 2.307 . . . . 62.34 111.81 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -139.02 166.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.384 -0.371 . . . . 75.25 110.64 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -105.74 -14.48 15.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.71 -0.848 . . . . 72.35 108.71 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -161.78 155.63 21.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.118 -1.067 . . . . 70.32 108.118 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.403 ' CD2' HG21 ' A' ' 72' ' ' VAL . 75.8 t-105 -161.34 143.41 11.96 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.349 0.405 . . . . 74.1 109.909 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.23 111.79 23.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.119 -1.067 . . . . 72.02 108.119 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 69.5 mt -56.46 135.95 54.13 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.902 0.705 . . . . 54.22 112.902 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.0 164.66 19.67 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.079 -1.082 . . . . 61.53 108.079 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.513 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 28.8 t70 -71.95 124.36 24.74 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.152 -0.476 . . . . 72.51 110.456 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.91 13.21 56.87 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.743 -0.662 . . . . 74.52 113.091 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.67 137.45 42.18 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 117.628 0.714 . . . . 54.14 111.714 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.1 112.16 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.276 -1.379 . . . . 63.51 107.276 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.5 mt -111.6 106.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 C-N-CA 119.322 -0.951 . . . . 72.42 109.44 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -104.26 131.89 51.09 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.635 -0.711 . . . . 73.51 109.678 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.3 pt? -125.18 164.5 20.14 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.412 -0.959 . . . . 74.24 108.412 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.26 125.82 25.9 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.995 -1.098 . . . . 75.33 110.532 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m170 83.1 -23.6 0.2 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.217 1.562 . . . . 62.24 115.217 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -153.21 -171.75 4.02 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.643 1.111 . . . . 74.22 111.999 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.66 147.58 30.14 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.988 -0.745 . . . . 74.41 108.988 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.6 tp -130.41 135.58 60.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.005 -1.109 . . . . 74.31 108.005 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 53.4 mt -101.0 132.09 47.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.698 -0.852 . . . . 72.12 108.698 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 82' ' ' LEU . 72.5 t -100.26 116.35 43.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.446 0.641 . . . . 72.42 111.158 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.513 ' HD3' ' OD1' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -115.63 125.87 53.45 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.415 -1.328 . . . . 70.22 107.415 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.5 mtm -112.52 111.74 22.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.229 -0.988 . . . . 43.23 110.547 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.494 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 21.1 m-70 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 108.012 -1.107 . . . . 71.12 108.012 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 N-CA-C 110.361 -1.096 . . . . 44.13 110.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -144.5 15.33 1.62 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.225 0.536 . . . . 72.03 111.3 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.13 172.58 14.18 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.647 -0.981 . . . . 65.32 110.647 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -80.37 73.1 7.26 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.19 0.995 . . . . 73.0 110.219 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.61 124.5 10.61 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.323 -1.308 . . . . 71.11 107.916 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.01 94.12 0.1 Allowed Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 110.409 -1.076 . . . . 51.33 110.409 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.0 m -55.05 116.66 2.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 124.246 0.615 . . . . 73.21 109.621 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m -107.65 117.28 33.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 115.746 -0.661 . . . . 71.14 109.644 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 23' ' ' LEU . 40.7 t -91.29 114.86 29.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 106.726 -1.583 . . . . 73.44 106.726 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -110.61 124.07 51.18 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.037 -0.727 . . . . 72.12 109.037 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 95' ' ' ILE . 4.5 pp -95.44 128.92 42.68 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.44 -0.578 . . . . 74.25 109.44 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -105.39 119.59 39.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.559 -0.904 . . . . 75.52 108.559 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -102.39 120.15 40.01 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 123.755 0.822 . . . . 71.25 108.934 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -100.17 100.99 11.91 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.659 -1.216 . . . . 73.4 110.153 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -103.53 5.03 36.49 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 112.99 -1.914 . . . . 65.14 108.502 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.16 -19.81 31.71 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.475 -1.45 . . . . 74.12 109.475 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -103.5 -53.5 2.78 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.226 -1.028 . . . . 63.34 108.226 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.34 83.03 1.69 Allowed Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.396 -0.82 . . . . 63.42 111.698 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 19' ' ' ARG . 4.5 mmp_? -100.37 163.81 12.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.724 -0.28 . . . . 72.12 110.273 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 14.9 p -135.61 152.24 51.05 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.741 0.305 . . . . 64.23 110.983 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.437 ' HB3' HD11 ' A' ' 11' ' ' LEU . 90.1 t80 -142.24 132.51 24.87 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.357 -0.979 . . . . 72.44 108.357 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.08 125.03 33.15 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.363 -0.606 . . . . 74.04 109.363 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.427 HD13 HG21 ' A' ' 52' ' ' ILE . 78.1 mt -71.28 127.64 33.25 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.165 -0.679 . . . . 72.54 109.165 174.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.78 168.6 10.56 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.568 -0.742 . . . . 64.51 109.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.94 131.5 40.73 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.674 0.749 . . . . 43.24 111.423 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.66 -173.79 15.05 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 108.382 -1.887 . . . . 64.1 108.382 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.3 p -106.81 142.77 35.91 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 118.549 1.174 . . . . 64.23 111.856 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -117.8 140.77 49.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.339 -0.615 . . . . 74.31 109.339 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.86 124.14 53.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.613 -0.884 . . . . 74.43 108.613 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 38' ' ' PHE . 52.6 mt -106.91 120.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 124.477 1.111 . . . . 71.01 110.147 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.63 -176.43 35.54 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.547 -1.421 . . . . 51.24 109.547 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 61.6 mtt180 -103.99 107.12 17.86 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 118.35 1.075 . . . . 71.53 111.418 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.38 -172.42 38.85 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 110.444 -1.062 . . . . 71.53 110.444 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -94.35 -29.26 15.11 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 122.959 0.504 . . . . 73.44 110.823 179.14 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -82.14 -19.73 39.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.873 -0.788 . . . . 72.24 108.873 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 137.69 54.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.048 -0.978 . . . . 60.31 109.566 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -97.89 -24.51 15.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.483 0.659 . . . . 70.02 110.318 -177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' HB3' HG12 ' A' ' 30' ' ' ILE . 40.2 t80 -131.14 124.26 30.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.373 -1.343 . . . . 71.42 107.373 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 134.25 55.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.406 -0.361 . . . . 74.52 110.93 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.423 HD13 HG11 ' A' ' 45' ' ' VAL . 6.8 mp -73.7 147.56 86.85 Favored Pre-proline 0 CA--C 1.502 -0.898 0 CA-C-N 115.604 -0.725 . . . . 74.43 111.807 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.13 26.37 0.61 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 123.584 2.856 . . . . 74.12 113.267 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -137.72 176.4 8.74 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.697 -0.853 . . . . 73.51 108.697 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -105.28 170.66 7.75 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.374 -0.602 . . . . 74.53 109.374 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 2.69 79.75 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.925 -0.47 . . . . 71.32 111.925 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 40' ' ' LEU . 33.4 t -95.13 133.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.989 -0.745 . . . . 74.5 108.989 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -72.39 176.34 5.41 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.122 0.569 . . . . 74.52 109.653 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.0 ptm180 -66.09 -34.92 79.16 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.379 0.609 . . . . 74.32 110.359 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.51 109.65 12.94 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.791 -1.188 . . . . 63.12 107.791 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 59.9 t60 -103.99 -34.16 8.56 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.854 -0.612 . . . . 75.22 109.501 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.409 HD11 HD21 ' A' ' 61' ' ' LEU . 9.0 tt -165.88 160.03 16.48 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.301 -1.0 . . . . 73.43 108.301 -176.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.8 138.52 32.3 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.089 0.471 . . . . 63.32 109.781 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 23' ' ' LEU . 64.0 mt -113.19 115.19 49.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 109.202 -0.666 . . . . 72.12 109.202 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 62.0 ttt180 -97.2 107.79 20.38 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 108.817 -0.809 . . . . 50.13 108.817 174.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -97.48 107.24 19.7 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.657 -0.868 . . . . 74.33 108.657 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.1 171.35 8.07 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.006 -1.85 . . . . 74.54 106.006 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.14 49.58 4.14 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 119.817 -1.182 . . . . 54.24 114.003 -174.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -171.66 -64.04 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.871 0.868 . . . . 74.25 109.178 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.32 149.67 17.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 CA-C-O 121.323 0.582 . . . . 73.4 112.15 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -99.75 103.18 14.81 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.275 -0.875 . . . . 65.31 109.347 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.24 113.49 21.15 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.362 -0.836 . . . . 71.02 109.162 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -100.52 120.32 39.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.145 -1.057 . . . . 73.5 108.145 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.89 126.68 43.7 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.875 -0.417 . . . . 74.45 109.875 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 11.3 t70 -97.25 139.17 33.62 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 122.848 0.459 . . . . 64.12 110.722 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.11 75.91 1.26 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.431 -0.952 . . . . 65.3 108.431 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.562 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 33.3 t-20 -166.46 154.04 9.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.57 -1.27 . . . . 73.45 107.57 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.4 t -108.92 -48.71 3.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.989 0.423 . . . . 70.04 110.341 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -89.33 -35.91 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.648 0.611 . . . . 71.32 112.648 -175.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.562 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.2 m120 -105.39 27.06 8.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.537 -0.542 . . . . 51.35 109.537 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.79 128.46 20.78 Favored Glycine 0 C--O 1.251 1.158 0 O-C-N 124.894 1.371 . . . . 51.11 112.264 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -62.01 133.04 54.83 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 124.124 0.969 . . . . 74.14 112.54 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.635 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.0 p -103.42 140.08 37.94 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.513 -0.767 . . . . 74.4 109.459 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 77' ' ' VAL . 27.5 m -124.26 119.58 56.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.937 -1.134 . . . . 75.35 107.937 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.26 30.97 20.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.404 0.682 . . . . 72.14 110.54 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 t30 82.09 -1.53 1.49 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.738 2.015 . . . . 64.3 112.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.98 124.19 44.52 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 121.487 -0.758 . . . . 75.15 109.431 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.14 124.3 4.83 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.765 1.643 . . . . 72.15 110.441 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 72' ' ' VAL . 28.2 m -148.68 151.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 73.24 107.432 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 77.1 mt-30 -96.69 -0.46 48.31 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.957 -0.697 . . . . 72.54 111.327 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.54 130.12 15.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.794 -0.639 . . . . 71.31 110.119 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -159.89 152.97 21.82 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.588 -1.264 . . . . 71.01 107.588 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.89 124.4 50.59 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.967 -1.093 . . . . 73.44 108.115 173.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.569 ' HB3' HG11 ' A' ' 97' ' ' VAL . 69.0 mt -65.1 139.4 58.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.949 0.722 . . . . 71.43 112.949 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -135.65 168.5 19.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.059 -0.719 . . . . 73.34 109.059 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.48 121.09 19.03 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.917 -0.401 . . . . 73.53 109.917 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.2 9.84 40.85 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.905 -0.664 . . . . 53.5 112.698 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -78.38 126.26 30.52 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 120.008 -0.677 . . . . 70.43 110.005 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.67 112.31 26.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.22 -1.4 . . . . 75.23 107.22 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 95' ' ' ILE . 57.4 mt -120.01 139.28 47.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 120.291 -0.564 . . . . 75.22 110.861 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.635 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.0 mpt_? -120.37 131.24 54.75 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.138 -1.06 . . . . 74.45 108.138 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 2.2 pt? -131.73 164.52 25.79 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.336 -0.987 . . . . 74.15 108.336 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -33.55 97.07 0.01 OUTLIER Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.002 1.161 . . . . 65.42 116.002 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.0 m170 72.07 13.95 5.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.698 1.599 . . . . 72.45 114.801 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t -153.62 -178.3 6.93 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.31 0.576 . . . . 71.32 110.178 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.74 153.08 45.75 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.762 -0.586 . . . . 72.44 109.448 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.519 HD11 HD13 ' A' ' 11' ' ' LEU . 8.9 tp -141.45 141.37 30.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.762 -0.829 . . . . 72.44 108.762 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.73 125.69 72.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.469 -0.937 . . . . 65.41 108.469 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.569 HG11 ' HB3' ' A' ' 82' ' ' LEU . 79.4 t -93.26 128.67 44.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 111.938 0.348 . . . . 62.44 111.938 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -119.16 151.26 38.63 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.767 -0.827 . . . . 72.13 108.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 89.2 mtp -128.34 120.01 26.19 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.314 -0.403 . . . . 73.33 110.262 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 . . . . . 0 C--N 1.294 -1.842 0 N-CA-C 108.333 -0.988 . . . . 72.14 108.333 -179.732 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.704 0 N-CA-C 110.622 -0.991 . . . . 43.05 110.622 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -92.89 -4.91 52.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.106 0.479 . . . . 70.41 111.762 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.22 98.79 1.77 Allowed Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 109.192 -1.563 . . . . 70.34 109.192 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 m -81.43 -35.52 30.54 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 121.126 -0.23 . . . . 64.24 111.359 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.26 112.64 19.72 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.512 -0.922 . . . . 71.24 108.512 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.68 -52.7 0.49 Allowed Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 108.873 -1.691 . . . . 71.23 108.873 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.577 HG22 ' HH2' ' A' ' 54' ' ' TRP . 31.9 m -146.15 115.88 7.25 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 108.56 -0.904 . . . . 65.43 108.56 171.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 99' ' ' MET . 54.0 p -158.43 143.98 16.69 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.337 -1.727 . . . . 33.51 106.337 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.82 126.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 120.159 -0.617 . . . . 63.4 111.226 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 25.3 m -120.77 132.07 54.84 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.984 -1.117 . . . . 72.1 107.984 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.12 135.76 33.72 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.68 -0.489 . . . . 74.24 109.68 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -116.57 124.86 50.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.726 -0.67 . . . . 70.34 111.19 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.6 133.66 48.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.137 -1.061 . . . . 74.45 108.137 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.96 101.71 7.72 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.04 -1.064 . . . . 64.33 112.592 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.04 -47.53 68.13 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.661 -1.607 . . . . 71.4 106.661 171.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.29 45.69 0.01 OUTLIER Glycine 0 N--CA 1.427 -1.9 0 N-CA-C 105.979 -2.848 . . . . 43.0 105.979 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -162.5 -52.79 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.193 -1.039 . . . . 73.02 108.193 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.12 92.37 2.14 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.691 -0.766 . . . . 44.14 111.93 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -99.13 150.24 22.23 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.31 -0.996 . . . . 74.1 108.31 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 35.8 p -142.94 132.25 23.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.663 0.602 . . . . 75.4 109.859 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -134.54 135.26 42.19 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.505 -1.665 . . . . 74.15 106.505 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 33.5 tt0 -101.71 144.31 30.57 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.093 -0.643 . . . . 54.21 111.156 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 52' ' ' ILE . 76.1 mt -78.88 139.23 38.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.715 -0.675 . . . . 33.21 110.359 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -95.29 157.86 15.71 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.347 -1.353 . . . . 74.51 107.347 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.5 146.03 55.2 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.182 0.515 . . . . 73.34 111.576 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.43 -171.44 15.81 Favored Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 107.723 -2.151 . . . . 75.15 107.723 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 67.1 p -96.63 127.46 42.63 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.638 -1.225 . . . . 52.32 111.084 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -103.57 113.58 27.19 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.389 -1.708 . . . . 73.42 106.389 -178.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -89.83 132.3 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.964 -0.562 . . . . 72.51 109.694 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -116.07 132.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.684 -0.689 . . . . 74.35 109.859 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 158.4 -162.23 32.23 Favored Glycine 0 CA--C 1.495 -1.162 0 N-CA-C 108.611 -1.796 . . . . 34.24 108.611 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 56.1 mtp180 -122.17 103.69 8.96 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.008 -1.479 . . . . 71.31 107.008 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.594 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 174.84 176.16 42.92 Favored Glycine 0 N--CA 1.414 -2.828 0 N-CA-C 110.935 -0.866 . . . . 61.42 110.935 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -52.1 -40.36 61.15 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.751 1.22 . . . . 74.04 113.373 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.68 -37.07 73.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.491 . . . . 71.02 111.453 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.78 15.9 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.357 -0.838 . . . . 72.22 112.795 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -75.35 -36.15 61.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.434 -0.95 . . . . 62.23 108.434 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -105.45 108.87 20.62 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.536 -0.913 . . . . 65.23 108.536 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.6 mmt85 -87.66 121.35 29.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.152 -0.931 . . . . 72.25 109.455 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD12 HG21 ' A' ' 45' ' ' VAL . 44.2 mt -79.19 130.53 68.94 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.362 -0.607 . . . . 72.14 109.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.02 -1.91 9.48 Favored 'Trans proline' 0 C--N 1.325 -0.696 0 C-N-CA 122.013 1.808 . . . . 53.24 111.049 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -88.67 -176.65 5.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.937 -1.029 . . . . 73.13 111.234 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.0 t -123.21 170.89 9.79 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.694 -0.484 . . . . 74.2 109.694 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.03 71.79 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.57 -1.412 . . . . 75.32 109.57 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 40' ' ' LEU . 7.1 p -113.85 144.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.295 -0.952 . . . . 72.33 111.0 -173.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.5 p -91.84 -167.68 1.84 Allowed 'General case' 0 C--O 1.254 1.292 0 C-N-CA 124.137 0.975 . . . . 64.04 109.499 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 5.6 ptt180 -80.84 -34.29 33.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 118.247 -1.381 . . . . 73.15 109.287 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -124.04 100.7 6.86 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.412 -1.699 . . . . 72.24 106.412 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -100.81 -34.37 9.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.124 -0.944 . . . . 64.42 109.717 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 tt -162.14 148.37 13.34 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.003 -0.74 . . . . 63.23 109.003 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.31 139.61 50.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.281 0.562 . . . . 75.55 109.824 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 23' ' ' LEU . 69.6 mt -113.85 113.81 44.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.981 -0.748 . . . . 74.13 108.981 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 86.6 mtt180 -91.71 107.03 18.92 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.915 -1.143 . . . . 64.32 107.915 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.577 ' HH2' HG22 ' A' ' 7' ' ' THR . 47.7 t-105 -103.13 126.93 50.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.721 -0.672 . . . . 73.33 111.289 -175.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -128.27 162.87 26.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.409 -2.071 . . . . 53.04 105.409 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.11 51.27 1.65 Allowed Glycine 0 CA--C 1.534 1.262 0 N-CA-C 116.345 1.298 . . . . 44.41 116.345 -172.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -62.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.525 -0.917 . . . . 75.42 108.525 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.76 138.85 38.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-O 121.42 0.628 . . . . 71.14 112.162 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -103.99 114.04 28.0 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.376 -0.829 . . . . 72.22 110.233 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 5.7 tt -91.25 110.34 21.62 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.623 -0.88 . . . . 70.44 108.623 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -94.21 121.9 36.2 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.233 -1.395 . . . . 75.11 107.233 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.29 120.56 24.58 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.154 0.502 . . . . 62.13 110.384 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.31 138.1 33.09 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.461 -0.791 . . . . 72.45 108.941 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.8 OUTLIER -123.06 76.8 1.4 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 109.356 -0.609 . . . . 73.22 109.356 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER 160.79 151.76 0.01 OUTLIER 'General case' 0 C--O 1.198 -1.653 0 C-N-CA 125.914 1.686 . . . . 73.44 109.606 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -104.35 -12.31 16.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 121.562 -0.711 . . . . 72.21 109.716 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -72.73 -64.36 0.98 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.645 -0.707 . . . . 44.21 111.674 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -107.12 28.93 7.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.958 -1.127 . . . . 73.32 107.958 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.79 120.89 2.73 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.452 -1.249 . . . . 74.14 113.245 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 m -70.29 142.8 52.23 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 124.903 1.281 . . . . 75.33 112.373 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 76' ' ' PRO . 12.9 p -105.38 141.25 37.22 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.613 -0.721 . . . . 65.11 111.262 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.86 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 106.67 -1.604 . . . . 51.04 106.67 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.49 23.92 11.27 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.456 -0.572 . . . . 75.03 109.456 -170.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 74.42 15.03 3.53 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.756 1.622 . . . . 72.3 111.712 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.57 123.71 37.2 Favored Pre-proline 0 C--N 1.315 -0.897 0 O-C-N 121.267 -0.896 . . . . 71.52 109.012 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.411 ' N ' HG22 ' A' ' 71' ' ' THR . 57.4 Cg_endo -77.31 125.16 7.58 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 121.981 1.787 . . . . 71.02 111.859 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.4 m -135.28 170.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.867 -0.606 . . . . 61.24 110.011 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -91.13 -47.02 7.78 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.163 -1.051 . . . . 70.45 108.163 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.5 pt-20 -141.26 151.8 43.99 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.169 -0.923 . . . . 74.53 109.875 177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.493 ' HB2' HG21 ' A' ' 77' ' ' VAL . 23.3 t-105 -157.11 152.03 25.87 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.268 -1.012 . . . . 73.21 108.268 -175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 79.3 mt-30 -101.36 119.36 38.64 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.903 -0.719 . . . . 63.53 109.348 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' HG11 ' A' ' 97' ' ' VAL . 78.2 mt -56.29 143.2 34.87 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 124.087 0.867 . . . . 54.41 111.656 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.97 39.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.602 -1.259 . . . . 73.32 107.602 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.79 127.85 34.05 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.729 -0.471 . . . . 75.21 109.729 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.22 -5.35 52.51 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.897 -0.592 . . . . 63.02 111.88 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.64 127.65 33.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 75.31 109.986 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.11 112.41 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.75 -1.204 . . . . 74.34 107.75 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.405 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 40.3 mt -103.39 125.02 57.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 108.196 -1.039 . . . . 75.1 108.196 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -129.55 124.92 35.06 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.061 0.458 . . . . 71.14 111.521 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.461 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -100.81 163.39 12.34 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 105.005 -2.22 . . . . 73.23 105.005 170.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.94 85.74 0.88 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 118.414 -1.851 . . . . 75.44 111.339 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 161.68 -54.07 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 126.632 1.973 . . . . 72.13 108.155 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -133.37 155.37 49.59 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.793 0.806 . . . . 74.31 111.734 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -121.27 144.02 48.85 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 114.359 -1.291 . . . . 74.23 109.038 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 8.3 tp -134.82 146.74 30.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.373 -1.343 . . . . 74.22 107.373 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.74 137.6 45.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.499 0.591 . . . . 74.33 109.456 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 82' ' ' LEU . 99.1 t -89.14 127.64 41.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.87 0.367 . . . . 61.32 111.421 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.09 145.18 47.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.684 -0.689 . . . . 73.12 109.208 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' SER . 90.0 mtp -122.02 124.35 43.78 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.523 -0.547 . . . . 73.53 109.523 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.4 m80 . . . . . 0 C--N 1.302 -1.485 0 CA-C-O 118.852 -0.594 . . . . 75.45 110.024 -175.393 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.505 0 N-CA-C 110.453 -1.059 . . . . 43.14 110.453 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -145.2 93.06 2.33 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.511 0.672 . . . . 74.55 109.612 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.21 -122.44 0.9 Allowed Glycine 0 N--CA 1.425 -2.08 0 C-N-CA 119.999 -1.096 . . . . 74.41 111.992 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.4 m -79.78 75.52 6.46 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 122.895 0.478 . . . . 72.33 111.583 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.47 100.86 0.09 Allowed 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.976 0.91 . . . . 51.15 109.88 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.85 45.94 1.37 Allowed Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.136 -1.586 . . . . 64.4 109.136 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m -139.17 116.84 11.44 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 114.804 -0.698 . . . . 73.13 110.055 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.9 m -116.13 115.29 25.78 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.875 -1.158 . . . . 70.12 107.875 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.3 p -95.44 117.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.965 -0.754 . . . . 54.54 108.965 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.443 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.8 m -123.68 135.58 53.97 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.888 -1.051 . . . . 63.41 110.643 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 mt -85.93 126.98 34.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.139 -1.06 . . . . 70.4 108.139 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -111.47 128.36 55.98 Favored 'General case' 0 C--N 1.286 -2.181 0 O-C-N 123.752 0.658 . . . . 75.21 111.099 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.5 tp -136.55 128.26 28.96 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.456 -0.942 . . . . 75.43 108.456 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.6 100.08 12.95 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.685 -1.228 . . . . 41.2 107.685 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -125.17 84.31 2.26 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 107.294 -1.372 . . . . 63.11 107.294 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.62 -73.14 1.23 Allowed Glycine 0 C--N 1.289 -2.029 0 CA-C-N 114.731 -1.122 . . . . 55.2 110.328 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -121.84 -35.58 3.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.554 -0.906 . . . . 61.14 108.554 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.38 115.97 1.21 Allowed Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 120.507 -0.854 . . . . 44.22 111.443 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -100.56 142.01 32.63 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.204 -1.406 . . . . 63.24 107.204 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.7 p -141.44 132.42 26.08 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.434 0.459 . . . . 61.41 111.415 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -121.52 111.99 17.94 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.82 -0.627 . . . . 75.54 109.469 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.15 132.02 34.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.556 -0.535 . . . . 70.44 109.556 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HB2' HG13 ' A' ' 9' ' ' VAL . 96.3 mt -74.42 138.19 43.16 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.898 -1.047 . . . . 63.44 109.997 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -103.5 168.5 9.11 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.411 -0.589 . . . . 75.33 109.411 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.5 pm0 -61.41 118.79 7.42 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 124.212 0.945 . . . . 55.32 112.745 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.19 -173.36 18.5 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.356 -1.498 . . . . 74.5 109.356 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 62.0 p -95.79 119.2 33.86 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 117.94 0.87 . . . . 72.11 110.904 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.472 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -96.28 110.24 22.59 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.091 -1.448 . . . . 75.44 107.091 -176.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.96 128.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.362 -0.607 . . . . 73.42 109.362 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.28 132.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.266 -0.642 . . . . 73.24 109.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 155.08 -171.06 33.3 Favored Glycine 0 CA--C 1.481 -2.067 0 N-CA-C 109.756 -1.338 . . . . 71.44 109.756 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 73.3 mtp180 -120.44 105.27 10.71 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.631 -0.828 . . . . 73.14 108.856 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 155.6 13.71 Favored Glycine 0 N--CA 1.416 -2.648 0 N-CA-C 107.327 -2.309 . . . . 72.45 107.327 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.89 -17.69 65.02 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 118.017 0.909 . . . . 74.24 112.25 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.626 ' OD2' ' HD3' ' A' ' 48' ' ' ARG . 19.9 t70 -89.51 -2.01 58.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.74 0.781 . . . . 74.35 109.629 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.44 152.81 19.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.802 -0.636 . . . . 74.21 109.486 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.14 -46.95 6.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.12 0.486 . . . . 62.1 110.984 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -107.87 118.56 37.05 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.597 -0.89 . . . . 74.12 108.597 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 22.5 mmt85 -95.91 123.79 39.65 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.639 -0.71 . . . . 73.23 109.138 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 HG21 ' A' ' 45' ' ' VAL . 57.6 mt -78.48 141.68 61.32 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.929 -0.397 . . . . 73.45 109.929 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.92 5.06 6.57 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.234 1.956 . . . . 71.23 114.333 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -111.7 172.72 6.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.572 -1.27 . . . . 74.44 107.572 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -112.65 156.5 22.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.052 -0.722 . . . . 71.22 109.052 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -22.46 17.28 Favored Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 109.955 -1.258 . . . . 73.23 109.955 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 40' ' ' LEU . 7.1 p -77.24 136.12 25.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.747 -0.726 . . . . 64.0 109.052 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -69.58 177.61 2.88 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 122.845 0.458 . . . . 74.13 110.96 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 3.8 ptp180 -63.64 -40.59 97.25 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.368 -0.533 . . . . 70.23 111.125 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.626 ' HD3' ' OD2' ' A' ' 35' ' ' ASP . 45.1 mtm180 -131.9 113.7 13.76 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 106.01 -1.848 . . . . 74.44 106.01 171.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -104.32 -38.43 6.85 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-O 121.526 0.679 . . . . 63.4 110.35 -174.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.485 HD11 HD21 ' A' ' 61' ' ' LEU . 5.1 tt -160.3 153.51 21.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.577 -0.897 . . . . 64.34 108.577 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -138.24 124.52 20.46 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.31 0.576 . . . . 64.53 109.968 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' SER . 61.7 mt -99.19 119.22 46.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.91 -0.774 . . . . 64.4 108.91 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.469 ' HD2' HD23 ' A' ' 60' ' ' LEU . 51.9 mtt-85 -91.44 107.06 18.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.131 -1.433 . . . . 71.35 107.131 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -102.46 116.8 33.36 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.882 0.849 . . . . 75.2 110.5 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -119.21 161.55 20.17 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.83 -1.545 . . . . 75.12 106.83 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.81 37.93 1.48 Allowed Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.429 0.559 . . . . 74.52 112.825 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -136.89 -70.04 0.46 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.622 1.169 . . . . 73.43 108.392 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.08 159.38 32.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.949 -0.389 . . . . 72.44 109.949 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.02 106.52 18.87 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.601 0.715 . . . . 73.33 109.39 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.469 HD23 ' HD2' ' A' ' 53' ' ' ARG . 60.8 tp -90.79 111.98 23.59 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.198 -0.91 . . . . 74.24 111.185 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 50' ' ' LEU . 2.9 tm? -86.95 122.34 30.67 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.54 -1.281 . . . . 63.54 107.54 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.94 123.08 31.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 72.45 110.014 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.61 145.97 27.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.507 -0.553 . . . . 62.04 109.507 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.67 77.09 1.7 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.247 -1.39 . . . . 73.45 107.247 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -174.18 159.48 3.2 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.58 -0.526 . . . . 74.53 109.58 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -108.27 -54.55 2.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 120.851 0.357 . . . . 62.55 111.29 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 t -90.15 -24.44 21.06 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.794 -0.566 . . . . 74.11 111.963 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -105.51 26.98 8.81 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.6 -0.518 . . . . 71.23 109.6 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.92 126.66 18.3 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.294 0.996 . . . . 74.42 113.022 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -72.49 147.47 46.01 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.315 0.646 . . . . 74.4 111.557 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -113.37 146.91 38.7 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.762 -0.654 . . . . 70.22 110.285 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.38 116.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.955 -1.128 . . . . 50.4 107.955 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.33 24.47 14.57 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.997 0.919 . . . . 63.3 109.704 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m120 83.69 5.85 0.74 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 126.723 2.009 . . . . 64.51 113.398 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.64 127.17 34.81 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.63 -0.507 . . . . 75.1 109.63 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.02 125.29 9.22 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.513 2.142 . . . . 74.24 112.489 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 80' ' ' TRP . 35.7 m -142.31 161.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.21 -0.663 . . . . 63.52 109.21 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -89.35 -28.19 19.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.207 0.527 . . . . 74.34 110.253 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.55 158.83 40.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.438 -0.949 . . . . 62.52 108.438 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.408 ' HB2' HG21 ' A' ' 77' ' ' VAL . 70.8 t-105 -157.68 152.2 24.99 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.69 -0.856 . . . . 73.02 108.69 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -100.04 107.7 19.69 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.277 -1.379 . . . . 65.23 107.277 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 97' ' ' VAL . 89.1 mt -56.87 143.51 37.11 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.946 0.779 . . . . 61.12 113.043 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.99 163.5 29.07 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 115.124 -0.944 . . . . 74.35 108.513 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.7 t70 -70.19 112.2 6.37 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.444 -0.576 . . . . 54.23 109.444 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 3.9 27.03 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 121.004 -0.617 . . . . 64.4 113.148 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.89 139.36 35.95 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 117.832 0.816 . . . . 53.01 110.931 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.9 t -98.95 113.12 32.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.919 -0.771 . . . . 73.22 108.919 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.79 110.75 26.11 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.08 -1.452 . . . . 74.43 107.08 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 18.5 ttt180 -113.73 121.35 43.81 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.659 0.742 . . . . 73.34 111.901 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.81 163.28 22.49 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.14 -1.391 . . . . 73.03 107.722 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.34 120.05 9.12 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 123.563 0.54 . . . . 74.5 113.133 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.2 m170 86.24 -17.02 0.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.041 1.736 . . . . 75.33 114.96 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.8 m -150.67 127.88 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 118.977 0.808 . . . . 73.3 112.652 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' OE1' ' HD2' ' A' ' 89' ' ' ARG . 10.1 pt-20 -110.8 131.92 54.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.498 -0.927 . . . . 74.35 108.498 171.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 144.72 34.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.807 -0.633 . . . . 72.14 110.184 -174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.38 127.81 58.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.539 -0.911 . . . . 72.21 108.539 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.453 HG21 HD22 ' A' ' 82' ' ' LEU . 74.3 t -87.54 128.16 40.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.638 -0.255 . . . . 61.04 110.459 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -116.47 149.38 39.59 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.471 -0.566 . . . . 74.03 109.471 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.43 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 88.8 mtp -126.92 106.22 9.16 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.087 -1.079 . . . . 73.41 108.087 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 44.0 m-70 . . . . . 0 C--N 1.272 -2.774 0 CA-C-N 114.281 -1.327 . . . . 62.0 108.058 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.462 0 N-CA-C 110.756 -0.938 . . . . 63.32 110.756 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -164.12 152.64 13.16 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 108.593 -0.891 . . . . 72.41 108.593 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -168.76 142.32 7.33 Favored Glycine 0 N--CA 1.424 -2.155 0 N-CA-C 110.572 -1.011 . . . . 51.13 110.572 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m -85.63 -25.57 26.55 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.319 -0.622 . . . . 72.23 109.319 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.34 146.51 36.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.134 -1.061 . . . . 73.13 108.134 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.01 -78.35 0.24 Allowed Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.251 -0.739 . . . . 45.42 111.251 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m -147.69 116.33 6.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.554 -0.38 . . . . 74.45 111.433 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.4 p -122.69 132.99 54.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.674 -1.232 . . . . 63.43 107.674 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.59 129.55 71.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 122.383 1.087 . . . . 53.33 111.118 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 m -132.43 128.71 38.1 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.759 -1.11 . . . . 74.22 108.309 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 95' ' ' ILE . 4.4 pp -92.38 148.83 21.81 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.405 -0.961 . . . . 75.53 108.405 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -126.81 125.42 41.66 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.195 -0.602 . . . . 71.22 110.202 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.3 tp -83.15 124.73 30.79 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.812 -0.81 . . . . 62.04 108.812 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -90.12 98.44 11.77 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 106.321 -1.733 . . . . 72.14 106.321 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -150.63 77.55 1.29 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.904 -1.043 . . . . 72.43 109.386 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.93 -65.61 4.02 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 115.375 -0.83 . . . . 55.34 113.025 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 p -100.56 -47.36 4.9 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.456 0.646 . . . . 70.31 111.193 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 106.82 91.27 2.21 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.367 -1.093 . . . . 72.14 110.367 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.52 158.21 15.65 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 110.478 -0.193 . . . . 61.33 110.478 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -121.88 148.93 44.1 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.108 0.781 . . . . 45.23 113.108 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -136.97 117.24 13.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.667 -1.234 . . . . 73.05 107.667 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -83.41 139.07 33.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.322 -0.621 . . . . 73.31 109.322 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 52' ' ' ILE . 94.5 mt -85.48 139.7 31.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.815 -0.439 . . . . 73.33 109.815 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -101.55 165.16 11.39 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.935 0.398 . . . . 70.24 110.344 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -69.75 113.26 6.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.096 -0.956 . . . . 75.44 109.914 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.28 -174.57 19.94 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.08 -1.608 . . . . 60.31 109.08 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 p -106.78 145.85 31.58 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.385 -0.926 . . . . 55.54 110.857 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -122.75 135.43 54.56 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.464 -0.569 . . . . 71.43 109.464 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.68 119.54 46.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.257 -1.016 . . . . 74.2 108.257 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 58.1 mt -101.8 127.73 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.301 0.572 . . . . 62.13 110.158 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.44 -178.09 37.49 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.335 -1.506 . . . . 75.11 109.335 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 29.1 mtm105 -110.99 106.52 15.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.356 1.078 . . . . 71.53 111.42 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.4 41.8 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 107.168 -2.373 . . . . 75.32 107.168 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -85.56 -16.01 40.79 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.175 0.988 . . . . 72.33 108.457 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.5 -12.57 60.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.113 -1.403 . . . . 70.5 109.273 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -98.37 158.02 15.84 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.776 -1.102 . . . . 72.02 108.553 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -106.65 -39.06 5.94 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.347 0.594 . . . . 71.12 110.397 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 89.7 t80 -115.72 114.88 25.42 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.904 -1.147 . . . . 74.42 107.904 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 61.7 mtm180 -96.91 124.14 40.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.094 -0.503 . . . . 74.23 110.499 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 66.6 mt -71.4 134.17 84.79 Favored Pre-proline 0 CA--C 1.501 -0.926 0 N-CA-C 107.573 -1.269 . . . . 75.3 107.573 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.28 35.01 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.967 1.778 . . . . 74.33 112.111 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.8 -175.55 3.44 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.043 0.449 . . . . 41.34 110.417 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.5 m -111.17 148.59 32.43 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.123 0.969 . . . . 74.33 110.005 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.82 -0.85 61.07 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 111.679 -0.568 . . . . 31.43 111.679 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.14 127.69 45.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.867 -0.79 . . . . 71.43 108.867 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.1 m -78.96 177.3 8.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.166 -0.47 . . . . 41.34 110.185 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.41 -50.63 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.904 0.32 . . . . 74.21 110.97 177.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.62 114.6 26.66 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 107.025 -1.472 . . . . 75.34 107.025 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -105.31 -42.97 5.11 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.605 0.717 . . . . 72.22 109.097 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 tt -163.17 159.8 23.4 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.56 -0.904 . . . . 74.32 108.56 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -138.85 151.1 46.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.518 -0.549 . . . . 65.43 109.518 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 23' ' ' LEU . 70.8 mt -123.48 121.44 62.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.542 -0.91 . . . . 63.24 108.542 176.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 63.4 mtt180 -105.6 107.94 19.2 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.206 -0.664 . . . . 73.15 109.206 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.72 133.98 52.07 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.996 -0.547 . . . . 75.44 110.616 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.79 -179.93 6.34 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.436 -2.431 . . . . 65.55 104.436 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.36 42.62 2.92 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 119.445 1.02 . . . . 25.5 113.867 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -141.62 -76.78 0.28 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 110.203 -0.295 . . . . 71.14 110.203 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.12 158.1 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.711 0.291 . . . . 63.25 110.557 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.51 112.38 24.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.403 0.62 . . . . 71.51 110.289 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 6.1 tt -88.96 124.87 34.66 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.272 -0.876 . . . . 61.13 108.797 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.74 123.55 49.71 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.347 -1.353 . . . . 74.25 107.347 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.74 124.68 28.59 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.187 0.518 . . . . 52.51 110.999 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 14.9 t70 -89.3 112.47 23.55 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.357 -0.979 . . . . 73.15 108.357 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 mt -101.53 76.45 1.67 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.422 -2.066 . . . . 73.14 105.422 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 68' ' ' ASN . 19.9 t30 -173.81 139.64 0.7 Allowed 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.899 -0.72 . . . . 71.13 109.708 -165.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -108.56 -53.38 2.65 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.283 0.563 . . . . 63.23 110.003 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -66.02 -48.64 70.45 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.277 -0.874 . . . . 34.13 113.05 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.477 ' HB2' HD21 ' A' ' 65' ' ' ASN . 20.0 m-80 -106.4 29.77 6.57 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 119.173 -0.441 . . . . 60.41 109.94 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.23 121.94 2.83 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.18 0.832 . . . . 65.05 115.18 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.7 m -69.08 149.17 49.01 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.734 1.614 . . . . 75.22 112.336 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 38.5 p -112.4 145.78 39.51 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.345 0.593 . . . . 54.22 111.814 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 88' ' ' ILE . 33.9 m -116.07 117.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 107.431 -1.322 . . . . 74.14 107.431 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 58.88 33.26 22.94 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.675 -0.693 . . . . 71.24 110.295 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 82.46 -3.36 1.4 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.86 1.664 . . . . 73.21 112.428 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.15 129.31 25.39 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.684 -0.635 . . . . 54.12 110.089 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.12 125.58 7.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.501 2.134 . . . . 73.52 113.529 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.68 174.47 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 107.295 -1.372 . . . . 73.33 107.295 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.456 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.2 mt-30 -117.4 -17.73 10.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 112.979 0.733 . . . . 71.34 112.979 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.61 131.52 27.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.421 . . . . 74.02 109.908 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -147.57 152.33 37.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.842 -0.799 . . . . 74.34 108.842 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -106.41 113.8 27.53 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.181 -1.044 . . . . 74.14 108.181 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.2 mt -57.85 149.56 22.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.107 -0.952 . . . . 71.33 112.486 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.09 166.79 23.8 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.321 -0.854 . . . . 54.44 109.15 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.8 t70 -71.67 115.72 11.19 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.994 0.426 . . . . 72.15 110.201 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.46 14.34 28.1 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.813 -0.63 . . . . 71.11 112.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -88.76 135.66 33.4 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 120.438 -0.505 . . . . 73.44 110.74 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.21 113.46 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.008 -0.738 . . . . 61.41 109.008 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -105.76 113.53 42.84 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.805 -1.183 . . . . 74.05 107.805 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 61.5 mtt180 -99.81 106.28 18.14 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 116.272 -0.422 . . . . 73.22 109.954 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -115.5 164.69 13.93 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.013 -0.994 . . . . 54.42 109.001 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -27.39 88.78 0.01 OUTLIER Glycine 0 N--CA 1.484 1.856 0 C-N-CA 125.303 1.43 . . . . 64.4 116.331 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 58.08 21.35 7.81 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.76 1.624 . . . . 72.54 111.491 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.0 m -137.01 114.25 10.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.12 -1.067 . . . . 63.44 108.12 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.22 125.4 54.1 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 120.099 -0.64 . . . . 70.52 109.799 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 13' ' ' LEU . 1.7 pp -122.48 149.43 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-O 120.953 0.406 . . . . 53.1 111.36 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -110.39 122.45 64.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.767 -1.568 . . . . 44.52 106.767 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' ' 82' ' ' LEU . 55.1 t -80.41 126.56 39.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 120.85 0.357 . . . . 75.04 111.057 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.0 mmm-85 -116.9 142.3 47.11 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.35 0.595 . . . . 64.54 109.678 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 79.6 mtp -123.06 121.25 35.57 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.925 -1.034 . . . . 74.24 109.144 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 107.168 -1.419 . . . . 73.44 107.168 -177.641 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.624 0 N-CA-C 110.468 -1.053 . . . . 63.24 110.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -118.34 59.76 0.8 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 122.901 1.334 . . . . 44.5 108.639 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.32 -82.69 1.63 Allowed Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 108.126 -1.989 . . . . 32.04 108.126 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 m -84.89 88.49 7.42 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.388 0.613 . . . . 53.01 109.925 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.28 81.7 1.66 Allowed 'General case' 0 N--CA 1.414 -2.272 0 CA-C-O 122.107 0.956 . . . . 74.41 108.978 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.17 -53.14 0.27 Allowed Glycine 0 C--N 1.288 -2.138 0 N-CA-C 108.028 -2.029 . . . . 73.12 108.028 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 m -70.83 115.3 9.82 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.831 -1.544 . . . . 73.4 106.831 172.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -121.48 114.77 21.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.494 -0.483 . . . . 74.13 109.95 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.7 p -95.76 126.41 48.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.713 -1.217 . . . . 55.02 107.713 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 m -131.06 136.54 48.54 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.28 -0.873 . . . . 72.45 109.264 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 95' ' ' ILE . 4.0 pp -101.8 131.41 48.13 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 116.151 -0.477 . . . . 73.04 109.966 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.92 114.26 28.24 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.28 -1.378 . . . . 62.34 107.28 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.16 119.31 38.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.43 0.692 . . . . 73.24 110.521 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -93.36 100.0 12.41 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.949 -1.13 . . . . 63.53 107.949 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.91 -13.59 15.76 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.167 -1.378 . . . . 73.44 109.179 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.22 -12.93 6.02 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.87 -1.292 . . . . 34.32 109.87 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -120.12 -35.81 3.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 120.816 0.341 . . . . 74.32 110.593 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 91.82 1.38 Allowed Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.139 -1.184 . . . . 33.24 110.139 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -113.51 159.43 19.56 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 110.476 -0.194 . . . . 74.43 110.476 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.8 p -130.22 136.33 49.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.882 0.373 . . . . 74.35 110.024 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -135.62 121.55 19.91 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.042 -0.526 . . . . 74.11 109.638 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.915 -0.584 . . . . 52.1 109.762 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.3 mt -76.86 133.91 39.17 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.503 -0.771 . . . . 61.21 110.265 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -102.99 158.45 16.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 108.767 -0.827 . . . . 72.11 108.767 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.587 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 1.9 mp0 -48.5 127.27 12.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.492 1.517 . . . . 73.22 111.445 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.1 -174.8 15.81 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.255 -1.538 . . . . 64.42 109.255 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 81.8 p -95.73 123.35 39.26 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 118.319 -1.353 . . . . 73.13 110.882 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.517 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -92.57 109.74 21.15 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.065 -1.828 . . . . 74.43 106.065 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.21 129.42 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.596 -0.729 . . . . 60.4 110.842 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -107.57 133.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.54 -0.911 . . . . 72.53 108.54 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 154.79 177.5 28.17 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.193 -1.563 . . . . 74.13 109.193 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 49.7 mtp85 -112.52 105.0 13.12 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.884 1.342 . . . . 75.53 109.858 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.89 179.32 46.31 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 110.039 -1.225 . . . . 74.23 110.039 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -72.41 -25.44 61.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.073 0.939 . . . . 73.32 108.937 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.98 8.48 12.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.665 -1.152 . . . . 71.13 111.526 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.91 155.19 44.59 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.079 0.466 . . . . 63.1 112.013 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -99.63 -54.73 2.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.017 -0.992 . . . . 71.42 109.987 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -101.48 108.92 20.64 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 71.43 109.217 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 33.5 ptt180 -96.08 118.13 32.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.105 -0.498 . . . . 75.04 111.802 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.65 140.19 97.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.278 -0.874 . . . . 71.34 110.509 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -92.71 17.92 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.601 2.201 . . . . 75.33 112.283 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.64 -173.49 2.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.491 -0.929 . . . . 71.32 108.491 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -112.0 146.91 37.04 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.193 0.597 . . . . 60.32 109.564 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 -27.36 16.82 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.818 -0.706 . . . . 73.52 111.384 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.34 133.02 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 123.435 0.694 . . . . 65.34 111.586 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -80.27 -171.47 3.02 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.392 1.077 . . . . 71.14 109.552 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 33.4 ptt180 -78.02 -34.78 50.49 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.35 -0.94 . . . . 63.44 109.587 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HB3' HD23 ' A' ' 64' ' ' LEU . 63.4 mtp180 -129.07 115.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 103.582 -2.748 . . . . 64.03 103.582 172.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 5.3 t60 -103.76 -42.41 5.63 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.55 0.691 . . . . 73.12 109.143 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 4.9 tt -166.45 151.14 7.78 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.429 -0.952 . . . . 72.41 108.429 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.63 134.94 45.5 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.122 -0.695 . . . . 72.13 109.122 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -102.55 112.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.028 -1.471 . . . . 75.2 107.028 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 40.2 ttt85 -91.65 107.38 19.17 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 121.548 0.689 . . . . 73.41 109.779 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -96.49 112.54 24.24 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.948 -1.024 . . . . 74.12 109.056 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -119.27 167.38 11.92 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.172 -1.788 . . . . 55.22 106.172 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.98 42.36 2.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.592 -0.813 . . . . 52.1 112.566 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -136.68 -66.86 0.52 Allowed 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 124.041 0.936 . . . . 71.02 108.56 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.11 159.77 4.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.719 1.208 . . . . 73.44 108.31 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.36 107.59 19.24 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.652 0.739 . . . . 75.55 109.101 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 tt -88.49 115.41 25.98 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.79 -1.095 . . . . 72.2 109.789 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.8 tm? -97.21 124.94 41.44 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.318 -1.364 . . . . 72.43 107.318 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -140.57 125.6 18.43 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 120.678 0.275 . . . . 62.23 111.409 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.667 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 1.2 m-20 -73.52 139.61 45.79 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 115.798 -0.637 . . . . 64.13 109.948 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.418 HD23 ' HB3' ' A' ' 48' ' ' ARG . 32.9 tp -130.68 77.15 1.77 Allowed 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.534 -1.284 . . . . 53.55 107.534 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -179.82 174.64 0.91 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.419 -1.326 . . . . 73.25 107.419 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 p -109.03 -55.03 2.46 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.642 0.608 . . . . 72.24 112.642 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -89.52 -29.95 18.58 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.466 0.913 . . . . 74.11 113.466 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.574 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 90.2 m-20 -84.57 27.38 0.72 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.427 0.691 . . . . 54.43 112.219 -172.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.51 122.73 6.68 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.967 1.417 . . . . 64.33 113.951 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.667 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 52.7 m -71.84 148.68 45.95 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 125.035 1.334 . . . . 71.32 112.622 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 p -112.92 141.03 47.22 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.435 -0.802 . . . . 54.24 109.505 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.03 118.25 53.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.755 -1.202 . . . . 64.32 107.755 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 57.81 38.22 27.23 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.556 -0.747 . . . . 70.23 109.88 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.39 -10.61 1.17 Allowed 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.605 1.962 . . . . 65.01 112.001 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -92.37 121.81 65.75 Favored Pre-proline 0 C--N 1.323 -0.57 0 O-C-N 122.124 -0.36 . . . . 52.24 110.7 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.47 125.19 13.0 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.837 2.358 . . . . 75.03 112.552 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.99 -177.9 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.974 -0.751 . . . . 75.21 108.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -128.83 6.25 5.53 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.589 -0.522 . . . . 72.23 109.589 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.45 153.16 3.44 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.907 -1.146 . . . . 73.33 107.907 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.448 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 76.3 t-105 -166.91 152.29 7.73 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.711 -0.848 . . . . 73.14 108.711 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -104.66 111.52 24.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.643 -1.243 . . . . 44.03 107.643 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' HG11 ' A' ' 97' ' ' VAL . 56.0 mt -58.13 141.3 50.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.898 1.073 . . . . 64.53 113.898 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.97 162.46 32.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.529 -1.286 . . . . 53.4 107.529 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.0 126.36 27.79 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.575 -0.284 . . . . 75.15 110.396 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.63 1.94 57.56 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.907 -0.663 . . . . 62.02 113.414 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -73.07 129.58 38.39 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.362 0.581 . . . . 53.2 111.135 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.43 116.28 35.32 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 N-CA-C 107.284 -1.376 . . . . 75.53 107.284 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.9 mt -122.43 134.28 66.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 C-N-CA 119.971 -0.692 . . . . 50.02 110.6 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.408 ' HG2' ' CB ' ' A' ' 94' ' ' GLU . 27.7 mtp-105 -124.19 123.35 40.08 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 73.1 110.004 175.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.5 pt? -101.81 162.57 12.81 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 105.81 -1.922 . . . . 65.54 105.81 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -46.33 102.86 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 O-C-N 123.749 0.655 . . . . 64.24 113.786 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 m170 79.52 15.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.712 1.375 . . . . 73.14 114.712 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -151.02 141.11 22.14 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.475 -0.766 . . . . 71.45 111.94 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 89' ' ' ARG . 9.2 pt-20 -118.75 139.29 51.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.037 0.446 . . . . 52.13 111.235 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.493 HD11 HD13 ' A' ' 11' ' ' LEU . 9.5 tp -139.8 142.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-N 115.301 -0.863 . . . . 75.24 109.527 -172.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -109.88 134.51 51.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.029 -1.1 . . . . 53.54 108.029 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' A' ' 82' ' ' LEU . 85.0 t -96.92 121.73 47.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.141 0.496 . . . . 75.43 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -117.47 132.29 56.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.865 -0.791 . . . . 72.12 108.865 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.0 mtp -116.36 116.87 28.52 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.064 -0.717 . . . . 64.11 109.064 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--N 1.278 -2.537 0 N-CA-C 107.506 -1.294 . . . . 63.42 107.506 -177.732 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.751 0 N-CA-C 111.328 -0.709 . . . . 43.05 111.328 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -59.92 123.83 18.28 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.969 0.908 . . . . 72.32 112.263 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.26 76.23 0.51 Allowed Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.408 -1.077 . . . . 45.5 110.408 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -62.79 121.07 12.54 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.185 -0.672 . . . . 64.31 109.185 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.86 -175.75 2.88 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 123.867 0.729 . . . . 74.51 110.109 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.14 -58.26 5.01 Favored Glycine 0 CA--C 1.496 -1.137 0 N-CA-C 109.888 -1.285 . . . . 70.35 109.888 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m -144.64 114.76 7.45 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 107.82 -1.178 . . . . 50.04 107.82 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -113.04 114.3 26.67 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.201 -1.407 . . . . 54.24 107.201 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 108.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.813 -1.18 . . . . 60.4 107.813 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 m -111.41 123.23 49.79 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.095 -1.076 . . . . 73.0 108.095 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.4 pp -88.53 130.02 35.33 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.602 -0.888 . . . . 62.2 108.602 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.93 108.85 19.76 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.622 -1.621 . . . . 54.12 106.622 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.48 117.8 29.39 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.524 -0.546 . . . . 73.21 109.524 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -126.77 103.53 7.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.951 -1.1 . . . . 72.1 112.925 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -48.87 9.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.9 -2.259 . . . . 74.43 104.9 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 171.29 44.27 0.04 OUTLIER Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 103.591 -3.804 . . . . 34.34 103.591 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -132.49 -45.94 0.9 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.644 -1.278 . . . . 72.1 110.86 -166.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.72 51.04 8.38 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.49 -1.044 . . . . 75.34 110.49 -172.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -84.47 143.1 29.6 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.747 0.419 . . . . 74.21 110.355 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.9 p -146.68 132.36 18.88 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.645 -0.707 . . . . 71.3 109.199 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -144.8 127.69 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.456 -0.338 . . . . 72.25 110.099 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.07 127.46 36.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.41 -0.959 . . . . 62.04 108.41 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.0 mt -58.31 143.46 44.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.567 0.951 . . . . 63.45 113.567 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 24' ' ' ARG . 2.3 mmp_? -100.01 151.61 21.16 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.559 -1.201 . . . . 72.43 108.022 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -70.85 130.14 40.88 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.683 0.754 . . . . 72.42 111.367 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.65 -176.54 16.61 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 106.763 -2.535 . . . . 62.32 106.763 -172.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 51.7 p -89.71 133.27 34.75 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 118.388 -1.325 . . . . 74.44 111.303 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -101.72 109.83 21.68 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.194 -2.15 . . . . 74.2 105.194 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.4 mt -86.2 123.96 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.976 -0.556 . . . . 75.25 111.149 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.467 HG23 ' HD2' ' A' ' 38' ' ' PHE . 67.7 mt -107.91 129.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.768 -0.827 . . . . 72.42 108.768 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.48 -179.03 37.15 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.888 -0.885 . . . . 74.44 110.888 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 40.1 mtp85 -107.43 106.38 16.75 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.732 -0.84 . . . . 73.51 108.732 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.71 -178.13 48.63 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 109.562 -1.415 . . . . 53.4 109.562 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -93.43 -21.05 19.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.004 0.431 . . . . 61.13 110.786 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -92.76 -3.59 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 73.04 110.056 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.11 165.96 20.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.049 -0.978 . . . . 42.23 108.911 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -109.35 -52.16 2.8 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.65 0.738 . . . . 64.24 110.028 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.467 ' HD2' HG23 ' A' ' 30' ' ' ILE . 92.0 t80 -108.82 116.73 32.53 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.366 -0.975 . . . . 74.31 108.366 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mpt_? -94.92 127.86 41.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.159 -0.473 . . . . 62.4 110.973 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.98 136.07 54.59 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.101 -0.5 . . . . 71.42 111.138 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.98 -29.15 81.5 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.407 2.738 . . . . 71.25 114.4 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 21.5 t70 -95.03 169.0 10.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.709 -0.849 . . . . 63.12 108.709 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -107.23 -177.34 3.33 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 121.036 -0.266 . . . . 74.15 110.321 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.22 78.39 Favored Glycine 0 C--O 1.238 0.395 0 N-CA-C 108.807 -1.717 . . . . 74.12 108.807 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.47 130.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 113.294 -1.453 . . . . 55.14 108.095 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.1 m -79.11 -177.48 5.65 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.244 -0.651 . . . . 74.3 109.244 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 15.4 ptt180 -64.49 -41.56 96.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.572 0.701 . . . . 74.11 109.415 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -121.02 104.36 9.74 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.245 -1.761 . . . . 72.22 106.245 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 15.2 t60 -100.0 -31.44 11.45 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.948 -1.024 . . . . 75.03 108.877 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.486 HD11 HD21 ' A' ' 61' ' ' LEU . 8.1 tt -164.28 145.89 8.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.108 -0.701 . . . . 74.23 109.108 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.95 132.92 47.66 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.292 0.567 . . . . 71.54 110.05 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.3 mt -108.53 112.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.642 -1.244 . . . . 74.02 107.642 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 16.3 ttt-85 -91.35 107.71 19.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.471 -1.307 . . . . 74.31 107.471 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -99.51 115.32 29.07 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-O 121.672 0.749 . . . . 74.52 110.324 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.83 164.6 14.42 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.051 -1.463 . . . . 62.42 107.051 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.56 52.91 3.91 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.415 -1.074 . . . . 70.41 110.415 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.36 -71.73 0.3 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 125.7 1.6 . . . . 64.41 107.793 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 m -149.76 160.0 5.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.908 1.283 . . . . 70.32 107.896 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -93.24 106.15 18.15 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.585 -0.895 . . . . 71.34 108.585 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -82.48 118.31 23.14 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.277 -0.874 . . . . 64.42 110.096 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.486 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -99.54 120.13 39.15 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.545 -0.909 . . . . 74.01 108.545 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.0 123.48 34.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.815 -0.439 . . . . 51.44 109.815 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.64 138.82 32.77 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.868 -0.605 . . . . 73.43 110.994 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.92 77.52 1.62 Allowed 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.979 0.511 . . . . 64.34 109.913 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 32.9 t-20 -175.31 138.67 0.43 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.842 0.746 . . . . 74.04 110.473 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 p -96.54 -38.46 9.97 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.361 -0.381 . . . . 75.32 111.854 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 t -89.32 -44.4 10.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.346 0.499 . . . . 63.44 112.346 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.438 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.4 m120 -105.98 27.37 8.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.129 -0.693 . . . . 74.21 109.129 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.96 138.36 26.32 Favored Glycine 0 C--O 1.248 1.004 0 CA-C-N 114.527 -1.215 . . . . 32.23 113.923 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 30.0 m -72.25 137.73 47.0 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 124.406 1.082 . . . . 64.23 113.299 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 p -105.91 140.75 38.45 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.373 -0.83 . . . . 72.53 109.674 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 88' ' ' ILE . 35.2 m -119.55 116.04 49.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.602 -1.259 . . . . 54.51 107.602 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 57.84 30.86 19.69 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.445 0.64 . . . . 72.21 110.167 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 88.72 -10.88 0.45 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.659 1.984 . . . . 74.54 113.677 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.7 117.81 66.3 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 121.413 -0.804 . . . . 71.44 110.913 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.86 124.91 11.5 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 121.76 1.64 . . . . 70.4 110.319 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.95 175.98 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 110.168 -0.308 . . . . 75.1 110.168 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.05 -31.84 9.49 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.659 0.599 . . . . 61.11 109.42 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -142.73 147.86 36.31 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.048 -0.524 . . . . 73.45 110.199 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -162.23 152.17 16.47 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.596 -1.261 . . . . 75.44 107.596 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -107.92 109.41 20.91 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.979 -0.688 . . . . 73.52 109.154 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 79.0 mt -57.1 122.02 11.41 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.479 -1.237 . . . . 54.05 111.923 -175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.9 166.59 11.08 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.924 -1.139 . . . . 72.11 107.924 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 126.4 29.13 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.462 -0.335 . . . . 71.41 110.628 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.16 57.73 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.929 -0.578 . . . . 44.11 113.071 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.06 139.88 46.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.984 0.392 . . . . 55.31 111.411 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.69 117.19 48.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.753 -0.658 . . . . 62.11 109.673 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -111.98 124.55 68.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 123.368 0.667 . . . . 63.44 109.28 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 70' ' ' THR . 38.5 ttm180 -120.37 115.73 24.11 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.405 -0.591 . . . . 72.43 109.405 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 90' ' ' LEU . 2.1 pt? -126.81 139.29 53.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.409 -1.33 . . . . 70.13 107.409 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.86 88.02 0.0 OUTLIER Glycine 0 N--CA 1.496 2.636 0 O-C-N 125.032 1.457 . . . . 44.34 116.297 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.5 t60 75.37 -19.66 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.327 1.451 . . . . 74.12 113.034 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.6 m -96.55 132.46 42.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 122.869 0.468 . . . . 72.3 111.171 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -125.78 117.63 23.83 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.013 0.911 . . . . 64.12 110.387 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -127.64 141.57 46.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 114.53 -1.214 . . . . 62.32 111.914 -170.559 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.86 133.34 51.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.095 -1.076 . . . . 74.2 108.095 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.38 124.54 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 120.869 0.366 . . . . 71.53 110.84 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -119.25 130.58 55.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.741 -0.663 . . . . 74.33 111.126 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.1 mtt -106.17 111.93 24.75 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.975 -0.75 . . . . 44.31 108.975 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 . . . . . 0 C--N 1.277 -2.586 0 N-CA-C 108.306 -0.998 . . . . 75.13 108.306 179.104 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.881 0 N-CA-C 110.412 -1.075 . . . . 43.05 110.412 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 65.68 -72.24 0.08 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.421 1.488 . . . . 55.04 112.174 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.02 164.38 18.4 Favored Glycine 0 N--CA 1.416 -2.691 0 N-CA-C 111.599 -0.601 . . . . 71.14 111.599 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -84.64 141.84 30.35 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.731 -0.84 . . . . 61.1 108.731 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.21 138.82 55.9 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.139 -1.06 . . . . 72.13 108.139 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.02 -53.55 45.48 Favored Glycine 0 CA--C 1.508 -0.399 0 C-N-CA 120.494 -0.86 . . . . 63.11 111.084 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m -73.87 116.0 13.98 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.305 -0.628 . . . . 75.51 109.305 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -101.56 115.57 30.81 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.804 -0.813 . . . . 64.33 108.804 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.24 122.02 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 106.251 -1.759 . . . . 72.22 106.251 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.6 m -135.66 131.22 35.46 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.615 -0.513 . . . . 74.0 109.615 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -93.94 126.86 39.39 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.377 -0.601 . . . . 70.42 109.377 175.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.8 108.72 21.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.759 -1.2 . . . . 74.45 107.759 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.02 114.36 28.23 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.824 -0.626 . . . . 72.41 109.778 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.7 99.62 11.69 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.551 -1.648 . . . . 74.02 106.551 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -146.89 79.75 1.52 Allowed 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.596 -1.184 . . . . 64.13 108.953 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.23 -62.39 0.29 Allowed Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.19 -0.914 . . . . 70.12 111.656 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -128.23 -38.92 1.75 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.425 0.528 . . . . 63.55 112.425 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.59 86.16 0.79 Allowed Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.784 -0.926 . . . . 73.14 110.784 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -100.38 167.37 10.44 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.462 0.305 . . . . 73.41 110.72 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.9 p -141.65 140.55 33.29 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.845 -0.616 . . . . 72.11 110.388 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.4 121.83 31.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.082 -1.081 . . . . 74.43 108.082 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -86.67 125.88 34.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.414 -1.328 . . . . 74.11 107.414 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.47 121.72 18.3 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.783 -0.644 . . . . 72.15 110.671 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -82.78 150.59 26.54 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.867 -0.79 . . . . 73.34 108.867 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -57.76 124.98 21.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.242 0.964 . . . . 61.34 110.309 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.17 -164.04 16.35 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.761 -2.136 . . . . 74.42 107.761 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 80.5 p -100.65 134.64 43.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.011 1.406 . . . . 75.23 111.31 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -111.78 110.07 20.24 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.205 -1.776 . . . . 72.42 106.205 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 45.7 mt -102.27 136.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.676 -0.693 . . . . 71.43 110.214 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -115.08 135.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.257 1.458 0 N-CA-C 109.49 -0.559 . . . . 71.01 109.49 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.88 -175.97 29.63 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 110.287 -1.125 . . . . 64.12 110.287 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 87.5 mtt180 -105.76 105.19 15.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.546 -0.861 . . . . 61.04 110.233 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.26 162.21 26.67 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 108.886 -1.686 . . . . 71.11 108.886 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.14 -18.32 62.52 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.218 0.532 . . . . 72.11 109.578 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.78 -29.03 65.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.624 -1.171 . . . . 72.13 109.596 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . . . -88.16 154.18 20.65 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.323 -0.853 . . . . 72.4 110.675 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -93.04 -46.57 7.4 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.598 -0.89 . . . . 63.04 108.598 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -111.74 117.7 33.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.916 -1.038 . . . . 73.22 109.313 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.5 mpt_? -96.55 136.7 36.7 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.705 -0.48 . . . . 70.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 82.2 mt -83.33 146.76 51.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.655 -0.248 . . . . 75.52 110.365 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 4.1 Cg_exo -79.92 12.54 2.42 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.051 2.501 . . . . 64.35 112.322 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.33 152.61 32.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.089 -0.505 . . . . 74.34 111.227 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.5 m -95.18 151.88 18.84 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.619 -1.252 . . . . 74.22 107.619 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.48 26.37 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 110.348 -1.101 . . . . 64.34 110.348 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -98.75 138.6 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.1 m -81.42 175.42 10.57 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.416 0.15 . . . . 61.11 111.347 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 2.3 ptm180 -60.86 -36.53 79.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.256 0.622 . . . . 74.03 111.42 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -131.94 97.55 4.2 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.366 -2.087 . . . . 74.32 105.366 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -95.85 -37.44 10.72 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.565 0.698 . . . . 64.1 109.746 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 61' ' ' LEU . 6.8 tt -158.99 143.24 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.696 -0.684 . . . . 74.44 109.182 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -134.57 126.68 29.77 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.596 -0.729 . . . . 74.11 111.073 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -103.46 112.91 38.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.465 -0.939 . . . . 72.42 108.465 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 0.0 OUTLIER -91.73 107.67 19.37 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 106.012 -1.847 . . . . 72.43 106.012 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -105.55 108.37 19.85 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.482 -0.781 . . . . 72.44 109.552 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.82 161.73 13.7 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 105.935 -1.876 . . . . 72.43 105.935 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.03 60.4 3.06 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.498 -0.858 . . . . 64.02 111.828 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -177.72 -50.36 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.729 1.212 . . . . 72.01 109.865 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.51 145.12 35.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 112.64 0.607 . . . . 74.25 112.64 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.92 102.14 11.52 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 115.235 -0.893 . . . . 72.01 109.432 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 tp -94.29 109.72 21.52 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.9 -1.046 . . . . 74.41 111.085 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 50' ' ' LEU . 3.0 tm? -94.98 116.75 29.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.621 -1.251 . . . . 61.2 107.621 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.6 121.13 32.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.942 0.401 . . . . 61.43 110.834 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.0 134.44 35.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.309 -0.859 . . . . 73.2 109.141 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.15 77.61 1.75 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.835 -1.172 . . . . 63.24 107.835 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -170.54 162.72 8.18 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.183 -1.043 . . . . 64.3 108.183 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 m -108.65 -53.27 2.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 120.475 -0.49 . . . . 75.03 112.103 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -88.43 -26.69 21.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.371 0.605 . . . . 74.32 111.895 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -104.85 28.25 7.32 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 122.887 0.475 . . . . 45.23 110.147 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.76 115.82 1.52 Allowed Glycine 0 C--O 1.246 0.87 0 O-C-N 125.004 1.44 . . . . 71.42 112.367 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 m -59.19 134.16 56.75 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.321 1.048 . . . . 61.13 112.676 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 139.67 38.01 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 108.161 -1.051 . . . . 44.15 108.161 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.51 120.59 62.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.508 -0.923 . . . . 65.4 108.508 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 59.22 29.13 18.63 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.584 1.183 . . . . 52.52 109.08 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.271 95.8 m-20 67.11 25.26 9.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 112.8 -2.0 . . . . 71.02 113.92 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.07 125.38 27.68 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.623 -0.881 . . . . 64.22 108.623 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.8 130.73 14.94 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.339 2.026 . . . . 70.11 112.675 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG21 ' HB2' ' A' ' 80' ' ' TRP . 34.7 m -141.77 176.89 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.186 -0.461 . . . . 74.42 110.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -106.44 -38.09 6.3 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.872 -0.788 . . . . 75.31 108.872 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.02 148.73 42.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.888 -1.051 . . . . 63.2 110.597 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.443 ' HB2' HG21 ' A' ' 77' ' ' VAL . 68.9 t-105 -153.16 151.97 30.73 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.674 -0.861 . . . . 73.22 108.674 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.2 116.35 32.48 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.578 -1.267 . . . . 74.52 107.578 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.403 HD22 HG21 ' A' ' 97' ' ' VAL . 77.9 mt -57.04 138.03 54.94 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 123.729 0.643 . . . . 74.33 112.152 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.25 169.06 14.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.688 -1.227 . . . . 74.3 107.688 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 24.9 t70 -79.54 124.8 28.84 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.476 -0.329 . . . . 73.44 110.648 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.97 6.06 56.17 Favored Glycine 0 N--CA 1.436 -1.348 0 CA-C-N 116.016 -0.538 . . . . 70.25 112.295 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.46 134.8 46.83 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.964 0.411 . . . . 71.52 111.383 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.42 113.21 35.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 N-CA-C 107.79 -1.189 . . . . 75.33 107.79 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.3 122.4 68.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 C-N-CA 119.863 -0.735 . . . . 73.33 111.238 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -105.73 109.98 22.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.658 -0.701 . . . . 63.55 109.13 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.9 pt? -110.7 164.83 12.36 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.672 -0.862 . . . . 61.13 108.672 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -47.23 106.29 0.15 Allowed Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.689 0.618 . . . . 61.21 113.444 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 75.81 12.63 2.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.696 1.599 . . . . 50.21 114.786 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.0 t -154.85 150.4 27.44 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.58 -0.848 . . . . 74.44 111.531 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.91 128.67 47.92 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.236 0.541 . . . . 75.23 109.818 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.4 tp -124.91 148.89 29.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 116.211 -0.45 . . . . 73.42 110.626 -170.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.91 122.82 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.684 -1.228 . . . . 73.14 107.684 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 82' ' ' LEU . 81.8 t -90.58 122.78 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.93 0.395 . . . . 64.53 110.184 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -119.54 140.98 49.65 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.77 -0.65 . . . . 61.22 110.516 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.416 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 58.2 mtt -121.82 114.53 21.19 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.24 -1.022 . . . . 74.24 108.24 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 . . . . . 0 C--N 1.278 -2.541 0 N-CA-C 107.024 -1.473 . . . . 74.44 107.024 -178.653 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.729 0 N-CA-C 110.854 -0.898 . . . . 43.05 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -137.76 172.36 13.06 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 122.282 0.233 . . . . 74.32 110.409 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' HA3' ' HB ' ' A' ' 7' ' ' THR . . . -121.36 -179.99 16.17 Favored Glycine 0 N--CA 1.434 -1.482 0 O-C-N 123.871 0.732 . . . . 54.21 111.302 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 m -50.94 -46.89 61.14 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.242 1.417 . . . . 64.23 114.434 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.09 10.62 30.83 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.677 0.621 . . . . 74.11 112.677 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.27 12.34 54.67 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 109.287 -1.525 . . . . 73.32 109.287 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.433 ' HB ' ' HA3' ' A' ' 3' ' ' GLY . 12.9 m -54.71 116.58 2.78 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 125.906 1.682 . . . . 74.42 111.404 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 m -115.85 114.64 24.99 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.829 -1.174 . . . . 74.15 107.829 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 25.5 t -91.35 115.9 31.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.402 -0.962 . . . . 73.14 108.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.479 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.9 m -118.6 127.74 53.89 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 115.742 -0.663 . . . . 73.35 110.231 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 20' ' ' THR . 69.1 mt -90.57 121.71 32.75 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.91 -1.041 . . . . 54.24 108.387 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.68 114.52 28.79 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 123.889 0.743 . . . . 75.21 109.339 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 tp -118.18 109.02 15.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 123.918 0.887 . . . . 64.23 109.713 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -97.44 101.6 13.17 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.105 -0.702 . . . . 71.33 109.105 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -97.18 5.26 50.45 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.835 -0.802 . . . . 71.22 108.835 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.99 -40.43 0.62 Allowed Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 114.671 -1.15 . . . . 74.54 110.269 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 m -112.01 -50.95 2.88 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 112.889 0.7 . . . . 60.04 112.889 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.76 82.25 0.55 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.669 -0.776 . . . . 64.11 111.983 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.11 150.19 22.84 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 110.133 -0.321 . . . . 64.21 110.133 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.8 p -133.61 145.87 50.42 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 116.138 -0.483 . . . . 61.33 111.114 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -137.97 129.58 28.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.572 -0.899 . . . . 65.44 108.572 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 53.1 tt0 -92.39 134.93 34.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.214 -0.662 . . . . 53.25 109.214 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -60.19 139.92 57.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.433 0.635 . . . . 72.25 111.971 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -95.88 169.65 9.85 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.255 -0.884 . . . . 71.42 109.757 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.54 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 1.2 pm0 -75.09 122.67 23.93 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 123.536 0.735 . . . . 73.24 110.758 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.52 -164.93 12.02 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.461 -1.056 . . . . 75.31 110.461 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.7 t -107.65 142.85 36.97 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 117.116 0.458 . . . . 54.12 111.433 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -117.89 117.75 30.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.532 0.682 . . . . 74.35 109.57 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -91.69 112.3 25.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.99 -1.005 . . . . 50.12 108.559 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.9 mt -90.3 128.1 42.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 123.914 0.759 . . . . 72.25 110.009 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.44 175.15 34.11 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.62 -0.992 . . . . 74.0 110.62 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 48.9 mtm180 -109.22 106.69 16.65 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.809 -0.811 . . . . 74.42 108.809 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.01 173.2 42.35 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 109.424 -1.47 . . . . 44.43 109.424 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -81.72 -16.53 50.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.144 0.497 . . . . 64.44 110.461 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.46 6.3 49.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.051 0.929 . . . . 64.12 109.739 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.79 161.46 13.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.107 -0.951 . . . . 65.33 110.07 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -109.42 -50.27 3.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.542 0.687 . . . . 75.4 109.595 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 54.2 t80 -106.51 123.85 48.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.2 -1.407 . . . . 75.55 107.2 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 51.0 mtt180 -111.3 133.34 53.7 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 120.867 -0.333 . . . . 75.3 110.599 -174.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.63 149.28 71.1 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.534 . . . . 74.31 110.484 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 -0.09 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.534 2.156 . . . . 72.35 114.123 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.19 -173.5 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.245 -0.982 . . . . 63.31 112.085 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 44' ' ' GLY . 7.1 m -96.31 174.35 6.92 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.33 1.052 . . . . 72.24 108.549 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 43' ' ' THR . . . 103.89 -21.05 39.41 Favored Glycine 0 CA--C 1.498 -0.996 0 N-CA-C 109.572 -1.411 . . . . 73.11 109.572 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.12 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.417 -1.392 . . . . 65.42 108.864 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -88.63 -173.51 4.17 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.451 -0.574 . . . . 53.32 109.451 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 21.1 ptt180 -72.39 -42.73 64.86 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.216 -1.031 . . . . 65.35 108.216 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.457 HH21 HD21 ' A' ' 64' ' ' LEU . 11.0 mtp180 -120.78 101.84 7.99 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.786 -1.931 . . . . 75.12 105.786 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -98.97 -43.93 6.52 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.855 -0.424 . . . . 74.12 109.855 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -159.49 151.17 20.31 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.442 -0.577 . . . . 73.43 109.442 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -126.78 127.37 44.93 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.351 0.596 . . . . 75.53 110.744 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -100.43 117.1 45.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.408 -1.33 . . . . 71.23 107.408 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 12.7 ttm180 -105.91 110.05 22.21 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.401 -0.592 . . . . 73.14 109.401 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -104.89 132.43 51.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.489 -0.778 . . . . 74.31 110.374 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.73 166.88 23.63 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.123 -2.177 . . . . 73.12 105.123 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.02 65.24 1.91 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 118.377 0.535 . . . . 33.5 113.13 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -159.16 -78.03 0.07 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.42 -0.956 . . . . 75.02 108.42 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 m -142.27 159.97 19.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.818 -0.808 . . . . 74.22 108.818 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.26 114.01 26.42 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.461 -0.57 . . . . 62.3 109.461 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 69.0 tp -83.71 108.35 16.71 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.912 -1.04 . . . . 63.43 109.867 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.5 tm? -93.92 110.83 22.48 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.324 -1.362 . . . . 62.14 107.324 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.33 119.0 29.82 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.629 -0.508 . . . . 64.32 109.629 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -95.18 141.18 29.09 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.907 -0.588 . . . . 43.0 111.445 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.457 HD21 HH21 ' A' ' 48' ' ' ARG . 3.6 mm? -102.15 102.07 12.47 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 122.863 0.465 . . . . 74.53 110.871 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 67.62 85.14 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.458 1.103 . . . . 61.52 111.628 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.0 m -65.16 -14.73 61.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.223 1.194 . . . . 74.32 114.223 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -55.17 -38.27 68.09 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.96 0.886 . . . . 74.43 110.429 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -121.87 0.52 9.76 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.144 -1.058 . . . . 71.44 108.144 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 -137.27 1.41 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.026 -1.443 . . . . 74.24 115.78 -170.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -114.18 152.8 30.65 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-O 122.068 0.937 . . . . 74.42 113.106 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -121.8 141.21 51.45 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.795 -1.093 . . . . 63.11 110.448 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 88' ' ' ILE . 29.6 m -110.79 124.77 67.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.488 -2.041 . . . . 64.21 105.488 174.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 62.21 24.13 14.34 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.477 0.711 . . . . 62.24 109.211 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 71.25 20.77 4.94 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.216 1.407 . . . . 74.24 110.668 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.63 130.49 24.77 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.981 -0.748 . . . . 65.15 108.981 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.33 137.39 30.9 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 122.709 2.273 . . . . 63.42 112.761 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 80' ' ' TRP . 22.4 m -143.56 161.22 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.435 -0.58 . . . . 51.33 109.435 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -85.65 -45.46 11.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.923 -0.769 . . . . 73.14 108.923 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 12.3 pt-20 -145.33 151.72 38.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.971 -1.013 . . . . 71.3 108.736 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.459 ' HB2' HG21 ' A' ' 77' ' ' VAL . 64.6 t-105 -151.94 148.87 28.28 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.141 -1.059 . . . . 64.11 108.141 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.45 108.04 19.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.731 -1.211 . . . . 72.31 107.731 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 81.8 mt -57.06 148.26 22.17 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.434 -0.803 . . . . 51.03 111.702 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -147.34 164.04 34.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.796 -1.187 . . . . 55.34 107.796 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.35 119.81 9.81 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.702 0.626 . . . . 75.34 111.867 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.34 16.27 35.32 Favored Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 115.525 -0.761 . . . . 64.42 113.034 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.07 146.75 23.48 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 119.212 -0.995 . . . . 61.44 108.615 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.04 112.91 42.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.11 -0.7 . . . . 62.2 109.11 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.83 119.69 55.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.414 -0.958 . . . . 70.22 108.414 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -121.9 116.96 25.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 119.493 -0.883 . . . . 74.13 111.343 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -116.54 164.97 13.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.536 -1.211 . . . . 74.33 108.547 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -39.2 107.91 0.08 OUTLIER Glycine 0 N--CA 1.479 1.55 0 O-C-N 123.964 0.79 . . . . 62.32 114.443 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 69.5 -4.03 1.47 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.304 1.442 . . . . 72.32 114.864 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 m -129.42 112.96 14.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.354 0.597 . . . . 73.33 111.345 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.73 132.68 49.77 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.775 -1.194 . . . . 75.34 107.775 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.1 tp -134.69 140.41 45.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.861 -0.422 . . . . 70.11 109.861 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.17 128.6 56.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.785 -1.191 . . . . 73.22 107.785 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.95 116.51 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.177 0.513 . . . . 62.03 110.774 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -110.77 129.31 55.88 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.608 -0.724 . . . . 75.25 109.336 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 86.4 mtp -111.62 108.54 18.05 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.777 -1.194 . . . . 63.23 107.777 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 C--N 1.27 -2.883 0 CA-C-N 114.756 -1.111 . . . . 74.42 108.463 -176.297 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.188 0 N-CA-C 109.853 -1.299 . . . . 62.23 109.853 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.495 ' HB3' ' HA3' ' A' ' 56' ' ' GLY . 16.5 p80 -130.77 144.54 51.52 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 115.11 1.522 . . . . 74.34 115.11 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.55 161.24 34.4 Favored Glycine 0 N--CA 1.412 -2.947 0 N-CA-C 104.509 -3.437 . . . . 73.43 104.509 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 m -86.39 71.5 10.45 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 119.44 1.62 . . . . 63.51 111.216 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.32 100.96 1.08 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.332 -1.304 . . . . 42.52 107.884 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.29 -45.75 1.09 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 108.248 -1.941 . . . . 71.41 108.248 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m -145.46 115.03 7.22 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.302 -0.999 . . . . 74.14 108.302 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -118.99 115.49 24.45 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.851 -1.166 . . . . 63.14 107.851 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 23' ' ' LEU . 6.2 p -93.63 127.76 45.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.022 0 CA-C-O 121.503 0.668 . . . . 74.2 109.211 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.4 m -125.64 131.73 52.59 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.409 -0.814 . . . . 55.24 109.142 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.65 133.07 36.35 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.346 -0.613 . . . . 73.24 109.346 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -105.2 109.21 21.11 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.068 -1.827 . . . . 55.2 106.068 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.21 122.21 44.27 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.078 -0.51 . . . . 63.44 110.502 -175.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.59 99.33 12.38 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.358 -2.089 . . . . 64.42 105.358 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -121.31 -6.77 9.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.16 -0.927 . . . . 74.4 110.778 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.17 -15.8 12.01 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 109.913 -1.275 . . . . 62.1 109.913 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 m -111.61 -44.24 3.53 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.969 -0.752 . . . . 62.33 108.969 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.59 67.67 1.19 Allowed Glycine 0 CA--C 1.48 -2.141 0 N-CA-C 107.848 -2.101 . . . . 61.53 107.848 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -91.92 154.08 19.07 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.015 -0.592 . . . . 61.3 110.479 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 45.6 p -130.17 131.95 45.84 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.025 -1.102 . . . . 54.24 108.025 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -134.84 125.64 27.22 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.586 -0.524 . . . . 73.53 109.586 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.81 121.84 26.95 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.946 -0.761 . . . . 75.44 108.946 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.546 ' HB2' HG13 ' A' ' 9' ' ' VAL . 80.0 mt -66.12 139.25 58.14 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.161 -0.927 . . . . 65.24 111.923 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.58 153.46 21.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.482 -1.673 . . . . 72.13 106.482 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.24 133.88 48.49 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 73.14 111.598 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.4 -166.6 13.26 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 107.522 -2.231 . . . . 72.51 107.522 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 61.1 p -106.45 128.96 54.47 Favored 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.432 -1.307 . . . . 70.22 111.19 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -96.99 111.87 23.89 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.55 -1.278 . . . . 74.22 107.55 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mm -85.8 123.81 39.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.98 -0.555 . . . . 73.32 110.342 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.4 mt -109.52 138.19 38.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.849 -0.614 . . . . 54.31 109.606 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 152.4 -162.51 29.92 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.952 -0.859 . . . . 61.02 110.952 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.638 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.4 mtt180 -121.52 105.88 10.87 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 117.663 0.732 . . . . 62.45 109.373 176.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.49 47.74 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 120.061 -1.066 . . . . 75.14 111.318 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -75.73 -23.73 56.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.764 0.792 . . . . 64.23 109.088 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.38 -18.87 44.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.759 -1.109 . . . . 71.13 110.498 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.18 136.25 36.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.895 -0.593 . . . . 74.24 111.833 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.73 -24.05 16.14 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.575 -0.898 . . . . 24.24 108.575 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -133.29 120.0 20.5 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.617 -1.174 . . . . 71.11 108.594 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 79.6 mtt180 -97.82 130.57 44.74 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.14 0.495 . . . . 72.54 111.321 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD12 HG11 ' A' ' 45' ' ' VAL . 82.2 mt -77.6 144.83 70.22 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.473 -0.785 . . . . 61.32 111.057 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 9.22 2.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.963 2.442 . . . . 63.04 113.448 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -123.42 163.64 20.45 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.503 -1.295 . . . . 72.23 107.503 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 44' ' ' GLY . 11.7 m -110.23 172.11 7.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.82 -0.807 . . . . 75.34 108.82 -176.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' H ' HG22 ' A' ' 43' ' ' THR . . . 94.19 5.27 62.33 Favored Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 109.472 -1.451 . . . . 52.41 109.472 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 40' ' ' LEU . 43.9 t -100.36 145.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.036 -1.082 . . . . 53.13 108.306 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -79.07 173.43 12.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.197 0.199 . . . . 41.14 110.627 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.5 ptp180 -65.15 -31.06 72.05 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.653 0.739 . . . . 72.14 110.566 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 64' ' ' LEU . 25.3 mtm-85 -134.08 109.59 9.05 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.728 -2.323 . . . . 72.31 104.728 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -104.56 -35.82 7.72 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 123.807 0.692 . . . . 71.11 110.247 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -162.86 149.57 12.8 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.689 -0.486 . . . . 62.13 109.689 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.25 122.53 37.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.451 0.643 . . . . 63.53 109.964 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.9 mt -96.29 104.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.783 -1.562 . . . . 63.31 106.783 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 63.8 ttt180 -91.84 107.29 19.11 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.777 0.799 . . . . 62.11 109.802 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -94.86 106.95 18.96 Favored 'General case' 0 N--CA 1.391 -3.395 0 N-CA-C 107.384 -1.339 . . . . 75.03 107.384 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -106.3 -175.36 2.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.671 -1.603 . . . . 63.22 106.671 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 2' ' ' HIS . . . -88.02 57.26 4.32 Favored Glycine 0 C--N 1.285 -2.261 0 C-N-CA 119.493 -1.337 . . . . 42.51 115.445 -171.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -179.3 -65.59 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.602 0.761 . . . . 70.52 109.666 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.46 156.56 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.269 -0.423 . . . . 61.51 109.998 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.35 109.8 22.49 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.161 -1.051 . . . . 51.31 108.161 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.39 122.52 31.99 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.979 -1.01 . . . . 75.45 110.505 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -103.27 125.51 49.95 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.678 -1.23 . . . . 73.53 107.678 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.07 124.65 26.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.995 -0.372 . . . . 73.45 109.995 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.53 137.87 32.17 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.495 -0.775 . . . . 74.52 109.183 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 48' ' ' ARG . 27.9 tp -133.89 75.97 1.63 Allowed 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.688 0.756 . . . . 31.41 109.121 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 38.5 t-20 -173.07 142.52 1.06 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.897 -1.52 . . . . 71.52 106.897 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -95.69 -47.68 6.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.89 -0.724 . . . . 61.43 110.834 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -88.92 -12.43 41.69 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.327 0.584 . . . . 60.44 112.302 -174.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.56 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 18.5 m120 -121.43 27.55 8.23 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.778 -0.576 . . . . 52.25 111.07 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.38 113.95 0.79 Allowed Glycine 0 N--CA 1.481 1.676 0 O-C-N 124.403 1.064 . . . . 72.44 113.777 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 90' ' ' LEU . 24.7 m -63.82 146.71 53.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.013 1.325 . . . . 65.43 112.57 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -109.73 140.74 43.25 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 115.183 -0.917 . . . . 63.3 112.467 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 27.5 m -118.88 122.03 68.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 105.832 -1.914 . . . . 75.31 105.832 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.4 m120 62.69 25.38 15.08 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.042 -0.725 . . . . 74.43 109.042 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.7 t30 79.58 4.86 2.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.215 1.406 . . . . 75.32 111.745 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.0 34.15 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 121.545 -0.722 . . . . 71.42 109.933 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.74 130.98 15.29 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.277 1.985 . . . . 73.54 111.596 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.9 m -135.4 159.07 40.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.255 -0.43 . . . . 54.11 110.645 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -82.11 -38.74 24.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.993 -0.743 . . . . 73.23 108.993 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.1 155.54 36.98 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.577 -0.897 . . . . 75.11 108.577 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.535 ' HB2' HG21 ' A' ' 77' ' ' VAL . 54.0 t-105 -159.98 149.1 17.6 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.309 -0.997 . . . . 73.24 108.309 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -100.8 115.17 29.69 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.045 -1.062 . . . . 72.15 108.642 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.552 HD22 HD11 ' A' ' 88' ' ' ILE . 62.3 mt -61.91 147.9 45.27 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.568 -1.196 . . . . 72.53 111.415 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.86 168.01 19.84 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.891 -1.522 . . . . 52.1 106.891 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 121.3 16.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.551 -0.537 . . . . 72.35 109.551 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.1 44.18 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 115.6 -0.727 . . . . 71.12 112.398 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.1 152.86 25.14 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 107.405 -1.331 . . . . 53.25 107.405 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 39.1 t -114.16 112.87 42.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.081 -0.34 . . . . 71.3 110.081 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.552 HD11 HD22 ' A' ' 82' ' ' LEU . 1.6 mp -107.44 114.14 45.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.558 -1.275 . . . . 72.41 107.558 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' HG3' ' HB3' ' A' ' 94' ' ' GLU . 15.5 ttt180 -123.43 127.6 48.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 120.275 -0.57 . . . . 65.1 110.361 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.0 OUTLIER -140.37 163.34 33.04 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.696 -1.594 . . . . 71.12 106.696 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -45.46 119.38 3.5 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.59 0.556 . . . . 62.35 114.003 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 29.0 t60 78.75 -33.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.134 1.374 . . . . 74.3 113.181 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.1 m -114.2 116.77 29.58 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.416 0.627 . . . . 64.13 111.56 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.572 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 11.5 pt-20 -116.9 121.71 42.24 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.828 -0.805 . . . . 75.22 108.828 173.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -126.49 136.83 59.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.881 -1.054 . . . . 71.2 111.94 -170.402 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -105.55 127.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.098 -1.075 . . . . 70.14 108.098 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 82' ' ' LEU . 55.5 t -86.99 125.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 116.412 -0.358 . . . . 75.33 110.969 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -115.68 149.52 38.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.718 -0.475 . . . . 73.2 109.718 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.3 mtt -130.26 116.92 19.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.456 0.646 . . . . 73.41 110.323 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.08 -1.081 . . . . 71.32 108.08 -178.846 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.621 0 N-CA-C 111.003 -0.839 . . . . 43.13 111.003 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -91.18 101.26 13.99 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.361 -0.494 . . . . 74.51 111.046 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.02 173.71 47.69 Favored Glycine 0 N--CA 1.432 -1.576 0 CA-C-N 115.408 -0.814 . . . . 72.25 111.838 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -72.37 118.8 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.222 -0.659 . . . . 63.13 109.222 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.92 15.72 2.86 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.041 0.924 . . . . 54.01 109.229 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.94 -165.24 30.29 Favored Glycine 0 N--CA 1.413 -2.888 0 N-CA-C 108.314 -1.914 . . . . 64.44 108.314 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 m -78.88 132.39 36.78 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.116 0.484 . . . . 70.44 110.682 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -111.15 116.87 31.82 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.542 -1.281 . . . . 74.32 107.542 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.418 HG22 ' HG2' ' A' ' 99' ' ' MET . 25.0 t -99.81 132.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.555 -0.535 . . . . 53.41 109.555 -175.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.1 m -135.66 127.64 29.59 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.912 -0.773 . . . . 51.41 108.912 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 95' ' ' ILE . 4.3 pp -95.84 139.96 31.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.821 -0.437 . . . . 75.51 109.821 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -112.05 106.32 14.93 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.115 -0.698 . . . . 65.23 109.115 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.07 126.42 50.24 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.404 -0.962 . . . . 70.21 108.404 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -94.25 100.87 12.85 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 117.752 -1.579 . . . . 74.32 110.479 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.61 -0.11 57.55 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.495 -1.23 . . . . 74.43 109.016 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 42.69 0.96 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.566 -1.814 . . . . 64.41 108.566 -173.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.4 t -177.59 -24.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.865 -0.668 . . . . 74.5 111.289 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.1 71.29 1.05 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.463 -0.875 . . . . 44.12 110.951 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -88.72 153.47 21.07 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 122.824 0.45 . . . . 72.33 110.228 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.8 p -129.75 132.63 46.63 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.461 0.648 . . . . 74.52 111.989 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -125.62 127.23 46.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.394 -0.965 . . . . 74.34 108.394 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.563 -0.532 . . . . 72.22 109.563 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.2 mt -81.03 122.19 26.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.881 -0.785 . . . . 74.02 108.881 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -91.67 156.18 17.78 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.0 -0.68 . . . . 75.31 109.314 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.17 132.71 51.19 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.621 1.201 . . . . 73.23 111.302 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.41 -162.5 12.47 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 107.279 -2.329 . . . . 71.25 107.279 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.5 p -106.21 131.57 53.29 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 118.618 -1.233 . . . . 74.43 111.164 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.67 111.52 23.85 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.493 -1.299 . . . . 73.31 107.493 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.9 mm -85.69 121.9 37.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.098 -0.704 . . . . 75.13 109.098 -176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 38' ' ' PHE . 71.0 mt -112.57 132.83 60.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.605 -0.725 . . . . 75.25 109.704 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 145.53 -161.24 28.2 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 109.807 -1.317 . . . . 40.02 109.807 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.733 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 84.1 mtt180 -121.55 106.53 11.47 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.908 -0.775 . . . . 55.41 108.908 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.83 179.0 43.79 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.541 -1.024 . . . . 75.4 110.541 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -64.41 -46.45 83.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.865 0.691 . . . . 63.03 112.865 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.22 1.95 55.96 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.877 0.37 . . . . 74.54 111.163 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 124.12 23.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.551 -0.907 . . . . 43.51 108.551 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -89.38 -38.04 14.41 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.672 0.749 . . . . 75.32 109.588 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HD2' HG23 ' A' ' 30' ' ' ILE . 86.1 t80 -117.61 112.17 20.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.191 -0.913 . . . . 75.0 109.051 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -89.41 133.54 34.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.488 -0.778 . . . . 62.11 111.174 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 90' ' ' LEU . 85.5 mt -89.67 140.22 28.05 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 115.458 -0.792 . . . . 61.1 111.628 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.95 -23.0 30.45 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.11 2.54 . . . . 74.55 112.018 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -72.01 164.67 25.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.788 -0.642 . . . . 64.14 109.518 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -129.71 149.38 51.48 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 108.446 -0.946 . . . . 74.43 108.446 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.28 48.2 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 107.553 -2.219 . . . . 41.11 107.553 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -88.28 143.14 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 112.695 -1.753 . . . . 74.35 108.743 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 m -78.01 169.48 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 19.2 ptt180 -65.39 -37.27 86.49 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.865 0.84 . . . . 75.33 109.115 172.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB3' HD12 ' A' ' 64' ' ' LEU . 98.9 mtt180 -123.69 100.41 6.77 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 105.098 -2.186 . . . . 74.52 105.098 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -95.07 -32.44 13.11 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.904 -0.776 . . . . 54.54 108.904 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD11 HD21 ' A' ' 61' ' ' LEU . 8.3 tt -167.57 143.17 3.99 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.59 -0.732 . . . . 74.13 109.222 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -124.47 126.12 45.38 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.941 -0.572 . . . . 74.13 110.337 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.14 112.9 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.519 -0.919 . . . . 64.42 108.519 175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 73.5 ttt180 -90.79 110.13 21.33 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.563 -0.903 . . . . 61.31 108.563 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -99.86 110.54 22.89 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 114.986 -1.006 . . . . 71.1 108.755 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -116.41 174.42 6.07 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.357 -2.09 . . . . 64.15 105.357 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.98 32.39 2.73 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 120.272 -0.966 . . . . 74.14 112.908 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -134.83 -65.59 0.62 Allowed 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.414 0.685 . . . . 73.24 109.315 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.04 159.51 26.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 115.886 -0.597 . . . . 53.24 109.7 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 109.97 21.76 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.662 -0.866 . . . . 71.33 108.662 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.65 119.54 30.15 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.131 -1.395 . . . . 54.24 112.935 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -100.94 108.41 20.15 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 113.311 -1.768 . . . . 73.14 108.08 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.0 115.76 25.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.884 -0.413 . . . . 71.44 109.884 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.45 134.85 34.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.812 -0.631 . . . . 75.43 110.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 48' ' ' ARG . 21.7 mt -126.35 75.97 1.58 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.508 -0.923 . . . . 62.32 108.508 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -170.3 122.63 0.66 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 121.107 0.479 . . . . 70.44 110.124 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.3 m -93.38 -14.22 27.11 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.891 -0.506 . . . . 71.35 111.269 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -89.14 -56.45 3.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.859 0.838 . . . . 71.11 110.706 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -119.71 29.55 7.52 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.157 -0.929 . . . . 75.33 109.423 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.4 130.98 5.96 Favored Glycine 0 C--O 1.251 1.184 0 CA-C-N 114.238 -1.346 . . . . 73.24 113.486 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -66.93 143.43 56.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 125.66 1.584 . . . . 52.53 113.168 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 p -107.95 141.72 39.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.591 -1.186 . . . . 75.4 110.275 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 80' ' ' TRP . 31.4 m -120.76 120.64 63.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.844 -1.539 . . . . 70.2 106.844 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 61.64 25.96 15.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.463 0.649 . . . . 60.34 109.621 -175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.8 t30 78.15 3.15 2.8 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.46 1.904 . . . . 75.32 111.358 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.73 124.02 51.85 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.371 -0.603 . . . . 74.43 109.371 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.14 125.94 11.92 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.248 1.966 . . . . 61.54 111.155 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.91 166.58 25.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 116.476 -0.329 . . . . 62.13 110.164 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.476 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 25.1 pt20 -100.67 -26.8 13.68 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.254 -0.646 . . . . 62.22 109.254 174.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.476 ' HG2' ' HG3' ' A' ' 78' ' ' GLN . 10.6 pt-20 -158.52 148.96 20.05 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.785 -0.643 . . . . 72.14 109.814 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.472 ' CD2' HG21 ' A' ' 72' ' ' VAL . 53.7 t-105 -163.84 152.93 14.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.302 -0.999 . . . . 72.55 108.302 -172.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -105.67 121.31 43.73 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.321 -0.952 . . . . 73.55 109.07 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.62 151.09 47.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.205 -0.907 . . . . 70.25 113.106 -174.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.49 165.75 25.52 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.14 -1.43 . . . . 64.3 107.14 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 19.4 t70 -69.12 121.25 16.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.933 0.396 . . . . 60.33 109.969 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.34 8.2 53.29 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.708 -0.678 . . . . 74.11 111.693 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.12 134.02 36.13 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 107.566 -1.272 . . . . 72.41 107.566 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -98.93 112.81 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.341 -0.614 . . . . 65.21 109.341 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.441 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.09 129.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 106.958 -1.497 . . . . 73.54 106.958 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -138.24 149.29 45.61 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.814 -0.754 . . . . 74.31 110.969 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.472 ' CD1' HD13 ' A' ' 40' ' ' LEU . 2.0 pt? -138.32 165.55 26.46 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.852 -2.277 . . . . 75.53 104.852 172.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -34.84 102.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.833 0 N-CA-C 115.98 1.152 . . . . 31.42 115.98 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 60.85 17.96 8.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.4 1.08 . . . . 64.11 113.908 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -131.6 114.01 14.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.819 -0.808 . . . . 72.41 108.819 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.06 139.8 49.92 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.586 0.708 . . . . 75.44 112.013 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -135.51 137.11 50.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.71 -1.132 . . . . 74.33 110.392 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.78 126.04 65.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.827 -0.805 . . . . 62.14 108.827 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.0 t -85.07 126.36 40.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.674 -0.239 . . . . 70.34 110.693 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -115.31 145.05 42.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.572 -0.529 . . . . 74.12 109.572 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.418 ' HG2' HG22 ' A' ' 9' ' ' VAL . 56.0 mtt -130.37 127.49 39.49 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.693 -0.685 . . . . 74.13 109.598 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 107.173 -1.417 . . . . 74.24 107.173 178.311 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.67 0 N-CA-C 111.731 -0.548 . . . . 74.04 111.731 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -105.05 -28.75 10.85 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.922 0.391 . . . . 70.42 110.349 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.62 -157.99 51.11 Favored Glycine 0 C--O 1.249 1.075 0 N-CA-C 110.861 -0.896 . . . . 60.23 110.861 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -88.3 84.22 6.87 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.04 -1.096 . . . . 73.1 108.04 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.55 36.61 0.65 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.118 -0.946 . . . . 74.45 108.669 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.45 -15.48 63.97 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.117 -0.947 . . . . 70.13 112.323 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m -57.42 115.9 3.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.204 0.526 . . . . 61.5 111.329 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -116.52 134.74 54.5 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.722 -1.214 . . . . 63.32 107.722 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.4 p -101.37 114.81 41.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.435 -0.95 . . . . 72.34 108.435 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.5 m -124.43 136.05 53.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 114.663 -1.153 . . . . 71.21 110.667 -169.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 20' ' ' THR . 57.7 mt -89.23 126.37 35.47 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.476 -1.238 . . . . 61.11 109.402 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -106.61 114.51 28.65 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.709 -1.219 . . . . 74.41 107.709 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 62.8 tp -118.07 110.99 18.31 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.671 -0.863 . . . . 63.43 108.671 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.06 100.26 12.41 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 117.764 -1.575 . . . . 65.32 109.629 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.6 30.43 3.61 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 106.382 -1.71 . . . . 72.53 106.382 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.5 47.08 17.18 Favored Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.177 -1.969 . . . . 63.13 108.177 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -162.81 -29.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.154 0.582 . . . . 72.13 111.785 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.91 3.46 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.692 -0.963 . . . . 62.01 110.692 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -87.95 148.21 24.68 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 110.062 -0.347 . . . . 73.24 110.062 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 22.9 p -135.45 132.24 37.18 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.076 0.465 . . . . 54.3 111.789 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -128.25 126.21 40.45 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.218 -1.401 . . . . 74.22 107.218 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -94.87 141.08 29.06 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.432 -0.507 . . . . 73.1 110.305 -175.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.445 ' HB2' HG13 ' A' ' 9' ' ' VAL . 95.6 mt -80.48 140.82 35.72 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.605 -0.517 . . . . 71.02 109.605 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -96.61 169.06 10.15 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.387 -0.525 . . . . 65.34 110.274 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -74.62 112.99 11.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.265 0.978 . . . . 73.32 110.43 -178.143 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.38 -159.65 23.19 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.124 -1.991 . . . . 62.3 108.124 -174.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.6 p -101.27 131.44 47.29 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.139 -1.024 . . . . 51.41 110.646 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.446 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 24.6 m-80 -106.67 112.33 25.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 74.1 107.774 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -96.95 126.1 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.401 -0.222 . . . . 74.13 110.401 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.06 142.97 31.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 C-N-CA 123.545 0.738 . . . . 64.04 109.837 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 153.49 -154.0 25.21 Favored Glycine 0 CA--C 1.475 -2.453 0 N-CA-C 110.683 -0.967 . . . . 45.14 110.683 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 16.7 mmm180 -131.73 104.83 7.12 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.256 0.55 . . . . 72.24 109.789 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 169.97 37.63 Favored Glycine 0 N--CA 1.41 -3.06 0 N-CA-C 108.99 -1.644 . . . . 71.45 108.99 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.16 -14.22 60.53 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.693 0.759 . . . . 74.01 109.701 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.19 -10.01 40.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.355 -0.838 . . . . 73.3 110.704 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -90.59 149.2 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.363 -0.606 . . . . 73.44 109.363 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 86.8 mt-30 -87.25 -49.28 7.37 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.742 -0.836 . . . . 75.51 108.742 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -105.44 111.42 24.13 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.397 -0.82 . . . . 73.35 109.069 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -91.16 122.55 33.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.477 -0.783 . . . . 63.24 110.725 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD12 HG11 ' A' ' 45' ' ' VAL . 79.9 mt -65.63 158.4 74.36 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.147 -0.933 . . . . 74.22 112.033 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.78 26.68 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.533 2.822 . . . . 73.45 112.161 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.72 153.38 47.19 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.181 -1.415 . . . . 73.51 107.181 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -121.39 161.32 22.34 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 120.235 -0.586 . . . . 73.33 109.625 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.56 -15.47 24.51 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 108.502 -1.839 . . . . 63.35 108.502 -172.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 40' ' ' LEU . 51.9 t -76.93 149.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 125.449 1.5 . . . . 72.32 108.894 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.0 m -75.67 163.39 27.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 119.597 -0.24 . . . . 75.23 110.901 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 44.6 ptt85 -60.28 -41.39 93.21 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 120.94 0.4 . . . . 73.13 110.681 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -121.53 107.07 11.99 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 106.323 -1.732 . . . . 74.22 106.323 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -103.21 -34.04 8.97 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.654 -1.157 . . . . 75.13 108.945 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.51 HD11 HD21 ' A' ' 61' ' ' LEU . 7.9 tt -166.39 148.51 6.72 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 115.669 -0.696 . . . . 72.51 109.134 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HG2' HD21 ' A' ' 64' ' ' LEU . 12.6 pt-20 -137.32 144.45 42.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.856 -0.794 . . . . 71.35 108.856 175.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.4 mt -117.2 119.13 60.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 109.555 -0.535 . . . . 74.33 109.555 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -91.17 107.72 19.39 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.599 -1.259 . . . . 75.11 107.599 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -105.44 118.71 37.26 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.714 -0.675 . . . . 71.23 109.366 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.45 -178.84 4.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.564 -2.384 . . . . 64.4 104.564 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.3 53.42 4.78 Favored Glycine 0 C--N 1.297 -1.601 0 C-N-CA 119.856 -1.164 . . . . 31.4 112.721 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -147.74 -77.45 0.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.487 0.715 . . . . 73.35 109.333 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.61 159.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.043 -0.725 . . . . 42.25 109.043 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.93 107.84 19.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.111 -1.07 . . . . 54.32 108.111 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.88 113.27 20.38 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.377 -0.828 . . . . 70.11 108.828 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -90.29 119.59 30.72 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 124.805 1.242 . . . . 62.32 108.347 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.14 119.72 28.28 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.535 -0.543 . . . . 43.15 109.535 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 131.58 42.35 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.844 -0.617 . . . . 74.22 111.148 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.5 mm? -118.68 76.72 1.11 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.057 -0.719 . . . . 63.43 109.057 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 38.1 t-20 -176.43 139.9 0.35 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.527 -0.916 . . . . 54.32 108.527 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -108.25 -50.23 3.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.928 -0.397 . . . . 53.21 109.928 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -59.1 -49.03 79.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.65 0.738 . . . . 72.51 111.549 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -121.38 28.14 7.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.695 0.76 . . . . 54.14 109.28 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 65' ' ' ASN . . . -49.95 144.65 9.7 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 113.83 -1.532 . . . . 74.03 115.182 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.8 m -75.65 143.13 42.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.492 1.117 . . . . 42.11 112.063 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.9 p -110.91 148.83 31.61 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.813 -0.631 . . . . 74.41 111.043 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG12 HG13 ' A' ' 88' ' ' ILE . 34.1 m -114.87 118.38 58.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.663 -1.236 . . . . 65.14 107.663 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.4 29.84 19.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.569 0.7 . . . . 72.33 110.415 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 77.62 13.26 1.86 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.198 1.799 . . . . 70.2 111.242 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.97 128.14 25.9 Favored Pre-proline 0 C--N 1.32 -0.706 0 O-C-N 121.859 -0.526 . . . . 73.3 109.598 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.19 125.74 11.69 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.689 2.259 . . . . 62.41 112.467 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.69 -177.2 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.125 -1.065 . . . . 72.35 108.125 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -125.39 -27.28 3.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.356 0.41 . . . . 64.44 110.784 175.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.76 134.47 28.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 45.33 109.727 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -149.13 152.15 35.61 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.917 -0.771 . . . . 73.54 108.917 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -101.7 107.52 18.77 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.468 -1.678 . . . . 71.22 106.468 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 82.9 mt -58.9 137.49 57.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.154 0.502 . . . . 61.23 112.054 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.01 163.47 24.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.859 -1.163 . . . . 42.02 107.859 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.91 117.93 8.31 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.426 -0.352 . . . . 64.42 110.204 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.48 -0.98 30.83 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.825 -0.702 . . . . 51.32 113.814 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -80.07 141.65 35.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.523 0.662 . . . . 73.33 111.305 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.22 113.77 39.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 N-CA-C 108.682 -0.859 . . . . 73.03 108.682 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.465 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -107.34 114.16 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.661 -0.866 . . . . 75.54 108.661 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 94' ' ' GLU . 37.3 ttt180 -106.57 109.42 21.33 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.031 -1.067 . . . . 72.14 112.04 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 90' ' ' LEU . 2.0 pt? -112.79 164.43 13.4 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.684 -1.599 . . . . 71.44 106.684 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -24.58 99.14 0.01 OUTLIER Glycine 0 N--CA 1.485 1.908 0 O-C-N 124.661 1.225 . . . . 73.22 116.092 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 t60 77.65 -28.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.79 1.636 . . . . 72.43 113.581 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 m -114.73 119.6 37.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 113.495 0.924 . . . . 73.43 113.495 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 6.8 pt-20 -94.16 115.11 27.35 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.661 -0.866 . . . . 64.03 108.661 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.0 tp -103.34 140.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.941 -1.027 . . . . 61.11 109.239 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 69.3 mt -101.68 121.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.063 -1.088 . . . . 64.32 108.063 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 82' ' ' LEU . 72.5 t -87.6 118.3 33.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.463 -0.335 . . . . 44.23 110.167 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -119.58 150.55 40.11 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 109.524 -0.547 . . . . 73.44 109.524 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mtt -117.25 120.41 38.15 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.347 -0.982 . . . . 64.34 108.347 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 . . . . . 0 C--N 1.273 -2.726 0 N-CA-C 107.633 -1.247 . . . . 70.03 107.633 -177.17 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.154 0 N-CA-C 110.321 -1.112 . . . . 43.05 110.321 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -134.38 168.19 19.37 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 117.514 0.657 . . . . 62.02 110.199 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -118.9 163.09 13.27 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.62 -0.992 . . . . 52.51 110.62 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -76.52 102.78 6.2 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.592 -0.892 . . . . 64.41 108.592 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.29 79.18 1.87 Allowed 'General case' 0 N--CA 1.415 -2.178 0 CA-C-O 121.826 0.822 . . . . 63.34 110.713 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.84 -30.22 21.37 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.374 -1.491 . . . . 74.14 109.374 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -65.7 116.75 7.24 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 123.433 0.693 . . . . 74.11 109.317 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -144.53 131.85 20.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.371 -0.603 . . . . 63.02 109.371 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.16 113.23 35.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.579 -1.267 . . . . 65.14 107.579 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 129.55 55.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.26 -0.882 . . . . 73.21 109.719 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' THR . 83.5 mt -87.56 123.54 32.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.202 -1.036 . . . . 74.13 108.202 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.72 120.72 41.79 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 116.145 -0.479 . . . . 61.12 109.746 -175.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.67 146.89 51.42 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 107.289 -1.374 . . . . 73.42 107.289 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -95.23 118.36 31.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.817 -1.153 . . . . 74.33 110.986 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' ' 19' ' ' ARG . 12.5 t70 -103.15 -6.18 22.46 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.08 -1.418 . . . . 73.31 109.273 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.81 31.85 2.02 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.829 -1.708 . . . . 70.03 108.829 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.5 t 171.37 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.781 -1.933 . . . . 71.24 105.781 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.5 100.58 1.25 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.167 -1.016 . . . . 71.31 113.011 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 15' ' ' ASP . 26.7 mtm-85 -86.21 158.68 19.68 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.81 -1.181 . . . . 73.21 107.81 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.7 p -139.61 138.43 36.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 116.053 -0.521 . . . . 72.13 110.191 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.0 118.4 30.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.121 -1.437 . . . . 72.25 107.121 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -92.82 132.22 37.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.469 -0.937 . . . . 52.01 108.469 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.06 122.05 25.06 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.04 -0.356 . . . . 43.31 110.04 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -85.84 166.89 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.928 -1.138 . . . . 73.22 107.928 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -67.61 123.29 20.06 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.263 -0.643 . . . . 73.24 109.263 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.37 -163.94 14.69 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 110.041 -1.224 . . . . 40.42 110.041 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.9 p -99.46 141.13 32.65 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 117.947 0.873 . . . . 71.13 111.565 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -122.71 115.59 22.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.891 -1.522 . . . . 61.24 106.891 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -97.15 133.61 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.544 -0.298 . . . . 72.52 111.396 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.429 HG12 ' HB3' ' A' ' 38' ' ' PHE . 67.9 mt -107.73 133.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.574 -0.899 . . . . 72.03 108.574 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.4 -161.21 31.98 Favored Glycine 0 CA--C 1.49 -1.478 0 N-CA-C 110.756 -0.938 . . . . 53.5 110.756 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.6 mtm180 -123.37 105.8 10.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.158 -1.053 . . . . 75.31 108.158 174.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.05 -176.29 48.01 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 109.21 -1.556 . . . . 74.54 109.21 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -88.18 -16.12 34.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.409 0.623 . . . . 62.41 109.438 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.921 0.867 . . . . 72.23 109.781 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.75 145.41 28.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.739 -0.664 . . . . 75.14 110.72 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -105.11 -12.36 16.16 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.895 0.855 . . . . 75.01 109.764 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.429 ' HB3' HG12 ' A' ' 30' ' ' ILE . 44.3 t80 -139.77 121.81 15.7 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.91 -1.885 . . . . 63.24 105.91 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.7 ttt180 -100.37 131.54 46.24 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.333 -0.394 . . . . 72.42 111.426 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 90' ' ' LEU . 61.2 mt -92.01 138.51 24.62 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.826 -0.625 . . . . 74.51 109.489 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -92.9 12.46 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 122.96 2.44 . . . . 74.44 111.691 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -93.31 -173.31 3.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.875 -0.602 . . . . 62.05 109.891 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -113.5 152.35 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.553 0.216 . . . . 72.43 111.139 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.74 86.92 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.237 0.354 . . . . 71.23 112.877 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 49' ' ' HIS . 48.8 t -88.51 114.51 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.438 -0.578 . . . . 72.32 109.438 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -64.22 176.69 0.97 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 124.186 0.994 . . . . 71.12 110.894 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 23.7 ptt85 -63.8 -34.75 78.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.63 0.729 . . . . 74.14 109.818 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -120.67 109.16 14.88 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.659 -1.238 . . . . 73.44 107.659 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 18.9 t60 -103.33 -31.76 9.89 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.479 -0.934 . . . . 62.15 108.479 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.449 HD11 HD21 ' A' ' 61' ' ' LEU . 8.4 tt -167.3 152.94 7.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.536 -0.913 . . . . 75.24 108.536 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -135.34 140.41 45.06 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.293 0.568 . . . . 75.2 109.923 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.0 mt -115.89 114.21 45.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.9 -0.778 . . . . 72.44 108.9 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 19.1 ttt180 -92.47 110.23 21.64 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.949 -0.759 . . . . 74.41 108.949 176.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -99.93 108.66 20.95 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.769 -0.65 . . . . 74.21 111.295 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -107.81 162.57 13.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.595 -1.632 . . . . 73.32 106.595 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.67 66.72 1.06 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.847 0.699 . . . . 72.23 114.847 -175.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -169.22 -72.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.953 0.901 . . . . 73.32 108.978 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.57 159.15 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.51 -0.922 . . . . 70.4 108.51 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -99.83 120.81 40.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.416 0.627 . . . . 73.41 110.145 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 67.2 tp -80.93 125.46 30.15 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.868 -1.06 . . . . 72.44 109.882 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.449 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -111.62 120.55 42.45 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.315 -0.624 . . . . 52.4 109.315 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.98 124.53 40.95 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.407 -0.59 . . . . 75.52 109.407 176.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.71 133.8 38.0 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.396 -0.366 . . . . 44.22 111.157 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.61 76.41 1.34 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.803 -0.443 . . . . 72.13 109.803 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -173.0 133.61 0.54 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.292 0.496 . . . . 64.0 109.748 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -98.75 -35.75 10.05 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.116 0.484 . . . . 60.02 111.271 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -87.93 -32.48 18.89 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.23 0.538 . . . . 52.03 112.151 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -122.56 28.66 7.25 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.07 -0.394 . . . . 74.13 110.334 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.05 133.17 6.54 Favored Glycine 0 C--O 1.246 0.902 0 O-C-N 124.949 1.405 . . . . 75.13 113.985 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 90' ' ' LEU . 22.1 m -74.11 136.68 42.96 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.906 0.882 . . . . 75.05 112.366 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 28.2 p -111.13 143.68 41.48 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.896 -0.593 . . . . 70.41 110.49 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 80' ' ' TRP . 35.0 m -111.9 121.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.687 -1.597 . . . . 74.43 106.687 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.13 23.41 13.61 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.504 0.721 . . . . 61.02 110.023 -169.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 75.66 9.31 3.58 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.054 1.342 . . . . 72.04 110.866 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.43 124.04 50.29 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.246 -0.65 . . . . 70.35 109.246 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.72 126.76 15.9 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.116 2.544 . . . . 35.33 113.038 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 159.87 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.386 -0.825 . . . . 53.32 109.013 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.34 -19.7 14.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.1 -0.704 . . . . 74.43 109.1 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.74 149.43 34.38 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.387 -0.824 . . . . 70.2 110.289 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.484 ' CD2' HG21 ' A' ' 72' ' ' VAL . 77.3 t-105 -159.76 152.83 21.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.194 -0.669 . . . . 65.3 109.194 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.16 114.95 29.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.58 -1.267 . . . . 72.24 107.58 174.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD22 HD11 ' A' ' 88' ' ' ILE . 32.8 mt -56.92 132.83 53.81 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 112.953 0.723 . . . . 74.41 112.953 -174.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.49 155.37 39.06 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.382 -1.34 . . . . 61.05 107.382 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.52 128.3 35.68 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 123.24 0.337 . . . . 62.15 111.169 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.04 55.41 Favored Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 115.757 -0.656 . . . . 62.43 112.487 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.13 136.76 34.33 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 108.705 -0.85 . . . . 74.22 108.705 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.65 111.61 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.456 -1.313 . . . . 74.13 107.456 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 82' ' ' LEU . 53.9 mt -107.67 118.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 CA-C-O 121.292 0.568 . . . . 72.44 109.554 -174.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 24.2 mtp180 -111.97 106.71 15.47 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.95 0.881 . . . . 72.04 110.439 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.613 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 0.5 OUTLIER -108.3 164.47 12.28 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.372 -1.286 . . . . 63.41 108.267 178.372 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -28.25 90.97 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 O-C-N 124.752 1.282 . . . . 61.11 115.837 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 60.68 11.78 3.32 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 125.86 1.664 . . . . 74.42 112.418 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 m -131.37 113.5 13.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.788 -0.819 . . . . 73.32 108.788 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -105.94 136.9 44.77 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.841 -0.744 . . . . 60.52 110.81 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 10.7 tp -129.72 146.31 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 108.741 -0.837 . . . . 71.14 108.741 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -111.97 133.24 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.622 -0.881 . . . . 74.5 108.622 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.0 t -90.9 114.54 28.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.901 -0.407 . . . . 65.31 109.901 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -114.49 122.44 46.58 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.002 -0.545 . . . . 64.13 110.315 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.7 mtt -101.93 125.9 48.71 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.37 -0.832 . . . . 74.05 110.573 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.293 -1.864 0 CA-C-N 114.519 -1.219 . . . . 72.32 108.877 178.502 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.796 0 N-CA-C 111.528 -0.629 . . . . 73.51 111.528 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -126.03 142.23 51.61 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.237 -0.653 . . . . 64.51 109.237 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.38 -16.42 80.62 Favored Glycine 0 C--N 1.313 -0.713 0 N-CA-C 111.206 -0.757 . . . . 34.34 111.206 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -57.97 -41.34 82.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.352 0.661 . . . . 62.42 110.024 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.24 104.42 16.38 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.141 -1.059 . . . . 64.44 108.141 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.04 -31.63 1.44 Allowed Glycine 0 C--N 1.3 -1.436 0 N-CA-C 109.716 -1.354 . . . . 70.43 109.716 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 m -146.04 116.63 7.6 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.811 -0.811 . . . . 74.34 108.811 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 17.4 m -123.41 146.75 47.74 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.338 -0.986 . . . . 74.13 108.338 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.1 p -135.85 115.81 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 107.349 -1.352 . . . . 52.32 107.349 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -114.79 131.96 56.63 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.175 -1.375 . . . . 60.55 110.361 -170.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 95' ' ' ILE . 4.2 pp -98.7 133.52 42.91 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.799 -0.815 . . . . 51.2 108.799 174.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' O ' HD12 ' A' ' 95' ' ' ILE . 43.3 mt-30 -99.9 120.64 40.1 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.782 -0.644 . . . . 65.23 110.692 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.5 tp -129.85 111.32 12.47 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.261 -0.882 . . . . 70.41 110.082 -174.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -89.0 100.58 13.33 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.04 -1.464 . . . . 53.41 108.848 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.61 9.62 40.97 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.699 -1.591 . . . . 61.43 108.568 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.4 -13.77 10.17 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.293 -0.867 . . . . 71.12 111.113 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 m -137.23 13.32 3.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.852 -0.174 . . . . 70.35 111.374 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.31 83.6 0.04 OUTLIER Glycine 0 C--N 1.345 1.079 0 N-CA-C 114.279 0.471 . . . . 73.51 114.279 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -98.77 144.38 28.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.281 0.562 . . . . 74.32 111.237 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.421 HG22 ' HG2' ' A' ' 12' ' ' GLN . 77.4 p -122.5 134.45 54.57 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.897 -1.149 . . . . 74.52 107.897 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -137.25 131.75 32.8 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.577 0.214 . . . . 74.32 111.577 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.39 136.07 38.38 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.846 -0.427 . . . . 61.23 109.846 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.576 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.8 mt -68.31 139.62 55.92 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.803 -0.635 . . . . 72.24 110.038 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -105.31 152.98 22.24 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.404 -0.591 . . . . 74.14 109.404 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.33 136.96 58.22 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 124.344 1.027 . . . . 73.31 111.518 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.49 -164.11 12.45 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.722 -2.151 . . . . 73.11 107.722 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.6 p -104.43 130.03 52.36 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.233 -1.387 . . . . 72.12 112.236 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -99.95 108.97 21.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 105.409 -2.071 . . . . 55.25 105.409 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.496 HG21 ' HG2' ' A' ' 48' ' ' ARG . 57.9 mt -98.57 130.34 47.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.886 -0.597 . . . . 72.04 110.948 -173.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.0 mt -101.99 123.4 55.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.143 -1.058 . . . . 71.31 108.143 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.4 -176.4 39.57 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.702 -1.359 . . . . 50.45 109.702 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -115.03 106.16 13.81 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 117.63 0.715 . . . . 73.32 109.309 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.56 177.49 44.65 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.509 -1.036 . . . . 62.5 110.509 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -81.19 -16.95 51.36 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.5 0.667 . . . . 72.0 109.622 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.61 -23.85 31.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.653 0.739 . . . . 74.43 110.086 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -82.99 162.42 21.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.127 -0.942 . . . . 72.02 110.95 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -104.36 -58.46 1.88 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.811 -0.811 . . . . 62.2 108.811 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.35 129.95 46.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.575 -0.738 . . . . 61.12 109.16 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 24.8 mtm180 -108.37 131.13 55.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.103 -0.499 . . . . 73.03 110.364 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.64 142.36 57.27 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 116.185 -0.461 . . . . 72.53 110.382 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -89.1 27.79 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.032 2.488 . . . . 71.23 110.917 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -135.09 -177.7 4.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.959 -1.126 . . . . 74.4 107.959 -174.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -116.46 178.68 4.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.731 -0.84 . . . . 71.13 108.731 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.76 79.52 Favored Glycine 0 C--N 1.317 -0.476 0 N-CA-C 110.213 -1.155 . . . . 63.14 110.213 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 49' ' ' HIS . 4.8 p -116.9 136.47 53.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 114.347 -0.927 . . . . 70.14 109.584 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -89.7 -164.43 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.821 -0.807 . . . . 62.22 108.821 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 35.8 ptt180 -78.27 -30.42 48.49 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 118.767 -1.173 . . . . 54.43 108.557 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HG2' HG21 ' A' ' 29' ' ' ILE . 78.5 mtt180 -121.87 108.03 12.98 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.038 -1.467 . . . . 65.22 107.038 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.567 ' HB2' HG23 ' A' ' 45' ' ' VAL . 25.3 t60 -104.21 -34.78 8.24 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.047 -1.094 . . . . 70.12 108.047 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tt -165.42 142.92 5.83 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.976 -1.12 . . . . 71.53 107.976 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -131.14 129.88 42.37 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.508 0.67 . . . . 72.2 110.936 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.44 110.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 115.376 -0.829 . . . . 71.12 108.951 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 25.2 ttt180 -90.57 110.19 21.33 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.994 -0.743 . . . . 64.54 108.994 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -94.68 107.64 19.64 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.146 -1.057 . . . . 75.03 108.146 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.36 152.49 31.39 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 105.145 -2.169 . . . . 71.34 105.145 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.24 57.54 2.81 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 118.423 0.556 . . . . 52.34 112.365 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -159.22 -60.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.432 -1.322 . . . . 74.13 107.432 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.7 m -143.88 156.91 16.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 115.54 -0.755 . . . . 64.43 109.924 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -95.25 102.64 14.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.787 -1.19 . . . . 71.34 107.787 175.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.23 116.9 23.84 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.226 -0.897 . . . . 72.51 109.858 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -99.4 119.35 37.83 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.901 -1.148 . . . . 74.52 107.901 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.16 27.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.183 0.516 . . . . 71.35 110.307 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 5.9 t70 -85.99 138.87 31.67 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.887 0.875 . . . . 72.31 109.316 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.04 76.67 1.69 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.508 -1.293 . . . . 75.31 107.508 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -166.24 150.07 7.58 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.802 -0.561 . . . . 50.31 109.899 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 m -108.22 -30.28 8.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.207 0.527 . . . . 60.35 111.409 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.9 m -88.94 -60.29 2.0 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.145 0.974 . . . . 65.41 111.867 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -104.4 28.6 6.77 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 125.048 1.339 . . . . 72.22 109.519 -168.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.86 139.25 5.0 Favored Glycine 0 C--O 1.256 1.531 0 CA-C-N 114.017 -1.447 . . . . 54.0 113.71 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 90' ' ' LEU . 7.0 m -83.61 155.74 23.07 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.13 0.972 . . . . 63.33 112.381 -172.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.4 p -118.98 153.71 34.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.952 -0.567 . . . . 65.13 110.261 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.431 HG12 HG13 ' A' ' 88' ' ' ILE . 35.6 m -116.6 116.28 51.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.816 -1.179 . . . . 54.11 107.816 175.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 62.36 27.1 16.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.018 0.913 . . . . 71.21 109.359 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.87 15.97 3.03 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.307 1.843 . . . . 74.05 111.26 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.23 123.74 38.7 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 108.693 -0.855 . . . . 73.11 108.693 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.62 124.4 9.28 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.173 1.915 . . . . 73.11 112.998 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 72' ' ' VAL . 35.8 m -156.25 169.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 104.963 -2.236 . . . . 73.4 104.963 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.1 mt-30 -113.24 -6.23 13.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.394 -0.923 . . . . 74.23 112.536 175.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 7.0 pt-20 -151.43 140.59 21.25 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.163 -0.615 . . . . 73.42 111.909 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -163.29 152.56 14.82 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.205 -1.035 . . . . 74.54 108.205 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.59 116.7 33.13 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.777 -0.823 . . . . 71.41 108.777 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.6 mt -61.77 130.38 45.51 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.678 0.622 . . . . 74.14 112.678 -175.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -126.78 167.84 15.23 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.88 -0.785 . . . . 72.22 108.88 173.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 26.2 t70 -60.55 124.45 20.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.465 -0.334 . . . . 64.04 110.634 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.9 -7.36 52.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.721 -0.752 . . . . 70.42 113.622 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -73.97 135.04 43.16 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 117.179 0.49 . . . . 74.1 111.488 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.92 113.07 39.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.718 -0.845 . . . . 74.24 108.718 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.506 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 1.8 mp -98.27 113.22 32.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 106.55 -1.648 . . . . 73.41 106.55 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -115.5 116.21 27.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.25 0.548 . . . . 73.2 111.193 -169.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.1 pt? -123.79 164.71 18.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.892 1.277 . . . . 71.33 108.365 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.39 113.8 0.9 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.642 0.617 . . . . 54.43 114.642 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.8 m80 64.82 7.13 3.69 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.85 1.26 . . . . 73.15 114.068 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.4 m -140.83 125.87 18.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.779 -0.369 . . . . 55.22 110.939 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.92 121.78 40.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.163 -0.68 . . . . 74.14 109.163 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.576 HD11 HD13 ' A' ' 11' ' ' LEU . 6.9 tp -109.74 125.7 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 N-CA-C 108.725 -0.843 . . . . 61.42 108.725 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.51 129.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.158 -0.682 . . . . 74.02 109.158 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.4 t -94.52 123.88 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.568 0.699 . . . . 71.24 111.961 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -112.92 119.24 37.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.043 -0.98 . . . . 73.21 108.677 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 85.6 mtp -107.1 120.99 43.59 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.298 -0.561 . . . . 71.31 110.591 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 28.4 m-70 . . . . . 0 C--N 1.283 -2.32 0 N-CA-C 107.137 -1.431 . . . . 73.54 107.137 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.545 0 N-CA-C 110.996 -0.842 . . . . 43.14 110.996 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -124.8 179.9 4.8 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 122.614 -0.345 . . . . 63.34 110.172 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.29 -59.88 4.8 Favored Glycine 0 C--N 1.316 -0.573 0 N-CA-C 110.533 -1.027 . . . . 41.22 110.533 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -151.57 133.41 14.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.769 -1.197 . . . . 75.0 107.769 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.47 104.2 9.91 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.845 0.355 . . . . 73.41 111.544 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.42 -27.87 50.2 Favored Glycine 0 C--N 1.316 -0.583 0 N-CA-C 110.419 -1.072 . . . . 34.32 110.419 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m -66.47 116.69 7.72 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.102 -0.703 . . . . 61.23 109.102 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.0 m -134.4 138.2 44.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.332 -0.618 . . . . 73.42 109.332 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.64 109.56 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.233 -1.395 . . . . 72.23 107.233 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.406 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 57.0 m -108.63 122.38 46.98 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.293 -1.003 . . . . 64.22 108.293 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.563 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 47.1 mt -87.7 128.7 35.3 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.672 -1.233 . . . . 73.11 107.672 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -100.97 117.64 35.41 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 107.055 -1.461 . . . . 74.52 107.055 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 95' ' ' ILE . 50.3 tp -91.94 125.85 36.8 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.672 -0.695 . . . . 55.54 109.385 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.58 100.13 11.72 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 107.466 -1.309 . . . . 75.2 107.466 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -126.95 -14.01 5.64 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.768 -1.106 . . . . 54.44 109.701 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.41 -29.98 6.18 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.382 -1.087 . . . . 61.14 110.382 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -90.11 -35.03 15.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.123 -1.066 . . . . 61.21 108.123 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.39 57.93 2.39 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 109.85 -1.3 . . . . 51.13 109.85 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 19' ' ' ARG . 3.9 mmp_? -87.51 162.88 16.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.562 -0.319 . . . . 64.45 110.304 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 33.9 p -128.59 143.4 50.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.872 0.368 . . . . 74.44 110.764 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -127.27 113.1 15.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.829 -0.804 . . . . 74.42 108.829 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.71 132.68 35.3 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.849 -0.797 . . . . 74.51 108.849 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD22 HD21 ' A' ' 28' ' ' ASN . 65.5 mt -59.89 132.13 53.02 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.051 0.845 . . . . 62.42 111.454 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.32 145.54 32.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.094 -1.076 . . . . 73.21 108.094 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.99 113.56 10.16 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.087 0.946 . . . . 73.42 109.901 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.83 -161.01 24.75 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 107.041 -2.424 . . . . 75.21 107.041 -173.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.2 p -107.56 137.69 45.13 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 118.449 1.125 . . . . 74.43 112.311 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.424 HD21 HD22 ' A' ' 23' ' ' LEU . 7.1 p30 -120.76 120.89 36.92 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.254 -0.647 . . . . 65.33 109.254 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.62 121.22 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.535 -0.913 . . . . 72.22 108.535 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 76.2 mt -97.96 130.01 47.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.005 -0.739 . . . . 64.21 109.005 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.97 -173.11 36.6 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 110.182 -1.167 . . . . 72.24 110.182 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 40' ' ' LEU . 25.9 mtm105 -124.08 107.22 11.04 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 117.678 0.739 . . . . 64.44 110.179 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.47 176.71 44.87 Favored Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.529 -1.028 . . . . 53.12 110.529 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -55.64 -32.22 62.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.954 0.902 . . . . 75.1 112.244 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -95.26 1.55 54.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.212 -0.449 . . . . 63.52 111.894 -173.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.03 149.76 24.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.039 0.447 . . . . 74.24 112.069 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -107.24 -57.77 2.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.867 0.867 . . . . 72.34 108.716 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 19.8 t80 -101.67 117.06 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.992 -1.855 . . . . 75.53 105.992 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 36.6 mtm180 -107.89 126.58 52.84 Favored 'General case' 0 C--N 1.279 -2.476 0 C-N-CA 120.445 -0.502 . . . . 45.02 111.573 -174.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.54 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 63.3 mt -75.45 148.75 83.49 Favored Pre-proline 0 C--O 1.21 -0.998 0 CA-C-N 115.756 -0.657 . . . . 74.21 109.434 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.57 11.65 2.84 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.476 2.118 . . . . 54.34 113.925 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -116.39 -177.37 3.16 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.427 -0.582 . . . . 70.14 109.427 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 m -128.69 149.65 50.59 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 123.234 0.614 . . . . 73.54 109.629 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -16.67 24.02 Favored Glycine 0 CA--C 1.495 -1.182 0 N-CA-C 108.548 -1.821 . . . . 60.11 108.548 -175.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' HA2' ' A' ' 31' ' ' GLY . 31.5 t -80.69 128.37 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.372 -1.414 . . . . 71.23 107.401 177.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -68.39 166.19 17.21 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 123.502 0.501 . . . . 63.32 112.104 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.486 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.3 ptt-85 -62.26 -37.63 86.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.58 0.705 . . . . 72.12 109.437 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.432 HH21 ' CD ' ' A' ' 51' ' ' GLU . 21.7 mtp180 -126.22 95.8 4.5 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.725 -2.695 . . . . 74.23 103.725 169.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -92.12 -37.47 12.73 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.772 0.796 . . . . 71.33 109.148 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 HD21 ' A' ' 61' ' ' LEU . 5.7 tt -161.75 150.02 15.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.094 -1.076 . . . . 54.02 108.094 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' CD ' HH21 ' A' ' 48' ' ' ARG . 8.4 pt-20 -139.77 125.98 20.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.662 0.744 . . . . 72.22 111.313 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.99 121.89 52.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.045 -0.98 . . . . 64.52 108.36 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -106.25 107.18 18.05 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.716 -1.216 . . . . 74.22 107.716 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -108.65 121.19 44.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.954 0.883 . . . . 74.01 112.959 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -133.41 158.13 43.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.542 -1.651 . . . . 50.21 106.542 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.41 68.41 0.53 Allowed Glycine 0 C--N 1.314 -0.684 0 N-CA-C 114.772 0.669 . . . . 70.13 114.772 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -165.79 -70.72 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.727 -1.212 . . . . 64.51 107.727 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.57 150.99 29.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.802 0.334 . . . . 72.32 110.614 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -97.98 112.69 24.53 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.294 0.568 . . . . 75.13 109.494 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 tt -84.23 117.7 23.69 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.954 -1.021 . . . . 71.0 108.873 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.479 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -100.77 109.94 21.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.222 -1.399 . . . . 73.11 107.222 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 111.09 21.09 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.264 0.554 . . . . 71.44 110.023 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 136.79 35.85 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.591 -0.892 . . . . 71.41 108.591 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.51 106.31 16.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.534 -0.913 . . . . 75.12 108.534 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.564 ' OD1' ' HB ' ' A' ' 67' ' ' THR . 28.7 t-20 69.78 89.47 0.1 Allowed 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.11 -0.95 . . . . 74.13 111.39 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.73 -18.14 64.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.956 . . . . 73.34 111.868 -175.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.564 ' HB ' ' OD1' ' A' ' 65' ' ' ASN . 18.5 m -46.44 -53.58 10.84 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 71.43 110.979 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -122.34 27.13 8.08 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.654 -1.61 . . . . 72.4 106.654 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.88 -144.91 17.91 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.337 -1.302 . . . . 62.41 115.854 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -107.4 156.47 18.9 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.124 -1.038 . . . . 74.51 112.842 -169.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 p -119.21 140.81 49.59 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.175 -0.921 . . . . 73.3 109.8 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.475 HG12 HG13 ' A' ' 88' ' ' ILE . 35.9 m -114.91 115.74 50.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.712 -1.218 . . . . 70.23 107.712 177.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.99 28.63 18.41 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.844 0.831 . . . . 72.12 109.115 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 81.18 0.06 1.71 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.194 2.198 . . . . 54.33 111.603 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -97.41 121.34 58.76 Favored Pre-proline 0 C--N 1.316 -0.884 0 O-C-N 121.556 -0.715 . . . . 74.14 109.724 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 5.7 Cg_exo -75.11 125.45 9.26 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.094 1.862 . . . . 75.15 110.941 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.78 161.65 18.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.0 -1.111 . . . . 72.44 108.0 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -88.5 -18.45 28.18 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.177 0.513 . . . . 62.15 111.518 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.73 152.39 17.7 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.2 -0.667 . . . . 74.44 109.2 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -154.52 151.76 29.28 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.589 -0.893 . . . . 75.42 108.589 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -101.93 108.26 19.66 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.53 -1.285 . . . . 52.44 107.53 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 97' ' ' VAL . 86.5 mt -59.31 146.81 38.19 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.879 0.737 . . . . 73.44 112.068 -176.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.4 170.62 18.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.754 -1.202 . . . . 54.15 107.754 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.27 128.27 35.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.706 0.288 . . . . 72.11 111.127 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.76 2.74 57.29 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 120.967 -0.635 . . . . 64.33 112.933 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -85.17 134.03 34.18 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 120.192 -0.603 . . . . 63.44 110.573 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.27 114.86 41.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.723 -0.672 . . . . 71.42 109.466 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.64 109.6 26.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 N-CA-C 107.475 -1.305 . . . . 73.33 107.475 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.2 ttp85 -110.41 120.02 41.1 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.681 0.753 . . . . 72.31 110.207 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.449 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.2 pt? -119.94 165.0 15.23 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 114.63 -1.168 . . . . 75.31 108.559 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.98 100.97 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.405 0.922 . . . . 34.23 115.405 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.9 m170 71.54 17.99 5.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.279 1.432 . . . . 71.3 113.603 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.5 m -154.28 135.7 14.18 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.947 -0.47 . . . . 72.11 111.778 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.839 -0.538 . . . . 65.42 110.025 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.2 tp -126.9 137.34 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.812 -0.81 . . . . 73.2 108.812 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -107.45 127.37 63.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.46 -0.57 . . . . 74.52 109.46 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 82' ' ' LEU . 53.3 t -85.15 119.98 34.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.142 0.496 . . . . 72.51 111.262 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -113.86 126.16 54.87 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.298 -1.001 . . . . 73.54 108.298 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.0 mtt -115.22 131.42 56.93 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.776 0.798 . . . . 43.41 111.416 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 . . . . . 0 C--N 1.279 -2.5 0 CA-C-N 114.385 -1.28 . . . . 71.04 108.123 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.966 0 N-CA-C 110.669 -0.972 . . . . 53.1 110.669 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -77.75 -59.86 2.61 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.608 -0.886 . . . . 63.52 108.608 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.2 137.32 2.17 Favored Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 115.381 -0.827 . . . . 51.34 111.435 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 m -87.81 -16.99 32.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.309 0.576 . . . . 70.53 109.587 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.49 92.81 2.96 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.312 -0.858 . . . . 72.51 108.816 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.44 80.59 0.26 Allowed Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 110.349 -1.1 . . . . 62.22 110.349 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 m -57.08 115.43 2.64 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.93 -0.767 . . . . 71.01 108.93 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -104.85 115.02 29.59 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.711 -0.848 . . . . 74.1 108.711 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.63 113.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.753 -1.203 . . . . 62.44 107.753 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -117.63 117.28 28.96 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.967 -0.753 . . . . 75.4 108.967 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -87.7 137.25 32.5 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 108.476 -0.935 . . . . 65.21 108.476 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -108.52 125.84 52.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.901 -0.778 . . . . 60.15 108.901 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -133.16 114.77 14.24 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.47 0.653 . . . . 75.32 110.968 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.9 102.17 13.5 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.106 -0.702 . . . . 64.43 109.106 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.64 10.77 37.59 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.57 1.176 . . . . 74.41 108.935 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.6 39.43 1.1 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.927 -1.269 . . . . 61.52 109.927 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -170.71 -61.87 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.983 -0.747 . . . . 44.4 108.983 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.09 92.58 1.56 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.012 -0.835 . . . . 70.32 111.012 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.5 mmp_? -123.65 165.63 16.89 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 122.21 -0.583 . . . . 61.11 110.858 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.2 p -136.45 149.16 48.09 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.946 -0.761 . . . . 31.32 108.946 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 88.3 t80 -140.34 119.69 13.02 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.879 -0.785 . . . . 64.35 108.879 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -85.13 134.11 34.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.052 -1.092 . . . . 74.43 108.052 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.83 131.12 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.654 0.596 . . . . 64.45 110.968 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -90.05 150.14 22.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.385 -1.339 . . . . 71.3 107.385 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.72 118.32 14.41 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.926 0.87 . . . . 51.43 111.333 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 -168.6 23.82 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 107.232 -2.347 . . . . 73.54 107.232 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.9 p -106.67 129.71 54.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 118.822 1.311 . . . . 71.41 110.687 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -110.54 129.27 55.83 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.209 -0.451 . . . . 65.11 109.849 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.4 mt -99.09 125.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.388 -0.597 . . . . 72.44 109.388 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.4 135.55 46.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.99 -0.744 . . . . 74.12 108.99 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 147.17 -168.06 28.34 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 110.566 -1.014 . . . . 64.1 110.566 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 mtm105 -116.31 106.6 13.84 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.536 -0.866 . . . . 74.14 110.868 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.21 177.84 46.27 Favored Glycine 0 N--CA 1.403 -3.563 0 N-CA-C 109.772 -1.331 . . . . 71.1 109.772 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -76.57 -20.13 57.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.653 0.74 . . . . 75.15 110.222 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.61 -29.11 19.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.165 -0.925 . . . . 61.3 109.511 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.09 142.31 57.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.855 -1.066 . . . . 51.01 110.62 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -94.98 -47.98 6.18 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.178 -1.045 . . . . 74.34 108.178 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -109.37 113.74 26.81 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.879 -1.055 . . . . 73.11 109.134 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mpt_? -90.01 113.5 25.2 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.747 -0.66 . . . . 54.44 111.677 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 mt -80.49 125.91 79.78 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.307 -0.406 . . . . 65.12 110.658 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 7.9 Cg_exo -69.83 6.92 1.15 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.243 2.629 . . . . 70.54 116.016 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.89 175.85 7.05 Favored 'General case' 0 C--O 1.252 1.184 0 O-C-N 121.187 -0.946 . . . . 72.45 110.141 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.5 ' HA ' HH21 ' A' ' 32' ' ' ARG . 25.0 m -113.15 138.71 49.55 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.229 -0.656 . . . . 74.35 109.229 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.58 -13.57 32.75 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 109.693 -1.363 . . . . 70.22 109.693 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.443 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 45.0 t -75.5 123.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 CA-C-N 114.081 -1.06 . . . . 62.53 108.639 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 m -75.56 171.91 13.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.964 -0.562 . . . . 65.02 111.878 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.9 ptm180 -61.01 -31.28 70.9 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.929 0.871 . . . . 72.32 110.464 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -134.58 99.86 4.47 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 103.446 -2.798 . . . . 64.01 103.446 171.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -96.18 -36.82 10.81 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.551 0.691 . . . . 72.21 109.42 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 61' ' ' LEU . 7.4 tt -162.62 148.06 12.33 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 71.21 108.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.47 142.49 49.26 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 109.456 -0.572 . . . . 72.21 109.456 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.63 114.31 45.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.46 -0.941 . . . . 75.34 108.46 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 50.2 ttt180 -91.71 107.55 19.29 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.034 -1.098 . . . . 64.1 108.034 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -106.98 117.75 34.87 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.927 -0.579 . . . . 65.31 110.417 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.4 160.63 19.62 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.125 -1.806 . . . . 75.55 106.125 174.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.82 59.35 1.72 Allowed Glycine 0 C--N 1.305 -1.171 0 C-N-CA 121.406 -0.426 . . . . 74.41 113.48 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -171.19 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.216 1.007 . . . . 71.15 109.545 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -134.35 150.68 31.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.963 0.411 . . . . 71.23 111.288 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -107.32 104.95 14.68 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.165 -0.925 . . . . 75.51 108.614 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.1 tp -89.18 109.73 20.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.776 -1.102 . . . . 61.21 110.236 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -92.45 124.2 36.32 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.018 -1.104 . . . . 75.43 108.018 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.49 127.34 40.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.795 0.331 . . . . 51.12 110.403 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.73 129.26 43.0 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.853 0.861 . . . . 71.42 111.289 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.82 76.91 1.47 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.787 0.435 . . . . 72.42 110.184 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 179.95 114.79 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 108.587 -0.894 . . . . 72.13 108.587 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.3 m -83.78 -24.07 31.22 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.85 -0.531 . . . . 70.4 111.264 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -80.49 -58.82 2.94 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.354 0.597 . . . . 74.25 109.893 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -103.82 28.57 6.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.477 0.711 . . . . 72.21 110.363 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.37 131.24 5.9 Favored Glycine 0 C--O 1.242 0.644 0 O-C-N 124.703 1.252 . . . . 63.43 114.793 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 m -76.68 137.64 39.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 124.196 0.999 . . . . 44.22 112.095 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 25.3 p -107.13 149.55 27.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.206 -0.452 . . . . 74.55 110.339 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 80' ' ' TRP . 30.4 m -114.0 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.865 -1.161 . . . . 74.21 107.865 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 62.16 26.82 16.13 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.201 -0.909 . . . . 72.2 109.9 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.54 26.04 0.9 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.324 1.85 . . . . 61.53 111.309 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.34 130.7 24.58 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.698 -0.683 . . . . 71.24 109.638 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.83 125.8 10.22 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.83 2.353 . . . . 53.42 113.372 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 80' ' ' TRP . 28.0 m -142.63 166.43 15.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.004 -0.739 . . . . 74.33 109.004 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -106.41 -30.43 9.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.346 -0.388 . . . . 40.43 110.856 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.95 146.69 49.36 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.805 -0.813 . . . . 64.41 108.805 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.432 ' HB2' HG21 ' A' ' 77' ' ' VAL . 74.0 t-105 -157.06 148.96 22.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 75.04 109.727 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -99.99 105.2 16.86 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.028 -1.101 . . . . 71.1 108.028 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 87.9 mt -56.66 131.02 47.79 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 116.044 -0.525 . . . . 73.01 111.932 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.22 163.23 18.86 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.611 -0.885 . . . . 65.04 108.611 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.27 123.58 20.34 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.047 0.451 . . . . 75.51 109.786 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -8.69 44.62 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-N 115.93 -0.577 . . . . 64.13 112.48 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.98 133.27 47.09 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 117.11 0.455 . . . . 71.32 111.321 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 t -103.5 113.55 40.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.89 -0.781 . . . . 74.24 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.49 118.63 43.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 N-CA-C 107.049 -1.463 . . . . 75.23 107.049 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 60.6 mtp180 -118.66 129.87 55.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.492 0.663 . . . . 62.54 111.863 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.7 164.87 19.0 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 106.231 -1.766 . . . . 74.25 106.231 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.21 108.41 0.16 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 123.719 0.637 . . . . 71.45 113.107 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 77.81 -35.79 0.21 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.959 1.703 . . . . 61.42 113.152 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.6 m -100.0 130.33 46.15 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.9 -0.5 . . . . 55.31 111.059 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.78 147.63 49.98 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.002 0.43 . . . . 63.33 111.033 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.7 137.71 42.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.705 -0.68 . . . . 73.11 110.927 -175.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.91 125.86 64.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.604 -0.888 . . . . 70.33 108.604 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.7 t -87.67 121.68 38.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.865 0.364 . . . . 75.33 110.82 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -121.24 143.04 49.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.697 -0.483 . . . . 72.14 109.697 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.05 140.04 50.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.048 -0.524 . . . . 65.22 109.928 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 . . . . . 0 C--N 1.287 -2.112 0 N-CA-C 107.772 -1.196 . . . . 63.4 107.772 177.136 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.187 0 N-CA-C 109.888 -1.285 . . . . 50.51 109.888 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -111.77 157.18 20.84 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 108.052 -1.092 . . . . 72.54 108.052 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.61 179.21 46.0 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 110.456 -1.058 . . . . 34.34 110.456 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m -85.73 152.04 23.38 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.163 -0.68 . . . . 64.03 109.163 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.67 -16.48 55.66 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.231 -1.025 . . . . 64.13 108.231 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.5 -37.54 3.77 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 109.592 -1.403 . . . . 44.31 109.592 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.6 m -146.78 134.83 21.5 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 106.273 -1.751 . . . . 64.12 106.273 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 m -107.17 114.29 28.25 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.108 -1.071 . . . . 74.22 108.108 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 23' ' ' LEU . 4.3 p -98.43 124.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.522 0.677 . . . . 72.42 109.708 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -128.7 130.17 46.78 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.521 -0.763 . . . . 73.41 109.817 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.41 136.39 33.01 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.449 -0.574 . . . . 73.31 109.449 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -122.74 134.03 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.572 0.749 . . . . 63.42 110.76 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.44 ' HB3' HD12 ' A' ' 95' ' ' ILE . 2.5 pp -148.28 146.63 28.69 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.567 -1.642 . . . . 73.24 106.567 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -105.67 118.55 36.88 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 119.043 -1.063 . . . . 72.44 111.326 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -113.89 6.65 16.71 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.286 -1.325 . . . . 63.12 108.808 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.14 33.41 0.79 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.724 -0.751 . . . . 71.44 112.611 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p 176.85 -39.41 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.975 0.91 . . . . 72.42 110.339 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.98 93.72 2.21 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.867 -1.293 . . . . 73.33 109.867 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 29.7 mmt180 -88.47 149.01 23.89 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.103 -1.073 . . . . 74.31 108.103 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 24.1 p -146.35 132.33 19.2 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.821 0.701 . . . . 73.14 111.088 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.415 ' HB3' HD11 ' A' ' 11' ' ' LEU . 55.4 t80 -129.51 124.68 34.55 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.169 -1.419 . . . . 72.53 107.169 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -93.11 131.52 38.08 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 120.993 0.425 . . . . 74.03 110.686 -177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.1 mt -77.08 140.08 40.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.229 -0.896 . . . . 52.42 108.854 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 2.8 mpt_? -109.25 169.96 8.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.664 -1.236 . . . . 73.33 107.664 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.16 130.97 46.9 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.637 0.732 . . . . 75.42 111.666 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.79 -170.54 14.92 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.519 -1.833 . . . . 70.32 108.519 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -99.61 129.57 45.77 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 118.727 -1.189 . . . . 74.32 110.441 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -108.27 109.7 21.11 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.584 -1.265 . . . . 75.03 107.584 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.34 131.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.382 -0.827 . . . . 72.13 109.502 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.69 128.21 64.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 109.209 -0.663 . . . . 75.01 109.209 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 162.99 -171.44 38.77 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 110.795 -0.922 . . . . 63.52 110.795 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -110.26 107.62 17.45 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 117.607 0.704 . . . . 74.32 109.91 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.68 177.14 45.41 Favored Glycine 0 N--CA 1.408 -3.172 0 N-CA-C 109.769 -1.332 . . . . 64.25 109.769 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -86.01 -22.99 27.0 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.866 -1.161 . . . . 62.44 107.866 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.65 -27.29 55.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.864 -1.062 . . . . 71.52 108.854 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 139.59 38.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.655 -1.157 . . . . 75.14 110.451 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -82.09 -45.52 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.497 0.665 . . . . 74.14 109.921 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -116.43 129.03 56.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.592 -0.892 . . . . 74.55 108.592 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -102.19 140.05 36.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.983 -0.553 . . . . 71.54 110.584 -178.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.23 147.77 39.16 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.343 -0.39 . . . . 65.52 111.038 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -86.0 8.28 4.59 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.948 2.432 . . . . 63.23 111.042 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -116.51 160.22 20.93 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.131 0.972 . . . . 62.42 108.835 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -111.51 -177.86 3.3 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.764 -0.374 . . . . 73.23 110.316 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.0 -11.8 71.31 Favored Glycine 0 CA--C 1.51 -0.229 0 N-CA-C 109.622 -1.391 . . . . 73.4 109.622 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' CG ' ' A' ' 49' ' ' HIS . 8.3 p -86.35 149.66 4.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 125.284 1.434 . . . . 71.2 110.094 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -97.4 -174.29 2.89 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 107.971 -1.122 . . . . 72.52 107.971 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -74.1 -37.6 64.11 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.884 -1.154 . . . . 71.44 107.884 175.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -115.47 94.05 4.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.504 -1.295 . . . . 75.34 107.504 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.408 ' CG ' HG23 ' A' ' 45' ' ' VAL . 24.0 t60 -105.24 -37.53 6.85 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.785 -1.098 . . . . 74.34 109.503 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -161.45 152.45 18.31 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.36 -0.978 . . . . 70.22 108.36 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -136.28 138.86 42.19 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.196 0.522 . . . . 71.3 109.86 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -110.61 114.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.965 -0.754 . . . . 74.14 108.965 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 63.7 ttt180 -90.42 109.54 20.66 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.101 -1.074 . . . . 74.02 108.101 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -107.71 114.94 29.25 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.422 -0.808 . . . . 72.14 110.958 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.98 167.75 13.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.678 -1.601 . . . . 73.45 106.678 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.7 72.79 1.49 Allowed Glycine 0 C--N 1.302 -1.328 0 C-N-CA 121.096 -0.573 . . . . 54.43 114.485 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -168.48 -71.42 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.844 0.858 . . . . 75.22 108.735 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.8 157.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.439 -0.948 . . . . 73.53 108.439 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -97.83 119.12 35.86 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.446 -0.576 . . . . 63.32 109.446 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.2 tt -86.96 110.57 20.12 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.087 -1.079 . . . . 71.35 108.087 -177.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -90.47 114.62 26.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.334 -1.358 . . . . 54.15 107.334 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.99 115.72 24.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.935 0.398 . . . . 53.42 110.685 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.24 136.33 37.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.704 -0.68 . . . . 74.42 109.473 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -132.97 76.67 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.17 -1.048 . . . . 74.33 108.17 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -174.58 146.25 0.99 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.883 -0.784 . . . . 72.01 108.883 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -102.3 -32.93 9.8 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.494 0.553 . . . . 64.11 112.494 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -90.16 -37.69 14.01 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.853 0.686 . . . . 74.33 112.853 -177.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -107.12 28.37 8.11 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.694 0.798 . . . . 72.23 110.102 -177.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.65 124.42 4.86 Favored Glycine 0 N--CA 1.474 1.209 0 O-C-N 124.471 1.107 . . . . 74.22 113.616 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -67.95 146.24 53.77 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.581 1.152 . . . . 64.3 113.354 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.0 p -117.06 141.11 48.67 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.144 -0.935 . . . . 73.23 110.332 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 88' ' ' ILE . 27.3 m -109.96 116.68 52.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.073 -1.084 . . . . 74.42 108.073 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 59.96 29.85 19.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.908 0.861 . . . . 71.35 109.253 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.7 t30 78.22 8.47 2.31 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.504 1.922 . . . . 75.15 111.357 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.79 122.24 49.82 Favored Pre-proline 0 C--N 1.318 -0.785 0 O-C-N 121.678 -0.639 . . . . 65.42 109.807 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.32 127.01 14.3 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 122.562 2.174 . . . . 71.22 111.903 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.69 168.26 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 122.488 0.315 . . . . 55.13 110.275 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.52 -34.58 10.93 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.375 -0.602 . . . . 74.43 109.375 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -148.23 153.84 39.27 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.843 -0.617 . . . . 75.22 109.717 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -157.32 151.34 24.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.274 -1.009 . . . . 75.12 108.274 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.281 0.8 OUTLIER -101.06 108.69 20.46 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-O 121.71 0.766 . . . . 74.5 111.192 174.144 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.1 mt -56.97 143.58 37.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.842 -1.072 . . . . 74.51 112.638 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.74 169.55 16.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.696 -1.224 . . . . 63.24 107.696 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -72.09 112.14 7.91 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.809 -0.441 . . . . 34.43 109.809 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.61 13.61 18.18 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.932 -0.652 . . . . 61.44 113.404 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -87.25 140.72 29.26 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 117.769 0.784 . . . . 73.23 110.863 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.81 113.36 36.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 N-CA-C 108.768 -0.827 . . . . 72.02 108.768 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.473 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.1 107.6 22.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 109.125 -0.694 . . . . 75.42 109.125 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.463 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 39.9 ttm180 -100.06 111.94 24.24 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.49 0.662 . . . . 65.15 110.95 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.6 pt? -115.82 164.33 14.54 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.177 -1.374 . . . . 72.4 107.445 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -36.68 99.55 0.01 OUTLIER Glycine 0 CA--C 1.535 1.343 0 N-CA-C 115.909 1.123 . . . . 71.4 115.909 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.9 m80 83.09 -1.32 1.21 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.346 1.858 . . . . 73.33 115.275 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -150.4 138.05 19.84 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.889 -1.124 . . . . 74.14 111.713 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 10.5 pt-20 -110.54 119.66 39.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.455 0.645 . . . . 73.11 109.566 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.6 tp -103.6 139.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.295 -0.866 . . . . 71.13 109.124 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.88 129.31 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.054 -1.091 . . . . 72.25 108.054 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 82' ' ' LEU . 69.9 t -95.88 120.46 45.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.482 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -117.01 150.91 37.83 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.313 -0.625 . . . . 70.35 109.313 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.0 mtt -126.44 122.17 34.52 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.711 0.767 . . . . 71.2 110.521 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 . . . . . 0 C--N 1.285 -2.214 0 N-CA-C 107.661 -1.237 . . . . 71.21 107.661 -178.0 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.913 0 N-CA-C 111.307 -0.717 . . . . 43.05 111.307 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -122.56 100.39 6.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.459 0.647 . . . . 74.41 109.904 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.22 29.49 2.92 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.145 -0.934 . . . . 45.41 111.304 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -120.4 157.64 28.87 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.767 -0.827 . . . . 61.34 108.767 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.21 155.95 39.92 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.272 -0.422 . . . . 75.22 110.321 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.36 63.59 2.94 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.169 -0.772 . . . . 50.25 111.169 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.3 m -141.7 115.79 9.34 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.711 -0.848 . . . . 70.21 108.711 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.0 p -121.71 118.87 30.18 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.454 -1.313 . . . . 75.3 107.454 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG13 HD12 ' A' ' 23' ' ' LEU . 3.3 p -96.64 123.19 48.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 122.201 1.001 . . . . 72.33 111.329 -173.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.7 m -118.21 129.5 55.53 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-N 114.179 -1.373 . . . . 60.32 108.277 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -92.61 130.0 38.38 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 108.373 -0.973 . . . . 51.4 108.373 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -101.11 114.98 29.42 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.397 -1.334 . . . . 72.52 107.397 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -111.36 124.9 53.19 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.163 -1.051 . . . . 72.34 108.163 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.57 101.44 11.31 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 117.081 -1.848 . . . . 72.03 111.959 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -83.24 -15.32 50.79 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.735 -1.575 . . . . 64.4 108.594 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.44 42.05 0.51 Allowed Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 107.362 -2.295 . . . . 73.03 107.362 -171.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -164.4 -25.85 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.725 -0.738 . . . . 64.12 111.794 -171.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 70.21 1.29 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 120.388 -0.91 . . . . 74.01 110.924 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -92.64 161.4 14.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.695 -0.483 . . . . 44.14 109.695 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.6 p -138.6 135.25 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.093 0.473 . . . . 61.02 110.507 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -130.76 117.2 19.05 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.141 -1.059 . . . . 64.13 108.141 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 32.5 tt0 -88.44 128.35 35.53 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.093 -0.643 . . . . 73.21 110.072 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 HG13 ' A' ' 9' ' ' VAL . 91.2 mt -64.88 136.83 57.3 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.124 -0.944 . . . . 62.23 112.064 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -93.23 163.39 13.64 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.387 -1.279 . . . . 72.43 109.266 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.82 126.95 29.29 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.821 0.7 . . . . 71.51 111.156 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.42 -161.75 15.27 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.938 -0.865 . . . . 44.24 110.938 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 67.8 p -93.99 126.0 38.94 Favored 'General case' 0 N--CA 1.418 -2.043 0 C-N-CA 119.381 -0.927 . . . . 71.21 111.81 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.6 129.94 45.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.954 -1.869 . . . . 63.33 105.954 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.5 mm -106.72 137.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 112.187 0.44 . . . . 73.24 112.187 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.01 136.39 50.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.76 -1.2 . . . . 52.25 107.76 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.74 -152.15 24.14 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.068 -1.213 . . . . 65.21 110.068 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 76.5 mtt180 -131.91 106.46 8.08 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.216 1.008 . . . . 63.13 108.617 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 36' ' ' ALA . . . 175.92 -168.1 40.19 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 119.739 -1.22 . . . . 71.24 111.974 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.6 -43.69 96.19 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.511 0.725 . . . . 72.04 109.914 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.25 -37.02 82.82 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 114.714 -1.13 . . . . 53.52 110.578 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB3' ' H ' ' A' ' 33' ' ' GLY . . . -72.54 105.49 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 114.288 1.218 . . . . 74.23 114.288 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 44.5 mt-30 -77.14 -47.77 19.5 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.814 -1.539 . . . . 74.05 107.076 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -95.24 115.45 27.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.788 -1.56 . . . . 74.32 106.788 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 99.2 mtt180 -109.45 137.38 47.4 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 120.78 0.324 . . . . 74.11 111.602 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 72.7 mt -90.65 134.5 30.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.773 -0.648 . . . . 73.41 111.964 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 18.3 Cg_exo -71.29 -19.74 28.83 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.35 2.7 . . . . 71.24 113.593 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.11 178.5 6.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 122.221 -0.299 . . . . 75.04 111.713 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 85.2 m -109.55 168.15 9.61 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 108.328 -0.989 . . . . 75.01 108.328 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.5 9.45 53.03 Favored Glycine 0 CA--C 1.499 -0.955 0 N-CA-C 108.408 -1.877 . . . . 63.22 108.408 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 49' ' ' HIS . 7.4 p -118.3 120.74 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 CA-C-N 113.326 -1.437 . . . . 73.31 109.744 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 m -82.15 -170.0 2.67 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.279 -0.638 . . . . 74.32 109.279 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 40.6 ptt180 -65.2 -28.12 69.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.928 -0.709 . . . . 73.32 111.436 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 48' ' ' ARG . 23.5 mtm180 -131.96 118.94 20.43 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.352 -0.981 . . . . 75.52 108.352 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.604 ' HB2' HG23 ' A' ' 45' ' ' VAL . 30.6 t60 -103.85 -31.03 9.99 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 124.43 1.092 . . . . 72.13 108.795 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 61' ' ' LEU . 9.3 tt -167.31 147.46 5.37 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.904 -0.776 . . . . 73.11 108.904 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.12 136.88 49.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.857 0.723 . . . . 74.0 110.112 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' SER . 64.9 mt -115.51 110.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.036 -1.098 . . . . 44.13 108.036 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 41.8 ttm105 -91.32 106.97 18.88 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.689 0.757 . . . . 75.14 109.03 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -97.17 107.06 19.5 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.644 -1.162 . . . . 74.11 110.33 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -107.25 -179.73 4.01 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.642 -1.984 . . . . 55.24 105.642 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.01 3.7 69.63 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 119.931 -1.128 . . . . 44.41 112.266 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -97.07 -75.2 0.55 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 122.893 0.477 . . . . 75.52 110.554 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.07 160.67 23.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.656 0.782 . . . . 73.44 109.639 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.07 104.88 17.41 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.391 -0.966 . . . . 41.52 108.391 177.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.2 tt -80.51 110.87 16.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.623 -1.171 . . . . 63.13 109.159 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -92.9 121.74 34.57 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.177 -1.046 . . . . 74.24 108.177 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.99 112.27 14.47 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.391 -0.596 . . . . 74.55 109.391 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.76 135.98 36.64 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.446 -0.946 . . . . 74.13 108.446 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.9 tp -133.83 76.6 1.67 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.508 0.67 . . . . 60.41 109.827 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -163.06 164.21 25.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.479 -1.304 . . . . 63.31 107.479 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.6 p -106.27 -54.19 2.51 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.768 0.318 . . . . 61.51 111.545 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -89.21 -35.79 16.01 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.685 0.994 . . . . 73.4 113.685 -171.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.533 ' OD1' ' HA3' ' A' ' 91' ' ' GLY . 64.2 t30 -114.26 27.5 9.44 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.044 -0.725 . . . . 61.33 109.044 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.15 136.59 25.35 Favored Glycine 0 C--O 1.245 0.814 0 CA-C-N 114.039 -1.437 . . . . 74.12 113.713 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 136.27 38.65 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 124.259 1.024 . . . . 53.14 110.899 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 142.06 35.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.297 -1.001 . . . . 73.53 108.297 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 88' ' ' ILE . 29.7 m -117.2 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.682 -0.488 . . . . 41.4 109.682 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.15 35.76 25.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 70.21 110.521 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 65.12 23.18 12.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.279 1.432 . . . . 74.44 110.11 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.29 122.03 29.03 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.901 -0.778 . . . . 73.04 108.901 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.44 124.1 3.12 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 121.039 1.159 . . . . 71.43 111.797 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -144.18 179.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.803 -1.184 . . . . 72.11 107.803 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -104.16 -37.2 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 71.42 109.799 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -134.04 151.58 51.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.09 -0.707 . . . . 62.13 109.09 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -160.8 152.46 19.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.902 -1.148 . . . . 74.43 107.902 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.253 4.9 pp0? -109.98 113.06 25.47 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.809 -0.756 . . . . 73.2 110.162 173.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.7 mt -60.89 126.25 26.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.549 -1.205 . . . . 62.01 112.408 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.12 160.4 22.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.508 -0.923 . . . . 72.31 108.508 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 33.6 t70 -61.82 119.53 8.95 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.201 0.524 . . . . 75.23 111.193 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.33 36.7 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.633 -0.712 . . . . 73.1 112.771 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.27 138.43 43.6 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 120.27 -0.572 . . . . 71.13 111.711 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -98.74 113.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.831 -0.803 . . . . 62.23 108.831 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.469 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -103.87 116.37 47.52 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 N-CA-C 107.277 -1.379 . . . . 74.02 107.277 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -114.51 121.71 44.34 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.709 -0.848 . . . . 64.13 108.709 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.69 162.87 18.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.441 -0.948 . . . . 72.22 108.441 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.533 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -76.97 87.13 0.97 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 119.038 -1.553 . . . . 70.31 110.694 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 t60 168.42 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.933 1.693 . . . . 64.42 108.366 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.7 p -168.15 -170.93 1.4 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.625 -0.716 . . . . 54.31 110.266 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.38 151.15 50.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.256 0.551 . . . . 62.01 109.979 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.447 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.95 142.24 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.056 -0.974 . . . . 72.4 110.833 -177.124 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.2 129.48 65.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.533 -0.914 . . . . 73.31 108.533 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.85 124.08 39.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.863 0.364 . . . . 71.51 110.231 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.449 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 12.9 mmm180 -123.66 135.07 53.7 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.576 -0.738 . . . . 64.33 110.324 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.1 mtt -113.66 124.88 53.37 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.534 0.683 . . . . 54.01 111.148 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.6 m80 . . . . . 0 C--N 1.291 -1.943 0 N-CA-C 107.359 -1.349 . . . . 62.35 107.359 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.568 0 N-CA-C 109.785 -1.326 . . . . 43.05 109.785 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -81.92 149.91 27.99 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 117.375 0.587 . . . . 71.42 110.407 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.54 30.07 11.23 Favored Glycine 0 C--N 1.294 -1.772 0 N-CA-C 109.43 -1.468 . . . . 73.42 109.43 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m -60.67 133.22 55.88 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 124.258 1.023 . . . . 73.41 111.468 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.08 146.5 25.41 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.961 -1.126 . . . . 54.3 107.961 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -144.63 161.36 28.02 Favored Glycine 0 N--CA 1.426 -1.984 0 N-CA-C 109.542 -1.423 . . . . 32.44 109.542 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m -129.7 116.27 18.56 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 117.391 0.595 . . . . 63.01 109.934 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -125.12 139.34 53.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.51 -1.293 . . . . 65.03 107.51 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -117.13 122.01 69.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-O 121.787 0.803 . . . . 61.45 112.051 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 13.2 m -113.21 131.58 55.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.954 -1.128 . . . . 75.25 107.954 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 95' ' ' ILE . 4.4 pp -102.95 135.47 44.57 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.336 -0.616 . . . . 75.51 109.336 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 76.6 mt-30 -102.09 119.07 38.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.391 -0.368 . . . . 75.13 110.082 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 tp -107.79 135.09 49.79 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.644 -0.707 . . . . 54.41 109.417 -175.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.47 99.21 12.11 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 118.673 -1.211 . . . . 75.12 108.63 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 36.7 t70 -108.8 38.93 2.13 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.049 -1.834 . . . . 70.32 106.049 176.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.07 -54.02 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.512 -1.222 . . . . 55.44 110.881 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -87.82 -26.81 22.64 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.715 0.769 . . . . 74.42 109.916 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.83 96.73 0.93 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.048 -1.221 . . . . 74.52 110.048 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.429 ' HG3' ' HB3' ' A' ' 15' ' ' ASP . 14.7 mtm180 -102.08 165.79 10.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.149 -0.686 . . . . 63.1 109.149 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 12' ' ' GLN . 38.1 p -128.43 136.95 51.56 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 120.733 0.302 . . . . 73.31 110.474 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.467 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 82.3 t80 -128.36 123.53 34.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.344 -1.354 . . . . 63.14 107.344 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.0 tt0 -96.12 133.22 40.66 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.964 -0.754 . . . . 73.4 108.964 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HB2' HG13 ' A' ' 9' ' ' VAL . 92.3 mt -73.46 143.58 46.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.824 -0.626 . . . . 73.44 109.787 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -108.4 152.11 25.12 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.512 -1.292 . . . . 75.32 107.512 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.68 126.76 28.49 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.538 0.685 . . . . 72.32 111.423 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.24 -169.37 19.11 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 107.254 -2.339 . . . . 53.35 107.254 -174.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -106.49 128.75 54.33 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 118.899 1.349 . . . . 65.15 110.239 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HG3' ' A' ' 37' ' ' GLN . 6.1 p30 -110.34 146.35 35.92 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.104 -0.953 . . . . 64.2 108.56 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.41 HG21 ' HG2' ' A' ' 48' ' ' ARG . 60.4 mt -123.73 135.47 63.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 109.814 -0.439 . . . . 73.31 109.814 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 64.9 mt -107.5 134.71 48.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.28 -1.007 . . . . 72.23 108.28 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 156.75 -152.02 23.4 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 108.667 -1.773 . . . . 41.33 108.667 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.702 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 67.2 mtp180 -135.49 106.88 6.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.566 1.183 . . . . 73.42 109.23 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.81 171.85 41.67 Favored Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.497 -1.841 . . . . 62.12 108.497 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -77.02 -17.05 59.08 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.197 0.999 . . . . 74.12 110.696 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -94.05 -4.4 49.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.416 -0.811 . . . . 63.24 110.198 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.27 133.86 34.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 54.24 109.816 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 28' ' ' ASN . 73.3 mm-40 -81.67 -57.85 3.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.748 -0.66 . . . . 63.42 109.706 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 84.2 t80 -101.31 110.23 22.2 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.825 -1.176 . . . . 70.21 107.825 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 90.8 mtt180 -96.52 123.1 40.08 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.548 -0.751 . . . . 74.33 111.27 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 45' ' ' VAL . 55.8 mt -75.98 138.36 69.14 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.716 -0.674 . . . . 74.44 112.006 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.04 38.16 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.39 2.726 . . . . 74.25 112.668 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -134.92 173.22 11.95 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.95 -1.13 . . . . 74.31 107.95 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -122.34 155.87 35.1 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.988 -0.745 . . . . 62.55 108.988 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.06 -23.86 26.37 Favored Glycine 0 C--N 1.312 -0.775 0 N-CA-C 109.155 -1.578 . . . . 74.2 109.155 -174.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG21 HD12 ' A' ' 40' ' ' LEU . 7.3 p -81.48 141.16 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.87 -1.165 . . . . 70.44 109.637 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -76.3 -177.23 3.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.35 -0.841 . . . . 71.55 111.146 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.702 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.3 ptm180 -65.46 -39.87 92.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 74.13 109.861 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.41 ' HG2' HG21 ' A' ' 29' ' ' ILE . 50.6 mtm-85 -126.2 119.85 28.54 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.176 -1.416 . . . . 73.51 107.176 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.404 ' HB2' HG23 ' A' ' 45' ' ' VAL . 49.6 t60 -105.33 -35.94 7.36 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.757 1.223 . . . . 51.53 109.641 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.491 HD11 HD21 ' A' ' 61' ' ' LEU . 9.1 tt -166.05 151.15 8.44 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 108.293 -1.003 . . . . 62.24 108.293 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -136.26 141.77 43.92 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.043 0.449 . . . . 61.22 110.323 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 70.0 mt -120.69 118.72 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 115.666 -0.697 . . . . 71.2 109.469 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.7 ttt180 -91.57 111.06 22.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.505 -1.295 . . . . 75.22 107.505 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -106.22 126.52 52.32 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.411 0.624 . . . . 73.11 109.793 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -139.0 172.42 12.87 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.422 -2.066 . . . . 71.34 105.422 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.7 69.32 2.39 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 120.761 -0.733 . . . . 53.44 112.311 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -162.88 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.46 -0.941 . . . . 74.03 108.46 177.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.17 159.5 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.779 -0.823 . . . . 64.3 108.779 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -94.59 115.1 27.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.118 -0.697 . . . . 52.14 109.118 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -85.64 110.44 19.28 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.351 -0.84 . . . . 61.21 111.212 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 50' ' ' LEU . 2.4 tm? -89.6 128.25 36.01 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.237 -1.023 . . . . 71.32 108.237 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -136.12 122.65 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.103 -0.703 . . . . 64.11 109.103 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.27 129.68 37.24 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.625 0.578 . . . . 64.34 110.069 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.49 75.26 1.57 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.477 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t30 169.53 107.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.784 0.833 . . . . 72.14 109.679 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.9 t -78.53 -22.24 47.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.342 -0.39 . . . . 64.14 110.735 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -65.02 -45.82 83.9 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.109 0.481 . . . . 74.42 111.907 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -118.95 28.33 8.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.139 -0.689 . . . . 73.12 109.139 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.14 129.63 4.53 Favored Glycine 0 C--O 1.258 1.649 0 O-C-N 124.838 1.336 . . . . 70.44 115.045 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -80.0 145.79 32.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.926 -1.137 . . . . 70.44 112.466 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -121.29 142.53 49.86 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.308 -0.86 . . . . 43.11 110.542 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 80' ' ' TRP . 35.6 m -117.53 119.46 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.684 -1.599 . . . . 73.11 106.684 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 62.24 24.58 14.64 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.035 0.934 . . . . 63.21 108.652 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 77.91 6.39 2.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.551 1.54 . . . . 62.0 112.854 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.63 118.26 66.15 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 74.02 108.795 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.76 125.28 11.47 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 121.552 1.501 . . . . 71.41 110.646 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.8 m -137.29 169.15 19.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.873 -0.788 . . . . 51.12 108.873 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -107.03 -20.16 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.353 . . . . 71.0 110.77 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.8 pt-20 -152.61 146.41 25.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.19 -0.67 . . . . 73.0 109.19 176.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CD2' HG21 ' A' ' 72' ' ' VAL . 66.7 t-105 -160.89 152.29 19.19 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.749 -0.834 . . . . 71.32 108.749 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -104.57 103.11 12.72 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.03 -0.73 . . . . 74.12 109.03 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.447 HD22 HD11 ' A' ' 88' ' ' ILE . 58.5 mt -59.52 145.04 45.6 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.967 -1.015 . . . . 63.22 111.414 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.01 169.51 17.67 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.123 -1.066 . . . . 73.3 108.123 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.83 119.12 12.0 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 123.346 0.404 . . . . 73.25 110.13 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.09 53.04 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.703 -0.68 . . . . 54.43 113.522 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -82.06 146.32 29.72 Favored 'General case' 0 C--O 1.255 1.384 0 N-CA-C 107.728 -1.212 . . . . 45.23 107.728 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.09 112.79 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.193 -0.669 . . . . 64.41 109.193 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.512 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.71 127.58 60.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.283 -1.377 . . . . 74.34 107.283 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 90' ' ' LEU . 2.4 tmm_? -134.56 134.35 41.26 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.088 -1.079 . . . . 70.13 108.088 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 90' ' ' LEU . 2.0 pt? -127.31 162.47 26.18 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.476 -1.305 . . . . 74.4 107.476 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.4 86.98 0.51 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 119.158 -1.496 . . . . 53.1 111.148 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.0 t60 169.46 -48.79 0.01 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.145 1.778 . . . . 71.25 108.781 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.0 t -164.16 -175.37 3.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.938 -0.574 . . . . 71.14 110.111 -174.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -123.62 145.15 49.15 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.46 -0.941 . . . . 72.13 108.46 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -136.64 137.1 47.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.687 0.756 . . . . 75.4 111.843 -176.36 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.9 mt -107.62 131.65 57.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.488 -0.93 . . . . 73.04 108.488 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.6 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.622 0.249 . . . . 63.32 110.665 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -127.28 140.95 51.86 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.402 -0.363 . . . . 72.21 110.597 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.8 mtt -113.45 134.28 54.75 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.945 -0.57 . . . . 64.5 109.999 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--N 1.289 -2.038 0 N-CA-C 106.962 -1.496 . . . . 72.24 106.962 -177.012 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.146 0 N-CA-C 110.479 -1.049 . . . . 64.42 110.479 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.3 m170 64.99 84.49 0.15 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.393 1.077 . . . . 64.11 110.754 -176.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.07 -99.51 1.55 Allowed Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 115.412 -0.813 . . . . 70.51 111.711 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.657 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 31.8 m -74.27 -41.11 61.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 113.075 0.769 . . . . 55.41 113.075 -176.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.38 34.14 20.69 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.148 -1.056 . . . . 51.04 108.148 -174.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.63 -94.75 0.75 Allowed Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.165 -1.574 . . . . 50.34 109.165 -174.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.0 m -119.98 124.96 47.22 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 117.131 0.466 . . . . 75.33 109.743 176.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.657 ' OG ' ' HA ' ' A' ' 4' ' ' SER . 15.2 m -85.07 115.11 22.69 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.616 -1.253 . . . . 72.33 107.616 174.206 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.44 106.85 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.846 -1.909 . . . . 71.42 105.846 174.119 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.6 m -113.97 119.36 36.95 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.496 -0.775 . . . . 53.5 109.216 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 3.2 pp -91.72 130.7 37.46 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.523 -0.762 . . . . 75.13 110.805 178.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.69 119.63 39.84 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.275 -1.33 . . . . 73.3 107.579 -175.185 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -107.5 116.91 32.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.508 -0.553 . . . . 61.21 109.508 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.98 99.52 12.21 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.642 -1.614 . . . . 60.1 106.642 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -115.06 -19.06 11.04 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.309 -1.314 . . . . 62.44 109.868 -177.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.2 4.85 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 110.757 -0.937 . . . . 63.01 110.757 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 t -122.29 -33.88 3.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.321 -0.622 . . . . 43.34 109.321 175.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.03 79.13 1.38 Allowed Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.463 -1.855 . . . . 70.21 108.463 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -89.51 145.46 25.27 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.883 -0.414 . . . . 55.5 109.883 -176.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 30.3 p -134.16 135.29 43.0 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.102 0.477 . . . . 64.12 111.211 -176.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 11' ' ' LEU . 46.4 t80 -139.03 120.42 14.91 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.75 -0.659 . . . . 74.44 110.69 178.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -83.46 127.23 33.53 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.523 -0.917 . . . . 73.11 108.523 176.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.78 149.33 50.7 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.05 -0.523 . . . . 74.11 111.019 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -102.64 162.38 12.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.199 -1.408 . . . . 70.35 107.199 173.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.88 145.66 51.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.215 -0.661 . . . . 72.24 109.215 177.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.51 -168.2 15.25 Favored Glycine 0 N--CA 1.412 -2.936 0 N-CA-C 106.887 -2.485 . . . . 64.44 106.887 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 30.0 p -103.03 130.95 50.32 Favored 'General case' 0 C--N 1.27 -2.853 0 C-N-CA 118.499 -1.28 . . . . 72.31 111.519 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.523 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -102.35 110.42 22.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.843 -1.91 . . . . 75.04 105.843 -179.009 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.2 mt -97.86 132.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 120.929 0.395 . . . . 33.25 111.538 -173.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.44 133.69 55.05 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 C-N-CA 123.846 0.858 . . . . 75.11 109.601 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA2' ' CG2' ' A' ' 45' ' ' VAL . . . 151.54 -173.75 30.82 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.686 -0.966 . . . . 43.43 110.686 177.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.687 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 97.5 mtt180 -118.19 104.23 10.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.119 -1.437 . . . . 74.11 107.119 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 -176.93 48.05 Favored Glycine 0 N--CA 1.42 -2.427 0 N-CA-C 111.401 -0.68 . . . . 72.12 111.401 -175.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 35' ' ' ASP . 10.4 pt20 -58.74 -49.6 77.02 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 124.016 0.926 . . . . 71.04 113.135 -176.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 13.5 m-20 -81.8 -19.87 40.29 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.203 0.525 . . . . 61.3 111.016 -172.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.62 145.5 45.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.572 -0.74 . . . . 75.24 112.12 -174.785 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -106.81 -55.84 2.27 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.014 -0.994 . . . . 74.54 108.667 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -95.0 125.37 39.62 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.809 -1.087 . . . . 74.01 109.872 -177.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -97.7 144.59 27.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.344 -0.984 . . . . 72.44 108.344 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 58.2 mt -94.56 131.16 31.47 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 109.489 -0.56 . . . . 65.44 109.489 173.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 21.2 Cg_exo -67.54 -26.48 40.12 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.112 2.542 . . . . 53.4 112.605 -178.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 168.38 11.4 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.349 -0.387 . . . . 51.32 110.633 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -84.68 -177.05 6.49 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.021 -0.733 . . . . 74.24 109.021 178.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.91 66.9 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.138 -0.785 . . . . 71.53 111.138 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.481 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 11.1 p -90.15 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.284 -0.958 . . . . 73.22 109.356 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -102.38 -174.07 2.48 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.861 -0.422 . . . . 75.21 109.861 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 36.1 ptt180 -64.43 -41.6 96.5 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.891 0.853 . . . . 72.44 110.269 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -129.26 107.75 9.79 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 104.012 -2.588 . . . . 73.21 104.012 172.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -101.35 -37.36 8.51 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.935 0.772 . . . . 72.42 109.145 -176.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.489 HD11 HD21 ' A' ' 61' ' ' LEU . 7.5 tt -165.09 147.97 8.22 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.996 -0.547 . . . . 53.05 109.896 -177.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HG2' HD21 ' A' ' 64' ' ' LEU . 11.8 pt-20 -133.27 132.45 41.42 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.491 -0.559 . . . . 71.13 109.491 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.5 mt -106.76 113.62 43.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 108.843 -0.799 . . . . 74.14 108.843 176.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 29.9 ttt180 -91.25 111.43 22.91 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.482 0.658 . . . . 71.35 109.541 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -104.4 127.45 52.08 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.47 -0.786 . . . . 75.42 110.567 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -132.14 172.73 12.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.531 -2.026 . . . . 74.22 105.531 176.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.67 53.09 3.97 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.684 -0.769 . . . . 74.44 111.681 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -140.79 -80.48 0.26 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 124.728 1.211 . . . . 71.51 107.784 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.34 160.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 C-N-CA 125.326 1.45 . . . . 65.22 107.1 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.24 115.49 28.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.47 0.652 . . . . 63.34 109.604 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 tp -85.17 114.12 22.05 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.07 -0.968 . . . . 73.51 110.5 -177.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.489 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -92.11 113.49 25.77 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.641 -1.244 . . . . 74.43 107.641 -179.027 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.75 121.14 39.39 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.826 -0.435 . . . . 64.4 109.826 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -91.48 133.0 35.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.627 -0.715 . . . . 74.5 111.43 -177.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.457 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.2 mm? -123.55 76.12 1.39 Allowed 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.645 -0.872 . . . . 51.33 108.645 173.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -173.7 112.14 0.19 Allowed 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 109.048 -0.723 . . . . 75.23 109.048 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -84.31 -17.67 38.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.322 0.49 . . . . 62.34 112.322 -178.34 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -89.19 -55.93 3.47 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.424 0.63 . . . . 61.42 111.084 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -110.5 29.57 7.59 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.659 0.784 . . . . 75.41 109.905 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.48 141.49 2.5 Favored Glycine 0 C--O 1.258 1.632 0 O-C-N 125.018 1.449 . . . . 73.45 115.745 -175.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.2 m -65.29 135.36 55.25 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.466 -1.367 . . . . 72.31 112.463 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 75' ' ' ALA . 1.3 m -113.37 139.84 48.54 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.594 -1.632 . . . . 74.2 106.594 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 88' ' ' ILE . 29.2 m -120.26 121.24 65.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.228 -0.656 . . . . 71.43 109.228 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 58.35 29.88 18.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.829 0.824 . . . . 72.15 110.319 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t30 76.9 23.78 0.96 Allowed 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 126.07 1.748 . . . . 74.44 111.05 179.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 71' ' ' THR . . . -125.82 118.04 24.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 121.752 -0.593 . . . . 73.22 110.144 177.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.86 133.4 31.29 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.566 2.177 . . . . 74.12 112.177 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.23 169.14 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 50.13 110.199 -177.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -102.81 -21.47 14.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.387 -0.968 . . . . 60.23 108.387 174.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -157.78 155.63 30.14 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.254 -1.017 . . . . 74.01 108.254 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.407 ' CD2' HG21 ' A' ' 72' ' ' VAL . 71.2 t-105 -161.0 151.99 18.63 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 72.12 108.741 -178.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -101.97 103.46 14.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.764 -0.828 . . . . 71.04 108.764 176.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 89.8 mt -57.6 139.99 52.16 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.93 0.715 . . . . 61.32 112.93 -176.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.9 166.6 23.25 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.814 -1.18 . . . . 63.02 107.814 173.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.15 118.78 9.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.872 0.368 . . . . 72.12 110.854 -179.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.15 35.71 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.004 -0.617 . . . . 43.25 113.134 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -87.1 136.51 32.9 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.909 -0.716 . . . . 74.23 109.874 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 t -100.33 113.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.074 -0.713 . . . . 73.24 109.074 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.48 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -102.71 111.95 34.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.972 -0.751 . . . . 73.33 108.972 -178.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -107.63 119.96 40.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.627 -0.715 . . . . 71.31 110.104 -178.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.6 pt? -125.27 164.3 20.65 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.405 -0.816 . . . . 74.53 108.942 -176.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.75 112.06 0.62 Allowed Glycine 0 CA--C 1.529 0.938 0 O-C-N 123.574 0.546 . . . . 52.23 113.315 178.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 71.7 6.67 5.74 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.399 1.479 . . . . 74.1 114.834 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.7 t -149.2 163.35 37.88 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.794 -0.762 . . . . 44.11 111.241 -177.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.88 126.36 13.22 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.518 -0.919 . . . . 74.43 108.518 176.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 7.9 tp -124.42 138.04 55.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.62 -0.718 . . . . 70.23 109.071 -173.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.8 125.15 65.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.859 -0.793 . . . . 71.15 108.859 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -89.87 121.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.706 0.288 . . . . 62.12 111.423 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -120.36 151.22 39.56 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.199 -0.667 . . . . 74.2 109.199 176.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.1 mtt -125.42 145.61 49.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.274 0.559 . . . . 70.13 111.597 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 12.3 m-70 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 107.932 -1.136 . . . . 75.45 107.932 178.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.761 0 N-CA-C 111.24 -0.744 . . . . 43.05 111.24 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -60.31 114.6 3.0 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.85 0.833 . . . . 72.42 111.765 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.15 -20.7 37.4 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.75 -0.738 . . . . 72.15 111.445 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.1 m -84.24 69.72 10.48 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.426 1.108 . . . . 72.45 109.592 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.12 165.74 33.83 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 105.878 -1.897 . . . . 51.22 105.878 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 141.28 -162.2 26.86 Favored Glycine 0 C--N 1.284 -2.326 0 N-CA-C 109.002 -1.639 . . . . 54.53 109.002 -177.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m -142.54 119.31 11.16 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 117.059 0.43 . . . . 50.34 110.457 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 m -93.05 115.29 27.97 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 106.966 -1.494 . . . . 72.24 106.966 174.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -105.51 120.79 56.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.895 0.855 . . . . 72.41 110.447 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 11.6 m -119.6 137.68 53.7 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.864 -1.062 . . . . 61.44 109.624 -172.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 95' ' ' ILE . 4.5 pp -97.55 136.68 37.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.333 -0.618 . . . . 71.5 109.333 178.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 115.87 28.72 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.584 -1.635 . . . . 71.32 106.584 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.79 134.71 49.53 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.986 -0.552 . . . . 73.5 111.826 -175.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.42 99.9 5.03 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.08 -1.822 . . . . 44.42 106.08 171.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 19' ' ' ARG . 23.9 t70 -114.78 8.17 16.01 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 113.82 -1.537 . . . . 64.22 110.206 -176.566 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.82 -48.03 0.99 Allowed Glycine 0 CA--C 1.491 -1.457 0 N-CA-C 109.358 -1.497 . . . . 70.11 109.358 -176.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -127.35 -39.57 1.87 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.967 -0.753 . . . . 52.44 108.967 175.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.97 116.8 1.61 Allowed Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 120.41 -0.9 . . . . 70.13 111.869 177.316 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 15' ' ' ASP . 44.5 mtm105 -118.61 156.73 28.68 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.28 -0.267 . . . . 74.13 110.28 175.134 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.5 p -126.36 152.88 45.68 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.067 -0.515 . . . . 74.43 110.587 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 57.3 t80 -148.02 131.58 16.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.698 -1.593 . . . . 74.31 106.698 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 21.0 tt0 -91.94 131.37 37.3 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.917 -0.713 . . . . 74.12 109.785 -178.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HB2' HG13 ' A' ' 9' ' ' VAL . 96.8 mt -68.51 147.15 52.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.744 . . . . 62.13 108.99 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -118.25 150.57 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.801 -0.814 . . . . 74.44 108.801 -177.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.32 116.97 2.7 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.97 1.418 . . . . 73.45 112.75 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.0 -172.67 20.08 Favored Glycine 0 N--CA 1.418 -2.524 0 N-CA-C 107.585 -2.206 . . . . 74.13 107.585 -174.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 33.6 p -106.72 134.25 50.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 118.487 1.144 . . . . 74.55 111.175 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -106.02 122.13 45.53 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.06 -0.718 . . . . 74.41 109.06 178.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.1 mm -88.86 121.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.358 -0.837 . . . . 64.44 108.997 -177.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 75.5 mt -103.12 126.12 57.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 74.13 108.725 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.41 -159.56 32.49 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 110.282 -1.127 . . . . 22.14 110.282 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.7 mtp180 -129.45 105.36 8.05 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.575 -0.898 . . . . 73.54 108.575 175.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.52 -164.54 34.31 Favored Glycine 0 N--CA 1.415 -2.717 0 N-CA-C 110.527 -1.029 . . . . 75.1 110.527 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -79.14 -38.47 35.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.21 -0.663 . . . . 73.11 109.21 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.48 -37.03 84.21 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.954 . . . . 74.31 109.552 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.96 118.56 7.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 114.137 -1.392 . . . . 51.42 111.894 -176.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -90.25 -37.47 14.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.402 -1.333 . . . . 64.13 107.402 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 34.7 t80 -107.1 114.19 28.1 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.184 -2.154 . . . . 73.24 105.184 176.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 92.9 mtt180 -106.9 131.55 53.85 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.939 -0.573 . . . . 63.11 110.899 -171.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.94 144.42 41.71 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.554 -0.748 . . . . 71.14 111.5 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -89.46 5.62 4.71 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.761 2.307 . . . . 74.41 114.3 -178.468 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.66 -176.12 3.17 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.884 -0.726 . . . . 64.44 109.317 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -106.3 175.97 5.32 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.7 0.286 . . . . 72.41 110.758 -174.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.84 80.88 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 110.763 -0.935 . . . . 72.32 110.763 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.461 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 22.5 t -103.69 130.19 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 114.903 -0.648 . . . . 61.41 109.915 -175.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 178.59 7.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.032 -0.729 . . . . 61.14 109.032 177.182 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 16.9 ptm180 -67.81 -31.16 70.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.702 0.763 . . . . 73.43 109.791 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -133.71 100.53 4.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.166 -2.161 . . . . 74.24 105.166 172.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -94.71 -38.5 10.78 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.091 -0.707 . . . . 73.04 109.091 -178.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.93 156.42 19.89 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.892 -1.151 . . . . 70.12 107.892 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -137.04 147.47 46.2 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 109.027 -0.731 . . . . 70.45 109.027 176.12 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.3 mt -116.14 111.29 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 107.948 -1.13 . . . . 73.31 107.948 174.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.6 ttt180 -91.23 115.48 28.06 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.843 -1.169 . . . . 72.22 107.843 175.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -108.67 106.8 17.01 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 108.573 -0.899 . . . . 73.01 108.573 176.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.38 172.42 6.97 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 105.471 -2.048 . . . . 71.42 105.471 177.16 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 63.15 4.44 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 120.25 -0.976 . . . . 63.35 112.004 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -162.92 -68.55 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 32.41 108.795 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.8 m -137.99 157.08 32.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 CA-C-N 116.178 -0.465 . . . . 71.33 109.877 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.31 106.08 18.09 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.479 -0.934 . . . . 74.04 108.479 178.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.7 tt -90.01 115.15 27.08 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.113 -0.949 . . . . 75.52 108.987 -174.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.2 117.6 31.77 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.705 -1.591 . . . . 70.43 106.705 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.63 33.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.86 -0.422 . . . . 73.02 109.86 178.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -95.7 128.17 42.35 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.117 -0.698 . . . . 74.33 109.117 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.47 77.37 1.05 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 105.681 -1.97 . . . . 74.04 105.681 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.454 HD21 ' C ' ' A' ' 68' ' ' ASN . 8.4 t30 -178.48 132.26 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.496 -0.482 . . . . 64.44 110.45 -164.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 p -109.21 -53.52 2.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.188 0.811 . . . . 75.12 113.188 178.157 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -71.68 -34.79 69.98 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.458 0.91 . . . . 42.53 113.458 -173.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.454 ' C ' HD21 ' A' ' 65' ' ' ASN . 5.0 m-20 -107.47 29.27 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.319 -0.623 . . . . 73.12 109.319 -176.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.27 129.38 4.67 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 124.263 0.977 . . . . 72.3 115.366 -171.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.6 m -74.23 139.0 44.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.503 -0.849 . . . . 71.52 111.152 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -103.35 141.26 36.24 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.379 0.609 . . . . 72.03 111.462 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.442 HG12 HG13 ' A' ' 88' ' ' ILE . 27.0 m -116.98 117.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.376 -1.342 . . . . 74.3 107.376 174.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.55 34.63 24.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.696 -0.684 . . . . 72.53 110.134 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 86.27 -10.2 0.69 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.784 1.634 . . . . 64.41 112.995 178.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.32 124.95 47.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 121.745 -0.597 . . . . 73.33 111.158 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.52 125.42 10.1 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 122.47 2.113 . . . . 73.4 111.502 178.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.19 172.87 15.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 110.24 -0.281 . . . . 70.25 110.24 -177.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -102.59 -35.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.205 -0.665 . . . . 64.32 109.205 175.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.41 149.72 30.41 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.915 -0.584 . . . . 60.3 110.008 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -159.05 152.56 22.8 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.254 -1.017 . . . . 72.43 108.254 -173.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.41 111.75 24.59 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.659 -0.817 . . . . 75.14 109.825 174.308 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -58.34 134.67 56.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.21 -1.359 . . . . 74.33 112.43 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.32 164.29 16.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.617 -0.883 . . . . 75.34 108.617 172.567 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.417 ' CG ' HH21 ' A' ' 98' ' ' ARG . 26.2 t70 -66.97 114.48 5.8 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.13 0.49 . . . . 74.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.05 0.55 33.72 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.399 -0.819 . . . . 73.33 112.567 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -72.01 142.46 49.33 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.218 0.509 . . . . 72.41 111.494 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.64 113.78 42.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.262 -0.881 . . . . 74.25 108.941 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.442 HG13 HG12 ' A' ' 72' ' ' VAL . 2.9 mp -110.79 116.61 52.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.421 -0.955 . . . . 71.51 108.421 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -117.35 130.78 56.73 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.691 0.758 . . . . 75.4 110.785 -177.168 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -131.28 163.98 26.6 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.576 -1.268 . . . . 54.51 107.576 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.35 98.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.959 0.787 . . . . 64.41 114.865 -177.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 75.02 19.64 2.31 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 125.762 1.625 . . . . 74.35 114.071 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -148.37 138.32 22.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.613 -0.514 . . . . 70.51 109.613 176.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -133.62 120.58 20.88 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.607 0.718 . . . . 73.03 109.862 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 11' ' ' LEU . 9.7 tp -116.04 140.83 36.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.961 -1.018 . . . . 62.25 110.178 -172.252 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.15 138.13 39.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.5 -0.926 . . . . 74.41 108.5 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.55 124.44 54.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 120.886 0.374 . . . . 75.12 110.993 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.417 HH21 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -121.19 139.6 53.15 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.683 -0.858 . . . . 71.21 108.683 177.878 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.4 mtt -123.27 138.33 54.65 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 120.855 0.36 . . . . 73.52 110.622 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 108.488 -0.93 . . . . 73.41 108.488 -178.401 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.633 0 N-CA-C 111.509 -0.637 . . . . 62.15 111.509 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -82.02 95.42 7.42 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.071 0.463 . . . . 73.21 110.985 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.25 -175.32 41.75 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.959 -1.656 . . . . 71.23 108.959 178.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -86.92 150.46 24.07 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.429 -0.582 . . . . 65.02 109.429 178.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.32 -30.81 67.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.26 0.552 . . . . 33.45 109.794 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.98 -49.09 0.92 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.757 -0.735 . . . . 30.02 111.919 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 m -146.31 124.99 12.52 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.172 -0.677 . . . . 74.43 109.172 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -119.66 114.85 22.83 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.249 -1.019 . . . . 52.23 108.249 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.79 126.29 48.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.683 -0.858 . . . . 62.14 108.683 -175.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 46.0 m -131.84 122.85 26.4 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.805 -0.813 . . . . 53.24 108.805 -175.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 pp -88.9 136.39 33.03 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-O 121.207 0.527 . . . . 55.24 109.999 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.78 109.8 21.03 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.815 -1.084 . . . . 75.52 109.031 -172.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -99.49 105.66 17.6 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.298 -1.001 . . . . 51.51 108.298 175.236 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -92.29 100.49 13.07 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.149 -1.021 . . . . 73.45 108.721 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.97 -28.84 12.88 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.276 -0.875 . . . . 71.54 109.203 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.07 -51.11 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.852 -1.067 . . . . 61.01 111.397 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.7 m -114.38 -2.3 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.366 -0.491 . . . . 74.35 111.857 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.91 103.07 1.13 Allowed Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 121.298 -0.477 . . . . 52.21 113.357 178.164 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.73 158.29 16.06 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.664 -0.865 . . . . 73.42 108.664 173.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -139.31 141.02 37.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 123.49 0.493 . . . . 75.12 110.182 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -136.06 114.32 11.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.523 -0.547 . . . . 73.31 109.523 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 28.8 tt0 -76.28 134.89 39.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 109.003 -0.74 . . . . 74.41 109.003 177.55 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.09 136.87 52.92 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.902 -0.59 . . . . 70.23 110.074 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HG2' ' OD1' ' A' ' 28' ' ' ASN . 9.4 ptp180 -75.37 158.4 32.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.287 -1.375 . . . . 74.13 107.287 175.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -73.54 132.87 43.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.287 -1.375 . . . . 72.31 107.287 171.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.43 -150.19 17.25 Favored Glycine 0 C--N 1.282 -2.45 0 N-CA-C 107.706 -2.157 . . . . 54.01 107.706 -173.006 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 p -104.56 139.69 39.07 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.578 -1.249 . . . . 74.25 112.539 -178.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 27.6 m-80 -107.16 110.05 22.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.172 -1.788 . . . . 60.34 106.172 176.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -100.47 122.38 52.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.657 -0.247 . . . . 70.35 111.047 -173.864 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 78.0 mt -109.51 129.0 65.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.712 -0.848 . . . . 75.11 108.712 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.35 179.27 37.7 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 109.701 -1.36 . . . . 63.13 109.701 178.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 70.8 mtp180 -112.1 105.37 13.73 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.766 -1.198 . . . . 73.32 107.766 179.047 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.48 164.76 31.05 Favored Glycine 0 N--CA 1.409 -3.112 0 N-CA-C 109.258 -1.537 . . . . 55.14 109.258 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.96 -25.72 67.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.836 0.318 . . . . 74.44 111.275 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.28 -29.04 59.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 45.41 110.405 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -75.62 153.36 37.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 73.21 112.386 -175.537 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -97.52 -43.61 7.17 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.35 -0.841 . . . . 73.34 109.633 -178.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 80.1 t80 -117.57 128.07 54.59 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.872 -1.159 . . . . 72.41 107.872 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.83 137.42 47.65 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 112.386 0.513 . . . . 72.51 112.386 -178.541 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.34 142.72 54.86 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 74.34 110.751 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -86.72 35.76 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.858 2.372 . . . . 71.2 112.304 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.27 -177.52 5.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.843 -0.799 . . . . 64.04 108.843 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.9 m -113.94 158.63 20.86 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.124 -0.695 . . . . 73.05 109.124 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.86 -2.18 44.97 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.06 -1.216 . . . . 53.41 110.06 -178.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.67 136.03 24.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 113.936 -1.132 . . . . 73.22 109.516 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 5.2 m -76.13 175.8 8.61 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.495 -0.928 . . . . 72.43 108.495 177.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.7 ptp180 -68.42 -29.46 68.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.831 0.824 . . . . 75.41 109.055 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' SER . 75.2 mtm180 -128.39 103.38 7.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 104.015 -2.587 . . . . 74.53 104.015 168.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -91.85 -33.36 14.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.356 -0.609 . . . . 75.23 109.356 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.437 HD11 HD21 ' A' ' 61' ' ' LEU . 7.2 tt -162.8 147.3 11.65 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.15 -0.685 . . . . 62.23 109.15 -178.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -129.23 143.86 51.01 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.425 0.631 . . . . 75.32 109.995 175.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -113.36 106.14 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 107.454 -1.313 . . . . 51.1 107.454 172.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -92.06 107.91 19.56 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.869 -1.16 . . . . 51.33 107.869 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.33 126.33 52.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 74.11 111.575 -174.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -136.68 155.19 50.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 105.551 -2.018 . . . . 63.55 105.551 176.482 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 55.43 1.74 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 118.302 0.501 . . . . 63.22 113.468 -177.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -149.21 -63.39 0.23 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.634 1.174 . . . . 72.54 108.048 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.93 159.61 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 123.536 0.734 . . . . 74.45 109.306 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.7 101.89 11.37 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.761 -1.199 . . . . 75.3 107.761 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.3 tp -90.13 101.81 14.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.019 -0.991 . . . . 75.44 111.225 -172.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -85.37 131.24 34.43 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.602 -1.259 . . . . 42.55 107.602 178.029 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 78' ' ' GLN . . . -138.77 116.88 11.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.39 . . . . 72.35 110.538 178.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -86.2 135.79 33.44 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.812 -0.631 . . . . 74.55 109.801 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.16 76.9 1.42 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.568 -1.271 . . . . 61.04 107.568 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 175.31 147.1 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.928 -0.767 . . . . 70.31 108.928 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 p -109.58 -48.01 3.29 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.962 0.727 . . . . 74.15 112.962 175.241 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -67.31 -33.94 76.33 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.642 0.734 . . . . 60.35 112.307 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' ND2' ' HA3' ' A' ' 91' ' ' GLY . 65.3 t30 -121.4 27.4 8.32 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.568 -1.271 . . . . 64.41 107.568 -173.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.41 143.01 4.87 Favored Glycine 0 C--O 1.25 1.147 0 CA-C-N 114.493 -1.231 . . . . 52.24 115.404 -175.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.2 m -84.53 151.23 24.71 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.003 0.906 . . . . 52.05 112.432 -176.014 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.4 p -121.38 143.8 49.01 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.164 -0.925 . . . . 64.21 110.967 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 80' ' ' TRP . 32.6 m -109.84 121.64 63.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 106.061 -1.829 . . . . 65.15 106.061 174.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 61.57 24.62 14.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.615 0.722 . . . . 72.22 109.302 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.5 10.26 2.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 126.326 1.85 . . . . 75.34 110.984 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.24 125.93 34.93 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.577 -0.702 . . . . 51.34 109.156 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 125.51 10.45 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.639 2.226 . . . . 72.35 114.124 -176.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -151.93 177.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 106.335 -1.728 . . . . 64.5 106.335 178.467 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 72.0 mt-30 -119.36 -37.08 3.23 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.195 0.521 . . . . 73.13 109.729 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.91 133.56 55.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.627 -0.715 . . . . 61.32 109.352 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.466 ' CD2' HG21 ' A' ' 72' ' ' VAL . 76.8 t-105 -158.49 141.39 14.66 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 121.779 0.8 . . . . 74.53 111.115 -176.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -88.58 104.26 16.68 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 113.735 -1.575 . . . . 61.14 107.088 173.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.97 150.84 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.749 -0.66 . . . . 63.01 111.98 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.28 165.49 26.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.71 -0.848 . . . . 73.3 108.71 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.39 111.47 7.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.307 0.575 . . . . 73.02 110.207 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.1 19.56 16.46 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.604 -0.725 . . . . 64.54 111.901 -178.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.99 129.46 34.87 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.274 -1.38 . . . . 71.12 107.274 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.42 113.03 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.49 -0.93 . . . . 72.45 108.49 -178.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.453 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 42.3 mm -96.23 106.53 18.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.04 -1.837 . . . . 72.3 106.04 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 24.8 ttt85 -103.19 106.28 16.76 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.556 -1.276 . . . . 71.23 107.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -106.95 163.93 12.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.706 -1.133 . . . . 71.3 109.433 -174.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.481 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -41.3 101.05 0.02 OUTLIER Glycine 0 C--N 1.309 -0.929 0 N-CA-C 115.924 1.129 . . . . 63.01 115.924 -175.252 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 36.2 m80 74.29 15.77 3.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.739 1.616 . . . . 70.1 113.463 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.2 t -151.66 176.63 11.18 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.921 -0.399 . . . . 70.22 109.921 178.235 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.61 144.57 24.5 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.27 -1.011 . . . . 75.34 108.27 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 9.8 tp -140.4 140.56 34.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.826 -0.805 . . . . 71.5 108.826 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.5 mt -104.66 117.39 50.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.96 -0.755 . . . . 73.24 108.96 -178.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.24 122.23 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 110.369 -0.234 . . . . 64.24 110.369 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -115.83 151.57 35.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.361 -0.607 . . . . 72.12 109.361 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 mtt -122.1 117.03 25.31 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.634 -0.712 . . . . 63.23 109.445 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 . . . . . 0 C--N 1.275 -2.66 0 N-CA-C 108.063 -1.088 . . . . 74.2 108.063 -178.579 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.574 0 N-CA-C 110.813 -0.915 . . . . 45.31 110.813 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -83.17 102.92 12.19 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.344 0.592 . . . . 53.54 109.815 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.14 43.61 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.217 -1.553 . . . . 62.44 109.217 -179.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -99.46 10.73 40.85 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.228 -0.486 . . . . 55.33 109.979 -176.046 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.05 85.33 0.14 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.011 1.324 . . . . 63.23 111.178 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.88 -163.32 20.42 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 109.265 -1.534 . . . . 62.13 109.265 175.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m -57.83 116.22 3.33 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 117.38 0.59 . . . . 73.31 109.525 178.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -108.67 115.53 30.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.078 -0.51 . . . . 75.34 109.744 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.25 110.5 26.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.766 -1.198 . . . . 72.41 107.766 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -112.53 120.8 42.86 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.687 -0.857 . . . . 72.53 108.687 -174.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -91.53 137.34 32.44 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.647 -0.501 . . . . 63.12 109.647 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 26.6 mt-30 -104.02 127.3 51.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.389 -1.337 . . . . 64.5 107.389 174.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.6 135.22 52.94 Favored 'General case' 0 C--N 1.269 -2.892 0 O-C-N 123.399 0.437 . . . . 61.1 111.385 -173.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 100.33 11.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.732 -1.581 . . . . 73.03 106.732 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.4 ' CB ' ' HG2' ' A' ' 19' ' ' ARG . 16.8 t70 -104.36 1.69 30.49 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 113.606 -1.633 . . . . 73.21 110.059 -176.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.5 -41.54 1.86 Allowed Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 108.584 -1.807 . . . . 64.24 108.584 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -112.59 -63.92 1.37 Allowed 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.28 -1.378 . . . . 51.42 107.28 173.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.49 109.04 0.39 Allowed Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 111.242 -0.743 . . . . 53.1 111.242 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.4 ' HG2' ' CB ' ' A' ' 15' ' ' ASP . 35.6 mmt180 -101.11 157.08 17.03 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.104 -0.702 . . . . 73.2 109.104 177.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.0 p -137.75 132.6 32.99 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.628 -1.249 . . . . 71.0 107.628 174.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -138.49 129.31 26.62 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.797 -0.816 . . . . 70.34 108.797 -173.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -87.46 120.94 29.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.679 -0.86 . . . . 72.33 108.679 177.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.52 137.87 23.43 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 124.355 1.034 . . . . 70.42 111.475 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -85.12 144.7 28.05 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 108.9 -0.778 . . . . 73.42 108.9 -177.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.7 113.53 8.82 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.077 0.941 . . . . 71.4 109.947 178.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.58 -167.37 23.15 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 106.573 -2.611 . . . . 74.32 106.573 -171.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 58.1 p -106.46 127.76 53.54 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 118.981 1.39 . . . . 52.5 111.179 177.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -102.0 112.58 25.28 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.425 -0.807 . . . . 64.12 108.97 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.34 120.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.255 -0.884 . . . . 73.23 109.443 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.4 mt -99.99 130.62 48.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.238 -0.892 . . . . 64.05 109.194 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 157.32 -161.34 31.17 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.713 -1.355 . . . . 73.03 109.713 178.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.725 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 60.6 mtp180 -129.76 105.23 7.89 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.056 -1.461 . . . . 74.43 107.056 173.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.34 -176.19 47.69 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.944 -0.646 . . . . 64.22 111.615 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -63.23 -30.03 71.25 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 124.739 1.216 . . . . 75.32 113.177 -176.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.39 -6.61 37.11 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.822 0.344 . . . . 75.33 111.686 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 115.12 18.23 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.892 0.377 . . . . 74.34 111.992 -174.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.459 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 12.9 mm-40 -89.31 -29.44 19.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.478 -0.783 . . . . 72.23 109.434 177.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 85.4 t80 -115.18 108.95 17.29 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.259 -1.756 . . . . 75.23 106.259 173.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 59.5 mtt180 -99.13 120.63 39.82 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.035 -0.984 . . . . 74.33 110.375 -172.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.9 mt -73.05 138.32 79.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.886 -0.597 . . . . 70.34 110.557 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -84.35 1.67 8.56 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.41 2.074 . . . . 71.41 113.868 -177.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -102.85 163.63 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.308 -0.627 . . . . 54.23 109.308 -178.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.6 m -100.45 147.93 25.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 120.909 0.385 . . . . 55.21 110.455 -177.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.69 7.99 30.94 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 110.626 -0.99 . . . . 74.45 110.626 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG13 ' HD1' ' A' ' 49' ' ' HIS . 38.2 t -99.31 133.61 41.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 70.24 108.391 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.6 m -69.94 175.87 4.11 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.753 0.311 . . . . 52.11 111.388 178.425 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.2 ptp180 -65.27 -28.85 69.63 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.606 0.717 . . . . 65.51 111.299 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -135.59 119.16 16.99 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.579 -2.378 . . . . 74.25 104.579 169.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 3.7 t60 -104.62 -45.16 4.69 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.96 -0.756 . . . . 75.02 108.96 -177.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -163.29 154.25 16.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.279 -1.378 . . . . 75.11 107.279 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -136.84 143.89 43.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.698 -0.482 . . . . 73.42 109.698 176.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -112.42 115.26 49.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 108.562 -0.903 . . . . 74.21 108.562 177.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 47.3 ttt180 -93.0 107.25 19.07 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-O 121.305 0.574 . . . . 71.31 109.539 176.607 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -97.31 107.16 19.61 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.522 -1.288 . . . . 75.55 107.522 175.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.62 -173.18 2.4 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 105.18 -2.156 . . . . 71.15 105.18 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.58 4.75 85.12 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 118.797 -1.668 . . . . 72.43 111.969 -177.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -117.94 -61.31 1.7 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.578 -0.311 . . . . 70.32 111.817 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 157.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.949 0.404 . . . . 74.1 111.414 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 82' ' ' LEU . . . -102.68 104.66 15.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.172 -1.047 . . . . 64.43 108.172 176.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.9 tt -91.25 118.34 30.4 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.737 -1.12 . . . . 60.44 110.077 -174.592 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.04 122.32 43.87 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.217 -1.401 . . . . 72.45 107.217 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.6 118.95 12.85 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.489 -0.485 . . . . 74.33 112.008 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 0.8 OUTLIER -66.05 139.75 58.21 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.399 -0.963 . . . . 74.2 108.399 172.577 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -126.82 75.4 1.56 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 105.858 -1.904 . . . . 63.54 105.858 178.736 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 11.2 t-20 158.11 163.63 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 106.46 -1.681 . . . . 75.13 106.46 -178.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.9 m -108.04 -44.82 4.09 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 118.014 0.37 . . . . 60.25 111.711 176.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 m -73.99 -30.21 62.37 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.454 0.645 . . . . 74.34 111.649 -175.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.586 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.7 m120 -86.65 28.29 0.89 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.045 -0.409 . . . . 51.43 110.51 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.0 123.62 4.83 Favored Glycine 0 C--O 1.24 0.528 0 N-CA-C 116.116 1.206 . . . . 42.42 116.116 -174.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.446 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 88.0 m -91.77 151.04 20.79 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 124.733 1.213 . . . . 72.41 110.019 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 p -118.76 140.68 49.54 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 116.226 -0.443 . . . . 65.34 110.508 176.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.27 117.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.84 -1.17 . . . . 53.04 107.84 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 59.85 30.01 19.56 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.71 0.804 . . . . 72.03 110.325 -177.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 t30 79.79 1.41 2.14 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.948 1.699 . . . . 72.32 110.949 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.76 25.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 O-C-N 121.884 -0.51 . . . . 34.14 110.139 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.39 125.91 5.92 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.705 2.27 . . . . 74.52 112.469 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.01 -177.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.884 -1.154 . . . . 74.15 107.884 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.11 -10.15 7.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.046 0.45 . . . . 64.51 110.112 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -153.41 135.24 14.57 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 109.6 -0.519 . . . . 73.42 109.6 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -151.73 151.93 32.06 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.748 -0.66 . . . . 74.31 109.916 -174.524 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -102.78 114.65 29.09 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 72.32 108.182 174.393 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD12 ' HB1' ' A' ' 59' ' ' ALA . 64.3 mt -59.5 143.74 49.18 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.87 0.692 . . . . 65.2 112.87 -176.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.3 166.57 23.47 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.255 -1.017 . . . . 74.53 108.255 171.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.78 115.7 10.23 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.133 -0.321 . . . . 73.33 110.133 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 0.87 26.8 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.076 -0.583 . . . . 63.33 113.05 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -74.15 129.87 38.68 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.296 -0.562 . . . . 74.11 111.073 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.67 112.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 108.009 -1.108 . . . . 64.44 108.009 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.83 129.87 70.24 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 N-CA-C 109.736 -0.468 . . . . 73.01 109.736 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -123.75 131.9 53.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 110.093 -0.336 . . . . 71.43 110.093 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.13 140.17 37.84 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.369 -1.345 . . . . 61.01 107.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.48 88.3 0.0 OUTLIER Glycine 0 N--CA 1.489 2.178 0 O-C-N 125.4 1.688 . . . . 73.21 116.482 -174.069 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.7 m80 80.68 -33.51 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.596 1.558 . . . . 73.42 114.367 177.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -101.1 162.27 13.01 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.268 -0.573 . . . . 64.41 110.918 -173.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.06 143.18 31.77 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.28 0.562 . . . . 63.2 110.116 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -140.16 138.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 114.9 -1.046 . . . . 74.44 110.118 -173.563 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.17 128.36 67.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.936 -0.764 . . . . 74.21 108.936 177.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 82' ' ' LEU . 63.9 t -89.18 129.26 40.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 112.521 0.563 . . . . 75.23 112.521 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.32 137.12 51.97 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.313 -0.995 . . . . 63.32 108.313 172.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.3 mtp -126.27 112.42 15.7 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.464 -0.569 . . . . 54.44 109.464 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 . . . . . 0 C--N 1.275 -2.654 0 N-CA-C 108.255 -1.017 . . . . 73.34 108.255 -178.631 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.22 0 N-CA-C 110.47 -1.052 . . . . 64.32 110.47 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -84.85 98.76 10.49 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 121.374 0.607 . . . . 73.5 111.149 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.04 128.23 1.65 Allowed Glycine 0 N--CA 1.416 -2.654 0 N-CA-C 109.154 -1.579 . . . . 62.14 109.154 178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.0 m -77.97 -28.1 49.3 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.621 0.724 . . . . 70.44 109.604 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.41 119.76 29.19 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.815 -1.18 . . . . 71.23 107.815 177.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.49 69.61 3.25 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 110.641 -0.984 . . . . 62.43 110.641 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 83.5 m -141.75 117.63 10.51 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 109.487 -0.56 . . . . 74.13 109.487 -177.152 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.5 m -105.16 114.59 28.88 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.433 -0.951 . . . . 72.44 108.433 176.31 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -99.61 114.14 36.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.525 -1.287 . . . . 74.55 107.525 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.5 m -124.18 123.77 41.0 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.891 -0.781 . . . . 70.32 108.891 -176.199 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -102.99 128.23 49.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.71 -0.677 . . . . 64.51 109.311 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.57 132.7 51.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.387 -0.824 . . . . 65.34 110.424 -175.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.7 tp -121.5 111.55 17.4 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.378 -0.828 . . . . 65.41 109.321 -177.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -127.23 100.79 6.22 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.916 0.865 . . . . 54.33 109.735 177.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.05 19.53 15.67 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.555 -1.276 . . . . 71.3 107.555 174.795 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.75 16.82 12.0 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.666 -1.373 . . . . 61.11 109.666 -171.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 p -117.36 -68.32 0.93 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.317 0.58 . . . . 71.43 110.542 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.66 53.31 1.56 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.919 -0.872 . . . . 64.11 110.919 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.08 156.76 17.0 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.852 0.358 . . . . 51.31 111.121 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.2 p -132.34 143.98 50.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.777 -0.823 . . . . 73.22 108.777 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -135.48 134.16 39.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.392 -1.336 . . . . 74.2 107.392 175.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -110.06 135.07 51.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.846 -0.798 . . . . 53.45 108.846 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.85 128.23 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.76 . . . . 73.34 111.65 -176.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -104.5 153.2 21.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.456 -2.424 . . . . 72.42 104.456 172.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.02 143.95 55.84 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.12 0.962 . . . . 72.34 113.336 -173.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.12 177.37 16.5 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 107.648 -2.181 . . . . 75.22 107.648 -174.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 29.8 t -100.09 125.17 46.15 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.479 -0.888 . . . . 72.33 108.854 176.033 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -108.07 120.57 42.7 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.942 -1.026 . . . . 74.42 110.319 -177.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.4 mt -86.05 127.81 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.889 -1.051 . . . . 74.01 110.539 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.602 HG23 HD21 ' A' ' 40' ' ' LEU . 55.4 mt -103.27 119.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 125.321 1.448 . . . . 65.21 108.329 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 167.46 -151.75 19.64 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.416 -0.674 . . . . 51.13 111.416 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 82.9 mtm180 -131.8 105.03 7.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 117.769 0.784 . . . . 74.1 109.519 176.376 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.84 -163.8 33.6 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.314 -0.946 . . . . 55.11 111.215 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -86.96 -34.16 19.4 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.931 -0.766 . . . . 75.05 108.931 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -33.48 74.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.385 -0.825 . . . . 65.23 109.585 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.03 129.19 39.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.833 -1.076 . . . . 71.02 110.779 -178.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -90.72 -26.67 19.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.544 -1.28 . . . . 74.04 107.544 178.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.63 116.17 25.46 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.218 -1.356 . . . . 71.53 107.411 178.004 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -101.58 117.34 34.7 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.974 -0.557 . . . . 65.2 111.218 -175.806 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.602 HD21 HG23 ' A' ' 30' ' ' ILE . 4.0 mm? -78.1 125.24 85.49 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.666 -0.697 . . . . 74.54 110.732 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -74.6 2.6 6.22 Favored 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 122.416 2.077 . . . . 63.44 113.658 178.159 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -104.85 -173.38 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.093 -1.077 . . . . 75.33 108.093 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -124.78 167.12 15.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.68 -0.859 . . . . 75.45 108.68 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.01 -3.48 62.27 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 108.818 -1.713 . . . . 64.12 108.818 -174.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.75 131.41 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.168 -1.516 . . . . 75.01 107.458 179.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -93.41 -177.57 4.47 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.503 -0.317 . . . . 72.25 111.81 -175.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.8 ptm180 -63.79 -36.03 82.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.516 0.674 . . . . 71.43 111.913 -177.196 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -133.17 99.4 4.54 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 105.481 -2.044 . . . . 62.23 105.481 175.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -104.37 -46.42 4.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.978 -1.01 . . . . 61.2 109.546 -176.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 tt -153.49 159.75 42.36 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.069 -1.086 . . . . 64.15 108.069 -176.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.0 149.68 40.34 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.177 -0.675 . . . . 63.23 109.177 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' SER . 68.3 mt -118.74 115.43 48.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.828 -0.804 . . . . 71.43 108.828 175.152 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -91.55 107.42 19.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.344 -1.354 . . . . 73.13 107.344 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -115.43 132.36 56.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.789 -0.641 . . . . 71.33 111.305 -177.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -143.0 169.39 17.65 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.627 -1.99 . . . . 53.44 105.627 173.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 65.67 1.77 Allowed Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.8 -0.714 . . . . 75.52 112.07 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -155.89 -73.47 0.11 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.249 1.02 . . . . 63.21 108.443 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.95 159.22 16.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.66 0.784 . . . . 63.02 109.332 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -103.85 104.69 14.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.193 -0.669 . . . . 70.04 109.193 178.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.28 114.07 26.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.204 -0.907 . . . . 71.23 109.788 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.75 122.51 36.29 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.896 -1.52 . . . . 74.44 106.896 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.78 124.47 18.33 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.71 -0.396 . . . . 72.22 110.568 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.512 ' OD2' ' HB ' ' A' ' 70' ' ' THR . 12.9 m-20 -72.45 143.98 48.27 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.466 -0.939 . . . . 61.3 108.466 174.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -121.98 75.72 1.24 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.874 -1.158 . . . . 72.23 107.874 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 165.87 153.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 104.939 -2.245 . . . . 73.32 104.939 -178.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -97.2 -33.66 11.4 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.798 -0.761 . . . . 74.01 112.387 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 t -89.1 -28.95 19.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.758 -0.377 . . . . 65.34 111.351 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -88.63 27.38 1.3 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 122.568 0.347 . . . . 71.22 111.882 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.82 129.38 47.08 Favored Glycine 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 43.43 112.001 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 15.6 m -86.79 157.75 19.52 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 124.821 1.248 . . . . 74.35 113.053 -173.201 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 p -102.69 140.7 36.62 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.134 0.492 . . . . 74.52 110.732 178.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.05 120.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.672 -1.232 . . . . 73.31 107.672 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 59.29 32.02 21.61 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.694 0.798 . . . . 74.53 109.924 -176.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.7 t30 75.4 9.27 3.74 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.0 1.32 . . . . 71.11 110.953 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.9 41.99 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.488 -0.56 . . . . 60.43 109.488 177.536 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.33 125.35 11.23 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.4 2.067 . . . . 62.12 111.913 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.28 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.635 -0.876 . . . . 53.33 108.635 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -126.61 -0.64 6.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.422 -0.584 . . . . 74.11 109.422 171.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -165.29 147.16 7.65 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.479 -0.934 . . . . 44.43 108.479 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -166.95 151.84 7.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.508 -0.923 . . . . 75.32 108.508 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -105.03 118.62 36.99 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.557 -0.857 . . . . 71.23 109.57 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 78.0 mt -61.62 150.23 36.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.644 -1.162 . . . . 73.3 113.717 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.52 174.77 10.66 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.844 -1.071 . . . . 73.21 108.154 172.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.06 112.3 12.36 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.655 -0.498 . . . . 73.31 109.655 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.0 14.85 11.41 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.665 -0.778 . . . . 71.21 113.153 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -79.98 121.46 25.51 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 119.523 -0.871 . . . . 72.32 110.692 175.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 112.61 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 106.743 -1.577 . . . . 62.3 106.743 175.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 95' ' ' ILE . 57.8 mt -120.45 140.1 45.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 109.388 -0.597 . . . . 63.23 109.388 -174.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -132.2 123.64 27.42 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.519 -0.872 . . . . 73.24 111.507 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.5 pt? -108.11 163.66 12.97 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.762 -1.57 . . . . 65.44 106.762 176.452 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.92 104.51 0.05 OUTLIER Glycine 0 CA--C 1.533 1.171 0 O-C-N 123.996 0.81 . . . . 72.02 114.403 -178.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.0 m80 80.32 -5.11 1.81 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.262 1.579 . . . . 73.14 115.262 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.4 m -138.17 136.51 36.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.995 0.816 . . . . 72.21 111.795 -177.668 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -107.56 138.44 43.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.226 -0.657 . . . . 64.1 109.226 175.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 5.4 tp -126.9 131.71 70.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.624 -0.88 . . . . 73.32 108.624 -175.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.5 119.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.654 -0.869 . . . . 72.31 108.654 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG11 ' HB3' ' A' ' 82' ' ' LEU . 95.6 t -90.62 125.01 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.209 0.528 . . . . 65.25 111.35 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.76 149.42 42.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.401 -0.818 . . . . 74.21 109.728 178.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' SER . 59.4 mtt -129.6 110.47 11.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.624 0.726 . . . . 53.44 109.459 176.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--N 1.278 -2.535 0 CA-C-N 114.852 -1.067 . . . . 72.02 109.857 -176.53 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.807 -0.917 . . . . 61.31 110.807 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -100.51 147.21 26.16 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 110.001 -0.37 . . . . 70.31 110.001 -179.448 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.55 -102.46 1.2 Allowed Glycine 0 C--N 1.302 -1.344 0 N-CA-C 109.156 -1.578 . . . . 72.22 109.156 176.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -105.7 -0.12 25.79 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.412 -0.588 . . . . 72.01 109.412 176.57 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.3 17.82 7.41 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.827 1.251 . . . . 62.11 111.96 179.189 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.07 -59.82 4.5 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 110.346 -1.102 . . . . 63.23 110.346 -175.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 52.3 m -138.7 121.05 15.97 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 123.876 0.871 . . . . 72.25 109.514 177.021 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -113.0 128.53 56.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.104 -0.498 . . . . 51.45 109.756 176.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -103.35 124.72 57.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 75.43 109.031 177.428 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.4 m -126.16 134.82 51.18 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.303 -0.862 . . . . 71.42 109.559 -173.35 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.7 mt -93.89 135.12 35.55 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.277 -1.009 . . . . 73.21 108.277 178.213 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -114.83 126.62 55.04 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 109.762 -0.458 . . . . 65.44 109.762 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -123.61 114.85 20.56 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.381 -0.97 . . . . 72.12 108.381 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -118.39 101.93 8.54 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.9 0.857 . . . . 63.53 111.608 -179.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.25 26.76 10.05 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.025 -1.843 . . . . 64.45 106.025 174.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.39 43.07 4.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.91 -2.076 . . . . 63.14 107.91 -173.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -147.73 -61.91 0.27 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.845 -0.677 . . . . 73.43 111.12 -172.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.88 39.8 5.73 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.002 -0.839 . . . . 74.21 111.002 -178.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.24 151.06 36.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 110.08 -0.341 . . . . 72.44 110.08 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.5 p -134.92 144.76 47.65 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.908 -0.587 . . . . 75.51 111.049 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -129.65 116.1 18.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.341 -0.615 . . . . 55.2 109.341 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -80.44 131.93 35.66 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.688 -0.486 . . . . 75.12 109.688 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.513 HD13 HG21 ' A' ' 52' ' ' ILE . 93.7 mt -85.05 122.34 29.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.817 -1.179 . . . . 72.41 107.817 174.745 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -93.89 178.88 5.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.966 -0.694 . . . . 71.31 109.236 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 132.46 45.99 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.441 0.639 . . . . 72.24 111.153 -176.038 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.37 -159.67 16.94 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.237 -1.545 . . . . 74.4 109.237 -176.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 p -106.6 144.61 33.01 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.371 -0.531 . . . . 60.03 109.625 177.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -121.89 112.05 17.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.134 -1.061 . . . . 43.32 108.134 -176.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.5 mm -86.2 130.56 36.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 109.399 -0.593 . . . . 71.34 109.399 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 38' ' ' PHE . 61.0 mt -115.69 135.79 54.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 123.238 0.615 . . . . 75.31 110.319 -178.049 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 148.23 -163.69 28.94 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 111.646 -0.582 . . . . 62.24 111.646 177.646 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.3 mtt180 -115.71 107.1 14.65 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.978 0.418 . . . . 74.44 110.114 176.205 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.62 -178.88 48.4 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.425 -1.47 . . . . 44.42 109.425 179.05 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.52 -13.69 53.99 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.502 0.668 . . . . 74.43 109.699 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -83.57 -24.38 31.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.2 -0.909 . . . . 52.24 109.449 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.67 139.25 31.53 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.55 -0.75 . . . . 54.21 111.955 -173.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -92.58 -44.92 8.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.474 -0.785 . . . . 74.23 108.942 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HB3' HG12 ' A' ' 30' ' ' ILE . 68.6 t80 -101.42 108.58 20.22 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.219 -1.03 . . . . 62.43 108.219 177.037 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.8 mtm-85 -96.19 127.39 42.16 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.865 -1.061 . . . . 74.21 108.464 -177.737 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 9.3 mp -80.14 149.75 70.17 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 112.006 0.373 . . . . 62.52 112.006 -178.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.3 Cg_exo -71.69 -12.28 28.79 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.755 2.303 . . . . 43.25 112.342 177.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.56 165.05 11.7 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.6 0.593 . . . . 73.51 112.6 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -102.1 162.56 12.82 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.917 -1.142 . . . . 73.14 107.917 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.99 -0.48 41.39 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 109.458 -1.457 . . . . 50.12 109.458 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.471 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 t -102.93 131.29 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.921 -1.139 . . . . 43.11 108.614 -176.449 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 m -75.88 172.23 13.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.297 -0.41 . . . . 74.25 111.565 -178.039 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 1.4 ptm180 -64.65 -42.2 95.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.384 0.611 . . . . 64.24 110.819 177.403 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -123.64 93.69 4.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 104.791 -2.3 . . . . 72.21 104.791 171.059 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.587 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 22.6 t60 -96.26 -30.61 13.36 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 115.182 -0.917 . . . . 74.42 109.524 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 tt -163.5 146.99 10.35 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 109.321 -0.622 . . . . 64.25 109.321 -178.194 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.04 123.38 30.36 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.382 0.611 . . . . 71.23 111.257 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 23' ' ' LEU . 69.1 mt -104.26 119.18 52.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.826 -0.625 . . . . 74.55 109.696 177.442 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -100.71 114.52 28.34 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.516 -0.92 . . . . 72.34 108.516 177.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -113.76 134.46 54.75 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.697 0.76 . . . . 73.14 112.164 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -148.18 164.71 33.1 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 103.758 -2.682 . . . . 63.31 103.758 174.144 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.14 58.23 1.08 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 118.893 0.77 . . . . 64.21 113.005 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -135.58 -78.41 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.203 -1.406 . . . . 75.21 107.203 178.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -149.41 159.37 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 105.705 -1.961 . . . . 73.25 105.705 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -95.58 113.12 24.74 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.171 -0.677 . . . . 54.25 109.171 178.092 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.5 tp -83.72 106.74 15.66 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.052 -0.976 . . . . 62.13 110.335 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.6 tm? -94.99 111.44 23.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.519 1.128 . . . . 72.02 108.246 -177.163 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.06 121.43 38.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.168 -0.308 . . . . 75.32 110.168 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.93 136.6 34.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.129 -0.693 . . . . 65.44 109.129 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.72 76.05 1.54 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.356 -1.72 . . . . 72.11 106.356 -177.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.573 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 30.4 t-20 174.55 141.91 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.055 -1.091 . . . . 75.25 108.055 -178.063 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -108.35 -53.12 2.67 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.91 0.386 . . . . 72.05 111.095 177.615 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.0 m -66.46 -37.32 84.87 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.83 0.852 . . . . 54.43 112.089 -175.785 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.573 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 25.9 m-80 -115.9 27.2 9.44 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.681 -1.229 . . . . 72.13 107.681 -178.254 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.26 152.06 3.31 Favored Glycine 0 C--O 1.243 0.709 0 CA-C-N 114.279 -1.328 . . . . 73.12 115.624 -174.477 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 m -87.95 147.3 25.11 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.675 0.79 . . . . 43.43 112.17 -176.53 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -118.03 146.67 43.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.183 0.993 . . . . 60.4 110.637 178.401 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.96 127.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.019 -1.475 . . . . 52.51 107.019 176.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.04 26.95 12.58 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.052 0.941 . . . . 63.24 111.933 -178.484 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 73.91 22.48 2.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.798 1.239 . . . . 72.21 110.272 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -122.97 134.2 24.93 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.338 -0.846 . . . . 53.12 108.904 176.111 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 6.1 Cg_exo -78.42 137.41 14.82 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.043 1.828 . . . . 63.54 111.856 179.629 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.1 170.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.091 -1.077 . . . . 72.34 108.091 179.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.71 -31.6 10.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.647 -0.501 . . . . 70.34 109.647 172.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.07 145.38 25.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 120.901 0.382 . . . . 65.21 110.091 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.41 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 63.4 t-105 -150.99 152.5 33.62 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.392 -0.966 . . . . 74.45 108.392 -173.816 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.95 124.22 49.12 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 107.549 -1.278 . . . . 61.21 107.549 174.688 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 42.3 mt -56.22 151.02 13.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.804 1.039 . . . . 73.1 113.804 -173.171 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.44 43.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.217 -1.401 . . . . 44.15 107.217 178.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.61 115.67 9.13 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.12 0.486 . . . . 73.01 110.843 -179.173 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.42 10.06 45.6 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.852 -0.689 . . . . 62.25 112.741 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.38 144.45 32.69 Favored 'General case' 0 C--O 1.252 1.201 0 C-N-CA 119.27 -0.972 . . . . 72.1 108.937 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.9 t -102.06 112.54 35.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.196 -1.039 . . . . 61.13 108.196 -178.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.7 mt -110.81 127.89 67.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 C-N-CA 120.093 -0.643 . . . . 71.11 109.744 -177.13 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -121.32 119.46 32.25 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 109.568 -0.53 . . . . 75.35 109.568 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.587 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 1.5 pt? -114.32 137.92 51.18 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.349 -1.723 . . . . 64.35 106.349 177.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 5.31 86.17 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 O-C-N 124.785 1.303 . . . . 60.42 115.638 -166.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 55.12 16.79 1.7 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.974 1.842 . . . . 73.44 115.974 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -123.8 128.01 48.91 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.117 -0.697 . . . . 60.43 109.117 177.705 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.57 139.25 46.0 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.149 0.796 . . . . 73.4 113.149 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 tp -127.39 142.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.407 -1.331 . . . . 74.3 107.407 -177.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.9 133.46 51.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.662 -0.866 . . . . 72.43 108.662 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 82' ' ' LEU . 81.4 t -100.72 126.18 54.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 120.836 0.351 . . . . 62.02 111.668 -178.392 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -119.79 138.2 53.5 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.009 -0.542 . . . . 75.15 109.807 174.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.1 mtp -124.11 113.73 18.75 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.345 -0.613 . . . . 73.33 109.345 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.465 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 56.6 m-70 . . . . . 0 C--N 1.28 -2.42 0 N-CA-C 108.295 -1.002 . . . . 62.14 108.295 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.227 0 N-CA-C 110.226 -1.15 . . . . 60.01 110.226 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -153.73 176.78 11.72 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.319 -0.993 . . . . 71.15 108.319 179.359 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.64 62.18 3.55 Favored Glycine 0 C--N 1.317 -0.502 0 N-CA-C 111.203 -0.759 . . . . 62.0 111.203 178.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.6 m -56.61 133.3 53.56 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.582 1.153 . . . . 63.32 111.789 -177.509 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.16 80.23 1.67 Allowed 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.105 -0.952 . . . . 70.41 108.888 177.623 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.06 -35.95 5.9 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 108.717 -1.753 . . . . 72.54 108.717 175.435 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.6 m -146.8 115.84 6.92 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.539 -0.911 . . . . 63.42 108.539 174.209 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -124.46 115.19 20.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.51 -1.293 . . . . 72.33 107.51 176.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.31 131.07 36.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.279 -1.008 . . . . 74.3 108.279 -177.346 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.534 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 37.9 m -137.61 132.81 33.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.502 -0.772 . . . . 74.43 108.922 -174.637 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.431 HD13 HD11 ' A' ' 95' ' ' ILE . 4.4 pp -93.23 136.75 33.2 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 120.216 -0.594 . . . . 60.45 109.649 177.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -109.04 129.52 55.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.732 -0.667 . . . . 74.34 111.476 -175.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -119.8 136.15 54.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.13 -1.396 . . . . 73.31 108.158 -177.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.79 98.91 11.7 Favored 'General case' 0 CA--C 1.467 -2.222 0 CA-C-O 122.574 1.178 . . . . 63.15 107.976 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 15.8 t70 -133.8 92.97 3.04 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 113.18 -1.827 . . . . 64.2 108.093 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.63 -61.54 4.12 Favored Glycine 0 C--N 1.292 -1.877 0 CA-C-N 114.565 -1.198 . . . . 54.14 110.634 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 p -135.73 -37.72 0.74 Allowed 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.609 -0.796 . . . . 71.4 109.792 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.9 120.07 1.06 Allowed Glycine 0 N--CA 1.41 -3.05 0 N-CA-C 110.444 -1.063 . . . . 62.32 110.444 -178.158 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 29.4 mmt180 -105.73 154.25 20.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.303 -1.369 . . . . 75.34 107.303 175.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 62.8 p -138.04 133.8 33.99 Favored 'General case' 0 C--N 1.283 -2.291 0 O-C-N 123.312 0.382 . . . . 70.24 110.685 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 55.9 t80 -117.85 114.48 23.31 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.752 -1.203 . . . . 74.01 107.752 174.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.18 135.72 38.53 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.13 -1.063 . . . . 64.55 108.13 179.126 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.3 mt -73.45 129.45 38.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.028 0.442 . . . . 72.34 110.034 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -79.58 151.83 30.42 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.2 -1.407 . . . . 73.32 107.2 176.691 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 4.6 pt-20 -75.25 113.35 12.51 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.274 1.035 . . . . 70.45 111.697 -178.775 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.13 -166.48 26.0 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 106.367 -2.693 . . . . 72.42 106.367 -172.301 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 97.3 p -97.42 119.49 36.05 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 119.622 1.711 . . . . 70.33 111.078 177.571 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 27.2 m-80 -88.03 108.46 19.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 106.998 -1.482 . . . . 74.01 106.998 -178.804 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.409 HG21 ' HG2' ' A' ' 48' ' ' ARG . 57.3 mt -91.21 116.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.278 -0.874 . . . . 74.54 109.225 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -99.34 128.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 123.484 0.714 . . . . 64.01 110.143 -177.642 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.68 26.65 Favored Glycine 0 CA--C 1.487 -1.661 0 CA-C-N 115.274 -0.875 . . . . 54.04 111.057 176.692 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -128.69 105.91 8.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.501 0.667 . . . . 64.34 111.349 176.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.07 166.52 33.56 Favored Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 108.92 -1.672 . . . . 65.42 108.92 176.424 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -74.88 -16.9 60.65 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.82 0.81 . . . . 73.24 109.283 176.497 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.98 -10.72 59.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.291 -0.868 . . . . 73.24 109.734 178.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.16 169.51 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 74.43 110.404 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -109.56 -47.39 3.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.447 0.641 . . . . 71.31 109.965 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -108.21 127.22 53.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.215 -0.902 . . . . 64.42 108.8 -177.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -95.23 127.28 41.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.048 -0.723 . . . . 74.13 109.048 -174.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 45' ' ' VAL . 38.1 mt -83.47 150.01 59.13 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.675 -0.41 . . . . 73.34 110.318 175.137 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -95.03 34.39 0.17 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 123.37 2.713 . . . . 75.04 112.325 179.015 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -138.6 179.75 6.29 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.13 -0.628 . . . . 63.42 110.004 -178.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 m -112.67 162.41 15.75 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.696 -0.853 . . . . 64.3 108.696 -176.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.08 -20.77 48.86 Favored Glycine 0 CA--C 1.5 -0.862 0 C-N-CA 121.021 -0.609 . . . . 51.33 111.938 176.936 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 40' ' ' LEU . 9.9 p -79.29 142.55 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.228 -0.486 . . . . 75.33 111.097 -178.099 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 m -80.13 -170.5 2.52 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.8 0.84 . . . . 55.51 109.317 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -77.8 -47.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.141 -1.024 . . . . 73.15 109.403 175.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.409 ' HG2' HG21 ' A' ' 29' ' ' ILE . 54.5 mtt180 -109.43 109.32 20.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 107.528 -1.286 . . . . 75.42 107.528 171.319 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -104.36 -45.28 4.71 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.664 -1.235 . . . . 75.25 107.664 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 5.8 tt -159.25 151.96 21.71 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 114.845 -1.07 . . . . 72.54 108.215 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HG2' HD21 ' A' ' 64' ' ' LEU . 14.5 pt-20 -136.96 140.77 42.45 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.757 -0.831 . . . . 75.43 108.757 175.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.8 mt -106.83 115.86 49.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 107.782 -1.192 . . . . 75.0 107.782 176.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 48.1 mtt180 -90.32 107.07 18.91 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.79 -1.559 . . . . 64.3 106.79 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -112.06 115.59 29.14 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.845 -1.07 . . . . 74.31 109.967 -176.279 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.01 160.46 22.74 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.107 -1.812 . . . . 64.2 106.107 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.14 54.07 2.25 Favored Glycine 0 C--N 1.311 -0.822 0 CA-C-N 118.078 0.399 . . . . 73.35 113.295 -178.358 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -156.27 -63.23 0.11 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.466 -0.939 . . . . 64.41 108.466 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.6 159.41 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 122.868 0.467 . . . . 64.44 110.833 -178.092 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.03 110.92 22.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.071 -0.513 . . . . 74.02 110.139 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 4.9 tt -100.74 118.04 36.04 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.746 -0.835 . . . . 54.2 108.746 -177.335 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -94.75 123.58 38.29 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.686 -1.227 . . . . 54.31 107.686 179.083 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.89 124.74 36.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 64.42 111.306 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.29 138.44 31.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.644 0.778 . . . . 44.54 109.892 179.085 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.7 mm? -127.0 76.53 1.66 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.732 -0.47 . . . . 74.32 109.732 177.187 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.52 142.45 0.57 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.748 -0.464 . . . . 71.33 109.748 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 p -96.32 -46.96 6.2 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.409 -0.516 . . . . 64.11 110.832 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 t -80.14 -36.85 34.61 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.937 -176.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -103.89 28.49 6.63 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 122.23 -0.294 . . . . 71.41 110.873 -176.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.07 125.67 5.76 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 124.561 1.163 . . . . 61.03 113.943 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.3 m -75.68 147.61 39.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 124.282 1.033 . . . . 55.4 112.505 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.2 p -112.4 140.89 46.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.454 -0.794 . . . . 64.41 110.747 176.733 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.68 119.53 58.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.79 -1.189 . . . . 73.34 107.79 177.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 55.26 36.26 26.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.388 0.613 . . . . 72.24 110.189 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 80.09 -2.92 1.99 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.029 1.731 . . . . 75.54 111.783 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.74 123.03 49.15 Favored Pre-proline 0 C--N 1.32 -0.692 0 O-C-N 121.524 -0.735 . . . . 75.23 110.77 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.55 125.47 10.12 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.653 2.235 . . . . 75.24 110.885 177.186 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 80' ' ' TRP . 35.7 m -142.57 173.93 6.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.73 -0.47 . . . . 72.21 109.73 -177.432 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.1 -30.99 8.12 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.739 -0.664 . . . . 62.02 109.567 172.758 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 13.2 pt-20 -145.53 146.55 31.47 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.041 0.448 . . . . 74.21 110.88 173.773 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.401 ' HB2' HG21 ' A' ' 77' ' ' VAL . 34.0 t-105 -154.9 152.17 29.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.739 -1.208 . . . . 72.42 107.739 -173.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -105.97 116.33 31.75 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.864 -1.134 . . . . 74.34 110.059 174.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 97' ' ' VAL . 74.2 mt -56.65 148.01 21.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.328 -1.305 . . . . 75.51 113.735 -174.668 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.78 37.6 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.425 -1.324 . . . . 60.31 107.425 170.625 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 21.3 t70 -71.26 120.93 17.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.105 0.479 . . . . 62.04 110.48 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.63 11.07 33.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.251 -0.886 . . . . 71.12 112.158 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -74.15 134.98 42.84 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 117.277 0.538 . . . . 64.45 111.362 177.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.8 t -97.31 112.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.151 -1.055 . . . . 75.51 108.151 179.612 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.14 125.59 74.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 119.801 -0.76 . . . . 74.25 110.54 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.473 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 59.3 mtt-85 -111.58 115.29 28.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.177 -0.465 . . . . 72.04 111.112 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.47 165.5 13.15 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.974 -1.012 . . . . 61.31 109.109 177.517 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.06 100.41 0.01 OUTLIER Glycine 0 N--CA 1.475 1.236 0 O-C-N 123.972 0.795 . . . . 42.43 114.765 -176.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.3 m170 65.53 10.79 6.93 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.584 1.554 . . . . 73.05 113.184 178.504 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 m -138.58 118.02 12.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.065 0.46 . . . . 71.41 111.447 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.15 142.1 33.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.744 -0.382 . . . . 75.11 110.01 172.662 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.431 HD11 HD13 ' A' ' 11' ' ' LEU . 7.9 tp -139.09 148.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.779 -0.452 . . . . 75.53 109.779 -172.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.15 131.19 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.128 -1.064 . . . . 64.2 108.128 176.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 82' ' ' LEU . 85.9 t -87.33 128.55 39.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 120.801 0.334 . . . . 70.43 110.239 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.411 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -125.01 151.32 45.71 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.129 -0.693 . . . . 75.15 109.129 -179.759 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -129.76 130.35 45.28 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.943 -0.571 . . . . 63.01 110.357 176.805 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 . . . . . 0 C--N 1.286 -2.153 0 N-CA-C 106.168 -1.79 . . . . 74.35 106.168 175.18 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.721 0 N-CA-C 111.65 -0.58 . . . . 71.1 111.65 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -80.9 86.45 6.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.032 -0.729 . . . . 63.22 109.032 177.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.38 -141.89 15.86 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.064 -1.215 . . . . 73.52 110.064 -176.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 t 55.38 -126.82 2.18 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.059 0.944 . . . . 63.14 109.807 178.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.28 -40.67 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.891 1.677 . . . . 74.31 112.875 178.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.15 -57.07 0.53 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 106.928 -2.469 . . . . 54.42 106.928 -178.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.0 m -107.33 115.98 31.12 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 108.739 -0.838 . . . . 75.12 108.739 175.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 m -103.82 119.93 39.93 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.843 -1.54 . . . . 70.23 106.843 176.391 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -107.51 124.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.615 0.722 . . . . 75.42 111.256 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 22.4 m -124.83 134.97 52.54 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.603 -1.258 . . . . 71.43 107.603 -175.635 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.471 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -100.55 143.78 30.31 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.566 -0.454 . . . . 65.44 110.812 -178.502 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HG2' HG22 ' A' ' 20' ' ' THR . 46.9 mt-30 -110.73 127.37 55.3 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 107.979 -1.119 . . . . 70.22 107.979 174.506 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.49 145.97 49.85 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.644 0.735 . . . . 73.25 110.724 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.41 101.56 13.49 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.063 -0.971 . . . . 60.13 110.251 -178.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.1 -32.5 10.55 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.603 -1.18 . . . . 74.15 109.605 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.73 -34.38 3.62 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 107.725 -2.15 . . . . 71.01 107.725 -171.251 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -87.91 -41.53 13.12 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.898 -1.149 . . . . 74.25 107.898 176.539 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 94.13 2.34 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 109.618 -1.393 . . . . 73.1 109.618 -177.23 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' ARG . 22.2 mmt180 -120.09 154.91 34.0 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.924 0.712 . . . . 74.13 112.924 -178.168 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.545 HG22 ' HG2' ' A' ' 12' ' ' GLN . 34.5 p -133.55 153.09 51.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.383 -1.28 . . . . 71.33 108.161 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.443 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 59.9 t80 -153.48 131.51 11.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.898 -1.149 . . . . 74.42 107.898 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.5 tt0 -93.75 141.25 28.71 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.356 -0.938 . . . . 74.44 110.649 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.4 mt -78.16 126.14 30.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.026 -0.534 . . . . 75.34 110.486 -178.431 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -82.79 152.87 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.317 -1.364 . . . . 65.12 107.317 178.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.42 120.66 21.96 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.988 0.899 . . . . 74.33 109.737 176.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.18 -167.89 24.25 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 105.548 -3.021 . . . . 40.01 105.548 -171.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -106.83 143.39 35.0 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 118.738 1.269 . . . . 72.42 110.694 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -125.56 145.26 50.2 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.701 -0.851 . . . . 73.15 108.701 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -121.83 131.9 72.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.61 -0.515 . . . . 64.32 109.61 -177.4 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 38' ' ' PHE . 80.1 mt -107.84 131.65 57.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 124.399 1.08 . . . . 60.31 109.779 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.73 -157.95 27.45 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 110.06 -1.216 . . . . 73.34 110.06 177.263 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 43.6 mtm180 -130.49 106.68 8.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.52 0.66 . . . . 72.31 109.997 174.741 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.82 -164.66 29.96 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 110.019 -1.232 . . . . 71.22 110.019 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -80.68 -39.3 27.45 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.135 0.493 . . . . 65.54 110.431 -178.082 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.0 -21.07 44.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 72.23 110.288 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.47 23.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.781 -0.645 . . . . 54.34 110.996 -178.569 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -99.15 -44.88 6.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.916 0.865 . . . . 65.24 108.803 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.424 ' HB3' HG12 ' A' ' 30' ' ' ILE . 60.3 t80 -100.27 122.55 43.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 106.743 -1.577 . . . . 75.11 106.743 178.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 17.8 mtp180 -98.14 134.82 40.67 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 112.754 0.65 . . . . 64.23 112.754 -174.289 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 38.9 mt -97.62 114.21 64.59 Favored Pre-proline 0 N--CA 1.42 -1.95 0 N-CA-C 107.477 -1.305 . . . . 71.45 107.477 169.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.521 ' HD2' ' NE2' ' A' ' 92' ' ' HIS . 16.2 Cg_exo -70.06 20.21 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.725 2.95 . . . . 74.3 113.907 -176.457 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -97.75 178.27 5.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.557 -0.534 . . . . 65.54 109.557 -176.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 m -115.59 133.05 56.41 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 109.399 -0.593 . . . . 71.31 109.399 -177.083 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.1 -2.85 35.27 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.433 -1.067 . . . . 42.0 110.433 -178.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.98 138.89 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 107.961 -1.126 . . . . 73.22 107.961 -179.435 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -83.76 166.4 18.05 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.668 -0.242 . . . . 64.4 111.145 -177.5 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 35.2 ptt180 -62.99 -36.66 84.3 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.8 0.81 . . . . 74.35 109.899 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -129.26 100.67 5.68 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 102.545 -3.132 . . . . 73.1 102.545 171.074 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -99.26 -37.29 9.33 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.781 -0.645 . . . . 72.13 109.328 -174.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -161.29 147.15 14.21 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.032 -1.469 . . . . 74.01 107.032 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -144.33 142.72 30.58 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 121.328 0.585 . . . . 73.35 110.971 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -119.58 128.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.262 -0.881 . . . . 41.41 109.523 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 36.1 ttt180 -107.38 111.76 24.25 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.157 -1.423 . . . . 63.25 107.157 177.332 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.293 0.568 . . . . 74.35 111.054 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -149.07 -174.03 4.53 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.74 -1.578 . . . . 74.01 106.74 173.414 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.11 2.59 60.56 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 119.961 -1.114 . . . . 35.15 114.704 -173.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HG2' HG13 ' A' ' 58' ' ' VAL . 61.6 tt0 -93.51 -75.24 0.5 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.167 0.484 . . . . 75.1 111.123 177.894 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.453 HG13 ' HG2' ' A' ' 57' ' ' GLN . 16.0 m -135.75 159.35 39.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 122.529 0.332 . . . . 64.44 110.6 -176.297 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -96.33 102.24 13.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.915 -1.143 . . . . 74.02 107.915 175.459 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 52.6 tp -93.67 113.41 25.48 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.357 -0.838 . . . . 73.44 111.093 -174.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.64 129.41 49.22 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.127 -1.064 . . . . 55.12 108.127 -179.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.27 125.71 28.28 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.863 0.363 . . . . 71.13 110.893 177.079 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.74 128.78 35.31 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.615 -1.254 . . . . 72.12 107.615 175.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.6 OUTLIER -124.37 78.27 1.64 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.932 -0.766 . . . . 65.43 108.932 -174.331 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 8.0 p30 175.52 161.92 0.28 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.029 -0.36 . . . . 73.51 110.029 177.054 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.9 m -108.97 -12.02 14.91 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.238 0.542 . . . . 75.25 111.369 176.22 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -79.17 -55.47 5.08 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.411 0.893 . . . . 75.42 113.411 -172.894 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -121.92 30.1 6.79 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.759 1.224 . . . . 75.13 110.1 -169.195 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.77 115.67 0.87 Allowed Glycine 0 C--O 1.251 1.192 0 O-C-N 124.861 1.351 . . . . 73.43 113.322 -172.179 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 m -61.07 139.04 58.17 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 125.751 1.621 . . . . 64.0 113.302 -172.413 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 p -102.65 142.18 34.25 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.955 -1.021 . . . . 64.33 110.927 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.62 118.55 56.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.448 -1.316 . . . . 62.1 107.448 175.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 60.88 32.95 20.07 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.332 1.053 . . . . 71.05 110.997 -177.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.7 t30 78.02 16.5 1.36 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.904 1.682 . . . . 63.55 112.031 174.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.57 134.77 26.65 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.19 -0.67 . . . . 63.33 109.19 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.14 140.83 25.53 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.414 2.076 . . . . 74.4 112.834 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.26 174.48 3.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.865 -0.791 . . . . 74.11 108.865 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -96.26 -47.29 6.09 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.405 -0.961 . . . . 74.34 108.405 173.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -142.26 150.74 41.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.849 -0.614 . . . . 73.33 110.68 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -152.2 151.23 30.74 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.303 -0.629 . . . . 54.54 109.303 -173.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -98.25 113.94 26.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.62 -0.882 . . . . 71.44 108.62 173.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 65.9 mt -60.51 131.84 52.02 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.758 -0.655 . . . . 72.1 112.251 -176.845 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.41 154.29 42.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.775 -1.194 . . . . 74.22 107.775 172.201 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.63 123.21 17.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.188 -0.46 . . . . 71.05 110.264 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.88 6.14 56.22 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 120.602 -0.809 . . . . 53.15 113.02 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -81.48 137.46 35.61 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.111 -0.636 . . . . 63.0 111.065 176.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.05 113.02 34.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.609 0 CA-C-N 115.581 -0.736 . . . . 70.23 109.264 -178.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.504 ' HB ' HG23 ' A' ' 95' ' ' ILE . 73.2 mt -112.15 141.35 27.92 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.127 0 N-CA-C 108.201 -1.037 . . . . 63.13 108.201 -177.436 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -140.27 126.07 19.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.728 -0.789 . . . . 75.35 112.85 -177.593 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.22 144.45 48.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.959 -1.497 . . . . 71.23 106.959 175.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.22 88.25 0.02 OUTLIER Glycine 0 C--O 1.239 0.458 0 N-CA-C 115.862 1.105 . . . . 24.2 115.862 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.521 ' NE2' ' HD2' ' A' ' 41' ' ' PRO . 84.2 t60 162.35 -47.88 0.0 OUTLIER 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.139 2.175 . . . . 74.32 107.04 176.114 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.8 m -149.27 134.78 18.53 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.845 -1.07 . . . . 74.01 111.541 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.53 141.92 27.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.22 -1.77 . . . . 52.1 106.22 169.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -132.91 136.15 56.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-O 121.035 0.445 . . . . 65.25 111.317 -172.113 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.4 mt -114.94 129.53 70.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.772 -0.825 . . . . 60.11 108.772 177.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.11 127.96 38.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.908 -0.587 . . . . 74.44 111.648 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -119.59 134.29 55.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.806 -0.634 . . . . 73.13 109.882 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.2 mtt -119.02 133.96 55.49 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 116.006 -0.543 . . . . 75.01 110.451 177.953 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 . . . . . 0 C--N 1.289 -2.06 0 N-CA-C 107.952 -1.129 . . . . 74.25 107.952 177.903 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.121 0 N-CA-C 110.062 -1.215 . . . . 54.24 110.062 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -102.61 146.38 28.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.952 -1.129 . . . . 74.15 107.952 175.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 108.77 123.85 4.88 Favored Glycine 0 C--N 1.288 -2.103 0 N-CA-C 109.852 -1.299 . . . . 41.32 109.852 -178.024 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m -109.78 -2.32 17.4 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.561 -0.162 . . . . 54.13 110.561 -177.066 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.82 27.6 16.94 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.921 0.867 . . . . 54.43 109.143 -175.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.09 101.83 2.4 Favored Glycine 0 N--CA 1.417 -2.597 0 CA-C-N 114.472 -1.24 . . . . 72.41 112.632 -173.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 m -103.99 129.12 51.56 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.386 -1.709 . . . . 73.1 106.386 174.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.4 m -121.84 139.63 53.39 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.699 -0.801 . . . . 72.11 110.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -124.04 120.52 59.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.065 -1.458 . . . . 60.43 107.065 176.4 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 m -118.43 128.43 54.61 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.661 -0.7 . . . . 74.45 109.275 -173.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.98 133.34 34.35 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.086 -0.709 . . . . 72.2 109.086 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.09 113.79 26.26 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.404 -1.332 . . . . 72.42 107.404 -176.469 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.0 tp -112.63 110.56 20.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.828 -0.623 . . . . 70.25 109.861 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -110.59 107.89 17.65 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.55 0.69 . . . . 63.45 110.415 176.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.47 24.51 11.53 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.79 -1.559 . . . . 74.35 106.79 177.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 44.36 2.86 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 108.345 -1.902 . . . . 41.51 108.345 -174.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -159.35 -70.76 0.08 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.424 0.631 . . . . 54.03 110.54 -175.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.65 73.29 0.91 Allowed Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.988 -1.245 . . . . 53.33 109.988 -177.396 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -103.67 155.65 18.4 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.87 -0.419 . . . . 71.45 109.87 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.5 p -141.46 136.0 30.84 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.239 0.542 . . . . 74.04 111.942 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 11' ' ' LEU . 92.5 t80 -133.58 139.88 46.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.375 -1.343 . . . . 73.12 107.375 176.803 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.46 135.43 46.87 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.48 -0.488 . . . . 54.01 110.003 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -63.78 145.88 54.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.582 -0.736 . . . . 71.35 112.834 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -97.91 161.25 13.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.909 -1.145 . . . . 72.3 107.909 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -75.01 117.93 17.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.504 0.669 . . . . 72.4 110.645 -178.57 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.64 -169.72 16.66 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 109.022 -1.631 . . . . 73.11 109.022 -175.606 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 t -107.43 146.57 31.53 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 121.794 0.807 . . . . 44.14 112.047 -179.336 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -122.01 129.92 52.86 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.072 -0.967 . . . . 74.12 109.01 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.32 125.85 54.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.048 -1.093 . . . . 42.04 108.048 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.92 131.05 56.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.334 -0.617 . . . . 75.01 109.334 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.72 -159.56 28.2 Favored Glycine 0 CA--C 1.488 -1.626 0 N-CA-C 110.255 -1.138 . . . . 53.42 110.255 177.617 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 71.6 mtt-85 -128.96 105.72 8.4 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 117.568 0.684 . . . . 53.14 109.613 176.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.11 -179.01 48.65 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.194 -1.162 . . . . 75.22 110.194 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -68.15 -22.36 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.476 0.711 . . . . 54.44 112.886 -176.683 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -97.74 -7.77 30.02 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 120.773 0.321 . . . . 73.2 110.509 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.43 130.71 38.41 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.263 0.554 . . . . 75.55 111.591 -173.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -92.3 -49.17 6.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.124 -1.065 . . . . 65.15 108.124 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -112.46 125.95 54.78 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.972 -1.013 . . . . 73.55 108.665 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 10.1 mmt180 -99.01 134.52 41.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.714 -0.847 . . . . 63.34 108.714 -177.005 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.88 141.5 47.6 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.197 -0.668 . . . . 72.34 109.197 174.384 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.07 -36.43 65.61 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.747 2.964 . . . . 71.03 114.181 -178.037 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.26 170.92 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.119 0.785 . . . . 74.24 113.119 -175.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p -103.16 165.23 11.15 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.017 -0.992 . . . . 64.35 108.5 173.292 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.0 -23.25 34.21 Favored Glycine 0 CA--C 1.501 -0.8 0 N-CA-C 109.781 -1.328 . . . . 74.31 109.781 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.1 136.36 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.271 -0.965 . . . . 43.14 108.751 175.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.7 m -67.04 161.38 24.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.413 0.523 . . . . 75.23 112.413 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 27.8 ptt180 -54.85 -40.54 69.74 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.967 0.889 . . . . 74.52 110.515 175.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.92 106.82 9.16 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 102.879 -3.008 . . . . 70.12 102.879 170.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -98.36 -39.4 8.82 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 109.091 -0.707 . . . . 51.14 109.091 -177.23 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 tt -162.36 150.32 14.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.756 -0.831 . . . . 74.24 108.756 -176.887 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.95 135.25 48.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.243 0.544 . . . . 74.41 110.011 178.656 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.54 120.96 62.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.093 -1.447 . . . . 74.22 107.093 174.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -111.65 111.74 22.95 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.069 0.461 . . . . 73.34 109.979 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -104.35 115.84 31.09 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.455 -0.793 . . . . 74.54 110.758 -178.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.81 171.6 7.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.217 -1.771 . . . . 74.42 106.217 177.757 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.79 53.35 4.31 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.973 -0.632 . . . . 64.2 112.98 -177.49 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -150.43 -78.41 0.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.508 1.123 . . . . 75.02 108.657 177.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.8 159.84 27.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 63.21 108.546 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.48 120.69 33.21 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.45 0.643 . . . . 45.42 110.556 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.05 133.41 34.36 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.943 -1.026 . . . . 70.25 108.508 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.1 125.29 45.87 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.265 -1.013 . . . . 70.34 108.265 -178.041 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.22 135.8 46.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.607 0.241 . . . . 74.11 110.436 177.12 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.72 119.08 38.15 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.932 0.893 . . . . 65.01 110.011 -177.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.87 77.91 1.62 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.036 -1.838 . . . . 74.43 106.036 179.106 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.509 HD21 ' C ' ' A' ' 68' ' ' ASN . 8.1 t30 -173.56 131.31 0.45 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.055 -0.52 . . . . 63.41 110.16 -165.121 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -108.15 -43.33 4.41 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 113.073 0.768 . . . . 70.02 113.073 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -88.62 -26.18 22.04 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.631 0.974 . . . . 61.31 113.631 -170.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.509 ' C ' HD21 ' A' ' 65' ' ' ASN . 5.8 m-20 -115.59 30.12 7.56 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.199 -0.667 . . . . 74.34 109.199 -177.205 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.93 127.22 4.13 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 124.528 1.143 . . . . 40.15 114.503 -171.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.0 m -66.69 136.71 55.94 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.103 0.961 . . . . 74.54 112.756 -176.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 17.8 p -107.58 140.46 40.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.581 -0.736 . . . . 64.55 110.688 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 80' ' ' TRP . 27.9 m -117.4 117.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.627 -1.249 . . . . 74.35 107.627 177.006 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 86' ' ' ASP . 1.7 m120 57.76 31.07 19.94 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.594 -0.73 . . . . 74.01 110.775 -172.569 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.9 t30 80.44 3.03 1.86 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 126.327 1.851 . . . . 70.42 111.777 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.26 118.9 65.19 Favored Pre-proline 0 C--N 1.319 -0.722 0 O-C-N 121.458 -0.776 . . . . 64.22 109.877 177.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.04 129.24 21.38 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.417 2.078 . . . . 73.21 111.772 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 m -140.97 167.68 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 110.021 -0.363 . . . . 65.02 110.021 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -109.14 -18.35 13.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.569 0.7 . . . . 62.42 109.289 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -151.61 155.15 37.82 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.194 -1.039 . . . . 65.23 108.194 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' TRP . . . . . 0.456 ' CD2' HG21 ' A' ' 72' ' ' VAL . 73.5 t-105 -159.87 151.92 20.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.015 -0.735 . . . . 74.14 109.015 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.74 111.56 24.12 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.507 -1.294 . . . . 64.04 107.507 174.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.507 ' HB3' HG11 ' A' ' 97' ' ' VAL . 64.9 mt -56.93 131.87 50.96 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.383 1.052 . . . . 61.13 112.636 -174.103 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.93 165.66 20.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.596 -0.89 . . . . 60.41 108.596 175.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.45 116.56 11.92 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.099 -0.704 . . . . 75.32 109.099 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.43 9.44 23.51 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.871 -0.68 . . . . 44.21 112.906 179.015 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.409 ' HA ' ' OD1' ' A' ' 73' ' ' ASN . 49.2 m-20 -81.44 117.5 21.93 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.652 -0.819 . . . . 71.21 111.884 177.328 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.76 112.34 25.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.161 -1.792 . . . . 64.42 106.161 175.454 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.9 mt -112.03 124.39 68.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.092 0 CA-C-O 120.894 0.378 . . . . 51.32 110.458 -172.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.3 mpt_? -109.55 120.37 42.29 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.226 -0.657 . . . . 72.42 109.226 177.653 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.55 164.16 20.38 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.172 -0.677 . . . . 74.22 109.172 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.3 108.58 0.6 Allowed Glycine 0 C--N 1.316 -0.575 0 O-C-N 123.506 0.504 . . . . 63.34 112.959 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 72.75 16.07 4.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.562 1.545 . . . . 75.01 114.093 177.8 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.8 t -154.05 167.0 31.26 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.901 -0.499 . . . . 54.31 110.581 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.24 132.31 14.34 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.749 -0.834 . . . . 65.5 108.749 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.426 HD11 HD13 ' A' ' 11' ' ' LEU . 11.0 tp -141.21 146.25 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.981 -0.377 . . . . 74.31 109.981 -173.605 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.52 135.27 53.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.043 -1.095 . . . . 74.22 108.043 175.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 82' ' ' LEU . 78.0 t -98.42 130.97 46.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 112.18 0.437 . . . . 71.02 112.18 -178.262 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -119.32 150.37 40.25 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.899 -0.778 . . . . 74.14 108.899 174.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.1 mtp -129.38 147.38 51.2 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.258 0.551 . . . . 65.23 111.314 -178.775 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 35.6 m-70 . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 106.693 -1.595 . . . . 64.34 106.693 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.968 0 N-CA-C 110.449 -1.06 . . . . 45.13 110.449 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -118.49 147.99 43.06 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.885 -0.783 . . . . 71.45 108.885 176.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.36 53.71 4.24 Favored Glycine 0 C--N 1.314 -0.667 0 O-C-N 123.399 0.437 . . . . 75.41 113.014 -177.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 m -88.61 137.64 32.14 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.413 -0.958 . . . . 72.43 108.413 178.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.15 95.13 9.05 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.915 0.388 . . . . 64.35 110.317 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.55 -76.98 1.27 Allowed Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 109.166 -1.573 . . . . 45.43 109.166 176.069 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' HIS . 86.3 m -123.21 116.92 24.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.682 -1.229 . . . . 65.25 107.682 175.561 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 21.1 m -101.53 124.34 47.04 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.279 -0.569 . . . . 74.41 109.638 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.79 115.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.009 -0.737 . . . . 74.53 109.009 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -112.26 123.66 50.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.289 -1.004 . . . . 72.03 108.289 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 95' ' ' ILE . 54.9 mt -94.43 128.85 41.25 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.777 -0.823 . . . . 63.54 108.777 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.64 110.48 21.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.894 -1.15 . . . . 71.5 107.894 -178.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 56.3 tp -104.41 131.17 52.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.831 0.852 . . . . 73.23 110.669 -175.618 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' OE2' ' A' ' 94' ' ' GLU . 32.9 t70 -98.32 101.23 12.63 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.996 0.903 . . . . 52.44 109.728 175.246 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -102.43 -0.62 32.17 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.449 -1.25 . . . . 71.24 107.759 176.106 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.43 -21.57 19.15 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.56 -1.2 . . . . 64.35 110.527 -176.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -109.77 -45.56 3.63 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.306 0.574 . . . . 62.32 109.918 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.56 102.42 2.36 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.379 -1.089 . . . . 71.3 110.379 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.443 ' NE ' ' HA ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -114.98 151.8 33.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 109.847 -0.427 . . . . 54.02 109.847 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.3 p -135.04 142.37 46.34 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.86 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -140.83 133.94 29.4 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.471 -1.307 . . . . 72.5 107.471 177.482 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -102.51 136.97 41.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.898 -0.779 . . . . 53.42 108.898 179.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 11' ' ' LEU . 83.8 mt -74.77 133.48 41.96 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.195 -0.457 . . . . 70.13 110.745 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -101.04 164.42 11.81 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.486 -1.301 . . . . 72.0 107.486 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.31 125.15 24.69 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.193 0.52 . . . . 71.14 111.172 -179.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.63 -164.73 12.16 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 109.112 -1.595 . . . . 73.21 109.112 -176.084 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 63.5 p -92.18 135.46 33.97 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 118.214 1.007 . . . . 73.31 111.588 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 27.1 m-80 -114.32 120.18 39.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.564 -1.643 . . . . 65.42 106.564 -178.799 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.19 133.0 59.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 120.495 0.188 . . . . 72.32 111.063 -175.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.13 137.79 42.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 109.181 -0.674 . . . . 65.11 109.181 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.54 -151.7 22.52 Favored Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 108.274 -1.93 . . . . 62.24 108.274 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.9 mtm180 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.361 -1.348 . . . . 71.41 107.361 172.091 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.14 -177.21 47.78 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.604 -1.398 . . . . 73.34 109.604 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -78.49 -18.72 54.41 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.101 0.45 . . . . 60.1 111.557 178.672 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.79 -6.47 55.91 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.046 0.451 . . . . 70.12 110.678 173.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.81 140.55 29.4 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.41 -0.959 . . . . 64.32 108.41 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 70.3 mt-30 -102.04 -52.43 3.16 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.043 -1.095 . . . . 74.25 108.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -98.92 108.47 21.16 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.73 -1.581 . . . . 62.51 106.73 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.716 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 19.8 ptt85 -97.21 129.46 44.55 Favored 'General case' 0 N--CA 1.41 -2.44 0 C-N-CA 119.907 -0.717 . . . . 62.43 110.69 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.96 137.54 72.95 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.677 -0.692 . . . . 74.12 109.535 178.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.57 -5.21 16.27 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.588 2.192 . . . . 63.02 111.632 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -86.27 -173.78 4.72 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.014 -0.539 . . . . 62.34 111.264 -176.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.526 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.8 t -132.17 164.91 25.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.615 -0.883 . . . . 74.32 108.615 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.88 -29.41 12.53 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.253 -1.539 . . . . 71.4 109.253 -175.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.34 143.33 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 CA-C-N 114.086 -1.057 . . . . 62.2 109.899 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -87.64 -176.75 5.67 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.055 0.542 . . . . 62.14 110.307 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 20.5 ptt180 -67.18 -39.3 86.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.253 0.549 . . . . 64.03 110.588 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -127.2 114.28 17.46 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.102 -1.814 . . . . 75.43 106.102 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.52 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 67.7 t60 -104.13 -37.36 7.35 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 121.369 0.604 . . . . 74.5 109.74 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 61' ' ' LEU . 7.9 tt -161.02 145.71 13.85 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 116.084 -0.507 . . . . 64.33 109.845 -176.543 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.39 139.68 49.51 Favored 'General case' 0 C--N 1.3 -1.543 0 CA-C-N 115.798 -0.637 . . . . 73.12 110.222 179.795 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 83.9 mt -121.75 116.74 50.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.455 -0.793 . . . . 73.44 109.268 178.214 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 38.6 mtp-105 -91.44 107.77 19.43 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.803 -1.184 . . . . 63.02 107.803 176.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -97.55 113.02 24.65 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.19 0.995 . . . . 74.01 112.766 -175.059 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.33 150.44 45.48 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.137 -1.801 . . . . 75.53 106.137 173.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.51 75.96 0.52 Allowed Glycine 0 C--N 1.307 -1.065 0 O-C-N 123.513 0.508 . . . . 64.43 113.834 -174.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -166.41 -68.29 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.148 -1.427 . . . . 72.31 107.148 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.9 m -149.06 150.86 13.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 106.449 -1.686 . . . . 73.25 106.449 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.9 126.39 36.04 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.26 -0.576 . . . . 74.41 109.849 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.9 tt -83.11 107.52 15.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.118 -1.067 . . . . 70.2 108.118 -178.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -93.75 120.96 34.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.148 -1.056 . . . . 74.31 108.148 -179.101 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.0 119.57 23.38 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.246 0.546 . . . . 74.33 110.219 176.637 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.44 134.73 37.33 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.819 -0.808 . . . . 75.13 108.819 177.358 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.42 77.24 1.63 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.439 -1.319 . . . . 74.32 107.439 -177.53 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.52 163.76 8.4 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.39 -0.524 . . . . 73.25 109.946 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 p -108.13 -54.86 2.45 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.527 179.461 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.445 HG23 ' OD1' ' A' ' 68' ' ' ASN . 5.9 t -90.0 -24.05 21.33 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.411 0.624 . . . . 52.45 112.518 -175.554 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' ' 67' ' ' THR . 3.1 m-20 -105.54 22.77 14.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.727 -0.608 . . . . 62.31 110.066 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.0 118.83 2.9 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 124.442 1.089 . . . . 73.02 114.384 -175.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 m -65.54 138.46 58.07 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.824 1.25 . . . . 65.54 113.298 -176.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.43 140.86 38.68 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 108.132 -1.062 . . . . 71.33 108.132 -179.576 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.08 121.13 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.165 -0.959 . . . . 74.22 110.208 178.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 58.98 25.86 14.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.232 1.013 . . . . 72.14 110.586 -177.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 77.7 20.79 1.03 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.997 1.719 . . . . 63.41 112.63 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.81 125.9 26.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.661 -0.866 . . . . 64.01 108.661 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.19 128.14 11.88 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.692 2.261 . . . . 72.03 113.839 -175.401 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -146.51 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.332 -0.988 . . . . 70.04 108.332 -178.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -116.89 -32.34 5.13 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.744 -0.382 . . . . 73.43 110.209 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -129.36 149.81 50.99 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.238 -0.653 . . . . 75.21 109.238 177.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -158.71 152.72 23.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.083 -0.71 . . . . 72.1 109.083 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -105.54 109.66 21.71 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.485 -0.931 . . . . 61.01 108.485 176.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 60.4 mt -64.56 137.55 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.648 0.592 . . . . 74.35 112.346 -177.26 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.2 163.76 28.89 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.787 -1.56 . . . . 65.41 106.787 171.74 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.41 121.89 13.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.633 0.254 . . . . 74.11 110.786 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.73 -11.21 30.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.701 -0.761 . . . . 72.33 113.37 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -67.04 138.39 57.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 113.065 0.765 . . . . 74.12 113.065 -179.12 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.18 113.4 39.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.083 -0.962 . . . . 71.4 108.468 175.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 95' ' ' ILE . 3.0 mp -109.09 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.548 -1.279 . . . . 72.54 107.548 179.222 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -100.33 106.76 18.42 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.356 -0.609 . . . . 72.22 109.356 -176.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -82.38 160.52 22.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.219 -1.4 . . . . 72.34 107.219 176.488 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' HIS . . . -70.64 86.42 0.35 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.978 -1.582 . . . . 71.31 111.192 179.113 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 61.1 t-80 163.61 -63.29 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.56 1.944 . . . . 74.03 108.765 177.515 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.8 m -143.47 174.98 10.28 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.066 -1.087 . . . . 71.54 108.066 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' OE2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -114.78 149.41 37.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.306 0.854 . . . . 73.21 113.306 177.159 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 11' ' ' LEU . 6.9 tp -119.56 127.39 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.711 -1.218 . . . . 63.52 107.711 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -103.55 132.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.101 -0.703 . . . . 50.43 109.101 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.17 117.86 37.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.16 -0.473 . . . . 51.42 111.332 -178.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -116.69 130.9 57.01 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.257 -1.016 . . . . 74.32 108.257 175.326 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.5 mtt -114.43 128.59 56.42 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.496 0.665 . . . . 64.41 111.807 -178.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' THR . 44.6 m-70 . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 107.38 -1.341 . . . . 74.41 107.38 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 N--CA 1.438 -1.052 0 N-CA-C 109.334 -0.617 . . . . 73.140000000000001 109.334 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.429 ' HB3' ' OE1' ' A' ' 22' ' ' GLN . 11.4 m -102.56 115.48 30.66 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.751 -0.833 . . . . 74.519999999999996 108.751 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.4 110.27 25.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.175 -0.676 . . . . 65.109999999999999 109.175 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 m -106.14 126.09 51.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.227 -0.897 . . . . 72.519999999999996 108.605 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 20' ' ' THR . 46.2 mt -93.05 115.04 27.73 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.858 -1.164 . . . . 61.119999999999997 107.858 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -92.16 114.36 26.89 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.232 -1.025 . . . . 74.420000000000002 108.232 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -113.26 130.68 56.17 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.852 -0.613 . . . . 73.019999999999996 110.27 -171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.73 99.96 12.76 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.11 -1.07 . . . . 63.329999999999998 108.11 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 7.3 p-10 -91.68 -13.47 31.7 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.114 -1.403 . . . . 74.420000000000002 108.019 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.74 -37.86 1.82 Allowed Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 108.392 -1.883 . . . . 74.140000000000001 108.392 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -100.52 -53.19 3.16 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.3 0.571 . . . . 54.109999999999999 110.075 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.33 89.19 0.89 Allowed Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 109.152 -1.579 . . . . 61.140000000000001 109.152 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 3.8 mmp_? -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.282 -0.636 . . . . 71.510000000000005 109.282 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.7 p -130.57 138.76 50.32 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.861 0.362 . . . . 75.420000000000002 110.853 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -132.79 124.65 28.44 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.638 -1.245 . . . . 74.209999999999994 107.638 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.429 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 25.9 tt0 -92.55 139.96 30.05 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.735 -0.786 . . . . 72.340000000000003 108.963 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.14 133.9 52.57 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.416 0.447 . . . . 73.329999999999998 111.548 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.08 156.03 21.25 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.706 -1.59 . . . . 74.109999999999999 106.706 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -76.18 116.59 17.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.521 0.677 . . . . 72.010000000000005 109.178 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.43 23.07 Favored Glycine 0 C--N 1.289 -2.062 0 N-CA-C 106.792 -2.523 . . . . 70.239999999999995 106.792 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 45.9 p -105.45 131.28 53.07 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 119.431 1.615 . . . . 72.109999999999999 112.004 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -103.2 110.29 22.19 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.458 -1.312 . . . . 54.549999999999997 107.458 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -95.64 121.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.411 -0.359 . . . . 53.409999999999997 110.262 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.6 mt -105.98 130.17 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 123.947 0.899 . . . . 54.140000000000001 109.808 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.03 -174.37 40.15 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 110.97 -0.852 . . . . 50.439999999999998 110.97 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 42' ' ' ASP . 25.0 mtp180 -107.21 104.94 14.69 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.608 -0.837 . . . . 73.430000000000007 109.448 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.67 169.28 37.14 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.198 -1.161 . . . . 64.439999999999998 110.198 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.62 -14.24 56.97 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.502 -1.295 . . . . 53.530000000000001 107.502 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.91 -4.56 59.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.138 -1.846 . . . . 71.430000000000007 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -109.35 147.56 32.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.978 -1.01 . . . . 61.200000000000003 109.375 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -93.68 -32.84 13.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.385 0.612 . . . . 73.420000000000002 110.988 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -118.82 124.96 48.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.919 -1.511 . . . . 74.439999999999998 106.919 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -105.76 130.73 53.7 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.781 0.324 . . . . 74.049999999999997 111.747 -174.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 52.8 mt -85.8 145.91 42.44 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 65.010000000000005 112.238 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.8 Cg_exo -72.18 -33.57 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.261 2.641 . . . . 65.439999999999998 114.598 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 5.3 t70 -93.25 179.95 5.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.577 -0.898 . . . . 42.100000000000001 108.577 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.4 t -118.68 171.04 8.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.116 0.484 . . . . 51.350000000000001 110.262 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.46 61.15 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 108.937 -1.665 . . . . 74.25 108.937 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.42 129.55 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 CA-C-N 113.281 -1.46 . . . . 71.219999999999999 107.834 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -77.11 171.9 14.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.849 -0.426 . . . . 73.030000000000001 109.849 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 16.9 ptt180 -58.2 -46.56 85.61 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-O 121.593 0.711 . . . . 75.430000000000007 109.792 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.421 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 37.3 mtp180 -119.12 95.9 5.0 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 104.42 -2.437 . . . . 75.519999999999996 104.42 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -98.22 -32.05 11.77 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.198 -0.91 . . . . 74.219999999999999 108.91 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.492 HD11 HD21 ' A' ' 61' ' ' LEU . 6.7 tt -163.87 145.39 9.0 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.816 -0.809 . . . . 72.040000000000006 108.816 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -137.84 143.61 41.05 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.02 0.438 . . . . 72.450000000000003 110.447 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 65.8 mt -125.42 116.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.71 -0.677 . . . . 73.439999999999998 109.783 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 58.0 ttp180 -91.39 113.63 25.94 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.805 -1.183 . . . . 70.409999999999997 107.805 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 -102.22 125.32 48.89 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 116.002 -0.545 . . . . 71.510000000000005 110.126 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -133.38 168.89 17.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.195 -1.409 . . . . 72.230000000000004 107.195 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.64 58.53 2.09 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 114.968 0.747 . . . . 43.25 114.968 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -170.73 -68.12 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.905 0.882 . . . . 60.140000000000001 108.974 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.85 156.83 42.91 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 CA-C-O 121.259 0.552 . . . . 74.109999999999999 111.52 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -102.2 114.62 28.93 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.088 -0.96 . . . . 51.450000000000003 109.442 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.4 tt -80.91 113.77 19.34 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.755 -1.111 . . . . 75.400000000000006 109.241 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.492 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -101.39 120.82 40.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.291 -1.003 . . . . 64.310000000000002 108.291 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.02 121.16 30.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.307 -0.257 . . . . 51.329999999999998 110.307 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -87.98 124.44 33.72 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.687 -0.857 . . . . 63.210000000000001 108.687 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.99 76.28 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 176.34 153.05 0.18 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.636 -1.987 . . . . 71.409999999999997 105.636 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.9 m -110.19 -53.44 2.68 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.237 0.829 . . . . 73.129999999999995 113.237 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 t -71.74 -38.57 70.42 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.567 0.58 . . . . 75.219999999999999 112.567 -172.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -116.89 23.74 11.71 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.318 -1.364 . . . . 75.430000000000007 107.318 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 163.43 19.65 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 113.41 -1.723 . . . . 52.039999999999999 113.864 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 m -84.74 143.86 28.88 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 123.894 0.877 . . . . 73.219999999999999 111.899 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 p -112.0 141.1 46.07 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.517 -0.765 . . . . 63.210000000000001 110.285 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 80' ' ' TRP . 33.3 m -114.11 120.86 65.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.822 -1.547 . . . . 54.43 106.822 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.465 HD22 ' CG ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 61.83 24.34 14.47 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.236 1.014 . . . . 70.349999999999994 109.83 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 79.59 5.34 2.05 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.534 1.533 . . . . 44.439999999999998 112.513 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.65 30.82 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.953 -0.388 . . . . 62.32 109.953 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.26 127.84 14.75 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.382 2.055 . . . . 54.229999999999997 111.737 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 80' ' ' TRP . 26.9 m -142.89 166.75 14.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.734 -0.839 . . . . 64.420000000000002 108.734 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -106.07 -31.91 8.51 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.973 -1.121 . . . . 65.420000000000002 107.973 174.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.08 35.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.99 -1.459 . . . . 63.32 110.338 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.486 ' HB2' HG21 ' A' ' 77' ' ' VAL . 72.7 t-105 -153.67 153.03 31.51 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.535 -0.913 . . . . 75.140000000000001 108.535 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -114.58 126.25 54.7 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.209 -1.034 . . . . 74.219999999999999 108.209 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 42.1 mt -56.88 147.55 23.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.032 1.123 . . . . 75.340000000000003 114.032 -171.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 147.96 39.52 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.005 -1.109 . . . . 74.439999999999998 108.005 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 28.9 t70 -65.39 124.89 23.46 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 71.030000000000001 110.862 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.87 64.43 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 115.22 -0.9 . . . . 70.049999999999997 112.992 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.465 ' CG ' HD22 ' A' ' 73' ' ' ASN . 2.6 t70 -83.23 156.88 22.92 Favored 'General case' 0 C--O 1.249 1.071 0 C-N-CA 119.505 -0.878 . . . . 64.25 108.717 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.08 113.23 43.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.361 -0.607 . . . . 74.409999999999997 109.361 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.414 HD11 HD22 ' A' ' 82' ' ' LEU . 59.2 mt -110.06 117.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.097 -0.705 . . . . 71.299999999999997 109.097 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -120.52 123.64 43.41 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.448 -0.501 . . . . 55.32 111.263 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 163.43 23.03 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.24 -0.891 . . . . 72.129999999999995 108.959 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -42.12 103.89 0.04 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 115.598 0.999 . . . . 64.219999999999999 115.598 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 m170 69.25 12.09 8.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.602 1.561 . . . . 73.219999999999999 113.503 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.7 m -149.21 115.37 5.76 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.334 0.588 . . . . 64.400000000000006 111.075 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.95 143.32 43.13 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.178 0.513 . . . . 65.25 111.243 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.28 142.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.215 -0.902 . . . . 73.450000000000003 111.387 -171.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.7 mm -111.41 132.81 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.0 -1.111 . . . . 74.340000000000003 108.0 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.55 126.86 43.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 120.846 0.355 . . . . 62.049999999999997 111.453 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.442 ' HA ' ' HE ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -117.15 125.97 52.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.755 -0.832 . . . . 63.32 108.755 176.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.505 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 84.3 mtp -114.35 116.5 29.04 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.852 -0.796 . . . . 75.439999999999998 108.852 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 . . . . . 0 C--N 1.28 -2.438 0 N-CA-C 107.463 -1.31 . . . . 75.140000000000001 107.463 -179.025 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.494 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 84.8 m . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 108.07 -1.085 . . . . 75.209999999999994 108.07 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -123.63 125.03 44.09 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.986 -0.746 . . . . 52.509999999999998 108.986 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.5 124.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.268 -1.012 . . . . 74.439999999999998 108.268 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.428 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.7 m -117.2 124.71 49.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.939 -0.763 . . . . 72.109999999999999 108.939 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 mt -90.88 124.9 35.54 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.231 -1.025 . . . . 75.420000000000002 108.231 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -107.82 120.12 41.36 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.821 -0.807 . . . . 74.099999999999994 108.821 -177.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -114.27 125.83 54.34 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.307 -0.998 . . . . 74.450000000000003 108.307 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.92 100.12 10.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 118.959 -1.096 . . . . 63.219999999999999 108.083 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.92 38.59 2.23 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 113.418 -1.719 . . . . 62.439999999999998 107.961 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.03 -54.81 0.64 Allowed Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.392 -1.083 . . . . 63.020000000000003 110.392 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 t -111.83 -56.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.711 -1.218 . . . . 74.219999999999999 107.711 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.79 109.83 0.47 Allowed Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.516 -0.849 . . . . 74.129999999999995 112.712 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -95.9 141.37 29.41 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.502 -0.925 . . . . 73.409999999999997 108.502 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.2 p -128.74 135.01 48.63 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.56 -0.456 . . . . 73.120000000000005 111.502 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -121.03 110.96 16.88 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.579 -0.897 . . . . 73.319999999999993 108.579 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -78.79 129.3 34.46 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.847 -0.797 . . . . 73.540000000000006 108.847 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.35 125.56 29.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.704 -0.851 . . . . 70.340000000000003 108.704 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -100.78 170.49 8.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.375 -0.602 . . . . 71.319999999999993 109.375 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.32 134.84 57.45 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.348 1.03 . . . . 62.420000000000002 111.594 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.52 -175.62 15.87 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 109.165 -1.574 . . . . 72.239999999999995 109.165 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 57.4 p -96.1 137.48 35.11 Favored 'General case' 0 N--CA 1.415 -2.176 0 C-N-CA 119.47 -0.892 . . . . 73.140000000000001 110.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -114.46 111.74 21.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.457 -0.942 . . . . 62.310000000000002 108.457 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.77 124.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.089 -1.078 . . . . 50.039999999999999 108.089 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -109.01 129.76 63.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 123.435 0.459 . . . . 64.329999999999998 109.791 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.26 -163.39 29.5 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.161 -1.576 . . . . 71.510000000000005 109.161 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.542 ' C ' ' HA ' ' A' ' 47' ' ' ARG . 52.1 mtm180 -126.34 105.86 9.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 119.105 1.453 . . . . 63.229999999999997 112.364 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' HA3' ' HG2' ' A' ' 47' ' ' ARG . . . -172.27 -178.52 42.52 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 107.129 -2.388 . . . . 64.109999999999999 107.129 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -74.96 -11.43 60.11 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.085 0.945 . . . . 72.329999999999998 110.333 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.55 -23.03 29.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.918 -1.037 . . . . 72.340000000000003 109.304 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.31 130.99 35.57 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.819 0.819 . . . . 51.420000000000002 113.037 -171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.24 -26.02 22.56 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.832 -1.076 . . . . 62.340000000000003 108.85 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -131.85 115.68 16.24 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.204 -1.036 . . . . 72.230000000000004 108.204 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.657 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -95.93 112.12 23.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.983 -0.553 . . . . 60.009999999999998 111.06 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 44.8 mt -71.63 128.99 89.09 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 110.266 -0.272 . . . . 62.049999999999997 110.266 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -73.61 40.19 0.53 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.203 2.602 . . . . 75.230000000000004 113.839 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.0 152.67 29.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.929 -0.767 . . . . 72.450000000000003 108.929 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.4 m -97.16 118.32 33.32 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.59 -0.522 . . . . 73.510000000000005 109.59 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.07 -13.43 21.77 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.521 -0.847 . . . . 70.340000000000003 112.448 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.36 122.28 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.429 0.633 . . . . 74.129999999999995 109.361 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -65.19 164.14 13.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.008 -0.997 . . . . 73.420000000000002 112.176 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HA ' ' C ' ' A' ' 32' ' ' ARG . 48.1 mtp180 -54.41 -49.29 70.26 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.829 0.852 . . . . 73.209999999999994 109.926 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -120.6 101.97 8.11 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 106.087 -1.819 . . . . 61.130000000000003 106.087 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -104.05 -32.49 9.18 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.473 0.654 . . . . 53.229999999999997 109.402 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -162.68 149.93 13.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.74 -0.837 . . . . 71.120000000000005 108.74 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.29 138.22 50.37 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.202 0.525 . . . . 61.420000000000002 110.269 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' SER . 79.4 mt -119.15 116.22 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.12 -0.696 . . . . 62.039999999999999 109.12 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -93.7 107.23 19.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.616 -1.624 . . . . 71.329999999999998 106.616 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.403 ' HZ2' ' O ' ' A' ' 7' ' ' THR . 50.8 t-105 -110.82 146.6 36.14 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.945 -1.025 . . . . 74.049999999999997 109.559 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -149.78 165.23 33.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 103.929 -2.619 . . . . 51.140000000000001 103.929 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.67 37.01 0.86 Allowed Glycine 0 C--N 1.305 -1.148 0 CA-C-N 119.133 0.879 . . . . 71.340000000000003 114.679 -175.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -137.4 -71.15 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 124.034 0.934 . . . . 75.209999999999994 109.903 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -130.81 159.32 42.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.53 -0.304 . . . . 64.400000000000006 110.692 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.54 116.68 31.26 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.763 -0.653 . . . . 75.329999999999998 110.289 -178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.8 116.7 32.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.098 -0.704 . . . . 72.099999999999994 109.098 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HD21 ' A' ' 82' ' ' LEU . 7.3 tt -104.81 142.6 34.44 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.332 -0.394 . . . . 72.510000000000005 110.537 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.14 127.62 26.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.817 -0.629 . . . . 64.540000000000006 109.676 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -83.0 140.42 32.74 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.644 -0.707 . . . . 73.140000000000001 109.226 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.26 77.44 1.73 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.035 -1.098 . . . . 71.239999999999995 108.035 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -178.1 121.21 0.1 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.438 -0.578 . . . . 71.109999999999999 109.438 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -88.75 -20.1 25.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.137 0.494 . . . . 72.120000000000005 110.447 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -89.33 -52.44 5.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.42 0.629 . . . . 75.329999999999998 111.382 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -111.21 28.75 8.43 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.7 -0.682 . . . . 75.239999999999995 110.194 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.06 129.98 5.5 Favored Glycine 0 N--CA 1.47 0.939 0 O-C-N 124.574 1.171 . . . . 53.420000000000002 114.933 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 90' ' ' LEU . 9.0 m -74.94 152.09 38.83 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 124.733 1.213 . . . . 70.329999999999998 113.044 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.6 p -119.3 144.66 46.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.121 -0.945 . . . . 73.420000000000002 110.107 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 80' ' ' TRP . 28.1 m -116.36 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.039 -1.097 . . . . 43.229999999999997 108.039 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 61.14 25.93 15.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.81 0.814 . . . . 45.030000000000001 109.666 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 85.54 -4.57 0.85 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.82 2.048 . . . . 74.420000000000002 113.855 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -89.61 124.39 64.24 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.864 -0.421 . . . . 63.210000000000001 109.864 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 16.2 Cg_exo -69.15 125.5 12.55 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.76 2.307 . . . . 62.340000000000003 111.81 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -139.02 166.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.384 -0.371 . . . . 75.25 110.64 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -105.74 -14.48 15.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.71 -0.848 . . . . 72.349999999999994 108.71 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -161.78 155.63 21.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.118 -1.067 . . . . 70.319999999999993 108.118 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.403 ' CD2' HG21 ' A' ' 72' ' ' VAL . 75.8 t-105 -161.34 143.41 11.96 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.349 0.405 . . . . 74.099999999999994 109.909 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.23 111.79 23.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.119 -1.067 . . . . 72.019999999999996 108.119 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 69.5 mt -56.46 135.95 54.13 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.902 0.705 . . . . 54.219999999999999 112.902 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.0 164.66 19.67 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.079 -1.082 . . . . 61.530000000000001 108.079 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.513 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 28.8 t70 -71.95 124.36 24.74 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.456 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.91 13.21 56.87 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.743 -0.662 . . . . 74.519999999999996 113.091 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.67 137.45 42.18 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 117.628 0.714 . . . . 54.140000000000001 111.714 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.1 112.16 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.276 -1.379 . . . . 63.509999999999998 107.276 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.5 mt -111.6 106.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 C-N-CA 119.322 -0.951 . . . . 72.420000000000002 109.44 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -104.26 131.89 51.09 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.635 -0.711 . . . . 73.510000000000005 109.678 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.3 pt? -125.18 164.5 20.14 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.412 -0.959 . . . . 74.239999999999995 108.412 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.26 125.82 25.9 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.995 -1.098 . . . . 75.329999999999998 110.532 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m170 83.1 -23.6 0.2 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.217 1.562 . . . . 62.240000000000002 115.217 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -153.21 -171.75 4.02 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.643 1.111 . . . . 74.219999999999999 111.999 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.66 147.58 30.14 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.988 -0.745 . . . . 74.409999999999997 108.988 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.6 tp -130.41 135.58 60.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.005 -1.109 . . . . 74.310000000000002 108.005 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 53.4 mt -101.0 132.09 47.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.698 -0.852 . . . . 72.120000000000005 108.698 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 82' ' ' LEU . 72.5 t -100.26 116.35 43.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.446 0.641 . . . . 72.420000000000002 111.158 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.513 ' HD3' ' OD1' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -115.63 125.87 53.45 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.415 -1.328 . . . . 70.219999999999999 107.415 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.5 mtm -112.52 111.74 22.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.229 -0.988 . . . . 43.229999999999997 110.547 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.494 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 21.1 m-70 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 108.012 -1.107 . . . . 71.120000000000005 108.012 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.439 -1.01 0 CA-C-O 121.305 0.574 . . . . 73.209999999999994 109.621 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m -107.65 117.28 33.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 115.746 -0.661 . . . . 71.140000000000001 109.644 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 23' ' ' LEU . 40.7 t -91.29 114.86 29.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 106.726 -1.583 . . . . 73.439999999999998 106.726 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -110.61 124.07 51.18 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.037 -0.727 . . . . 72.120000000000005 109.037 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 95' ' ' ILE . 4.5 pp -95.44 128.92 42.68 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.44 -0.578 . . . . 74.25 109.44 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -105.39 119.59 39.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.559 -0.904 . . . . 75.519999999999996 108.559 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -102.39 120.15 40.01 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 123.755 0.822 . . . . 71.25 108.934 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -100.17 100.99 11.91 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.659 -1.216 . . . . 73.400000000000006 110.153 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -103.53 5.03 36.49 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 112.99 -1.914 . . . . 65.140000000000001 108.502 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.16 -19.81 31.71 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.475 -1.45 . . . . 74.120000000000005 109.475 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -103.5 -53.5 2.78 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.226 -1.028 . . . . 63.340000000000003 108.226 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.34 83.03 1.69 Allowed Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.396 -0.82 . . . . 63.420000000000002 111.698 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 4.5 mmp_? -100.37 163.81 12.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.724 -0.28 . . . . 72.120000000000005 110.273 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 14.9 p -135.61 152.24 51.05 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.741 0.305 . . . . 64.230000000000004 110.983 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.437 ' HB3' HD11 ' A' ' 11' ' ' LEU . 90.1 t80 -142.24 132.51 24.87 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.357 -0.979 . . . . 72.439999999999998 108.357 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.08 125.03 33.15 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.363 -0.606 . . . . 74.040000000000006 109.363 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 28' ' ' ASN . 78.1 mt -71.28 127.64 33.25 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.165 -0.679 . . . . 72.540000000000006 109.165 174.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.78 168.6 10.56 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.568 -0.742 . . . . 64.510000000000005 109.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.94 131.5 40.73 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.674 0.749 . . . . 43.240000000000002 111.423 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.66 -173.79 15.05 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 108.382 -1.887 . . . . 64.099999999999994 108.382 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.3 p -106.81 142.77 35.91 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 118.549 1.174 . . . . 64.230000000000004 111.856 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 7.5 p30 -117.8 140.77 49.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.339 -0.615 . . . . 74.310000000000002 109.339 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.86 124.14 53.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.613 -0.884 . . . . 74.430000000000007 108.613 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 38' ' ' PHE . 52.6 mt -106.91 120.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 124.477 1.111 . . . . 71.010000000000005 110.147 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.63 -176.43 35.54 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.547 -1.421 . . . . 51.240000000000002 109.547 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 61.6 mtt180 -103.99 107.12 17.86 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 118.35 1.075 . . . . 71.530000000000001 111.418 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.38 -172.42 38.85 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 110.444 -1.062 . . . . 71.530000000000001 110.444 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -94.35 -29.26 15.11 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 122.959 0.504 . . . . 73.439999999999998 110.823 179.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -82.14 -19.73 39.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 137.69 54.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.048 -0.978 . . . . 60.310000000000002 109.566 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 28' ' ' ASN . 49.8 mt-30 -97.89 -24.51 15.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.483 0.659 . . . . 70.019999999999996 110.318 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' HB3' HG12 ' A' ' 30' ' ' ILE . 40.2 t80 -131.14 124.26 30.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.373 -1.343 . . . . 71.420000000000002 107.373 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 134.25 55.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.406 -0.361 . . . . 74.519999999999996 110.93 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.423 HD13 HG11 ' A' ' 45' ' ' VAL . 6.8 mp -73.7 147.56 86.85 Favored Pre-proline 0 CA--C 1.502 -0.898 0 CA-C-N 115.604 -0.725 . . . . 74.430000000000007 111.807 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.13 26.37 0.61 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 123.584 2.856 . . . . 74.120000000000005 113.267 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -137.72 176.4 8.74 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.697 -0.853 . . . . 73.510000000000005 108.697 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -105.28 170.66 7.75 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.374 -0.602 . . . . 74.530000000000001 109.374 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 2.69 79.75 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.925 -0.47 . . . . 71.319999999999993 111.925 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 40' ' ' LEU . 33.4 t -95.13 133.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.989 -0.745 . . . . 74.5 108.989 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -72.39 176.34 5.41 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.122 0.569 . . . . 74.519999999999996 109.653 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.0 ptm180 -66.09 -34.92 79.16 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.379 0.609 . . . . 74.319999999999993 110.359 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.51 109.65 12.94 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.791 -1.188 . . . . 63.119999999999997 107.791 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 59.9 t60 -103.99 -34.16 8.56 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.854 -0.612 . . . . 75.219999999999999 109.501 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.409 HD11 HD21 ' A' ' 61' ' ' LEU . 9.0 tt -165.88 160.03 16.48 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.301 -1.0 . . . . 73.430000000000007 108.301 -176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.8 138.52 32.3 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.089 0.471 . . . . 63.32 109.781 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 23' ' ' LEU . 64.0 mt -113.19 115.19 49.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 109.202 -0.666 . . . . 72.120000000000005 109.202 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 62.0 ttt180 -97.2 107.79 20.38 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 108.817 -0.809 . . . . 50.130000000000003 108.817 174.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -97.48 107.24 19.7 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.1 171.35 8.07 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.006 -1.85 . . . . 74.540000000000006 106.006 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.14 49.58 4.14 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 119.817 -1.182 . . . . 54.240000000000002 114.003 -174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -171.66 -64.04 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.871 0.868 . . . . 74.25 109.178 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.32 149.67 17.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 CA-C-O 121.323 0.582 . . . . 73.400000000000006 112.15 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -99.75 103.18 14.81 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.275 -0.875 . . . . 65.310000000000002 109.347 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.24 113.49 21.15 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.362 -0.836 . . . . 71.019999999999996 109.162 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -100.52 120.32 39.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.145 -1.057 . . . . 73.5 108.145 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.89 126.68 43.7 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.875 -0.417 . . . . 74.450000000000003 109.875 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 11.3 t70 -97.25 139.17 33.62 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 122.848 0.459 . . . . 64.120000000000005 110.722 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.11 75.91 1.26 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.431 -0.952 . . . . 65.299999999999997 108.431 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.562 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 33.3 t-20 -166.46 154.04 9.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.57 -1.27 . . . . 73.450000000000003 107.57 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.4 t -108.92 -48.71 3.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.989 0.423 . . . . 70.040000000000006 110.341 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -89.33 -35.91 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.648 0.611 . . . . 71.319999999999993 112.648 -175.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.562 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.2 m120 -105.39 27.06 8.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.537 -0.542 . . . . 51.350000000000001 109.537 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.79 128.46 20.78 Favored Glycine 0 C--O 1.251 1.158 0 O-C-N 124.894 1.371 . . . . 51.109999999999999 112.264 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -62.01 133.04 54.83 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 124.124 0.969 . . . . 74.140000000000001 112.54 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.635 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.0 p -103.42 140.08 37.94 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.513 -0.767 . . . . 74.400000000000006 109.459 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 77' ' ' VAL . 27.5 m -124.26 119.58 56.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.937 -1.134 . . . . 75.349999999999994 107.937 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.26 30.97 20.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.404 0.682 . . . . 72.140000000000001 110.54 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 t30 82.09 -1.53 1.49 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.738 2.015 . . . . 64.299999999999997 112.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.98 124.19 44.52 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 121.487 -0.758 . . . . 75.150000000000006 109.431 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.14 124.3 4.83 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.765 1.643 . . . . 72.150000000000006 110.441 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 72' ' ' VAL . 28.2 m -148.68 151.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 73.239999999999995 107.432 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 77.1 mt-30 -96.69 -0.46 48.31 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.957 -0.697 . . . . 72.540000000000006 111.327 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.54 130.12 15.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.794 -0.639 . . . . 71.310000000000002 110.119 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -159.89 152.97 21.82 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.588 -1.264 . . . . 71.010000000000005 107.588 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.89 124.4 50.59 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.967 -1.093 . . . . 73.439999999999998 108.115 173.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.569 ' HB3' HG11 ' A' ' 97' ' ' VAL . 69.0 mt -65.1 139.4 58.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.949 0.722 . . . . 71.430000000000007 112.949 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -135.65 168.5 19.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.059 -0.719 . . . . 73.340000000000003 109.059 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.48 121.09 19.03 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.917 -0.401 . . . . 73.530000000000001 109.917 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.2 9.84 40.85 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.905 -0.664 . . . . 53.5 112.698 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -78.38 126.26 30.52 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 120.008 -0.677 . . . . 70.430000000000007 110.005 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.67 112.31 26.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.22 -1.4 . . . . 75.230000000000004 107.22 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 95' ' ' ILE . 57.4 mt -120.01 139.28 47.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 120.291 -0.564 . . . . 75.219999999999999 110.861 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.635 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.0 mpt_? -120.37 131.24 54.75 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.138 -1.06 . . . . 74.450000000000003 108.138 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 2.2 pt? -131.73 164.52 25.79 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.336 -0.987 . . . . 74.150000000000006 108.336 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -33.55 97.07 0.01 OUTLIER Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.002 1.161 . . . . 65.420000000000002 116.002 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.0 m170 72.07 13.95 5.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.698 1.599 . . . . 72.450000000000003 114.801 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t -153.62 -178.3 6.93 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.31 0.576 . . . . 71.319999999999993 110.178 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.74 153.08 45.75 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.762 -0.586 . . . . 72.439999999999998 109.448 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.519 HD11 HD13 ' A' ' 11' ' ' LEU . 8.9 tp -141.45 141.37 30.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.762 -0.829 . . . . 72.439999999999998 108.762 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.73 125.69 72.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.469 -0.937 . . . . 65.409999999999997 108.469 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.569 HG11 ' HB3' ' A' ' 82' ' ' LEU . 79.4 t -93.26 128.67 44.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 111.938 0.348 . . . . 62.439999999999998 111.938 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -119.16 151.26 38.63 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.767 -0.827 . . . . 72.129999999999995 108.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 89.2 mtp -128.34 120.01 26.19 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.314 -0.403 . . . . 73.329999999999998 110.262 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 . . . . . 0 C--N 1.294 -1.842 0 N-CA-C 108.333 -0.988 . . . . 72.140000000000001 108.333 -179.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.577 HG22 ' HH2' ' A' ' 54' ' ' TRP . 31.9 m . . . . . 0 N--CA 1.415 -2.216 0 N-CA-C 108.56 -0.904 . . . . 65.430000000000007 108.56 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 99' ' ' MET . 54.0 p -158.43 143.98 16.69 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.337 -1.727 . . . . 33.509999999999998 106.337 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.82 126.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 120.159 -0.617 . . . . 63.399999999999999 111.226 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 25.3 m -120.77 132.07 54.84 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.984 -1.117 . . . . 72.099999999999994 107.984 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.12 135.76 33.72 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.68 -0.489 . . . . 74.239999999999995 109.68 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -116.57 124.86 50.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.726 -0.67 . . . . 70.340000000000003 111.19 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.6 133.66 48.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.137 -1.061 . . . . 74.450000000000003 108.137 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.96 101.71 7.72 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.04 -1.064 . . . . 64.329999999999998 112.592 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.04 -47.53 68.13 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.661 -1.607 . . . . 71.400000000000006 106.661 171.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.29 45.69 0.01 OUTLIER Glycine 0 N--CA 1.427 -1.9 0 N-CA-C 105.979 -2.848 . . . . 43.0 105.979 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -162.5 -52.79 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.193 -1.039 . . . . 73.019999999999996 108.193 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.12 92.37 2.14 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.691 -0.766 . . . . 44.140000000000001 111.93 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -99.13 150.24 22.23 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.31 -0.996 . . . . 74.099999999999994 108.31 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 35.8 p -142.94 132.25 23.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.663 0.602 . . . . 75.400000000000006 109.859 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -134.54 135.26 42.19 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.505 -1.665 . . . . 74.150000000000006 106.505 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 33.5 tt0 -101.71 144.31 30.57 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.093 -0.643 . . . . 54.210000000000001 111.156 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 52' ' ' ILE . 76.1 mt -78.88 139.23 38.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.715 -0.675 . . . . 33.210000000000001 110.359 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -95.29 157.86 15.71 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.347 -1.353 . . . . 74.510000000000005 107.347 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.5 146.03 55.2 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.182 0.515 . . . . 73.340000000000003 111.576 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.43 -171.44 15.81 Favored Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 107.723 -2.151 . . . . 75.150000000000006 107.723 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 67.1 p -96.63 127.46 42.63 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.638 -1.225 . . . . 52.32 111.084 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' N ' HD22 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -103.57 113.58 27.19 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.389 -1.708 . . . . 73.420000000000002 106.389 -178.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -89.83 132.3 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.964 -0.562 . . . . 72.510000000000005 109.694 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -116.07 132.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.684 -0.689 . . . . 74.349999999999994 109.859 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 158.4 -162.23 32.23 Favored Glycine 0 CA--C 1.495 -1.162 0 N-CA-C 108.611 -1.796 . . . . 34.240000000000002 108.611 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 56.1 mtp180 -122.17 103.69 8.96 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.008 -1.479 . . . . 71.310000000000002 107.008 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.594 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 174.84 176.16 42.92 Favored Glycine 0 N--CA 1.414 -2.828 0 N-CA-C 110.935 -0.866 . . . . 61.420000000000002 110.935 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -52.1 -40.36 61.15 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.751 1.22 . . . . 74.040000000000006 113.373 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.68 -37.07 73.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.491 . . . . 71.019999999999996 111.453 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.78 15.9 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.357 -0.838 . . . . 72.219999999999999 112.795 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -75.35 -36.15 61.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.434 -0.95 . . . . 62.229999999999997 108.434 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -105.45 108.87 20.62 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.536 -0.913 . . . . 65.230000000000004 108.536 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.6 mmt85 -87.66 121.35 29.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.152 -0.931 . . . . 72.25 109.455 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.432 HD12 HG21 ' A' ' 45' ' ' VAL . 44.2 mt -79.19 130.53 68.94 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.362 -0.607 . . . . 72.140000000000001 109.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.02 -1.91 9.48 Favored 'Trans proline' 0 C--N 1.325 -0.696 0 C-N-CA 122.013 1.808 . . . . 53.240000000000002 111.049 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -88.67 -176.65 5.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.937 -1.029 . . . . 73.129999999999995 111.234 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.0 t -123.21 170.89 9.79 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.694 -0.484 . . . . 74.200000000000003 109.694 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.03 71.79 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.57 -1.412 . . . . 75.319999999999993 109.57 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 40' ' ' LEU . 7.1 p -113.85 144.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.295 -0.952 . . . . 72.329999999999998 111.0 -173.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.5 p -91.84 -167.68 1.84 Allowed 'General case' 0 C--O 1.254 1.292 0 C-N-CA 124.137 0.975 . . . . 64.040000000000006 109.499 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 5.6 ptt180 -80.84 -34.29 33.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 118.247 -1.381 . . . . 73.150000000000006 109.287 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -124.04 100.7 6.86 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.412 -1.699 . . . . 72.239999999999995 106.412 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -100.81 -34.37 9.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.124 -0.944 . . . . 64.420000000000002 109.717 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 tt -162.14 148.37 13.34 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.003 -0.74 . . . . 63.229999999999997 109.003 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.31 139.61 50.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.281 0.562 . . . . 75.549999999999997 109.824 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 23' ' ' LEU . 69.6 mt -113.85 113.81 44.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.981 -0.748 . . . . 74.129999999999995 108.981 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 86.6 mtt180 -91.71 107.03 18.92 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.915 -1.143 . . . . 64.319999999999993 107.915 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.577 ' HH2' HG22 ' A' ' 7' ' ' THR . 47.7 t-105 -103.13 126.93 50.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.721 -0.672 . . . . 73.329999999999998 111.289 -175.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -128.27 162.87 26.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.409 -2.071 . . . . 53.039999999999999 105.409 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.11 51.27 1.65 Allowed Glycine 0 CA--C 1.534 1.262 0 N-CA-C 116.345 1.298 . . . . 44.409999999999997 116.345 -172.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -62.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.525 -0.917 . . . . 75.420000000000002 108.525 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.76 138.85 38.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-O 121.42 0.628 . . . . 71.140000000000001 112.162 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -103.99 114.04 28.0 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.376 -0.829 . . . . 72.219999999999999 110.233 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 5.7 tt -91.25 110.34 21.62 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.623 -0.88 . . . . 70.439999999999998 108.623 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -94.21 121.9 36.2 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.233 -1.395 . . . . 75.109999999999999 107.233 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.29 120.56 24.58 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.154 0.502 . . . . 62.130000000000003 110.384 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.31 138.1 33.09 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.461 -0.791 . . . . 72.450000000000003 108.941 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.8 OUTLIER -123.06 76.8 1.4 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 109.356 -0.609 . . . . 73.219999999999999 109.356 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER 160.79 151.76 0.01 OUTLIER 'General case' 0 C--O 1.198 -1.653 0 C-N-CA 125.914 1.686 . . . . 73.439999999999998 109.606 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -104.35 -12.31 16.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 121.562 -0.711 . . . . 72.209999999999994 109.716 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -72.73 -64.36 0.98 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.645 -0.707 . . . . 44.210000000000001 111.674 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -107.12 28.93 7.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.958 -1.127 . . . . 73.319999999999993 107.958 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.79 120.89 2.73 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.452 -1.249 . . . . 74.140000000000001 113.245 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 m -70.29 142.8 52.23 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 124.903 1.281 . . . . 75.329999999999998 112.373 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 76' ' ' PRO . 12.9 p -105.38 141.25 37.22 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.613 -0.721 . . . . 65.109999999999999 111.262 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.86 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 106.67 -1.604 . . . . 51.039999999999999 106.67 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.49 23.92 11.27 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.456 -0.572 . . . . 75.030000000000001 109.456 -170.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 74.42 15.03 3.53 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.756 1.622 . . . . 72.299999999999997 111.712 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.57 123.71 37.2 Favored Pre-proline 0 C--N 1.315 -0.897 0 O-C-N 121.267 -0.896 . . . . 71.519999999999996 109.012 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.411 ' N ' HG22 ' A' ' 71' ' ' THR . 57.4 Cg_endo -77.31 125.16 7.58 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 121.981 1.787 . . . . 71.019999999999996 111.859 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.4 m -135.28 170.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.867 -0.606 . . . . 61.240000000000002 110.011 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -91.13 -47.02 7.78 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.163 -1.051 . . . . 70.450000000000003 108.163 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.5 pt-20 -141.26 151.8 43.99 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.169 -0.923 . . . . 74.530000000000001 109.875 177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.493 ' HB2' HG21 ' A' ' 77' ' ' VAL . 23.3 t-105 -157.11 152.03 25.87 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.268 -1.012 . . . . 73.209999999999994 108.268 -175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 79.3 mt-30 -101.36 119.36 38.64 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.903 -0.719 . . . . 63.530000000000001 109.348 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' HG11 ' A' ' 97' ' ' VAL . 78.2 mt -56.29 143.2 34.87 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 124.087 0.867 . . . . 54.409999999999997 111.656 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.97 39.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.602 -1.259 . . . . 73.319999999999993 107.602 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.79 127.85 34.05 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.729 -0.471 . . . . 75.209999999999994 109.729 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.22 -5.35 52.51 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.897 -0.592 . . . . 63.020000000000003 111.88 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.64 127.65 33.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 75.310000000000002 109.986 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.11 112.41 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.75 -1.204 . . . . 74.340000000000003 107.75 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.405 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 40.3 mt -103.39 125.02 57.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 108.196 -1.039 . . . . 75.099999999999994 108.196 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -129.55 124.92 35.06 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.061 0.458 . . . . 71.140000000000001 111.521 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 90' ' ' LEU . 1.3 pt? -100.81 163.39 12.34 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 105.005 -2.22 . . . . 73.230000000000004 105.005 170.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.94 85.74 0.88 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 118.414 -1.851 . . . . 75.439999999999998 111.339 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 161.68 -54.07 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 126.632 1.973 . . . . 72.129999999999995 108.155 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -133.37 155.37 49.59 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.793 0.806 . . . . 74.310000000000002 111.734 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -121.27 144.02 48.85 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 114.359 -1.291 . . . . 74.230000000000004 109.038 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 8.3 tp -134.82 146.74 30.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.373 -1.343 . . . . 74.219999999999999 107.373 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.74 137.6 45.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.499 0.591 . . . . 74.329999999999998 109.456 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 82' ' ' LEU . 99.1 t -89.14 127.64 41.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.87 0.367 . . . . 61.32 111.421 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.09 145.18 47.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.684 -0.689 . . . . 73.120000000000005 109.208 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' SER . 90.0 mtp -122.02 124.35 43.78 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.523 -0.547 . . . . 73.530000000000001 109.523 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.0 m170 . . . . . 0 C--N 1.302 -1.485 0 CA-C-O 118.852 -0.594 . . . . 75.450000000000003 110.024 -175.393 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m . . . . . 0 N--CA 1.421 -1.924 0 N-CA-C 110.055 -0.35 . . . . 73.129999999999995 110.055 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.9 m -116.13 115.29 25.78 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.875 -1.158 . . . . 70.120000000000005 107.875 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.3 p -95.44 117.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.965 -0.754 . . . . 54.539999999999999 108.965 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.443 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.8 m -123.68 135.58 53.97 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.888 -1.051 . . . . 63.409999999999997 110.643 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 mt -85.93 126.98 34.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.139 -1.06 . . . . 70.400000000000006 108.139 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -111.47 128.36 55.98 Favored 'General case' 0 C--N 1.286 -2.181 0 O-C-N 123.752 0.658 . . . . 75.209999999999994 111.099 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.5 tp -136.55 128.26 28.96 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.456 -0.942 . . . . 75.430000000000007 108.456 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.6 100.08 12.95 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.685 -1.228 . . . . 41.200000000000003 107.685 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -125.17 84.31 2.26 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 107.294 -1.372 . . . . 63.109999999999999 107.294 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.62 -73.14 1.23 Allowed Glycine 0 C--N 1.289 -2.029 0 CA-C-N 114.731 -1.122 . . . . 55.200000000000003 110.328 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -121.84 -35.58 3.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.554 -0.906 . . . . 61.140000000000001 108.554 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.38 115.97 1.21 Allowed Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 120.507 -0.854 . . . . 44.219999999999999 111.443 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -100.56 142.01 32.63 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.204 -1.406 . . . . 63.240000000000002 107.204 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.7 p -141.44 132.42 26.08 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.434 0.459 . . . . 61.409999999999997 111.415 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -121.52 111.99 17.94 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.82 -0.627 . . . . 75.540000000000006 109.469 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.15 132.02 34.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.556 -0.535 . . . . 70.439999999999998 109.556 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HB2' HG13 ' A' ' 9' ' ' VAL . 96.3 mt -74.42 138.19 43.16 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.898 -1.047 . . . . 63.439999999999998 109.997 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -103.5 168.5 9.11 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.411 -0.589 . . . . 75.329999999999998 109.411 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.5 pm0 -61.41 118.79 7.42 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 124.212 0.945 . . . . 55.32 112.745 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.19 -173.36 18.5 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.356 -1.498 . . . . 74.5 109.356 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 62.0 p -95.79 119.2 33.86 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 117.94 0.87 . . . . 72.109999999999999 110.904 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.472 ' N ' HD22 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -96.28 110.24 22.59 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.091 -1.448 . . . . 75.439999999999998 107.091 -176.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.96 128.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.362 -0.607 . . . . 73.420000000000002 109.362 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.28 132.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.266 -0.642 . . . . 73.239999999999995 109.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 155.08 -171.06 33.3 Favored Glycine 0 CA--C 1.481 -2.067 0 N-CA-C 109.756 -1.338 . . . . 71.439999999999998 109.756 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 73.3 mtp180 -120.44 105.27 10.71 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.631 -0.828 . . . . 73.140000000000001 108.856 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 155.6 13.71 Favored Glycine 0 N--CA 1.416 -2.648 0 N-CA-C 107.327 -2.309 . . . . 72.450000000000003 107.327 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.89 -17.69 65.02 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 118.017 0.909 . . . . 74.239999999999995 112.25 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.626 ' OD2' ' HD3' ' A' ' 48' ' ' ARG . 19.9 t70 -89.51 -2.01 58.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.74 0.781 . . . . 74.349999999999994 109.629 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.44 152.81 19.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.802 -0.636 . . . . 74.209999999999994 109.486 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.14 -46.95 6.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.12 0.486 . . . . 62.100000000000001 110.984 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -107.87 118.56 37.05 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.597 -0.89 . . . . 74.120000000000005 108.597 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 22.5 mmt85 -95.91 123.79 39.65 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.639 -0.71 . . . . 73.230000000000004 109.138 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 HG21 ' A' ' 45' ' ' VAL . 57.6 mt -78.48 141.68 61.32 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.929 -0.397 . . . . 73.450000000000003 109.929 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.92 5.06 6.57 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.234 1.956 . . . . 71.230000000000004 114.333 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -111.7 172.72 6.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.572 -1.27 . . . . 74.439999999999998 107.572 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -112.65 156.5 22.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.052 -0.722 . . . . 71.219999999999999 109.052 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -22.46 17.28 Favored Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 109.955 -1.258 . . . . 73.230000000000004 109.955 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 40' ' ' LEU . 7.1 p -77.24 136.12 25.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.747 -0.726 . . . . 64.0 109.052 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -69.58 177.61 2.88 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 122.845 0.458 . . . . 74.129999999999995 110.96 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 3.8 ptp180 -63.64 -40.59 97.25 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.368 -0.533 . . . . 70.230000000000004 111.125 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.626 ' HD3' ' OD2' ' A' ' 35' ' ' ASP . 45.1 mtm180 -131.9 113.7 13.76 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 106.01 -1.848 . . . . 74.439999999999998 106.01 171.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -104.32 -38.43 6.85 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-O 121.526 0.679 . . . . 63.399999999999999 110.35 -174.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.485 HD11 HD21 ' A' ' 61' ' ' LEU . 5.1 tt -160.3 153.51 21.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.577 -0.897 . . . . 64.340000000000003 108.577 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -138.24 124.52 20.46 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.31 0.576 . . . . 64.530000000000001 109.968 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' SER . 61.7 mt -99.19 119.22 46.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.91 -0.774 . . . . 64.400000000000006 108.91 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.469 ' HD2' HD23 ' A' ' 60' ' ' LEU . 51.9 mtt-85 -91.44 107.06 18.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.131 -1.433 . . . . 71.349999999999994 107.131 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -102.46 116.8 33.36 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.882 0.849 . . . . 75.200000000000003 110.5 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -119.21 161.55 20.17 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.83 -1.545 . . . . 75.120000000000005 106.83 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.81 37.93 1.48 Allowed Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.429 0.559 . . . . 74.519999999999996 112.825 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -136.89 -70.04 0.46 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.622 1.169 . . . . 73.430000000000007 108.392 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.08 159.38 32.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.949 -0.389 . . . . 72.439999999999998 109.949 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.02 106.52 18.87 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.601 0.715 . . . . 73.329999999999998 109.39 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.469 HD23 ' HD2' ' A' ' 53' ' ' ARG . 60.8 tp -90.79 111.98 23.59 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.198 -0.91 . . . . 74.239999999999995 111.185 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 50' ' ' LEU . 2.9 tm? -86.95 122.34 30.67 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.54 -1.281 . . . . 63.539999999999999 107.54 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.94 123.08 31.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 72.450000000000003 110.014 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.61 145.97 27.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.507 -0.553 . . . . 62.039999999999999 109.507 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.67 77.09 1.7 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.247 -1.39 . . . . 73.450000000000003 107.247 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -174.18 159.48 3.2 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.58 -0.526 . . . . 74.530000000000001 109.58 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -108.27 -54.55 2.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 120.851 0.357 . . . . 62.549999999999997 111.29 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 t -90.15 -24.44 21.06 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.794 -0.566 . . . . 74.109999999999999 111.963 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -105.51 26.98 8.81 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.6 -0.518 . . . . 71.230000000000004 109.6 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.92 126.66 18.3 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.294 0.996 . . . . 74.420000000000002 113.022 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -72.49 147.47 46.01 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.315 0.646 . . . . 74.400000000000006 111.557 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -113.37 146.91 38.7 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.762 -0.654 . . . . 70.219999999999999 110.285 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.38 116.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.955 -1.128 . . . . 50.399999999999999 107.955 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.33 24.47 14.57 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.997 0.919 . . . . 63.299999999999997 109.704 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m120 83.69 5.85 0.74 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 126.723 2.009 . . . . 64.510000000000005 113.398 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.64 127.17 34.81 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.63 -0.507 . . . . 75.099999999999994 109.63 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.02 125.29 9.22 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.513 2.142 . . . . 74.239999999999995 112.489 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 80' ' ' TRP . 35.7 m -142.31 161.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.21 -0.663 . . . . 63.520000000000003 109.21 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -89.35 -28.19 19.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.207 0.527 . . . . 74.340000000000003 110.253 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.55 158.83 40.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.438 -0.949 . . . . 62.520000000000003 108.438 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.408 ' HB2' HG21 ' A' ' 77' ' ' VAL . 70.8 t-105 -157.68 152.2 24.99 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.69 -0.856 . . . . 73.019999999999996 108.69 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -100.04 107.7 19.69 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.277 -1.379 . . . . 65.230000000000004 107.277 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 97' ' ' VAL . 89.1 mt -56.87 143.51 37.11 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.946 0.779 . . . . 61.119999999999997 113.043 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.99 163.5 29.07 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 115.124 -0.944 . . . . 74.349999999999994 108.513 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.7 t70 -70.19 112.2 6.37 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.444 -0.576 . . . . 54.229999999999997 109.444 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 3.9 27.03 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 121.004 -0.617 . . . . 64.400000000000006 113.148 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.89 139.36 35.95 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 117.832 0.816 . . . . 53.009999999999998 110.931 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.9 t -98.95 113.12 32.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.919 -0.771 . . . . 73.219999999999999 108.919 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.79 110.75 26.11 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.08 -1.452 . . . . 74.430000000000007 107.08 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 18.5 ttt180 -113.73 121.35 43.81 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.659 0.742 . . . . 73.340000000000003 111.901 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.81 163.28 22.49 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.14 -1.391 . . . . 73.030000000000001 107.722 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.34 120.05 9.12 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 123.563 0.54 . . . . 74.5 113.133 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.2 m170 86.24 -17.02 0.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.041 1.736 . . . . 75.329999999999998 114.96 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.8 m -150.67 127.88 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 118.977 0.808 . . . . 73.299999999999997 112.652 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' OE1' ' HD2' ' A' ' 89' ' ' ARG . 10.1 pt-20 -110.8 131.92 54.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.498 -0.927 . . . . 74.349999999999994 108.498 171.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 144.72 34.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.807 -0.633 . . . . 72.140000000000001 110.184 -174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.38 127.81 58.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.539 -0.911 . . . . 72.209999999999994 108.539 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.453 HG21 HD22 ' A' ' 82' ' ' LEU . 74.3 t -87.54 128.16 40.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.638 -0.255 . . . . 61.039999999999999 110.459 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -116.47 149.38 39.59 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.471 -0.566 . . . . 74.030000000000001 109.471 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.43 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 88.8 mtp -126.92 106.22 9.16 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.087 -1.079 . . . . 73.409999999999997 108.087 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 44.0 m-70 . . . . . 0 C--N 1.272 -2.774 0 CA-C-N 114.281 -1.327 . . . . 62.0 108.058 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.436 -1.134 0 CA-C-O 120.757 0.313 . . . . 74.450000000000003 111.433 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.4 p -122.69 132.99 54.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.674 -1.232 . . . . 63.43 107.674 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.59 129.55 71.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 122.383 1.087 . . . . 53.329999999999998 111.118 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 m -132.43 128.71 38.1 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.759 -1.11 . . . . 74.219999999999999 108.309 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 95' ' ' ILE . 4.4 pp -92.38 148.83 21.81 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.405 -0.961 . . . . 75.530000000000001 108.405 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -126.81 125.42 41.66 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.195 -0.602 . . . . 71.219999999999999 110.202 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.3 tp -83.15 124.73 30.79 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.812 -0.81 . . . . 62.039999999999999 108.812 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -90.12 98.44 11.77 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 106.321 -1.733 . . . . 72.140000000000001 106.321 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -150.63 77.55 1.29 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.904 -1.043 . . . . 72.430000000000007 109.386 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.93 -65.61 4.02 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 115.375 -0.83 . . . . 55.340000000000003 113.025 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 p -100.56 -47.36 4.9 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.456 0.646 . . . . 70.310000000000002 111.193 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 106.82 91.27 2.21 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.367 -1.093 . . . . 72.140000000000001 110.367 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.52 158.21 15.65 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 110.478 -0.193 . . . . 61.329999999999998 110.478 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -121.88 148.93 44.1 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.108 0.781 . . . . 45.229999999999997 113.108 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -136.97 117.24 13.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.667 -1.234 . . . . 73.049999999999997 107.667 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -83.41 139.07 33.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.322 -0.621 . . . . 73.310000000000002 109.322 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 52' ' ' ILE . 94.5 mt -85.48 139.7 31.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.815 -0.439 . . . . 73.329999999999998 109.815 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -101.55 165.16 11.39 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.935 0.398 . . . . 70.239999999999995 110.344 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -69.75 113.26 6.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.096 -0.956 . . . . 75.439999999999998 109.914 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.28 -174.57 19.94 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.08 -1.608 . . . . 60.310000000000002 109.08 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 p -106.78 145.85 31.58 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.385 -0.926 . . . . 55.539999999999999 110.857 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.75 135.43 54.56 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.464 -0.569 . . . . 71.430000000000007 109.464 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.68 119.54 46.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.257 -1.016 . . . . 74.200000000000003 108.257 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 58.1 mt -101.8 127.73 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.301 0.572 . . . . 62.130000000000003 110.158 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.44 -178.09 37.49 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.335 -1.506 . . . . 75.109999999999999 109.335 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 29.1 mtm105 -110.99 106.52 15.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.356 1.078 . . . . 71.530000000000001 111.42 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.4 41.8 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 107.168 -2.373 . . . . 75.319999999999993 107.168 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -85.56 -16.01 40.79 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.175 0.988 . . . . 72.329999999999998 108.457 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.5 -12.57 60.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.113 -1.403 . . . . 70.5 109.273 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -98.37 158.02 15.84 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.776 -1.102 . . . . 72.019999999999996 108.553 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -106.65 -39.06 5.94 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.347 0.594 . . . . 71.120000000000005 110.397 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 89.7 t80 -115.72 114.88 25.42 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.904 -1.147 . . . . 74.420000000000002 107.904 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 61.7 mtm180 -96.91 124.14 40.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.094 -0.503 . . . . 74.230000000000004 110.499 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 66.6 mt -71.4 134.17 84.79 Favored Pre-proline 0 CA--C 1.501 -0.926 0 N-CA-C 107.573 -1.269 . . . . 75.299999999999997 107.573 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.28 35.01 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.967 1.778 . . . . 74.329999999999998 112.111 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.8 -175.55 3.44 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.043 0.449 . . . . 41.340000000000003 110.417 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.5 m -111.17 148.59 32.43 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.123 0.969 . . . . 74.329999999999998 110.005 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.82 -0.85 61.07 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 111.679 -0.568 . . . . 31.43 111.679 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.14 127.69 45.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.867 -0.79 . . . . 71.430000000000007 108.867 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.1 m -78.96 177.3 8.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.166 -0.47 . . . . 41.340000000000003 110.185 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.41 -50.63 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.904 0.32 . . . . 74.209999999999994 110.97 177.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.62 114.6 26.66 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 107.025 -1.472 . . . . 75.340000000000003 107.025 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -105.31 -42.97 5.11 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.605 0.717 . . . . 72.219999999999999 109.097 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 tt -163.17 159.8 23.4 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.56 -0.904 . . . . 74.319999999999993 108.56 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -138.85 151.1 46.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.518 -0.549 . . . . 65.430000000000007 109.518 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 23' ' ' LEU . 70.8 mt -123.48 121.44 62.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.542 -0.91 . . . . 63.240000000000002 108.542 176.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 63.4 mtt180 -105.6 107.94 19.2 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.206 -0.664 . . . . 73.150000000000006 109.206 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.72 133.98 52.07 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.996 -0.547 . . . . 75.439999999999998 110.616 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.79 -179.93 6.34 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.436 -2.431 . . . . 65.549999999999997 104.436 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.36 42.62 2.92 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 119.445 1.02 . . . . 25.5 113.867 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -141.62 -76.78 0.28 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 110.203 -0.295 . . . . 71.140000000000001 110.203 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.12 158.1 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.711 0.291 . . . . 63.25 110.557 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.51 112.38 24.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.403 0.62 . . . . 71.510000000000005 110.289 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 6.1 tt -88.96 124.87 34.66 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.272 -0.876 . . . . 61.130000000000003 108.797 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.74 123.55 49.71 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.347 -1.353 . . . . 74.25 107.347 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.74 124.68 28.59 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.187 0.518 . . . . 52.509999999999998 110.999 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 14.9 t70 -89.3 112.47 23.55 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.357 -0.979 . . . . 73.150000000000006 108.357 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 mt -101.53 76.45 1.67 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.422 -2.066 . . . . 73.140000000000001 105.422 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 68' ' ' ASN . 19.9 t30 -173.81 139.64 0.7 Allowed 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.899 -0.72 . . . . 71.129999999999995 109.708 -165.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -108.56 -53.38 2.65 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.283 0.563 . . . . 63.229999999999997 110.003 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -66.02 -48.64 70.45 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.277 -0.874 . . . . 34.130000000000003 113.05 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.477 ' HB2' HD21 ' A' ' 65' ' ' ASN . 20.0 m-80 -106.4 29.77 6.57 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 119.173 -0.441 . . . . 60.409999999999997 109.94 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.23 121.94 2.83 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.18 0.832 . . . . 65.049999999999997 115.18 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.7 m -69.08 149.17 49.01 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.734 1.614 . . . . 75.219999999999999 112.336 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 38.5 p -112.4 145.78 39.51 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.345 0.593 . . . . 54.219999999999999 111.814 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 88' ' ' ILE . 33.9 m -116.07 117.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 107.431 -1.322 . . . . 74.140000000000001 107.431 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 58.88 33.26 22.94 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.675 -0.693 . . . . 71.239999999999995 110.295 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 82.46 -3.36 1.4 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.86 1.664 . . . . 73.209999999999994 112.428 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.15 129.31 25.39 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.684 -0.635 . . . . 54.119999999999997 110.089 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.12 125.58 7.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.501 2.134 . . . . 73.519999999999996 113.529 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.68 174.47 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 107.295 -1.372 . . . . 73.329999999999998 107.295 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.456 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.2 mt-30 -117.4 -17.73 10.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 112.979 0.733 . . . . 71.340000000000003 112.979 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.61 131.52 27.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 109.908 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -147.57 152.33 37.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.842 -0.799 . . . . 74.340000000000003 108.842 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -106.41 113.8 27.53 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.181 -1.044 . . . . 74.140000000000001 108.181 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.2 mt -57.85 149.56 22.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.107 -0.952 . . . . 71.329999999999998 112.486 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.09 166.79 23.8 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.321 -0.854 . . . . 54.439999999999998 109.15 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.8 t70 -71.67 115.72 11.19 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.994 0.426 . . . . 72.150000000000006 110.201 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.46 14.34 28.1 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.813 -0.63 . . . . 71.109999999999999 112.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -88.76 135.66 33.4 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 120.438 -0.505 . . . . 73.439999999999998 110.74 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.21 113.46 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.008 -0.738 . . . . 61.409999999999997 109.008 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -105.76 113.53 42.84 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.805 -1.183 . . . . 74.049999999999997 107.805 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 61.5 mtt180 -99.81 106.28 18.14 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 116.272 -0.422 . . . . 73.219999999999999 109.954 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -115.5 164.69 13.93 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.013 -0.994 . . . . 54.420000000000002 109.001 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -27.39 88.78 0.01 OUTLIER Glycine 0 N--CA 1.484 1.856 0 C-N-CA 125.303 1.43 . . . . 64.400000000000006 116.331 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 58.08 21.35 7.81 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.76 1.624 . . . . 72.540000000000006 111.491 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.0 m -137.01 114.25 10.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.12 -1.067 . . . . 63.439999999999998 108.12 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.22 125.4 54.1 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 120.099 -0.64 . . . . 70.519999999999996 109.799 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 13' ' ' LEU . 1.7 pp -122.48 149.43 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-O 120.953 0.406 . . . . 53.100000000000001 111.36 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -110.39 122.45 64.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.767 -1.568 . . . . 44.520000000000003 106.767 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' ' 82' ' ' LEU . 55.1 t -80.41 126.56 39.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 120.85 0.357 . . . . 75.040000000000006 111.057 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.0 mmm-85 -116.9 142.3 47.11 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.35 0.595 . . . . 64.540000000000006 109.678 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 79.6 mtp -123.06 121.25 35.57 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.925 -1.034 . . . . 74.239999999999995 109.144 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 107.168 -1.419 . . . . 73.439999999999998 107.168 -177.641 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 m . . . . . 0 N--CA 1.433 -1.312 0 N-CA-C 106.831 -1.544 . . . . 73.400000000000006 106.831 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -121.48 114.77 21.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.494 -0.483 . . . . 74.129999999999995 109.95 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.7 p -95.76 126.41 48.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.713 -1.217 . . . . 55.020000000000003 107.713 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 m -131.06 136.54 48.54 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.28 -0.873 . . . . 72.450000000000003 109.264 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 95' ' ' ILE . 4.0 pp -101.8 131.41 48.13 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 109.966 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.92 114.26 28.24 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.28 -1.378 . . . . 62.340000000000003 107.28 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.16 119.31 38.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.43 0.692 . . . . 73.239999999999995 110.521 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -93.36 100.0 12.41 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.949 -1.13 . . . . 63.530000000000001 107.949 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.91 -13.59 15.76 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.167 -1.378 . . . . 73.439999999999998 109.179 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.22 -12.93 6.02 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.87 -1.292 . . . . 34.32 109.87 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -120.12 -35.81 3.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 120.816 0.341 . . . . 74.319999999999993 110.593 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 91.82 1.38 Allowed Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.139 -1.184 . . . . 33.240000000000002 110.139 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -113.51 159.43 19.56 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 110.476 -0.194 . . . . 74.430000000000007 110.476 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.8 p -130.22 136.33 49.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.882 0.373 . . . . 74.349999999999994 110.024 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -135.62 121.55 19.91 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.042 -0.526 . . . . 74.109999999999999 109.638 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.915 -0.584 . . . . 52.100000000000001 109.762 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.3 mt -76.86 133.91 39.17 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.503 -0.771 . . . . 61.210000000000001 110.265 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -102.99 158.45 16.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 108.767 -0.827 . . . . 72.109999999999999 108.767 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.9 mp0 -48.5 127.27 12.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.492 1.517 . . . . 73.219999999999999 111.445 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.1 -174.8 15.81 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.255 -1.538 . . . . 64.420000000000002 109.255 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 81.8 p -95.73 123.35 39.26 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 118.319 -1.353 . . . . 73.129999999999995 110.882 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.517 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -92.57 109.74 21.15 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.065 -1.828 . . . . 74.430000000000007 106.065 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.21 129.42 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.596 -0.729 . . . . 60.399999999999999 110.842 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -107.57 133.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.54 -0.911 . . . . 72.530000000000001 108.54 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 154.79 177.5 28.17 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.193 -1.563 . . . . 74.129999999999995 109.193 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 49.7 mtp85 -112.52 105.0 13.12 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.884 1.342 . . . . 75.530000000000001 109.858 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.89 179.32 46.31 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 110.039 -1.225 . . . . 74.230000000000004 110.039 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -72.41 -25.44 61.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.073 0.939 . . . . 73.319999999999993 108.937 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.98 8.48 12.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.665 -1.152 . . . . 71.129999999999995 111.526 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.91 155.19 44.59 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.079 0.466 . . . . 63.100000000000001 112.013 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -99.63 -54.73 2.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.017 -0.992 . . . . 71.420000000000002 109.987 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -101.48 108.92 20.64 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 71.430000000000007 109.217 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 33.5 ptt180 -96.08 118.13 32.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.105 -0.498 . . . . 75.040000000000006 111.802 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.65 140.19 97.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.278 -0.874 . . . . 71.340000000000003 110.509 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -92.71 17.92 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.601 2.201 . . . . 75.329999999999998 112.283 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.64 -173.49 2.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -112.0 146.91 37.04 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.193 0.597 . . . . 60.32 109.564 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 -27.36 16.82 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.818 -0.706 . . . . 73.519999999999996 111.384 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.34 133.02 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 123.435 0.694 . . . . 65.340000000000003 111.586 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -80.27 -171.47 3.02 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.392 1.077 . . . . 71.140000000000001 109.552 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 33.4 ptt180 -78.02 -34.78 50.49 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.35 -0.94 . . . . 63.439999999999998 109.587 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HB3' HD23 ' A' ' 64' ' ' LEU . 63.4 mtp180 -129.07 115.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 103.582 -2.748 . . . . 64.030000000000001 103.582 172.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 5.3 t60 -103.76 -42.41 5.63 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.55 0.691 . . . . 73.120000000000005 109.143 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 4.9 tt -166.45 151.14 7.78 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.429 -0.952 . . . . 72.409999999999997 108.429 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.63 134.94 45.5 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.122 -0.695 . . . . 72.129999999999995 109.122 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -102.55 112.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.028 -1.471 . . . . 75.200000000000003 107.028 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 40.2 ttt85 -91.65 107.38 19.17 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 121.548 0.689 . . . . 73.409999999999997 109.779 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -96.49 112.54 24.24 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.948 -1.024 . . . . 74.120000000000005 109.056 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -119.27 167.38 11.92 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.172 -1.788 . . . . 55.219999999999999 106.172 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.98 42.36 2.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.592 -0.813 . . . . 52.100000000000001 112.566 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -136.68 -66.86 0.52 Allowed 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 124.041 0.936 . . . . 71.019999999999996 108.56 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.11 159.77 4.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.719 1.208 . . . . 73.439999999999998 108.31 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.36 107.59 19.24 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.652 0.739 . . . . 75.549999999999997 109.101 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 tt -88.49 115.41 25.98 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.79 -1.095 . . . . 72.200000000000003 109.789 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.8 tm? -97.21 124.94 41.44 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.318 -1.364 . . . . 72.430000000000007 107.318 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -140.57 125.6 18.43 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 120.678 0.275 . . . . 62.229999999999997 111.409 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.667 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 1.2 m-20 -73.52 139.61 45.79 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 115.798 -0.637 . . . . 64.129999999999995 109.948 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.418 HD23 ' HB3' ' A' ' 48' ' ' ARG . 32.9 tp -130.68 77.15 1.77 Allowed 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.534 -1.284 . . . . 53.549999999999997 107.534 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -179.82 174.64 0.91 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.419 -1.326 . . . . 73.25 107.419 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 p -109.03 -55.03 2.46 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.642 0.608 . . . . 72.239999999999995 112.642 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -89.52 -29.95 18.58 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.466 0.913 . . . . 74.109999999999999 113.466 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.574 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 90.2 m-20 -84.57 27.38 0.72 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.427 0.691 . . . . 54.43 112.219 -172.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.51 122.73 6.68 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.967 1.417 . . . . 64.329999999999998 113.951 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.667 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 52.7 m -71.84 148.68 45.95 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 125.035 1.334 . . . . 71.319999999999993 112.622 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 p -112.92 141.03 47.22 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.435 -0.802 . . . . 54.240000000000002 109.505 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.03 118.25 53.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.755 -1.202 . . . . 64.319999999999993 107.755 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 57.81 38.22 27.23 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.556 -0.747 . . . . 70.230000000000004 109.88 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.39 -10.61 1.17 Allowed 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.605 1.962 . . . . 65.010000000000005 112.001 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -92.37 121.81 65.75 Favored Pre-proline 0 C--N 1.323 -0.57 0 O-C-N 122.124 -0.36 . . . . 52.240000000000002 110.7 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.47 125.19 13.0 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.837 2.358 . . . . 75.030000000000001 112.552 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.99 -177.9 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.974 -0.751 . . . . 75.209999999999994 108.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -128.83 6.25 5.53 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.589 -0.522 . . . . 72.230000000000004 109.589 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.45 153.16 3.44 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.907 -1.146 . . . . 73.329999999999998 107.907 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.448 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 76.3 t-105 -166.91 152.29 7.73 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.711 -0.848 . . . . 73.140000000000001 108.711 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -104.66 111.52 24.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.643 -1.243 . . . . 44.030000000000001 107.643 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' HG11 ' A' ' 97' ' ' VAL . 56.0 mt -58.13 141.3 50.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.898 1.073 . . . . 64.530000000000001 113.898 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.97 162.46 32.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.529 -1.286 . . . . 53.399999999999999 107.529 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.0 126.36 27.79 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.575 -0.284 . . . . 75.150000000000006 110.396 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.63 1.94 57.56 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.907 -0.663 . . . . 62.020000000000003 113.414 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -73.07 129.58 38.39 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.362 0.581 . . . . 53.200000000000003 111.135 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.43 116.28 35.32 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 N-CA-C 107.284 -1.376 . . . . 75.530000000000001 107.284 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.9 mt -122.43 134.28 66.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 C-N-CA 119.971 -0.692 . . . . 50.020000000000003 110.6 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.408 ' HG2' ' CB ' ' A' ' 94' ' ' GLU . 27.7 mtp-105 -124.19 123.35 40.08 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 73.099999999999994 110.004 175.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.5 pt? -101.81 162.57 12.81 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 105.81 -1.922 . . . . 65.540000000000006 105.81 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -46.33 102.86 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 O-C-N 123.749 0.655 . . . . 64.239999999999995 113.786 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 m170 79.52 15.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.712 1.375 . . . . 73.140000000000001 114.712 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -151.02 141.11 22.14 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.475 -0.766 . . . . 71.450000000000003 111.94 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 89' ' ' ARG . 9.2 pt-20 -118.75 139.29 51.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.037 0.446 . . . . 52.130000000000003 111.235 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.493 HD11 HD13 ' A' ' 11' ' ' LEU . 9.5 tp -139.8 142.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-N 115.301 -0.863 . . . . 75.239999999999995 109.527 -172.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -109.88 134.51 51.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.029 -1.1 . . . . 53.539999999999999 108.029 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' A' ' 82' ' ' LEU . 85.0 t -96.92 121.73 47.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.141 0.496 . . . . 75.430000000000007 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -117.47 132.29 56.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.865 -0.791 . . . . 72.120000000000005 108.865 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.0 mtp -116.36 116.87 28.52 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.064 -0.717 . . . . 64.109999999999999 109.064 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--N 1.278 -2.537 0 N-CA-C 107.506 -1.294 . . . . 63.420000000000002 107.506 -177.732 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m . . . . . 0 N--CA 1.409 -2.491 0 N-CA-C 107.82 -1.178 . . . . 50.039999999999999 107.82 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -113.04 114.3 26.67 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.201 -1.407 . . . . 54.240000000000002 107.201 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 108.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.813 -1.18 . . . . 60.399999999999999 107.813 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 m -111.41 123.23 49.79 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.095 -1.076 . . . . 73.0 108.095 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.4 pp -88.53 130.02 35.33 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.602 -0.888 . . . . 62.200000000000003 108.602 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.93 108.85 19.76 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.622 -1.621 . . . . 54.119999999999997 106.622 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.48 117.8 29.39 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.524 -0.546 . . . . 73.209999999999994 109.524 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -126.77 103.53 7.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.951 -1.1 . . . . 72.099999999999994 112.925 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -48.87 9.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.9 -2.259 . . . . 74.430000000000007 104.9 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 171.29 44.27 0.04 OUTLIER Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 103.591 -3.804 . . . . 34.340000000000003 103.591 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -132.49 -45.94 0.9 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.644 -1.278 . . . . 72.099999999999994 110.86 -166.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.72 51.04 8.38 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.49 -1.044 . . . . 75.340000000000003 110.49 -172.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -84.47 143.1 29.6 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.747 0.419 . . . . 74.209999999999994 110.355 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.9 p -146.68 132.36 18.88 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.645 -0.707 . . . . 71.299999999999997 109.199 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -144.8 127.69 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.456 -0.338 . . . . 72.25 110.099 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.07 127.46 36.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.41 -0.959 . . . . 62.039999999999999 108.41 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.0 mt -58.31 143.46 44.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.567 0.951 . . . . 63.450000000000003 113.567 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 2.3 mmp_? -100.01 151.61 21.16 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.559 -1.201 . . . . 72.430000000000007 108.022 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -70.85 130.14 40.88 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.683 0.754 . . . . 72.420000000000002 111.367 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.65 -176.54 16.61 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 106.763 -2.535 . . . . 62.32 106.763 -172.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 51.7 p -89.71 133.27 34.75 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 118.388 -1.325 . . . . 74.439999999999998 111.303 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.504 ' N ' HD22 ' A' ' 28' ' ' ASN . 0.5 OUTLIER -101.72 109.83 21.68 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.194 -2.15 . . . . 74.200000000000003 105.194 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.4 mt -86.2 123.96 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.976 -0.556 . . . . 75.25 111.149 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.467 HG23 ' HD2' ' A' ' 38' ' ' PHE . 67.7 mt -107.91 129.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.768 -0.827 . . . . 72.420000000000002 108.768 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.48 -179.03 37.15 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.888 -0.885 . . . . 74.439999999999998 110.888 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 40.1 mtp85 -107.43 106.38 16.75 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.732 -0.84 . . . . 73.510000000000005 108.732 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.71 -178.13 48.63 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 109.562 -1.415 . . . . 53.399999999999999 109.562 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -93.43 -21.05 19.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.004 0.431 . . . . 61.130000000000003 110.786 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -92.76 -3.59 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 73.040000000000006 110.056 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.11 165.96 20.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.049 -0.978 . . . . 42.229999999999997 108.911 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -109.35 -52.16 2.8 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.65 0.738 . . . . 64.239999999999995 110.028 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.467 ' HD2' HG23 ' A' ' 30' ' ' ILE . 92.0 t80 -108.82 116.73 32.53 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.366 -0.975 . . . . 74.310000000000002 108.366 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mpt_? -94.92 127.86 41.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.159 -0.473 . . . . 62.399999999999999 110.973 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.98 136.07 54.59 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.101 -0.5 . . . . 71.420000000000002 111.138 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.98 -29.15 81.5 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.407 2.738 . . . . 71.25 114.4 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 21.5 t70 -95.03 169.0 10.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.709 -0.849 . . . . 63.119999999999997 108.709 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -107.23 -177.34 3.33 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 121.036 -0.266 . . . . 74.150000000000006 110.321 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.22 78.39 Favored Glycine 0 C--O 1.238 0.395 0 N-CA-C 108.807 -1.717 . . . . 74.120000000000005 108.807 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.47 130.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 113.294 -1.453 . . . . 55.140000000000001 108.095 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.1 m -79.11 -177.48 5.65 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.244 -0.651 . . . . 74.299999999999997 109.244 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 15.4 ptt180 -64.49 -41.56 96.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.572 0.701 . . . . 74.109999999999999 109.415 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -121.02 104.36 9.74 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.245 -1.761 . . . . 72.219999999999999 106.245 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 15.2 t60 -100.0 -31.44 11.45 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.948 -1.024 . . . . 75.030000000000001 108.877 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.486 HD11 HD21 ' A' ' 61' ' ' LEU . 8.1 tt -164.28 145.89 8.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.108 -0.701 . . . . 74.230000000000004 109.108 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.95 132.92 47.66 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.292 0.567 . . . . 71.540000000000006 110.05 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.3 mt -108.53 112.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.642 -1.244 . . . . 74.019999999999996 107.642 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 16.3 ttt-85 -91.35 107.71 19.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -99.51 115.32 29.07 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-O 121.672 0.749 . . . . 74.519999999999996 110.324 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.83 164.6 14.42 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.051 -1.463 . . . . 62.420000000000002 107.051 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.56 52.91 3.91 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.415 -1.074 . . . . 70.409999999999997 110.415 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.36 -71.73 0.3 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 125.7 1.6 . . . . 64.409999999999997 107.793 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 m -149.76 160.0 5.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.908 1.283 . . . . 70.319999999999993 107.896 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -93.24 106.15 18.15 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.585 -0.895 . . . . 71.340000000000003 108.585 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -82.48 118.31 23.14 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.277 -0.874 . . . . 64.420000000000002 110.096 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.486 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -99.54 120.13 39.15 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.545 -0.909 . . . . 74.010000000000005 108.545 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.0 123.48 34.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.815 -0.439 . . . . 51.439999999999998 109.815 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.64 138.82 32.77 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.868 -0.605 . . . . 73.430000000000007 110.994 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.92 77.52 1.62 Allowed 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.979 0.511 . . . . 64.340000000000003 109.913 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 32.9 t-20 -175.31 138.67 0.43 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.842 0.746 . . . . 74.040000000000006 110.473 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 p -96.54 -38.46 9.97 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.361 -0.381 . . . . 75.319999999999993 111.854 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 t -89.32 -44.4 10.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.346 0.499 . . . . 63.439999999999998 112.346 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.438 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.4 m120 -105.98 27.37 8.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.129 -0.693 . . . . 74.209999999999994 109.129 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.96 138.36 26.32 Favored Glycine 0 C--O 1.248 1.004 0 CA-C-N 114.527 -1.215 . . . . 32.229999999999997 113.923 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 30.0 m -72.25 137.73 47.0 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 124.406 1.082 . . . . 64.230000000000004 113.299 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 p -105.91 140.75 38.45 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.373 -0.83 . . . . 72.530000000000001 109.674 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 88' ' ' ILE . 35.2 m -119.55 116.04 49.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.602 -1.259 . . . . 54.509999999999998 107.602 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 57.84 30.86 19.69 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.445 0.64 . . . . 72.209999999999994 110.167 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 88.72 -10.88 0.45 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.659 1.984 . . . . 74.540000000000006 113.677 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.7 117.81 66.3 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 121.413 -0.804 . . . . 71.439999999999998 110.913 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.86 124.91 11.5 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 121.76 1.64 . . . . 70.400000000000006 110.319 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.95 175.98 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 110.168 -0.308 . . . . 75.099999999999994 110.168 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.05 -31.84 9.49 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.659 0.599 . . . . 61.109999999999999 109.42 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -142.73 147.86 36.31 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.048 -0.524 . . . . 73.450000000000003 110.199 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -162.23 152.17 16.47 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -107.92 109.41 20.91 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.979 -0.688 . . . . 73.519999999999996 109.154 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 79.0 mt -57.1 122.02 11.41 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.479 -1.237 . . . . 54.049999999999997 111.923 -175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.9 166.59 11.08 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.924 -1.139 . . . . 72.109999999999999 107.924 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 126.4 29.13 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.462 -0.335 . . . . 71.409999999999997 110.628 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.16 57.73 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.929 -0.578 . . . . 44.109999999999999 113.071 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.06 139.88 46.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.984 0.392 . . . . 55.310000000000002 111.411 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.69 117.19 48.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.753 -0.658 . . . . 62.109999999999999 109.673 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -111.98 124.55 68.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 123.368 0.667 . . . . 63.439999999999998 109.28 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 70' ' ' THR . 38.5 ttm180 -120.37 115.73 24.11 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.405 -0.591 . . . . 72.430000000000007 109.405 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 90' ' ' LEU . 2.1 pt? -126.81 139.29 53.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.409 -1.33 . . . . 70.129999999999995 107.409 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.86 88.02 0.0 OUTLIER Glycine 0 N--CA 1.496 2.636 0 O-C-N 125.032 1.457 . . . . 44.340000000000003 116.297 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.5 t60 75.37 -19.66 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.327 1.451 . . . . 74.120000000000005 113.034 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.6 m -96.55 132.46 42.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 122.869 0.468 . . . . 72.299999999999997 111.171 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -125.78 117.63 23.83 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.013 0.911 . . . . 64.120000000000005 110.387 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -127.64 141.57 46.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 114.53 -1.214 . . . . 62.32 111.914 -170.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.86 133.34 51.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.095 -1.076 . . . . 74.200000000000003 108.095 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.38 124.54 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 120.869 0.366 . . . . 71.530000000000001 110.84 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -119.25 130.58 55.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.741 -0.663 . . . . 74.329999999999998 111.126 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.1 mtt -106.17 111.93 24.75 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.975 -0.75 . . . . 44.310000000000002 108.975 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 . . . . . 0 C--N 1.277 -2.586 0 N-CA-C 108.306 -0.998 . . . . 75.129999999999995 108.306 179.104 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m . . . . . 0 N--CA 1.426 -1.633 0 N-CA-C 109.305 -0.628 . . . . 75.510000000000005 109.305 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -101.56 115.57 30.81 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.804 -0.813 . . . . 64.329999999999998 108.804 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.24 122.02 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 106.251 -1.759 . . . . 72.219999999999999 106.251 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.6 m -135.66 131.22 35.46 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.615 -0.513 . . . . 74.0 109.615 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -93.94 126.86 39.39 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.377 -0.601 . . . . 70.420000000000002 109.377 175.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.8 108.72 21.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.759 -1.2 . . . . 74.450000000000003 107.759 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.02 114.36 28.23 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.824 -0.626 . . . . 72.409999999999997 109.778 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.7 99.62 11.69 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.551 -1.648 . . . . 74.019999999999996 106.551 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -146.89 79.75 1.52 Allowed 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.596 -1.184 . . . . 64.129999999999995 108.953 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.23 -62.39 0.29 Allowed Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.19 -0.914 . . . . 70.120000000000005 111.656 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -128.23 -38.92 1.75 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.425 0.528 . . . . 63.549999999999997 112.425 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.59 86.16 0.79 Allowed Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.784 -0.926 . . . . 73.140000000000001 110.784 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -100.38 167.37 10.44 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.462 0.305 . . . . 73.409999999999997 110.72 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.9 p -141.65 140.55 33.29 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.845 -0.616 . . . . 72.109999999999999 110.388 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.4 121.83 31.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.082 -1.081 . . . . 74.430000000000007 108.082 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -86.67 125.88 34.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.414 -1.328 . . . . 74.109999999999999 107.414 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.47 121.72 18.3 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.783 -0.644 . . . . 72.150000000000006 110.671 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -82.78 150.59 26.54 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.867 -0.79 . . . . 73.340000000000003 108.867 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -57.76 124.98 21.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.242 0.964 . . . . 61.340000000000003 110.309 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.17 -164.04 16.35 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.761 -2.136 . . . . 74.420000000000002 107.761 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 80.5 p -100.65 134.64 43.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.011 1.406 . . . . 75.230000000000004 111.31 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -111.78 110.07 20.24 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.205 -1.776 . . . . 72.420000000000002 106.205 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 45.7 mt -102.27 136.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.676 -0.693 . . . . 71.430000000000007 110.214 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -115.08 135.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.257 1.458 0 N-CA-C 109.49 -0.559 . . . . 71.010000000000005 109.49 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.88 -175.97 29.63 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 110.287 -1.125 . . . . 64.120000000000005 110.287 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 87.5 mtt180 -105.76 105.19 15.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.546 -0.861 . . . . 61.039999999999999 110.233 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.26 162.21 26.67 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 108.886 -1.686 . . . . 71.109999999999999 108.886 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.14 -18.32 62.52 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.218 0.532 . . . . 72.109999999999999 109.578 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.78 -29.03 65.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.624 -1.171 . . . . 72.129999999999995 109.596 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . . . -88.16 154.18 20.65 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.323 -0.853 . . . . 72.400000000000006 110.675 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -93.04 -46.57 7.4 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.598 -0.89 . . . . 63.039999999999999 108.598 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -111.74 117.7 33.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.916 -1.038 . . . . 73.219999999999999 109.313 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.5 mpt_? -96.55 136.7 36.7 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.705 -0.48 . . . . 70.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 82.2 mt -83.33 146.76 51.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.655 -0.248 . . . . 75.519999999999996 110.365 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 4.1 Cg_exo -79.92 12.54 2.42 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.051 2.501 . . . . 64.349999999999994 112.322 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.33 152.61 32.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 111.227 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.5 m -95.18 151.88 18.84 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.48 26.37 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 110.348 -1.101 . . . . 64.340000000000003 110.348 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -98.75 138.6 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.1 m -81.42 175.42 10.57 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.416 0.15 . . . . 61.109999999999999 111.347 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 2.3 ptm180 -60.86 -36.53 79.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.256 0.622 . . . . 74.030000000000001 111.42 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -131.94 97.55 4.2 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.366 -2.087 . . . . 74.319999999999993 105.366 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -95.85 -37.44 10.72 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.565 0.698 . . . . 64.099999999999994 109.746 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 61' ' ' LEU . 6.8 tt -158.99 143.24 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.696 -0.684 . . . . 74.439999999999998 109.182 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -134.57 126.68 29.77 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.596 -0.729 . . . . 74.109999999999999 111.073 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -103.46 112.91 38.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.465 -0.939 . . . . 72.420000000000002 108.465 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 0.0 OUTLIER -91.73 107.67 19.37 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 106.012 -1.847 . . . . 72.430000000000007 106.012 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -105.55 108.37 19.85 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.482 -0.781 . . . . 72.439999999999998 109.552 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.82 161.73 13.7 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 105.935 -1.876 . . . . 72.430000000000007 105.935 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.03 60.4 3.06 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.498 -0.858 . . . . 64.019999999999996 111.828 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -177.72 -50.36 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.729 1.212 . . . . 72.010000000000005 109.865 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.51 145.12 35.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 112.64 0.607 . . . . 74.25 112.64 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.92 102.14 11.52 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 115.235 -0.893 . . . . 72.010000000000005 109.432 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 tp -94.29 109.72 21.52 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.9 -1.046 . . . . 74.409999999999997 111.085 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 50' ' ' LEU . 3.0 tm? -94.98 116.75 29.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.621 -1.251 . . . . 61.200000000000003 107.621 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.6 121.13 32.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.942 0.401 . . . . 61.43 110.834 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.0 134.44 35.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.309 -0.859 . . . . 73.200000000000003 109.141 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.15 77.61 1.75 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.835 -1.172 . . . . 63.240000000000002 107.835 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -170.54 162.72 8.18 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.183 -1.043 . . . . 64.299999999999997 108.183 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 m -108.65 -53.27 2.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 120.475 -0.49 . . . . 75.030000000000001 112.103 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -88.43 -26.69 21.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.371 0.605 . . . . 74.319999999999993 111.895 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -104.85 28.25 7.32 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 122.887 0.475 . . . . 45.229999999999997 110.147 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.76 115.82 1.52 Allowed Glycine 0 C--O 1.246 0.87 0 O-C-N 125.004 1.44 . . . . 71.420000000000002 112.367 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 m -59.19 134.16 56.75 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.321 1.048 . . . . 61.130000000000003 112.676 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 139.67 38.01 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 108.161 -1.051 . . . . 44.149999999999999 108.161 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.51 120.59 62.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.508 -0.923 . . . . 65.400000000000006 108.508 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 59.22 29.13 18.63 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.584 1.183 . . . . 52.520000000000003 109.08 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.271 95.8 m-20 67.11 25.26 9.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 112.8 -2.0 . . . . 71.019999999999996 113.92 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.07 125.38 27.68 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.623 -0.881 . . . . 64.219999999999999 108.623 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.8 130.73 14.94 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.339 2.026 . . . . 70.109999999999999 112.675 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG21 ' HB2' ' A' ' 80' ' ' TRP . 34.7 m -141.77 176.89 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -106.44 -38.09 6.3 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.872 -0.788 . . . . 75.310000000000002 108.872 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.02 148.73 42.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.888 -1.051 . . . . 63.200000000000003 110.597 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.443 ' HB2' HG21 ' A' ' 77' ' ' VAL . 68.9 t-105 -153.16 151.97 30.73 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.674 -0.861 . . . . 73.219999999999999 108.674 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.509 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -102.2 116.35 32.48 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.578 -1.267 . . . . 74.519999999999996 107.578 173.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.403 HD22 HG21 ' A' ' 97' ' ' VAL . 77.9 mt -57.04 138.03 54.94 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 123.729 0.643 . . . . 74.329999999999998 112.152 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.25 169.06 14.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.688 -1.227 . . . . 74.299999999999997 107.688 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 24.9 t70 -79.54 124.8 28.84 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.476 -0.329 . . . . 73.439999999999998 110.648 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.97 6.06 56.17 Favored Glycine 0 N--CA 1.436 -1.348 0 CA-C-N 116.016 -0.538 . . . . 70.25 112.295 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.46 134.8 46.83 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.964 0.411 . . . . 71.519999999999996 111.383 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.42 113.21 35.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 N-CA-C 107.79 -1.189 . . . . 75.329999999999998 107.79 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.3 122.4 68.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 C-N-CA 119.863 -0.735 . . . . 73.329999999999998 111.238 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -105.73 109.98 22.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.658 -0.701 . . . . 63.549999999999997 109.13 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.9 pt? -110.7 164.83 12.36 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.672 -0.862 . . . . 61.130000000000003 108.672 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -47.23 106.29 0.15 Allowed Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.689 0.618 . . . . 61.210000000000001 113.444 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 75.81 12.63 2.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.696 1.599 . . . . 50.210000000000001 114.786 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.0 t -154.85 150.4 27.44 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.58 -0.848 . . . . 74.439999999999998 111.531 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.91 128.67 47.92 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.236 0.541 . . . . 75.230000000000004 109.818 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.4 tp -124.91 148.89 29.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 116.211 -0.45 . . . . 73.420000000000002 110.626 -170.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.91 122.82 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.684 -1.228 . . . . 73.140000000000001 107.684 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 82' ' ' LEU . 81.8 t -90.58 122.78 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.93 0.395 . . . . 64.530000000000001 110.184 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -119.54 140.98 49.65 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.77 -0.65 . . . . 61.219999999999999 110.516 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.416 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 58.2 mtt -121.82 114.53 21.19 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.24 -1.022 . . . . 74.239999999999995 108.24 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 . . . . . 0 C--N 1.278 -2.541 0 N-CA-C 107.024 -1.473 . . . . 74.439999999999998 107.024 -178.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.423 -1.804 0 CA-C-O 120.877 0.37 . . . . 74.420000000000002 111.404 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 m -115.85 114.64 24.99 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.829 -1.174 . . . . 74.150000000000006 107.829 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 25.5 t -91.35 115.9 31.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.402 -0.962 . . . . 73.140000000000001 108.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.479 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.9 m -118.6 127.74 53.89 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 115.742 -0.663 . . . . 73.349999999999994 110.231 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 20' ' ' THR . 69.1 mt -90.57 121.71 32.75 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.91 -1.041 . . . . 54.240000000000002 108.387 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.68 114.52 28.79 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 123.889 0.743 . . . . 75.209999999999994 109.339 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 tp -118.18 109.02 15.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 123.918 0.887 . . . . 64.230000000000004 109.713 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -97.44 101.6 13.17 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.105 -0.702 . . . . 71.329999999999998 109.105 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -97.18 5.26 50.45 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.835 -0.802 . . . . 71.219999999999999 108.835 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.99 -40.43 0.62 Allowed Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 114.671 -1.15 . . . . 74.540000000000006 110.269 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 m -112.01 -50.95 2.88 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 112.889 0.7 . . . . 60.039999999999999 112.889 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.76 82.25 0.55 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.669 -0.776 . . . . 64.109999999999999 111.983 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.11 150.19 22.84 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 110.133 -0.321 . . . . 64.209999999999994 110.133 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.8 p -133.61 145.87 50.42 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 116.138 -0.483 . . . . 61.329999999999998 111.114 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -137.97 129.58 28.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.572 -0.899 . . . . 65.439999999999998 108.572 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 53.1 tt0 -92.39 134.93 34.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.214 -0.662 . . . . 53.25 109.214 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -60.19 139.92 57.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.433 0.635 . . . . 72.25 111.971 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -95.88 169.65 9.85 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.255 -0.884 . . . . 71.420000000000002 109.757 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.54 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.2 pm0 -75.09 122.67 23.93 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 123.536 0.735 . . . . 73.239999999999995 110.758 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.52 -164.93 12.02 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.461 -1.056 . . . . 75.310000000000002 110.461 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.7 t -107.65 142.85 36.97 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 117.116 0.458 . . . . 54.119999999999997 111.433 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.415 ' ND2' ' HB ' ' A' ' 52' ' ' ILE . 7.2 p30 -117.89 117.75 30.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.532 0.682 . . . . 74.349999999999994 109.57 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -91.69 112.3 25.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.99 -1.005 . . . . 50.119999999999997 108.559 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.9 mt -90.3 128.1 42.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 123.914 0.759 . . . . 72.25 110.009 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.44 175.15 34.11 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.62 -0.992 . . . . 74.0 110.62 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 48.9 mtm180 -109.22 106.69 16.65 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.809 -0.811 . . . . 74.420000000000002 108.809 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.01 173.2 42.35 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 109.424 -1.47 . . . . 44.43 109.424 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -81.72 -16.53 50.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.144 0.497 . . . . 64.439999999999998 110.461 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.46 6.3 49.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.051 0.929 . . . . 64.120000000000005 109.739 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.79 161.46 13.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.107 -0.951 . . . . 65.329999999999998 110.07 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -109.42 -50.27 3.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.542 0.687 . . . . 75.400000000000006 109.595 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 54.2 t80 -106.51 123.85 48.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.2 -1.407 . . . . 75.549999999999997 107.2 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 51.0 mtt180 -111.3 133.34 53.7 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 120.867 -0.333 . . . . 75.299999999999997 110.599 -174.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.63 149.28 71.1 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.534 . . . . 74.310000000000002 110.484 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 -0.09 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.534 2.156 . . . . 72.349999999999994 114.123 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.19 -173.5 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.245 -0.982 . . . . 63.310000000000002 112.085 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 44' ' ' GLY . 7.1 m -96.31 174.35 6.92 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.33 1.052 . . . . 72.239999999999995 108.549 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 43' ' ' THR . . . 103.89 -21.05 39.41 Favored Glycine 0 CA--C 1.498 -0.996 0 N-CA-C 109.572 -1.411 . . . . 73.109999999999999 109.572 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.12 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.417 -1.392 . . . . 65.420000000000002 108.864 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -88.63 -173.51 4.17 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.451 -0.574 . . . . 53.32 109.451 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 21.1 ptt180 -72.39 -42.73 64.86 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.216 -1.031 . . . . 65.349999999999994 108.216 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.457 HH21 HD21 ' A' ' 64' ' ' LEU . 11.0 mtp180 -120.78 101.84 7.99 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.786 -1.931 . . . . 75.120000000000005 105.786 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -98.97 -43.93 6.52 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.855 -0.424 . . . . 74.120000000000005 109.855 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -159.49 151.17 20.31 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.442 -0.577 . . . . 73.430000000000007 109.442 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -126.78 127.37 44.93 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.351 0.596 . . . . 75.530000000000001 110.744 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' HB ' ' ND2' ' A' ' 28' ' ' ASN . 70.8 mt -100.43 117.1 45.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.408 -1.33 . . . . 71.230000000000004 107.408 174.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 12.7 ttm180 -105.91 110.05 22.21 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.401 -0.592 . . . . 73.140000000000001 109.401 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -104.89 132.43 51.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.489 -0.778 . . . . 74.310000000000002 110.374 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.73 166.88 23.63 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.123 -2.177 . . . . 73.120000000000005 105.123 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.02 65.24 1.91 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 118.377 0.535 . . . . 33.5 113.13 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -159.16 -78.03 0.07 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.42 -0.956 . . . . 75.019999999999996 108.42 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 m -142.27 159.97 19.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.818 -0.808 . . . . 74.219999999999999 108.818 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.26 114.01 26.42 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.461 -0.57 . . . . 62.299999999999997 109.461 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 69.0 tp -83.71 108.35 16.71 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.912 -1.04 . . . . 63.43 109.867 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.5 tm? -93.92 110.83 22.48 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.324 -1.362 . . . . 62.140000000000001 107.324 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.33 119.0 29.82 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.629 -0.508 . . . . 64.319999999999993 109.629 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -95.18 141.18 29.09 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.907 -0.588 . . . . 43.0 111.445 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.457 HD21 HH21 ' A' ' 48' ' ' ARG . 3.6 mm? -102.15 102.07 12.47 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 122.863 0.465 . . . . 74.530000000000001 110.871 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 67.62 85.14 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.458 1.103 . . . . 61.520000000000003 111.628 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.0 m -65.16 -14.73 61.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.223 1.194 . . . . 74.319999999999993 114.223 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -55.17 -38.27 68.09 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.96 0.886 . . . . 74.430000000000007 110.429 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -121.87 0.52 9.76 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.144 -1.058 . . . . 71.439999999999998 108.144 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 -137.27 1.41 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.026 -1.443 . . . . 74.239999999999995 115.78 -170.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -114.18 152.8 30.65 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-O 122.068 0.937 . . . . 74.420000000000002 113.106 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -121.8 141.21 51.45 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.795 -1.093 . . . . 63.109999999999999 110.448 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 88' ' ' ILE . 29.6 m -110.79 124.77 67.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.488 -2.041 . . . . 64.209999999999994 105.488 174.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 62.21 24.13 14.34 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.477 0.711 . . . . 62.240000000000002 109.211 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 71.25 20.77 4.94 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.216 1.407 . . . . 74.239999999999995 110.668 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.63 130.49 24.77 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.981 -0.748 . . . . 65.150000000000006 108.981 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.33 137.39 30.9 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 122.709 2.273 . . . . 63.420000000000002 112.761 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 80' ' ' TRP . 22.4 m -143.56 161.22 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.435 -0.58 . . . . 51.329999999999998 109.435 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -85.65 -45.46 11.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.923 -0.769 . . . . 73.140000000000001 108.923 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 12.3 pt-20 -145.33 151.72 38.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.971 -1.013 . . . . 71.299999999999997 108.736 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.459 ' HB2' HG21 ' A' ' 77' ' ' VAL . 64.6 t-105 -151.94 148.87 28.28 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.141 -1.059 . . . . 64.109999999999999 108.141 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.45 108.04 19.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.731 -1.211 . . . . 72.310000000000002 107.731 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 81.8 mt -57.06 148.26 22.17 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.434 -0.803 . . . . 51.030000000000001 111.702 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -147.34 164.04 34.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.796 -1.187 . . . . 55.340000000000003 107.796 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.35 119.81 9.81 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.702 0.626 . . . . 75.340000000000003 111.867 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.34 16.27 35.32 Favored Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 115.525 -0.761 . . . . 64.420000000000002 113.034 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.07 146.75 23.48 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 119.212 -0.995 . . . . 61.439999999999998 108.615 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.04 112.91 42.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.11 -0.7 . . . . 62.200000000000003 109.11 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.83 119.69 55.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.414 -0.958 . . . . 70.219999999999999 108.414 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -121.9 116.96 25.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 119.493 -0.883 . . . . 74.129999999999995 111.343 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -116.54 164.97 13.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.536 -1.211 . . . . 74.329999999999998 108.547 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -39.2 107.91 0.08 OUTLIER Glycine 0 N--CA 1.479 1.55 0 O-C-N 123.964 0.79 . . . . 62.32 114.443 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 69.5 -4.03 1.47 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.304 1.442 . . . . 72.319999999999993 114.864 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 m -129.42 112.96 14.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.354 0.597 . . . . 73.329999999999998 111.345 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.73 132.68 49.77 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.775 -1.194 . . . . 75.340000000000003 107.775 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.1 tp -134.69 140.41 45.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.861 -0.422 . . . . 70.109999999999999 109.861 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.17 128.6 56.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.785 -1.191 . . . . 73.219999999999999 107.785 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.95 116.51 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.177 0.513 . . . . 62.030000000000001 110.774 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -110.77 129.31 55.88 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.608 -0.724 . . . . 75.25 109.336 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 86.4 mtp -111.62 108.54 18.05 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.777 -1.194 . . . . 63.229999999999997 107.777 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 C--N 1.27 -2.883 0 CA-C-N 114.756 -1.111 . . . . 74.420000000000002 108.463 -176.297 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m . . . . . 0 N--CA 1.418 -2.048 0 N-CA-C 108.302 -0.999 . . . . 74.140000000000001 108.302 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -118.99 115.49 24.45 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.851 -1.166 . . . . 63.140000000000001 107.851 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 23' ' ' LEU . 6.2 p -93.63 127.76 45.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.022 0 CA-C-O 121.503 0.668 . . . . 74.200000000000003 109.211 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.4 m -125.64 131.73 52.59 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.409 -0.814 . . . . 55.240000000000002 109.142 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.65 133.07 36.35 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.346 -0.613 . . . . 73.239999999999995 109.346 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -105.2 109.21 21.11 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.068 -1.827 . . . . 55.200000000000003 106.068 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.21 122.21 44.27 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.078 -0.51 . . . . 63.439999999999998 110.502 -175.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.59 99.33 12.38 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.358 -2.089 . . . . 64.420000000000002 105.358 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -121.31 -6.77 9.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.16 -0.927 . . . . 74.400000000000006 110.778 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.17 -15.8 12.01 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 109.913 -1.275 . . . . 62.100000000000001 109.913 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 m -111.61 -44.24 3.53 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.969 -0.752 . . . . 62.329999999999998 108.969 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.59 67.67 1.19 Allowed Glycine 0 CA--C 1.48 -2.141 0 N-CA-C 107.848 -2.101 . . . . 61.530000000000001 107.848 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -91.92 154.08 19.07 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.015 -0.592 . . . . 61.299999999999997 110.479 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 45.6 p -130.17 131.95 45.84 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.025 -1.102 . . . . 54.240000000000002 108.025 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -134.84 125.64 27.22 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.586 -0.524 . . . . 73.530000000000001 109.586 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.81 121.84 26.95 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.946 -0.761 . . . . 75.439999999999998 108.946 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.546 ' HB2' HG13 ' A' ' 9' ' ' VAL . 80.0 mt -66.12 139.25 58.14 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.161 -0.927 . . . . 65.239999999999995 111.923 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.58 153.46 21.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.482 -1.673 . . . . 72.129999999999995 106.482 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.24 133.88 48.49 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 73.140000000000001 111.598 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.4 -166.6 13.26 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 107.522 -2.231 . . . . 72.510000000000005 107.522 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 61.1 p -106.45 128.96 54.47 Favored 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.432 -1.307 . . . . 70.219999999999999 111.19 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -96.99 111.87 23.89 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.55 -1.278 . . . . 74.219999999999999 107.55 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mm -85.8 123.81 39.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.98 -0.555 . . . . 73.319999999999993 110.342 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.4 mt -109.52 138.19 38.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.849 -0.614 . . . . 54.310000000000002 109.606 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 152.4 -162.51 29.92 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.952 -0.859 . . . . 61.020000000000003 110.952 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.638 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.4 mtt180 -121.52 105.88 10.87 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 117.663 0.732 . . . . 62.450000000000003 109.373 176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.49 47.74 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 120.061 -1.066 . . . . 75.140000000000001 111.318 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -75.73 -23.73 56.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.764 0.792 . . . . 64.230000000000004 109.088 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.38 -18.87 44.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.759 -1.109 . . . . 71.129999999999995 110.498 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.18 136.25 36.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.895 -0.593 . . . . 74.239999999999995 111.833 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.73 -24.05 16.14 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.575 -0.898 . . . . 24.239999999999998 108.575 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -133.29 120.0 20.5 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.617 -1.174 . . . . 71.109999999999999 108.594 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 79.6 mtt180 -97.82 130.57 44.74 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.14 0.495 . . . . 72.540000000000006 111.321 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD12 HG11 ' A' ' 45' ' ' VAL . 82.2 mt -77.6 144.83 70.22 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.473 -0.785 . . . . 61.32 111.057 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 9.22 2.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.963 2.442 . . . . 63.039999999999999 113.448 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -123.42 163.64 20.45 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.503 -1.295 . . . . 72.230000000000004 107.503 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 44' ' ' GLY . 11.7 m -110.23 172.11 7.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.82 -0.807 . . . . 75.340000000000003 108.82 -176.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.406 ' H ' HG22 ' A' ' 43' ' ' THR . . . 94.19 5.27 62.33 Favored Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 109.472 -1.451 . . . . 52.409999999999997 109.472 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 40' ' ' LEU . 43.9 t -100.36 145.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.036 -1.082 . . . . 53.130000000000003 108.306 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -79.07 173.43 12.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.197 0.199 . . . . 41.140000000000001 110.627 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.5 ptp180 -65.15 -31.06 72.05 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.653 0.739 . . . . 72.140000000000001 110.566 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 64' ' ' LEU . 25.3 mtm-85 -134.08 109.59 9.05 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.728 -2.323 . . . . 72.310000000000002 104.728 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -104.56 -35.82 7.72 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 123.807 0.692 . . . . 71.109999999999999 110.247 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -162.86 149.57 12.8 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.689 -0.486 . . . . 62.130000000000003 109.689 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.25 122.53 37.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.451 0.643 . . . . 63.530000000000001 109.964 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.9 mt -96.29 104.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.783 -1.562 . . . . 63.310000000000002 106.783 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 63.8 ttt180 -91.84 107.29 19.11 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.777 0.799 . . . . 62.109999999999999 109.802 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -94.86 106.95 18.96 Favored 'General case' 0 N--CA 1.391 -3.395 0 N-CA-C 107.384 -1.339 . . . . 75.030000000000001 107.384 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -106.3 -175.36 2.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.671 -1.603 . . . . 63.219999999999999 106.671 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.02 57.26 4.32 Favored Glycine 0 C--N 1.285 -2.261 0 C-N-CA 119.493 -1.337 . . . . 42.509999999999998 115.445 -171.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -179.3 -65.59 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.602 0.761 . . . . 70.519999999999996 109.666 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.46 156.56 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.269 -0.423 . . . . 61.509999999999998 109.998 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.35 109.8 22.49 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.161 -1.051 . . . . 51.310000000000002 108.161 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.39 122.52 31.99 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.979 -1.01 . . . . 75.450000000000003 110.505 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -103.27 125.51 49.95 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.678 -1.23 . . . . 73.530000000000001 107.678 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.07 124.65 26.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.995 -0.372 . . . . 73.450000000000003 109.995 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.53 137.87 32.17 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.495 -0.775 . . . . 74.519999999999996 109.183 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 48' ' ' ARG . 27.9 tp -133.89 75.97 1.63 Allowed 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.688 0.756 . . . . 31.41 109.121 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 38.5 t-20 -173.07 142.52 1.06 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.897 -1.52 . . . . 71.519999999999996 106.897 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -95.69 -47.68 6.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.89 -0.724 . . . . 61.43 110.834 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.459 HG23 ' ND2' ' A' ' 68' ' ' ASN . 12.2 t -88.92 -12.43 41.69 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.327 0.584 . . . . 60.439999999999998 112.302 -174.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.56 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 36.5 m-80 -121.43 27.55 8.23 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.778 -0.576 . . . . 52.25 111.07 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.38 113.95 0.79 Allowed Glycine 0 N--CA 1.481 1.676 0 O-C-N 124.403 1.064 . . . . 72.439999999999998 113.777 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 90' ' ' LEU . 24.7 m -63.82 146.71 53.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.013 1.325 . . . . 65.430000000000007 112.57 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -109.73 140.74 43.25 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 115.183 -0.917 . . . . 63.299999999999997 112.467 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 27.5 m -118.88 122.03 68.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 105.832 -1.914 . . . . 75.310000000000002 105.832 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 62.69 25.38 15.08 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.042 -0.725 . . . . 74.430000000000007 109.042 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.7 t30 79.58 4.86 2.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.215 1.406 . . . . 75.319999999999993 111.745 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.0 34.15 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 121.545 -0.722 . . . . 71.420000000000002 109.933 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.74 130.98 15.29 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.277 1.985 . . . . 73.540000000000006 111.596 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.9 m -135.4 159.07 40.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.255 -0.43 . . . . 54.109999999999999 110.645 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -82.11 -38.74 24.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.993 -0.743 . . . . 73.230000000000004 108.993 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.1 155.54 36.98 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.577 -0.897 . . . . 75.109999999999999 108.577 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.535 ' HB2' HG21 ' A' ' 77' ' ' VAL . 54.0 t-105 -159.98 149.1 17.6 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.309 -0.997 . . . . 73.239999999999995 108.309 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -100.8 115.17 29.69 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.045 -1.062 . . . . 72.150000000000006 108.642 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.552 HD22 HD11 ' A' ' 88' ' ' ILE . 62.3 mt -61.91 147.9 45.27 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.568 -1.196 . . . . 72.530000000000001 111.415 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.86 168.01 19.84 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.891 -1.522 . . . . 52.100000000000001 106.891 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 121.3 16.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.551 -0.537 . . . . 72.349999999999994 109.551 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.1 44.18 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 115.6 -0.727 . . . . 71.120000000000005 112.398 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.1 152.86 25.14 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 107.405 -1.331 . . . . 53.25 107.405 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 39.1 t -114.16 112.87 42.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.081 -0.34 . . . . 71.299999999999997 110.081 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.552 HD11 HD22 ' A' ' 82' ' ' LEU . 1.6 mp -107.44 114.14 45.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.558 -1.275 . . . . 72.409999999999997 107.558 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.572 ' HG3' ' HB3' ' A' ' 94' ' ' GLU . 15.5 ttt180 -123.43 127.6 48.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 120.275 -0.57 . . . . 65.099999999999994 110.361 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.0 OUTLIER -140.37 163.34 33.04 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.696 -1.594 . . . . 71.120000000000005 106.696 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -45.46 119.38 3.5 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.59 0.556 . . . . 62.350000000000001 114.003 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 29.0 t60 78.75 -33.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.134 1.374 . . . . 74.299999999999997 113.181 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.1 m -114.2 116.77 29.58 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.416 0.627 . . . . 64.129999999999995 111.56 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.572 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 11.5 pt-20 -116.9 121.71 42.24 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.828 -0.805 . . . . 75.219999999999999 108.828 173.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.435 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -126.49 136.83 59.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.881 -1.054 . . . . 71.200000000000003 111.94 -170.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -105.55 127.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.098 -1.075 . . . . 70.140000000000001 108.098 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 82' ' ' LEU . 55.5 t -86.99 125.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 116.412 -0.358 . . . . 75.329999999999998 110.969 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -115.68 149.52 38.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.718 -0.475 . . . . 73.200000000000003 109.718 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.3 mtt -130.26 116.92 19.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.456 0.646 . . . . 73.409999999999997 110.323 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.08 -1.081 . . . . 71.319999999999993 108.08 -178.846 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.432 -1.368 0 CA-C-O 121.116 0.484 . . . . 70.439999999999998 110.682 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -111.15 116.87 31.82 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.542 -1.281 . . . . 74.319999999999993 107.542 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.418 HG22 ' HG2' ' A' ' 99' ' ' MET . 25.0 t -99.81 132.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.555 -0.535 . . . . 53.409999999999997 109.555 -175.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.1 m -135.66 127.64 29.59 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.912 -0.773 . . . . 51.409999999999997 108.912 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 95' ' ' ILE . 4.3 pp -95.84 139.96 31.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.821 -0.437 . . . . 75.510000000000005 109.821 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -112.05 106.32 14.93 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.115 -0.698 . . . . 65.230000000000004 109.115 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.07 126.42 50.24 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.404 -0.962 . . . . 70.209999999999994 108.404 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -94.25 100.87 12.85 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 117.752 -1.579 . . . . 74.319999999999993 110.479 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.61 -0.11 57.55 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.495 -1.23 . . . . 74.430000000000007 109.016 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 42.69 0.96 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.566 -1.814 . . . . 64.409999999999997 108.566 -173.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.4 t -177.59 -24.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.865 -0.668 . . . . 74.5 111.289 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.1 71.29 1.05 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.463 -0.875 . . . . 44.119999999999997 110.951 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -88.72 153.47 21.07 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 122.824 0.45 . . . . 72.329999999999998 110.228 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.8 p -129.75 132.63 46.63 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.461 0.648 . . . . 74.519999999999996 111.989 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -125.62 127.23 46.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.394 -0.965 . . . . 74.340000000000003 108.394 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.563 -0.532 . . . . 72.219999999999999 109.563 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.2 mt -81.03 122.19 26.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.881 -0.785 . . . . 74.019999999999996 108.881 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -91.67 156.18 17.78 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.0 -0.68 . . . . 75.310000000000002 109.314 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.17 132.71 51.19 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.621 1.201 . . . . 73.230000000000004 111.302 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.41 -162.5 12.47 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 107.279 -2.329 . . . . 71.25 107.279 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.5 p -106.21 131.57 53.29 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 118.618 -1.233 . . . . 74.430000000000007 111.164 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.67 111.52 23.85 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.493 -1.299 . . . . 73.310000000000002 107.493 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.9 mm -85.69 121.9 37.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.098 -0.704 . . . . 75.129999999999995 109.098 -176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 38' ' ' PHE . 71.0 mt -112.57 132.83 60.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.605 -0.725 . . . . 75.25 109.704 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 145.53 -161.24 28.2 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 109.807 -1.317 . . . . 40.020000000000003 109.807 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.733 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 84.1 mtt180 -121.55 106.53 11.47 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.908 -0.775 . . . . 55.409999999999997 108.908 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.83 179.0 43.79 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.541 -1.024 . . . . 75.400000000000006 110.541 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -64.41 -46.45 83.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.865 0.691 . . . . 63.030000000000001 112.865 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.22 1.95 55.96 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.163 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 124.12 23.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.551 -0.907 . . . . 43.509999999999998 108.551 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -89.38 -38.04 14.41 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.672 0.749 . . . . 75.319999999999993 109.588 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HD2' HG23 ' A' ' 30' ' ' ILE . 86.1 t80 -117.61 112.17 20.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.191 -0.913 . . . . 75.0 109.051 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -89.41 133.54 34.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.488 -0.778 . . . . 62.109999999999999 111.174 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 90' ' ' LEU . 85.5 mt -89.67 140.22 28.05 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 115.458 -0.792 . . . . 61.100000000000001 111.628 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.95 -23.0 30.45 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.11 2.54 . . . . 74.549999999999997 112.018 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -72.01 164.67 25.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.788 -0.642 . . . . 64.140000000000001 109.518 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -129.71 149.38 51.48 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 108.446 -0.946 . . . . 74.430000000000007 108.446 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.28 48.2 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 107.553 -2.219 . . . . 41.109999999999999 107.553 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -88.28 143.14 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 112.695 -1.753 . . . . 74.349999999999994 108.743 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 m -78.01 169.48 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 19.2 ptt180 -65.39 -37.27 86.49 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.865 0.84 . . . . 75.329999999999998 109.115 172.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB3' HD12 ' A' ' 64' ' ' LEU . 98.9 mtt180 -123.69 100.41 6.77 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 105.098 -2.186 . . . . 74.519999999999996 105.098 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -95.07 -32.44 13.11 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.904 -0.776 . . . . 54.539999999999999 108.904 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD11 HD21 ' A' ' 61' ' ' LEU . 8.3 tt -167.57 143.17 3.99 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.59 -0.732 . . . . 74.129999999999995 109.222 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -124.47 126.12 45.38 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.941 -0.572 . . . . 74.129999999999995 110.337 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.14 112.9 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.519 -0.919 . . . . 64.420000000000002 108.519 175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 73.5 ttt180 -90.79 110.13 21.33 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.563 -0.903 . . . . 61.310000000000002 108.563 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -99.86 110.54 22.89 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 114.986 -1.006 . . . . 71.099999999999994 108.755 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -116.41 174.42 6.07 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.357 -2.09 . . . . 64.150000000000006 105.357 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.98 32.39 2.73 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 120.272 -0.966 . . . . 74.140000000000001 112.908 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -134.83 -65.59 0.62 Allowed 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.414 0.685 . . . . 73.239999999999995 109.315 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.04 159.51 26.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 115.886 -0.597 . . . . 53.240000000000002 109.7 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 109.97 21.76 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.662 -0.866 . . . . 71.329999999999998 108.662 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.65 119.54 30.15 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.131 -1.395 . . . . 54.240000000000002 112.935 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -100.94 108.41 20.15 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 113.311 -1.768 . . . . 73.140000000000001 108.08 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.0 115.76 25.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.884 -0.413 . . . . 71.439999999999998 109.884 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.45 134.85 34.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.812 -0.631 . . . . 75.430000000000007 110.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 48' ' ' ARG . 21.7 mt -126.35 75.97 1.58 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.508 -0.923 . . . . 62.32 108.508 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -170.3 122.63 0.66 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 121.107 0.479 . . . . 70.439999999999998 110.124 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.3 m -93.38 -14.22 27.11 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.891 -0.506 . . . . 71.349999999999994 111.269 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -89.14 -56.45 3.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.859 0.838 . . . . 71.109999999999999 110.706 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -119.71 29.55 7.52 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.157 -0.929 . . . . 75.329999999999998 109.423 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.4 130.98 5.96 Favored Glycine 0 C--O 1.251 1.184 0 CA-C-N 114.238 -1.346 . . . . 73.239999999999995 113.486 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -66.93 143.43 56.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 125.66 1.584 . . . . 52.530000000000001 113.168 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 p -107.95 141.72 39.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.591 -1.186 . . . . 75.400000000000006 110.275 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 80' ' ' TRP . 31.4 m -120.76 120.64 63.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.844 -1.539 . . . . 70.200000000000003 106.844 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 61.64 25.96 15.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.463 0.649 . . . . 60.340000000000003 109.621 -175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.8 t30 78.15 3.15 2.8 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.46 1.904 . . . . 75.319999999999993 111.358 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.73 124.02 51.85 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.371 -0.603 . . . . 74.430000000000007 109.371 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.14 125.94 11.92 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.248 1.966 . . . . 61.539999999999999 111.155 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.91 166.58 25.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 116.476 -0.329 . . . . 62.130000000000003 110.164 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.476 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 25.1 pt20 -100.67 -26.8 13.68 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.254 -0.646 . . . . 62.219999999999999 109.254 174.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.476 ' HG2' ' HG3' ' A' ' 78' ' ' GLN . 10.6 pt-20 -158.52 148.96 20.05 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.785 -0.643 . . . . 72.140000000000001 109.814 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.472 ' CD2' HG21 ' A' ' 72' ' ' VAL . 53.7 t-105 -163.84 152.93 14.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.302 -0.999 . . . . 72.549999999999997 108.302 -172.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -105.67 121.31 43.73 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.321 -0.952 . . . . 73.549999999999997 109.07 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.62 151.09 47.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.205 -0.907 . . . . 70.25 113.106 -174.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.49 165.75 25.52 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.14 -1.43 . . . . 64.299999999999997 107.14 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 19.4 t70 -69.12 121.25 16.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.933 0.396 . . . . 60.329999999999998 109.969 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.34 8.2 53.29 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.708 -0.678 . . . . 74.109999999999999 111.693 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.12 134.02 36.13 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 107.566 -1.272 . . . . 72.409999999999997 107.566 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -98.93 112.81 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.341 -0.614 . . . . 65.209999999999994 109.341 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.441 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.09 129.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 106.958 -1.497 . . . . 73.540000000000006 106.958 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -138.24 149.29 45.61 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.814 -0.754 . . . . 74.310000000000002 110.969 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.472 ' CD1' HD13 ' A' ' 40' ' ' LEU . 2.0 pt? -138.32 165.55 26.46 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.852 -2.277 . . . . 75.530000000000001 104.852 172.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -34.84 102.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.833 0 N-CA-C 115.98 1.152 . . . . 31.420000000000002 115.98 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 60.85 17.96 8.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.4 1.08 . . . . 64.109999999999999 113.908 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -131.6 114.01 14.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.819 -0.808 . . . . 72.409999999999997 108.819 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.06 139.8 49.92 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.586 0.708 . . . . 75.439999999999998 112.013 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -135.51 137.11 50.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.71 -1.132 . . . . 74.329999999999998 110.392 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.78 126.04 65.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.827 -0.805 . . . . 62.140000000000001 108.827 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.0 t -85.07 126.36 40.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.674 -0.239 . . . . 70.340000000000003 110.693 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -115.31 145.05 42.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.572 -0.529 . . . . 74.120000000000005 109.572 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.418 ' HG2' HG22 ' A' ' 9' ' ' VAL . 56.0 mtt -130.37 127.49 39.49 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.693 -0.685 . . . . 74.129999999999995 109.598 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 107.173 -1.417 . . . . 74.239999999999995 107.173 178.311 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.204 0.526 . . . . 61.5 111.329 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -116.52 134.74 54.5 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.722 -1.214 . . . . 63.32 107.722 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.4 p -101.37 114.81 41.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.435 -0.95 . . . . 72.340000000000003 108.435 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.5 m -124.43 136.05 53.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 114.663 -1.153 . . . . 71.209999999999994 110.667 -169.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 20' ' ' THR . 57.7 mt -89.23 126.37 35.47 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.476 -1.238 . . . . 61.109999999999999 109.402 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -106.61 114.51 28.65 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.709 -1.219 . . . . 74.409999999999997 107.709 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 62.8 tp -118.07 110.99 18.31 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.671 -0.863 . . . . 63.43 108.671 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.06 100.26 12.41 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 117.764 -1.575 . . . . 65.319999999999993 109.629 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.6 30.43 3.61 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 106.382 -1.71 . . . . 72.530000000000001 106.382 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.5 47.08 17.18 Favored Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.177 -1.969 . . . . 63.130000000000003 108.177 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -162.81 -29.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.154 0.582 . . . . 72.129999999999995 111.785 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.91 3.46 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.692 -0.963 . . . . 62.009999999999998 110.692 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -87.95 148.21 24.68 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 110.062 -0.347 . . . . 73.239999999999995 110.062 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 22.9 p -135.45 132.24 37.18 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.076 0.465 . . . . 54.299999999999997 111.789 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -128.25 126.21 40.45 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.218 -1.401 . . . . 74.219999999999999 107.218 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -94.87 141.08 29.06 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.432 -0.507 . . . . 73.099999999999994 110.305 -175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.445 ' HB2' HG13 ' A' ' 9' ' ' VAL . 95.6 mt -80.48 140.82 35.72 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.605 -0.517 . . . . 71.019999999999996 109.605 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -96.61 169.06 10.15 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.387 -0.525 . . . . 65.340000000000003 110.274 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -74.62 112.99 11.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.265 0.978 . . . . 73.319999999999993 110.43 -178.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.38 -159.65 23.19 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.124 -1.991 . . . . 62.299999999999997 108.124 -174.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.6 p -101.27 131.44 47.29 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.139 -1.024 . . . . 51.409999999999997 110.646 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.446 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 24.6 m-80 -106.67 112.33 25.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 74.099999999999994 107.774 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -96.95 126.1 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.401 -0.222 . . . . 74.129999999999995 110.401 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.06 142.97 31.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 C-N-CA 123.545 0.738 . . . . 64.040000000000006 109.837 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 153.49 -154.0 25.21 Favored Glycine 0 CA--C 1.475 -2.453 0 N-CA-C 110.683 -0.967 . . . . 45.140000000000001 110.683 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 16.7 mmm180 -131.73 104.83 7.12 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.256 0.55 . . . . 72.239999999999995 109.789 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 169.97 37.63 Favored Glycine 0 N--CA 1.41 -3.06 0 N-CA-C 108.99 -1.644 . . . . 71.450000000000003 108.99 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.16 -14.22 60.53 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.693 0.759 . . . . 74.010000000000005 109.701 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.19 -10.01 40.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.355 -0.838 . . . . 73.299999999999997 110.704 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -90.59 149.2 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.363 -0.606 . . . . 73.439999999999998 109.363 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 86.8 mt-30 -87.25 -49.28 7.37 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.742 -0.836 . . . . 75.510000000000005 108.742 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -105.44 111.42 24.13 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.397 -0.82 . . . . 73.349999999999994 109.069 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -91.16 122.55 33.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.477 -0.783 . . . . 63.240000000000002 110.725 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.4 HD12 HG11 ' A' ' 45' ' ' VAL . 79.9 mt -65.63 158.4 74.36 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.147 -0.933 . . . . 74.219999999999999 112.033 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.78 26.68 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.533 2.822 . . . . 73.450000000000003 112.161 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.72 153.38 47.19 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.181 -1.415 . . . . 73.510000000000005 107.181 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -121.39 161.32 22.34 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 120.235 -0.586 . . . . 73.329999999999998 109.625 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.56 -15.47 24.51 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 108.502 -1.839 . . . . 63.350000000000001 108.502 -172.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 40' ' ' LEU . 51.9 t -76.93 149.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 125.449 1.5 . . . . 72.319999999999993 108.894 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.0 m -75.67 163.39 27.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 119.597 -0.24 . . . . 75.230000000000004 110.901 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 44.6 ptt85 -60.28 -41.39 93.21 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 120.94 0.4 . . . . 73.129999999999995 110.681 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -121.53 107.07 11.99 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 106.323 -1.732 . . . . 74.219999999999999 106.323 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -103.21 -34.04 8.97 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.654 -1.157 . . . . 75.129999999999995 108.945 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.51 HD11 HD21 ' A' ' 61' ' ' LEU . 7.9 tt -166.39 148.51 6.72 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 115.669 -0.696 . . . . 72.510000000000005 109.134 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HG2' HD21 ' A' ' 64' ' ' LEU . 12.6 pt-20 -137.32 144.45 42.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.856 -0.794 . . . . 71.349999999999994 108.856 175.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.4 mt -117.2 119.13 60.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 109.555 -0.535 . . . . 74.329999999999998 109.555 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -91.17 107.72 19.39 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.599 -1.259 . . . . 75.109999999999999 107.599 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -105.44 118.71 37.26 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.714 -0.675 . . . . 71.230000000000004 109.366 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.45 -178.84 4.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.564 -2.384 . . . . 64.400000000000006 104.564 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.3 53.42 4.78 Favored Glycine 0 C--N 1.297 -1.601 0 C-N-CA 119.856 -1.164 . . . . 31.399999999999999 112.721 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -147.74 -77.45 0.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.487 0.715 . . . . 73.349999999999994 109.333 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.61 159.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.043 -0.725 . . . . 42.25 109.043 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.93 107.84 19.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.111 -1.07 . . . . 54.32 108.111 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.88 113.27 20.38 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.377 -0.828 . . . . 70.109999999999999 108.828 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -90.29 119.59 30.72 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 124.805 1.242 . . . . 62.32 108.347 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.14 119.72 28.28 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.535 -0.543 . . . . 43.149999999999999 109.535 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 131.58 42.35 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.844 -0.617 . . . . 74.219999999999999 111.148 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.5 mm? -118.68 76.72 1.11 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.057 -0.719 . . . . 63.43 109.057 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 38.1 t-20 -176.43 139.9 0.35 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.527 -0.916 . . . . 54.32 108.527 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -108.25 -50.23 3.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.928 -0.397 . . . . 53.210000000000001 109.928 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -59.1 -49.03 79.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.65 0.738 . . . . 72.510000000000005 111.549 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -121.38 28.14 7.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.695 0.76 . . . . 54.140000000000001 109.28 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 65' ' ' ASN . . . -49.95 144.65 9.7 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 113.83 -1.532 . . . . 74.030000000000001 115.182 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.8 m -75.65 143.13 42.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.492 1.117 . . . . 42.109999999999999 112.063 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.9 p -110.91 148.83 31.61 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.813 -0.631 . . . . 74.409999999999997 111.043 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG12 HG13 ' A' ' 88' ' ' ILE . 34.1 m -114.87 118.38 58.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.663 -1.236 . . . . 65.140000000000001 107.663 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.4 29.84 19.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.569 0.7 . . . . 72.329999999999998 110.415 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 77.62 13.26 1.86 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.198 1.799 . . . . 70.200000000000003 111.242 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.97 128.14 25.9 Favored Pre-proline 0 C--N 1.32 -0.706 0 O-C-N 121.859 -0.526 . . . . 73.299999999999997 109.598 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.19 125.74 11.69 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.689 2.259 . . . . 62.409999999999997 112.467 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.69 -177.2 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.125 -1.065 . . . . 72.349999999999994 108.125 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -125.39 -27.28 3.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.356 0.41 . . . . 64.439999999999998 110.784 175.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.76 134.47 28.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 45.329999999999998 109.727 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -149.13 152.15 35.61 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.917 -0.771 . . . . 73.540000000000006 108.917 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -101.7 107.52 18.77 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.468 -1.678 . . . . 71.219999999999999 106.468 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 82.9 mt -58.9 137.49 57.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.154 0.502 . . . . 61.229999999999997 112.054 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.01 163.47 24.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.859 -1.163 . . . . 42.020000000000003 107.859 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.91 117.93 8.31 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.426 -0.352 . . . . 64.420000000000002 110.204 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.48 -0.98 30.83 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.825 -0.702 . . . . 51.32 113.814 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -80.07 141.65 35.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.523 0.662 . . . . 73.329999999999998 111.305 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.22 113.77 39.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 N-CA-C 108.682 -0.859 . . . . 73.030000000000001 108.682 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.465 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -107.34 114.16 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.661 -0.866 . . . . 75.540000000000006 108.661 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 94' ' ' GLU . 37.3 ttt180 -106.57 109.42 21.33 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.031 -1.067 . . . . 72.140000000000001 112.04 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 90' ' ' LEU . 2.0 pt? -112.79 164.43 13.4 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.684 -1.599 . . . . 71.439999999999998 106.684 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -24.58 99.14 0.01 OUTLIER Glycine 0 N--CA 1.485 1.908 0 O-C-N 124.661 1.225 . . . . 73.219999999999999 116.092 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 t60 77.65 -28.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.79 1.636 . . . . 72.430000000000007 113.581 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 m -114.73 119.6 37.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 113.495 0.924 . . . . 73.430000000000007 113.495 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 6.8 pt-20 -94.16 115.11 27.35 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.661 -0.866 . . . . 64.030000000000001 108.661 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.0 tp -103.34 140.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.941 -1.027 . . . . 61.109999999999999 109.239 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 69.3 mt -101.68 121.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.063 -1.088 . . . . 64.319999999999993 108.063 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 82' ' ' LEU . 72.5 t -87.6 118.3 33.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.463 -0.335 . . . . 44.229999999999997 110.167 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -119.58 150.55 40.11 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 109.524 -0.547 . . . . 73.439999999999998 109.524 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mtt -117.25 120.41 38.15 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.347 -0.982 . . . . 64.340000000000003 108.347 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 . . . . . 0 C--N 1.273 -2.726 0 N-CA-C 107.633 -1.247 . . . . 70.030000000000001 107.633 -177.17 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.432 -1.369 0 N-CA-C 109.317 -0.623 . . . . 74.109999999999999 109.317 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -144.53 131.85 20.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.371 -0.603 . . . . 63.020000000000003 109.371 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.16 113.23 35.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.579 -1.267 . . . . 65.140000000000001 107.579 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 129.55 55.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.26 -0.882 . . . . 73.209999999999994 109.719 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' THR . 83.5 mt -87.56 123.54 32.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.202 -1.036 . . . . 74.129999999999995 108.202 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.72 120.72 41.79 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 116.145 -0.479 . . . . 61.119999999999997 109.746 -175.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.67 146.89 51.42 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 107.289 -1.374 . . . . 73.420000000000002 107.289 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -95.23 118.36 31.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.817 -1.153 . . . . 74.329999999999998 110.986 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' ' 19' ' ' ARG . 12.5 t70 -103.15 -6.18 22.46 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.08 -1.418 . . . . 73.310000000000002 109.273 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.81 31.85 2.02 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.829 -1.708 . . . . 70.030000000000001 108.829 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.5 t 171.37 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.781 -1.933 . . . . 71.239999999999995 105.781 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.5 100.58 1.25 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.167 -1.016 . . . . 71.310000000000002 113.011 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 15' ' ' ASP . 26.7 mtm-85 -86.21 158.68 19.68 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.81 -1.181 . . . . 73.209999999999994 107.81 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.7 p -139.61 138.43 36.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 116.053 -0.521 . . . . 72.129999999999995 110.191 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.0 118.4 30.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.121 -1.437 . . . . 72.25 107.121 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -92.82 132.22 37.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.469 -0.937 . . . . 52.009999999999998 108.469 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.06 122.05 25.06 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.04 -0.356 . . . . 43.310000000000002 110.04 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -85.84 166.89 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.928 -1.138 . . . . 73.219999999999999 107.928 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -67.61 123.29 20.06 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.263 -0.643 . . . . 73.239999999999995 109.263 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.37 -163.94 14.69 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 110.041 -1.224 . . . . 40.420000000000002 110.041 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.9 p -99.46 141.13 32.65 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 117.947 0.873 . . . . 71.129999999999995 111.565 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -122.71 115.59 22.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.891 -1.522 . . . . 61.240000000000002 106.891 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -97.15 133.61 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.544 -0.298 . . . . 72.519999999999996 111.396 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.429 HG12 ' HB3' ' A' ' 38' ' ' PHE . 67.9 mt -107.73 133.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.574 -0.899 . . . . 72.030000000000001 108.574 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.4 -161.21 31.98 Favored Glycine 0 CA--C 1.49 -1.478 0 N-CA-C 110.756 -0.938 . . . . 53.5 110.756 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.6 mtm180 -123.37 105.8 10.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.158 -1.053 . . . . 75.310000000000002 108.158 174.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.05 -176.29 48.01 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 109.21 -1.556 . . . . 74.540000000000006 109.21 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -88.18 -16.12 34.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.409 0.623 . . . . 62.409999999999997 109.438 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.921 0.867 . . . . 72.230000000000004 109.781 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.75 145.41 28.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.739 -0.664 . . . . 75.140000000000001 110.72 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -105.11 -12.36 16.16 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.895 0.855 . . . . 75.010000000000005 109.764 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.429 ' HB3' HG12 ' A' ' 30' ' ' ILE . 44.3 t80 -139.77 121.81 15.7 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.91 -1.885 . . . . 63.240000000000002 105.91 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.7 ttt180 -100.37 131.54 46.24 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.333 -0.394 . . . . 72.420000000000002 111.426 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 90' ' ' LEU . 61.2 mt -92.01 138.51 24.62 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.826 -0.625 . . . . 74.510000000000005 109.489 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -92.9 12.46 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 122.96 2.44 . . . . 74.439999999999998 111.691 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -93.31 -173.31 3.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.875 -0.602 . . . . 62.049999999999997 109.891 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -113.5 152.35 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.553 0.216 . . . . 72.430000000000007 111.139 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.74 86.92 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.237 0.354 . . . . 71.230000000000004 112.877 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 49' ' ' HIS . 48.8 t -88.51 114.51 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.438 -0.578 . . . . 72.319999999999993 109.438 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -64.22 176.69 0.97 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 124.186 0.994 . . . . 71.120000000000005 110.894 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 23.7 ptt85 -63.8 -34.75 78.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.63 0.729 . . . . 74.140000000000001 109.818 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -120.67 109.16 14.88 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.659 -1.238 . . . . 73.439999999999998 107.659 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 18.9 t60 -103.33 -31.76 9.89 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.479 -0.934 . . . . 62.149999999999999 108.479 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.449 HD11 HD21 ' A' ' 61' ' ' LEU . 8.4 tt -167.3 152.94 7.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.536 -0.913 . . . . 75.239999999999995 108.536 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -135.34 140.41 45.06 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.293 0.568 . . . . 75.200000000000003 109.923 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.0 mt -115.89 114.21 45.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.9 -0.778 . . . . 72.439999999999998 108.9 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 19.1 ttt180 -92.47 110.23 21.64 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.949 -0.759 . . . . 74.409999999999997 108.949 176.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -99.93 108.66 20.95 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.769 -0.65 . . . . 74.209999999999994 111.295 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -107.81 162.57 13.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.595 -1.632 . . . . 73.319999999999993 106.595 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.67 66.72 1.06 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.847 0.699 . . . . 72.230000000000004 114.847 -175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -169.22 -72.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.953 0.901 . . . . 73.319999999999993 108.978 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.57 159.15 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.51 -0.922 . . . . 70.400000000000006 108.51 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -99.83 120.81 40.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.416 0.627 . . . . 73.409999999999997 110.145 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 67.2 tp -80.93 125.46 30.15 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.868 -1.06 . . . . 72.439999999999998 109.882 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.449 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -111.62 120.55 42.45 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.315 -0.624 . . . . 52.399999999999999 109.315 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.98 124.53 40.95 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.407 -0.59 . . . . 75.519999999999996 109.407 176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.71 133.8 38.0 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.396 -0.366 . . . . 44.219999999999999 111.157 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.61 76.41 1.34 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.803 -0.443 . . . . 72.129999999999995 109.803 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -173.0 133.61 0.54 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.292 0.496 . . . . 64.0 109.748 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -98.75 -35.75 10.05 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.116 0.484 . . . . 60.020000000000003 111.271 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -87.93 -32.48 18.89 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.23 0.538 . . . . 52.030000000000001 112.151 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -122.56 28.66 7.25 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.07 -0.394 . . . . 74.129999999999995 110.334 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.05 133.17 6.54 Favored Glycine 0 C--O 1.246 0.902 0 O-C-N 124.949 1.405 . . . . 75.129999999999995 113.985 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 90' ' ' LEU . 22.1 m -74.11 136.68 42.96 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.906 0.882 . . . . 75.049999999999997 112.366 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 28.2 p -111.13 143.68 41.48 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.896 -0.593 . . . . 70.409999999999997 110.49 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 80' ' ' TRP . 35.0 m -111.9 121.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.687 -1.597 . . . . 74.430000000000007 106.687 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.13 23.41 13.61 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.504 0.721 . . . . 61.020000000000003 110.023 -169.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 75.66 9.31 3.58 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.054 1.342 . . . . 72.040000000000006 110.866 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.43 124.04 50.29 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.246 -0.65 . . . . 70.349999999999994 109.246 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.72 126.76 15.9 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.116 2.544 . . . . 35.329999999999998 113.038 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 159.87 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.386 -0.825 . . . . 53.32 109.013 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.34 -19.7 14.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.1 -0.704 . . . . 74.430000000000007 109.1 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.74 149.43 34.38 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.387 -0.824 . . . . 70.200000000000003 110.289 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.484 ' CD2' HG21 ' A' ' 72' ' ' VAL . 77.3 t-105 -159.76 152.83 21.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.194 -0.669 . . . . 65.299999999999997 109.194 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.16 114.95 29.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.58 -1.267 . . . . 72.239999999999995 107.58 174.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.485 HD22 HD11 ' A' ' 88' ' ' ILE . 32.8 mt -56.92 132.83 53.81 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 112.953 0.723 . . . . 74.409999999999997 112.953 -174.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.49 155.37 39.06 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.382 -1.34 . . . . 61.049999999999997 107.382 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.52 128.3 35.68 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 123.24 0.337 . . . . 62.149999999999999 111.169 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.04 55.41 Favored Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 115.757 -0.656 . . . . 62.43 112.487 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.13 136.76 34.33 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 108.705 -0.85 . . . . 74.219999999999999 108.705 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.65 111.61 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.456 -1.313 . . . . 74.129999999999995 107.456 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 82' ' ' LEU . 53.9 mt -107.67 118.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 CA-C-O 121.292 0.568 . . . . 72.439999999999998 109.554 -174.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 24.2 mtp180 -111.97 106.71 15.47 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.95 0.881 . . . . 72.040000000000006 110.439 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.613 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 0.5 OUTLIER -108.3 164.47 12.28 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.372 -1.286 . . . . 63.409999999999997 108.267 178.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -28.25 90.97 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 O-C-N 124.752 1.282 . . . . 61.109999999999999 115.837 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 60.68 11.78 3.32 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 125.86 1.664 . . . . 74.420000000000002 112.418 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 m -131.37 113.5 13.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.788 -0.819 . . . . 73.319999999999993 108.788 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -105.94 136.9 44.77 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.841 -0.744 . . . . 60.520000000000003 110.81 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 10.7 tp -129.72 146.31 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 108.741 -0.837 . . . . 71.140000000000001 108.741 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -111.97 133.24 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.622 -0.881 . . . . 74.5 108.622 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.0 t -90.9 114.54 28.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.901 -0.407 . . . . 65.310000000000002 109.901 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -114.49 122.44 46.58 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.002 -0.545 . . . . 64.129999999999995 110.315 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.7 mtt -101.93 125.9 48.71 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.37 -0.832 . . . . 74.049999999999997 110.573 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.293 -1.864 0 CA-C-N 114.519 -1.219 . . . . 72.319999999999993 108.877 178.502 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 m . . . . . 0 N--CA 1.431 -1.402 0 N-CA-C 108.811 -0.811 . . . . 74.340000000000003 108.811 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 17.4 m -123.41 146.75 47.74 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.338 -0.986 . . . . 74.129999999999995 108.338 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.1 p -135.85 115.81 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 107.349 -1.352 . . . . 52.32 107.349 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -114.79 131.96 56.63 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.175 -1.375 . . . . 60.549999999999997 110.361 -170.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 95' ' ' ILE . 4.2 pp -98.7 133.52 42.91 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.799 -0.815 . . . . 51.200000000000003 108.799 174.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' O ' HD12 ' A' ' 95' ' ' ILE . 43.3 mt-30 -99.9 120.64 40.1 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.782 -0.644 . . . . 65.230000000000004 110.692 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.5 tp -129.85 111.32 12.47 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.261 -0.882 . . . . 70.409999999999997 110.082 -174.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -89.0 100.58 13.33 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.04 -1.464 . . . . 53.409999999999997 108.848 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.61 9.62 40.97 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.699 -1.591 . . . . 61.43 108.568 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.4 -13.77 10.17 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.293 -0.867 . . . . 71.120000000000005 111.113 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 m -137.23 13.32 3.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.852 -0.174 . . . . 70.349999999999994 111.374 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.31 83.6 0.04 OUTLIER Glycine 0 C--N 1.345 1.079 0 N-CA-C 114.279 0.471 . . . . 73.510000000000005 114.279 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -98.77 144.38 28.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.281 0.562 . . . . 74.319999999999993 111.237 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.421 HG22 ' HG2' ' A' ' 12' ' ' GLN . 77.4 p -122.5 134.45 54.57 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.897 -1.149 . . . . 74.519999999999996 107.897 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -137.25 131.75 32.8 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.577 0.214 . . . . 74.319999999999993 111.577 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.39 136.07 38.38 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.846 -0.427 . . . . 61.229999999999997 109.846 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.576 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.8 mt -68.31 139.62 55.92 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.803 -0.635 . . . . 72.239999999999995 110.038 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -105.31 152.98 22.24 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.404 -0.591 . . . . 74.140000000000001 109.404 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.33 136.96 58.22 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 124.344 1.027 . . . . 73.310000000000002 111.518 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.49 -164.11 12.45 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.722 -2.151 . . . . 73.109999999999999 107.722 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.6 p -104.43 130.03 52.36 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.233 -1.387 . . . . 72.120000000000005 112.236 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -99.95 108.97 21.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 105.409 -2.071 . . . . 55.25 105.409 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.496 HG21 ' HG2' ' A' ' 48' ' ' ARG . 57.9 mt -98.57 130.34 47.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.886 -0.597 . . . . 72.040000000000006 110.948 -173.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.0 mt -101.99 123.4 55.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.143 -1.058 . . . . 71.310000000000002 108.143 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.4 -176.4 39.57 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.702 -1.359 . . . . 50.450000000000003 109.702 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -115.03 106.16 13.81 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 117.63 0.715 . . . . 73.319999999999993 109.309 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.56 177.49 44.65 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.509 -1.036 . . . . 62.5 110.509 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -81.19 -16.95 51.36 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.5 0.667 . . . . 72.0 109.622 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.61 -23.85 31.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.653 0.739 . . . . 74.430000000000007 110.086 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -82.99 162.42 21.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.127 -0.942 . . . . 72.019999999999996 110.95 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -104.36 -58.46 1.88 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.811 -0.811 . . . . 62.200000000000003 108.811 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.35 129.95 46.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.575 -0.738 . . . . 61.119999999999997 109.16 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 24.8 mtm180 -108.37 131.13 55.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.103 -0.499 . . . . 73.030000000000001 110.364 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.64 142.36 57.27 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.382 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -89.1 27.79 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.032 2.488 . . . . 71.230000000000004 110.917 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -135.09 -177.7 4.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.959 -1.126 . . . . 74.400000000000006 107.959 -174.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -116.46 178.68 4.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.731 -0.84 . . . . 71.129999999999995 108.731 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.76 79.52 Favored Glycine 0 C--N 1.317 -0.476 0 N-CA-C 110.213 -1.155 . . . . 63.140000000000001 110.213 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 49' ' ' HIS . 4.8 p -116.9 136.47 53.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 114.347 -0.927 . . . . 70.140000000000001 109.584 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -89.7 -164.43 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.821 -0.807 . . . . 62.219999999999999 108.821 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 35.8 ptt180 -78.27 -30.42 48.49 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 118.767 -1.173 . . . . 54.43 108.557 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HG2' HG21 ' A' ' 29' ' ' ILE . 78.5 mtt180 -121.87 108.03 12.98 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.038 -1.467 . . . . 65.219999999999999 107.038 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.567 ' HB2' HG23 ' A' ' 45' ' ' VAL . 25.3 t60 -104.21 -34.78 8.24 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.047 -1.094 . . . . 70.120000000000005 108.047 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tt -165.42 142.92 5.83 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.976 -1.12 . . . . 71.530000000000001 107.976 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -131.14 129.88 42.37 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.508 0.67 . . . . 72.200000000000003 110.936 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.44 110.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 115.376 -0.829 . . . . 71.120000000000005 108.951 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 25.2 ttt180 -90.57 110.19 21.33 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.994 -0.743 . . . . 64.540000000000006 108.994 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -94.68 107.64 19.64 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.146 -1.057 . . . . 75.030000000000001 108.146 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.36 152.49 31.39 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 105.145 -2.169 . . . . 71.340000000000003 105.145 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.24 57.54 2.81 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 118.423 0.556 . . . . 52.340000000000003 112.365 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -159.22 -60.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.432 -1.322 . . . . 74.129999999999995 107.432 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.7 m -143.88 156.91 16.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 115.54 -0.755 . . . . 64.430000000000007 109.924 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -95.25 102.64 14.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.787 -1.19 . . . . 71.340000000000003 107.787 175.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.23 116.9 23.84 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.226 -0.897 . . . . 72.510000000000005 109.858 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -99.4 119.35 37.83 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.901 -1.148 . . . . 74.519999999999996 107.901 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.16 27.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.183 0.516 . . . . 71.349999999999994 110.307 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 5.9 t70 -85.99 138.87 31.67 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.887 0.875 . . . . 72.310000000000002 109.316 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.04 76.67 1.69 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -166.24 150.07 7.58 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.802 -0.561 . . . . 50.310000000000002 109.899 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 m -108.22 -30.28 8.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.207 0.527 . . . . 60.350000000000001 111.409 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.9 m -88.94 -60.29 2.0 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.145 0.974 . . . . 65.409999999999997 111.867 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -104.4 28.6 6.77 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 125.048 1.339 . . . . 72.219999999999999 109.519 -168.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.86 139.25 5.0 Favored Glycine 0 C--O 1.256 1.531 0 CA-C-N 114.017 -1.447 . . . . 54.0 113.71 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 90' ' ' LEU . 7.0 m -83.61 155.74 23.07 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.13 0.972 . . . . 63.329999999999998 112.381 -172.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.4 p -118.98 153.71 34.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.952 -0.567 . . . . 65.129999999999995 110.261 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.431 HG12 HG13 ' A' ' 88' ' ' ILE . 35.6 m -116.6 116.28 51.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.816 -1.179 . . . . 54.109999999999999 107.816 175.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 62.36 27.1 16.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.018 0.913 . . . . 71.209999999999994 109.359 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.87 15.97 3.03 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.307 1.843 . . . . 74.049999999999997 111.26 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.23 123.74 38.7 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 108.693 -0.855 . . . . 73.109999999999999 108.693 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.62 124.4 9.28 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.173 1.915 . . . . 73.109999999999999 112.998 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 72' ' ' VAL . 35.8 m -156.25 169.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 104.963 -2.236 . . . . 73.400000000000006 104.963 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.1 mt-30 -113.24 -6.23 13.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.394 -0.923 . . . . 74.230000000000004 112.536 175.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 7.0 pt-20 -151.43 140.59 21.25 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.163 -0.615 . . . . 73.420000000000002 111.909 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -163.29 152.56 14.82 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.205 -1.035 . . . . 74.540000000000006 108.205 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.59 116.7 33.13 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.777 -0.823 . . . . 71.409999999999997 108.777 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.6 mt -61.77 130.38 45.51 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.678 0.622 . . . . 74.140000000000001 112.678 -175.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -126.78 167.84 15.23 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.88 -0.785 . . . . 72.219999999999999 108.88 173.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 26.2 t70 -60.55 124.45 20.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.465 -0.334 . . . . 64.040000000000006 110.634 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.9 -7.36 52.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.721 -0.752 . . . . 70.420000000000002 113.622 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -73.97 135.04 43.16 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 117.179 0.49 . . . . 74.099999999999994 111.488 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.92 113.07 39.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.718 -0.845 . . . . 74.239999999999995 108.718 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.506 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 1.8 mp -98.27 113.22 32.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 106.55 -1.648 . . . . 73.409999999999997 106.55 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -115.5 116.21 27.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.25 0.548 . . . . 73.200000000000003 111.193 -169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.1 pt? -123.79 164.71 18.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.892 1.277 . . . . 71.329999999999998 108.365 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.39 113.8 0.9 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.642 0.617 . . . . 54.43 114.642 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.8 m80 64.82 7.13 3.69 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.85 1.26 . . . . 73.150000000000006 114.068 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.4 m -140.83 125.87 18.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.779 -0.369 . . . . 55.219999999999999 110.939 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.92 121.78 40.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.163 -0.68 . . . . 74.140000000000001 109.163 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.576 HD11 HD13 ' A' ' 11' ' ' LEU . 6.9 tp -109.74 125.7 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 N-CA-C 108.725 -0.843 . . . . 61.420000000000002 108.725 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.51 129.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.158 -0.682 . . . . 74.019999999999996 109.158 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.4 t -94.52 123.88 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.568 0.699 . . . . 71.239999999999995 111.961 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -112.92 119.24 37.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.043 -0.98 . . . . 73.209999999999994 108.677 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 85.6 mtp -107.1 120.99 43.59 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.298 -0.561 . . . . 71.310000000000002 110.591 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 28.4 m-70 . . . . . 0 C--N 1.283 -2.32 0 N-CA-C 107.137 -1.431 . . . . 73.540000000000006 107.137 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.436 -1.174 0 N-CA-C 109.102 -0.703 . . . . 61.229999999999997 109.102 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.0 m -134.4 138.2 44.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.332 -0.618 . . . . 73.420000000000002 109.332 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.64 109.56 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.233 -1.395 . . . . 72.230000000000004 107.233 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.406 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 57.0 m -108.63 122.38 46.98 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.293 -1.003 . . . . 64.219999999999999 108.293 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.563 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 47.1 mt -87.7 128.7 35.3 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.672 -1.233 . . . . 73.109999999999999 107.672 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -100.97 117.64 35.41 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 107.055 -1.461 . . . . 74.519999999999996 107.055 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 95' ' ' ILE . 50.3 tp -91.94 125.85 36.8 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.672 -0.695 . . . . 55.539999999999999 109.385 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.58 100.13 11.72 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 107.466 -1.309 . . . . 75.200000000000003 107.466 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -126.95 -14.01 5.64 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.768 -1.106 . . . . 54.439999999999998 109.701 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.41 -29.98 6.18 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.382 -1.087 . . . . 61.140000000000001 110.382 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -90.11 -35.03 15.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.123 -1.066 . . . . 61.210000000000001 108.123 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.39 57.93 2.39 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 109.85 -1.3 . . . . 51.130000000000003 109.85 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.9 mmp_? -87.51 162.88 16.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.562 -0.319 . . . . 64.450000000000003 110.304 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 33.9 p -128.59 143.4 50.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.872 0.368 . . . . 74.439999999999998 110.764 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -127.27 113.1 15.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.829 -0.804 . . . . 74.420000000000002 108.829 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.71 132.68 35.3 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.849 -0.797 . . . . 74.510000000000005 108.849 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD22 HD21 ' A' ' 28' ' ' ASN . 65.5 mt -59.89 132.13 53.02 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.051 0.845 . . . . 62.420000000000002 111.454 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.32 145.54 32.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.094 -1.076 . . . . 73.209999999999994 108.094 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.99 113.56 10.16 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.087 0.946 . . . . 73.420000000000002 109.901 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.83 -161.01 24.75 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 107.041 -2.424 . . . . 75.209999999999994 107.041 -173.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.2 p -107.56 137.69 45.13 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 118.449 1.125 . . . . 74.430000000000007 112.311 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.424 HD21 HD22 ' A' ' 23' ' ' LEU . 7.1 p30 -120.76 120.89 36.92 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.254 -0.647 . . . . 65.329999999999998 109.254 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.62 121.22 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.535 -0.913 . . . . 72.219999999999999 108.535 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 76.2 mt -97.96 130.01 47.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.005 -0.739 . . . . 64.209999999999994 109.005 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.97 -173.11 36.6 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 110.182 -1.167 . . . . 72.239999999999995 110.182 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 40' ' ' LEU . 25.9 mtm105 -124.08 107.22 11.04 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 117.678 0.739 . . . . 64.439999999999998 110.179 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.47 176.71 44.87 Favored Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.529 -1.028 . . . . 53.119999999999997 110.529 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -55.64 -32.22 62.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.954 0.902 . . . . 75.099999999999994 112.244 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -95.26 1.55 54.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.212 -0.449 . . . . 63.520000000000003 111.894 -173.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.03 149.76 24.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.039 0.447 . . . . 74.239999999999995 112.069 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -107.24 -57.77 2.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.867 0.867 . . . . 72.340000000000003 108.716 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 19.8 t80 -101.67 117.06 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.992 -1.855 . . . . 75.530000000000001 105.992 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 36.6 mtm180 -107.89 126.58 52.84 Favored 'General case' 0 C--N 1.279 -2.476 0 C-N-CA 120.445 -0.502 . . . . 45.020000000000003 111.573 -174.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.54 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 63.3 mt -75.45 148.75 83.49 Favored Pre-proline 0 C--O 1.21 -0.998 0 CA-C-N 115.756 -0.657 . . . . 74.209999999999994 109.434 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.57 11.65 2.84 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.476 2.118 . . . . 54.340000000000003 113.925 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -116.39 -177.37 3.16 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.427 -0.582 . . . . 70.140000000000001 109.427 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 m -128.69 149.65 50.59 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 123.234 0.614 . . . . 73.540000000000006 109.629 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -16.67 24.02 Favored Glycine 0 CA--C 1.495 -1.182 0 N-CA-C 108.548 -1.821 . . . . 60.109999999999999 108.548 -175.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' HA2' ' A' ' 31' ' ' GLY . 31.5 t -80.69 128.37 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.372 -1.414 . . . . 71.230000000000004 107.401 177.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -68.39 166.19 17.21 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 123.502 0.501 . . . . 63.32 112.104 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.486 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.3 ptt-85 -62.26 -37.63 86.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.58 0.705 . . . . 72.120000000000005 109.437 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.432 HH21 ' CD ' ' A' ' 51' ' ' GLU . 21.7 mtp180 -126.22 95.8 4.5 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.725 -2.695 . . . . 74.230000000000004 103.725 169.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -92.12 -37.47 12.73 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.772 0.796 . . . . 71.329999999999998 109.148 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 HD21 ' A' ' 61' ' ' LEU . 5.7 tt -161.75 150.02 15.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.094 -1.076 . . . . 54.020000000000003 108.094 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' CD ' HH21 ' A' ' 48' ' ' ARG . 8.4 pt-20 -139.77 125.98 20.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.662 0.744 . . . . 72.219999999999999 111.313 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.99 121.89 52.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.045 -0.98 . . . . 64.519999999999996 108.36 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -106.25 107.18 18.05 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.716 -1.216 . . . . 74.219999999999999 107.716 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -108.65 121.19 44.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.954 0.883 . . . . 74.010000000000005 112.959 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -133.41 158.13 43.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.542 -1.651 . . . . 50.210000000000001 106.542 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.41 68.41 0.53 Allowed Glycine 0 C--N 1.314 -0.684 0 N-CA-C 114.772 0.669 . . . . 70.129999999999995 114.772 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -165.79 -70.72 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.727 -1.212 . . . . 64.510000000000005 107.727 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.57 150.99 29.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.802 0.334 . . . . 72.319999999999993 110.614 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -97.98 112.69 24.53 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.294 0.568 . . . . 75.129999999999995 109.494 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 tt -84.23 117.7 23.69 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.954 -1.021 . . . . 71.0 108.873 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.479 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -100.77 109.94 21.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.222 -1.399 . . . . 73.109999999999999 107.222 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 111.09 21.09 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.264 0.554 . . . . 71.439999999999998 110.023 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 136.79 35.85 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.591 -0.892 . . . . 71.409999999999997 108.591 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.51 106.31 16.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.534 -0.913 . . . . 75.120000000000005 108.534 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.564 ' OD1' ' HB ' ' A' ' 67' ' ' THR . 28.7 t-20 69.78 89.47 0.1 Allowed 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.11 -0.95 . . . . 74.129999999999995 111.39 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.73 -18.14 64.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.956 . . . . 73.340000000000003 111.868 -175.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.564 ' HB ' ' OD1' ' A' ' 65' ' ' ASN . 18.5 m -46.44 -53.58 10.84 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 71.430000000000007 110.979 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -122.34 27.13 8.08 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.654 -1.61 . . . . 72.400000000000006 106.654 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.88 -144.91 17.91 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.337 -1.302 . . . . 62.409999999999997 115.854 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -107.4 156.47 18.9 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.124 -1.038 . . . . 74.510000000000005 112.842 -169.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 p -119.21 140.81 49.59 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.175 -0.921 . . . . 73.299999999999997 109.8 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.475 HG12 HG13 ' A' ' 88' ' ' ILE . 35.9 m -114.91 115.74 50.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.712 -1.218 . . . . 70.230000000000004 107.712 177.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.99 28.63 18.41 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.844 0.831 . . . . 72.120000000000005 109.115 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 81.18 0.06 1.71 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.194 2.198 . . . . 54.329999999999998 111.603 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -97.41 121.34 58.76 Favored Pre-proline 0 C--N 1.316 -0.884 0 O-C-N 121.556 -0.715 . . . . 74.140000000000001 109.724 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 5.7 Cg_exo -75.11 125.45 9.26 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.094 1.862 . . . . 75.150000000000006 110.941 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.78 161.65 18.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.0 -1.111 . . . . 72.439999999999998 108.0 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -88.5 -18.45 28.18 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.177 0.513 . . . . 62.149999999999999 111.518 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.73 152.39 17.7 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.2 -0.667 . . . . 74.439999999999998 109.2 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -154.52 151.76 29.28 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.589 -0.893 . . . . 75.420000000000002 108.589 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -101.93 108.26 19.66 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.53 -1.285 . . . . 52.439999999999998 107.53 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 97' ' ' VAL . 86.5 mt -59.31 146.81 38.19 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.879 0.737 . . . . 73.439999999999998 112.068 -176.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.4 170.62 18.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.754 -1.202 . . . . 54.149999999999999 107.754 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.27 128.27 35.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.706 0.288 . . . . 72.109999999999999 111.127 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.76 2.74 57.29 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 120.967 -0.635 . . . . 64.329999999999998 112.933 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -85.17 134.03 34.18 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 120.192 -0.603 . . . . 63.439999999999998 110.573 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.27 114.86 41.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.723 -0.672 . . . . 71.420000000000002 109.466 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.64 109.6 26.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 N-CA-C 107.475 -1.305 . . . . 73.329999999999998 107.475 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.2 ttp85 -110.41 120.02 41.1 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.681 0.753 . . . . 72.310000000000002 110.207 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 90' ' ' LEU . 1.2 pt? -119.94 165.0 15.23 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 114.63 -1.168 . . . . 75.310000000000002 108.559 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.98 100.97 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.405 0.922 . . . . 34.229999999999997 115.405 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.9 m170 71.54 17.99 5.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.279 1.432 . . . . 71.299999999999997 113.603 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.5 m -154.28 135.7 14.18 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.947 -0.47 . . . . 72.109999999999999 111.778 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.839 -0.538 . . . . 65.420000000000002 110.025 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.2 tp -126.9 137.34 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.812 -0.81 . . . . 73.200000000000003 108.812 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -107.45 127.37 63.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.46 -0.57 . . . . 74.519999999999996 109.46 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 82' ' ' LEU . 53.3 t -85.15 119.98 34.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.142 0.496 . . . . 72.510000000000005 111.262 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -113.86 126.16 54.87 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.0 mtt -115.22 131.42 56.93 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.776 0.798 . . . . 43.409999999999997 111.416 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 . . . . . 0 C--N 1.279 -2.5 0 CA-C-N 114.385 -1.28 . . . . 71.040000000000006 108.123 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.93 -0.767 . . . . 71.010000000000005 108.93 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -104.85 115.02 29.59 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.711 -0.848 . . . . 74.099999999999994 108.711 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.63 113.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.753 -1.203 . . . . 62.439999999999998 107.753 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -117.63 117.28 28.96 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.967 -0.753 . . . . 75.400000000000006 108.967 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -87.7 137.25 32.5 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 108.476 -0.935 . . . . 65.209999999999994 108.476 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -108.52 125.84 52.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.901 -0.778 . . . . 60.149999999999999 108.901 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -133.16 114.77 14.24 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.47 0.653 . . . . 75.319999999999993 110.968 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.9 102.17 13.5 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.106 -0.702 . . . . 64.430000000000007 109.106 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.64 10.77 37.59 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.57 1.176 . . . . 74.409999999999997 108.935 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.6 39.43 1.1 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.927 -1.269 . . . . 61.520000000000003 109.927 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -170.71 -61.87 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.983 -0.747 . . . . 44.399999999999999 108.983 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.09 92.58 1.56 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.012 -0.835 . . . . 70.319999999999993 111.012 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.5 mmp_? -123.65 165.63 16.89 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 122.21 -0.583 . . . . 61.109999999999999 110.858 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.2 p -136.45 149.16 48.09 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.946 -0.761 . . . . 31.32 108.946 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 88.3 t80 -140.34 119.69 13.02 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.879 -0.785 . . . . 64.349999999999994 108.879 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -85.13 134.11 34.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.052 -1.092 . . . . 74.430000000000007 108.052 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.83 131.12 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.654 0.596 . . . . 64.450000000000003 110.968 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -90.05 150.14 22.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.385 -1.339 . . . . 71.299999999999997 107.385 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.72 118.32 14.41 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.926 0.87 . . . . 51.43 111.333 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 -168.6 23.82 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 107.232 -2.347 . . . . 73.540000000000006 107.232 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.9 p -106.67 129.71 54.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 118.822 1.311 . . . . 71.409999999999997 110.687 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -110.54 129.27 55.83 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.209 -0.451 . . . . 65.109999999999999 109.849 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.4 mt -99.09 125.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.388 -0.597 . . . . 72.439999999999998 109.388 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.4 135.55 46.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.99 -0.744 . . . . 74.120000000000005 108.99 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 147.17 -168.06 28.34 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 110.566 -1.014 . . . . 64.099999999999994 110.566 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 mtm105 -116.31 106.6 13.84 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.536 -0.866 . . . . 74.140000000000001 110.868 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.21 177.84 46.27 Favored Glycine 0 N--CA 1.403 -3.563 0 N-CA-C 109.772 -1.331 . . . . 71.099999999999994 109.772 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -76.57 -20.13 57.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.653 0.74 . . . . 75.150000000000006 110.222 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.61 -29.11 19.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.165 -0.925 . . . . 61.299999999999997 109.511 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.09 142.31 57.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.855 -1.066 . . . . 51.009999999999998 110.62 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -94.98 -47.98 6.18 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.178 -1.045 . . . . 74.340000000000003 108.178 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -109.37 113.74 26.81 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.879 -1.055 . . . . 73.109999999999999 109.134 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mpt_? -90.01 113.5 25.2 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.747 -0.66 . . . . 54.439999999999998 111.677 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 mt -80.49 125.91 79.78 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.307 -0.406 . . . . 65.120000000000005 110.658 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 7.9 Cg_exo -69.83 6.92 1.15 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.243 2.629 . . . . 70.540000000000006 116.016 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.89 175.85 7.05 Favored 'General case' 0 C--O 1.252 1.184 0 O-C-N 121.187 -0.946 . . . . 72.450000000000003 110.141 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.5 ' HA ' HH21 ' A' ' 32' ' ' ARG . 25.0 m -113.15 138.71 49.55 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.229 -0.656 . . . . 74.349999999999994 109.229 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.58 -13.57 32.75 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 109.693 -1.363 . . . . 70.219999999999999 109.693 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.443 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 45.0 t -75.5 123.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 CA-C-N 114.081 -1.06 . . . . 62.530000000000001 108.639 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 m -75.56 171.91 13.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.964 -0.562 . . . . 65.019999999999996 111.878 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.9 ptm180 -61.01 -31.28 70.9 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.929 0.871 . . . . 72.319999999999993 110.464 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -134.58 99.86 4.47 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 103.446 -2.798 . . . . 64.010000000000005 103.446 171.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -96.18 -36.82 10.81 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.551 0.691 . . . . 72.209999999999994 109.42 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 61' ' ' LEU . 7.4 tt -162.62 148.06 12.33 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 71.209999999999994 108.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.47 142.49 49.26 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 109.456 -0.572 . . . . 72.209999999999994 109.456 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.63 114.31 45.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.46 -0.941 . . . . 75.340000000000003 108.46 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 50.2 ttt180 -91.71 107.55 19.29 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.034 -1.098 . . . . 64.099999999999994 108.034 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -106.98 117.75 34.87 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.927 -0.579 . . . . 65.310000000000002 110.417 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.4 160.63 19.62 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.125 -1.806 . . . . 75.549999999999997 106.125 174.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.82 59.35 1.72 Allowed Glycine 0 C--N 1.305 -1.171 0 C-N-CA 121.406 -0.426 . . . . 74.409999999999997 113.48 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -171.19 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.216 1.007 . . . . 71.150000000000006 109.545 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -134.35 150.68 31.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.963 0.411 . . . . 71.230000000000004 111.288 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -107.32 104.95 14.68 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.165 -0.925 . . . . 75.510000000000005 108.614 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.1 tp -89.18 109.73 20.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.776 -1.102 . . . . 61.210000000000001 110.236 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -92.45 124.2 36.32 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.018 -1.104 . . . . 75.430000000000007 108.018 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.49 127.34 40.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.795 0.331 . . . . 51.119999999999997 110.403 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.73 129.26 43.0 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.853 0.861 . . . . 71.420000000000002 111.289 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.82 76.91 1.47 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.787 0.435 . . . . 72.420000000000002 110.184 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 179.95 114.79 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 108.587 -0.894 . . . . 72.129999999999995 108.587 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.3 m -83.78 -24.07 31.22 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.85 -0.531 . . . . 70.400000000000006 111.264 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -80.49 -58.82 2.94 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.354 0.597 . . . . 74.25 109.893 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -103.82 28.57 6.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.477 0.711 . . . . 72.209999999999994 110.363 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.37 131.24 5.9 Favored Glycine 0 C--O 1.242 0.644 0 O-C-N 124.703 1.252 . . . . 63.43 114.793 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 m -76.68 137.64 39.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 124.196 0.999 . . . . 44.219999999999999 112.095 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 25.3 p -107.13 149.55 27.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.206 -0.452 . . . . 74.549999999999997 110.339 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 80' ' ' TRP . 30.4 m -114.0 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.865 -1.161 . . . . 74.209999999999994 107.865 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 62.16 26.82 16.13 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.201 -0.909 . . . . 72.200000000000003 109.9 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.54 26.04 0.9 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.324 1.85 . . . . 61.530000000000001 111.309 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.34 130.7 24.58 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.698 -0.683 . . . . 71.239999999999995 109.638 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.83 125.8 10.22 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.83 2.353 . . . . 53.420000000000002 113.372 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 80' ' ' TRP . 28.0 m -142.63 166.43 15.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.004 -0.739 . . . . 74.329999999999998 109.004 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -106.41 -30.43 9.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.346 -0.388 . . . . 40.43 110.856 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.95 146.69 49.36 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.805 -0.813 . . . . 64.409999999999997 108.805 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.432 ' HB2' HG21 ' A' ' 77' ' ' VAL . 74.0 t-105 -157.06 148.96 22.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 75.040000000000006 109.727 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -99.99 105.2 16.86 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.028 -1.101 . . . . 71.099999999999994 108.028 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 87.9 mt -56.66 131.02 47.79 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 116.044 -0.525 . . . . 73.010000000000005 111.932 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.22 163.23 18.86 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.611 -0.885 . . . . 65.040000000000006 108.611 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.27 123.58 20.34 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.047 0.451 . . . . 75.510000000000005 109.786 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -8.69 44.62 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-N 115.93 -0.577 . . . . 64.129999999999995 112.48 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.98 133.27 47.09 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 117.11 0.455 . . . . 71.319999999999993 111.321 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 t -103.5 113.55 40.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.89 -0.781 . . . . 74.239999999999995 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.49 118.63 43.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 N-CA-C 107.049 -1.463 . . . . 75.230000000000004 107.049 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 60.6 mtp180 -118.66 129.87 55.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.492 0.663 . . . . 62.539999999999999 111.863 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.7 164.87 19.0 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 106.231 -1.766 . . . . 74.25 106.231 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.21 108.41 0.16 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 123.719 0.637 . . . . 71.450000000000003 113.107 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 77.81 -35.79 0.21 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.959 1.703 . . . . 61.420000000000002 113.152 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.6 m -100.0 130.33 46.15 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.9 -0.5 . . . . 55.310000000000002 111.059 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.78 147.63 49.98 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.002 0.43 . . . . 63.329999999999998 111.033 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.7 137.71 42.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.705 -0.68 . . . . 73.109999999999999 110.927 -175.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.91 125.86 64.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.604 -0.888 . . . . 70.329999999999998 108.604 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.7 t -87.67 121.68 38.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 110.82 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -121.24 143.04 49.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.697 -0.483 . . . . 72.140000000000001 109.697 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.05 140.04 50.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.048 -0.524 . . . . 65.219999999999999 109.928 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 . . . . . 0 C--N 1.287 -2.112 0 N-CA-C 107.772 -1.196 . . . . 63.399999999999999 107.772 177.136 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.6 m . . . . . 0 N--CA 1.411 -2.395 0 N-CA-C 106.273 -1.751 . . . . 64.120000000000005 106.273 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.442 ' HB3' ' NE2' ' A' ' 22' ' ' GLN . 18.7 m -107.17 114.29 28.25 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.108 -1.071 . . . . 74.219999999999999 108.108 176.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 23' ' ' LEU . 4.3 p -98.43 124.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.522 0.677 . . . . 72.420000000000002 109.708 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -128.7 130.17 46.78 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.521 -0.763 . . . . 73.409999999999997 109.817 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.41 136.39 33.01 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.449 -0.574 . . . . 73.310000000000002 109.449 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -122.74 134.03 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.572 0.749 . . . . 63.420000000000002 110.76 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.44 ' HB3' HD12 ' A' ' 95' ' ' ILE . 2.5 pp -148.28 146.63 28.69 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.567 -1.642 . . . . 73.239999999999995 106.567 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -105.67 118.55 36.88 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 119.043 -1.063 . . . . 72.439999999999998 111.326 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -113.89 6.65 16.71 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.286 -1.325 . . . . 63.119999999999997 108.808 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.14 33.41 0.79 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.724 -0.751 . . . . 71.439999999999998 112.611 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p 176.85 -39.41 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.975 0.91 . . . . 72.420000000000002 110.339 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.98 93.72 2.21 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.867 -1.293 . . . . 73.329999999999998 109.867 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 29.7 mmt180 -88.47 149.01 23.89 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.103 -1.073 . . . . 74.310000000000002 108.103 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 24.1 p -146.35 132.33 19.2 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.821 0.701 . . . . 73.140000000000001 111.088 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.415 ' HB3' HD11 ' A' ' 11' ' ' LEU . 55.4 t80 -129.51 124.68 34.55 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.169 -1.419 . . . . 72.530000000000001 107.169 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 8' ' ' SER . 35.6 tt0 -93.11 131.52 38.08 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 120.993 0.425 . . . . 74.030000000000001 110.686 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.1 mt -77.08 140.08 40.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.229 -0.896 . . . . 52.420000000000002 108.854 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 2.8 mpt_? -109.25 169.96 8.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.664 -1.236 . . . . 73.329999999999998 107.664 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.16 130.97 46.9 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.637 0.732 . . . . 75.420000000000002 111.666 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.79 -170.54 14.92 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.519 -1.833 . . . . 70.319999999999993 108.519 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -99.61 129.57 45.77 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 118.727 -1.189 . . . . 74.319999999999993 110.441 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -108.27 109.7 21.11 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.584 -1.265 . . . . 75.030000000000001 107.584 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.34 131.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.382 -0.827 . . . . 72.129999999999995 109.502 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.69 128.21 64.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 109.209 -0.663 . . . . 75.010000000000005 109.209 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 162.99 -171.44 38.77 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 110.795 -0.922 . . . . 63.520000000000003 110.795 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -110.26 107.62 17.45 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 117.607 0.704 . . . . 74.319999999999993 109.91 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.68 177.14 45.41 Favored Glycine 0 N--CA 1.408 -3.172 0 N-CA-C 109.769 -1.332 . . . . 64.25 109.769 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -86.01 -22.99 27.0 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.866 -1.161 . . . . 62.439999999999998 107.866 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.65 -27.29 55.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.864 -1.062 . . . . 71.519999999999996 108.854 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 139.59 38.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.655 -1.157 . . . . 75.140000000000001 110.451 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -82.09 -45.52 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.497 0.665 . . . . 74.140000000000001 109.921 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -116.43 129.03 56.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.592 -0.892 . . . . 74.549999999999997 108.592 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -102.19 140.05 36.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.983 -0.553 . . . . 71.540000000000006 110.584 -178.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.23 147.77 39.16 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.343 -0.39 . . . . 65.519999999999996 111.038 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -86.0 8.28 4.59 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.948 2.432 . . . . 63.229999999999997 111.042 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -116.51 160.22 20.93 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.131 0.972 . . . . 62.420000000000002 108.835 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -111.51 -177.86 3.3 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.764 -0.374 . . . . 73.230000000000004 110.316 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.0 -11.8 71.31 Favored Glycine 0 CA--C 1.51 -0.229 0 N-CA-C 109.622 -1.391 . . . . 73.400000000000006 109.622 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' CG ' ' A' ' 49' ' ' HIS . 8.3 p -86.35 149.66 4.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 125.284 1.434 . . . . 71.200000000000003 110.094 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -97.4 -174.29 2.89 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 107.971 -1.122 . . . . 72.519999999999996 107.971 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -74.1 -37.6 64.11 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.884 -1.154 . . . . 71.439999999999998 107.884 175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -115.47 94.05 4.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.504 -1.295 . . . . 75.340000000000003 107.504 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.408 ' CG ' HG23 ' A' ' 45' ' ' VAL . 24.0 t60 -105.24 -37.53 6.85 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.785 -1.098 . . . . 74.340000000000003 109.503 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -161.45 152.45 18.31 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.36 -0.978 . . . . 70.219999999999999 108.36 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -136.28 138.86 42.19 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.196 0.522 . . . . 71.299999999999997 109.86 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -110.61 114.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.965 -0.754 . . . . 74.140000000000001 108.965 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 63.7 ttt180 -90.42 109.54 20.66 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.101 -1.074 . . . . 74.019999999999996 108.101 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -107.71 114.94 29.25 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.422 -0.808 . . . . 72.140000000000001 110.958 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.98 167.75 13.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.678 -1.601 . . . . 73.450000000000003 106.678 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.7 72.79 1.49 Allowed Glycine 0 C--N 1.302 -1.328 0 C-N-CA 121.096 -0.573 . . . . 54.43 114.485 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -168.48 -71.42 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.844 0.858 . . . . 75.219999999999999 108.735 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.8 157.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.439 -0.948 . . . . 73.530000000000001 108.439 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -97.83 119.12 35.86 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.446 -0.576 . . . . 63.32 109.446 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.2 tt -86.96 110.57 20.12 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.087 -1.079 . . . . 71.349999999999994 108.087 -177.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -90.47 114.62 26.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.334 -1.358 . . . . 54.149999999999999 107.334 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.99 115.72 24.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.935 0.398 . . . . 53.420000000000002 110.685 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.24 136.33 37.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.704 -0.68 . . . . 74.420000000000002 109.473 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -132.97 76.67 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.17 -1.048 . . . . 74.329999999999998 108.17 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -174.58 146.25 0.99 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.883 -0.784 . . . . 72.010000000000005 108.883 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -102.3 -32.93 9.8 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.494 0.553 . . . . 64.109999999999999 112.494 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.401 HG23 ' ND2' ' A' ' 68' ' ' ASN . 6.2 t -90.16 -37.69 14.01 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.853 0.686 . . . . 74.329999999999998 112.853 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.401 ' ND2' HG23 ' A' ' 67' ' ' THR . 48.7 m-80 -107.12 28.37 8.11 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.694 0.798 . . . . 72.230000000000004 110.102 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.65 124.42 4.86 Favored Glycine 0 N--CA 1.474 1.209 0 O-C-N 124.471 1.107 . . . . 74.219999999999999 113.616 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -67.95 146.24 53.77 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.581 1.152 . . . . 64.299999999999997 113.354 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.0 p -117.06 141.11 48.67 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.144 -0.935 . . . . 73.230000000000004 110.332 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 88' ' ' ILE . 27.3 m -109.96 116.68 52.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.073 -1.084 . . . . 74.420000000000002 108.073 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 59.96 29.85 19.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.908 0.861 . . . . 71.349999999999994 109.253 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.7 t30 78.22 8.47 2.31 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.504 1.922 . . . . 75.150000000000006 111.357 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.79 122.24 49.82 Favored Pre-proline 0 C--N 1.318 -0.785 0 O-C-N 121.678 -0.639 . . . . 65.420000000000002 109.807 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.32 127.01 14.3 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 122.562 2.174 . . . . 71.219999999999999 111.903 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.69 168.26 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 122.488 0.315 . . . . 55.130000000000003 110.275 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.52 -34.58 10.93 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.375 -0.602 . . . . 74.430000000000007 109.375 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -148.23 153.84 39.27 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.843 -0.617 . . . . 75.219999999999999 109.717 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -157.32 151.34 24.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.274 -1.009 . . . . 75.120000000000005 108.274 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.281 0.8 OUTLIER -101.06 108.69 20.46 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-O 121.71 0.766 . . . . 74.5 111.192 174.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.1 mt -56.97 143.58 37.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.842 -1.072 . . . . 74.510000000000005 112.638 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.74 169.55 16.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.696 -1.224 . . . . 63.240000000000002 107.696 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -72.09 112.14 7.91 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.809 -0.441 . . . . 34.43 109.809 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.61 13.61 18.18 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.932 -0.652 . . . . 61.439999999999998 113.404 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -87.25 140.72 29.26 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 117.769 0.784 . . . . 73.230000000000004 110.863 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.81 113.36 36.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 N-CA-C 108.768 -0.827 . . . . 72.019999999999996 108.768 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.473 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.1 107.6 22.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 109.125 -0.694 . . . . 75.420000000000002 109.125 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.463 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 39.9 ttm180 -100.06 111.94 24.24 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.49 0.662 . . . . 65.150000000000006 110.95 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.6 pt? -115.82 164.33 14.54 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.177 -1.374 . . . . 72.400000000000006 107.445 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -36.68 99.55 0.01 OUTLIER Glycine 0 CA--C 1.535 1.343 0 N-CA-C 115.909 1.123 . . . . 71.400000000000006 115.909 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.9 m80 83.09 -1.32 1.21 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.346 1.858 . . . . 73.329999999999998 115.275 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -150.4 138.05 19.84 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.889 -1.124 . . . . 74.140000000000001 111.713 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 10.5 pt-20 -110.54 119.66 39.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.455 0.645 . . . . 73.109999999999999 109.566 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.6 tp -103.6 139.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.295 -0.866 . . . . 71.129999999999995 109.124 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.88 129.31 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.054 -1.091 . . . . 72.25 108.054 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 82' ' ' LEU . 69.9 t -95.88 120.46 45.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.482 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -117.01 150.91 37.83 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.313 -0.625 . . . . 70.349999999999994 109.313 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.0 mtt -126.44 122.17 34.52 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.711 0.767 . . . . 71.200000000000003 110.521 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 . . . . . 0 C--N 1.285 -2.214 0 N-CA-C 107.661 -1.237 . . . . 71.209999999999994 107.661 -178.0 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.3 m . . . . . 0 N--CA 1.413 -2.316 0 N-CA-C 108.711 -0.848 . . . . 70.209999999999994 108.711 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.0 p -121.71 118.87 30.18 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.454 -1.313 . . . . 75.299999999999997 107.454 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG13 HD12 ' A' ' 23' ' ' LEU . 3.3 p -96.64 123.19 48.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 122.201 1.001 . . . . 72.329999999999998 111.329 -173.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.7 m -118.21 129.5 55.53 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-N 114.179 -1.373 . . . . 60.32 108.277 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -92.61 130.0 38.38 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 108.373 -0.973 . . . . 51.399999999999999 108.373 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -101.11 114.98 29.42 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.397 -1.334 . . . . 72.519999999999996 107.397 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -111.36 124.9 53.19 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.163 -1.051 . . . . 72.340000000000003 108.163 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.57 101.44 11.31 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 117.081 -1.848 . . . . 72.030000000000001 111.959 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -83.24 -15.32 50.79 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.735 -1.575 . . . . 64.400000000000006 108.594 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.44 42.05 0.51 Allowed Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 107.362 -2.295 . . . . 73.030000000000001 107.362 -171.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -164.4 -25.85 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.725 -0.738 . . . . 64.120000000000005 111.794 -171.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 70.21 1.29 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 120.388 -0.91 . . . . 74.010000000000005 110.924 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -92.64 161.4 14.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.695 -0.483 . . . . 44.140000000000001 109.695 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.6 p -138.6 135.25 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.093 0.473 . . . . 61.020000000000003 110.507 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -130.76 117.2 19.05 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.141 -1.059 . . . . 64.129999999999995 108.141 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 32.5 tt0 -88.44 128.35 35.53 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.093 -0.643 . . . . 73.209999999999994 110.072 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 HG13 ' A' ' 9' ' ' VAL . 91.2 mt -64.88 136.83 57.3 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.124 -0.944 . . . . 62.229999999999997 112.064 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -93.23 163.39 13.64 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.387 -1.279 . . . . 72.430000000000007 109.266 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.82 126.95 29.29 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.821 0.7 . . . . 71.510000000000005 111.156 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.42 -161.75 15.27 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.938 -0.865 . . . . 44.240000000000002 110.938 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 67.8 p -93.99 126.0 38.94 Favored 'General case' 0 N--CA 1.418 -2.043 0 C-N-CA 119.381 -0.927 . . . . 71.209999999999994 111.81 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.6 129.94 45.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.954 -1.869 . . . . 63.329999999999998 105.954 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.5 mm -106.72 137.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 112.187 0.44 . . . . 73.239999999999995 112.187 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.01 136.39 50.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.76 -1.2 . . . . 52.25 107.76 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.74 -152.15 24.14 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.068 -1.213 . . . . 65.209999999999994 110.068 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 76.5 mtt180 -131.91 106.46 8.08 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.216 1.008 . . . . 63.130000000000003 108.617 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 36' ' ' ALA . . . 175.92 -168.1 40.19 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 119.739 -1.22 . . . . 71.239999999999995 111.974 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.6 -43.69 96.19 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.511 0.725 . . . . 72.040000000000006 109.914 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.25 -37.02 82.82 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 114.714 -1.13 . . . . 53.520000000000003 110.578 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB3' ' H ' ' A' ' 33' ' ' GLY . . . -72.54 105.49 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 114.288 1.218 . . . . 74.230000000000004 114.288 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 44.5 mt-30 -77.14 -47.77 19.5 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.814 -1.539 . . . . 74.049999999999997 107.076 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -95.24 115.45 27.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.788 -1.56 . . . . 74.319999999999993 106.788 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 99.2 mtt180 -109.45 137.38 47.4 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 120.78 0.324 . . . . 74.109999999999999 111.602 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 72.7 mt -90.65 134.5 30.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.773 -0.648 . . . . 73.409999999999997 111.964 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 18.3 Cg_exo -71.29 -19.74 28.83 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.35 2.7 . . . . 71.239999999999995 113.593 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.11 178.5 6.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 122.221 -0.299 . . . . 75.040000000000006 111.713 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 85.2 m -109.55 168.15 9.61 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 108.328 -0.989 . . . . 75.010000000000005 108.328 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.5 9.45 53.03 Favored Glycine 0 CA--C 1.499 -0.955 0 N-CA-C 108.408 -1.877 . . . . 63.219999999999999 108.408 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 49' ' ' HIS . 7.4 p -118.3 120.74 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 CA-C-N 113.326 -1.437 . . . . 73.310000000000002 109.744 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 m -82.15 -170.0 2.67 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.279 -0.638 . . . . 74.319999999999993 109.279 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 40.6 ptt180 -65.2 -28.12 69.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.928 -0.709 . . . . 73.319999999999993 111.436 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 48' ' ' ARG . 23.5 mtm180 -131.96 118.94 20.43 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.352 -0.981 . . . . 75.519999999999996 108.352 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.604 ' HB2' HG23 ' A' ' 45' ' ' VAL . 30.6 t60 -103.85 -31.03 9.99 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 124.43 1.092 . . . . 72.129999999999995 108.795 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 61' ' ' LEU . 9.3 tt -167.31 147.46 5.37 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.904 -0.776 . . . . 73.109999999999999 108.904 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.12 136.88 49.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.857 0.723 . . . . 74.0 110.112 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' SER . 64.9 mt -115.51 110.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.036 -1.098 . . . . 44.130000000000003 108.036 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 41.8 ttm105 -91.32 106.97 18.88 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.689 0.757 . . . . 75.140000000000001 109.03 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -97.17 107.06 19.5 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.644 -1.162 . . . . 74.109999999999999 110.33 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -107.25 -179.73 4.01 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.642 -1.984 . . . . 55.240000000000002 105.642 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.01 3.7 69.63 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 119.931 -1.128 . . . . 44.409999999999997 112.266 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -97.07 -75.2 0.55 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 122.893 0.477 . . . . 75.519999999999996 110.554 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.07 160.67 23.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.656 0.782 . . . . 73.439999999999998 109.639 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.07 104.88 17.41 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.391 -0.966 . . . . 41.520000000000003 108.391 177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.2 tt -80.51 110.87 16.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.623 -1.171 . . . . 63.130000000000003 109.159 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -92.9 121.74 34.57 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.177 -1.046 . . . . 74.239999999999995 108.177 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.99 112.27 14.47 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.391 -0.596 . . . . 74.549999999999997 109.391 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.76 135.98 36.64 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.446 -0.946 . . . . 74.129999999999995 108.446 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.9 tp -133.83 76.6 1.67 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.508 0.67 . . . . 60.409999999999997 109.827 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -163.06 164.21 25.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.479 -1.304 . . . . 63.310000000000002 107.479 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.6 p -106.27 -54.19 2.51 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.768 0.318 . . . . 61.509999999999998 111.545 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -89.21 -35.79 16.01 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.685 0.994 . . . . 73.400000000000006 113.685 -171.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.533 ' OD1' ' HA3' ' A' ' 91' ' ' GLY . 64.2 t30 -114.26 27.5 9.44 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.044 -0.725 . . . . 61.329999999999998 109.044 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.15 136.59 25.35 Favored Glycine 0 C--O 1.245 0.814 0 CA-C-N 114.039 -1.437 . . . . 74.120000000000005 113.713 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 136.27 38.65 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 124.259 1.024 . . . . 53.140000000000001 110.899 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 142.06 35.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.297 -1.001 . . . . 73.530000000000001 108.297 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 88' ' ' ILE . 29.7 m -117.2 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.682 -0.488 . . . . 41.399999999999999 109.682 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.15 35.76 25.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 70.209999999999994 110.521 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 65.12 23.18 12.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.279 1.432 . . . . 74.439999999999998 110.11 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.29 122.03 29.03 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.901 -0.778 . . . . 73.040000000000006 108.901 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.44 124.1 3.12 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 121.039 1.159 . . . . 71.430000000000007 111.797 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -144.18 179.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.803 -1.184 . . . . 72.109999999999999 107.803 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -104.16 -37.2 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 71.420000000000002 109.799 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -134.04 151.58 51.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.09 -0.707 . . . . 62.130000000000003 109.09 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -160.8 152.46 19.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.902 -1.148 . . . . 74.430000000000007 107.902 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.253 4.9 pp0? -109.98 113.06 25.47 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.809 -0.756 . . . . 73.200000000000003 110.162 173.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.7 mt -60.89 126.25 26.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.549 -1.205 . . . . 62.009999999999998 112.408 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.12 160.4 22.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.508 -0.923 . . . . 72.310000000000002 108.508 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 33.6 t70 -61.82 119.53 8.95 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 111.193 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.33 36.7 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.633 -0.712 . . . . 73.099999999999994 112.771 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.27 138.43 43.6 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 120.27 -0.572 . . . . 71.129999999999995 111.711 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -98.74 113.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.831 -0.803 . . . . 62.229999999999997 108.831 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.469 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -103.87 116.37 47.52 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 N-CA-C 107.277 -1.379 . . . . 74.019999999999996 107.277 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -114.51 121.71 44.34 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.709 -0.848 . . . . 64.129999999999995 108.709 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.69 162.87 18.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.441 -0.948 . . . . 72.219999999999999 108.441 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.533 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -76.97 87.13 0.97 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 119.038 -1.553 . . . . 70.310000000000002 110.694 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 t60 168.42 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.933 1.693 . . . . 64.420000000000002 108.366 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.7 p -168.15 -170.93 1.4 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.625 -0.716 . . . . 54.310000000000002 110.266 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.38 151.15 50.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.256 0.551 . . . . 62.009999999999998 109.979 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.447 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.95 142.24 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.056 -0.974 . . . . 72.400000000000006 110.833 -177.124 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.2 129.48 65.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.533 -0.914 . . . . 73.310000000000002 108.533 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.85 124.08 39.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.863 0.364 . . . . 71.510000000000005 110.231 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.449 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 12.9 mmm180 -123.66 135.07 53.7 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.576 -0.738 . . . . 64.329999999999998 110.324 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.1 mtt -113.66 124.88 53.37 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.534 0.683 . . . . 54.009999999999998 111.148 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 C--N 1.291 -1.943 0 N-CA-C 107.359 -1.349 . . . . 62.350000000000001 107.359 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.427 -1.617 0 CA-C-O 120.942 0.401 . . . . 63.009999999999998 109.934 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -125.12 139.34 53.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.51 -1.293 . . . . 65.030000000000001 107.51 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -117.13 122.01 69.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-O 121.787 0.803 . . . . 61.450000000000003 112.051 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 13.2 m -113.21 131.58 55.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.954 -1.128 . . . . 75.25 107.954 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 95' ' ' ILE . 4.4 pp -102.95 135.47 44.57 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.336 -0.616 . . . . 75.510000000000005 109.336 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 24.1 mt-30 -102.09 119.07 38.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.391 -0.368 . . . . 75.129999999999995 110.082 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 tp -107.79 135.09 49.79 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.644 -0.707 . . . . 54.409999999999997 109.417 -175.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.47 99.21 12.11 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 118.673 -1.211 . . . . 75.120000000000005 108.63 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 36.7 t70 -108.8 38.93 2.13 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.049 -1.834 . . . . 70.319999999999993 106.049 176.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.07 -54.02 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.512 -1.222 . . . . 55.439999999999998 110.881 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -87.82 -26.81 22.64 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.715 0.769 . . . . 74.420000000000002 109.916 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.83 96.73 0.93 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.048 -1.221 . . . . 74.519999999999996 110.048 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.429 ' HG3' ' HB3' ' A' ' 15' ' ' ASP . 14.7 mtm180 -102.08 165.79 10.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.149 -0.686 . . . . 63.100000000000001 109.149 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 12' ' ' GLN . 38.1 p -128.43 136.95 51.56 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 120.733 0.302 . . . . 73.310000000000002 110.474 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.467 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 82.3 t80 -128.36 123.53 34.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.344 -1.354 . . . . 63.140000000000001 107.344 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.0 tt0 -96.12 133.22 40.66 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.964 -0.754 . . . . 73.400000000000006 108.964 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HB2' HG13 ' A' ' 9' ' ' VAL . 92.3 mt -73.46 143.58 46.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.824 -0.626 . . . . 73.439999999999998 109.787 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -108.4 152.11 25.12 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.512 -1.292 . . . . 75.319999999999993 107.512 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.68 126.76 28.49 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.538 0.685 . . . . 72.319999999999993 111.423 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.24 -169.37 19.11 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 107.254 -2.339 . . . . 53.350000000000001 107.254 -174.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -106.49 128.75 54.33 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 118.899 1.349 . . . . 65.150000000000006 110.239 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HG3' ' A' ' 37' ' ' GLN . 6.1 p30 -110.34 146.35 35.92 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.104 -0.953 . . . . 64.200000000000003 108.56 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.41 HG21 ' HG2' ' A' ' 48' ' ' ARG . 60.4 mt -123.73 135.47 63.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 109.814 -0.439 . . . . 73.310000000000002 109.814 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 64.9 mt -107.5 134.71 48.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.28 -1.007 . . . . 72.230000000000004 108.28 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 156.75 -152.02 23.4 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 108.667 -1.773 . . . . 41.329999999999998 108.667 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.702 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 67.2 mtp180 -135.49 106.88 6.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.566 1.183 . . . . 73.420000000000002 109.23 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.81 171.85 41.67 Favored Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.497 -1.841 . . . . 62.119999999999997 108.497 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -77.02 -17.05 59.08 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.197 0.999 . . . . 74.120000000000005 110.696 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -94.05 -4.4 49.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.416 -0.811 . . . . 63.240000000000002 110.198 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.27 133.86 34.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 54.240000000000002 109.816 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 28' ' ' ASN . 73.3 mm-40 -81.67 -57.85 3.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.748 -0.66 . . . . 63.420000000000002 109.706 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 84.2 t80 -101.31 110.23 22.2 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.825 -1.176 . . . . 70.209999999999994 107.825 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 90.8 mtt180 -96.52 123.1 40.08 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.548 -0.751 . . . . 74.329999999999998 111.27 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 45' ' ' VAL . 55.8 mt -75.98 138.36 69.14 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.716 -0.674 . . . . 74.439999999999998 112.006 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.04 38.16 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.39 2.726 . . . . 74.25 112.668 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -134.92 173.22 11.95 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.95 -1.13 . . . . 74.310000000000002 107.95 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -122.34 155.87 35.1 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.988 -0.745 . . . . 62.549999999999997 108.988 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.06 -23.86 26.37 Favored Glycine 0 C--N 1.312 -0.775 0 N-CA-C 109.155 -1.578 . . . . 74.200000000000003 109.155 -174.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG21 HD12 ' A' ' 40' ' ' LEU . 7.3 p -81.48 141.16 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.87 -1.165 . . . . 70.439999999999998 109.637 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -76.3 -177.23 3.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.35 -0.841 . . . . 71.549999999999997 111.146 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.702 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.3 ptm180 -65.46 -39.87 92.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 74.129999999999995 109.861 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.41 ' HG2' HG21 ' A' ' 29' ' ' ILE . 50.6 mtm-85 -126.2 119.85 28.54 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.176 -1.416 . . . . 73.510000000000005 107.176 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.404 ' HB2' HG23 ' A' ' 45' ' ' VAL . 49.6 t60 -105.33 -35.94 7.36 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.757 1.223 . . . . 51.530000000000001 109.641 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.491 HD11 HD21 ' A' ' 61' ' ' LEU . 9.1 tt -166.05 151.15 8.44 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 108.293 -1.003 . . . . 62.240000000000002 108.293 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -136.26 141.77 43.92 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.043 0.449 . . . . 61.219999999999999 110.323 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 70.0 mt -120.69 118.72 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 115.666 -0.697 . . . . 71.200000000000003 109.469 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.7 ttt180 -91.57 111.06 22.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.505 -1.295 . . . . 75.219999999999999 107.505 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -106.22 126.52 52.32 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.411 0.624 . . . . 73.109999999999999 109.793 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -139.0 172.42 12.87 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.422 -2.066 . . . . 71.340000000000003 105.422 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.7 69.32 2.39 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 120.761 -0.733 . . . . 53.439999999999998 112.311 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.425 HE21 HG22 ' A' ' 58' ' ' VAL . 25.4 tt0 -162.88 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.46 -0.941 . . . . 74.030000000000001 108.46 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.425 HG22 HE21 ' A' ' 57' ' ' GLN . 30.8 m -143.17 159.5 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.779 -0.823 . . . . 64.299999999999997 108.779 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -94.59 115.1 27.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.118 -0.697 . . . . 52.140000000000001 109.118 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -85.64 110.44 19.28 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.351 -0.84 . . . . 61.210000000000001 111.212 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 50' ' ' LEU . 2.4 tm? -89.6 128.25 36.01 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.237 -1.023 . . . . 71.319999999999993 108.237 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -136.12 122.65 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.103 -0.703 . . . . 64.109999999999999 109.103 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.27 129.68 37.24 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.625 0.578 . . . . 64.340000000000003 110.069 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.49 75.26 1.57 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.477 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t30 169.53 107.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.784 0.833 . . . . 72.140000000000001 109.679 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.9 t -78.53 -22.24 47.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.342 -0.39 . . . . 64.140000000000001 110.735 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -65.02 -45.82 83.9 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.109 0.481 . . . . 74.420000000000002 111.907 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -118.95 28.33 8.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.139 -0.689 . . . . 73.120000000000005 109.139 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.14 129.63 4.53 Favored Glycine 0 C--O 1.258 1.649 0 O-C-N 124.838 1.336 . . . . 70.439999999999998 115.045 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -80.0 145.79 32.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.926 -1.137 . . . . 70.439999999999998 112.466 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -121.29 142.53 49.86 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.308 -0.86 . . . . 43.109999999999999 110.542 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 80' ' ' TRP . 35.6 m -117.53 119.46 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.684 -1.599 . . . . 73.109999999999999 106.684 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 62.24 24.58 14.64 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.035 0.934 . . . . 63.210000000000001 108.652 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 77.91 6.39 2.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.551 1.54 . . . . 62.0 112.854 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.63 118.26 66.15 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 74.019999999999996 108.795 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.76 125.28 11.47 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 121.552 1.501 . . . . 71.409999999999997 110.646 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.8 m -137.29 169.15 19.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.873 -0.788 . . . . 51.119999999999997 108.873 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -107.03 -20.16 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.353 . . . . 71.0 110.77 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.8 pt-20 -152.61 146.41 25.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.19 -0.67 . . . . 73.0 109.19 176.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CD2' HG21 ' A' ' 72' ' ' VAL . 66.7 t-105 -160.89 152.29 19.19 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.749 -0.834 . . . . 71.319999999999993 108.749 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -104.57 103.11 12.72 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.03 -0.73 . . . . 74.120000000000005 109.03 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.447 HD22 HD11 ' A' ' 88' ' ' ILE . 58.5 mt -59.52 145.04 45.6 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.967 -1.015 . . . . 63.219999999999999 111.414 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.01 169.51 17.67 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.123 -1.066 . . . . 73.299999999999997 108.123 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.83 119.12 12.0 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 123.346 0.404 . . . . 73.25 110.13 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.09 53.04 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.703 -0.68 . . . . 54.43 113.522 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -82.06 146.32 29.72 Favored 'General case' 0 C--O 1.255 1.384 0 N-CA-C 107.728 -1.212 . . . . 45.229999999999997 107.728 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.09 112.79 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.193 -0.669 . . . . 64.409999999999997 109.193 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.512 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.71 127.58 60.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.283 -1.377 . . . . 74.340000000000003 107.283 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 90' ' ' LEU . 2.4 tmm_? -134.56 134.35 41.26 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.088 -1.079 . . . . 70.129999999999995 108.088 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 90' ' ' LEU . 2.0 pt? -127.31 162.47 26.18 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.476 -1.305 . . . . 74.400000000000006 107.476 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.4 86.98 0.51 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 119.158 -1.496 . . . . 53.100000000000001 111.148 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.0 t60 169.46 -48.79 0.01 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.145 1.778 . . . . 71.25 108.781 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.0 t -164.16 -175.37 3.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.938 -0.574 . . . . 71.140000000000001 110.111 -174.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -123.62 145.15 49.15 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.46 -0.941 . . . . 72.129999999999995 108.46 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -136.64 137.1 47.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.687 0.756 . . . . 75.400000000000006 111.843 -176.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.9 mt -107.62 131.65 57.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.488 -0.93 . . . . 73.040000000000006 108.488 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.6 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.622 0.249 . . . . 63.32 110.665 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -127.28 140.95 51.86 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.402 -0.363 . . . . 72.209999999999994 110.597 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.8 mtt -113.45 134.28 54.75 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.945 -0.57 . . . . 64.5 109.999 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--N 1.289 -2.038 0 N-CA-C 106.962 -1.496 . . . . 72.239999999999995 106.962 -177.012 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.0 m . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 109.743 -0.465 . . . . 75.329999999999998 109.743 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.448 ' HB2' ' CD2' ' A' ' 100' ' ' HIS . 15.2 m -85.07 115.11 22.69 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.616 -1.253 . . . . 72.329999999999998 107.616 174.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.44 106.85 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.846 -1.909 . . . . 71.420000000000002 105.846 174.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.6 m -113.97 119.36 36.95 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.496 -0.775 . . . . 53.5 109.216 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 3.2 pp -91.72 130.7 37.46 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.523 -0.762 . . . . 75.129999999999995 110.805 178.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.69 119.63 39.84 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.275 -1.33 . . . . 73.299999999999997 107.579 -175.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -107.5 116.91 32.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.508 -0.553 . . . . 61.210000000000001 109.508 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.98 99.52 12.21 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.642 -1.614 . . . . 60.100000000000001 106.642 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -115.06 -19.06 11.04 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.309 -1.314 . . . . 62.439999999999998 109.868 -177.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.2 4.85 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 110.757 -0.937 . . . . 63.009999999999998 110.757 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 t -122.29 -33.88 3.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.321 -0.622 . . . . 43.340000000000003 109.321 175.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.03 79.13 1.38 Allowed Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.463 -1.855 . . . . 70.209999999999994 108.463 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -89.51 145.46 25.27 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.883 -0.414 . . . . 55.5 109.883 -176.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 30.3 p -134.16 135.29 43.0 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.102 0.477 . . . . 64.120000000000005 111.211 -176.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 11' ' ' LEU . 46.4 t80 -139.03 120.42 14.91 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.75 -0.659 . . . . 74.439999999999998 110.69 178.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -83.46 127.23 33.53 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.523 -0.917 . . . . 73.109999999999999 108.523 176.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.78 149.33 50.7 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.05 -0.523 . . . . 74.109999999999999 111.019 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -102.64 162.38 12.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.199 -1.408 . . . . 70.349999999999994 107.199 173.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.88 145.66 51.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.215 -0.661 . . . . 72.239999999999995 109.215 177.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.51 -168.2 15.25 Favored Glycine 0 N--CA 1.412 -2.936 0 N-CA-C 106.887 -2.485 . . . . 64.439999999999998 106.887 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 30.0 p -103.03 130.95 50.32 Favored 'General case' 0 C--N 1.27 -2.853 0 C-N-CA 118.499 -1.28 . . . . 72.310000000000002 111.519 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.523 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -102.35 110.42 22.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.843 -1.91 . . . . 75.040000000000006 105.843 -179.009 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.2 mt -97.86 132.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 120.929 0.395 . . . . 33.25 111.538 -173.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.44 133.69 55.05 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 C-N-CA 123.846 0.858 . . . . 75.109999999999999 109.601 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA2' ' CG2' ' A' ' 45' ' ' VAL . . . 151.54 -173.75 30.82 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.686 -0.966 . . . . 43.43 110.686 177.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.687 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 97.5 mtt180 -118.19 104.23 10.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.119 -1.437 . . . . 74.109999999999999 107.119 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 -176.93 48.05 Favored Glycine 0 N--CA 1.42 -2.427 0 N-CA-C 111.401 -0.68 . . . . 72.120000000000005 111.401 -175.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 35' ' ' ASP . 10.4 pt20 -58.74 -49.6 77.02 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 124.016 0.926 . . . . 71.040000000000006 113.135 -176.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 13.5 m-20 -81.8 -19.87 40.29 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.203 0.525 . . . . 61.299999999999997 111.016 -172.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.62 145.5 45.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.572 -0.74 . . . . 75.239999999999995 112.12 -174.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -106.81 -55.84 2.27 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.014 -0.994 . . . . 74.540000000000006 108.667 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -95.0 125.37 39.62 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.809 -1.087 . . . . 74.010000000000005 109.872 -177.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -97.7 144.59 27.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.344 -0.984 . . . . 72.439999999999998 108.344 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 58.2 mt -94.56 131.16 31.47 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 109.489 -0.56 . . . . 65.439999999999998 109.489 173.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 21.2 Cg_exo -67.54 -26.48 40.12 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.112 2.542 . . . . 53.399999999999999 112.605 -178.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 168.38 11.4 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.349 -0.387 . . . . 51.32 110.633 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -84.68 -177.05 6.49 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.021 -0.733 . . . . 74.239999999999995 109.021 178.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.91 66.9 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.138 -0.785 . . . . 71.530000000000001 111.138 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.481 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 11.1 p -90.15 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.284 -0.958 . . . . 73.219999999999999 109.356 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -102.38 -174.07 2.48 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.861 -0.422 . . . . 75.209999999999994 109.861 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 36.1 ptt180 -64.43 -41.6 96.5 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.891 0.853 . . . . 72.439999999999998 110.269 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -129.26 107.75 9.79 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 104.012 -2.588 . . . . 73.209999999999994 104.012 172.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -101.35 -37.36 8.51 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.935 0.772 . . . . 72.420000000000002 109.145 -176.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.489 HD11 HD21 ' A' ' 61' ' ' LEU . 7.5 tt -165.09 147.97 8.22 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.996 -0.547 . . . . 53.049999999999997 109.896 -177.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HG2' HD21 ' A' ' 64' ' ' LEU . 11.8 pt-20 -133.27 132.45 41.42 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.491 -0.559 . . . . 71.129999999999995 109.491 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.5 mt -106.76 113.62 43.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 108.843 -0.799 . . . . 74.140000000000001 108.843 176.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 29.9 ttt180 -91.25 111.43 22.91 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.482 0.658 . . . . 71.349999999999994 109.541 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -104.4 127.45 52.08 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.47 -0.786 . . . . 75.420000000000002 110.567 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -132.14 172.73 12.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.531 -2.026 . . . . 74.219999999999999 105.531 176.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.67 53.09 3.97 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.684 -0.769 . . . . 74.439999999999998 111.681 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -140.79 -80.48 0.26 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 124.728 1.211 . . . . 71.510000000000005 107.784 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.34 160.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 C-N-CA 125.326 1.45 . . . . 65.219999999999999 107.1 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.24 115.49 28.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.47 0.652 . . . . 63.340000000000003 109.604 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 tp -85.17 114.12 22.05 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.07 -0.968 . . . . 73.510000000000005 110.5 -177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.489 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -92.11 113.49 25.77 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.641 -1.244 . . . . 74.430000000000007 107.641 -179.027 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.75 121.14 39.39 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.826 -0.435 . . . . 64.400000000000006 109.826 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -91.48 133.0 35.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.627 -0.715 . . . . 74.5 111.43 -177.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.457 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.2 mm? -123.55 76.12 1.39 Allowed 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.645 -0.872 . . . . 51.329999999999998 108.645 173.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -173.7 112.14 0.19 Allowed 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 109.048 -0.723 . . . . 75.230000000000004 109.048 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -84.31 -17.67 38.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.322 0.49 . . . . 62.340000000000003 112.322 -178.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -89.19 -55.93 3.47 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.424 0.63 . . . . 61.420000000000002 111.084 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -110.5 29.57 7.59 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.659 0.784 . . . . 75.409999999999997 109.905 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.48 141.49 2.5 Favored Glycine 0 C--O 1.258 1.632 0 O-C-N 125.018 1.449 . . . . 73.450000000000003 115.745 -175.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.2 m -65.29 135.36 55.25 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.466 -1.367 . . . . 72.310000000000002 112.463 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 75' ' ' ALA . 1.3 m -113.37 139.84 48.54 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.594 -1.632 . . . . 74.200000000000003 106.594 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 88' ' ' ILE . 29.2 m -120.26 121.24 65.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.228 -0.656 . . . . 71.430000000000007 109.228 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 58.35 29.88 18.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.829 0.824 . . . . 72.150000000000006 110.319 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t30 76.9 23.78 0.96 Allowed 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 126.07 1.748 . . . . 74.439999999999998 111.05 179.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 71' ' ' THR . . . -125.82 118.04 24.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 121.752 -0.593 . . . . 73.219999999999999 110.144 177.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.86 133.4 31.29 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.566 2.177 . . . . 74.120000000000005 112.177 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.23 169.14 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 50.130000000000003 110.199 -177.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -102.81 -21.47 14.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.387 -0.968 . . . . 60.229999999999997 108.387 174.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -157.78 155.63 30.14 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.254 -1.017 . . . . 74.010000000000005 108.254 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.407 ' CD2' HG21 ' A' ' 72' ' ' VAL . 71.2 t-105 -161.0 151.99 18.63 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 72.120000000000005 108.741 -178.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.97 103.46 14.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.764 -0.828 . . . . 71.040000000000006 108.764 176.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 89.8 mt -57.6 139.99 52.16 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.93 0.715 . . . . 61.32 112.93 -176.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.9 166.6 23.25 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.814 -1.18 . . . . 63.020000000000003 107.814 173.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.15 118.78 9.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.872 0.368 . . . . 72.120000000000005 110.854 -179.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.15 35.71 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.004 -0.617 . . . . 43.25 113.134 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -87.1 136.51 32.9 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.909 -0.716 . . . . 74.230000000000004 109.874 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 t -100.33 113.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.074 -0.713 . . . . 73.239999999999995 109.074 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.48 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -102.71 111.95 34.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.972 -0.751 . . . . 73.329999999999998 108.972 -178.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -107.63 119.96 40.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.627 -0.715 . . . . 71.310000000000002 110.104 -178.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.6 pt? -125.27 164.3 20.65 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.405 -0.816 . . . . 74.530000000000001 108.942 -176.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.75 112.06 0.62 Allowed Glycine 0 CA--C 1.529 0.938 0 O-C-N 123.574 0.546 . . . . 52.229999999999997 113.315 178.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 71.7 6.67 5.74 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.399 1.479 . . . . 74.099999999999994 114.834 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.7 t -149.2 163.35 37.88 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.794 -0.762 . . . . 44.109999999999999 111.241 -177.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.88 126.36 13.22 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.518 -0.919 . . . . 74.430000000000007 108.518 176.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 7.9 tp -124.42 138.04 55.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.62 -0.718 . . . . 70.230000000000004 109.071 -173.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.8 125.15 65.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.859 -0.793 . . . . 71.150000000000006 108.859 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -89.87 121.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.706 0.288 . . . . 62.119999999999997 111.423 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -120.36 151.22 39.56 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.199 -0.667 . . . . 74.200000000000003 109.199 176.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.1 mtt -125.42 145.61 49.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.274 0.559 . . . . 70.129999999999995 111.597 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 12.3 m-70 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 107.932 -1.136 . . . . 75.450000000000003 107.932 178.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m . . . . . 0 N--CA 1.425 -1.678 0 CA-C-O 120.685 0.279 . . . . 50.340000000000003 110.457 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 m -93.05 115.29 27.97 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 106.966 -1.494 . . . . 72.239999999999995 106.966 174.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -105.51 120.79 56.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.895 0.855 . . . . 72.409999999999997 110.447 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 11.6 m -119.6 137.68 53.7 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.864 -1.062 . . . . 61.439999999999998 109.624 -172.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 95' ' ' ILE . 4.5 pp -97.55 136.68 37.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.333 -0.618 . . . . 71.5 109.333 178.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 115.87 28.72 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.584 -1.635 . . . . 71.319999999999993 106.584 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.79 134.71 49.53 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.986 -0.552 . . . . 73.5 111.826 -175.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.42 99.9 5.03 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.08 -1.822 . . . . 44.420000000000002 106.08 171.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 19' ' ' ARG . 23.9 t70 -114.78 8.17 16.01 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 113.82 -1.537 . . . . 64.219999999999999 110.206 -176.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.82 -48.03 0.99 Allowed Glycine 0 CA--C 1.491 -1.457 0 N-CA-C 109.358 -1.497 . . . . 70.109999999999999 109.358 -176.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -127.35 -39.57 1.87 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.967 -0.753 . . . . 52.439999999999998 108.967 175.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.97 116.8 1.61 Allowed Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 120.41 -0.9 . . . . 70.129999999999995 111.869 177.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 15' ' ' ASP . 44.5 mtm105 -118.61 156.73 28.68 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.28 -0.267 . . . . 74.129999999999995 110.28 175.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.5 p -126.36 152.88 45.68 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.067 -0.515 . . . . 74.430000000000007 110.587 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 57.3 t80 -148.02 131.58 16.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.698 -1.593 . . . . 74.310000000000002 106.698 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 21.0 tt0 -91.94 131.37 37.3 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.917 -0.713 . . . . 74.120000000000005 109.785 -178.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HB2' HG13 ' A' ' 9' ' ' VAL . 96.8 mt -68.51 147.15 52.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.744 . . . . 62.130000000000003 108.99 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -118.25 150.57 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.801 -0.814 . . . . 74.439999999999998 108.801 -177.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.32 116.97 2.7 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.97 1.418 . . . . 73.450000000000003 112.75 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.0 -172.67 20.08 Favored Glycine 0 N--CA 1.418 -2.524 0 N-CA-C 107.585 -2.206 . . . . 74.129999999999995 107.585 -174.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 33.6 p -106.72 134.25 50.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 118.487 1.144 . . . . 74.549999999999997 111.175 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.43 HD21 HD22 ' A' ' 23' ' ' LEU . 6.1 p30 -106.02 122.13 45.53 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.06 -0.718 . . . . 74.409999999999997 109.06 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.1 mm -88.86 121.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.358 -0.837 . . . . 64.439999999999998 108.997 -177.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 75.5 mt -103.12 126.12 57.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 74.129999999999995 108.725 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.41 -159.56 32.49 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 110.282 -1.127 . . . . 22.140000000000001 110.282 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.7 mtp180 -129.45 105.36 8.05 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.575 -0.898 . . . . 73.540000000000006 108.575 175.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.52 -164.54 34.31 Favored Glycine 0 N--CA 1.415 -2.717 0 N-CA-C 110.527 -1.029 . . . . 75.099999999999994 110.527 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -79.14 -38.47 35.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.21 -0.663 . . . . 73.109999999999999 109.21 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.48 -37.03 84.21 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.954 . . . . 74.310000000000002 109.552 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.96 118.56 7.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 114.137 -1.392 . . . . 51.420000000000002 111.894 -176.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -90.25 -37.47 14.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.402 -1.333 . . . . 64.129999999999995 107.402 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 34.7 t80 -107.1 114.19 28.1 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.184 -2.154 . . . . 73.239999999999995 105.184 176.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 92.9 mtt180 -106.9 131.55 53.85 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.939 -0.573 . . . . 63.109999999999999 110.899 -171.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.94 144.42 41.71 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.554 -0.748 . . . . 71.140000000000001 111.5 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -89.46 5.62 4.71 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.761 2.307 . . . . 74.409999999999997 114.3 -178.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.66 -176.12 3.17 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.884 -0.726 . . . . 64.439999999999998 109.317 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -106.3 175.97 5.32 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.7 0.286 . . . . 72.409999999999997 110.758 -174.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.84 80.88 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 110.763 -0.935 . . . . 72.319999999999993 110.763 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.461 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 22.5 t -103.69 130.19 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 114.903 -0.648 . . . . 61.409999999999997 109.915 -175.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 178.59 7.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.032 -0.729 . . . . 61.140000000000001 109.032 177.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 16.9 ptm180 -67.81 -31.16 70.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.702 0.763 . . . . 73.430000000000007 109.791 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -133.71 100.53 4.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.166 -2.161 . . . . 74.239999999999995 105.166 172.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -94.71 -38.5 10.78 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.091 -0.707 . . . . 73.040000000000006 109.091 -178.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.93 156.42 19.89 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.892 -1.151 . . . . 70.120000000000005 107.892 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -137.04 147.47 46.2 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 109.027 -0.731 . . . . 70.450000000000003 109.027 176.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.3 mt -116.14 111.29 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 107.948 -1.13 . . . . 73.310000000000002 107.948 174.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.6 ttt180 -91.23 115.48 28.06 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.843 -1.169 . . . . 72.219999999999999 107.843 175.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -108.67 106.8 17.01 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 108.573 -0.899 . . . . 73.010000000000005 108.573 176.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.38 172.42 6.97 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 105.471 -2.048 . . . . 71.420000000000002 105.471 177.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 63.15 4.44 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 120.25 -0.976 . . . . 63.350000000000001 112.004 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -162.92 -68.55 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 32.409999999999997 108.795 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.8 m -137.99 157.08 32.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 CA-C-N 116.178 -0.465 . . . . 71.329999999999998 109.877 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.31 106.08 18.09 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.479 -0.934 . . . . 74.040000000000006 108.479 178.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.7 tt -90.01 115.15 27.08 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.113 -0.949 . . . . 75.519999999999996 108.987 -174.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.2 117.6 31.77 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.705 -1.591 . . . . 70.430000000000007 106.705 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.63 33.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.86 -0.422 . . . . 73.019999999999996 109.86 178.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -95.7 128.17 42.35 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.117 -0.698 . . . . 74.329999999999998 109.117 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.47 77.37 1.05 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 105.681 -1.97 . . . . 74.040000000000006 105.681 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.454 HD21 ' C ' ' A' ' 68' ' ' ASN . 8.4 t30 -178.48 132.26 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.496 -0.482 . . . . 64.439999999999998 110.45 -164.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 p -109.21 -53.52 2.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.188 0.811 . . . . 75.120000000000005 113.188 178.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -71.68 -34.79 69.98 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.458 0.91 . . . . 42.530000000000001 113.458 -173.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.454 ' C ' HD21 ' A' ' 65' ' ' ASN . 5.0 m-20 -107.47 29.27 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.319 -0.623 . . . . 73.120000000000005 109.319 -176.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.27 129.38 4.67 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 124.263 0.977 . . . . 72.299999999999997 115.366 -171.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.6 m -74.23 139.0 44.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.503 -0.849 . . . . 71.519999999999996 111.152 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -103.35 141.26 36.24 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.379 0.609 . . . . 72.030000000000001 111.462 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.442 HG12 HG13 ' A' ' 88' ' ' ILE . 27.0 m -116.98 117.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.376 -1.342 . . . . 74.299999999999997 107.376 174.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.55 34.63 24.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.696 -0.684 . . . . 72.530000000000001 110.134 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 86.27 -10.2 0.69 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.784 1.634 . . . . 64.409999999999997 112.995 178.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.32 124.95 47.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 121.745 -0.597 . . . . 73.329999999999998 111.158 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.52 125.42 10.1 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 122.47 2.113 . . . . 73.400000000000006 111.502 178.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.19 172.87 15.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 110.24 -0.281 . . . . 70.25 110.24 -177.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -102.59 -35.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.205 -0.665 . . . . 64.319999999999993 109.205 175.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.41 149.72 30.41 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.915 -0.584 . . . . 60.299999999999997 110.008 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -159.05 152.56 22.8 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.254 -1.017 . . . . 72.430000000000007 108.254 -173.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.41 111.75 24.59 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.659 -0.817 . . . . 75.140000000000001 109.825 174.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -58.34 134.67 56.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.21 -1.359 . . . . 74.329999999999998 112.43 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.32 164.29 16.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.617 -0.883 . . . . 75.340000000000003 108.617 172.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.417 ' CG ' HH21 ' A' ' 98' ' ' ARG . 26.2 t70 -66.97 114.48 5.8 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.13 0.49 . . . . 74.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.05 0.55 33.72 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.399 -0.819 . . . . 73.329999999999998 112.567 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -72.01 142.46 49.33 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.218 0.509 . . . . 72.409999999999997 111.494 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.64 113.78 42.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.262 -0.881 . . . . 74.25 108.941 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.442 HG13 HG12 ' A' ' 72' ' ' VAL . 2.9 mp -110.79 116.61 52.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.421 -0.955 . . . . 71.510000000000005 108.421 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -117.35 130.78 56.73 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.691 0.758 . . . . 75.400000000000006 110.785 -177.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -131.28 163.98 26.6 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.576 -1.268 . . . . 54.509999999999998 107.576 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.35 98.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.959 0.787 . . . . 64.409999999999997 114.865 -177.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 75.02 19.64 2.31 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 125.762 1.625 . . . . 74.349999999999994 114.071 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -148.37 138.32 22.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.613 -0.514 . . . . 70.510000000000005 109.613 176.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -133.62 120.58 20.88 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.607 0.718 . . . . 73.030000000000001 109.862 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 11' ' ' LEU . 9.7 tp -116.04 140.83 36.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.961 -1.018 . . . . 62.25 110.178 -172.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.15 138.13 39.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.5 -0.926 . . . . 74.409999999999997 108.5 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.55 124.44 54.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 120.886 0.374 . . . . 75.120000000000005 110.993 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.417 HH21 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -121.19 139.6 53.15 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.683 -0.858 . . . . 71.209999999999994 108.683 177.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.4 mtt -123.27 138.33 54.65 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 120.855 0.36 . . . . 73.519999999999996 110.622 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 108.488 -0.93 . . . . 73.409999999999997 108.488 -178.401 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.436 -1.163 0 N-CA-C 109.172 -0.677 . . . . 74.430000000000007 109.172 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -119.66 114.85 22.83 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.249 -1.019 . . . . 52.229999999999997 108.249 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.79 126.29 48.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.683 -0.858 . . . . 62.140000000000001 108.683 -175.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 46.0 m -131.84 122.85 26.4 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.805 -0.813 . . . . 53.240000000000002 108.805 -175.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 pp -88.9 136.39 33.03 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-O 121.207 0.527 . . . . 55.240000000000002 109.999 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.78 109.8 21.03 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.815 -1.084 . . . . 75.519999999999996 109.031 -172.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -99.49 105.66 17.6 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.298 -1.001 . . . . 51.509999999999998 108.298 175.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -92.29 100.49 13.07 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.149 -1.021 . . . . 73.450000000000003 108.721 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.97 -28.84 12.88 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.276 -0.875 . . . . 71.540000000000006 109.203 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.07 -51.11 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.852 -1.067 . . . . 61.009999999999998 111.397 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.7 m -114.38 -2.3 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.366 -0.491 . . . . 74.349999999999994 111.857 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.91 103.07 1.13 Allowed Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 121.298 -0.477 . . . . 52.210000000000001 113.357 178.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.73 158.29 16.06 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.664 -0.865 . . . . 73.420000000000002 108.664 173.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -139.31 141.02 37.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 123.49 0.493 . . . . 75.120000000000005 110.182 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -136.06 114.32 11.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.523 -0.547 . . . . 73.310000000000002 109.523 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 35.7 tt0 -76.28 134.89 39.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 109.003 -0.74 . . . . 74.409999999999997 109.003 177.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.09 136.87 52.92 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.902 -0.59 . . . . 70.230000000000004 110.074 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HG2' ' OD1' ' A' ' 28' ' ' ASN . 9.4 ptp180 -75.37 158.4 32.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.287 -1.375 . . . . 74.129999999999995 107.287 175.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -73.54 132.87 43.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.287 -1.375 . . . . 72.310000000000002 107.287 171.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.43 -150.19 17.25 Favored Glycine 0 C--N 1.282 -2.45 0 N-CA-C 107.706 -2.157 . . . . 54.009999999999998 107.706 -173.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 p -104.56 139.69 39.07 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.578 -1.249 . . . . 74.25 112.539 -178.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 27.6 m-80 -107.16 110.05 22.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.172 -1.788 . . . . 60.340000000000003 106.172 176.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -100.47 122.38 52.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.657 -0.247 . . . . 70.349999999999994 111.047 -173.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 78.0 mt -109.51 129.0 65.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.712 -0.848 . . . . 75.109999999999999 108.712 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.35 179.27 37.7 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 109.701 -1.36 . . . . 63.130000000000003 109.701 178.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 70.8 mtp180 -112.1 105.37 13.73 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.766 -1.198 . . . . 73.319999999999993 107.766 179.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.48 164.76 31.05 Favored Glycine 0 N--CA 1.409 -3.112 0 N-CA-C 109.258 -1.537 . . . . 55.140000000000001 109.258 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.96 -25.72 67.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.836 0.318 . . . . 74.439999999999998 111.275 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.28 -29.04 59.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 45.409999999999997 110.405 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -75.62 153.36 37.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 73.209999999999994 112.386 -175.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -97.52 -43.61 7.17 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.35 -0.841 . . . . 73.340000000000003 109.633 -178.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 80.1 t80 -117.57 128.07 54.59 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.872 -1.159 . . . . 72.409999999999997 107.872 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.83 137.42 47.65 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 112.386 0.513 . . . . 72.510000000000005 112.386 -178.541 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.34 142.72 54.86 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 74.340000000000003 110.751 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -86.72 35.76 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.858 2.372 . . . . 71.200000000000003 112.304 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.27 -177.52 5.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.843 -0.799 . . . . 64.040000000000006 108.843 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.9 m -113.94 158.63 20.86 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.124 -0.695 . . . . 73.049999999999997 109.124 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.86 -2.18 44.97 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.06 -1.216 . . . . 53.409999999999997 110.06 -178.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.67 136.03 24.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 113.936 -1.132 . . . . 73.219999999999999 109.516 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 5.2 m -76.13 175.8 8.61 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.495 -0.928 . . . . 72.430000000000007 108.495 177.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.7 ptp180 -68.42 -29.46 68.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.831 0.824 . . . . 75.409999999999997 109.055 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' SER . 75.2 mtm180 -128.39 103.38 7.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 104.015 -2.587 . . . . 74.530000000000001 104.015 168.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -91.85 -33.36 14.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.356 -0.609 . . . . 75.230000000000004 109.356 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.437 HD11 HD21 ' A' ' 61' ' ' LEU . 7.2 tt -162.8 147.3 11.65 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.15 -0.685 . . . . 62.229999999999997 109.15 -178.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -129.23 143.86 51.01 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.425 0.631 . . . . 75.319999999999993 109.995 175.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -113.36 106.14 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 107.454 -1.313 . . . . 51.100000000000001 107.454 172.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -92.06 107.91 19.56 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.869 -1.16 . . . . 51.329999999999998 107.869 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.33 126.33 52.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 74.109999999999999 111.575 -174.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -136.68 155.19 50.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 105.551 -2.018 . . . . 63.549999999999997 105.551 176.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 55.43 1.74 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 118.302 0.501 . . . . 63.219999999999999 113.468 -177.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -149.21 -63.39 0.23 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.634 1.174 . . . . 72.540000000000006 108.048 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.93 159.61 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 123.536 0.734 . . . . 74.450000000000003 109.306 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.7 101.89 11.37 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.761 -1.199 . . . . 75.299999999999997 107.761 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.3 tp -90.13 101.81 14.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.019 -0.991 . . . . 75.439999999999998 111.225 -172.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -85.37 131.24 34.43 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.602 -1.259 . . . . 42.549999999999997 107.602 178.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 78' ' ' GLN . . . -138.77 116.88 11.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.39 . . . . 72.349999999999994 110.538 178.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -86.2 135.79 33.44 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.812 -0.631 . . . . 74.549999999999997 109.801 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.16 76.9 1.42 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.568 -1.271 . . . . 61.039999999999999 107.568 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 175.31 147.1 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.928 -0.767 . . . . 70.310000000000002 108.928 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 p -109.58 -48.01 3.29 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.962 0.727 . . . . 74.150000000000006 112.962 175.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -67.31 -33.94 76.33 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.642 0.734 . . . . 60.350000000000001 112.307 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.481 ' ND2' ' HA3' ' A' ' 91' ' ' GLY . 65.3 t30 -121.4 27.4 8.32 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.568 -1.271 . . . . 64.409999999999997 107.568 -173.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.41 143.01 4.87 Favored Glycine 0 C--O 1.25 1.147 0 CA-C-N 114.493 -1.231 . . . . 52.240000000000002 115.404 -175.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.2 m -84.53 151.23 24.71 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.003 0.906 . . . . 52.049999999999997 112.432 -176.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.4 p -121.38 143.8 49.01 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.164 -0.925 . . . . 64.209999999999994 110.967 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 80' ' ' TRP . 32.6 m -109.84 121.64 63.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 106.061 -1.829 . . . . 65.150000000000006 106.061 174.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 61.57 24.62 14.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.615 0.722 . . . . 72.219999999999999 109.302 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.5 10.26 2.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 126.326 1.85 . . . . 75.340000000000003 110.984 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.24 125.93 34.93 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.577 -0.702 . . . . 51.340000000000003 109.156 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 125.51 10.45 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.639 2.226 . . . . 72.349999999999994 114.124 -176.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -151.93 177.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 106.335 -1.728 . . . . 64.5 106.335 178.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 21.5 mt-30 -119.36 -37.08 3.23 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 109.729 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.91 133.56 55.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.627 -0.715 . . . . 61.32 109.352 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.466 ' CD2' HG21 ' A' ' 72' ' ' VAL . 76.8 t-105 -158.49 141.39 14.66 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 121.779 0.8 . . . . 74.530000000000001 111.115 -176.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -88.58 104.26 16.68 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 113.735 -1.575 . . . . 61.140000000000001 107.088 173.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.97 150.84 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.749 -0.66 . . . . 63.009999999999998 111.98 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.28 165.49 26.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.71 -0.848 . . . . 73.299999999999997 108.71 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.39 111.47 7.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.307 0.575 . . . . 73.019999999999996 110.207 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.1 19.56 16.46 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.604 -0.725 . . . . 64.540000000000006 111.901 -178.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.99 129.46 34.87 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.274 -1.38 . . . . 71.120000000000005 107.274 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.42 113.03 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.49 -0.93 . . . . 72.450000000000003 108.49 -178.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.453 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 42.3 mm -96.23 106.53 18.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.04 -1.837 . . . . 72.299999999999997 106.04 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 24.8 ttt85 -103.19 106.28 16.76 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.556 -1.276 . . . . 71.230000000000004 107.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -106.95 163.93 12.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.706 -1.133 . . . . 71.299999999999997 109.433 -174.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.481 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -41.3 101.05 0.02 OUTLIER Glycine 0 C--N 1.309 -0.929 0 N-CA-C 115.924 1.129 . . . . 63.009999999999998 115.924 -175.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 36.2 m80 74.29 15.77 3.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.739 1.616 . . . . 70.099999999999994 113.463 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.2 t -151.66 176.63 11.18 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.921 -0.399 . . . . 70.219999999999999 109.921 178.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.61 144.57 24.5 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.27 -1.011 . . . . 75.340000000000003 108.27 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 9.8 tp -140.4 140.56 34.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.826 -0.805 . . . . 71.5 108.826 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.5 mt -104.66 117.39 50.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.96 -0.755 . . . . 73.239999999999995 108.96 -178.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.24 122.23 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 110.369 -0.234 . . . . 64.239999999999995 110.369 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -115.83 151.57 35.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.361 -0.607 . . . . 72.120000000000005 109.361 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 mtt -122.1 117.03 25.31 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.634 -0.712 . . . . 63.229999999999997 109.445 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 . . . . . 0 C--N 1.275 -2.66 0 N-CA-C 108.063 -1.088 . . . . 74.200000000000003 108.063 -178.579 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.44 -0.936 0 N-CA-C 109.525 -0.546 . . . . 73.310000000000002 109.525 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -108.67 115.53 30.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.078 -0.51 . . . . 75.340000000000003 109.744 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.25 110.5 26.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.766 -1.198 . . . . 72.409999999999997 107.766 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -112.53 120.8 42.86 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.687 -0.857 . . . . 72.530000000000001 108.687 -174.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -91.53 137.34 32.44 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.647 -0.501 . . . . 63.119999999999997 109.647 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 26.6 mt-30 -104.02 127.3 51.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.389 -1.337 . . . . 64.5 107.389 174.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.6 135.22 52.94 Favored 'General case' 0 C--N 1.269 -2.892 0 O-C-N 123.399 0.437 . . . . 61.100000000000001 111.385 -173.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 100.33 11.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.732 -1.581 . . . . 73.030000000000001 106.732 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.4 ' CB ' ' HG2' ' A' ' 19' ' ' ARG . 16.8 t70 -104.36 1.69 30.49 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 113.606 -1.633 . . . . 73.209999999999994 110.059 -176.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.5 -41.54 1.86 Allowed Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 108.584 -1.807 . . . . 64.239999999999995 108.584 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -112.59 -63.92 1.37 Allowed 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.28 -1.378 . . . . 51.420000000000002 107.28 173.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.49 109.04 0.39 Allowed Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 111.242 -0.743 . . . . 53.100000000000001 111.242 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.4 ' HG2' ' CB ' ' A' ' 15' ' ' ASP . 35.6 mmt180 -101.11 157.08 17.03 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.104 -0.702 . . . . 73.200000000000003 109.104 177.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.0 p -137.75 132.6 32.99 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.628 -1.249 . . . . 71.0 107.628 174.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -138.49 129.31 26.62 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.797 -0.816 . . . . 70.340000000000003 108.797 -173.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -87.46 120.94 29.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.679 -0.86 . . . . 72.329999999999998 108.679 177.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.52 137.87 23.43 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 124.355 1.034 . . . . 70.420000000000002 111.475 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -85.12 144.7 28.05 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 108.9 -0.778 . . . . 73.420000000000002 108.9 -177.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.7 113.53 8.82 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.077 0.941 . . . . 71.400000000000006 109.947 178.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.58 -167.37 23.15 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 106.573 -2.611 . . . . 74.319999999999993 106.573 -171.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 58.1 p -106.46 127.76 53.54 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 118.981 1.39 . . . . 52.5 111.179 177.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -102.0 112.58 25.28 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.425 -0.807 . . . . 64.120000000000005 108.97 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.34 120.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.255 -0.884 . . . . 73.230000000000004 109.443 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.4 mt -99.99 130.62 48.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.238 -0.892 . . . . 64.049999999999997 109.194 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 157.32 -161.34 31.17 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.713 -1.355 . . . . 73.030000000000001 109.713 178.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.725 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 60.6 mtp180 -129.76 105.23 7.89 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.056 -1.461 . . . . 74.430000000000007 107.056 173.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.34 -176.19 47.69 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.944 -0.646 . . . . 64.219999999999999 111.615 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -63.23 -30.03 71.25 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 124.739 1.216 . . . . 75.319999999999993 113.177 -176.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.39 -6.61 37.11 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.822 0.344 . . . . 75.329999999999998 111.686 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 115.12 18.23 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.892 0.377 . . . . 74.340000000000003 111.992 -174.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.459 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 12.9 mm-40 -89.31 -29.44 19.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.478 -0.783 . . . . 72.230000000000004 109.434 177.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 85.4 t80 -115.18 108.95 17.29 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.259 -1.756 . . . . 75.230000000000004 106.259 173.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 59.5 mtt180 -99.13 120.63 39.82 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.035 -0.984 . . . . 74.329999999999998 110.375 -172.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.9 mt -73.05 138.32 79.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.886 -0.597 . . . . 70.340000000000003 110.557 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -84.35 1.67 8.56 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.41 2.074 . . . . 71.409999999999997 113.868 -177.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -102.85 163.63 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.308 -0.627 . . . . 54.229999999999997 109.308 -178.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.6 m -100.45 147.93 25.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 120.909 0.385 . . . . 55.210000000000001 110.455 -177.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.69 7.99 30.94 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 110.626 -0.99 . . . . 74.450000000000003 110.626 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG13 ' HD1' ' A' ' 49' ' ' HIS . 38.2 t -99.31 133.61 41.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 70.239999999999995 108.391 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.6 m -69.94 175.87 4.11 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.753 0.311 . . . . 52.109999999999999 111.388 178.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.2 ptp180 -65.27 -28.85 69.63 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.606 0.717 . . . . 65.510000000000005 111.299 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -135.59 119.16 16.99 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.579 -2.378 . . . . 74.25 104.579 169.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 3.7 t60 -104.62 -45.16 4.69 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.96 -0.756 . . . . 75.019999999999996 108.96 -177.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -163.29 154.25 16.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.279 -1.378 . . . . 75.109999999999999 107.279 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -136.84 143.89 43.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.698 -0.482 . . . . 73.420000000000002 109.698 176.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -112.42 115.26 49.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 108.562 -0.903 . . . . 74.209999999999994 108.562 177.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 47.3 ttt180 -93.0 107.25 19.07 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-O 121.305 0.574 . . . . 71.310000000000002 109.539 176.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -97.31 107.16 19.61 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.522 -1.288 . . . . 75.549999999999997 107.522 175.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.62 -173.18 2.4 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 105.18 -2.156 . . . . 71.150000000000006 105.18 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.58 4.75 85.12 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 118.797 -1.668 . . . . 72.430000000000007 111.969 -177.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -117.94 -61.31 1.7 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.578 -0.311 . . . . 70.319999999999993 111.817 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 157.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.949 0.404 . . . . 74.099999999999994 111.414 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 82' ' ' LEU . . . -102.68 104.66 15.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.172 -1.047 . . . . 64.430000000000007 108.172 176.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.9 tt -91.25 118.34 30.4 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.737 -1.12 . . . . 60.439999999999998 110.077 -174.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.04 122.32 43.87 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.217 -1.401 . . . . 72.450000000000003 107.217 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.6 118.95 12.85 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.489 -0.485 . . . . 74.329999999999998 112.008 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.446 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 0.8 OUTLIER -66.05 139.75 58.21 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.399 -0.963 . . . . 74.200000000000003 108.399 172.577 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -126.82 75.4 1.56 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 105.858 -1.904 . . . . 63.539999999999999 105.858 178.736 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 11.2 t-20 158.11 163.63 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 106.46 -1.681 . . . . 75.129999999999995 106.46 -178.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.9 m -108.04 -44.82 4.09 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 118.014 0.37 . . . . 60.25 111.711 176.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 m -73.99 -30.21 62.37 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.454 0.645 . . . . 74.340000000000003 111.649 -175.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.586 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.7 m120 -86.65 28.29 0.89 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.045 -0.409 . . . . 51.43 110.51 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.0 123.62 4.83 Favored Glycine 0 C--O 1.24 0.528 0 N-CA-C 116.116 1.206 . . . . 42.420000000000002 116.116 -174.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.446 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 88.0 m -91.77 151.04 20.79 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 124.733 1.213 . . . . 72.409999999999997 110.019 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 p -118.76 140.68 49.54 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 116.226 -0.443 . . . . 65.340000000000003 110.508 176.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.27 117.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.84 -1.17 . . . . 53.039999999999999 107.84 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 59.85 30.01 19.56 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.71 0.804 . . . . 72.030000000000001 110.325 -177.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 t30 79.79 1.41 2.14 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.948 1.699 . . . . 72.319999999999993 110.949 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.76 25.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 O-C-N 121.884 -0.51 . . . . 34.140000000000001 110.139 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.39 125.91 5.92 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.705 2.27 . . . . 74.519999999999996 112.469 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.01 -177.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.884 -1.154 . . . . 74.150000000000006 107.884 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.11 -10.15 7.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.046 0.45 . . . . 64.510000000000005 110.112 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -153.41 135.24 14.57 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 109.6 -0.519 . . . . 73.420000000000002 109.6 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -151.73 151.93 32.06 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.748 -0.66 . . . . 74.310000000000002 109.916 -174.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -102.78 114.65 29.09 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 72.319999999999993 108.182 174.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.435 HD12 ' HB1' ' A' ' 59' ' ' ALA . 64.3 mt -59.5 143.74 49.18 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.87 0.692 . . . . 65.200000000000003 112.87 -176.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.3 166.57 23.47 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.255 -1.017 . . . . 74.530000000000001 108.255 171.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.78 115.7 10.23 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.133 -0.321 . . . . 73.329999999999998 110.133 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 0.87 26.8 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.076 -0.583 . . . . 63.329999999999998 113.05 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -74.15 129.87 38.68 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.296 -0.562 . . . . 74.109999999999999 111.073 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.67 112.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 108.009 -1.108 . . . . 64.439999999999998 108.009 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.83 129.87 70.24 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 N-CA-C 109.736 -0.468 . . . . 73.010000000000005 109.736 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -123.75 131.9 53.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 110.093 -0.336 . . . . 71.430000000000007 110.093 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.13 140.17 37.84 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.369 -1.345 . . . . 61.009999999999998 107.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.48 88.3 0.0 OUTLIER Glycine 0 N--CA 1.489 2.178 0 O-C-N 125.4 1.688 . . . . 73.209999999999994 116.482 -174.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.7 m80 80.68 -33.51 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.596 1.558 . . . . 73.420000000000002 114.367 177.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -101.1 162.27 13.01 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.268 -0.573 . . . . 64.409999999999997 110.918 -173.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.06 143.18 31.77 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.28 0.562 . . . . 63.200000000000003 110.116 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -140.16 138.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 114.9 -1.046 . . . . 74.439999999999998 110.118 -173.563 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.17 128.36 67.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.936 -0.764 . . . . 74.209999999999994 108.936 177.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 82' ' ' LEU . 63.9 t -89.18 129.26 40.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 112.521 0.563 . . . . 75.230000000000004 112.521 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.32 137.12 51.97 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.313 -0.995 . . . . 63.32 108.313 172.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.3 mtp -126.27 112.42 15.7 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.464 -0.569 . . . . 54.439999999999998 109.464 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 . . . . . 0 C--N 1.275 -2.654 0 N-CA-C 108.255 -1.017 . . . . 73.340000000000003 108.255 -178.631 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 83.5 m . . . . . 0 N--CA 1.423 -1.82 0 N-CA-C 109.487 -0.56 . . . . 74.129999999999995 109.487 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.5 m -105.16 114.59 28.88 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.433 -0.951 . . . . 72.439999999999998 108.433 176.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -99.61 114.14 36.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.525 -1.287 . . . . 74.549999999999997 107.525 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.5 m -124.18 123.77 41.0 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.891 -0.781 . . . . 70.319999999999993 108.891 -176.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -102.99 128.23 49.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.71 -0.677 . . . . 64.510000000000005 109.311 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.57 132.7 51.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.387 -0.824 . . . . 65.340000000000003 110.424 -175.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.7 tp -121.5 111.55 17.4 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.378 -0.828 . . . . 65.409999999999997 109.321 -177.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -127.23 100.79 6.22 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.916 0.865 . . . . 54.329999999999998 109.735 177.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.05 19.53 15.67 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.555 -1.276 . . . . 71.299999999999997 107.555 174.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.75 16.82 12.0 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.666 -1.373 . . . . 61.109999999999999 109.666 -171.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 p -117.36 -68.32 0.93 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.317 0.58 . . . . 71.430000000000007 110.542 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.66 53.31 1.56 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.919 -0.872 . . . . 64.109999999999999 110.919 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.08 156.76 17.0 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.852 0.358 . . . . 51.310000000000002 111.121 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.2 p -132.34 143.98 50.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.777 -0.823 . . . . 73.219999999999999 108.777 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -135.48 134.16 39.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.392 -1.336 . . . . 74.200000000000003 107.392 175.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -110.06 135.07 51.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.846 -0.798 . . . . 53.450000000000003 108.846 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD22 HD21 ' A' ' 28' ' ' ASN . 83.5 mt -72.85 128.23 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.76 . . . . 73.340000000000003 111.65 -176.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -104.5 153.2 21.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.456 -2.424 . . . . 72.420000000000002 104.456 172.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.02 143.95 55.84 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.12 0.962 . . . . 72.340000000000003 113.336 -173.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.12 177.37 16.5 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 107.648 -2.181 . . . . 75.219999999999999 107.648 -174.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 29.8 t -100.09 125.17 46.15 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.479 -0.888 . . . . 72.329999999999998 108.854 176.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.42 HD21 HD22 ' A' ' 23' ' ' LEU . 3.4 p30 -108.07 120.57 42.7 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.942 -1.026 . . . . 74.420000000000002 110.319 -177.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.4 mt -86.05 127.81 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.889 -1.051 . . . . 74.010000000000005 110.539 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.602 HG23 HD21 ' A' ' 40' ' ' LEU . 55.4 mt -103.27 119.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 125.321 1.448 . . . . 65.209999999999994 108.329 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 167.46 -151.75 19.64 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.416 -0.674 . . . . 51.130000000000003 111.416 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 82.9 mtm180 -131.8 105.03 7.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 117.769 0.784 . . . . 74.099999999999994 109.519 176.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.84 -163.8 33.6 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.314 -0.946 . . . . 55.109999999999999 111.215 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -86.96 -34.16 19.4 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.931 -0.766 . . . . 75.049999999999997 108.931 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -33.48 74.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.385 -0.825 . . . . 65.230000000000004 109.585 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.03 129.19 39.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.833 -1.076 . . . . 71.019999999999996 110.779 -178.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -90.72 -26.67 19.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.544 -1.28 . . . . 74.040000000000006 107.544 178.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.63 116.17 25.46 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.218 -1.356 . . . . 71.530000000000001 107.411 178.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -101.58 117.34 34.7 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.974 -0.557 . . . . 65.200000000000003 111.218 -175.806 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.602 HD21 HG23 ' A' ' 30' ' ' ILE . 4.0 mm? -78.1 125.24 85.49 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.666 -0.697 . . . . 74.540000000000006 110.732 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -74.6 2.6 6.22 Favored 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 122.416 2.077 . . . . 63.439999999999998 113.658 178.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -104.85 -173.38 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.093 -1.077 . . . . 75.329999999999998 108.093 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -124.78 167.12 15.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.68 -0.859 . . . . 75.450000000000003 108.68 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.01 -3.48 62.27 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 108.818 -1.713 . . . . 64.120000000000005 108.818 -174.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.75 131.41 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.168 -1.516 . . . . 75.010000000000005 107.458 179.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -93.41 -177.57 4.47 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.503 -0.317 . . . . 72.25 111.81 -175.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.8 ptm180 -63.79 -36.03 82.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.516 0.674 . . . . 71.430000000000007 111.913 -177.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -133.17 99.4 4.54 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 105.481 -2.044 . . . . 62.229999999999997 105.481 175.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -104.37 -46.42 4.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.978 -1.01 . . . . 61.200000000000003 109.546 -176.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 tt -153.49 159.75 42.36 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.069 -1.086 . . . . 64.150000000000006 108.069 -176.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.0 149.68 40.34 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.177 -0.675 . . . . 63.229999999999997 109.177 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' SER . 68.3 mt -118.74 115.43 48.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.828 -0.804 . . . . 71.430000000000007 108.828 175.152 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -91.55 107.42 19.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.344 -1.354 . . . . 73.129999999999995 107.344 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -115.43 132.36 56.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.789 -0.641 . . . . 71.329999999999998 111.305 -177.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -143.0 169.39 17.65 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.627 -1.99 . . . . 53.439999999999998 105.627 173.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 65.67 1.77 Allowed Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.8 -0.714 . . . . 75.519999999999996 112.07 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -155.89 -73.47 0.11 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.249 1.02 . . . . 63.210000000000001 108.443 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.95 159.22 16.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.66 0.784 . . . . 63.020000000000003 109.332 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -103.85 104.69 14.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.193 -0.669 . . . . 70.040000000000006 109.193 178.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.28 114.07 26.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.204 -0.907 . . . . 71.230000000000004 109.788 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.75 122.51 36.29 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.896 -1.52 . . . . 74.439999999999998 106.896 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.78 124.47 18.33 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.71 -0.396 . . . . 72.219999999999999 110.568 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.512 ' OD2' ' HB ' ' A' ' 70' ' ' THR . 12.9 m-20 -72.45 143.98 48.27 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.466 -0.939 . . . . 61.299999999999997 108.466 174.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -121.98 75.72 1.24 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.874 -1.158 . . . . 72.230000000000004 107.874 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 165.87 153.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 104.939 -2.245 . . . . 73.319999999999993 104.939 -178.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -97.2 -33.66 11.4 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.798 -0.761 . . . . 74.010000000000005 112.387 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 t -89.1 -28.95 19.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.758 -0.377 . . . . 65.340000000000003 111.351 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -88.63 27.38 1.3 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 122.568 0.347 . . . . 71.219999999999999 111.882 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.82 129.38 47.08 Favored Glycine 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 43.43 112.001 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 15.6 m -86.79 157.75 19.52 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 124.821 1.248 . . . . 74.349999999999994 113.053 -173.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 p -102.69 140.7 36.62 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.134 0.492 . . . . 74.519999999999996 110.732 178.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.05 120.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.672 -1.232 . . . . 73.310000000000002 107.672 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 59.29 32.02 21.61 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.694 0.798 . . . . 74.530000000000001 109.924 -176.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.7 t30 75.4 9.27 3.74 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.0 1.32 . . . . 71.109999999999999 110.953 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.9 41.99 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.488 -0.56 . . . . 60.43 109.488 177.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.33 125.35 11.23 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.4 2.067 . . . . 62.119999999999997 111.913 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.28 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.635 -0.876 . . . . 53.329999999999998 108.635 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -126.61 -0.64 6.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.422 -0.584 . . . . 74.109999999999999 109.422 171.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -165.29 147.16 7.65 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.479 -0.934 . . . . 44.43 108.479 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -166.95 151.84 7.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.508 -0.923 . . . . 75.319999999999993 108.508 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -105.03 118.62 36.99 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.557 -0.857 . . . . 71.230000000000004 109.57 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 78.0 mt -61.62 150.23 36.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.644 -1.162 . . . . 73.299999999999997 113.717 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.52 174.77 10.66 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.844 -1.071 . . . . 73.209999999999994 108.154 172.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.06 112.3 12.36 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.655 -0.498 . . . . 73.310000000000002 109.655 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.0 14.85 11.41 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.665 -0.778 . . . . 71.209999999999994 113.153 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -79.98 121.46 25.51 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 119.523 -0.871 . . . . 72.319999999999993 110.692 175.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 112.61 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 106.743 -1.577 . . . . 62.299999999999997 106.743 175.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 95' ' ' ILE . 57.8 mt -120.45 140.1 45.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 109.388 -0.597 . . . . 63.229999999999997 109.388 -174.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -132.2 123.64 27.42 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.519 -0.872 . . . . 73.239999999999995 111.507 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.5 pt? -108.11 163.66 12.97 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.762 -1.57 . . . . 65.439999999999998 106.762 176.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.92 104.51 0.05 OUTLIER Glycine 0 CA--C 1.533 1.171 0 O-C-N 123.996 0.81 . . . . 72.019999999999996 114.403 -178.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.0 m80 80.32 -5.11 1.81 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.262 1.579 . . . . 73.140000000000001 115.262 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.4 m -138.17 136.51 36.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.995 0.816 . . . . 72.209999999999994 111.795 -177.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -107.56 138.44 43.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.226 -0.657 . . . . 64.099999999999994 109.226 175.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 5.4 tp -126.9 131.71 70.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.624 -0.88 . . . . 73.319999999999993 108.624 -175.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.5 119.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.654 -0.869 . . . . 72.310000000000002 108.654 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG11 ' HB3' ' A' ' 82' ' ' LEU . 95.6 t -90.62 125.01 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.209 0.528 . . . . 65.25 111.35 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.76 149.42 42.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.401 -0.818 . . . . 74.209999999999994 109.728 178.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' SER . 59.4 mtt -129.6 110.47 11.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.624 0.726 . . . . 53.439999999999998 109.459 176.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--N 1.278 -2.535 0 CA-C-N 114.852 -1.067 . . . . 72.019999999999996 109.857 -176.53 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.465 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 52.3 m . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 109.514 -0.55 . . . . 72.25 109.514 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -113.0 128.53 56.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.104 -0.498 . . . . 51.450000000000003 109.756 176.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -103.35 124.72 57.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 75.430000000000007 109.031 177.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.4 m -126.16 134.82 51.18 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.303 -0.862 . . . . 71.420000000000002 109.559 -173.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.7 mt -93.89 135.12 35.55 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.277 -1.009 . . . . 73.209999999999994 108.277 178.213 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -114.83 126.62 55.04 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 109.762 -0.458 . . . . 65.439999999999998 109.762 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -123.61 114.85 20.56 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.381 -0.97 . . . . 72.120000000000005 108.381 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -118.39 101.93 8.54 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.9 0.857 . . . . 63.530000000000001 111.608 -179.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.25 26.76 10.05 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.025 -1.843 . . . . 64.450000000000003 106.025 174.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.39 43.07 4.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.91 -2.076 . . . . 63.140000000000001 107.91 -173.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -147.73 -61.91 0.27 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.845 -0.677 . . . . 73.430000000000007 111.12 -172.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.88 39.8 5.73 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.002 -0.839 . . . . 74.209999999999994 111.002 -178.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.24 151.06 36.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 110.08 -0.341 . . . . 72.439999999999998 110.08 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.5 p -134.92 144.76 47.65 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.908 -0.587 . . . . 75.510000000000005 111.049 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -129.65 116.1 18.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.341 -0.615 . . . . 55.200000000000003 109.341 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -80.44 131.93 35.66 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.688 -0.486 . . . . 75.120000000000005 109.688 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.513 HD13 HG21 ' A' ' 52' ' ' ILE . 93.7 mt -85.05 122.34 29.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.817 -1.179 . . . . 72.409999999999997 107.817 174.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -93.89 178.88 5.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.966 -0.694 . . . . 71.310000000000002 109.236 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 132.46 45.99 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.441 0.639 . . . . 72.239999999999995 111.153 -176.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.37 -159.67 16.94 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.237 -1.545 . . . . 74.400000000000006 109.237 -176.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 p -106.6 144.61 33.01 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.371 -0.531 . . . . 60.030000000000001 109.625 177.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -121.89 112.05 17.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.134 -1.061 . . . . 43.32 108.134 -176.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.5 mm -86.2 130.56 36.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 109.399 -0.593 . . . . 71.340000000000003 109.399 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 38' ' ' PHE . 61.0 mt -115.69 135.79 54.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 123.238 0.615 . . . . 75.310000000000002 110.319 -178.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 148.23 -163.69 28.94 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 111.646 -0.582 . . . . 62.240000000000002 111.646 177.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.3 mtt180 -115.71 107.1 14.65 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.978 0.418 . . . . 74.439999999999998 110.114 176.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.62 -178.88 48.4 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.425 -1.47 . . . . 44.420000000000002 109.425 179.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.52 -13.69 53.99 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.502 0.668 . . . . 74.430000000000007 109.699 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -83.57 -24.38 31.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.2 -0.909 . . . . 52.240000000000002 109.449 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.67 139.25 31.53 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.55 -0.75 . . . . 54.210000000000001 111.955 -173.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -92.58 -44.92 8.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.474 -0.785 . . . . 74.230000000000004 108.942 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HB3' HG12 ' A' ' 30' ' ' ILE . 68.6 t80 -101.42 108.58 20.22 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.219 -1.03 . . . . 62.43 108.219 177.037 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.8 mtm-85 -96.19 127.39 42.16 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.865 -1.061 . . . . 74.209999999999994 108.464 -177.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 9.3 mp -80.14 149.75 70.17 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 112.006 0.373 . . . . 62.520000000000003 112.006 -178.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.3 Cg_exo -71.69 -12.28 28.79 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.755 2.303 . . . . 43.25 112.342 177.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.56 165.05 11.7 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.6 0.593 . . . . 73.510000000000005 112.6 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -102.1 162.56 12.82 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.917 -1.142 . . . . 73.140000000000001 107.917 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.99 -0.48 41.39 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 109.458 -1.457 . . . . 50.119999999999997 109.458 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.471 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 t -102.93 131.29 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.921 -1.139 . . . . 43.109999999999999 108.614 -176.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 m -75.88 172.23 13.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.297 -0.41 . . . . 74.25 111.565 -178.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 1.4 ptm180 -64.65 -42.2 95.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.384 0.611 . . . . 64.239999999999995 110.819 177.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -123.64 93.69 4.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 104.791 -2.3 . . . . 72.209999999999994 104.791 171.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.587 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 22.6 t60 -96.26 -30.61 13.36 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 115.182 -0.917 . . . . 74.420000000000002 109.524 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 tt -163.5 146.99 10.35 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 109.321 -0.622 . . . . 64.25 109.321 -178.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.04 123.38 30.36 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.382 0.611 . . . . 71.230000000000004 111.257 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 23' ' ' LEU . 69.1 mt -104.26 119.18 52.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.826 -0.625 . . . . 74.549999999999997 109.696 177.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -100.71 114.52 28.34 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.516 -0.92 . . . . 72.340000000000003 108.516 177.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -113.76 134.46 54.75 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.697 0.76 . . . . 73.140000000000001 112.164 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -148.18 164.71 33.1 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 103.758 -2.682 . . . . 63.310000000000002 103.758 174.144 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.14 58.23 1.08 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 118.893 0.77 . . . . 64.209999999999994 113.005 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -135.58 -78.41 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.203 -1.406 . . . . 75.209999999999994 107.203 178.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -149.41 159.37 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 105.705 -1.961 . . . . 73.25 105.705 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -95.58 113.12 24.74 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.171 -0.677 . . . . 54.25 109.171 178.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.5 tp -83.72 106.74 15.66 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.052 -0.976 . . . . 62.130000000000003 110.335 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.6 tm? -94.99 111.44 23.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.519 1.128 . . . . 72.019999999999996 108.246 -177.163 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.06 121.43 38.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.168 -0.308 . . . . 75.319999999999993 110.168 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.93 136.6 34.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.129 -0.693 . . . . 65.439999999999998 109.129 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.72 76.05 1.54 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.356 -1.72 . . . . 72.109999999999999 106.356 -177.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.573 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 30.4 t-20 174.55 141.91 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.055 -1.091 . . . . 75.25 108.055 -178.063 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -108.35 -53.12 2.67 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.91 0.386 . . . . 72.049999999999997 111.095 177.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.0 m -66.46 -37.32 84.87 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.83 0.852 . . . . 54.43 112.089 -175.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.573 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 25.9 m-80 -115.9 27.2 9.44 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.681 -1.229 . . . . 72.129999999999995 107.681 -178.254 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.26 152.06 3.31 Favored Glycine 0 C--O 1.243 0.709 0 CA-C-N 114.279 -1.328 . . . . 73.120000000000005 115.624 -174.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 m -87.95 147.3 25.11 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.675 0.79 . . . . 43.43 112.17 -176.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -118.03 146.67 43.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.183 0.993 . . . . 60.399999999999999 110.637 178.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.96 127.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.019 -1.475 . . . . 52.509999999999998 107.019 176.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.04 26.95 12.58 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.052 0.941 . . . . 63.240000000000002 111.933 -178.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 73.91 22.48 2.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.798 1.239 . . . . 72.209999999999994 110.272 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -122.97 134.2 24.93 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.338 -0.846 . . . . 53.119999999999997 108.904 176.111 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 6.1 Cg_exo -78.42 137.41 14.82 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.043 1.828 . . . . 63.539999999999999 111.856 179.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.1 170.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.091 -1.077 . . . . 72.340000000000003 108.091 179.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.71 -31.6 10.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.647 -0.501 . . . . 70.340000000000003 109.647 172.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.07 145.38 25.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 120.901 0.382 . . . . 65.209999999999994 110.091 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.41 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 63.4 t-105 -150.99 152.5 33.62 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.392 -0.966 . . . . 74.450000000000003 108.392 -173.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.95 124.22 49.12 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 107.549 -1.278 . . . . 61.210000000000001 107.549 174.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 42.3 mt -56.22 151.02 13.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.804 1.039 . . . . 73.099999999999994 113.804 -173.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.44 43.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.217 -1.401 . . . . 44.149999999999999 107.217 178.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.61 115.67 9.13 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.12 0.486 . . . . 73.010000000000005 110.843 -179.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.42 10.06 45.6 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.852 -0.689 . . . . 62.25 112.741 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.38 144.45 32.69 Favored 'General case' 0 C--O 1.252 1.201 0 C-N-CA 119.27 -0.972 . . . . 72.099999999999994 108.937 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.9 t -102.06 112.54 35.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.196 -1.039 . . . . 61.130000000000003 108.196 -178.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.7 mt -110.81 127.89 67.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 C-N-CA 120.093 -0.643 . . . . 71.109999999999999 109.744 -177.13 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -121.32 119.46 32.25 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 109.568 -0.53 . . . . 75.349999999999994 109.568 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.587 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 1.5 pt? -114.32 137.92 51.18 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.349 -1.723 . . . . 64.349999999999994 106.349 177.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 5.31 86.17 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 O-C-N 124.785 1.303 . . . . 60.420000000000002 115.638 -166.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 55.12 16.79 1.7 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.974 1.842 . . . . 73.439999999999998 115.974 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -123.8 128.01 48.91 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.117 -0.697 . . . . 60.43 109.117 177.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.57 139.25 46.0 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.149 0.796 . . . . 73.400000000000006 113.149 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 tp -127.39 142.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.407 -1.331 . . . . 74.299999999999997 107.407 -177.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.9 133.46 51.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.662 -0.866 . . . . 72.430000000000007 108.662 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 82' ' ' LEU . 81.4 t -100.72 126.18 54.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 120.836 0.351 . . . . 62.020000000000003 111.668 -178.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -119.79 138.2 53.5 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.009 -0.542 . . . . 75.150000000000006 109.807 174.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.1 mtp -124.11 113.73 18.75 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.345 -0.613 . . . . 73.329999999999998 109.345 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.465 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 56.6 m-70 . . . . . 0 C--N 1.28 -2.42 0 N-CA-C 108.295 -1.002 . . . . 62.140000000000001 108.295 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 N--CA 1.428 -1.554 0 N-CA-C 108.539 -0.911 . . . . 63.420000000000002 108.539 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -124.46 115.19 20.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.51 -1.293 . . . . 72.329999999999998 107.51 176.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.31 131.07 36.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.279 -1.008 . . . . 74.299999999999997 108.279 -177.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.534 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 37.9 m -137.61 132.81 33.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.502 -0.772 . . . . 74.430000000000007 108.922 -174.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.431 HD13 HD11 ' A' ' 95' ' ' ILE . 4.4 pp -93.23 136.75 33.2 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 120.216 -0.594 . . . . 60.450000000000003 109.649 177.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -109.04 129.52 55.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.732 -0.667 . . . . 74.340000000000003 111.476 -175.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -119.8 136.15 54.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.13 -1.396 . . . . 73.310000000000002 108.158 -177.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.79 98.91 11.7 Favored 'General case' 0 CA--C 1.467 -2.222 0 CA-C-O 122.574 1.178 . . . . 63.149999999999999 107.976 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 15.8 t70 -133.8 92.97 3.04 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 113.18 -1.827 . . . . 64.200000000000003 108.093 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.63 -61.54 4.12 Favored Glycine 0 C--N 1.292 -1.877 0 CA-C-N 114.565 -1.198 . . . . 54.140000000000001 110.634 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 p -135.73 -37.72 0.74 Allowed 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.609 -0.796 . . . . 71.400000000000006 109.792 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.9 120.07 1.06 Allowed Glycine 0 N--CA 1.41 -3.05 0 N-CA-C 110.444 -1.063 . . . . 62.32 110.444 -178.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 29.4 mmt180 -105.73 154.25 20.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.303 -1.369 . . . . 75.340000000000003 107.303 175.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 62.8 p -138.04 133.8 33.99 Favored 'General case' 0 C--N 1.283 -2.291 0 O-C-N 123.312 0.382 . . . . 70.239999999999995 110.685 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 55.9 t80 -117.85 114.48 23.31 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.752 -1.203 . . . . 74.010000000000005 107.752 174.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.18 135.72 38.53 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.13 -1.063 . . . . 64.549999999999997 108.13 179.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.3 mt -73.45 129.45 38.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.028 0.442 . . . . 72.340000000000003 110.034 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -79.58 151.83 30.42 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.2 -1.407 . . . . 73.319999999999993 107.2 176.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 4.6 pt-20 -75.25 113.35 12.51 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.274 1.035 . . . . 70.450000000000003 111.697 -178.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.13 -166.48 26.0 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 106.367 -2.693 . . . . 72.420000000000002 106.367 -172.301 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 97.3 p -97.42 119.49 36.05 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 119.622 1.711 . . . . 70.329999999999998 111.078 177.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 27.2 m-80 -88.03 108.46 19.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 106.998 -1.482 . . . . 74.010000000000005 106.998 -178.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.409 HG21 ' HG2' ' A' ' 48' ' ' ARG . 57.3 mt -91.21 116.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.278 -0.874 . . . . 74.540000000000006 109.225 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -99.34 128.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 123.484 0.714 . . . . 64.010000000000005 110.143 -177.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.68 26.65 Favored Glycine 0 CA--C 1.487 -1.661 0 CA-C-N 115.274 -0.875 . . . . 54.039999999999999 111.057 176.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -128.69 105.91 8.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.501 0.667 . . . . 64.340000000000003 111.349 176.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.07 166.52 33.56 Favored Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 108.92 -1.672 . . . . 65.420000000000002 108.92 176.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -74.88 -16.9 60.65 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.82 0.81 . . . . 73.239999999999995 109.283 176.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.98 -10.72 59.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.291 -0.868 . . . . 73.239999999999995 109.734 178.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.16 169.51 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 74.430000000000007 110.404 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -109.56 -47.39 3.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.447 0.641 . . . . 71.310000000000002 109.965 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -108.21 127.22 53.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.215 -0.902 . . . . 64.420000000000002 108.8 -177.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -95.23 127.28 41.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.048 -0.723 . . . . 74.129999999999995 109.048 -174.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 45' ' ' VAL . 38.1 mt -83.47 150.01 59.13 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.675 -0.41 . . . . 73.340000000000003 110.318 175.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -95.03 34.39 0.17 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 123.37 2.713 . . . . 75.040000000000006 112.325 179.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -138.6 179.75 6.29 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.13 -0.628 . . . . 63.420000000000002 110.004 -178.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 m -112.67 162.41 15.75 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.696 -0.853 . . . . 64.299999999999997 108.696 -176.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.08 -20.77 48.86 Favored Glycine 0 CA--C 1.5 -0.862 0 C-N-CA 121.021 -0.609 . . . . 51.329999999999998 111.938 176.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 40' ' ' LEU . 9.9 p -79.29 142.55 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.228 -0.486 . . . . 75.329999999999998 111.097 -178.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 m -80.13 -170.5 2.52 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.8 0.84 . . . . 55.509999999999998 109.317 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -77.8 -47.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.141 -1.024 . . . . 73.150000000000006 109.403 175.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.409 ' HG2' HG21 ' A' ' 29' ' ' ILE . 54.5 mtt180 -109.43 109.32 20.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 107.528 -1.286 . . . . 75.420000000000002 107.528 171.319 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -104.36 -45.28 4.71 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.664 -1.235 . . . . 75.25 107.664 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 5.8 tt -159.25 151.96 21.71 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 114.845 -1.07 . . . . 72.540000000000006 108.215 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HG2' HD21 ' A' ' 64' ' ' LEU . 14.5 pt-20 -136.96 140.77 42.45 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.757 -0.831 . . . . 75.430000000000007 108.757 175.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.8 mt -106.83 115.86 49.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 107.782 -1.192 . . . . 75.0 107.782 176.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 48.1 mtt180 -90.32 107.07 18.91 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.79 -1.559 . . . . 64.299999999999997 106.79 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -112.06 115.59 29.14 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.845 -1.07 . . . . 74.310000000000002 109.967 -176.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.01 160.46 22.74 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.107 -1.812 . . . . 64.200000000000003 106.107 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.14 54.07 2.25 Favored Glycine 0 C--N 1.311 -0.822 0 CA-C-N 118.078 0.399 . . . . 73.349999999999994 113.295 -178.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -156.27 -63.23 0.11 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.466 -0.939 . . . . 64.409999999999997 108.466 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.6 159.41 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 122.868 0.467 . . . . 64.439999999999998 110.833 -178.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.03 110.92 22.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.071 -0.513 . . . . 74.019999999999996 110.139 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 4.9 tt -100.74 118.04 36.04 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.746 -0.835 . . . . 54.200000000000003 108.746 -177.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -94.75 123.58 38.29 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.686 -1.227 . . . . 54.310000000000002 107.686 179.083 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.89 124.74 36.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 64.420000000000002 111.306 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.29 138.44 31.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.644 0.778 . . . . 44.539999999999999 109.892 179.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.7 mm? -127.0 76.53 1.66 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.732 -0.47 . . . . 74.319999999999993 109.732 177.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.52 142.45 0.57 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.748 -0.464 . . . . 71.329999999999998 109.748 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 p -96.32 -46.96 6.2 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.409 -0.516 . . . . 64.109999999999999 110.832 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 t -80.14 -36.85 34.61 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.937 -176.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -103.89 28.49 6.63 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 122.23 -0.294 . . . . 71.409999999999997 110.873 -176.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.07 125.67 5.76 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 124.561 1.163 . . . . 61.030000000000001 113.943 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.3 m -75.68 147.61 39.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 124.282 1.033 . . . . 55.399999999999999 112.505 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.2 p -112.4 140.89 46.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.454 -0.794 . . . . 64.409999999999997 110.747 176.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.68 119.53 58.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.79 -1.189 . . . . 73.340000000000003 107.79 177.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 55.26 36.26 26.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.388 0.613 . . . . 72.239999999999995 110.189 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 80.09 -2.92 1.99 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.029 1.731 . . . . 75.540000000000006 111.783 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.74 123.03 49.15 Favored Pre-proline 0 C--N 1.32 -0.692 0 O-C-N 121.524 -0.735 . . . . 75.230000000000004 110.77 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.55 125.47 10.12 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.653 2.235 . . . . 75.239999999999995 110.885 177.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 80' ' ' TRP . 35.7 m -142.57 173.93 6.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.73 -0.47 . . . . 72.209999999999994 109.73 -177.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.1 -30.99 8.12 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.739 -0.664 . . . . 62.020000000000003 109.567 172.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 13.2 pt-20 -145.53 146.55 31.47 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.041 0.448 . . . . 74.209999999999994 110.88 173.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.401 ' HB2' HG21 ' A' ' 77' ' ' VAL . 34.0 t-105 -154.9 152.17 29.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.739 -1.208 . . . . 72.420000000000002 107.739 -173.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -105.97 116.33 31.75 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.864 -1.134 . . . . 74.340000000000003 110.059 174.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 97' ' ' VAL . 74.2 mt -56.65 148.01 21.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.328 -1.305 . . . . 75.510000000000005 113.735 -174.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.78 37.6 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.425 -1.324 . . . . 60.310000000000002 107.425 170.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 21.3 t70 -71.26 120.93 17.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.105 0.479 . . . . 62.039999999999999 110.48 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.63 11.07 33.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.251 -0.886 . . . . 71.120000000000005 112.158 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -74.15 134.98 42.84 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 117.277 0.538 . . . . 64.450000000000003 111.362 177.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.8 t -97.31 112.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.151 -1.055 . . . . 75.510000000000005 108.151 179.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.14 125.59 74.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 119.801 -0.76 . . . . 74.25 110.54 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.473 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 59.3 mtt-85 -111.58 115.29 28.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 111.112 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.47 165.5 13.15 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.974 -1.012 . . . . 61.310000000000002 109.109 177.517 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.06 100.41 0.01 OUTLIER Glycine 0 N--CA 1.475 1.236 0 O-C-N 123.972 0.795 . . . . 42.43 114.765 -176.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.3 m170 65.53 10.79 6.93 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.584 1.554 . . . . 73.049999999999997 113.184 178.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 m -138.58 118.02 12.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.065 0.46 . . . . 71.409999999999997 111.447 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.15 142.1 33.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.744 -0.382 . . . . 75.109999999999999 110.01 172.662 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.431 HD11 HD13 ' A' ' 11' ' ' LEU . 7.9 tp -139.09 148.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.779 -0.452 . . . . 75.530000000000001 109.779 -172.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.15 131.19 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.128 -1.064 . . . . 64.200000000000003 108.128 176.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 82' ' ' LEU . 85.9 t -87.33 128.55 39.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 120.801 0.334 . . . . 70.430000000000007 110.239 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.411 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -125.01 151.32 45.71 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.129 -0.693 . . . . 75.150000000000006 109.129 -179.759 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -129.76 130.35 45.28 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.943 -0.571 . . . . 63.009999999999998 110.357 176.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 . . . . . 0 C--N 1.286 -2.153 0 N-CA-C 106.168 -1.79 . . . . 74.349999999999994 106.168 175.18 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.0 m . . . . . 0 N--CA 1.41 -2.436 0 N-CA-C 108.739 -0.838 . . . . 75.120000000000005 108.739 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 m -103.82 119.93 39.93 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.843 -1.54 . . . . 70.230000000000004 106.843 176.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -107.51 124.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.615 0.722 . . . . 75.420000000000002 111.256 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 22.4 m -124.83 134.97 52.54 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.603 -1.258 . . . . 71.430000000000007 107.603 -175.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.471 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -100.55 143.78 30.31 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.566 -0.454 . . . . 65.439999999999998 110.812 -178.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HG2' HG22 ' A' ' 20' ' ' THR . 46.9 mt-30 -110.73 127.37 55.3 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 107.979 -1.119 . . . . 70.219999999999999 107.979 174.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.49 145.97 49.85 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.644 0.735 . . . . 73.25 110.724 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.41 101.56 13.49 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.063 -0.971 . . . . 60.130000000000003 110.251 -178.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.1 -32.5 10.55 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.603 -1.18 . . . . 74.150000000000006 109.605 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.73 -34.38 3.62 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 107.725 -2.15 . . . . 71.010000000000005 107.725 -171.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -87.91 -41.53 13.12 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.898 -1.149 . . . . 74.25 107.898 176.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 94.13 2.34 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 109.618 -1.393 . . . . 73.099999999999994 109.618 -177.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' ARG . 22.2 mmt180 -120.09 154.91 34.0 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.924 0.712 . . . . 74.129999999999995 112.924 -178.168 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.545 HG22 ' HG2' ' A' ' 12' ' ' GLN . 34.5 p -133.55 153.09 51.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.383 -1.28 . . . . 71.329999999999998 108.161 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.443 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 59.9 t80 -153.48 131.51 11.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.898 -1.149 . . . . 74.420000000000002 107.898 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.5 tt0 -93.75 141.25 28.71 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.356 -0.938 . . . . 74.439999999999998 110.649 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.4 mt -78.16 126.14 30.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.026 -0.534 . . . . 75.340000000000003 110.486 -178.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -82.79 152.87 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.317 -1.364 . . . . 65.120000000000005 107.317 178.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.42 120.66 21.96 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.988 0.899 . . . . 74.329999999999998 109.737 176.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.18 -167.89 24.25 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 105.548 -3.021 . . . . 40.009999999999998 105.548 -171.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -106.83 143.39 35.0 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 118.738 1.269 . . . . 72.420000000000002 110.694 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -125.56 145.26 50.2 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.701 -0.851 . . . . 73.150000000000006 108.701 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -121.83 131.9 72.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.61 -0.515 . . . . 64.319999999999993 109.61 -177.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 38' ' ' PHE . 80.1 mt -107.84 131.65 57.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 124.399 1.08 . . . . 60.310000000000002 109.779 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.73 -157.95 27.45 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 110.06 -1.216 . . . . 73.340000000000003 110.06 177.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 43.6 mtm180 -130.49 106.68 8.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.52 0.66 . . . . 72.310000000000002 109.997 174.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.82 -164.66 29.96 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 110.019 -1.232 . . . . 71.219999999999999 110.019 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -80.68 -39.3 27.45 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.135 0.493 . . . . 65.540000000000006 110.431 -178.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.0 -21.07 44.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 72.230000000000004 110.288 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.47 23.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.781 -0.645 . . . . 54.340000000000003 110.996 -178.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -99.15 -44.88 6.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.916 0.865 . . . . 65.239999999999995 108.803 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.424 ' HB3' HG12 ' A' ' 30' ' ' ILE . 60.3 t80 -100.27 122.55 43.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 106.743 -1.577 . . . . 75.109999999999999 106.743 178.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 17.8 mtp180 -98.14 134.82 40.67 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 112.754 0.65 . . . . 64.230000000000004 112.754 -174.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 38.9 mt -97.62 114.21 64.59 Favored Pre-proline 0 N--CA 1.42 -1.95 0 N-CA-C 107.477 -1.305 . . . . 71.450000000000003 107.477 169.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.521 ' HD2' ' NE2' ' A' ' 92' ' ' HIS . 16.2 Cg_exo -70.06 20.21 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.725 2.95 . . . . 74.299999999999997 113.907 -176.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -97.75 178.27 5.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.557 -0.534 . . . . 65.540000000000006 109.557 -176.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 m -115.59 133.05 56.41 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 109.399 -0.593 . . . . 71.310000000000002 109.399 -177.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.1 -2.85 35.27 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.433 -1.067 . . . . 42.0 110.433 -178.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.98 138.89 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 107.961 -1.126 . . . . 73.219999999999999 107.961 -179.435 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -83.76 166.4 18.05 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.668 -0.242 . . . . 64.400000000000006 111.145 -177.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 35.2 ptt180 -62.99 -36.66 84.3 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.8 0.81 . . . . 74.349999999999994 109.899 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -129.26 100.67 5.68 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 102.545 -3.132 . . . . 73.099999999999994 102.545 171.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -99.26 -37.29 9.33 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.781 -0.645 . . . . 72.129999999999995 109.328 -174.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -161.29 147.15 14.21 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.032 -1.469 . . . . 74.010000000000005 107.032 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -144.33 142.72 30.58 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 121.328 0.585 . . . . 73.349999999999994 110.971 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -119.58 128.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.262 -0.881 . . . . 41.409999999999997 109.523 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 36.1 ttt180 -107.38 111.76 24.25 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.157 -1.423 . . . . 63.25 107.157 177.332 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.293 0.568 . . . . 74.349999999999994 111.054 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -149.07 -174.03 4.53 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.74 -1.578 . . . . 74.010000000000005 106.74 173.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.11 2.59 60.56 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 119.961 -1.114 . . . . 35.149999999999999 114.704 -173.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HG2' HG13 ' A' ' 58' ' ' VAL . 61.6 tt0 -93.51 -75.24 0.5 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.167 0.484 . . . . 75.099999999999994 111.123 177.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.453 HG13 ' HG2' ' A' ' 57' ' ' GLN . 16.0 m -135.75 159.35 39.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 122.529 0.332 . . . . 64.439999999999998 110.6 -176.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -96.33 102.24 13.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.915 -1.143 . . . . 74.019999999999996 107.915 175.459 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 52.6 tp -93.67 113.41 25.48 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.357 -0.838 . . . . 73.439999999999998 111.093 -174.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.64 129.41 49.22 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.127 -1.064 . . . . 55.119999999999997 108.127 -179.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.27 125.71 28.28 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.863 0.363 . . . . 71.129999999999995 110.893 177.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.74 128.78 35.31 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.615 -1.254 . . . . 72.120000000000005 107.615 175.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.6 OUTLIER -124.37 78.27 1.64 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.932 -0.766 . . . . 65.430000000000007 108.932 -174.331 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 8.0 p30 175.52 161.92 0.28 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.029 -0.36 . . . . 73.510000000000005 110.029 177.054 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.9 m -108.97 -12.02 14.91 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.238 0.542 . . . . 75.25 111.369 176.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -79.17 -55.47 5.08 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.411 0.893 . . . . 75.420000000000002 113.411 -172.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -121.92 30.1 6.79 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.759 1.224 . . . . 75.129999999999995 110.1 -169.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.77 115.67 0.87 Allowed Glycine 0 C--O 1.251 1.192 0 O-C-N 124.861 1.351 . . . . 73.430000000000007 113.322 -172.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 m -61.07 139.04 58.17 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 125.751 1.621 . . . . 64.0 113.302 -172.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 p -102.65 142.18 34.25 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.955 -1.021 . . . . 64.329999999999998 110.927 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.62 118.55 56.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.448 -1.316 . . . . 62.100000000000001 107.448 175.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 60.88 32.95 20.07 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.332 1.053 . . . . 71.049999999999997 110.997 -177.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.7 t30 78.02 16.5 1.36 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.904 1.682 . . . . 63.549999999999997 112.031 174.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.57 134.77 26.65 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.19 -0.67 . . . . 63.329999999999998 109.19 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.14 140.83 25.53 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.414 2.076 . . . . 74.400000000000006 112.834 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.26 174.48 3.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.865 -0.791 . . . . 74.109999999999999 108.865 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -96.26 -47.29 6.09 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.405 -0.961 . . . . 74.340000000000003 108.405 173.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -142.26 150.74 41.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.849 -0.614 . . . . 73.329999999999998 110.68 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -152.2 151.23 30.74 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.303 -0.629 . . . . 54.539999999999999 109.303 -173.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -98.25 113.94 26.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.62 -0.882 . . . . 71.439999999999998 108.62 173.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 65.9 mt -60.51 131.84 52.02 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.758 -0.655 . . . . 72.099999999999994 112.251 -176.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.41 154.29 42.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.775 -1.194 . . . . 74.219999999999999 107.775 172.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.63 123.21 17.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.188 -0.46 . . . . 71.049999999999997 110.264 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.88 6.14 56.22 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 120.602 -0.809 . . . . 53.149999999999999 113.02 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -81.48 137.46 35.61 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.111 -0.636 . . . . 63.0 111.065 176.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.05 113.02 34.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.609 0 CA-C-N 115.581 -0.736 . . . . 70.230000000000004 109.264 -178.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.504 ' HB ' HG23 ' A' ' 95' ' ' ILE . 73.2 mt -112.15 141.35 27.92 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.127 0 N-CA-C 108.201 -1.037 . . . . 63.130000000000003 108.201 -177.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -140.27 126.07 19.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.728 -0.789 . . . . 75.349999999999994 112.85 -177.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.22 144.45 48.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.959 -1.497 . . . . 71.230000000000004 106.959 175.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.22 88.25 0.02 OUTLIER Glycine 0 C--O 1.239 0.458 0 N-CA-C 115.862 1.105 . . . . 24.199999999999999 115.862 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.521 ' NE2' ' HD2' ' A' ' 41' ' ' PRO . 84.2 t60 162.35 -47.88 0.0 OUTLIER 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.139 2.175 . . . . 74.319999999999993 107.04 176.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.8 m -149.27 134.78 18.53 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.845 -1.07 . . . . 74.010000000000005 111.541 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.53 141.92 27.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.22 -1.77 . . . . 52.100000000000001 106.22 169.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -132.91 136.15 56.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-O 121.035 0.445 . . . . 65.25 111.317 -172.113 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.4 mt -114.94 129.53 70.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.772 -0.825 . . . . 60.109999999999999 108.772 177.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.11 127.96 38.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.908 -0.587 . . . . 74.439999999999998 111.648 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -119.59 134.29 55.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.806 -0.634 . . . . 73.129999999999995 109.882 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.2 mtt -119.02 133.96 55.49 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 116.006 -0.543 . . . . 75.010000000000005 110.451 177.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 . . . . . 0 C--N 1.289 -2.06 0 N-CA-C 107.952 -1.129 . . . . 74.25 107.952 177.903 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.417 -2.106 0 N-CA-C 106.386 -1.709 . . . . 73.099999999999994 106.386 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.4 m -121.84 139.63 53.39 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.699 -0.801 . . . . 72.109999999999999 110.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -124.04 120.52 59.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.065 -1.458 . . . . 60.43 107.065 176.4 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 m -118.43 128.43 54.61 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.661 -0.7 . . . . 74.450000000000003 109.275 -173.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.98 133.34 34.35 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.086 -0.709 . . . . 72.200000000000003 109.086 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.09 113.79 26.26 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.404 -1.332 . . . . 72.420000000000002 107.404 -176.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.0 tp -112.63 110.56 20.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.828 -0.623 . . . . 70.25 109.861 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -110.59 107.89 17.65 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.55 0.69 . . . . 63.450000000000003 110.415 176.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.47 24.51 11.53 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.79 -1.559 . . . . 74.349999999999994 106.79 177.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 44.36 2.86 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 108.345 -1.902 . . . . 41.509999999999998 108.345 -174.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -159.35 -70.76 0.08 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.424 0.631 . . . . 54.030000000000001 110.54 -175.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.65 73.29 0.91 Allowed Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.988 -1.245 . . . . 53.329999999999998 109.988 -177.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -103.67 155.65 18.4 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.87 -0.419 . . . . 71.450000000000003 109.87 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.5 p -141.46 136.0 30.84 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.239 0.542 . . . . 74.040000000000006 111.942 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 11' ' ' LEU . 92.5 t80 -133.58 139.88 46.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.375 -1.343 . . . . 73.120000000000005 107.375 176.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.46 135.43 46.87 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.48 -0.488 . . . . 54.009999999999998 110.003 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -63.78 145.88 54.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.582 -0.736 . . . . 71.349999999999994 112.834 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -97.91 161.25 13.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.909 -1.145 . . . . 72.299999999999997 107.909 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -75.01 117.93 17.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.504 0.669 . . . . 72.400000000000006 110.645 -178.57 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.64 -169.72 16.66 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 109.022 -1.631 . . . . 73.109999999999999 109.022 -175.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 t -107.43 146.57 31.53 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 121.794 0.807 . . . . 44.140000000000001 112.047 -179.336 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -122.01 129.92 52.86 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.072 -0.967 . . . . 74.120000000000005 109.01 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.32 125.85 54.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.048 -1.093 . . . . 42.039999999999999 108.048 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.92 131.05 56.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.334 -0.617 . . . . 75.010000000000005 109.334 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.72 -159.56 28.2 Favored Glycine 0 CA--C 1.488 -1.626 0 N-CA-C 110.255 -1.138 . . . . 53.420000000000002 110.255 177.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 71.6 mtt-85 -128.96 105.72 8.4 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 117.568 0.684 . . . . 53.140000000000001 109.613 176.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.11 -179.01 48.65 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.194 -1.162 . . . . 75.219999999999999 110.194 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -68.15 -22.36 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.476 0.711 . . . . 54.439999999999998 112.886 -176.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -97.74 -7.77 30.02 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 120.773 0.321 . . . . 73.200000000000003 110.509 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.43 130.71 38.41 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.263 0.554 . . . . 75.549999999999997 111.591 -173.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -92.3 -49.17 6.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.124 -1.065 . . . . 65.150000000000006 108.124 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -112.46 125.95 54.78 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.972 -1.013 . . . . 73.549999999999997 108.665 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 10.1 mmt180 -99.01 134.52 41.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.714 -0.847 . . . . 63.340000000000003 108.714 -177.005 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.88 141.5 47.6 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.197 -0.668 . . . . 72.340000000000003 109.197 174.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.07 -36.43 65.61 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.747 2.964 . . . . 71.030000000000001 114.181 -178.037 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.26 170.92 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.119 0.785 . . . . 74.239999999999995 113.119 -175.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p -103.16 165.23 11.15 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.017 -0.992 . . . . 64.349999999999994 108.5 173.292 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.0 -23.25 34.21 Favored Glycine 0 CA--C 1.501 -0.8 0 N-CA-C 109.781 -1.328 . . . . 74.310000000000002 109.781 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.1 136.36 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.271 -0.965 . . . . 43.140000000000001 108.751 175.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.7 m -67.04 161.38 24.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.413 0.523 . . . . 75.230000000000004 112.413 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 27.8 ptt180 -54.85 -40.54 69.74 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.515 175.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.92 106.82 9.16 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 102.879 -3.008 . . . . 70.120000000000005 102.879 170.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -98.36 -39.4 8.82 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 109.091 -0.707 . . . . 51.140000000000001 109.091 -177.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 tt -162.36 150.32 14.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.756 -0.831 . . . . 74.239999999999995 108.756 -176.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.95 135.25 48.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.243 0.544 . . . . 74.409999999999997 110.011 178.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.54 120.96 62.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.093 -1.447 . . . . 74.219999999999999 107.093 174.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -111.65 111.74 22.95 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.069 0.461 . . . . 73.340000000000003 109.979 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -104.35 115.84 31.09 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.455 -0.793 . . . . 74.540000000000006 110.758 -178.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.81 171.6 7.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.217 -1.771 . . . . 74.420000000000002 106.217 177.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.79 53.35 4.31 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.973 -0.632 . . . . 64.200000000000003 112.98 -177.49 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -150.43 -78.41 0.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.508 1.123 . . . . 75.019999999999996 108.657 177.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.8 159.84 27.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 63.210000000000001 108.546 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.48 120.69 33.21 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.45 0.643 . . . . 45.420000000000002 110.556 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.05 133.41 34.36 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.943 -1.026 . . . . 70.25 108.508 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.1 125.29 45.87 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.265 -1.013 . . . . 70.340000000000003 108.265 -178.041 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.22 135.8 46.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.607 0.241 . . . . 74.109999999999999 110.436 177.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.72 119.08 38.15 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.932 0.893 . . . . 65.010000000000005 110.011 -177.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.87 77.91 1.62 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.036 -1.838 . . . . 74.430000000000007 106.036 179.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.509 HD21 ' C ' ' A' ' 68' ' ' ASN . 8.1 t30 -173.56 131.31 0.45 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.055 -0.52 . . . . 63.409999999999997 110.16 -165.121 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -108.15 -43.33 4.41 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 113.073 0.768 . . . . 70.019999999999996 113.073 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -88.62 -26.18 22.04 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.631 0.974 . . . . 61.310000000000002 113.631 -170.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.509 ' C ' HD21 ' A' ' 65' ' ' ASN . 5.8 m-20 -115.59 30.12 7.56 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.199 -0.667 . . . . 74.340000000000003 109.199 -177.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.93 127.22 4.13 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 124.528 1.143 . . . . 40.149999999999999 114.503 -171.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.0 m -66.69 136.71 55.94 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.103 0.961 . . . . 74.540000000000006 112.756 -176.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 17.8 p -107.58 140.46 40.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.581 -0.736 . . . . 64.549999999999997 110.688 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 80' ' ' TRP . 27.9 m -117.4 117.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.627 -1.249 . . . . 74.349999999999994 107.627 177.006 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' A' ' 86' ' ' ASP . 5.5 m-80 57.76 31.07 19.94 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.594 -0.73 . . . . 74.010000000000005 110.775 -172.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.9 t30 80.44 3.03 1.86 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 126.327 1.851 . . . . 70.420000000000002 111.777 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.26 118.9 65.19 Favored Pre-proline 0 C--N 1.319 -0.722 0 O-C-N 121.458 -0.776 . . . . 64.219999999999999 109.877 177.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.04 129.24 21.38 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.417 2.078 . . . . 73.209999999999994 111.772 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 m -140.97 167.68 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 110.021 -0.363 . . . . 65.019999999999996 110.021 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -109.14 -18.35 13.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.569 0.7 . . . . 62.420000000000002 109.289 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -151.61 155.15 37.82 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.194 -1.039 . . . . 65.230000000000004 108.194 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . 0.456 ' CD2' HG21 ' A' ' 72' ' ' VAL . 73.5 t-105 -159.87 151.92 20.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.015 -0.735 . . . . 74.140000000000001 109.015 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.74 111.56 24.12 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.507 -1.294 . . . . 64.040000000000006 107.507 174.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.507 ' HB3' HG11 ' A' ' 97' ' ' VAL . 64.9 mt -56.93 131.87 50.96 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.383 1.052 . . . . 61.130000000000003 112.636 -174.103 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.93 165.66 20.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.596 -0.89 . . . . 60.409999999999997 108.596 175.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.45 116.56 11.92 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.099 -0.704 . . . . 75.319999999999993 109.099 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.43 9.44 23.51 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.871 -0.68 . . . . 44.210000000000001 112.906 179.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.563 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 49.2 m-20 -81.44 117.5 21.93 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.652 -0.819 . . . . 71.209999999999994 111.884 177.328 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.76 112.34 25.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.161 -1.792 . . . . 64.420000000000002 106.161 175.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.9 mt -112.03 124.39 68.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.092 0 CA-C-O 120.894 0.378 . . . . 51.32 110.458 -172.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.3 mpt_? -109.55 120.37 42.29 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.226 -0.657 . . . . 72.420000000000002 109.226 177.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.55 164.16 20.38 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.172 -0.677 . . . . 74.219999999999999 109.172 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.3 108.58 0.6 Allowed Glycine 0 C--N 1.316 -0.575 0 O-C-N 123.506 0.504 . . . . 63.340000000000003 112.959 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 72.75 16.07 4.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.562 1.545 . . . . 75.010000000000005 114.093 177.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.8 t -154.05 167.0 31.26 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.901 -0.499 . . . . 54.310000000000002 110.581 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.24 132.31 14.34 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.749 -0.834 . . . . 65.5 108.749 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.426 HD11 HD13 ' A' ' 11' ' ' LEU . 11.0 tp -141.21 146.25 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.981 -0.377 . . . . 74.310000000000002 109.981 -173.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.52 135.27 53.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.043 -1.095 . . . . 74.219999999999999 108.043 175.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 82' ' ' LEU . 78.0 t -98.42 130.97 46.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 112.18 0.437 . . . . 71.019999999999996 112.18 -178.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -119.32 150.37 40.25 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.899 -0.778 . . . . 74.140000000000001 108.899 174.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.1 mtp -129.38 147.38 51.2 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.258 0.551 . . . . 65.230000000000004 111.314 -178.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 35.6 m-70 . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 106.693 -1.595 . . . . 64.340000000000003 106.693 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' HIS . 86.3 m . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 107.682 -1.229 . . . . 65.25 107.682 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 21.1 m -101.53 124.34 47.04 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.279 -0.569 . . . . 74.409999999999997 109.638 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.79 115.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.009 -0.737 . . . . 74.530000000000001 109.009 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -112.26 123.66 50.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.289 -1.004 . . . . 72.030000000000001 108.289 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 95' ' ' ILE . 54.9 mt -94.43 128.85 41.25 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.777 -0.823 . . . . 63.539999999999999 108.777 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.64 110.48 21.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.894 -1.15 . . . . 71.5 107.894 -178.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 56.3 tp -104.41 131.17 52.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.831 0.852 . . . . 73.230000000000004 110.669 -175.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' OE2' ' A' ' 94' ' ' GLU . 32.9 t70 -98.32 101.23 12.63 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.996 0.903 . . . . 52.439999999999998 109.728 175.246 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -102.43 -0.62 32.17 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.449 -1.25 . . . . 71.239999999999995 107.759 176.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.43 -21.57 19.15 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.56 -1.2 . . . . 64.349999999999994 110.527 -176.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -109.77 -45.56 3.63 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.306 0.574 . . . . 62.32 109.918 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.56 102.42 2.36 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.379 -1.089 . . . . 71.299999999999997 110.379 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -114.98 151.8 33.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 109.847 -0.427 . . . . 54.020000000000003 109.847 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.3 p -135.04 142.37 46.34 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.86 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -140.83 133.94 29.4 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.471 -1.307 . . . . 72.5 107.471 177.482 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -102.51 136.97 41.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.898 -0.779 . . . . 53.420000000000002 108.898 179.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 11' ' ' LEU . 83.8 mt -74.77 133.48 41.96 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.195 -0.457 . . . . 70.129999999999995 110.745 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -101.04 164.42 11.81 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.486 -1.301 . . . . 72.0 107.486 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.31 125.15 24.69 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.193 0.52 . . . . 71.140000000000001 111.172 -179.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.63 -164.73 12.16 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 109.112 -1.595 . . . . 73.209999999999994 109.112 -176.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 63.5 p -92.18 135.46 33.97 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 118.214 1.007 . . . . 73.310000000000002 111.588 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.406 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 27.1 m-80 -114.32 120.18 39.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.564 -1.643 . . . . 65.420000000000002 106.564 -178.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.19 133.0 59.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 120.495 0.188 . . . . 72.319999999999993 111.063 -175.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.13 137.79 42.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 109.181 -0.674 . . . . 65.109999999999999 109.181 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.54 -151.7 22.52 Favored Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 108.274 -1.93 . . . . 62.240000000000002 108.274 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.9 mtm180 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.361 -1.348 . . . . 71.409999999999997 107.361 172.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.14 -177.21 47.78 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.604 -1.398 . . . . 73.340000000000003 109.604 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -78.49 -18.72 54.41 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.101 0.45 . . . . 60.100000000000001 111.557 178.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.79 -6.47 55.91 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.046 0.451 . . . . 70.120000000000005 110.678 173.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.81 140.55 29.4 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.41 -0.959 . . . . 64.319999999999993 108.41 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 70.3 mt-30 -102.04 -52.43 3.16 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.043 -1.095 . . . . 74.25 108.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -98.92 108.47 21.16 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.73 -1.581 . . . . 62.509999999999998 106.73 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.716 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 19.8 ptt85 -97.21 129.46 44.55 Favored 'General case' 0 N--CA 1.41 -2.44 0 C-N-CA 119.907 -0.717 . . . . 62.43 110.69 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.96 137.54 72.95 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.677 -0.692 . . . . 74.120000000000005 109.535 178.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.57 -5.21 16.27 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.588 2.192 . . . . 63.020000000000003 111.632 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -86.27 -173.78 4.72 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.014 -0.539 . . . . 62.340000000000003 111.264 -176.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.526 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.8 t -132.17 164.91 25.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.615 -0.883 . . . . 74.319999999999993 108.615 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.88 -29.41 12.53 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.253 -1.539 . . . . 71.400000000000006 109.253 -175.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.34 143.33 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 CA-C-N 114.086 -1.057 . . . . 62.200000000000003 109.899 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -87.64 -176.75 5.67 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.055 0.542 . . . . 62.140000000000001 110.307 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 20.5 ptt180 -67.18 -39.3 86.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.253 0.549 . . . . 64.030000000000001 110.588 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -127.2 114.28 17.46 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.102 -1.814 . . . . 75.430000000000007 106.102 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.52 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 67.7 t60 -104.13 -37.36 7.35 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 121.369 0.604 . . . . 74.5 109.74 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 61' ' ' LEU . 7.9 tt -161.02 145.71 13.85 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 116.084 -0.507 . . . . 64.329999999999998 109.845 -176.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.39 139.68 49.51 Favored 'General case' 0 C--N 1.3 -1.543 0 CA-C-N 115.798 -0.637 . . . . 73.120000000000005 110.222 179.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 83.9 mt -121.75 116.74 50.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.455 -0.793 . . . . 73.439999999999998 109.268 178.214 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 38.6 mtp-105 -91.44 107.77 19.43 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.803 -1.184 . . . . 63.020000000000003 107.803 176.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -97.55 113.02 24.65 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.19 0.995 . . . . 74.010000000000005 112.766 -175.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.33 150.44 45.48 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.137 -1.801 . . . . 75.530000000000001 106.137 173.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.51 75.96 0.52 Allowed Glycine 0 C--N 1.307 -1.065 0 O-C-N 123.513 0.508 . . . . 64.430000000000007 113.834 -174.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -166.41 -68.29 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.148 -1.427 . . . . 72.310000000000002 107.148 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.9 m -149.06 150.86 13.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 106.449 -1.686 . . . . 73.25 106.449 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.9 126.39 36.04 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.26 -0.576 . . . . 74.409999999999997 109.849 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.9 tt -83.11 107.52 15.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.118 -1.067 . . . . 70.200000000000003 108.118 -178.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -93.75 120.96 34.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.148 -1.056 . . . . 74.310000000000002 108.148 -179.101 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.0 119.57 23.38 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.246 0.546 . . . . 74.329999999999998 110.219 176.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.44 134.73 37.33 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.819 -0.808 . . . . 75.129999999999995 108.819 177.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.42 77.24 1.63 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.439 -1.319 . . . . 74.319999999999993 107.439 -177.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.52 163.76 8.4 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.39 -0.524 . . . . 73.25 109.946 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 p -108.13 -54.86 2.45 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.527 179.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.445 HG23 ' OD1' ' A' ' 68' ' ' ASN . 5.9 t -90.0 -24.05 21.33 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.411 0.624 . . . . 52.450000000000003 112.518 -175.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' ' 67' ' ' THR . 3.1 m-20 -105.54 22.77 14.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.727 -0.608 . . . . 62.310000000000002 110.066 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.0 118.83 2.9 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 124.442 1.089 . . . . 73.019999999999996 114.384 -175.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 m -65.54 138.46 58.07 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.824 1.25 . . . . 65.540000000000006 113.298 -176.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.43 140.86 38.68 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 108.132 -1.062 . . . . 71.329999999999998 108.132 -179.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.08 121.13 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.165 -0.959 . . . . 74.219999999999999 110.208 178.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 58.98 25.86 14.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.232 1.013 . . . . 72.140000000000001 110.586 -177.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 77.7 20.79 1.03 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.997 1.719 . . . . 63.409999999999997 112.63 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.81 125.9 26.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.661 -0.866 . . . . 64.010000000000005 108.661 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.19 128.14 11.88 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.692 2.261 . . . . 72.030000000000001 113.839 -175.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -146.51 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.332 -0.988 . . . . 70.040000000000006 108.332 -178.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -116.89 -32.34 5.13 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.744 -0.382 . . . . 73.430000000000007 110.209 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -129.36 149.81 50.99 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.238 -0.653 . . . . 75.209999999999994 109.238 177.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -158.71 152.72 23.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.083 -0.71 . . . . 72.099999999999994 109.083 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -105.54 109.66 21.71 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.485 -0.931 . . . . 61.009999999999998 108.485 176.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 60.4 mt -64.56 137.55 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.648 0.592 . . . . 74.349999999999994 112.346 -177.26 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.2 163.76 28.89 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.787 -1.56 . . . . 65.409999999999997 106.787 171.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.41 121.89 13.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.633 0.254 . . . . 74.109999999999999 110.786 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.73 -11.21 30.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.701 -0.761 . . . . 72.329999999999998 113.37 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -67.04 138.39 57.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 113.065 0.765 . . . . 74.120000000000005 113.065 -179.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.18 113.4 39.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.083 -0.962 . . . . 71.400000000000006 108.468 175.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 95' ' ' ILE . 3.0 mp -109.09 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.548 -1.279 . . . . 72.540000000000006 107.548 179.222 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -100.33 106.76 18.42 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.356 -0.609 . . . . 72.219999999999999 109.356 -176.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -82.38 160.52 22.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.219 -1.4 . . . . 72.340000000000003 107.219 176.488 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' HIS . . . -70.64 86.42 0.35 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.978 -1.582 . . . . 71.310000000000002 111.192 179.113 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 61.1 t-80 163.61 -63.29 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.56 1.944 . . . . 74.030000000000001 108.765 177.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.8 m -143.47 174.98 10.28 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.066 -1.087 . . . . 71.540000000000006 108.066 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' OE2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -114.78 149.41 37.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.306 0.854 . . . . 73.209999999999994 113.306 177.159 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 11' ' ' LEU . 6.9 tp -119.56 127.39 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.711 -1.218 . . . . 63.520000000000003 107.711 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -103.55 132.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.101 -0.703 . . . . 50.43 109.101 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.17 117.86 37.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.16 -0.473 . . . . 51.420000000000002 111.332 -178.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -116.69 130.9 57.01 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.257 -1.016 . . . . 74.319999999999993 108.257 175.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.5 mtt -114.43 128.59 56.42 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.496 0.665 . . . . 64.409999999999997 111.807 -178.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' THR . 44.6 m-70 . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 107.38 -1.341 . . . . 74.409999999999997 107.38 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.731 0 N-CA-C 110.091 -1.203 . . . . 54.020000000000003 110.091 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -106.27 176.54 5.13 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 117.071 0.435 . . . . 75.239999999999995 110.453 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.64 -59.41 2.53 Favored Glycine 0 C--N 1.306 -1.093 0 N-CA-C 109.748 -1.341 . . . . 73.530000000000001 109.748 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.3 m -134.07 144.39 48.6 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.105 -1.072 . . . . 72.329999999999998 108.105 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.77 159.9 21.61 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.65 -0.5 . . . . 63.520000000000003 109.65 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.87 -144.44 16.87 Favored Glycine 0 N--CA 1.435 -1.43 0 N-CA-C 110.758 -0.937 . . . . 73.140000000000001 110.758 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.8 m -60.74 116.09 4.15 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.334 -0.617 . . . . 73.140000000000001 109.334 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.429 ' HB3' ' OE1' ' A' ' 22' ' ' GLN . 11.4 m -102.56 115.48 30.66 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.751 -0.833 . . . . 74.519999999999996 108.751 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.4 110.27 25.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 109.175 -0.676 . . . . 65.109999999999999 109.175 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 m -106.14 126.09 51.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 115.227 -0.897 . . . . 72.519999999999996 108.605 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.448 ' O ' ' HA ' ' A' ' 20' ' ' THR . 46.2 mt -93.05 115.04 27.73 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.858 -1.164 . . . . 61.119999999999997 107.858 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -92.16 114.36 26.89 Favored 'General case' 0 C--N 1.276 -2.596 0 N-CA-C 108.232 -1.025 . . . . 74.420000000000002 108.232 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -113.26 130.68 56.17 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.852 -0.613 . . . . 73.019999999999996 110.27 -171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.73 99.96 12.76 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.11 -1.07 . . . . 63.329999999999998 108.11 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.411 ' OD1' ' HG2' ' A' ' 19' ' ' ARG . 7.3 p-10 -91.68 -13.47 31.7 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.114 -1.403 . . . . 74.420000000000002 108.019 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.74 -37.86 1.82 Allowed Glycine 0 N--CA 1.419 -2.444 0 N-CA-C 108.392 -1.883 . . . . 74.140000000000001 108.392 -173.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.5 p -100.52 -53.19 3.16 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.3 0.571 . . . . 54.109999999999999 110.075 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.33 89.19 0.89 Allowed Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 109.152 -1.579 . . . . 61.140000000000001 109.152 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HG2' ' OD1' ' A' ' 15' ' ' ASP . 3.8 mmp_? -103.72 166.98 10.08 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.282 -0.636 . . . . 71.510000000000005 109.282 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 21.7 p -130.57 138.76 50.32 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 120.861 0.362 . . . . 75.420000000000002 110.853 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -132.79 124.65 28.44 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.638 -1.245 . . . . 74.209999999999994 107.638 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.429 ' OE1' ' HB3' ' A' ' 8' ' ' SER . 25.9 tt0 -92.55 139.96 30.05 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.735 -0.786 . . . . 72.340000000000003 108.963 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.4 mt -65.14 133.9 52.57 Favored 'General case' 0 C--N 1.309 -1.166 0 O-C-N 123.416 0.447 . . . . 73.329999999999998 111.548 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -85.08 156.03 21.25 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.706 -1.59 . . . . 74.109999999999999 106.706 175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.7 OUTLIER -76.18 116.59 17.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.521 0.677 . . . . 72.010000000000005 109.178 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.43 23.07 Favored Glycine 0 C--N 1.289 -2.062 0 N-CA-C 106.792 -2.523 . . . . 70.239999999999995 106.792 -172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 45.9 p -105.45 131.28 53.07 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 119.431 1.615 . . . . 72.109999999999999 112.004 178.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -103.2 110.29 22.19 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.458 -1.312 . . . . 54.549999999999997 107.458 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 65.1 mt -95.64 121.06 45.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 116.411 -0.359 . . . . 53.409999999999997 110.262 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.6 mt -105.98 130.17 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 123.947 0.899 . . . . 54.140000000000001 109.808 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.03 -174.37 40.15 Favored Glycine 0 N--CA 1.432 -1.614 0 N-CA-C 110.97 -0.852 . . . . 50.439999999999998 110.97 177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 42' ' ' ASP . 25.0 mtp180 -107.21 104.94 14.69 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.608 -0.837 . . . . 73.430000000000007 109.448 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.67 169.28 37.14 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.198 -1.161 . . . . 64.439999999999998 110.198 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -81.62 -14.24 56.97 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.502 -1.295 . . . . 53.530000000000001 107.502 174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.91 -4.56 59.17 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 113.138 -1.846 . . . . 71.430000000000007 109.196 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -109.35 147.56 32.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.978 -1.01 . . . . 61.200000000000003 109.375 177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.2 mm-40 -93.68 -32.84 13.89 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.385 0.612 . . . . 73.420000000000002 110.988 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -118.82 124.96 48.46 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.919 -1.511 . . . . 74.439999999999998 106.919 178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -105.76 130.73 53.7 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 120.781 0.324 . . . . 74.049999999999997 111.747 -174.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 52.8 mt -85.8 145.91 42.44 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.756 -0.656 . . . . 65.010000000000005 112.238 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.8 Cg_exo -72.18 -33.57 9.19 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.261 2.641 . . . . 65.439999999999998 114.598 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 5.3 t70 -93.25 179.95 5.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.577 -0.898 . . . . 42.100000000000001 108.577 -175.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.4 t -118.68 171.04 8.47 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-O 121.116 0.484 . . . . 51.350000000000001 110.262 -175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.18 -5.46 61.15 Favored Glycine 0 CA--C 1.502 -0.761 0 N-CA-C 108.937 -1.665 . . . . 74.25 108.937 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 91.0 t -89.42 129.55 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.716 0 CA-C-N 113.281 -1.46 . . . . 71.219999999999999 107.834 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 m -77.11 171.9 14.09 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.849 -0.426 . . . . 73.030000000000001 109.849 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 16.9 ptt180 -58.2 -46.56 85.61 Favored 'General case' 0 C--O 1.208 -1.095 0 CA-C-O 121.593 0.711 . . . . 75.430000000000007 109.792 176.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.421 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 37.3 mtp180 -119.12 95.9 5.0 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 104.42 -2.437 . . . . 75.519999999999996 104.42 174.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -98.22 -32.05 11.77 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.198 -0.91 . . . . 74.219999999999999 108.91 -176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.492 HD11 HD21 ' A' ' 61' ' ' LEU . 6.7 tt -163.87 145.39 9.0 Favored 'General case' 0 N--CA 1.424 -1.743 0 N-CA-C 108.816 -0.809 . . . . 72.040000000000006 108.816 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -137.84 143.61 41.05 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 121.02 0.438 . . . . 72.450000000000003 110.447 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 65.8 mt -125.42 116.41 46.54 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-N 115.71 -0.677 . . . . 73.439999999999998 109.783 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 58.0 ttp180 -91.39 113.63 25.94 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.805 -1.183 . . . . 70.409999999999997 107.805 175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.3 t-105 -102.22 125.32 48.89 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 116.002 -0.545 . . . . 71.510000000000005 110.126 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -133.38 168.89 17.78 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.195 -1.409 . . . . 72.230000000000004 107.195 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.64 58.53 2.09 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 114.968 0.747 . . . . 43.25 114.968 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -170.73 -68.12 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.905 0.882 . . . . 60.140000000000001 108.974 174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.7 m -131.85 156.83 42.91 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 CA-C-O 121.259 0.552 . . . . 74.109999999999999 111.52 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -102.2 114.62 28.93 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 115.088 -0.96 . . . . 51.450000000000003 109.442 178.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 7.4 tt -80.91 113.77 19.34 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.755 -1.111 . . . . 75.400000000000006 109.241 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.492 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -101.39 120.82 40.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.291 -1.003 . . . . 64.310000000000002 108.291 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.02 121.16 30.81 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 110.307 -0.257 . . . . 51.329999999999998 110.307 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -87.98 124.44 33.72 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.687 -0.857 . . . . 63.210000000000001 108.687 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.99 76.28 1.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.771 -1.196 . . . . 73.25 107.771 -175.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 176.34 153.05 0.18 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.636 -1.987 . . . . 71.409999999999997 105.636 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.9 m -110.19 -53.44 2.68 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 113.237 0.829 . . . . 73.129999999999995 113.237 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 t -71.74 -38.57 70.42 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.567 0.58 . . . . 75.219999999999999 112.567 -172.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -116.89 23.74 11.71 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.318 -1.364 . . . . 75.430000000000007 107.318 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.83 163.43 19.65 Favored Glycine 0 N--CA 1.435 -1.382 0 CA-C-N 113.41 -1.723 . . . . 52.039999999999999 113.864 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.7 m -84.74 143.86 28.88 Favored 'General case' 0 C--N 1.272 -2.789 0 C-N-CA 123.894 0.877 . . . . 73.219999999999999 111.899 -175.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 p -112.0 141.1 46.07 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.517 -0.765 . . . . 63.210000000000001 110.285 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.415 HG21 ' CD2' ' A' ' 80' ' ' TRP . 33.3 m -114.11 120.86 65.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 106.822 -1.547 . . . . 54.43 106.822 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.465 HD22 ' CG ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER 61.83 24.34 14.47 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 124.236 1.014 . . . . 70.349999999999994 109.83 -175.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.1 m-80 79.59 5.34 2.05 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 125.534 1.533 . . . . 44.439999999999998 112.513 -177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -101.67 127.65 30.82 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.953 -0.388 . . . . 62.32 109.953 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.26 127.84 14.75 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.382 2.055 . . . . 54.229999999999997 111.737 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 80' ' ' TRP . 26.9 m -142.89 166.75 14.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 N-CA-C 108.734 -0.839 . . . . 64.420000000000002 108.734 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -106.07 -31.91 8.51 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.973 -1.121 . . . . 65.420000000000002 107.973 174.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.65 130.08 35.83 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.99 -1.459 . . . . 63.32 110.338 -174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.486 ' HB2' HG21 ' A' ' 77' ' ' VAL . 72.7 t-105 -153.67 153.03 31.51 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.535 -0.913 . . . . 75.140000000000001 108.535 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -114.58 126.25 54.7 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.209 -1.034 . . . . 74.219999999999999 108.209 174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 42.1 mt -56.88 147.55 23.25 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.032 1.123 . . . . 75.340000000000003 114.032 -171.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 147.96 39.52 Favored 'General case' 0 N--CA 1.424 -1.733 0 N-CA-C 108.005 -1.109 . . . . 74.439999999999998 108.005 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 28.9 t70 -65.39 124.89 23.46 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.954 0.407 . . . . 71.030000000000001 110.862 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.87 64.43 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 115.22 -0.9 . . . . 70.049999999999997 112.992 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.465 ' CG ' HD22 ' A' ' 73' ' ' ASN . 2.6 t70 -83.23 156.88 22.92 Favored 'General case' 0 C--O 1.249 1.071 0 C-N-CA 119.505 -0.878 . . . . 64.25 108.717 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -112.08 113.23 43.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 109.361 -0.607 . . . . 74.409999999999997 109.361 -174.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.414 HD11 HD22 ' A' ' 82' ' ' LEU . 59.2 mt -110.06 117.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 N-CA-C 109.097 -0.705 . . . . 71.299999999999997 109.097 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -120.52 123.64 43.41 Favored 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 120.448 -0.501 . . . . 55.32 111.263 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.0 163.43 23.03 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.24 -0.891 . . . . 72.129999999999995 108.959 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -42.12 103.89 0.04 OUTLIER Glycine 0 CA--C 1.524 0.643 0 N-CA-C 115.598 0.999 . . . . 64.219999999999999 115.598 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 m170 69.25 12.09 8.33 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.602 1.561 . . . . 73.219999999999999 113.503 176.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.7 m -149.21 115.37 5.76 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.334 0.588 . . . . 64.400000000000006 111.075 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -111.95 143.32 43.13 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.178 0.513 . . . . 65.25 111.243 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.28 142.67 34.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 115.215 -0.902 . . . . 73.450000000000003 111.387 -171.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.7 mm -111.41 132.81 58.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.0 -1.111 . . . . 74.340000000000003 108.0 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -90.55 126.86 43.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-O 120.846 0.355 . . . . 62.049999999999997 111.453 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.442 ' HA ' ' HE ' ' A' ' 98' ' ' ARG . 0.7 OUTLIER -117.15 125.97 52.06 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.755 -0.832 . . . . 63.32 108.755 176.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.505 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 84.3 mtp -114.35 116.5 29.04 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.852 -0.796 . . . . 75.439999999999998 108.852 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 . . . . . 0 C--N 1.28 -2.438 0 N-CA-C 107.463 -1.31 . . . . 75.140000000000001 107.463 -179.025 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.49 0 N-CA-C 110.002 -1.239 . . . . 43.049999999999997 110.002 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -79.88 131.52 35.88 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.689 -0.856 . . . . 70.209999999999994 108.689 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.41 65.71 3.95 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 110.659 -0.976 . . . . 74.209999999999994 110.659 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -150.38 158.36 44.07 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.24 -0.652 . . . . 65.099999999999994 109.24 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.32 160.04 17.81 Favored 'General case' 0 C--O 1.247 0.974 0 CA-C-O 121.249 0.547 . . . . 63.119999999999997 110.709 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -171.34 -69.71 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 109.482 -1.447 . . . . 54.329999999999998 109.482 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.494 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 84.8 m -137.14 128.0 27.34 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 108.07 -1.085 . . . . 75.209999999999994 108.07 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.9 m -123.63 125.03 44.09 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 108.986 -0.746 . . . . 52.509999999999998 108.986 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -89.5 124.41 42.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.268 -1.012 . . . . 74.439999999999998 108.268 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.428 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.7 m -117.2 124.71 49.78 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 108.939 -0.763 . . . . 72.109999999999999 108.939 -178.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 20' ' ' THR . 62.7 mt -90.88 124.9 35.54 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.231 -1.025 . . . . 75.420000000000002 108.231 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.1 OUTLIER -107.82 120.12 41.36 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 108.821 -0.807 . . . . 74.099999999999994 108.821 -177.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.2 tp -114.27 125.83 54.34 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.307 -0.998 . . . . 74.450000000000003 108.307 178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.92 100.12 10.19 Favored 'General case' 0 N--CA 1.423 -1.818 0 C-N-CA 118.959 -1.096 . . . . 63.219999999999999 108.083 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.92 38.59 2.23 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 113.418 -1.719 . . . . 62.439999999999998 107.961 178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.03 -54.81 0.64 Allowed Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 110.392 -1.083 . . . . 63.020000000000003 110.392 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 t -111.83 -56.56 2.37 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.711 -1.218 . . . . 74.219999999999999 107.711 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 150.79 109.83 0.47 Allowed Glycine 0 N--CA 1.428 -1.835 0 C-N-CA 120.516 -0.849 . . . . 74.129999999999995 112.712 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 74.4 mtt180 -95.9 141.37 29.41 Favored 'General case' 0 CA--C 1.485 -1.525 0 N-CA-C 108.502 -0.925 . . . . 73.409999999999997 108.502 174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.2 p -128.74 135.01 48.63 Favored 'General case' 0 C--N 1.286 -2.167 0 C-N-CA 120.56 -0.456 . . . . 73.120000000000005 111.502 -177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -121.03 110.96 16.88 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.579 -0.897 . . . . 73.319999999999993 108.579 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -78.79 129.3 34.46 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.847 -0.797 . . . . 73.540000000000006 108.847 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.35 125.56 29.53 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.704 -0.851 . . . . 70.340000000000003 108.704 176.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -100.78 170.49 8.29 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 109.375 -0.602 . . . . 71.319999999999993 109.375 173.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.32 134.84 57.45 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 124.348 1.03 . . . . 62.420000000000002 111.594 -175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 116.52 -175.62 15.87 Favored Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 109.165 -1.574 . . . . 72.239999999999995 109.165 -176.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 57.4 p -96.1 137.48 35.11 Favored 'General case' 0 N--CA 1.415 -2.176 0 C-N-CA 119.47 -0.892 . . . . 73.140000000000001 110.471 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -114.46 111.74 21.9 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.457 -0.942 . . . . 62.310000000000002 108.457 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.77 124.66 40.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.089 -1.078 . . . . 50.039999999999999 108.089 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -109.01 129.76 63.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 O-C-N 123.435 0.459 . . . . 64.329999999999998 109.791 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.657 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.26 -163.39 29.5 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 109.161 -1.576 . . . . 71.510000000000005 109.161 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.542 ' C ' ' HA ' ' A' ' 47' ' ' ARG . 52.1 mtm180 -126.34 105.86 9.09 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 119.105 1.453 . . . . 63.229999999999997 112.364 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' HA3' ' HG2' ' A' ' 47' ' ' ARG . . . -172.27 -178.52 42.52 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 107.129 -2.388 . . . . 64.109999999999999 107.129 173.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -74.96 -11.43 60.11 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 122.085 0.945 . . . . 72.329999999999998 110.333 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.55 -23.03 29.88 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.918 -1.037 . . . . 72.340000000000003 109.304 -178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.31 130.99 35.57 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-O 121.819 0.819 . . . . 51.420000000000002 113.037 -171.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -88.24 -26.02 22.56 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 114.832 -1.076 . . . . 62.340000000000003 108.85 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -131.85 115.68 16.24 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.204 -1.036 . . . . 72.230000000000004 108.204 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.657 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -95.93 112.12 23.94 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.983 -0.553 . . . . 60.009999999999998 111.06 -176.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 44.8 mt -71.63 128.99 89.09 Favored Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 110.266 -0.272 . . . . 62.049999999999997 110.266 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -73.61 40.19 0.53 Allowed 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 123.203 2.602 . . . . 75.230000000000004 113.839 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -113.0 152.67 29.15 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.929 -0.767 . . . . 72.450000000000003 108.929 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 37.4 m -97.16 118.32 33.32 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.59 -0.522 . . . . 73.510000000000005 109.59 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 114.07 -13.43 21.77 Favored Glycine 0 C--N 1.306 -1.137 0 C-N-CA 120.521 -0.847 . . . . 70.340000000000003 112.448 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.36 122.28 24.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.429 0.633 . . . . 74.129999999999995 109.361 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.7 m -65.19 164.14 13.8 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.008 -0.997 . . . . 73.420000000000002 112.176 -175.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.542 ' HA ' ' C ' ' A' ' 32' ' ' ARG . 48.1 mtp180 -54.41 -49.29 70.26 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.829 0.852 . . . . 73.209999999999994 109.926 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -120.6 101.97 8.11 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 106.087 -1.819 . . . . 61.130000000000003 106.087 177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -104.05 -32.49 9.18 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-O 121.473 0.654 . . . . 53.229999999999997 109.402 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.7 tt -162.68 149.93 13.42 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.74 -0.837 . . . . 71.120000000000005 108.74 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -130.29 138.22 50.37 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.202 0.525 . . . . 61.420000000000002 110.269 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 27' ' ' SER . 79.4 mt -119.15 116.22 50.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.12 -0.696 . . . . 62.039999999999999 109.12 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -93.7 107.23 19.13 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 106.616 -1.624 . . . . 71.329999999999998 106.616 177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.403 ' HZ2' ' O ' ' A' ' 7' ' ' THR . 50.8 t-105 -110.82 146.6 36.14 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 114.945 -1.025 . . . . 74.049999999999997 109.559 -176.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -149.78 165.23 33.11 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 103.929 -2.619 . . . . 51.140000000000001 103.929 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.67 37.01 0.86 Allowed Glycine 0 C--N 1.305 -1.148 0 CA-C-N 119.133 0.879 . . . . 71.340000000000003 114.679 -175.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -137.4 -71.15 0.44 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 124.034 0.934 . . . . 75.209999999999994 109.903 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.9 m -130.81 159.32 42.93 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-N 116.53 -0.304 . . . . 64.400000000000006 110.692 -178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -111.54 116.68 31.26 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.763 -0.653 . . . . 75.329999999999998 110.289 -178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.8 116.7 32.16 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.098 -0.704 . . . . 72.099999999999994 109.098 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.424 ' CD1' HD21 ' A' ' 82' ' ' LEU . 7.3 tt -104.81 142.6 34.44 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 116.332 -0.394 . . . . 72.510000000000005 110.537 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.14 127.62 26.71 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.817 -0.629 . . . . 64.540000000000006 109.676 177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -83.0 140.42 32.74 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 115.644 -0.707 . . . . 73.140000000000001 109.226 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.26 77.44 1.73 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.035 -1.098 . . . . 71.239999999999995 108.035 -178.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -178.1 121.21 0.1 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.438 -0.578 . . . . 71.109999999999999 109.438 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -88.75 -20.1 25.2 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.137 0.494 . . . . 72.120000000000005 110.447 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 23.8 m -89.33 -52.44 5.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.42 0.629 . . . . 75.329999999999998 111.382 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -111.21 28.75 8.43 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.7 -0.682 . . . . 75.239999999999995 110.194 -173.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.06 129.98 5.5 Favored Glycine 0 N--CA 1.47 0.939 0 O-C-N 124.574 1.171 . . . . 53.420000000000002 114.933 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 90' ' ' LEU . 9.0 m -74.94 152.09 38.83 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 124.733 1.213 . . . . 70.329999999999998 113.044 -172.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.6 p -119.3 144.66 46.69 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 115.121 -0.945 . . . . 73.420000000000002 110.107 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG21 ' CD2' ' A' ' 80' ' ' TRP . 28.1 m -116.36 117.64 56.15 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.255 0 N-CA-C 108.039 -1.097 . . . . 43.229999999999997 108.039 177.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 61.14 25.93 15.89 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.81 0.814 . . . . 45.030000000000001 109.666 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 85.54 -4.57 0.85 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 126.82 2.048 . . . . 74.420000000000002 113.855 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -89.61 124.39 64.24 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 109.864 -0.421 . . . . 63.210000000000001 109.864 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 16.2 Cg_exo -69.15 125.5 12.55 Favored 'Trans proline' 0 C--O 1.236 0.418 0 C-N-CA 122.76 2.307 . . . . 62.340000000000003 111.81 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.0 m -139.02 166.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.384 -0.371 . . . . 75.25 110.64 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -105.74 -14.48 15.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.71 -0.848 . . . . 72.349999999999994 108.71 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -161.78 155.63 21.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.118 -1.067 . . . . 70.319999999999993 108.118 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.403 ' CD2' HG21 ' A' ' 72' ' ' VAL . 75.8 t-105 -161.34 143.41 11.96 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 123.349 0.405 . . . . 74.099999999999994 109.909 -178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -92.23 111.79 23.49 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 108.119 -1.067 . . . . 72.019999999999996 108.119 173.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 69.5 mt -56.46 135.95 54.13 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 112.902 0.705 . . . . 54.219999999999999 112.902 -176.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.0 164.66 19.67 Favored 'General case' 0 N--CA 1.415 -2.212 0 N-CA-C 108.079 -1.082 . . . . 61.530000000000001 108.079 172.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.513 ' OD1' ' HD3' ' A' ' 98' ' ' ARG . 28.8 t70 -71.95 124.36 24.74 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 116.152 -0.476 . . . . 72.510000000000005 110.456 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.91 13.21 56.87 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 115.743 -0.662 . . . . 74.519999999999996 113.091 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -74.67 137.45 42.18 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 117.628 0.714 . . . . 54.140000000000001 111.714 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.2 t -97.1 112.16 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 N-CA-C 107.276 -1.379 . . . . 63.509999999999998 107.276 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.5 mt -111.6 106.58 21.04 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.877 0 C-N-CA 119.322 -0.951 . . . . 72.420000000000002 109.44 -176.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 19.0 mtp180 -104.26 131.89 51.09 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.635 -0.711 . . . . 73.510000000000005 109.678 -175.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.3 pt? -125.18 164.5 20.14 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 108.412 -0.959 . . . . 74.239999999999995 108.412 -176.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.26 125.82 25.9 Favored Glycine 0 N--CA 1.436 -1.303 0 C-N-CA 119.995 -1.098 . . . . 75.329999999999998 110.532 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m170 83.1 -23.6 0.2 Allowed 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 115.217 1.562 . . . . 62.240000000000002 115.217 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 t -153.21 -171.75 4.02 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 119.643 1.111 . . . . 74.219999999999999 111.999 -174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -147.66 147.58 30.14 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.988 -0.745 . . . . 74.409999999999997 108.988 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.6 tp -130.41 135.58 60.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.005 -1.109 . . . . 74.310000000000002 108.005 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 53.4 mt -101.0 132.09 47.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 108.698 -0.852 . . . . 72.120000000000005 108.698 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 82' ' ' LEU . 72.5 t -100.26 116.35 43.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-O 121.446 0.641 . . . . 72.420000000000002 111.158 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.513 ' HD3' ' OD1' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -115.63 125.87 53.45 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 107.415 -1.328 . . . . 70.219999999999999 107.415 178.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 45.5 mtm -112.52 111.74 22.78 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.229 -0.988 . . . . 43.229999999999997 110.547 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.494 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 21.1 m-70 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 108.012 -1.107 . . . . 71.120000000000005 108.012 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.145 0 N-CA-C 110.361 -1.096 . . . . 44.130000000000003 110.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -144.5 15.33 1.62 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.225 0.536 . . . . 72.030000000000001 111.3 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.13 172.58 14.18 Favored Glycine 0 N--CA 1.435 -1.371 0 N-CA-C 110.647 -0.981 . . . . 65.319999999999993 110.647 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -80.37 73.1 7.26 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 122.19 0.995 . . . . 73.0 110.219 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -148.61 124.5 10.61 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 114.323 -1.308 . . . . 71.109999999999999 107.916 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -172.01 94.12 0.1 Allowed Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 110.409 -1.076 . . . . 51.329999999999998 110.409 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.0 m -55.05 116.66 2.89 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 124.246 0.615 . . . . 73.209999999999994 109.621 178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m -107.65 117.28 33.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 115.746 -0.661 . . . . 71.140000000000001 109.644 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 23' ' ' LEU . 40.7 t -91.29 114.86 29.28 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.393 0 N-CA-C 106.726 -1.583 . . . . 73.439999999999998 106.726 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -110.61 124.07 51.18 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.037 -0.727 . . . . 72.120000000000005 109.037 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 95' ' ' ILE . 4.5 pp -95.44 128.92 42.68 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 109.44 -0.578 . . . . 74.25 109.44 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -105.39 119.59 39.47 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 108.559 -0.904 . . . . 75.519999999999996 108.559 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -102.39 120.15 40.01 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 123.755 0.822 . . . . 71.25 108.934 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -100.17 100.99 11.91 Favored 'General case' 0 N--CA 1.418 -2.067 0 C-N-CA 118.659 -1.216 . . . . 73.400000000000006 110.153 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -103.53 5.03 36.49 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 112.99 -1.914 . . . . 65.140000000000001 108.502 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.16 -19.81 31.71 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 109.475 -1.45 . . . . 74.120000000000005 109.475 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -103.5 -53.5 2.78 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 108.226 -1.028 . . . . 63.340000000000003 108.226 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 102.34 83.03 1.69 Allowed Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.396 -0.82 . . . . 63.420000000000002 111.698 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 4.5 mmp_? -100.37 163.81 12.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 122.724 -0.28 . . . . 72.120000000000005 110.273 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 14.9 p -135.61 152.24 51.05 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.741 0.305 . . . . 64.230000000000004 110.983 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.437 ' HB3' HD11 ' A' ' 11' ' ' LEU . 90.1 t80 -142.24 132.51 24.87 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.357 -0.979 . . . . 72.439999999999998 108.357 176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -86.08 125.03 33.15 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.363 -0.606 . . . . 74.040000000000006 109.363 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD22 HD21 ' A' ' 28' ' ' ASN . 78.1 mt -71.28 127.64 33.25 Favored 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 109.165 -0.679 . . . . 72.540000000000006 109.165 174.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.2 ptp180 -95.78 168.6 10.56 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.568 -0.742 . . . . 64.510000000000005 109.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -74.94 131.5 40.73 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.674 0.749 . . . . 43.240000000000002 111.423 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.66 -173.79 15.05 Favored Glycine 0 N--CA 1.429 -1.813 0 N-CA-C 108.382 -1.887 . . . . 64.099999999999994 108.382 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.3 p -106.81 142.77 35.91 Favored 'General case' 0 C--N 1.282 -2.338 0 CA-C-N 118.549 1.174 . . . . 64.230000000000004 111.856 178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' HA ' ' NE2' ' A' ' 37' ' ' GLN . 7.5 p30 -117.8 140.77 49.22 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.339 -0.615 . . . . 74.310000000000002 109.339 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.3 mt -99.86 124.14 53.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.613 -0.884 . . . . 74.430000000000007 108.613 -179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HG12 ' HB3' ' A' ' 38' ' ' PHE . 52.6 mt -106.91 120.58 58.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 124.477 1.111 . . . . 71.010000000000005 110.147 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.63 -176.43 35.54 Favored Glycine 0 CA--C 1.488 -1.599 0 N-CA-C 109.547 -1.421 . . . . 51.240000000000002 109.547 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 61.6 mtt180 -103.99 107.12 17.86 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 118.35 1.075 . . . . 71.530000000000001 111.418 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -173.38 -172.42 38.85 Favored Glycine 0 N--CA 1.418 -2.532 0 N-CA-C 110.444 -1.062 . . . . 71.530000000000001 110.444 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 0.1 OUTLIER -94.35 -29.26 15.11 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 122.959 0.504 . . . . 73.439999999999998 110.823 179.14 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -82.14 -19.73 39.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.873 -0.788 . . . . 72.239999999999995 108.873 177.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 137.69 54.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.048 -0.978 . . . . 60.310000000000002 109.566 175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.474 ' NE2' ' HA ' ' A' ' 28' ' ' ASN . 49.8 mt-30 -97.89 -24.51 15.38 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.483 0.659 . . . . 70.019999999999996 110.318 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' HB3' HG12 ' A' ' 30' ' ' ILE . 40.2 t80 -131.14 124.26 30.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.373 -1.343 . . . . 71.420000000000002 107.373 178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.05 134.25 55.15 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 116.406 -0.361 . . . . 74.519999999999996 110.93 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.423 HD13 HG11 ' A' ' 45' ' ' VAL . 6.8 mp -73.7 147.56 86.85 Favored Pre-proline 0 CA--C 1.502 -0.898 0 CA-C-N 115.604 -0.725 . . . . 74.430000000000007 111.807 -177.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -81.13 26.37 0.61 Allowed 'Trans proline' 0 C--N 1.321 -0.891 0 C-N-CA 123.584 2.856 . . . . 74.120000000000005 113.267 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -137.72 176.4 8.74 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.697 -0.853 . . . . 73.510000000000005 108.697 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -105.28 170.66 7.75 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.374 -0.602 . . . . 74.530000000000001 109.374 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.28 2.69 79.75 Favored Glycine 0 CA--C 1.506 -0.53 0 N-CA-C 111.925 -0.47 . . . . 71.319999999999993 111.925 176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.423 HG11 HD13 ' A' ' 40' ' ' LEU . 33.4 t -95.13 133.92 34.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 108.989 -0.745 . . . . 74.5 108.989 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.0 m -72.39 176.34 5.41 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 123.122 0.569 . . . . 74.519999999999996 109.653 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.0 ptm180 -66.09 -34.92 79.16 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.379 0.609 . . . . 74.319999999999993 110.359 178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -125.51 109.65 12.94 Favored 'General case' 0 N--CA 1.422 -1.83 0 N-CA-C 107.791 -1.188 . . . . 63.119999999999997 107.791 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 59.9 t60 -103.99 -34.16 8.56 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-N 115.854 -0.612 . . . . 75.219999999999999 109.501 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.409 HD11 HD21 ' A' ' 61' ' ' LEU . 9.0 tt -165.88 160.03 16.48 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.301 -1.0 . . . . 73.430000000000007 108.301 -176.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -141.8 138.52 32.3 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 121.089 0.471 . . . . 63.32 109.781 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 23' ' ' LEU . 64.0 mt -113.19 115.19 49.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 109.202 -0.666 . . . . 72.120000000000005 109.202 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 62.0 ttt180 -97.2 107.79 20.38 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 108.817 -0.809 . . . . 50.130000000000003 108.817 174.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 33.8 t-105 -97.48 107.24 19.7 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 108.657 -0.868 . . . . 74.329999999999998 108.657 177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.1 171.35 8.07 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.006 -1.85 . . . . 74.540000000000006 106.006 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.14 49.58 4.14 Favored Glycine 0 C--N 1.305 -1.144 0 C-N-CA 119.817 -1.182 . . . . 54.240000000000002 114.003 -174.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -171.66 -64.04 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.871 0.868 . . . . 74.25 109.178 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -115.32 149.67 17.48 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 CA-C-O 121.323 0.582 . . . . 73.400000000000006 112.15 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -99.75 103.18 14.81 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.275 -0.875 . . . . 65.310000000000002 109.347 178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 tt -84.24 113.49 21.15 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 115.362 -0.836 . . . . 71.019999999999996 109.162 -176.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.409 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -100.52 120.32 39.83 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.145 -1.057 . . . . 73.5 108.145 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.89 126.68 43.7 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.875 -0.417 . . . . 74.450000000000003 109.875 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 11.3 t70 -97.25 139.17 33.62 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 122.848 0.459 . . . . 64.120000000000005 110.722 -177.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -122.11 75.91 1.26 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 108.431 -0.952 . . . . 65.299999999999997 108.431 174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.562 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 33.3 t-20 -166.46 154.04 9.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.57 -1.27 . . . . 73.450000000000003 107.57 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.4 t -108.92 -48.71 3.24 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 120.989 0.423 . . . . 70.040000000000006 110.341 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -89.33 -35.91 15.84 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.648 0.611 . . . . 71.319999999999993 112.648 -175.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.562 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.2 m120 -105.39 27.06 8.68 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.537 -0.542 . . . . 51.350000000000001 109.537 -178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.79 128.46 20.78 Favored Glycine 0 C--O 1.251 1.158 0 O-C-N 124.894 1.371 . . . . 51.109999999999999 112.264 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.8 m -62.01 133.04 54.83 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 124.124 0.969 . . . . 74.140000000000001 112.54 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.635 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.0 p -103.42 140.08 37.94 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.513 -0.767 . . . . 74.400000000000006 109.459 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 77' ' ' VAL . 27.5 m -124.26 119.58 56.97 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 107.937 -1.134 . . . . 75.349999999999994 107.937 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 58.26 30.97 20.26 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 123.404 0.682 . . . . 72.140000000000001 110.54 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.0 t30 82.09 -1.53 1.49 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.738 2.015 . . . . 64.299999999999997 112.302 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.98 124.19 44.52 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 121.487 -0.758 . . . . 75.150000000000006 109.431 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -81.14 124.3 4.83 Favored 'Trans proline' 0 CA--C 1.506 -0.9 0 C-N-CA 121.765 1.643 . . . . 72.150000000000006 110.441 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 72' ' ' VAL . 28.2 m -148.68 151.79 12.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 107.432 -1.322 . . . . 73.239999999999995 107.432 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 77.1 mt-30 -96.69 -0.46 48.31 Favored 'General case' 0 C--N 1.291 -1.936 0 C-N-CA 119.957 -0.697 . . . . 72.540000000000006 111.327 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.54 130.12 15.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.794 -0.639 . . . . 71.310000000000002 110.119 178.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.2 t-105 -159.89 152.97 21.82 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 107.588 -1.264 . . . . 71.010000000000005 107.588 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.89 124.4 50.59 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.967 -1.093 . . . . 73.439999999999998 108.115 173.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.569 ' HB3' HG11 ' A' ' 97' ' ' VAL . 69.0 mt -65.1 139.4 58.7 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 112.949 0.722 . . . . 71.430000000000007 112.949 -174.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -135.65 168.5 19.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.059 -0.719 . . . . 73.340000000000003 109.059 173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.48 121.09 19.03 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.917 -0.401 . . . . 73.530000000000001 109.917 -178.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.2 9.84 40.85 Favored Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 120.905 -0.664 . . . . 53.5 112.698 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -78.38 126.26 30.52 Favored 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 120.008 -0.677 . . . . 70.430000000000007 110.005 177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -93.67 112.31 26.41 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 107.22 -1.4 . . . . 75.230000000000004 107.22 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 95' ' ' ILE . 57.4 mt -120.01 139.28 47.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.411 0 C-N-CA 120.291 -0.564 . . . . 75.219999999999999 110.861 -172.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.635 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.0 mpt_? -120.37 131.24 54.75 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.138 -1.06 . . . . 74.450000000000003 108.138 176.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 2.2 pt? -131.73 164.52 25.79 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 108.336 -0.987 . . . . 74.150000000000006 108.336 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -33.55 97.07 0.01 OUTLIER Glycine 0 CA--C 1.54 1.652 0 N-CA-C 116.002 1.161 . . . . 65.420000000000002 116.002 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.0 m170 72.07 13.95 5.78 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.698 1.599 . . . . 72.450000000000003 114.801 176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.1 t -153.62 -178.3 6.93 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.31 0.576 . . . . 71.319999999999993 110.178 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.74 153.08 45.75 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.762 -0.586 . . . . 72.439999999999998 109.448 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.519 HD11 HD13 ' A' ' 11' ' ' LEU . 8.9 tp -141.45 141.37 30.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.762 -0.829 . . . . 72.439999999999998 108.762 -175.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 64.9 mt -115.73 125.69 72.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 108.469 -0.937 . . . . 65.409999999999997 108.469 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.569 HG11 ' HB3' ' A' ' 82' ' ' LEU . 79.4 t -93.26 128.67 44.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 111.938 0.348 . . . . 62.439999999999998 111.938 -177.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -119.16 151.26 38.63 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 108.767 -0.827 . . . . 72.129999999999995 108.767 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 89.2 mtp -128.34 120.01 26.19 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 116.314 -0.403 . . . . 73.329999999999998 110.262 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 . . . . . 0 C--N 1.294 -1.842 0 N-CA-C 108.333 -0.988 . . . . 72.140000000000001 108.333 -179.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.704 0 N-CA-C 110.622 -0.991 . . . . 43.049999999999997 110.622 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -92.89 -4.91 52.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.106 0.479 . . . . 70.409999999999997 111.762 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -102.22 98.79 1.77 Allowed Glycine 0 N--CA 1.421 -2.359 0 N-CA-C 109.192 -1.563 . . . . 70.340000000000003 109.192 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.3 m -81.43 -35.52 30.54 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 121.126 -0.23 . . . . 64.239999999999995 111.359 -178.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.26 112.64 19.72 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.512 -0.922 . . . . 71.239999999999995 108.512 177.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.68 -52.7 0.49 Allowed Glycine 0 CA--C 1.488 -1.639 0 N-CA-C 108.873 -1.691 . . . . 71.230000000000004 108.873 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.577 HG22 ' HH2' ' A' ' 54' ' ' TRP . 31.9 m -146.15 115.88 7.25 Favored 'General case' 0 N--CA 1.415 -2.216 0 N-CA-C 108.56 -0.904 . . . . 65.430000000000007 108.56 171.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 99' ' ' MET . 54.0 p -158.43 143.98 16.69 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.337 -1.727 . . . . 33.509999999999998 106.337 174.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.9 t -105.82 126.83 61.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 120.159 -0.617 . . . . 63.399999999999999 111.226 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 25.3 m -120.77 132.07 54.84 Favored 'General case' 0 N--CA 1.418 -2.036 0 N-CA-C 107.984 -1.117 . . . . 72.099999999999994 107.984 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.12 135.76 33.72 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.68 -0.489 . . . . 74.239999999999995 109.68 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -116.57 124.86 50.89 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.726 -0.67 . . . . 70.340000000000003 111.19 -176.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 58.8 tp -128.6 133.66 48.37 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.137 -1.061 . . . . 74.450000000000003 108.137 -177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -121.96 101.71 7.72 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.04 -1.064 . . . . 64.329999999999998 112.592 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.04 -47.53 68.13 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 106.661 -1.607 . . . . 71.400000000000006 106.661 171.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 157.29 45.69 0.01 OUTLIER Glycine 0 N--CA 1.427 -1.9 0 N-CA-C 105.979 -2.848 . . . . 43.0 105.979 -176.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -162.5 -52.79 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.193 -1.039 . . . . 73.019999999999996 108.193 -170.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 101.12 92.37 2.14 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.691 -0.766 . . . . 44.140000000000001 111.93 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -99.13 150.24 22.23 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 108.31 -0.996 . . . . 74.099999999999994 108.31 178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 35.8 p -142.94 132.25 23.37 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.663 0.602 . . . . 75.400000000000006 109.859 173.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -134.54 135.26 42.19 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.505 -1.665 . . . . 74.150000000000006 106.505 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 33.5 tt0 -101.71 144.31 30.57 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 120.093 -0.643 . . . . 54.210000000000001 111.156 -175.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 52' ' ' ILE . 76.1 mt -78.88 139.23 38.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.715 -0.675 . . . . 33.210000000000001 110.359 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -95.29 157.86 15.71 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.347 -1.353 . . . . 74.510000000000005 107.347 177.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -64.5 146.03 55.2 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.182 0.515 . . . . 73.340000000000003 111.576 -177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.43 -171.44 15.81 Favored Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 107.723 -2.151 . . . . 75.150000000000006 107.723 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.49 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 67.1 p -96.63 127.46 42.63 Favored 'General case' 0 C--N 1.284 -2.259 0 C-N-CA 118.638 -1.225 . . . . 52.32 111.084 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' N ' HD22 ' A' ' 28' ' ' ASN . 0.6 OUTLIER -103.57 113.58 27.19 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 106.389 -1.708 . . . . 73.420000000000002 106.389 -178.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.7 mt -89.83 132.3 34.87 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-N 115.964 -0.562 . . . . 72.510000000000005 109.694 -177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.7 mt -116.07 132.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 CA-C-N 115.684 -0.689 . . . . 74.349999999999994 109.859 -178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 158.4 -162.23 32.23 Favored Glycine 0 CA--C 1.495 -1.162 0 N-CA-C 108.611 -1.796 . . . . 34.240000000000002 108.611 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 56.1 mtp180 -122.17 103.69 8.96 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 107.008 -1.479 . . . . 71.310000000000002 107.008 173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.594 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 174.84 176.16 42.92 Favored Glycine 0 N--CA 1.414 -2.828 0 N-CA-C 110.935 -0.866 . . . . 61.420000000000002 110.935 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -52.1 -40.36 61.15 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 124.751 1.22 . . . . 74.040000000000006 113.373 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.68 -37.07 73.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.132 0.491 . . . . 71.019999999999996 111.453 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.28 119.78 15.9 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.357 -0.838 . . . . 72.219999999999999 112.795 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -75.35 -36.15 61.04 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.434 -0.95 . . . . 62.229999999999997 108.434 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -105.45 108.87 20.62 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.536 -0.913 . . . . 65.230000000000004 108.536 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.6 mmt85 -87.66 121.35 29.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.152 -0.931 . . . . 72.25 109.455 -176.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.432 HD12 HG21 ' A' ' 45' ' ' VAL . 44.2 mt -79.19 130.53 68.94 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 109.362 -0.607 . . . . 72.140000000000001 109.362 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -85.02 -1.91 9.48 Favored 'Trans proline' 0 C--N 1.325 -0.696 0 C-N-CA 122.013 1.808 . . . . 53.240000000000002 111.049 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -88.67 -176.65 5.33 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.937 -1.029 . . . . 73.129999999999995 111.234 -175.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.0 t -123.21 170.89 9.79 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.694 -0.484 . . . . 74.200000000000003 109.694 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.9 9.03 71.79 Favored Glycine 0 C--O 1.222 -0.641 0 N-CA-C 109.57 -1.412 . . . . 75.319999999999993 109.57 -175.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG21 HD12 ' A' ' 40' ' ' LEU . 7.1 p -113.85 144.36 21.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 114.295 -0.952 . . . . 72.329999999999998 111.0 -173.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.5 p -91.84 -167.68 1.84 Allowed 'General case' 0 C--O 1.254 1.292 0 C-N-CA 124.137 0.975 . . . . 64.040000000000006 109.499 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 5.6 ptt180 -80.84 -34.29 33.94 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 118.247 -1.381 . . . . 73.150000000000006 109.287 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -124.04 100.7 6.86 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 106.412 -1.699 . . . . 72.239999999999995 106.412 171.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -100.81 -34.37 9.85 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.124 -0.944 . . . . 64.420000000000002 109.717 -176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.4 tt -162.14 148.37 13.34 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 109.003 -0.74 . . . . 63.229999999999997 109.003 -177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.31 139.61 50.7 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.281 0.562 . . . . 75.549999999999997 109.824 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 23' ' ' LEU . 69.6 mt -113.85 113.81 44.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.981 -0.748 . . . . 74.129999999999995 108.981 175.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 86.6 mtt180 -91.71 107.03 18.92 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.915 -1.143 . . . . 64.319999999999993 107.915 178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.577 ' HH2' HG22 ' A' ' 7' ' ' THR . 47.7 t-105 -103.13 126.93 50.53 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.721 -0.672 . . . . 73.329999999999998 111.289 -175.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -128.27 162.87 26.02 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.409 -2.071 . . . . 53.039999999999999 105.409 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.11 51.27 1.65 Allowed Glycine 0 CA--C 1.534 1.262 0 N-CA-C 116.345 1.298 . . . . 44.409999999999997 116.345 -172.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.4 -62.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.525 -0.917 . . . . 75.420000000000002 108.525 175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -111.76 138.85 38.83 Favored 'Isoleucine or valine' 0 C--O 1.25 1.088 0 CA-C-O 121.42 0.628 . . . . 71.140000000000001 112.162 -178.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -103.99 114.04 28.0 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.376 -0.829 . . . . 72.219999999999999 110.233 178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 5.7 tt -91.25 110.34 21.62 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.623 -0.88 . . . . 70.439999999999998 108.623 -178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -94.21 121.9 36.2 Favored 'General case' 0 C--N 1.285 -2.231 0 N-CA-C 107.233 -1.395 . . . . 75.109999999999999 107.233 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.29 120.56 24.58 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.154 0.502 . . . . 62.130000000000003 110.384 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -84.31 138.1 33.09 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.461 -0.791 . . . . 72.450000000000003 108.941 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.8 OUTLIER -123.06 76.8 1.4 Allowed 'General case' 0 CA--C 1.549 0.925 0 N-CA-C 109.356 -0.609 . . . . 73.219999999999999 109.356 -174.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER 160.79 151.76 0.01 OUTLIER 'General case' 0 C--O 1.198 -1.653 0 C-N-CA 125.914 1.686 . . . . 73.439999999999998 109.606 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -104.35 -12.31 16.66 Favored 'General case' 0 C--N 1.289 -2.05 0 O-C-N 121.562 -0.711 . . . . 72.209999999999994 109.716 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.0 m -72.73 -64.36 0.98 Allowed 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.645 -0.707 . . . . 44.210000000000001 111.674 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -107.12 28.93 7.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.958 -1.127 . . . . 73.319999999999993 107.958 -176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.79 120.89 2.73 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 114.452 -1.249 . . . . 74.140000000000001 113.245 -176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 m -70.29 142.8 52.23 Favored 'General case' 0 C--N 1.288 -2.076 0 C-N-CA 124.903 1.281 . . . . 75.329999999999998 112.373 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 76' ' ' PRO . 12.9 p -105.38 141.25 37.22 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.613 -0.721 . . . . 65.109999999999999 111.262 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.0 m -114.86 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 106.67 -1.604 . . . . 51.039999999999999 106.67 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.49 23.92 11.27 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 109.456 -0.572 . . . . 75.030000000000001 109.456 -170.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.2 t30 74.42 15.03 3.53 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 125.756 1.622 . . . . 72.299999999999997 111.712 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -107.57 123.71 37.2 Favored Pre-proline 0 C--N 1.315 -0.897 0 O-C-N 121.267 -0.896 . . . . 71.519999999999996 109.012 175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.411 ' N ' HG22 ' A' ' 71' ' ' THR . 57.4 Cg_endo -77.31 125.16 7.58 Favored 'Trans proline' 0 C--O 1.245 0.851 0 C-N-CA 121.981 1.787 . . . . 71.019999999999996 111.859 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.493 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.4 m -135.28 170.25 19.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.867 -0.606 . . . . 61.240000000000002 110.011 -176.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -91.13 -47.02 7.78 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.163 -1.051 . . . . 70.450000000000003 108.163 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.5 pt-20 -141.26 151.8 43.99 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.169 -0.923 . . . . 74.530000000000001 109.875 177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.493 ' HB2' HG21 ' A' ' 77' ' ' VAL . 23.3 t-105 -157.11 152.03 25.87 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.268 -1.012 . . . . 73.209999999999994 108.268 -175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 79.3 mt-30 -101.36 119.36 38.64 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.903 -0.719 . . . . 63.530000000000001 109.348 174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.533 ' HB3' HG11 ' A' ' 97' ' ' VAL . 78.2 mt -56.29 143.2 34.87 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 124.087 0.867 . . . . 54.409999999999997 111.656 -176.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.35 151.97 39.13 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.602 -1.259 . . . . 73.319999999999993 107.602 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -66.79 127.85 34.05 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 109.729 -0.471 . . . . 75.209999999999994 109.729 -176.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.22 -5.35 52.51 Favored Glycine 0 N--CA 1.435 -1.433 0 CA-C-N 115.897 -0.592 . . . . 63.020000000000003 111.88 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -72.64 127.65 33.18 Favored 'General case' 0 CA--C 1.497 -1.083 0 CA-C-O 121.212 0.529 . . . . 75.310000000000002 109.986 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.4 t -100.11 112.41 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.832 0 N-CA-C 107.75 -1.204 . . . . 74.340000000000003 107.75 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.405 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 40.3 mt -103.39 125.02 57.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 N-CA-C 108.196 -1.039 . . . . 75.099999999999994 108.196 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -129.55 124.92 35.06 Favored 'General case' 0 C--N 1.287 -2.11 0 CA-C-O 121.061 0.458 . . . . 71.140000000000001 111.521 -175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.461 HD23 ' H ' ' A' ' 90' ' ' LEU . 1.3 pt? -100.81 163.39 12.34 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 105.005 -2.22 . . . . 73.230000000000004 105.005 170.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -75.94 85.74 0.88 Allowed Glycine 0 N--CA 1.436 -1.361 0 C-N-CA 118.414 -1.851 . . . . 75.439999999999998 111.339 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 161.68 -54.07 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 126.632 1.973 . . . . 72.129999999999995 108.155 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.1 m -133.37 155.37 49.59 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.793 0.806 . . . . 74.310000000000002 111.734 -173.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -121.27 144.02 48.85 Favored 'General case' 0 C--N 1.288 -2.065 0 CA-C-N 114.359 -1.291 . . . . 74.230000000000004 109.038 178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.405 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 8.3 tp -134.82 146.74 30.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 N-CA-C 107.373 -1.343 . . . . 74.219999999999999 107.373 -177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.74 137.6 45.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 118.499 0.591 . . . . 74.329999999999998 109.456 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 82' ' ' LEU . 99.1 t -89.14 127.64 41.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-O 120.87 0.367 . . . . 61.32 111.421 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -120.09 145.18 47.13 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.684 -0.689 . . . . 73.120000000000005 109.208 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 8' ' ' SER . 90.0 mtp -122.02 124.35 43.78 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.523 -0.547 . . . . 73.530000000000001 109.523 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.0 m170 . . . . . 0 C--N 1.302 -1.485 0 CA-C-O 118.852 -0.594 . . . . 75.450000000000003 110.024 -175.393 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.505 0 N-CA-C 110.453 -1.059 . . . . 43.140000000000001 110.453 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -145.2 93.06 2.33 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.511 0.672 . . . . 74.549999999999997 109.612 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 174.21 -122.44 0.9 Allowed Glycine 0 N--CA 1.425 -2.08 0 C-N-CA 119.999 -1.096 . . . . 74.409999999999997 111.992 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.4 m -79.78 75.52 6.46 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 122.895 0.478 . . . . 72.329999999999998 111.583 -176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.47 100.86 0.09 Allowed 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.976 0.91 . . . . 51.149999999999999 109.88 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.85 45.94 1.37 Allowed Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.136 -1.586 . . . . 64.400000000000006 109.136 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.5 m -139.17 116.84 11.44 Favored 'General case' 0 N--CA 1.421 -1.924 0 CA-C-N 114.804 -0.698 . . . . 73.129999999999995 110.055 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.416 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.9 m -116.13 115.29 25.78 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 107.875 -1.158 . . . . 70.120000000000005 107.875 174.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.3 p -95.44 117.26 39.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 108.965 -0.754 . . . . 54.539999999999999 108.965 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.443 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.8 m -123.68 135.58 53.97 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.888 -1.051 . . . . 63.409999999999997 110.643 -171.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 20' ' ' THR . 54.4 mt -85.93 126.98 34.5 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 108.139 -1.06 . . . . 70.400000000000006 108.139 178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -111.47 128.36 55.98 Favored 'General case' 0 C--N 1.286 -2.181 0 O-C-N 123.752 0.658 . . . . 75.209999999999994 111.099 -175.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.5 tp -136.55 128.26 28.96 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.456 -0.942 . . . . 75.430000000000007 108.456 176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -89.6 100.08 12.95 Favored 'General case' 0 CA--C 1.483 -1.611 0 N-CA-C 107.685 -1.228 . . . . 41.200000000000003 107.685 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -125.17 84.31 2.26 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 107.294 -1.372 . . . . 63.109999999999999 107.294 176.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.62 -73.14 1.23 Allowed Glycine 0 C--N 1.289 -2.029 0 CA-C-N 114.731 -1.122 . . . . 55.200000000000003 110.328 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.3 t -121.84 -35.58 3.17 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.554 -0.906 . . . . 61.140000000000001 108.554 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.38 115.97 1.21 Allowed Glycine 0 N--CA 1.415 -2.756 0 C-N-CA 120.507 -0.854 . . . . 44.219999999999999 111.443 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -100.56 142.01 32.63 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 107.204 -1.406 . . . . 63.240000000000002 107.204 175.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.7 p -141.44 132.42 26.08 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 123.434 0.459 . . . . 61.409999999999997 111.415 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -121.52 111.99 17.94 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.82 -0.627 . . . . 75.540000000000006 109.469 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -84.15 132.02 34.72 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.556 -0.535 . . . . 70.439999999999998 109.556 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.422 ' HB2' HG13 ' A' ' 9' ' ' VAL . 96.3 mt -74.42 138.19 43.16 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 114.898 -1.047 . . . . 63.439999999999998 109.997 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -103.5 168.5 9.11 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.411 -0.589 . . . . 75.329999999999998 109.411 175.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.5 pm0 -61.41 118.79 7.42 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 124.212 0.945 . . . . 55.32 112.745 -175.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.19 -173.36 18.5 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 109.356 -1.498 . . . . 74.5 109.356 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 62.0 p -95.79 119.2 33.86 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 117.94 0.87 . . . . 72.109999999999999 110.904 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.472 ' N ' HD22 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -96.28 110.24 22.59 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.091 -1.448 . . . . 75.439999999999998 107.091 -176.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.4 mt -85.96 128.82 38.98 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 109.362 -0.607 . . . . 73.420000000000002 109.362 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.5 mt -108.28 132.92 54.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.266 -0.642 . . . . 73.239999999999995 109.266 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 155.08 -171.06 33.3 Favored Glycine 0 CA--C 1.481 -2.067 0 N-CA-C 109.756 -1.338 . . . . 71.439999999999998 109.756 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 73.3 mtp180 -120.44 105.27 10.71 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.631 -0.828 . . . . 73.140000000000001 108.856 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 155.6 13.71 Favored Glycine 0 N--CA 1.416 -2.648 0 N-CA-C 107.327 -2.309 . . . . 72.450000000000003 107.327 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -66.89 -17.69 65.02 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 118.017 0.909 . . . . 74.239999999999995 112.25 -176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.626 ' OD2' ' HD3' ' A' ' 48' ' ' ARG . 19.9 t70 -89.51 -2.01 58.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.74 0.781 . . . . 74.349999999999994 109.629 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -98.44 152.81 19.12 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.802 -0.636 . . . . 74.209999999999994 109.486 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -96.14 -46.95 6.26 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.12 0.486 . . . . 62.100000000000001 110.984 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -107.87 118.56 37.05 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.597 -0.89 . . . . 74.120000000000005 108.597 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 22.5 mmt85 -95.91 123.79 39.65 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.639 -0.71 . . . . 73.230000000000004 109.138 -175.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.435 HD12 HG21 ' A' ' 45' ' ' VAL . 57.6 mt -78.48 141.68 61.32 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 109.929 -0.397 . . . . 73.450000000000003 109.929 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -83.92 5.06 6.57 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.234 1.956 . . . . 71.230000000000004 114.333 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -111.7 172.72 6.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.572 -1.27 . . . . 74.439999999999998 107.572 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 m -112.65 156.5 22.62 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.052 -0.722 . . . . 71.219999999999999 109.052 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -22.46 17.28 Favored Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 109.955 -1.258 . . . . 73.230000000000004 109.955 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 40' ' ' LEU . 7.1 p -77.24 136.12 25.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.747 -0.726 . . . . 64.0 109.052 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 11.3 m -69.58 177.61 2.88 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 122.845 0.458 . . . . 74.129999999999995 110.96 -178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.654 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 3.8 ptp180 -63.64 -40.59 97.25 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.368 -0.533 . . . . 70.230000000000004 111.125 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.626 ' HD3' ' OD2' ' A' ' 35' ' ' ASP . 45.1 mtm180 -131.9 113.7 13.76 Favored 'General case' 0 CA--C 1.48 -1.725 0 N-CA-C 106.01 -1.848 . . . . 74.439999999999998 106.01 171.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -104.32 -38.43 6.85 Favored 'General case' 0 C--N 1.271 -2.824 0 CA-C-O 121.526 0.679 . . . . 63.399999999999999 110.35 -174.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.485 HD11 HD21 ' A' ' 61' ' ' LEU . 5.1 tt -160.3 153.51 21.86 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.577 -0.897 . . . . 64.340000000000003 108.577 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -138.24 124.52 20.46 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.31 0.576 . . . . 64.530000000000001 109.968 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 27' ' ' SER . 61.7 mt -99.19 119.22 46.9 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 108.91 -0.774 . . . . 64.400000000000006 108.91 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.469 ' HD2' HD23 ' A' ' 60' ' ' LEU . 51.9 mtt-85 -91.44 107.06 18.95 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.131 -1.433 . . . . 71.349999999999994 107.131 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 41.3 t-105 -102.46 116.8 33.36 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.882 0.849 . . . . 75.200000000000003 110.5 -177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -119.21 161.55 20.17 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 106.83 -1.545 . . . . 75.120000000000005 106.83 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.81 37.93 1.48 Allowed Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.429 0.559 . . . . 74.519999999999996 112.825 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -136.89 -70.04 0.46 Allowed 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 124.622 1.169 . . . . 73.430000000000007 108.392 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.7 m -138.08 159.38 32.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.949 -0.389 . . . . 72.439999999999998 109.949 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.02 106.52 18.87 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.601 0.715 . . . . 73.329999999999998 109.39 178.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.469 HD23 ' HD2' ' A' ' 53' ' ' ARG . 60.8 tp -90.79 111.98 23.59 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.198 -0.91 . . . . 74.239999999999995 111.185 -176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.485 HD21 HD11 ' A' ' 50' ' ' LEU . 2.9 tm? -86.95 122.34 30.67 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 107.54 -1.281 . . . . 63.539999999999999 107.54 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.464 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.94 123.08 31.61 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 110.014 -0.365 . . . . 72.450000000000003 110.014 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.61 145.97 27.09 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.507 -0.553 . . . . 62.039999999999999 109.507 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -133.67 77.09 1.7 Allowed 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.247 -1.39 . . . . 73.450000000000003 107.247 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -174.18 159.48 3.2 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.58 -0.526 . . . . 74.530000000000001 109.58 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 m -108.27 -54.55 2.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 120.851 0.357 . . . . 62.549999999999997 111.29 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.0 t -90.15 -24.44 21.06 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.794 -0.566 . . . . 74.109999999999999 111.963 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -105.51 26.98 8.81 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.6 -0.518 . . . . 71.230000000000004 109.6 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -48.92 126.66 18.3 Favored Glycine 0 C--O 1.248 0.983 0 O-C-N 124.294 0.996 . . . . 74.420000000000002 113.022 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.9 m -72.49 147.47 46.01 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.315 0.646 . . . . 74.400000000000006 111.557 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.6 p -113.37 146.91 38.7 Favored 'General case' 0 N--CA 1.424 -1.774 0 CA-C-N 115.762 -0.654 . . . . 70.219999999999999 110.285 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.38 116.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.19 0 N-CA-C 107.955 -1.128 . . . . 50.399999999999999 107.955 175.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 62.33 24.47 14.57 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 123.997 0.919 . . . . 63.299999999999997 109.704 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.8 m120 83.69 5.85 0.74 Allowed 'General case' 0 C--N 1.356 0.874 0 C-N-CA 126.723 2.009 . . . . 64.510000000000005 113.398 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.64 127.17 34.81 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.63 -0.507 . . . . 75.099999999999994 109.63 176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.02 125.29 9.22 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.513 2.142 . . . . 74.239999999999995 112.489 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.408 HG21 ' HB2' ' A' ' 80' ' ' TRP . 35.7 m -142.31 161.74 19.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 109.21 -0.663 . . . . 63.520000000000003 109.21 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -89.35 -28.19 19.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.207 0.527 . . . . 74.340000000000003 110.253 176.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.55 158.83 40.39 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.438 -0.949 . . . . 62.520000000000003 108.438 178.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.408 ' HB2' HG21 ' A' ' 77' ' ' VAL . 70.8 t-105 -157.68 152.2 24.99 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.69 -0.856 . . . . 73.019999999999996 108.69 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -100.04 107.7 19.69 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.277 -1.379 . . . . 65.230000000000004 107.277 174.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 97' ' ' VAL . 89.1 mt -56.87 143.51 37.11 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.946 0.779 . . . . 61.119999999999997 113.043 -175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.99 163.5 29.07 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-N 115.124 -0.944 . . . . 74.349999999999994 108.513 173.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.43 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.7 t70 -70.19 112.2 6.37 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.444 -0.576 . . . . 54.229999999999997 109.444 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.5 3.9 27.03 Favored Glycine 0 N--CA 1.432 -1.579 0 C-N-CA 121.004 -0.617 . . . . 64.400000000000006 113.148 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -80.89 139.36 35.95 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 117.832 0.816 . . . . 53.009999999999998 110.931 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.9 t -98.95 113.12 32.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.919 -0.771 . . . . 73.219999999999999 108.919 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.79 110.75 26.11 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 107.08 -1.452 . . . . 74.430000000000007 107.08 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HD2' ' OE1' ' A' ' 94' ' ' GLU . 18.5 ttt180 -113.73 121.35 43.81 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.659 0.742 . . . . 73.340000000000003 111.901 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -124.81 163.28 22.49 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.14 -1.391 . . . . 73.030000000000001 107.722 177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.34 120.05 9.12 Favored Glycine 0 C--N 1.313 -0.709 0 O-C-N 123.563 0.54 . . . . 74.5 113.133 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.2 m170 86.24 -17.02 0.4 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.041 1.736 . . . . 75.329999999999998 114.96 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.8 m -150.67 127.88 11.26 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 118.977 0.808 . . . . 73.299999999999997 112.652 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' OE1' ' HD2' ' A' ' 89' ' ' ARG . 10.1 pt-20 -110.8 131.92 54.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.498 -0.927 . . . . 74.349999999999994 108.498 171.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.32 144.72 34.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.807 -0.633 . . . . 72.140000000000001 110.184 -174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt -104.38 127.81 58.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.539 -0.911 . . . . 72.209999999999994 108.539 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.453 HG21 HD22 ' A' ' 82' ' ' LEU . 74.3 t -87.54 128.16 40.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 CA-C-N 116.638 -0.255 . . . . 61.039999999999999 110.459 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.2 mmm-85 -116.47 149.38 39.59 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 109.471 -0.566 . . . . 74.030000000000001 109.471 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.43 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 88.8 mtp -126.92 106.22 9.16 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.087 -1.079 . . . . 73.409999999999997 108.087 176.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 44.0 m-70 . . . . . 0 C--N 1.272 -2.774 0 CA-C-N 114.281 -1.327 . . . . 62.0 108.058 -176.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.462 0 N-CA-C 110.756 -0.938 . . . . 63.32 110.756 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -164.12 152.64 13.16 Favored 'General case' 0 C--O 1.251 1.157 0 N-CA-C 108.593 -0.891 . . . . 72.409999999999997 108.593 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -168.76 142.32 7.33 Favored Glycine 0 N--CA 1.424 -2.155 0 N-CA-C 110.572 -1.011 . . . . 51.130000000000003 110.572 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.1 m -85.63 -25.57 26.55 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.319 -0.622 . . . . 72.230000000000004 109.319 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.34 146.51 36.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.134 -1.061 . . . . 73.129999999999995 108.134 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.01 -78.35 0.24 Allowed Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 111.251 -0.739 . . . . 45.420000000000002 111.251 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.6 m -147.69 116.33 6.7 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 122.554 -0.38 . . . . 74.450000000000003 111.433 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.4 p -122.69 132.99 54.51 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.674 -1.232 . . . . 63.43 107.674 173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 p -115.59 129.55 71.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 CA-C-O 122.383 1.087 . . . . 53.329999999999998 111.118 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 81.3 m -132.43 128.71 38.1 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 114.759 -1.11 . . . . 74.219999999999999 108.309 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.407 HD13 HG21 ' A' ' 95' ' ' ILE . 4.4 pp -92.38 148.83 21.81 Favored 'General case' 0 N--CA 1.424 -1.726 0 N-CA-C 108.405 -0.961 . . . . 75.530000000000001 108.405 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -126.81 125.42 41.66 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 120.195 -0.602 . . . . 71.219999999999999 110.202 -177.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.572 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.3 tp -83.15 124.73 30.79 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 108.812 -0.81 . . . . 62.039999999999999 108.812 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -90.12 98.44 11.77 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 106.321 -1.733 . . . . 72.140000000000001 106.321 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -150.63 77.55 1.29 Allowed 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.904 -1.043 . . . . 72.430000000000007 109.386 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.93 -65.61 4.02 Favored Glycine 0 C--N 1.303 -1.283 0 CA-C-N 115.375 -0.83 . . . . 55.340000000000003 113.025 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.3 p -100.56 -47.36 4.9 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.456 0.646 . . . . 70.310000000000002 111.193 -176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA2' ' O ' ' A' ' 13' ' ' LEU . . . 106.82 91.27 2.21 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.367 -1.093 . . . . 72.140000000000001 110.367 -175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -94.52 158.21 15.65 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 110.478 -0.193 . . . . 61.329999999999998 110.478 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.3 p -121.88 148.93 44.1 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.108 0.781 . . . . 45.229999999999997 113.108 -176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -136.97 117.24 13.54 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.667 -1.234 . . . . 73.049999999999997 107.667 173.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -83.41 139.07 33.2 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.322 -0.621 . . . . 73.310000000000002 109.322 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.408 HD13 HG21 ' A' ' 52' ' ' ILE . 94.5 mt -85.48 139.7 31.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.815 -0.439 . . . . 73.329999999999998 109.815 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -101.55 165.16 11.39 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.935 0.398 . . . . 70.239999999999995 110.344 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -69.75 113.26 6.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.096 -0.956 . . . . 75.439999999999998 109.914 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.28 -174.57 19.94 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.08 -1.608 . . . . 60.310000000000002 109.08 -176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.7 p -106.78 145.85 31.58 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.385 -0.926 . . . . 55.539999999999999 110.857 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -122.75 135.43 54.56 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 109.464 -0.569 . . . . 71.430000000000007 109.464 177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.68 119.54 46.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 108.257 -1.016 . . . . 74.200000000000003 108.257 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 58.1 mt -101.8 127.73 54.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-O 121.301 0.572 . . . . 62.130000000000003 110.158 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.6 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.44 -178.09 37.49 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.335 -1.506 . . . . 75.109999999999999 109.335 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 29.1 mtm105 -110.99 106.52 15.63 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 118.356 1.078 . . . . 71.530000000000001 111.42 176.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.28 172.4 41.8 Favored Glycine 0 N--CA 1.416 -2.659 0 N-CA-C 107.168 -2.373 . . . . 75.319999999999993 107.168 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -85.56 -16.01 40.79 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 122.175 0.988 . . . . 72.329999999999998 108.457 177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -76.5 -12.57 60.06 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.113 -1.403 . . . . 70.5 109.273 175.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -98.37 158.02 15.84 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-N 114.776 -1.102 . . . . 72.019999999999996 108.553 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -106.65 -39.06 5.94 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.347 0.594 . . . . 71.120000000000005 110.397 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 89.7 t80 -115.72 114.88 25.42 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.904 -1.147 . . . . 74.420000000000002 107.904 177.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 61.7 mtm180 -96.91 124.14 40.81 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 116.094 -0.503 . . . . 74.230000000000004 110.499 -177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 66.6 mt -71.4 134.17 84.79 Favored Pre-proline 0 CA--C 1.501 -0.926 0 N-CA-C 107.573 -1.269 . . . . 75.299999999999997 107.573 173.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -83.28 35.01 0.55 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.967 1.778 . . . . 74.329999999999998 112.111 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -126.8 -175.55 3.44 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-O 121.043 0.449 . . . . 41.340000000000003 110.417 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 24.5 m -111.17 148.59 32.43 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 124.123 0.969 . . . . 74.329999999999998 110.005 -174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.82 -0.85 61.07 Favored Glycine 0 CA--C 1.505 -0.587 0 N-CA-C 111.679 -0.568 . . . . 31.43 111.679 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.14 127.69 45.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.867 -0.79 . . . . 71.430000000000007 108.867 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.1 m -78.96 177.3 8.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.166 -0.47 . . . . 41.340000000000003 110.185 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.516 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -57.41 -50.63 72.38 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.904 0.32 . . . . 74.209999999999994 110.97 177.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.62 114.6 26.66 Favored 'General case' 0 CA--C 1.482 -1.641 0 N-CA-C 107.025 -1.472 . . . . 75.340000000000003 107.025 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -105.31 -42.97 5.11 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.605 0.717 . . . . 72.219999999999999 109.097 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 tt -163.17 159.8 23.4 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.56 -0.904 . . . . 74.319999999999993 108.56 -175.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -138.85 151.1 46.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 109.518 -0.549 . . . . 65.430000000000007 109.518 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 23' ' ' LEU . 70.8 mt -123.48 121.44 62.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.542 -0.91 . . . . 63.240000000000002 108.542 176.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 63.4 mtt180 -105.6 107.94 19.2 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.206 -0.664 . . . . 73.150000000000006 109.206 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.72 133.98 52.07 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.996 -0.547 . . . . 75.439999999999998 110.616 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -140.79 -179.93 6.34 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 104.436 -2.431 . . . . 65.549999999999997 104.436 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.36 42.62 2.92 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 119.445 1.02 . . . . 25.5 113.867 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -141.62 -76.78 0.28 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 110.203 -0.295 . . . . 71.140000000000001 110.203 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -134.12 158.1 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.711 0.291 . . . . 63.25 110.557 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.51 112.38 24.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.403 0.62 . . . . 71.510000000000005 110.289 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.488 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 6.1 tt -88.96 124.87 34.66 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.272 -0.876 . . . . 61.130000000000003 108.797 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -109.74 123.55 49.71 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.347 -1.353 . . . . 74.25 107.347 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.74 124.68 28.59 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.187 0.518 . . . . 52.509999999999998 110.999 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 14.9 t70 -89.3 112.47 23.55 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.357 -0.979 . . . . 73.150000000000006 108.357 178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 24.5 mt -101.53 76.45 1.67 Allowed 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 105.422 -2.066 . . . . 73.140000000000001 105.422 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 68' ' ' ASN . 19.9 t30 -173.81 139.64 0.7 Allowed 'General case' 0 C--N 1.294 -1.824 0 C-N-CA 119.899 -0.72 . . . . 71.129999999999995 109.708 -165.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.5 m -108.56 -53.38 2.65 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.283 0.563 . . . . 63.229999999999997 110.003 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.6 m -66.02 -48.64 70.45 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.277 -0.874 . . . . 34.130000000000003 113.05 -173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.477 ' HB2' HD21 ' A' ' 65' ' ' ASN . 20.0 m-80 -106.4 29.77 6.57 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 119.173 -0.441 . . . . 60.409999999999997 109.94 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.23 121.94 2.83 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 115.18 0.832 . . . . 65.049999999999997 115.18 -170.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.7 m -69.08 149.17 49.01 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.734 1.614 . . . . 75.219999999999999 112.336 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 38.5 p -112.4 145.78 39.51 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.345 0.593 . . . . 54.219999999999999 111.814 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.438 HG12 HG13 ' A' ' 88' ' ' ILE . 33.9 m -116.07 117.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.877 0 N-CA-C 107.431 -1.322 . . . . 74.140000000000001 107.431 175.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 58.88 33.26 22.94 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.675 -0.693 . . . . 71.239999999999995 110.295 -177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 82.46 -3.36 1.4 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.86 1.664 . . . . 73.209999999999994 112.428 177.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.15 129.31 25.39 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.684 -0.635 . . . . 54.119999999999997 110.089 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.12 125.58 7.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.501 2.134 . . . . 73.519999999999996 113.529 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.68 174.47 5.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 107.295 -1.372 . . . . 73.329999999999998 107.295 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.456 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.2 mt-30 -117.4 -17.73 10.02 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 112.979 0.733 . . . . 71.340000000000003 112.979 174.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.61 131.52 27.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.983 0.421 . . . . 74.019999999999996 109.908 172.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -147.57 152.33 37.77 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.842 -0.799 . . . . 74.340000000000003 108.842 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -106.41 113.8 27.53 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 108.181 -1.044 . . . . 74.140000000000001 108.181 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.508 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.2 mt -57.85 149.56 22.28 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.107 -0.952 . . . . 71.329999999999998 112.486 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.09 166.79 23.8 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.321 -0.854 . . . . 54.439999999999998 109.15 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 34.8 t70 -71.67 115.72 11.19 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 120.994 0.426 . . . . 72.150000000000006 110.201 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.46 14.34 28.1 Favored Glycine 0 N--CA 1.43 -1.758 0 CA-C-N 115.813 -0.63 . . . . 71.109999999999999 112.084 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -88.76 135.66 33.4 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 120.438 -0.505 . . . . 73.439999999999998 110.74 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.4 t -101.21 113.46 37.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 109.008 -0.738 . . . . 61.409999999999997 109.008 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.438 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -105.76 113.53 42.84 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.805 -1.183 . . . . 74.049999999999997 107.805 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 61.5 mtt180 -99.81 106.28 18.14 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 116.272 -0.422 . . . . 73.219999999999999 109.954 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -115.5 164.69 13.93 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 115.013 -0.994 . . . . 54.420000000000002 109.001 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -27.39 88.78 0.01 OUTLIER Glycine 0 N--CA 1.484 1.856 0 C-N-CA 125.303 1.43 . . . . 64.400000000000006 116.331 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 58.08 21.35 7.81 Favored 'General case' 0 CA--C 1.558 1.271 0 C-N-CA 125.76 1.624 . . . . 72.540000000000006 111.491 176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.0 m -137.01 114.25 10.79 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.12 -1.067 . . . . 63.439999999999998 108.12 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -112.22 125.4 54.1 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 120.099 -0.64 . . . . 70.519999999999996 109.799 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 13' ' ' LEU . 1.7 pp -122.48 149.43 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-O 120.953 0.406 . . . . 53.100000000000001 111.36 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -110.39 122.45 64.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 106.767 -1.568 . . . . 44.520000000000003 106.767 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.508 HG11 ' HB3' ' A' ' 82' ' ' LEU . 55.1 t -80.41 126.56 39.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-O 120.85 0.357 . . . . 75.040000000000006 111.057 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.0 mmm-85 -116.9 142.3 47.11 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.35 0.595 . . . . 64.540000000000006 109.678 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.46 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 79.6 mtp -123.06 121.25 35.57 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 114.925 -1.034 . . . . 74.239999999999995 109.144 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 107.168 -1.419 . . . . 73.439999999999998 107.168 -177.641 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.624 0 N-CA-C 110.468 -1.053 . . . . 63.240000000000002 110.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -118.34 59.76 0.8 Allowed 'General case' 0 N--CA 1.412 -2.336 0 CA-C-O 122.901 1.334 . . . . 44.5 108.639 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.32 -82.69 1.63 Allowed Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 108.126 -1.989 . . . . 32.039999999999999 108.126 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 m -84.89 88.49 7.42 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.388 0.613 . . . . 53.009999999999998 109.925 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -116.28 81.7 1.66 Allowed 'General case' 0 N--CA 1.414 -2.272 0 CA-C-O 122.107 0.956 . . . . 74.409999999999997 108.978 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.17 -53.14 0.27 Allowed Glycine 0 C--N 1.288 -2.138 0 N-CA-C 108.028 -2.029 . . . . 73.120000000000005 108.028 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 m -70.83 115.3 9.82 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 106.831 -1.544 . . . . 73.400000000000006 106.831 172.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -121.48 114.77 21.73 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 120.494 -0.483 . . . . 74.129999999999995 109.95 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.7 p -95.76 126.41 48.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 N-CA-C 107.713 -1.217 . . . . 55.020000000000003 107.713 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.8 m -131.06 136.54 48.54 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.28 -0.873 . . . . 72.450000000000003 109.264 -172.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.493 HD13 HD11 ' A' ' 95' ' ' ILE . 4.0 pp -101.8 131.41 48.13 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 116.151 -0.477 . . . . 73.040000000000006 109.966 177.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.92 114.26 28.24 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.28 -1.378 . . . . 62.340000000000003 107.28 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.9 tp -102.16 119.31 38.59 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 123.43 0.692 . . . . 73.239999999999995 110.521 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -93.36 100.0 12.41 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 107.949 -1.13 . . . . 63.530000000000001 107.949 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -104.91 -13.59 15.76 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 114.167 -1.378 . . . . 73.439999999999998 109.179 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.22 -12.93 6.02 Favored Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 109.87 -1.292 . . . . 34.32 109.87 -173.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.6 p -120.12 -35.81 3.39 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 120.816 0.341 . . . . 74.319999999999993 110.593 175.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.62 91.82 1.38 Allowed Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 110.139 -1.184 . . . . 33.240000000000002 110.139 178.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -113.51 159.43 19.56 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 110.476 -0.194 . . . . 74.430000000000007 110.476 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.8 p -130.22 136.33 49.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 120.882 0.373 . . . . 74.349999999999994 110.024 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -135.62 121.55 19.91 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 116.042 -0.526 . . . . 74.109999999999999 109.638 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -85.83 135.51 33.68 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.915 -0.584 . . . . 52.100000000000001 109.762 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.457 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.3 mt -76.86 133.91 39.17 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.503 -0.771 . . . . 61.210000000000001 110.265 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -102.99 158.45 16.28 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 108.767 -0.827 . . . . 72.109999999999999 108.767 175.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.587 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.9 mp0 -48.5 127.27 12.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 125.492 1.517 . . . . 73.219999999999999 111.445 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.1 -174.8 15.81 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 109.255 -1.538 . . . . 64.420000000000002 109.255 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 81.8 p -95.73 123.35 39.26 Favored 'General case' 0 N--CA 1.42 -1.948 0 C-N-CA 118.319 -1.353 . . . . 73.129999999999995 110.882 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.517 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -92.57 109.74 21.15 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.065 -1.828 . . . . 74.430000000000007 106.065 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -90.21 129.42 41.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.596 -0.729 . . . . 60.399999999999999 110.842 -173.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.5 mt -107.57 133.72 51.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.54 -0.911 . . . . 72.530000000000001 108.54 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 154.79 177.5 28.17 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.193 -1.563 . . . . 74.129999999999995 109.193 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 49.7 mtp85 -112.52 105.0 13.12 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.884 1.342 . . . . 75.530000000000001 109.858 179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.89 179.32 46.31 Favored Glycine 0 N--CA 1.416 -2.64 0 N-CA-C 110.039 -1.225 . . . . 74.230000000000004 110.039 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -72.41 -25.44 61.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.073 0.939 . . . . 73.319999999999993 108.937 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.98 8.48 12.58 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.665 -1.152 . . . . 71.129999999999995 111.526 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.91 155.19 44.59 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.079 0.466 . . . . 63.100000000000001 112.013 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -99.63 -54.73 2.85 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.017 -0.992 . . . . 71.420000000000002 109.987 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -101.48 108.92 20.64 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 71.430000000000007 109.217 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 33.5 ptt180 -96.08 118.13 32.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 116.105 -0.498 . . . . 75.040000000000006 111.802 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.65 140.19 97.35 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.278 -0.874 . . . . 71.340000000000003 110.509 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -92.71 17.92 1.12 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.601 2.201 . . . . 75.329999999999998 112.283 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.64 -173.49 2.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.491 -0.929 . . . . 71.319999999999993 108.491 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.5 m -112.0 146.91 37.04 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 123.193 0.597 . . . . 60.32 109.564 -175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.63 -27.36 16.82 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.818 -0.706 . . . . 73.519999999999996 111.384 178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.34 133.02 28.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 123.435 0.694 . . . . 65.340000000000003 111.586 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.3 m -80.27 -171.47 3.02 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.392 1.077 . . . . 71.140000000000001 109.552 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 33.4 ptt180 -78.02 -34.78 50.49 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.35 -0.94 . . . . 63.439999999999998 109.587 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HB3' HD23 ' A' ' 64' ' ' LEU . 63.4 mtp180 -129.07 115.18 17.35 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 103.582 -2.748 . . . . 64.030000000000001 103.582 172.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.574 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 5.3 t60 -103.76 -42.41 5.63 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.55 0.691 . . . . 73.120000000000005 109.143 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 4.9 tt -166.45 151.14 7.78 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.429 -0.952 . . . . 72.409999999999997 108.429 -177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -132.63 134.94 45.5 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 109.122 -0.695 . . . . 72.129999999999995 109.122 176.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -102.55 112.99 37.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 N-CA-C 107.028 -1.471 . . . . 75.200000000000003 107.028 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 40.2 ttt85 -91.65 107.38 19.17 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-O 121.548 0.689 . . . . 73.409999999999997 109.779 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -96.49 112.54 24.24 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-N 114.948 -1.024 . . . . 74.120000000000005 109.056 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -119.27 167.38 11.92 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.172 -1.788 . . . . 55.219999999999999 106.172 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.98 42.36 2.5 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 120.592 -0.813 . . . . 52.100000000000001 112.566 -176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -136.68 -66.86 0.52 Allowed 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 124.041 0.936 . . . . 71.019999999999996 108.56 -177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.11 159.77 4.92 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.719 1.208 . . . . 73.439999999999998 108.31 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.36 107.59 19.24 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.652 0.739 . . . . 75.549999999999997 109.101 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 tt -88.49 115.41 25.98 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 114.79 -1.095 . . . . 72.200000000000003 109.789 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.8 tm? -97.21 124.94 41.44 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.318 -1.364 . . . . 72.430000000000007 107.318 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.446 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -140.57 125.6 18.43 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-O 120.678 0.275 . . . . 62.229999999999997 111.409 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.667 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 1.2 m-20 -73.52 139.61 45.79 Favored 'General case' 0 CA--C 1.49 -1.34 0 CA-C-N 115.798 -0.637 . . . . 64.129999999999995 109.948 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.418 HD23 ' HB3' ' A' ' 48' ' ' ARG . 32.9 tp -130.68 77.15 1.77 Allowed 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 107.534 -1.284 . . . . 53.549999999999997 107.534 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -179.82 174.64 0.91 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.419 -1.326 . . . . 73.25 107.419 -174.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 p -109.03 -55.03 2.46 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.642 0.608 . . . . 72.239999999999995 112.642 176.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.3 t -89.52 -29.95 18.58 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.466 0.913 . . . . 74.109999999999999 113.466 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.574 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 90.2 m-20 -84.57 27.38 0.72 Allowed 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 123.427 0.691 . . . . 54.43 112.219 -172.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.51 122.73 6.68 Favored Glycine 0 N--CA 1.442 -0.947 0 O-C-N 124.967 1.417 . . . . 64.329999999999998 113.951 -175.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.667 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 52.7 m -71.84 148.68 45.95 Favored 'General case' 0 C--N 1.269 -2.899 0 C-N-CA 125.035 1.334 . . . . 71.319999999999993 112.622 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 p -112.92 141.03 47.22 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.435 -0.802 . . . . 54.240000000000002 109.505 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.03 118.25 53.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.755 -1.202 . . . . 64.319999999999993 107.755 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 57.81 38.22 27.23 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.556 -0.747 . . . . 70.230000000000004 109.88 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.39 -10.61 1.17 Allowed 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.605 1.962 . . . . 65.010000000000005 112.001 177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -92.37 121.81 65.75 Favored Pre-proline 0 C--N 1.323 -0.57 0 O-C-N 122.124 -0.36 . . . . 52.240000000000002 110.7 -178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.47 125.19 13.0 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 122.837 2.358 . . . . 75.030000000000001 112.552 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.99 -177.9 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 108.974 -0.751 . . . . 75.209999999999994 108.974 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -128.83 6.25 5.53 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.589 -0.522 . . . . 72.230000000000004 109.589 171.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -171.45 153.16 3.44 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.907 -1.146 . . . . 73.329999999999998 107.907 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.448 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 76.3 t-105 -166.91 152.29 7.73 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.711 -0.848 . . . . 73.140000000000001 108.711 -178.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -104.66 111.52 24.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.643 -1.243 . . . . 44.030000000000001 107.643 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.438 ' HB3' HG11 ' A' ' 97' ' ' VAL . 56.0 mt -58.13 141.3 50.75 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 113.898 1.073 . . . . 64.530000000000001 113.898 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.97 162.46 32.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.529 -1.286 . . . . 53.399999999999999 107.529 171.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -65.0 126.36 27.79 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 116.575 -0.284 . . . . 75.150000000000006 110.396 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.63 1.94 57.56 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.907 -0.663 . . . . 62.020000000000003 113.414 176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -73.07 129.58 38.39 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 117.362 0.581 . . . . 53.200000000000003 111.135 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.5 t -94.43 116.28 35.32 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.701 0 N-CA-C 107.284 -1.376 . . . . 75.530000000000001 107.284 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.9 mt -122.43 134.28 66.11 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.654 0 C-N-CA 119.971 -0.692 . . . . 50.020000000000003 110.6 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.408 ' HG2' ' CB ' ' A' ' 94' ' ' GLU . 27.7 mtp-105 -124.19 123.35 40.08 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.415 0.626 . . . . 73.099999999999994 110.004 175.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.5 pt? -101.81 162.57 12.81 Favored 'General case' 0 C--N 1.258 -3.403 0 N-CA-C 105.81 -1.922 . . . . 65.540000000000006 105.81 175.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -46.33 102.86 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 O-C-N 123.749 0.655 . . . . 64.239999999999995 113.786 -177.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 m170 79.52 15.28 0.94 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.712 1.375 . . . . 73.140000000000001 114.712 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 69.3 m -151.02 141.11 22.14 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 121.475 -0.766 . . . . 71.450000000000003 111.94 176.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.408 ' CB ' ' HG2' ' A' ' 89' ' ' ARG . 9.2 pt-20 -118.75 139.29 51.81 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.037 0.446 . . . . 52.130000000000003 111.235 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.493 HD11 HD13 ' A' ' 11' ' ' LEU . 9.5 tp -139.8 142.38 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 CA-C-N 115.301 -0.863 . . . . 75.239999999999995 109.527 -172.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -109.88 134.51 51.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.029 -1.1 . . . . 53.539999999999999 108.029 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.438 HG11 ' HB3' ' A' ' 82' ' ' LEU . 85.0 t -96.92 121.73 47.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 121.141 0.496 . . . . 75.430000000000007 111.168 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -117.47 132.29 56.58 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.865 -0.791 . . . . 72.120000000000005 108.865 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.0 mtp -116.36 116.87 28.52 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.064 -0.717 . . . . 64.109999999999999 109.064 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 . . . . . 0 C--N 1.278 -2.537 0 N-CA-C 107.506 -1.294 . . . . 63.420000000000002 107.506 -177.732 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.751 0 N-CA-C 111.328 -0.709 . . . . 43.049999999999997 111.328 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -59.92 123.83 18.28 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.969 0.908 . . . . 72.319999999999993 112.263 -177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.26 76.23 0.51 Allowed Glycine 0 N--CA 1.428 -1.871 0 N-CA-C 110.408 -1.077 . . . . 45.5 110.408 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.6 m -62.79 121.07 12.54 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 109.185 -0.672 . . . . 64.310000000000002 109.185 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -104.86 -175.75 2.88 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 123.867 0.729 . . . . 74.510000000000005 110.109 -175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.14 -58.26 5.01 Favored Glycine 0 CA--C 1.496 -1.137 0 N-CA-C 109.888 -1.285 . . . . 70.349999999999994 109.888 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 m -144.64 114.76 7.45 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 107.82 -1.178 . . . . 50.039999999999999 107.82 173.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -113.04 114.3 26.67 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 107.201 -1.407 . . . . 54.240000000000002 107.201 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 108.23 18.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 N-CA-C 107.813 -1.18 . . . . 60.399999999999999 107.813 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.9 m -111.41 123.23 49.79 Favored 'General case' 0 N--CA 1.408 -2.527 0 N-CA-C 108.095 -1.076 . . . . 73.0 108.095 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.4 pp -88.53 130.02 35.33 Favored 'General case' 0 N--CA 1.409 -2.494 0 N-CA-C 108.602 -0.888 . . . . 62.200000000000003 108.602 177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.93 108.85 19.76 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 106.622 -1.621 . . . . 54.119999999999997 106.622 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.48 117.8 29.39 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.524 -0.546 . . . . 73.209999999999994 109.524 -174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -126.77 103.53 7.58 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.951 -1.1 . . . . 72.099999999999994 112.925 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -48.87 9.42 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.9 -2.259 . . . . 74.430000000000007 104.9 172.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 171.29 44.27 0.04 OUTLIER Glycine 0 N--CA 1.42 -2.421 0 N-CA-C 103.591 -3.804 . . . . 34.340000000000003 103.591 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.1 m -132.49 -45.94 0.9 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 113.644 -1.278 . . . . 72.099999999999994 110.86 -166.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.72 51.04 8.38 Favored Glycine 0 N--CA 1.435 -1.368 0 N-CA-C 110.49 -1.044 . . . . 75.340000000000003 110.49 -172.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -84.47 143.1 29.6 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 122.747 0.419 . . . . 74.209999999999994 110.355 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 16.9 p -146.68 132.36 18.88 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.645 -0.707 . . . . 71.299999999999997 109.199 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -144.8 127.69 16.39 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.456 -0.338 . . . . 72.25 110.099 -177.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -90.07 127.46 36.08 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 108.41 -0.959 . . . . 62.039999999999999 108.41 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.0 mt -58.31 143.46 44.69 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.567 0.951 . . . . 63.450000000000003 113.567 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 2.3 mmp_? -100.01 151.61 21.16 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.559 -1.201 . . . . 72.430000000000007 108.022 176.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -70.85 130.14 40.88 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-O 121.683 0.754 . . . . 72.420000000000002 111.367 -179.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.65 -176.54 16.61 Favored Glycine 0 N--CA 1.424 -2.148 0 N-CA-C 106.763 -2.535 . . . . 62.32 106.763 -172.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 51.7 p -89.71 133.27 34.75 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 118.388 -1.325 . . . . 74.439999999999998 111.303 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.504 ' N ' HD22 ' A' ' 28' ' ' ASN . 0.5 OUTLIER -101.72 109.83 21.68 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 105.194 -2.15 . . . . 74.200000000000003 105.194 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.4 mt -86.2 123.96 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.976 -0.556 . . . . 75.25 111.149 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.467 HG23 ' HD2' ' A' ' 38' ' ' PHE . 67.7 mt -107.91 129.62 61.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 N-CA-C 108.768 -0.827 . . . . 72.420000000000002 108.768 178.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.55 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 161.48 -179.03 37.15 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 110.888 -0.885 . . . . 74.439999999999998 110.888 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 40.1 mtp85 -107.43 106.38 16.75 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 108.732 -0.84 . . . . 73.510000000000005 108.732 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.71 -178.13 48.63 Favored Glycine 0 N--CA 1.42 -2.388 0 N-CA-C 109.562 -1.415 . . . . 53.399999999999999 109.562 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -93.43 -21.05 19.74 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.004 0.431 . . . . 61.130000000000003 110.786 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -92.76 -3.59 54.51 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 73.040000000000006 110.056 179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.11 165.96 20.11 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.049 -0.978 . . . . 42.229999999999997 108.911 174.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -109.35 -52.16 2.8 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.65 0.738 . . . . 64.239999999999995 110.028 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.467 ' HD2' HG23 ' A' ' 30' ' ' ILE . 92.0 t80 -108.82 116.73 32.53 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.366 -0.975 . . . . 74.310000000000002 108.366 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.55 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 8.0 mpt_? -94.92 127.86 41.28 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 116.159 -0.473 . . . . 62.399999999999999 110.973 -176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.7 mt -79.98 136.07 54.59 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 116.101 -0.5 . . . . 71.420000000000002 111.138 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.98 -29.15 81.5 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.407 2.738 . . . . 71.25 114.4 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.517 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 21.5 t70 -95.03 169.0 10.42 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.709 -0.849 . . . . 63.119999999999997 108.709 -177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 t -107.23 -177.34 3.33 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 121.036 -0.266 . . . . 74.150000000000006 110.321 -176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.92 -9.22 78.39 Favored Glycine 0 C--O 1.238 0.395 0 N-CA-C 108.807 -1.717 . . . . 74.120000000000005 108.807 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.0 t -86.47 130.64 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.234 0 CA-C-N 113.294 -1.453 . . . . 55.140000000000001 108.095 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.1 m -79.11 -177.48 5.65 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.244 -0.651 . . . . 74.299999999999997 109.244 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 15.4 ptt180 -64.49 -41.56 96.39 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.572 0.701 . . . . 74.109999999999999 109.415 177.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -121.02 104.36 9.74 Favored 'General case' 0 N--CA 1.416 -2.144 0 N-CA-C 106.245 -1.761 . . . . 72.219999999999999 106.245 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 15.2 t60 -100.0 -31.44 11.45 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-N 114.948 -1.024 . . . . 75.030000000000001 108.877 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.486 HD11 HD21 ' A' ' 61' ' ' LEU . 8.1 tt -164.28 145.89 8.6 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.108 -0.701 . . . . 74.230000000000004 109.108 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -128.95 132.92 47.66 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 121.292 0.567 . . . . 71.540000000000006 110.05 176.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.3 mt -108.53 112.22 39.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.642 -1.244 . . . . 74.019999999999996 107.642 175.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 16.3 ttt-85 -91.35 107.71 19.39 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.471 -1.307 . . . . 74.310000000000002 107.471 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -99.51 115.32 29.07 Favored 'General case' 0 N--CA 1.412 -2.325 0 CA-C-O 121.672 0.749 . . . . 74.519999999999996 110.324 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.83 164.6 14.42 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 107.051 -1.463 . . . . 62.420000000000002 107.051 174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.56 52.91 3.91 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.415 -1.074 . . . . 70.409999999999997 110.415 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -143.36 -71.73 0.3 Allowed 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 125.7 1.6 . . . . 64.409999999999997 107.793 -176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 m -149.76 160.0 5.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 124.908 1.283 . . . . 70.319999999999993 107.896 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -93.24 106.15 18.15 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.585 -0.895 . . . . 71.340000000000003 108.585 176.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -82.48 118.31 23.14 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.277 -0.874 . . . . 64.420000000000002 110.096 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.486 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -99.54 120.13 39.15 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.545 -0.909 . . . . 74.010000000000005 108.545 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -128.0 123.48 34.85 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.815 -0.439 . . . . 51.439999999999998 109.815 176.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -95.64 138.82 32.77 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.868 -0.605 . . . . 73.430000000000007 110.994 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.92 77.52 1.62 Allowed 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 122.979 0.511 . . . . 64.340000000000003 109.913 175.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 32.9 t-20 -175.31 138.67 0.43 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.842 0.746 . . . . 74.040000000000006 110.473 176.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 p -96.54 -38.46 9.97 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.361 -0.381 . . . . 75.319999999999993 111.854 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.2 t -89.32 -44.4 10.25 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.346 0.499 . . . . 63.439999999999998 112.346 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.438 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 16.4 m120 -105.98 27.37 8.64 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.129 -0.693 . . . . 74.209999999999994 109.129 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.96 138.36 26.32 Favored Glycine 0 C--O 1.248 1.004 0 CA-C-N 114.527 -1.215 . . . . 32.229999999999997 113.923 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 89' ' ' ARG . 30.0 m -72.25 137.73 47.0 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 124.406 1.082 . . . . 64.230000000000004 113.299 -176.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.2 p -105.91 140.75 38.45 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.373 -0.83 . . . . 72.530000000000001 109.674 173.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 88' ' ' ILE . 35.2 m -119.55 116.04 49.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 107.602 -1.259 . . . . 54.509999999999998 107.602 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 57.84 30.86 19.69 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.445 0.64 . . . . 72.209999999999994 110.167 -176.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 88.72 -10.88 0.45 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.659 1.984 . . . . 74.540000000000006 113.677 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.7 117.81 66.3 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 121.413 -0.804 . . . . 71.439999999999998 110.913 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -69.86 124.91 11.5 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 121.76 1.64 . . . . 70.400000000000006 110.319 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.95 175.98 7.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 110.168 -0.308 . . . . 75.099999999999994 110.168 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -104.05 -31.84 9.49 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 123.659 0.599 . . . . 61.109999999999999 109.42 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -142.73 147.86 36.31 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.048 -0.524 . . . . 73.450000000000003 110.199 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.4 t-105 -162.23 152.17 16.47 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -107.92 109.41 20.91 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 119.979 -0.688 . . . . 73.519999999999996 109.154 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 79.0 mt -57.1 122.02 11.41 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 114.479 -1.237 . . . . 54.049999999999997 111.923 -175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.9 166.59 11.08 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.924 -1.139 . . . . 72.109999999999999 107.924 174.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.35 126.4 29.13 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 116.462 -0.335 . . . . 71.409999999999997 110.628 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.48 -3.16 57.73 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.929 -0.578 . . . . 44.109999999999999 113.071 178.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.06 139.88 46.84 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 116.984 0.392 . . . . 55.310000000000002 111.411 -178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.7 t -103.69 117.19 48.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.753 -0.658 . . . . 62.109999999999999 109.673 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 72' ' ' VAL . 1.9 mp -111.98 124.55 68.81 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 C-N-CA 123.368 0.667 . . . . 63.439999999999998 109.28 -177.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 70' ' ' THR . 38.5 ttm180 -120.37 115.73 24.11 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.405 -0.591 . . . . 72.430000000000007 109.405 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 90' ' ' LEU . 2.1 pt? -126.81 139.29 53.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.409 -1.33 . . . . 70.129999999999995 107.409 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.86 88.02 0.0 OUTLIER Glycine 0 N--CA 1.496 2.636 0 O-C-N 125.032 1.457 . . . . 44.340000000000003 116.297 -174.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.5 t60 75.37 -19.66 0.38 Allowed 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 125.327 1.451 . . . . 74.120000000000005 113.034 176.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.6 m -96.55 132.46 42.13 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 122.869 0.468 . . . . 72.299999999999997 111.171 -174.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -125.78 117.63 23.83 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.013 0.911 . . . . 64.120000000000005 110.387 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.465 HG13 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -127.64 141.57 46.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 114.53 -1.214 . . . . 62.32 111.914 -170.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -106.86 133.34 51.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 108.095 -1.076 . . . . 74.200000000000003 108.095 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.38 124.54 42.16 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-O 120.869 0.366 . . . . 71.530000000000001 110.84 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.4 mmm180 -119.25 130.58 55.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.741 -0.663 . . . . 74.329999999999998 111.126 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.1 mtt -106.17 111.93 24.75 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.975 -0.75 . . . . 44.310000000000002 108.975 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 . . . . . 0 C--N 1.277 -2.586 0 N-CA-C 108.306 -0.998 . . . . 75.129999999999995 108.306 179.104 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.881 0 N-CA-C 110.412 -1.075 . . . . 43.049999999999997 110.412 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.5 t-80 65.68 -72.24 0.08 Allowed 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.421 1.488 . . . . 55.039999999999999 112.174 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -101.02 164.38 18.4 Favored Glycine 0 N--CA 1.416 -2.691 0 N-CA-C 111.599 -0.601 . . . . 71.140000000000001 111.599 -177.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -84.64 141.84 30.35 Favored 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 108.731 -0.84 . . . . 61.100000000000001 108.731 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.21 138.82 55.9 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.139 -1.06 . . . . 72.129999999999995 108.139 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.02 -53.55 45.48 Favored Glycine 0 CA--C 1.508 -0.399 0 C-N-CA 120.494 -0.86 . . . . 63.109999999999999 111.084 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.7 m -73.87 116.0 13.98 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 109.305 -0.628 . . . . 75.510000000000005 109.305 176.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.9 m -101.56 115.57 30.81 Favored 'General case' 0 N--CA 1.414 -2.253 0 N-CA-C 108.804 -0.813 . . . . 64.329999999999998 108.804 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -90.24 122.02 41.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 106.251 -1.759 . . . . 72.219999999999999 106.251 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.6 m -135.66 131.22 35.46 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.615 -0.513 . . . . 74.0 109.615 -173.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.8 OUTLIER -93.94 126.86 39.39 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 109.377 -0.601 . . . . 70.420000000000002 109.377 175.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -97.8 108.72 21.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.759 -1.2 . . . . 74.450000000000003 107.759 -176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.1 tp -101.02 114.36 28.23 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 115.824 -0.626 . . . . 72.409999999999997 109.778 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -94.7 99.62 11.69 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 106.551 -1.648 . . . . 74.019999999999996 106.551 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -146.89 79.75 1.52 Allowed 'General case' 0 N--CA 1.411 -2.401 0 CA-C-N 114.596 -1.184 . . . . 64.129999999999995 108.953 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.23 -62.39 0.29 Allowed Glycine 0 C--N 1.292 -1.914 0 CA-C-N 115.19 -0.914 . . . . 70.120000000000005 111.656 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.0 m -128.23 -38.92 1.75 Allowed 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.425 0.528 . . . . 63.549999999999997 112.425 -178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 122.59 86.16 0.79 Allowed Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.784 -0.926 . . . . 73.140000000000001 110.784 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -100.38 167.37 10.44 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.462 0.305 . . . . 73.409999999999997 110.72 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.9 p -141.65 140.55 33.29 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.845 -0.616 . . . . 72.109999999999999 110.388 -176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -127.4 121.83 31.97 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 108.082 -1.081 . . . . 74.430000000000007 108.082 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -86.67 125.88 34.16 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.414 -1.328 . . . . 74.109999999999999 107.414 178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.0 mt -70.47 121.72 18.3 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.783 -0.644 . . . . 72.150000000000006 110.671 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -82.78 150.59 26.54 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 108.867 -0.79 . . . . 73.340000000000003 108.867 177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -57.76 124.98 21.0 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 124.242 0.964 . . . . 61.340000000000003 110.309 176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 123.17 -164.04 16.35 Favored Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.761 -2.136 . . . . 74.420000000000002 107.761 -173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 80.5 p -100.65 134.64 43.32 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 119.011 1.406 . . . . 75.230000000000004 111.31 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -111.78 110.07 20.24 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 106.205 -1.776 . . . . 72.420000000000002 106.205 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' ALA . 45.7 mt -102.27 136.31 35.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-N 115.676 -0.693 . . . . 71.430000000000007 110.214 -173.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -115.08 135.11 56.05 Favored 'Isoleucine or valine' 0 C--O 1.257 1.458 0 N-CA-C 109.49 -0.559 . . . . 71.010000000000005 109.49 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.88 -175.97 29.63 Favored Glycine 0 CA--C 1.484 -1.889 0 N-CA-C 110.287 -1.125 . . . . 64.120000000000005 110.287 177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 87.5 mtt180 -105.76 105.19 15.11 Favored 'General case' 0 CA--C 1.489 -1.391 0 C-N-CA 119.546 -0.861 . . . . 61.039999999999999 110.233 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.26 162.21 26.67 Favored Glycine 0 N--CA 1.4 -3.762 0 N-CA-C 108.886 -1.686 . . . . 71.109999999999999 108.886 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -71.14 -18.32 62.52 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.218 0.532 . . . . 72.109999999999999 109.578 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -70.78 -29.03 65.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.624 -1.171 . . . . 72.129999999999995 109.596 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HA ' ' HB ' ' A' ' 29' ' ' ILE . . . -88.16 154.18 20.65 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.323 -0.853 . . . . 72.400000000000006 110.675 -176.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -93.04 -46.57 7.4 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.598 -0.89 . . . . 63.039999999999999 108.598 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -111.74 117.7 33.58 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.916 -1.038 . . . . 73.219999999999999 109.313 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 3.5 mpt_? -96.55 136.7 36.7 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.705 -0.48 . . . . 70.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 82.2 mt -83.33 146.76 51.57 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 116.655 -0.248 . . . . 75.519999999999996 110.365 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 4.1 Cg_exo -79.92 12.54 2.42 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.051 2.501 . . . . 64.349999999999994 112.322 177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -115.33 152.61 32.48 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 116.089 -0.505 . . . . 74.340000000000003 111.227 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.5 m -95.18 151.88 18.84 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.619 -1.252 . . . . 74.219999999999999 107.619 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.52 -6.48 26.37 Favored Glycine 0 CA--C 1.498 -0.993 0 N-CA-C 110.348 -1.101 . . . . 64.340000000000003 110.348 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.6 p -98.75 138.6 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.1 m -81.42 175.42 10.57 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 120.416 0.15 . . . . 61.109999999999999 111.347 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 2.3 ptm180 -60.86 -36.53 79.42 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.256 0.622 . . . . 74.030000000000001 111.42 176.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -131.94 97.55 4.2 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.366 -2.087 . . . . 74.319999999999993 105.366 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -95.85 -37.44 10.72 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 121.565 0.698 . . . . 64.099999999999994 109.746 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.433 HD11 HD21 ' A' ' 61' ' ' LEU . 6.8 tt -158.99 143.24 15.48 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 115.696 -0.684 . . . . 74.439999999999998 109.182 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -134.57 126.68 29.77 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 115.596 -0.729 . . . . 74.109999999999999 111.073 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -103.46 112.91 38.72 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 108.465 -0.939 . . . . 72.420000000000002 108.465 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 0.0 OUTLIER -91.73 107.67 19.37 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 106.012 -1.847 . . . . 72.430000000000007 106.012 177.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -105.55 108.37 19.85 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.482 -0.781 . . . . 72.439999999999998 109.552 -178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.82 161.73 13.7 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 105.935 -1.876 . . . . 72.430000000000007 105.935 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.03 60.4 3.06 Favored Glycine 0 C--N 1.305 -1.167 0 C-N-CA 120.498 -0.858 . . . . 64.019999999999996 111.828 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -177.72 -50.36 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.729 1.212 . . . . 72.010000000000005 109.865 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.51 145.12 35.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 N-CA-C 112.64 0.607 . . . . 74.25 112.64 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -106.92 102.14 11.52 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 115.235 -0.893 . . . . 72.010000000000005 109.432 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.8 tp -94.29 109.72 21.52 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.9 -1.046 . . . . 74.409999999999997 111.085 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.433 HD21 HD11 ' A' ' 50' ' ' LEU . 3.0 tm? -94.98 116.75 29.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.621 -1.251 . . . . 61.200000000000003 107.621 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.6 121.13 32.69 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.942 0.401 . . . . 61.43 110.834 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.0 134.44 35.37 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.309 -0.859 . . . . 73.200000000000003 109.141 177.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -127.15 77.61 1.75 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.835 -1.172 . . . . 63.240000000000002 107.835 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -170.54 162.72 8.18 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.183 -1.043 . . . . 64.299999999999997 108.183 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 m -108.65 -53.27 2.66 Favored 'General case' 0 N--CA 1.422 -1.842 0 C-N-CA 120.475 -0.49 . . . . 75.030000000000001 112.103 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.0 t -88.43 -26.69 21.99 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 121.371 0.605 . . . . 74.319999999999993 111.895 -174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -104.85 28.25 7.32 Favored 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 122.887 0.475 . . . . 45.229999999999997 110.147 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.76 115.82 1.52 Allowed Glycine 0 C--O 1.246 0.87 0 O-C-N 125.004 1.44 . . . . 71.420000000000002 112.367 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.0 m -59.19 134.16 56.75 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 124.321 1.048 . . . . 61.130000000000003 112.676 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.74 139.67 38.01 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 108.161 -1.051 . . . . 44.149999999999999 108.161 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.51 120.59 62.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.508 -0.923 . . . . 65.400000000000006 108.508 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 59.22 29.13 18.63 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 122.584 1.183 . . . . 52.520000000000003 109.08 -175.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.271 95.8 m-20 67.11 25.26 9.15 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 112.8 -2.0 . . . . 71.019999999999996 113.92 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -119.07 125.38 27.68 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.623 -0.881 . . . . 64.219999999999999 108.623 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.8 130.73 14.94 Favored 'Trans proline' 0 C--O 1.237 0.452 0 C-N-CA 122.339 2.026 . . . . 70.109999999999999 112.675 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG21 ' HB2' ' A' ' 80' ' ' TRP . 34.7 m -141.77 176.89 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.186 -0.461 . . . . 74.420000000000002 110.044 -178.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -106.44 -38.09 6.3 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 108.872 -0.788 . . . . 75.310000000000002 108.872 173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.02 148.73 42.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 114.888 -1.051 . . . . 63.200000000000003 110.597 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.443 ' HB2' HG21 ' A' ' 77' ' ' VAL . 68.9 t-105 -153.16 151.97 30.73 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 108.674 -0.861 . . . . 73.219999999999999 108.674 -176.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.509 ' NE2' ' H ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -102.2 116.35 32.48 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 107.578 -1.267 . . . . 74.519999999999996 107.578 173.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.403 HD22 HG21 ' A' ' 97' ' ' VAL . 77.9 mt -57.04 138.03 54.94 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 123.729 0.643 . . . . 74.329999999999998 112.152 -177.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.25 169.06 14.62 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 107.688 -1.227 . . . . 74.299999999999997 107.688 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 24.9 t70 -79.54 124.8 28.84 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 116.476 -0.329 . . . . 73.439999999999998 110.648 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.97 6.06 56.17 Favored Glycine 0 N--CA 1.436 -1.348 0 CA-C-N 116.016 -0.538 . . . . 70.25 112.295 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -71.46 134.8 46.83 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 120.964 0.411 . . . . 71.519999999999996 111.383 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.42 113.21 35.43 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.116 0 N-CA-C 107.79 -1.189 . . . . 75.329999999999998 107.79 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.3 122.4 68.34 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 C-N-CA 119.863 -0.735 . . . . 73.329999999999998 111.238 -175.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -105.73 109.98 22.13 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.658 -0.701 . . . . 63.549999999999997 109.13 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.472 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.9 pt? -110.7 164.83 12.36 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.672 -0.862 . . . . 61.130000000000003 108.672 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -47.23 106.29 0.15 Allowed Glycine 0 CA--C 1.525 0.7 0 O-C-N 123.689 0.618 . . . . 61.210000000000001 113.444 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 75.81 12.63 2.95 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.696 1.599 . . . . 50.210000000000001 114.786 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.0 t -154.85 150.4 27.44 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.58 -0.848 . . . . 74.439999999999998 111.531 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.91 128.67 47.92 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.236 0.541 . . . . 75.230000000000004 109.818 174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.486 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.4 tp -124.91 148.89 29.25 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 116.211 -0.45 . . . . 73.420000000000002 110.626 -170.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -109.91 122.82 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 107.684 -1.228 . . . . 73.140000000000001 107.684 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HD22 ' A' ' 82' ' ' LEU . 81.8 t -90.58 122.78 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.93 0.395 . . . . 64.530000000000001 110.184 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -119.54 140.98 49.65 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.77 -0.65 . . . . 61.219999999999999 110.516 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.416 ' HB2' ' HB2' ' A' ' 84' ' ' ASP . 58.2 mtt -121.82 114.53 21.19 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 108.24 -1.022 . . . . 74.239999999999995 108.24 174.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 . . . . . 0 C--N 1.278 -2.541 0 N-CA-C 107.024 -1.473 . . . . 74.439999999999998 107.024 -178.653 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.729 0 N-CA-C 110.854 -0.898 . . . . 43.049999999999997 110.854 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -137.76 172.36 13.06 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 122.282 0.233 . . . . 74.319999999999993 110.409 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' HA3' ' HB ' ' A' ' 7' ' ' THR . . . -121.36 -179.99 16.17 Favored Glycine 0 N--CA 1.434 -1.482 0 O-C-N 123.871 0.732 . . . . 54.210000000000001 111.302 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 6.0 m -50.94 -46.89 61.14 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.242 1.417 . . . . 64.230000000000004 114.434 -173.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -93.09 10.62 30.83 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.677 0.621 . . . . 74.109999999999999 112.677 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.27 12.34 54.67 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 109.287 -1.525 . . . . 73.319999999999993 109.287 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.433 ' HB ' ' HA3' ' A' ' 3' ' ' GLY . 12.9 m -54.71 116.58 2.78 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 125.906 1.682 . . . . 74.420000000000002 111.404 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 m -115.85 114.64 24.99 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.829 -1.174 . . . . 74.150000000000006 107.829 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 22' ' ' GLN . 25.5 t -91.35 115.9 31.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.402 -0.962 . . . . 73.140000000000001 108.402 -178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.479 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 27.9 m -118.6 127.74 53.89 Favored 'General case' 0 N--CA 1.411 -2.406 0 CA-C-N 115.742 -0.663 . . . . 73.349999999999994 110.231 -173.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.6 ' O ' ' HA ' ' A' ' 20' ' ' THR . 69.1 mt -90.57 121.71 32.75 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 114.91 -1.041 . . . . 54.240000000000002 108.387 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -104.68 114.52 28.79 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 123.889 0.743 . . . . 75.209999999999994 109.339 -177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.6 tp -118.18 109.02 15.87 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 123.918 0.887 . . . . 64.230000000000004 109.713 179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -97.44 101.6 13.17 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 109.105 -0.702 . . . . 71.329999999999998 109.105 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -97.18 5.26 50.45 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.835 -0.802 . . . . 71.219999999999999 108.835 173.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.99 -40.43 0.62 Allowed Glycine 0 N--CA 1.42 -2.386 0 CA-C-N 114.671 -1.15 . . . . 74.540000000000006 110.269 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.8 m -112.01 -50.95 2.88 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 112.889 0.7 . . . . 60.039999999999999 112.889 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.76 82.25 0.55 Allowed Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.669 -0.776 . . . . 64.109999999999999 111.983 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -89.11 150.19 22.84 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 110.133 -0.321 . . . . 64.209999999999994 110.133 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.6 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 23.8 p -133.61 145.87 50.42 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 116.138 -0.483 . . . . 61.329999999999998 111.114 -175.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -137.97 129.58 28.1 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.572 -0.899 . . . . 65.439999999999998 108.572 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 53.1 tt0 -92.39 134.93 34.47 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.214 -0.662 . . . . 53.25 109.214 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 68.7 mt -60.19 139.92 57.28 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.433 0.635 . . . . 72.25 111.971 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -95.88 169.65 9.85 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.255 -0.884 . . . . 71.420000000000002 109.757 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.54 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 1.2 pm0 -75.09 122.67 23.93 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 123.536 0.735 . . . . 73.239999999999995 110.758 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 112.52 -164.93 12.02 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.461 -1.056 . . . . 75.310000000000002 110.461 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.7 t -107.65 142.85 36.97 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 117.116 0.458 . . . . 54.119999999999997 111.433 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.415 ' ND2' ' HB ' ' A' ' 52' ' ' ILE . 7.2 p30 -117.89 117.75 30.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.532 0.682 . . . . 74.349999999999994 109.57 177.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -91.69 112.3 25.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 114.99 -1.005 . . . . 50.119999999999997 108.559 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.9 mt -90.3 128.1 42.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 O-C-N 123.914 0.759 . . . . 72.25 110.009 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.44 175.15 34.11 Favored Glycine 0 N--CA 1.424 -2.105 0 N-CA-C 110.62 -0.992 . . . . 74.0 110.62 176.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 48.9 mtm180 -109.22 106.69 16.65 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.809 -0.811 . . . . 74.420000000000002 108.809 176.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.01 173.2 42.35 Favored Glycine 0 N--CA 1.409 -3.155 0 N-CA-C 109.424 -1.47 . . . . 44.43 109.424 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -81.72 -16.53 50.88 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.144 0.497 . . . . 64.439999999999998 110.461 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.46 6.3 49.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 122.051 0.929 . . . . 64.120000000000005 109.739 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.79 161.46 13.92 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.107 -0.951 . . . . 65.329999999999998 110.07 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -109.42 -50.27 3.01 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-O 121.542 0.687 . . . . 75.400000000000006 109.595 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.548 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 54.2 t80 -106.51 123.85 48.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.2 -1.407 . . . . 75.549999999999997 107.2 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 51.0 mtt180 -111.3 133.34 53.7 Favored 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 120.867 -0.333 . . . . 75.299999999999997 110.599 -174.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.2 mt -79.63 149.28 71.1 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.026 -0.534 . . . . 74.310000000000002 110.484 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.21 -0.09 10.26 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.534 2.156 . . . . 72.349999999999994 114.123 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -138.19 -173.5 3.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.245 -0.982 . . . . 63.310000000000002 112.085 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.404 HG22 ' H ' ' A' ' 44' ' ' GLY . 7.1 m -96.31 174.35 6.92 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 124.33 1.052 . . . . 72.239999999999995 108.549 -176.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' H ' HG22 ' A' ' 43' ' ' THR . . . 103.89 -21.05 39.41 Favored Glycine 0 CA--C 1.498 -0.996 0 N-CA-C 109.572 -1.411 . . . . 73.109999999999999 109.572 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -92.12 149.1 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 CA-C-N 113.417 -1.392 . . . . 65.420000000000002 108.864 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -88.63 -173.51 4.17 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 109.451 -0.574 . . . . 53.32 109.451 176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 21.1 ptt180 -72.39 -42.73 64.86 Favored 'General case' 0 C--O 1.211 -0.942 0 N-CA-C 108.216 -1.031 . . . . 65.349999999999994 108.216 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.457 HH21 HD21 ' A' ' 64' ' ' LEU . 11.0 mtp180 -120.78 101.84 7.99 Favored 'General case' 0 N--CA 1.417 -2.117 0 N-CA-C 105.786 -1.931 . . . . 75.120000000000005 105.786 169.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -98.97 -43.93 6.52 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 109.855 -0.424 . . . . 74.120000000000005 109.855 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -159.49 151.17 20.31 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.442 -0.577 . . . . 73.430000000000007 109.442 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -126.78 127.37 44.93 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 121.351 0.596 . . . . 75.530000000000001 110.744 175.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' HB ' ' ND2' ' A' ' 28' ' ' ASN . 70.8 mt -100.43 117.1 45.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 107.408 -1.33 . . . . 71.230000000000004 107.408 174.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 12.7 ttm180 -105.91 110.05 22.21 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.401 -0.592 . . . . 73.140000000000001 109.401 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -104.89 132.43 51.14 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 115.489 -0.778 . . . . 74.310000000000002 110.374 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -143.73 166.88 23.63 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 105.123 -2.177 . . . . 73.120000000000005 105.123 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.02 65.24 1.91 Allowed Glycine 0 C--N 1.314 -0.687 0 CA-C-N 118.377 0.535 . . . . 33.5 113.13 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -159.16 -78.03 0.07 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.42 -0.956 . . . . 75.019999999999996 108.42 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.7 m -142.27 159.97 19.87 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.818 -0.808 . . . . 74.219999999999999 108.818 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.26 114.01 26.42 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.461 -0.57 . . . . 62.299999999999997 109.461 178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 69.0 tp -83.71 108.35 16.71 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 114.912 -1.04 . . . . 63.43 109.867 -178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.5 tm? -93.92 110.83 22.48 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.324 -1.362 . . . . 62.140000000000001 107.324 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.33 119.0 29.82 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.629 -0.508 . . . . 64.319999999999993 109.629 178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -95.18 141.18 29.09 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.907 -0.588 . . . . 43.0 111.445 -175.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.457 HD21 HH21 ' A' ' 48' ' ' ARG . 3.6 mm? -102.15 102.07 12.47 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 122.863 0.465 . . . . 74.530000000000001 110.871 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 67.62 85.14 0.15 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.458 1.103 . . . . 61.520000000000003 111.628 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.0 m -65.16 -14.73 61.29 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 114.223 1.194 . . . . 74.319999999999993 114.223 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 t -55.17 -38.27 68.09 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.96 0.886 . . . . 74.430000000000007 110.429 177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -121.87 0.52 9.76 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.144 -1.058 . . . . 71.439999999999998 108.144 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -79.29 -137.27 1.41 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 114.026 -1.443 . . . . 74.239999999999995 115.78 -170.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.5 m -114.18 152.8 30.65 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-O 122.068 0.937 . . . . 74.420000000000002 113.106 -169.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 p -121.8 141.21 51.45 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.795 -1.093 . . . . 63.109999999999999 110.448 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.466 HG12 HG13 ' A' ' 88' ' ' ILE . 29.6 m -110.79 124.77 67.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 105.488 -2.041 . . . . 64.209999999999994 105.488 174.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 62.21 24.13 14.34 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.477 0.711 . . . . 62.240000000000002 109.211 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.7 t30 71.25 20.77 4.94 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.216 1.407 . . . . 74.239999999999995 110.668 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -118.63 130.49 24.77 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 108.981 -0.748 . . . . 65.150000000000006 108.981 175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.33 137.39 30.9 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 122.709 2.273 . . . . 63.420000000000002 112.761 -178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.459 HG21 ' HB2' ' A' ' 80' ' ' TRP . 22.4 m -143.56 161.22 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.435 -0.58 . . . . 51.329999999999998 109.435 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -85.65 -45.46 11.68 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.923 -0.769 . . . . 73.140000000000001 108.923 176.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 12.3 pt-20 -145.33 151.72 38.75 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.971 -1.013 . . . . 71.299999999999997 108.736 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.459 ' HB2' HG21 ' A' ' 77' ' ' VAL . 64.6 t-105 -151.94 148.87 28.28 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.141 -1.059 . . . . 64.109999999999999 108.141 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -101.45 108.04 19.53 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 107.731 -1.211 . . . . 72.310000000000002 107.731 176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 81.8 mt -57.06 148.26 22.17 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.434 -0.803 . . . . 51.030000000000001 111.702 -176.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -147.34 164.04 34.54 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.796 -1.187 . . . . 55.340000000000003 107.796 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -62.35 119.81 9.81 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 123.702 0.626 . . . . 75.340000000000003 111.867 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.34 16.27 35.32 Favored Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 115.525 -0.761 . . . . 64.420000000000002 113.034 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -92.07 146.75 23.48 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 119.212 -0.995 . . . . 61.439999999999998 108.615 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.1 t -109.04 112.91 42.55 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 109.11 -0.7 . . . . 62.200000000000003 109.11 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.83 119.69 55.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.414 -0.958 . . . . 70.219999999999999 108.414 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -121.9 116.96 25.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 C-N-CA 119.493 -0.883 . . . . 74.129999999999995 111.343 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.412 HD23 ' H ' ' A' ' 90' ' ' LEU . 1.3 pt? -116.54 164.97 13.79 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.536 -1.211 . . . . 74.329999999999998 108.547 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -39.2 107.91 0.08 OUTLIER Glycine 0 N--CA 1.479 1.55 0 O-C-N 123.964 0.79 . . . . 62.32 114.443 -178.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 69.5 -4.03 1.47 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.304 1.442 . . . . 72.319999999999993 114.864 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.7 m -129.42 112.96 14.33 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.354 0.597 . . . . 73.329999999999998 111.345 -176.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -103.73 132.68 49.77 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.775 -1.194 . . . . 75.340000000000003 107.775 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.1 tp -134.69 140.41 45.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.861 -0.422 . . . . 70.109999999999999 109.861 -174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.17 128.6 56.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 107.785 -1.191 . . . . 73.219999999999999 107.785 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.95 116.51 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.177 0.513 . . . . 62.030000000000001 110.774 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -110.77 129.31 55.88 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.608 -0.724 . . . . 75.25 109.336 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.51 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 86.4 mtp -111.62 108.54 18.05 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.777 -1.194 . . . . 63.229999999999997 107.777 178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 C--N 1.27 -2.883 0 CA-C-N 114.756 -1.111 . . . . 74.420000000000002 108.463 -176.297 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.188 0 N-CA-C 109.853 -1.299 . . . . 62.229999999999997 109.853 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.495 ' HB3' ' HA3' ' A' ' 56' ' ' GLY . 16.5 p80 -130.77 144.54 51.52 Favored 'General case' 0 CA--C 1.496 -1.113 0 N-CA-C 115.11 1.522 . . . . 74.340000000000003 115.11 -175.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.55 161.24 34.4 Favored Glycine 0 N--CA 1.412 -2.947 0 N-CA-C 104.509 -3.437 . . . . 73.430000000000007 104.509 176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 m -86.39 71.5 10.45 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 119.44 1.62 . . . . 63.509999999999998 111.216 -178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -162.32 100.96 1.08 Allowed 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 114.332 -1.304 . . . . 42.520000000000003 107.884 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.29 -45.75 1.09 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 108.248 -1.941 . . . . 71.409999999999997 108.248 -176.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 92.9 m -145.46 115.03 7.22 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.302 -0.999 . . . . 74.140000000000001 108.302 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.1 m -118.99 115.49 24.45 Favored 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 107.851 -1.166 . . . . 63.140000000000001 107.851 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 23' ' ' LEU . 6.2 p -93.63 127.76 45.47 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.022 0 CA-C-O 121.503 0.668 . . . . 74.200000000000003 109.211 -178.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 33.4 m -125.64 131.73 52.59 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.409 -0.814 . . . . 55.240000000000002 109.142 -174.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -92.65 133.07 36.35 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.346 -0.613 . . . . 73.239999999999995 109.346 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -105.2 109.21 21.11 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.068 -1.827 . . . . 55.200000000000003 106.068 175.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.9 tp -103.21 122.21 44.27 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 116.078 -0.51 . . . . 63.439999999999998 110.502 -175.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.59 99.33 12.38 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 105.358 -2.089 . . . . 64.420000000000002 105.358 175.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -121.31 -6.77 9.34 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.16 -0.927 . . . . 74.400000000000006 110.778 -175.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.17 -15.8 12.01 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 109.913 -1.275 . . . . 62.100000000000001 109.913 -173.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.0 m -111.61 -44.24 3.53 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.969 -0.752 . . . . 62.329999999999998 108.969 177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.59 67.67 1.19 Allowed Glycine 0 CA--C 1.48 -2.141 0 N-CA-C 107.848 -2.101 . . . . 61.530000000000001 107.848 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -91.92 154.08 19.07 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 115.015 -0.592 . . . . 61.299999999999997 110.479 -173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.589 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 45.6 p -130.17 131.95 45.84 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.025 -1.102 . . . . 54.240000000000002 108.025 173.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -134.84 125.64 27.22 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.586 -0.524 . . . . 73.530000000000001 109.586 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -81.81 121.84 26.95 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 108.946 -0.761 . . . . 75.439999999999998 108.946 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.546 ' HB2' HG13 ' A' ' 9' ' ' VAL . 80.0 mt -66.12 139.25 58.14 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.161 -0.927 . . . . 65.239999999999995 111.923 -176.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -88.58 153.46 21.11 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.482 -1.673 . . . . 72.129999999999995 106.482 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -69.24 133.88 48.49 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.271 0.557 . . . . 73.140000000000001 111.598 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.4 -166.6 13.26 Favored Glycine 0 N--CA 1.424 -2.137 0 N-CA-C 107.522 -2.231 . . . . 72.510000000000005 107.522 -173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.525 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 61.1 p -106.45 128.96 54.47 Favored 'General case' 0 C--N 1.285 -2.211 0 C-N-CA 118.432 -1.307 . . . . 70.219999999999999 111.19 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.6 m-80 -96.99 111.87 23.89 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 107.55 -1.278 . . . . 74.219999999999999 107.55 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 39.1 mm -85.8 123.81 39.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.98 -0.555 . . . . 73.319999999999993 110.342 -175.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.4 mt -109.52 138.19 38.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.849 -0.614 . . . . 54.310000000000002 109.606 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 152.4 -162.51 29.92 Favored Glycine 0 CA--C 1.491 -1.446 0 N-CA-C 110.952 -0.859 . . . . 61.020000000000003 110.952 176.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.638 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.4 mtt180 -121.52 105.88 10.87 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 117.663 0.732 . . . . 62.450000000000003 109.373 176.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.49 47.74 Favored Glycine 0 N--CA 1.412 -2.912 0 C-N-CA 120.061 -1.066 . . . . 75.140000000000001 111.318 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -75.73 -23.73 56.07 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.764 0.792 . . . . 64.230000000000004 109.088 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.38 -18.87 44.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.759 -1.109 . . . . 71.129999999999995 110.498 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.18 136.25 36.45 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.895 -0.593 . . . . 74.239999999999995 111.833 -174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -96.73 -24.05 16.14 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.575 -0.898 . . . . 24.239999999999998 108.575 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -133.29 120.0 20.5 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 114.617 -1.174 . . . . 71.109999999999999 108.594 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 79.6 mtt180 -97.82 130.57 44.74 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.14 0.495 . . . . 72.540000000000006 111.321 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD12 HG11 ' A' ' 45' ' ' VAL . 82.2 mt -77.6 144.83 70.22 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 115.473 -0.785 . . . . 61.32 111.057 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 9.22 2.9 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 122.963 2.442 . . . . 63.039999999999999 113.448 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -123.42 163.64 20.45 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 107.503 -1.295 . . . . 72.230000000000004 107.503 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 44' ' ' GLY . 11.7 m -110.23 172.11 7.06 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.82 -0.807 . . . . 75.340000000000003 108.82 -176.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.406 ' H ' HG22 ' A' ' 43' ' ' THR . . . 94.19 5.27 62.33 Favored Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 109.472 -1.451 . . . . 52.409999999999997 109.472 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.412 HG11 HD12 ' A' ' 40' ' ' LEU . 43.9 t -100.36 145.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.036 -1.082 . . . . 53.130000000000003 108.306 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.8 m -79.07 173.43 12.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 122.197 0.199 . . . . 41.140000000000001 110.627 -179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.638 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.5 ptp180 -65.15 -31.06 72.05 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.653 0.739 . . . . 72.140000000000001 110.566 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.437 ' HB3' HD23 ' A' ' 64' ' ' LEU . 25.3 mtm-85 -134.08 109.59 9.05 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.728 -2.323 . . . . 72.310000000000002 104.728 174.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -104.56 -35.82 7.72 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 123.807 0.692 . . . . 71.109999999999999 110.247 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.0 tt -162.86 149.57 12.8 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.689 -0.486 . . . . 62.130000000000003 109.689 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -125.25 122.53 37.21 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.451 0.643 . . . . 63.530000000000001 109.964 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.9 mt -96.29 104.69 16.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 106.783 -1.562 . . . . 63.310000000000002 106.783 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 63.8 ttt180 -91.84 107.29 19.11 Favored 'General case' 0 N--CA 1.421 -1.904 0 CA-C-O 121.777 0.799 . . . . 62.109999999999999 109.802 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 28.5 t-105 -94.86 106.95 18.96 Favored 'General case' 0 N--CA 1.391 -3.395 0 N-CA-C 107.384 -1.339 . . . . 75.030000000000001 107.384 175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -106.3 -175.36 2.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 106.671 -1.603 . . . . 63.219999999999999 106.671 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 2' ' ' HIS . . . -88.02 57.26 4.32 Favored Glycine 0 C--N 1.285 -2.261 0 C-N-CA 119.493 -1.337 . . . . 42.509999999999998 115.445 -171.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -179.3 -65.59 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.602 0.761 . . . . 70.519999999999996 109.666 176.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.3 m -117.46 156.56 18.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.269 -0.423 . . . . 61.509999999999998 109.998 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.35 109.8 22.49 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 108.161 -1.051 . . . . 51.310000000000002 108.161 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.5 tp -88.39 122.52 31.99 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 114.979 -1.01 . . . . 75.450000000000003 110.505 -175.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -103.27 125.51 49.95 Favored 'General case' 0 C--N 1.281 -2.386 0 N-CA-C 107.678 -1.23 . . . . 73.530000000000001 107.678 -179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.07 124.65 26.54 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.995 -0.372 . . . . 73.450000000000003 109.995 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -86.53 137.87 32.17 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.495 -0.775 . . . . 74.519999999999996 109.183 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 48' ' ' ARG . 27.9 tp -133.89 75.97 1.63 Allowed 'General case' 0 N--CA 1.421 -1.92 0 CA-C-O 121.688 0.756 . . . . 31.41 109.121 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.56 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 38.5 t-20 -173.07 142.52 1.06 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.897 -1.52 . . . . 71.519999999999996 106.897 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.3 t -95.69 -47.68 6.1 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 119.89 -0.724 . . . . 61.43 110.834 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.459 HG23 ' ND2' ' A' ' 68' ' ' ASN . 12.2 t -88.92 -12.43 41.69 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-O 121.327 0.584 . . . . 60.439999999999998 112.302 -174.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.56 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 36.5 m-80 -121.43 27.55 8.23 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.778 -0.576 . . . . 52.25 111.07 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.38 113.95 0.79 Allowed Glycine 0 N--CA 1.481 1.676 0 O-C-N 124.403 1.064 . . . . 72.439999999999998 113.777 -176.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.46 HG23 ' HB3' ' A' ' 90' ' ' LEU . 24.7 m -63.82 146.71 53.44 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 125.013 1.325 . . . . 65.430000000000007 112.57 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -109.73 140.74 43.25 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 115.183 -0.917 . . . . 63.299999999999997 112.467 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 27.5 m -118.88 122.03 68.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 105.832 -1.914 . . . . 75.310000000000002 105.832 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 62.69 25.38 15.08 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.042 -0.725 . . . . 74.430000000000007 109.042 -176.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.7 t30 79.58 4.86 2.09 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.215 1.406 . . . . 75.319999999999993 111.745 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -106.1 125.0 34.15 Favored Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 121.545 -0.722 . . . . 71.420000000000002 109.933 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -73.74 130.98 15.29 Favored 'Trans proline' 0 C--O 1.244 0.782 0 C-N-CA 122.277 1.985 . . . . 73.540000000000006 111.596 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.535 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.9 m -135.4 159.07 40.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 116.255 -0.43 . . . . 54.109999999999999 110.645 -175.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -82.11 -38.74 24.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.993 -0.743 . . . . 73.230000000000004 108.993 173.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -153.1 155.54 36.98 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.577 -0.897 . . . . 75.109999999999999 108.577 176.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.535 ' HB2' HG21 ' A' ' 77' ' ' VAL . 54.0 t-105 -159.98 149.1 17.6 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.309 -0.997 . . . . 73.239999999999995 108.309 -176.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -100.8 115.17 29.69 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.045 -1.062 . . . . 72.150000000000006 108.642 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.552 HD22 HD11 ' A' ' 88' ' ' ILE . 62.3 mt -61.91 147.9 45.27 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.568 -1.196 . . . . 72.530000000000001 111.415 -178.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.86 168.01 19.84 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 106.891 -1.522 . . . . 52.100000000000001 106.891 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -68.41 121.3 16.03 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.551 -0.537 . . . . 72.349999999999994 109.551 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.1 44.18 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 115.6 -0.727 . . . . 71.120000000000005 112.398 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -83.1 152.86 25.14 Favored 'General case' 0 C--O 1.247 0.961 0 N-CA-C 107.405 -1.331 . . . . 53.25 107.405 177.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 39.1 t -114.16 112.87 42.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.081 -0.34 . . . . 71.299999999999997 110.081 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.552 HD11 HD22 ' A' ' 82' ' ' LEU . 1.6 mp -107.44 114.14 45.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 107.558 -1.275 . . . . 72.409999999999997 107.558 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.572 ' HG3' ' HB3' ' A' ' 94' ' ' GLU . 15.5 ttt180 -123.43 127.6 48.65 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 120.275 -0.57 . . . . 65.099999999999994 110.361 -176.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.46 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.0 OUTLIER -140.37 163.34 33.04 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.696 -1.594 . . . . 71.120000000000005 106.696 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -45.46 119.38 3.5 Favored Glycine 0 CA--C 1.526 0.755 0 O-C-N 123.59 0.556 . . . . 62.350000000000001 114.003 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 29.0 t60 78.75 -33.0 0.15 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.134 1.374 . . . . 74.299999999999997 113.181 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.1 m -114.2 116.77 29.58 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.416 0.627 . . . . 64.129999999999995 111.56 -173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.572 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 11.5 pt-20 -116.9 121.71 42.24 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.828 -0.805 . . . . 75.219999999999999 108.828 173.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.435 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -126.49 136.83 59.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 CA-C-N 114.881 -1.054 . . . . 71.200000000000003 111.94 -170.402 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.8 mm -105.55 127.62 60.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 108.098 -1.075 . . . . 70.140000000000001 108.098 178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 82' ' ' LEU . 55.5 t -86.99 125.32 40.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-N 116.412 -0.358 . . . . 75.329999999999998 110.969 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.5 mmm-85 -115.68 149.52 38.24 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.718 -0.475 . . . . 73.200000000000003 109.718 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.3 mtt -130.26 116.92 19.06 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.456 0.646 . . . . 73.409999999999997 110.323 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 . . . . . 0 C--N 1.283 -2.295 0 N-CA-C 108.08 -1.081 . . . . 71.319999999999993 108.08 -178.846 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.621 0 N-CA-C 111.003 -0.839 . . . . 43.130000000000003 111.003 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -91.18 101.26 13.99 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 122.361 -0.494 . . . . 74.510000000000005 111.046 -177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.02 173.71 47.69 Favored Glycine 0 N--CA 1.432 -1.576 0 CA-C-N 115.408 -0.814 . . . . 72.25 111.838 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.5 m -72.37 118.8 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 109.222 -0.659 . . . . 63.130000000000003 109.222 178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.92 15.72 2.86 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.041 0.924 . . . . 54.009999999999998 109.229 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.94 -165.24 30.29 Favored Glycine 0 N--CA 1.413 -2.888 0 N-CA-C 108.314 -1.914 . . . . 64.439999999999998 108.314 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.8 m -78.88 132.39 36.78 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.116 0.484 . . . . 70.439999999999998 110.682 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.8 m -111.15 116.87 31.82 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.542 -1.281 . . . . 74.319999999999993 107.542 175.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.418 HG22 ' HG2' ' A' ' 99' ' ' MET . 25.0 t -99.81 132.68 44.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 N-CA-C 109.555 -0.535 . . . . 53.409999999999997 109.555 -175.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.1 m -135.66 127.64 29.59 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.912 -0.773 . . . . 51.409999999999997 108.912 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' HB2' HD11 ' A' ' 95' ' ' ILE . 4.3 pp -95.84 139.96 31.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.821 -0.437 . . . . 75.510000000000005 109.821 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -112.05 106.32 14.93 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.115 -0.698 . . . . 65.230000000000004 109.115 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.07 126.42 50.24 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.404 -0.962 . . . . 70.209999999999994 108.404 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -94.25 100.87 12.85 Favored 'General case' 0 N--CA 1.422 -1.83 0 C-N-CA 117.752 -1.579 . . . . 74.319999999999993 110.479 178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -91.61 -0.11 57.55 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.495 -1.23 . . . . 74.430000000000007 109.016 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.38 42.69 0.96 Allowed Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 108.566 -1.814 . . . . 64.409999999999997 108.566 -173.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.4 t -177.59 -24.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.865 -0.668 . . . . 74.5 111.289 -171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.1 71.29 1.05 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 120.463 -0.875 . . . . 44.119999999999997 110.951 -172.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 88.1 mtt180 -88.72 153.47 21.07 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 122.824 0.45 . . . . 72.329999999999998 110.228 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 26.8 p -129.75 132.63 46.63 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.461 0.648 . . . . 74.519999999999996 111.989 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -125.62 127.23 46.0 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.394 -0.965 . . . . 74.340000000000003 108.394 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -87.26 134.28 33.57 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.563 -0.532 . . . . 72.219999999999999 109.563 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.2 mt -81.03 122.19 26.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.881 -0.785 . . . . 74.019999999999996 108.881 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtt180 -91.67 156.18 17.78 Favored 'General case' 0 N--CA 1.417 -2.105 0 C-N-CA 120.0 -0.68 . . . . 75.310000000000002 109.314 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.17 132.71 51.19 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 124.621 1.201 . . . . 73.230000000000004 111.302 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.41 -162.5 12.47 Favored Glycine 0 N--CA 1.42 -2.412 0 N-CA-C 107.279 -2.329 . . . . 71.25 107.279 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 50.5 p -106.21 131.57 53.29 Favored 'General case' 0 C--N 1.276 -2.594 0 C-N-CA 118.618 -1.233 . . . . 74.430000000000007 111.164 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -99.67 111.52 23.85 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.493 -1.299 . . . . 73.310000000000002 107.493 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.9 mm -85.69 121.9 37.8 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 N-CA-C 109.098 -0.704 . . . . 75.129999999999995 109.098 -176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 38' ' ' PHE . 71.0 mt -112.57 132.83 60.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 115.605 -0.725 . . . . 75.25 109.704 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 145.53 -161.24 28.2 Favored Glycine 0 CA--C 1.491 -1.429 0 N-CA-C 109.807 -1.317 . . . . 40.020000000000003 109.807 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.733 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 84.1 mtt180 -121.55 106.53 11.47 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.908 -0.775 . . . . 55.409999999999997 108.908 177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -171.83 179.0 43.79 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 110.541 -1.024 . . . . 75.400000000000006 110.541 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -64.41 -46.45 83.2 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.865 0.691 . . . . 63.030000000000001 112.865 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -94.22 1.95 55.96 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.877 0.37 . . . . 74.540000000000006 111.163 -176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.58 124.12 23.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.551 -0.907 . . . . 43.509999999999998 108.551 176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -89.38 -38.04 14.41 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 121.672 0.749 . . . . 75.319999999999993 109.588 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' HD2' HG23 ' A' ' 30' ' ' ILE . 86.1 t80 -117.61 112.17 20.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 115.191 -0.913 . . . . 75.0 109.051 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -89.41 133.54 34.48 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.488 -0.778 . . . . 62.109999999999999 111.174 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 90' ' ' LEU . 85.5 mt -89.67 140.22 28.05 Favored Pre-proline 0 C--N 1.305 -1.338 0 CA-C-N 115.458 -0.792 . . . . 61.100000000000001 111.628 -178.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.95 -23.0 30.45 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.11 2.54 . . . . 74.549999999999997 112.018 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -72.01 164.67 25.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.788 -0.642 . . . . 64.140000000000001 109.518 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -129.71 149.38 51.48 Favored 'General case' 0 N--CA 1.414 -2.244 0 N-CA-C 108.446 -0.946 . . . . 74.430000000000007 108.446 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.29 9.28 48.2 Favored Glycine 0 C--N 1.312 -0.796 0 N-CA-C 107.553 -2.219 . . . . 41.109999999999999 107.553 -168.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.2 p -88.28 143.14 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 CA-C-N 112.695 -1.753 . . . . 74.349999999999994 108.743 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 m -78.01 169.48 18.21 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 110.055 -0.35 . . . . 71.0 110.055 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 19.2 ptt180 -65.39 -37.27 86.49 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.865 0.84 . . . . 75.329999999999998 109.115 172.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HB3' HD12 ' A' ' 64' ' ' LEU . 98.9 mtt180 -123.69 100.41 6.77 Favored 'General case' 0 N--CA 1.416 -2.135 0 N-CA-C 105.098 -2.186 . . . . 74.519999999999996 105.098 169.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 25.7 t60 -95.07 -32.44 13.11 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.904 -0.776 . . . . 54.539999999999999 108.904 -173.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.416 HD11 HD21 ' A' ' 61' ' ' LEU . 8.3 tt -167.57 143.17 3.99 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-N 115.59 -0.732 . . . . 74.129999999999995 109.222 -177.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -124.47 126.12 45.38 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 115.941 -0.572 . . . . 74.129999999999995 110.337 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.1 mt -103.14 112.9 38.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 N-CA-C 108.519 -0.919 . . . . 64.420000000000002 108.519 175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 73.5 ttt180 -90.79 110.13 21.33 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.563 -0.903 . . . . 61.310000000000002 108.563 176.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -99.86 110.54 22.89 Favored 'General case' 0 N--CA 1.396 -3.164 0 CA-C-N 114.986 -1.006 . . . . 71.099999999999994 108.755 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -116.41 174.42 6.07 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 105.357 -2.09 . . . . 64.150000000000006 105.357 177.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -81.98 32.39 2.73 Favored Glycine 0 C--N 1.301 -1.41 0 C-N-CA 120.272 -0.966 . . . . 74.140000000000001 112.908 -175.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -134.83 -65.59 0.62 Allowed 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 123.414 0.685 . . . . 73.239999999999995 109.315 -177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.04 159.51 26.36 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 115.886 -0.597 . . . . 53.240000000000002 109.7 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 109.97 21.76 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.662 -0.866 . . . . 71.329999999999998 108.662 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.65 119.54 30.15 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.131 -1.395 . . . . 54.240000000000002 112.935 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -100.94 108.41 20.15 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 113.311 -1.768 . . . . 73.140000000000001 108.08 -177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.0 115.76 25.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.884 -0.413 . . . . 71.439999999999998 109.884 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -85.45 134.85 34.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.812 -0.631 . . . . 75.430000000000007 110.147 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 48' ' ' ARG . 21.7 mt -126.35 75.97 1.58 Allowed 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 108.508 -0.923 . . . . 62.32 108.508 177.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -170.3 122.63 0.66 Allowed 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 121.107 0.479 . . . . 70.439999999999998 110.124 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.3 m -93.38 -14.22 27.11 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.891 -0.506 . . . . 71.349999999999994 111.269 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.0 m -89.14 -56.45 3.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.859 0.838 . . . . 71.109999999999999 110.706 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -119.71 29.55 7.52 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.157 -0.929 . . . . 75.329999999999998 109.423 -170.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.4 130.98 5.96 Favored Glycine 0 C--O 1.251 1.184 0 CA-C-N 114.238 -1.346 . . . . 73.239999999999995 113.486 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.0 m -66.93 143.43 56.83 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 125.66 1.584 . . . . 52.530000000000001 113.168 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 p -107.95 141.72 39.15 Favored 'General case' 0 N--CA 1.422 -1.871 0 CA-C-N 114.591 -1.186 . . . . 75.400000000000006 110.275 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.472 HG21 ' CD2' ' A' ' 80' ' ' TRP . 31.4 m -120.76 120.64 63.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 106.844 -1.539 . . . . 70.200000000000003 106.844 176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 61.64 25.96 15.74 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.463 0.649 . . . . 60.340000000000003 109.621 -175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.8 t30 78.15 3.15 2.8 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 126.46 1.904 . . . . 75.319999999999993 111.358 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.73 124.02 51.85 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 109.371 -0.603 . . . . 74.430000000000007 109.371 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.14 125.94 11.92 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.248 1.966 . . . . 61.539999999999999 111.155 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.7 m -136.91 166.58 25.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 116.476 -0.329 . . . . 62.130000000000003 110.164 -178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.476 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 25.1 pt20 -100.67 -26.8 13.68 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.254 -0.646 . . . . 62.219999999999999 109.254 174.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.476 ' HG2' ' HG3' ' A' ' 78' ' ' GLN . 10.6 pt-20 -158.52 148.96 20.05 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.785 -0.643 . . . . 72.140000000000001 109.814 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.472 ' CD2' HG21 ' A' ' 72' ' ' VAL . 53.7 t-105 -163.84 152.93 14.03 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.302 -0.999 . . . . 72.549999999999997 108.302 -172.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -105.67 121.31 43.73 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.321 -0.952 . . . . 73.549999999999997 109.07 174.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.62 151.09 47.31 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.205 -0.907 . . . . 70.25 113.106 -174.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.49 165.75 25.52 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.14 -1.43 . . . . 64.299999999999997 107.14 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 19.4 t70 -69.12 121.25 16.35 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.933 0.396 . . . . 60.329999999999998 109.969 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.34 8.2 53.29 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 115.708 -0.678 . . . . 74.109999999999999 111.693 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.12 134.02 36.13 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 107.566 -1.272 . . . . 72.409999999999997 107.566 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.1 t -98.93 112.81 31.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 109.341 -0.614 . . . . 65.209999999999994 109.341 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.441 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.09 129.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.319 0 N-CA-C 106.958 -1.497 . . . . 73.540000000000006 106.958 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 28.8 ttp180 -138.24 149.29 45.61 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.814 -0.754 . . . . 74.310000000000002 110.969 -176.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.472 ' CD1' HD13 ' A' ' 40' ' ' LEU . 2.0 pt? -138.32 165.55 26.46 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 104.852 -2.277 . . . . 75.530000000000001 104.852 172.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -34.84 102.38 0.01 OUTLIER Glycine 0 N--CA 1.484 1.833 0 N-CA-C 115.98 1.152 . . . . 31.420000000000002 115.98 -174.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 60.85 17.96 8.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.4 1.08 . . . . 64.109999999999999 113.908 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 m -131.6 114.01 14.31 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.819 -0.808 . . . . 72.409999999999997 108.819 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -116.06 139.8 49.92 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.586 0.708 . . . . 75.439999999999998 112.013 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.504 HD11 ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -135.51 137.11 50.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.71 -1.132 . . . . 74.329999999999998 110.392 -178.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -108.78 126.04 65.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.827 -0.805 . . . . 62.140000000000001 108.827 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 64.0 t -85.07 126.36 40.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 116.674 -0.239 . . . . 70.340000000000003 110.693 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 47.3 mmm-85 -115.31 145.05 42.86 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.572 -0.529 . . . . 74.120000000000005 109.572 177.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.418 ' HG2' HG22 ' A' ' 9' ' ' VAL . 56.0 mtt -130.37 127.49 39.49 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 115.693 -0.685 . . . . 74.129999999999995 109.598 178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 . . . . . 0 C--N 1.281 -2.37 0 N-CA-C 107.173 -1.417 . . . . 74.239999999999995 107.173 178.311 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.67 0 N-CA-C 111.731 -0.548 . . . . 74.040000000000006 111.731 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 68.3 m-70 -105.05 -28.75 10.85 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.922 0.391 . . . . 70.420000000000002 110.349 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 74.62 -157.99 51.11 Favored Glycine 0 C--O 1.249 1.075 0 N-CA-C 110.861 -0.896 . . . . 60.229999999999997 110.861 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -88.3 84.22 6.87 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.04 -1.096 . . . . 73.099999999999994 108.04 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.55 36.61 0.65 Allowed 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.118 -0.946 . . . . 74.450000000000003 108.669 -176.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.45 -15.48 63.97 Favored Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 115.117 -0.947 . . . . 70.129999999999995 112.323 -177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m -57.42 115.9 3.01 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.204 0.526 . . . . 61.5 111.329 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.5 m -116.52 134.74 54.5 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 107.722 -1.214 . . . . 63.32 107.722 175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.4 p -101.37 114.81 41.73 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.435 -0.95 . . . . 72.340000000000003 108.435 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 50.5 m -124.43 136.05 53.74 Favored 'General case' 0 N--CA 1.41 -2.439 0 CA-C-N 114.663 -1.153 . . . . 71.209999999999994 110.667 -169.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 20' ' ' THR . 57.7 mt -89.23 126.37 35.47 Favored 'General case' 0 N--CA 1.421 -1.884 0 CA-C-N 114.476 -1.238 . . . . 61.109999999999999 109.402 -178.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -106.61 114.51 28.65 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 107.709 -1.219 . . . . 74.409999999999997 107.709 179.122 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.468 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 62.8 tp -118.07 110.99 18.31 Favored 'General case' 0 N--CA 1.425 -1.677 0 N-CA-C 108.671 -0.863 . . . . 63.43 108.671 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.06 100.26 12.41 Favored 'General case' 0 N--CA 1.401 -2.92 0 C-N-CA 117.764 -1.575 . . . . 65.319999999999993 109.629 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -99.6 30.43 3.61 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 106.382 -1.71 . . . . 72.530000000000001 106.382 176.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 74.5 47.08 17.18 Favored Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.177 -1.969 . . . . 63.130000000000003 108.177 -172.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.7 m -162.81 -29.28 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 123.154 0.582 . . . . 72.129999999999995 111.785 -174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.91 3.46 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.692 -0.963 . . . . 62.009999999999998 110.692 -172.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 60.4 mtt180 -87.95 148.21 24.68 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 110.062 -0.347 . . . . 73.239999999999995 110.062 -177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 22.9 p -135.45 132.24 37.18 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 121.076 0.465 . . . . 54.299999999999997 111.789 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -128.25 126.21 40.45 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 107.218 -1.401 . . . . 74.219999999999999 107.218 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -94.87 141.08 29.06 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.432 -0.507 . . . . 73.099999999999994 110.305 -175.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.445 ' HB2' HG13 ' A' ' 9' ' ' VAL . 95.6 mt -80.48 140.82 35.72 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.605 -0.517 . . . . 71.019999999999996 109.605 177.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -96.61 169.06 10.15 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.387 -0.525 . . . . 65.340000000000003 110.274 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -74.62 112.99 11.36 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 124.265 0.978 . . . . 73.319999999999993 110.43 -178.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.38 -159.65 23.19 Favored Glycine 0 N--CA 1.43 -1.742 0 N-CA-C 108.124 -1.991 . . . . 62.299999999999997 108.124 -174.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 78.6 p -101.27 131.44 47.29 Favored 'General case' 0 C--N 1.292 -1.906 0 C-N-CA 119.139 -1.024 . . . . 51.409999999999997 110.646 178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.446 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 24.6 m-80 -106.67 112.33 25.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 107.774 -1.195 . . . . 74.099999999999994 107.774 -177.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 58.9 mt -96.95 126.1 49.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 110.401 -0.222 . . . . 74.129999999999995 110.401 -176.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.06 142.97 31.66 Favored 'Isoleucine or valine' 0 C--O 1.25 1.094 0 C-N-CA 123.545 0.738 . . . . 64.040000000000006 109.837 -177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 153.49 -154.0 25.21 Favored Glycine 0 CA--C 1.475 -2.453 0 N-CA-C 110.683 -0.967 . . . . 45.140000000000001 110.683 177.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.576 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 16.7 mmm180 -131.73 104.83 7.12 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.256 0.55 . . . . 72.239999999999995 109.789 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.19 169.97 37.63 Favored Glycine 0 N--CA 1.41 -3.06 0 N-CA-C 108.99 -1.644 . . . . 71.450000000000003 108.99 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -75.16 -14.22 60.53 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.693 0.759 . . . . 74.010000000000005 109.701 177.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -92.19 -10.01 40.24 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.355 -0.838 . . . . 73.299999999999997 110.704 -177.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -90.59 149.2 22.23 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.363 -0.606 . . . . 73.439999999999998 109.363 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 86.8 mt-30 -87.25 -49.28 7.37 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.742 -0.836 . . . . 75.510000000000005 108.742 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -105.44 111.42 24.13 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 115.397 -0.82 . . . . 73.349999999999994 109.069 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.507 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -91.16 122.55 33.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-N 115.477 -0.783 . . . . 63.240000000000002 110.725 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.4 HD12 HG11 ' A' ' 45' ' ' VAL . 79.9 mt -65.63 158.4 74.36 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.147 -0.933 . . . . 74.219999999999999 112.033 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -87.78 26.68 0.58 Allowed 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.533 2.822 . . . . 73.450000000000003 112.161 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -139.72 153.38 47.19 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 107.181 -1.415 . . . . 73.510000000000005 107.181 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.3 t -121.39 161.32 22.34 Favored 'General case' 0 N--CA 1.413 -2.313 0 C-N-CA 120.235 -0.586 . . . . 73.329999999999998 109.625 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.56 -15.47 24.51 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 108.502 -1.839 . . . . 63.350000000000001 108.502 -172.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 40' ' ' LEU . 51.9 t -76.93 149.29 6.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 C-N-CA 125.449 1.5 . . . . 72.319999999999993 108.894 179.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.0 m -75.67 163.39 27.36 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 119.597 -0.24 . . . . 75.230000000000004 110.901 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 44.6 ptt85 -60.28 -41.39 93.21 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-O 120.94 0.4 . . . . 73.129999999999995 110.681 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.6 mtm180 -121.53 107.07 11.99 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 106.323 -1.732 . . . . 74.219999999999999 106.323 170.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 35.8 t60 -103.21 -34.04 8.97 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.654 -1.157 . . . . 75.129999999999995 108.945 -176.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.51 HD11 HD21 ' A' ' 61' ' ' LEU . 7.9 tt -166.39 148.51 6.72 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 115.669 -0.696 . . . . 72.510000000000005 109.134 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' HG2' HD21 ' A' ' 64' ' ' LEU . 12.6 pt-20 -137.32 144.45 42.59 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.856 -0.794 . . . . 71.349999999999994 108.856 175.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 80.4 mt -117.2 119.13 60.97 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 N-CA-C 109.555 -0.535 . . . . 74.329999999999998 109.555 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -91.17 107.72 19.39 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.599 -1.259 . . . . 75.109999999999999 107.599 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.4 t-105 -105.44 118.71 37.26 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-N 115.714 -0.675 . . . . 71.230000000000004 109.366 -179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -125.45 -178.84 4.37 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 104.564 -2.384 . . . . 64.400000000000006 104.564 177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.3 53.42 4.78 Favored Glycine 0 C--N 1.297 -1.601 0 C-N-CA 119.856 -1.164 . . . . 31.399999999999999 112.721 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -147.74 -77.45 0.17 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 123.487 0.715 . . . . 73.349999999999994 109.333 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.61 159.29 27.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.043 -0.725 . . . . 42.25 109.043 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.93 107.84 19.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.111 -1.07 . . . . 54.32 108.111 177.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 tt -82.88 113.27 20.38 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.377 -0.828 . . . . 70.109999999999999 108.828 -176.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -90.29 119.59 30.72 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 124.805 1.242 . . . . 62.32 108.347 -176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.14 119.72 28.28 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.535 -0.543 . . . . 43.149999999999999 109.535 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 131.58 42.35 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 115.844 -0.617 . . . . 74.219999999999999 111.148 -177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.5 mm? -118.68 76.72 1.11 Allowed 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.057 -0.719 . . . . 63.43 109.057 178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' HB3' ' HA2' ' A' ' 69' ' ' GLY . 38.1 t-20 -176.43 139.9 0.35 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.527 -0.916 . . . . 54.32 108.527 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.8 m -108.25 -50.23 3.07 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 109.928 -0.397 . . . . 53.210000000000001 109.928 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.3 m -59.1 -49.03 79.42 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.65 0.738 . . . . 72.510000000000005 111.549 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -121.38 28.14 7.93 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.695 0.76 . . . . 54.140000000000001 109.28 -170.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 65' ' ' ASN . . . -49.95 144.65 9.7 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 113.83 -1.532 . . . . 74.030000000000001 115.182 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.8 m -75.65 143.13 42.39 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 124.492 1.117 . . . . 42.109999999999999 112.063 -176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 16.9 p -110.91 148.83 31.61 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 115.813 -0.631 . . . . 74.409999999999997 111.043 177.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG12 HG13 ' A' ' 88' ' ' ILE . 34.1 m -114.87 118.38 58.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.663 -1.236 . . . . 65.140000000000001 107.663 175.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 59.4 29.84 19.45 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.569 0.7 . . . . 72.329999999999998 110.415 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.8 t30 77.62 13.26 1.86 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.198 1.799 . . . . 70.200000000000003 111.242 178.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.97 128.14 25.9 Favored Pre-proline 0 C--N 1.32 -0.706 0 O-C-N 121.859 -0.526 . . . . 73.299999999999997 109.598 176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -71.19 125.74 11.69 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.689 2.259 . . . . 62.409999999999997 112.467 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.3 m -141.69 -177.2 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 108.125 -1.065 . . . . 72.349999999999994 108.125 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -125.39 -27.28 3.48 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 123.356 0.41 . . . . 64.439999999999998 110.784 175.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -141.76 134.47 28.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.727 -0.471 . . . . 45.329999999999998 109.727 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -149.13 152.15 35.61 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.917 -0.771 . . . . 73.540000000000006 108.917 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -101.7 107.52 18.77 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 106.468 -1.678 . . . . 71.219999999999999 106.468 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 82.9 mt -58.9 137.49 57.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.154 0.502 . . . . 61.229999999999997 112.054 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.01 163.47 24.47 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.859 -1.163 . . . . 42.020000000000003 107.859 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -64.91 117.93 8.31 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 116.426 -0.352 . . . . 64.420000000000002 110.204 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.48 -0.98 30.83 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.825 -0.702 . . . . 51.32 113.814 177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -80.07 141.65 35.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 117.523 0.662 . . . . 73.329999999999998 111.305 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.0 t -102.22 113.77 39.67 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.839 0 N-CA-C 108.682 -0.859 . . . . 73.030000000000001 108.682 178.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.465 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -107.34 114.16 45.47 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 108.661 -0.866 . . . . 75.540000000000006 108.661 -177.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 94' ' ' GLU . 37.3 ttt180 -106.57 109.42 21.33 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.031 -1.067 . . . . 72.140000000000001 112.04 -178.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 90' ' ' LEU . 2.0 pt? -112.79 164.43 13.4 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 106.684 -1.599 . . . . 71.439999999999998 106.684 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -24.58 99.14 0.01 OUTLIER Glycine 0 N--CA 1.485 1.908 0 O-C-N 124.661 1.225 . . . . 73.219999999999999 116.092 -176.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 26.3 t60 77.65 -28.42 0.17 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.79 1.636 . . . . 72.430000000000007 113.581 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.6 m -114.73 119.6 37.23 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 113.495 0.924 . . . . 73.430000000000007 113.495 -172.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 6.8 pt-20 -94.16 115.11 27.35 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 108.661 -0.866 . . . . 64.030000000000001 108.661 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.491 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.0 tp -103.34 140.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.132 0 CA-C-N 114.941 -1.027 . . . . 61.109999999999999 109.239 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 12' ' ' GLN . 69.3 mt -101.68 121.56 52.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.063 -1.088 . . . . 64.319999999999993 108.063 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 82' ' ' LEU . 72.5 t -87.6 118.3 33.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 116.463 -0.335 . . . . 44.229999999999997 110.167 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 31.1 mmm-85 -119.58 150.55 40.11 Favored 'General case' 0 N--CA 1.42 -1.97 0 N-CA-C 109.524 -0.547 . . . . 73.439999999999998 109.524 176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mtt -117.25 120.41 38.15 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 108.347 -0.982 . . . . 64.340000000000003 108.347 176.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 . . . . . 0 C--N 1.273 -2.726 0 N-CA-C 107.633 -1.247 . . . . 70.030000000000001 107.633 -177.17 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.154 0 N-CA-C 110.321 -1.112 . . . . 43.049999999999997 110.321 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -134.38 168.19 19.37 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 117.514 0.657 . . . . 62.020000000000003 110.199 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -118.9 163.09 13.27 Favored Glycine 0 N--CA 1.426 -1.992 0 N-CA-C 110.62 -0.992 . . . . 52.509999999999998 110.62 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.9 m -76.52 102.78 6.2 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.592 -0.892 . . . . 64.409999999999997 108.592 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.29 79.18 1.87 Allowed 'General case' 0 N--CA 1.415 -2.178 0 CA-C-O 121.826 0.822 . . . . 63.340000000000003 110.713 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.84 -30.22 21.37 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 109.374 -1.491 . . . . 74.140000000000001 109.374 176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 m -65.7 116.75 7.24 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 123.433 0.693 . . . . 74.109999999999999 109.317 178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 m -144.53 131.85 20.74 Favored 'General case' 0 C--N 1.292 -1.915 0 N-CA-C 109.371 -0.603 . . . . 63.020000000000003 109.371 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.4 t -100.16 113.23 35.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.579 -1.267 . . . . 65.140000000000001 107.579 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.5 m -117.35 129.55 55.95 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.26 -0.882 . . . . 73.209999999999994 109.719 -176.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' THR . 83.5 mt -87.56 123.54 32.55 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.202 -1.036 . . . . 74.129999999999995 108.202 177.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.72 120.72 41.79 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 116.145 -0.479 . . . . 61.119999999999997 109.746 -175.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 pp -129.67 146.89 51.42 Favored 'General case' 0 C--O 1.247 0.921 0 N-CA-C 107.289 -1.374 . . . . 73.420000000000002 107.289 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -95.23 118.36 31.86 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 118.817 -1.153 . . . . 74.329999999999998 110.986 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' HB2' ' HG3' ' A' ' 19' ' ' ARG . 12.5 t70 -103.15 -6.18 22.46 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.08 -1.418 . . . . 73.310000000000002 109.273 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.81 31.85 2.02 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 108.829 -1.708 . . . . 70.030000000000001 108.829 -172.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.5 t 171.37 -54.74 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.781 -1.933 . . . . 71.239999999999995 105.781 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 125.5 100.58 1.25 Allowed Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.167 -1.016 . . . . 71.310000000000002 113.011 175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HG3' ' HB2' ' A' ' 15' ' ' ASP . 26.7 mtm-85 -86.21 158.68 19.68 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 107.81 -1.181 . . . . 73.209999999999994 107.81 176.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 38.7 p -139.61 138.43 36.15 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 116.053 -0.521 . . . . 72.129999999999995 110.191 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -120.0 118.4 30.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.121 -1.437 . . . . 72.25 107.121 174.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -92.82 132.22 37.18 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.469 -0.937 . . . . 52.009999999999998 108.469 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.06 122.05 25.06 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 110.04 -0.356 . . . . 43.310000000000002 110.04 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -85.84 166.89 15.67 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.928 -1.138 . . . . 73.219999999999999 107.928 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -67.61 123.29 20.06 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.263 -0.643 . . . . 73.239999999999995 109.263 -176.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.37 -163.94 14.69 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 110.041 -1.224 . . . . 40.420000000000002 110.041 -176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 53.9 p -99.46 141.13 32.65 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 117.947 0.873 . . . . 71.129999999999995 111.565 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -122.71 115.59 22.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.891 -1.522 . . . . 61.240000000000002 106.891 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -97.15 133.61 38.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 116.544 -0.298 . . . . 72.519999999999996 111.396 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.429 HG12 ' HB3' ' A' ' 38' ' ' PHE . 67.9 mt -107.73 133.9 51.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.574 -0.899 . . . . 72.030000000000001 108.574 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.4 -161.21 31.98 Favored Glycine 0 CA--C 1.49 -1.478 0 N-CA-C 110.756 -0.938 . . . . 53.5 110.756 177.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.6 mtm180 -123.37 105.8 10.13 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.158 -1.053 . . . . 75.310000000000002 108.158 174.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.05 -176.29 48.01 Favored Glycine 0 N--CA 1.419 -2.499 0 N-CA-C 109.21 -1.556 . . . . 74.540000000000006 109.21 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -88.18 -16.12 34.21 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.409 0.623 . . . . 62.409999999999997 109.438 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -89.89 -5.78 56.45 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.921 0.867 . . . . 72.230000000000004 109.781 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.75 145.41 28.74 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.739 -0.664 . . . . 75.140000000000001 110.72 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -105.11 -12.36 16.16 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.895 0.855 . . . . 75.010000000000005 109.764 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.429 ' HB3' HG12 ' A' ' 30' ' ' ILE . 44.3 t80 -139.77 121.81 15.7 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 105.91 -1.885 . . . . 63.240000000000002 105.91 178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 40.7 ttt180 -100.37 131.54 46.24 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 116.333 -0.394 . . . . 72.420000000000002 111.426 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 90' ' ' LEU . 61.2 mt -92.01 138.51 24.62 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.826 -0.625 . . . . 74.510000000000005 109.489 174.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -92.9 12.46 1.94 Allowed 'Trans proline' 0 C--N 1.322 -0.831 0 C-N-CA 122.96 2.44 . . . . 74.439999999999998 111.691 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -93.31 -173.31 3.19 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.875 -0.602 . . . . 62.049999999999997 109.891 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -113.5 152.35 30.29 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.553 0.216 . . . . 72.430000000000007 111.139 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.74 86.92 Favored Glycine 0 N--CA 1.467 0.758 0 CA-C-O 121.237 0.354 . . . . 71.230000000000004 112.877 177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.417 HG13 ' HB2' ' A' ' 49' ' ' HIS . 48.8 t -88.51 114.51 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 N-CA-C 109.438 -0.578 . . . . 72.319999999999993 109.438 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 m -64.22 176.69 0.97 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 124.186 0.994 . . . . 71.120000000000005 110.894 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 23.7 ptt85 -63.8 -34.75 78.6 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.63 0.729 . . . . 74.140000000000001 109.818 179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.2 mtp85 -120.67 109.16 14.88 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.659 -1.238 . . . . 73.439999999999998 107.659 174.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 18.9 t60 -103.33 -31.76 9.89 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.479 -0.934 . . . . 62.149999999999999 108.479 177.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.449 HD11 HD21 ' A' ' 61' ' ' LEU . 8.4 tt -167.3 152.94 7.56 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.536 -0.913 . . . . 75.239999999999995 108.536 -179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -135.34 140.41 45.06 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 121.293 0.568 . . . . 75.200000000000003 109.923 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.0 mt -115.89 114.21 45.55 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.9 -0.778 . . . . 72.439999999999998 108.9 176.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 19.1 ttt180 -92.47 110.23 21.64 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.949 -0.759 . . . . 74.409999999999997 108.949 176.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -99.93 108.66 20.95 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.769 -0.65 . . . . 74.209999999999994 111.295 -178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -107.81 162.57 13.88 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.595 -1.632 . . . . 73.319999999999993 106.595 172.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.67 66.72 1.06 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 114.847 0.699 . . . . 72.230000000000004 114.847 -175.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -169.22 -72.29 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.953 0.901 . . . . 73.319999999999993 108.978 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.0 m -134.57 159.15 41.95 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 108.51 -0.922 . . . . 70.400000000000006 108.51 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.402 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -99.83 120.81 40.34 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.416 0.627 . . . . 73.409999999999997 110.145 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 67.2 tp -80.93 125.46 30.15 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.868 -1.06 . . . . 72.439999999999998 109.882 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.449 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -111.62 120.55 42.45 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.315 -0.624 . . . . 52.399999999999999 109.315 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.98 124.53 40.95 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.407 -0.59 . . . . 75.519999999999996 109.407 176.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -94.71 133.8 38.0 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.396 -0.366 . . . . 44.219999999999999 111.157 -178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.61 76.41 1.34 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.803 -0.443 . . . . 72.129999999999995 109.803 175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -173.0 133.61 0.54 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.292 0.496 . . . . 64.0 109.748 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.1 m -98.75 -35.75 10.05 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.116 0.484 . . . . 60.020000000000003 111.271 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -87.93 -32.48 18.89 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 121.23 0.538 . . . . 52.030000000000001 112.151 -174.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -122.56 28.66 7.25 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 122.07 -0.394 . . . . 74.129999999999995 110.334 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.05 133.17 6.54 Favored Glycine 0 C--O 1.246 0.902 0 O-C-N 124.949 1.405 . . . . 75.129999999999995 113.985 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 90' ' ' LEU . 22.1 m -74.11 136.68 42.96 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.906 0.882 . . . . 75.049999999999997 112.366 -174.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.419 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 28.2 p -111.13 143.68 41.48 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.896 -0.593 . . . . 70.409999999999997 110.49 179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG21 ' CD2' ' A' ' 80' ' ' TRP . 35.0 m -111.9 121.88 65.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.687 -1.597 . . . . 74.430000000000007 106.687 176.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.13 23.41 13.61 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.504 0.721 . . . . 61.020000000000003 110.023 -169.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 75.66 9.31 3.58 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.054 1.342 . . . . 72.040000000000006 110.866 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.43 124.04 50.29 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 109.246 -0.65 . . . . 70.349999999999994 109.246 176.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -66.72 126.76 15.9 Favored 'Trans proline' 0 C--O 1.249 1.071 0 C-N-CA 123.116 2.544 . . . . 35.329999999999998 113.038 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.5 m -143.88 159.87 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.386 -0.825 . . . . 53.32 109.013 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -103.34 -19.7 14.36 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.1 -0.704 . . . . 74.430000000000007 109.1 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.74 149.43 34.38 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.387 -0.824 . . . . 70.200000000000003 110.289 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.484 ' CD2' HG21 ' A' ' 72' ' ' VAL . 77.3 t-105 -159.76 152.83 21.87 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.194 -0.669 . . . . 65.299999999999997 109.194 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -109.16 114.95 29.11 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.58 -1.267 . . . . 72.239999999999995 107.58 174.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.485 HD22 HD11 ' A' ' 88' ' ' ILE . 32.8 mt -56.92 132.83 53.81 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 112.953 0.723 . . . . 74.409999999999997 112.953 -174.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.49 155.37 39.06 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.382 -1.34 . . . . 61.049999999999997 107.382 177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.52 128.3 35.68 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 123.24 0.337 . . . . 62.149999999999999 111.169 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.71 19.04 55.41 Favored Glycine 0 N--CA 1.429 -1.791 0 CA-C-N 115.757 -0.656 . . . . 62.43 112.487 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.13 136.76 34.33 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 108.705 -0.85 . . . . 74.219999999999999 108.705 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.3 t -99.65 111.61 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 107.456 -1.313 . . . . 74.129999999999995 107.456 178.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 82' ' ' LEU . 53.9 mt -107.67 118.49 55.49 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.641 0 CA-C-O 121.292 0.568 . . . . 72.439999999999998 109.554 -174.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.419 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 24.2 mtp180 -111.97 106.71 15.47 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.95 0.881 . . . . 72.040000000000006 110.439 -176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.613 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 0.5 OUTLIER -108.3 164.47 12.28 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.372 -1.286 . . . . 63.409999999999997 108.267 178.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -28.25 90.97 0.01 OUTLIER Glycine 0 N--CA 1.486 2.005 0 O-C-N 124.752 1.282 . . . . 61.109999999999999 115.837 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 60.68 11.78 3.32 Favored 'General case' 0 CA--C 1.565 1.521 0 C-N-CA 125.86 1.664 . . . . 74.420000000000002 112.418 177.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.6 m -131.37 113.5 13.83 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.788 -0.819 . . . . 73.319999999999993 108.788 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -105.94 136.9 44.77 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 119.841 -0.744 . . . . 60.520000000000003 110.81 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 10.7 tp -129.72 146.31 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.636 0 N-CA-C 108.741 -0.837 . . . . 71.140000000000001 108.741 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 74.9 mt -111.97 133.24 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.622 -0.881 . . . . 74.5 108.622 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 72.0 t -90.9 114.54 28.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.901 -0.407 . . . . 65.310000000000002 109.901 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -114.49 122.44 46.58 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 116.002 -0.545 . . . . 64.129999999999995 110.315 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.7 mtt -101.93 125.9 48.71 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.37 -0.832 . . . . 74.049999999999997 110.573 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.8 m170 . . . . . 0 C--N 1.293 -1.864 0 CA-C-N 114.519 -1.219 . . . . 72.319999999999993 108.877 178.502 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.796 0 N-CA-C 111.528 -0.629 . . . . 73.510000000000005 111.528 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.8 m170 -126.03 142.23 51.61 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.237 -0.653 . . . . 64.510000000000005 109.237 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.38 -16.42 80.62 Favored Glycine 0 C--N 1.313 -0.713 0 N-CA-C 111.206 -0.757 . . . . 34.340000000000003 111.206 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 m -57.97 -41.34 82.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.352 0.661 . . . . 62.420000000000002 110.024 175.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.24 104.42 16.38 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 108.141 -1.059 . . . . 64.439999999999998 108.141 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 147.04 -31.63 1.44 Allowed Glycine 0 C--N 1.3 -1.436 0 N-CA-C 109.716 -1.354 . . . . 70.430000000000007 109.716 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.3 m -146.04 116.63 7.6 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 108.811 -0.811 . . . . 74.340000000000003 108.811 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 17.4 m -123.41 146.75 47.74 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.338 -0.986 . . . . 74.129999999999995 108.338 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.1 p -135.85 115.81 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.415 0 N-CA-C 107.349 -1.352 . . . . 52.32 107.349 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.8 m -114.79 131.96 56.63 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-N 114.175 -1.375 . . . . 60.549999999999997 110.361 -170.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 95' ' ' ILE . 4.2 pp -98.7 133.52 42.91 Favored 'General case' 0 N--CA 1.414 -2.226 0 N-CA-C 108.799 -0.815 . . . . 51.200000000000003 108.799 174.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' O ' HD12 ' A' ' 95' ' ' ILE . 43.3 mt-30 -99.9 120.64 40.1 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.782 -0.644 . . . . 65.230000000000004 110.692 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 30.5 tp -129.85 111.32 12.47 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.261 -0.882 . . . . 70.409999999999997 110.082 -174.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -89.0 100.58 13.33 Favored 'General case' 0 N--CA 1.416 -2.13 0 C-N-CA 118.04 -1.464 . . . . 53.409999999999997 108.848 175.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -96.61 9.62 40.97 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.699 -1.591 . . . . 61.43 108.568 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.4 -13.77 10.17 Favored Glycine 0 N--CA 1.441 -1.014 0 CA-C-N 115.293 -0.867 . . . . 71.120000000000005 111.113 -179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.8 m -137.23 13.32 3.05 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.852 -0.174 . . . . 70.349999999999994 111.374 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 54.31 83.6 0.04 OUTLIER Glycine 0 C--N 1.345 1.079 0 N-CA-C 114.279 0.471 . . . . 73.510000000000005 114.279 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -98.77 144.38 28.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.281 0.562 . . . . 74.319999999999993 111.237 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.421 HG22 ' HG2' ' A' ' 12' ' ' GLN . 77.4 p -122.5 134.45 54.57 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 107.897 -1.149 . . . . 74.519999999999996 107.897 177.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -137.25 131.75 32.8 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 111.577 0.214 . . . . 74.319999999999993 111.577 -174.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.39 136.07 38.38 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 109.846 -0.427 . . . . 61.229999999999997 109.846 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.576 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.8 mt -68.31 139.62 55.92 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.803 -0.635 . . . . 72.239999999999995 110.038 175.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 -105.31 152.98 22.24 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 109.404 -0.591 . . . . 74.140000000000001 109.404 177.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -61.33 136.96 58.22 Favored 'General case' 0 C--O 1.245 0.829 0 O-C-N 124.344 1.027 . . . . 73.310000000000002 111.518 -177.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.49 -164.11 12.45 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 107.722 -2.151 . . . . 73.109999999999999 107.722 -175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 35.6 p -104.43 130.03 52.36 Favored 'General case' 0 C--N 1.283 -2.294 0 C-N-CA 118.233 -1.387 . . . . 72.120000000000005 112.236 178.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -99.95 108.97 21.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 105.409 -2.071 . . . . 55.25 105.409 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.496 HG21 ' HG2' ' A' ' 48' ' ' ARG . 57.9 mt -98.57 130.34 47.56 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.886 -0.597 . . . . 72.040000000000006 110.948 -173.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.0 mt -101.99 123.4 55.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.143 -1.058 . . . . 71.310000000000002 108.143 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.4 -176.4 39.57 Favored Glycine 0 N--CA 1.425 -2.096 0 N-CA-C 109.702 -1.359 . . . . 50.450000000000003 109.702 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -115.03 106.16 13.81 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 117.63 0.715 . . . . 73.319999999999993 109.309 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.56 177.49 44.65 Favored Glycine 0 N--CA 1.424 -2.146 0 N-CA-C 110.509 -1.036 . . . . 62.5 110.509 178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -81.19 -16.95 51.36 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.5 0.667 . . . . 72.0 109.622 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -83.61 -23.85 31.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.653 0.739 . . . . 74.430000000000007 110.086 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -82.99 162.42 21.45 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.127 -0.942 . . . . 72.019999999999996 110.95 179.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -104.36 -58.46 1.88 Allowed 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.811 -0.811 . . . . 62.200000000000003 108.811 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -100.35 129.95 46.39 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.575 -0.738 . . . . 61.119999999999997 109.16 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 24.8 mtm180 -108.37 131.13 55.06 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 116.103 -0.499 . . . . 73.030000000000001 110.364 -176.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.64 142.36 57.27 Favored Pre-proline 0 C--N 1.31 -1.119 0 CA-C-N 116.185 -0.461 . . . . 72.530000000000001 110.382 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -89.1 27.79 0.49 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.032 2.488 . . . . 71.230000000000004 110.917 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -135.09 -177.7 4.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.959 -1.126 . . . . 74.400000000000006 107.959 -174.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.9 t -116.46 178.68 4.24 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.731 -0.84 . . . . 71.129999999999995 108.731 -178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.14 9.76 79.52 Favored Glycine 0 C--N 1.317 -0.476 0 N-CA-C 110.213 -1.155 . . . . 63.140000000000001 110.213 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 49' ' ' HIS . 4.8 p -116.9 136.47 53.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 114.347 -0.927 . . . . 70.140000000000001 109.584 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.0 m -89.7 -164.43 1.15 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.821 -0.807 . . . . 62.219999999999999 108.821 178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 35.8 ptt180 -78.27 -30.42 48.49 Favored 'General case' 0 C--O 1.214 -0.798 0 C-N-CA 118.767 -1.173 . . . . 54.43 108.557 174.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.496 ' HG2' HG21 ' A' ' 29' ' ' ILE . 78.5 mtt180 -121.87 108.03 12.98 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 107.038 -1.467 . . . . 65.219999999999999 107.038 170.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.567 ' HB2' HG23 ' A' ' 45' ' ' VAL . 25.3 t60 -104.21 -34.78 8.24 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 108.047 -1.094 . . . . 70.120000000000005 108.047 177.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tt -165.42 142.92 5.83 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 107.976 -1.12 . . . . 71.530000000000001 107.976 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -131.14 129.88 42.37 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-O 121.508 0.67 . . . . 72.200000000000003 110.936 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.0 mt -105.44 110.06 29.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-N 115.376 -0.829 . . . . 71.120000000000005 108.951 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 25.2 ttt180 -90.57 110.19 21.33 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.994 -0.743 . . . . 64.540000000000006 108.994 177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -94.68 107.64 19.64 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.146 -1.057 . . . . 75.030000000000001 108.146 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -114.36 152.49 31.39 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 105.145 -2.169 . . . . 71.340000000000003 105.145 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.24 57.54 2.81 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 118.423 0.556 . . . . 52.340000000000003 112.365 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -159.22 -60.33 0.07 Allowed 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 107.432 -1.322 . . . . 74.129999999999995 107.432 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.7 m -143.88 156.91 16.01 Favored 'Isoleucine or valine' 0 C--O 1.245 0.835 0 CA-C-N 115.54 -0.755 . . . . 64.430000000000007 109.924 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -95.25 102.64 14.46 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.787 -1.19 . . . . 71.340000000000003 107.787 175.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.0 tt -85.23 116.9 23.84 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.226 -0.897 . . . . 72.510000000000005 109.858 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 tm? -99.4 119.35 37.83 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.901 -1.148 . . . . 74.519999999999996 107.901 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.74 120.16 27.34 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.183 0.516 . . . . 71.349999999999994 110.307 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 78' ' ' GLN . 5.9 t70 -85.99 138.87 31.67 Favored 'General case' 0 C--N 1.292 -1.935 0 C-N-CA 123.887 0.875 . . . . 72.310000000000002 109.316 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.04 76.67 1.69 Allowed 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.508 -1.293 . . . . 75.310000000000002 107.508 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -166.24 150.07 7.58 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 121.802 -0.561 . . . . 50.310000000000002 109.899 177.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 m -108.22 -30.28 8.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.207 0.527 . . . . 60.350000000000001 111.409 -178.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 42.9 m -88.94 -60.29 2.0 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.145 0.974 . . . . 65.409999999999997 111.867 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -104.4 28.6 6.77 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 125.048 1.339 . . . . 72.219999999999999 109.519 -168.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.86 139.25 5.0 Favored Glycine 0 C--O 1.256 1.531 0 CA-C-N 114.017 -1.447 . . . . 54.0 113.71 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 90' ' ' LEU . 7.0 m -83.61 155.74 23.07 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 124.13 0.972 . . . . 63.329999999999998 112.381 -172.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 33.4 p -118.98 153.71 34.21 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.952 -0.567 . . . . 65.129999999999995 110.261 177.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.431 HG12 HG13 ' A' ' 88' ' ' ILE . 35.6 m -116.6 116.28 51.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.816 -1.179 . . . . 54.109999999999999 107.816 175.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 62.36 27.1 16.19 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.018 0.913 . . . . 71.209999999999994 109.359 -176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 t30 74.87 15.97 3.03 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.307 1.843 . . . . 74.049999999999997 111.26 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.23 123.74 38.7 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 108.693 -0.855 . . . . 73.109999999999999 108.693 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -73.62 124.4 9.28 Favored 'Trans proline' 0 C--O 1.241 0.627 0 C-N-CA 122.173 1.915 . . . . 73.109999999999999 112.998 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 72' ' ' VAL . 35.8 m -156.25 169.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 104.963 -2.236 . . . . 73.400000000000006 104.963 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 63' ' ' ASP . 36.1 mt-30 -113.24 -6.23 13.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.394 -0.923 . . . . 74.230000000000004 112.536 175.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 7.0 pt-20 -151.43 140.59 21.25 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.163 -0.615 . . . . 73.420000000000002 111.909 177.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -163.29 152.56 14.82 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.205 -1.035 . . . . 74.540000000000006 108.205 -171.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -100.59 116.7 33.13 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.777 -0.823 . . . . 71.409999999999997 108.777 174.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.6 mt -61.77 130.38 45.51 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 112.678 0.622 . . . . 74.140000000000001 112.678 -175.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' HA ' ' SD ' ' A' ' 99' ' ' MET . . . -126.78 167.84 15.23 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.88 -0.785 . . . . 72.219999999999999 108.88 173.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 99' ' ' MET . 26.2 t70 -60.55 124.45 20.42 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.465 -0.334 . . . . 64.040000000000006 110.634 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.9 -7.36 52.8 Favored Glycine 0 N--CA 1.436 -1.336 0 C-N-CA 120.721 -0.752 . . . . 70.420000000000002 113.622 175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -73.97 135.04 43.16 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 117.179 0.49 . . . . 74.099999999999994 111.488 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.9 t -103.92 113.07 39.82 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 108.718 -0.845 . . . . 74.239999999999995 108.718 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.506 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 1.8 mp -98.27 113.22 32.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 106.55 -1.648 . . . . 73.409999999999997 106.55 178.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 30.9 ttt85 -115.5 116.21 27.81 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.25 0.548 . . . . 73.200000000000003 111.193 -169.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.459 ' HB3' HG23 ' A' ' 70' ' ' THR . 1.1 pt? -123.79 164.71 18.64 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.892 1.277 . . . . 71.329999999999998 108.365 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.39 113.8 0.9 Allowed Glycine 0 CA--C 1.531 1.092 0 N-CA-C 114.642 0.617 . . . . 54.43 114.642 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.8 m80 64.82 7.13 3.69 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.85 1.26 . . . . 73.150000000000006 114.068 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.4 m -140.83 125.87 18.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.779 -0.369 . . . . 55.219999999999999 110.939 -177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -118.92 121.78 40.76 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.163 -0.68 . . . . 74.140000000000001 109.163 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.576 HD11 HD13 ' A' ' 11' ' ' LEU . 6.9 tp -109.74 125.7 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 N-CA-C 108.725 -0.843 . . . . 61.420000000000002 108.725 -176.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -102.51 129.05 54.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.158 -0.682 . . . . 74.019999999999996 109.158 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.4 t -94.52 123.88 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 121.568 0.699 . . . . 71.239999999999995 111.961 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -112.92 119.24 37.26 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.043 -0.98 . . . . 73.209999999999994 108.677 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.527 ' SD ' ' HA ' ' A' ' 83' ' ' ALA . 85.6 mtp -107.1 120.99 43.59 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.298 -0.561 . . . . 71.310000000000002 110.591 177.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 28.4 m-70 . . . . . 0 C--N 1.283 -2.32 0 N-CA-C 107.137 -1.431 . . . . 73.540000000000006 107.137 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.545 0 N-CA-C 110.996 -0.842 . . . . 43.140000000000001 110.996 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -124.8 179.9 4.8 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 122.614 -0.345 . . . . 63.340000000000003 110.172 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.29 -59.88 4.8 Favored Glycine 0 C--N 1.316 -0.573 0 N-CA-C 110.533 -1.027 . . . . 41.219999999999999 110.533 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.0 m -151.57 133.41 14.96 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.769 -1.197 . . . . 75.0 107.769 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.47 104.2 9.91 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.845 0.355 . . . . 73.409999999999997 111.544 -177.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.42 -27.87 50.2 Favored Glycine 0 C--N 1.316 -0.583 0 N-CA-C 110.419 -1.072 . . . . 34.32 110.419 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.6 m -66.47 116.69 7.72 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.102 -0.703 . . . . 61.229999999999997 109.102 176.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.0 m -134.4 138.2 44.64 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 109.332 -0.618 . . . . 73.420000000000002 109.332 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.64 109.56 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 107.233 -1.395 . . . . 72.230000000000004 107.233 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.406 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 57.0 m -108.63 122.38 46.98 Favored 'General case' 0 C--N 1.271 -2.805 0 N-CA-C 108.293 -1.003 . . . . 64.219999999999999 108.293 -177.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.563 ' HB3' ' CG1' ' A' ' 95' ' ' ILE . 47.1 mt -87.7 128.7 35.3 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 107.672 -1.233 . . . . 73.109999999999999 107.672 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -100.97 117.64 35.41 Favored 'General case' 0 C--N 1.265 -3.071 0 N-CA-C 107.055 -1.461 . . . . 74.519999999999996 107.055 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 95' ' ' ILE . 50.3 tp -91.94 125.85 36.8 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 115.672 -0.695 . . . . 55.539999999999999 109.385 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -96.58 100.13 11.72 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 107.466 -1.309 . . . . 75.200000000000003 107.466 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -126.95 -14.01 5.64 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 114.768 -1.106 . . . . 54.439999999999998 109.701 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 118.41 -29.98 6.18 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.382 -1.087 . . . . 61.140000000000001 110.382 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.4 t -90.11 -35.03 15.66 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 108.123 -1.066 . . . . 61.210000000000001 108.123 178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 83.39 57.93 2.39 Favored Glycine 0 CA--C 1.488 -1.653 0 N-CA-C 109.85 -1.3 . . . . 51.130000000000003 109.85 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.9 mmp_? -87.51 162.88 16.98 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.562 -0.319 . . . . 64.450000000000003 110.304 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.406 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 33.9 p -128.59 143.4 50.95 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 120.872 0.368 . . . . 74.439999999999998 110.764 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -127.27 113.1 15.85 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.829 -0.804 . . . . 74.420000000000002 108.829 175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -81.71 132.68 35.3 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.849 -0.797 . . . . 74.510000000000005 108.849 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD22 HD21 ' A' ' 28' ' ' ASN . 65.5 mt -59.89 132.13 53.02 Favored 'General case' 0 CA--C 1.499 -1.01 0 O-C-N 124.051 0.845 . . . . 62.420000000000002 111.454 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -80.32 145.54 32.05 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 108.094 -1.076 . . . . 73.209999999999994 108.094 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.99 113.56 10.16 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 122.087 0.946 . . . . 73.420000000000002 109.901 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.83 -161.01 24.75 Favored Glycine 0 N--CA 1.417 -2.631 0 N-CA-C 107.041 -2.424 . . . . 75.209999999999994 107.041 -173.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.2 p -107.56 137.69 45.13 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-N 118.449 1.125 . . . . 74.430000000000007 112.311 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.424 HD21 HD22 ' A' ' 23' ' ' LEU . 7.1 p30 -120.76 120.89 36.92 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 109.254 -0.647 . . . . 65.329999999999998 109.254 178.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 61.6 mt -99.62 121.22 50.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 108.535 -0.913 . . . . 72.219999999999999 108.535 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 76.2 mt -97.96 130.01 47.33 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.005 -0.739 . . . . 64.209999999999994 109.005 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.97 -173.11 36.6 Favored Glycine 0 N--CA 1.424 -2.121 0 N-CA-C 110.182 -1.167 . . . . 72.239999999999995 110.182 176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 40' ' ' LEU . 25.9 mtm105 -124.08 107.22 11.04 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 117.678 0.739 . . . . 64.439999999999998 110.179 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.47 176.71 44.87 Favored Glycine 0 N--CA 1.418 -2.502 0 N-CA-C 110.529 -1.028 . . . . 53.119999999999997 110.529 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -55.64 -32.22 62.99 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 123.954 0.902 . . . . 75.099999999999994 112.244 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -95.26 1.55 54.59 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.212 -0.449 . . . . 63.520000000000003 111.894 -173.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.03 149.76 24.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.039 0.447 . . . . 74.239999999999995 112.069 -175.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -107.24 -57.77 2.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 123.867 0.867 . . . . 72.340000000000003 108.716 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.539 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 19.8 t80 -101.67 117.06 34.11 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 105.992 -1.855 . . . . 75.530000000000001 105.992 178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 36.6 mtm180 -107.89 126.58 52.84 Favored 'General case' 0 C--N 1.279 -2.476 0 C-N-CA 120.445 -0.502 . . . . 45.020000000000003 111.573 -174.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.54 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 63.3 mt -75.45 148.75 83.49 Favored Pre-proline 0 C--O 1.21 -0.998 0 CA-C-N 115.756 -0.657 . . . . 74.209999999999994 109.434 176.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -80.57 11.65 2.84 Favored 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 122.476 2.118 . . . . 54.340000000000003 113.925 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -116.39 -177.37 3.16 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 109.427 -0.582 . . . . 70.140000000000001 109.427 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.4 m -128.69 149.65 50.59 Favored 'General case' 0 N--CA 1.424 -1.735 0 C-N-CA 123.234 0.614 . . . . 73.540000000000006 109.629 -175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.51 -16.67 24.02 Favored Glycine 0 CA--C 1.495 -1.182 0 N-CA-C 108.548 -1.821 . . . . 60.109999999999999 108.548 -175.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.436 HG12 ' HA2' ' A' ' 31' ' ' GLY . 31.5 t -80.69 128.37 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 113.372 -1.414 . . . . 71.230000000000004 107.401 177.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.0 m -68.39 166.19 17.21 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 123.502 0.501 . . . . 63.32 112.104 -175.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.486 ' HB2' ' HA3' ' A' ' 33' ' ' GLY . 28.3 ptt-85 -62.26 -37.63 86.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.58 0.705 . . . . 72.120000000000005 109.437 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.432 HH21 ' CD ' ' A' ' 51' ' ' GLU . 21.7 mtp180 -126.22 95.8 4.5 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 103.725 -2.695 . . . . 74.230000000000004 103.725 169.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -92.12 -37.47 12.73 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.772 0.796 . . . . 71.329999999999998 109.148 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD11 HD21 ' A' ' 61' ' ' LEU . 5.7 tt -161.75 150.02 15.21 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.094 -1.076 . . . . 54.020000000000003 108.094 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' CD ' HH21 ' A' ' 48' ' ' ARG . 8.4 pt-20 -139.77 125.98 20.0 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 121.662 0.744 . . . . 72.219999999999999 111.313 179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.99 121.89 52.37 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.045 -0.98 . . . . 64.519999999999996 108.36 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -106.25 107.18 18.05 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 107.716 -1.216 . . . . 74.219999999999999 107.716 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 43.7 t-105 -108.65 121.19 44.5 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 121.954 0.883 . . . . 74.010000000000005 112.959 -173.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -133.41 158.13 43.81 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.542 -1.651 . . . . 50.210000000000001 106.542 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.41 68.41 0.53 Allowed Glycine 0 C--N 1.314 -0.684 0 N-CA-C 114.772 0.669 . . . . 70.129999999999995 114.772 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -165.79 -70.72 0.03 OUTLIER 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 107.727 -1.212 . . . . 64.510000000000005 107.727 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.9 m -135.57 150.99 29.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.802 0.334 . . . . 72.319999999999993 110.614 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -97.98 112.69 24.53 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.294 0.568 . . . . 75.129999999999995 109.494 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.3 tt -84.23 117.7 23.69 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.954 -1.021 . . . . 71.0 108.873 -177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.479 HD21 HD11 ' A' ' 50' ' ' LEU . 2.8 tm? -100.77 109.94 21.99 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.222 -1.399 . . . . 73.109999999999999 107.222 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -113.99 111.09 21.09 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.264 0.554 . . . . 71.439999999999998 110.023 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -81.24 136.79 35.85 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.591 -0.892 . . . . 71.409999999999997 108.591 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.51 106.31 16.64 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.534 -0.913 . . . . 75.120000000000005 108.534 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.564 ' OD1' ' HB ' ' A' ' 67' ' ' THR . 28.7 t-20 69.78 89.47 0.1 Allowed 'General case' 0 C--O 1.215 -0.756 0 CA-C-N 115.11 -0.95 . . . . 74.129999999999995 111.39 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.6 m -68.73 -18.14 64.18 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.096 -0.956 . . . . 73.340000000000003 111.868 -175.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.564 ' HB ' ' OD1' ' A' ' 65' ' ' ASN . 18.5 m -46.44 -53.58 10.84 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 71.430000000000007 110.979 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -122.34 27.13 8.08 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.654 -1.61 . . . . 72.400000000000006 106.654 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -95.88 -144.91 17.91 Favored Glycine 0 N--CA 1.433 -1.54 0 CA-C-N 114.337 -1.302 . . . . 62.409999999999997 115.854 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.9 m -107.4 156.47 18.9 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.124 -1.038 . . . . 74.510000000000005 112.842 -169.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 p -119.21 140.81 49.59 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.175 -0.921 . . . . 73.299999999999997 109.8 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.475 HG12 HG13 ' A' ' 88' ' ' ILE . 35.9 m -114.91 115.74 50.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 107.712 -1.218 . . . . 70.230000000000004 107.712 177.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 60.99 28.63 18.41 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.844 0.831 . . . . 72.120000000000005 109.115 -175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 81.18 0.06 1.71 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 127.194 2.198 . . . . 54.329999999999998 111.603 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -97.41 121.34 58.76 Favored Pre-proline 0 C--N 1.316 -0.884 0 O-C-N 121.556 -0.715 . . . . 74.140000000000001 109.724 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 5.7 Cg_exo -75.11 125.45 9.26 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.094 1.862 . . . . 75.150000000000006 110.941 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.8 m -142.78 161.65 18.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.0 -1.111 . . . . 72.439999999999998 108.0 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -88.5 -18.45 28.18 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.177 0.513 . . . . 62.149999999999999 111.518 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -161.73 152.39 17.7 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.2 -0.667 . . . . 74.439999999999998 109.2 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -154.52 151.76 29.28 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.589 -0.893 . . . . 75.420000000000002 108.589 -176.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -101.93 108.26 19.66 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 107.53 -1.285 . . . . 52.439999999999998 107.53 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD22 HG21 ' A' ' 97' ' ' VAL . 86.5 mt -59.31 146.81 38.19 Favored 'General case' 0 C--O 1.243 0.736 0 O-C-N 123.879 0.737 . . . . 73.439999999999998 112.068 -176.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -150.4 170.62 18.62 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.754 -1.202 . . . . 54.149999999999999 107.754 173.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.27 128.27 35.49 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.706 0.288 . . . . 72.109999999999999 111.127 -177.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.76 2.74 57.29 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 120.967 -0.635 . . . . 64.329999999999998 112.933 176.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -85.17 134.03 34.18 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 120.192 -0.603 . . . . 63.439999999999998 110.573 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.8 t -101.27 114.86 41.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.723 -0.672 . . . . 71.420000000000002 109.466 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.475 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -101.64 109.6 26.32 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 N-CA-C 107.475 -1.305 . . . . 73.329999999999998 107.475 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 47.2 ttp85 -110.41 120.02 41.1 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.681 0.753 . . . . 72.310000000000002 110.207 -178.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 90' ' ' LEU . 1.2 pt? -119.94 165.0 15.23 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 114.63 -1.168 . . . . 75.310000000000002 108.559 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -38.98 100.97 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 N-CA-C 115.405 0.922 . . . . 34.229999999999997 115.405 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.9 m170 71.54 17.99 5.52 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.279 1.432 . . . . 71.299999999999997 113.603 174.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.5 m -154.28 135.7 14.18 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.947 -0.47 . . . . 72.109999999999999 111.778 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -120.84 136.6 54.87 Favored 'General case' 0 C--N 1.312 -1.047 0 O-C-N 121.839 -0.538 . . . . 65.420000000000002 110.025 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.563 ' CG1' ' HB3' ' A' ' 11' ' ' LEU . 9.2 tp -126.9 137.34 58.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.812 -0.81 . . . . 73.200000000000003 108.812 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 63.9 mt -107.45 127.37 63.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.46 -0.57 . . . . 74.519999999999996 109.46 -178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 82' ' ' LEU . 53.3 t -85.15 119.98 34.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.142 0.496 . . . . 72.510000000000005 111.262 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -113.86 126.16 54.87 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.298 -1.001 . . . . 73.540000000000006 108.298 177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 54.0 mtt -115.22 131.42 56.93 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-O 121.776 0.798 . . . . 43.409999999999997 111.416 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 78.6 m-70 . . . . . 0 C--N 1.279 -2.5 0 CA-C-N 114.385 -1.28 . . . . 71.040000000000006 108.123 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.966 0 N-CA-C 110.669 -0.972 . . . . 53.100000000000001 110.669 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -77.75 -59.86 2.61 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.608 -0.886 . . . . 63.520000000000003 108.608 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 162.2 137.32 2.17 Favored Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 115.381 -0.827 . . . . 51.340000000000003 111.435 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.8 m -87.81 -16.99 32.54 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.309 0.576 . . . . 70.530000000000001 109.587 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.49 92.81 2.96 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 115.312 -0.858 . . . . 72.510000000000005 108.816 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.44 80.59 0.26 Allowed Glycine 0 N--CA 1.424 -2.131 0 N-CA-C 110.349 -1.1 . . . . 62.219999999999999 110.349 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 m -57.08 115.43 2.64 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.93 -0.767 . . . . 71.010000000000005 108.93 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.1 m -104.85 115.02 29.59 Favored 'General case' 0 N--CA 1.418 -2.057 0 N-CA-C 108.711 -0.848 . . . . 74.099999999999994 108.711 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.63 113.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.753 -1.203 . . . . 62.439999999999998 107.753 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -117.63 117.28 28.96 Favored 'General case' 0 C--N 1.28 -2.449 0 N-CA-C 108.967 -0.753 . . . . 75.400000000000006 108.967 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -87.7 137.25 32.5 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 108.476 -0.935 . . . . 65.209999999999994 108.476 178.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -108.52 125.84 52.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 108.901 -0.778 . . . . 60.149999999999999 108.901 178.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -133.16 114.77 14.24 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 121.47 0.653 . . . . 75.319999999999993 110.968 -172.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -99.9 102.17 13.5 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 109.106 -0.702 . . . . 64.430000000000007 109.106 174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.64 10.77 37.59 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.57 1.176 . . . . 74.409999999999997 108.935 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.6 39.43 1.1 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 109.927 -1.269 . . . . 61.520000000000003 109.927 -176.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.7 t -170.71 -61.87 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.983 -0.747 . . . . 44.399999999999999 108.983 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 118.09 92.58 1.56 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 111.012 -0.835 . . . . 70.319999999999993 111.012 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.5 mmp_? -123.65 165.63 16.89 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 122.21 -0.583 . . . . 61.109999999999999 110.858 179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 36.2 p -136.45 149.16 48.09 Favored 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.946 -0.761 . . . . 31.32 108.946 176.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.438 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 88.3 t80 -140.34 119.69 13.02 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.879 -0.785 . . . . 64.349999999999994 108.879 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -85.13 134.11 34.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.052 -1.092 . . . . 74.430000000000007 108.052 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.83 131.12 44.61 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 123.654 0.596 . . . . 64.450000000000003 110.968 -178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.1 mmm180 -90.05 150.14 22.21 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.385 -1.339 . . . . 71.299999999999997 107.385 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -71.72 118.32 14.41 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.926 0.87 . . . . 51.43 111.333 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.63 -168.6 23.82 Favored Glycine 0 N--CA 1.426 -1.987 0 N-CA-C 107.232 -2.347 . . . . 73.540000000000006 107.232 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 64.9 p -106.67 129.71 54.53 Favored 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 118.822 1.311 . . . . 71.409999999999997 110.687 177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -110.54 129.27 55.83 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.209 -0.451 . . . . 65.109999999999999 109.849 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.4 mt -99.09 125.45 52.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 109.388 -0.597 . . . . 72.439999999999998 109.388 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.0 mt -108.4 135.55 46.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.99 -0.744 . . . . 74.120000000000005 108.99 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 147.17 -168.06 28.34 Favored Glycine 0 CA--C 1.475 -2.466 0 N-CA-C 110.566 -1.014 . . . . 64.099999999999994 110.566 178.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.603 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 42.5 mtm105 -116.31 106.6 13.84 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.536 -0.866 . . . . 74.140000000000001 110.868 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.21 177.84 46.27 Favored Glycine 0 N--CA 1.403 -3.563 0 N-CA-C 109.772 -1.331 . . . . 71.099999999999994 109.772 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -76.57 -20.13 57.15 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.653 0.74 . . . . 75.150000000000006 110.222 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -89.61 -29.11 19.08 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.165 -0.925 . . . . 61.299999999999997 109.511 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.09 142.31 57.83 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 114.855 -1.066 . . . . 51.009999999999998 110.62 -176.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -94.98 -47.98 6.18 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.178 -1.045 . . . . 74.340000000000003 108.178 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -109.37 113.74 26.81 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 114.879 -1.055 . . . . 73.109999999999999 109.134 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mpt_? -90.01 113.5 25.2 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.747 -0.66 . . . . 54.439999999999998 111.677 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 mt -80.49 125.91 79.78 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.307 -0.406 . . . . 65.120000000000005 110.658 175.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 7.9 Cg_exo -69.83 6.92 1.15 Allowed 'Trans proline' 0 CA--C 1.556 1.608 0 C-N-CA 123.243 2.629 . . . . 70.540000000000006 116.016 -175.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -89.89 175.85 7.05 Favored 'General case' 0 C--O 1.252 1.184 0 O-C-N 121.187 -0.946 . . . . 72.450000000000003 110.141 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.5 ' HA ' HH21 ' A' ' 32' ' ' ARG . 25.0 m -113.15 138.71 49.55 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 109.229 -0.656 . . . . 74.349999999999994 109.229 -176.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.58 -13.57 32.75 Favored Glycine 0 CA--C 1.499 -0.96 0 N-CA-C 109.693 -1.363 . . . . 70.219999999999999 109.693 -176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.443 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 45.0 t -75.5 123.53 31.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.37 0 CA-C-N 114.081 -1.06 . . . . 62.530000000000001 108.639 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.9 m -75.56 171.91 13.47 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.964 -0.562 . . . . 65.019999999999996 111.878 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.603 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.9 ptm180 -61.01 -31.28 70.9 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.929 0.871 . . . . 72.319999999999993 110.464 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -134.58 99.86 4.47 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 103.446 -2.798 . . . . 64.010000000000005 103.446 171.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -96.18 -36.82 10.81 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.551 0.691 . . . . 72.209999999999994 109.42 -175.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.428 HD11 HD21 ' A' ' 61' ' ' LEU . 7.4 tt -162.62 148.06 12.33 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 71.209999999999994 108.137 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -132.47 142.49 49.26 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 109.456 -0.572 . . . . 72.209999999999994 109.456 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -115.63 114.31 45.92 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 108.46 -0.941 . . . . 75.340000000000003 108.46 176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 50.2 ttt180 -91.71 107.55 19.29 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 108.034 -1.098 . . . . 64.099999999999994 108.034 175.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 44.2 t-105 -106.98 117.75 34.87 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 115.927 -0.579 . . . . 65.310000000000002 110.417 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -115.4 160.63 19.62 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.125 -1.806 . . . . 75.549999999999997 106.125 174.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.82 59.35 1.72 Allowed Glycine 0 C--N 1.305 -1.171 0 C-N-CA 121.406 -0.426 . . . . 74.409999999999997 113.48 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -171.19 -57.62 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.216 1.007 . . . . 71.150000000000006 109.545 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.4 m -134.35 150.68 31.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.821 0 CA-C-O 120.963 0.411 . . . . 71.230000000000004 111.288 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -107.32 104.95 14.68 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.165 -0.925 . . . . 75.510000000000005 108.614 179.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.1 tp -89.18 109.73 20.57 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 114.776 -1.102 . . . . 61.210000000000001 110.236 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -92.45 124.2 36.32 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.018 -1.104 . . . . 75.430000000000007 108.018 -178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.49 127.34 40.63 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.795 0.331 . . . . 51.119999999999997 110.403 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.73 129.26 43.0 Favored 'General case' 0 C--N 1.313 -0.981 0 C-N-CA 123.853 0.861 . . . . 71.420000000000002 111.289 -176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -123.82 76.91 1.47 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.787 0.435 . . . . 72.420000000000002 110.184 178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 179.95 114.79 0.05 OUTLIER 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 108.587 -0.894 . . . . 72.129999999999995 108.587 178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.3 m -83.78 -24.07 31.22 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.85 -0.531 . . . . 70.400000000000006 111.264 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 m -80.49 -58.82 2.94 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-O 121.354 0.597 . . . . 74.25 109.893 -178.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -103.82 28.57 6.52 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 123.477 0.711 . . . . 72.209999999999994 110.363 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.37 131.24 5.9 Favored Glycine 0 C--O 1.242 0.644 0 O-C-N 124.703 1.252 . . . . 63.43 114.793 -176.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.4 m -76.68 137.64 39.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 124.196 0.999 . . . . 44.219999999999999 112.095 -173.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 25.3 p -107.13 149.55 27.53 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 116.206 -0.452 . . . . 74.549999999999997 110.339 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.429 HG21 ' CD2' ' A' ' 80' ' ' TRP . 30.4 m -114.0 116.95 54.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.865 -1.161 . . . . 74.209999999999994 107.865 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 62.16 26.82 16.13 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.201 -0.909 . . . . 72.200000000000003 109.9 -175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.54 26.04 0.9 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.324 1.85 . . . . 61.530000000000001 111.309 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -122.34 130.7 24.58 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.698 -0.683 . . . . 71.239999999999995 109.638 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.83 125.8 10.22 Favored 'Trans proline' 0 C--O 1.24 0.589 0 C-N-CA 122.83 2.353 . . . . 53.420000000000002 113.372 -177.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.432 HG21 ' HB2' ' A' ' 80' ' ' TRP . 28.0 m -142.63 166.43 15.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.004 -0.739 . . . . 74.329999999999998 109.004 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -106.41 -30.43 9.12 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.346 -0.388 . . . . 40.43 110.856 174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.95 146.69 49.36 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.805 -0.813 . . . . 64.409999999999997 108.805 175.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.432 ' HB2' HG21 ' A' ' 77' ' ' VAL . 74.0 t-105 -157.06 148.96 22.62 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 75.040000000000006 109.727 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -99.99 105.2 16.86 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 108.028 -1.101 . . . . 71.099999999999994 108.028 174.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 87.9 mt -56.66 131.02 47.79 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 116.044 -0.525 . . . . 73.010000000000005 111.932 -176.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.22 163.23 18.86 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 108.611 -0.885 . . . . 65.040000000000006 108.611 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.27 123.58 20.34 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.047 0.451 . . . . 75.510000000000005 109.786 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.4 -8.69 44.62 Favored Glycine 0 N--CA 1.428 -1.87 0 CA-C-N 115.93 -0.577 . . . . 64.129999999999995 112.48 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.98 133.27 47.09 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 117.11 0.455 . . . . 71.319999999999993 111.321 -178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.2 t -103.5 113.55 40.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.89 -0.781 . . . . 74.239999999999995 108.89 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.49 118.63 43.23 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.903 0 N-CA-C 107.049 -1.463 . . . . 75.230000000000004 107.049 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.467 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 60.6 mtp180 -118.66 129.87 55.54 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.492 0.663 . . . . 62.539999999999999 111.863 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -124.7 164.87 19.0 Favored 'General case' 0 C--N 1.264 -3.146 0 N-CA-C 106.231 -1.766 . . . . 74.25 106.231 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.21 108.41 0.16 Allowed Glycine 0 CA--C 1.529 0.908 0 O-C-N 123.719 0.637 . . . . 71.450000000000003 113.107 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 77.81 -35.79 0.21 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.959 1.703 . . . . 61.420000000000002 113.152 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.6 m -100.0 130.33 46.15 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.9 -0.5 . . . . 55.310000000000002 111.059 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.78 147.63 49.98 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 121.002 0.43 . . . . 63.329999999999998 111.033 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.484 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -138.7 137.71 42.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 CA-C-N 115.705 -0.68 . . . . 73.109999999999999 110.927 -175.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.91 125.86 64.43 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 108.604 -0.888 . . . . 70.329999999999998 108.604 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 75.7 t -87.67 121.68 38.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 110.82 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -121.24 143.04 49.36 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.697 -0.483 . . . . 72.140000000000001 109.697 175.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.5 mtt -119.05 140.04 50.72 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.048 -0.524 . . . . 65.219999999999999 109.928 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 . . . . . 0 C--N 1.287 -2.112 0 N-CA-C 107.772 -1.196 . . . . 63.399999999999999 107.772 177.136 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.187 0 N-CA-C 109.888 -1.285 . . . . 50.509999999999998 109.888 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -111.77 157.18 20.84 Favored 'General case' 0 C--O 1.251 1.151 0 N-CA-C 108.052 -1.092 . . . . 72.540000000000006 108.052 176.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 175.61 179.21 46.0 Favored Glycine 0 N--CA 1.413 -2.882 0 N-CA-C 110.456 -1.058 . . . . 34.340000000000003 110.456 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 m -85.73 152.04 23.38 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.163 -0.68 . . . . 64.030000000000001 109.163 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.67 -16.48 55.66 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.231 -1.025 . . . . 64.129999999999995 108.231 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.5 -37.54 3.77 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 109.592 -1.403 . . . . 44.310000000000002 109.592 177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 91.6 m -146.78 134.83 21.5 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 106.273 -1.751 . . . . 64.120000000000005 106.273 177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.442 ' HB3' ' NE2' ' A' ' 22' ' ' GLN . 18.7 m -107.17 114.29 28.25 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.108 -1.071 . . . . 74.219999999999999 108.108 176.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.508 HG13 ' HB2' ' A' ' 23' ' ' LEU . 4.3 p -98.43 124.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.522 0.677 . . . . 72.420000000000002 109.708 -177.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -128.7 130.17 46.78 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-N 115.521 -0.763 . . . . 73.409999999999997 109.817 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.41 136.39 33.01 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.449 -0.574 . . . . 73.310000000000002 109.449 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -122.74 134.03 54.46 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 123.572 0.749 . . . . 63.420000000000002 110.76 -174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.44 ' HB3' HD12 ' A' ' 95' ' ' ILE . 2.5 pp -148.28 146.63 28.69 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 106.567 -1.642 . . . . 73.239999999999995 106.567 175.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -105.67 118.55 36.88 Favored 'General case' 0 C--N 1.281 -2.4 0 C-N-CA 119.043 -1.063 . . . . 72.439999999999998 111.326 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -113.89 6.65 16.71 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-N 114.286 -1.325 . . . . 63.119999999999997 108.808 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.14 33.41 0.79 Allowed Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.724 -0.751 . . . . 71.439999999999998 112.611 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 p 176.85 -39.41 0.01 OUTLIER 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.975 0.91 . . . . 72.420000000000002 110.339 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 110.98 93.72 2.21 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.867 -1.293 . . . . 73.329999999999998 109.867 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 29.7 mmt180 -88.47 149.01 23.89 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 108.103 -1.073 . . . . 74.310000000000002 108.103 -178.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 24.1 p -146.35 132.33 19.2 Favored 'General case' 0 C--N 1.288 -2.079 0 O-C-N 123.821 0.701 . . . . 73.140000000000001 111.088 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.415 ' HB3' HD11 ' A' ' 11' ' ' LEU . 55.4 t80 -129.51 124.68 34.55 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.169 -1.419 . . . . 72.530000000000001 107.169 178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.442 ' NE2' ' HB3' ' A' ' 8' ' ' SER . 35.6 tt0 -93.11 131.52 38.08 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 120.993 0.425 . . . . 74.030000000000001 110.686 -177.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB2' HG13 ' A' ' 9' ' ' VAL . 88.1 mt -77.08 140.08 40.18 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.229 -0.896 . . . . 52.420000000000002 108.854 179.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 24' ' ' ARG . 2.8 mpt_? -109.25 169.96 8.36 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.664 -1.236 . . . . 73.329999999999998 107.664 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.16 130.97 46.9 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-O 121.637 0.732 . . . . 75.420000000000002 111.666 -177.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 121.79 -170.54 14.92 Favored Glycine 0 N--CA 1.426 -1.977 0 N-CA-C 108.519 -1.833 . . . . 70.319999999999993 108.519 -176.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.0 p -99.61 129.57 45.77 Favored 'General case' 0 N--CA 1.417 -2.115 0 C-N-CA 118.727 -1.189 . . . . 74.319999999999993 110.441 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -108.27 109.7 21.11 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.584 -1.265 . . . . 75.030000000000001 107.584 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.34 131.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.382 -0.827 . . . . 72.129999999999995 109.502 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.6 mt -108.69 128.21 64.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 109.209 -0.663 . . . . 75.010000000000005 109.209 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 162.99 -171.44 38.77 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 110.795 -0.922 . . . . 63.520000000000003 110.795 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -110.26 107.62 17.45 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 117.607 0.704 . . . . 74.319999999999993 109.91 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.68 177.14 45.41 Favored Glycine 0 N--CA 1.408 -3.172 0 N-CA-C 109.769 -1.332 . . . . 64.25 109.769 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -86.01 -22.99 27.0 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 107.866 -1.161 . . . . 62.439999999999998 107.866 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -76.65 -27.29 55.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 114.864 -1.062 . . . . 71.519999999999996 108.854 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.43 139.59 38.73 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 114.655 -1.157 . . . . 75.140000000000001 110.451 179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -82.09 -45.52 15.11 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.497 0.665 . . . . 74.140000000000001 109.921 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -116.43 129.03 56.0 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.592 -0.892 . . . . 74.549999999999997 108.592 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.656 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -102.19 140.05 36.99 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 115.983 -0.553 . . . . 71.540000000000006 110.584 -178.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 56.5 mt -89.23 147.77 39.16 Favored Pre-proline 0 C--N 1.312 -1.023 0 CA-C-N 116.343 -0.39 . . . . 65.519999999999996 111.038 179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -86.0 8.28 4.59 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 122.948 2.432 . . . . 63.229999999999997 111.042 176.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -116.51 160.22 20.93 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 124.131 0.972 . . . . 62.420000000000002 108.835 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -111.51 -177.86 3.3 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.764 -0.374 . . . . 73.230000000000004 110.316 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 93.0 -11.8 71.31 Favored Glycine 0 CA--C 1.51 -0.229 0 N-CA-C 109.622 -1.391 . . . . 73.400000000000006 109.622 -174.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' CG ' ' A' ' 49' ' ' HIS . 8.3 p -86.35 149.66 4.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 C-N-CA 125.284 1.434 . . . . 71.200000000000003 110.094 -176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -97.4 -174.29 2.89 Favored 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 107.971 -1.122 . . . . 72.519999999999996 107.971 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -74.1 -37.6 64.11 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 107.884 -1.154 . . . . 71.439999999999998 107.884 175.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 62.3 mtp85 -115.47 94.05 4.54 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.504 -1.295 . . . . 75.340000000000003 107.504 174.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.408 ' CG ' HG23 ' A' ' 45' ' ' VAL . 24.0 t60 -105.24 -37.53 6.85 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 114.785 -1.098 . . . . 74.340000000000003 109.503 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 tt -161.45 152.45 18.31 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 108.36 -0.978 . . . . 70.219999999999999 108.36 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -136.28 138.86 42.19 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 121.196 0.522 . . . . 71.299999999999997 109.86 176.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.7 mt -110.61 114.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 108.965 -0.754 . . . . 74.140000000000001 108.965 176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 63.7 ttt180 -90.42 109.54 20.66 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 108.101 -1.074 . . . . 74.019999999999996 108.101 177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -107.71 114.94 29.25 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-N 115.422 -0.808 . . . . 72.140000000000001 110.958 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -123.98 167.75 13.74 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.678 -1.601 . . . . 73.450000000000003 106.678 172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.7 72.79 1.49 Allowed Glycine 0 C--N 1.302 -1.328 0 C-N-CA 121.096 -0.573 . . . . 54.43 114.485 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -168.48 -71.42 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.844 0.858 . . . . 75.219999999999999 108.735 174.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.8 157.09 29.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 108.439 -0.948 . . . . 73.530000000000001 108.439 -179.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -97.83 119.12 35.86 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 109.446 -0.576 . . . . 63.32 109.446 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.2 tt -86.96 110.57 20.12 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.087 -1.079 . . . . 71.349999999999994 108.087 -177.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -90.47 114.62 26.82 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.334 -1.358 . . . . 54.149999999999999 107.334 179.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.99 115.72 24.31 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.935 0.398 . . . . 53.420000000000002 110.685 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.24 136.33 37.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.704 -0.68 . . . . 74.420000000000002 109.473 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -132.97 76.67 1.7 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.17 -1.048 . . . . 74.329999999999998 108.17 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -174.58 146.25 0.99 Allowed 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.883 -0.784 . . . . 72.010000000000005 108.883 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.2 m -102.3 -32.93 9.8 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 112.494 0.553 . . . . 64.109999999999999 112.494 -178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.401 HG23 ' ND2' ' A' ' 68' ' ' ASN . 6.2 t -90.16 -37.69 14.01 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 112.853 0.686 . . . . 74.329999999999998 112.853 -177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.401 ' ND2' HG23 ' A' ' 67' ' ' THR . 48.7 m-80 -107.12 28.37 8.11 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.694 0.798 . . . . 72.230000000000004 110.102 -177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.65 124.42 4.86 Favored Glycine 0 N--CA 1.474 1.209 0 O-C-N 124.471 1.107 . . . . 74.219999999999999 113.616 -176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -67.95 146.24 53.77 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.581 1.152 . . . . 64.299999999999997 113.354 -174.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.0 p -117.06 141.11 48.67 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 115.144 -0.935 . . . . 73.230000000000004 110.332 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.473 HG12 HG13 ' A' ' 88' ' ' ILE . 27.3 m -109.96 116.68 52.88 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 108.073 -1.084 . . . . 74.420000000000002 108.073 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 59.96 29.85 19.39 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.908 0.861 . . . . 71.349999999999994 109.253 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 66.7 t30 78.22 8.47 2.31 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 126.504 1.922 . . . . 75.150000000000006 111.357 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -100.79 122.24 49.82 Favored Pre-proline 0 C--N 1.318 -0.785 0 O-C-N 121.678 -0.639 . . . . 65.420000000000002 109.807 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -69.32 127.01 14.3 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 122.562 2.174 . . . . 71.219999999999999 111.903 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.2 m -144.69 168.26 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 122.488 0.315 . . . . 55.130000000000003 110.275 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.52 -34.58 10.93 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.375 -0.602 . . . . 74.430000000000007 109.375 174.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.9 pt-20 -148.23 153.84 39.27 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.843 -0.617 . . . . 75.219999999999999 109.717 177.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -157.32 151.34 24.62 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.274 -1.009 . . . . 75.120000000000005 108.274 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.281 0.8 OUTLIER -101.06 108.69 20.46 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-O 121.71 0.766 . . . . 74.5 111.192 174.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.486 ' HB3' HG11 ' A' ' 97' ' ' VAL . 86.1 mt -56.97 143.58 37.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.842 -1.072 . . . . 74.510000000000005 112.638 -175.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -133.74 169.55 16.88 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.696 -1.224 . . . . 63.240000000000002 107.696 173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -72.09 112.14 7.91 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.809 -0.441 . . . . 34.43 109.809 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.61 13.61 18.18 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 120.932 -0.652 . . . . 61.439999999999998 113.404 178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -87.25 140.72 29.26 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-N 117.769 0.784 . . . . 73.230000000000004 110.863 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.81 113.36 36.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.9 0 N-CA-C 108.768 -0.827 . . . . 72.019999999999996 108.768 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.473 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.1 107.6 22.96 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 109.125 -0.694 . . . . 75.420000000000002 109.125 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.463 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 39.9 ttm180 -100.06 111.94 24.24 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.49 0.662 . . . . 65.150000000000006 110.95 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.6 pt? -115.82 164.33 14.54 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 114.177 -1.374 . . . . 72.400000000000006 107.445 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -36.68 99.55 0.01 OUTLIER Glycine 0 CA--C 1.535 1.343 0 N-CA-C 115.909 1.123 . . . . 71.400000000000006 115.909 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.9 m80 83.09 -1.32 1.21 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.346 1.858 . . . . 73.329999999999998 115.275 175.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -150.4 138.05 19.84 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.889 -1.124 . . . . 74.140000000000001 111.713 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 89' ' ' ARG . 10.5 pt-20 -110.54 119.66 39.88 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.455 0.645 . . . . 73.109999999999999 109.566 176.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.455 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 10.6 tp -103.6 139.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-N 115.295 -0.866 . . . . 71.129999999999995 109.124 -174.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 45.7 mm -102.88 129.31 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 108.054 -1.091 . . . . 72.25 108.054 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.486 HG11 ' HB3' ' A' ' 82' ' ' LEU . 69.9 t -95.88 120.46 45.29 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.502 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 110.482 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.8 mmm-85 -117.01 150.91 37.83 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 109.313 -0.625 . . . . 70.349999999999994 109.313 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 61.0 mtt -126.44 122.17 34.52 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.711 0.767 . . . . 71.200000000000003 110.521 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.0 m-70 . . . . . 0 C--N 1.285 -2.214 0 N-CA-C 107.661 -1.237 . . . . 71.209999999999994 107.661 -178.0 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.913 0 N-CA-C 111.307 -0.717 . . . . 43.049999999999997 111.307 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -122.56 100.39 6.9 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.459 0.647 . . . . 74.409999999999997 109.904 179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.22 29.49 2.92 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.145 -0.934 . . . . 45.409999999999997 111.304 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.7 m -120.4 157.64 28.87 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.767 -0.827 . . . . 61.340000000000003 108.767 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.21 155.95 39.92 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.272 -0.422 . . . . 75.219999999999999 110.321 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.36 63.59 2.94 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.169 -0.772 . . . . 50.25 111.169 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.3 m -141.7 115.79 9.34 Favored 'General case' 0 N--CA 1.413 -2.316 0 N-CA-C 108.711 -0.848 . . . . 70.209999999999994 108.711 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.0 p -121.71 118.87 30.18 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.454 -1.313 . . . . 75.299999999999997 107.454 171.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG13 HD12 ' A' ' 23' ' ' LEU . 3.3 p -96.64 123.19 48.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-O 122.201 1.001 . . . . 72.329999999999998 111.329 -173.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 19.7 m -118.21 129.5 55.53 Favored 'General case' 0 N--CA 1.402 -2.87 0 CA-C-N 114.179 -1.373 . . . . 60.32 108.277 -176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -92.61 130.0 38.38 Favored 'General case' 0 N--CA 1.406 -2.656 0 N-CA-C 108.373 -0.973 . . . . 51.399999999999999 108.373 176.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -101.11 114.98 29.42 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.397 -1.334 . . . . 72.519999999999996 107.397 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -111.36 124.9 53.19 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.163 -1.051 . . . . 72.340000000000003 108.163 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -103.57 101.44 11.31 Favored 'General case' 0 N--CA 1.408 -2.546 0 C-N-CA 117.081 -1.848 . . . . 72.030000000000001 111.959 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -83.24 -15.32 50.79 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 113.735 -1.575 . . . . 64.400000000000006 108.594 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 120.44 42.05 0.51 Allowed Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 107.362 -2.295 . . . . 73.030000000000001 107.362 -171.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.2 m -164.4 -25.85 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 114.725 -0.738 . . . . 64.120000000000005 111.794 -171.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.13 70.21 1.29 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 120.388 -0.91 . . . . 74.010000000000005 110.924 -172.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -92.64 161.4 14.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 109.695 -0.483 . . . . 44.140000000000001 109.695 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.6 p -138.6 135.25 34.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.093 0.473 . . . . 61.020000000000003 110.507 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -130.76 117.2 19.05 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.141 -1.059 . . . . 64.129999999999995 108.141 175.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 32.5 tt0 -88.44 128.35 35.53 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 120.093 -0.643 . . . . 73.209999999999994 110.072 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.417 HD12 HG13 ' A' ' 9' ' ' VAL . 91.2 mt -64.88 136.83 57.3 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.124 -0.944 . . . . 62.229999999999997 112.064 -174.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -93.23 163.39 13.64 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.387 -1.279 . . . . 72.430000000000007 109.266 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -63.82 126.95 29.29 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 123.821 0.7 . . . . 71.510000000000005 111.156 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.42 -161.75 15.27 Favored Glycine 0 N--CA 1.431 -1.657 0 N-CA-C 110.938 -0.865 . . . . 44.240000000000002 110.938 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 67.8 p -93.99 126.0 38.94 Favored 'General case' 0 N--CA 1.418 -2.043 0 C-N-CA 119.381 -0.927 . . . . 71.209999999999994 111.81 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 0.6 OUTLIER -98.6 129.94 45.13 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 105.954 -1.869 . . . . 63.329999999999998 105.954 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.5 mm -106.72 137.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 112.187 0.44 . . . . 73.239999999999995 112.187 -171.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.3 mt -114.01 136.39 50.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 107.76 -1.2 . . . . 52.25 107.76 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.74 -152.15 24.14 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.068 -1.213 . . . . 65.209999999999994 110.068 177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.706 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 76.5 mtt180 -131.91 106.46 8.08 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 118.216 1.008 . . . . 63.130000000000003 108.617 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.42 ' H ' ' HB3' ' A' ' 36' ' ' ALA . . . 175.92 -168.1 40.19 Favored Glycine 0 N--CA 1.416 -2.651 0 C-N-CA 119.739 -1.22 . . . . 71.239999999999995 111.974 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -63.6 -43.69 96.19 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.511 0.725 . . . . 72.040000000000006 109.914 177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -67.25 -37.02 82.82 Favored 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 114.714 -1.13 . . . . 53.520000000000003 110.578 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' HB3' ' H ' ' A' ' 33' ' ' GLY . . . -72.54 105.49 4.22 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 114.288 1.218 . . . . 74.230000000000004 114.288 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 44.5 mt-30 -77.14 -47.77 19.5 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 113.814 -1.539 . . . . 74.049999999999997 107.076 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -95.24 115.45 27.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 106.788 -1.56 . . . . 74.319999999999993 106.788 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 99.2 mtt180 -109.45 137.38 47.4 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 120.78 0.324 . . . . 74.109999999999999 111.602 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 72.7 mt -90.65 134.5 30.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.773 -0.648 . . . . 73.409999999999997 111.964 -178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 18.3 Cg_exo -71.29 -19.74 28.83 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.35 2.7 . . . . 71.239999999999995 113.593 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -89.11 178.5 6.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 122.221 -0.299 . . . . 75.040000000000006 111.713 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 85.2 m -109.55 168.15 9.61 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 108.328 -0.989 . . . . 75.010000000000005 108.328 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.5 9.45 53.03 Favored Glycine 0 CA--C 1.499 -0.955 0 N-CA-C 108.408 -1.877 . . . . 63.219999999999999 108.408 -174.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.604 HG23 ' HB2' ' A' ' 49' ' ' HIS . 7.4 p -118.3 120.74 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.37 0 CA-C-N 113.326 -1.437 . . . . 73.310000000000002 109.744 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.6 m -82.15 -170.0 2.67 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.279 -0.638 . . . . 74.319999999999993 109.279 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 40.6 ptt180 -65.2 -28.12 69.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 119.928 -0.709 . . . . 73.319999999999993 111.436 178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 48' ' ' ARG . 23.5 mtm180 -131.96 118.94 20.43 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 108.352 -0.981 . . . . 75.519999999999996 108.352 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.604 ' HB2' HG23 ' A' ' 45' ' ' VAL . 30.6 t60 -103.85 -31.03 9.99 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 124.43 1.092 . . . . 72.129999999999995 108.795 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 HD21 ' A' ' 61' ' ' LEU . 9.3 tt -167.31 147.46 5.37 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 108.904 -0.776 . . . . 73.109999999999999 108.904 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -130.12 136.88 49.79 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 123.857 0.723 . . . . 74.0 110.112 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' SER . 64.9 mt -115.51 110.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 N-CA-C 108.036 -1.098 . . . . 44.130000000000003 108.036 175.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 41.8 ttm105 -91.32 106.97 18.88 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-O 121.689 0.757 . . . . 75.140000000000001 109.03 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.5 t-105 -97.17 107.06 19.5 Favored 'General case' 0 N--CA 1.408 -2.561 0 CA-C-N 114.644 -1.162 . . . . 74.109999999999999 110.33 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -107.25 -179.73 4.01 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 105.642 -1.984 . . . . 55.240000000000002 105.642 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.01 3.7 69.63 Favored Glycine 0 C--N 1.308 -1.011 0 C-N-CA 119.931 -1.128 . . . . 44.409999999999997 112.266 -177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -97.07 -75.2 0.55 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 122.893 0.477 . . . . 75.519999999999996 110.554 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.07 160.67 23.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.656 0.782 . . . . 73.439999999999998 109.639 -176.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.467 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.07 104.88 17.41 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.391 -0.966 . . . . 41.520000000000003 108.391 177.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.2 tt -80.51 110.87 16.39 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.623 -1.171 . . . . 63.130000000000003 109.159 -176.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.431 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -92.9 121.74 34.57 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.177 -1.046 . . . . 74.239999999999995 108.177 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.99 112.27 14.47 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.391 -0.596 . . . . 74.549999999999997 109.391 175.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.76 135.98 36.64 Favored 'General case' 0 C--O 1.249 1.067 0 N-CA-C 108.446 -0.946 . . . . 74.129999999999995 108.446 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 23.9 tp -133.83 76.6 1.67 Allowed 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.508 0.67 . . . . 60.409999999999997 109.827 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -163.06 164.21 25.58 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 107.479 -1.304 . . . . 63.310000000000002 107.479 -179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.6 p -106.27 -54.19 2.51 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 120.768 0.318 . . . . 61.509999999999998 111.545 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -89.21 -35.79 16.01 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.685 0.994 . . . . 73.400000000000006 113.685 -171.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.533 ' OD1' ' HA3' ' A' ' 91' ' ' GLY . 64.2 t30 -114.26 27.5 9.44 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 109.044 -0.725 . . . . 61.329999999999998 109.044 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -50.15 136.59 25.35 Favored Glycine 0 C--O 1.245 0.814 0 CA-C-N 114.039 -1.437 . . . . 74.120000000000005 113.713 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 m -77.07 136.27 38.65 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 124.259 1.024 . . . . 53.140000000000001 110.899 -175.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.69 142.06 35.36 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.297 -1.001 . . . . 73.530000000000001 108.297 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 88' ' ' ILE . 29.7 m -117.2 119.24 61.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.682 -0.488 . . . . 41.399999999999999 109.682 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.15 35.76 25.32 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.678 0.791 . . . . 70.209999999999994 110.521 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 65.12 23.18 12.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.279 1.432 . . . . 74.439999999999998 110.11 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.29 122.03 29.03 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 108.901 -0.778 . . . . 73.040000000000006 108.901 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -84.44 124.1 3.12 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 121.039 1.159 . . . . 71.430000000000007 111.797 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.5 m -144.18 179.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.803 -1.184 . . . . 72.109999999999999 107.803 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -104.16 -37.2 7.4 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.056 0.455 . . . . 71.420000000000002 109.799 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -134.04 151.58 51.48 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 109.09 -0.707 . . . . 62.130000000000003 109.09 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -160.8 152.46 19.57 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.902 -1.148 . . . . 74.430000000000007 107.902 -177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . 0.253 4.9 pp0? -109.98 113.06 25.47 Favored 'General case' 0 C--N 1.282 -2.363 0 C-N-CA 119.809 -0.756 . . . . 73.200000000000003 110.162 173.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 75.7 mt -60.89 126.25 26.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.549 -1.205 . . . . 62.009999999999998 112.408 -173.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.12 160.4 22.93 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.508 -0.923 . . . . 72.310000000000002 108.508 173.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.449 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 33.6 t70 -61.82 119.53 8.95 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.201 0.524 . . . . 75.230000000000004 111.193 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.72 0.33 36.7 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 115.633 -0.712 . . . . 73.099999999999994 112.771 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -74.27 138.43 43.6 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 120.27 -0.572 . . . . 71.129999999999995 111.711 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 33.0 t -98.74 113.39 33.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 108.831 -0.803 . . . . 62.229999999999997 108.831 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.469 HG13 HG12 ' A' ' 72' ' ' VAL . 1.7 mp -103.87 116.37 47.52 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 N-CA-C 107.277 -1.379 . . . . 74.019999999999996 107.277 178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -114.51 121.71 44.34 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.709 -0.848 . . . . 64.129999999999995 108.709 -175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -119.69 162.87 18.28 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.441 -0.948 . . . . 72.219999999999999 108.441 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.533 ' HA3' ' OD1' ' A' ' 68' ' ' ASN . . . -76.97 87.13 0.97 Allowed Glycine 0 N--CA 1.439 -1.108 0 C-N-CA 119.038 -1.553 . . . . 70.310000000000002 110.694 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 85.5 t60 168.42 -47.87 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 125.933 1.693 . . . . 64.420000000000002 108.366 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.7 p -168.15 -170.93 1.4 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.625 -0.716 . . . . 54.310000000000002 110.266 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.38 151.15 50.34 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.256 0.551 . . . . 62.009999999999998 109.979 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.447 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -132.95 142.24 42.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 115.056 -0.974 . . . . 72.400000000000006 110.833 -177.124 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.5 mt -110.2 129.48 65.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.533 -0.914 . . . . 73.310000000000002 108.533 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 47.7 t -82.85 124.08 39.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 120.863 0.364 . . . . 71.510000000000005 110.231 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.449 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 12.9 mmm180 -123.66 135.07 53.7 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.576 -0.738 . . . . 64.329999999999998 110.324 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.1 mtt -113.66 124.88 53.37 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.534 0.683 . . . . 54.009999999999998 111.148 179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 . . . . . 0 C--N 1.291 -1.943 0 N-CA-C 107.359 -1.349 . . . . 62.350000000000001 107.359 179.845 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.568 0 N-CA-C 109.785 -1.326 . . . . 43.049999999999997 109.785 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -81.92 149.91 27.99 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 117.375 0.587 . . . . 71.420000000000002 110.407 -179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.54 30.07 11.23 Favored Glycine 0 C--N 1.294 -1.772 0 N-CA-C 109.43 -1.468 . . . . 73.420000000000002 109.43 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 m -60.67 133.22 55.88 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 124.258 1.023 . . . . 73.409999999999997 111.468 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.08 146.5 25.41 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.961 -1.126 . . . . 54.299999999999997 107.961 176.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -144.63 161.36 28.02 Favored Glycine 0 N--CA 1.426 -1.984 0 N-CA-C 109.542 -1.423 . . . . 32.439999999999998 109.542 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 m -129.7 116.27 18.56 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-N 117.391 0.595 . . . . 63.009999999999998 109.934 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.8 p -125.12 139.34 53.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.51 -1.293 . . . . 65.030000000000001 107.51 173.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.433 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -117.13 122.01 69.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 CA-C-O 121.787 0.803 . . . . 61.450000000000003 112.051 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 13.2 m -113.21 131.58 55.83 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 107.954 -1.128 . . . . 75.25 107.954 -177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.474 ' HB2' HD11 ' A' ' 95' ' ' ILE . 4.4 pp -102.95 135.47 44.57 Favored 'General case' 0 N--CA 1.42 -1.974 0 N-CA-C 109.336 -0.616 . . . . 75.510000000000005 109.336 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.623 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 24.1 mt-30 -102.09 119.07 38.2 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.391 -0.368 . . . . 75.129999999999995 110.082 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.8 tp -107.79 135.09 49.79 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 115.644 -0.707 . . . . 54.409999999999997 109.417 -175.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -88.47 99.21 12.11 Favored 'General case' 0 N--CA 1.421 -1.911 0 C-N-CA 118.673 -1.211 . . . . 75.120000000000005 108.63 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 19' ' ' ARG . 36.7 t70 -108.8 38.93 2.13 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.049 -1.834 . . . . 70.319999999999993 106.049 176.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.07 -54.02 4.93 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 114.512 -1.222 . . . . 55.439999999999998 110.881 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.1 p -87.82 -26.81 22.64 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-O 121.715 0.769 . . . . 74.420000000000002 109.916 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.83 96.73 0.93 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 110.048 -1.221 . . . . 74.519999999999996 110.048 -176.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.429 ' HG3' ' HB3' ' A' ' 15' ' ' ASP . 14.7 mtm180 -102.08 165.79 10.96 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.149 -0.686 . . . . 63.100000000000001 109.149 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.497 HG22 ' HG2' ' A' ' 12' ' ' GLN . 38.1 p -128.43 136.95 51.56 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-O 120.733 0.302 . . . . 73.310000000000002 110.474 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.467 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 82.3 t80 -128.36 123.53 34.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.344 -1.354 . . . . 63.140000000000001 107.344 176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.0 tt0 -96.12 133.22 40.66 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 108.964 -0.754 . . . . 73.400000000000006 108.964 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.433 ' HB2' HG13 ' A' ' 9' ' ' VAL . 92.3 mt -73.46 143.58 46.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.824 -0.626 . . . . 73.439999999999998 109.787 -177.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -108.4 152.11 25.12 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 107.512 -1.292 . . . . 75.319999999999993 107.512 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -61.68 126.76 28.49 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 121.538 0.685 . . . . 72.319999999999993 111.423 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 127.24 -169.37 19.11 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 107.254 -2.339 . . . . 53.350000000000001 107.254 -174.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.8 p -106.49 128.75 54.33 Favored 'General case' 0 C--N 1.287 -2.113 0 CA-C-N 118.899 1.349 . . . . 65.150000000000006 110.239 176.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HG3' ' A' ' 37' ' ' GLN . 6.1 p30 -110.34 146.35 35.92 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.104 -0.953 . . . . 64.200000000000003 108.56 -177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.41 HG21 ' HG2' ' A' ' 48' ' ' ARG . 60.4 mt -123.73 135.47 63.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 109.814 -0.439 . . . . 73.310000000000002 109.814 -175.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 64.9 mt -107.5 134.71 48.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.28 -1.007 . . . . 72.230000000000004 108.28 178.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 156.75 -152.02 23.4 Favored Glycine 0 CA--C 1.488 -1.608 0 N-CA-C 108.667 -1.773 . . . . 41.329999999999998 108.667 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.702 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 67.2 mtp180 -135.49 106.88 6.83 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 118.566 1.183 . . . . 73.420000000000002 109.23 175.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.81 171.85 41.67 Favored Glycine 0 C--N 1.291 -1.965 0 N-CA-C 108.497 -1.841 . . . . 62.119999999999997 108.497 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -77.02 -17.05 59.08 Favored 'General case' 0 C--O 1.246 0.902 0 CA-C-N 118.197 0.999 . . . . 74.120000000000005 110.696 -177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -94.05 -4.4 49.53 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.416 -0.811 . . . . 63.240000000000002 110.198 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.27 133.86 34.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.045 -0.525 . . . . 54.240000000000002 109.816 175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' HG3' ' HA ' ' A' ' 28' ' ' ASN . 73.3 mm-40 -81.67 -57.85 3.27 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.748 -0.66 . . . . 63.420000000000002 109.706 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 84.2 t80 -101.31 110.23 22.2 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.825 -1.176 . . . . 70.209999999999994 107.825 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.733 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 90.8 mtt180 -96.52 123.1 40.08 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.548 -0.751 . . . . 74.329999999999998 111.27 -173.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.43 HD12 HG21 ' A' ' 45' ' ' VAL . 55.8 mt -75.98 138.36 69.14 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.716 -0.674 . . . . 74.439999999999998 112.006 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -88.04 38.16 0.48 Allowed 'Trans proline' 0 CA--C 1.547 1.157 0 C-N-CA 123.39 2.726 . . . . 74.25 112.668 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -134.92 173.22 11.95 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.95 -1.13 . . . . 74.310000000000002 107.95 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -122.34 155.87 35.1 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.988 -0.745 . . . . 62.549999999999997 108.988 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.06 -23.86 26.37 Favored Glycine 0 C--N 1.312 -0.775 0 N-CA-C 109.155 -1.578 . . . . 74.200000000000003 109.155 -174.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG21 HD12 ' A' ' 40' ' ' LEU . 7.3 p -81.48 141.16 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.87 -1.165 . . . . 70.439999999999998 109.637 178.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 m -76.3 -177.23 3.96 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.35 -0.841 . . . . 71.549999999999997 111.146 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.702 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.3 ptm180 -65.46 -39.87 92.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.47 0.652 . . . . 74.129999999999995 109.861 174.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.41 ' HG2' HG21 ' A' ' 29' ' ' ILE . 50.6 mtm-85 -126.2 119.85 28.54 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.176 -1.416 . . . . 73.510000000000005 107.176 174.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.404 ' HB2' HG23 ' A' ' 45' ' ' VAL . 49.6 t60 -105.33 -35.94 7.36 Favored 'General case' 0 C--N 1.295 -1.766 0 C-N-CA 124.757 1.223 . . . . 51.530000000000001 109.641 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.491 HD11 HD21 ' A' ' 61' ' ' LEU . 9.1 tt -166.05 151.15 8.44 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 108.293 -1.003 . . . . 62.240000000000002 108.293 -175.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -136.26 141.77 43.92 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 121.043 0.449 . . . . 61.219999999999999 110.323 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 70.0 mt -120.69 118.72 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 115.666 -0.697 . . . . 71.200000000000003 109.469 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.7 ttt180 -91.57 111.06 22.41 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.505 -1.295 . . . . 75.219999999999999 107.505 175.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -106.22 126.52 52.32 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 121.411 0.624 . . . . 73.109999999999999 109.793 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -139.0 172.42 12.87 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.422 -2.066 . . . . 71.340000000000003 105.422 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -76.7 69.32 2.39 Favored Glycine 0 C--N 1.31 -0.905 0 C-N-CA 120.761 -0.733 . . . . 53.439999999999998 112.311 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.425 HE21 HG22 ' A' ' 58' ' ' VAL . 25.4 tt0 -162.88 -76.57 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 108.46 -0.941 . . . . 74.030000000000001 108.46 177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.425 HG22 HE21 ' A' ' 57' ' ' GLN . 30.8 m -143.17 159.5 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.779 -0.823 . . . . 64.299999999999997 108.779 -179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.429 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -94.59 115.1 27.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.118 -0.697 . . . . 52.140000000000001 109.118 178.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.499 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 56.6 tp -85.64 110.44 19.28 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.351 -0.84 . . . . 61.210000000000001 111.212 -176.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.491 HD21 HD11 ' A' ' 50' ' ' LEU . 2.4 tm? -89.6 128.25 36.01 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.237 -1.023 . . . . 71.319999999999993 108.237 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -136.12 122.65 20.82 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.103 -0.703 . . . . 64.109999999999999 109.103 175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -91.27 129.68 37.24 Favored 'General case' 0 C--N 1.31 -1.142 0 O-C-N 123.625 0.578 . . . . 64.340000000000003 110.069 -177.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.5 tp -134.49 75.26 1.57 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.44 -0.345 . . . . 62.32 110.477 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 46.8 t30 169.53 107.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.784 0.833 . . . . 72.140000000000001 109.679 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.9 t -78.53 -22.24 47.6 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.342 -0.39 . . . . 64.140000000000001 110.735 -176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 29.3 m -65.02 -45.82 83.9 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-O 121.109 0.481 . . . . 74.420000000000002 111.907 -178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -118.95 28.33 8.34 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.139 -0.689 . . . . 73.120000000000005 109.139 -174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.14 129.63 4.53 Favored Glycine 0 C--O 1.258 1.649 0 O-C-N 124.838 1.336 . . . . 70.439999999999998 115.045 -169.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -80.0 145.79 32.36 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 113.926 -1.137 . . . . 70.439999999999998 112.466 -172.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -121.29 142.53 49.86 Favored 'General case' 0 N--CA 1.427 -1.621 0 CA-C-N 115.308 -0.86 . . . . 43.109999999999999 110.542 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 80' ' ' TRP . 35.6 m -117.53 119.46 61.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.684 -1.599 . . . . 73.109999999999999 106.684 175.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 62.24 24.58 14.64 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.035 0.934 . . . . 63.210000000000001 108.652 -174.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 77.91 6.39 2.74 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.551 1.54 . . . . 62.0 112.854 -177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.63 118.26 66.15 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 74.019999999999996 108.795 176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -70.76 125.28 11.47 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 121.552 1.501 . . . . 71.409999999999997 110.646 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 80' ' ' TRP . 27.8 m -137.29 169.15 19.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.873 -0.788 . . . . 51.119999999999997 108.873 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -107.03 -20.16 13.4 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 120.84 0.353 . . . . 71.0 110.77 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 11.8 pt-20 -152.61 146.41 25.17 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.19 -0.67 . . . . 73.0 109.19 176.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.536 ' CD2' HG21 ' A' ' 72' ' ' VAL . 66.7 t-105 -160.89 152.29 19.19 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.749 -0.834 . . . . 71.319999999999993 108.749 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -104.57 103.11 12.72 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.03 -0.73 . . . . 74.120000000000005 109.03 176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.447 HD22 HD11 ' A' ' 88' ' ' ILE . 58.5 mt -59.52 145.04 45.6 Favored 'General case' 0 C--O 1.246 0.901 0 CA-C-N 114.967 -1.015 . . . . 63.219999999999999 111.414 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.01 169.51 17.67 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.123 -1.066 . . . . 73.299999999999997 108.123 177.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -67.83 119.12 12.0 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 123.346 0.404 . . . . 73.25 110.13 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.9 10.09 53.04 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.703 -0.68 . . . . 54.43 113.522 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -82.06 146.32 29.72 Favored 'General case' 0 C--O 1.255 1.384 0 N-CA-C 107.728 -1.212 . . . . 45.229999999999997 107.728 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.1 t -104.09 112.79 39.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 109.193 -0.669 . . . . 64.409999999999997 109.193 -177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.512 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -105.71 127.58 60.55 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 N-CA-C 107.283 -1.377 . . . . 74.340000000000003 107.283 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 90' ' ' LEU . 2.4 tmm_? -134.56 134.35 41.26 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 108.088 -1.079 . . . . 70.129999999999995 108.088 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 90' ' ' LEU . 2.0 pt? -127.31 162.47 26.18 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 107.476 -1.305 . . . . 74.400000000000006 107.476 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.4 86.98 0.51 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 119.158 -1.496 . . . . 53.100000000000001 111.148 178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 78.0 t60 169.46 -48.79 0.01 OUTLIER 'General case' 0 C--O 1.235 0.342 0 C-N-CA 126.145 1.778 . . . . 71.25 108.781 -178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 36.0 t -164.16 -175.37 3.95 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.938 -0.574 . . . . 71.140000000000001 110.111 -174.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -123.62 145.15 49.15 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.46 -0.941 . . . . 72.129999999999995 108.46 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -136.64 137.1 47.93 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.903 0 CA-C-O 121.687 0.756 . . . . 75.400000000000006 111.843 -176.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 50.9 mt -107.62 131.65 57.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 108.488 -0.93 . . . . 73.040000000000006 108.488 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 44.6 t -97.87 121.19 48.14 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-O 120.622 0.249 . . . . 63.32 110.665 176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -127.28 140.95 51.86 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 116.402 -0.363 . . . . 72.209999999999994 110.597 177.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.8 mtt -113.45 134.28 54.75 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.945 -0.57 . . . . 64.5 109.999 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 C--N 1.289 -2.038 0 N-CA-C 106.962 -1.496 . . . . 72.239999999999995 106.962 -177.012 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.146 0 N-CA-C 110.479 -1.049 . . . . 64.420000000000002 110.479 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.3 m170 64.99 84.49 0.15 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.393 1.077 . . . . 64.109999999999999 110.754 -176.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.07 -99.51 1.55 Allowed Glycine 0 N--CA 1.435 -1.394 0 CA-C-N 115.412 -0.813 . . . . 70.510000000000005 111.711 -179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.657 ' HA ' ' OG ' ' A' ' 8' ' ' SER . 31.8 m -74.27 -41.11 61.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 113.075 0.769 . . . . 55.409999999999997 113.075 -176.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.38 34.14 20.69 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 108.148 -1.056 . . . . 51.039999999999999 108.148 -174.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.63 -94.75 0.75 Allowed Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.165 -1.574 . . . . 50.340000000000003 109.165 -174.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 96.0 m -119.98 124.96 47.22 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 117.131 0.466 . . . . 75.329999999999998 109.743 176.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.657 ' OG ' ' HA ' ' A' ' 4' ' ' SER . 15.2 m -85.07 115.11 22.69 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 107.616 -1.253 . . . . 72.329999999999998 107.616 174.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.1 t -98.44 106.85 19.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.1 0 N-CA-C 105.846 -1.909 . . . . 71.420000000000002 105.846 174.119 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.6 m -113.97 119.36 36.95 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.496 -0.775 . . . . 53.5 109.216 -173.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.531 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 3.2 pp -91.72 130.7 37.46 Favored 'General case' 0 N--CA 1.408 -2.527 0 CA-C-N 115.523 -0.762 . . . . 75.129999999999995 110.805 178.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -106.69 119.63 39.84 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 114.275 -1.33 . . . . 73.299999999999997 107.579 -175.185 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -107.5 116.91 32.78 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 109.508 -0.553 . . . . 61.210000000000001 109.508 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -87.98 99.52 12.21 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.642 -1.614 . . . . 60.100000000000001 106.642 176.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -115.06 -19.06 11.04 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.309 -1.314 . . . . 62.439999999999998 109.868 -177.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.53 -13.2 4.85 Favored Glycine 0 N--CA 1.425 -2.1 0 N-CA-C 110.757 -0.937 . . . . 63.009999999999998 110.757 -175.205 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.2 t -122.29 -33.88 3.4 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 109.321 -0.622 . . . . 43.340000000000003 109.321 175.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.03 79.13 1.38 Allowed Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 108.463 -1.855 . . . . 70.209999999999994 108.463 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -89.51 145.46 25.27 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.883 -0.414 . . . . 55.5 109.883 -176.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 30.3 p -134.16 135.29 43.0 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-O 121.102 0.477 . . . . 64.120000000000005 111.211 -176.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.425 ' HB3' HD11 ' A' ' 11' ' ' LEU . 46.4 t80 -139.03 120.42 14.91 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.75 -0.659 . . . . 74.439999999999998 110.69 178.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -83.46 127.23 33.53 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.523 -0.917 . . . . 73.109999999999999 108.523 176.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.78 149.33 50.7 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 116.05 -0.523 . . . . 74.109999999999999 111.019 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -102.64 162.38 12.97 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.199 -1.408 . . . . 70.349999999999994 107.199 173.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -69.88 145.66 51.84 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 109.215 -0.661 . . . . 72.239999999999995 109.215 177.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 105.51 -168.2 15.25 Favored Glycine 0 N--CA 1.412 -2.936 0 N-CA-C 106.887 -2.485 . . . . 64.439999999999998 106.887 -174.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 30.0 p -103.03 130.95 50.32 Favored 'General case' 0 C--N 1.27 -2.853 0 C-N-CA 118.499 -1.28 . . . . 72.310000000000002 111.519 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.523 ' N ' HD22 ' A' ' 28' ' ' ASN . 0.5 OUTLIER -102.35 110.42 22.36 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.843 -1.91 . . . . 75.040000000000006 105.843 -179.009 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.2 mt -97.86 132.4 42.79 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-O 120.929 0.395 . . . . 33.25 111.538 -173.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.0 mt -110.44 133.69 55.05 Favored 'Isoleucine or valine' 0 C--O 1.255 1.354 0 C-N-CA 123.846 0.858 . . . . 75.109999999999999 109.601 179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.481 ' HA2' ' CG2' ' A' ' 45' ' ' VAL . . . 151.54 -173.75 30.82 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.686 -0.966 . . . . 43.43 110.686 177.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.687 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 97.5 mtt180 -118.19 104.23 10.6 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.119 -1.437 . . . . 74.109999999999999 107.119 175.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.6 -176.93 48.05 Favored Glycine 0 N--CA 1.42 -2.427 0 N-CA-C 111.401 -0.68 . . . . 72.120000000000005 111.401 -175.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HG3' ' N ' ' A' ' 35' ' ' ASP . 10.4 pt20 -58.74 -49.6 77.02 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 124.016 0.926 . . . . 71.040000000000006 113.135 -176.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 13.5 m-20 -81.8 -19.87 40.29 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.203 0.525 . . . . 61.299999999999997 111.016 -172.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.62 145.5 45.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.572 -0.74 . . . . 75.239999999999995 112.12 -174.785 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -106.81 -55.84 2.27 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 115.014 -0.994 . . . . 74.540000000000006 108.667 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -95.0 125.37 39.62 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 114.809 -1.087 . . . . 74.010000000000005 109.872 -177.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -97.7 144.59 27.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.344 -0.984 . . . . 72.439999999999998 108.344 -179.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 58.2 mt -94.56 131.16 31.47 Favored Pre-proline 0 C--N 1.31 -1.123 0 N-CA-C 109.489 -0.56 . . . . 65.439999999999998 109.489 173.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 21.2 Cg_exo -67.54 -26.48 40.12 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.112 2.542 . . . . 53.399999999999999 112.605 -178.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -92.14 168.38 11.4 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.349 -0.387 . . . . 51.32 110.633 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 t -84.68 -177.05 6.49 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.021 -0.733 . . . . 74.239999999999995 109.021 178.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.91 66.9 Favored Glycine 0 CA--C 1.497 -1.039 0 N-CA-C 111.138 -0.785 . . . . 71.530000000000001 111.138 -179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.481 ' CG2' ' HA2' ' A' ' 31' ' ' GLY . 11.1 p -90.15 144.18 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 CA-C-N 114.284 -0.958 . . . . 73.219999999999999 109.356 -179.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.7 m -102.38 -174.07 2.48 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.861 -0.422 . . . . 75.209999999999994 109.861 178.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 36.1 ptt180 -64.43 -41.6 96.5 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.891 0.853 . . . . 72.439999999999998 110.269 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -129.26 107.75 9.79 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 104.012 -2.588 . . . . 73.209999999999994 104.012 172.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -101.35 -37.36 8.51 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.935 0.772 . . . . 72.420000000000002 109.145 -176.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.489 HD11 HD21 ' A' ' 61' ' ' LEU . 7.5 tt -165.09 147.97 8.22 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.996 -0.547 . . . . 53.049999999999997 109.896 -177.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HG2' HD21 ' A' ' 64' ' ' LEU . 11.8 pt-20 -133.27 132.45 41.42 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 109.491 -0.559 . . . . 71.129999999999995 109.491 176.105 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 27' ' ' SER . 66.5 mt -106.76 113.62 43.77 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 108.843 -0.799 . . . . 74.140000000000001 108.843 176.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 29.9 ttt180 -91.25 111.43 22.91 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.482 0.658 . . . . 71.349999999999994 109.541 177.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -104.4 127.45 52.08 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.47 -0.786 . . . . 75.420000000000002 110.567 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -132.14 172.73 12.03 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 105.531 -2.026 . . . . 74.219999999999999 105.531 176.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.67 53.09 3.97 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 120.684 -0.769 . . . . 74.439999999999998 111.681 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -140.79 -80.48 0.26 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 124.728 1.211 . . . . 71.510000000000005 107.784 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.1 m -148.34 160.21 6.84 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 C-N-CA 125.326 1.45 . . . . 65.219999999999999 107.1 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.462 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -91.24 115.49 28.06 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.47 0.652 . . . . 63.340000000000003 109.604 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.6 tp -85.17 114.12 22.05 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.07 -0.968 . . . . 73.510000000000005 110.5 -177.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.489 HD21 HD11 ' A' ' 50' ' ' LEU . 2.5 tm? -92.11 113.49 25.77 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 107.641 -1.244 . . . . 74.430000000000007 107.641 -179.027 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.75 121.14 39.39 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.826 -0.435 . . . . 64.400000000000006 109.826 178.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -91.48 133.0 35.87 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.627 -0.715 . . . . 74.5 111.43 -177.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.457 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.2 mm? -123.55 76.12 1.39 Allowed 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.645 -0.872 . . . . 51.329999999999998 108.645 173.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -173.7 112.14 0.19 Allowed 'General case' 0 C--O 1.209 -1.062 0 N-CA-C 109.048 -0.723 . . . . 75.230000000000004 109.048 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 p -84.31 -17.67 38.83 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.322 0.49 . . . . 62.340000000000003 112.322 -178.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.6 m -89.19 -55.93 3.47 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.424 0.63 . . . . 61.420000000000002 111.084 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -110.5 29.57 7.59 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 123.659 0.784 . . . . 75.409999999999997 109.905 -174.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -43.48 141.49 2.5 Favored Glycine 0 C--O 1.258 1.632 0 O-C-N 125.018 1.449 . . . . 73.450000000000003 115.745 -175.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.2 m -65.29 135.36 55.25 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 113.466 -1.367 . . . . 72.310000000000002 112.463 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 75' ' ' ALA . 1.3 m -113.37 139.84 48.54 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 106.594 -1.632 . . . . 74.200000000000003 106.594 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.48 HG12 HG13 ' A' ' 88' ' ' ILE . 29.2 m -120.26 121.24 65.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 109.228 -0.656 . . . . 71.430000000000007 109.228 -179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 58.35 29.88 18.79 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.829 0.824 . . . . 72.150000000000006 110.319 -179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.1 t30 76.9 23.78 0.96 Allowed 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 126.07 1.748 . . . . 74.439999999999998 111.05 179.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' N ' HG22 ' A' ' 71' ' ' THR . . . -125.82 118.04 24.21 Favored Pre-proline 0 C--N 1.325 -0.482 0 O-C-N 121.752 -0.593 . . . . 73.219999999999999 110.144 177.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.86 133.4 31.29 Favored 'Trans proline' 0 C--O 1.247 0.956 0 C-N-CA 122.566 2.177 . . . . 74.120000000000005 112.177 -178.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 m -144.23 169.14 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.935 -0.575 . . . . 50.130000000000003 110.199 -177.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -102.81 -21.47 14.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.387 -0.968 . . . . 60.229999999999997 108.387 174.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -157.78 155.63 30.14 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 108.254 -1.017 . . . . 74.010000000000005 108.254 -178.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.407 ' CD2' HG21 ' A' ' 72' ' ' VAL . 71.2 t-105 -161.0 151.99 18.63 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.741 -0.837 . . . . 72.120000000000005 108.741 -178.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.97 103.46 14.09 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.764 -0.828 . . . . 71.040000000000006 108.764 176.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 89.8 mt -57.6 139.99 52.16 Favored 'General case' 0 C--O 1.245 0.842 0 N-CA-C 112.93 0.715 . . . . 61.32 112.93 -176.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.9 166.6 23.25 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.814 -1.18 . . . . 63.020000000000003 107.814 173.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.15 118.78 9.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.872 0.368 . . . . 72.120000000000005 110.854 -179.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.76 12.15 35.71 Favored Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 121.004 -0.617 . . . . 43.25 113.134 177.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -87.1 136.51 32.9 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.909 -0.716 . . . . 74.230000000000004 109.874 177.249 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.7 t -100.33 113.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 109.074 -0.713 . . . . 73.239999999999995 109.074 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.48 HG13 HG12 ' A' ' 72' ' ' VAL . 1.8 mp -102.71 111.95 34.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.972 -0.751 . . . . 73.329999999999998 108.972 -178.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -107.63 119.96 40.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 115.627 -0.715 . . . . 71.310000000000002 110.104 -178.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 90' ' ' LEU . 1.6 pt? -125.27 164.3 20.65 Favored 'General case' 0 C--N 1.28 -2.437 0 CA-C-N 115.405 -0.816 . . . . 74.530000000000001 108.942 -176.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -44.75 112.06 0.62 Allowed Glycine 0 CA--C 1.529 0.938 0 O-C-N 123.574 0.546 . . . . 52.229999999999997 113.315 178.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 71.7 6.67 5.74 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.399 1.479 . . . . 74.099999999999994 114.834 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.7 t -149.2 163.35 37.88 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 119.794 -0.762 . . . . 44.109999999999999 111.241 -177.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -146.88 126.36 13.22 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.518 -0.919 . . . . 74.430000000000007 108.518 176.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 7.9 tp -124.42 138.04 55.25 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 CA-C-N 115.62 -0.718 . . . . 70.230000000000004 109.071 -173.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -108.8 125.15 65.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 108.859 -0.793 . . . . 71.150000000000006 108.859 -179.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -89.87 121.55 40.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.706 0.288 . . . . 62.119999999999997 111.423 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -120.36 151.22 39.56 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.199 -0.667 . . . . 74.200000000000003 109.199 176.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 63.1 mtt -125.42 145.61 49.98 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.274 0.559 . . . . 70.129999999999995 111.597 -179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 8' ' ' SER . 12.3 m-70 . . . . . 0 C--N 1.298 -1.65 0 N-CA-C 107.932 -1.136 . . . . 75.450000000000003 107.932 178.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.761 0 N-CA-C 111.24 -0.744 . . . . 43.049999999999997 111.24 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -60.31 114.6 3.0 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.85 0.833 . . . . 72.420000000000002 111.765 -178.161 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.15 -20.7 37.4 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.75 -0.738 . . . . 72.150000000000006 111.445 -179.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.1 m -84.24 69.72 10.48 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.426 1.108 . . . . 72.450000000000003 109.592 179.351 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.12 165.74 33.83 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 105.878 -1.897 . . . . 51.219999999999999 105.878 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 141.28 -162.2 26.86 Favored Glycine 0 C--N 1.284 -2.326 0 N-CA-C 109.002 -1.639 . . . . 54.530000000000001 109.002 -177.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.2 m -142.54 119.31 11.16 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 117.059 0.43 . . . . 50.340000000000003 110.457 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.6 m -93.05 115.29 27.97 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 106.966 -1.494 . . . . 72.239999999999995 106.966 174.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.498 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -105.51 120.79 56.82 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.895 0.855 . . . . 72.409999999999997 110.447 -177.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 11.6 m -119.6 137.68 53.7 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 114.864 -1.062 . . . . 61.439999999999998 109.624 -172.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 95' ' ' ILE . 4.5 pp -97.55 136.68 37.61 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.333 -0.618 . . . . 71.5 109.333 178.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 115.87 28.72 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 106.584 -1.635 . . . . 71.319999999999993 106.584 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.4 tp -106.79 134.71 49.53 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.986 -0.552 . . . . 73.5 111.826 -175.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -76.42 99.9 5.03 Favored 'General case' 0 CA--C 1.487 -1.444 0 N-CA-C 106.08 -1.822 . . . . 44.420000000000002 106.08 171.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.437 ' CG ' ' HE ' ' A' ' 19' ' ' ARG . 23.9 t70 -114.78 8.17 16.01 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 113.82 -1.537 . . . . 64.219999999999999 110.206 -176.566 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.82 -48.03 0.99 Allowed Glycine 0 CA--C 1.491 -1.457 0 N-CA-C 109.358 -1.497 . . . . 70.109999999999999 109.358 -176.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.5 m -127.35 -39.57 1.87 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.967 -0.753 . . . . 52.439999999999998 108.967 175.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.97 116.8 1.61 Allowed Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 120.41 -0.9 . . . . 70.129999999999995 111.869 177.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HE ' ' CG ' ' A' ' 15' ' ' ASP . 44.5 mtm105 -118.61 156.73 28.68 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 110.28 -0.267 . . . . 74.129999999999995 110.28 175.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.5 p -126.36 152.88 45.68 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 116.067 -0.515 . . . . 74.430000000000007 110.587 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.401 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 57.3 t80 -148.02 131.58 16.78 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.698 -1.593 . . . . 74.310000000000002 106.698 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 21.0 tt0 -91.94 131.37 37.3 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.917 -0.713 . . . . 74.120000000000005 109.785 -178.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HB2' HG13 ' A' ' 9' ' ' VAL . 96.8 mt -68.51 147.15 52.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.99 -0.744 . . . . 62.130000000000003 108.99 179.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -118.25 150.57 39.22 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 108.801 -0.814 . . . . 74.439999999999998 108.801 -177.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.32 116.97 2.7 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 124.97 1.418 . . . . 73.450000000000003 112.75 -179.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.0 -172.67 20.08 Favored Glycine 0 N--CA 1.418 -2.524 0 N-CA-C 107.585 -2.206 . . . . 74.129999999999995 107.585 -174.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 33.6 p -106.72 134.25 50.16 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 118.487 1.144 . . . . 74.549999999999997 111.175 178.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.43 HD21 HD22 ' A' ' 23' ' ' LEU . 6.1 p30 -106.02 122.13 45.53 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.06 -0.718 . . . . 74.409999999999997 109.06 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.1 mm -88.86 121.42 38.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.358 -0.837 . . . . 64.439999999999998 108.997 -177.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 75.5 mt -103.12 126.12 57.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.725 -0.842 . . . . 74.129999999999995 108.725 178.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 164.41 -159.56 32.49 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 110.282 -1.127 . . . . 22.140000000000001 110.282 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 74.7 mtp180 -129.45 105.36 8.05 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.575 -0.898 . . . . 73.540000000000006 108.575 175.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.52 -164.54 34.31 Favored Glycine 0 N--CA 1.415 -2.717 0 N-CA-C 110.527 -1.029 . . . . 75.099999999999994 110.527 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -79.14 -38.47 35.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.21 -0.663 . . . . 73.109999999999999 109.21 179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.48 -37.03 84.21 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.086 0.954 . . . . 74.310000000000002 109.552 -178.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.96 118.56 7.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 114.137 -1.392 . . . . 51.420000000000002 111.894 -176.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -90.25 -37.47 14.08 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.402 -1.333 . . . . 64.129999999999995 107.402 179.105 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 34.7 t80 -107.1 114.19 28.1 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 105.184 -2.154 . . . . 73.239999999999995 105.184 176.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 92.9 mtt180 -106.9 131.55 53.85 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.939 -0.573 . . . . 63.109999999999999 110.899 -171.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.1 mt -84.94 144.42 41.71 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.554 -0.748 . . . . 71.140000000000001 111.5 -178.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -89.46 5.62 4.71 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.761 2.307 . . . . 74.409999999999997 114.3 -178.468 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -120.66 -176.12 3.17 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.884 -0.726 . . . . 64.439999999999998 109.317 -178.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.2 t -106.3 175.97 5.32 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.7 0.286 . . . . 72.409999999999997 110.758 -174.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.24 6.84 80.88 Favored Glycine 0 CA--C 1.502 -0.725 0 N-CA-C 110.763 -0.935 . . . . 72.319999999999993 110.763 -178.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.461 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 22.5 t -103.69 130.19 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 CA-C-N 114.903 -0.648 . . . . 61.409999999999997 109.915 -175.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -78.64 178.59 7.72 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.032 -0.729 . . . . 61.140000000000001 109.032 177.182 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.548 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 16.9 ptm180 -67.81 -31.16 70.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.702 0.763 . . . . 73.430000000000007 109.791 177.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 29.9 mtp180 -133.71 100.53 4.8 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.166 -2.161 . . . . 74.239999999999995 105.166 172.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -94.71 -38.5 10.78 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.091 -0.707 . . . . 73.040000000000006 109.091 -178.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.93 156.42 19.89 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.892 -1.151 . . . . 70.120000000000005 107.892 -176.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -137.04 147.47 46.2 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 109.027 -0.731 . . . . 70.450000000000003 109.027 176.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.3 mt -116.14 111.29 34.81 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 107.948 -1.13 . . . . 73.310000000000002 107.948 174.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 59.6 ttt180 -91.23 115.48 28.06 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 107.843 -1.169 . . . . 72.219999999999999 107.843 175.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -108.67 106.8 17.01 Favored 'General case' 0 N--CA 1.391 -3.411 0 N-CA-C 108.573 -0.899 . . . . 73.010000000000005 108.573 176.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -113.38 172.42 6.97 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 105.471 -2.048 . . . . 71.420000000000002 105.471 177.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.02 63.15 4.44 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 120.25 -0.976 . . . . 63.350000000000001 112.004 -177.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -162.92 -68.55 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 108.795 -0.817 . . . . 32.409999999999997 108.795 177.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 20.8 m -137.99 157.08 32.04 Favored 'Isoleucine or valine' 0 C--O 1.249 1.075 0 CA-C-N 116.178 -0.465 . . . . 71.329999999999998 109.877 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.31 106.08 18.09 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.479 -0.934 . . . . 74.040000000000006 108.479 178.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.474 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 5.7 tt -90.01 115.15 27.08 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.113 -0.949 . . . . 75.519999999999996 108.987 -174.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -97.2 117.6 31.77 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 106.705 -1.591 . . . . 70.430000000000007 106.705 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.19 121.63 33.32 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.86 -0.422 . . . . 73.019999999999996 109.86 178.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -95.7 128.17 42.35 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 109.117 -0.698 . . . . 74.329999999999998 109.117 -179.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -109.47 77.37 1.05 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 105.681 -1.97 . . . . 74.040000000000006 105.681 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.454 HD21 ' C ' ' A' ' 68' ' ' ASN . 8.4 t30 -178.48 132.26 0.13 Allowed 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.496 -0.482 . . . . 64.439999999999998 110.45 -164.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.9 p -109.21 -53.52 2.64 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 113.188 0.811 . . . . 75.120000000000005 113.188 178.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -71.68 -34.79 69.98 Favored 'General case' 0 CA--C 1.551 0.987 0 N-CA-C 113.458 0.91 . . . . 42.530000000000001 113.458 -173.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.454 ' C ' HD21 ' A' ' 65' ' ' ASN . 5.0 m-20 -107.47 29.27 7.33 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.319 -0.623 . . . . 73.120000000000005 109.319 -176.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -42.27 129.38 4.67 Favored Glycine 0 N--CA 1.472 1.068 0 O-C-N 124.263 0.977 . . . . 72.299999999999997 115.366 -171.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.6 m -74.23 139.0 44.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.503 -0.849 . . . . 71.519999999999996 111.152 -177.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.6 p -103.35 141.26 36.24 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.379 0.609 . . . . 72.030000000000001 111.462 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.442 HG12 HG13 ' A' ' 88' ' ' ILE . 27.0 m -116.98 117.44 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.071 0 N-CA-C 107.376 -1.342 . . . . 74.299999999999997 107.376 174.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 56.55 34.63 24.7 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.696 -0.684 . . . . 72.530000000000001 110.134 -178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.3 t30 86.27 -10.2 0.69 Allowed 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 125.784 1.634 . . . . 64.409999999999997 112.995 178.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.32 124.95 47.26 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 121.745 -0.597 . . . . 73.329999999999998 111.158 -179.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.52 125.42 10.1 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 122.47 2.113 . . . . 73.400000000000006 111.502 178.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.9 m -135.19 172.87 15.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 110.24 -0.281 . . . . 70.25 110.24 -177.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -102.59 -35.22 8.8 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.205 -0.665 . . . . 64.319999999999993 109.205 175.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -150.41 149.72 30.41 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.915 -0.584 . . . . 60.299999999999997 110.008 176.368 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.8 t-105 -159.05 152.56 22.8 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.254 -1.017 . . . . 72.430000000000007 108.254 -173.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -105.41 111.75 24.59 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.659 -0.817 . . . . 75.140000000000001 109.825 174.308 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.7 mt -58.34 134.67 56.79 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.21 -1.359 . . . . 74.329999999999998 112.43 -175.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.32 164.29 16.53 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.617 -0.883 . . . . 75.340000000000003 108.617 172.567 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.417 ' CG ' HH21 ' A' ' 98' ' ' ARG . 26.2 t70 -66.97 114.48 5.8 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.13 0.49 . . . . 74.0 110.864 179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.05 0.55 33.72 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.399 -0.819 . . . . 73.329999999999998 112.567 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -72.01 142.46 49.33 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-N 117.218 0.509 . . . . 72.409999999999997 111.494 178.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.64 113.78 42.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.262 -0.881 . . . . 74.25 108.941 179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.442 HG13 HG12 ' A' ' 72' ' ' VAL . 2.9 mp -110.79 116.61 52.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 108.421 -0.955 . . . . 71.510000000000005 108.421 -179.58 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -117.35 130.78 56.73 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.691 0.758 . . . . 75.400000000000006 110.785 -177.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -131.28 163.98 26.6 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 107.576 -1.268 . . . . 54.509999999999998 107.576 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -43.35 98.47 0.01 OUTLIER Glycine 0 CA--C 1.529 0.961 0 O-C-N 123.959 0.787 . . . . 64.409999999999997 114.865 -177.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 75.02 19.64 2.31 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 125.762 1.625 . . . . 74.349999999999994 114.071 176.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -148.37 138.32 22.39 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 109.613 -0.514 . . . . 70.510000000000005 109.613 176.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -133.62 120.58 20.88 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.607 0.718 . . . . 73.030000000000001 109.862 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 11' ' ' LEU . 9.7 tp -116.04 140.83 36.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 114.961 -1.018 . . . . 62.25 110.178 -172.252 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.6 mm -110.15 138.13 39.31 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 108.5 -0.926 . . . . 74.409999999999997 108.5 177.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.1 t -100.55 124.44 54.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-O 120.886 0.374 . . . . 75.120000000000005 110.993 -179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.417 HH21 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -121.19 139.6 53.15 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.683 -0.858 . . . . 71.209999999999994 108.683 177.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 62.4 mtt -123.27 138.33 54.65 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 120.855 0.36 . . . . 73.519999999999996 110.622 179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.7 m-70 . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 108.488 -0.93 . . . . 73.409999999999997 108.488 -178.401 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.633 0 N-CA-C 111.509 -0.637 . . . . 62.149999999999999 111.509 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -82.02 95.42 7.42 Favored 'General case' 0 CA--C 1.51 -0.58 0 CA-C-O 121.071 0.463 . . . . 73.209999999999994 110.985 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.25 -175.32 41.75 Favored Glycine 0 N--CA 1.422 -2.246 0 N-CA-C 108.959 -1.656 . . . . 71.230000000000004 108.959 178.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.3 m -86.92 150.46 24.07 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.429 -0.582 . . . . 65.019999999999996 109.429 178.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.32 -30.81 67.89 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.26 0.552 . . . . 33.450000000000003 109.794 179.349 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 123.98 -49.09 0.92 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.757 -0.735 . . . . 30.02 111.919 176.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 m -146.31 124.99 12.52 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.172 -0.677 . . . . 74.430000000000007 109.172 178.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 m -119.66 114.85 22.83 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.249 -1.019 . . . . 52.229999999999997 108.249 176.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.79 126.29 48.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.683 -0.858 . . . . 62.140000000000001 108.683 -175.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 46.0 m -131.84 122.85 26.4 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.805 -0.813 . . . . 53.240000000000002 108.805 -175.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.8 pp -88.9 136.39 33.03 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-O 121.207 0.527 . . . . 55.240000000000002 109.999 178.084 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -108.78 109.8 21.03 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 114.815 -1.084 . . . . 75.519999999999996 109.031 -172.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 tp -99.49 105.66 17.6 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.298 -1.001 . . . . 51.509999999999998 108.298 175.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -92.29 100.49 13.07 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.149 -1.021 . . . . 73.450000000000003 108.721 178.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.97 -28.84 12.88 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.276 -0.875 . . . . 71.540000000000006 109.203 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.07 -51.11 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.452 0 CA-C-N 114.852 -1.067 . . . . 61.009999999999998 111.397 179.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 39.7 m -114.38 -2.3 13.29 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.366 -0.491 . . . . 74.349999999999994 111.857 -178.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.91 103.07 1.13 Allowed Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 121.298 -0.477 . . . . 52.210000000000001 113.357 178.164 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -100.73 158.29 16.06 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.664 -0.865 . . . . 73.420000000000002 108.664 173.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.8 p -139.31 141.02 37.72 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 123.49 0.493 . . . . 75.120000000000005 110.182 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -136.06 114.32 11.56 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.523 -0.547 . . . . 73.310000000000002 109.523 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 35.7 tt0 -76.28 134.89 39.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 109.003 -0.74 . . . . 74.409999999999997 109.003 177.55 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 86.8 mt -69.09 136.87 52.92 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.902 -0.59 . . . . 70.230000000000004 110.074 -179.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HG2' ' OD1' ' A' ' 28' ' ' ASN . 9.4 ptp180 -75.37 158.4 32.8 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.287 -1.375 . . . . 74.129999999999995 107.287 175.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -73.54 132.87 43.33 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.287 -1.375 . . . . 72.310000000000002 107.287 171.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.43 -150.19 17.25 Favored Glycine 0 C--N 1.282 -2.45 0 N-CA-C 107.706 -2.157 . . . . 54.009999999999998 107.706 -173.006 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 68.3 p -104.56 139.69 39.07 Favored 'General case' 0 C--N 1.287 -2.12 0 C-N-CA 118.578 -1.249 . . . . 74.25 112.539 -178.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 27.6 m-80 -107.16 110.05 22.03 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 106.172 -1.788 . . . . 60.340000000000003 106.172 176.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -100.47 122.38 52.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 CA-C-N 116.657 -0.247 . . . . 70.349999999999994 111.047 -173.864 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.423 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 78.0 mt -109.51 129.0 65.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.712 -0.848 . . . . 75.109999999999999 108.712 178.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 163.35 179.27 37.7 Favored Glycine 0 CA--C 1.482 -2.004 0 N-CA-C 109.701 -1.36 . . . . 63.130000000000003 109.701 178.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 70.8 mtp180 -112.1 105.37 13.73 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.766 -1.198 . . . . 73.319999999999993 107.766 179.047 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 47' ' ' ARG . . . 176.48 164.76 31.05 Favored Glycine 0 N--CA 1.409 -3.112 0 N-CA-C 109.258 -1.537 . . . . 55.140000000000001 109.258 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.96 -25.72 67.24 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.836 0.318 . . . . 74.439999999999998 111.275 -179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -75.28 -29.04 59.99 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 45.409999999999997 110.405 -178.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 47' ' ' ARG . . . -75.62 153.36 37.32 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.782 -0.645 . . . . 73.209999999999994 112.386 -175.537 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -97.52 -43.61 7.17 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.35 -0.841 . . . . 73.340000000000003 109.633 -178.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 80.1 t80 -117.57 128.07 54.59 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.872 -1.159 . . . . 72.409999999999997 107.872 179.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -109.83 137.42 47.65 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 112.386 0.513 . . . . 72.510000000000005 112.386 -178.541 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 85.6 mt -80.34 142.72 54.86 Favored Pre-proline 0 C--N 1.314 -0.959 0 CA-C-N 115.398 -0.819 . . . . 74.340000000000003 110.751 179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -86.72 35.76 0.47 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.858 2.372 . . . . 71.200000000000003 112.304 -178.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -140.27 -177.52 5.06 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.843 -0.799 . . . . 64.040000000000006 108.843 178.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.9 m -113.94 158.63 20.86 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.124 -0.695 . . . . 73.049999999999997 109.124 -177.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.86 -2.18 44.97 Favored Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.06 -1.216 . . . . 53.409999999999997 110.06 -178.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.1 t -89.67 136.03 24.68 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 CA-C-N 113.936 -1.132 . . . . 73.219999999999999 109.516 -174.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' ARG . 5.2 m -76.13 175.8 8.61 Favored 'General case' 0 C--O 1.247 0.966 0 N-CA-C 108.495 -0.928 . . . . 72.430000000000007 108.495 177.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 12.7 ptp180 -68.42 -29.46 68.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 121.831 0.824 . . . . 75.409999999999997 109.055 174.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' SER . 75.2 mtm180 -128.39 103.38 7.12 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 104.015 -2.587 . . . . 74.530000000000001 104.015 168.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -91.85 -33.36 14.97 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.356 -0.609 . . . . 75.230000000000004 109.356 -177.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.437 HD11 HD21 ' A' ' 61' ' ' LEU . 7.2 tt -162.8 147.3 11.65 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 109.15 -0.685 . . . . 62.229999999999997 109.15 -178.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -129.23 143.86 51.01 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.425 0.631 . . . . 75.319999999999993 109.995 175.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -113.36 106.14 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.435 0 N-CA-C 107.454 -1.313 . . . . 51.100000000000001 107.454 172.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -92.06 107.91 19.56 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.869 -1.16 . . . . 51.329999999999998 107.869 -179.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -108.33 126.33 52.72 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.082 -0.963 . . . . 74.109999999999999 111.575 -174.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -136.68 155.19 50.2 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 105.551 -2.018 . . . . 63.549999999999997 105.551 176.482 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.83 55.43 1.74 Allowed Glycine 0 CA--C 1.528 0.857 0 CA-C-N 118.302 0.501 . . . . 63.219999999999999 113.468 -177.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -149.21 -63.39 0.23 Allowed 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 124.634 1.174 . . . . 72.540000000000006 108.048 -179.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -140.93 159.61 23.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 123.536 0.734 . . . . 74.450000000000003 109.306 -179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.7 101.89 11.37 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.761 -1.199 . . . . 75.299999999999997 107.761 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 40.3 tp -90.13 101.81 14.53 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.019 -0.991 . . . . 75.439999999999998 111.225 -172.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -85.37 131.24 34.43 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.602 -1.259 . . . . 42.549999999999997 107.602 178.029 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 78' ' ' GLN . . . -138.77 116.88 11.75 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.918 0.39 . . . . 72.349999999999994 110.538 178.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -86.2 135.79 33.44 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.812 -0.631 . . . . 74.549999999999997 109.801 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.16 76.9 1.42 Allowed 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.568 -1.271 . . . . 61.039999999999999 107.568 -177.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 175.31 147.1 0.08 Allowed 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.928 -0.767 . . . . 70.310000000000002 108.928 -179.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.1 p -109.58 -48.01 3.29 Favored 'General case' 0 CA--C 1.555 1.157 0 N-CA-C 112.962 0.727 . . . . 74.150000000000006 112.962 175.241 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.8 t -67.31 -33.94 76.33 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.642 0.734 . . . . 60.350000000000001 112.307 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.481 ' ND2' ' HA3' ' A' ' 91' ' ' GLY . 65.3 t30 -121.4 27.4 8.32 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 107.568 -1.271 . . . . 64.409999999999997 107.568 -173.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -46.41 143.01 4.87 Favored Glycine 0 C--O 1.25 1.147 0 CA-C-N 114.493 -1.231 . . . . 52.240000000000002 115.404 -175.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.2 m -84.53 151.23 24.71 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.003 0.906 . . . . 52.049999999999997 112.432 -176.014 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 89' ' ' ARG . 21.4 p -121.38 143.8 49.01 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 115.164 -0.925 . . . . 64.209999999999994 110.967 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.466 HG21 ' CD2' ' A' ' 80' ' ' TRP . 32.6 m -109.84 121.64 63.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 106.061 -1.829 . . . . 65.150000000000006 106.061 174.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 61.57 24.62 14.69 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.615 0.722 . . . . 72.219999999999999 109.302 -174.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.7 t30 76.5 10.26 2.91 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 126.326 1.85 . . . . 75.340000000000003 110.984 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.24 125.93 34.93 Favored Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 121.577 -0.702 . . . . 51.340000000000003 109.156 176.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.98 125.51 10.45 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 122.639 2.226 . . . . 72.349999999999994 114.124 -176.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.8 m -151.93 177.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 106.335 -1.728 . . . . 64.5 106.335 178.467 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 21.5 mt-30 -119.36 -37.08 3.23 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.195 0.521 . . . . 73.129999999999995 109.729 175.066 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.91 133.56 55.89 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.627 -0.715 . . . . 61.32 109.352 -178.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.466 ' CD2' HG21 ' A' ' 72' ' ' VAL . 76.8 t-105 -158.49 141.39 14.66 Favored 'General case' 0 CA--C 1.488 -1.429 0 CA-C-O 121.779 0.8 . . . . 74.530000000000001 111.115 -176.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -88.58 104.26 16.68 Favored 'General case' 0 C--N 1.272 -2.774 0 CA-C-N 113.735 -1.575 . . . . 61.140000000000001 107.088 173.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.6 mt -56.97 150.84 15.99 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.749 -0.66 . . . . 63.009999999999998 111.98 -179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.28 165.49 26.03 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.71 -0.848 . . . . 73.299999999999997 108.71 178.664 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.39 111.47 7.61 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.307 0.575 . . . . 73.019999999999996 110.207 179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.1 19.56 16.46 Favored Glycine 0 N--CA 1.424 -2.104 0 CA-C-N 115.604 -0.725 . . . . 64.540000000000006 111.901 -178.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -86.99 129.46 34.87 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.274 -1.38 . . . . 71.120000000000005 107.274 178.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.42 113.03 30.78 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.49 -0.93 . . . . 72.450000000000003 108.49 -178.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.453 ' HB ' ' CG2' ' A' ' 95' ' ' ILE . 42.3 mm -96.23 106.53 18.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.771 0 N-CA-C 106.04 -1.837 . . . . 72.299999999999997 106.04 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HB3' ' OG1' ' A' ' 71' ' ' THR . 24.8 ttt85 -103.19 106.28 16.76 Favored 'General case' 0 N--CA 1.405 -2.693 0 N-CA-C 107.556 -1.276 . . . . 71.230000000000004 107.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -106.95 163.93 12.56 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.706 -1.133 . . . . 71.299999999999997 109.433 -174.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.481 ' HA3' ' ND2' ' A' ' 68' ' ' ASN . . . -41.3 101.05 0.02 OUTLIER Glycine 0 C--N 1.309 -0.929 0 N-CA-C 115.924 1.129 . . . . 63.009999999999998 115.924 -175.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 36.2 m80 74.29 15.77 3.51 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 125.739 1.616 . . . . 70.099999999999994 113.463 176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.2 t -151.66 176.63 11.18 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 109.921 -0.399 . . . . 70.219999999999999 109.921 178.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -151.61 144.57 24.5 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.27 -1.011 . . . . 75.340000000000003 108.27 179.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.453 ' CG2' ' HB ' ' A' ' 88' ' ' ILE . 9.8 tp -140.4 140.56 34.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 108.826 -0.805 . . . . 71.5 108.826 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 52.5 mt -104.66 117.39 50.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 108.96 -0.755 . . . . 73.239999999999995 108.96 -178.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 78.8 t -84.24 122.23 37.63 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 110.369 -0.234 . . . . 64.239999999999995 110.369 179.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 -115.83 151.57 35.0 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.361 -0.607 . . . . 72.120000000000005 109.361 177.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 57.7 mtt -122.1 117.03 25.31 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 115.634 -0.712 . . . . 63.229999999999997 109.445 177.618 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 66.5 m-70 . . . . . 0 C--N 1.275 -2.66 0 N-CA-C 108.063 -1.088 . . . . 74.200000000000003 108.063 -178.579 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.574 0 N-CA-C 110.813 -0.915 . . . . 45.310000000000002 110.813 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -83.17 102.92 12.19 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.344 0.592 . . . . 53.539999999999999 109.815 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.14 43.61 0.02 OUTLIER Glycine 0 N--CA 1.427 -1.959 0 N-CA-C 109.217 -1.553 . . . . 62.439999999999998 109.217 -179.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.0 m -99.46 10.73 40.85 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.228 -0.486 . . . . 55.329999999999998 109.979 -176.046 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.05 85.33 0.14 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 125.011 1.324 . . . . 63.229999999999997 111.178 -179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -108.88 -163.32 20.42 Favored Glycine 0 N--CA 1.432 -1.585 0 N-CA-C 109.265 -1.534 . . . . 62.130000000000003 109.265 175.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m -57.83 116.22 3.33 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 117.38 0.59 . . . . 73.310000000000002 109.525 178.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -108.67 115.53 30.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 116.078 -0.51 . . . . 75.340000000000003 109.744 -177.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -99.25 110.5 26.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.766 -1.198 . . . . 72.409999999999997 107.766 177.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 26.2 m -112.53 120.8 42.86 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.687 -0.857 . . . . 72.530000000000001 108.687 -174.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.524 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -91.53 137.34 32.44 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.647 -0.501 . . . . 63.119999999999997 109.647 179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' ILE . 26.6 mt-30 -104.02 127.3 51.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.389 -1.337 . . . . 64.5 107.389 174.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 36.6 tp -124.6 135.22 52.94 Favored 'General case' 0 C--N 1.269 -2.892 0 O-C-N 123.399 0.437 . . . . 61.100000000000001 111.385 -173.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -84.61 100.33 11.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.732 -1.581 . . . . 73.030000000000001 106.732 173.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.4 ' CB ' ' HG2' ' A' ' 19' ' ' ARG . 16.8 t70 -104.36 1.69 30.49 Favored 'General case' 0 C--N 1.278 -2.512 0 CA-C-N 113.606 -1.633 . . . . 73.209999999999994 110.059 -176.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.5 -41.54 1.86 Allowed Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 108.584 -1.807 . . . . 64.239999999999995 108.584 -175.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 m -112.59 -63.92 1.37 Allowed 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 107.28 -1.378 . . . . 51.420000000000002 107.28 173.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.49 109.04 0.39 Allowed Glycine 0 N--CA 1.428 -1.875 0 N-CA-C 111.242 -0.743 . . . . 53.100000000000001 111.242 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.4 ' HG2' ' CB ' ' A' ' 15' ' ' ASP . 35.6 mmt180 -101.11 157.08 17.03 Favored 'General case' 0 CA--C 1.485 -1.526 0 N-CA-C 109.104 -0.702 . . . . 73.200000000000003 109.104 177.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 27.0 p -137.75 132.6 32.99 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.628 -1.249 . . . . 71.0 107.628 174.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -138.49 129.31 26.62 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.797 -0.816 . . . . 70.340000000000003 108.797 -173.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -87.46 120.94 29.27 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.679 -0.86 . . . . 72.329999999999998 108.679 177.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 67.3 mt -51.52 137.87 23.43 Favored 'General case' 0 CA--C 1.498 -1.05 0 O-C-N 124.355 1.034 . . . . 70.420000000000002 111.475 -178.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -85.12 144.7 28.05 Favored 'General case' 0 CA--C 1.479 -1.783 0 N-CA-C 108.9 -0.778 . . . . 73.420000000000002 108.9 -177.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.7 113.53 8.82 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.077 0.941 . . . . 71.400000000000006 109.947 178.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.58 -167.37 23.15 Favored Glycine 0 N--CA 1.414 -2.792 0 N-CA-C 106.573 -2.611 . . . . 74.319999999999993 106.573 -171.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 53' ' ' ARG . 58.1 p -106.46 127.76 53.54 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 118.981 1.39 . . . . 52.5 111.179 177.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -102.0 112.58 25.28 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.425 -0.807 . . . . 64.120000000000005 108.97 -179.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.34 120.73 37.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 115.255 -0.884 . . . . 73.230000000000004 109.443 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' PHE . 69.4 mt -99.99 130.62 48.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.238 -0.892 . . . . 64.049999999999997 109.194 -179.227 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 157.32 -161.34 31.17 Favored Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.713 -1.355 . . . . 73.030000000000001 109.713 178.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.725 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 60.6 mtp180 -129.76 105.23 7.89 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.056 -1.461 . . . . 74.430000000000007 107.056 173.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.34 -176.19 47.69 Favored Glycine 0 N--CA 1.425 -2.066 0 C-N-CA 120.944 -0.646 . . . . 64.219999999999999 111.615 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -63.23 -30.03 71.25 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 124.739 1.216 . . . . 75.319999999999993 113.177 -176.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.39 -6.61 37.11 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.822 0.344 . . . . 75.329999999999998 111.686 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.74 115.12 18.23 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.892 0.377 . . . . 74.340000000000003 111.992 -174.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.459 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 12.9 mm-40 -89.31 -29.44 19.16 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.478 -0.783 . . . . 72.230000000000004 109.434 177.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 85.4 t80 -115.18 108.95 17.29 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.259 -1.756 . . . . 75.230000000000004 106.259 173.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 59.5 mtt180 -99.13 120.63 39.82 Favored 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 115.035 -0.984 . . . . 74.329999999999998 110.375 -172.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 59.9 mt -73.05 138.32 79.23 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.886 -0.597 . . . . 70.340000000000003 110.557 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -84.35 1.67 8.56 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.41 2.074 . . . . 71.409999999999997 113.868 -177.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -102.85 163.63 12.1 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.308 -0.627 . . . . 54.229999999999997 109.308 -178.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.6 m -100.45 147.93 25.31 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-O 120.909 0.385 . . . . 55.210000000000001 110.455 -177.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.69 7.99 30.94 Favored Glycine 0 C--N 1.31 -0.875 0 N-CA-C 110.626 -0.99 . . . . 74.450000000000003 110.626 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG13 ' HD1' ' A' ' 49' ' ' HIS . 38.2 t -99.31 133.61 41.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.391 -0.966 . . . . 70.239999999999995 108.391 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 62.6 m -69.94 175.87 4.11 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.753 0.311 . . . . 52.109999999999999 111.388 178.425 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 5.2 ptp180 -65.27 -28.85 69.63 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.606 0.717 . . . . 65.510000000000005 111.299 178.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 43.1 mtp180 -135.59 119.16 16.99 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 104.579 -2.378 . . . . 74.25 104.579 169.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 68' ' ' ASN . 3.7 t60 -104.62 -45.16 4.69 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.96 -0.756 . . . . 75.019999999999996 108.96 -177.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 tt -163.29 154.25 16.64 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.279 -1.378 . . . . 75.109999999999999 107.279 -178.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -136.84 143.89 43.32 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.698 -0.482 . . . . 73.420000000000002 109.698 176.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.7 mt -112.42 115.26 49.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 108.562 -0.903 . . . . 74.209999999999994 108.562 177.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 47.3 ttt180 -93.0 107.25 19.07 Favored 'General case' 0 N--CA 1.411 -2.423 0 CA-C-O 121.305 0.574 . . . . 71.310000000000002 109.539 176.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -97.31 107.16 19.61 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 107.522 -1.288 . . . . 75.549999999999997 107.522 175.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -99.62 -173.18 2.4 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 105.18 -2.156 . . . . 71.150000000000006 105.18 178.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.58 4.75 85.12 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 118.797 -1.668 . . . . 72.430000000000007 111.969 -177.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -117.94 -61.31 1.7 Allowed 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.578 -0.311 . . . . 70.319999999999993 111.817 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.0 m -125.81 157.81 35.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-O 120.949 0.404 . . . . 74.099999999999994 111.414 -178.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.435 ' HB1' HD12 ' A' ' 82' ' ' LEU . . . -102.68 104.66 15.01 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.172 -1.047 . . . . 64.430000000000007 108.172 176.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 6.9 tt -91.25 118.34 30.4 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.737 -1.12 . . . . 60.439999999999998 110.077 -174.592 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.04 122.32 43.87 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 107.217 -1.401 . . . . 72.450000000000003 107.217 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.6 118.95 12.85 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 120.489 -0.485 . . . . 74.329999999999998 112.008 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.446 ' OD1' ' HB ' ' A' ' 70' ' ' THR . 0.8 OUTLIER -66.05 139.75 58.21 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.399 -0.963 . . . . 74.200000000000003 108.399 172.577 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.522 ' O ' ' HB2' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -126.82 75.4 1.56 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 105.858 -1.904 . . . . 63.539999999999999 105.858 178.736 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 64' ' ' LEU . 11.2 t-20 158.11 163.63 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 106.46 -1.681 . . . . 75.129999999999995 106.46 -178.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.9 m -108.04 -44.82 4.09 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 118.014 0.37 . . . . 60.25 111.711 176.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 m -73.99 -30.21 62.37 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-O 121.454 0.645 . . . . 74.340000000000003 111.649 -175.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.586 ' HB3' ' CE1' ' A' ' 49' ' ' HIS . 12.7 m120 -86.65 28.29 0.89 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 122.045 -0.409 . . . . 51.43 110.51 178.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.0 123.62 4.83 Favored Glycine 0 C--O 1.24 0.528 0 N-CA-C 116.116 1.206 . . . . 42.420000000000002 116.116 -174.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.446 ' HB ' ' OD1' ' A' ' 63' ' ' ASP . 88.0 m -91.77 151.04 20.79 Favored 'General case' 0 N--CA 1.411 -2.406 0 C-N-CA 124.733 1.213 . . . . 72.409999999999997 110.019 178.371 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 p -118.76 140.68 49.54 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 116.226 -0.443 . . . . 65.340000000000003 110.508 176.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.27 117.79 55.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.84 -1.17 . . . . 53.039999999999999 107.84 177.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 59.85 30.01 19.56 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.71 0.804 . . . . 72.030000000000001 110.325 -177.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.4 t30 79.79 1.41 2.14 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.948 1.699 . . . . 72.319999999999993 110.949 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -98.45 131.76 25.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 O-C-N 121.884 -0.51 . . . . 34.140000000000001 110.139 179.484 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.39 125.91 5.92 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.705 2.27 . . . . 74.519999999999996 112.469 179.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.01 -177.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 107.884 -1.154 . . . . 74.150000000000006 107.884 179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -124.11 -10.15 7.61 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.046 0.45 . . . . 64.510000000000005 110.112 171.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -153.41 135.24 14.57 Favored 'General case' 0 C--O 1.25 1.094 0 N-CA-C 109.6 -0.519 . . . . 73.420000000000002 109.6 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -151.73 151.93 32.06 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.748 -0.66 . . . . 74.310000000000002 109.916 -174.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -102.78 114.65 29.09 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.182 -1.044 . . . . 72.319999999999993 108.182 174.393 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.435 HD12 ' HB1' ' A' ' 59' ' ' ALA . 64.3 mt -59.5 143.74 49.18 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.87 0.692 . . . . 65.200000000000003 112.87 -176.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.3 166.57 23.47 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.255 -1.017 . . . . 74.530000000000001 108.255 171.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -70.78 115.7 10.23 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.133 -0.321 . . . . 73.329999999999998 110.133 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.14 0.87 26.8 Favored Glycine 0 N--CA 1.431 -1.697 0 C-N-CA 121.076 -0.583 . . . . 63.329999999999998 113.05 177.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -74.15 129.87 38.68 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 120.296 -0.562 . . . . 74.109999999999999 111.073 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.67 112.85 33.18 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.09 0 N-CA-C 108.009 -1.108 . . . . 64.439999999999998 108.009 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 64.7 mt -114.83 129.87 70.24 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.777 0 N-CA-C 109.736 -0.468 . . . . 73.010000000000005 109.736 -175.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -123.75 131.9 53.69 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 110.093 -0.336 . . . . 71.430000000000007 110.093 178.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.13 140.17 37.84 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.369 -1.345 . . . . 61.009999999999998 107.369 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 4.48 88.3 0.0 OUTLIER Glycine 0 N--CA 1.489 2.178 0 O-C-N 125.4 1.688 . . . . 73.209999999999994 116.482 -174.069 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.7 m80 80.68 -33.51 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 125.596 1.558 . . . . 73.420000000000002 114.367 177.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.0 t -101.1 162.27 13.01 Favored 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 120.268 -0.573 . . . . 64.409999999999997 110.918 -173.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.06 143.18 31.77 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.28 0.562 . . . . 63.200000000000003 110.116 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -140.16 138.11 37.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 CA-C-N 114.9 -1.046 . . . . 74.439999999999998 110.118 -173.563 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.9 mt -111.17 128.36 67.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 N-CA-C 108.936 -0.764 . . . . 74.209999999999994 108.936 177.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.416 HG11 ' HB3' ' A' ' 82' ' ' LEU . 63.9 t -89.18 129.26 40.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 N-CA-C 112.521 0.563 . . . . 75.230000000000004 112.521 -177.083 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 41.0 mmt180 -113.32 137.12 51.97 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.313 -0.995 . . . . 63.32 108.313 172.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 83.3 mtp -126.27 112.42 15.7 Favored 'General case' 0 C--N 1.283 -2.299 0 N-CA-C 109.464 -0.569 . . . . 54.439999999999998 109.464 178.809 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 . . . . . 0 C--N 1.275 -2.654 0 N-CA-C 108.255 -1.017 . . . . 73.340000000000003 108.255 -178.631 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.22 0 N-CA-C 110.47 -1.052 . . . . 64.319999999999993 110.47 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -84.85 98.76 10.49 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-O 121.374 0.607 . . . . 73.5 111.149 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.04 128.23 1.65 Allowed Glycine 0 N--CA 1.416 -2.654 0 N-CA-C 109.154 -1.579 . . . . 62.140000000000001 109.154 178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.0 m -77.97 -28.1 49.3 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.621 0.724 . . . . 70.439999999999998 109.604 179.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.41 119.76 29.19 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.815 -1.18 . . . . 71.230000000000004 107.815 177.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.49 69.61 3.25 Favored Glycine 0 CA--C 1.501 -0.829 0 N-CA-C 110.641 -0.984 . . . . 62.43 110.641 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 83.5 m -141.75 117.63 10.51 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 109.487 -0.56 . . . . 74.129999999999995 109.487 -177.152 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 99' ' ' MET . 16.5 m -105.16 114.59 28.88 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 108.433 -0.951 . . . . 72.439999999999998 108.433 176.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -99.61 114.14 36.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 107.525 -1.287 . . . . 74.549999999999997 107.525 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.5 m -124.18 123.77 41.0 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 108.891 -0.781 . . . . 70.319999999999993 108.891 -176.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 0.4 OUTLIER -102.99 128.23 49.91 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.71 -0.677 . . . . 64.510000000000005 109.311 178.871 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -105.57 132.7 51.39 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.387 -0.824 . . . . 65.340000000000003 110.424 -175.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.7 tp -121.5 111.55 17.4 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 115.378 -0.828 . . . . 65.409999999999997 109.321 -177.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -127.23 100.79 6.22 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.916 0.865 . . . . 54.329999999999998 109.735 177.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -115.05 19.53 15.67 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 107.555 -1.276 . . . . 71.299999999999997 107.555 174.795 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.75 16.82 12.0 Favored Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 109.666 -1.373 . . . . 61.109999999999999 109.666 -171.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.5 p -117.36 -68.32 0.93 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.317 0.58 . . . . 71.430000000000007 110.542 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.66 53.31 1.56 Allowed Glycine 0 N--CA 1.428 -1.84 0 N-CA-C 110.919 -0.872 . . . . 64.109999999999999 110.919 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -100.08 156.76 17.0 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 120.852 0.358 . . . . 51.310000000000002 111.121 -179.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.2 p -132.34 143.98 50.24 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.777 -0.823 . . . . 73.219999999999999 108.777 178.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -135.48 134.16 39.25 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.392 -1.336 . . . . 74.200000000000003 107.392 175.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -110.06 135.07 51.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.846 -0.798 . . . . 53.450000000000003 108.846 179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD22 HD21 ' A' ' 28' ' ' ASN . 83.5 mt -72.85 128.23 34.9 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.529 -0.76 . . . . 73.340000000000003 111.65 -176.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -104.5 153.2 21.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 104.456 -2.424 . . . . 72.420000000000002 104.456 172.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.02 143.95 55.84 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.12 0.962 . . . . 72.340000000000003 113.336 -173.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.12 177.37 16.5 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 107.648 -2.181 . . . . 75.219999999999999 107.648 -174.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 29.8 t -100.09 125.17 46.15 Favored 'General case' 0 C--N 1.275 -2.637 0 C-N-CA 119.479 -0.888 . . . . 72.329999999999998 108.854 176.033 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.42 HD21 HD22 ' A' ' 23' ' ' LEU . 3.4 p30 -108.07 120.57 42.7 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-N 114.942 -1.026 . . . . 74.420000000000002 110.319 -177.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.4 mt -86.05 127.81 39.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-N 114.889 -1.051 . . . . 74.010000000000005 110.539 -177.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.602 HG23 HD21 ' A' ' 40' ' ' LEU . 55.4 mt -103.27 119.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 125.321 1.448 . . . . 65.209999999999994 108.329 -179.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.597 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 167.46 -151.75 19.64 Favored Glycine 0 CA--C 1.503 -0.711 0 N-CA-C 111.416 -0.674 . . . . 51.130000000000003 111.416 -179.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 82.9 mtm180 -131.8 105.03 7.22 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 117.769 0.784 . . . . 74.099999999999994 109.519 176.376 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 175.84 -163.8 33.6 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.314 -0.946 . . . . 55.109999999999999 111.215 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -86.96 -34.16 19.4 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.931 -0.766 . . . . 75.049999999999997 108.931 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -67.79 -33.48 74.89 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.385 -0.825 . . . . 65.230000000000004 109.585 178.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.03 129.19 39.08 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 114.833 -1.076 . . . . 71.019999999999996 110.779 -178.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -90.72 -26.67 19.41 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.544 -1.28 . . . . 74.040000000000006 107.544 178.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -119.63 116.17 25.46 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 114.218 -1.356 . . . . 71.530000000000001 107.411 178.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -101.58 117.34 34.7 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.974 -0.557 . . . . 65.200000000000003 111.218 -175.806 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.602 HD21 HG23 ' A' ' 30' ' ' ILE . 4.0 mm? -78.1 125.24 85.49 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 115.666 -0.697 . . . . 74.540000000000006 110.732 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 9.0 Cg_exo -74.6 2.6 6.22 Favored 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 122.416 2.077 . . . . 63.439999999999998 113.658 178.159 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -104.85 -173.38 2.29 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.093 -1.077 . . . . 75.329999999999998 108.093 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -124.78 167.12 15.04 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.68 -0.859 . . . . 75.450000000000003 108.68 179.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 97.01 -3.48 62.27 Favored Glycine 0 CA--C 1.508 -0.396 0 N-CA-C 108.818 -1.713 . . . . 64.120000000000005 108.818 -174.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 p -112.75 131.41 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 CA-C-N 113.168 -1.516 . . . . 75.010000000000005 107.458 179.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.4 m -93.41 -177.57 4.47 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.503 -0.317 . . . . 72.25 111.81 -175.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 17.8 ptm180 -63.79 -36.03 82.55 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.516 0.674 . . . . 71.430000000000007 111.913 -177.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -133.17 99.4 4.54 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 105.481 -2.044 . . . . 62.229999999999997 105.481 175.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -104.37 -46.42 4.4 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.978 -1.01 . . . . 61.200000000000003 109.546 -176.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.6 tt -153.49 159.75 42.36 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.069 -1.086 . . . . 64.150000000000006 108.069 -176.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.0 149.68 40.34 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 109.177 -0.675 . . . . 63.229999999999997 109.177 176.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 27' ' ' SER . 68.3 mt -118.74 115.43 48.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 N-CA-C 108.828 -0.804 . . . . 71.430000000000007 108.828 175.152 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -91.55 107.42 19.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 107.344 -1.354 . . . . 73.129999999999995 107.344 179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 57.3 t-105 -115.43 132.36 56.64 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.789 -0.641 . . . . 71.329999999999998 111.305 -177.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -143.0 169.39 17.65 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 105.627 -1.99 . . . . 53.439999999999998 105.627 173.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.71 65.67 1.77 Allowed Glycine 0 C--N 1.31 -0.899 0 C-N-CA 120.8 -0.714 . . . . 75.519999999999996 112.07 178.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -155.89 -73.47 0.11 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.249 1.02 . . . . 63.210000000000001 108.443 -179.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.95 159.22 16.02 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 123.66 0.784 . . . . 63.020000000000003 109.332 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -103.85 104.69 14.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.193 -0.669 . . . . 70.040000000000006 109.193 178.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 tt -91.28 114.07 26.5 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.204 -0.907 . . . . 71.230000000000004 109.788 -176.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -93.75 122.51 36.29 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 106.896 -1.52 . . . . 74.439999999999998 106.896 179.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.78 124.47 18.33 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.71 -0.396 . . . . 72.219999999999999 110.568 179.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.512 ' OD2' ' HB ' ' A' ' 70' ' ' THR . 12.9 m-20 -72.45 143.98 48.27 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.466 -0.939 . . . . 61.299999999999997 108.466 174.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.5 tp -121.98 75.72 1.24 Allowed 'General case' 0 C--N 1.282 -2.367 0 N-CA-C 107.874 -1.158 . . . . 72.230000000000004 107.874 -178.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 165.87 153.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 104.939 -2.245 . . . . 73.319999999999993 104.939 -178.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -97.2 -33.66 11.4 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 119.798 -0.761 . . . . 74.010000000000005 112.387 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 t -89.1 -28.95 19.75 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 120.758 -0.377 . . . . 65.340000000000003 111.351 -176.804 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -88.63 27.38 1.3 Allowed 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 122.568 0.347 . . . . 71.219999999999999 111.882 -179.275 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.82 129.38 47.08 Favored Glycine 0 C--O 1.247 0.923 0 O-C-N 123.905 0.753 . . . . 43.43 112.001 -179.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' ' OD2' ' A' ' 63' ' ' ASP . 15.6 m -86.79 157.75 19.52 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 124.821 1.248 . . . . 74.349999999999994 113.053 -173.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 p -102.69 140.7 36.62 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.134 0.492 . . . . 74.519999999999996 110.732 178.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -128.05 120.57 53.96 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 107.672 -1.232 . . . . 73.310000000000002 107.672 177.247 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 59.29 32.02 21.61 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 123.694 0.798 . . . . 74.530000000000001 109.924 -176.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.7 t30 75.4 9.27 3.74 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 125.0 1.32 . . . . 71.109999999999999 110.953 179.006 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -104.66 122.9 41.99 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 109.488 -0.56 . . . . 60.43 109.488 177.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.33 125.35 11.23 Favored 'Trans proline' 0 C--O 1.24 0.617 0 C-N-CA 122.4 2.067 . . . . 62.119999999999997 111.913 178.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.28 -177.06 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 N-CA-C 108.635 -0.876 . . . . 53.329999999999998 108.635 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -126.61 -0.64 6.8 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 109.422 -0.584 . . . . 74.109999999999999 109.422 171.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -165.29 147.16 7.65 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 108.479 -0.934 . . . . 44.43 108.479 -177.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -166.95 151.84 7.39 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.508 -0.923 . . . . 75.319999999999993 108.508 -176.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -105.03 118.62 36.99 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 119.557 -0.857 . . . . 71.230000000000004 109.57 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 78.0 mt -61.62 150.23 36.91 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.644 -1.162 . . . . 73.299999999999997 113.717 -173.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -144.52 174.77 10.66 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.844 -1.071 . . . . 73.209999999999994 108.154 172.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -76.06 112.3 12.36 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.655 -0.498 . . . . 73.310000000000002 109.655 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.0 14.85 11.41 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 120.665 -0.778 . . . . 71.209999999999994 113.153 178.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -79.98 121.46 25.51 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 119.523 -0.871 . . . . 72.319999999999993 110.692 175.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.91 112.61 24.34 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.017 0 N-CA-C 106.743 -1.577 . . . . 62.299999999999997 106.743 175.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.425 ' HB ' HG23 ' A' ' 95' ' ' ILE . 57.8 mt -120.45 140.1 45.61 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.595 0 N-CA-C 109.388 -0.597 . . . . 63.229999999999997 109.388 -174.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.5 ttt85 -132.2 123.64 27.42 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 119.519 -0.872 . . . . 73.239999999999995 111.507 179.631 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.5 pt? -108.11 163.66 12.97 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.762 -1.57 . . . . 65.439999999999998 106.762 176.452 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.92 104.51 0.05 OUTLIER Glycine 0 CA--C 1.533 1.171 0 O-C-N 123.996 0.81 . . . . 72.019999999999996 114.403 -178.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 37.0 m80 80.32 -5.11 1.81 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.262 1.579 . . . . 73.140000000000001 115.262 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.4 m -138.17 136.51 36.72 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 118.995 0.816 . . . . 72.209999999999994 111.795 -177.668 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -107.56 138.44 43.77 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.226 -0.657 . . . . 64.099999999999994 109.226 175.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.497 ' CG1' ' HB2' ' A' ' 11' ' ' LEU . 5.4 tp -126.9 131.71 70.73 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.624 -0.88 . . . . 73.319999999999993 108.624 -175.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mp -106.5 119.42 55.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.654 -0.869 . . . . 72.310000000000002 108.654 179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG11 ' HB3' ' A' ' 82' ' ' LEU . 95.6 t -90.62 125.01 43.46 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-O 121.209 0.528 . . . . 65.25 111.35 -178.358 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.3 mmm-85 -119.76 149.42 42.05 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-N 115.401 -0.818 . . . . 74.209999999999994 109.728 178.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 8' ' ' SER . 59.4 mtt -129.6 110.47 11.84 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.624 0.726 . . . . 53.439999999999998 109.459 176.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 C--N 1.278 -2.535 0 CA-C-N 114.852 -1.067 . . . . 72.019999999999996 109.857 -176.53 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.762 0 N-CA-C 110.807 -0.917 . . . . 61.310000000000002 110.807 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -100.51 147.21 26.16 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 110.001 -0.37 . . . . 70.310000000000002 110.001 -179.448 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.55 -102.46 1.2 Allowed Glycine 0 C--N 1.302 -1.344 0 N-CA-C 109.156 -1.578 . . . . 72.219999999999999 109.156 176.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 15.7 m -105.7 -0.12 25.79 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.412 -0.588 . . . . 72.010000000000005 109.412 176.57 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.3 17.82 7.41 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.827 1.251 . . . . 62.109999999999999 111.96 179.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.07 -59.82 4.5 Favored Glycine 0 N--CA 1.442 -0.923 0 N-CA-C 110.346 -1.102 . . . . 63.229999999999997 110.346 -175.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 ' HA ' ' OXT' ' A' ' 100' ' ' HIS . 52.3 m -138.7 121.05 15.97 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 123.876 0.871 . . . . 72.25 109.514 177.021 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.0 m -113.0 128.53 56.52 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.104 -0.498 . . . . 51.450000000000003 109.756 176.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.2 p -103.35 124.72 57.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.031 -0.729 . . . . 75.430000000000007 109.031 177.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 18.4 m -126.16 134.82 51.18 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.303 -0.862 . . . . 71.420000000000002 109.559 -173.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 20' ' ' THR . 51.7 mt -93.89 135.12 35.55 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.277 -1.009 . . . . 73.209999999999994 108.277 178.213 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -114.83 126.62 55.04 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 109.762 -0.458 . . . . 65.439999999999998 109.762 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -123.61 114.85 20.56 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.381 -0.97 . . . . 72.120000000000005 108.381 -179.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -118.39 101.93 8.54 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-O 121.9 0.857 . . . . 63.530000000000001 111.608 -179.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -108.25 26.76 10.05 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.025 -1.843 . . . . 64.450000000000003 106.025 174.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.39 43.07 4.09 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 107.91 -2.076 . . . . 63.140000000000001 107.91 -173.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -147.73 -61.91 0.27 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.845 -0.677 . . . . 73.430000000000007 111.12 -172.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 90.88 39.8 5.73 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.002 -0.839 . . . . 74.209999999999994 111.002 -178.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -76.24 151.06 36.93 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 110.08 -0.341 . . . . 72.439999999999998 110.08 179.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 12.5 p -134.92 144.76 47.65 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-N 115.908 -0.587 . . . . 75.510000000000005 111.049 -177.818 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -129.65 116.1 18.34 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 109.341 -0.615 . . . . 55.200000000000003 109.341 178.295 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -80.44 131.93 35.66 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 109.688 -0.486 . . . . 75.120000000000005 109.688 177.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.513 HD13 HG21 ' A' ' 52' ' ' ILE . 93.7 mt -85.05 122.34 29.13 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.817 -1.179 . . . . 72.409999999999997 107.817 174.745 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -93.89 178.88 5.52 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.966 -0.694 . . . . 71.310000000000002 109.236 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.94 132.46 45.99 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.441 0.639 . . . . 72.239999999999995 111.153 -176.038 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.37 -159.67 16.94 Favored Glycine 0 N--CA 1.416 -2.682 0 N-CA-C 109.237 -1.545 . . . . 74.400000000000006 109.237 -176.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 24.7 p -106.6 144.61 33.01 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 120.371 -0.531 . . . . 60.030000000000001 109.625 177.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -121.89 112.05 17.84 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 108.134 -1.061 . . . . 43.32 108.134 -176.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.5 mm -86.2 130.56 36.37 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 109.399 -0.593 . . . . 71.340000000000003 109.399 -178.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' HB3' ' A' ' 38' ' ' PHE . 61.0 mt -115.69 135.79 54.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 C-N-CA 123.238 0.615 . . . . 75.310000000000002 110.319 -178.049 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 148.23 -163.69 28.94 Favored Glycine 0 N--CA 1.432 -1.63 0 N-CA-C 111.646 -0.582 . . . . 62.240000000000002 111.646 177.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.3 mtt180 -115.71 107.1 14.65 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.978 0.418 . . . . 74.439999999999998 110.114 176.205 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 177.62 -178.88 48.4 Favored Glycine 0 N--CA 1.411 -2.991 0 N-CA-C 109.425 -1.47 . . . . 44.420000000000002 109.425 179.05 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -83.52 -13.69 53.99 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.502 0.668 . . . . 74.430000000000007 109.699 179.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -83.57 -24.38 31.58 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 115.2 -0.909 . . . . 52.240000000000002 109.449 179.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.67 139.25 31.53 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.55 -0.75 . . . . 54.210000000000001 111.955 -173.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -92.58 -44.92 8.35 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.474 -0.785 . . . . 74.230000000000004 108.942 -179.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HB3' HG12 ' A' ' 30' ' ' ILE . 68.6 t80 -101.42 108.58 20.22 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.219 -1.03 . . . . 62.43 108.219 177.037 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 26.8 mtm-85 -96.19 127.39 42.16 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.865 -1.061 . . . . 74.209999999999994 108.464 -177.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 9.3 mp -80.14 149.75 70.17 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 112.006 0.373 . . . . 62.520000000000003 112.006 -178.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 40' ' ' LEU . 13.3 Cg_exo -71.69 -12.28 28.79 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.755 2.303 . . . . 43.25 112.342 177.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -107.56 165.05 11.7 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 112.6 0.593 . . . . 73.510000000000005 112.6 -175.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 18.3 m -102.1 162.56 12.82 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.917 -1.142 . . . . 73.140000000000001 107.917 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.99 -0.48 41.39 Favored Glycine 0 CA--C 1.495 -1.203 0 N-CA-C 109.458 -1.457 . . . . 50.119999999999997 109.458 -177.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.471 ' CG1' ' HA2' ' A' ' 31' ' ' GLY . 25.7 t -102.93 131.29 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 CA-C-N 113.921 -1.139 . . . . 43.109999999999999 108.614 -176.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.4 m -75.88 172.23 13.05 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.297 -0.41 . . . . 74.25 111.565 -178.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 1.4 ptm180 -64.65 -42.2 95.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 121.384 0.611 . . . . 64.239999999999995 110.819 177.403 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 80.4 mtt180 -123.64 93.69 4.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 104.791 -2.3 . . . . 72.209999999999994 104.791 171.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.587 ' HE2' ' HB2' ' A' ' 90' ' ' LEU . 22.6 t60 -96.26 -30.61 13.36 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 115.182 -0.917 . . . . 74.420000000000002 109.524 -174.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 tt -163.5 146.99 10.35 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 109.321 -0.622 . . . . 64.25 109.321 -178.194 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -130.04 123.38 30.36 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 121.382 0.611 . . . . 71.230000000000004 111.257 -179.776 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.513 HG21 HD13 ' A' ' 23' ' ' LEU . 69.1 mt -104.26 119.18 52.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.826 -0.625 . . . . 74.549999999999997 109.696 177.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -100.71 114.52 28.34 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 108.516 -0.92 . . . . 72.340000000000003 108.516 177.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -113.76 134.46 54.75 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.697 0.76 . . . . 73.140000000000001 112.164 -175.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -148.18 164.71 33.1 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 103.758 -2.682 . . . . 63.310000000000002 103.758 174.144 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -71.14 58.23 1.08 Allowed Glycine 0 CA--C 1.536 1.404 0 CA-C-N 118.893 0.77 . . . . 64.209999999999994 113.005 179.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -135.58 -78.41 0.43 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.203 -1.406 . . . . 75.209999999999994 107.203 178.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.5 m -149.41 159.37 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 105.705 -1.961 . . . . 73.25 105.705 179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.428 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -95.58 113.12 24.74 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 109.171 -0.677 . . . . 54.25 109.171 178.092 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.5 tp -83.72 106.74 15.66 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 115.052 -0.976 . . . . 62.130000000000003 110.335 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 80' ' ' TRP . 2.6 tm? -94.99 111.44 23.24 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.519 1.128 . . . . 72.019999999999996 108.246 -177.163 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.06 121.43 38.85 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 110.168 -0.308 . . . . 75.319999999999993 110.168 177.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -82.93 136.6 34.51 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.129 -0.693 . . . . 65.439999999999998 109.129 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.72 76.05 1.54 Allowed 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.356 -1.72 . . . . 72.109999999999999 106.356 -177.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.573 ' ND2' ' HB2' ' A' ' 68' ' ' ASN . 30.4 t-20 174.55 141.91 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.055 -1.091 . . . . 75.25 108.055 -178.063 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.6 p -108.35 -53.12 2.67 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 120.91 0.386 . . . . 72.049999999999997 111.095 177.615 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.0 m -66.46 -37.32 84.87 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.83 0.852 . . . . 54.43 112.089 -175.785 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.573 ' HB2' ' ND2' ' A' ' 65' ' ' ASN . 25.9 m-80 -115.9 27.2 9.44 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.681 -1.229 . . . . 72.129999999999995 107.681 -178.254 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -49.26 152.06 3.31 Favored Glycine 0 C--O 1.243 0.709 0 CA-C-N 114.279 -1.328 . . . . 73.120000000000005 115.624 -174.477 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.6 m -87.95 147.3 25.11 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 123.675 0.79 . . . . 43.43 112.17 -176.53 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 p -118.03 146.67 43.89 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 124.183 0.993 . . . . 60.399999999999999 110.637 178.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.8 m -121.96 127.25 75.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.019 -1.475 . . . . 52.509999999999998 107.019 176.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.04 26.95 12.58 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 124.052 0.941 . . . . 63.240000000000002 111.933 -178.484 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 73.91 22.48 2.43 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.798 1.239 . . . . 72.209999999999994 110.272 -179.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . . . -122.97 134.2 24.93 Favored Pre-proline 0 C--N 1.319 -0.761 0 CA-C-N 115.338 -0.846 . . . . 53.119999999999997 108.904 176.111 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' ALA . 6.1 Cg_exo -78.42 137.41 14.82 Favored 'Trans proline' 0 C--O 1.245 0.853 0 C-N-CA 122.043 1.828 . . . . 63.539999999999999 111.856 179.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.4 m -148.1 170.42 3.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.091 -1.077 . . . . 72.340000000000003 108.091 179.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -102.71 -31.6 10.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.647 -0.501 . . . . 70.340000000000003 109.647 172.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.07 145.38 25.45 Favored 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 120.901 0.382 . . . . 65.209999999999994 110.091 178.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.41 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 63.4 t-105 -150.99 152.5 33.62 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.392 -0.966 . . . . 74.450000000000003 108.392 -173.816 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.95 124.22 49.12 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 107.549 -1.278 . . . . 61.210000000000001 107.549 174.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 42.3 mt -56.22 151.02 13.24 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 113.804 1.039 . . . . 73.099999999999994 113.804 -173.171 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.44 43.04 Favored 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.217 -1.401 . . . . 44.149999999999999 107.217 178.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.61 115.67 9.13 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.12 0.486 . . . . 73.010000000000005 110.843 -179.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.42 10.06 45.6 Favored Glycine 0 N--CA 1.429 -1.805 0 C-N-CA 120.852 -0.689 . . . . 62.25 112.741 178.517 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.38 144.45 32.69 Favored 'General case' 0 C--O 1.252 1.201 0 C-N-CA 119.27 -0.972 . . . . 72.099999999999994 108.937 178.336 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 57.9 t -102.06 112.54 35.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 108.196 -1.039 . . . . 61.130000000000003 108.196 -178.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.7 mt -110.81 127.89 67.58 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 C-N-CA 120.093 -0.643 . . . . 71.109999999999999 109.744 -177.13 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -121.32 119.46 32.25 Favored 'General case' 0 N--CA 1.418 -2.031 0 N-CA-C 109.568 -0.53 . . . . 75.349999999999994 109.568 179.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.587 ' HB2' ' HE2' ' A' ' 49' ' ' HIS . 1.5 pt? -114.32 137.92 51.18 Favored 'General case' 0 C--N 1.281 -2.385 0 N-CA-C 106.349 -1.723 . . . . 64.349999999999994 106.349 177.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 5.31 86.17 0.01 OUTLIER Glycine 0 N--CA 1.495 2.614 0 O-C-N 124.785 1.303 . . . . 60.420000000000002 115.638 -166.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 55.12 16.79 1.7 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 115.974 1.842 . . . . 73.439999999999998 115.974 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 20.2 m -123.8 128.01 48.91 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.117 -0.697 . . . . 60.43 109.117 177.705 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -110.57 139.25 46.0 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 113.149 0.796 . . . . 73.400000000000006 113.149 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.0 tp -127.39 142.33 43.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 107.407 -1.331 . . . . 74.299999999999997 107.407 -177.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.9 133.46 51.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 108.662 -0.866 . . . . 72.430000000000007 108.662 179.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG11 ' HB3' ' A' ' 82' ' ' LEU . 81.4 t -100.72 126.18 54.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-O 120.836 0.351 . . . . 62.020000000000003 111.668 -178.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.0 mmt180 -119.79 138.2 53.5 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.009 -0.542 . . . . 75.150000000000006 109.807 174.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.1 mtp -124.11 113.73 18.75 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.345 -0.613 . . . . 73.329999999999998 109.345 177.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.465 ' OXT' ' HA ' ' A' ' 7' ' ' THR . 56.6 m-70 . . . . . 0 C--N 1.28 -2.42 0 N-CA-C 108.295 -1.002 . . . . 62.140000000000001 108.295 -178.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.227 0 N-CA-C 110.226 -1.15 . . . . 60.009999999999998 110.226 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -153.73 176.78 11.72 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.319 -0.993 . . . . 71.150000000000006 108.319 179.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.64 62.18 3.55 Favored Glycine 0 C--N 1.317 -0.502 0 N-CA-C 111.203 -0.759 . . . . 62.0 111.203 178.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.6 m -56.61 133.3 53.56 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.582 1.153 . . . . 63.32 111.789 -177.509 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -143.16 80.23 1.67 Allowed 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 115.105 -0.952 . . . . 70.409999999999997 108.888 177.623 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.06 -35.95 5.9 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 108.717 -1.753 . . . . 72.540000000000006 108.717 175.435 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.6 m -146.8 115.84 6.92 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.539 -0.911 . . . . 63.420000000000002 108.539 174.209 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.5 m -124.46 115.19 20.51 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.51 -1.293 . . . . 72.329999999999998 107.51 176.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.6 t -88.31 131.07 36.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 108.279 -1.008 . . . . 74.299999999999997 108.279 -177.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.534 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 37.9 m -137.61 132.81 33.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 115.502 -0.772 . . . . 74.430000000000007 108.922 -174.637 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.431 HD13 HD11 ' A' ' 95' ' ' ILE . 4.4 pp -93.23 136.75 33.2 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 120.216 -0.594 . . . . 60.450000000000003 109.649 177.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -109.04 129.52 55.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.732 -0.667 . . . . 74.340000000000003 111.476 -175.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 tp -119.8 136.15 54.58 Favored 'General case' 0 C--N 1.277 -2.582 0 CA-C-N 114.13 -1.396 . . . . 73.310000000000002 108.158 -177.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.79 98.91 11.7 Favored 'General case' 0 CA--C 1.467 -2.222 0 CA-C-O 122.574 1.178 . . . . 63.149999999999999 107.976 178.395 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.554 ' HB3' ' HG2' ' A' ' 19' ' ' ARG . 15.8 t70 -133.8 92.97 3.04 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 113.18 -1.827 . . . . 64.200000000000003 108.093 178.546 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.63 -61.54 4.12 Favored Glycine 0 C--N 1.292 -1.877 0 CA-C-N 114.565 -1.198 . . . . 54.140000000000001 110.634 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 p -135.73 -37.72 0.74 Allowed 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 114.609 -0.796 . . . . 71.400000000000006 109.792 177.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.9 120.07 1.06 Allowed Glycine 0 N--CA 1.41 -3.05 0 N-CA-C 110.444 -1.063 . . . . 62.32 110.444 -178.158 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HG2' ' HB3' ' A' ' 15' ' ' ASP . 29.4 mmt180 -105.73 154.25 20.74 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.303 -1.369 . . . . 75.340000000000003 107.303 175.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.534 ' HB ' ' CG2' ' A' ' 10' ' ' THR . 62.8 p -138.04 133.8 33.99 Favored 'General case' 0 C--N 1.283 -2.291 0 O-C-N 123.312 0.382 . . . . 70.239999999999995 110.685 179.066 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . 55.9 t80 -117.85 114.48 23.31 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.752 -1.203 . . . . 74.010000000000005 107.752 174.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -77.18 135.72 38.53 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.13 -1.063 . . . . 64.549999999999997 108.13 179.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 90.3 mt -73.45 129.45 38.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.028 0.442 . . . . 72.340000000000003 110.034 -179.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -79.58 151.83 30.42 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.2 -1.407 . . . . 73.319999999999993 107.2 176.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 25' ' ' GLU . 4.6 pt-20 -75.25 113.35 12.51 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 122.274 1.035 . . . . 70.450000000000003 111.697 -178.775 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.13 -166.48 26.0 Favored Glycine 0 N--CA 1.426 -1.982 0 N-CA-C 106.367 -2.693 . . . . 72.420000000000002 106.367 -172.301 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.457 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 97.3 p -97.42 119.49 36.05 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 119.622 1.711 . . . . 70.329999999999998 111.078 177.571 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 27.2 m-80 -88.03 108.46 19.24 Favored 'General case' 0 CA--C 1.486 -1.518 0 N-CA-C 106.998 -1.482 . . . . 74.010000000000005 106.998 -178.804 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.409 HG21 ' HG2' ' A' ' 48' ' ' ARG . 57.3 mt -91.21 116.78 33.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.275 0 CA-C-N 115.278 -0.874 . . . . 74.540000000000006 109.225 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.0 mt -99.34 128.49 51.01 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.339 0 C-N-CA 123.484 0.714 . . . . 64.010000000000005 110.143 -177.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 157.86 -155.68 26.65 Favored Glycine 0 CA--C 1.487 -1.661 0 CA-C-N 115.274 -0.875 . . . . 54.039999999999999 111.057 176.692 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -128.69 105.91 8.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.501 0.667 . . . . 64.340000000000003 111.349 176.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.07 166.52 33.56 Favored Glycine 0 N--CA 1.414 -2.78 0 N-CA-C 108.92 -1.672 . . . . 65.420000000000002 108.92 176.424 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -74.88 -16.9 60.65 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 117.82 0.81 . . . . 73.239999999999995 109.283 176.497 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.98 -10.72 59.8 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.291 -0.868 . . . . 73.239999999999995 109.734 178.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -93.16 169.51 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.995 -0.548 . . . . 74.430000000000007 110.404 178.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -109.56 -47.39 3.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.447 0.641 . . . . 71.310000000000002 109.965 178.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -108.21 127.22 53.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.215 -0.902 . . . . 64.420000000000002 108.8 -177.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 9.9 tpt180 -95.23 127.28 41.16 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.048 -0.723 . . . . 74.129999999999995 109.048 -174.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.495 HD12 HG21 ' A' ' 45' ' ' VAL . 38.1 mt -83.47 150.01 59.13 Favored Pre-proline 0 C--N 1.32 -0.702 0 C-N-CA 120.675 -0.41 . . . . 73.340000000000003 110.318 175.137 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -95.03 34.39 0.17 Allowed 'Trans proline' 0 C--O 1.244 0.799 0 C-N-CA 123.37 2.713 . . . . 75.040000000000006 112.325 179.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -138.6 179.75 6.29 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.13 -0.628 . . . . 63.420000000000002 110.004 -178.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.1 m -112.67 162.41 15.75 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.696 -0.853 . . . . 64.299999999999997 108.696 -176.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.08 -20.77 48.86 Favored Glycine 0 CA--C 1.5 -0.862 0 C-N-CA 121.021 -0.609 . . . . 51.329999999999998 111.938 176.936 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG21 HD12 ' A' ' 40' ' ' LEU . 9.9 p -79.29 142.55 13.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.228 -0.486 . . . . 75.329999999999998 111.097 -178.099 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.1 m -80.13 -170.5 2.52 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.8 0.84 . . . . 55.509999999999998 109.317 178.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -77.8 -47.46 18.87 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 119.141 -1.024 . . . . 73.150000000000006 109.403 175.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.409 ' HG2' HG21 ' A' ' 29' ' ' ILE . 54.5 mtt180 -109.43 109.32 20.13 Favored 'General case' 0 CA--C 1.475 -1.912 0 N-CA-C 107.528 -1.286 . . . . 75.420000000000002 107.528 171.319 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -104.36 -45.28 4.71 Favored 'General case' 0 C--N 1.273 -2.725 0 N-CA-C 107.664 -1.235 . . . . 75.25 107.664 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 62' ' ' ALA . 5.8 tt -159.25 151.96 21.71 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 114.845 -1.07 . . . . 72.540000000000006 108.215 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HG2' HD21 ' A' ' 64' ' ' LEU . 14.5 pt-20 -136.96 140.77 42.45 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.757 -0.831 . . . . 75.430000000000007 108.757 175.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.8 mt -106.83 115.86 49.29 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 107.782 -1.192 . . . . 75.0 107.782 176.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HB3' ' A' ' 60' ' ' LEU . 48.1 mtt180 -90.32 107.07 18.91 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 106.79 -1.559 . . . . 64.299999999999997 106.79 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -112.06 115.59 29.14 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.845 -1.07 . . . . 74.310000000000002 109.967 -176.279 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -120.01 160.46 22.74 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 106.107 -1.812 . . . . 64.200000000000003 106.107 177.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.14 54.07 2.25 Favored Glycine 0 C--N 1.311 -0.822 0 CA-C-N 118.078 0.399 . . . . 73.349999999999994 113.295 -178.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -156.27 -63.23 0.11 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.466 -0.939 . . . . 64.409999999999997 108.466 179.234 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 m -137.6 159.41 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 122.868 0.467 . . . . 64.439999999999998 110.833 -178.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.03 110.92 22.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.071 -0.513 . . . . 74.019999999999996 110.139 179.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 53' ' ' ARG . 4.9 tt -100.74 118.04 36.04 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.746 -0.835 . . . . 54.200000000000003 108.746 -177.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' A' ' 79' ' ' GLU . 2.8 tm? -94.75 123.58 38.29 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.686 -1.227 . . . . 54.310000000000002 107.686 179.083 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.5 ' O ' ' HG ' ' A' ' 50' ' ' LEU . . . -128.89 124.74 36.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.066 0.46 . . . . 64.420000000000002 111.306 -178.958 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -91.29 138.44 31.58 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 123.644 0.778 . . . . 44.539999999999999 109.892 179.085 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD21 ' HG2' ' A' ' 51' ' ' GLU . 2.7 mm? -127.0 76.53 1.66 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.732 -0.47 . . . . 74.319999999999993 109.732 177.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -175.52 142.45 0.57 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.748 -0.464 . . . . 71.329999999999998 109.748 176.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.6 p -96.32 -46.96 6.2 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.409 -0.516 . . . . 64.109999999999999 110.832 179.563 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 t -80.14 -36.85 34.61 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.034 -0.53 . . . . 61.32 111.937 -176.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -103.89 28.49 6.63 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 122.23 -0.294 . . . . 71.409999999999997 110.873 -176.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -44.07 125.67 5.76 Favored Glycine 0 C--N 1.341 0.83 0 O-C-N 124.561 1.163 . . . . 61.030000000000001 113.943 -178.003 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.3 m -75.68 147.61 39.29 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 124.282 1.033 . . . . 55.399999999999999 112.505 -175.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.403 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 3.2 p -112.4 140.89 46.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 115.454 -0.794 . . . . 64.409999999999997 110.747 176.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.68 119.53 58.31 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 N-CA-C 107.79 -1.189 . . . . 73.340000000000003 107.79 177.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 55.26 36.26 26.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.388 0.613 . . . . 72.239999999999995 110.189 -176.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 65.1 t30 80.09 -2.92 1.99 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 126.029 1.731 . . . . 75.540000000000006 111.783 176.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.74 123.03 49.15 Favored Pre-proline 0 C--N 1.32 -0.692 0 O-C-N 121.524 -0.735 . . . . 75.230000000000004 110.77 -179.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.55 125.47 10.12 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.653 2.235 . . . . 75.239999999999995 110.885 177.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 80' ' ' TRP . 35.7 m -142.57 173.93 6.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 109.73 -0.47 . . . . 72.209999999999994 109.73 -177.432 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.1 -30.99 8.12 Favored 'General case' 0 N--CA 1.433 -1.325 0 CA-C-N 115.739 -0.664 . . . . 62.020000000000003 109.567 172.758 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 61' ' ' LEU . 13.2 pt-20 -145.53 146.55 31.47 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.041 0.448 . . . . 74.209999999999994 110.88 173.773 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.401 ' HB2' HG21 ' A' ' 77' ' ' VAL . 34.0 t-105 -154.9 152.17 29.43 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.739 -1.208 . . . . 72.420000000000002 107.739 -173.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -105.97 116.33 31.75 Favored 'General case' 0 C--N 1.29 -2.011 0 C-N-CA 118.864 -1.134 . . . . 74.340000000000003 110.059 174.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.488 HD22 HG21 ' A' ' 97' ' ' VAL . 74.2 mt -56.65 148.01 21.09 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.328 -1.305 . . . . 75.510000000000005 113.735 -174.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -136.1 160.78 37.6 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 107.425 -1.324 . . . . 60.310000000000002 107.425 170.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 98' ' ' ARG . 21.3 t70 -71.26 120.93 17.55 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.105 0.479 . . . . 62.039999999999999 110.48 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.63 11.07 33.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 115.251 -0.886 . . . . 71.120000000000005 112.158 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -74.15 134.98 42.84 Favored 'General case' 0 C--O 1.246 0.899 0 CA-C-N 117.277 0.538 . . . . 64.450000000000003 111.362 177.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 38.8 t -97.31 112.79 30.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 108.151 -1.055 . . . . 75.510000000000005 108.151 179.612 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.0 mt -118.14 125.59 74.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.338 0 C-N-CA 119.801 -0.76 . . . . 74.25 110.54 -176.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.473 ' HG2' ' HB3' ' A' ' 94' ' ' GLU . 59.3 mtt-85 -111.58 115.29 28.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 111.112 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.47 165.5 13.15 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.974 -1.012 . . . . 61.310000000000002 109.109 177.517 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -41.06 100.41 0.01 OUTLIER Glycine 0 N--CA 1.475 1.236 0 O-C-N 123.972 0.795 . . . . 42.43 114.765 -176.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 31.3 m170 65.53 10.79 6.93 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.584 1.554 . . . . 73.049999999999997 113.184 178.504 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 60.6 m -138.58 118.02 12.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.065 0.46 . . . . 71.409999999999997 111.447 179.702 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HB3' ' HG2' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.15 142.1 33.09 Favored 'General case' 0 C--N 1.287 -2.13 0 C-N-CA 120.744 -0.382 . . . . 75.109999999999999 110.01 172.662 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.431 HD11 HD13 ' A' ' 11' ' ' LEU . 7.9 tp -139.09 148.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 109.779 -0.452 . . . . 75.530000000000001 109.779 -172.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 47.2 mm -112.15 131.19 64.28 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.128 -1.064 . . . . 64.200000000000003 108.128 176.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 82' ' ' LEU . 85.9 t -87.33 128.55 39.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 CA-C-O 120.801 0.334 . . . . 70.430000000000007 110.239 179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.411 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -125.01 151.32 45.71 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 109.129 -0.693 . . . . 75.150000000000006 109.129 -179.759 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 64.7 mtt -129.76 130.35 45.28 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.943 -0.571 . . . . 63.009999999999998 110.357 176.805 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 . . . . . 0 C--N 1.286 -2.153 0 N-CA-C 106.168 -1.79 . . . . 74.349999999999994 106.168 175.18 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.721 0 N-CA-C 111.65 -0.58 . . . . 71.099999999999994 111.65 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -80.9 86.45 6.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.032 -0.729 . . . . 63.219999999999999 109.032 177.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.38 -141.89 15.86 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 110.064 -1.215 . . . . 73.519999999999996 110.064 -176.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.7 t 55.38 -126.82 2.18 Favored 'General case' 0 C--O 1.248 1.021 0 C-N-CA 124.059 0.944 . . . . 63.140000000000001 109.807 178.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 69.28 -40.67 0.46 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.891 1.677 . . . . 74.310000000000002 112.875 178.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 145.15 -57.07 0.53 Allowed Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 106.928 -2.469 . . . . 54.420000000000002 106.928 -178.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 93.0 m -107.33 115.98 31.12 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 108.739 -0.838 . . . . 75.120000000000005 108.739 175.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.6 m -103.82 119.93 39.93 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.843 -1.54 . . . . 70.230000000000004 106.843 176.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 23' ' ' LEU . 3.5 p -107.51 124.36 63.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 CA-C-O 121.615 0.722 . . . . 75.420000000000002 111.256 -176.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 22' ' ' GLN . 22.4 m -124.83 134.97 52.54 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 107.603 -1.258 . . . . 71.430000000000007 107.603 -175.635 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.471 ' HB2' ' CG1' ' A' ' 95' ' ' ILE . 4.3 pp -100.55 143.78 30.31 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 120.566 -0.454 . . . . 65.439999999999998 110.812 -178.502 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HG2' HG22 ' A' ' 20' ' ' THR . 46.9 mt-30 -110.73 127.37 55.3 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 107.979 -1.119 . . . . 70.219999999999999 107.979 174.506 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.8 pp -125.49 145.97 49.85 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.644 0.735 . . . . 73.25 110.724 -174.884 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -94.41 101.56 13.49 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.063 -0.971 . . . . 60.130000000000003 110.251 -178.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -101.1 -32.5 10.55 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.603 -1.18 . . . . 74.150000000000006 109.605 -179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.73 -34.38 3.62 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 107.725 -2.15 . . . . 71.010000000000005 107.725 -171.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 m -87.91 -41.53 13.12 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 107.898 -1.149 . . . . 74.25 107.898 176.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 105.02 94.13 2.34 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 109.618 -1.393 . . . . 73.099999999999994 109.618 -177.23 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HA ' ' HD3' ' A' ' 19' ' ' ARG . 22.2 mmt180 -120.09 154.91 34.0 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.924 0.712 . . . . 74.129999999999995 112.924 -178.168 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.545 HG22 ' HG2' ' A' ' 12' ' ' GLN . 34.5 p -133.55 153.09 51.93 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.383 -1.28 . . . . 71.329999999999998 108.161 179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.443 ' O ' ' HG ' ' A' ' 11' ' ' LEU . 59.9 t80 -153.48 131.51 11.79 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.898 -1.149 . . . . 74.420000000000002 107.898 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 34.5 tt0 -93.75 141.25 28.71 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.356 -0.938 . . . . 74.439999999999998 110.649 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.454 ' HB2' HG13 ' A' ' 9' ' ' VAL . 91.4 mt -78.16 126.14 30.37 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.026 -0.534 . . . . 75.340000000000003 110.486 -178.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -82.79 152.87 25.5 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.317 -1.364 . . . . 65.120000000000005 107.317 178.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -76.42 120.66 21.96 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.988 0.899 . . . . 74.329999999999998 109.737 176.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.18 -167.89 24.25 Favored Glycine 0 N--CA 1.41 -3.089 0 N-CA-C 105.548 -3.021 . . . . 40.009999999999998 105.548 -171.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.0 p -106.83 143.39 35.0 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 118.738 1.269 . . . . 72.420000000000002 110.694 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -125.56 145.26 50.2 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 108.701 -0.851 . . . . 73.150000000000006 108.701 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -121.83 131.9 72.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 109.61 -0.515 . . . . 64.319999999999993 109.61 -177.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 38' ' ' PHE . 80.1 mt -107.84 131.65 57.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 124.399 1.08 . . . . 60.310000000000002 109.779 -179.255 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.598 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 149.73 -157.95 27.45 Favored Glycine 0 CA--C 1.485 -1.819 0 N-CA-C 110.06 -1.216 . . . . 73.340000000000003 110.06 177.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 43.6 mtm180 -130.49 106.68 8.68 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 117.52 0.66 . . . . 72.310000000000002 109.997 174.741 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -174.82 -164.66 29.96 Favored Glycine 0 N--CA 1.419 -2.492 0 N-CA-C 110.019 -1.232 . . . . 71.219999999999999 110.019 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -80.68 -39.3 27.45 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.135 0.493 . . . . 65.540000000000006 110.431 -178.082 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 49.9 m-20 -80.0 -21.07 44.04 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 72.230000000000004 110.288 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.68 124.47 23.73 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.781 -0.645 . . . . 54.340000000000003 110.996 -178.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -99.15 -44.88 6.1 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.916 0.865 . . . . 65.239999999999995 108.803 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.424 ' HB3' HG12 ' A' ' 30' ' ' ILE . 60.3 t80 -100.27 122.55 43.25 Favored 'General case' 0 N--CA 1.426 -1.674 0 N-CA-C 106.743 -1.577 . . . . 75.109999999999999 106.743 178.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.598 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 17.8 mtp180 -98.14 134.82 40.67 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 112.754 0.65 . . . . 64.230000000000004 112.754 -174.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 41' ' ' PRO . 38.9 mt -97.62 114.21 64.59 Favored Pre-proline 0 N--CA 1.42 -1.95 0 N-CA-C 107.477 -1.305 . . . . 71.450000000000003 107.477 169.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.521 ' HD2' ' NE2' ' A' ' 92' ' ' HIS . 16.2 Cg_exo -70.06 20.21 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.242 0 C-N-CA 123.725 2.95 . . . . 74.299999999999997 113.907 -176.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -97.75 178.27 5.2 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.557 -0.534 . . . . 65.540000000000006 109.557 -176.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 m -115.59 133.05 56.41 Favored 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 109.399 -0.593 . . . . 71.310000000000002 109.399 -177.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.1 -2.85 35.27 Favored Glycine 0 N--CA 1.438 -1.18 0 N-CA-C 110.433 -1.067 . . . . 42.0 110.433 -178.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.7 t -76.98 138.89 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 107.961 -1.126 . . . . 73.219999999999999 107.961 -179.435 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -83.76 166.4 18.05 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 116.668 -0.242 . . . . 64.400000000000006 111.145 -177.5 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 35.2 ptt180 -62.99 -36.66 84.3 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.8 0.81 . . . . 74.349999999999994 109.899 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -129.26 100.67 5.68 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 102.545 -3.132 . . . . 73.099999999999994 102.545 171.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -99.26 -37.29 9.33 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 115.781 -0.645 . . . . 72.129999999999995 109.328 -174.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 tt -161.29 147.15 14.21 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.032 -1.469 . . . . 74.010000000000005 107.032 178.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -144.33 142.72 30.58 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-O 121.328 0.585 . . . . 73.349999999999994 110.971 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -119.58 128.2 75.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 115.262 -0.881 . . . . 41.409999999999997 109.523 -177.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.415 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 36.1 ttt180 -107.38 111.76 24.25 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.157 -1.423 . . . . 63.25 107.157 177.332 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 58.7 t-105 -115.19 130.93 57.05 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 121.293 0.568 . . . . 74.349999999999994 111.054 -178.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -149.07 -174.03 4.53 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 106.74 -1.578 . . . . 74.010000000000005 106.74 173.414 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -77.11 2.59 60.56 Favored Glycine 0 C--N 1.313 -0.736 0 C-N-CA 119.961 -1.114 . . . . 35.149999999999999 114.704 -173.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.453 ' HG2' HG13 ' A' ' 58' ' ' VAL . 61.6 tt0 -93.51 -75.24 0.5 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.167 0.484 . . . . 75.099999999999994 111.123 177.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.453 HG13 ' HG2' ' A' ' 57' ' ' GLN . 16.0 m -135.75 159.35 39.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 C-N-CA 122.529 0.332 . . . . 64.439999999999998 110.6 -176.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -96.33 102.24 13.99 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.915 -1.143 . . . . 74.019999999999996 107.915 175.459 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 53' ' ' ARG . 52.6 tp -93.67 113.41 25.48 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 115.357 -0.838 . . . . 73.439999999999998 111.093 -174.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -102.64 129.41 49.22 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.127 -1.064 . . . . 55.119999999999997 108.127 -179.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.27 125.71 28.28 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.863 0.363 . . . . 71.129999999999995 110.893 177.079 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.74 128.78 35.31 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.615 -1.254 . . . . 72.120000000000005 107.615 175.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 65' ' ' ASN . 0.6 OUTLIER -124.37 78.27 1.64 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.932 -0.766 . . . . 65.430000000000007 108.932 -174.331 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 64' ' ' LEU . 8.0 p30 175.52 161.92 0.28 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 110.029 -0.36 . . . . 73.510000000000005 110.029 177.054 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 26.9 m -108.97 -12.02 14.91 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.238 0.542 . . . . 75.25 111.369 176.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.5 m -79.17 -55.47 5.08 Favored 'General case' 0 CA--C 1.556 1.194 0 N-CA-C 113.411 0.893 . . . . 75.420000000000002 113.411 -172.894 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -121.92 30.1 6.79 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 124.759 1.224 . . . . 75.129999999999995 110.1 -169.195 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.77 115.67 0.87 Allowed Glycine 0 C--O 1.251 1.192 0 O-C-N 124.861 1.351 . . . . 73.430000000000007 113.322 -172.179 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 m -61.07 139.04 58.17 Favored 'General case' 0 N--CA 1.425 -1.722 0 C-N-CA 125.751 1.621 . . . . 64.0 113.302 -172.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 p -102.65 142.18 34.25 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 114.955 -1.021 . . . . 64.329999999999998 110.927 178.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.62 118.55 56.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 107.448 -1.316 . . . . 62.100000000000001 107.448 175.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 60.88 32.95 20.07 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 124.332 1.053 . . . . 71.049999999999997 110.997 -177.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 62.7 t30 78.02 16.5 1.36 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.904 1.682 . . . . 63.549999999999997 112.031 174.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -128.57 134.77 26.65 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.19 -0.67 . . . . 63.329999999999998 109.19 175.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.14 140.83 25.53 Favored 'Trans proline' 0 C--O 1.239 0.532 0 C-N-CA 122.414 2.076 . . . . 74.400000000000006 112.834 -178.581 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 26.8 m -144.26 174.48 3.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.865 -0.791 . . . . 74.109999999999999 108.865 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -96.26 -47.29 6.09 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.405 -0.961 . . . . 74.340000000000003 108.405 173.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -142.26 150.74 41.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.849 -0.614 . . . . 73.329999999999998 110.68 -179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -152.2 151.23 30.74 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.303 -0.629 . . . . 54.539999999999999 109.303 -173.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -98.25 113.94 26.04 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.62 -0.882 . . . . 71.439999999999998 108.62 173.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 65.9 mt -60.51 131.84 52.02 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.758 -0.655 . . . . 72.099999999999994 112.251 -176.845 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.41 154.29 42.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.775 -1.194 . . . . 74.219999999999999 107.775 172.201 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -62.63 123.21 17.78 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.188 -0.46 . . . . 71.049999999999997 110.264 179.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.88 6.14 56.22 Favored Glycine 0 C--N 1.308 -1.021 0 C-N-CA 120.602 -0.809 . . . . 53.149999999999999 113.02 -179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -81.48 137.46 35.61 Favored 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 120.111 -0.636 . . . . 63.0 111.065 176.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.05 113.02 34.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.609 0 CA-C-N 115.581 -0.736 . . . . 70.230000000000004 109.264 -178.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.504 ' HB ' HG23 ' A' ' 95' ' ' ILE . 73.2 mt -112.15 141.35 27.92 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.127 0 N-CA-C 108.201 -1.037 . . . . 63.130000000000003 108.201 -177.436 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -140.27 126.07 19.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.728 -0.789 . . . . 75.349999999999994 112.85 -177.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.22 144.45 48.44 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 106.959 -1.497 . . . . 71.230000000000004 106.959 175.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.22 88.25 0.02 OUTLIER Glycine 0 C--O 1.239 0.458 0 N-CA-C 115.862 1.105 . . . . 24.199999999999999 115.862 -174.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.521 ' NE2' ' HD2' ' A' ' 41' ' ' PRO . 84.2 t60 162.35 -47.88 0.0 OUTLIER 'General case' 0 C--O 1.243 0.762 0 C-N-CA 127.139 2.175 . . . . 74.319999999999993 107.04 176.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 68.8 m -149.27 134.78 18.53 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 114.845 -1.07 . . . . 74.010000000000005 111.541 -175.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -92.53 141.92 27.97 Favored 'General case' 0 N--CA 1.418 -2.071 0 N-CA-C 106.22 -1.77 . . . . 52.100000000000001 106.22 169.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -132.91 136.15 56.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-O 121.035 0.445 . . . . 65.25 111.317 -172.113 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.4 mt -114.94 129.53 70.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 N-CA-C 108.772 -0.825 . . . . 60.109999999999999 108.772 177.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.0 t -80.11 127.96 38.95 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-N 115.908 -0.587 . . . . 74.439999999999998 111.648 -178.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -119.59 134.29 55.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 115.806 -0.634 . . . . 73.129999999999995 109.882 178.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 65.2 mtt -119.02 133.96 55.49 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 116.006 -0.543 . . . . 75.010000000000005 110.451 177.953 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 . . . . . 0 C--N 1.289 -2.06 0 N-CA-C 107.952 -1.129 . . . . 74.25 107.952 177.903 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.121 0 N-CA-C 110.062 -1.215 . . . . 54.240000000000002 110.062 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -102.61 146.38 28.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 107.952 -1.129 . . . . 74.150000000000006 107.952 175.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 108.77 123.85 4.88 Favored Glycine 0 C--N 1.288 -2.103 0 N-CA-C 109.852 -1.299 . . . . 41.32 109.852 -178.024 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 m -109.78 -2.32 17.4 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 110.561 -0.162 . . . . 54.130000000000003 110.561 -177.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.82 27.6 16.94 Favored 'General case' 0 C--O 1.243 0.735 0 CA-C-O 121.921 0.867 . . . . 54.43 109.143 -175.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.09 101.83 2.4 Favored Glycine 0 N--CA 1.417 -2.597 0 CA-C-N 114.472 -1.24 . . . . 72.409999999999997 112.632 -173.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.2 m -103.99 129.12 51.56 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.386 -1.709 . . . . 73.099999999999994 106.386 174.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.478 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 15.4 m -121.84 139.63 53.39 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.699 -0.801 . . . . 72.109999999999999 110.349 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.1 t -124.04 120.52 59.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 107.065 -1.458 . . . . 60.43 107.065 176.4 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.8 m -118.43 128.43 54.61 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 115.661 -0.7 . . . . 74.450000000000003 109.275 -173.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 20' ' ' THR . 4.5 pp -88.98 133.34 34.35 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 109.086 -0.709 . . . . 72.200000000000003 109.086 178.139 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -112.09 113.79 26.26 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 107.404 -1.332 . . . . 72.420000000000002 107.404 -176.469 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.0 tp -112.63 110.56 20.79 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.828 -0.623 . . . . 70.25 109.861 -178.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -110.59 107.89 17.65 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.55 0.69 . . . . 63.450000000000003 110.415 176.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -115.47 24.51 11.53 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.79 -1.559 . . . . 74.349999999999994 106.79 177.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.97 44.36 2.86 Favored Glycine 0 N--CA 1.432 -1.593 0 N-CA-C 108.345 -1.902 . . . . 41.509999999999998 108.345 -174.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 p -159.35 -70.76 0.08 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 121.424 0.631 . . . . 54.030000000000001 110.54 -175.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 104.65 73.29 0.91 Allowed Glycine 0 N--CA 1.428 -1.882 0 N-CA-C 109.988 -1.245 . . . . 53.329999999999998 109.988 -177.396 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -103.67 155.65 18.4 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.87 -0.419 . . . . 71.450000000000003 109.87 -179.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 20.5 p -141.46 136.0 30.84 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.239 0.542 . . . . 74.040000000000006 111.942 -177.07 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 11' ' ' LEU . 92.5 t80 -133.58 139.88 46.82 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.375 -1.343 . . . . 73.120000000000005 107.375 176.803 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.46 135.43 46.87 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 120.48 -0.488 . . . . 54.009999999999998 110.003 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 97.8 mt -63.78 145.88 54.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.582 -0.736 . . . . 71.349999999999994 112.834 -175.572 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -97.91 161.25 13.83 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.909 -1.145 . . . . 72.299999999999997 107.909 -179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 25' ' ' GLU . 0.4 OUTLIER -75.01 117.93 17.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.504 0.669 . . . . 72.400000000000006 110.645 -178.57 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.64 -169.72 16.66 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 109.022 -1.631 . . . . 73.109999999999999 109.022 -175.606 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 t -107.43 146.57 31.53 Favored 'General case' 0 C--N 1.279 -2.473 0 CA-C-O 121.794 0.807 . . . . 44.140000000000001 112.047 -179.336 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -122.01 129.92 52.86 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.072 -0.967 . . . . 74.120000000000005 109.01 177.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 36.4 mm -100.32 125.85 54.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.048 -1.093 . . . . 42.039999999999999 108.048 -178.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.7 mt -105.92 131.05 56.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 N-CA-C 109.334 -0.617 . . . . 75.010000000000005 109.334 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 150.72 -159.56 28.2 Favored Glycine 0 CA--C 1.488 -1.626 0 N-CA-C 110.255 -1.138 . . . . 53.420000000000002 110.255 177.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 71.6 mtt-85 -128.96 105.72 8.4 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 117.568 0.684 . . . . 53.140000000000001 109.613 176.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -179.11 -179.01 48.65 Favored Glycine 0 N--CA 1.427 -1.904 0 N-CA-C 110.194 -1.162 . . . . 75.219999999999999 110.194 -179.2 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -68.15 -22.36 64.86 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.476 0.711 . . . . 54.439999999999998 112.886 -176.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -97.74 -7.77 30.02 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 120.773 0.321 . . . . 73.200000000000003 110.509 -179.348 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.43 130.71 38.41 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.263 0.554 . . . . 75.549999999999997 111.591 -173.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -92.3 -49.17 6.3 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.124 -1.065 . . . . 65.150000000000006 108.124 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -112.46 125.95 54.78 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.972 -1.013 . . . . 73.549999999999997 108.665 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 10.1 mmt180 -99.01 134.52 41.73 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.714 -0.847 . . . . 63.340000000000003 108.714 -177.005 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.3 mt -81.88 141.5 47.6 Favored Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 109.197 -0.668 . . . . 72.340000000000003 109.197 174.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.07 -36.43 65.61 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.747 2.964 . . . . 71.030000000000001 114.181 -178.037 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -88.26 170.92 10.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 113.119 0.785 . . . . 74.239999999999995 113.119 -175.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.3 p -103.16 165.23 11.15 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.017 -0.992 . . . . 64.349999999999994 108.5 173.292 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.0 -23.25 34.21 Favored Glycine 0 CA--C 1.501 -0.8 0 N-CA-C 109.781 -1.328 . . . . 74.310000000000002 109.781 -177.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.1 136.36 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 CA-C-N 114.271 -0.965 . . . . 43.140000000000001 108.751 175.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.7 m -67.04 161.38 24.52 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.413 0.523 . . . . 75.230000000000004 112.413 -177.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 27.8 ptt180 -54.85 -40.54 69.74 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.967 0.889 . . . . 74.519999999999996 110.515 175.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -128.92 106.82 9.16 Favored 'General case' 0 N--CA 1.413 -2.315 0 N-CA-C 102.879 -3.008 . . . . 70.120000000000005 102.879 170.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -98.36 -39.4 8.82 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 109.091 -0.707 . . . . 51.140000000000001 109.091 -177.23 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.2 tt -162.36 150.32 14.33 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.756 -0.831 . . . . 74.239999999999995 108.756 -176.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -128.95 135.25 48.76 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.243 0.544 . . . . 74.409999999999997 110.011 178.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.54 120.96 62.46 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 107.093 -1.447 . . . . 74.219999999999999 107.093 174.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.4 ttm105 -111.65 111.74 22.95 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 121.069 0.461 . . . . 73.340000000000003 109.979 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -104.35 115.84 31.09 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.455 -0.793 . . . . 74.540000000000006 110.758 -178.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -117.81 171.6 7.94 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.217 -1.771 . . . . 74.420000000000002 106.217 177.757 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -79.79 53.35 4.31 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.973 -0.632 . . . . 64.200000000000003 112.98 -177.49 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -150.43 -78.41 0.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.508 1.123 . . . . 75.019999999999996 108.657 177.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.1 m -139.8 159.84 27.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.546 -0.909 . . . . 63.210000000000001 108.546 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.48 120.69 33.21 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.45 0.643 . . . . 45.420000000000002 110.556 -178.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.05 133.41 34.36 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.943 -1.026 . . . . 70.25 108.508 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -122.1 125.29 45.87 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.265 -1.013 . . . . 70.340000000000003 108.265 -178.041 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -132.22 135.8 46.56 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.607 0.241 . . . . 74.109999999999999 110.436 177.12 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -104.72 119.08 38.15 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 123.932 0.893 . . . . 65.010000000000005 110.011 -177.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -102.87 77.91 1.62 Allowed 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 106.036 -1.838 . . . . 74.430000000000007 106.036 179.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.509 HD21 ' C ' ' A' ' 68' ' ' ASN . 8.1 t30 -173.56 131.31 0.45 Allowed 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 116.055 -0.52 . . . . 63.409999999999997 110.16 -165.121 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -108.15 -43.33 4.41 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 113.073 0.768 . . . . 70.019999999999996 113.073 -178.275 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -88.62 -26.18 22.04 Favored 'General case' 0 CA--C 1.551 0.999 0 N-CA-C 113.631 0.974 . . . . 61.310000000000002 113.631 -170.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.509 ' C ' HD21 ' A' ' 65' ' ' ASN . 5.8 m-20 -115.59 30.12 7.56 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.199 -0.667 . . . . 74.340000000000003 109.199 -177.205 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -41.93 127.22 4.13 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 124.528 1.143 . . . . 40.149999999999999 114.503 -171.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.0 m -66.69 136.71 55.94 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.103 0.961 . . . . 74.540000000000006 112.756 -176.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 89' ' ' ARG . 17.8 p -107.58 140.46 40.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 115.581 -0.736 . . . . 64.549999999999997 110.688 178.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.456 HG21 ' CD2' ' A' ' 80' ' ' TRP . 27.9 m -117.4 117.27 54.61 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 107.627 -1.249 . . . . 74.349999999999994 107.627 177.006 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' A' ' 86' ' ' ASP . 5.5 m-80 57.76 31.07 19.94 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.594 -0.73 . . . . 74.010000000000005 110.775 -172.569 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 64.9 t30 80.44 3.03 1.86 Allowed 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 126.327 1.851 . . . . 70.420000000000002 111.777 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.26 118.9 65.19 Favored Pre-proline 0 C--N 1.319 -0.722 0 O-C-N 121.458 -0.776 . . . . 64.219999999999999 109.877 177.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.04 129.24 21.38 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.417 2.078 . . . . 73.209999999999994 111.772 179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.4 m -140.97 167.68 17.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 110.021 -0.363 . . . . 65.019999999999996 110.021 -178.675 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -109.14 -18.35 13.66 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.569 0.7 . . . . 62.420000000000002 109.289 172.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -151.61 155.15 37.82 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.194 -1.039 . . . . 65.230000000000004 108.194 174.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . 0.456 ' CD2' HG21 ' A' ' 72' ' ' VAL . 73.5 t-105 -159.87 151.92 20.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.015 -0.735 . . . . 74.140000000000001 109.015 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -103.74 111.56 24.12 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.507 -1.294 . . . . 64.040000000000006 107.507 174.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.507 ' HB3' HG11 ' A' ' 97' ' ' VAL . 64.9 mt -56.93 131.87 50.96 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 124.383 1.052 . . . . 61.130000000000003 112.636 -174.103 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -128.93 165.66 20.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.596 -0.89 . . . . 60.409999999999997 108.596 175.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -71.45 116.56 11.92 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.099 -0.704 . . . . 75.319999999999993 109.099 179.851 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.43 9.44 23.51 Favored Glycine 0 N--CA 1.435 -1.371 0 C-N-CA 120.871 -0.68 . . . . 44.210000000000001 112.906 179.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.563 ' HA ' ' ND2' ' A' ' 73' ' ' ASN . 49.2 m-20 -81.44 117.5 21.93 Favored 'General case' 0 CA--C 1.487 -1.478 0 C-N-CA 119.652 -0.819 . . . . 71.209999999999994 111.884 177.328 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.5 t -91.76 112.34 25.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 106.161 -1.792 . . . . 64.420000000000002 106.161 175.454 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.9 mt -112.03 124.39 68.7 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.092 0 CA-C-O 120.894 0.378 . . . . 51.32 110.458 -172.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.569 ' HB2' ' OG1' ' A' ' 71' ' ' THR . 2.3 mpt_? -109.55 120.37 42.29 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.226 -0.657 . . . . 72.420000000000002 109.226 177.653 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -124.55 164.16 20.38 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.172 -0.677 . . . . 74.219999999999999 109.172 -178.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -51.3 108.58 0.6 Allowed Glycine 0 C--N 1.316 -0.575 0 O-C-N 123.506 0.504 . . . . 63.340000000000003 112.959 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 72.75 16.07 4.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.562 1.545 . . . . 75.010000000000005 114.093 177.8 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.8 t -154.05 167.0 31.26 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 121.901 -0.499 . . . . 54.310000000000002 110.581 178.06 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.24 132.31 14.34 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.749 -0.834 . . . . 65.5 108.749 178.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.426 HD11 HD13 ' A' ' 11' ' ' LEU . 11.0 tp -141.21 146.25 23.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.981 -0.377 . . . . 74.310000000000002 109.981 -173.605 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 62.9 mt -113.52 135.27 53.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 108.043 -1.095 . . . . 74.219999999999999 108.043 175.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG11 ' HB3' ' A' ' 82' ' ' LEU . 78.0 t -98.42 130.97 46.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 112.18 0.437 . . . . 71.019999999999996 112.18 -178.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.2 mmm-85 -119.32 150.37 40.25 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.899 -0.778 . . . . 74.140000000000001 108.899 174.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.1 mtp -129.38 147.38 51.2 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.258 0.551 . . . . 65.230000000000004 111.314 -178.775 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 8' ' ' SER . 35.6 m-70 . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 106.693 -1.595 . . . . 64.340000000000003 106.693 178.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.968 0 N-CA-C 110.449 -1.06 . . . . 45.130000000000003 110.449 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -118.49 147.99 43.06 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.885 -0.783 . . . . 71.450000000000003 108.885 176.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.36 53.71 4.24 Favored Glycine 0 C--N 1.314 -0.667 0 O-C-N 123.399 0.437 . . . . 75.409999999999997 113.014 -177.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.8 m -88.61 137.64 32.14 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.413 -0.958 . . . . 72.430000000000007 108.413 178.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.15 95.13 9.05 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 120.915 0.388 . . . . 64.349999999999994 110.317 -178.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.55 -76.98 1.27 Allowed Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 109.166 -1.573 . . . . 45.43 109.166 176.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 100' ' ' HIS . 86.3 m -123.21 116.92 24.2 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.682 -1.229 . . . . 65.25 107.682 175.561 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.402 ' HB2' ' HB2' ' A' ' 100' ' ' HIS . 21.1 m -101.53 124.34 47.04 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 120.279 -0.569 . . . . 74.409999999999997 109.638 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.4 t -100.79 115.82 43.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 109.009 -0.737 . . . . 74.530000000000001 109.009 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -112.26 123.66 50.76 Favored 'General case' 0 N--CA 1.419 -1.998 0 N-CA-C 108.289 -1.004 . . . . 72.030000000000001 108.289 -178.816 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 95' ' ' ILE . 54.9 mt -94.43 128.85 41.25 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.777 -0.823 . . . . 63.539999999999999 108.777 -179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.64 110.48 21.19 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.894 -1.15 . . . . 71.5 107.894 -178.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 95' ' ' ILE . 56.3 tp -104.41 131.17 52.07 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 123.831 0.852 . . . . 73.230000000000004 110.669 -175.618 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' OE2' ' A' ' 94' ' ' GLU . 32.9 t70 -98.32 101.23 12.63 Favored 'General case' 0 N--CA 1.422 -1.85 0 CA-C-O 121.996 0.903 . . . . 52.439999999999998 109.728 175.246 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -102.43 -0.62 32.17 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-N 114.449 -1.25 . . . . 71.239999999999995 107.759 176.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 112.43 -21.57 19.15 Favored Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 114.56 -1.2 . . . . 64.349999999999994 110.527 -176.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.5 m -109.77 -45.56 3.63 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-O 121.306 0.574 . . . . 62.32 109.918 179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.56 102.42 2.36 Favored Glycine 0 N--CA 1.429 -1.829 0 N-CA-C 110.379 -1.089 . . . . 71.299999999999997 110.379 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.443 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 3.2 mmp_? -114.98 151.8 33.52 Favored 'General case' 0 CA--C 1.483 -1.598 0 N-CA-C 109.847 -0.427 . . . . 54.020000000000003 109.847 179.296 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' LEU . 33.3 p -135.04 142.37 46.34 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 116.165 -0.47 . . . . 63.43 110.86 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -140.83 133.94 29.4 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 107.471 -1.307 . . . . 72.5 107.471 177.482 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -102.51 136.97 41.38 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.898 -0.779 . . . . 53.420000000000002 108.898 179.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 11' ' ' LEU . 83.8 mt -74.77 133.48 41.96 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.195 -0.457 . . . . 70.129999999999995 110.745 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -101.04 164.42 11.81 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 107.486 -1.301 . . . . 72.0 107.486 176.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.31 125.15 24.69 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.193 0.52 . . . . 71.140000000000001 111.172 -179.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.63 -164.73 12.16 Favored Glycine 0 C--N 1.299 -1.504 0 N-CA-C 109.112 -1.595 . . . . 73.209999999999994 109.112 -176.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HG2' ' A' ' 53' ' ' ARG . 63.5 p -92.18 135.46 33.97 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 118.214 1.007 . . . . 73.310000000000002 111.588 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.406 ' HA ' ' OE1' ' A' ' 37' ' ' GLN . 27.1 m-80 -114.32 120.18 39.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.564 -1.643 . . . . 65.420000000000002 106.564 -178.799 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 56.2 mt -112.19 133.0 59.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 120.495 0.188 . . . . 72.319999999999993 111.063 -175.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.13 137.79 42.17 Favored 'Isoleucine or valine' 0 C--O 1.246 0.892 0 N-CA-C 109.181 -0.674 . . . . 65.109999999999999 109.181 179.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.716 ' O ' ' HA ' ' A' ' 39' ' ' ARG . . . 159.54 -151.7 22.52 Favored Glycine 0 CA--C 1.485 -1.792 0 N-CA-C 108.274 -1.93 . . . . 62.240000000000002 108.274 179.821 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 47' ' ' ARG . 45.9 mtm180 -138.1 106.21 5.73 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.361 -1.348 . . . . 71.409999999999997 107.361 172.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 176.14 -177.21 47.78 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.604 -1.398 . . . . 73.340000000000003 109.604 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -78.49 -18.72 54.41 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.101 0.45 . . . . 60.100000000000001 111.557 178.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -89.79 -6.47 55.91 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.046 0.451 . . . . 70.120000000000005 110.678 173.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.81 140.55 29.4 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 108.41 -0.959 . . . . 64.319999999999993 108.41 177.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 28' ' ' ASN . 70.3 mt-30 -102.04 -52.43 3.16 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.043 -1.095 . . . . 74.25 108.043 179.773 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -98.92 108.47 21.16 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.73 -1.581 . . . . 62.509999999999998 106.73 173.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.716 ' HA ' ' O ' ' A' ' 31' ' ' GLY . 19.8 ptt85 -97.21 129.46 44.55 Favored 'General case' 0 N--CA 1.41 -2.44 0 C-N-CA 119.907 -0.717 . . . . 62.43 110.69 -178.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.96 137.54 72.95 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.677 -0.692 . . . . 74.120000000000005 109.535 178.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -75.57 -5.21 16.27 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.588 2.192 . . . . 63.020000000000003 111.632 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -86.27 -173.78 4.72 Favored 'General case' 0 C--O 1.248 0.978 0 CA-C-N 116.014 -0.539 . . . . 62.340000000000003 111.264 -176.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.526 ' HA ' ' NH1' ' A' ' 32' ' ' ARG . 2.8 t -132.17 164.91 25.28 Favored 'General case' 0 N--CA 1.41 -2.462 0 N-CA-C 108.615 -0.883 . . . . 74.319999999999993 108.615 179.235 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.88 -29.41 12.53 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.253 -1.539 . . . . 71.400000000000006 109.253 -175.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.3 p -73.34 143.33 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 CA-C-N 114.086 -1.057 . . . . 62.200000000000003 109.899 178.085 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.2 m -87.64 -176.75 5.67 Favored 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 123.055 0.542 . . . . 62.140000000000001 110.307 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 20.5 ptt180 -67.18 -39.3 86.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.253 0.549 . . . . 64.030000000000001 110.588 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -127.2 114.28 17.46 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 106.102 -1.814 . . . . 75.430000000000007 106.102 174.331 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.52 ' NE2' ' HB2' ' A' ' 90' ' ' LEU . 67.7 t60 -104.13 -37.36 7.35 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-O 121.369 0.604 . . . . 74.5 109.74 179.145 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD11 HD21 ' A' ' 61' ' ' LEU . 7.9 tt -161.02 145.71 13.85 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 116.084 -0.507 . . . . 64.329999999999998 109.845 -176.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -131.39 139.68 49.51 Favored 'General case' 0 C--N 1.3 -1.543 0 CA-C-N 115.798 -0.637 . . . . 73.120000000000005 110.222 179.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 83.9 mt -121.75 116.74 50.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-N 115.455 -0.793 . . . . 73.439999999999998 109.268 178.214 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG2' ' HB3' ' A' ' 27' ' ' SER . 38.6 mtp-105 -91.44 107.77 19.43 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.803 -1.184 . . . . 63.020000000000003 107.803 176.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 50.8 t-105 -97.55 113.02 24.65 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 122.19 0.995 . . . . 74.010000000000005 112.766 -175.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -124.33 150.44 45.48 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.137 -1.801 . . . . 75.530000000000001 106.137 173.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -70.51 75.96 0.52 Allowed Glycine 0 C--N 1.307 -1.065 0 O-C-N 123.513 0.508 . . . . 64.430000000000007 113.834 -174.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -166.41 -68.29 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.148 -1.427 . . . . 72.310000000000002 107.148 179.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.9 m -149.06 150.86 13.58 Favored 'Isoleucine or valine' 0 C--O 1.248 1.008 0 N-CA-C 106.449 -1.686 . . . . 73.25 106.449 177.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 82' ' ' LEU . . . -90.9 126.39 36.04 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 120.26 -0.576 . . . . 74.409999999999997 109.849 -179.483 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 5.9 tt -83.11 107.52 15.74 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.118 -1.067 . . . . 70.200000000000003 108.118 -178.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.465 HD21 HD11 ' A' ' 50' ' ' LEU . 2.7 tm? -93.75 120.96 34.69 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.148 -1.056 . . . . 74.310000000000002 108.148 -179.101 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.0 119.57 23.38 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.246 0.546 . . . . 74.329999999999998 110.219 176.637 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -78.44 134.73 37.33 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.819 -0.808 . . . . 75.129999999999995 108.819 177.358 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.42 77.24 1.63 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.439 -1.319 . . . . 74.319999999999993 107.439 -177.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -170.52 163.76 8.4 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.39 -0.524 . . . . 73.25 109.946 179.304 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.3 p -108.13 -54.86 2.45 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.527 179.461 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.445 HG23 ' OD1' ' A' ' 68' ' ' ASN . 5.9 t -90.0 -24.05 21.33 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.411 0.624 . . . . 52.450000000000003 112.518 -175.554 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.445 ' OD1' HG23 ' A' ' 67' ' ' THR . 3.1 m-20 -105.54 22.77 14.92 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.727 -0.608 . . . . 62.310000000000002 110.066 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -45.0 118.83 2.9 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 124.442 1.089 . . . . 73.019999999999996 114.384 -175.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 m -65.54 138.46 58.07 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.824 1.25 . . . . 65.540000000000006 113.298 -176.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.43 140.86 38.68 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 108.132 -1.062 . . . . 71.329999999999998 108.132 -179.576 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.08 121.13 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 121.165 -0.959 . . . . 74.219999999999999 110.208 178.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 58.98 25.86 14.32 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.232 1.013 . . . . 72.140000000000001 110.586 -177.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 77.7 20.79 1.03 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 125.997 1.719 . . . . 63.409999999999997 112.63 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.81 125.9 26.9 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.661 -0.866 . . . . 64.010000000000005 108.661 176.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.19 128.14 11.88 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 122.692 2.261 . . . . 72.030000000000001 113.839 -175.401 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -146.51 179.45 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.332 -0.988 . . . . 70.040000000000006 108.332 -178.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -116.89 -32.34 5.13 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.744 -0.382 . . . . 73.430000000000007 110.209 172.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -129.36 149.81 50.99 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.238 -0.653 . . . . 75.209999999999994 109.238 177.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 75.4 t-105 -158.71 152.72 23.65 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.083 -0.71 . . . . 72.099999999999994 109.083 -177.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -105.54 109.66 21.71 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.485 -0.931 . . . . 61.009999999999998 108.485 176.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 60.4 mt -64.56 137.55 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 O-C-N 123.648 0.592 . . . . 74.349999999999994 112.346 -177.26 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -134.2 163.76 28.89 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.787 -1.56 . . . . 65.409999999999997 106.787 171.74 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.41 121.89 13.22 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 120.633 0.254 . . . . 74.109999999999999 110.786 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.73 -11.21 30.07 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.701 -0.761 . . . . 72.329999999999998 113.37 178.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -67.04 138.39 57.15 Favored 'General case' 0 C--O 1.247 0.958 0 N-CA-C 113.065 0.765 . . . . 74.120000000000005 113.065 -179.12 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 49.7 t -103.18 113.4 39.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.083 -0.962 . . . . 71.400000000000006 108.468 175.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 95' ' ' ILE . 3.0 mp -109.09 106.6 21.0 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.614 0 N-CA-C 107.548 -1.279 . . . . 72.540000000000006 107.548 179.222 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -100.33 106.76 18.42 Favored 'General case' 0 C--N 1.288 -2.082 0 N-CA-C 109.356 -0.609 . . . . 72.219999999999999 109.356 -176.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.52 ' HB2' ' NE2' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -82.38 160.52 22.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 107.219 -1.4 . . . . 72.340000000000003 107.219 176.488 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 92' ' ' HIS . . . -70.64 86.42 0.35 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 118.978 -1.582 . . . . 71.310000000000002 111.192 179.113 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 91' ' ' GLY . 61.1 t-80 163.61 -63.29 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.56 1.944 . . . . 74.030000000000001 108.765 177.515 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.8 m -143.47 174.98 10.28 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.066 -1.087 . . . . 71.540000000000006 108.066 -175.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' OE2' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -114.78 149.41 37.01 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.306 0.854 . . . . 73.209999999999994 113.306 177.159 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.49 HD11 ' HB3' ' A' ' 11' ' ' LEU . 6.9 tp -119.56 127.39 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 N-CA-C 107.711 -1.218 . . . . 63.520000000000003 107.711 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 67.5 mt -103.55 132.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 109.101 -0.703 . . . . 50.43 109.101 179.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 70.6 t -93.17 117.86 37.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-N 116.16 -0.473 . . . . 51.420000000000002 111.332 -178.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -116.69 130.9 57.01 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 108.257 -1.016 . . . . 74.319999999999993 108.257 175.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 59.5 mtt -114.43 128.59 56.42 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.496 0.665 . . . . 64.409999999999997 111.807 -178.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 7' ' ' THR . 44.6 m-70 . . . . . 0 C--N 1.293 -1.853 0 N-CA-C 107.38 -1.341 . . . . 74.409999999999997 107.38 178.13 . . . . . . . . 1 1 . 1 stop_ save_